data_2kuf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kuf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.9 0 CA-C-O 120.854 0.359 . . . . 75.340000000000003 111.382 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 21.8 p -134.84 147.96 50.04 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.231 -0.655 . . . . 73.230000000000004 109.231 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -148.26 143.94 27.31 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.844 -1.539 . . . . 73.530000000000001 106.844 -177.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.2 p-10 -88.93 137.88 31.92 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.028 -0.669 . . . . 70.140000000000001 109.414 178.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.9 pt -89.63 134.39 32.49 Favored Pre-proline 0 C--N 1.297 -1.691 0 CA-C-N 116.147 -0.479 . . . . 72.310000000000002 111.94 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -84.71 156.45 11.94 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.543 2.162 . . . . 74.219999999999999 110.051 171.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -88.54 121.22 30.68 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-O 122.401 1.096 . . . . 70.120000000000005 109.055 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 5.6 m -109.62 61.11 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.655 0 CA-C-N 113.999 -1.455 . . . . 72.540000000000006 109.378 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -105.73 109.95 22.08 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 112.462 -2.154 . . . . 75.530000000000001 109.426 174.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 152.57 -29.44 0.85 Allowed Glycine 0 C--N 1.305 -1.193 0 C-N-CA 119.561 -1.304 . . . . 61.409999999999997 113.124 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.408 ' O ' HG11 ' A' ' 534' ' ' VAL . 0.3 OUTLIER -107.81 -169.73 1.57 Allowed 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.856 -0.424 . . . . 70.120000000000005 109.856 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 9.7 m -70.57 155.46 40.7 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.409 -0.96 . . . . 72.120000000000005 108.409 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.1 p -60.95 -41.43 88.99 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.792 0 O-C-N 123.135 0.272 . . . . 64.239999999999995 110.915 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -59.85 -44.28 94.19 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 120.767 0.317 . . . . 73.219999999999999 110.534 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 46.3 t -69.18 -38.63 78.21 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.137 0 CA-C-N 115.529 -0.76 . . . . 75.319999999999993 109.548 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.431 ' CB ' HG12 ' A' ' 534' ' ' VAL . . . -63.68 -45.6 89.35 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.252 -0.431 . . . . 62.340000000000003 110.957 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.7 mt-30 -64.93 -41.34 95.61 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.935 -0.575 . . . . 73.019999999999996 110.552 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.495 ' O ' HG21 ' A' ' 514' ' ' VAL . 47.8 mmtm -66.11 -42.28 89.45 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 116.097 -0.501 . . . . 75.239999999999995 110.459 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -62.51 -44.89 95.25 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 116.289 -0.414 . . . . 75.540000000000006 111.493 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . 0.448 HD11 ' N ' ' A' ' 513' ' ' ASN . 3.9 pp -68.14 -35.24 77.77 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-O 121.132 0.492 . . . . 74.019999999999996 110.829 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.46 ' ND2' ' HA ' ' A' ' 517' ' ' PHE . 2.4 t-20 -59.8 -35.7 75.22 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 123.894 0.878 . . . . 73.530000000000001 109.938 176.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.495 HG21 ' O ' ' A' ' 510' ' ' LYS . 89.5 t -64.63 -33.65 64.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-O 121.251 0.548 . . . . 74.510000000000005 110.929 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -97.71 -0.78 44.85 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.463 -0.335 . . . . 70.140000000000001 110.451 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -134.96 -57.09 0.06 OUTLIER Glycine 0 CA--C 1.484 -1.868 0 C-N-CA 119.619 -1.277 . . . . 64.030000000000001 114.841 -169.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.46 ' HA ' ' ND2' ' A' ' 513' ' ' ASN . 97.6 m-85 69.24 20.56 7.45 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 122.143 0.973 . . . . 74.530000000000001 109.3 -171.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.5 p -79.37 -172.02 3.01 Favored 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 125.973 1.709 . . . . 65.450000000000003 110.65 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.0 142.09 38.66 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.758 -1.201 . . . . 75.25 107.758 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -133.14 147.9 52.1 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.142 0.496 . . . . 74.230000000000004 111.846 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 55.6 m -140.91 151.78 44.52 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.193 -1.04 . . . . 54.130000000000003 108.193 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -121.1 145.34 47.9 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 120.96 0.41 . . . . 74.430000000000007 111.683 -174.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -138.6 132.82 31.63 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.687 -0.857 . . . . 61.329999999999998 108.687 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 11.1 p -96.32 126.74 41.74 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 113.421 0.897 . . . . 74.140000000000001 113.421 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.1 p -121.18 150.85 24.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.076 -1.083 . . . . 74.439999999999998 108.076 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.98 136.14 45.09 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.493 -0.558 . . . . 75.310000000000002 109.493 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.512 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 39.4 m -159.51 168.14 12.8 Favored Pre-proline 0 C--N 1.301 -1.505 0 N-CA-C 108.117 -1.068 . . . . 65.319999999999993 108.117 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -71.75 -14.27 29.9 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.019 1.813 . . . . 64.140000000000001 111.853 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.12 140.81 95.96 Favored Pre-proline 0 C--O 1.219 -0.549 0 N-CA-C 109.297 -0.631 . . . . 75.299999999999997 109.297 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.41 146.86 86.49 Favored 'Trans proline' 0 C--O 1.252 1.213 0 C-N-CA 121.935 1.756 . . . . 73.0 111.236 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.16 113.57 1.78 Allowed 'General case' 0 C--O 1.242 0.678 0 CA-C-N 116.002 -0.544 . . . . 72.109999999999999 111.644 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 132.37 -22.9 4.12 Favored Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 115.4 -0.818 . . . . 65.209999999999994 111.551 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.01 139.49 33.25 Favored 'General case' 0 CA--C 1.493 -1.222 0 CA-C-O 121.018 0.437 . . . . 74.349999999999994 110.04 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.431 HG12 ' CB ' ' A' ' 508' ' ' ALA . 7.4 p -102.96 124.86 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.817 0 CA-C-O 121.884 0.849 . . . . 73.209999999999994 109.667 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.63 -4.93 59.24 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.697 -1.138 . . . . 65.439999999999998 112.635 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 141.53 -162.68 26.93 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 119.772 -1.204 . . . . 74.219999999999999 113.488 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 13.2 p -116.45 159.19 22.39 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 107.651 -1.24 . . . . 70.239999999999995 107.651 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -60.02 -53.59 63.69 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 119.103 -1.039 . . . . 71.049999999999997 112.36 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -82.21 140.73 11.19 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 121.266 1.311 . . . . 74.340000000000003 110.521 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.6 162.95 40.59 Favored 'Trans proline' 0 C--O 1.251 1.137 0 C-N-CA 122.999 2.466 . . . . 64.219999999999999 113.613 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.71 129.7 43.18 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.639 -0.71 . . . . 71.450000000000003 110.461 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.83 -5.44 34.66 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.778 -0.646 . . . . 74.420000000000002 111.536 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 99.7 m -77.1 121.02 22.99 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 122.64 -0.33 . . . . 73.140000000000001 110.238 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 4.0 t -80.3 124.1 28.55 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.887 -0.783 . . . . 74.109999999999999 108.887 176.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 32.6 m -126.45 160.07 59.91 Favored Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 107.658 -1.238 . . . . 75.230000000000004 107.658 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -63.97 138.62 63.56 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 120.942 1.095 . . . . 74.519999999999996 109.512 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.1 p -60.7 -19.86 20.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.518 0.675 . . . . 75.340000000000003 111.475 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -100.02 3.41 44.18 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.148 0.499 . . . . 62.149999999999999 110.694 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 97.4 p -83.88 171.78 12.74 Favored 'General case' 0 C--O 1.251 1.133 0 O-C-N 121.404 -0.81 . . . . 64.329999999999998 111.525 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.2 p -103.83 134.43 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 CA-C-N 115.268 -0.878 . . . . 64.329999999999998 110.394 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 55.8 mt -103.37 136.26 36.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.106 -1.072 . . . . 74.430000000000007 108.106 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.52 118.58 37.06 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.985 0.898 . . . . 65.129999999999995 111.52 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.6 118.89 32.41 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.839 -1.528 . . . . 64.5 109.786 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -86.28 102.54 14.06 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.813 0.816 . . . . 74.420000000000002 110.383 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 524' ' ' SER . 23.3 t -85.63 128.17 39.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 114.304 -1.316 . . . . 74.310000000000002 107.523 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 527' ' ' SER . 62.7 m -88.63 125.65 34.92 Favored 'General case' 0 N--CA 1.394 -3.25 0 CA-C-O 121.173 0.511 . . . . 72.439999999999998 110.823 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -101.64 134.21 45.13 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 107.275 -1.38 . . . . 75.420000000000002 107.275 173.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -63.29 -22.3 65.2 Favored Glycine 0 CA--C 1.493 -1.312 0 O-C-N 124.049 0.843 . . . . 75.430000000000007 112.365 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 79.55 2.88 2.21 Favored 'General case' 0 C--O 1.215 -0.725 0 C-N-CA 125.022 1.329 . . . . 73.409999999999997 108.674 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -113.09 150.23 32.37 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 114.998 -1.001 . . . . 73.340000000000003 112.363 -171.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -128.0 155.91 43.55 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.81 -1.181 . . . . 72.310000000000002 107.81 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 6.4 p -71.22 118.51 16.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 109.512 -0.551 . . . . 74.430000000000007 109.512 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 52.5 ttp -76.1 129.87 79.47 Favored Pre-proline 0 C--N 1.306 -1.322 0 C-N-CA 119.925 -0.71 . . . . 74.140000000000001 110.459 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.98 166.38 23.03 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.659 2.24 . . . . 61.509999999999998 111.27 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -81.03 131.85 35.33 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-O 121.368 0.604 . . . . 72.140000000000001 111.102 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.2 pp -159.82 20.3 0.17 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.58 -1.191 . . . . 74.319999999999993 110.196 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 8.3 t -79.88 147.51 31.68 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 109.11 -0.7 . . . . 74.5 109.11 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 74.84 69.16 1.43 Allowed Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 120.922 -0.656 . . . . 75.209999999999994 112.068 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -147.97 174.05 12.27 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.143 -1.058 . . . . 73.099999999999994 108.143 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -98.77 169.42 9.48 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.786 -1.561 . . . . 61.329999999999998 106.786 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -67.88 -31.67 71.63 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.94 -0.763 . . . . 73.25 108.94 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 30.3 m -78.16 -13.9 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-N 115.907 -0.588 . . . . 74.239999999999995 110.929 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.495 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 37.2 t70 -95.29 -34.19 12.27 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.402 -1.333 . . . . 72.530000000000001 107.402 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . 0.692 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -57.76 -53.55 56.91 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.529 -1.214 . . . . 72.299999999999997 111.856 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 38.0 mt-10 -51.23 -54.56 36.97 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 113.871 1.063 . . . . 72.0 113.871 -175.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -57.53 -38.3 94.36 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 121.515 1.477 . . . . 71.030000000000001 112.225 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 24.2 mmm-85 -65.08 -38.66 91.49 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.342 0.115 . . . . 72.409999999999997 110.967 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 25.7 mt -66.69 -47.93 70.86 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.947 -0.39 . . . . 71.120000000000005 109.947 -176.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 2.3 ptp180 -66.56 -34.93 78.99 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 112.558 0.577 . . . . 75.530000000000001 112.558 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.82 -34.27 77.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.249 0.547 . . . . 63.43 110.272 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 12.5 tp -82.05 -9.76 59.44 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.635 -0.711 . . . . 73.150000000000006 110.339 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 64.11 41.02 98.61 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.892 -0.594 . . . . 62.409999999999997 112.382 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . 0.438 ' CE3' HD22 ' A' ' 578' ' ' LEU . 18.2 t90 -78.55 127.24 31.87 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.919 0.39 . . . . 75.439999999999998 110.686 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 35.9 p -96.19 -22.2 17.42 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 112.988 0.736 . . . . 73.299999999999997 112.988 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -77.85 -173.09 40.16 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.353 -0.451 . . . . 75.310000000000002 113.995 -176.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 22.5 ttt -104.69 141.59 36.19 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 122.771 0.428 . . . . 62.420000000000002 110.871 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 33.9 tp -86.86 110.13 19.76 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.619 -0.882 . . . . 74.5 108.619 176.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 621' ' ' THR . 22.4 t70 -95.86 104.62 16.56 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.967 0.889 . . . . 65.430000000000007 110.26 -175.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -87.66 123.35 32.41 Favored 'General case' 0 N--CA 1.396 -3.171 0 CA-C-N 114.645 -1.161 . . . . 72.200000000000003 109.462 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -84.88 -100.04 0.66 Allowed Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.757 -0.937 . . . . 64.120000000000005 110.757 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -107.78 154.94 20.8 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 109.851 -0.426 . . . . 71.439999999999998 109.851 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -106.53 145.69 31.55 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.469 -0.937 . . . . 61.210000000000001 108.469 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 57.4 t -104.5 138.71 28.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.033 -0.729 . . . . 70.420000000000002 109.033 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . 0.406 ' HA ' ' CD ' ' A' ' 626' ' ' GLN . 3.8 p30 -73.06 124.72 26.07 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 121.388 0.613 . . . . 71.219999999999999 110.045 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -159.64 -62.07 0.07 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.724 -1.125 . . . . 70.019999999999996 108.493 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 105.77 153.24 20.92 Favored Glycine 0 N--CA 1.422 -2.264 0 C-N-CA 119.659 -1.258 . . . . 71.430000000000007 111.787 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.34 -32.2 60.36 Favored Glycine 0 C--N 1.311 -0.851 0 C-N-CA 123.511 0.577 . . . . 52.420000000000002 113.643 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 4.9 p -72.67 -25.04 61.12 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-O 121.965 0.888 . . . . 62.130000000000003 110.383 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -95.09 -0.91 53.07 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.937 -1.029 . . . . 65.400000000000006 109.495 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 39.8 m80 74.06 99.51 0.07 Allowed 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 125.051 1.34 . . . . 72.140000000000001 112.148 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -80.3 83.32 6.17 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.382 -0.827 . . . . 71.209999999999994 110.99 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -108.17 160.31 15.92 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.282 -0.872 . . . . 73.239999999999995 109.728 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 71.2 t -64.83 130.2 29.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.084 -1.45 . . . . 72.340000000000003 107.084 171.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 43.5 t -108.61 -40.33 4.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 121.524 0.678 . . . . 71.400000000000006 110.108 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -142.9 142.07 31.65 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.793 -0.817 . . . . 73.239999999999995 108.793 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -137.56 143.56 41.63 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.906 -1.516 . . . . 73.120000000000005 106.906 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.41 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 24.6 t-20 -65.84 -53.11 37.33 Favored Pre-proline 0 C--N 1.308 -1.218 0 C-N-CA 119.235 -0.986 . . . . 74.420000000000002 112.132 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.8 Cg_endo -90.64 107.93 0.33 Allowed 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.09 1.86 . . . . 73.129999999999995 110.351 173.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 607' ' ' ASN . 14.5 Cg_exo -71.13 160.37 49.34 Favored 'Trans proline' 0 C--O 1.246 0.896 0 C-N-CA 123.258 2.638 . . . . 72.099999999999994 113.411 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.85 138.54 56.17 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.351 -0.981 . . . . 64.430000000000007 108.351 175.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 96.69 -8.95 66.27 Favored Glycine 0 C--N 1.297 -1.6 0 C-N-CA 120.27 -0.967 . . . . 72.5 110.904 -175.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 24.2 m -101.88 153.17 20.09 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 108.06 -1.089 . . . . 65.340000000000003 108.06 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -74.77 127.16 9.38 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 121.242 -0.504 . . . . 71.510000000000005 112.151 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 30.9 m -119.98 142.6 34.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.898 -1.149 . . . . 74.209999999999994 107.898 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -51.7 169.14 0.07 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.708 0.803 . . . . 75.209999999999994 112.736 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -60.29 -26.17 66.3 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 120.859 0.361 . . . . 64.329999999999998 111.699 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.427 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 5.4 m-20 -83.31 -7.82 59.53 Favored 'General case' 0 C--O 1.204 -1.324 0 CA-C-N 116.069 -0.514 . . . . 74.120000000000005 110.398 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.18 19.34 68.1 Favored Glycine 0 C--O 1.22 -0.776 0 O-C-N 123.285 0.366 . . . . 71.010000000000005 112.996 171.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.79 119.4 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-O 121.913 0.863 . . . . 75.150000000000006 111.217 -167.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 48.3 pt -126.21 133.92 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 115.096 -0.957 . . . . 72.319999999999993 110.522 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 14.9 t -105.8 128.73 53.91 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.924 -1.139 . . . . 63.409999999999997 107.924 177.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.5 pp -139.24 166.69 23.87 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 114.16 1.17 . . . . 72.510000000000005 114.16 -173.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -127.68 137.04 52.37 Favored 'General case' 0 C--O 1.256 1.411 0 N-CA-C 108.173 -1.047 . . . . 75.329999999999998 108.173 175.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -142.3 166.89 23.45 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.859 -0.61 . . . . 75.140000000000001 109.617 -174.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -60.94 145.79 47.96 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 121.102 -0.571 . . . . 75.239999999999995 112.296 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.406 ' CD ' ' HA ' ' A' ' 594' ' ' ASP . 3.3 pt20 . . . . . 0 C--O 1.251 1.179 0 N-CA-C 113.885 1.068 . . . . 72.219999999999999 113.885 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.874 0 CA-C-O 121.813 0.816 . . . . 64.140000000000001 110.838 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 15.0 p -136.55 155.06 50.47 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 114.981 -1.008 . . . . 62.32 110.317 -176.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . 0.554 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 4.6 tmtt? -150.49 139.66 21.18 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.884 -0.784 . . . . 74.329999999999998 108.884 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.554 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 8.3 p-10 -78.18 129.75 35.51 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 123.633 0.773 . . . . 74.420000000000002 109.58 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.5 pt -99.03 131.65 25.0 Favored Pre-proline 0 C--N 1.304 -1.374 0 C-N-CA 120.45 -0.5 . . . . 71.329999999999998 111.689 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.08 158.54 34.0 Favored 'Trans proline' 0 C--O 1.243 0.742 0 C-N-CA 122.78 2.32 . . . . 73.430000000000007 112.167 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . 0.436 ' HA ' ' HB1' ' A' ' 541' ' ' ALA . 5.1 p-10 -82.23 112.7 19.48 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.95 0.881 . . . . 74.540000000000006 108.979 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 31.7 m -117.41 0.95 8.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 112.973 0.731 . . . . 65.420000000000002 112.973 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -69.63 100.98 1.55 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.298 0.57 . . . . 74.239999999999995 109.917 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 138.8 -13.5 3.39 Favored Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 110.717 -0.953 . . . . 63.539999999999999 110.717 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 508' ' ' ALA . 31.7 mm-40 -82.2 -178.25 6.95 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 108.692 -0.855 . . . . 73.010000000000005 108.692 175.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.7 m -78.6 156.15 29.27 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 104.293 -2.484 . . . . 62.25 104.293 169.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.486 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 8.4 p -60.13 -42.4 89.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 119.557 1.071 . . . . 75.540000000000006 112.224 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 17.3 t70 -64.68 -43.43 93.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.945 0.402 . . . . 63.409999999999997 110.455 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 62.9 t -67.82 -39.11 81.31 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.252 0 CA-C-N 115.628 -0.714 . . . . 75.200000000000003 109.803 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' A' ' 503' ' ' GLN . . . -62.4 -45.14 94.5 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.951 -0.389 . . . . 74.549999999999997 109.951 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.8 mt-30 -62.05 -46.68 88.06 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.759 -0.655 . . . . 71.239999999999995 111.353 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.558 ' O ' HG21 ' A' ' 514' ' ' VAL 0.359 0.0 OUTLIER -67.37 -38.15 84.32 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 112.48 0.548 . . . . 74.239999999999995 112.48 177.333 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -60.71 -50.04 75.07 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 110.602 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 513' ' ' ASN . 3.8 pp -68.49 -36.06 78.4 Favored 'General case' 0 C--O 1.208 -1.098 0 C-N-CA 120.156 -0.618 . . . . 73.209999999999994 111.598 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.483 ' N ' HD12 ' A' ' 512' ' ' LEU . 3.4 t-20 -69.79 -35.19 74.66 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 112.558 0.577 . . . . 73.430000000000007 112.558 -175.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.558 HG21 ' O ' ' A' ' 510' ' ' LYS . 72.2 t -57.33 -31.1 37.24 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 CA-C-O 121.438 0.637 . . . . 73.510000000000005 110.121 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -120.22 29.17 7.63 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.771 -0.649 . . . . 74.200000000000003 109.591 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -145.84 -56.79 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.423 0 C-N-CA 120.058 -1.068 . . . . 72.239999999999995 112.181 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 62.89 33.78 14.79 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.521 1.153 . . . . 73.340000000000003 111.151 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 518' ' ' THR . . . . . 0.403 HG22 ' HA ' ' A' ' 547' ' ' VAL . 3.1 p -88.52 -171.43 3.33 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-N 113.83 -1.532 . . . . 75.019999999999996 109.047 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -111.77 142.49 44.06 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.891 -1.522 . . . . 74.219999999999999 106.891 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -132.47 148.81 52.4 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 113.201 0.815 . . . . 75.340000000000003 113.201 -174.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 51.0 m -133.06 157.66 44.7 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 106.713 -1.588 . . . . 61.219999999999999 106.713 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -125.97 126.89 45.07 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 109.693 -0.484 . . . . 73.019999999999996 109.693 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . 0.53 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -124.16 143.27 50.59 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.45 -1.315 . . . . 74.409999999999997 107.45 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 65.8 p -102.8 139.94 37.72 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.094 -1.043 . . . . 72.530000000000001 112.426 -175.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 12.1 p -131.15 151.52 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 N-CA-C 107.768 -1.197 . . . . 75.329999999999998 107.768 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -87.34 137.2 32.55 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 121.3 0.571 . . . . 72.340000000000003 110.94 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.4 m -160.08 157.51 25.25 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 106.802 -1.555 . . . . 63.530000000000001 106.802 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -64.56 2.07 1.42 Allowed 'Trans proline' 0 CA--C 1.555 1.549 0 C-N-CA 122.653 2.235 . . . . 71.299999999999997 114.076 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -96.1 144.17 27.37 Favored Pre-proline 0 N--CA 1.433 -1.319 0 N-CA-C 109.523 -0.547 . . . . 74.239999999999995 109.523 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.03 146.59 97.53 Favored 'Trans proline' 0 C--O 1.249 1.07 0 C-N-CA 123.418 2.745 . . . . 75.530000000000001 114.618 -173.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.706 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.66 113.64 2.12 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.663 -1.153 . . . . 74.25 111.064 178.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 139.91 -23.53 2.76 Favored Glycine 0 C--N 1.301 -1.368 0 N-CA-C 111.083 -0.807 . . . . 62.109999999999999 111.083 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -79.33 144.91 33.79 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.81 -0.811 . . . . 73.420000000000002 108.81 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.35 114.99 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 N-CA-C 108.288 -1.004 . . . . 75.129999999999995 108.288 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.2 -31.3 72.44 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.18 -1.373 . . . . 75.409999999999997 109.433 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 152.78 -168.34 31.71 Favored Glycine 0 N--CA 1.407 -3.244 0 N-CA-C 109.728 -1.349 . . . . 74.230000000000004 109.728 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 537' ' ' THR . . . . . 0.423 HG23 ' HG ' ' A' ' 553' ' ' LEU . 3.6 p -116.62 153.53 32.11 Favored 'General case' 0 C--N 1.268 -2.943 0 N-CA-C 107.807 -1.183 . . . . 61.100000000000001 107.807 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.466 ' HB3' ' CD ' ' A' ' 552' ' ' GLU . 54.0 t30 -67.41 -48.0 46.74 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 118.382 -1.327 . . . . 73.420000000000002 110.706 176.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.48 ' HD3' ' OE1' ' A' ' 552' ' ' GLU . 20.7 Cg_exo -71.9 129.66 15.67 Favored 'Trans proline' 0 C--N 1.374 1.882 0 N-CA-C 108.398 -1.424 . . . . 73.299999999999997 108.398 168.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.73 139.99 93.1 Favored 'Trans proline' 0 C--O 1.245 0.87 0 C-N-CA 122.955 2.437 . . . . 74.0 115.335 -174.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' A' ' 499' ' ' ASP . . . -68.27 135.85 52.58 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.297 -1.32 . . . . 74.430000000000007 110.236 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 93.54 -16.58 60.38 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 111.455 -0.658 . . . . 54.520000000000003 111.455 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 63.1 m -88.67 139.16 30.75 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 124.151 0.98 . . . . 70.519999999999996 110.821 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.1 t -73.88 128.09 34.58 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 121.529 0.68 . . . . 75.439999999999998 109.21 175.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.72 164.98 27.65 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 107.13 -1.433 . . . . 70.209999999999994 107.13 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -67.25 136.07 39.11 Favored 'Trans proline' 0 N--CA 1.442 -1.543 0 CA-C-N 120.564 1.237 . . . . 73.200000000000003 110.437 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.403 ' HA ' HG22 ' A' ' 518' ' ' THR . 9.2 p -67.49 -22.11 28.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 122.037 0.923 . . . . 64.319999999999993 109.639 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -84.26 -12.68 54.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.141 -1.391 . . . . 72.310000000000002 110.992 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 11.4 t -93.14 153.12 18.84 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-O 121.555 0.693 . . . . 70.420000000000002 110.246 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 13.2 p -94.89 134.78 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.07 0 CA-C-N 114.865 -1.061 . . . . 72.219999999999999 108.583 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 62.1 mt -102.63 135.73 38.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.553 -0.748 . . . . 71.420000000000002 109.12 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . 0.48 ' OE1' ' HD3' ' A' ' 539' ' ' PRO . 2.1 pm0 -102.93 121.61 42.87 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-O 121.764 0.793 . . . . 70.439999999999998 110.551 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . 0.423 ' HG ' HG23 ' A' ' 537' ' ' THR . 7.0 mp -98.66 122.19 41.56 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.208 -1.36 . . . . 74.439999999999998 108.369 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 2.7 mp0 -88.09 127.09 35.41 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.844 -0.616 . . . . 75.400000000000006 110.971 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 25.2 t -95.21 125.94 47.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.057 -0.974 . . . . 73.349999999999994 108.437 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.706 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 5.5 m -77.63 119.38 21.09 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.106 -1.072 . . . . 73.349999999999994 108.106 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -108.72 134.73 51.04 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 107.468 -1.308 . . . . 74.450000000000003 107.468 169.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -59.18 -23.49 57.54 Favored Glycine 0 CA--C 1.509 -0.297 0 O-C-N 124.035 0.834 . . . . 72.450000000000003 112.181 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 76.52 7.88 3.29 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.977 1.711 . . . . 74.439999999999998 108.181 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 89.0 mt-30 -126.77 146.16 50.34 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 114.889 -1.051 . . . . 72.040000000000006 110.649 -176.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . 0.44 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 53.8 p90 -124.01 152.83 42.14 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.332 -0.988 . . . . 74.430000000000007 108.332 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.47 124.4 13.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.401 0.62 . . . . 73.109999999999999 111.981 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 47.9 ttp -92.89 134.83 26.85 Favored Pre-proline 0 C--O 1.256 1.41 0 CA-C-N 115.697 -0.683 . . . . 74.129999999999995 110.057 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.73 169.07 16.82 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.884 2.389 . . . . 73.319999999999993 111.075 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.79 115.03 26.04 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.42 -0.955 . . . . 75.329999999999998 108.42 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . 0.407 ' O ' ' HG2' ' A' ' 569' ' ' MET . 91.5 mt -107.0 -0.21 23.21 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.722 0.772 . . . . 75.450000000000003 110.384 -176.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 20.6 t -79.52 153.47 29.53 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.502 -0.772 . . . . 75.329999999999998 109.317 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 82.62 25.26 51.03 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 120.22 -0.99 . . . . 71.140000000000001 114.031 177.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 569' ' ' MET . . . . . 0.411 ' O ' HG23 ' A' ' 603' ' ' VAL . 23.2 ptp -140.69 176.77 8.52 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.305 -0.998 . . . . 73.430000000000007 108.305 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -98.34 169.12 9.79 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.656 -0.868 . . . . 75.219999999999999 108.656 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -64.18 -27.62 69.19 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.579 0.704 . . . . 72.299999999999997 109.355 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.5 p -72.95 -17.32 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 CA-C-N 115.46 -0.791 . . . . 74.239999999999995 110.74 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.49 ' O ' ' HD2' ' A' ' 576' ' ' PRO . 16.5 m-20 -91.17 -38.92 12.42 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 107.97 -1.122 . . . . 74.549999999999997 107.97 175.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . 0.646 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -56.79 -52.97 62.97 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.229 -1.351 . . . . 75.439999999999998 112.068 -178.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.448 ' HB2' ' HD3' ' A' ' 576' ' ' PRO . 47.2 mt-10 -51.08 -54.02 42.26 Favored Pre-proline 0 CA--C 1.559 1.304 0 N-CA-C 113.782 1.031 . . . . 74.200000000000003 113.782 -176.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 573' ' ' ASP . 35.9 Cg_exo -61.15 -36.32 81.58 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 121.557 1.505 . . . . 74.239999999999995 112.137 177.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.444 ' HA ' ' NE ' ' A' ' 577' ' ' ARG . 3.3 mmp_? -62.84 -40.17 96.63 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.743 0.275 . . . . 71.239999999999995 111.743 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 25.0 mt -65.4 -48.92 71.2 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.333 0.587 . . . . 74.319999999999993 110.327 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -66.7 -36.84 83.45 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.704 -0.68 . . . . 65.310000000000002 112.455 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.12 -34.26 72.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.78 0.324 . . . . 43.219999999999999 111.258 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 1.5 pp -81.51 -6.22 58.75 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.396 0.617 . . . . 73.540000000000006 109.916 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.54 44.14 27.75 Favored Glycine 0 CA--C 1.498 -0.978 0 CA-C-N 115.585 -0.734 . . . . 74.430000000000007 111.988 177.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . 0.438 ' CE3' HD21 ' A' ' 578' ' ' LEU . 15.3 t90 -87.35 127.04 35.2 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 109.32 -0.622 . . . . 71.450000000000003 109.32 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 17.2 p -101.27 -21.13 14.97 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.167 -0.469 . . . . 71.450000000000003 111.94 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -73.98 -175.12 31.74 Favored Glycine 0 C--O 1.242 0.628 0 CA-C-N 116.535 -0.302 . . . . 75.230000000000004 113.459 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 53.1 mtt -106.03 144.15 33.16 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.835 -0.182 . . . . 73.439999999999998 111.016 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 37.5 tp -89.64 108.02 19.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.473 0.654 . . . . 75.319999999999993 109.413 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . 0.569 ' O ' ' HA ' ' A' ' 621' ' ' THR . 28.4 t70 -97.73 117.1 31.28 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.139 -0.937 . . . . 75.439999999999998 110.351 -176.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.98 133.55 44.2 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 119.042 -1.063 . . . . 75.439999999999998 108.987 174.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -80.42 -54.39 3.77 Favored Glycine 0 C--N 1.299 -1.527 0 N-CA-C 111.267 -0.733 . . . . 61.140000000000001 111.267 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.04 146.9 39.6 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.644 -0.502 . . . . 60.32 109.644 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -113.31 131.83 55.8 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.694 -1.595 . . . . 71.25 106.694 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 46.2 t -105.0 115.59 47.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 C-N-CA 119.891 -0.724 . . . . 73.200000000000003 109.107 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . 0.458 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 24.3 t70 -78.0 126.63 31.11 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 112.756 0.65 . . . . 72.109999999999999 112.756 -175.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -158.2 -30.62 0.08 Allowed 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.811 0.694 . . . . 71.109999999999999 111.153 174.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 108.66 144.08 10.72 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 119.45 -1.357 . . . . 34.43 112.959 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -60.67 -32.79 79.85 Favored Glycine 0 C--N 1.317 -0.506 0 C-N-CA 123.014 0.34 . . . . 52.450000000000003 113.267 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 31.3 t -62.18 -23.93 66.89 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.862 0.839 . . . . 71.219999999999999 110.326 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -86.78 -0.62 56.71 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.675 -1.148 . . . . 72.540000000000006 110.773 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 52.0 m80 66.19 38.7 4.52 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 122.137 0.97 . . . . 74.310000000000002 109.473 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -74.72 89.63 2.28 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.701 -1.59 . . . . 61.409999999999997 108.629 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -97.52 171.65 8.23 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.763 -1.562 . . . . 74.450000000000003 110.896 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 569' ' ' MET . 83.7 t -58.52 130.73 22.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.244 -1.021 . . . . 74.040000000000006 108.244 174.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 27.7 m -106.26 -30.44 2.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 120.535 -0.466 . . . . 73.420000000000002 111.901 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -149.43 135.98 19.33 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 120.258 -0.577 . . . . 74.430000000000007 110.717 -176.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -120.88 143.12 49.09 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.491 -1.67 . . . . 73.219999999999999 106.491 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.443 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 19.9 t-20 -52.61 -58.17 12.94 Favored Pre-proline 0 N--CA 1.487 1.387 0 N-CA-C 113.95 1.093 . . . . 70.430000000000007 113.95 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.1 Cg_endo -91.04 135.25 1.84 Allowed 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 121.476 1.451 . . . . 72.140000000000001 110.739 177.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -67.08 160.04 49.25 Favored 'Trans proline' 0 C--O 1.249 1.057 0 C-N-CA 121.518 1.479 . . . . 63.039999999999999 110.856 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.17 127.17 30.22 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 110.257 -0.275 . . . . 74.519999999999996 110.257 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 104.71 -5.21 43.28 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.317 -0.944 . . . . 75.530000000000001 112.251 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 73.9 m -90.63 147.35 23.36 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.861 -0.792 . . . . 61.450000000000003 108.861 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -78.72 137.89 20.12 Favored Glycine 0 N--CA 1.425 -2.043 0 C-N-CA 121.529 -0.367 . . . . 61.200000000000003 113.234 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.3 m -117.99 142.76 30.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.744 -0.836 . . . . 62.43 108.744 175.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -49.85 170.8 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.433 1.093 . . . . 75.319999999999993 113.608 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -58.9 -26.99 64.81 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.999 -0.546 . . . . 74.109999999999999 111.946 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -84.75 -7.28 59.27 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 121.22 0.533 . . . . 75.340000000000003 110.264 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.6 18.93 68.56 Favored Glycine 0 C--O 1.219 -0.838 0 CA-C-N 115.928 -0.578 . . . . 61.329999999999998 113.967 172.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.49 119.93 17.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 122.555 1.169 . . . . 71.329999999999998 112.121 -167.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.11 130.78 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 114.212 -1.358 . . . . 73.140000000000001 109.46 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 13.0 t -104.66 137.06 43.05 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.031 -1.1 . . . . 73.430000000000007 108.031 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -138.63 167.51 21.81 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.354 0.597 . . . . 73.519999999999996 112.338 -173.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -127.03 134.63 50.27 Favored 'General case' 0 C--O 1.251 1.138 0 N-CA-C 104.806 -2.294 . . . . 74.129999999999995 104.806 174.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 603' ' ' VAL . 29.3 p90 -142.94 165.33 27.65 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.627 -0.829 . . . . 75.400000000000006 112.221 -174.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -79.74 126.64 7.55 Favored Glycine 1 N--CA 1.388 -4.552 0 C-N-CA 120.65 -0.786 . . . . 54.229999999999997 111.609 173.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.458 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 9.3 tt0 . . . . . 0 C--O 1.271 2.204 0 C-N-CA 124.75 1.22 . . . . 72.430000000000007 107.812 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.625 0 CA-C-O 121.852 0.834 . . . . 62.229999999999997 110.288 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 40.9 p -138.23 149.89 46.19 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.42 -1.326 . . . . 74.420000000000002 107.42 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -141.64 145.03 34.49 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.728 -1.212 . . . . 73.120000000000005 107.728 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.425 ' OD1' ' HB ' ' A' ' 544' ' ' THR . 17.2 m-20 -88.93 141.94 28.06 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.34 -0.615 . . . . 74.439999999999998 109.34 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.7 pt -101.76 123.83 42.64 Favored Pre-proline 0 C--N 1.3 -1.564 0 C-N-CA 120.609 -0.436 . . . . 74.420000000000002 110.288 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -84.58 172.39 9.18 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.383 2.055 . . . . 75.430000000000007 112.018 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -85.97 100.66 12.28 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 122.399 1.095 . . . . 74.540000000000006 109.998 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 31.4 m -89.38 1.73 7.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 114.401 -1.272 . . . . 74.340000000000003 111.261 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -64.52 100.74 0.39 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.564 -0.744 . . . . 73.0 110.079 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 158.2 -32.06 0.5 Allowed Glycine 0 C--N 1.302 -1.356 0 C-N-CA 120.797 -0.716 . . . . 61.409999999999997 111.583 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.442 ' O ' HG11 ' A' ' 534' ' ' VAL . 10.1 pm0 -102.62 -179.69 4.04 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 109.816 -0.438 . . . . 71.230000000000004 109.816 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 17.5 m -70.31 155.76 40.21 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.579 -1.267 . . . . 74.329999999999998 107.579 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.494 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 14.2 p -64.71 -40.38 88.86 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 N-CA-C 109.657 -0.497 . . . . 73.530000000000001 109.657 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . 0.593 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 11.8 t70 -58.79 -39.86 82.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.422 -0.808 . . . . 72.299999999999997 109.842 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 86.0 t -74.93 -43.55 45.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.099 -0.955 . . . . 74.25 110.61 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -58.82 -43.29 90.57 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.472 0.177 . . . . 72.129999999999995 110.739 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.2 mt-30 -64.66 -46.44 82.48 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.043 -0.526 . . . . 73.439999999999998 110.915 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 2.7 ptpp? -67.36 -38.4 84.74 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 112.802 0.667 . . . . 75.430000000000007 112.802 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 56.1 m-20 -61.98 -48.07 81.97 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.238 0.542 . . . . 74.209999999999994 110.353 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.44 -36.92 84.0 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.203 -0.908 . . . . 74.299999999999997 108.849 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 2.2 t-20 -59.4 -35.39 73.87 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 124.046 0.938 . . . . 74.329999999999998 110.534 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.512 HG21 ' O ' ' A' ' 510' ' ' LYS . 86.0 t -61.99 -33.14 56.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-O 121.286 0.565 . . . . 73.120000000000005 110.789 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -105.08 4.07 31.08 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.588 -0.523 . . . . 72.340000000000003 109.588 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -133.32 -60.96 0.08 OUTLIER Glycine 0 N--CA 1.426 -1.994 0 C-N-CA 119.987 -1.102 . . . . 72.200000000000003 114.425 -171.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.415 ' HA ' ' ND2' ' A' ' 513' ' ' ASN . 93.6 m-85 62.84 29.02 16.63 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.158 0.98 . . . . 73.420000000000002 109.102 -172.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 518' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 547' ' ' VAL . 17.2 p -85.62 -166.21 1.45 Allowed 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 126.019 1.728 . . . . 73.510000000000005 109.851 -177.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -108.55 137.68 46.11 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.312 -0.625 . . . . 74.439999999999998 109.312 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -132.2 147.37 52.41 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 116.017 -0.538 . . . . 74.329999999999998 110.203 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.1 m -140.26 145.91 37.92 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.342 -0.984 . . . . 73.120000000000005 108.342 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -117.97 135.22 54.28 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 121.371 0.605 . . . . 75.329999999999998 111.065 -175.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -123.02 126.81 47.83 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.235 -1.024 . . . . 55.210000000000001 108.235 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 22.2 m -88.14 125.87 34.83 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.297 0.57 . . . . 74.150000000000006 111.404 -176.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 10.5 p -120.31 150.67 23.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 106.611 -1.625 . . . . 74.209999999999994 106.611 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.42 ' OD1' ' HE2' ' A' ' 557' ' ' LYS . 21.1 m-20 -75.29 135.63 40.92 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 120.311 -0.556 . . . . 74.140000000000001 109.71 -174.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 73.9 m -153.11 169.57 9.52 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 108.343 -0.984 . . . . 72.219999999999999 108.343 -175.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -82.35 -17.53 7.63 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.597 1.531 . . . . 75.239999999999995 111.182 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.596 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 53.1 mtt-85 -75.51 143.68 76.26 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 116.089 -0.505 . . . . 74.040000000000006 110.273 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.97 143.18 96.59 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 123.164 2.576 . . . . 72.239999999999995 112.521 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.643 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -56.51 108.97 0.54 Allowed 'General case' 0 C--O 1.242 0.7 0 O-C-N 124.092 0.87 . . . . 64.340000000000003 112.321 -177.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 140.38 -20.0 2.8 Favored Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 115.381 -0.827 . . . . 51.020000000000003 112.494 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . 0.596 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 31.1 tt0 -82.86 144.83 29.82 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.602 -0.518 . . . . 74.25 109.602 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 503' ' ' GLN . 8.0 p -91.5 115.8 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 CA-C-O 122.094 0.949 . . . . 74.299999999999997 110.455 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.8 -30.86 69.52 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 113.671 -1.604 . . . . 74.0 110.253 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 154.82 -164.87 31.91 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 110.587 -1.005 . . . . 64.420000000000002 110.587 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 6.4 p -117.29 154.88 30.47 Favored 'General case' 0 C--N 1.288 -2.109 0 N-CA-C 109.542 -0.54 . . . . 63.100000000000001 109.542 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -63.79 -51.57 64.01 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 120.149 -0.621 . . . . 73.299999999999997 110.84 177.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -74.23 134.3 19.01 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 N-CA-C 108.644 -1.329 . . . . 63.340000000000003 108.644 170.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.45 154.4 71.85 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 122.753 2.302 . . . . 73.010000000000005 113.381 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.02 139.89 58.39 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.588 -0.733 . . . . 75.219999999999999 110.284 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 96.86 -8.8 65.76 Favored Glycine 0 C--N 1.302 -1.339 0 C-N-CA 120.595 -0.812 . . . . 65.129999999999995 111.695 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 25.2 m -82.5 133.97 35.2 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.646 -0.872 . . . . 60.329999999999998 108.646 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.425 ' HB ' ' OD1' ' A' ' 496' ' ' ASP . 15.1 t -94.64 132.79 38.98 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 108.301 -1.0 . . . . 75.209999999999994 108.301 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.17 155.2 64.96 Favored Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 107.839 -1.171 . . . . 72.319999999999993 107.839 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . 0.519 ' HG2' ' OG ' ' A' ' 549' ' ' SER . 7.6 Cg_endo -60.32 136.52 68.72 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 N-CA-C 109.421 -1.03 . . . . 73.439999999999998 109.421 176.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 518' ' ' THR . 9.7 p -66.56 -21.38 28.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.34 -0.845 . . . . 73.319999999999993 112.941 -172.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -93.35 3.69 55.2 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.766 0.793 . . . . 64.0 111.043 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 549' ' ' SER . . . . . 0.519 ' OG ' ' HG2' ' A' ' 546' ' ' PRO . 68.3 m -87.56 -174.7 4.91 Favored 'General case' 0 C--O 1.251 1.171 0 O-C-N 121.544 -0.723 . . . . 64.409999999999997 112.389 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 13.3 p -113.48 138.25 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 115.221 -0.9 . . . . 75.340000000000003 109.741 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.7 mt -102.92 137.4 31.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.76 -0.83 . . . . 73.340000000000003 108.76 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -102.43 117.49 34.83 Favored 'General case' 0 C--O 1.251 1.132 0 N-CA-C 107.999 -1.111 . . . . 74.010000000000005 107.999 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.44 129.93 55.25 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 123.343 0.402 . . . . 74.340000000000003 110.505 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -90.66 119.38 30.86 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.003 -0.544 . . . . 74.340000000000003 110.785 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 40.2 t -92.99 129.57 43.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.316 -0.994 . . . . 54.229999999999997 108.316 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.643 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 16.1 m -75.71 117.72 17.77 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 108.081 -1.081 . . . . 74.420000000000002 108.081 176.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.42 ' HE2' ' OD1' ' A' ' 526' ' ' ASP . 26.5 pttm -109.05 118.49 36.91 Favored 'General case' 0 N--CA 1.411 -2.399 0 N-CA-C 107.576 -1.268 . . . . 72.150000000000006 107.576 171.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -56.79 -23.86 46.5 Favored Glycine 0 CA--C 1.497 -1.09 0 O-C-N 124.319 1.012 . . . . 44.310000000000002 113.175 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 77.85 -3.84 2.32 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 125.331 1.452 . . . . 75.230000000000004 109.24 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.509 ' HG2' ' N ' ' A' ' 615' ' ' ASN . 63.2 mt-30 -112.58 150.21 31.67 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 115.592 -0.731 . . . . 70.299999999999997 112.831 -173.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -133.13 156.5 47.32 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.646 -1.613 . . . . 74.120000000000005 106.646 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 47.5 t -73.41 122.87 27.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.595 -0.891 . . . . 70.25 108.595 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 57.0 ttp -73.97 127.37 88.28 Favored Pre-proline 0 C--O 1.25 1.082 0 O-C-N 123.22 0.325 . . . . 74.120000000000005 111.428 -175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -61.71 169.64 6.79 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.598 2.865 . . . . 73.209999999999994 112.59 175.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -65.92 129.47 39.9 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.373 0.669 . . . . 72.019999999999996 112.766 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.7 pp -152.45 14.32 0.58 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.182 0.992 . . . . 74.209999999999994 109.075 172.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 4.2 m -79.95 140.89 36.46 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.414 -1.267 . . . . 70.420000000000002 111.995 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 53.18 43.1 63.37 Favored Glycine 0 C--O 1.223 -0.544 0 N-CA-C 115.112 0.805 . . . . 53.130000000000003 115.112 172.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 18.1 ptp -127.15 -179.65 4.97 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.874 -1.158 . . . . 75.099999999999994 107.874 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -96.24 168.96 10.27 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.665 -0.865 . . . . 75.409999999999997 108.665 -175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 37.8 t-105 -63.39 -28.08 69.74 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.445 -0.576 . . . . 73.030000000000001 109.445 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 8.9 p -75.11 -9.58 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 CA-C-N 115.695 -0.684 . . . . 74.040000000000006 110.484 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.578 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 42.6 m-20 -101.1 -42.0 6.54 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 107.858 -1.164 . . . . 61.030000000000001 107.858 173.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . 0.54 ' O ' HD13 ' A' ' 578' ' ' LEU . . . -55.54 -45.92 77.15 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.782 -1.099 . . . . 70.299999999999997 112.044 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.493 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 3.0 tm-20 -53.98 -58.46 13.33 Favored Pre-proline 0 CA--C 1.567 1.616 0 CA-C-O 118.949 -0.548 . . . . 72.25 110.533 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 57.9 Cg_exo -53.17 -32.25 58.94 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 121.978 1.785 . . . . 75.230000000000004 112.808 173.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 26.2 mmm180 -61.93 -36.25 80.81 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-O 118.659 -0.686 . . . . 75.099999999999994 112.42 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.617 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 5.4 mp -62.66 -48.54 78.88 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.708 -1.197 . . . . 74.519999999999996 110.115 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.1 -41.23 90.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.824 -0.625 . . . . 73.25 112.322 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.28 -39.54 74.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.746 0.647 . . . . 62.32 112.746 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.01 -9.02 58.46 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.926 0.394 . . . . 75.430000000000007 110.433 -175.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 72.47 48.36 24.12 Favored Glycine 0 CA--C 1.505 -0.556 0 N-CA-C 111.316 -0.713 . . . . 63.210000000000001 111.316 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . 0.617 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 8.6 t90 -85.99 133.4 33.92 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.0 0.429 . . . . 72.450000000000003 110.011 -176.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 1.3 p -86.82 -39.36 15.95 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.583 1.553 . . . . 73.430000000000007 112.826 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -79.7 -162.16 24.28 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-O 121.797 0.665 . . . . 73.120000000000005 114.279 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 61.5 mtm -122.79 152.87 40.24 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.974 -0.75 . . . . 75.530000000000001 108.974 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 4.4 tt -81.92 111.67 18.32 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.648 -1.241 . . . . 74.310000000000002 107.648 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . 0.571 ' O ' ' HA ' ' A' ' 621' ' ' THR . 33.0 t70 -95.34 107.97 20.12 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.658 0.742 . . . . 74.099999999999994 110.049 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.1 133.66 41.46 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.677 -0.861 . . . . 71.400000000000006 108.677 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.25 -69.29 1.4 Allowed Glycine 0 C--N 1.28 -2.532 0 N-CA-C 110.57 -1.012 . . . . 71.450000000000003 110.57 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -137.22 149.34 47.13 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 110.065 -0.346 . . . . 73.400000000000006 110.065 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -115.77 124.7 51.42 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.645 0.736 . . . . 75.209999999999994 109.072 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 44.2 t -106.74 153.52 7.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.758 -1.201 . . . . 73.420000000000002 107.758 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.42 126.2 29.26 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.934 0.873 . . . . 71.540000000000006 110.752 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -133.54 -48.34 0.83 Allowed 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 114.386 -1.279 . . . . 65.019999999999996 108.747 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 102.51 123.14 5.2 Favored Glycine 0 N--CA 1.422 -2.254 0 N-CA-C 111.254 -0.738 . . . . 64.450000000000003 111.254 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -60.58 -33.83 83.5 Favored Glycine 0 C--N 1.317 -0.514 0 N-CA-C 111.704 -0.559 . . . . 33.229999999999997 111.704 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.2 m -70.27 -23.88 62.96 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-O 121.819 0.819 . . . . 62.210000000000001 110.135 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -92.06 -1.58 57.13 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.195 -0.911 . . . . 74.129999999999995 110.085 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 69.82 81.73 0.17 Allowed 'General case' 0 C--O 1.244 0.772 0 CA-C-O 123.229 1.49 . . . . 74.5 111.283 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 625' ' ' GLY . 15.8 p-10 -79.77 89.31 5.21 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 113.32 -1.764 . . . . 74.439999999999998 113.056 -174.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -81.9 170.93 15.06 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.146 -0.934 . . . . 64.319999999999993 111.722 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 75.0 t -70.29 131.83 33.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 114.55 -1.205 . . . . 74.209999999999994 108.529 171.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 86.5 t -91.07 -43.92 14.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.499 0.666 . . . . 73.150000000000006 110.568 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -153.14 140.05 19.14 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.783 -0.644 . . . . 73.420000000000002 109.693 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -127.51 139.49 52.75 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.663 -1.236 . . . . 74.219999999999999 107.663 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.5 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 23.8 t-20 -58.99 -62.48 5.73 Favored Pre-proline 0 CA--C 1.555 1.153 0 CA-C-O 118.922 -0.561 . . . . 73.450000000000003 111.929 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 7.4 Cg_endo -95.74 120.44 0.24 Allowed 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 122.003 1.802 . . . . 75.239999999999995 110.027 171.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -70.34 156.82 60.99 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.437 2.091 . . . . 74.450000000000003 112.276 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.38 138.61 56.85 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.466 -0.938 . . . . 71.400000000000006 108.466 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 97.77 -2.13 60.14 Favored Glycine 0 C--N 1.301 -1.398 0 N-CA-C 110.637 -0.985 . . . . 62.240000000000002 110.637 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 26.9 m -109.54 155.52 21.28 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.281 -1.377 . . . . 73.430000000000007 107.281 175.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -78.43 138.46 21.12 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.972 -0.632 . . . . 75.439999999999998 113.393 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.89 143.05 42.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 124.068 0.947 . . . . 72.040000000000006 109.11 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.509 ' N ' ' HG2' ' A' ' 560' ' ' GLN . 30.2 p-10 -48.38 168.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.852 0.861 . . . . 70.450000000000003 113.023 175.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -57.14 -25.54 59.04 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.531 0.732 . . . . 71.120000000000005 112.806 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.95 -8.53 58.71 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 120.037 -0.665 . . . . 71.129999999999995 109.37 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.16 15.77 63.56 Favored Glycine 0 C--O 1.216 -1.024 0 CA-C-N 116.127 -0.488 . . . . 64.329999999999998 113.141 172.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.4 119.38 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-O 122.623 1.202 . . . . 73.209999999999994 112.409 -166.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.457 HG12 ' HD2' ' A' ' 608' ' ' PRO . 0.0 OUTLIER -125.62 128.25 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 CA-C-N 113.694 -1.594 . . . . 74.319999999999993 110.2 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 21.2 m -100.51 129.59 46.47 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.673 -1.149 . . . . 74.409999999999997 108.896 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.8 pp -138.92 166.24 24.99 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.742 0.645 . . . . 74.409999999999997 112.742 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -127.57 137.46 52.6 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.519 -2.03 . . . . 73.239999999999995 105.519 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -140.8 165.67 26.87 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 120.199 -0.6 . . . . 74.219999999999999 111.113 -172.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 601' ' ' ASN . . . -81.2 142.64 23.29 Favored Glycine 0 N--CA 1.412 -2.913 0 CA-C-N 115.405 -0.816 . . . . 43.149999999999999 111.125 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.402 -2.865 0 C-N-CA 124.336 1.054 . . . . 73.140000000000001 108.472 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.669 0 CA-C-O 122.44 1.114 . . . . 74.510000000000005 109.82 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 3.5 p -137.64 147.47 44.97 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 113.998 -1.455 . . . . 71.129999999999995 108.907 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -130.86 149.7 52.37 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.965 -0.754 . . . . 73.319999999999993 108.965 177.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.7 p-10 -87.71 135.55 33.32 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 122.986 0.514 . . . . 71.519999999999996 109.744 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 29.6 pt -88.43 130.39 45.79 Favored Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 116.586 -0.279 . . . . 75.510000000000005 110.957 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -88.44 172.75 4.81 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.629 2.219 . . . . 71.549999999999997 112.807 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -92.31 111.94 23.7 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.369 -0.832 . . . . 73.439999999999998 108.85 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 24.1 m -106.41 16.44 6.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.408 -0.815 . . . . 73.530000000000001 111.212 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -67.06 98.12 0.55 Allowed 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.822 -0.627 . . . . 73.519999999999996 111.399 -176.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 146.34 -26.03 1.7 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 115.667 -0.697 . . . . 72.519999999999996 111.637 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.425 ' O ' HG11 ' A' ' 534' ' ' VAL . 31.8 mt-30 -82.65 171.08 14.42 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.82 -0.807 . . . . 72.310000000000002 108.82 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 4.8 m -74.25 155.94 37.74 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 105.129 -2.174 . . . . 63.100000000000001 105.129 172.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.435 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.2 p -61.93 -41.94 92.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 118.648 0.658 . . . . 73.530000000000001 111.442 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . 0.534 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 17.1 t70 -62.4 -41.66 98.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.546 -0.297 . . . . 73.030000000000001 110.357 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 87.4 t -67.1 -44.15 88.26 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.247 0 CA-C-N 116.036 -0.529 . . . . 72.349999999999994 109.843 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.453 ' CB ' HG12 ' A' ' 534' ' ' VAL . . . -60.84 -39.79 90.4 Favored 'General case' 0 C--O 1.214 -0.809 0 O-C-N 123.18 0.3 . . . . 72.040000000000006 111.159 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.1 mt-30 -65.06 -43.94 90.62 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.473 -0.195 . . . . 74.439999999999998 110.473 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.537 ' O ' HG21 ' A' ' 514' ' ' VAL . 75.7 mmtt -63.95 -45.21 90.16 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.049 -0.723 . . . . 73.310000000000002 109.049 177.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -61.22 -43.06 99.49 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.279 -1.328 . . . . 75.230000000000004 110.077 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 66.3 tp -67.23 -45.81 75.66 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.14 -1.391 . . . . 74.430000000000007 109.219 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -64.88 -34.98 79.68 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 123.942 0.897 . . . . 70.150000000000006 113.155 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.537 HG21 ' O ' ' A' ' 510' ' ' LYS . 85.8 t -57.18 -33.06 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 120.928 0.394 . . . . 63.43 111.278 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -118.5 8.57 12.09 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.924 0.869 . . . . 71.329999999999998 110.267 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -114.42 -59.08 0.37 Allowed Glycine 0 N--CA 1.416 -2.688 0 CA-C-N 114.936 -1.029 . . . . 70.019999999999996 111.707 -174.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 65.53 18.72 11.36 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 122.479 1.133 . . . . 75.409999999999997 109.53 -176.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.2 p -92.54 -175.86 4.11 Favored 'General case' 0 N--CA 1.403 -2.795 0 CA-C-N 114.04 -1.436 . . . . 73.209999999999994 110.416 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -107.82 142.21 38.21 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.531 -0.914 . . . . 75.25 108.531 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -129.03 153.3 47.73 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.458 0.647 . . . . 72.400000000000006 111.427 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 71.0 m -140.12 155.71 46.87 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 107.095 -1.446 . . . . 72.099999999999994 107.095 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -124.14 123.23 39.84 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.313 0.578 . . . . 74.349999999999994 111.274 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -105.56 119.31 38.79 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.429 -0.952 . . . . 71.129999999999995 108.429 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 20.2 m -100.72 137.19 39.45 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.877 -0.329 . . . . 75.120000000000005 110.905 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.1 p -144.21 153.91 15.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.754 -1.202 . . . . 75.230000000000004 107.754 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -84.08 136.22 34.1 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.304 0.573 . . . . 74.329999999999998 110.927 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 50.6 m -159.04 171.38 7.49 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 106.394 -1.706 . . . . 64.409999999999997 106.394 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.99 -10.11 28.26 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 121.4 1.4 . . . . 62.210000000000001 112.597 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -72.59 140.14 81.46 Favored Pre-proline 0 N--CA 1.435 -1.189 0 N-CA-C 109.573 -0.529 . . . . 72.439999999999998 109.573 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.36 151.34 83.48 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.608 2.206 . . . . 72.400000000000006 113.344 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -64.96 121.55 14.91 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.187 -0.915 . . . . 74.120000000000005 111.542 -177.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 114.58 -18.91 17.02 Favored Glycine 0 C--O 1.249 1.044 0 C-N-CA 120.838 -0.696 . . . . 73.310000000000002 111.373 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -78.2 129.18 34.81 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 109.025 -0.732 . . . . 64.329999999999998 109.025 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 10.1 p -90.81 117.42 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.844 0 N-CA-C 106.78 -1.563 . . . . 74.549999999999997 106.78 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.4 m -92.94 9.74 34.25 Favored 'General case' 0 C--N 1.27 -2.886 0 CA-C-N 114.341 -1.3 . . . . 72.299999999999997 110.567 -173.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 132.7 -154.79 21.27 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 111.338 -0.705 . . . . 60.109999999999999 111.338 176.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.8 p -116.96 157.95 24.89 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.804 -0.813 . . . . 72.120000000000005 108.804 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -60.53 -55.76 41.91 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 119.004 -0.522 . . . . 72.099999999999994 111.448 176.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -70.53 144.78 50.9 Favored 'Trans proline' 0 C--N 1.367 1.533 0 N-CA-C 108.658 -1.324 . . . . 72.510000000000005 108.658 171.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -58.15 147.52 83.09 Favored 'Trans proline' 0 C--O 1.24 0.577 0 C-N-CA 122.79 2.327 . . . . 70.310000000000002 113.047 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.05 137.89 57.76 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-N 116.27 -0.423 . . . . 65.310000000000002 110.432 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.62 -19.98 48.17 Favored Glycine 0 C--N 1.31 -0.896 0 C-N-CA 120.926 -0.654 . . . . 63.340000000000003 111.948 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 35.4 m -67.46 136.79 55.19 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.705 -0.48 . . . . 74.329999999999998 109.705 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 14.8 t -96.34 133.23 40.98 Favored 'General case' 0 N--CA 1.406 -2.67 0 N-CA-C 108.984 -0.747 . . . . 74.420000000000002 108.984 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.7 m -123.39 155.88 64.67 Favored Pre-proline 0 C--N 1.296 -1.753 0 N-CA-C 108.042 -1.096 . . . . 74.439999999999998 108.042 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -63.9 138.28 62.19 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 121.385 1.39 . . . . 75.409999999999997 110.486 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 13.2 p -62.2 -19.99 23.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.611 -0.722 . . . . 75.209999999999994 111.426 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -90.18 -15.89 30.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.172 0.51 . . . . 71.409999999999997 111.507 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 60.0 m -80.39 -175.69 5.27 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 121.109 0.481 . . . . 73.439999999999998 111.723 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 12.4 p -113.19 137.61 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 115.931 -0.577 . . . . 73.340000000000003 110.168 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 70.2 mt -97.33 129.89 46.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 109.371 -0.603 . . . . 74.230000000000004 109.371 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -102.56 117.59 35.01 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.135 -0.691 . . . . 74.409999999999997 109.135 -177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.3 mp -98.59 134.84 40.97 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.813 -0.631 . . . . 74.25 110.006 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -91.82 113.63 25.95 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 116.292 -0.413 . . . . 72.219999999999999 110.365 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 524' ' ' SER . 20.1 t -106.65 126.93 62.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.421 -0.955 . . . . 75.140000000000001 108.421 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 50.5 m -95.55 143.34 26.94 Favored 'General case' 0 C--N 1.277 -2.58 0 C-N-CA 119.661 -0.816 . . . . 73.099999999999994 110.824 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 0.6 OUTLIER -105.79 144.38 32.61 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 106.163 -1.792 . . . . 74.439999999999998 106.163 168.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -55.02 -23.35 31.34 Favored Glycine 0 CA--C 1.492 -1.36 0 O-C-N 124.903 1.377 . . . . 64.120000000000005 114.624 -171.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 77.09 -27.29 0.18 Allowed 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 124.604 1.162 . . . . 74.120000000000005 110.92 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.482 ' H ' ' C ' ' A' ' 558' ' ' GLY . 72.1 mt-30 -114.1 162.18 16.81 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 114.517 -1.22 . . . . 75.329999999999998 109.665 -175.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -127.19 155.9 42.68 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 107.805 -1.183 . . . . 74.420000000000002 107.805 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 6.2 p -77.78 121.05 29.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.554 -0.536 . . . . 73.209999999999994 109.554 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 563' ' ' MET . . . . . 0.481 ' SD ' HG21 ' A' ' 620' ' ' ILE . 47.6 ttp -74.11 125.23 90.27 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 116.403 -0.362 . . . . 74.540000000000006 111.43 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -72.45 170.61 18.89 Favored 'Trans proline' 0 C--O 1.242 0.721 0 C-N-CA 123.491 2.794 . . . . 74.209999999999994 111.891 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.06 114.47 5.86 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.914 0.864 . . . . 74.420000000000002 112.703 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.5 pp -125.12 7.15 7.89 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.105 -1.407 . . . . 74.239999999999995 107.476 171.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 16.7 m -79.81 144.04 33.87 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 113.497 -1.683 . . . . 74.540000000000006 110.564 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 68.03 43.13 83.02 Favored Glycine 0 CA--C 1.521 0.413 0 O-C-N 123.686 0.616 . . . . 74.019999999999996 114.007 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 22.2 ptp -146.91 174.79 11.18 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.288 -0.634 . . . . 75.430000000000007 109.288 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -98.05 172.87 7.34 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.547 -1.279 . . . . 73.420000000000002 107.547 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -62.97 -35.63 80.79 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.708 -0.849 . . . . 75.219999999999999 108.708 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.8 -22.36 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 115.636 -0.711 . . . . 70.0 111.506 -175.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -102.18 -31.35 10.62 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-O 121.479 0.657 . . . . 75.099999999999994 110.667 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -71.41 -32.39 68.34 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.506 -0.77 . . . . 71.019999999999996 111.484 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.605 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 34.3 tt0 -64.56 -48.95 73.2 Favored Pre-proline 0 CA--C 1.56 1.336 0 CA-C-N 116.47 -0.332 . . . . 72.329999999999998 111.196 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 88.5 Cg_exo -54.69 -38.01 91.38 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 121.471 1.447 . . . . 72.430000000000007 111.76 170.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.414 ' HA ' ' NE ' ' A' ' 577' ' ' ARG . 1.4 mmp_? -58.94 -43.18 91.14 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 121.359 -0.136 . . . . 75.329999999999998 111.325 176.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.5 pp -67.05 -45.66 76.71 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.542 0.571 . . . . 73.299999999999997 112.542 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.464 ' N ' HD11 ' A' ' 578' ' ' LEU . 5.9 ptp85 -66.71 -35.04 79.18 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.478 0.547 . . . . 72.510000000000005 112.478 176.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.97 -36.56 83.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.181 0.515 . . . . 64.530000000000001 110.03 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 12.1 tp -81.26 -9.85 59.7 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.651 -0.704 . . . . 74.109999999999999 110.694 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 67.79 42.82 85.97 Favored Glycine 0 C--O 1.243 0.671 0 N-CA-C 111.883 -0.487 . . . . 74.230000000000004 111.883 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 13.7 t90 -75.19 126.49 31.13 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 120.977 0.418 . . . . 72.519999999999996 109.879 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 18.1 p -103.52 -15.44 15.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.822 -0.626 . . . . 73.25 112.084 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -83.79 -176.71 51.37 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 121.161 -0.542 . . . . 71.120000000000005 112.953 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 51.5 ttp -100.86 141.37 33.84 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 122.344 0.258 . . . . 74.430000000000007 111.286 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 8.0 tt -80.96 107.5 13.83 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.075 -1.083 . . . . 74.230000000000004 108.075 174.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 621' ' ' THR . 24.5 t70 -98.39 116.2 30.12 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.486 -0.779 . . . . 72.0 109.578 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.0 OUTLIER -106.46 134.38 49.68 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.534 -0.757 . . . . 73.140000000000001 109.192 178.61 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -70.84 -75.24 0.63 Allowed Glycine 0 C--N 1.293 -1.846 0 N-CA-C 111.116 -0.793 . . . . 72.150000000000006 111.116 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.09 121.32 15.87 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.284 -0.635 . . . . 72.439999999999998 109.284 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -84.57 137.01 33.54 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.992 -1.114 . . . . 75.349999999999994 107.992 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 47.0 t -105.76 126.75 61.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 116.223 -0.444 . . . . 72.409999999999997 110.049 -174.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . 0.458 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 9.7 p-10 -72.12 111.55 7.44 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 122.403 1.097 . . . . 63.310000000000002 111.489 -176.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -133.98 -45.68 0.79 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.356 -1.293 . . . . 51.240000000000002 109.133 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 103.44 149.36 20.79 Favored Glycine 0 N--CA 1.422 -2.261 0 C-N-CA 120.837 -0.697 . . . . 75.409999999999997 112.356 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.479 ' HA2' ' OD1' ' A' ' 601' ' ' ASN . . . -61.51 -32.58 81.74 Favored Glycine 0 C--N 1.302 -1.339 0 CA-C-N 114.981 -0.61 . . . . 72.109999999999999 112.71 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 10.6 t -71.03 -23.56 62.19 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 122.253 1.025 . . . . 75.030000000000001 109.449 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -88.58 -1.13 57.9 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.681 -1.145 . . . . 74.25 110.672 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 48.4 m80 70.29 80.7 0.17 Allowed 'General case' 0 C--O 1.244 0.792 0 CA-C-O 122.755 1.264 . . . . 72.219999999999999 110.567 -178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . 0.479 ' OD1' ' HA2' ' A' ' 597' ' ' GLY . 30.0 p-10 -87.58 78.53 8.53 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 113.812 -1.54 . . . . 74.109999999999999 111.452 -175.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -94.07 171.61 8.74 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.601 -1.181 . . . . 73.25 109.232 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . 0.446 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 96.4 t -64.93 130.75 30.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 106.829 -1.545 . . . . 73.010000000000005 106.829 170.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.8 t -96.51 -52.72 8.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 121.169 0.509 . . . . 70.530000000000001 110.535 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -147.91 150.55 34.3 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.161 -0.681 . . . . 75.239999999999995 109.161 -175.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -139.4 144.34 38.09 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.871 -1.159 . . . . 72.430000000000007 107.871 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -63.52 -51.48 66.66 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 120.444 -0.502 . . . . 74.129999999999995 111.98 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -93.13 116.67 0.32 Allowed 'Trans proline' 0 N--CA 1.442 -1.532 0 C-N-CA 121.212 1.275 . . . . 75.120000000000005 110.328 171.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.88 160.96 34.8 Favored 'Trans proline' 0 C--O 1.248 0.989 0 C-N-CA 122.857 2.371 . . . . 75.510000000000005 112.215 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.61 133.67 56.32 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.085 -0.709 . . . . 73.109999999999999 109.085 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 100.65 -0.56 55.44 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.636 -0.792 . . . . 63.109999999999999 112.265 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 35.3 m -90.18 145.76 24.78 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.555 -0.535 . . . . 72.150000000000006 109.555 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -77.28 124.21 6.82 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 110.733 -0.947 . . . . 74.430000000000007 110.733 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.9 m -125.78 143.2 40.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 108.374 -0.972 . . . . 74.420000000000002 108.374 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -48.23 163.03 0.07 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.92 0.888 . . . . 74.409999999999997 111.965 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . 0.331 0.0 OUTLIER -56.04 -24.5 39.98 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.971 1.471 . . . . 73.239999999999995 114.971 -178.387 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -83.65 -6.26 59.4 Favored 'General case' 0 C--O 1.199 -1.589 0 C-N-CA 119.256 -0.977 . . . . 75.219999999999999 112.497 175.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.83 19.52 69.61 Favored Glycine 0 CA--C 1.491 -1.441 0 CA-C-O 119.464 -0.631 . . . . 64.099999999999994 114.561 166.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.83 118.63 14.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-O 122.12 0.962 . . . . 74.239999999999995 110.419 -168.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.481 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.7 pp -129.36 133.86 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 114.708 -1.133 . . . . 73.329999999999998 111.866 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 15.4 t -102.21 122.92 45.12 Favored 'General case' 0 C--O 1.26 1.633 0 CA-C-O 121.802 0.81 . . . . 73.310000000000002 109.553 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 1.8 pt? -139.36 167.27 22.47 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.334 -0.848 . . . . 74.409999999999997 111.742 -173.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -128.22 137.08 51.86 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.262 -1.014 . . . . 75.019999999999996 108.262 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.446 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 35.0 p90 -141.28 166.63 24.24 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.788 -0.187 . . . . 64.019999999999996 111.126 -174.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -75.57 135.2 17.8 Favored Glycine 0 N--CA 1.435 -1.4 0 CA-C-O 121.69 0.605 . . . . 71.420000000000002 113.954 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.458 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 4.2 tt0 . . . . . 0 C--N 1.296 -1.755 0 N-CA-C 107.1 -1.445 . . . . 74.230000000000004 107.1 175.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.193 0 CA-C-O 121.357 0.598 . . . . 73.150000000000006 111.594 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 16.1 p -139.18 141.1 37.99 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.823 -0.806 . . . . 61.240000000000002 108.823 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -143.02 148.42 36.74 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.818 0.342 . . . . 75.310000000000002 111.32 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.489 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.9 p-10 -79.1 139.08 38.17 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 115.407 -0.815 . . . . 72.349999999999994 110.209 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.4 pt -96.17 137.35 21.69 Favored Pre-proline 0 C--N 1.296 -1.722 0 CA-C-N 115.628 -0.715 . . . . 72.209999999999994 111.116 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -89.86 -177.22 1.34 Allowed 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.487 2.124 . . . . 72.420000000000002 109.829 170.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -99.9 137.28 38.57 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.919 -1.141 . . . . 73.450000000000003 107.919 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 16.7 m -110.81 17.31 7.65 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 CA-C-N 115.543 -0.753 . . . . 73.329999999999998 110.178 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -72.93 100.83 3.03 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.456 -0.793 . . . . 72.439999999999998 110.206 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 169.12 -46.43 0.22 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-N 115.379 -0.828 . . . . 72.219999999999999 111.864 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.415 ' O ' HG12 ' A' ' 534' ' ' VAL . 18.2 pm0 -98.07 -171.06 2.08 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 122.344 -0.504 . . . . 75.530000000000001 110.505 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 15.1 m -70.92 155.12 41.2 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.452 -0.944 . . . . 71.329999999999998 108.452 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 9.7 p -65.5 -41.73 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 O-C-N 123.06 0.225 . . . . 71.510000000000005 110.88 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -61.82 -37.98 86.44 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.913 -0.773 . . . . 65.120000000000005 108.913 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 95.1 t -71.02 -48.77 53.74 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.624 0 CA-C-N 115.525 -0.761 . . . . 71.430000000000007 109.684 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 511' ' ' ASN . . . -60.58 -36.73 79.25 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 122.769 0.428 . . . . 72.510000000000005 111.767 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 513' ' ' ASN . 23.8 mt-30 -65.23 -45.2 85.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.56 0.219 . . . . 61.340000000000003 110.47 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.514 ' O ' HG22 ' A' ' 514' ' ' VAL . 75.1 mmtt -66.6 -39.53 88.43 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 109.137 -0.69 . . . . 75.430000000000007 109.137 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 508' ' ' ALA . 20.3 t-20 -60.18 -47.02 87.68 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 125.771 1.628 . . . . 71.109999999999999 110.091 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -69.48 -42.06 75.32 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.761 -1.109 . . . . 71.129999999999995 108.592 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 1.0 OUTLIER -63.7 -35.59 81.07 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.421 -0.809 . . . . 75.120000000000005 111.392 -174.005 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 510' ' ' LYS . 71.4 t -57.78 -32.46 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.068 0.461 . . . . 72.239999999999995 111.737 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -115.36 4.76 14.45 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.559 0.695 . . . . 74.420000000000002 110.108 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -120.21 -57.59 0.24 Allowed Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 115.817 -0.629 . . . . 55.43 113.094 -174.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 64.76 28.96 12.9 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.89 0.876 . . . . 75.329999999999998 111.411 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 16.7 p -89.09 -166.92 1.72 Allowed 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.665 -1.152 . . . . 72.200000000000003 109.208 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -107.74 143.98 35.51 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 106.754 -1.572 . . . . 73.349999999999994 106.754 173.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -126.84 144.8 50.86 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.387 0.613 . . . . 71.099999999999994 112.327 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 73.5 m -132.81 149.92 52.22 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.651 -0.87 . . . . 72.25 108.651 176.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -123.18 131.78 53.81 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.025 0.44 . . . . 74.129999999999995 110.536 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -120.45 118.88 31.43 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.576 -0.898 . . . . 73.200000000000003 108.576 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 78.4 p -94.78 139.3 31.45 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.451 0.643 . . . . 73.310000000000002 112.203 -176.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.8 p -133.6 150.17 31.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.097 -1.075 . . . . 75.209999999999994 108.097 178.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.11 136.03 44.83 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.348 0.594 . . . . 72.319999999999993 111.281 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 74.3 m -156.01 163.2 25.59 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 106.803 -1.554 . . . . 74.030000000000001 106.803 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.52 -10.83 27.45 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.387 1.392 . . . . 72.140000000000001 112.709 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.452 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 10.2 mtm180 -84.48 152.51 60.77 Favored Pre-proline 0 N--CA 1.429 -1.483 0 N-CA-C 108.891 -0.781 . . . . 74.329999999999998 108.891 -176.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.17 149.35 70.57 Favored 'Trans proline' 0 C--O 1.246 0.893 0 C-N-CA 122.239 1.959 . . . . 73.530000000000001 114.41 -170.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.644 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -63.94 124.45 21.58 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.399 -1.273 . . . . 71.010000000000005 110.689 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 125.71 -21.65 6.26 Favored Glycine 0 C--N 1.291 -1.927 0 N-CA-C 111.049 -0.82 . . . . 50.219999999999999 111.049 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -75.0 137.59 41.64 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.584 -0.524 . . . . 63.520000000000003 109.584 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 503' ' ' GLN . 4.3 p -90.87 113.22 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.95 0 CA-C-O 122.084 0.945 . . . . 72.230000000000004 108.825 174.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -24.72 64.33 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.21 -1.359 . . . . 75.530000000000001 111.087 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 152.24 -157.42 27.25 Favored Glycine 0 N--CA 1.432 -1.617 0 N-CA-C 110.013 -1.235 . . . . 61.409999999999997 110.013 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.2 p -117.37 155.01 30.32 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 117.356 0.578 . . . . 72.519999999999996 109.903 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.447 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 25.7 t-20 -53.39 -51.7 73.27 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 119.252 -0.404 . . . . 74.219999999999999 111.902 174.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.9 Cg_endo -87.02 153.29 8.37 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 121.773 1.649 . . . . 75.420000000000002 110.453 174.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.32 160.68 48.86 Favored 'Trans proline' 0 C--O 1.26 1.58 0 C-N-CA 122.413 2.075 . . . . 72.319999999999993 112.545 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.6 131.83 46.86 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.84 -0.618 . . . . 53.310000000000002 109.712 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.74 -6.63 38.12 Favored Glycine 0 C--N 1.303 -1.256 0 C-N-CA 120.831 -0.7 . . . . 73.329999999999998 111.848 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 25.7 m -78.78 126.45 30.74 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.452 -0.574 . . . . 74.439999999999998 109.452 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 9.4 t -87.05 126.33 34.68 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.431 0.634 . . . . 73.530000000000001 109.319 176.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.67 159.49 55.38 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 107.782 -1.192 . . . . 74.25 107.782 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -66.38 137.56 47.52 Favored 'Trans proline' 0 N--CA 1.437 -1.808 0 C-N-CA 120.874 1.049 . . . . 75.239999999999995 110.354 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.41 -19.06 23.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.323 -0.853 . . . . 73.120000000000005 111.408 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -96.39 -9.8 29.11 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 112.211 0.448 . . . . 72.239999999999995 112.211 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 60.3 m -89.6 -175.99 4.86 Favored 'General case' 0 C--O 1.255 1.345 0 N-CA-C 112.871 0.693 . . . . 53.32 112.871 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.9 p -104.03 138.07 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 115.508 -0.769 . . . . 73.219999999999999 111.024 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 61.0 mt -107.55 138.34 34.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.88 -1.155 . . . . 74.209999999999994 107.88 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -102.84 126.89 50.15 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.145 0.498 . . . . 72.409999999999997 111.083 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.2 mp -108.04 134.72 50.53 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.108 -0.951 . . . . 75.349999999999994 109.281 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -89.41 134.04 34.26 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.921 -1.14 . . . . 75.409999999999997 107.921 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 524' ' ' SER . 38.3 t -116.08 131.2 69.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 110.21 -0.293 . . . . 74.340000000000003 110.21 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.644 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 2.3 m -83.79 122.03 28.11 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 107.839 -1.171 . . . . 73.329999999999998 107.839 177.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.73 140.18 30.91 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 106.725 -1.583 . . . . 74.109999999999999 106.725 171.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -57.91 -23.44 51.23 Favored Glycine 0 CA--C 1.489 -1.592 0 O-C-N 124.894 1.371 . . . . 73.409999999999997 114.282 -171.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 77.98 -19.52 0.43 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.759 1.224 . . . . 75.109999999999999 110.851 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.426 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 75.8 mt-30 -112.41 155.29 24.45 Favored 'General case' 0 N--CA 1.428 -1.549 0 O-C-N 121.502 -0.749 . . . . 73.549999999999997 112.042 -174.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -135.36 150.6 49.97 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.377 -1.342 . . . . 75.230000000000004 107.377 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 6.2 p -66.95 125.35 24.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 121.202 0.525 . . . . 73.400000000000006 111.661 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 563' ' ' MET . . . . . 0.495 ' SD ' HG22 ' A' ' 620' ' ' ILE . 51.3 ttp -88.34 131.02 43.66 Favored Pre-proline 0 C--N 1.309 -1.189 0 CA-C-N 116.095 -0.502 . . . . 72.239999999999995 109.731 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.18 169.21 17.21 Favored 'Trans proline' 0 C--O 1.244 0.803 0 C-N-CA 122.51 2.14 . . . . 74.219999999999999 110.88 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . 0.415 ' HA ' ' CB ' ' A' ' 610' ' ' ALA . 0.9 OUTLIER -79.22 127.83 32.54 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.286 1.041 . . . . 73.340000000000003 111.916 -177.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.3 pp -135.51 19.64 3.35 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 113.62 -1.627 . . . . 75.099999999999994 108.534 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 13.2 m -79.14 143.08 35.81 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 114.376 -1.284 . . . . 72.140000000000001 109.417 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 74.54 46.0 21.03 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 121.046 -0.597 . . . . 72.120000000000005 112.256 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -129.05 174.35 9.62 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 109.076 -0.712 . . . . 63.25 109.076 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -111.37 165.65 11.78 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.018 -1.845 . . . . 72.530000000000001 106.018 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 18.6 t-105 -61.75 -31.49 71.67 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.134 0.492 . . . . 74.230000000000004 110.139 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.5 p -65.37 -25.62 37.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 115.694 -0.684 . . . . 75.209999999999994 111.08 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.626 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 37.1 t70 -93.8 -26.2 17.06 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.578 -0.527 . . . . 74.400000000000006 109.578 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.19 -45.48 93.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.128 -0.942 . . . . 71.340000000000003 111.877 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.529 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 40.7 mt-10 -57.15 -52.95 70.31 Favored Pre-proline 0 CA--C 1.56 1.329 0 N-CA-C 112.547 0.573 . . . . 75.530000000000001 112.547 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.456 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 31.5 Cg_exo -61.28 -35.22 85.67 Favored 'Trans proline' 0 C--N 1.365 1.439 0 CA-C-N 120.491 1.211 . . . . 74.230000000000004 112.414 173.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.626 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 5.7 mmp_? -60.4 -44.74 95.39 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 120.934 -0.306 . . . . 73.310000000000002 110.651 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.6 pp -65.88 -47.09 76.02 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.023 -0.535 . . . . 71.430000000000007 112.203 -174.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.485 ' N ' HD12 ' A' ' 578' ' ' LEU . 16.8 ptm180 -66.64 -37.63 85.22 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.261 -0.427 . . . . 75.329999999999998 111.707 177.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.47 -35.61 73.39 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 111.822 0.305 . . . . 73.420000000000002 111.822 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.0 pp -83.97 -9.15 58.89 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 119.654 -0.818 . . . . 72.439999999999998 110.532 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 78.96 41.99 13.32 Favored Glycine 0 C--O 1.243 0.718 0 C-N-CA 121.197 -0.525 . . . . 74.150000000000006 112.211 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -78.21 128.78 34.26 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.565 -0.531 . . . . 73.519999999999996 109.565 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 5.2 p -82.18 -47.98 11.84 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 123.732 0.813 . . . . 75.129999999999995 112.092 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -68.42 -166.4 3.94 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 115.698 1.039 . . . . 43.450000000000003 115.698 -176.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 17.5 tpt -118.46 149.15 41.75 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 123.452 0.701 . . . . 60.350000000000001 109.538 -175.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 28.5 tp -80.46 117.61 21.34 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 121.252 0.548 . . . . 74.450000000000003 109.82 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 621' ' ' THR . 25.5 t70 -100.49 120.58 40.21 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 115.237 -0.892 . . . . 74.549999999999997 109.5 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.18 134.29 51.24 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.217 0.532 . . . . 72.019999999999996 109.784 178.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -86.47 -70.28 1.32 Allowed Glycine 0 C--N 1.288 -2.098 0 CA-C-N 115.396 -0.82 . . . . 73.120000000000005 112.651 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.42 154.13 47.73 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.656 0.265 . . . . 73.420000000000002 111.433 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -93.07 124.76 37.27 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.177 -0.92 . . . . 71.340000000000003 108.813 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 52.3 t -104.96 147.81 10.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 107.589 -1.263 . . . . 74.329999999999998 107.589 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . 0.475 ' HA ' ' HG2' ' A' ' 626' ' ' GLN . 10.7 p-10 -78.38 120.76 23.58 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.58 -0.896 . . . . 72.230000000000004 108.58 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -124.22 -52.39 1.74 Allowed 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.231 -0.588 . . . . 72.409999999999997 110.611 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 96.04 143.48 14.79 Favored Glycine 0 N--CA 1.427 -1.915 0 C-N-CA 119.935 -1.126 . . . . 64.230000000000004 111.697 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -60.5 -33.31 81.0 Favored Glycine 0 C--N 1.309 -0.956 0 N-CA-C 115.096 0.798 . . . . 75.129999999999995 115.096 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 33.4 t -77.14 -27.77 54.01 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 118.104 0.952 . . . . 75.450000000000003 109.528 -175.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -90.28 -3.42 57.8 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.102 -0.954 . . . . 70.129999999999995 109.947 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 34.0 m80 69.07 111.25 0.05 OUTLIER 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 114.491 -1.231 . . . . 72.219999999999999 112.486 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 625' ' ' GLY . 21.5 p-10 -79.4 65.01 4.44 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 123.306 1.527 . . . . 73.319999999999993 110.83 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -91.53 171.23 9.33 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 113.055 -1.884 . . . . 73.450000000000003 110.07 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 94.8 t -65.65 130.11 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 106.645 -1.613 . . . . 73.299999999999997 106.645 170.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 29.9 m -101.29 -36.32 4.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.152 0.501 . . . . 71.230000000000004 111.206 -176.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -144.27 135.98 25.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 116.167 -0.469 . . . . 73.209999999999994 109.965 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -126.62 137.79 53.35 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.161 -1.422 . . . . 72.040000000000006 107.161 174.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.461 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 45.0 t-20 -62.63 -59.11 13.62 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-O 118.99 -0.529 . . . . 72.430000000000007 112.162 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.0 Cg_exo -82.84 120.67 3.1 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.553 1.502 . . . . 75.319999999999993 110.065 175.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.8 148.31 64.55 Favored 'Trans proline' 0 C--O 1.243 0.758 0 C-N-CA 122.341 2.027 . . . . 74.5 112.29 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . 0.415 ' CB ' ' HA ' ' A' ' 565' ' ' ASP . . . -68.07 129.46 39.98 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.761 -0.654 . . . . 74.109999999999999 109.403 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.04 -10.4 47.82 Favored Glycine 0 C--N 1.302 -1.333 0 N-CA-C 110.219 -1.152 . . . . 73.040000000000006 110.219 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 37.1 m -101.68 161.92 13.29 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.801 -1.185 . . . . 70.010000000000005 107.801 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -82.82 135.22 13.72 Favored Glycine 0 N--CA 1.418 -2.528 0 C-N-CA 121.271 -0.49 . . . . 71.0 112.537 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.1 m -114.08 142.98 24.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 107.434 -1.321 . . . . 60.399999999999999 107.434 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.426 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 33.1 p-10 -56.37 170.86 0.32 Allowed 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 112.683 0.623 . . . . 75.540000000000006 112.683 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -56.98 -25.19 57.79 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.181 0.808 . . . . 74.120000000000005 113.181 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -87.57 -9.05 55.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.497 0.665 . . . . 73.150000000000006 109.5 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.54 14.92 63.18 Favored Glycine 0 C--O 1.217 -0.917 0 CA-C-N 115.628 -0.714 . . . . 72.430000000000007 113.406 172.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.57 119.74 17.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 122.416 1.103 . . . . 73.349999999999994 112.458 -167.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.495 HG22 ' SD ' ' A' ' 563' ' ' MET . 36.0 pt -122.42 133.32 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.975 0 CA-C-N 114.337 -1.301 . . . . 75.219999999999999 109.02 178.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 9.9 t -109.49 131.37 55.12 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.189 -1.041 . . . . 73.319999999999993 108.189 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.7 pp -138.73 165.91 25.76 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 112.873 0.694 . . . . 74.430000000000007 112.873 -175.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -128.45 137.83 52.02 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.51 -1.293 . . . . 72.109999999999999 107.51 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -133.44 163.13 30.04 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 120.161 -0.616 . . . . 73.540000000000006 111.387 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 601' ' ' ASN . . . -84.41 153.16 28.63 Favored Glycine 0 N--CA 1.42 -2.388 0 CA-C-N 115.446 -0.797 . . . . 73.340000000000003 112.507 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.475 ' HG2' ' HA ' ' A' ' 594' ' ' ASP . 1.0 OUTLIER . . . . . 0 C--O 1.271 2.202 0 N-CA-C 107.577 -1.268 . . . . 74.120000000000005 107.577 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 120.989 0.423 . . . . 64.219999999999999 112.035 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.406 ' HB ' HG22 ' A' ' 544' ' ' THR . 40.3 p -138.96 139.87 38.09 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.035 -0.728 . . . . 71.230000000000004 109.035 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . 0.597 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 6.1 tmtt? -134.8 143.0 46.82 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.699 -0.852 . . . . 64.109999999999999 108.699 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.597 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 9.3 p-10 -77.41 128.9 35.04 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.879 0.872 . . . . 55.25 110.712 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.7 pt -84.15 138.01 39.75 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.352 -0.84 . . . . 75.030000000000001 111.007 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.08 176.56 8.95 Favored 'Trans proline' 0 C--O 1.238 0.511 0 C-N-CA 122.666 2.244 . . . . 75.209999999999994 112.516 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -81.45 127.85 33.24 Favored 'General case' 0 C--O 1.253 1.263 0 N-CA-C 108.177 -1.046 . . . . 74.140000000000001 108.177 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.586 ' HA ' ' NE2' ' A' ' 503' ' ' GLN . 34.8 m -123.28 -16.92 4.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 113.465 0.913 . . . . 73.140000000000001 113.465 -175.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -71.11 94.84 1.16 Allowed 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 120.721 0.296 . . . . 74.430000000000007 110.897 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 153.01 -39.23 0.73 Allowed Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 120.224 -0.989 . . . . 75.439999999999998 112.224 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.586 ' NE2' ' HA ' ' A' ' 500' ' ' VAL . 15.2 pm0 -88.2 -176.91 5.56 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 119.98 -0.688 . . . . 75.049999999999997 109.685 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 14.7 m -70.84 155.3 40.97 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.435 -1.32 . . . . 74.150000000000006 107.435 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.492 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.5 p -64.39 -41.48 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 121.031 -0.267 . . . . 74.5 110.713 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 14.3 t70 -61.75 -40.88 96.68 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.596 -0.52 . . . . 73.239999999999995 109.596 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.37 -43.35 84.31 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.803 0 CA-C-N 115.576 -0.738 . . . . 72.109999999999999 109.794 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -58.37 -45.04 89.0 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 123.15 0.281 . . . . 73.450000000000003 110.6 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.2 mt-30 -63.52 -45.29 91.3 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.754 -0.657 . . . . 63.140000000000001 110.369 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.524 ' O ' HG21 ' A' ' 514' ' ' VAL . 47.0 mmtm -62.99 -43.91 97.47 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.142 -0.481 . . . . 74.530000000000001 110.535 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -64.58 -43.74 92.9 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.656 -0.702 . . . . 74.310000000000002 111.85 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.2 pp -69.22 -36.43 77.22 Favored 'General case' 0 C--O 1.207 -1.181 0 C-N-CA 120.308 -0.557 . . . . 73.310000000000002 110.63 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.435 ' ND2' ' HA ' ' A' ' 517' ' ' PHE . 2.0 t-20 -63.13 -35.79 81.45 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 123.155 0.582 . . . . 75.340000000000003 110.45 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.524 HG21 ' O ' ' A' ' 510' ' ' LYS . 89.1 t -60.84 -36.34 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.05 0.452 . . . . 75.319999999999993 110.83 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . 0.471 ' O ' ' HE3' ' A' ' 495' ' ' LYS . 84.2 m-85 -112.71 22.64 14.32 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.15 0.5 . . . . 75.25 110.024 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -144.3 -58.83 0.02 OUTLIER Glycine 0 CA--C 1.48 -2.11 0 C-N-CA 119.849 -1.167 . . . . 64.140000000000001 112.797 -176.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.435 ' HA ' ' ND2' ' A' ' 513' ' ' ASN . 96.6 m-85 66.06 23.66 11.06 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 122.93 1.347 . . . . 75.150000000000006 109.656 -173.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 518' ' ' THR . . . . . 0.479 ' C ' ' HD2' ' A' ' 519' ' ' LYS . 5.8 p -83.08 174.7 10.61 Favored 'General case' 0 N--CA 1.394 -3.233 0 CA-C-N 112.646 -2.07 . . . . 74.530000000000001 108.373 176.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.479 ' HD2' ' C ' ' A' ' 518' ' ' THR . 11.8 mptt -107.94 140.28 41.3 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 108.848 -0.797 . . . . 75.430000000000007 108.848 -177.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -125.41 154.03 42.55 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 121.16 0.505 . . . . 73.230000000000004 111.81 -172.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 32.9 p -135.59 147.17 48.6 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 107.724 -1.213 . . . . 74.340000000000003 107.724 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -119.74 119.83 34.81 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.245 0.545 . . . . 74.5 110.687 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -110.77 116.66 31.67 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.053 -1.092 . . . . 75.129999999999995 108.053 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.6 m -96.39 126.91 41.92 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.587 -0.445 . . . . 73.25 110.199 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.35 149.09 24.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 106.819 -1.549 . . . . 74.420000000000002 106.819 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.402 ' HA ' ' CG ' ' A' ' 557' ' ' LYS . 6.1 p-10 -80.18 135.85 36.37 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-O 121.186 0.517 . . . . 73.219999999999999 110.565 -176.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 43.7 m -153.0 168.91 10.55 Favored Pre-proline 0 C--N 1.293 -1.869 0 N-CA-C 106.152 -1.796 . . . . 74.120000000000005 106.152 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -75.78 -10.63 20.02 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 121.255 1.303 . . . . 73.329999999999998 111.503 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -81.01 137.2 49.91 Favored Pre-proline 0 N--CA 1.413 -2.289 0 N-CA-C 108.252 -1.018 . . . . 72.340000000000003 108.252 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -65.3 142.39 72.73 Favored 'Trans proline' 0 C--O 1.255 1.325 0 C-N-CA 123.351 2.701 . . . . 72.319999999999993 115.304 -170.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.714 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -59.58 118.2 5.8 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 114.613 -1.176 . . . . 73.219999999999999 111.739 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 136.0 -27.04 3.07 Favored Glycine 0 C--N 1.296 -1.69 0 N-CA-C 109.846 -1.302 . . . . 72.430000000000007 109.846 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -74.46 136.04 42.28 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.943 -0.629 . . . . 73.150000000000006 110.273 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 5.7 p -100.95 113.9 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.315 0 N-CA-C 108.201 -1.037 . . . . 63.140000000000001 108.201 172.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.95 -8.1 58.6 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.024 -0.534 . . . . 52.420000000000002 112.11 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 147.06 -171.86 27.66 Favored Glycine 0 N--CA 1.42 -2.408 0 C-N-CA 120.271 -0.966 . . . . 73.239999999999995 112.178 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 4.5 p -116.9 159.0 23.09 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 107.485 -1.302 . . . . 64.519999999999996 107.485 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -64.77 -47.17 75.71 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 118.33 -1.348 . . . . 74.549999999999997 112.084 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -73.58 137.07 24.6 Favored 'Trans proline' 0 C--N 1.366 1.465 0 N-CA-C 108.384 -1.429 . . . . 65.129999999999995 108.384 169.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . 0.428 ' HG2' ' OG1' ' A' ' 543' ' ' THR . 15.7 Cg_endo -59.97 140.62 93.68 Favored 'Trans proline' 0 C--O 1.246 0.89 0 C-N-CA 122.299 1.999 . . . . 73.430000000000007 112.589 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.6 132.69 54.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.758 -0.655 . . . . 63.140000000000001 109.59 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.44 -21.01 36.01 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.207 -0.757 . . . . 72.109999999999999 111.207 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 543' ' ' THR . . . . . 0.428 ' OG1' ' HG2' ' A' ' 540' ' ' PRO . 70.5 m -77.08 137.93 39.24 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.21 0.529 . . . . 72.340000000000003 110.873 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 7.1 m -84.39 123.2 29.96 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 108.628 -0.878 . . . . 73.439999999999998 108.628 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.98 157.39 63.71 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 108.424 -0.954 . . . . 73.0 108.424 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -59.99 136.26 68.27 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 121.355 1.37 . . . . 75.349999999999994 112.866 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.93 -20.54 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.671 -1.15 . . . . 75.209999999999994 111.105 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -84.13 -17.93 38.47 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.434 -1.257 . . . . 72.200000000000003 111.535 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 50.0 m -97.28 163.29 12.96 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 114.107 1.151 . . . . 61.520000000000003 114.107 -171.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.8 p -89.81 129.72 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 114.568 -1.196 . . . . 62.420000000000002 110.522 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 56.4 mt -92.74 132.13 37.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 107.697 -1.223 . . . . 73.329999999999998 107.697 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.43 117.75 35.17 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 121.509 0.671 . . . . 72.519999999999996 110.293 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.0 mp -103.96 124.51 49.13 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.884 -1.053 . . . . 74.219999999999999 108.948 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -92.46 118.79 31.32 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.412 0.625 . . . . 72.140000000000001 110.252 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.69 133.82 41.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.002 -0.999 . . . . 72.310000000000002 109.24 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.714 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 3.1 m -83.13 119.75 24.92 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.312 -1.366 . . . . 74.549999999999997 107.312 176.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.402 ' CG ' ' HA ' ' A' ' 526' ' ' ASP . 8.6 ptpp? -96.07 142.95 27.66 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.922 -1.51 . . . . 72.530000000000001 106.922 172.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -56.04 -23.47 39.37 Favored Glycine 0 C--O 1.244 0.773 0 O-C-N 124.641 1.213 . . . . 60.310000000000002 114.773 -171.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 78.55 -9.26 1.53 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 124.082 0.953 . . . . 72.319999999999993 110.364 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -112.6 156.88 21.93 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 113.387 0.884 . . . . 73.420000000000002 113.387 -170.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -130.67 157.04 43.86 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.479 -1.237 . . . . 73.209999999999994 107.915 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 97.0 t -74.72 121.49 26.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 O-C-N 123.212 0.32 . . . . 73.420000000000002 110.838 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 563' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 564' ' ' PRO . 42.8 ttm -64.84 125.81 89.74 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 123.461 0.705 . . . . 74.299999999999997 111.836 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . 0.448 ' O ' ' HG2' ' A' ' 563' ' ' MET . 16.2 Cg_exo -74.07 169.35 22.64 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.825 2.35 . . . . 74.299999999999997 110.504 172.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.87 138.42 46.27 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.41 0.624 . . . . 75.439999999999998 112.263 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -152.79 24.62 0.58 Allowed 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.786 -1.191 . . . . 71.420000000000002 107.786 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 6.2 m -78.07 141.53 38.76 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.434 -1.257 . . . . 72.430000000000007 111.371 -173.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 70.42 27.6 72.44 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 116.065 -0.516 . . . . 73.230000000000004 113.51 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 569' ' ' MET . . . . . 0.539 ' O ' ' HA ' ' A' ' 602' ' ' ARG . 27.0 ptt? -99.51 160.02 14.59 Favored 'General case' 0 CA--C 1.476 -1.884 0 C-N-CA 120.233 -0.587 . . . . 72.25 109.936 -176.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . 0.552 ' HA ' ' O ' ' A' ' 601' ' ' ASN . 6.5 m-85 -103.38 175.05 5.61 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.638 -1.986 . . . . 74.409999999999997 105.638 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -70.1 -28.49 65.44 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 118.507 -1.277 . . . . 71.530000000000001 109.579 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.9 m -73.37 -13.38 16.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.557 -0.747 . . . . 71.230000000000004 110.548 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.585 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 24.0 t70 -101.46 -28.63 12.46 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.899 -0.778 . . . . 75.25 108.899 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -59.11 -53.05 62.77 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.046 -0.979 . . . . 75.329999999999998 111.803 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -54.8 -50.5 85.59 Favored Pre-proline 0 CA--C 1.558 1.287 0 N-CA-C 113.365 0.876 . . . . 74.420000000000002 113.365 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -57.67 -28.96 83.79 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 121.336 1.357 . . . . 62.240000000000002 112.766 172.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 23.0 mmm180 -68.76 -38.9 80.41 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 121.802 -0.561 . . . . 72.040000000000006 110.805 176.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.521 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 11.0 mp -59.75 -48.05 83.22 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 120.707 0.289 . . . . 74.439999999999998 110.453 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -66.37 -38.44 87.58 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.838 -0.619 . . . . 72.219999999999999 112.411 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.03 -39.06 76.0 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.545 0.688 . . . . 73.319999999999993 111.018 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . 0.456 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 8.5 tp -83.28 -9.5 59.07 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 115.24 -0.891 . . . . 73.299999999999997 110.522 -178.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 60.87 42.35 99.57 Favored Glycine 0 CA--C 1.507 -0.466 0 N-CA-C 111.028 -0.829 . . . . 55.329999999999998 111.028 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . 0.521 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 14.6 t90 -85.21 126.74 33.9 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.469 -0.567 . . . . 71.319999999999993 109.469 -175.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 12.7 t -99.14 -16.24 18.67 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 116.127 -0.488 . . . . 54.399999999999999 110.956 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -77.15 -177.49 45.88 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 121.509 -0.377 . . . . 74.219999999999999 112.691 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 48.4 tpp -112.8 147.16 37.5 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.192 -0.67 . . . . 72.140000000000001 109.192 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.4 tt -86.91 127.87 35.06 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.42 -1.326 . . . . 64.140000000000001 107.42 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -100.07 119.11 37.8 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.547 -0.538 . . . . 75.340000000000003 109.547 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.49 133.79 46.87 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.461 -0.896 . . . . 74.219999999999999 109.91 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.36 -79.05 0.95 Allowed Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.456 -0.793 . . . . 45.240000000000002 112.091 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -137.72 145.77 42.93 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 110.047 -0.353 . . . . 74.150000000000006 110.047 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -88.15 124.63 34.0 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.729 -1.582 . . . . 74.239999999999995 106.729 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 39.1 t -104.43 126.18 59.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.531 -0.914 . . . . 73.310000000000002 108.531 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . 0.478 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 32.2 t70 -73.58 106.39 5.33 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.379 -0.528 . . . . 75.439999999999998 111.114 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -113.54 -12.33 12.92 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.142 -0.936 . . . . 75.109999999999999 109.536 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 114.49 137.6 6.52 Favored Glycine 0 N--CA 1.428 -1.855 0 N-CA-C 111.084 -0.807 . . . . 42.420000000000002 111.084 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -63.23 -38.49 96.56 Favored Glycine 0 C--N 1.318 -0.464 0 C-N-CA 121.725 -0.274 . . . . 75.299999999999997 112.887 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 33.6 t -72.79 -22.82 60.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.869 0.842 . . . . 73.409999999999997 109.414 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -86.92 -3.43 59.08 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.006 -0.997 . . . . 65.030000000000001 110.546 -175.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 70.5 m80 67.67 158.11 0.14 Allowed 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.798 1.239 . . . . 75.219999999999999 113.199 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 570' ' ' PHE . 21.1 p30 -93.77 68.16 3.9 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.592 0.71 . . . . 75.420000000000002 112.905 -179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 569' ' ' MET . 2.7 ptp180 -85.47 146.72 26.81 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 119.365 -0.934 . . . . 72.530000000000001 112.171 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 74.2 t -57.95 130.11 20.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 114.053 -1.431 . . . . 74.219999999999999 109.516 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.17 -23.02 4.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.025 0.441 . . . . 73.400000000000006 111.086 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -155.97 135.9 12.76 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.548 -0.751 . . . . 75.400000000000006 109.726 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -124.5 137.64 54.4 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.698 -1.964 . . . . 74.120000000000005 105.698 173.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.71 -53.52 35.68 Favored Pre-proline 0 C--N 1.317 -0.832 0 C-N-CA 119.066 -1.053 . . . . 72.010000000000005 112.86 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -91.94 113.76 0.34 Allowed 'Trans proline' 0 N--CA 1.438 -1.789 0 C-N-CA 121.217 1.278 . . . . 72.219999999999999 109.344 171.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -70.14 160.11 50.75 Favored 'Trans proline' 0 C--O 1.247 0.947 0 C-N-CA 122.332 2.021 . . . . 73.530000000000001 111.539 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -62.18 138.89 58.48 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 109.844 -0.428 . . . . 73.200000000000003 109.844 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 102.1 -14.74 57.01 Favored Glycine 0 C--N 1.306 -1.113 0 N-CA-C 111.579 -0.608 . . . . 62.530000000000001 111.579 -175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 6.0 m -92.05 155.03 18.37 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.881 -0.785 . . . . 71.310000000000002 108.881 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -80.01 134.22 13.31 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 121.033 -0.603 . . . . 71.140000000000001 112.496 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 13.6 m -127.06 143.13 41.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 124.226 1.01 . . . . 72.430000000000007 109.879 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -49.58 162.87 0.14 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.322 1.049 . . . . 75.129999999999995 112.971 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -59.45 -24.83 63.87 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 114.056 1.132 . . . . 75.319999999999993 114.056 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -82.71 -8.82 59.57 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 119.598 -0.841 . . . . 73.030000000000001 109.523 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.2 14.68 64.31 Favored Glycine 0 C--O 1.221 -0.68 0 C-N-CA 123.519 0.581 . . . . 72.109999999999999 113.678 173.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.29 119.9 17.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 122.099 0.952 . . . . 73.239999999999995 110.556 -168.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.414 HG22 ' HE3' ' A' ' 563' ' ' MET . 2.7 pp -128.64 134.62 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-N 115.087 -0.961 . . . . 75.400000000000006 112.768 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 10.2 t -105.11 124.69 49.97 Favored 'General case' 0 C--O 1.258 1.551 0 CA-C-N 115.355 -0.839 . . . . 65.010000000000005 109.641 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.1 pp -140.12 167.35 22.33 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.514 -0.767 . . . . 73.310000000000002 112.411 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -127.3 140.25 52.33 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.788 -0.819 . . . . 75.0 108.788 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -139.97 167.37 22.28 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.628 -0.715 . . . . 75.340000000000003 110.039 -170.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -60.1 177.15 3.33 Favored Glycine 0 CA--C 1.538 1.472 0 O-C-N 124.008 0.818 . . . . 71.349999999999994 113.847 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.478 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 5.6 tp-100 . . . . . 0 C--N 1.292 -1.921 0 C-N-CA 123.712 0.805 . . . . 73.230000000000004 108.971 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.231 0 CA-C-O 121.895 0.855 . . . . 72.200000000000003 110.882 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 7.9 p -135.27 144.82 47.02 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.807 -1.183 . . . . 72.409999999999997 107.807 176.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -141.34 143.79 34.21 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 109.533 -0.543 . . . . 75.120000000000005 109.533 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.5 m-20 -83.02 124.73 30.7 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.036 -0.529 . . . . 72.400000000000006 110.46 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.4 pt -88.83 137.35 30.0 Favored Pre-proline 0 C--N 1.305 -1.327 0 CA-C-N 115.81 -0.632 . . . . 74.420000000000002 110.434 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.89 -177.34 3.76 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.311 2.007 . . . . 75.409999999999997 111.776 177.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -93.61 127.44 39.29 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.317 -0.994 . . . . 65.409999999999997 108.317 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.556 ' O ' ' HG2' ' A' ' 503' ' ' GLN . 28.2 m -122.06 -3.98 8.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 112.717 0.636 . . . . 73.439999999999998 112.717 -176.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -66.3 102.3 0.84 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.018 0.437 . . . . 75.420000000000002 110.423 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 141.94 -22.28 2.47 Favored Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 120.808 -0.711 . . . . 63.340000000000003 112.742 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.556 ' HG2' ' O ' ' A' ' 500' ' ' VAL . 6.3 pt20 -100.46 -179.1 4.0 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 109.091 -0.707 . . . . 75.030000000000001 109.091 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 21.1 m -74.4 155.41 38.11 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 108.495 -0.928 . . . . 73.200000000000003 108.495 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.18 -41.57 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 C-N-CA 122.697 0.399 . . . . 74.299999999999997 110.883 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . 0.484 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 28.5 t70 -59.69 -43.7 93.93 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.056 0.455 . . . . 62.140000000000001 110.162 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 90.2 t -67.99 -46.61 81.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 114.491 -1.231 . . . . 74.150000000000006 110.052 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.6 -45.79 90.86 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 123.41 0.444 . . . . 72.230000000000004 111.258 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -65.23 -44.49 88.07 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.178 -0.464 . . . . 75.329999999999998 111.745 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.557 ' O ' HG22 ' A' ' 514' ' ' VAL . 3.4 ptpp? -67.45 -39.92 85.4 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 119.632 -0.827 . . . . 64.430000000000007 111.186 176.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -62.44 -44.27 96.81 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.524 0.678 . . . . 74.200000000000003 110.918 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.65 -47.14 86.8 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-N 114.395 -1.275 . . . . 74.299999999999997 108.951 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -65.98 -35.23 80.02 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 115.439 -0.8 . . . . 70.030000000000001 112.675 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 510' ' ' LYS . 72.5 t -58.45 -33.76 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.115 0.483 . . . . 73.310000000000002 110.552 176.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -114.2 11.34 17.47 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.056 0.455 . . . . 74.439999999999998 110.117 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -127.47 -59.82 0.13 Allowed Glycine 0 CA--C 1.475 -2.416 0 C-N-CA 120.437 -0.887 . . . . 60.5 113.242 -172.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 66.25 21.55 11.03 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 121.926 0.87 . . . . 75.540000000000006 109.134 -172.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.4 p -91.48 -173.57 3.62 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 114.16 -1.382 . . . . 74.099999999999994 110.148 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 52.5 mtmt -108.11 143.85 36.28 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.384 -0.969 . . . . 75.519999999999996 108.384 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -129.17 151.08 50.23 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 120.866 0.365 . . . . 73.409999999999997 111.357 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 67.7 m -140.25 151.5 45.18 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 107.419 -1.326 . . . . 74.340000000000003 107.419 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -121.66 124.47 44.38 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.704 0.764 . . . . 74.329999999999998 112.334 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -101.43 133.05 46.66 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.999 -1.482 . . . . 75.409999999999997 106.999 175.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 22.2 m -118.37 122.12 42.06 Favored 'General case' 0 C--N 1.29 -1.978 0 C-N-CA 120.114 -0.634 . . . . 71.129999999999995 111.519 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.9 p -122.41 149.56 25.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.691 -1.226 . . . . 75.329999999999998 107.691 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.424 ' C ' ' HG ' ' A' ' 527' ' ' SER . 2.8 p30 -85.79 136.72 33.21 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 119.808 -0.757 . . . . 64.450000000000003 111.636 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.424 ' HG ' ' C ' ' A' ' 526' ' ' ASP . 53.1 m -157.47 162.22 27.75 Favored Pre-proline 0 C--N 1.302 -1.486 0 N-CA-C 106.346 -1.724 . . . . 72.329999999999998 106.346 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.13 10.26 0.42 Allowed 'Trans proline' 0 CA--C 1.556 1.578 0 C-N-CA 122.343 2.028 . . . . 74.019999999999996 114.44 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.551 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 0.6 OUTLIER -95.26 145.77 30.13 Favored Pre-proline 0 CA--C 1.506 -0.716 0 N-CA-C 107.453 -1.314 . . . . 63.329999999999998 107.453 175.724 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -64.81 148.38 89.99 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.45 2.1 . . . . 72.109999999999999 114.341 -172.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.85 113.76 2.96 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-N 114.323 -1.308 . . . . 74.040000000000006 110.742 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 126.57 -16.95 6.54 Favored Glycine 0 N--CA 1.42 -2.396 0 C-N-CA 119.918 -1.134 . . . . 64.409999999999997 111.768 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -82.92 128.18 34.21 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.28 -0.637 . . . . 75.430000000000007 109.28 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 5.3 p -94.36 112.71 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 N-CA-C 107.207 -1.405 . . . . 75.140000000000001 107.207 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 29.7 p -102.86 12.81 35.68 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 115.253 -0.885 . . . . 73.120000000000005 112.523 -172.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 169.04 172.42 35.77 Favored Glycine 0 N--CA 1.432 -1.616 0 C-N-CA 120.007 -1.092 . . . . 64.430000000000007 111.693 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 4.0 p -131.21 146.82 52.48 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.864 -0.791 . . . . 73.040000000000006 108.864 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.46 ' HB3' ' HB3' ' A' ' 552' ' ' GLU . 2.8 t-20 -64.44 -51.58 59.19 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 119.784 -0.767 . . . . 75.540000000000006 109.872 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.62 139.75 23.08 Favored 'Trans proline' 0 C--N 1.366 1.457 0 C-N-CA 120.859 1.039 . . . . 75.319999999999993 109.975 171.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -64.55 140.53 69.35 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 122.259 1.973 . . . . 75.510000000000005 112.834 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -68.15 132.54 47.38 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.452 -0.795 . . . . 72.310000000000002 109.752 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.68 -9.07 58.5 Favored Glycine 0 N--CA 1.436 -1.33 0 N-CA-C 111.187 -0.765 . . . . 73.140000000000001 111.187 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 91.3 m -86.2 136.83 33.04 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.187 0.518 . . . . 74.530000000000001 111.291 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 9.8 t -81.31 125.79 30.78 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.757 -0.831 . . . . 73.230000000000004 108.757 174.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.74 161.8 44.32 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 107.89 -1.152 . . . . 72.319999999999993 107.89 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -62.54 138.51 70.77 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 120.967 1.112 . . . . 75.439999999999998 110.768 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.87 -19.9 24.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 121.376 0.608 . . . . 75.209999999999994 111.343 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -96.17 -0.74 49.61 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 121.789 -0.569 . . . . 55.409999999999997 110.523 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 10.4 t -86.6 171.95 10.63 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.4 0.619 . . . . 63.420000000000002 109.501 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 7.6 p -115.68 137.86 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.296 0 CA-C-N 115.379 -0.828 . . . . 73.120000000000005 110.071 -177.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 3.1 mp -94.48 135.1 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 108.342 -0.985 . . . . 75.049999999999997 108.342 175.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 538' ' ' ASN . 6.3 tp10 -102.46 117.32 34.46 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.695 -1.224 . . . . 74.519999999999996 107.695 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -91.58 121.45 33.27 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.43 -0.952 . . . . 74.519999999999996 108.43 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -89.9 101.99 14.69 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.641 -1.244 . . . . 73.239999999999995 107.641 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 38.4 t -101.31 136.83 31.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-N 115.223 -0.899 . . . . 73.340000000000003 110.025 -174.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 59.7 m -91.71 128.18 37.45 Favored 'General case' 0 N--CA 1.41 -2.469 0 CA-C-N 115.973 -0.558 . . . . 72.25 109.744 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.4 ptpt -90.58 142.93 27.25 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 105.904 -1.887 . . . . 74.439999999999998 105.904 169.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -54.48 -24.07 29.74 Favored Glycine 0 CA--C 1.479 -2.182 0 O-C-N 125.145 1.528 . . . . 73.540000000000006 115.25 -168.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 74.43 -22.74 0.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.441 1.097 . . . . 74.329999999999998 110.794 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.508 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 44.3 mt-30 -113.37 148.31 36.03 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-O 121.488 0.661 . . . . 75.239999999999995 111.461 -172.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -125.53 158.02 35.58 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.886 -1.052 . . . . 74.349999999999994 108.835 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.88 125.12 22.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 121.315 0.578 . . . . 65.209999999999994 111.127 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 20.2 ttt -75.42 125.83 88.34 Favored Pre-proline 0 N--CA 1.427 -1.601 0 CA-C-N 115.356 -0.838 . . . . 73.430000000000007 110.988 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.06 169.74 20.68 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 123.039 2.493 . . . . 74.209999999999994 111.799 177.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -75.29 130.04 38.41 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.682 0.753 . . . . 61.049999999999997 112.036 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . 0.441 ' O ' ' HG2' ' A' ' 569' ' ' MET . 2.6 pp -141.27 18.26 2.24 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 123.021 1.391 . . . . 74.310000000000002 107.823 174.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 7.3 m -79.14 132.2 36.48 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 113.283 -1.781 . . . . 63.219999999999999 111.174 -173.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 64.54 39.66 96.99 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.541 -0.754 . . . . 72.450000000000003 114.29 174.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 569' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 16.0 ptp -128.89 -177.34 4.17 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 117.312 0.556 . . . . 74.319999999999993 109.933 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 601' ' ' ASN . 49.3 m-85 -93.53 163.44 13.57 Favored 'General case' 0 C--O 1.25 1.083 0 N-CA-C 108.202 -1.036 . . . . 75.239999999999995 108.202 -178.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . 0.465 ' CH2' HD12 ' A' ' 587' ' ' LEU . 16.3 t-105 -63.07 -32.16 73.47 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.166 -1.05 . . . . 71.319999999999993 108.166 174.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.75 -10.48 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.471 -0.786 . . . . 72.019999999999996 111.159 -176.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -101.36 -43.9 5.8 Favored 'General case' 0 C--O 1.256 1.401 0 N-CA-C 108.09 -1.078 . . . . 73.329999999999998 108.09 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . 0.5 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -62.82 -51.44 67.05 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.326 -1.306 . . . . 75.319999999999993 111.945 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.524 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 37.8 tt0 -51.75 -54.1 43.64 Favored Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 112.395 0.517 . . . . 75.200000000000003 112.395 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 52.9 Cg_exo -59.55 -38.29 83.47 Favored 'Trans proline' 0 C--N 1.38 2.237 0 C-N-CA 121.972 1.782 . . . . 73.430000000000007 112.721 177.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -66.76 -37.14 84.04 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 120.381 -0.528 . . . . 72.230000000000004 112.198 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.579 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 89.7 mt -66.75 -47.49 72.08 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.898 -0.592 . . . . 75.0 110.529 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -65.59 -34.52 78.43 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.635 -0.426 . . . . 74.519999999999996 111.048 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.24 -32.02 71.92 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.953 0.406 . . . . 74.310000000000002 110.943 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 578' ' ' LEU . 2.8 pp -80.89 -6.92 59.27 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.537 -0.465 . . . . 72.299999999999997 110.033 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 85.6 34.86 12.65 Favored Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 115.833 -0.621 . . . . 65.140000000000001 112.878 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . 0.422 ' CZ3' HD12 ' A' ' 578' ' ' LEU . 21.3 t90 -67.19 130.6 43.64 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.544 0.172 . . . . 75.209999999999994 111.054 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 62.8 p -103.24 -23.14 13.63 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-O 120.987 0.422 . . . . 72.549999999999997 112.023 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -75.98 -175.92 39.82 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-O 121.72 0.622 . . . . 72.349999999999994 114.359 -174.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 54.3 ttp -115.05 141.35 48.12 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.951 -0.625 . . . . 75.549999999999997 109.753 -176.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . 0.465 HD12 ' CH2' ' A' ' 571' ' ' TRP . 5.5 tt -85.64 125.68 33.34 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.061 0.457 . . . . 71.340000000000003 110.074 -175.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -95.89 104.35 16.28 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.543 -0.753 . . . . 74.120000000000005 110.333 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.16 133.51 54.25 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.138 -1.43 . . . . 72.420000000000002 107.138 173.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -111.68 -42.33 1.04 Allowed Glycine 0 C--N 1.284 -2.318 0 C-N-CA 119.874 -1.155 . . . . 74.530000000000001 113.993 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.4 135.64 33.86 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 120.569 -0.453 . . . . 63.140000000000001 111.379 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -90.86 124.44 35.17 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 105.954 -1.869 . . . . 70.0 105.954 172.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . 0.498 ' O ' ' HG2' ' A' ' 626' ' ' GLN . 46.3 t -104.81 156.26 6.02 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 N-CA-C 109.049 -0.723 . . . . 74.310000000000002 109.049 -174.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . 0.433 ' HA ' ' HG2' ' A' ' 626' ' ' GLN . 1.6 p-10 -71.49 126.94 30.99 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.298 0.571 . . . . 75.140000000000001 109.894 -176.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -148.36 -57.09 0.22 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.953 -1.021 . . . . 74.420000000000002 109.318 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 116.34 124.57 3.66 Favored Glycine 0 N--CA 1.426 -2.005 0 C-N-CA 120.638 -0.791 . . . . 71.409999999999997 111.764 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -63.64 -35.96 92.72 Favored Glycine 0 C--N 1.316 -0.542 0 N-CA-C 112.113 -0.395 . . . . 75.219999999999999 112.113 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 6.5 m -76.04 -24.02 55.15 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-O 122.014 0.911 . . . . 75.25 108.99 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -87.96 -2.41 58.59 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.607 -1.179 . . . . 73.129999999999995 109.343 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . 0.523 ' HB3' ' CE2' ' A' ' 570' ' ' PHE . 30.6 m80 81.56 125.19 0.04 OUTLIER 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.41 1.884 . . . . 74.140000000000001 111.952 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . 0.544 ' O ' ' HA ' ' A' ' 570' ' ' PHE . 8.5 p30 -73.57 96.23 2.41 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 122.597 1.189 . . . . 74.510000000000005 109.42 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 21.4 mmm-85 -100.17 151.49 21.36 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 107.351 -1.351 . . . . 74.530000000000001 107.351 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 8.1 p -65.58 131.68 31.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 106.971 -1.492 . . . . 74.329999999999998 106.971 172.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.61 -26.21 3.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 120.112 -0.635 . . . . 71.5 111.895 -174.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -155.6 138.21 15.1 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.949 -0.76 . . . . 72.519999999999996 108.949 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -133.64 139.5 46.52 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.524 -1.288 . . . . 72.5 107.524 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -71.99 -51.47 8.45 Favored Pre-proline 0 C--N 1.307 -1.246 0 C-N-CA 119.627 -0.829 . . . . 74.129999999999995 111.152 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -92.3 122.19 0.58 Allowed 'Trans proline' 0 N--CA 1.442 -1.516 0 C-N-CA 121.111 1.207 . . . . 73.209999999999994 111.332 174.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -70.35 153.35 66.29 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 121.77 1.646 . . . . 75.310000000000002 110.11 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -65.36 133.08 50.6 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.266 -0.642 . . . . 72.439999999999998 109.266 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.15 -7.68 44.27 Favored Glycine 0 C--N 1.314 -0.656 0 C-N-CA 120.786 -0.721 . . . . 73.540000000000006 111.481 -176.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 19.5 m -88.16 155.59 19.69 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.532 -0.914 . . . . 71.019999999999996 108.532 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.54 126.53 7.51 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 111.116 -0.794 . . . . 74.239999999999995 111.116 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 18.5 m -113.84 141.97 28.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.609 -0.515 . . . . 65.239999999999995 109.609 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.508 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.3 p-10 -53.4 167.94 0.18 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.682 1.193 . . . . 72.340000000000003 113.16 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -57.68 -24.66 57.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.533 -0.758 . . . . 73.450000000000003 112.98 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.436 ' OD2' ' HB ' ' A' ' 619' ' ' ILE . 28.2 t70 -82.47 -9.49 59.41 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.493 -0.483 . . . . 72.510000000000005 109.703 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.63 18.3 67.89 Favored Glycine 0 CA--C 1.506 -0.525 0 CA-C-N 116.094 -0.503 . . . . 53.049999999999997 112.649 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . 0.436 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -69.86 119.5 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-O 122.269 1.033 . . . . 73.430000000000007 111.329 -167.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.459 ' O ' HD11 ' A' ' 620' ' ' ILE . 2.6 pp -116.98 131.3 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.067 0 CA-C-N 114.703 -1.135 . . . . 74.329999999999998 111.191 177.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 54.4 m -104.68 117.88 35.19 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.549 -0.908 . . . . 73.319999999999993 108.549 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.6 pp -139.72 165.82 26.25 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.602 -0.272 . . . . 72.349999999999994 111.16 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -139.47 140.9 37.39 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.647 -0.871 . . . . 75.209999999999994 108.647 174.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -128.0 166.44 18.38 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 116.216 -0.447 . . . . 74.430000000000007 111.192 -171.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -71.77 153.34 50.08 Favored Glycine 0 N--CA 1.428 -1.864 0 CA-C-N 115.524 -0.762 . . . . 65.040000000000006 113.529 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 593' ' ' VAL . 3.4 pt20 . . . . . 0 C--N 1.299 -1.593 0 C-N-CA 123.514 0.726 . . . . 71.140000000000001 110.171 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.595 0 CA-C-O 121.152 0.501 . . . . 70.140000000000001 109.916 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.9 p -135.55 149.41 49.43 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.65 -0.705 . . . . 74.109999999999999 110.711 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . 0.422 ' HE2' ' H ' ' A' ' 496' ' ' ASP . 0.1 OUTLIER -150.6 132.61 15.21 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.259 -1.756 . . . . 75.019999999999996 106.259 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.3 p-10 -81.47 133.1 35.35 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.149 0.5 . . . . 74.349999999999994 110.349 175.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.1 pt -86.09 138.22 34.86 Favored Pre-proline 0 C--N 1.304 -1.383 0 CA-C-N 115.465 -0.789 . . . . 74.129999999999995 111.886 -177.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.64 178.41 7.61 Favored 'Trans proline' 0 C--O 1.245 0.832 0 C-N-CA 122.408 2.072 . . . . 74.430000000000007 112.009 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -80.07 96.99 6.65 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 122.627 1.203 . . . . 73.329999999999998 110.446 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.433 ' HA ' ' NE2' ' A' ' 503' ' ' GLN . 28.5 m -95.39 -1.07 10.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 CA-C-N 115.313 -0.858 . . . . 75.349999999999994 111.828 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -76.12 107.27 8.23 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 108.738 -0.838 . . . . 64.010000000000005 108.738 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 142.71 -30.17 2.08 Favored Glycine 0 C--N 1.299 -1.494 0 C-N-CA 120.746 -0.74 . . . . 71.319999999999993 112.791 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.433 ' NE2' ' HA ' ' A' ' 500' ' ' VAL . 7.8 pt20 -100.35 -177.88 3.64 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 120.109 -0.636 . . . . 72.299999999999997 110.501 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 2.8 m -70.34 155.61 40.43 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.565 -0.532 . . . . 65.439999999999998 109.565 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.416 ' HA ' ' CG2' ' A' ' 534' ' ' VAL . 5.9 p -55.04 -46.32 77.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 123.394 0.678 . . . . 72.530000000000001 112.1 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.69 -39.18 90.51 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.898 -0.592 . . . . 65.519999999999996 110.543 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 59.9 t -73.07 -49.01 41.61 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.258 0 CA-C-N 115.337 -0.847 . . . . 74.420000000000002 109.888 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' A' ' 500' ' ' VAL . . . -58.73 -44.8 90.54 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 122.994 0.518 . . . . 73.209999999999994 110.972 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -64.99 -45.68 84.61 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.367 -0.378 . . . . 74.209999999999994 111.304 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.533 ' O ' HG23 ' A' ' 514' ' ' VAL . 17.8 ptpt -68.0 -37.86 81.97 Favored 'General case' 0 C--O 1.21 -1.0 0 C-N-CA 120.656 -0.418 . . . . 75.340000000000003 111.254 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -60.04 -48.4 81.86 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 123.4 0.437 . . . . 71.540000000000006 110.517 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . 0.432 HD11 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -68.71 -36.21 78.14 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 120.259 -0.577 . . . . 74.129999999999995 110.886 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.432 ' N ' HD11 ' A' ' 512' ' ' LEU . 1.2 t-20 -66.14 -35.59 80.88 Favored 'General case' 0 C--O 1.203 -1.376 0 C-N-CA 123.783 0.833 . . . . 75.219999999999999 110.505 -178.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 510' ' ' LYS . 75.9 t -60.94 -33.41 55.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.95 0.405 . . . . 63.310000000000002 111.11 177.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -102.51 -4.67 24.99 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.145 -0.622 . . . . 71.0 111.014 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -122.85 -50.84 0.22 Allowed Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 120.427 -0.892 . . . . 72.5 113.544 -171.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 67.5 27.18 8.02 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 122.515 1.15 . . . . 74.010000000000005 109.337 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.7 p -80.29 -167.09 1.2 Allowed 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 113.027 -1.897 . . . . 74.420000000000002 110.981 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -119.2 142.79 47.69 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.595 -1.261 . . . . 73.510000000000005 107.595 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -132.65 153.41 51.12 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 112.545 0.572 . . . . 73.549999999999997 112.545 -175.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.7 m -132.65 151.51 51.94 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.057 -1.461 . . . . 71.340000000000003 107.057 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -124.27 133.36 53.51 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 109.179 -0.674 . . . . 75.319999999999993 109.179 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -125.41 116.1 21.33 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.221 -1.029 . . . . 75.299999999999997 108.221 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 23.9 m -98.46 124.97 43.48 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.13 0.491 . . . . 75.019999999999996 111.053 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 11.0 p -126.56 154.19 36.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.799 -1.185 . . . . 74.219999999999999 107.799 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.93 135.63 35.38 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.34 0.59 . . . . 72.340000000000003 110.183 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 50.3 m -167.65 139.13 2.47 Favored Pre-proline 0 C--O 1.197 -1.68 0 N-CA-C 105.097 -2.186 . . . . 55.310000000000002 105.097 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.43 9.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.566 2.124 0 C-N-CA 123.466 2.777 . . . . 72.150000000000006 116.997 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.23 147.07 63.93 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 106.338 -1.727 . . . . 74.230000000000004 106.338 172.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.72 141.56 95.62 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.194 1.93 . . . . 75.299999999999997 112.921 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 557' ' ' LYS . . . -61.69 116.12 4.53 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 114.811 -1.086 . . . . 65.129999999999995 112.128 -176.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 121.46 -16.24 9.12 Favored Glycine 0 N--CA 1.423 -2.226 0 CA-C-N 115.044 -0.98 . . . . 74.140000000000001 111.538 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -77.47 128.28 33.95 Favored 'General case' 0 C--O 1.248 1.012 0 N-CA-C 109.328 -0.619 . . . . 74.209999999999994 109.328 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.416 ' CG2' ' HA ' ' A' ' 505' ' ' VAL . 38.0 t -86.1 112.43 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.165 0 N-CA-C 106.952 -1.499 . . . . 73.129999999999995 106.952 173.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 17.4 p -84.33 -2.42 57.04 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.594 0.712 . . . . 74.230000000000004 111.209 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.66 179.43 27.33 Favored Glycine 0 N--CA 1.419 -2.491 0 C-N-CA 120.606 -0.806 . . . . 65.540000000000006 112.435 174.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 1.6 p -116.69 158.05 24.43 Favored 'General case' 0 C--N 1.271 -2.825 0 N-CA-C 106.694 -1.595 . . . . 72.0 106.694 177.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -60.43 -49.5 89.97 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 118.794 -1.162 . . . . 73.049999999999997 112.015 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -73.61 128.8 12.97 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 N-CA-C 108.238 -1.485 . . . . 53.439999999999998 108.238 167.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.72 155.93 60.53 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 122.501 2.134 . . . . 72.519999999999996 113.126 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.05 129.63 43.08 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.245 0.618 . . . . 72.530000000000001 110.152 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.2 -15.22 54.8 Favored Glycine 0 N--CA 1.435 -1.422 0 N-CA-C 111.715 -0.554 . . . . 54.439999999999998 111.715 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 37.6 m -76.27 134.1 39.88 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.939 0.4 . . . . 70.109999999999999 111.407 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.0 t -76.53 124.06 27.02 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.45 -0.945 . . . . 72.420000000000002 108.45 173.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.04 160.72 50.77 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 108.14 -1.059 . . . . 54.340000000000003 108.14 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.48 136.84 26.89 Favored 'Trans proline' 0 N--CA 1.435 -1.952 0 CA-C-N 119.627 0.903 . . . . 72.450000000000003 110.218 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.17 -19.85 26.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.764 0.792 . . . . 74.239999999999995 110.943 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -89.64 -7.71 54.11 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.058 -0.974 . . . . 74.409999999999997 110.812 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.4 t -88.08 167.51 13.6 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.46 0.648 . . . . 73.400000000000006 109.887 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 9.8 p -108.73 121.25 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 CA-C-N 115.266 -0.879 . . . . 74.019999999999996 109.254 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 58.5 mt -87.24 133.14 30.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 115.298 -0.864 . . . . 74.409999999999997 110.045 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.15 117.6 34.91 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.763 0.792 . . . . 74.299999999999997 111.85 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.36 114.01 26.43 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 113.614 -1.63 . . . . 73.120000000000005 108.862 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -85.35 104.86 15.56 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.75 0.786 . . . . 70.340000000000003 109.766 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 23.7 t -92.96 132.8 36.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 114.667 -1.151 . . . . 71.239999999999995 108.171 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 53.0 m -105.47 135.83 46.15 Favored 'General case' 0 N--CA 1.409 -2.516 0 CA-C-O 121.244 0.545 . . . . 71.25 111.093 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.0 ptpt -116.57 128.01 55.02 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 108.107 -1.071 . . . . 73.420000000000002 108.107 174.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -58.71 -24.81 57.8 Favored Glycine 0 CA--C 1.496 -1.125 0 O-C-N 123.877 0.735 . . . . 24.120000000000001 111.37 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . 0.419 ' ND2' ' HB3' ' A' ' 616' ' ' ARG . 65.0 t30 63.88 28.03 14.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 122.846 1.308 . . . . 72.549999999999997 109.063 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.476 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 82.7 mt-30 -112.5 151.03 30.43 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 113.725 -1.58 . . . . 74.329999999999998 108.333 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -130.42 147.42 52.12 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 109.254 -0.647 . . . . 74.450000000000003 109.254 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.93 120.07 13.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 O-C-N 123.896 0.748 . . . . 73.150000000000006 109.683 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 563' ' ' MET . . . . . 0.585 ' SD ' HG23 ' A' ' 620' ' ' ILE . 42.9 ttp -83.17 129.08 62.35 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 116.26 -0.427 . . . . 72.340000000000003 111.158 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . 0.408 ' O ' ' HG2' ' A' ' 563' ' ' MET . 57.9 Cg_endo -73.76 169.57 22.05 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.547 2.165 . . . . 71.319999999999993 110.317 174.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -76.93 135.31 38.76 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.383 0.611 . . . . 73.200000000000003 111.259 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . 0.4 ' O ' ' HG2' ' A' ' 569' ' ' MET . 0.9 OUTLIER -114.53 -14.98 12.08 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.326 -0.99 . . . . 73.5 108.326 -177.259 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 33.2 t -77.47 147.39 35.92 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.585 -0.697 . . . . 75.239999999999995 110.91 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 96.26 11.01 55.37 Favored Glycine 0 CA--C 1.501 -0.798 0 CA-C-N 115.806 -0.634 . . . . 75.519999999999996 113.411 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 569' ' ' MET . . . . . 0.4 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 19.2 ptm -133.49 169.11 17.46 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.749 -0.463 . . . . 62.149999999999999 109.749 177.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -89.52 158.25 17.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.683 -0.858 . . . . 74.25 108.683 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -65.6 -25.05 67.23 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.189 -0.671 . . . . 74.340000000000003 109.189 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 23.0 m -69.22 -26.99 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 115.599 -0.728 . . . . 74.010000000000005 112.497 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.509 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 12.0 t70 -101.85 -23.45 14.17 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 108.538 -0.912 . . . . 74.230000000000004 108.538 175.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 577' ' ' ARG . . . -61.98 -46.73 87.96 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 115.531 -0.759 . . . . 71.450000000000003 112.341 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.473 ' HA ' HD12 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -60.31 -49.19 91.65 Favored Pre-proline 0 CA--C 1.565 1.532 0 C-N-CA 120.279 -0.568 . . . . 75.329999999999998 110.199 179.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 62.5 Cg_exo -52.59 -29.78 42.36 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.328 2.019 . . . . 72.019999999999996 113.328 169.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 10.4 mmm180 -62.57 -39.53 93.97 Favored 'General case' 0 C--O 1.21 -1.007 0 O-C-N 121.791 -0.568 . . . . 72.010000000000005 110.47 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.765 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 9.6 mp -58.84 -49.65 76.94 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.155 0.503 . . . . 64.109999999999999 110.615 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -66.74 -38.37 86.52 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.388 -0.823 . . . . 73.319999999999993 112.389 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.29 -35.7 73.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.982 0.42 . . . . 44.310000000000002 111.583 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 6.0 tp -81.7 -9.67 59.58 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 123.892 0.877 . . . . 64.340000000000003 110.801 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 66.05 39.8 94.89 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.905 -0.878 . . . . 61.149999999999999 110.905 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . 0.765 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 7.3 t90 -79.69 127.52 32.29 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 108.528 -0.916 . . . . 72.340000000000003 108.528 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 584' ' ' THR . . . . . 0.478 ' OG1' ' HA ' ' A' ' 617' ' ' ASP . 0.8 OUTLIER -78.62 -39.7 36.48 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 125.345 1.458 . . . . 75.319999999999993 112.78 -176.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -77.92 -162.01 17.92 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.929 -0.578 . . . . 71.030000000000001 111.759 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 65.8 mtt -133.82 160.76 36.64 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 122.426 -0.456 . . . . 72.140000000000001 109.867 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 22.7 tp -80.53 111.06 16.59 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.853 -1.166 . . . . 64.400000000000006 107.853 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 621' ' ' THR . 22.6 t70 -99.51 112.63 24.81 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.073 -0.512 . . . . 63.229999999999997 111.198 -172.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.88 133.61 34.23 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 118.848 -1.141 . . . . 74.340000000000003 109.975 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.71 -63.84 1.8 Allowed Glycine 0 C--N 1.296 -1.663 0 N-CA-C 110.998 -0.841 . . . . 60.149999999999999 110.998 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -137.04 145.12 43.64 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 121.012 0.434 . . . . 74.25 109.965 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -91.79 127.38 37.23 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.4 -1.704 . . . . 64.0 106.4 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 61.3 t -102.98 125.63 57.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 108.328 -0.99 . . . . 72.25 108.328 -175.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -72.31 107.99 5.21 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 121.491 0.662 . . . . 75.409999999999997 109.802 -173.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -123.56 -54.47 1.76 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.572 -0.74 . . . . 72.319999999999993 110.957 -175.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 104.18 147.55 17.45 Favored Glycine 0 N--CA 1.413 -2.879 0 N-CA-C 109.636 -1.386 . . . . 75.120000000000005 109.636 -173.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.74 -33.08 62.49 Favored Glycine 0 C--N 1.309 -0.921 0 N-CA-C 113.875 0.31 . . . . 53.450000000000003 113.875 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 11.8 m -68.33 -24.06 64.79 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 123.918 0.887 . . . . 73.109999999999999 110.879 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -88.6 -1.85 58.28 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.317 -0.856 . . . . 74.040000000000006 110.303 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 41.5 m80 74.5 121.23 0.04 OUTLIER 'General case' 0 C--O 1.242 0.689 0 C-N-CA 125.527 1.531 . . . . 72.230000000000004 111.952 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -82.4 63.4 6.55 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 115.493 -0.776 . . . . 72.120000000000005 111.497 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -95.55 160.5 14.48 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.397 -0.82 . . . . 75.230000000000004 109.729 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 72.7 t -71.11 130.37 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.104 0 N-CA-C 105.144 -2.169 . . . . 70.109999999999999 105.144 169.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.7 m -102.69 -28.6 3.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 120.284 -0.567 . . . . 73.230000000000004 111.763 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -157.08 135.81 11.58 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 116.62 -0.264 . . . . 74.329999999999998 111.049 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -111.62 128.95 56.21 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.731 -1.211 . . . . 72.430000000000007 107.731 170.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.43 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 8.4 t30 -57.78 -52.37 74.9 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 112.206 0.447 . . . . 75.430000000000007 112.206 -176.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 5.2 Cg_exo -83.65 122.74 3.15 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 121.823 1.682 . . . . 72.409999999999997 109.318 171.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.02 155.8 61.13 Favored 'Trans proline' 0 C--O 1.258 1.484 0 C-N-CA 122.859 2.373 . . . . 74.450000000000003 113.848 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.53 138.72 58.3 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.436 -0.802 . . . . 51.25 109.599 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 103.53 -11.64 54.04 Favored Glycine 0 C--N 1.298 -1.531 0 C-N-CA 120.438 -0.887 . . . . 74.420000000000002 111.864 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 17.2 m -83.48 141.97 31.26 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.377 -0.601 . . . . 71.319999999999993 109.377 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.69 113.9 3.75 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.109 -1.196 . . . . 54.100000000000001 110.109 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.5 m -102.01 142.67 16.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 O-C-N 122.982 -0.128 . . . . 71.329999999999998 110.667 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.476 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 0.7 OUTLIER -50.33 164.78 0.11 Allowed 'General case' 0 C--O 1.21 -0.982 0 N-CA-C 113.465 0.913 . . . . 71.010000000000005 113.465 177.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . 0.419 ' HB3' ' ND2' ' A' ' 559' ' ' ASN . 14.9 ptm180 -48.74 -27.89 3.24 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.66 1.726 . . . . 75.25 115.66 -171.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.478 ' HA ' ' OG1' ' A' ' 584' ' ' THR . 20.0 p-10 -97.2 -7.06 33.27 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.545 -0.462 . . . . 72.310000000000002 111.287 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.0 17.14 65.14 Favored Glycine 0 C--O 1.215 -1.058 0 CA-C-O 119.657 -0.524 . . . . 64.319999999999993 114.311 167.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.49 119.09 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-O 121.716 0.77 . . . . 70.409999999999997 110.768 -168.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.585 HG23 ' SD ' ' A' ' 563' ' ' MET . 2.6 pp -129.35 134.05 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-N 115.277 -0.874 . . . . 75.530000000000001 111.31 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 13.1 t -99.03 130.42 45.36 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.45 -0.795 . . . . 74.120000000000005 108.984 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -139.59 167.91 21.03 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.671 -0.695 . . . . 73.349999999999994 111.76 -174.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -127.07 140.74 52.06 Favored 'General case' 0 C--O 1.256 1.41 0 N-CA-C 109.045 -0.724 . . . . 75.25 109.045 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -139.26 165.75 26.36 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.465 -0.334 . . . . 74.010000000000005 110.354 -175.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -78.64 139.47 22.3 Favored Glycine 0 N--CA 1.434 -1.467 0 O-C-N 123.677 0.611 . . . . 61.350000000000001 113.328 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 C--N 1.288 -2.108 0 C-N-CA 125.525 1.53 . . . . 72.400000000000006 107.881 -179.301 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.744 0 CA-C-O 121.044 0.449 . . . . 64.329999999999998 110.589 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 25.9 p -140.12 145.36 37.49 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 110.043 -0.354 . . . . 74.129999999999995 110.043 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -139.64 155.51 47.37 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.428 -1.323 . . . . 73.340000000000003 107.428 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.4 p-10 -98.15 144.26 27.8 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.203 -0.599 . . . . 71.129999999999995 110.749 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.1 pt -87.09 137.42 33.05 Favored Pre-proline 0 C--N 1.295 -1.781 0 CA-C-N 115.073 -0.967 . . . . 75.150000000000006 111.592 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -85.03 -176.03 2.26 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.551 2.168 . . . . 74.120000000000005 111.053 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -86.22 114.94 23.45 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.18 0.514 . . . . 74.010000000000005 109.793 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 17.5 m -119.73 58.78 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-O 122.746 1.26 . . . . 70.230000000000004 110.422 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -118.73 107.47 13.7 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.181 -1.372 . . . . 62.530000000000001 108.677 174.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 142.42 -25.38 2.32 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 118.972 -1.585 . . . . 74.5 113.734 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -101.74 -174.68 2.65 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 117.782 0.791 . . . . 74.340000000000003 109.858 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 7.5 m -73.13 155.5 39.61 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.895 -1.15 . . . . 73.530000000000001 107.895 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.542 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.4 p -60.2 -44.72 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 111.715 0.265 . . . . 71.109999999999999 111.715 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.12 -36.11 82.96 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 120.543 -0.463 . . . . 70.239999999999995 110.084 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 68.4 t -68.9 -45.38 80.66 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.445 0 CA-C-N 115.616 -0.72 . . . . 74.200000000000003 109.257 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.424 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -60.29 -42.95 96.56 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 123.228 0.33 . . . . 72.420000000000002 110.538 177.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.542 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.7 mt-30 -63.46 -43.22 97.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.011 -0.366 . . . . 74.150000000000006 110.011 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.535 ' O ' HG21 ' A' ' 514' ' ' VAL . 46.0 mmtm -64.48 -43.91 92.67 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.443 0.639 . . . . 74.230000000000004 109.792 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -61.95 -48.26 81.21 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.109 -1.405 . . . . 75.400000000000006 110.13 -175.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . 0.4 HD11 ' N ' ' A' ' 513' ' ' ASN . 4.2 pp -69.65 -35.78 75.49 Favored 'General case' 0 C--O 1.208 -1.082 0 CA-C-N 115.509 -0.769 . . . . 75.430000000000007 110.862 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 1.7 t-20 -61.44 -35.32 77.24 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 123.925 0.89 . . . . 74.120000000000005 110.105 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 510' ' ' LYS . 97.7 t -59.18 -38.0 71.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.872 0.368 . . . . 70.310000000000002 111.298 178.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -108.22 10.26 27.89 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.628 -0.508 . . . . 62.520000000000003 109.628 -176.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -132.66 -56.74 0.08 OUTLIER Glycine 0 N--CA 1.428 -1.835 0 C-N-CA 120.074 -1.06 . . . . 75.010000000000005 113.813 -172.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 63.41 23.21 13.62 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 122.055 0.931 . . . . 72.209999999999994 110.082 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 518' ' ' THR . . . . . 0.404 HG22 ' HA ' ' A' ' 547' ' ' VAL . 1.0 OUTLIER -83.72 -174.8 5.49 Favored 'General case' 0 N--CA 1.412 -2.327 0 C-N-CA 125.984 1.714 . . . . 72.239999999999995 110.669 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.74 141.89 38.6 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.357 -1.349 . . . . 74.150000000000006 107.357 178.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -133.05 148.37 52.21 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.056 0.455 . . . . 70.150000000000006 112.192 -175.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 48.4 m -141.48 155.39 45.84 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.57 -0.9 . . . . 71.040000000000006 108.57 173.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -116.92 139.29 50.81 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.07 0.462 . . . . 75.140000000000001 111.493 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -122.37 118.71 29.07 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.333 -1.358 . . . . 74.120000000000005 107.333 176.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 11.6 m -103.93 127.32 51.46 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 120.689 -0.404 . . . . 75.340000000000003 111.493 -174.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 14.3 p -121.08 156.7 24.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.883 -1.155 . . . . 71.109999999999999 107.883 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -70.85 135.15 47.88 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-O 120.84 0.353 . . . . 75.150000000000006 110.647 -176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 65.9 m -165.04 158.07 14.05 Favored Pre-proline 0 C--N 1.31 -1.148 0 N-CA-C 107.667 -1.235 . . . . 75.230000000000004 107.667 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -66.25 -15.05 46.9 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.332 2.022 . . . . 65.209999999999994 113.257 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.66 140.22 81.32 Favored Pre-proline 0 CA--C 1.519 -0.225 0 N-CA-C 108.936 -0.765 . . . . 75.129999999999995 108.936 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.56 146.28 97.07 Favored 'Trans proline' 0 C--O 1.252 1.192 0 C-N-CA 122.764 2.31 . . . . 65.420000000000002 112.888 -175.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -59.82 110.95 1.28 Allowed 'General case' 0 C--O 1.244 0.813 0 CA-C-N 115.29 -0.868 . . . . 74.349999999999994 110.883 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 136.03 -20.86 3.56 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 120.569 -0.824 . . . . 62.329999999999998 112.129 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -82.79 132.91 35.15 Favored 'General case' 0 C--O 1.248 1.019 0 CA-C-O 121.15 0.5 . . . . 74.299999999999997 110.673 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.424 HG11 ' CB ' ' A' ' 508' ' ' ALA . 7.3 p -99.32 119.64 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.533 0 N-CA-C 107.902 -1.147 . . . . 75.340000000000003 107.902 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.5 p -98.77 12.92 34.12 Favored 'General case' 0 C--N 1.274 -2.694 0 CA-C-N 115.107 -0.951 . . . . 72.349999999999994 113.301 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 143.23 -176.93 22.43 Favored Glycine 0 CA--C 1.493 -1.296 0 C-N-CA 120.433 -0.889 . . . . 73.230000000000004 112.196 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 7.0 p -117.41 157.1 26.78 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.372 -0.973 . . . . 55.25 108.372 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.406 ' HB2' ' OE2' ' A' ' 552' ' ' GLU . 44.3 t-20 -56.5 -58.22 18.4 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 119.983 -0.687 . . . . 75.409999999999997 110.689 175.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.96 140.75 32.06 Favored 'Trans proline' 0 C--N 1.365 1.422 0 CA-C-N 120.63 1.261 . . . . 73.109999999999999 109.965 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.57 156.48 63.74 Favored 'Trans proline' 0 C--O 1.252 1.18 0 C-N-CA 122.466 2.111 . . . . 65.120000000000005 112.348 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.58 137.62 58.3 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.015 -0.539 . . . . 54.219999999999999 110.798 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.1 -16.13 50.32 Favored Glycine 0 CA--C 1.492 -1.347 0 N-CA-C 111.485 -0.646 . . . . 73.319999999999993 111.485 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 71.0 m -74.05 122.95 23.47 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 109.945 -0.391 . . . . 75.109999999999999 109.945 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.3 t -80.43 124.62 29.06 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 108.473 -0.936 . . . . 73.329999999999998 108.473 176.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.7 m -122.72 156.58 61.54 Favored Pre-proline 0 C--N 1.294 -1.835 0 N-CA-C 107.468 -1.308 . . . . 73.230000000000004 107.468 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -67.67 138.47 45.4 Favored 'Trans proline' 0 N--CA 1.436 -1.894 0 C-N-CA 121.68 1.587 . . . . 75.120000000000005 111.82 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.404 ' HA ' HG22 ' A' ' 518' ' ' THR . 7.5 p -63.79 -20.53 26.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 115.087 -0.961 . . . . 71.409999999999997 111.455 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -87.79 -17.46 31.53 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.882 0.372 . . . . 72.109999999999999 110.488 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 53.3 m -88.07 159.61 18.17 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-O 122.312 1.053 . . . . 74.310000000000002 113.304 -173.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 68.9 t -89.85 129.49 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 CA-C-N 113.204 -1.816 . . . . 73.340000000000003 110.267 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 56.0 mt -91.57 140.59 15.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.727 -1.212 . . . . 75.230000000000004 107.727 176.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . 0.406 ' OE2' ' HB2' ' A' ' 538' ' ' ASN . 21.9 tt0 -103.26 117.7 35.11 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 110.339 -0.245 . . . . 72.329999999999998 110.339 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.3 mp -99.76 123.22 43.8 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 123.851 0.72 . . . . 73.439999999999998 110.016 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -85.95 106.89 17.46 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 123.472 0.709 . . . . 71.400000000000006 109.193 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 524' ' ' SER . 42.8 t -105.63 144.96 14.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.479 -0.782 . . . . 74.129999999999995 109.492 -176.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 46.8 m -93.35 126.92 38.73 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 116.077 -0.511 . . . . 64.109999999999999 109.961 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -99.01 131.43 45.06 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 106.175 -1.787 . . . . 74.239999999999995 106.175 169.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -62.92 -24.25 66.56 Favored Glycine 0 CA--C 1.492 -1.394 0 O-C-N 124.673 1.233 . . . . 73.019999999999996 114.271 -170.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 75.15 -27.02 0.19 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.52 1.128 . . . . 70.209999999999994 111.199 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.475 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 59.9 mt-30 -111.92 163.53 14.12 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 115.713 -0.676 . . . . 73.219999999999999 110.646 -172.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -141.09 157.28 45.52 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.895 -1.048 . . . . 73.5 108.841 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.22 126.75 33.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.931 -0.396 . . . . 73.420000000000002 109.931 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 563' ' ' MET . . . . . 0.446 ' SD ' HG23 ' A' ' 620' ' ' ILE . 49.5 ttp -94.23 137.13 22.92 Favored Pre-proline 0 C--N 1.314 -0.958 0 N-CA-C 111.946 0.351 . . . . 73.140000000000001 111.946 -176.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.25 169.81 21.36 Favored 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 122.861 2.374 . . . . 73.549999999999997 111.261 173.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -84.79 140.65 31.06 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.796 -0.446 . . . . 65.420000000000002 109.796 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . 0.446 ' O ' ' HG2' ' A' ' 569' ' ' MET . 2.4 pp -138.73 16.62 2.69 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.622 0.725 . . . . 74.310000000000002 111.471 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 60.1 p -79.8 150.28 30.79 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.453 -0.573 . . . . 71.340000000000003 109.453 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . 0.41 ' O ' ' HD2' ' A' ' 602' ' ' ARG . . . 85.32 29.95 26.29 Favored Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 120.077 -1.059 . . . . 71.120000000000005 113.289 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 569' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 19.8 ptp -131.84 -176.1 3.94 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.796 -0.816 . . . . 75.400000000000006 108.796 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -109.53 165.43 11.67 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.149 -1.426 . . . . 63.310000000000002 107.149 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -64.78 -30.45 71.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.41 0.624 . . . . 74.120000000000005 109.348 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.6 p -72.37 -10.97 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.882 0.849 . . . . 74.299999999999997 109.955 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.553 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 45.8 t0 -101.7 -40.84 6.79 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.974 -1.121 . . . . 75.439999999999998 107.974 174.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.29 -42.53 95.66 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.067 -0.97 . . . . 72.049999999999997 112.817 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.678 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 32.8 tt0 -59.7 -53.24 67.57 Favored Pre-proline 0 CA--C 1.567 1.628 0 C-N-CA 120.236 -0.586 . . . . 71.530000000000001 110.977 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 80.2 Cg_exo -56.32 -32.32 87.86 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 121.812 1.675 . . . . 74.420000000000002 112.716 172.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 3.6 mmp_? -59.82 -42.47 93.57 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-O 119.39 -0.338 . . . . 75.430000000000007 111.034 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.7 pp -65.81 -47.08 76.26 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 120.71 -0.396 . . . . 75.430000000000007 111.846 -175.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.457 ' N ' HD12 ' A' ' 578' ' ' LEU . 4.5 ptp180 -65.72 -37.27 85.94 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 112.175 0.435 . . . . 75.200000000000003 112.175 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.99 -32.68 69.57 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.009 0.433 . . . . 71.420000000000002 112.038 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 14.3 tp -85.82 -9.1 57.58 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 121.424 0.631 . . . . 64.409999999999997 110.926 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 75.63 21.47 76.96 Favored Glycine 0 C--N 1.311 -0.806 0 C-N-CA 120.563 -0.827 . . . . 64.510000000000005 112.652 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 15.0 t90 -87.46 127.35 35.23 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.576 -1.268 . . . . 75.510000000000005 107.576 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 15.0 t -116.07 2.26 13.38 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 119.678 -0.809 . . . . 71.329999999999998 112.254 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -74.06 177.07 45.91 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 119.448 -1.358 . . . . 65.120000000000005 110.402 172.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 67.2 mtt -97.57 140.14 32.43 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.145 -0.622 . . . . 75.200000000000003 112.124 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 48.5 tp -88.43 116.72 26.86 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.878 -1.156 . . . . 75.120000000000005 107.878 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 621' ' ' THR . 30.6 t70 -106.66 117.49 34.18 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.066 0.46 . . . . 75.230000000000004 111.327 -176.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.14 134.55 35.19 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.971 -0.559 . . . . 74.129999999999995 110.524 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -75.51 -84.34 0.38 Allowed Glycine 0 C--N 1.294 -1.793 0 CA-C-N 115.357 -0.838 . . . . 60.329999999999998 111.812 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.05 154.5 47.1 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.343 0.116 . . . . 61.409999999999997 110.777 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -101.63 127.84 48.19 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 124.795 1.238 . . . . 74.200000000000003 108.346 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 626' ' ' GLN . 40.2 t -104.13 132.72 50.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 115.527 -0.761 . . . . 73.099999999999994 109.243 -175.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -72.4 126.82 30.78 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.202 0.525 . . . . 70.019999999999996 111.771 -175.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . 0.432 ' HB3' ' ND2' ' A' ' 601' ' ' ASN . . . -150.97 -57.9 0.16 Allowed 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.865 -1.061 . . . . 74.439999999999998 108.701 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 140.88 130.92 2.65 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 111.016 -0.834 . . . . 72.150000000000006 111.016 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.67 -31.95 61.07 Favored Glycine 0 C--O 1.22 -0.771 0 C-N-CA 122.856 0.265 . . . . 54.530000000000001 112.54 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 29.4 t -61.55 -23.61 66.08 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.033 0.933 . . . . 73.239999999999995 110.312 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -87.41 -12.2 46.91 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.503 -0.771 . . . . 75.049999999999997 110.343 -176.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 55.05 72.96 0.44 Allowed 'General case' 0 C--O 1.249 1.061 0 C-N-CA 123.956 0.902 . . . . 71.530000000000001 111.437 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . 0.432 ' ND2' ' HB3' ' A' ' 595' ' ' ALA . 45.3 m-80 -84.44 93.72 8.36 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.531 1.158 . . . . 75.150000000000006 111.213 -174.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . 0.41 ' HD2' ' O ' ' A' ' 568' ' ' GLY . 18.6 mtm180 -74.46 171.49 13.68 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 113.027 -1.897 . . . . 73.150000000000006 110.282 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 90.0 t -58.7 129.33 20.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.185 -0.672 . . . . 73.109999999999999 109.185 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 24.2 m -110.19 -27.98 2.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-O 120.972 0.415 . . . . 73.219999999999999 111.358 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -139.49 135.51 33.59 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 116.025 -0.534 . . . . 74.340000000000003 110.439 -176.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -132.66 128.77 37.75 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 104.642 -2.355 . . . . 73.140000000000001 104.642 171.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.416 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 28.5 t-20 -59.36 -55.5 45.44 Favored Pre-proline 0 N--CA 1.471 0.608 0 N-CA-C 113.232 0.826 . . . . 73.109999999999999 113.232 -175.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.449 ' HG2' HG22 ' A' ' 620' ' ' ILE . 12.4 Cg_exo -79.17 116.39 3.65 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 121.056 1.171 . . . . 73.019999999999996 109.328 171.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.71 161.27 46.64 Favored 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 123.129 2.553 . . . . 73.439999999999998 112.85 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.08 139.0 57.75 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.937 -0.574 . . . . 73.140000000000001 109.707 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 90.56 -8.05 80.41 Favored Glycine 0 C--N 1.303 -1.262 0 C-N-CA 120.402 -0.904 . . . . 62.340000000000003 112.305 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 52.6 m -90.62 151.65 21.2 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.236 -0.653 . . . . 63.409999999999997 109.236 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -76.98 130.14 10.24 Favored Glycine 0 N--CA 1.433 -1.546 0 N-CA-C 111.416 -0.674 . . . . 63.310000000000002 111.416 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.49 142.79 33.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 109.898 -0.408 . . . . 75.329999999999998 109.898 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.475 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.0 p-10 -51.42 166.94 0.1 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.646 1.179 . . . . 64.340000000000003 112.749 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -58.64 -25.8 63.08 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 113.037 0.754 . . . . 75.140000000000001 113.037 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.528 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 68.0 m-20 -86.17 -7.13 58.78 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 119.855 -0.738 . . . . 75.439999999999998 111.007 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 65.59 18.55 65.97 Favored Glycine 0 C--O 1.215 -1.052 0 O-C-N 123.448 0.467 . . . . 62.340000000000003 112.865 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.89 119.62 17.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 122.349 1.071 . . . . 72.329999999999998 111.802 -166.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.449 HG22 ' HG2' ' A' ' 608' ' ' PRO . 40.1 pt -128.21 134.37 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 CA-C-N 114.544 -1.207 . . . . 73.450000000000003 110.753 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 8.9 t -104.9 130.06 53.14 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.611 -1.255 . . . . 74.239999999999995 107.611 174.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -138.79 165.65 26.45 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.221 -0.445 . . . . 74.340000000000003 110.435 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -137.8 147.32 44.51 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.253 0.549 . . . . 74.010000000000005 110.587 175.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -136.14 165.31 26.03 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.161 -1.052 . . . . 74.340000000000003 108.161 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -86.17 -164.78 39.93 Favored Glycine 0 N--CA 1.422 -2.245 0 C-N-CA 119.77 -1.205 . . . . 72.030000000000001 112.058 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' A' ' 593' ' ' VAL . 3.1 tp-100 . . . . . 0 C--N 1.281 -2.399 0 C-N-CA 123.52 0.728 . . . . 75.5 109.45 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.708 0 CA-C-O 121.518 0.675 . . . . 73.409999999999997 111.357 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 48.8 p -133.75 155.44 49.76 Favored 'General case' 0 C--O 1.25 1.125 0 N-CA-C 107.405 -1.332 . . . . 64.109999999999999 107.405 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . 0.614 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 4.9 tmtt? -131.28 134.02 45.98 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.693 -0.854 . . . . 75.5 108.693 175.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.614 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 0.8 OUTLIER -78.05 124.05 27.57 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 124.679 1.192 . . . . 74.349999999999994 110.954 176.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.3 pt -86.77 131.52 45.04 Favored Pre-proline 0 C--N 1.295 -1.79 0 CA-C-N 115.703 -0.68 . . . . 75.430000000000007 110.846 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -93.48 176.92 1.34 Allowed 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 122.133 1.889 . . . . 71.219999999999999 111.571 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -90.22 103.36 16.04 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.273 1.035 . . . . 74.340000000000003 108.233 176.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 534' ' ' VAL . 17.9 m -92.45 23.99 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 114.595 -1.184 . . . . 72.340000000000003 111.77 -175.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -74.11 99.03 3.25 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.21 -0.45 . . . . 70.230000000000004 110.321 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 163.04 -44.0 0.34 Allowed Glycine 0 N--CA 1.428 -1.843 0 C-N-CA 119.541 -1.314 . . . . 74.329999999999998 113.004 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.418 ' O ' HG11 ' A' ' 534' ' ' VAL . 18.6 pm0 -92.75 -171.27 2.68 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 120.231 -0.588 . . . . 74.319999999999993 110.419 -177.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 6.8 m -77.77 155.22 31.3 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 108.167 -1.049 . . . . 74.129999999999995 108.167 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.413 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.9 p -63.4 -42.01 94.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 111.859 0.318 . . . . 65.530000000000001 111.859 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . 0.421 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 27.4 t70 -62.8 -39.02 92.98 Favored 'General case' 0 C--O 1.199 -1.554 0 N-CA-C 109.442 -0.577 . . . . 71.010000000000005 109.442 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 90.1 t -66.06 -44.82 91.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.74 -0.664 . . . . 74.040000000000006 109.567 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.42 ' HB2' HG12 ' A' ' 534' ' ' VAL . . . -60.78 -44.06 97.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 120.189 -0.604 . . . . 75.120000000000005 111.668 175.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.4 mt-30 -63.62 -43.38 97.01 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 122.515 0.326 . . . . 72.420000000000002 110.914 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.473 ' O ' HG23 ' A' ' 514' ' ' VAL . 32.0 mmtp -65.1 -39.82 93.69 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.997 -0.547 . . . . 74.439999999999998 110.067 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . 0.422 ' O ' ' HD1' ' A' ' 515' ' ' TYR . 5.8 m-80 -61.31 -45.97 92.22 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 116.105 -0.498 . . . . 71.540000000000006 110.633 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.26 -37.51 83.61 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.699 -0.682 . . . . 73.450000000000003 110.882 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.472 ' ND2' ' HA ' ' A' ' 517' ' ' PHE . 1.1 t-20 -65.09 -37.63 88.12 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 116.555 -0.293 . . . . 72.25 110.542 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 510' ' ' LYS . 95.3 t -62.58 -32.53 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 121.154 0.502 . . . . 70.209999999999994 111.119 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . 0.422 ' HD1' ' O ' ' A' ' 511' ' ' ASN . 97.3 m-85 -108.78 14.9 24.01 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.986 -0.446 . . . . 73.150000000000006 110.267 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -146.99 -58.36 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 119.043 -1.551 . . . . 53.240000000000002 115.056 -172.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.472 ' HA ' ' ND2' ' A' ' 513' ' ' ASN . 61.3 m-85 67.93 31.97 5.38 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.451 1.119 . . . . 62.340000000000003 108.047 -169.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 518' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 12.9 p -79.91 179.04 7.79 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 113.238 -1.801 . . . . 72.319999999999993 110.479 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -108.67 138.83 44.36 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.129 -1.434 . . . . 54.5 107.129 176.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -132.73 145.54 51.11 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.162 0.506 . . . . 75.329999999999998 111.961 -176.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.1 m -141.59 150.28 41.84 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.751 -0.833 . . . . 63.030000000000001 108.751 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . 0.404 ' HB2' ' CG2' ' A' ' 555' ' ' VAL . 3.0 pt20 -119.65 149.91 41.2 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-O 120.907 0.384 . . . . 73.099999999999994 111.25 -174.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -123.47 143.01 50.43 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.215 -1.772 . . . . 61.119999999999997 106.215 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 20.0 m -118.85 130.91 56.01 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.231 0.539 . . . . 53.420000000000002 112.254 -175.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.5 p -123.75 151.01 28.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.746 -0.661 . . . . 72.5 110.05 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.478 ' C ' ' HG ' ' A' ' 527' ' ' SER . 5.8 t70 -66.17 134.11 52.07 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.104 -1.073 . . . . 74.530000000000001 108.104 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.478 ' HG ' ' C ' ' A' ' 526' ' ' ASP . 62.6 m -156.81 176.85 2.35 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-O 119.485 -0.293 . . . . 75.109999999999999 110.596 -176.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -79.45 -25.29 5.73 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 122.2 1.933 . . . . 71.409999999999997 112.777 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.87 146.74 34.45 Favored Pre-proline 0 CA--C 1.506 -0.713 0 C-N-CA 120.132 -0.627 . . . . 75.140000000000001 110.38 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.62 159.92 30.45 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 123.419 2.746 . . . . 73.140000000000001 113.947 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -63.64 99.19 0.21 Allowed 'General case' 0 C--O 1.245 0.825 0 CA-C-N 114.698 -1.137 . . . . 74.109999999999999 110.132 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 163.9 -29.94 0.24 Allowed Glycine 0 N--CA 1.414 -2.769 0 CA-C-N 114.862 -1.063 . . . . 63.310000000000002 111.127 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -71.12 130.38 41.35 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 120.36 -0.536 . . . . 75.420000000000002 110.194 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 7.2 p -96.6 119.5 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.675 0 N-CA-C 106.559 -1.645 . . . . 71.030000000000001 106.559 171.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.4 m -104.66 20.54 18.45 Favored 'General case' 0 C--N 1.261 -3.252 0 CA-C-N 114.328 -1.306 . . . . 74.209999999999994 110.715 -171.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 126.3 -168.05 18.55 Favored Glycine 0 N--CA 1.429 -1.823 0 C-N-CA 120.721 -0.752 . . . . 74.120000000000005 112.053 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 33.4 p -116.89 146.42 42.95 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.53 -1.285 . . . . 74.239999999999995 107.53 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -68.66 -46.74 34.65 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 119.102 -1.039 . . . . 72.209999999999994 111.18 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -66.53 151.23 83.38 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 120.948 1.099 . . . . 62.329999999999998 109.966 171.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -57.66 140.73 94.43 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.142 2.561 . . . . 74.219999999999999 113.722 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -68.03 129.76 40.89 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.714 -0.847 . . . . 75.439999999999998 108.714 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.53 -14.37 46.67 Favored Glycine 0 C--N 1.294 -1.786 0 N-CA-C 110.851 -0.9 . . . . 63.119999999999997 110.851 -176.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 98.7 m -75.83 127.49 33.11 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 109.563 -0.532 . . . . 75.510000000000005 109.563 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.2 t -93.85 130.25 39.96 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 108.351 -0.981 . . . . 72.540000000000006 108.351 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.01 154.15 64.46 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 108.19 -1.041 . . . . 74.129999999999995 108.19 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . 0.428 ' HG2' ' OG ' ' A' ' 549' ' ' SER . 3.2 Cg_endo -59.42 137.83 80.49 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 121.43 1.42 . . . . 73.040000000000006 111.837 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 518' ' ' THR . 12.8 p -57.02 -29.5 31.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.662 -1.154 . . . . 75.540000000000006 113.08 -176.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -90.03 3.31 53.61 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 123.266 0.627 . . . . 73.129999999999995 110.582 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 549' ' ' SER . . . . . 0.428 ' OG ' ' HG2' ' A' ' 546' ' ' PRO . 52.2 m -104.38 177.56 4.81 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 116.234 -0.439 . . . . 74.319999999999993 111.013 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 7.5 p -97.63 130.67 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 N-CA-C 113.084 0.772 . . . . 75.150000000000006 113.084 -172.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 66.1 mt -93.48 129.62 43.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 106.256 -1.757 . . . . 74.209999999999994 106.256 172.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -103.52 116.99 33.4 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.289 0.566 . . . . 70.230000000000004 110.923 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.53 133.06 50.9 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.809 -1.087 . . . . 74.420000000000002 111.346 -177.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -87.43 117.71 26.4 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.959 -0.564 . . . . 75.140000000000001 110.397 178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 524' ' ' SER . 43.3 t -108.64 126.64 65.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 109.079 -0.712 . . . . 72.0 109.079 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 74.9 m -89.24 132.07 35.06 Favored 'General case' 0 N--CA 1.408 -2.562 0 CA-C-N 115.84 -0.618 . . . . 71.540000000000006 109.43 176.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -114.05 138.62 50.15 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.327 -1.36 . . . . 74.329999999999998 107.327 174.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.566 ' O ' ' HG3' ' A' ' 560' ' ' GLN . . . -67.41 -26.82 73.51 Favored Glycine 0 CA--C 1.493 -1.324 0 N-CA-C 109.92 -1.272 . . . . 74.340000000000003 109.92 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 60.6 t30 61.14 29.3 18.75 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-O 122.757 1.265 . . . . 73.099999999999994 108.247 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.566 ' HG3' ' O ' ' A' ' 558' ' ' GLY . 91.9 mt-30 -129.33 172.2 11.73 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 113.642 -1.617 . . . . 73.450000000000003 110.755 -174.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -143.81 152.51 41.29 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.506 -1.294 . . . . 75.239999999999995 107.506 174.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 68.0 t -78.1 116.54 21.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 108.684 -0.858 . . . . 64.030000000000001 108.684 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 563' ' ' MET . . . . . 0.507 ' SD ' HG22 ' A' ' 620' ' ' ILE . 45.1 ttp -73.6 128.53 86.91 Favored Pre-proline 0 C--N 1.315 -0.912 0 CA-C-N 116.314 -0.403 . . . . 73.400000000000006 112.016 -175.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.7 170.2 18.27 Favored 'Trans proline' 0 C--O 1.242 0.705 0 C-N-CA 123.189 2.592 . . . . 70.409999999999997 112.118 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.8 128.62 37.44 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 113.054 0.761 . . . . 75.349999999999994 113.054 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.07 -9.85 3.4 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 114.81 -1.086 . . . . 75.040000000000006 108.604 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 22.6 t -79.25 151.81 30.95 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.653 -0.654 . . . . 74.310000000000002 110.645 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 62.65 52.05 51.51 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 116.004 -0.544 . . . . 55.039999999999999 114.172 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 23.6 ptp -158.4 169.69 23.9 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 107.568 -1.271 . . . . 74.430000000000007 107.568 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -88.32 167.98 13.08 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.217 -0.66 . . . . 72.340000000000003 109.217 -174.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 26.3 t-105 -64.89 -27.61 68.97 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.51 -0.922 . . . . 72.450000000000003 108.51 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.3 m -73.59 -9.99 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 115.398 -0.819 . . . . 74.030000000000001 111.371 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -96.39 -44.08 7.37 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.719 -1.215 . . . . 74.519999999999996 107.719 173.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -57.47 -44.74 85.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.764 -1.107 . . . . 72.010000000000005 112.585 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.625 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 1.6 tm-20 -57.25 -58.99 14.19 Favored Pre-proline 0 CA--C 1.571 1.777 0 C-N-CA 122.824 0.45 . . . . 74.109999999999999 111.288 -177.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -61.37 -31.89 88.92 Favored 'Trans proline' 0 C--N 1.372 1.81 0 CA-C-N 120.652 1.269 . . . . 73.430000000000007 112.323 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -68.99 -33.82 74.3 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.24 0.83 . . . . 75.030000000000001 113.24 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.6 pp -66.34 -47.15 74.41 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.238 0.542 . . . . 75.109999999999999 110.733 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.473 ' N ' HD13 ' A' ' 578' ' ' LEU . 15.1 ptm180 -65.86 -34.53 78.35 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.671 -0.695 . . . . 74.230000000000004 111.133 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.79 -38.39 88.88 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 123.375 0.67 . . . . 73.129999999999995 111.502 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.0 pp -85.98 -8.16 58.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.313 0.577 . . . . 73.129999999999995 110.751 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 82.5 39.3 11.02 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.737 -0.665 . . . . 73.340000000000003 111.706 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 12.6 t90 -87.04 126.29 34.66 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.548 -0.908 . . . . 73.030000000000001 108.548 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 1.9 p -108.24 2.96 23.1 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.967 0.729 . . . . 50.229999999999997 112.967 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -94.64 -173.38 38.15 Favored Glycine 0 N--CA 1.438 -1.186 0 N-CA-C 110.381 -1.088 . . . . 75.299999999999997 110.381 176.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 60.6 mtm -114.27 151.33 33.03 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.397 -0.594 . . . . 75.450000000000003 109.397 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.7 tt -83.07 125.18 31.19 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.962 -1.125 . . . . 72.219999999999999 107.962 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 621' ' ' THR . 30.8 t70 -104.05 123.55 47.43 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.081 0.467 . . . . 63.310000000000002 109.941 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . 0.412 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -101.39 133.44 45.99 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 108.566 -0.902 . . . . 74.019999999999996 108.566 177.22 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -77.42 -68.7 1.48 Allowed Glycine 0 C--N 1.283 -2.387 0 N-CA-C 110.505 -1.038 . . . . 72.340000000000003 110.505 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.53 142.73 37.23 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.854 -0.795 . . . . 72.109999999999999 108.854 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -83.63 134.49 34.79 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.762 -1.199 . . . . 73.329999999999998 107.762 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . 0.465 ' O ' ' HG2' ' A' ' 626' ' ' GLN . 42.8 t -104.13 141.62 19.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 107.893 -1.151 . . . . 74.219999999999999 107.893 -176.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -72.46 118.2 15.06 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 109.484 -0.561 . . . . 74.200000000000003 109.484 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -137.3 -59.76 0.68 Allowed 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 115.466 -0.788 . . . . 63.539999999999999 109.768 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 85.84 154.09 23.0 Favored Glycine 0 N--CA 1.412 -2.903 0 C-N-CA 119.07 -1.538 . . . . 44.43 109.818 -173.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.96 -33.82 75.78 Favored Glycine 0 C--N 1.284 -2.357 0 N-CA-C 114.934 0.733 . . . . 52.109999999999999 114.934 -177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 6.9 t -73.62 -24.74 60.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 117.68 0.74 . . . . 74.230000000000004 110.231 -174.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -87.92 -1.68 58.13 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.16 0.505 . . . . 75.400000000000006 109.827 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 57.0 m80 68.34 86.64 0.13 Allowed 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 124.993 1.317 . . . . 73.319999999999993 110.868 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -74.37 82.38 1.91 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 112.697 -2.047 . . . . 75.329999999999998 111.623 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -129.28 171.32 12.59 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.015 -1.448 . . . . 75.430000000000007 110.47 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . 0.454 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 70.7 t -57.94 130.77 21.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 O-C-N 123.338 0.399 . . . . 73.140000000000001 110.075 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 27.0 m -106.53 -34.1 2.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 C-N-CA 120.579 -0.448 . . . . 75.310000000000002 110.922 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -152.92 135.92 15.54 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 116.352 -0.386 . . . . 72.409999999999997 110.5 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -118.79 128.59 54.62 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.593 -1.632 . . . . 75.010000000000005 106.593 171.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.407 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 4.4 t-20 -63.09 -47.94 84.95 Favored Pre-proline 0 N--CA 1.469 0.496 0 C-N-CA 119.717 -0.793 . . . . 73.310000000000002 110.954 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.9 Cg_exo -84.64 108.66 1.26 Allowed 'Trans proline' 0 C--N 1.361 1.187 0 N-CA-C 108.17 -1.512 . . . . 75.349999999999994 108.17 168.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.38 161.02 47.54 Favored 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 123.386 2.724 . . . . 75.530000000000001 113.13 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.78 134.72 57.08 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.35 -0.611 . . . . 73.409999999999997 109.35 176.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 103.55 -5.03 47.56 Favored Glycine 0 C--N 1.304 -1.211 0 C-N-CA 120.554 -0.831 . . . . 71.150000000000006 111.508 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 59.1 m -86.36 141.36 29.25 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.725 -0.472 . . . . 75.430000000000007 109.725 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -78.33 117.36 4.63 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 110.072 -1.211 . . . . 74.120000000000005 110.072 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 28.6 m -115.48 142.2 29.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 110.167 -0.308 . . . . 74.230000000000004 110.167 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -50.08 170.15 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.961 1.304 . . . . 73.409999999999997 113.041 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -60.98 -25.64 67.0 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.85 0.685 . . . . 73.219999999999999 112.85 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.454 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 17.8 m-20 -82.84 -8.83 59.55 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 119.185 -1.006 . . . . 75.109999999999999 110.832 177.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 64.85 15.48 60.17 Favored Glycine 0 C--O 1.219 -0.826 0 C-N-CA 123.599 0.618 . . . . 75.030000000000001 114.592 168.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.71 118.37 15.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 122.612 1.196 . . . . 74.519999999999996 112.515 -164.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.507 HG22 ' SD ' ' A' ' 563' ' ' MET . 2.8 pp -128.46 134.34 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 114.012 -1.449 . . . . 71.430000000000007 111.266 -177.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 15.1 t -104.11 129.16 51.8 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.456 -0.572 . . . . 73.019999999999996 109.456 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.5 pp -139.43 167.2 22.62 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.355 0.502 . . . . 63.340000000000003 112.355 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 25.9 ptt85 -127.8 137.81 52.52 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.49 -0.559 . . . . 75.510000000000005 109.49 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.454 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 20.0 p90 -139.94 165.93 26.0 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.918 -0.583 . . . . 75.129999999999995 110.896 -173.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -76.15 134.64 16.16 Favored Glycine 0 N--CA 1.431 -1.647 0 CA-C-N 115.832 -0.622 . . . . 72.439999999999998 112.615 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 593' ' ' VAL . 2.7 pt20 . . . . . 0 C--N 1.305 -1.36 0 C-N-CA 123.768 0.827 . . . . 73.430000000000007 109.293 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.702 0 CA-C-O 121.517 0.675 . . . . 70.540000000000006 111.174 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 31.2 p -137.66 147.3 44.79 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 115.338 -0.847 . . . . 72.219999999999999 109.744 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -127.68 139.86 52.44 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.614 -0.884 . . . . 75.420000000000002 108.614 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.4 p-10 -96.02 130.25 43.07 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.485 0.659 . . . . 74.219999999999999 110.414 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 34.8 pt -91.12 127.06 52.94 Favored Pre-proline 0 C--N 1.304 -1.383 0 CA-C-N 114.717 -1.129 . . . . 75.430000000000007 111.198 -176.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -84.42 -179.42 3.85 Favored 'Trans proline' 0 N--CA 1.441 -1.585 0 C-N-CA 121.632 1.555 . . . . 72.109999999999999 110.696 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -82.3 103.37 11.83 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 122.253 1.025 . . . . 75.510000000000005 110.182 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.79 7.67 9.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 114.946 -1.025 . . . . 74.430000000000007 111.384 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -80.56 102.81 10.0 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 109.054 -0.721 . . . . 60.210000000000001 109.054 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 159.05 -36.14 0.49 Allowed Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.566 -0.826 . . . . 72.439999999999998 112.131 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 16.6 pm0 -94.45 -173.08 2.95 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 109.301 -0.629 . . . . 73.409999999999997 109.301 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 27.9 m -70.1 154.89 41.37 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.856 -1.164 . . . . 72.219999999999999 107.856 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.443 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.2 p -63.02 -41.89 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 C-N-CA 120.891 -0.324 . . . . 74.010000000000005 111.049 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . 0.525 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 18.7 t70 -62.18 -43.95 97.68 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 109.645 -0.502 . . . . 60.219999999999999 109.645 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 64.0 t -66.61 -41.85 88.93 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 CA-C-N 115.79 -0.641 . . . . 75.319999999999993 109.737 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.405 ' CB ' HG13 ' A' ' 534' ' ' VAL . . . -61.15 -44.57 97.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 120.442 0.163 . . . . 63.140000000000001 110.684 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 26.3 mt-30 -65.0 -43.82 91.28 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.266 -0.425 . . . . 65.430000000000007 111.086 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.556 ' O ' HG22 ' A' ' 514' ' ' VAL . 32.7 mmtp -62.92 -47.14 84.54 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.429 -0.582 . . . . 74.430000000000007 109.429 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -63.99 -37.95 89.3 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.515 -0.766 . . . . 74.099999999999994 111.345 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.64 -46.28 69.61 Favored 'General case' 0 C--O 1.203 -1.348 0 N-CA-C 108.151 -1.055 . . . . 64.25 108.151 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -59.99 -38.13 81.7 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 124.077 0.951 . . . . 73.200000000000003 111.188 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 510' ' ' LYS . 57.7 t -57.57 -37.56 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-O 120.845 0.355 . . . . 73.230000000000004 111.326 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -110.0 0.91 18.69 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.865 0.84 . . . . 74.439999999999998 111.098 -176.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -113.5 -60.4 0.41 Allowed Glycine 0 N--CA 1.416 -2.698 0 CA-C-N 115.18 -0.918 . . . . 70.109999999999999 111.331 -174.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 70.74 16.49 6.74 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.58 1.152 . . . . 74.400000000000006 110.415 -175.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.4 p -83.05 -176.17 6.2 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-N 114.082 -1.417 . . . . 75.25 109.496 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' A' ' 519' ' ' LYS . 0.1 OUTLIER -108.69 143.14 38.18 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.29 -1.004 . . . . 71.230000000000004 108.29 177.018 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -123.1 148.61 45.46 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-O 121.428 0.633 . . . . 74.129999999999995 111.804 -175.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 16.9 p -135.31 140.26 44.97 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 107.369 -1.345 . . . . 75.219999999999999 107.369 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -117.45 127.27 53.85 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-O 121.246 0.546 . . . . 73.010000000000005 110.466 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -116.11 143.36 45.58 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.161 -1.422 . . . . 74.219999999999999 107.161 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.0 p -119.44 132.66 55.85 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 113.783 1.031 . . . . 72.109999999999999 113.783 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.64 149.97 24.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 107.902 -1.147 . . . . 74.420000000000002 107.902 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -79.61 136.86 36.95 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.923 -0.311 . . . . 71.0 110.881 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 59.9 m -163.24 155.08 15.13 Favored Pre-proline 0 C--O 1.204 -1.335 0 N-CA-C 107.106 -1.442 . . . . 74.230000000000004 107.106 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.39 -14.66 36.01 Favored 'Trans proline' 0 CA--C 1.552 1.376 0 C-N-CA 122.439 2.093 . . . . 73.25 114.587 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -70.9 145.58 91.99 Favored Pre-proline 0 C--O 1.215 -0.711 0 N-CA-C 109.529 -0.545 . . . . 75.519999999999996 109.529 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.33 144.39 91.13 Favored 'Trans proline' 0 C--O 1.26 1.59 0 C-N-CA 122.317 2.012 . . . . 73.0 112.619 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.683 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -64.14 100.34 0.32 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.246 -0.888 . . . . 63.009999999999998 111.171 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 157.43 -23.41 0.43 Allowed Glycine 0 N--CA 1.427 -1.93 0 C-N-CA 120.559 -0.829 . . . . 74.349999999999994 111.979 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -80.65 138.92 36.43 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 119.904 -0.718 . . . . 75.099999999999994 109.842 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.405 HG13 ' CB ' ' A' ' 508' ' ' ALA . 5.4 p -93.85 113.93 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 N-CA-C 107.294 -1.373 . . . . 72.239999999999995 107.294 172.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.7 m -99.62 8.74 44.15 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 113.929 -1.487 . . . . 74.319999999999993 111.186 -172.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 157.31 172.89 25.05 Favored Glycine 0 N--CA 1.428 -1.883 0 C-N-CA 119.704 -1.236 . . . . 42.43 113.245 174.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.6 p -120.52 158.27 27.65 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 105.798 -1.927 . . . . 73.319999999999993 105.798 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.409 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 3.9 t-20 -67.05 -54.33 20.83 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 117.517 -1.673 . . . . 70.230000000000004 111.368 177.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.409 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 8.2 Cg_exo -74.33 143.21 31.2 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 121.282 1.321 . . . . 71.310000000000002 109.792 174.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.74 157.99 59.61 Favored 'Trans proline' 0 C--O 1.25 1.106 0 C-N-CA 122.635 2.224 . . . . 71.319999999999993 113.284 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.28 139.59 58.08 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.806 -0.633 . . . . 64.010000000000005 110.505 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.18 -14.36 59.79 Favored Glycine 0 C--N 1.3 -1.436 0 N-CA-C 111.706 -0.557 . . . . 71.439999999999998 111.706 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 20.4 m -75.32 135.23 40.89 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 109.771 -0.455 . . . . 70.239999999999995 109.771 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.8 t -96.58 125.47 41.07 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 107.916 -1.142 . . . . 75.030000000000001 107.916 177.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.26 154.55 65.44 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 108.622 -0.881 . . . . 64.519999999999996 108.622 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.64 137.48 77.56 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.784 1.656 . . . . 70.209999999999994 112.283 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 13.5 p -65.33 -24.03 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-N 115.19 -0.913 . . . . 73.400000000000006 110.82 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -78.02 -10.02 59.4 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.559 -1.201 . . . . 73.25 111.632 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 22.9 t -94.01 -176.84 4.13 Favored 'General case' 0 C--O 1.26 1.637 0 CA-C-O 121.631 0.729 . . . . 63.539999999999999 112.176 -174.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 14.7 p -119.13 137.92 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 114.774 -1.103 . . . . 74.310000000000002 109.037 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.3 mt -108.71 138.33 36.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 109.149 -0.686 . . . . 73.439999999999998 109.149 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.53 122.06 44.17 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.689 0.757 . . . . 73.519999999999996 111.756 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.1 mp -108.08 122.23 46.45 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.212 -1.358 . . . . 74.209999999999994 108.776 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -90.63 116.23 28.35 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.916 0.865 . . . . 73.329999999999998 111.26 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.8 135.21 34.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 114.263 -1.335 . . . . 64.129999999999995 108.811 -177.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.683 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 66.4 m -86.33 129.04 34.99 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.538 -0.541 . . . . 74.400000000000006 109.538 174.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -101.03 130.05 46.98 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 105.883 -1.895 . . . . 74.319999999999993 105.883 172.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -62.22 -24.93 65.92 Favored Glycine 0 CA--C 1.5 -0.898 0 O-C-N 124.006 0.816 . . . . 74.510000000000005 114.146 -173.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . 0.484 ' OD1' ' HG3' ' A' ' 616' ' ' ARG . 49.0 t-20 71.93 -14.62 0.51 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.841 1.256 . . . . 74.439999999999998 111.363 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -111.93 149.55 31.76 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.307 -0.87 . . . . 72.150000000000006 112.856 -170.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -131.0 158.4 40.39 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.248 -1.342 . . . . 75.120000000000005 107.449 177.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.61 125.33 32.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 120.991 0.424 . . . . 72.349999999999994 111.217 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 55.2 ttp -86.6 129.51 52.64 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 110.092 -0.336 . . . . 73.239999999999995 110.092 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.07 170.46 20.07 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.363 2.708 . . . . 73.120000000000005 112.337 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.02 126.65 28.7 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 112.784 0.661 . . . . 72.310000000000002 112.784 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . 0.448 ' O ' ' HG2' ' A' ' 569' ' ' MET . 0.0 OUTLIER -132.05 7.25 4.31 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.504 1.145 . . . . 55.439999999999998 109.06 171.382 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 3.1 m -79.19 138.19 37.75 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.559 -1.201 . . . . 75.120000000000005 108.926 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 84.15 18.62 62.46 Favored Glycine 0 C--N 1.315 -0.624 0 C-N-CA 120.533 -0.841 . . . . 74.310000000000002 113.876 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 569' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 20.2 ptp -124.0 175.12 7.16 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.291 -1.003 . . . . 75.349999999999994 108.291 176.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -94.8 164.98 12.71 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.595 -1.631 . . . . 72.209999999999994 106.595 -175.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . 0.495 ' O ' ' HG3' ' A' ' 575' ' ' GLU . 10.8 t-105 -63.49 -34.16 77.17 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.781 -0.822 . . . . 73.400000000000006 108.781 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.6 p -74.23 -14.78 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.648 -0.705 . . . . 73.310000000000002 110.669 -175.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -100.98 -28.6 12.65 Favored 'General case' 0 C--O 1.263 1.814 0 CA-C-O 122.025 0.917 . . . . 54.43 108.766 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . 0.616 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -64.12 -41.67 97.14 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.486 -1.234 . . . . 51.109999999999999 109.98 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 571' ' ' TRP . 46.0 mt-10 -51.21 -56.12 22.83 Favored Pre-proline 0 CA--C 1.567 1.615 0 N-CA-C 112.519 0.562 . . . . 74.319999999999993 112.519 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -58.4 -33.34 97.76 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 121.554 1.502 . . . . 73.510000000000005 112.71 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -68.64 -34.3 75.5 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 119.487 -0.885 . . . . 71.319999999999993 111.735 176.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 41.0 mt -63.06 -48.31 79.23 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.147 0.499 . . . . 71.439999999999998 110.383 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 6.9 ptp85 -66.19 -36.83 84.1 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.136 -0.484 . . . . 75.219999999999999 111.324 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.31 77.85 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.134 -0.484 . . . . 72.5 112.097 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 1.7 pp -81.93 -8.54 59.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.158 0.504 . . . . 73.340000000000003 109.868 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 80.3 42.45 10.52 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.528 -0.76 . . . . 71.319999999999993 112.311 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . 0.429 ' CE3' HD23 ' A' ' 578' ' ' LEU . 18.1 t90 -87.31 126.59 34.94 Favored 'General case' 0 N--CA 1.427 -1.619 0 C-N-CA 120.147 -0.621 . . . . 73.519999999999996 109.888 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 26.9 p -100.95 -14.28 17.95 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.33 0.492 . . . . 74.409999999999997 112.33 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -82.96 -171.09 46.91 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 121.344 -0.455 . . . . 60.350000000000001 113.349 -177.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 92.3 mmm -117.57 147.47 42.79 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.907 -0.405 . . . . 75.030000000000001 109.907 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . 0.407 HD21 ' HG ' ' A' ' 622' ' ' LEU . 3.6 tt -93.02 129.56 38.9 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.88 0.372 . . . . 72.319999999999993 110.203 -175.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -113.96 124.85 53.16 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-N 115.911 -0.586 . . . . 73.319999999999993 109.719 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.8 133.95 34.81 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.806 -0.442 . . . . 55.329999999999998 109.806 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -84.06 -106.8 0.57 Allowed Glycine 0 C--N 1.291 -1.937 0 CA-C-N 115.829 -0.623 . . . . 70.219999999999999 112.32 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . 0.588 ' O ' ' HB2' ' A' ' 623' ' ' ARG . . . -96.14 116.58 29.21 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.948 0.404 . . . . 75.239999999999995 110.343 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -87.24 140.08 29.9 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 123.499 0.719 . . . . 74.200000000000003 110.898 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 48.4 t -122.36 128.74 75.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.313 -0.995 . . . . 74.109999999999999 108.313 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.59 122.61 21.66 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.92 0.391 . . . . 65.049999999999997 110.397 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -134.45 -43.47 0.77 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.815 -0.63 . . . . 75.519999999999996 110.596 -177.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 106.86 128.92 6.1 Favored Glycine 0 N--CA 1.433 -1.524 0 N-CA-C 111.543 -0.623 . . . . 74.25 111.543 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.17 -32.95 84.33 Favored Glycine 0 N--CA 1.46 0.235 0 CA-C-O 121.067 0.26 . . . . 54.350000000000001 112.485 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 3.0 p -64.94 -23.94 67.37 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 124.938 1.295 . . . . 72.430000000000007 110.944 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -92.23 -0.78 57.4 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.776 -0.647 . . . . 72.209999999999994 110.283 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 30.5 m170 75.01 97.23 0.07 Allowed 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 125.017 1.327 . . . . 71.239999999999995 112.29 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . 0.662 ' HB2' ' O ' ' A' ' 625' ' ' GLY . 19.2 p30 -83.2 88.85 6.91 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 114.016 -1.447 . . . . 73.310000000000002 112.748 -175.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 -91.85 155.68 18.03 Favored 'General case' 0 C--O 1.254 1.307 0 CA-C-N 114.504 -1.226 . . . . 75.319999999999993 110.818 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 88.0 t -62.86 131.89 28.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 114.955 -1.021 . . . . 75.510000000000005 108.3 172.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.74 -46.55 12.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 120.996 0.427 . . . . 73.530000000000001 110.666 -175.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -151.69 154.11 35.69 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.346 -0.983 . . . . 71.340000000000003 108.346 -176.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -142.55 149.31 38.92 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.309 -0.626 . . . . 74.150000000000006 109.309 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.481 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 50.8 t-20 -69.23 -56.45 8.59 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 120.611 -0.436 . . . . 74.140000000000001 111.265 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.8 Cg_exo -84.44 115.36 1.89 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 120.729 1.296 . . . . 74.219999999999999 108.888 173.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -70.2 157.91 58.04 Favored 'Trans proline' 0 C--O 1.248 1.017 0 C-N-CA 122.303 2.002 . . . . 75.219999999999999 112.458 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.31 137.81 56.34 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.721 -0.844 . . . . 63.409999999999997 108.721 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 96.94 -7.18 64.71 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.892 -0.671 . . . . 74.349999999999994 111.646 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 38.5 m -94.71 150.15 20.51 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.987 -0.375 . . . . 74.439999999999998 109.987 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -75.63 126.5 8.54 Favored Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 111.823 -0.511 . . . . 73.409999999999997 111.823 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.3 m -118.65 142.65 32.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 109.077 -0.712 . . . . 75.349999999999994 109.077 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -52.25 165.87 0.2 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.887 0.875 . . . . 72.099999999999994 112.035 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . 0.484 ' HG3' ' OD1' ' A' ' 559' ' ' ASN . 0.0 OUTLIER -57.82 -25.3 60.42 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.864 1.061 . . . . 75.319999999999993 113.864 -178.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.38 -10.31 59.75 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 119.95 -0.7 . . . . 72.310000000000002 109.48 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 65.34 16.1 62.19 Favored Glycine 0 CA--C 1.498 -1.019 0 CA-C-N 115.61 -0.723 . . . . 73.140000000000001 113.472 169.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.16 119.29 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 122.567 1.175 . . . . 73.219999999999999 111.067 -165.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.403 HG12 ' HD2' ' A' ' 608' ' ' PRO . 0.0 OUTLIER -129.2 132.48 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.176 0 CA-C-N 113.824 -1.535 . . . . 72.409999999999997 109.11 -176.071 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 8.9 t -114.96 133.53 55.94 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.399 -0.963 . . . . 72.239999999999995 108.399 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . 0.407 ' HG ' HD21 ' A' ' 587' ' ' LEU . 3.1 pp -138.97 166.65 23.93 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.748 -0.66 . . . . 74.400000000000006 112.073 -174.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . 0.588 ' HB2' ' O ' ' A' ' 591' ' ' ALA . 7.4 ptm180 -126.93 137.42 53.13 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 106.915 -1.513 . . . . 75.230000000000004 106.915 175.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -139.49 165.93 25.92 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 115.808 -0.633 . . . . 74.299999999999997 109.324 -171.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . 0.662 ' O ' ' HB2' ' A' ' 601' ' ' ASN . . . -72.7 140.03 28.45 Favored Glycine 0 N--CA 1.418 -2.561 0 N-CA-C 108.493 -1.843 . . . . 63.219999999999999 108.493 174.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 . . . . . 0 C--N 1.265 -3.107 0 CA-C-O 118.11 -0.947 . . . . 74.200000000000003 108.643 -179.401 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.443 0 CA-C-O 121.133 0.492 . . . . 73.409999999999997 111.677 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 38.3 p -139.5 144.18 37.81 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.423 -0.584 . . . . 64.109999999999999 109.423 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . 0.531 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 4.3 tmtt? -134.93 139.38 44.91 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.05 -1.093 . . . . 75.5 108.05 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.531 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 10.5 p-10 -78.77 132.97 37.12 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 124.097 0.959 . . . . 74.349999999999994 110.051 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 42.6 pt -98.58 128.45 32.81 Favored Pre-proline 0 C--N 1.306 -1.309 0 C-N-CA 120.386 -0.526 . . . . 75.430000000000007 110.584 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.92 -163.33 0.19 Allowed 'Trans proline' 0 C--O 1.251 1.139 0 C-N-CA 122.682 2.254 . . . . 71.219999999999999 111.018 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -86.18 127.3 34.7 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.609 0.719 . . . . 74.340000000000003 109.984 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.42 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 15.9 m -122.99 62.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-O 123.359 1.552 . . . . 72.340000000000003 108.425 171.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -120.43 108.58 14.29 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 112.825 -1.988 . . . . 70.230000000000004 109.191 176.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 138.39 -25.47 2.87 Favored Glycine 0 N--CA 1.431 -1.661 0 C-N-CA 119.613 -1.279 . . . . 74.329999999999998 113.42 175.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.428 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.4 OUTLIER -101.39 -177.0 3.31 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 117.835 0.817 . . . . 74.319999999999993 109.382 179.342 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 9.1 m -74.36 155.45 38.13 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.78 -1.193 . . . . 74.129999999999995 107.78 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.5 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 8.9 p -64.3 -41.32 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-O 119.471 -0.3 . . . . 65.530000000000001 111.715 -177.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 15.5 t70 -59.56 -42.6 92.77 Favored 'General case' 0 C--O 1.213 -0.844 0 N-CA-C 108.417 -0.957 . . . . 71.010000000000005 108.417 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 76.9 t -65.34 -44.84 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 114.983 -1.008 . . . . 74.040000000000006 110.044 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.42 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -63.24 -44.98 93.68 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 111.725 0.269 . . . . 75.120000000000005 111.725 177.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.6 mt-30 -61.88 -45.26 94.55 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 122.804 0.441 . . . . 72.420000000000002 110.08 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.543 ' O ' HG23 ' A' ' 514' ' ' VAL . 31.5 mmtp -67.01 -39.28 87.05 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.631 -0.713 . . . . 74.439999999999998 110.579 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -61.49 -43.98 97.9 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 121.31 0.576 . . . . 71.540000000000006 110.492 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.57 -43.06 86.04 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.842 -1.17 . . . . 73.450000000000003 107.842 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -59.81 -36.5 76.88 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 124.035 0.934 . . . . 72.25 111.664 -177.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 510' ' ' LYS . 90.4 t -60.07 -40.48 83.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.732 0.301 . . . . 70.209999999999994 110.929 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -107.15 13.17 27.63 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.414 0.626 . . . . 73.150000000000006 110.281 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -134.65 -54.29 0.07 OUTLIER Glycine 0 N--CA 1.429 -1.801 0 C-N-CA 120.534 -0.841 . . . . 53.240000000000002 113.72 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 65.22 25.76 12.3 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.404 1.097 . . . . 62.340000000000003 109.088 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 518' ' ' THR . . . . . 0.437 HG21 ' HA ' ' A' ' 547' ' ' VAL . 6.2 p -80.77 -173.54 4.25 Favored 'General case' 0 N--CA 1.416 -2.143 0 C-N-CA 125.719 1.608 . . . . 72.319999999999993 111.602 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -108.76 138.41 45.14 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.451 -1.685 . . . . 54.5 106.451 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -132.43 149.01 52.42 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.065 0.459 . . . . 75.329999999999998 111.607 -178.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 71.3 m -141.22 150.9 43.26 Favored 'General case' 0 N--CA 1.418 -2.025 0 N-CA-C 108.515 -0.92 . . . . 63.030000000000001 108.515 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . 0.446 ' HB2' ' CG2' ' A' ' 555' ' ' VAL . 3.6 pt20 -119.56 136.63 54.27 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.036 0.446 . . . . 73.099999999999994 110.294 -178.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -120.04 137.34 54.16 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.184 -1.413 . . . . 61.119999999999997 107.184 176.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 33.8 m -106.1 134.5 49.12 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 112.295 0.48 . . . . 53.420000000000002 112.295 -175.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.6 p -131.13 153.04 38.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.357 -0.838 . . . . 72.5 109.006 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -73.24 134.92 44.45 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.24 -1.022 . . . . 74.530000000000001 108.24 177.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 65.5 m -161.13 168.04 12.3 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.513 -0.551 . . . . 75.109999999999999 109.513 -177.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -71.96 -21.91 23.78 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.055 1.837 . . . . 71.409999999999997 112.077 176.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -69.73 144.22 93.39 Favored Pre-proline 0 C--O 1.221 -0.426 0 CA-C-N 116.2 -0.455 . . . . 75.140000000000001 111.311 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.47 152.42 81.67 Favored 'Trans proline' 0 C--O 1.248 0.996 0 C-N-CA 122.586 2.191 . . . . 73.140000000000001 111.72 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.31 112.01 2.24 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 115.63 -0.714 . . . . 74.109999999999999 110.999 -177.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 131.53 -23.62 4.24 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 115.427 -0.806 . . . . 63.310000000000002 111.623 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -80.08 133.83 36.14 Favored 'General case' 0 C--O 1.246 0.912 0 CA-C-O 121.262 0.553 . . . . 75.420000000000002 109.768 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 503' ' ' GLN . 8.1 p -97.32 120.09 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.875 0 N-CA-C 108.094 -1.076 . . . . 71.030000000000001 108.094 -178.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 4.1 p -90.13 1.24 56.62 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.207 -0.906 . . . . 74.209999999999994 112.376 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 144.0 -161.7 27.83 Favored Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.314 -0.946 . . . . 74.120000000000005 112.321 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 3.8 p -116.97 155.14 29.65 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.807 -0.812 . . . . 74.239999999999995 108.807 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -65.31 -50.52 58.63 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.306 -0.627 . . . . 72.209999999999994 109.306 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.67 138.91 46.73 Favored 'Trans proline' 0 C--N 1.375 1.966 0 N-CA-C 108.97 -1.204 . . . . 62.329999999999998 108.97 170.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.01 143.64 91.34 Favored 'Trans proline' 0 C--O 1.243 0.725 0 C-N-CA 122.86 2.373 . . . . 74.219999999999999 113.659 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.01 131.53 47.88 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.63 -0.714 . . . . 75.439999999999998 109.745 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.22 -5.39 35.91 Favored Glycine 0 N--CA 1.434 -1.448 0 CA-C-N 115.708 -0.678 . . . . 63.119999999999997 111.465 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 5.9 t -84.97 138.16 32.65 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.233 0.54 . . . . 75.510000000000005 110.714 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 9.2 t -81.56 131.37 35.27 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.158 -1.053 . . . . 72.540000000000006 108.158 174.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.0 m -126.51 154.99 75.24 Favored Pre-proline 0 C--N 1.315 -0.935 0 N-CA-C 108.786 -0.82 . . . . 74.129999999999995 108.786 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -70.18 138.89 37.51 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.635 1.557 . . . . 73.040000000000006 111.29 176.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.437 ' HA ' HG21 ' A' ' 518' ' ' THR . 8.9 p -64.73 -19.08 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 CA-C-O 122.345 1.069 . . . . 75.540000000000006 110.608 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -86.38 -18.35 32.06 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.17 -0.923 . . . . 73.129999999999995 110.768 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 50.4 m -91.98 167.78 11.86 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.362 0.601 . . . . 74.319999999999993 111.968 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 10.7 p -97.22 138.15 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-N 115.096 -0.956 . . . . 75.150000000000006 111.051 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 56.7 mt -97.48 134.19 36.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 107.615 -1.254 . . . . 74.209999999999994 107.615 176.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -103.33 117.34 34.27 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.097 -0.705 . . . . 70.230000000000004 109.097 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.8 mp -104.42 133.13 49.82 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 120.916 0.388 . . . . 74.420000000000002 111.657 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -87.51 108.83 19.22 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 123.558 0.743 . . . . 75.140000000000001 110.853 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 522' ' ' GLN . 32.5 t -95.85 124.3 48.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.468 -0.938 . . . . 72.0 108.468 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.5 ' HB3' ' HB2' ' A' ' 527' ' ' SER . 58.0 m -88.05 133.24 34.02 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 115.972 -0.558 . . . . 71.540000000000006 110.733 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.1 ptpt -115.72 130.96 57.05 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 107.843 -1.169 . . . . 74.329999999999998 107.843 171.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 527' ' ' SER . . . -64.93 -23.75 69.6 Favored Glycine 0 CA--C 1.497 -1.061 0 N-CA-C 110.264 -1.134 . . . . 74.340000000000003 110.264 178.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 53.9 t30 70.22 -5.55 1.31 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.041 1.736 . . . . 73.099999999999994 111.051 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 77.9 mt-30 -113.54 142.72 45.62 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 115.796 -0.638 . . . . 73.450000000000003 110.572 -176.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -123.36 158.21 31.59 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.665 -0.865 . . . . 75.239999999999995 108.665 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.29 118.3 10.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 O-C-N 123.499 0.499 . . . . 64.030000000000001 109.78 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 563' ' ' MET . . . . . 0.548 ' SD ' HG22 ' A' ' 620' ' ' ILE . 35.9 ttp -79.32 136.93 56.26 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 116.219 -0.446 . . . . 73.400000000000006 111.402 -178.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.32 171.24 10.71 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.623 2.882 . . . . 70.409999999999997 111.742 172.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -82.53 129.39 34.91 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 116.529 -0.305 . . . . 75.349999999999994 111.314 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -123.05 16.5 9.99 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.258 1.028 . . . . 75.040000000000006 109.191 176.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 50.8 m -79.03 130.91 36.03 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 114.386 -1.279 . . . . 74.310000000000002 112.363 -175.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 71.12 62.53 3.49 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.45 -0.796 . . . . 55.039999999999999 114.377 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 24.4 ptp -159.86 164.84 33.26 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 109.057 -0.719 . . . . 74.430000000000007 109.057 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -92.88 174.7 7.11 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.835 -0.431 . . . . 72.340000000000003 109.835 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 35.3 t-105 -64.48 -29.64 70.68 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.885 -0.783 . . . . 72.450000000000003 108.885 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 22.1 m -74.96 -6.4 8.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.469 -0.787 . . . . 74.030000000000001 111.214 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -102.21 -44.35 5.45 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.501 -0.925 . . . . 74.519999999999996 108.501 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -64.68 -40.09 94.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.94 -1.027 . . . . 72.010000000000005 113.122 -177.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.694 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 6.0 tm-20 -66.22 -50.81 48.12 Favored Pre-proline 0 CA--C 1.564 1.482 0 N-CA-C 109.943 -0.392 . . . . 74.109999999999999 109.943 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 61.7 Cg_exo -53.12 -34.32 67.99 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 121.584 1.523 . . . . 73.430000000000007 111.646 169.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -60.88 -39.63 89.94 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.433 0.531 . . . . 75.030000000000001 112.433 175.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 3.9 pp -65.98 -44.45 84.85 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 120.184 -0.606 . . . . 75.109999999999999 110.727 -178.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.454 ' N ' HD13 ' A' ' 578' ' ' LEU . 6.6 ptm180 -66.46 -34.58 78.26 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.833 0.349 . . . . 74.230000000000004 111.69 176.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.24 -36.53 74.55 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.161 0.505 . . . . 73.129999999999995 111.35 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.5 tp -87.9 -9.22 54.33 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 123.695 0.798 . . . . 73.129999999999995 110.622 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 66.04 37.51 93.2 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.114 -0.795 . . . . 73.340000000000003 111.114 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -80.73 126.43 31.29 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.409 0.623 . . . . 73.030000000000001 110.172 -176.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 17.0 p -96.67 -18.5 19.65 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 113.313 0.857 . . . . 50.229999999999997 113.313 -174.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -80.36 -156.57 13.23 Favored Glycine 0 C--O 1.24 0.471 0 C-N-CA 121.327 -0.463 . . . . 75.299999999999997 114.115 -176.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 67.2 mtm -128.68 155.32 45.22 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.561 -0.533 . . . . 75.450000000000003 109.561 -176.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.5 tt -106.67 113.71 27.38 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.648 -1.241 . . . . 72.219999999999999 107.648 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 621' ' ' THR . 51.9 m-20 -98.65 110.1 22.75 Favored 'General case' 0 CA--C 1.478 -1.804 0 N-CA-C 109.305 -0.628 . . . . 63.310000000000002 109.305 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.0 OUTLIER -87.55 133.07 33.85 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 118.418 -1.313 . . . . 74.019999999999996 107.633 174.115 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -82.59 -55.67 2.96 Favored Glycine 0 C--N 1.29 -1.976 0 CA-C-N 115.605 -0.725 . . . . 72.340000000000003 112.04 -174.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.85 154.13 47.23 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.569 -0.53 . . . . 72.109999999999999 109.569 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 626' ' ' GLN . 10.5 m-20 -99.54 129.79 45.74 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 105.385 -2.08 . . . . 73.329999999999998 105.385 173.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 16.5 t -103.49 135.78 39.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 107.138 -1.43 . . . . 74.219999999999999 107.138 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.71 121.86 19.61 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 118.219 0.463 . . . . 74.200000000000003 111.083 -169.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -138.3 -56.99 0.65 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.547 -0.751 . . . . 63.539999999999999 110.489 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 100.06 142.31 12.96 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 109.573 -1.411 . . . . 44.43 109.573 -173.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.93 -35.4 83.02 Favored Glycine 0 C--N 1.314 -0.676 0 N-CA-C 113.914 0.326 . . . . 52.109999999999999 113.914 -176.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 9.3 t -71.85 -24.41 61.69 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.284 0.564 . . . . 74.230000000000004 110.329 -176.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -88.19 -0.55 57.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.33 -0.396 . . . . 75.400000000000006 110.734 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 50.8 m80 79.2 84.33 0.06 Allowed 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 125.426 1.49 . . . . 73.319999999999993 110.275 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -81.16 71.98 8.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 123.21 1.481 . . . . 75.329999999999998 111.182 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -115.21 172.32 7.14 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 113.233 -1.803 . . . . 75.430000000000007 110.653 -177.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . 0.428 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 63.2 t -56.54 130.79 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 109.588 -0.523 . . . . 73.140000000000001 109.588 -178.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 26.3 m -110.39 -30.04 2.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.277 -0.874 . . . . 75.310000000000002 111.488 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -156.75 135.71 11.83 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 109.68 -0.489 . . . . 72.409999999999997 109.68 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -116.17 136.24 53.19 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.601 -0.518 . . . . 75.010000000000005 109.601 173.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.406 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 9.5 t30 -56.99 -50.76 86.36 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 123.627 0.579 . . . . 73.310000000000002 111.594 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.46 ' O ' ' HE1' ' A' ' 563' ' ' MET . 57.8 Cg_endo -89.3 112.32 0.56 Allowed 'Trans proline' 0 N--CA 1.43 -2.216 0 N-CA-C 109.361 -1.053 . . . . 75.349999999999994 109.361 169.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.18 161.03 47.48 Favored 'Trans proline' 0 C--O 1.249 1.049 0 C-N-CA 122.709 2.272 . . . . 75.530000000000001 111.132 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -54.89 132.91 47.58 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 122.622 0.369 . . . . 73.409999999999997 110.316 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.64 -6.54 59.0 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.159 -1.019 . . . . 71.150000000000006 112.972 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 37.5 m -86.25 149.54 25.0 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.857 -0.423 . . . . 75.430000000000007 109.857 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.5 123.3 6.07 Favored Glycine 0 N--CA 1.433 -1.562 0 C-N-CA 121.211 -0.519 . . . . 74.120000000000005 112.478 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 35.5 m -116.28 142.31 30.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.716 -0.846 . . . . 74.230000000000004 108.716 176.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -55.74 175.31 0.09 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.922 0.889 . . . . 73.409999999999997 113.287 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -60.99 -27.0 67.98 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.5 -0.318 . . . . 73.219999999999999 111.639 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -82.34 -8.24 59.63 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.171 -0.612 . . . . 75.109999999999999 109.799 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.19 18.75 67.49 Favored Glycine 0 C--O 1.214 -1.131 0 O-C-N 123.302 0.376 . . . . 75.030000000000001 113.105 173.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.68 120.09 17.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 121.739 0.781 . . . . 74.519999999999996 111.396 -167.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.548 HG22 ' SD ' ' A' ' 563' ' ' MET . 50.7 pt -126.88 135.49 63.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 115.026 -0.988 . . . . 71.430000000000007 111.985 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 14.0 t -109.62 128.25 55.09 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.796 -0.816 . . . . 73.019999999999996 108.796 177.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 3.8 pp -139.78 168.08 20.65 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.297 -0.41 . . . . 63.340000000000003 111.631 -176.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -127.6 138.1 52.76 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.435 -0.58 . . . . 75.510000000000005 109.435 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.428 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 22.9 p90 -129.67 165.8 21.09 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 112.53 0.567 . . . . 75.129999999999995 112.53 -175.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -64.85 137.61 39.05 Favored Glycine 0 N--CA 1.423 -2.21 0 CA-C-N 114.886 -1.052 . . . . 72.439999999999998 112.488 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.459 ' HB2' ' HB3' ' A' ' 592' ' ' ASP . 10.3 tt0 . . . . . 0 C--N 1.277 -2.567 0 C-N-CA 125.431 1.492 . . . . 73.430000000000007 107.416 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 114.148 1.166 . . . . 74.230000000000004 114.148 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.8 p -147.94 147.29 29.53 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 122.169 -0.332 . . . . 74.439999999999998 111.465 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -143.83 143.69 31.44 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 123.689 0.795 . . . . 74.329999999999998 109.443 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.8 p-10 -91.13 139.48 30.72 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.825 -0.806 . . . . 74.549999999999997 108.825 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.5 pt -97.65 132.17 25.6 Favored Pre-proline 0 C--N 1.293 -1.861 0 CA-C-N 115.463 -0.79 . . . . 75.319999999999993 111.9 -176.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -83.96 175.85 7.29 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.22 1.947 . . . . 60.229999999999997 110.187 173.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -86.55 127.09 34.86 Favored 'General case' 0 CA--C 1.489 -1.376 0 CA-C-O 122.047 0.927 . . . . 74.099999999999994 109.909 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 16.2 m -113.85 59.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 CA-C-O 122.827 1.298 . . . . 74.099999999999994 109.481 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -112.57 105.77 14.05 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 113.61 -1.632 . . . . 74.25 109.648 174.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 141.97 -17.03 2.57 Favored Glycine 0 C--N 1.313 -0.705 0 C-N-CA 118.472 -1.823 . . . . 73.329999999999998 114.61 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.428 ' O ' HG11 ' A' ' 534' ' ' VAL . 0.1 OUTLIER -112.72 -175.27 2.63 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.041 -0.726 . . . . 73.040000000000006 109.041 177.686 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 2.8 m -74.66 155.44 37.76 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 107.973 -1.121 . . . . 74.530000000000001 107.973 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.529 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 8.3 p -62.82 -42.13 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 121.123 -0.231 . . . . 74.409999999999997 111.48 -178.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.25 -34.41 78.28 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 110.06 -0.348 . . . . 75.409999999999997 110.06 -178.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 59.0 t -71.9 -44.32 67.41 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.966 0 N-CA-C 109.351 -0.611 . . . . 74.439999999999998 109.351 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -58.58 -43.68 89.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.78 0.324 . . . . 73.349999999999994 110.83 177.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.3 mt-30 -62.75 -44.24 96.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.722 -0.672 . . . . 74.319999999999993 110.445 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.505 ' O ' HG21 ' A' ' 514' ' ' VAL . 71.8 mmtt -65.86 -42.61 90.18 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.924 -0.58 . . . . 71.420000000000002 111.129 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -62.86 -47.23 84.25 Favored 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 124.06 0.85 . . . . 72.209999999999994 111.237 -176.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -68.41 -35.31 77.46 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 115.689 -0.687 . . . . 75.030000000000001 110.6 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.442 ' N ' HD12 ' A' ' 512' ' ' LEU . 4.0 t-20 -63.87 -34.0 76.95 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 115.171 -0.922 . . . . 74.519999999999996 111.431 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.505 HG21 ' O ' ' A' ' 510' ' ' LYS . 84.0 t -57.22 -32.53 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 121.164 0.507 . . . . 75.099999999999994 110.731 177.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -107.85 4.77 25.81 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.489 -0.93 . . . . 70.549999999999997 108.489 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -126.96 -60.18 0.14 Allowed Glycine 0 N--CA 1.416 -2.666 0 C-N-CA 119.547 -1.311 . . . . 75.420000000000002 114.577 -169.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 64.8 25.12 12.89 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 122.561 1.172 . . . . 70.409999999999997 108.224 -171.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.6 p -82.87 -172.88 4.36 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 113.271 -1.786 . . . . 74.319999999999993 111.007 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.477 ' HD2' ' N ' ' A' ' 519' ' ' LYS . 0.1 OUTLIER -108.71 136.56 48.1 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.537 -1.282 . . . . 74.450000000000003 107.537 179.461 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -132.26 147.22 52.4 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.121 0.486 . . . . 74.329999999999998 111.699 -177.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 64.5 m -140.74 149.24 41.89 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.637 -0.875 . . . . 71.420000000000002 108.637 176.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -117.9 140.55 49.56 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 116.255 -0.429 . . . . 63.509999999999998 110.326 -176.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -132.23 130.51 41.06 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.421 -0.955 . . . . 43.210000000000001 108.421 176.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 27.0 m -88.61 126.78 35.45 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 120.933 0.397 . . . . 73.209999999999994 111.522 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.77 150.68 25.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.216 -1.031 . . . . 73.430000000000007 108.216 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -66.91 135.02 53.2 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.453 -0.573 . . . . 64.099999999999994 109.453 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 33.4 m -154.17 165.94 16.9 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 107.935 -1.135 . . . . 73.030000000000001 107.935 -177.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -83.42 -18.47 5.87 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 120.979 1.119 . . . . 73.310000000000002 111.394 172.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.428 HH21 ' CD ' ' A' ' 533' ' ' GLU . 25.1 mtp180 -79.17 145.72 65.52 Favored Pre-proline 0 N--CA 1.437 -1.086 0 C-N-CA 124.697 1.199 . . . . 72.219999999999999 109.668 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.5 146.3 97.15 Favored 'Trans proline' 0 C--O 1.25 1.087 0 C-N-CA 123.638 2.892 . . . . 73.519999999999996 115.056 -170.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.653 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.91 105.31 0.55 Allowed 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.859 -1.064 . . . . 75.230000000000004 112.012 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 142.51 -26.22 2.28 Favored Glycine 0 C--N 1.308 -1.011 0 N-CA-C 110.656 -0.977 . . . . 74.010000000000005 110.656 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . 0.428 ' CD ' HH21 ' A' ' 529' ' ' ARG . 43.9 tt0 -80.35 136.48 36.4 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 121.227 0.536 . . . . 74.340000000000003 110.182 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 8.0 p -98.27 124.78 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.66 0 CA-C-N 115.491 -0.777 . . . . 73.010000000000005 109.104 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.43 8.95 40.28 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.827 -1.079 . . . . 75.120000000000005 113.465 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 127.82 -163.57 21.45 Favored Glycine 0 C--N 1.298 -1.57 0 C-N-CA 120.288 -0.958 . . . . 73.420000000000002 112.703 174.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 28.1 p -116.69 158.94 22.99 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.504 -0.925 . . . . 72.340000000000003 108.504 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -59.87 -57.08 29.46 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 120.134 -0.626 . . . . 71.530000000000001 110.352 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -68.81 144.68 60.09 Favored 'Trans proline' 0 C--N 1.376 1.984 0 CA-C-N 120.26 1.128 . . . . 75.5 110.72 173.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.7 157.64 60.87 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 123.063 2.508 . . . . 73.019999999999996 113.506 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.22 130.74 46.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.517 -0.765 . . . . 74.409999999999997 110.765 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.82 -12.79 41.89 Favored Glycine 0 C--N 1.303 -1.299 0 CA-C-N 116.025 -0.534 . . . . 72.340000000000003 112.236 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 45.8 m -73.83 125.72 28.79 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 110.174 -0.306 . . . . 74.519999999999996 110.174 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 11.7 t -81.39 124.36 29.34 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.38 -0.97 . . . . 65.25 108.38 176.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.2 m -123.95 159.26 57.18 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 107.903 -1.147 . . . . 75.239999999999995 107.903 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -66.69 137.66 46.59 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 120.723 0.948 . . . . 75.439999999999998 111.191 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.5 p -63.24 -23.61 33.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.233 -0.894 . . . . 72.409999999999997 112.104 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -101.7 3.17 39.42 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.744 -0.782 . . . . 72.510000000000005 110.194 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 9.9 t -95.86 -178.62 4.43 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 108.619 -0.882 . . . . 73.239999999999995 108.619 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.2 p -103.24 137.24 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 CA-C-O 121.635 0.731 . . . . 74.340000000000003 111.639 -174.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.37 128.24 50.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 106.647 -1.612 . . . . 74.439999999999998 106.647 175.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -103.4 117.5 34.62 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.613 0.72 . . . . 73.150000000000006 112.08 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.7 mp -102.04 130.65 48.66 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.368 -1.287 . . . . 74.030000000000001 110.17 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -93.58 115.85 28.35 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.752 0.787 . . . . 73.340000000000003 112.135 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 40.1 t -88.41 129.77 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 107.281 -1.378 . . . . 65.5 107.281 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.653 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 2.2 m -84.06 117.74 23.62 Favored 'General case' 0 C--N 1.271 -2.813 0 N-CA-C 108.498 -0.927 . . . . 73.319999999999993 108.498 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -94.32 125.75 39.16 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.77 -1.567 . . . . 74.219999999999999 106.77 171.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -61.85 -23.4 63.37 Favored Glycine 0 C--N 1.308 -1.011 0 N-CA-C 115.014 0.766 . . . . 73.400000000000006 115.014 -173.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 78.08 -20.3 0.39 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.87 1.268 . . . . 74.230000000000004 108.532 -175.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.497 ' H ' ' C ' ' A' ' 558' ' ' GLY . 78.3 mt-30 -112.78 148.17 35.36 Favored 'General case' 0 N--CA 1.403 -2.784 0 CA-C-N 115.376 -0.829 . . . . 75.129999999999995 111.012 -174.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -123.84 154.9 38.96 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 106.205 -1.776 . . . . 71.439999999999998 106.205 175.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 44.2 t -71.96 126.97 33.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 109.314 -0.624 . . . . 71.340000000000003 109.314 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 51.9 ttp -84.24 127.53 66.0 Favored Pre-proline 0 C--O 1.251 1.153 0 CA-C-N 116.28 -0.418 . . . . 72.030000000000001 110.19 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.73 169.53 19.92 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.707 2.271 . . . . 65.239999999999995 111.101 175.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -72.53 142.13 48.49 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.381 0.61 . . . . 71.239999999999995 111.321 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.8 pp -154.87 25.9 0.44 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.599 -1.182 . . . . 73.230000000000004 109.624 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 21.7 m -79.58 146.81 32.38 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.101 -0.954 . . . . 71.450000000000003 110.372 -177.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 63.72 53.79 35.7 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.116 -0.564 . . . . 71.239999999999995 113.098 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -130.04 173.07 11.08 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.19 -1.041 . . . . 72.409999999999997 108.19 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -108.4 172.29 6.92 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.808 -1.182 . . . . 74.219999999999999 107.808 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . 0.47 ' CZ3' HD21 ' A' ' 587' ' ' LEU . 12.8 t-105 -65.93 -32.27 73.68 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.452 -0.944 . . . . 72.420000000000002 108.452 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.59 -15.1 18.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.537 -0.756 . . . . 73.530000000000001 111.238 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.544 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 25.9 t70 -101.07 -21.56 14.96 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.608 -0.886 . . . . 63.520000000000003 108.608 177.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -68.24 -39.18 82.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.189 -0.914 . . . . 73.25 111.92 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.634 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 2.7 tm-20 -58.77 -52.31 75.66 Favored Pre-proline 0 CA--C 1.57 1.742 0 N-CA-C 109.283 -0.636 . . . . 75.439999999999998 109.283 177.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 75.1 Cg_exo -55.23 -40.66 84.55 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 121.271 1.314 . . . . 72.349999999999994 112.486 171.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 16.7 mmt180 -61.62 -38.21 86.81 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 111.906 0.336 . . . . 74.310000000000002 111.906 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.1 pp -66.5 -47.13 73.99 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.969 -0.692 . . . . 72.430000000000007 110.964 -176.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.471 ' N ' HD12 ' A' ' 578' ' ' LEU . 14.7 ptm180 -66.12 -34.85 78.99 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.528 -0.305 . . . . 75.510000000000005 110.696 176.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.31 -39.52 92.59 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.823 -0.626 . . . . 54.530000000000001 111.284 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 1.1 pp -92.51 -8.73 43.67 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.01 -0.676 . . . . 75.530000000000001 110.963 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 76.83 42.91 19.4 Favored Glycine 0 CA--C 1.517 0.165 0 N-CA-C 111.53 -0.628 . . . . 72.25 111.53 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -87.22 127.56 35.16 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 123.276 0.63 . . . . 75.400000000000006 110.145 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 5.8 m -103.99 -21.3 13.63 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.064 0.459 . . . . 73.040000000000006 111.557 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -72.56 177.97 39.7 Favored Glycine 0 C--O 1.241 0.567 0 CA-C-O 121.598 0.555 . . . . 73.109999999999999 114.472 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 586' ' ' MET . . . . . 0.423 ' O ' HG12 ' A' ' 619' ' ' ILE . 55.7 ttp -95.54 145.6 25.09 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 123.597 0.759 . . . . 61.43 110.654 -177.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . 0.47 HD21 ' CZ3' ' A' ' 571' ' ' TRP . 5.4 tt -85.64 112.44 21.01 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.438 -0.949 . . . . 73.420000000000002 108.438 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 621' ' ' THR . 25.4 t70 -101.83 105.26 16.08 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.686 0.755 . . . . 75.150000000000006 110.324 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.48 133.87 34.75 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 115.033 -0.985 . . . . 74.239999999999995 108.561 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -73.35 -63.35 2.8 Favored Glycine 0 C--N 1.288 -2.106 0 N-CA-C 110.792 -0.923 . . . . 74.209999999999994 110.792 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.16 151.3 45.15 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.462 -0.369 . . . . 65.430000000000007 111.032 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -115.6 123.49 48.57 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 104.41 -2.441 . . . . 71.040000000000006 104.41 168.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 50.7 t -112.64 120.69 63.37 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 CA-C-N 116.007 -0.542 . . . . 74.239999999999995 109.579 -174.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . 0.413 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 21.9 t70 -76.35 106.7 8.12 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 106.385 -1.709 . . . . 74.310000000000002 106.385 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -134.83 8.0 3.51 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.607 -0.437 . . . . 64.340000000000003 111.75 -175.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 117.28 95.68 1.84 Allowed Glycine 0 N--CA 1.422 -2.241 0 C-N-CA 120.194 -1.003 . . . . 74.340000000000003 111.7 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.25 -31.29 59.24 Favored Glycine 0 C--N 1.32 -0.348 0 N-CA-C 111.951 -0.46 . . . . 61.32 111.951 177.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 46.4 t -59.4 -24.6 63.6 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.185 0.994 . . . . 65.310000000000002 110.669 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -87.33 -4.22 59.05 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.568 -0.742 . . . . 74.540000000000006 111.169 -175.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 39.6 m80 63.7 94.06 0.05 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 122.102 0.953 . . . . 71.219999999999999 111.051 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . 0.494 HD21 ' N ' ' A' ' 601' ' ' ASN . 0.8 OUTLIER -85.28 87.86 7.43 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.967 0.889 . . . . 72.239999999999995 112.215 -173.249 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -90.82 169.93 10.52 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.045 -1.434 . . . . 62.210000000000001 108.996 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 85.1 t -60.45 129.83 23.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.007 -0.738 . . . . 75.019999999999996 109.007 176.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 11.7 p -112.79 -35.75 2.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 O-C-N 123.645 0.591 . . . . 73.439999999999998 111.041 -175.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -136.58 139.62 42.28 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.306 -0.406 . . . . 64.25 110.082 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -137.75 139.2 39.97 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.295 -1.372 . . . . 71.129999999999995 107.295 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -65.7 -52.81 40.54 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 113.125 0.787 . . . . 73.239999999999995 113.125 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -85.92 125.19 2.69 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 CA-C-N 120.424 1.187 . . . . 74.239999999999995 110.941 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.88 158.99 53.98 Favored 'Trans proline' 0 C--O 1.244 0.823 0 C-N-CA 122.382 2.055 . . . . 72.040000000000006 112.81 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.58 130.79 44.14 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 108.488 -0.93 . . . . 70.310000000000002 108.488 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 98.18 0.01 58.6 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 120.222 -0.989 . . . . 65.409999999999997 112.084 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 35.6 m -102.17 154.52 18.94 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.421 -0.955 . . . . 75.5 108.421 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.45 133.2 12.15 Favored Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 120.914 -0.66 . . . . 54.039999999999999 111.792 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.5 m -117.38 142.36 31.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.922 -0.77 . . . . 71.409999999999997 108.922 176.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.404 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 34.2 p30 -47.55 166.35 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 114.112 1.153 . . . . 72.049999999999997 114.112 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -61.35 -26.03 67.55 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.303 -0.862 . . . . 74.519999999999996 112.626 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -83.46 -10.89 58.08 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 119.037 -1.065 . . . . 73.209999999999994 109.481 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.73 9.77 56.73 Favored Glycine 0 CA--C 1.499 -0.946 0 N-CA-C 111.293 -0.723 . . . . 75.049999999999997 111.293 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 586' ' ' MET . 0.0 OUTLIER -70.45 118.83 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.167 0 CA-C-O 122.212 1.006 . . . . 73.129999999999995 108.615 -171.041 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.428 ' O ' HD13 ' A' ' 620' ' ' ILE . 2.7 pp -121.11 132.6 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.872 0 CA-C-N 114.02 -1.445 . . . . 75.010000000000005 110.251 -177.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 15.3 t -104.93 119.35 38.79 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.57 -0.9 . . . . 70.129999999999995 108.57 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -139.49 165.88 26.05 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.4 -0.818 . . . . 74.439999999999998 110.813 -175.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -128.82 142.32 51.01 Favored 'General case' 0 C--O 1.257 1.469 0 CA-C-O 121.279 0.561 . . . . 74.340000000000003 110.458 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -142.0 166.75 23.87 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.186 -1.413 . . . . 72.120000000000005 107.186 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -79.31 -142.94 2.55 Favored Glycine 0 C--N 1.294 -1.785 0 C-N-CA 119.107 -1.52 . . . . 64.340000000000003 113.096 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.413 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 6.5 tp-100 . . . . . 0 C--N 1.279 -2.488 0 N-CA-C 109.294 -0.632 . . . . 63.119999999999997 109.294 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 112.661 0.615 . . . . 73.329999999999998 112.661 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.0 p -139.21 143.43 38.06 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.675 -0.491 . . . . 75.400000000000006 109.675 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -131.81 143.47 50.22 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 121.197 0.523 . . . . 74.340000000000003 110.546 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 2.3 m-20 -88.32 121.85 31.18 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.897 -1.047 . . . . 72.209999999999994 109.817 -177.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.0 pt -86.62 122.56 71.7 Favored Pre-proline 0 C--N 1.302 -1.465 0 CA-C-N 116.318 -0.401 . . . . 71.310000000000002 110.637 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -85.86 -169.57 0.6 Allowed 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.294 1.996 . . . . 73.420000000000002 110.593 177.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -89.5 129.81 35.93 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.569 -0.9 . . . . 75.0 108.569 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.414 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 27.8 m -121.77 7.84 5.85 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 CA-C-N 115.208 -0.905 . . . . 74.209999999999994 109.969 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.97 103.78 4.59 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.397 -0.82 . . . . 74.129999999999995 110.119 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 161.98 -41.39 0.38 Allowed Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 115.517 -0.765 . . . . 73.329999999999998 111.195 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 14.3 pm0 -93.94 -177.51 4.36 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 108.984 -0.747 . . . . 71.540000000000006 108.984 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 7.8 m -70.56 155.4 40.77 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 108.467 -0.938 . . . . 74.25 108.467 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.474 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 11.5 p -64.87 -42.05 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 O-C-N 123.122 0.264 . . . . 74.530000000000001 110.717 -177.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -62.2 -40.72 97.04 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 109.866 -0.42 . . . . 72.519999999999996 109.866 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 84.4 t -66.14 -47.28 85.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.894 0 CA-C-N 115.271 -0.877 . . . . 74.319999999999993 109.333 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.414 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -60.9 -45.15 95.76 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 111.828 0.307 . . . . 72.439999999999998 111.828 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.5 mt-30 -64.88 -46.76 80.42 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 116.038 -0.528 . . . . 75.420000000000002 111.232 -177.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.506 ' O ' HG23 ' A' ' 514' ' ' VAL . 21.5 ptmt -67.49 -38.84 84.95 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 116.208 -0.451 . . . . 74.209999999999994 110.645 -178.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -62.87 -42.32 99.72 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.186 0.517 . . . . 72.299999999999997 111.15 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -68.71 -41.97 78.34 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.337 -0.847 . . . . 64.25 108.74 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -59.38 -40.84 87.82 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.644 1.178 . . . . 73.209999999999994 111.734 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 510' ' ' LYS . 91.6 t -57.58 -33.18 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 121.173 0.511 . . . . 74.209999999999994 111.507 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -114.84 16.42 17.3 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.621 -0.511 . . . . 74.409999999999997 109.621 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -133.94 -58.46 0.07 OUTLIER Glycine 0 N--CA 1.428 -1.879 0 C-N-CA 119.64 -1.267 . . . . 55.530000000000001 113.618 -173.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 64.07 28.2 14.22 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 122.629 1.204 . . . . 74.450000000000003 111.013 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.2 p -79.61 171.99 14.4 Favored 'General case' 0 N--CA 1.396 -3.137 0 CA-C-N 113.643 -1.617 . . . . 74.409999999999997 108.17 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.523 ' N ' ' HD2' ' A' ' 519' ' ' LYS . 10.2 mptt -107.56 136.06 47.96 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 107.549 -1.278 . . . . 74.409999999999997 107.549 -176.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -133.51 149.24 51.71 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.026 0.441 . . . . 75.310000000000002 112.145 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.7 m -138.73 142.93 38.88 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.076 -1.453 . . . . 75.019999999999996 107.076 174.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -117.54 137.75 52.36 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.62 -0.432 . . . . 75.019999999999996 111.094 -176.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -122.62 119.73 31.64 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.63 -0.878 . . . . 64.219999999999999 108.63 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 12.8 m -96.36 120.34 36.48 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.097 0.475 . . . . 74.109999999999999 111.17 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.7 p -123.82 155.31 30.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.448 -1.316 . . . . 75.400000000000006 107.448 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -75.78 136.42 40.27 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.496 0.665 . . . . 72.510000000000005 111.745 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 64.9 m -160.45 159.69 26.06 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 107.047 -1.464 . . . . 72.25 107.047 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -65.58 -9.77 23.82 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 C-N-CA 122.788 2.326 . . . . 74.219999999999999 113.561 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.436 ' HB2' ' CB ' ' A' ' 556' ' ' SER . 14.7 mmm180 -78.36 141.94 62.21 Favored Pre-proline 0 N--CA 1.436 -1.15 0 N-CA-C 107.27 -1.382 . . . . 72.549999999999997 107.27 176.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -64.43 152.2 82.5 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 122.862 2.374 . . . . 73.140000000000001 113.958 -173.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.643 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.91 111.15 1.19 Allowed 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.815 -0.629 . . . . 63.539999999999999 111.963 -178.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 123.85 -16.17 7.83 Favored Glycine 0 C--N 1.299 -1.491 0 CA-C-N 115.283 -0.871 . . . . 53.25 112.121 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.16 138.36 34.74 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.535 -0.542 . . . . 64.150000000000006 109.535 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 6.1 p -87.16 116.84 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 CA-C-O 122.136 0.969 . . . . 74.0 109.48 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.97 -27.31 60.93 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 113.976 -1.466 . . . . 74.219999999999999 109.884 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.51 -162.31 29.54 Favored Glycine 0 N--CA 1.416 -2.651 0 N-CA-C 110.583 -1.007 . . . . 73.450000000000003 110.583 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 5.3 p -117.03 157.7 25.39 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 109.481 -0.563 . . . . 72.420000000000002 109.481 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -63.94 -54.14 43.21 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 120.766 -0.374 . . . . 72.450000000000003 110.2 174.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -69.32 134.4 28.81 Favored 'Trans proline' 0 C--N 1.369 1.617 0 N-CA-C 108.679 -1.316 . . . . 74.109999999999999 108.679 170.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.57 155.96 50.12 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 122.437 2.091 . . . . 75.0 112.93 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.4 131.21 45.86 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.964 -0.562 . . . . 75.049999999999997 109.718 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.84 -7.44 38.52 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 111.459 -0.656 . . . . 73.140000000000001 111.459 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 30.1 m -80.9 137.25 36.15 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.842 -0.429 . . . . 73.420000000000002 109.842 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 5.6 t -92.04 128.32 37.84 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 107.819 -1.178 . . . . 74.200000000000003 107.819 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 29.5 m -123.95 154.85 67.83 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.74 -0.837 . . . . 73.230000000000004 108.74 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -65.56 137.94 52.46 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 121.054 1.169 . . . . 74.409999999999997 111.269 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.6 -19.76 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-O 122.219 1.009 . . . . 74.439999999999998 109.691 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -84.76 -16.05 42.91 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.148 -1.387 . . . . 71.219999999999999 110.747 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 22.8 t -94.45 -173.29 3.01 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-N 115.869 -0.605 . . . . 71.200000000000003 110.737 -175.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.2 p -118.95 138.15 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 C-N-CA 123.6 0.76 . . . . 75.129999999999995 111.207 -175.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 43.8 mt -95.0 143.9 10.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.509 -0.922 . . . . 63.439999999999998 108.509 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -103.8 117.06 33.46 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.43 -0.952 . . . . 73.450000000000003 108.43 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.95 120.6 41.86 Favored 'General case' 0 C--N 1.311 -1.071 0 O-C-N 123.735 0.647 . . . . 73.430000000000007 110.083 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -90.74 120.96 32.22 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.215 0.531 . . . . 72.150000000000006 109.991 176.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 23.9 t -105.59 137.22 36.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.216 -1.031 . . . . 74.310000000000002 108.216 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.643 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 71.2 m -89.89 133.15 34.92 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-O 120.756 0.312 . . . . 75.109999999999999 110.362 176.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 18.8 ptpt -106.1 127.18 53.01 Favored 'General case' 0 N--CA 1.406 -2.638 0 N-CA-C 104.317 -2.475 . . . . 72.239999999999995 104.317 164.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -55.42 -23.66 35.39 Favored Glycine 0 CA--C 1.506 -0.511 0 O-C-N 124.062 0.851 . . . . 75.549999999999997 114.128 -173.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 81.77 -19.13 0.44 Allowed 'General case' 0 CA--C 1.495 -1.161 0 C-N-CA 126.236 1.815 . . . . 72.430000000000007 108.903 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 85.2 mt-30 -111.83 144.91 40.36 Favored 'General case' 0 N--CA 1.407 -2.59 0 CA-C-N 115.259 -0.882 . . . . 73.209999999999994 110.528 -173.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -123.29 146.67 47.71 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 107.535 -1.284 . . . . 64.549999999999997 107.535 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 84.5 t -62.33 116.63 2.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 123.66 0.6 . . . . 74.310000000000002 109.825 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 56.3 ttp -77.59 126.63 84.24 Favored Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 116.387 -0.37 . . . . 63.439999999999998 110.686 -176.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.45 168.49 21.01 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.5 2.133 . . . . 64.109999999999999 110.95 175.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -77.66 132.13 38.07 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 113.122 0.786 . . . . 74.349999999999994 113.122 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.0 pp -140.49 16.21 2.37 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.384 -1.28 . . . . 74.439999999999998 110.07 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 71.3 p -73.89 148.3 42.41 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 116.151 -0.477 . . . . 73.040000000000006 112.227 -175.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 72.97 57.28 5.35 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 115.689 -0.687 . . . . 62.25 113.987 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -136.93 167.93 20.54 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.115 -0.698 . . . . 74.230000000000004 109.115 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -95.5 165.76 12.19 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.387 -1.338 . . . . 75.5 107.387 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -67.21 -29.04 68.6 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.356 -0.609 . . . . 71.239999999999995 109.356 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.2 p -71.78 -22.81 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.558 0.694 . . . . 73.430000000000007 109.982 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -95.97 -34.29 11.84 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.039 -0.982 . . . . 55.240000000000002 108.936 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -54.7 -53.11 59.24 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 114.973 -1.012 . . . . 73.109999999999999 112.635 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -53.82 -54.95 40.91 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 115.122 1.527 . . . . 71.439999999999998 115.122 -176.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.83 -28.11 81.17 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.413 1.409 . . . . 53.409999999999997 111.446 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -67.98 -35.12 77.82 Favored 'General case' 0 C--O 1.198 -1.646 0 CA-C-O 118.999 -0.524 . . . . 71.340000000000003 111.847 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.578 HD23 ' CZ3' ' A' ' 583' ' ' TRP . 16.6 mt -60.25 -48.95 79.55 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.406 -0.59 . . . . 73.129999999999995 109.406 -176.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -66.5 -40.82 89.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.764 -0.653 . . . . 72.230000000000004 111.492 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.76 65.43 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.132 0.492 . . . . 74.239999999999995 111.762 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.7 tp -91.87 -9.11 44.49 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 124.33 1.052 . . . . 70.319999999999993 110.022 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.65 22.35 77.31 Favored Glycine 0 C--N 1.315 -0.588 0 C-N-CA 121.112 -0.566 . . . . 53.229999999999997 112.55 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . 0.578 ' CZ3' HD23 ' A' ' 578' ' ' LEU . 16.7 t90 -87.48 127.31 35.23 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.053 -0.721 . . . . 74.120000000000005 109.053 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 14.8 p -100.11 -14.49 18.55 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 113.877 1.066 . . . . 75.540000000000006 113.877 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -80.11 -159.29 18.73 Favored Glycine 0 C--N 1.313 -0.711 0 N-CA-C 114.321 0.488 . . . . 73.319999999999993 114.321 -175.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 65.7 mtt -114.41 139.5 49.45 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.868 0.366 . . . . 71.340000000000003 111.383 -174.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 21.5 tp -80.71 101.88 9.56 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 106.709 -1.589 . . . . 61.030000000000001 106.709 177.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -98.99 117.45 33.54 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.872 -0.331 . . . . 75.219999999999999 111.036 -173.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.0 OUTLIER -91.19 133.44 35.37 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 119.587 -0.845 . . . . 70.409999999999997 110.503 -179.102 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -74.34 -72.99 0.96 Allowed Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 110.798 -0.921 . . . . 42.329999999999998 110.798 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.16 142.28 35.97 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.715 -0.846 . . . . 75.349999999999994 108.715 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -79.88 123.58 27.89 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 107.079 -1.452 . . . . 74.549999999999997 107.079 174.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 50.4 t -104.68 128.28 58.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.398 -1.334 . . . . 75.519999999999996 107.398 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -72.01 114.04 9.68 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.768 -0.827 . . . . 63.140000000000001 108.768 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -124.53 -44.29 1.99 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.918 -1.037 . . . . 70.129999999999995 111.0 -173.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 109.08 122.52 4.62 Favored Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.561 -0.828 . . . . 61.299999999999997 112.111 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -61.22 -33.63 85.04 Favored Glycine 0 C--N 1.316 -0.548 0 CA-C-N 116.001 -0.1 . . . . 72.310000000000002 113.057 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 22.8 t -70.59 -22.85 62.51 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.94 0.876 . . . . 60.340000000000003 110.377 -177.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -87.12 -1.3 57.79 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.304 -0.862 . . . . 72.140000000000001 108.935 -175.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 69.77 82.63 0.16 Allowed 'General case' 0 CA--C 1.492 -1.274 0 C-N-CA 124.59 1.156 . . . . 73.420000000000002 108.611 -173.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -79.43 79.63 5.87 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 114.16 -1.382 . . . . 75.230000000000004 111.549 -176.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -87.68 173.23 9.15 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.746 -1.57 . . . . 75.120000000000005 108.234 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 624' ' ' PHE . 91.1 t -58.68 130.4 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.322 -1.733 . . . . 74.120000000000005 106.322 168.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.2 m -101.57 -29.92 3.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 120.703 -0.399 . . . . 71.150000000000006 111.687 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -155.78 144.55 20.42 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 109.824 -0.436 . . . . 74.0 109.824 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -135.04 140.73 45.82 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.977 -1.49 . . . . 73.129999999999995 106.977 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.404 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 27.4 t-20 -66.32 -54.82 22.78 Favored Pre-proline 0 C--N 1.312 -1.046 0 C-N-CA 119.647 -0.821 . . . . 75.439999999999998 112.314 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.3 Cg_exo -84.8 119.16 2.17 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 121.996 1.797 . . . . 74.319999999999993 111.388 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.14 160.77 48.1 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 123.048 2.498 . . . . 64.209999999999994 112.252 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.07 134.94 51.46 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.657 -0.868 . . . . 62.409999999999997 108.657 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.32 -15.09 47.11 Favored Glycine 0 C--N 1.293 -1.81 0 N-CA-C 110.948 -0.861 . . . . 63.340000000000003 110.948 -175.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 37.3 m -92.61 146.77 23.41 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.042 -1.096 . . . . 74.310000000000002 108.042 178.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -78.2 130.92 10.47 Favored Glycine 0 N--CA 1.426 -1.995 0 C-N-CA 121.163 -0.541 . . . . 70.439999999999998 112.427 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 26.8 m -114.69 142.12 28.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.829 -1.174 . . . . 73.420000000000002 107.829 176.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.412 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.9 p-10 -50.92 172.85 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.149 0.98 . . . . 72.109999999999999 113.397 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -54.71 -27.14 38.46 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 113.811 1.041 . . . . 74.409999999999997 113.811 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.419 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 1.2 m-20 -94.77 -6.5 42.89 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.17 -0.612 . . . . 74.120000000000005 110.645 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.49 19.19 68.59 Favored Glycine 0 C--O 1.214 -1.118 0 CA-C-O 119.806 -0.441 . . . . 71.140000000000001 113.35 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.72 119.15 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 122.083 0.944 . . . . 74.25 110.835 -167.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 48.7 pt -125.54 134.98 65.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.89 -1.05 . . . . 63.210000000000001 110.909 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 15.1 t -100.31 125.37 46.52 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 108.461 -0.94 . . . . 73.340000000000003 108.461 177.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 1.8 pt? -139.32 165.27 27.63 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.285 -0.87 . . . . 74.319999999999993 110.288 -175.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -128.81 140.06 51.88 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.64 -0.504 . . . . 71.430000000000007 109.64 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 603' ' ' VAL . 5.2 p90 -130.97 165.16 23.76 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.862 0.363 . . . . 72.129999999999995 111.452 -174.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -76.96 141.89 26.82 Favored Glycine 0 N--CA 1.415 -2.762 0 CA-C-N 114.955 -1.021 . . . . 64.109999999999999 113.604 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 . . . . . 0 C--N 1.272 -2.798 0 N-CA-C 106.98 -1.489 . . . . 72.310000000000002 106.98 178.66 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 112.449 0.537 . . . . 72.299999999999997 112.449 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 29.5 p -139.84 145.46 38.14 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.572 -0.529 . . . . 73.540000000000006 109.572 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -128.51 137.04 51.57 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 123.396 0.435 . . . . 75.439999999999998 110.305 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.9 p-10 -84.87 124.79 32.02 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.474 0.654 . . . . 54.43 110.099 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.3 pt -84.89 125.35 71.02 Favored Pre-proline 0 C--N 1.305 -1.357 0 CA-C-N 115.673 -0.694 . . . . 72.230000000000004 111.735 -176.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -74.44 172.65 15.7 Favored 'Trans proline' 0 C--O 1.254 1.28 0 C-N-CA 122.449 2.099 . . . . 62.340000000000003 111.124 174.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -80.25 105.44 11.52 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.989 -0.55 . . . . 73.319999999999993 109.616 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 15.4 m -106.87 59.3 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-O 123.24 1.495 . . . . 75.329999999999998 110.308 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -118.0 111.49 19.01 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 112.658 -2.064 . . . . 64.310000000000002 108.127 173.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 136.22 -15.85 3.93 Favored Glycine 0 C--N 1.303 -1.289 0 C-N-CA 119.042 -1.551 . . . . 62.140000000000001 113.937 177.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.451 ' O ' HG13 ' A' ' 534' ' ' VAL . 0.4 OUTLIER -111.39 -175.46 2.71 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 117.695 0.748 . . . . 74.319999999999993 109.231 176.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 10.6 m -71.67 155.0 40.99 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.542 -0.91 . . . . 72.519999999999996 108.542 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.433 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.7 p -61.64 -42.48 94.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 111.508 0.188 . . . . 74.349999999999994 111.508 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 25.7 t70 -62.51 -41.63 98.96 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.965 -0.383 . . . . 73.239999999999995 109.965 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 68.0 t -67.46 -41.66 86.3 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.966 0 CA-C-N 115.64 -0.709 . . . . 72.129999999999995 109.476 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.495 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -61.97 -43.51 98.69 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 121.365 -0.134 . . . . 72.340000000000003 111.146 176.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 26.3 mt-30 -64.85 -43.13 94.0 Favored 'General case' 0 CA--C 1.511 -0.539 0 O-C-N 123.089 0.243 . . . . 71.420000000000002 110.811 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.55 ' O ' HG21 ' A' ' 514' ' ' VAL . 75.9 mmtt -63.77 -46.6 84.52 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.586 -0.524 . . . . 64.409999999999997 109.586 176.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -63.57 -38.63 91.84 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.733 -0.667 . . . . 73.349999999999994 111.715 -177.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.71 -45.29 83.31 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.552 -1.277 . . . . 71.409999999999997 107.552 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -59.77 -36.1 75.97 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 124.03 0.932 . . . . 75.030000000000001 110.947 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.55 HG21 ' O ' ' A' ' 510' ' ' LYS . 83.5 t -57.2 -39.5 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 122.875 0.47 . . . . 60.100000000000001 111.317 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -105.0 -8.32 18.63 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.584 0.707 . . . . 73.25 110.012 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -108.43 -59.6 0.54 Allowed Glycine 0 N--CA 1.414 -2.802 0 CA-C-N 115.574 -0.739 . . . . 73.129999999999995 112.836 -169.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 65.44 25.81 11.92 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 122.398 1.094 . . . . 75.430000000000007 109.434 -173.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 518' ' ' THR . . . . . 0.463 HG22 ' HA ' ' A' ' 547' ' ' VAL . 1.9 p -90.61 -172.99 3.59 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 113.741 -1.572 . . . . 75.510000000000005 110.239 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -108.75 142.05 39.86 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.38 -1.341 . . . . 74.209999999999994 107.38 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -132.44 153.11 51.18 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.11 0.481 . . . . 73.239999999999995 112.278 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.7 m -141.4 152.73 44.56 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.169 -1.048 . . . . 74.040000000000006 108.169 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -117.46 126.43 52.61 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.396 0.617 . . . . 62.43 111.719 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.02 130.38 56.17 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.891 -1.151 . . . . 74.019999999999996 107.891 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 18.7 p -103.87 139.58 38.86 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.323 0.582 . . . . 65.420000000000002 112.435 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.0 p -136.64 149.58 26.87 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 107.276 -1.379 . . . . 71.530000000000001 107.276 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.425 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 1.6 p-10 -87.61 136.83 32.79 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.93 -0.708 . . . . 73.200000000000003 110.521 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 50.6 m -156.27 163.79 23.67 Favored Pre-proline 0 C--N 1.293 -1.879 0 N-CA-C 106.415 -1.698 . . . . 75.239999999999995 106.415 -178.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.4 10.69 0.7 Allowed 'Trans proline' 0 CA--C 1.558 1.676 0 C-N-CA 121.935 1.757 . . . . 73.430000000000007 114.355 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.446 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 0.0 OUTLIER -96.59 140.99 22.46 Favored Pre-proline 0 C--O 1.214 -0.788 0 N-CA-C 108.686 -0.857 . . . . 74.099999999999994 108.686 177.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.1 145.88 73.15 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 123.251 2.634 . . . . 73.109999999999999 113.643 -176.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 557' ' ' LYS . . . -66.83 99.39 0.62 Allowed 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.972 -1.013 . . . . 74.349999999999994 112.781 -174.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 152.3 -26.64 0.88 Allowed Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 115.045 -0.98 . . . . 64.519999999999996 110.734 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -74.39 131.4 41.06 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.687 0.756 . . . . 70.329999999999998 110.831 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.495 HG11 ' CB ' ' A' ' 508' ' ' ALA . 12.4 p -97.97 125.65 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.063 0 N-CA-C 107.33 -1.359 . . . . 73.510000000000005 107.33 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 p -97.59 10.95 38.58 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 115.184 -0.916 . . . . 71.519999999999996 113.024 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 133.18 -165.77 23.93 Favored Glycine 0 N--CA 1.434 -1.491 0 C-N-CA 119.963 -1.113 . . . . 74.040000000000006 113.448 173.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 14.2 p -116.94 158.4 24.13 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 124.293 1.037 . . . . 73.299999999999997 108.736 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -62.14 -50.4 80.38 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 119.31 -0.956 . . . . 62.219999999999999 112.454 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -69.17 143.27 53.12 Favored 'Trans proline' 0 C--N 1.367 1.529 0 N-CA-C 108.929 -1.219 . . . . 65.340000000000003 108.929 170.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.94 144.93 89.34 Favored 'Trans proline' 0 C--O 1.253 1.229 0 C-N-CA 122.411 2.074 . . . . 72.299999999999997 112.634 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.27 137.51 58.27 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.458 -0.792 . . . . 73.329999999999998 109.629 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.52 -12.59 47.17 Favored Glycine 0 C--N 1.304 -1.242 0 N-CA-C 111.48 -0.648 . . . . 63.240000000000002 111.48 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 31.9 m -81.03 136.81 36.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.518 0.199 . . . . 74.209999999999994 110.895 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.2 t -90.59 128.32 36.55 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 108.214 -1.032 . . . . 75.030000000000001 108.214 173.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.77 153.99 67.0 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 108.907 -0.775 . . . . 65.519999999999996 108.907 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -60.54 138.19 78.61 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.76 1.64 . . . . 74.420000000000002 111.702 178.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.463 ' HA ' HG22 ' A' ' 518' ' ' THR . 8.7 p -61.27 -19.03 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 CA-C-O 122.177 0.989 . . . . 74.349999999999994 110.552 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -81.12 -15.8 54.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.638 -1.165 . . . . 75.540000000000006 111.954 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 77.6 p -92.79 157.96 16.14 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 112.905 0.706 . . . . 75.019999999999996 112.905 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.9 p -98.56 128.15 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 115.261 -0.881 . . . . 75.400000000000006 110.119 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.6 mt -98.95 136.05 31.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.508 -0.769 . . . . 73.409999999999997 109.798 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.88 125.25 50.16 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.889 0.852 . . . . 74.430000000000007 111.754 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.63 120.92 39.89 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 113.884 -1.507 . . . . 75.329999999999998 109.128 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -85.7 108.5 18.07 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.731 0.777 . . . . 63.43 112.057 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 16.2 t -90.6 129.84 40.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 114.962 -1.017 . . . . 74.439999999999998 108.307 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 67.7 m -94.69 117.99 31.01 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 109.83 -0.433 . . . . 74.040000000000006 109.83 177.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 18.2 ptpt -90.94 136.74 32.87 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.431 -1.692 . . . . 75.120000000000005 106.431 173.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -62.85 -24.39 66.55 Favored Glycine 0 CA--C 1.489 -1.561 0 O-C-N 124.233 0.958 . . . . 65.109999999999999 114.423 -171.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . 0.425 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 31.7 t-20 77.75 -24.99 0.2 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.571 1.148 . . . . 73.409999999999997 109.574 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.485 ' H ' ' C ' ' A' ' 558' ' ' GLY . 86.5 mt-30 -111.46 150.46 29.85 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 115.782 -0.645 . . . . 73.219999999999999 111.078 -174.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -132.35 149.86 52.27 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.347 -1.297 . . . . 75.420000000000002 107.622 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 63.2 t -68.25 125.72 26.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 109.833 -0.432 . . . . 73.519999999999996 109.833 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 48.1 ttp -92.18 125.63 55.88 Favored Pre-proline 0 C--N 1.308 -1.233 0 CA-C-N 116.072 -0.513 . . . . 70.310000000000002 111.184 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.81 155.01 71.57 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.957 2.438 . . . . 71.450000000000003 111.027 174.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . 0.513 ' HA ' ' CB ' ' A' ' 610' ' ' ALA . 29.4 t70 -67.03 139.42 57.63 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 114.851 1.426 . . . . 71.299999999999997 114.851 -174.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . 0.408 ' O ' ' HG2' ' A' ' 569' ' ' MET . 2.1 pt? -141.35 15.63 2.21 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.772 -1.103 . . . . 75.040000000000006 109.688 176.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 84.2 p -80.06 153.28 28.88 Favored 'General case' 0 C--O 1.251 1.161 0 C-N-CA 120.171 -0.611 . . . . 71.450000000000003 110.571 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 79.08 31.49 42.76 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.856 -0.688 . . . . 61.399999999999999 113.91 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 569' ' ' MET . . . . . 0.473 ' SD ' ' HG3' ' A' ' 577' ' ' ARG . 21.5 ptp -134.01 -179.07 5.32 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.795 -0.817 . . . . 73.109999999999999 108.795 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -101.82 167.43 10.08 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.275 -1.38 . . . . 74.540000000000006 107.275 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 -67.24 -30.01 69.8 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.678 -0.86 . . . . 74.319999999999993 108.678 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 11.5 p -72.11 -16.83 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 115.395 -0.821 . . . . 74.209999999999994 110.34 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.601 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 18.6 t70 -101.35 -39.16 7.72 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.706 -0.85 . . . . 73.140000000000001 108.706 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.7 -42.46 97.23 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 115.034 -0.984 . . . . 74.299999999999997 112.019 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.5 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 39.2 tt0 -55.4 -53.18 64.96 Favored Pre-proline 0 CA--C 1.569 1.701 0 CA-C-O 119.142 -0.456 . . . . 74.299999999999997 111.776 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 71.6 Cg_exo -55.77 -30.33 75.72 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 122.124 1.883 . . . . 74.099999999999994 112.6 171.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 11.4 mmm180 -62.81 -38.29 90.14 Favored 'General case' 0 C--O 1.202 -1.421 0 C-N-CA 120.707 -0.397 . . . . 74.439999999999998 110.816 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.73 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 10.5 mp -58.01 -49.28 77.4 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 118.001 0.364 . . . . 73.510000000000005 110.807 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -66.17 -40.87 90.8 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.62 -0.718 . . . . 73.0 112.675 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.02 -27.78 64.96 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.898 0.38 . . . . 65.129999999999995 111.735 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . 0.447 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 8.3 tp -89.73 -9.36 49.67 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 123.939 0.896 . . . . 75.049999999999997 110.545 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 68.73 32.11 73.9 Favored Glycine 0 C--O 1.243 0.672 0 C-N-CA 120.829 -0.701 . . . . 73.299999999999997 111.995 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . 0.73 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 10.9 t90 -87.03 126.78 34.97 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 107.576 -1.268 . . . . 73.230000000000004 107.576 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 4.2 p -91.78 -27.95 17.68 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 113.031 0.752 . . . . 74.230000000000004 113.031 -174.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -71.7 179.36 34.23 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 116.122 -0.49 . . . . 75.150000000000006 112.878 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 62.6 mtm -107.28 148.8 28.52 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.073 0.463 . . . . 75.319999999999993 111.056 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 29.9 tp -80.63 111.47 17.09 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 107.182 -1.414 . . . . 75.430000000000007 107.182 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . 0.543 ' O ' ' HA ' ' A' ' 621' ' ' THR . 15.3 t70 -97.94 114.92 27.15 Favored 'General case' 0 CA--C 1.485 -1.531 0 CA-C-N 116.086 -0.506 . . . . 74.109999999999999 110.237 -174.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.6 133.45 35.54 Favored 'General case' 0 C--N 1.276 -2.6 0 C-N-CA 119.853 -0.739 . . . . 74.140000000000001 109.399 177.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -83.01 -61.77 1.89 Allowed Glycine 0 C--N 1.291 -1.952 0 N-CA-C 109.884 -1.286 . . . . 74.549999999999997 109.884 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.67 149.45 43.73 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 109.348 -0.612 . . . . 65.329999999999998 109.348 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -90.06 150.14 22.21 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.221 -1.029 . . . . 61.039999999999999 108.221 176.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 19.9 t -117.44 136.7 53.75 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 108.636 -0.876 . . . . 71.209999999999994 108.636 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.59 106.97 5.59 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.709 -1.219 . . . . 54.43 107.709 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -120.42 -61.5 1.57 Allowed 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.618 -0.719 . . . . 75.409999999999997 109.342 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 89.08 151.83 24.84 Favored Glycine 0 N--CA 1.419 -2.457 0 C-N-CA 119.575 -1.298 . . . . 70.409999999999997 111.238 -176.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.4 -33.69 62.34 Favored Glycine 0 C--N 1.3 -1.441 0 N-CA-C 114.649 0.62 . . . . 73.25 114.649 -177.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 32.2 t -73.1 -24.89 60.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.95 0.881 . . . . 75.310000000000002 109.794 -176.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -99.83 -3.38 32.72 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.044 -0.98 . . . . 73.230000000000004 109.645 -177.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 56.6 m80 74.37 126.98 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.201 1.4 . . . . 72.129999999999995 112.677 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -83.74 51.07 1.93 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.249 1.023 . . . . 75.340000000000003 108.987 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 37.4 mtp180 -83.91 158.17 21.69 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.729 -1.123 . . . . 70.239999999999995 113.299 -176.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.16 131.73 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 106.136 -1.801 . . . . 74.540000000000006 106.136 167.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 44.0 t -97.47 -44.07 12.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-O 121.594 0.712 . . . . 72.329999999999998 109.512 -177.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -154.24 145.38 22.81 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.431 -0.804 . . . . 74.349999999999994 110.167 -176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -126.41 133.58 51.24 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 105.833 -1.914 . . . . 72.519999999999996 105.833 174.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -63.52 -51.09 69.47 Favored Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 112.744 0.646 . . . . 61.399999999999999 112.744 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -87.65 111.15 0.76 Allowed 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 122.002 1.801 . . . . 64.430000000000007 109.815 172.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.92 143.49 45.38 Favored 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 122.588 2.192 . . . . 73.0 113.485 -177.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . 0.513 ' CB ' ' HA ' ' A' ' 565' ' ' ASP . . . -65.82 139.85 58.35 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.81 -0.632 . . . . 72.420000000000002 109.737 176.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.45 -9.16 44.96 Favored Glycine 0 C--N 1.301 -1.365 0 N-CA-C 109.578 -1.409 . . . . 43.32 109.578 -172.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 63.0 m -108.67 154.18 22.38 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.491 -0.929 . . . . 75.109999999999999 108.491 176.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -72.74 128.54 12.59 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 111.898 -0.481 . . . . 75.430000000000007 111.898 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 30.1 m -112.7 143.14 23.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 123.666 0.786 . . . . 72.310000000000002 109.464 178.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -43.56 167.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 125.492 1.517 . . . . 71.099999999999994 113.259 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -57.29 -25.35 59.13 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 113.907 1.077 . . . . 74.230000000000004 113.907 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -93.04 -7.57 45.33 Favored 'General case' 0 C--O 1.208 -1.103 0 C-N-CA 119.327 -0.949 . . . . 75.120000000000005 108.543 -178.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 68.09 11.7 61.62 Favored Glycine 0 CA--C 1.491 -1.444 0 CA-C-N 115.557 -0.747 . . . . 64.239999999999995 111.788 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.46 118.85 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-O 122.279 1.037 . . . . 72.239999999999995 111.627 -169.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 45.0 pt -121.18 134.33 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 113.8 -1.546 . . . . 72.340000000000003 110.265 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 14.1 t -98.66 131.31 44.94 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 108.035 -1.098 . . . . 73.340000000000003 108.035 177.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -139.36 167.57 21.79 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.863 -0.608 . . . . 75.219999999999999 111.733 -174.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -126.75 136.42 52.4 Favored 'General case' 0 C--O 1.255 1.392 0 N-CA-C 107.228 -1.397 . . . . 74.409999999999997 107.228 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -141.39 163.23 33.5 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.448 -0.342 . . . . 75.420000000000002 110.603 -172.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -76.27 129.43 10.06 Favored Glycine 0 N--CA 1.416 -2.643 0 O-C-N 123.827 0.705 . . . . 74.5 111.545 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 C--N 1.299 -1.6 0 C-N-CA 123.948 0.899 . . . . 63.240000000000002 109.678 -179.503 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.374 0 CA-C-O 120.861 0.362 . . . . 74.329999999999998 110.329 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 25.4 p -130.89 140.32 50.2 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.891 -0.411 . . . . 75.450000000000003 109.891 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . 0.559 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 8.8 tmtm? -150.56 144.22 25.17 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.724 -1.213 . . . . 75.430000000000007 107.724 172.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.559 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 9.6 p-10 -78.58 130.13 35.59 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.48 0.657 . . . . 60.210000000000001 110.808 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 29.3 pt -87.24 133.69 38.17 Favored Pre-proline 0 C--N 1.288 -2.103 0 C-N-CA 120.212 -0.595 . . . . 73.409999999999997 110.331 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -69.52 170.87 15.29 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 121.864 1.709 . . . . 75.109999999999999 111.85 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -78.01 83.23 4.32 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 122.876 1.322 . . . . 73.109999999999999 110.626 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.413 ' HB ' ' CB ' ' A' ' 508' ' ' ALA . 26.9 m -86.73 -6.82 10.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 114.399 -1.273 . . . . 75.329999999999998 112.268 -177.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.67 101.85 3.76 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.817 -0.809 . . . . 70.230000000000004 108.817 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 157.18 -38.54 0.56 Allowed Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.799 -0.715 . . . . 63.409999999999997 111.89 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 17.4 pm0 -97.54 -168.02 1.62 Allowed 'General case' 0 C--O 1.243 0.738 0 C-N-CA 120.761 -0.376 . . . . 63.409999999999997 110.006 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 14.5 m -70.15 155.35 40.76 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.21 -0.663 . . . . 74.549999999999997 109.21 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.433 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.3 p -63.18 -41.45 92.86 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.547 0 O-C-N 123.302 0.376 . . . . 73.450000000000003 110.72 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . 0.447 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 18.7 t70 -59.84 -42.91 94.64 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.891 0.377 . . . . 63.0 110.04 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.32 -45.42 82.58 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.622 0 CA-C-N 115.352 -0.84 . . . . 72.230000000000004 109.226 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.413 ' CB ' ' HB ' ' A' ' 500' ' ' VAL . . . -58.83 -45.38 90.15 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 120.638 0.256 . . . . 75.510000000000005 111.006 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.0 mt-30 -64.12 -45.64 87.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.972 -0.558 . . . . 72.430000000000007 111.237 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.557 ' O ' HG21 ' A' ' 514' ' ' VAL 0.314 0.0 OUTLIER -67.32 -37.65 83.66 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 119.632 -0.827 . . . . 73.140000000000001 111.607 177.353 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . 0.458 ' N ' ' HD3' ' A' ' 510' ' ' LYS . 7.9 m-20 -60.45 -50.2 74.53 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 116.276 -0.42 . . . . 72.230000000000004 110.723 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . 0.439 HD11 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -68.05 -36.25 79.56 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.937 -0.574 . . . . 74.129999999999995 111.239 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.439 ' N ' HD11 ' A' ' 512' ' ' LEU . 1.5 t-20 -65.9 -38.43 88.73 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 122.999 0.52 . . . . 61.210000000000001 110.528 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.557 HG21 ' O ' ' A' ' 510' ' ' LYS . 78.2 t -59.59 -32.98 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.093 0.473 . . . . 71.049999999999997 111.102 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -111.54 16.35 20.73 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.881 -0.328 . . . . 74.510000000000005 110.275 -177.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -143.01 -53.83 0.03 OUTLIER Glycine 0 CA--C 1.488 -1.62 0 C-N-CA 119.421 -1.371 . . . . 65.439999999999998 113.826 -173.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 61.46 39.37 15.09 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.652 1.215 . . . . 74.430000000000007 108.899 -174.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 518' ' ' THR . . . . . 0.481 HG23 ' HA ' ' A' ' 547' ' ' VAL . 20.3 p -91.23 -172.24 3.23 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 112.814 -1.994 . . . . 65.519999999999996 109.3 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.5 142.38 39.0 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.393 -1.336 . . . . 73.019999999999996 107.393 176.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -131.53 152.05 51.07 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.401 0.619 . . . . 74.219999999999999 112.244 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 20.4 p -140.29 146.42 38.52 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 107.962 -1.125 . . . . 73.549999999999997 107.962 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -119.79 129.47 54.47 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.237 -0.585 . . . . 74.349999999999994 110.942 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -121.01 118.7 30.5 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.945 -0.761 . . . . 74.420000000000002 108.945 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.8 m -90.78 137.09 32.63 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.132 0.491 . . . . 72.430000000000007 111.895 -176.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 47.2 t -128.89 149.06 33.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 105.793 -1.929 . . . . 73.239999999999995 105.793 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.1 135.68 36.38 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 118.327 0.512 . . . . 63.539999999999999 110.941 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 42.9 m -159.46 169.75 9.92 Favored Pre-proline 0 C--N 1.31 -1.151 0 N-CA-C 107.623 -1.251 . . . . 52.240000000000002 107.623 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -73.12 -13.78 25.97 Favored 'Trans proline' 0 C--O 1.25 1.078 0 C-N-CA 122.004 1.803 . . . . 73.430000000000007 112.838 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.491 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 48.6 mtt180 -73.35 143.05 82.41 Favored Pre-proline 0 N--CA 1.442 -0.825 0 N-CA-C 108.988 -0.745 . . . . 75.319999999999993 108.988 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.71 144.6 97.36 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 122.5 2.133 . . . . 74.329999999999998 112.034 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.78 99.21 0.08 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.367 -0.833 . . . . 71.129999999999995 111.762 -178.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 153.56 -22.4 0.73 Allowed Glycine 0 N--CA 1.423 -2.185 0 C-N-CA 120.573 -0.823 . . . . 53.140000000000001 112.154 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . 0.491 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 32.6 tt0 -79.99 138.35 37.03 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 117.239 0.52 . . . . 74.310000000000002 109.97 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 5.1 p -91.97 113.2 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 N-CA-C 108.502 -0.925 . . . . 74.329999999999998 108.502 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.54 -33.25 73.78 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.199 -1.364 . . . . 75.549999999999997 110.189 -177.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 167.91 177.78 39.44 Favored Glycine 0 N--CA 1.42 -2.401 0 CA-C-N 115.089 -0.959 . . . . 63.329999999999998 110.959 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.0 p -118.1 153.83 33.11 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 108.502 -0.925 . . . . 71.519999999999996 108.502 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -72.32 -48.01 10.08 Favored Pre-proline 0 C--N 1.318 -0.784 0 C-N-CA 118.235 -1.386 . . . . 75.340000000000003 110.246 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.52 131.5 34.03 Favored 'Trans proline' 0 C--N 1.381 2.274 0 N-CA-C 108.529 -1.373 . . . . 73.310000000000002 108.529 169.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -69.01 139.97 44.24 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 122.184 1.923 . . . . 75.319999999999993 114.732 -173.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -68.66 133.66 48.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.93 -1.032 . . . . 65.510000000000005 110.415 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 91.16 -19.29 47.45 Favored Glycine 0 C--N 1.306 -1.115 0 N-CA-C 110.839 -0.904 . . . . 73.409999999999997 110.839 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.2 m -87.82 139.46 30.5 Favored 'General case' 0 N--CA 1.413 -2.324 0 C-N-CA 123.623 0.769 . . . . 74.310000000000002 110.555 -175.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 3.4 t -72.45 124.6 25.51 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.662 -0.699 . . . . 75.120000000000005 109.323 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.72 163.82 36.68 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 107.236 -1.394 . . . . 74.219999999999999 107.236 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -76.46 135.3 16.32 Favored 'Trans proline' 0 N--CA 1.423 -2.642 0 CA-C-N 120.004 1.037 . . . . 73.519999999999996 111.715 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.481 ' HA ' HG23 ' A' ' 518' ' ' THR . 35.3 t -67.53 -24.91 31.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-N 114.122 -1.399 . . . . 62.219999999999999 110.46 176.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -78.19 -17.86 56.23 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.441 -1.254 . . . . 73.450000000000003 111.509 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 94.6 p -90.82 177.38 6.32 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.637 -0.425 . . . . 73.150000000000006 110.993 -177.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 12.9 p -109.07 126.31 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.831 0 CA-C-O 121.75 0.786 . . . . 72.209999999999994 109.908 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 63.1 mt -86.11 129.45 38.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 108.794 -0.817 . . . . 71.340000000000003 108.794 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -103.79 117.32 34.08 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.718 0.771 . . . . 75.140000000000001 110.664 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -95.45 114.03 25.75 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.653 -1.612 . . . . 73.049999999999997 108.218 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -84.32 116.39 22.99 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.922 -0.77 . . . . 74.120000000000005 108.922 176.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 524' ' ' SER . 23.9 t -104.15 131.79 52.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 115.099 -0.955 . . . . 74.349999999999994 109.244 -175.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.631 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 74.1 m -84.76 122.22 28.8 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 109.621 -0.511 . . . . 72.439999999999998 109.621 175.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.0 ptpt -93.49 141.25 28.68 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 104.672 -2.344 . . . . 74.219999999999999 104.672 169.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.575 ' O ' ' HG3' ' A' ' 560' ' ' GLN . . . -66.46 -27.17 72.95 Favored Glycine 0 CA--C 1.488 -1.649 0 C-N-CA 120.138 -1.03 . . . . 44.340000000000003 110.652 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 64.4 t30 65.27 11.84 7.58 Favored 'General case' 0 C--O 1.216 -0.689 0 C-N-CA 124.697 1.199 . . . . 63.210000000000001 109.885 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.575 ' HG3' ' O ' ' A' ' 558' ' ' GLY . 40.9 mt-30 -124.68 142.85 51.09 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 115.478 -0.783 . . . . 64.329999999999998 109.21 -176.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . 0.4 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 53.6 p90 -123.34 148.24 46.21 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.389 -0.967 . . . . 71.120000000000005 108.389 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.1 122.14 14.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.144 0.497 . . . . 72.25 111.002 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 563' ' ' MET . . . . . 0.422 ' SD ' HD12 ' A' ' 620' ' ' ILE . 56.9 ttp -97.45 122.43 55.58 Favored Pre-proline 0 C--N 1.31 -1.133 0 CA-C-N 115.885 -0.598 . . . . 74.430000000000007 110.953 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -68.15 169.81 15.88 Favored 'Trans proline' 0 C--O 1.241 0.661 0 C-N-CA 123.065 2.51 . . . . 72.040000000000006 110.843 172.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.6 142.42 38.95 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.138 0.494 . . . . 75.120000000000005 110.569 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . 0.443 ' O ' ' HG2' ' A' ' 569' ' ' MET . 2.0 pt? -126.69 5.29 6.73 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 122.206 1.003 . . . . 74.010000000000005 108.91 174.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 567' ' ' SER . . . . . 0.458 ' HA ' ' HB ' ' A' ' 603' ' ' VAL . 29.0 t -79.44 140.62 37.31 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 107.808 -1.182 . . . . 65.519999999999996 107.808 176.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 99.39 -2.46 57.6 Favored Glycine 0 C--N 1.302 -1.314 0 C-N-CA 120.018 -1.086 . . . . 74.109999999999999 112.878 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 569' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 24.0 ptp -120.06 169.35 10.29 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.561 -0.903 . . . . 73.340000000000003 108.561 177.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -92.59 171.59 8.92 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.004 -1.11 . . . . 74.319999999999993 108.004 -174.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -62.44 -32.87 73.79 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.69 -0.856 . . . . 75.209999999999994 108.69 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 30.7 m -68.9 -12.88 16.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 CA-C-N 116.076 -0.511 . . . . 74.329999999999998 112.107 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -102.27 -43.91 5.57 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 110.033 -0.358 . . . . 75.25 110.033 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -61.32 -39.5 90.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.799 -0.637 . . . . 74.109999999999999 112.235 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.646 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 44.0 tt0 -63.16 -53.36 54.87 Favored Pre-proline 0 CA--C 1.561 1.382 0 CA-C-N 116.622 -0.263 . . . . 74.120000000000005 111.494 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 92.7 Cg_exo -54.14 -40.43 81.87 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 121.547 1.498 . . . . 75.329999999999998 112.315 171.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.24 -42.49 91.2 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.479 0.18 . . . . 74.409999999999997 110.634 178.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.5 pp -66.17 -46.85 75.94 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 120.359 -0.536 . . . . 72.299999999999997 111.716 -175.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.447 ' N ' HD12 ' A' ' 578' ' ' LEU . 1.7 ptm180 -66.24 -36.23 82.46 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.792 -0.64 . . . . 75.310000000000002 111.563 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -71.17 -37.99 72.18 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 112.367 0.506 . . . . 75.5 112.367 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.0 pp -80.65 -8.66 59.7 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.22 0.533 . . . . 73.030000000000001 110.496 -176.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 85.6 32.55 18.65 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 115.46 -0.791 . . . . 71.120000000000005 112.509 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -77.02 126.2 30.57 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 107.197 -1.408 . . . . 75.349999999999994 107.197 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 2.1 p -106.08 6.42 31.07 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 112.833 0.679 . . . . 61.140000000000001 112.833 -175.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -95.68 -152.96 29.68 Favored Glycine 0 N--CA 1.436 -1.338 0 N-CA-C 110.723 -0.951 . . . . 73.430000000000007 110.723 174.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 57.6 ttp -136.87 147.0 46.23 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.03 -1.1 . . . . 71.109999999999999 108.03 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 6.0 tt -80.16 118.34 21.77 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.494 -0.928 . . . . 73.209999999999994 108.494 -177.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 621' ' ' THR . 26.5 t70 -98.76 120.61 39.48 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.641 -0.708 . . . . 71.340000000000003 109.332 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.5 133.21 43.18 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 119.194 -1.002 . . . . 73.439999999999998 108.724 176.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -85.2 -51.64 3.67 Favored Glycine 0 C--N 1.284 -2.35 0 N-CA-C 109.616 -1.394 . . . . 71.209999999999994 109.616 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -134.81 117.69 16.2 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 109.362 -0.607 . . . . 72.200000000000003 109.362 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -105.31 123.84 48.53 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.712 -1.218 . . . . 71.120000000000005 107.712 173.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 53.9 t -112.09 129.34 67.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 109.087 -0.708 . . . . 61.200000000000003 109.087 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . 0.403 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 23.3 t70 -72.67 114.47 10.84 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 108.798 -0.816 . . . . 64.530000000000001 108.798 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -124.27 -57.41 1.59 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.572 -0.74 . . . . 74.340000000000003 109.843 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 106.53 151.16 18.47 Favored Glycine 0 N--CA 1.423 -2.222 0 C-N-CA 120.062 -1.066 . . . . 72.219999999999999 110.863 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.482 ' HA2' ' OD1' ' A' ' 601' ' ' ASN . . . -58.77 -33.99 75.43 Favored Glycine 0 C--N 1.311 -0.811 0 N-CA-C 115.038 0.775 . . . . 74.450000000000003 115.038 -177.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 11.3 t -74.83 -23.91 58.53 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 122.125 0.964 . . . . 74.019999999999996 109.117 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -89.84 0.18 57.19 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.822 -1.081 . . . . 74.230000000000004 110.301 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 27.3 m170 78.41 85.67 0.07 Allowed 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 125.821 1.648 . . . . 60.310000000000002 109.789 -177.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . 0.482 ' OD1' ' HA2' ' A' ' 597' ' ' GLY . 26.0 p-10 -89.15 58.91 4.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 122.987 1.375 . . . . 75.239999999999995 110.428 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -97.16 163.59 12.86 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.893 -1.503 . . . . 74.310000000000002 108.431 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . 0.458 ' HB ' ' HA ' ' A' ' 567' ' ' SER . 92.8 t -70.17 130.52 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 104.74 -2.318 . . . . 74.030000000000001 104.74 168.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 13.4 p -103.11 -35.52 3.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 121.289 0.566 . . . . 73.530000000000001 111.133 -173.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -146.1 134.62 22.05 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 109.147 -0.686 . . . . 74.150000000000006 109.147 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -115.78 131.93 56.79 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.402 -1.703 . . . . 74.150000000000006 106.402 174.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.423 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 20.8 t-20 -58.25 -51.7 79.87 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 112.376 0.51 . . . . 73.209999999999994 112.376 -175.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.1 Cg_endo -87.13 118.97 1.44 Allowed 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.234 1.289 . . . . 75.109999999999999 109.494 172.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -64.56 159.71 43.39 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 122.549 2.166 . . . . 64.329999999999998 111.906 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.9 135.23 57.72 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.174 -0.466 . . . . 71.409999999999997 110.415 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.43 -11.94 47.3 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 111.35 -0.7 . . . . 73.129999999999995 111.35 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 34.2 m -82.1 136.75 35.14 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.592 -0.521 . . . . 75.530000000000001 109.592 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -77.33 123.13 6.36 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 110.271 -1.131 . . . . 63.020000000000003 110.271 175.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.6 m -113.62 142.38 26.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 109.643 -0.503 . . . . 71.140000000000001 109.643 178.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 559' ' ' ASN . 29.9 p30 -48.59 164.62 0.06 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.176 1.176 . . . . 74.129999999999995 114.176 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -57.74 -27.9 63.42 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.788 0.835 . . . . 73.439999999999998 112.629 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.42 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 4.4 p-10 -90.24 -9.37 48.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 119.486 -0.885 . . . . 72.430000000000007 110.459 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.11 14.86 62.1 Favored Glycine 0 CA--C 1.49 -1.503 0 C-N-CA 124.065 0.841 . . . . 65.439999999999998 114.685 163.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.05 117.66 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-O 122.566 1.174 . . . . 64.519999999999996 110.869 -167.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.422 HD12 ' SD ' ' A' ' 563' ' ' MET . 49.3 pt -129.81 135.28 61.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 113.755 -1.566 . . . . 71.239999999999995 110.37 -177.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 13.8 t -99.21 129.87 45.48 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 108.235 -1.024 . . . . 75.319999999999993 108.235 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 4.0 pp -138.76 167.13 22.65 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 116.136 -0.484 . . . . 75.340000000000003 111.462 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -128.09 136.33 51.04 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.808 -0.812 . . . . 72.349999999999994 108.808 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -142.55 165.58 27.02 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 116.187 -0.46 . . . . 75.120000000000005 111.827 -172.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -86.73 132.47 11.17 Favored Glycine 0 N--CA 1.42 -2.407 0 N-CA-C 109.221 -1.552 . . . . 40.229999999999997 109.221 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 9.9 tt0 . . . . . 0 C--N 1.279 -2.463 0 C-N-CA 123.066 0.547 . . . . 74.120000000000005 109.593 -178.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.605 0 CA-C-O 121.599 0.714 . . . . 72.510000000000005 109.899 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 13.0 p -129.96 155.32 46.26 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 115.53 -0.759 . . . . 75.319999999999993 110.827 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -143.11 146.36 33.7 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.426 -0.806 . . . . 71.109999999999999 109.758 176.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.1 p-10 -91.56 140.03 30.12 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.094 -0.706 . . . . 73.019999999999996 109.094 177.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.4 pt -96.53 124.6 50.24 Favored Pre-proline 0 C--N 1.298 -1.664 0 CA-C-N 115.673 -0.694 . . . . 75.540000000000006 110.467 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -66.76 157.5 60.85 Favored 'Trans proline' 0 C--O 1.245 0.829 0 C-N-CA 122.475 2.117 . . . . 72.5 111.843 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -77.65 99.98 6.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.587 0.708 . . . . 63.210000000000001 109.704 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 30.3 m -105.63 11.14 8.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 114.96 -1.018 . . . . 74.120000000000005 112.169 -175.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -80.01 96.96 6.59 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.036 0.445 . . . . 70.329999999999998 110.798 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 162.38 -40.93 0.37 Allowed Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.777 -0.725 . . . . 74.319999999999993 111.914 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 16.1 pm0 -90.77 -171.89 3.19 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 110.251 -0.277 . . . . 74.549999999999997 110.251 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 28.1 m -70.1 155.0 41.23 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.818 -0.808 . . . . 72.120000000000005 108.818 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.417 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.2 p -62.48 -41.63 92.62 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 O-C-N 123.075 0.235 . . . . 75.420000000000002 110.722 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -59.4 -40.83 87.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.385 0.612 . . . . 74.299999999999997 109.645 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . 0.413 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 75.4 t -71.88 -45.95 62.61 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.608 0 CA-C-N 115.292 -0.867 . . . . 74.109999999999999 110.057 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.44 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -58.85 -44.34 90.99 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 111.917 0.34 . . . . 73.209999999999994 111.917 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.6 mt-30 -62.42 -45.79 91.53 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.295 -0.411 . . . . 64.310000000000002 110.957 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.56 ' O ' HG21 ' A' ' 514' ' ' VAL . 16.6 ptpt -67.97 -38.82 83.19 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 120.486 -0.485 . . . . 75.299999999999997 110.175 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -60.84 -47.36 86.7 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 116.056 -0.52 . . . . 74.340000000000003 110.86 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . 0.465 HD13 ' N ' ' A' ' 513' ' ' ASN . 3.9 pp -68.48 -35.73 77.95 Favored 'General case' 0 C--O 1.211 -0.923 0 CA-C-N 115.863 -0.608 . . . . 74.219999999999999 111.154 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.465 ' N ' HD13 ' A' ' 512' ' ' LEU . 4.1 t-20 -66.02 -34.86 79.06 Favored 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 123.287 0.635 . . . . 74.219999999999999 111.99 -178.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 510' ' ' LYS . 89.1 t -57.0 -32.42 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 121.491 0.663 . . . . 75.129999999999995 110.354 177.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -114.45 17.26 17.5 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.757 -0.656 . . . . 73.109999999999999 109.666 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -138.09 -55.03 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 119.923 -1.132 . . . . 63.210000000000001 113.57 -174.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 66.87 17.85 10.58 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.277 1.037 . . . . 74.340000000000003 109.922 -176.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.7 p -78.13 -170.7 2.06 Favored 'General case' 0 N--CA 1.411 -2.401 0 C-N-CA 125.481 1.512 . . . . 73.510000000000005 111.492 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -108.24 143.12 37.5 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.013 -1.477 . . . . 74.230000000000004 107.013 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -132.7 150.43 52.16 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.242 -0.583 . . . . 74.450000000000003 111.938 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.2 m -140.83 146.29 37.37 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.98 -1.489 . . . . 71.409999999999997 106.98 175.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -118.08 136.01 53.83 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 120.13 -0.628 . . . . 74.010000000000005 110.104 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -130.29 131.95 45.67 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.624 -0.88 . . . . 64.129999999999995 108.624 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 73.1 m -100.18 131.36 46.17 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.542 0.687 . . . . 71.019999999999996 112.596 -178.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.78 149.27 25.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.373 -1.714 . . . . 73.439999999999998 106.373 176.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -76.83 135.63 38.9 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 121.49 0.662 . . . . 64.430000000000007 111.674 -176.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 50.3 m -162.79 156.09 17.0 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 106.338 -1.727 . . . . 61.32 106.338 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -63.93 -3.12 5.35 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 122.762 2.308 . . . . 74.239999999999995 114.288 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -80.12 136.58 53.62 Favored Pre-proline 0 CA--C 1.51 -0.587 0 N-CA-C 106.967 -1.494 . . . . 74.409999999999997 106.967 176.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -61.6 147.94 94.2 Favored 'Trans proline' 0 C--O 1.256 1.382 0 C-N-CA 122.343 2.028 . . . . 51.32 112.701 -175.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -56.61 115.89 2.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.292 -0.867 . . . . 72.409999999999997 110.88 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 134.21 -27.78 3.24 Favored Glycine 0 N--CA 1.434 -1.436 0 C-N-CA 120.825 -0.703 . . . . 73.030000000000001 111.643 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -80.85 135.68 35.97 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-O 121.254 0.549 . . . . 74.329999999999998 110.295 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.44 HG11 ' CB ' ' A' ' 508' ' ' ALA . 7.2 p -96.67 120.78 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.722 0 N-CA-C 107.702 -1.221 . . . . 73.129999999999995 107.702 178.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.2 p -97.74 -1.23 43.85 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.167 -0.924 . . . . 74.530000000000001 113.132 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 163.23 -166.56 37.13 Favored Glycine 0 N--CA 1.423 -2.219 0 C-N-CA 120.278 -0.963 . . . . 60.020000000000003 111.52 176.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 2.4 p -135.39 152.91 51.87 Favored 'General case' 0 C--N 1.273 -2.746 0 N-CA-C 107.866 -1.161 . . . . 65.439999999999998 107.866 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.44 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 62.0 t30 -58.29 -50.83 85.93 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 119.834 -0.747 . . . . 72.239999999999995 111.201 175.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 4.8 Cg_exo -81.36 128.47 6.27 Favored 'Trans proline' 0 C--N 1.37 1.676 0 N-CA-C 107.568 -1.743 . . . . 54.130000000000003 107.568 168.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.38 140.31 88.41 Favored 'Trans proline' 0 C--O 1.245 0.846 0 C-N-CA 122.42 2.08 . . . . 75.099999999999994 113.04 -176.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.82 138.65 58.51 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.91 -0.587 . . . . 74.409999999999997 110.122 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.72 -11.58 57.8 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 120.752 -0.737 . . . . 72.510000000000005 111.294 -176.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 18.4 m -88.32 137.49 32.28 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.167 -0.309 . . . . 75.530000000000001 110.167 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 13.3 t -81.16 129.79 34.73 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 109.233 -0.655 . . . . 71.340000000000003 109.233 173.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.5 m -123.83 164.13 30.95 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 107.315 -1.365 . . . . 73.519999999999996 107.315 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -68.23 139.38 45.88 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 120.936 1.09 . . . . 63.299999999999997 110.646 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.8 p -62.6 -20.3 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 CA-C-N 115.696 -0.684 . . . . 73.140000000000001 112.296 -175.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -93.31 -7.35 45.14 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.757 0.313 . . . . 54.399999999999999 110.916 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 69.9 m -82.06 165.69 20.4 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.697 0.761 . . . . 73.540000000000006 112.624 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.2 p -102.31 137.7 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.292 0 CA-C-N 114.697 -1.138 . . . . 60.43 109.554 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 60.2 mt -101.96 132.38 48.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.076 -1.083 . . . . 72.109999999999999 108.076 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -102.8 117.95 35.75 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.218 0.532 . . . . 72.329999999999998 110.541 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -88.31 114.47 24.97 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.394 -1.275 . . . . 75.109999999999999 108.522 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -83.27 101.7 11.45 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.226 -1.028 . . . . 74.409999999999997 108.226 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 524' ' ' SER . 17.2 t -96.06 144.18 10.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 107.541 -1.281 . . . . 73.310000000000002 107.541 -177.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 67.9 m -97.8 133.82 41.79 Favored 'General case' 0 N--CA 1.394 -3.245 0 C-N-CA 119.444 -0.902 . . . . 73.5 110.694 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -97.5 129.5 44.67 Favored 'General case' 0 N--CA 1.405 -2.706 0 N-CA-C 103.882 -2.636 . . . . 75.109999999999999 103.882 168.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -60.47 -23.92 61.02 Favored Glycine 0 CA--C 1.49 -1.507 0 O-C-N 123.923 0.764 . . . . 62.119999999999997 113.599 -173.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 79.95 -15.54 0.74 Allowed 'General case' 0 C--O 1.211 -0.967 0 C-N-CA 124.946 1.298 . . . . 71.430000000000007 107.87 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.495 ' H ' ' C ' ' A' ' 558' ' ' GLY . 92.7 mt-30 -112.62 145.04 41.09 Favored 'General case' 0 N--CA 1.402 -2.832 0 CA-C-N 114.71 -1.132 . . . . 73.200000000000003 110.496 -175.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . 0.425 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 48.5 p90 -123.84 154.53 39.49 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 107.193 -1.41 . . . . 74.209999999999994 107.193 177.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.25 121.89 16.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.018 0.437 . . . . 70.450000000000003 110.864 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 563' ' ' MET . . . . . 0.601 ' SD ' HG21 ' A' ' 620' ' ' ILE . 47.4 ttp -79.23 122.73 84.53 Favored Pre-proline 0 C--N 1.316 -0.86 0 N-CA-C 109.653 -0.499 . . . . 64.310000000000002 109.653 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.77 169.62 20.71 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.214 1.942 . . . . 75.150000000000006 111.006 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -72.01 118.18 14.55 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.536 0.684 . . . . 71.219999999999999 110.424 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.9 pp -136.11 11.55 3.32 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.206 -0.907 . . . . 75.120000000000005 110.477 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 2.2 t -80.24 144.15 33.14 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.318 -0.855 . . . . 71.540000000000006 109.985 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 80.82 70.01 1.36 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.643 -0.789 . . . . 72.340000000000003 113.58 175.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -163.91 179.85 6.76 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.345 -1.354 . . . . 72.349999999999994 107.345 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -95.14 176.4 6.24 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.567 -0.531 . . . . 71.5 109.567 -178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . 0.53 ' CZ3' HD21 ' A' ' 587' ' ' LEU . 11.6 t-105 -71.56 -28.1 63.62 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.989 -1.486 . . . . 74.409999999999997 106.989 175.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 9.0 p -71.61 -6.72 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-N 115.429 -0.805 . . . . 74.140000000000001 110.264 178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 6.7 m-20 -101.11 -45.06 5.5 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.341 -0.985 . . . . 65.120000000000005 108.341 171.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -63.21 -46.0 89.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.331 -0.849 . . . . 72.319999999999993 113.25 -176.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.469 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 31.4 tt0 -64.19 -49.94 70.69 Favored Pre-proline 0 CA--C 1.561 1.376 0 N-CA-C 111.838 0.31 . . . . 74.519999999999996 111.838 -177.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 51.5 Cg_exo -61.1 -34.42 89.7 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.675 1.583 . . . . 75.439999999999998 112.279 174.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 30.6 mmm180 -68.98 -33.97 74.55 Favored 'General case' 0 C--O 1.216 -0.663 0 C-N-CA 120.147 -0.621 . . . . 75.200000000000003 110.625 176.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.441 ' HG ' ' HB3' ' A' ' 583' ' ' TRP . 5.4 tt -60.41 -48.87 79.89 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.348 0.659 . . . . 74.510000000000005 109.363 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 576' ' ' PRO . 7.7 ptm180 -66.25 -41.09 90.44 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.914 0.339 . . . . 74.409999999999997 111.914 176.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.42 -37.01 82.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.152 -0.476 . . . . 72.329999999999998 112.168 -177.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.56 -9.28 54.86 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.154 0.502 . . . . 65.329999999999998 110.02 -177.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 70.52 46.66 46.63 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.768 -0.933 . . . . 73.420000000000002 110.768 -178.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . 0.441 ' HB3' ' HG ' ' A' ' 578' ' ' LEU . 11.3 t90 -73.39 126.76 30.9 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 109.357 -0.608 . . . . 74.310000000000002 109.357 -177.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 584' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 617' ' ' ASP . 7.6 p -90.42 -24.38 20.77 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.409 -0.814 . . . . 53.240000000000002 112.101 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -85.19 -174.3 50.15 Favored Glycine 0 N--CA 1.432 -1.589 0 CA-C-N 116.076 -0.511 . . . . 61.140000000000001 113.075 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 27.4 ttt -117.33 149.04 41.14 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.967 -0.383 . . . . 74.230000000000004 109.967 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . 0.53 HD21 ' CZ3' ' A' ' 571' ' ' TRP . 6.1 tt -80.7 108.83 14.67 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.27 -1.382 . . . . 62.140000000000001 107.27 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -105.37 119.28 38.7 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.942 -0.572 . . . . 74.549999999999997 111.612 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.1 OUTLIER -111.91 133.21 54.25 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.035 -1.098 . . . . 74.310000000000002 108.035 171.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -111.01 -5.13 27.26 Favored Glycine 0 C--N 1.297 -1.625 0 C-N-CA 120.096 -1.05 . . . . 65.109999999999999 112.83 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.35 130.57 26.7 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 121.137 -0.225 . . . . 73.310000000000002 110.743 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.35 124.2 31.02 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 123.907 0.755 . . . . 75.049999999999997 109.829 176.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . 0.508 ' O ' ' HA2' ' A' ' 625' ' ' GLY . 86.9 t -104.64 131.85 52.7 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 105.22 -2.141 . . . . 74.430000000000007 105.22 171.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -82.88 122.95 28.91 Favored 'General case' 0 C--N 1.281 -2.406 0 C-N-CA 118.681 -1.208 . . . . 73.040000000000006 110.93 -177.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -147.46 -68.86 0.24 Allowed 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.002 -1.453 . . . . 73.430000000000007 108.359 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 92.75 157.8 33.85 Favored Glycine 0 N--CA 1.417 -2.628 0 C-N-CA 119.827 -1.178 . . . . 54.549999999999997 110.985 -176.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -57.99 -37.63 86.06 Favored Glycine 0 C--N 1.291 -1.931 0 N-CA-C 115.441 0.936 . . . . 75.299999999999997 115.441 -176.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 36.4 m -76.11 -24.55 54.98 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-N 118.05 0.925 . . . . 74.450000000000003 110.628 -174.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -89.13 -0.04 57.12 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.601 -1.181 . . . . 72.329999999999998 111.458 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 40.1 m80 77.6 89.79 0.07 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.619 1.2 . . . . 74.25 109.833 -176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -81.62 85.99 6.46 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 113.93 -1.487 . . . . 74.010000000000005 109.964 -171.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -111.52 170.03 8.4 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.567 0.951 . . . . 74.329999999999998 113.567 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 99.3 t -77.72 133.27 30.88 Favored 'Isoleucine or valine' 0 C--O 1.248 0.995 0 CA-C-N 114.27 -1.332 . . . . 75.439999999999998 108.05 173.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.5 m -112.21 -42.42 4.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 120.285 -0.566 . . . . 73.329999999999998 112.36 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -144.69 151.04 38.32 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.969 -0.382 . . . . 72.209999999999994 109.969 -174.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -140.06 144.67 36.97 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 123.491 0.494 . . . . 64.099999999999994 110.355 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.402 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 58.4 t30 -64.77 -51.82 55.12 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-N 116.181 -0.463 . . . . 64.239999999999995 111.734 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.4 Cg_exo -85.21 115.74 1.69 Allowed 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 121.756 1.637 . . . . 73.310000000000002 110.134 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.21 152.31 66.92 Favored 'Trans proline' 0 C--O 1.256 1.379 0 C-N-CA 122.401 2.067 . . . . 75.310000000000002 111.799 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -58.71 135.84 57.54 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.49 -0.559 . . . . 75.299999999999997 109.49 176.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 103.23 -7.36 51.61 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.571 -0.823 . . . . 60.039999999999999 111.908 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 28.0 m -93.78 144.46 25.39 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.237 -0.653 . . . . 71.450000000000003 109.237 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -70.34 131.22 22.08 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 111.952 -0.459 . . . . 73.239999999999995 111.952 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.7 m -124.56 141.64 44.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.917 -0.772 . . . . 74.420000000000002 108.917 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.411 ' N ' ' HG2' ' A' ' 560' ' ' GLN . 28.4 p-10 -51.52 171.72 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.204 1.402 . . . . 64.230000000000004 114.301 -176.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.68 -27.1 37.81 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.824 1.046 . . . . 74.230000000000004 113.824 -179.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.429 ' HA ' ' OG1' ' A' ' 584' ' ' THR . 11.0 m-20 -87.74 -8.18 56.36 Favored 'General case' 0 C--O 1.198 -1.632 0 C-N-CA 119.149 -1.02 . . . . 74.530000000000001 110.988 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.02 17.81 65.99 Favored Glycine 0 C--O 1.219 -0.784 0 C-N-CA 121.755 -0.259 . . . . 64.319999999999993 112.661 173.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.96 119.28 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 121.724 0.773 . . . . 75.239999999999995 110.726 -169.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.601 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.6 pp -123.76 133.29 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 115.29 -0.868 . . . . 64.109999999999999 112.546 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 14.2 t -102.86 122.48 44.63 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 122.118 0.961 . . . . 74.239999999999995 109.26 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -136.64 169.43 17.73 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.777 -1.101 . . . . 73.319999999999993 110.471 -173.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -125.95 135.84 52.33 Favored 'General case' 0 C--O 1.261 1.667 0 N-CA-C 107.866 -1.161 . . . . 75.109999999999999 107.866 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -142.98 169.05 18.29 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.783 -1.192 . . . . 74.310000000000002 107.783 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 593' ' ' VAL . . . -49.47 109.5 0.62 Allowed Glycine 0 CA--C 1.544 1.896 0 O-C-N 124.193 0.933 . . . . 71.340000000000003 113.549 175.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 . . . . . 0 C--O 1.253 1.277 0 C-N-CA 125.816 1.646 . . . . 71.319999999999993 112.934 176.843 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.69 0 N-CA-C 112.976 0.732 . . . . 73.530000000000001 112.976 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 19.3 p -141.0 142.42 34.27 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.936 -0.478 . . . . 73.319999999999993 110.521 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -138.88 135.01 34.04 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.75 -0.833 . . . . 74.329999999999998 108.75 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.3 p-10 -83.66 144.99 29.03 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.186 0.517 . . . . 74.430000000000007 110.318 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.5 pt -90.38 116.92 67.5 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 115.13 -0.941 . . . . 65.120000000000005 111.086 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . 0.405 ' HD2' HD22 ' A' ' 512' ' ' LEU . 27.5 Cg_exo -66.2 160.57 44.3 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.484 2.122 . . . . 72.439999999999998 111.106 173.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -67.91 110.99 4.11 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.801 0.81 . . . . 74.450000000000003 110.423 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 14.2 m -130.27 65.17 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 122.757 1.265 . . . . 70.420000000000002 109.494 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -128.99 93.29 3.56 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 113.559 -1.655 . . . . 73.340000000000003 108.382 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 160.82 -38.73 0.43 Allowed Glycine 0 N--CA 1.428 -1.861 0 C-N-CA 119.905 -1.14 . . . . 54.539999999999999 112.787 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.517 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.3 OUTLIER -89.71 -170.27 2.76 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 110.231 -0.285 . . . . 74.340000000000003 110.231 -178.784 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 21.3 m -71.79 155.58 40.28 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.15 -0.685 . . . . 73.120000000000005 109.15 178.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.418 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.6 p -60.38 -41.77 88.48 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.587 0 O-C-N 123.243 0.34 . . . . 73.219999999999999 111.391 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.77 -40.7 97.34 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 109.684 -0.487 . . . . 74.450000000000003 109.684 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.03 -42.88 89.09 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.177 0 N-CA-C 109.073 -0.714 . . . . 73.299999999999997 109.073 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.416 ' HB2' HG13 ' A' ' 534' ' ' VAL . . . -59.34 -45.55 91.05 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.855 0.36 . . . . 75.340000000000003 110.959 177.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 26.0 mt-30 -65.32 -42.58 92.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.66 -0.7 . . . . 72.430000000000007 110.689 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.596 ' O ' HG21 ' A' ' 514' ' ' VAL . 45.0 mmtm -61.63 -45.69 92.97 Favored 'General case' 0 CA--C 1.495 -1.152 0 O-C-N 123.392 0.433 . . . . 71.450000000000003 110.122 177.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -61.88 -41.49 97.92 Favored 'General case' 0 N--CA 1.435 -1.221 0 O-C-N 123.821 0.701 . . . . 72.329999999999998 110.89 -176.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . 0.405 HD22 ' HD2' ' A' ' 498' ' ' PRO . 0.2 OUTLIER -68.04 -46.62 70.63 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.859 -1.064 . . . . 71.230000000000004 108.208 -179.196 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.413 ' ND2' ' HA ' ' A' ' 517' ' ' PHE . 2.1 t-20 -61.7 -35.87 79.28 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 124.001 0.92 . . . . 73.329999999999998 111.612 -174.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.596 HG21 ' O ' ' A' ' 510' ' ' LYS . 89.6 t -57.62 -38.97 67.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 O-C-N 123.269 0.356 . . . . 74.340000000000003 111.525 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -105.21 -3.73 22.57 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.458 0.647 . . . . 74.040000000000006 109.523 -176.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -116.33 -58.64 0.32 Allowed Glycine 0 N--CA 1.42 -2.4 0 CA-C-N 115.473 -0.785 . . . . 71.129999999999995 113.828 -170.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.413 ' HA ' ' ND2' ' A' ' 513' ' ' ASN . 75.6 m-85 63.31 26.78 15.2 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 122.351 1.072 . . . . 75.319999999999993 110.212 -172.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.4 p -83.46 -177.14 6.62 Favored 'General case' 0 N--CA 1.403 -2.817 0 CA-C-N 113.872 -1.513 . . . . 72.120000000000005 109.447 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -107.99 139.69 42.24 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.371 -1.344 . . . . 64.219999999999999 107.371 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -129.2 149.07 51.16 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-O 121.117 0.485 . . . . 74.310000000000002 111.255 -176.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.3 m -139.97 152.44 46.32 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 106.688 -1.597 . . . . 74.299999999999997 106.688 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -122.84 142.07 51.16 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 112.51 0.559 . . . . 73.030000000000001 112.51 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -132.26 143.33 49.84 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.086 -1.45 . . . . 73.219999999999999 107.086 176.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 80.2 p -103.14 138.11 40.41 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.427 -0.909 . . . . 74.430000000000007 111.676 -175.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.9 p -121.43 149.64 24.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 106.547 -1.649 . . . . 74.329999999999998 106.547 177.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -72.32 136.93 46.34 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.521 -0.548 . . . . 74.230000000000004 109.521 -177.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.424 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 56.6 m -153.51 160.07 31.37 Favored Pre-proline 0 C--N 1.291 -1.971 0 N-CA-C 107.768 -1.197 . . . . 73.120000000000005 107.768 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.32 -2.75 12.96 Favored 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 121.865 1.71 . . . . 74.329999999999998 113.09 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.18 152.02 38.56 Favored Pre-proline 0 N--CA 1.451 -0.412 0 N-CA-C 109.624 -0.51 . . . . 71.340000000000003 109.624 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -57.34 146.61 81.85 Favored 'Trans proline' 0 C--O 1.25 1.087 0 C-N-CA 122.96 2.44 . . . . 75.209999999999994 113.458 -177.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.697 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.16 99.83 0.11 Allowed 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 114.943 -1.026 . . . . 73.319999999999993 111.651 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 157.82 -23.09 0.4 Allowed Glycine 0 C--N 1.3 -1.464 0 CA-C-N 115.758 -0.656 . . . . 74.439999999999998 111.874 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -74.38 144.74 44.25 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.349 -0.982 . . . . 74.230000000000004 108.349 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 503' ' ' GLN . 11.0 p -91.38 118.6 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.413 0 CA-C-O 121.854 0.835 . . . . 64.430000000000007 108.779 176.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.83 -23.59 60.79 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.514 -1.221 . . . . 62.509999999999998 109.374 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 138.99 -152.8 22.41 Favored Glycine 0 N--CA 1.421 -2.305 0 N-CA-C 110.581 -1.007 . . . . 63.049999999999997 110.581 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.0 p -116.48 157.93 24.4 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 109.71 -0.478 . . . . 71.530000000000001 109.71 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -66.45 -53.68 28.79 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 120.236 -0.586 . . . . 74.129999999999995 110.261 173.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.71 149.82 79.03 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 121.319 1.346 . . . . 74.150000000000006 109.767 173.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.04 139.36 66.85 Favored 'Trans proline' 0 C--O 1.246 0.923 0 C-N-CA 121.659 1.572 . . . . 70.120000000000005 113.02 -176.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.97 137.43 55.13 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-N 115.204 -0.907 . . . . 61.399999999999999 110.178 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 93.81 -11.8 70.42 Favored Glycine 0 N--CA 1.442 -0.967 0 C-N-CA 121.092 -0.575 . . . . 61.140000000000001 111.668 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 51.8 m -88.52 137.83 31.97 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 122.745 0.418 . . . . 74.329999999999998 110.358 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.9 t -74.74 136.83 41.74 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.95 -0.568 . . . . 72.340000000000003 109.729 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.3 m -130.89 154.46 81.96 Favored Pre-proline 0 C--N 1.312 -1.064 0 N-CA-C 108.161 -1.051 . . . . 72.299999999999997 108.161 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -61.72 136.88 65.02 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.15 1.233 . . . . 71.319999999999993 111.202 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 13.3 p -65.99 -23.22 31.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.724 0.773 . . . . 74.219999999999999 111.872 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -78.06 -17.41 57.04 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.096 -0.502 . . . . 74.530000000000001 110.75 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 25.2 t -78.29 162.54 26.44 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.885 0.85 . . . . 74.239999999999995 111.499 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.8 p -98.64 137.74 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.388 0 CA-C-N 114.246 -1.343 . . . . 74.549999999999997 108.282 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 61.7 mt -100.88 137.53 28.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.168 -0.678 . . . . 74.409999999999997 109.168 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -103.24 117.78 35.29 Favored 'General case' 0 C--O 1.254 1.336 0 N-CA-C 108.816 -0.809 . . . . 73.519999999999996 108.816 -177.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -101.49 120.36 40.17 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 123.735 0.814 . . . . 71.319999999999993 109.624 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 2.8 mp0 -86.52 123.17 31.43 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 121.17 0.51 . . . . 73.430000000000007 110.795 178.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 39.6 t -96.01 132.19 40.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.781 -1.192 . . . . 71.209999999999994 107.781 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.697 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 13.0 m -79.7 117.35 20.53 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 107.033 -1.469 . . . . 75.549999999999997 107.033 176.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -107.52 128.78 54.82 Favored 'General case' 0 N--CA 1.422 -1.869 0 C-N-CA 119.566 -0.854 . . . . 75.310000000000002 108.838 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -58.61 -24.83 57.5 Favored Glycine 0 CA--C 1.501 -0.79 0 O-C-N 124.462 1.101 . . . . 74.340000000000003 113.993 -175.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 73.93 -0.16 3.44 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.995 1.318 . . . . 73.219999999999999 109.8 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.43 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 70.3 mt-30 -113.74 149.63 34.54 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 115.661 -0.699 . . . . 72.040000000000006 111.971 -174.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -124.12 158.79 31.47 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.454 -1.248 . . . . 72.409999999999997 108.351 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.15 126.94 37.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.336 0.589 . . . . 72.519999999999996 110.516 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 18.8 ttt -78.21 125.15 85.47 Favored Pre-proline 0 N--CA 1.432 -1.344 0 C-N-CA 124.542 1.137 . . . . 74.340000000000003 111.436 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.66 169.43 22.58 Favored 'Trans proline' 0 C--O 1.245 0.869 0 C-N-CA 122.805 2.336 . . . . 74.040000000000006 111.125 174.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.79 116.79 26.19 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.86 0.838 . . . . 75.510000000000005 111.36 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -117.64 9.11 13.01 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.204 -1.406 . . . . 71.439999999999998 107.204 170.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 22.0 t -80.65 147.22 30.77 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 114.211 -1.359 . . . . 71.409999999999997 107.953 176.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 66.75 56.74 11.68 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 121.357 -0.449 . . . . 63.509999999999998 112.897 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 22.9 ptp -168.49 179.76 4.23 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.165 -1.791 . . . . 75.099999999999994 106.165 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -100.1 170.45 8.47 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.06 -0.719 . . . . 74.219999999999999 109.06 -176.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . 0.401 ' CH2' HD23 ' A' ' 587' ' ' LEU . 12.1 t-105 -65.63 -27.53 68.45 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 108.569 -0.9 . . . . 74.310000000000002 108.569 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.6 p -71.16 -13.2 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 115.735 -0.666 . . . . 73.230000000000004 110.479 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -99.41 -35.87 9.77 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 109.017 -0.735 . . . . 74.439999999999998 109.017 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . 0.615 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -62.64 -39.61 94.41 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 115.323 -0.853 . . . . 74.049999999999997 110.397 177.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.403 ' HB3' ' CD ' ' A' ' 576' ' ' PRO . 2.5 tm-20 -51.3 -59.13 8.42 Favored Pre-proline 0 CA--C 1.585 2.303 0 C-N-CA 124.138 0.975 . . . . 75.340000000000003 110.57 -178.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.403 ' CD ' ' HB3' ' A' ' 575' ' ' GLU . 19.8 Cg_endo -61.57 -32.49 87.78 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 121.891 1.727 . . . . 61.409999999999997 113.013 175.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 7.6 mmp_? -61.98 -41.25 97.82 Favored 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 120.593 -0.443 . . . . 74.409999999999997 110.726 177.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 16.8 mt -65.99 -46.39 78.19 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-O 120.782 0.325 . . . . 65.219999999999999 110.465 -175.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -65.76 -39.73 91.34 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 112.472 0.545 . . . . 73.310000000000002 112.472 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -69.17 -33.61 73.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.878 0.371 . . . . 72.329999999999998 111.247 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.3 tp -81.01 -10.16 59.74 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 121.471 0.653 . . . . 74.540000000000006 110.156 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 62.0 35.6 91.65 Favored Glycine 0 C--O 1.224 -0.496 0 CA-C-N 115.961 -0.563 . . . . 65.030000000000001 112.569 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . 0.455 ' CE3' HD21 ' A' ' 578' ' ' LEU . 18.4 t90 -78.83 126.68 31.03 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.638 -0.504 . . . . 74.310000000000002 109.638 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 12.9 t -109.39 6.62 24.49 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 111.966 0.358 . . . . 72.219999999999999 111.966 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -89.11 -171.82 45.8 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 119.955 -1.117 . . . . 73.420000000000002 111.261 176.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 94.4 mmm -105.05 139.16 40.15 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 116.749 0.274 . . . . 75.010000000000005 110.375 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . 0.401 HD23 ' CH2' ' A' ' 571' ' ' TRP . 6.4 tt -80.64 110.01 15.72 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 107.354 -1.35 . . . . 74.120000000000005 107.354 176.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . 0.488 ' O ' ' HA ' ' A' ' 621' ' ' THR . 30.6 t70 -95.65 114.23 25.95 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.909 -1.041 . . . . 72.430000000000007 109.679 -178.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.9 134.78 52.28 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 108.172 -1.047 . . . . 73.409999999999997 108.172 177.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -101.07 -89.69 2.07 Favored Glycine 0 C--N 1.268 -3.197 0 CA-C-N 115.306 -0.861 . . . . 44.100000000000001 112.646 -175.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -99.63 149.15 23.58 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.025 0.44 . . . . 73.219999999999999 111.665 -176.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -93.45 139.18 31.0 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.395 -0.965 . . . . 74.549999999999997 108.395 176.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 39.5 t -105.11 153.96 6.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 109.014 -0.735 . . . . 74.420000000000002 109.014 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -73.11 119.2 17.02 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 121.599 0.714 . . . . 75.430000000000007 109.728 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -143.46 -65.35 0.38 Allowed 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.154 -1.424 . . . . 73.299999999999997 107.154 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 100.05 158.8 28.34 Favored Glycine 0 N--CA 1.4 -3.753 0 C-N-CA 119.967 -1.111 . . . . 74.349999999999994 112.074 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.23 -32.38 60.19 Favored Glycine 0 C--N 1.302 -1.324 0 C-N-CA 123.689 0.662 . . . . 61.210000000000001 113.514 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 26.8 t -69.5 -23.91 63.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 122.057 0.932 . . . . 75.239999999999995 109.828 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 55.9 mm-40 -100.96 -12.09 19.2 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.553 -0.748 . . . . 74.209999999999994 109.712 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 43.7 m80 67.11 172.69 0.26 Allowed 'General case' 0 C--O 1.242 0.658 0 C-N-CA 124.603 1.161 . . . . 75.129999999999995 111.824 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -89.55 84.85 6.39 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 112.526 0.565 . . . . 75.019999999999996 112.526 -174.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . 0.405 ' O ' ' HB2' ' A' ' 624' ' ' PHE . 48.0 mtp180 -91.08 145.96 24.24 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.09 -0.959 . . . . 75.120000000000005 110.542 176.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . 0.402 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 59.5 t -74.43 130.51 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 105.904 -1.887 . . . . 64.329999999999998 105.904 173.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 73.8 t -102.96 -59.91 3.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-O 120.738 0.304 . . . . 65.409999999999997 111.206 -173.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -144.61 141.05 29.13 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.162 -0.472 . . . . 75.140000000000001 110.037 -172.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.56 160.89 22.29 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 107.251 -1.389 . . . . 72.129999999999995 107.251 176.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.476 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 3.2 t-20 -67.03 -52.61 30.16 Favored Pre-proline 0 C--N 1.312 -1.034 0 N-CA-C 109.689 -0.486 . . . . 75.040000000000006 109.689 171.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.2 Cg_exo -87.47 122.8 1.78 Allowed 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 121.589 1.526 . . . . 71.030000000000001 110.91 173.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -67.26 158.39 57.18 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.184 1.923 . . . . 74.219999999999999 110.874 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.5 127.63 33.44 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.79 -0.448 . . . . 74.519999999999996 109.79 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.31 -0.02 40.64 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.713 -0.756 . . . . 71.5 112.091 -177.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 10.2 m -92.32 166.34 12.63 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.81 -0.811 . . . . 54.530000000000001 108.81 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -90.73 130.69 10.39 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.91 -0.662 . . . . 74.400000000000006 112.082 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.4 m -125.05 141.93 43.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.783 -0.821 . . . . 75.400000000000006 108.783 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.43 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.9 p-10 -62.42 179.28 0.33 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.437 0.902 . . . . 71.310000000000002 113.437 -175.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -61.03 -25.78 67.15 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.375 -0.375 . . . . 74.129999999999995 112.0 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.487 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 34.5 t70 -83.18 -9.45 59.16 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.091 -0.707 . . . . 75.129999999999995 109.091 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . 0.417 ' HA3' ' CD1' ' A' ' 583' ' ' TRP . . . 64.9 15.9 60.89 Favored Glycine 0 CA--C 1.492 -1.355 0 CA-C-N 115.195 -0.911 . . . . 75.129999999999995 113.704 168.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.58 119.13 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 CA-C-O 122.974 1.368 . . . . 70.129999999999995 113.255 -164.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 48.1 pt -123.47 133.09 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 CA-C-N 113.42 -1.718 . . . . 74.239999999999995 108.581 177.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 12.1 t -109.86 124.93 52.19 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.419 -0.956 . . . . 63.399999999999999 108.419 177.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.38 167.17 21.53 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 113.229 0.826 . . . . 75.099999999999994 113.229 -176.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -127.21 137.52 52.92 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.501 -1.227 . . . . 74.019999999999996 107.86 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 602' ' ' ARG . 15.1 p90 -139.35 166.7 23.85 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.486 -0.325 . . . . 71.230000000000004 111.162 -175.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -57.93 145.61 40.18 Favored Glycine 0 N--CA 1.447 -0.621 0 O-C-N 123.978 0.799 . . . . 75.430000000000007 114.412 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 . . . . . 0 C--N 1.308 -1.232 0 C-N-CA 124.391 1.076 . . . . 74.219999999999999 109.924 177.654 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.479 0 CA-C-O 121.873 0.844 . . . . 70.239999999999995 110.996 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 5.9 p -140.59 144.59 35.9 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.787 -1.19 . . . . 73.329999999999998 107.787 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -139.03 135.51 34.31 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 108.806 -0.813 . . . . 74.510000000000005 108.806 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.4 p-10 -81.53 133.99 35.46 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.885 -0.598 . . . . 70.340000000000003 109.936 177.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 498' ' ' PRO . 33.0 pt -89.63 131.23 40.52 Favored Pre-proline 0 C--N 1.291 -1.945 0 CA-C-N 115.061 -0.972 . . . . 74.129999999999995 110.993 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 3.4 Cg_exo -76.49 -174.4 2.11 Favored 'Trans proline' 0 C--O 1.251 1.144 0 C-N-CA 121.966 1.777 . . . . 73.209999999999994 110.011 174.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -85.38 117.17 24.14 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.002 0.906 . . . . 65.040000000000006 110.773 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.58 66.29 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.38 0 CA-C-O 123.277 1.513 . . . . 74.439999999999998 108.487 172.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -129.75 109.55 11.05 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 112.018 -2.355 . . . . 72.099999999999994 107.369 174.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 138.44 -20.05 3.16 Favored Glycine 0 C--N 1.299 -1.477 0 C-N-CA 119.837 -1.173 . . . . 53.409999999999997 112.956 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.43 ' O ' HG13 ' A' ' 534' ' ' VAL . 0.0 OUTLIER -107.44 -173.88 2.4 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 117.484 0.642 . . . . 72.140000000000001 110.087 178.416 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 10.0 m -75.99 155.99 34.48 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.229 -1.026 . . . . 73.019999999999996 108.229 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.44 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 6.0 p -57.5 -46.59 85.98 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 111.801 0.297 . . . . 74.319999999999993 111.801 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -64.33 -37.93 89.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.308 0.575 . . . . 75.340000000000003 110.559 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 97.7 t -68.04 -42.42 85.23 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.982 0 CA-C-N 115.231 -0.895 . . . . 74.450000000000003 109.554 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.412 ' HB3' HG11 ' A' ' 534' ' ' VAL . . . -62.34 -45.36 93.56 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 122.298 0.239 . . . . 72.329999999999998 110.87 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 22.9 mt-30 -64.89 -45.81 84.38 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.458 -0.337 . . . . 74.530000000000001 111.261 -178.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.471 ' O ' HG21 ' A' ' 514' ' ' VAL . 0.0 OUTLIER -67.27 -38.92 85.88 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 120.473 -0.491 . . . . 74.120000000000005 110.716 179.165 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -63.2 -45.61 90.88 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 121.152 0.501 . . . . 73.209999999999994 110.479 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -62.17 -42.19 99.03 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 108.172 -1.047 . . . . 73.230000000000004 108.172 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -59.7 -34.95 73.55 Favored 'General case' 0 N--CA 1.428 -1.561 0 C-N-CA 123.613 0.765 . . . . 70.230000000000004 112.54 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 510' ' ' LYS . 75.2 t -57.89 -34.44 48.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-O 121.682 0.753 . . . . 73.109999999999999 110.866 177.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -104.47 -6.49 20.61 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.49 0.662 . . . . 74.519999999999996 109.763 -177.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -114.8 -66.59 0.43 Allowed Glycine 0 N--CA 1.416 -2.686 0 CA-C-N 115.352 -0.84 . . . . 64.510000000000005 113.425 -171.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 64.31 30.01 13.51 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 122.8 1.285 . . . . 74.219999999999999 109.07 -168.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 10.7 p -88.99 -175.35 4.8 Favored 'General case' 0 N--CA 1.409 -2.516 0 CA-C-N 112.954 -1.93 . . . . 71.430000000000007 109.545 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 13.5 mptt -108.24 143.47 37.02 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.131 -1.063 . . . . 75.120000000000005 108.131 177.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -132.41 157.14 45.3 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.364 0.602 . . . . 72.219999999999999 112.493 -175.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 62.3 m -140.42 150.16 43.5 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.716 -1.216 . . . . 74.040000000000006 107.716 174.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -123.82 138.18 54.54 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 120.713 0.292 . . . . 64.349999999999994 110.493 -176.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -136.33 143.23 44.02 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.712 -0.848 . . . . 72.510000000000005 108.712 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 45.5 m -97.17 135.13 39.56 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.404 1.097 . . . . 73.099999999999994 111.906 -178.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.43 153.01 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.813 0 CA-C-N 113.028 -1.897 . . . . 72.519999999999996 107.023 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -90.58 133.92 34.75 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.774 -0.77 . . . . 70.150000000000006 109.704 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.558 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 69.0 m -162.26 162.8 19.38 Favored Pre-proline 0 C--O 1.202 -1.438 0 N-CA-C 107.926 -1.138 . . . . 73.439999999999998 107.926 177.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -68.27 -3.93 11.79 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 122.194 1.929 . . . . 75.25 113.157 177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -79.48 136.66 55.9 Favored Pre-proline 0 N--CA 1.425 -1.69 0 N-CA-C 107.948 -1.13 . . . . 74.299999999999997 107.948 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -59.34 147.98 88.6 Favored 'Trans proline' 0 C--O 1.247 0.927 0 C-N-CA 123.047 2.498 . . . . 72.310000000000002 113.391 -175.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.701 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.72 108.12 0.8 Allowed 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.391 -0.822 . . . . 73.319999999999993 111.232 -177.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 131.62 -21.05 4.54 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 115.387 -0.824 . . . . 63.350000000000001 111.203 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.65 137.21 36.32 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.638 -0.875 . . . . 72.299999999999997 108.638 178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 503' ' ' GLN . 10.3 p -91.42 121.43 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.719 0 CA-C-O 121.939 0.875 . . . . 73.340000000000003 109.207 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.5 p -79.47 -16.56 55.88 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.774 -1.103 . . . . 75.5 111.174 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 145.98 -162.7 28.35 Favored Glycine 0 N--CA 1.425 -2.082 0 C-N-CA 120.774 -0.727 . . . . 75.049999999999997 112.18 175.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.9 p -116.26 157.68 24.55 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.646 -1.242 . . . . 75.219999999999999 107.646 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.402 ' HB3' ' CD ' ' A' ' 552' ' ' GLU . 23.5 t-20 -63.38 -49.4 79.1 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 118.634 -1.226 . . . . 73.519999999999996 112.279 178.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -71.48 136.11 27.88 Favored 'Trans proline' 0 C--N 1.364 1.347 0 N-CA-C 108.705 -1.306 . . . . 70.019999999999996 108.705 170.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -66.12 159.34 50.0 Favored 'Trans proline' 0 C--O 1.248 0.984 0 C-N-CA 122.324 2.016 . . . . 74.430000000000007 113.199 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.96 139.19 58.74 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.756 -0.656 . . . . 73.319999999999993 109.86 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.81 -19.67 51.22 Favored Glycine 0 N--CA 1.432 -1.585 0 N-CA-C 111.781 -0.528 . . . . 71.219999999999999 111.781 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 17.5 m -74.13 129.06 37.1 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 110.354 -0.239 . . . . 70.25 110.354 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 14.6 t -82.7 126.76 32.73 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-O 121.578 0.704 . . . . 71.310000000000002 109.388 175.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.3 m -123.81 155.52 66.61 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 107.716 -1.216 . . . . 73.420000000000002 107.716 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -61.69 137.65 69.97 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 120.973 1.115 . . . . 75.030000000000001 111.531 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.26 -20.23 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.961 0.886 . . . . 72.420000000000002 110.655 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -87.72 -18.07 30.3 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.143 -0.935 . . . . 75.299999999999997 111.647 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 85.1 p -89.89 175.05 7.36 Favored 'General case' 0 C--O 1.252 1.235 0 N-CA-C 113.453 0.909 . . . . 73.129999999999995 113.453 -172.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 11.1 p -96.93 138.6 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 CA-C-N 114.281 -1.327 . . . . 73.540000000000006 111.175 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.4 mt -114.52 137.96 46.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.791 -1.189 . . . . 73.200000000000003 107.791 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . 0.402 ' CD ' ' HB3' ' A' ' 538' ' ' ASN . 1.7 pm0 -103.39 128.69 50.45 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.788 0.804 . . . . 72.450000000000003 112.188 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.86 122.03 42.74 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.678 -1.601 . . . . 73.530000000000001 108.876 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -88.23 113.2 23.61 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.53 0.681 . . . . 65.519999999999996 110.344 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 524' ' ' SER . 18.2 t -93.07 122.96 44.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 107.341 -1.355 . . . . 71.430000000000007 107.341 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.701 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 48.5 t -81.92 131.95 35.26 Favored 'General case' 0 N--CA 1.405 -2.681 0 N-CA-C 108.797 -0.816 . . . . 53.340000000000003 108.797 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -95.11 141.55 28.61 Favored 'General case' 0 N--CA 1.412 -2.363 0 N-CA-C 105.526 -2.028 . . . . 75.349999999999994 105.526 168.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -56.05 -23.94 41.15 Favored Glycine 0 CA--C 1.499 -0.952 0 O-C-N 124.48 1.112 . . . . 62.240000000000002 112.564 -177.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.2 t30 68.16 20.98 8.77 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-O 123.129 1.442 . . . . 74.310000000000002 109.026 174.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.533 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 66.7 mt-30 -141.79 164.54 29.93 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 113.094 -1.866 . . . . 75.120000000000005 107.117 178.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -143.23 151.65 40.84 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.785 -1.191 . . . . 75.030000000000001 107.785 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 13.6 p -70.45 132.23 33.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 121.01 0.433 . . . . 73.109999999999999 110.116 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 563' ' ' MET . . . . . 0.403 ' SD ' HG22 ' A' ' 620' ' ' ILE . 44.2 ttp -91.15 109.52 36.04 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 108.405 -0.961 . . . . 72.430000000000007 108.405 175.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.75 160.24 44.62 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.478 2.118 . . . . 73.450000000000003 110.897 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -73.8 115.06 12.79 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.971 0.891 . . . . 73.120000000000005 112.329 -178.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.7 pp -135.3 18.98 3.38 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.096 -1.411 . . . . 75.349999999999994 107.789 174.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 8.7 t -74.41 136.89 42.39 Favored 'General case' 0 N--CA 1.417 -2.08 0 CA-C-N 114.603 -1.18 . . . . 75.519999999999996 108.902 -175.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . 0.457 ' HA2' ' CZ ' ' A' ' 602' ' ' ARG . . . 113.96 50.28 0.51 Allowed Glycine 0 N--CA 1.42 -2.377 0 CA-C-N 115.546 -0.752 . . . . 73.430000000000007 111.914 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 19.8 ptp -142.17 173.36 11.59 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 120.099 -0.64 . . . . 64.340000000000003 110.246 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -98.61 175.63 5.93 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.987 -1.116 . . . . 73.0 107.987 -177.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 38.3 t-105 -68.82 -29.91 68.35 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.188 -0.671 . . . . 74.409999999999997 109.188 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.38 -15.64 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 115.579 -0.737 . . . . 64.439999999999998 110.299 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.583 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 9.0 m-20 -96.5 -44.69 7.06 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 108.44 -0.948 . . . . 73.299999999999997 108.44 176.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.98 -45.86 90.44 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.705 -1.134 . . . . 74.129999999999995 113.529 -174.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.493 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 35.4 tt0 -60.46 -50.46 85.54 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 120.664 -0.414 . . . . 70.439999999999998 111.828 -177.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 51.5 Cg_exo -58.88 -28.46 87.39 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 121.469 1.446 . . . . 74.5 111.576 173.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.667 ' O ' ' HB3' ' A' ' 581' ' ' LEU . 17.0 mmt180 -62.88 -38.45 90.92 Favored 'General case' 0 C--O 1.204 -1.324 0 CA-C-O 118.306 -0.854 . . . . 75.129999999999995 112.688 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.774 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 6.5 mp -59.38 -49.51 77.52 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.652 -1.219 . . . . 74.129999999999995 109.547 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -67.33 -42.07 84.2 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.518 -1.219 . . . . 74.019999999999996 113.515 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -71.15 -39.64 71.83 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.839 0.681 . . . . 73.349999999999994 112.839 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . 0.667 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 1.7 tp -82.97 -9.43 59.29 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.38 0.672 . . . . 71.439999999999998 111.053 -176.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 69.48 40.81 78.63 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 110.616 -0.993 . . . . 73.409999999999997 110.616 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . 0.774 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 11.3 t90 -87.46 126.45 34.9 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.217 -1.401 . . . . 74.019999999999996 107.217 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 17.4 p -86.81 -28.79 22.73 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 123.08 0.552 . . . . 71.530000000000001 112.389 -174.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -74.71 -175.5 34.99 Favored Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 115.588 -0.733 . . . . 75.219999999999999 111.636 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 23.9 mmt -123.3 155.21 37.69 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.681 -0.489 . . . . 74.040000000000006 109.681 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 47.4 tp -94.12 118.51 31.64 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 123.613 0.571 . . . . 74.340000000000003 109.578 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -118.14 122.12 42.27 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.127 -1.064 . . . . 74.530000000000001 108.127 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.34 130.02 34.79 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 106.928 -1.508 . . . . 75.209999999999994 106.928 172.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.75 -35.12 23.06 Favored Glycine 0 C--N 1.285 -2.253 0 CA-C-N 115.585 -0.734 . . . . 51.439999999999998 111.688 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.61 147.72 39.81 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 120.828 0.347 . . . . 73.129999999999995 110.8 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -100.18 123.66 44.68 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 102.814 -3.032 . . . . 75.129999999999995 102.814 170.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.89 137.41 32.7 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.611 0 N-CA-C 106.531 -1.655 . . . . 75.329999999999998 106.531 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -75.53 106.88 7.32 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 118.418 -1.313 . . . . 65.510000000000005 111.122 -178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -129.61 -64.34 0.89 Allowed 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.023 -1.473 . . . . 74.140000000000001 107.023 172.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 111.8 150.15 11.41 Favored Glycine 0 N--CA 1.42 -2.367 0 C-N-CA 120.394 -0.908 . . . . 73.409999999999997 111.111 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.95 -32.76 62.77 Favored Glycine 0 C--N 1.307 -1.083 0 C-N-CA 123.356 0.503 . . . . 72.0 113.685 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 20.3 t -72.37 -24.18 61.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.952 0.882 . . . . 74.230000000000004 109.968 -175.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -90.3 -0.98 57.87 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.301 -0.863 . . . . 75.049999999999997 109.82 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 37.1 m80 75.99 99.61 0.07 Allowed 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 124.975 1.31 . . . . 73.140000000000001 109.906 -173.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -82.75 72.28 9.83 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.615 1.197 . . . . 71.519999999999996 112.076 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . 0.457 ' CZ ' ' HA2' ' A' ' 568' ' ' GLY . 9.9 ptm180 -100.14 166.48 10.99 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.362 -1.29 . . . . 74.209999999999994 109.594 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 10.4 p -62.86 131.64 28.37 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 CA-C-N 115.995 -0.548 . . . . 73.420000000000002 109.931 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 12.9 p -109.99 -26.68 3.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 121.724 0.773 . . . . 71.129999999999995 110.276 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -154.01 135.53 14.28 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.52 -0.764 . . . . 74.340000000000003 110.188 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -127.09 136.1 51.68 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.035 -1.468 . . . . 74.209999999999994 107.035 171.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -65.68 -51.62 48.42 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 112.816 0.673 . . . . 65.400000000000006 112.816 -175.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -79.11 114.01 3.3 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.576 1.517 . . . . 75.120000000000005 108.934 172.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.06 145.19 54.66 Favored 'Trans proline' 0 C--O 1.25 1.121 0 C-N-CA 122.359 2.039 . . . . 72.530000000000001 113.046 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -63.42 132.46 51.49 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.603 -0.726 . . . . 73.040000000000006 109.227 176.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 102.65 0.03 49.34 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 110.971 -0.852 . . . . 72.25 110.971 -175.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 32.3 m -105.51 150.43 25.34 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 109.559 -0.534 . . . . 71.129999999999995 109.559 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -73.38 127.19 10.56 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 111.172 -0.771 . . . . 71.230000000000004 111.172 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.6 m -117.09 142.76 29.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 108.22 -1.03 . . . . 74.540000000000006 108.22 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.533 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 29.3 p30 -44.1 167.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.073 1.509 . . . . 74.540000000000006 115.073 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -55.08 -25.53 31.72 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.483 1.113 . . . . 73.109999999999999 113.739 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -96.27 -8.93 31.5 Favored 'General case' 0 C--O 1.207 -1.163 0 C-N-CA 120.05 -0.66 . . . . 64.200000000000003 110.105 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.64 18.96 70.66 Favored Glycine 0 C--O 1.217 -0.923 0 CA-C-O 120.044 -0.309 . . . . 74.430000000000007 113.765 167.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.93 119.74 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-O 121.82 0.819 . . . . 75.219999999999999 110.711 -171.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.403 HG22 ' SD ' ' A' ' 563' ' ' MET . 2.7 pp -127.36 133.97 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 115.132 -0.94 . . . . 75.319999999999993 110.767 -177.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.2 t -103.24 135.93 43.96 Favored 'General case' 0 C--O 1.259 1.597 0 N-CA-C 108.748 -0.834 . . . . 74.299999999999997 108.748 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.7 pp -139.2 165.99 25.7 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.815 -0.629 . . . . 75.420000000000002 111.608 -178.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -131.4 137.93 48.89 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.944 -0.761 . . . . 72.420000000000002 108.944 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -136.65 166.48 23.45 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.038 -0.528 . . . . 71.439999999999998 110.319 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -71.58 67.84 0.99 Allowed Glycine 0 CA--C 1.527 0.803 0 O-C-N 124.069 0.855 . . . . 75.400000000000006 114.925 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 . . . . . 0 C--O 1.262 1.715 0 C-N-CA 126.628 1.971 . . . . 75.530000000000001 112.064 -175.371 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.508 0 CA-C-O 122.26 1.029 . . . . 73.019999999999996 109.341 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 27.8 p -140.03 153.97 46.97 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.69 -1.141 . . . . 73.129999999999995 109.003 -176.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . 0.47 ' NZ ' ' HB2' ' A' ' 495' ' ' LYS . 0.0 OUTLIER -137.97 145.09 41.53 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.893 -0.41 . . . . 75.519999999999996 109.893 173.371 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 19.9 m-20 -77.89 141.89 38.8 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.849 -0.797 . . . . 63.25 108.849 173.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.6 pt -108.71 130.12 23.12 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 115.728 -0.669 . . . . 75.400000000000006 110.336 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -80.7 -177.49 3.79 Favored 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.705 2.27 . . . . 64.340000000000003 112.333 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -87.78 89.83 8.14 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 122.459 1.123 . . . . 71.120000000000005 110.521 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.0 m -80.59 -0.31 4.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-N 114.936 -1.029 . . . . 63.109999999999999 111.96 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -69.53 100.84 1.48 Allowed 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.734 -0.666 . . . . 71.140000000000001 110.494 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 156.86 -38.11 0.57 Allowed Glycine 0 C--N 1.304 -1.224 0 C-N-CA 120.808 -0.71 . . . . 64.430000000000007 111.979 178.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -92.62 -175.66 4.03 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 109.543 -0.54 . . . . 74.310000000000002 109.543 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 13.2 m -70.18 154.86 41.42 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.35 -0.981 . . . . 73.319999999999993 108.35 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.476 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.4 p -64.14 -41.33 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 C-N-CA 120.737 -0.385 . . . . 74.010000000000005 110.797 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . 0.577 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 28.1 t70 -59.69 -43.24 94.11 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 109.815 -0.439 . . . . 54.240000000000002 109.815 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 46.3 t -69.29 -41.54 81.08 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 CA-C-N 115.868 -0.606 . . . . 64.120000000000005 110.085 -178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -58.24 -44.02 88.09 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.753 0.311 . . . . 35.310000000000002 110.671 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.0 mt-30 -64.8 -44.88 88.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.027 -0.533 . . . . 75.120000000000005 110.617 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.577 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 33.4 mmtp -64.76 -40.17 94.84 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 116.19 -0.459 . . . . 75.510000000000005 110.129 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . 0.475 ' O ' HG13 ' A' ' 514' ' ' VAL . 85.9 m-20 -66.72 -40.49 88.44 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.856 -0.611 . . . . 71.230000000000004 111.585 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . 0.471 HD11 ' N ' ' A' ' 513' ' ' ASN . 4.4 pp -69.9 -41.37 74.78 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.42 -0.912 . . . . 73.319999999999993 110.776 177.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.471 ' N ' HD11 ' A' ' 512' ' ' LEU . 2.4 t-20 -64.38 -38.91 92.69 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 124.136 0.974 . . . . 74.319999999999993 111.259 -177.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 511' ' ' ASN . 9.0 p -64.06 -31.62 54.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.196 0.522 . . . . 75.230000000000004 110.876 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -112.62 23.24 13.73 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.409 -0.589 . . . . 75.400000000000006 109.409 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -146.07 -56.13 0.02 OUTLIER Glycine 0 CA--C 1.484 -1.866 0 C-N-CA 119.653 -1.26 . . . . 63.240000000000002 113.963 -174.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 65.76 26.28 11.32 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.211 1.005 . . . . 74.519999999999996 109.618 -175.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 14.7 p -82.95 -175.71 5.97 Favored 'General case' 0 N--CA 1.409 -2.489 0 CA-C-N 113.755 -1.566 . . . . 74.519999999999996 108.905 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.51 142.92 38.2 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.042 -1.095 . . . . 75.200000000000003 108.042 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -130.33 148.78 52.2 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.078 0.466 . . . . 72.099999999999994 111.332 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 32.2 m -138.32 139.99 39.33 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.058 -0.719 . . . . 74.299999999999997 109.058 176.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -118.09 138.67 52.09 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.85 0.357 . . . . 73.120000000000005 110.795 -176.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -135.02 130.42 35.65 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.268 -0.424 . . . . 71.030000000000001 109.862 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 73.9 m -88.96 129.15 35.68 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.695 0.76 . . . . 74.030000000000001 112.175 -178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.83 149.68 25.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.109 -1.811 . . . . 71.340000000000003 106.109 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -81.48 136.44 35.64 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.908 -0.717 . . . . 73.510000000000005 109.772 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 67.2 m -158.56 164.85 19.91 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 107.982 -1.118 . . . . 53.43 107.982 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -65.35 -14.78 46.77 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.251 1.968 . . . . 72.409999999999997 113.534 178.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.36 146.85 40.74 Favored Pre-proline 0 C--N 1.326 -0.413 0 C-N-CA 120.945 -0.302 . . . . 73.340000000000003 110.993 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.77 155.47 37.56 Favored 'Trans proline' 0 C--O 1.263 1.758 0 C-N-CA 123.633 2.889 . . . . 73.439999999999998 115.378 -175.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.669 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -68.71 110.4 4.28 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 113.617 -1.629 . . . . 73.340000000000003 110.602 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 137.39 -21.63 3.26 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.574 -0.822 . . . . 75.329999999999998 111.546 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -82.88 138.18 33.99 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.99 -0.745 . . . . 71.219999999999999 108.99 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 6.6 p -86.16 114.74 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.193 0 CA-C-O 122.12 0.962 . . . . 75.140000000000001 108.907 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.06 -32.57 74.34 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 113.575 -1.648 . . . . 70.340000000000003 109.681 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 153.26 -166.69 31.68 Favored Glycine 0 N--CA 1.418 -2.546 0 N-CA-C 110.102 -1.199 . . . . 65.439999999999998 110.102 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 6.6 p -116.96 157.44 25.75 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 109.448 -0.575 . . . . 65.140000000000001 109.448 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -63.45 -55.17 37.55 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 119.17 -0.443 . . . . 75.329999999999998 110.495 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -69.02 126.5 13.88 Favored 'Trans proline' 0 C--N 1.365 1.442 0 N-CA-C 108.346 -1.444 . . . . 54.420000000000002 108.346 170.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.59 155.22 67.89 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.497 2.131 . . . . 53.240000000000002 113.293 -176.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.98 130.81 47.32 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.925 -0.58 . . . . 55.32 110.294 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.85 -4.82 42.44 Favored Glycine 0 C--N 1.303 -1.258 0 C-N-CA 120.205 -0.998 . . . . 74.230000000000004 111.725 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 25.3 m -88.16 133.28 34.05 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.467 -0.568 . . . . 74.549999999999997 109.467 178.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 0.2 OUTLIER -86.71 123.9 32.39 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 106.84 -1.541 . . . . 75.030000000000001 106.84 174.74 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.67 155.06 63.53 Favored Pre-proline 0 C--N 1.295 -1.798 0 N-CA-C 108.454 -0.943 . . . . 73.040000000000006 108.454 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -64.34 138.3 59.94 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 121.552 1.501 . . . . 74.430000000000007 111.636 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.31 -19.96 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 CA-C-O 122.168 0.985 . . . . 71.099999999999994 109.858 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -91.12 -8.38 48.94 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.785 -1.098 . . . . 73.439999999999998 111.687 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 15.1 t -89.79 -175.64 4.7 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-O 121.282 0.563 . . . . 63.210000000000001 110.416 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.1 p -118.89 137.65 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-N 115.869 -0.605 . . . . 72.409999999999997 109.511 -177.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 59.8 mt -97.55 132.56 41.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.883 -0.784 . . . . 73.310000000000002 108.883 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -103.12 116.1 31.84 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.416 -1.327 . . . . 72.219999999999999 107.416 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.84 125.8 52.36 Favored 'General case' 0 C--N 1.312 -1.035 0 O-C-N 123.625 0.578 . . . . 75.219999999999999 111.0 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -93.09 121.66 34.66 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.699 -0.682 . . . . 74.519999999999996 109.293 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 15.1 t -104.37 137.4 33.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 107.447 -1.316 . . . . 71.450000000000003 107.447 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.669 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 24.5 p -88.08 139.53 30.42 Favored 'General case' 0 N--CA 1.413 -2.315 0 C-N-CA 119.92 -0.712 . . . . 74.239999999999995 109.839 178.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -108.41 145.03 35.2 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 105.299 -2.112 . . . . 73.219999999999999 105.299 167.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 559' ' ' ASN . . . -54.68 -22.58 25.98 Favored Glycine 0 CA--C 1.506 -0.516 0 O-C-N 124.72 1.262 . . . . 62.340000000000003 114.743 -174.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 558' ' ' GLY . 18.9 t-20 82.79 -16.4 0.59 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.816 1.246 . . . . 62.140000000000001 109.678 -178.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.443 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 86.9 mt-30 -113.48 157.33 22.12 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.283 -0.871 . . . . 73.239999999999995 111.383 -176.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -136.8 157.85 45.81 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.278 -1.379 . . . . 74.239999999999995 107.278 176.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.97 119.3 23.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.434 -0.58 . . . . 74.420000000000002 109.434 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 54.8 ttp -79.98 133.46 58.02 Favored Pre-proline 0 C--N 1.311 -1.077 0 C-N-CA 120.817 -0.353 . . . . 75.409999999999997 110.088 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.95 169.67 17.33 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.71 2.273 . . . . 74.540000000000006 111.525 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -89.62 119.87 30.42 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 113.219 0.822 . . . . 75.310000000000002 113.219 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.36 12.73 3.02 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.504 -1.225 . . . . 63.340000000000003 109.272 173.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 84.5 p -69.03 153.41 43.83 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 115.69 -0.686 . . . . 75.329999999999998 112.824 -173.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 86.13 56.66 2.26 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.793 -0.923 . . . . 44.329999999999998 110.793 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 569' ' ' MET . . . . . 0.467 ' O ' ' HA ' ' A' ' 602' ' ' ARG . 14.4 ptm -142.49 177.04 8.55 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.01 -0.367 . . . . 73.439999999999998 110.01 -175.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -95.5 160.63 14.42 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 106.69 -1.596 . . . . 75.310000000000002 106.69 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . 0.452 ' CZ3' ' HB3' ' A' ' 589' ' ' LYS . 19.3 t-105 -66.49 -32.32 73.61 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.482 -0.932 . . . . 75.209999999999994 108.482 176.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.1 m -76.2 -13.53 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.284 -0.871 . . . . 62.32 111.159 -174.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -96.96 -27.23 14.73 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.779 -1.193 . . . . 73.310000000000002 107.779 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -68.82 -40.33 79.57 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.25 -0.886 . . . . 70.310000000000002 111.773 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.633 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 44.9 mt-10 -55.36 -55.6 38.07 Favored Pre-proline 0 CA--C 1.567 1.606 0 N-CA-C 112.725 0.639 . . . . 75.019999999999996 112.725 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.5 -30.38 79.75 Favored 'Trans proline' 0 C--N 1.364 1.391 0 CA-C-N 120.707 1.288 . . . . 71.219999999999999 112.606 172.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -68.73 -36.36 78.31 Favored 'General case' 0 N--CA 1.435 -1.197 0 O-C-N 122.091 -0.38 . . . . 62.420000000000002 111.009 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.3 pp -64.51 -45.97 84.96 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 120.728 0.299 . . . . 74.019999999999996 110.655 -178.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.522 ' N ' HD11 ' A' ' 578' ' ' LEU . 8.5 ptm180 -65.93 -34.84 79.04 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.358 -0.383 . . . . 73.219999999999999 111.242 175.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.24 -39.31 82.32 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 116.41 -0.359 . . . . 63.240000000000002 111.548 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.93 -9.66 42.32 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.555 -0.458 . . . . 75.209999999999994 111.399 -177.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 79.43 42.37 11.85 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.071 -0.585 . . . . 73.230000000000004 112.339 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . 0.434 ' CH2' ' HG ' ' A' ' 587' ' ' LEU . 10.0 t90 -81.46 127.26 32.62 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.799 -0.815 . . . . 74.450000000000003 108.799 178.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 22.5 m -83.19 -29.63 28.42 Favored 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 113.083 0.771 . . . . 55.109999999999999 113.083 -176.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -90.72 -175.62 44.3 Favored Glycine 0 C--N 1.315 -0.611 0 CA-C-N 116.555 -0.293 . . . . 72.329999999999998 112.905 -177.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 70.1 mtm -117.73 163.33 16.65 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.368 -0.604 . . . . 65.140000000000001 109.368 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . 0.434 ' HG ' ' CH2' ' A' ' 583' ' ' TRP . 5.1 mp -84.26 131.14 34.76 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 109.703 -0.48 . . . . 71.439999999999998 109.703 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -101.86 116.07 31.9 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 108.831 -0.803 . . . . 73.329999999999998 108.831 177.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . 0.452 ' HB3' ' CZ3' ' A' ' 571' ' ' TRP . 0.0 OUTLIER -95.08 134.23 38.02 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.659 0.742 . . . . 74.239999999999995 112.204 -175.077 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -95.58 -145.0 18.03 Favored Glycine 0 C--N 1.29 -1.982 0 N-CA-C 109.264 -1.534 . . . . 74.109999999999999 109.264 174.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -74.49 126.16 30.16 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 117.309 0.554 . . . . 73.340000000000003 110.547 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -69.75 144.21 52.8 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 123.913 0.758 . . . . 72.010000000000005 109.703 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 58.6 t -106.68 143.44 17.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-N 115.272 -0.877 . . . . 73.420000000000002 109.638 -174.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -74.94 107.0 6.73 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.968 -0.753 . . . . 63.009999999999998 108.968 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -126.98 -53.88 1.4 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 116.057 -0.52 . . . . 72.540000000000006 110.125 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 101.81 129.44 6.68 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.963 -0.855 . . . . 72.310000000000002 110.963 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.68 -43.11 91.55 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 116.539 0.169 . . . . 72.439999999999998 113.224 -177.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 35.3 t -68.7 -24.68 64.52 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.323 0.583 . . . . 73.109999999999999 110.65 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -93.53 -1.75 55.16 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 116.088 -0.505 . . . . 75.510000000000005 110.593 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 42.2 m170 80.55 98.33 0.06 Allowed 'General case' 0 C--O 1.246 0.892 0 C-N-CA 125.437 1.495 . . . . 72.329999999999998 113.216 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -73.08 90.39 1.53 Allowed 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 114.091 -1.413 . . . . 73.409999999999997 109.952 177.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 569' ' ' MET . 19.6 mtm180 -107.94 171.14 7.57 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.865 -0.607 . . . . 75.349999999999994 110.003 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 14.7 p -73.4 137.97 22.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.751 -0.833 . . . . 72.219999999999999 108.751 175.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 33.5 m -107.26 -29.19 2.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 119.752 -0.779 . . . . 73.519999999999996 110.865 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -156.55 139.17 15.03 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.65 -0.705 . . . . 74.310000000000002 109.464 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -133.02 141.96 48.55 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.057 -1.831 . . . . 70.150000000000006 106.057 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.479 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 23.7 t-20 -62.14 -60.36 10.37 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-O 118.923 -0.561 . . . . 74.200000000000003 112.483 -177.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 6.3 Cg_exo -87.98 109.26 0.62 Allowed 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 121.752 1.635 . . . . 72.430000000000007 109.844 173.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -71.11 160.63 48.58 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 123.225 2.616 . . . . 71.409999999999997 113.112 -178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.02 132.67 47.7 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.821 -0.807 . . . . 65.420000000000002 108.821 175.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 103.18 -11.88 55.32 Favored Glycine 0 C--N 1.302 -1.336 0 N-CA-C 110.852 -0.899 . . . . 44.539999999999999 110.852 -175.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 44.8 m -100.27 159.5 15.07 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.787 -0.82 . . . . 72.540000000000006 108.787 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -76.86 120.61 5.72 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 112.036 -0.426 . . . . 71.129999999999995 112.036 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.7 m -112.42 143.32 22.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 107.793 -1.188 . . . . 72.019999999999996 107.793 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.443 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.2 p-10 -52.99 168.8 0.11 Allowed 'General case' 0 C--O 1.216 -0.704 0 C-N-CA 123.534 0.734 . . . . 74.120000000000005 112.184 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . 0.267 0.0 OUTLIER -60.91 -24.95 66.4 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 113.642 0.978 . . . . 74.340000000000003 113.642 -176.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -80.97 -9.2 59.87 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 119.686 -0.806 . . . . 73.219999999999999 109.522 176.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.18 18.9 67.66 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 112.008 -0.437 . . . . 75.239999999999995 112.008 175.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.49 119.34 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-O 122.379 1.085 . . . . 75.519999999999996 111.694 -166.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.467 ' O ' HD11 ' A' ' 620' ' ' ILE . 2.8 pp -118.17 132.19 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 CA-C-N 114.77 -1.105 . . . . 72.329999999999998 110.352 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 12.9 t -99.19 128.76 45.37 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.007 -1.479 . . . . 73.140000000000001 107.007 174.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.1 166.64 23.97 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 112.599 0.592 . . . . 74.230000000000004 112.599 -172.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -126.21 134.88 51.11 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 105.231 -2.137 . . . . 75.010000000000005 105.231 173.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -142.29 166.05 25.74 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.912 -0.585 . . . . 71.209999999999994 110.571 -169.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -63.45 130.49 40.72 Favored Glycine 0 N--CA 1.433 -1.546 0 O-C-N 124.203 0.939 . . . . 53.049999999999997 111.956 175.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 . . . . . 0 C--N 1.301 -1.501 0 C-N-CA 126.162 1.785 . . . . 75.230000000000004 114.446 -178.878 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.985 0 CA-C-O 120.96 0.409 . . . . 62.310000000000002 110.816 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.451 ' HB ' ' OG1' ' A' ' 544' ' ' THR . 33.9 p -137.49 144.87 42.43 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.389 -0.596 . . . . 75.5 109.389 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -141.93 148.9 39.42 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 123.493 0.717 . . . . 74.230000000000004 109.343 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 14.3 m-20 -89.58 131.17 35.72 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 120.942 0.401 . . . . 73.030000000000001 110.759 -175.07 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.0 pt -90.77 128.05 49.81 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 116.048 -0.524 . . . . 75.400000000000006 110.579 178.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.27 -177.57 2.17 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.706 2.271 . . . . 70.409999999999997 112.463 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -81.26 99.84 8.84 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.789 -0.641 . . . . 71.310000000000002 109.556 177.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.1 m -102.13 -3.31 9.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.301 -0.863 . . . . 73.310000000000002 111.442 -179.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -64.87 103.65 0.74 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.836 -0.62 . . . . 52.450000000000003 110.219 -178.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 145.87 -24.08 1.79 Allowed Glycine 0 C--N 1.295 -1.707 0 CA-C-N 115.476 -0.784 . . . . 74.219999999999999 111.984 178.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.421 ' O ' HG12 ' A' ' 534' ' ' VAL . 2.2 mp0 -92.04 -179.24 5.22 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.124 -1.065 . . . . 74.109999999999999 108.124 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 31.5 m -75.85 155.17 35.57 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.457 -1.683 . . . . 61.399999999999999 106.457 175.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.556 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.2 p -61.29 -43.19 96.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 118.103 0.41 . . . . 73.329999999999998 111.438 -177.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . 0.54 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 25.6 t70 -63.17 -41.29 99.21 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.415 -0.357 . . . . 75.400000000000006 110.176 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 94.5 t -68.04 -42.99 85.69 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.984 0 CA-C-N 115.386 -0.825 . . . . 64.310000000000002 110.33 -178.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.412 ' CB ' HG13 ' A' ' 534' ' ' VAL . . . -62.5 -44.38 96.53 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 121.12 -0.232 . . . . 73.439999999999998 110.532 178.582 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 21.5 mt-30 -64.54 -46.5 82.56 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 116.437 -0.347 . . . . 74.150000000000006 110.676 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.54 ' HG3' ' O ' ' A' ' 506' ' ' ASP 0.359 0.0 OUTLIER -65.68 -37.0 85.27 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 112.386 0.513 . . . . 72.400000000000006 112.386 179.468 . . . . . . . . 4 4 . 1 . 021 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -60.55 -47.4 86.36 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.445 -0.576 . . . . 75.450000000000003 109.445 178.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.54 -37.66 80.16 Favored 'General case' 0 C--O 1.205 -1.275 0 CA-C-N 115.457 -0.792 . . . . 70.25 109.743 177.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -59.74 -34.44 72.95 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 123.884 0.874 . . . . 73.239999999999995 111.745 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.507 HG21 ' O ' ' A' ' 510' ' ' LYS . 73.6 t -56.57 -31.33 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 O-C-N 123.645 0.591 . . . . 60.149999999999999 110.524 176.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -114.08 5.92 16.2 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.095 -0.706 . . . . 74.340000000000003 109.095 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -124.42 -62.09 0.18 Allowed Glycine 0 CA--C 1.481 -2.06 0 C-N-CA 120.342 -0.932 . . . . 73.420000000000002 113.988 -169.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 61.07 32.66 19.74 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 122.144 0.973 . . . . 75.420000000000002 109.071 -172.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.9 p -87.02 -178.43 6.27 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.377 -1.283 . . . . 75.239999999999995 111.331 -177.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -108.22 143.11 37.49 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.98 -1.119 . . . . 74.329999999999998 107.98 178.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -125.3 146.14 49.69 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.745 0.307 . . . . 74.430000000000007 110.71 -174.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 56.3 p -126.92 141.07 51.9 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 106.18 -1.785 . . . . 74.319999999999993 106.18 171.043 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -129.72 122.57 29.15 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.299 0.571 . . . . 74.319999999999993 110.996 -174.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -118.09 125.31 50.04 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.632 -0.713 . . . . 74.209999999999994 109.493 -179.041 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 40.3 m -85.78 130.44 34.55 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-O 121.558 0.694 . . . . 55.030000000000001 111.287 -179.188 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.4 p -121.05 149.14 24.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 107.146 -1.427 . . . . 75.140000000000001 107.146 178.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.402 ' C ' ' HG ' ' A' ' 527' ' ' SER . 9.1 p-10 -80.63 135.44 36.05 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.164 -0.615 . . . . 75.420000000000002 109.762 -177.069 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.402 ' HG ' ' C ' ' A' ' 526' ' ' ASP . 70.8 m -159.75 165.27 18.3 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 108.1 -1.074 . . . . 74.099999999999994 108.1 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -71.5 -8.08 22.55 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.103 1.869 . . . . 73.310000000000002 112.549 177.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.464 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 16.0 mtm180 -81.57 141.71 48.96 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 123.48 0.712 . . . . 71.409999999999997 109.866 178.106 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.61 153.67 59.89 Favored 'Trans proline' 0 C--O 1.249 1.056 0 C-N-CA 123.431 2.754 . . . . 75.200000000000003 113.596 -174.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.689 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -68.37 105.98 2.35 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.192 -0.913 . . . . 71.310000000000002 110.576 -177.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 139.44 -17.13 3.11 Favored Glycine 0 N--CA 1.434 -1.5 0 CA-C-N 115.293 -0.867 . . . . 72.230000000000004 112.162 -179.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -81.33 130.05 34.87 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 109.594 -0.521 . . . . 75.200000000000003 109.594 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.431 ' HB ' ' HA ' ' A' ' 505' ' ' VAL . 7.8 p -81.36 118.01 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.252 0 CA-C-O 122.612 1.196 . . . . 74.329999999999998 108.871 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 m -80.07 -17.73 51.91 Favored 'General case' 0 C--N 1.269 -2.905 0 CA-C-N 112.938 -1.937 . . . . 74.010000000000005 110.177 -175.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 139.93 -163.12 26.3 Favored Glycine 0 N--CA 1.41 -3.034 0 C-N-CA 120.544 -0.836 . . . . 65.530000000000001 111.234 176.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.6 p -117.37 157.92 25.32 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 109.194 -0.669 . . . . 73.109999999999999 109.194 -179.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -66.61 -54.52 22.71 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 120.364 -0.535 . . . . 62.350000000000001 110.002 175.438 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -67.93 138.85 45.52 Favored 'Trans proline' 0 C--N 1.373 1.844 0 N-CA-C 109.395 -1.04 . . . . 74.230000000000004 109.395 170.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -62.9 155.39 60.49 Favored 'Trans proline' 0 C--O 1.244 0.801 0 C-N-CA 122.763 2.309 . . . . 71.230000000000004 113.106 -177.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.89 134.61 53.38 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.264 -0.426 . . . . 64.25 109.904 179.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.31 -5.53 57.45 Favored Glycine 0 C--N 1.303 -1.283 0 N-CA-C 111.344 -0.702 . . . . 54.450000000000003 111.344 -177.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 20.6 m -88.72 135.25 33.61 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.516 -0.55 . . . . 73.0 109.516 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 14.5 t -82.44 132.98 35.2 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.503 -0.925 . . . . 64.420000000000002 108.503 175.062 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.1 m -123.6 156.4 64.59 Favored Pre-proline 0 C--N 1.294 -1.834 0 N-CA-C 107.269 -1.382 . . . . 71.030000000000001 107.269 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.3 135.37 26.71 Favored 'Trans proline' 0 N--CA 1.433 -2.064 0 CA-C-N 119.833 0.976 . . . . 72.010000000000005 111.219 -178.061 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.68 -22.24 28.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 122.496 1.141 . . . . 75.040000000000006 108.838 177.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -79.9 -18.12 51.39 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 113.113 -1.858 . . . . 71.209999999999994 110.188 -175.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 18.7 t -102.07 -166.6 1.31 Allowed 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.612 -0.722 . . . . 73.310000000000002 109.512 -176.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 8.7 p -117.09 137.67 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.398 0 CA-C-N 115.162 -0.926 . . . . 73.5 109.196 -177.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.0 mt -91.68 141.37 14.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.324 -0.991 . . . . 74.400000000000006 108.324 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -102.29 116.93 33.68 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 108.506 -0.924 . . . . 73.430000000000007 108.506 -177.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.78 121.11 43.74 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.785 0.834 . . . . 70.340000000000003 109.921 -179.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -88.35 122.76 32.22 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.922 -0.769 . . . . 62.340000000000003 108.922 174.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 524' ' ' SER . 25.4 t -110.2 134.66 51.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 108.763 -0.828 . . . . 75.340000000000003 108.763 -178.269 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.689 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 75.5 m -81.57 131.1 35.26 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 120.093 -0.643 . . . . 74.150000000000006 109.885 176.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -99.69 131.78 45.46 Favored 'General case' 0 N--CA 1.411 -2.407 0 N-CA-C 104.28 -2.489 . . . . 72.510000000000005 104.28 166.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -60.17 -26.01 63.09 Favored Glycine 0 CA--C 1.49 -1.517 0 O-C-N 124.13 0.893 . . . . 73.439999999999998 112.924 -173.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 71.77 -15.44 0.45 Allowed 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 125.191 1.396 . . . . 74.310000000000002 110.721 178.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 558' ' ' GLY . 89.9 mt-30 -113.18 144.34 42.84 Favored 'General case' 0 N--CA 1.416 -2.167 0 C-N-CA 123.37 0.668 . . . . 75.209999999999994 111.754 -174.371 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -123.31 146.69 47.7 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.678 -1.23 . . . . 73.209999999999994 107.678 177.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.81 117.97 12.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.417 0.627 . . . . 75.099999999999994 110.504 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 51.9 ttp -81.11 120.51 78.82 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 115.626 -0.715 . . . . 73.0 110.246 -177.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.76 169.78 12.49 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 123.156 2.571 . . . . 65.299999999999997 111.917 176.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -65.53 115.49 5.81 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 122.195 0.998 . . . . 72.310000000000002 112.634 -178.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.2 pp -131.37 6.19 4.46 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 113.81 -1.541 . . . . 74.140000000000001 107.784 170.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 14.5 m -80.08 142.09 35.2 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 113.627 -1.624 . . . . 72.519999999999996 109.499 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . 0.489 ' H ' ' CG1' ' A' ' 603' ' ' VAL . . . 80.64 48.17 6.38 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 121.353 -0.451 . . . . 73.319999999999993 112.839 178.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 21.6 ptp -152.31 -174.71 4.98 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 109.331 -0.618 . . . . 74.239999999999995 109.331 178.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -95.08 166.65 11.82 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.637 -0.875 . . . . 72.150000000000006 108.637 -173.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 -66.58 -29.06 69.03 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.998 -0.742 . . . . 75.319999999999993 108.998 178.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.9 p -73.89 -12.36 15.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 CA-C-O 121.968 0.89 . . . . 74.299999999999997 109.948 -178.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -101.49 -29.48 11.96 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 115.725 -0.671 . . . . 64.430000000000007 111.146 173.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.46 -47.77 82.55 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.75 0.657 . . . . 71.140000000000001 111.166 179.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.479 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 43.1 mt-10 -55.5 -51.81 77.0 Favored Pre-proline 0 CA--C 1.56 1.348 0 N-CA-C 113.463 0.912 . . . . 72.430000000000007 113.463 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.439 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 31.9 Cg_exo -61.86 -40.24 45.93 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.613 1.542 . . . . 73.409999999999997 113.128 174.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -60.76 -40.58 93.04 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 111.4 0.148 . . . . 73.319999999999993 111.4 179.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.543 HD13 ' N ' ' A' ' 579' ' ' ARG . 4.3 pp -65.97 -46.58 77.54 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.543 -0.463 . . . . 72.239999999999995 112.029 -176.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.543 ' N ' HD13 ' A' ' 578' ' ' LEU . 15.1 ptp180 -66.82 -36.1 81.6 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.503 -0.317 . . . . 74.219999999999999 111.611 178.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.1 -30.67 67.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.255 0.55 . . . . 72.439999999999998 110.53 178.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 11.4 tp -81.43 -9.73 59.66 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.294 0.569 . . . . 62.299999999999997 110.452 177.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 76.5 26.71 62.73 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.445 -0.884 . . . . 75.030000000000001 112.062 179.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . 0.409 ' CD1' ' HA3' ' A' ' 618' ' ' GLY . 16.0 t90 -87.33 126.49 34.88 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 107.705 -1.22 . . . . 71.340000000000003 107.705 176.192 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 41.7 p -115.24 0.49 13.54 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 112.918 0.711 . . . . 72.239999999999995 112.918 -175.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -81.5 -173.88 48.58 Favored Glycine 0 C--O 1.248 0.996 0 C-N-CA 120.499 -0.857 . . . . 64.450000000000003 112.011 178.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 65.8 mtt -100.27 147.91 25.24 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 120.853 0.359 . . . . 74.010000000000005 110.729 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.1 tt -91.56 122.49 34.18 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.346 -1.353 . . . . 75.219999999999999 107.346 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . 0.538 ' O ' ' HA ' ' A' ' 621' ' ' THR . 32.3 t70 -98.65 119.87 38.11 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.231 -0.655 . . . . 75.439999999999998 109.231 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.88 135.05 53.02 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 116.181 -0.463 . . . . 65.530000000000001 110.035 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -73.01 -88.4 0.17 Allowed Glycine 0 C--N 1.297 -1.609 0 N-CA-C 110.727 -0.949 . . . . 64.010000000000005 110.727 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.7 154.12 47.4 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.778 -0.452 . . . . 73.340000000000003 109.778 177.192 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 624' ' ' PHE . 3.3 p30 -100.49 132.54 45.82 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.62 -0.881 . . . . 75.439999999999998 108.62 174.254 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 46.3 t -105.08 139.09 27.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 108.651 -0.87 . . . . 75.299999999999997 108.651 -176.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . 0.54 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 7.3 p-10 -71.53 110.9 6.41 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 122.185 0.993 . . . . 73.219999999999999 111.884 -173.316 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -113.24 -55.78 2.48 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.008 -0.996 . . . . 64.120000000000005 108.469 179.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 139.18 141.7 4.14 Favored Glycine 0 N--CA 1.416 -2.64 0 CA-C-N 115.613 -0.721 . . . . 71.209999999999994 111.465 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -59.77 -36.05 88.52 Favored Glycine 0 N--CA 1.446 -0.686 0 O-C-N 123.844 0.379 . . . . 73.299999999999997 112.744 -178.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 15.1 m -67.07 -24.7 66.0 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 123.053 0.541 . . . . 75.540000000000006 111.269 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -92.81 -12.75 30.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.867 0.365 . . . . 75.120000000000005 110.759 -178.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 23.2 m170 67.71 145.83 0.04 OUTLIER 'General case' 0 C--O 1.246 0.889 0 N-CA-C 114.914 1.45 . . . . 75.450000000000003 114.914 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -77.68 89.15 3.96 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 114.11 -1.405 . . . . 74.140000000000001 111.027 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -101.13 154.34 18.82 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.651 -1.24 . . . . 73.400000000000006 107.651 176.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . 0.489 ' CG1' ' H ' ' A' ' 568' ' ' GLY . 8.8 p -67.87 141.96 17.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.402 -0.962 . . . . 72.239999999999995 108.402 176.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.51 -53.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.726 -0.842 . . . . 74.200000000000003 108.726 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -149.0 145.65 27.42 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.779 -0.823 . . . . 75.420000000000002 108.779 -178.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -129.19 136.26 49.91 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.543 -1.28 . . . . 74.109999999999999 107.543 173.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.45 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 48.7 t30 -55.4 -54.1 54.81 Favored Pre-proline 0 C--N 1.314 -0.959 0 N-CA-C 112.697 0.629 . . . . 74.409999999999997 112.697 -178.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.8 Cg_endo -87.72 107.2 0.6 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 121.579 1.519 . . . . 75.230000000000004 109.47 173.53 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.29 160.8 47.76 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 123.308 2.672 . . . . 71.420000000000002 113.362 -177.407 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.64 130.07 44.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.149 -0.478 . . . . 71.25 109.772 177.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.3 -3.08 40.18 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.707 -0.758 . . . . 70.439999999999998 112.833 -178.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 2.1 t -101.88 162.99 12.49 Favored 'General case' 0 C--O 1.25 1.104 0 N-CA-C 108.329 -0.989 . . . . 75.120000000000005 108.329 178.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -85.13 127.81 8.39 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 120.657 -0.782 . . . . 72.129999999999995 111.726 179.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 32.7 m -112.04 141.65 26.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.801 -0.814 . . . . 65.540000000000006 108.801 177.243 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -56.47 176.27 0.09 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.631 1.173 . . . . 73.319999999999993 114.025 -175.481 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -56.93 -27.98 61.56 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.881 0.872 . . . . 74.310000000000002 112.504 -177.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.438 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 6.5 m-20 -94.25 -6.11 45.31 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 120.629 -0.428 . . . . 75.120000000000005 110.592 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . 0.409 ' HA3' ' CD1' ' A' ' 583' ' ' TRP . . . 66.19 17.93 66.51 Favored Glycine 0 CA--C 1.497 -1.053 0 C-N-CA 124.088 0.851 . . . . 51.130000000000003 113.993 170.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.21 119.24 15.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 122.312 1.053 . . . . 73.430000000000007 111.767 -165.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 45.0 pt -122.18 134.56 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 114.679 -1.146 . . . . 74.129999999999995 110.141 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 9.7 t -105.8 129.85 53.9 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.447 -0.945 . . . . 74.329999999999998 108.447 177.571 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.5 pp -138.86 166.03 25.49 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 113.037 0.754 . . . . 73.310000000000002 113.037 -176.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -128.11 137.33 52.08 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.085 -1.45 . . . . 74.239999999999995 107.085 176.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 592' ' ' ASP . 3.0 p90 -140.09 166.1 25.57 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.316 -0.554 . . . . 74.420000000000002 111.909 -172.321 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -76.27 169.39 54.87 Favored Glycine 0 N--CA 1.429 -1.817 0 CA-C-N 115.621 -0.718 . . . . 52.420000000000002 113.136 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.54 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 27.0 tt0 . . . . . 0 C--N 1.274 -2.717 0 N-CA-C 106.919 -1.511 . . . . 75.319999999999993 106.919 178.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 113.687 0.995 . . . . 64.129999999999995 113.687 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 14.1 p -138.01 139.57 39.7 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 109.079 -0.712 . . . . 75.150000000000006 109.079 179.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 516' ' ' GLY . 74.7 mmtt -123.27 134.01 54.13 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-O 121.007 0.432 . . . . 75.430000000000007 110.311 -175.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -95.78 127.77 42.09 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.091 -0.959 . . . . 74.209999999999994 109.135 178.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 498' ' ' PRO . 27.0 pt -106.2 122.87 40.8 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 115.976 -0.556 . . . . 74.519999999999996 111.217 -178.556 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 11.3 Cg_exo -72.41 -175.45 1.79 Allowed 'Trans proline' 0 C--O 1.248 0.992 0 C-N-CA 122.165 1.91 . . . . 73.329999999999998 110.477 175.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -79.71 89.98 5.19 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.617 1.199 . . . . 52.340000000000003 110.565 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.29 -11.01 12.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.001 -1.454 . . . . 74.430000000000007 110.178 177.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -67.38 103.15 1.22 Allowed 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 114.53 -1.214 . . . . 72.519999999999996 109.12 178.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 148.86 -30.92 1.22 Allowed Glycine 0 C--N 1.293 -1.816 0 C-N-CA 120.493 -0.86 . . . . 73.109999999999999 112.095 178.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.401 ' O ' HG12 ' A' ' 534' ' ' VAL . 10.0 pt20 -94.76 -169.83 2.1 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 120.009 -0.677 . . . . 74.239999999999995 110.14 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 2.9 m -74.16 156.08 37.71 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.785 -0.82 . . . . 73.430000000000007 108.785 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.539 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.7 p -57.91 -47.76 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 O-C-N 123.464 0.477 . . . . 73.219999999999999 112.152 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -65.24 -36.69 84.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 120.565 -0.454 . . . . 74.030000000000001 110.012 -178.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.79 -41.92 85.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.831 0 CA-C-N 115.907 -0.588 . . . . 74.340000000000003 109.523 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -65.39 -45.24 84.76 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.749 -0.205 . . . . 72.409999999999997 110.912 177.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.5 mt-30 -63.97 -45.75 87.69 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 123.395 0.435 . . . . 74.510000000000005 110.759 -178.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.52 ' O ' HG21 ' A' ' 514' ' ' VAL . 0.1 OUTLIER -67.34 -39.35 85.78 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 116.154 -0.476 . . . . 64.230000000000004 110.007 -178.229 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -62.62 -46.89 86.16 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 123.39 0.431 . . . . 71.439999999999998 111.013 -179.332 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.3 pp -68.5 -35.81 78.03 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 115.83 -0.623 . . . . 71.209999999999994 110.995 -178.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -63.3 -35.98 82.17 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 123.512 0.725 . . . . 72.439999999999998 110.315 179.016 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.52 HG21 ' O ' ' A' ' 510' ' ' LYS . 85.0 t -63.47 -32.47 56.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.884 0 CA-C-O 121.127 0.489 . . . . 75.209999999999994 110.838 177.107 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . 0.43 ' O ' ' HD2' ' A' ' 495' ' ' LYS . 11.1 m-85 -103.32 3.65 35.57 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.928 -0.397 . . . . 71.310000000000002 109.928 -178.052 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . 0.432 ' O ' ' HE3' ' A' ' 495' ' ' LYS . . . -134.88 -54.99 0.07 OUTLIER Glycine 0 N--CA 1.416 -2.634 0 C-N-CA 118.803 -1.665 . . . . 74.439999999999998 115.019 -169.094 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 66.1 20.82 11.21 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.94 0.876 . . . . 74.329999999999998 109.032 -172.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.8 p -81.6 -174.87 5.23 Favored 'General case' 0 N--CA 1.407 -2.59 0 CA-C-N 114.155 -1.384 . . . . 73.400000000000006 110.462 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.69 138.99 42.92 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.951 -1.129 . . . . 72.299999999999997 107.951 -178.204 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 18.9 p90 -130.02 152.56 49.35 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 123.303 0.377 . . . . 72.219999999999999 110.588 -178.464 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 11.1 p -140.83 144.69 35.5 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 107.888 -1.153 . . . . 73.319999999999993 107.888 177.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -117.71 136.68 53.19 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.112 -0.635 . . . . 71.409999999999997 111.084 -178.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -132.29 129.85 40.1 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.013 -1.106 . . . . 73.319999999999993 108.013 177.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 32.6 t -99.73 135.03 41.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.443 0.64 . . . . 73.340000000000003 110.716 -177.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.7 p -135.21 150.99 29.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 107.747 -1.205 . . . . 75.019999999999996 107.747 178.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -82.79 135.67 34.9 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.398 0.618 . . . . 74.209999999999994 111.308 -178.012 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 72.4 m -164.23 160.2 16.36 Favored Pre-proline 0 C--N 1.308 -1.217 0 N-CA-C 106.32 -1.733 . . . . 75.540000000000006 106.32 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -64.29 -4.6 8.19 Favored 'Trans proline' 0 CA--C 1.553 1.471 0 C-N-CA 122.576 2.184 . . . . 62.450000000000003 114.084 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -70.69 130.08 89.18 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 107.755 -1.202 . . . . 73.409999999999997 107.755 173.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.8 148.13 76.83 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 122.417 2.078 . . . . 74.150000000000006 112.283 -176.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.25 111.52 1.1 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.303 -0.862 . . . . 75.400000000000006 111.614 -176.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 123.88 -16.76 7.75 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 115.397 -0.82 . . . . 71.030000000000001 112.143 178.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.69 129.42 34.96 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.216 -0.661 . . . . 72.209999999999994 109.216 179.505 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 503' ' ' GLN . 6.5 p -87.38 115.35 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 CA-C-O 121.459 0.647 . . . . 73.219999999999999 109.345 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -31.74 72.71 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.109 -0.951 . . . . 74.239999999999995 110.04 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 164.15 -174.61 40.27 Favored Glycine 0 N--CA 1.416 -2.656 0 CA-C-N 115.243 -0.89 . . . . 63.439999999999998 111.309 179.079 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 5.8 p -116.36 153.21 32.42 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 108.215 -1.032 . . . . 72.409999999999997 108.215 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -61.9 -47.57 91.08 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 119.47 -0.892 . . . . 72.420000000000002 111.431 179.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -67.82 120.32 7.32 Favored 'Trans proline' 0 C--N 1.367 1.551 0 N-CA-C 107.216 -1.878 . . . . 74.099999999999994 107.216 165.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.21 142.57 97.35 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.887 2.391 . . . . 75.420000000000002 113.687 -174.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.57 129.89 43.31 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.855 -0.612 . . . . 71.420000000000002 110.253 178.072 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.69 -7.05 49.34 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 111.386 -0.686 . . . . 54.030000000000001 111.386 -178.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 24.0 m -89.33 137.11 32.61 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 122.729 -0.277 . . . . 72.519999999999996 110.507 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 8.8 t -88.7 125.35 34.81 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 107.028 -1.471 . . . . 74.430000000000007 107.028 171.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 36.0 m -122.87 159.77 52.15 Favored Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 109.416 -0.587 . . . . 74.420000000000002 109.416 -175.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -66.92 139.91 53.22 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.92 1.746 . . . . 72.5 111.031 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.5 p -61.2 -20.85 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 CA-C-O 121.591 0.71 . . . . 73.019999999999996 110.378 178.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -77.87 -19.04 55.51 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.222 -0.899 . . . . 71.120000000000005 112.105 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 78.5 p -83.21 174.0 11.15 Favored 'General case' 0 C--O 1.247 0.958 0 N-CA-C 112.635 0.605 . . . . 64.120000000000005 112.635 -176.223 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.6 p -113.52 137.92 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 109.133 -0.691 . . . . 74.209999999999994 109.133 -178.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 59.8 mt -103.95 115.39 45.8 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 N-CA-C 107.706 -1.22 . . . . 72.230000000000004 107.706 178.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -103.73 129.18 51.06 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.399 -0.92 . . . . 72.5 110.556 178.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.78 126.91 43.37 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 114.314 -1.312 . . . . 73.299999999999997 110.259 -177.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -88.15 111.94 22.16 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 107.058 -1.46 . . . . 61.409999999999997 107.058 173.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 524' ' ' SER . 22.2 t -97.52 132.68 41.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 107.207 -1.405 . . . . 72.209999999999994 107.207 -178.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 72.3 m -94.7 134.03 37.73 Favored 'General case' 0 N--CA 1.404 -2.772 0 C-N-CA 119.36 -0.936 . . . . 74.150000000000006 111.684 177.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.441 ' HZ2' ' HB3' ' A' ' 557' ' ' LYS . 0.4 OUTLIER -98.0 133.88 41.86 Favored 'General case' 0 N--CA 1.402 -2.859 0 N-CA-C 104.637 -2.357 . . . . 72.420000000000002 104.637 168.886 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -54.32 -23.27 25.63 Favored Glycine 0 N--CA 1.468 0.822 0 O-C-N 124.493 1.12 . . . . 73.340000000000003 114.842 -171.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 81.06 -23.85 0.21 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.988 1.715 . . . . 72.25 109.253 -177.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.47 ' H ' ' C ' ' A' ' 558' ' ' GLY . 77.6 mt-30 -110.75 161.44 15.77 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 115.208 -0.905 . . . . 75.299999999999997 109.922 -172.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . 0.414 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 47.5 p90 -137.56 155.44 49.22 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 107.793 -1.188 . . . . 71.409999999999997 107.793 177.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.14 118.65 14.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 O-C-N 123.751 0.657 . . . . 74.120000000000005 110.188 179.177 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 40.2 ttp -85.86 128.48 58.22 Favored Pre-proline 0 C--N 1.298 -1.633 0 CA-C-N 116.026 -0.533 . . . . 73.400000000000006 110.495 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.54 169.96 14.69 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.183 2.589 . . . . 74.340000000000003 111.514 175.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -66.09 124.11 21.71 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.742 0.782 . . . . 72.530000000000001 112.355 -179.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 8.9 tt -115.76 3.91 13.91 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.746 -1.576 . . . . 72.420000000000002 106.746 174.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 14.3 m -76.39 131.42 39.12 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.055 -1.429 . . . . 74.25 109.123 179.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 74.22 61.06 3.33 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.989 -0.624 . . . . 74.140000000000001 113.44 176.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 569' ' ' MET . . . . . 0.456 ' HB2' ' HB2' ' A' ' 573' ' ' ASP . 20.1 ptp -162.66 173.12 14.31 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.696 -0.853 . . . . 73.140000000000001 108.696 177.528 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -101.15 175.73 5.49 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.864 -0.791 . . . . 75.439999999999998 108.864 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -61.64 -34.89 76.48 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.169 -1.049 . . . . 74.409999999999997 108.169 177.34 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 31.6 m -69.29 -10.25 13.22 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 115.386 -0.825 . . . . 73.209999999999994 112.084 -179.171 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 569' ' ' MET . 16.0 m-20 -101.87 -44.22 5.58 Favored 'General case' 0 C--O 1.248 1.02 0 N-CA-C 108.946 -0.761 . . . . 64.349999999999994 108.946 174.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . 0.423 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -62.0 -53.22 58.64 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 114.173 -1.376 . . . . 70.239999999999995 112.107 -175.741 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.436 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 33.8 tt0 -56.93 -47.83 98.42 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 123.396 0.435 . . . . 73.129999999999995 111.993 -176.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 73.8 Cg_exo -52.72 -44.74 45.51 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.242 1.961 . . . . 75.510000000000005 113.411 172.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -64.64 -37.92 89.21 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.705 -0.479 . . . . 75.409999999999997 109.705 178.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.588 HD12 ' CZ3' ' A' ' 583' ' ' TRP . 78.5 mt -67.38 -48.29 67.83 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.564 -0.744 . . . . 65.140000000000001 111.679 -178.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -65.85 -34.18 77.56 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 120.953 0.406 . . . . 73.209999999999994 111.086 177.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -69.95 -30.81 68.28 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.208 -0.451 . . . . 73.129999999999995 110.409 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 578' ' ' LEU . 3.1 pp -81.34 -8.54 59.76 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 119.751 -0.779 . . . . 73.219999999999999 111.244 177.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 80.08 54.43 3.85 Favored Glycine 0 CA--C 1.504 -0.648 0 N-CA-C 110.824 -0.911 . . . . 65.439999999999998 110.824 -178.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . 0.588 ' CZ3' HD12 ' A' ' 578' ' ' LEU . 14.0 t90 -80.45 127.89 32.94 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.758 0.313 . . . . 73.109999999999999 111.361 -178.651 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 32.0 p -106.59 -12.95 15.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.508 -0.314 . . . . 75.540000000000006 111.727 179.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -85.95 -175.18 49.95 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 121.055 -0.593 . . . . 51.229999999999997 112.809 -175.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 64.1 mtt -118.91 149.28 41.84 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.674 0.273 . . . . 75.219999999999999 110.27 -178.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 7.7 tt -87.91 130.17 35.0 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-O 121.212 0.53 . . . . 75.239999999999995 111.08 -175.494 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 621' ' ' THR . 18.9 t70 -117.59 121.76 41.8 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.041 -0.981 . . . . 72.439999999999998 109.172 175.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.4 133.48 49.22 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.743 -1.206 . . . . 75.329999999999998 107.743 174.351 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -85.75 -26.39 35.26 Favored Glycine 0 C--N 1.294 -1.804 0 C-N-CA 120.784 -0.722 . . . . 65.239999999999995 112.548 -176.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.42 139.76 37.18 Favored 'General case' 0 N--CA 1.42 -1.973 0 C-N-CA 120.847 -0.341 . . . . 75.209999999999994 110.905 -178.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -116.11 124.45 50.4 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 105.046 -2.205 . . . . 61.310000000000002 105.046 171.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 58.6 t -115.29 117.44 55.62 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 N-CA-C 108.659 -0.867 . . . . 74.409999999999997 108.659 -177.05 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -73.69 106.65 5.53 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.617 0.722 . . . . 71.140000000000001 109.838 -179.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -123.51 -58.37 1.61 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.976 -1.011 . . . . 75.349999999999994 108.899 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 131.8 148.23 6.1 Favored Glycine 0 N--CA 1.431 -1.648 0 N-CA-C 110.717 -0.953 . . . . 72.540000000000006 110.717 178.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.99 -33.95 88.62 Favored Glycine 0 C--N 1.314 -0.676 0 N-CA-C 112.468 -0.253 . . . . 73.310000000000002 112.468 -178.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 23.4 t -75.14 -23.51 57.85 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.199 1.0 . . . . 72.420000000000002 108.661 -179.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -87.81 -3.02 58.97 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.713 -1.13 . . . . 64.140000000000001 110.236 -178.178 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 47.4 m80 69.73 95.44 0.07 Allowed 'General case' 0 C--O 1.247 0.925 0 C-N-CA 124.987 1.315 . . . . 71.340000000000003 112.977 175.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -83.93 80.22 9.23 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 109.044 -0.724 . . . . 70.400000000000006 109.044 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -98.48 159.8 14.71 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.535 -0.757 . . . . 62.520000000000003 109.964 -179.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 59.6 t -70.84 130.2 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 107.331 -1.359 . . . . 74.420000000000002 107.331 176.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 31.5 m -108.84 -29.8 2.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 123.574 0.546 . . . . 73.540000000000006 111.516 -176.207 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -155.91 139.27 15.75 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 120.74 0.305 . . . . 74.030000000000001 110.252 -179.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -121.19 128.38 52.4 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.516 -0.766 . . . . 62.509999999999998 109.19 173.609 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -56.6 -51.1 83.81 Favored Pre-proline 0 N--CA 1.475 0.816 0 O-C-N 123.846 0.716 . . . . 71.140000000000001 110.799 178.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -77.07 111.81 3.29 Favored 'Trans proline' 0 C--N 1.371 1.756 0 N-CA-C 108.495 -1.387 . . . . 61.340000000000003 108.495 168.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.93 155.19 62.51 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.78 2.32 . . . . 75.140000000000001 113.491 -177.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.58 130.76 44.02 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.378 -0.828 . . . . 61.549999999999997 109.876 177.335 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.18 -5.88 59.42 Favored Glycine 0 C--N 1.305 -1.159 0 N-CA-C 111.245 -0.742 . . . . 64.129999999999995 111.245 -177.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 28.8 m -101.66 156.11 17.69 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.889 -0.782 . . . . 73.140000000000001 108.889 -179.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -80.28 135.07 14.28 Favored Glycine 0 N--CA 1.422 -2.274 0 CA-C-N 116.363 -0.381 . . . . 71.25 112.431 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.3 m -120.74 142.98 34.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 107.777 -1.194 . . . . 75.349999999999994 107.777 175.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.407 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 29.4 p-10 -48.97 163.47 0.08 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.766 0.826 . . . . 71.519999999999996 112.144 -179.098 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -58.67 -27.7 65.03 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.43 0.53 . . . . 71.420000000000002 112.43 -175.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -81.15 -7.18 59.51 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 119.931 -0.708 . . . . 74.519999999999996 111.138 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.35 19.66 68.76 Favored Glycine 0 CA--C 1.492 -1.374 0 CA-C-O 119.831 -0.427 . . . . 74.030000000000001 113.445 169.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.88 119.27 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-O 121.834 0.826 . . . . 74.430000000000007 109.69 -168.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 39.4 pt -118.84 133.84 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 CA-C-N 114.857 -1.065 . . . . 74.340000000000003 112.258 -176.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 8.8 t -110.84 118.24 35.58 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 107.327 -1.36 . . . . 64.200000000000003 107.327 174.702 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.54 168.95 18.68 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.578 -0.737 . . . . 75.129999999999995 111.476 -173.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -125.95 135.76 52.23 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-O 122.53 1.157 . . . . 74.219999999999999 110.026 175.482 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -142.9 169.63 17.2 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 105.114 -2.18 . . . . 74.219999999999999 105.114 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -52.33 -128.08 0.0 OUTLIER Glycine 0 CA--C 1.559 2.802 0 N-CA-C 115.878 1.111 . . . . 71.099999999999994 115.878 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 . . . . . 0 C--N 1.277 -2.554 0 O-C-N 120.805 -1.409 . . . . 64.120000000000005 110.561 -176.292 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.607 0 CA-C-O 121.461 0.648 . . . . 65.109999999999999 111.114 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 44.9 p -136.02 147.01 47.76 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.244 -0.889 . . . . 64.209999999999994 108.987 178.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -135.77 145.84 46.98 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.151 0.5 . . . . 75.439999999999998 110.272 176.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.0 m-20 -79.87 126.83 31.5 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.077 -0.965 . . . . 74.450000000000003 108.992 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.5 pt -91.93 131.12 36.17 Favored Pre-proline 0 C--N 1.306 -1.313 0 C-N-CA 120.455 -0.498 . . . . 74.349999999999994 110.746 178.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -83.39 177.06 6.72 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.371 2.047 . . . . 72.310000000000002 111.626 177.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -88.44 122.71 32.23 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.289 0.566 . . . . 74.439999999999998 109.942 178.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.27 8.28 6.36 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-N 115.234 -0.893 . . . . 74.319999999999993 110.803 -179.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -78.13 99.86 6.35 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 116.024 -0.535 . . . . 74.299999999999997 110.953 -177.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 157.55 -37.67 0.55 Allowed Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.667 -0.778 . . . . 65.530000000000001 111.945 178.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -89.46 -172.04 3.45 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 122.534 -0.392 . . . . 74.430000000000007 109.983 -178.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 3.6 m -71.2 155.53 40.63 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.618 -0.882 . . . . 72.230000000000004 108.618 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.49 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.7 p -62.65 -43.56 98.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 O-C-N 123.109 0.256 . . . . 74.230000000000004 111.584 -178.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.17 -37.89 88.78 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.061 -0.256 . . . . 74.430000000000007 110.526 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 66.0 t -67.59 -45.92 84.06 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.375 0 N-CA-C 109.272 -0.64 . . . . 75.129999999999995 109.272 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.88 92.16 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.553 0.216 . . . . 74.319999999999993 111.43 179.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.2 mt-30 -63.84 -45.88 87.53 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.098 -0.501 . . . . 74.109999999999999 111.028 -178.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.539 ' O ' HG21 ' A' ' 514' ' ' VAL . 13.7 ptmm? -67.54 -37.97 83.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.335 -0.393 . . . . 73.420000000000002 111.086 179.325 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -61.18 -48.86 79.61 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 116.059 -0.519 . . . . 73.340000000000003 110.631 -179.566 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.4 pp -68.17 -35.47 78.09 Favored 'General case' 0 C--O 1.209 -1.046 0 CA-C-N 115.945 -0.57 . . . . 73.099999999999994 110.619 -178.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -59.95 -35.73 75.57 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 123.951 0.9 . . . . 72.450000000000003 110.751 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.539 HG21 ' O ' ' A' ' 510' ' ' LYS . 98.8 t -58.28 -35.03 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 122.763 0.425 . . . . 74.349999999999994 111.862 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -112.28 -1.38 15.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.567 0.699 . . . . 75.239999999999995 109.959 -177.612 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -113.37 -60.2 0.41 Allowed Glycine 0 N--CA 1.421 -2.35 0 CA-C-N 115.321 -0.854 . . . . 71.140000000000001 113.033 -171.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 63.0 27.09 15.79 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.519 1.152 . . . . 75.239999999999995 109.293 -174.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.3 p -85.43 -170.03 2.93 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 113.914 -1.494 . . . . 75.140000000000001 109.722 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -107.95 139.41 42.61 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.466 -1.309 . . . . 73.409999999999997 107.466 174.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -130.7 149.49 52.32 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.149 0.5 . . . . 72.040000000000006 111.224 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.7 p -140.8 157.67 45.07 Favored 'General case' 0 N--CA 1.405 -2.693 0 N-CA-C 107.142 -1.429 . . . . 71.430000000000007 107.142 178.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -125.57 141.17 52.17 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 120.711 -0.396 . . . . 71.430000000000007 110.094 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -131.63 143.16 50.11 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.249 -1.389 . . . . 62.420000000000002 107.249 178.173 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.9 m -105.47 139.64 39.79 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.071 -0.651 . . . . 73.400000000000006 111.839 -175.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.47 149.54 33.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 109.218 -0.66 . . . . 71.219999999999999 109.218 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.407 ' C ' ' HG ' ' A' ' 527' ' ' SER . 10.1 t70 -68.28 134.79 50.92 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.445 -0.576 . . . . 71.549999999999997 109.445 177.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' A' ' 556' ' ' SER . 74.1 m -160.22 166.59 15.47 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 109.885 -0.413 . . . . 54.509999999999998 109.885 179.534 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -78.1 -6.91 16.08 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.976 1.784 . . . . 53.210000000000001 113.03 175.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.451 ' HG2' ' OE2' ' A' ' 533' ' ' GLU . 3.3 mpt_? -88.52 149.32 44.09 Favored Pre-proline 0 CA--C 1.516 -0.352 0 N-CA-C 109.769 -0.456 . . . . 75.310000000000002 109.769 -179.351 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.47 147.01 86.55 Favored 'Trans proline' 0 C--O 1.258 1.488 0 C-N-CA 122.668 2.245 . . . . 73.310000000000002 112.792 -178.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.91 106.9 0.63 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.054 -0.975 . . . . 74.209999999999994 110.759 -179.282 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 152.1 -31.58 0.88 Allowed Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 110.193 -1.163 . . . . 73.299999999999997 110.193 -178.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . 0.451 ' OE2' ' HG2' ' A' ' 529' ' ' ARG . 34.1 tt0 -76.98 139.1 40.0 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.154 0.502 . . . . 73.420000000000002 109.977 178.148 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.25 118.44 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.462 0 N-CA-C 108.132 -1.062 . . . . 70.209999999999994 108.132 174.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.4 p -79.51 -11.33 59.9 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.43 -0.804 . . . . 73.530000000000001 112.56 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.87 -168.17 29.36 Favored Glycine 0 CA--C 1.481 -2.087 0 C-N-CA 120.119 -1.039 . . . . 73.140000000000001 112.404 175.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 12.6 p -116.68 158.18 24.21 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 107.469 -1.308 . . . . 75.200000000000003 107.469 179.188 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -63.21 -49.44 80.07 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 118.505 -1.278 . . . . 73.140000000000001 111.995 176.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -70.24 149.25 63.57 Favored 'Trans proline' 0 C--N 1.369 1.647 0 CA-C-N 120.486 1.209 . . . . 74.340000000000003 110.447 173.103 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.5 144.85 51.24 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.706 2.271 . . . . 74.340000000000003 113.167 -178.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -68.41 129.73 40.79 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.428 -0.582 . . . . 73.409999999999997 109.428 176.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.35 -10.82 50.8 Favored Glycine 0 C--N 1.309 -0.938 0 N-CA-C 110.94 -0.864 . . . . 71.400000000000006 110.94 -176.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 92.3 m -88.09 137.11 32.62 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 109.985 -0.376 . . . . 65.340000000000003 109.985 178.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.1 t -86.36 132.28 34.0 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.688 -0.856 . . . . 71.219999999999999 108.688 175.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.89 155.98 74.7 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 108.289 -1.004 . . . . 74.519999999999996 108.289 -179.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -58.48 137.11 78.57 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.551 1.501 . . . . 73.230000000000004 111.289 178.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.63 -23.85 34.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 123.701 0.801 . . . . 73.209999999999994 113.016 -174.088 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -97.38 -0.11 46.91 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 120.317 -0.553 . . . . 74.420000000000002 111.857 -177.2 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 89.4 p -78.08 170.94 15.77 Favored 'General case' 0 C--O 1.256 1.429 0 C-N-CA 119.63 -0.828 . . . . 74.200000000000003 110.96 -178.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.8 p -110.24 115.75 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-O 121.934 0.874 . . . . 75.25 109.839 -178.256 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 52.1 mt -85.55 130.82 35.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 114.94 -1.027 . . . . 74.010000000000005 108.579 -177.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.55 120.73 41.44 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.727 0.775 . . . . 73.420000000000002 111.182 178.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.1 mp -99.2 124.09 43.99 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 113.983 -1.462 . . . . 74.549999999999997 109.338 178.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 2.9 mp0 -88.28 117.73 27.39 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.436 -0.802 . . . . 71.230000000000004 111.04 -179.087 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 32.0 t -93.23 126.41 45.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.004 -0.998 . . . . 74.319999999999993 108.35 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 17.0 p -82.04 117.87 22.57 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 109.489 -0.56 . . . . 43.210000000000001 109.489 178.402 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -97.68 137.46 36.54 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 108.432 -0.951 . . . . 72.230000000000004 108.432 174.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -63.02 -22.3 64.64 Favored Glycine 0 CA--C 1.5 -0.894 0 O-C-N 124.174 0.921 . . . . 55.109999999999999 111.846 177.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 81.01 -5.92 1.65 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.684 1.593 . . . . 75.439999999999998 109.282 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 42.5 mt-30 -111.93 144.3 41.5 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 115.655 -0.702 . . . . 73.049999999999997 111.517 -172.117 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . 0.458 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 55.1 p90 -123.69 154.59 39.19 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.68 -1.146 . . . . 74.299999999999997 108.052 178.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.32 117.82 5.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.031 0.443 . . . . 75.040000000000006 110.492 177.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 50.8 ttp -81.56 130.91 59.75 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.953 -0.567 . . . . 63.399999999999999 111.889 -176.077 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -65.58 169.46 12.76 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.988 2.458 . . . . 75.129999999999995 111.068 172.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -87.14 143.13 27.44 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.215 0.531 . . . . 71.409999999999997 111.582 -177.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -133.03 25.21 4.26 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.155 -1.794 . . . . 73.310000000000002 106.155 176.131 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 4.4 m -75.61 148.69 38.59 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 113.13 -1.85 . . . . 73.239999999999995 111.909 -174.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 70.09 59.04 5.69 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.254 -0.885 . . . . 64.540000000000006 114.066 173.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 569' ' ' MET . . . . . 0.441 ' SD ' ' HG3' ' A' ' 577' ' ' ARG . 23.0 ptp -159.55 175.07 13.69 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-N 117.335 0.568 . . . . 74.230000000000004 111.079 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -97.79 176.13 5.92 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.102 -1.073 . . . . 75.129999999999995 108.102 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . 0.417 ' CZ3' HD22 ' A' ' 587' ' ' LEU . 23.1 t-105 -64.19 -33.91 76.87 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.723 -0.843 . . . . 74.439999999999998 108.723 173.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.72 -14.65 18.57 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 CA-C-N 115.762 -0.653 . . . . 74.129999999999995 111.765 -178.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.415 ' CB ' ' HB2' ' A' ' 569' ' ' MET . 14.5 m-20 -93.66 -41.14 9.87 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.172 -1.047 . . . . 62.039999999999999 108.172 174.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -52.67 -47.63 67.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.961 -1.018 . . . . 62.119999999999997 113.067 -177.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 578' ' ' LEU 0.255 32.0 mt-10 -60.18 -56.16 38.22 Favored Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 114.059 1.133 . . . . 72.319999999999993 114.059 179.416 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -58.72 -31.1 94.25 Favored 'Trans proline' 0 C--N 1.365 1.4 0 C-N-CA 121.392 1.395 . . . . 72.040000000000006 112.874 174.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.441 ' HG3' ' SD ' ' A' ' 569' ' ' MET . 2.8 mmp_? -66.2 -45.37 81.01 Favored 'General case' 0 C--O 1.209 -1.07 0 C-N-CA 121.314 -0.154 . . . . 71.340000000000003 110.626 176.116 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.3 pp -66.12 -39.75 90.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.263 0.468 . . . . 73.010000000000005 112.263 -174.192 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.406 ' N ' HD12 ' A' ' 578' ' ' LEU . 15.2 ptm180 -66.33 -39.6 89.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.388 -0.369 . . . . 72.549999999999997 111.072 176.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.24 -34.56 73.0 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 121.055 0.455 . . . . 71.409999999999997 110.876 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 28.6 tp -81.22 -9.15 59.83 Favored 'General case' 0 N--CA 1.42 -1.929 0 C-N-CA 123.939 0.895 . . . . 71.230000000000004 110.808 -179.261 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 65.62 36.53 92.54 Favored Glycine 0 C--N 1.315 -0.601 0 CA-C-N 116.199 -0.455 . . . . 75.349999999999994 112.079 178.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -78.38 127.13 31.76 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 107.825 -1.176 . . . . 72.109999999999999 107.825 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 10.2 m -94.37 -20.03 20.11 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.979 0.418 . . . . 70.530000000000001 111.671 -176.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -83.4 175.59 52.51 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 121.094 -0.574 . . . . 71.530000000000001 113.397 -178.029 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 586' ' ' MET . . . . . 0.434 ' HA ' ' HE3' ' A' ' 586' ' ' MET . 10.4 mmt -101.31 155.27 18.14 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.396 -0.594 . . . . 72.230000000000004 109.396 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . 0.417 HD22 ' CZ3' ' A' ' 571' ' ' TRP . 6.1 tt -89.88 118.2 29.27 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.904 -0.589 . . . . 74.530000000000001 109.761 -176.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 621' ' ' THR . 26.4 t70 -95.91 117.47 30.67 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 109.017 -0.735 . . . . 73.400000000000006 109.017 178.043 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.31 135.47 52.95 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.693 -0.685 . . . . 75.340000000000003 110.572 -178.716 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -70.21 -87.65 0.11 Allowed Glycine 0 C--N 1.296 -1.67 0 CA-C-N 115.313 -0.858 . . . . 74.299999999999997 111.076 -179.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.29 154.16 47.88 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 122.728 -0.278 . . . . 73.5 110.371 177.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.9 128.24 35.97 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 107.76 -1.2 . . . . 73.049999999999997 107.76 176.146 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 81.7 t -104.01 135.91 39.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 109.688 -0.486 . . . . 72.150000000000006 109.688 -179.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.95 107.32 11.62 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 122.062 0.934 . . . . 60.049999999999997 111.327 -177.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -119.35 -44.97 2.55 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.757 -1.111 . . . . 72.340000000000003 109.317 177.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 103.84 143.35 12.51 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.076 -1.059 . . . . 73.239999999999995 111.718 179.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.37 -37.4 87.54 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 114.228 0.451 . . . . 63.219999999999999 114.228 -177.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 23.0 t -77.35 -23.62 50.84 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.43 0.633 . . . . 71.400000000000006 109.573 -176.264 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -91.08 -5.01 55.8 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.412 -0.813 . . . . 72.019999999999996 109.84 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 32.9 m170 66.31 97.13 0.05 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.406 1.082 . . . . 74.319999999999993 112.474 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . 0.56 ' HB3' ' C ' ' A' ' 625' ' ' GLY . 62.2 m-80 -70.93 85.3 0.69 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.902 -1.045 . . . . 72.340000000000003 111.973 -177.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -110.33 172.52 6.82 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.9 -0.591 . . . . 72.420000000000002 111.253 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 13.0 p -57.53 134.98 21.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 CA-C-N 116.064 -0.516 . . . . 73.310000000000002 110.37 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 29.6 m -108.6 -34.72 2.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 116.235 -0.439 . . . . 64.019999999999996 111.137 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -156.22 142.11 18.01 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.449 -0.341 . . . . 75.319999999999993 110.203 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -129.03 134.67 48.22 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.162 -1.792 . . . . 64.209999999999994 106.162 173.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.512 ' O ' ' HD3' ' A' ' 609' ' ' PRO . 4.4 t-20 -67.21 -49.48 44.36 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 119.623 -0.831 . . . . 72.25 111.786 -176.202 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.428 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.7 Cg_endo -90.62 105.05 0.3 Allowed 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 121.567 1.511 . . . . 74.519999999999996 109.522 170.331 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 607' ' ' ASN . 19.0 Cg_exo -68.67 160.75 48.19 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 122.682 2.255 . . . . 73.340000000000003 111.448 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -57.67 130.03 44.57 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.257 -0.429 . . . . 75.109999999999999 110.35 178.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.3 -9.83 46.19 Favored Glycine 0 C--N 1.31 -0.869 0 C-N-CA 120.542 -0.837 . . . . 65.540000000000006 111.882 -176.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 34.4 m -87.3 151.28 23.26 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.824 -0.806 . . . . 73.439999999999998 108.824 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -75.96 131.9 12.35 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 120.702 -0.761 . . . . 73.219999999999999 111.855 177.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 29.4 m -125.63 143.4 39.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.134 -1.061 . . . . 73.200000000000003 108.134 176.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -54.25 176.29 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.729 0.812 . . . . 64.519999999999996 113.152 -177.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -55.58 -27.61 50.28 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.883 0.873 . . . . 73.109999999999999 112.761 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.454 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 1.0 OUTLIER -85.79 -6.55 59.09 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 120.897 -0.321 . . . . 74.030000000000001 111.083 178.119 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.77 20.52 72.36 Favored Glycine 0 CA--C 1.496 -1.116 0 C-N-CA 121.511 -0.376 . . . . 73.140000000000001 112.507 173.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.52 119.75 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 CA-C-O 122.595 1.188 . . . . 74.219999999999999 111.194 -168.685 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.64 132.38 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 CA-C-N 113.926 -1.488 . . . . 74.510000000000005 108.651 -177.801 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 10.1 t -106.37 124.25 49.3 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-N 115.48 -0.782 . . . . 75.219999999999999 109.551 -178.347 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -138.69 166.25 24.86 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.754 -0.657 . . . . 74.0 111.501 -176.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -128.89 137.52 51.49 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.127 -1.064 . . . . 74.310000000000002 108.127 175.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -139.74 165.44 27.27 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 116.367 -0.379 . . . . 74.25 111.032 -171.115 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . 0.56 ' C ' ' HB3' ' A' ' 601' ' ' ASN . . . -66.52 139.54 37.47 Favored Glycine 0 N--CA 1.427 -1.937 0 O-C-N 124.088 0.867 . . . . 53.130000000000003 111.524 175.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 . . . . . 0 C--N 1.306 -1.32 0 C-N-CA 126.306 1.843 . . . . 74.420000000000002 114.676 -177.138 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.547 0 CA-C-O 121.897 0.856 . . . . 73.400000000000006 109.852 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 25.4 p -129.71 158.41 39.45 Favored 'General case' 0 N--CA 1.409 -2.525 0 N-CA-C 107.257 -1.386 . . . . 75.140000000000001 107.257 -179.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -149.03 142.47 25.27 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 108.211 -1.033 . . . . 73.040000000000006 108.211 179.368 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.04 134.65 35.37 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.278 0.561 . . . . 70.140000000000001 110.638 179.195 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 39.5 pt -85.03 137.96 37.29 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 114.972 -1.013 . . . . 74.129999999999995 111.953 -177.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.99 166.14 29.84 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.741 2.294 . . . . 72.409999999999997 113.776 178.426 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -88.21 44.76 1.22 Allowed 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 125.158 1.383 . . . . 75.439999999999998 111.223 -177.427 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 17.2 m -72.05 14.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 114.516 1.302 . . . . 74.439999999999998 114.516 -175.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -79.66 101.63 8.48 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.351 -0.611 . . . . 75.409999999999997 109.351 178.2 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 150.79 -31.09 1.01 Allowed Glycine 0 C--N 1.297 -1.602 0 N-CA-C 110.951 -0.86 . . . . 71.099999999999994 110.951 -179.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -81.61 -177.26 6.46 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 109.103 -0.703 . . . . 74.299999999999997 109.103 177.537 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 2.4 m -71.5 155.94 40.01 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 107.451 -1.314 . . . . 73.310000000000002 107.451 176.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.421 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.5 p -63.27 -42.0 94.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 117.737 0.244 . . . . 71.239999999999995 110.999 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 23.4 t70 -59.77 -43.77 94.19 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.258 0.551 . . . . 74.340000000000003 110.045 178.482 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 95.8 t -67.74 -44.81 85.52 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.126 0 CA-C-N 114.868 -1.06 . . . . 73.510000000000005 109.871 -178.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.35 -45.19 94.33 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 123.104 0.253 . . . . 61.25 111.458 179.092 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 27.2 mt-30 -62.27 -46.79 87.22 Favored 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 123.404 0.44 . . . . 73.099999999999994 110.996 -179.25 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.492 ' O ' HG23 ' A' ' 514' ' ' VAL 0.321 20.4 pttp -68.79 -37.55 79.35 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 112.375 0.509 . . . . 71.129999999999995 112.375 178.359 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -61.03 -49.5 77.17 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 120.771 0.319 . . . . 71.109999999999999 110.501 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . 0.407 HD11 ' N ' ' A' ' 513' ' ' ASN . 4.2 pp -65.85 -35.75 81.55 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-N 116.071 -0.513 . . . . 75.230000000000004 110.962 -178.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.407 ' N ' HD11 ' A' ' 512' ' ' LEU . 1.7 t-20 -62.9 -36.17 82.49 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 123.085 0.554 . . . . 75.230000000000004 110.669 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 510' ' ' LYS . 93.9 t -63.08 -34.27 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 121.261 0.553 . . . . 73.340000000000003 110.829 177.516 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -106.58 12.2 29.7 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.221 0.534 . . . . 73.400000000000006 110.371 -176.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -141.45 -54.05 0.04 OUTLIER Glycine 0 CA--C 1.488 -1.596 0 C-N-CA 119.935 -1.126 . . . . 70.140000000000001 114.023 -172.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 66.66 20.49 10.73 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.811 0.815 . . . . 74.530000000000001 110.032 -173.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.2 p -76.12 -178.48 4.47 Favored 'General case' 0 N--CA 1.415 -2.219 0 C-N-CA 125.449 1.499 . . . . 75.430000000000007 109.371 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -107.62 142.98 36.71 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 108.168 -1.049 . . . . 75.109999999999999 108.168 175.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -126.54 147.46 49.86 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.301 0.572 . . . . 73.340000000000003 111.977 -176.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 13.6 p -133.75 146.65 50.95 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 114.537 -1.211 . . . . 74.319999999999993 107.763 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -121.67 136.5 54.94 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 120.96 0.409 . . . . 74.439999999999998 111.245 -177.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -122.54 122.09 38.06 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.838 -0.801 . . . . 73.349999999999994 108.838 178.018 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.1 m -87.48 134.79 33.55 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.834 0.35 . . . . 71.0 110.891 -177.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 556' ' ' SER . 47.6 t -136.55 150.14 27.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 106.086 -1.82 . . . . 72.150000000000006 106.086 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -99.21 135.82 40.06 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.655 -0.869 . . . . 71.099999999999994 108.655 175.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 66.7 m -162.58 171.4 6.52 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 107.289 -1.374 . . . . 73.450000000000003 107.289 -176.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.92 -15.05 44.98 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 121.935 1.757 . . . . 74.239999999999995 113.104 177.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.43 135.65 94.79 Favored Pre-proline 0 C--O 1.224 -0.268 0 N-CA-C 108.472 -0.936 . . . . 75.530000000000001 108.472 176.207 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.8 149.84 86.44 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.575 2.183 . . . . 74.239999999999995 113.392 -175.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 557' ' ' LYS . . . -59.77 106.89 0.53 Allowed 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 115.146 -0.934 . . . . 44.200000000000003 111.679 -178.657 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 124.09 -14.4 7.9 Favored Glycine 0 N--CA 1.424 -2.161 0 CA-C-N 115.129 -0.941 . . . . 63.140000000000001 111.578 179.151 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -82.45 130.75 35.17 Favored 'General case' 0 C--O 1.258 1.541 0 N-CA-C 108.873 -0.788 . . . . 75.129999999999995 108.873 179.485 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 7.0 p -81.67 117.87 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.833 0 N-CA-C 107.509 -1.293 . . . . 65.340000000000003 107.509 176.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.3 m -72.79 -27.13 61.81 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 113.533 -1.667 . . . . 74.239999999999995 109.311 -175.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 153.15 -166.46 31.56 Favored Glycine 0 N--CA 1.412 -2.929 0 N-CA-C 110.086 -1.206 . . . . 61.229999999999997 110.086 177.097 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.0 p -116.2 157.85 24.22 Favored 'General case' 0 C--N 1.267 -3.002 0 N-CA-C 106.88 -1.526 . . . . 75.329999999999998 106.88 178.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -62.68 -51.11 74.58 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 118.469 -1.292 . . . . 73.319999999999993 111.439 177.229 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -73.07 147.13 42.47 Favored 'Trans proline' 0 C--N 1.369 1.606 0 CA-C-N 120.191 1.104 . . . . 73.040000000000006 110.173 173.332 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.55 145.1 75.36 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.497 2.131 . . . . 74.019999999999996 111.679 -179.207 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.11 142.0 57.83 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 110.128 -0.323 . . . . 73.430000000000007 110.128 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.19 -21.86 43.83 Favored Glycine 0 C--N 1.313 -0.701 0 N-CA-C 111.635 -0.586 . . . . 73.140000000000001 111.635 -177.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 47.1 m -71.53 137.3 47.99 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 122.872 0.469 . . . . 74.299999999999997 111.354 -177.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 12.4 t -84.44 126.29 33.12 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 109.254 -0.647 . . . . 73.150000000000006 109.254 176.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.63 157.96 73.51 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 106.973 -1.491 . . . . 73.319999999999993 106.973 177.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -59.43 135.31 64.15 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 CA-C-N 120.639 1.264 . . . . 74.349999999999994 111.81 -179.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.84 -19.89 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-N 114.95 -1.023 . . . . 74.340000000000003 112.835 -174.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -92.4 -17.55 24.46 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.796 -0.638 . . . . 74.310000000000002 112.038 -178.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 99.0 p -78.4 179.41 7.01 Favored 'General case' 0 C--O 1.253 1.288 0 N-CA-C 112.506 0.558 . . . . 70.230000000000004 112.506 -174.067 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.3 p -109.85 128.42 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.809 0 CA-C-O 121.513 0.673 . . . . 75.340000000000003 110.41 -178.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 47.8 mt -98.0 138.86 21.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.286 -1.005 . . . . 71.319999999999993 108.286 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.6 120.29 40.6 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.717 0.77 . . . . 73.450000000000003 112.224 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.7 mp -102.18 122.13 43.57 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 113.853 -1.521 . . . . 71.409999999999997 108.644 178.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -85.87 122.68 30.27 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 115.433 -0.803 . . . . 73.109999999999999 108.996 179.14 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.13 125.33 68.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.514 -0.921 . . . . 71.430000000000007 108.514 -176.203 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 525' ' ' VAL . 67.9 m -97.29 147.63 23.95 Favored 'General case' 0 C--N 1.285 -2.237 0 C-N-CA 119.515 -0.874 . . . . 54.539999999999999 111.973 179.026 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.4 ptpt -111.57 141.39 45.21 Favored 'General case' 0 N--CA 1.404 -2.74 0 N-CA-C 105.323 -2.103 . . . . 74.420000000000002 105.323 169.243 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -54.71 -22.09 24.45 Favored Glycine 0 C--O 1.242 0.633 0 O-C-N 124.441 1.088 . . . . 72.530000000000001 114.52 -174.488 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 88.14 -22.35 0.14 Allowed 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 126.576 1.95 . . . . 51.399999999999999 107.594 -176.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.476 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 77.6 mt-30 -112.99 146.92 38.21 Favored 'General case' 0 N--CA 1.405 -2.676 0 CA-C-N 114.468 -1.242 . . . . 72.010000000000005 111.298 -175.677 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -124.65 153.32 42.45 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 107.282 -1.377 . . . . 75.540000000000006 107.282 176.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.99 121.61 22.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 109.556 -0.535 . . . . 75.120000000000005 109.556 -179.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 54.3 ttp -79.53 130.1 69.33 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 116.292 -0.413 . . . . 73.400000000000006 110.318 -177.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.69 168.97 9.23 Favored 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.782 2.321 . . . . 73.420000000000002 110.881 174.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.2 129.9 34.79 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.739 0.78 . . . . 71.420000000000002 110.42 -179.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . 0.483 ' O ' ' HG2' ' A' ' 569' ' ' MET . 3.1 pp -126.74 10.33 7.12 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.148 -1.387 . . . . 75.299999999999997 108.677 176.086 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 567' ' ' SER . . . . . 0.433 ' HB3' ' OE1' ' A' ' 606' ' ' GLN . 1.6 p -79.06 131.71 36.36 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 114.548 -1.206 . . . . 72.25 110.959 -179.332 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 87.85 37.03 8.1 Favored Glycine 0 N--CA 1.428 -1.888 0 C-N-CA 120.809 -0.71 . . . . 74.540000000000006 113.178 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 569' ' ' MET . . . . . 0.483 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 22.4 ptp -142.73 174.72 10.39 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 117.654 0.727 . . . . 72.430000000000007 109.422 177.424 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -99.45 177.8 5.07 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.037 -0.727 . . . . 73.430000000000007 109.037 -177.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -72.59 -26.01 61.54 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.671 -0.863 . . . . 75.530000000000001 108.671 -178.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.2 p -71.57 -14.84 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-N 115.3 -0.863 . . . . 73.519999999999996 109.75 178.151 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 10.9 m-20 -94.33 -39.14 10.64 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.103 -0.703 . . . . 72.140000000000001 109.103 175.547 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -55.83 -46.48 78.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.653 -0.703 . . . . 73.340000000000003 112.429 -178.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.516 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 11.9 mm-40 -54.0 -58.08 15.06 Favored Pre-proline 0 CA--C 1.573 1.864 0 N-CA-C 112.757 0.651 . . . . 71.049999999999997 112.757 -179.552 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -61.54 -36.0 78.87 Favored 'Trans proline' 0 C--N 1.369 1.648 0 CA-C-N 120.727 1.295 . . . . 75.219999999999999 113.066 175.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.497 ' HA ' ' NE ' ' A' ' 577' ' ' ARG . 9.0 mmp_? -63.4 -39.63 95.03 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.762 -0.375 . . . . 73.129999999999995 111.058 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.517 HD11 ' N ' ' A' ' 579' ' ' ARG . 4.3 pp -65.92 -47.31 75.16 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 112.664 0.616 . . . . 74.349999999999994 112.664 -176.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.517 ' N ' HD11 ' A' ' 578' ' ' LEU . 5.8 ptp180 -66.44 -35.14 79.54 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 111.711 0.263 . . . . 75.439999999999998 111.711 177.636 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -71.12 -38.92 72.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.313 0.486 . . . . 71.0 112.313 -178.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 1.3 pp -82.38 -8.98 59.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.463 0.649 . . . . 73.140000000000001 110.219 -178.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 82.91 35.96 17.07 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.607 -0.724 . . . . 60.409999999999997 112.261 177.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -87.35 127.49 35.2 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 108.506 -0.924 . . . . 75.200000000000003 108.506 177.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 24.4 p -106.1 -10.33 16.56 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.39 0.885 . . . . 73.239999999999995 113.39 -176.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -84.36 -170.37 46.75 Favored Glycine 0 C--N 1.323 -0.182 0 C-N-CA 120.754 -0.736 . . . . 60.439999999999998 113.909 -177.34 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 69.6 mtm -102.8 145.42 29.79 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 123.003 0.521 . . . . 73.530000000000001 111.679 -175.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 28.2 tp -94.76 125.67 39.57 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.555 -0.906 . . . . 75.409999999999997 108.555 177.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 621' ' ' THR . 23.5 t70 -113.63 121.18 43.39 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.85 -0.613 . . . . 74.129999999999995 109.804 -177.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.78 133.82 45.92 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.86 -1.136 . . . . 75.230000000000004 110.134 175.655 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -79.25 -65.59 1.78 Allowed Glycine 0 N--CA 1.428 -1.883 0 C-N-CA 120.65 -0.786 . . . . 64.540000000000006 111.68 179.33 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.24 140.99 35.91 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 120.762 0.315 . . . . 70.420000000000002 110.742 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 624' ' ' PHE . 9.5 p-10 -110.49 124.76 52.4 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 105.339 -2.097 . . . . 62.329999999999998 105.339 170.201 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 73.8 t -104.59 137.6 32.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 120.909 -0.316 . . . . 72.25 110.75 -173.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.73 108.04 4.85 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 109.153 -0.684 . . . . 65.25 109.153 -174.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -127.07 -36.13 2.19 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 120.791 0.329 . . . . 73.219999999999999 110.895 -179.642 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 104.83 146.75 15.46 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 119.823 -1.179 . . . . 64.140000000000001 112.324 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.34 -32.2 60.33 Favored Glycine 0 C--N 1.314 -0.659 0 C-N-CA 123.909 0.766 . . . . 73.209999999999994 114.147 -178.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.3 t -59.46 -23.27 62.58 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.276 1.43 . . . . 74.239999999999995 110.99 -176.212 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -86.42 -9.63 55.91 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.472 -0.785 . . . . 74.120000000000005 111.713 -173.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 55.14 70.87 0.58 Allowed 'General case' 0 C--O 1.245 0.839 0 CA-C-O 122.371 1.081 . . . . 73.349999999999994 109.104 -174.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -77.97 89.83 4.15 Favored 'General case' 0 CA--C 1.481 -1.687 0 CA-C-N 113.699 -1.591 . . . . 75.540000000000006 113.675 -171.159 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -84.86 172.1 11.68 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 113.844 -1.526 . . . . 70.450000000000003 107.413 176.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.09 131.66 26.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 107.436 -1.32 . . . . 74.25 107.436 171.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 30.4 m -107.76 -27.12 3.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 112.53 0.566 . . . . 75.450000000000003 112.53 -174.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -147.48 141.37 25.83 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 109.194 -0.669 . . . . 72.230000000000004 109.194 -178.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . 0.433 ' OE1' ' HB3' ' A' ' 567' ' ' SER . 18.0 pt20 -140.42 146.19 38.0 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.547 -0.908 . . . . 65.430000000000007 108.547 177.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.491 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 22.0 t-20 -61.38 -61.52 7.73 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 112.648 0.61 . . . . 75.329999999999998 112.648 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.4 Cg_endo -91.87 120.55 0.56 Allowed 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 122.027 1.818 . . . . 71.239999999999995 109.458 175.189 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.33 160.6 46.92 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 122.348 2.032 . . . . 71.430000000000007 112.278 178.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -59.99 127.38 31.6 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.03 -0.532 . . . . 74.25 109.87 178.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 101.05 -1.34 54.93 Favored Glycine 0 C--N 1.309 -0.93 0 C-N-CA 120.039 -1.076 . . . . 55.439999999999998 112.084 -178.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 54.6 m -95.39 146.76 24.15 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.903 -0.406 . . . . 72.420000000000002 109.903 178.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -74.47 123.8 7.85 Favored Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 115.912 -0.586 . . . . 72.150000000000006 112.175 177.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 19.1 m -107.08 142.53 19.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.949 -0.76 . . . . 71.310000000000002 108.949 176.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.476 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.7 p-10 -51.85 174.82 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.756 1.222 . . . . 75.109999999999999 113.353 -177.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -54.04 -32.25 53.92 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.7 0.63 . . . . 75.409999999999997 112.7 -179.238 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.456 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 37.4 t70 -85.75 -7.52 58.72 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 120.991 0.424 . . . . 74.340000000000003 109.994 -177.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.12 19.73 70.37 Favored Glycine 0 CA--C 1.499 -0.965 0 CA-C-N 116.077 -0.51 . . . . 72.530000000000001 112.558 174.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.05 120.94 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-O 122.68 1.229 . . . . 74.099999999999994 111.511 -166.26 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.409 HG12 ' HD2' ' A' ' 608' ' ' PRO . 0.0 OUTLIER -128.83 132.17 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 0 CA-C-N 113.605 -1.634 . . . . 74.209999999999994 108.725 -179.015 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 6.6 t -113.03 137.42 51.45 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.334 -0.987 . . . . 51.109999999999999 108.334 178.493 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.4 pp -138.6 165.72 26.19 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 113.66 0.985 . . . . 74.340000000000003 113.66 -173.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -128.9 137.41 51.41 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.555 -1.276 . . . . 75.25 107.555 176.534 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 592' ' ' ASP . 50.2 p90 -141.3 165.64 26.95 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 120.797 0.332 . . . . 73.439999999999998 110.812 -175.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -88.05 146.78 19.93 Favored Glycine 0 N--CA 1.423 -2.215 0 C-N-CA 120.329 -0.939 . . . . 72.129999999999995 111.363 177.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 C--N 1.281 -2.373 0 N-CA-C 107.214 -1.402 . . . . 74.099999999999994 107.214 177.976 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 122.125 0.964 . . . . 55.210000000000001 108.854 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 13.8 p -135.74 140.53 44.44 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-N 114.556 -1.202 . . . . 73.400000000000006 107.825 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -130.12 142.49 50.59 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 120.946 0.403 . . . . 74.230000000000004 111.331 -179.395 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.5 p-10 -78.96 124.2 28.02 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.949 -1.023 . . . . 71.109999999999999 109.184 176.229 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.7 pt -77.97 133.38 65.55 Favored Pre-proline 0 C--N 1.302 -1.49 0 CA-C-N 115.78 -0.645 . . . . 74.209999999999994 111.532 -177.062 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.89 -174.85 2.4 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.349 2.033 . . . . 72.209999999999994 111.26 174.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -98.67 122.96 42.56 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.098 0.475 . . . . 73.200000000000003 110.034 179.137 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 508' ' ' ALA . 17.0 m -124.86 49.73 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-O 122.245 1.022 . . . . 73.200000000000003 110.206 178.041 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -107.31 108.54 19.98 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.076 -0.965 . . . . 73.129999999999995 109.368 176.076 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 136.69 -17.13 3.72 Favored Glycine 0 C--N 1.304 -1.218 0 C-N-CA 120.323 -0.942 . . . . 63.140000000000001 111.971 177.27 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -91.79 179.12 5.71 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.412 -0.959 . . . . 63.399999999999999 108.412 178.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 21.1 m -75.05 155.55 37.11 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 105.455 -2.054 . . . . 71.239999999999995 105.455 171.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.501 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 9.2 p -62.23 -43.79 98.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 118.794 0.725 . . . . 74.510000000000005 111.642 -176.624 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 20.5 t70 -63.56 -40.3 96.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.74 0.305 . . . . 71.25 110.477 179.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 58.5 t -70.23 -39.81 77.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.33 0 CA-C-N 116.146 -0.479 . . . . 75.299999999999997 109.991 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' A' ' 500' ' ' VAL . . . -60.9 -44.76 96.68 Favored 'General case' 0 C--O 1.209 -1.069 0 N-CA-C 109.671 -0.492 . . . . 71.019999999999996 109.671 176.569 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 22.8 mt-30 -64.81 -42.69 94.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.157 -0.474 . . . . 61.219999999999999 110.715 -179.216 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.509 ' O ' HG22 ' A' ' 514' ' ' VAL . 75.3 mmtt -66.46 -42.67 87.2 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.252 -0.431 . . . . 75.209999999999994 110.49 177.792 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -67.62 -38.05 83.36 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.621 0.724 . . . . 74.140000000000001 111.08 -177.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.43 -46.49 86.09 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.565 -1.198 . . . . 74.439999999999998 108.343 177.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -61.09 -33.83 73.97 Favored 'General case' 0 N--CA 1.423 -1.823 0 C-N-CA 124.088 0.955 . . . . 65.329999999999998 112.937 -178.129 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 510' ' ' LYS . 65.9 t -56.58 -34.26 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.199 0.523 . . . . 74.209999999999994 110.54 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -110.96 -2.21 16.08 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.584 0.707 . . . . 72.400000000000006 110.147 -178.359 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -110.33 -63.54 0.52 Allowed Glycine 0 N--CA 1.414 -2.802 0 CA-C-N 115.439 -0.8 . . . . 74.0 112.366 -173.354 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 64.82 21.95 12.44 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 122.426 1.108 . . . . 74.25 109.503 -172.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.3 p -89.19 -169.89 2.68 Favored 'General case' 0 N--CA 1.408 -2.54 0 CA-C-N 113.367 -1.742 . . . . 73.040000000000006 110.417 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -111.79 141.13 45.8 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 109.173 -0.677 . . . . 72.439999999999998 109.173 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -132.48 151.11 52.02 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.657 0.741 . . . . 73.019999999999996 112.25 -175.121 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 55.1 p -138.82 157.18 46.54 Favored 'General case' 0 N--CA 1.403 -2.803 0 N-CA-C 106.62 -1.622 . . . . 71.530000000000001 106.62 178.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -131.44 147.11 52.52 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 109.524 -0.547 . . . . 73.450000000000003 109.524 -178.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -142.45 143.29 32.53 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.27 -1.381 . . . . 62.039999999999999 107.27 175.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 18.3 m -103.15 136.1 43.58 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-O 121.442 0.639 . . . . 73.420000000000002 112.07 -174.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 10.8 p -124.11 154.02 30.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 106.285 -1.746 . . . . 74.400000000000006 106.285 175.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.447 ' C ' ' HG ' ' A' ' 527' ' ' SER . 6.0 p-10 -91.52 135.88 33.53 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 120.078 -0.649 . . . . 73.540000000000006 111.146 -178.228 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.524 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 57.4 m -163.64 165.13 14.35 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 107.163 -1.421 . . . . 54.340000000000003 107.163 -178.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -66.72 -7.95 19.78 Favored 'Trans proline' 0 CA--C 1.549 1.24 0 C-N-CA 122.177 1.918 . . . . 74.129999999999995 113.962 179.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.426 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 0.0 OUTLIER -74.12 127.51 87.85 Favored Pre-proline 0 C--O 1.238 0.482 0 N-CA-C 107.898 -1.149 . . . . 72.409999999999997 107.898 176.555 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.9 145.66 83.39 Favored 'Trans proline' 0 C--O 1.25 1.12 0 C-N-CA 122.888 2.392 . . . . 74.239999999999995 112.911 -177.18 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -54.56 117.96 3.78 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.739 -1.119 . . . . 72.0 111.806 -177.186 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 127.62 -24.74 5.17 Favored Glycine 0 N--CA 1.428 -1.839 0 CA-C-N 115.227 -0.897 . . . . 73.239999999999995 111.458 178.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -83.11 138.5 33.65 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.91 -0.404 . . . . 71.219999999999999 109.91 178.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.431 HG13 ' CB ' ' A' ' 508' ' ' ALA . 4.3 p -101.25 116.78 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 CA-C-O 121.902 0.858 . . . . 74.430000000000007 109.361 -177.403 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.1 p -81.04 -8.68 59.82 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.575 -1.193 . . . . 74.409999999999997 112.809 -178.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.65 -164.96 29.14 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.471 -0.871 . . . . 70.140000000000001 112.487 175.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 21.8 p -116.77 158.5 23.79 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.423 -1.325 . . . . 73.099999999999994 107.423 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -63.54 -56.82 23.16 Favored Pre-proline 0 C--O 1.241 0.626 0 C-N-CA 118.184 -1.406 . . . . 72.299999999999997 112.172 176.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.14 137.34 40.36 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 120.822 1.014 . . . . 72.239999999999995 109.628 173.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.38 148.03 93.05 Favored 'Trans proline' 0 C--O 1.25 1.106 0 C-N-CA 122.464 2.109 . . . . 62.539999999999999 112.422 -178.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.35 143.07 50.61 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.009 -0.541 . . . . 74.040000000000006 110.31 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.66 -18.73 54.65 Favored Glycine 0 C--N 1.303 -1.283 0 N-CA-C 111.549 -0.62 . . . . 40.109999999999999 111.549 -177.348 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 53.3 m -73.26 136.85 44.64 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.533 0.206 . . . . 70.510000000000005 110.772 -179.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 13.5 t -88.59 134.53 33.85 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.502 -0.555 . . . . 75.010000000000005 109.502 177.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.49 155.92 80.69 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 107.847 -1.168 . . . . 75.540000000000006 107.847 177.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -59.09 141.68 98.45 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.598 1.532 . . . . 73.109999999999999 111.17 177.12 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 8.3 p -60.16 -19.79 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 CA-C-N 115.627 -0.715 . . . . 75.150000000000006 111.619 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -98.92 -5.15 31.27 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 121.539 0.685 . . . . 75.439999999999998 111.107 178.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 34.2 t -72.82 151.61 41.94 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 121.185 0.516 . . . . 73.400000000000006 110.273 -178.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.9 p -98.24 121.2 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.983 0 CA-C-N 115.358 -0.837 . . . . 73.120000000000005 109.015 179.273 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 54.9 mt -92.79 139.51 17.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.76 -0.83 . . . . 75.319999999999993 108.76 -177.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -103.71 123.42 46.99 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.756 0.789 . . . . 62.130000000000003 111.82 178.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.3 mp -103.57 126.95 51.03 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.409 -1.268 . . . . 72.129999999999995 108.832 177.159 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -90.13 116.01 27.81 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.566 0.698 . . . . 72.0 110.804 -178.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 524' ' ' SER . 25.6 t -90.72 129.21 41.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 107.704 -1.221 . . . . 74.299999999999997 107.704 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 43.4 t -87.48 125.09 34.1 Favored 'General case' 0 N--CA 1.403 -2.798 0 N-CA-C 108.6 -0.889 . . . . 73.209999999999994 108.6 177.114 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -105.46 139.31 40.28 Favored 'General case' 0 N--CA 1.406 -2.667 0 N-CA-C 106.706 -1.59 . . . . 74.310000000000002 106.706 169.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -58.18 -21.9 48.21 Favored Glycine 0 C--N 1.312 -0.769 0 O-C-N 124.295 0.997 . . . . 71.450000000000003 112.126 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 24.5 t-20 90.43 -2.74 0.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 126.771 2.028 . . . . 73.120000000000005 107.796 -179.468 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.424 ' HG2' ' N ' ' A' ' 615' ' ' ASN . 98.0 mt-30 -112.82 147.73 36.32 Favored 'General case' 0 N--CA 1.405 -2.724 0 CA-C-N 114.135 -1.393 . . . . 72.310000000000002 112.64 -169.33 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -123.31 158.34 31.21 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 114.19 -1.368 . . . . 73.319999999999993 107.496 177.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.84 120.31 13.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 121.114 0.483 . . . . 64.319999999999993 111.368 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 22.2 ttt -70.52 123.62 89.38 Favored Pre-proline 0 N--CA 1.434 -1.243 0 C-N-CA 123.86 0.864 . . . . 75.409999999999997 111.335 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -67.25 169.32 15.57 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.316 2.677 . . . . 63.520000000000003 112.16 176.248 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -87.43 124.31 33.29 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.088 0.471 . . . . 64.310000000000002 111.753 -177.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . 0.528 ' O ' HD21 ' A' ' 566' ' ' LEU . 9.5 tt -133.66 18.93 3.89 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 122.533 1.158 . . . . 72.349999999999994 108.35 -177.704 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 77.2 p -77.46 143.76 38.29 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 121.496 -0.752 . . . . 73.109999999999999 112.36 -174.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 65.24 42.76 96.12 Favored Glycine 0 N--CA 1.453 -0.182 0 CA-C-N 115.693 -0.685 . . . . 72.319999999999993 114.642 174.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 22.7 ptp -137.57 177.5 7.82 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.042 -0.725 . . . . 74.349999999999994 109.042 177.193 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -94.42 178.24 5.68 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.616 -0.513 . . . . 74.430000000000007 109.616 -178.044 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . 0.434 ' CZ3' HD22 ' A' ' 587' ' ' LEU . 18.9 t-105 -68.97 -30.22 68.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.786 -1.191 . . . . 74.540000000000006 107.786 175.919 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.0 p -74.94 -9.21 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-N 115.203 -0.908 . . . . 65.329999999999998 110.388 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.622 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 15.3 m-20 -99.25 -37.49 9.25 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 108.519 -0.919 . . . . 72.299999999999997 108.519 173.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -59.46 -43.95 93.08 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.108 -0.951 . . . . 74.310000000000002 111.926 179.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.602 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 33.3 mt-10 -57.66 -52.43 74.38 Favored Pre-proline 0 CA--C 1.556 1.187 0 N-CA-C 113.941 1.089 . . . . 74.239999999999995 113.941 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.3 -33.76 98.0 Favored 'Trans proline' 0 C--N 1.364 1.349 0 CA-C-N 120.438 1.192 . . . . 62.520000000000003 112.993 173.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.622 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 9.3 mmp_? -64.29 -45.55 87.48 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 109.57 -0.53 . . . . 72.140000000000001 109.57 178.101 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.3 pp -66.11 -44.04 85.45 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.833 -0.621 . . . . 65.340000000000003 112.162 -172.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -66.67 -37.83 85.56 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.161 -0.472 . . . . 74.299999999999997 110.928 178.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -71.28 -37.12 71.9 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 112.008 0.373 . . . . 73.439999999999998 112.008 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.0 pp -83.76 -9.35 58.88 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 120.532 -0.467 . . . . 74.129999999999995 110.794 -179.022 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 75.95 44.96 17.62 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 121.232 -0.509 . . . . 72.430000000000007 112.467 179.033 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -75.96 127.46 33.03 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.968 -0.753 . . . . 63.539999999999999 108.968 178.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 1.3 p -86.72 -32.68 20.32 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 124.303 1.041 . . . . 75.129999999999995 113.006 -178.068 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -82.91 -169.35 44.37 Favored Glycine 0 C--N 1.311 -0.836 0 N-CA-C 113.951 0.341 . . . . 73.420000000000002 113.951 -178.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 85.3 mtp -115.55 150.38 36.68 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 110.216 -0.29 . . . . 73.329999999999998 110.216 -178.408 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . 0.434 HD22 ' CZ3' ' A' ' 571' ' ' TRP . 2.3 tt -80.43 130.23 35.03 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.228 -1.027 . . . . 72.400000000000006 108.228 -179.563 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -126.77 122.63 35.34 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.611 -0.722 . . . . 72.349999999999994 110.933 -178.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.0 OUTLIER -101.94 128.48 48.33 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 118.302 -1.359 . . . . 74.150000000000006 109.109 173.311 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -76.96 -38.3 30.94 Favored Glycine 0 N--CA 1.428 -1.885 0 C-N-CA 120.763 -0.732 . . . . 70.420000000000002 112.444 -176.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -136.74 147.66 46.83 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 121.012 0.434 . . . . 72.409999999999997 110.714 -177.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -99.18 125.79 44.83 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.002 -1.481 . . . . 71.400000000000006 107.002 176.04 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 59.5 t -104.19 131.23 53.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 107.911 -1.144 . . . . 72.319999999999993 107.911 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . 0.414 ' HA ' ' NE2' ' A' ' 626' ' ' GLN . 6.8 p-10 -74.34 117.78 16.55 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.824 0.821 . . . . 73.239999999999995 110.285 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -141.82 -62.84 0.45 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.487 -1.233 . . . . 73.140000000000001 109.356 -179.222 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 95.22 160.72 33.72 Favored Glycine 0 N--CA 1.407 -3.279 0 N-CA-C 110.655 -0.978 . . . . 62.020000000000003 110.655 -178.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.6 -33.04 61.97 Favored Glycine 0 C--N 1.292 -1.864 0 CA-C-N 115.031 -0.584 . . . . 51.009999999999998 113.735 -178.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 35.3 t -70.25 -29.19 65.93 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 109.647 -0.501 . . . . 75.519999999999996 109.647 -178.076 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -95.69 -2.28 48.31 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.493 -0.322 . . . . 73.519999999999996 110.991 -178.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 73.24 116.45 0.05 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.966 1.307 . . . . 75.140000000000001 111.268 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -78.4 61.69 2.87 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.736 0.779 . . . . 70.420000000000002 110.781 -179.025 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -87.07 160.09 18.7 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.712 -0.676 . . . . 75.019999999999996 109.402 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . 0.488 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 99.5 t -63.6 130.23 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 106.904 -1.517 . . . . 72.439999999999998 106.904 170.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.7 t -96.31 -47.45 12.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.384 0.611 . . . . 63.210000000000001 109.504 -175.173 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -150.58 144.43 25.27 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 106.925 -1.509 . . . . 73.040000000000006 106.925 -178.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -128.64 143.99 51.06 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.325 -0.991 . . . . 73.049999999999997 108.325 178.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.429 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 3.3 t-20 -60.18 -54.62 53.43 Favored Pre-proline 0 CA--C 1.553 1.067 0 N-CA-C 112.504 0.557 . . . . 75.409999999999997 112.504 -179.412 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 9.3 Cg_endo -94.24 123.44 0.41 Allowed 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 121.929 1.753 . . . . 72.349999999999994 111.954 178.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -67.67 153.46 76.01 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 122.168 1.912 . . . . 62.409999999999997 110.747 175.05 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.4 139.46 58.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.744 0.307 . . . . 62.299999999999997 110.275 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.14 -11.69 62.03 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 120.317 -0.944 . . . . 72.230000000000004 111.993 -178.368 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 90.6 m -76.58 146.34 38.38 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.763 -0.829 . . . . 65.319999999999993 108.763 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -73.81 122.69 7.75 Favored Glycine 0 N--CA 1.42 -2.415 0 C-N-CA 119.654 -1.26 . . . . 71.200000000000003 110.531 175.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.7 m -114.08 141.57 29.79 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 108.676 -0.861 . . . . 74.340000000000003 108.676 176.407 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.424 ' N ' ' HG2' ' A' ' 560' ' ' GLN . 33.4 p-10 -52.0 168.42 0.09 Allowed 'General case' 0 C--O 1.209 -1.072 0 C-N-CA 124.457 1.103 . . . . 75.030000000000001 112.696 -176.423 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -58.15 -24.77 60.1 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.819 0.674 . . . . 74.340000000000003 112.819 -176.486 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -88.56 -8.55 54.56 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 109.402 -0.592 . . . . 73.230000000000004 109.402 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.12 16.08 63.92 Favored Glycine 0 CA--C 1.502 -0.757 0 CA-C-N 116.016 -0.538 . . . . 64.230000000000004 113.95 171.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.17 119.31 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 122.208 1.004 . . . . 73.5 110.927 -167.165 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.417 ' O ' HD12 ' A' ' 620' ' ' ILE . 2.8 pp -129.0 134.05 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 114.477 -1.238 . . . . 73.310000000000002 110.673 -177.351 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 11.9 t -110.03 133.02 53.64 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.7 -0.852 . . . . 75.450000000000003 108.7 179.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 3.2 pp -138.78 168.75 19.12 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.69 -0.686 . . . . 75.400000000000006 110.788 -175.384 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -126.92 135.82 51.44 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.343 -0.984 . . . . 73.409999999999997 108.343 174.253 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.488 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 2.1 p90 -142.41 168.23 20.23 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.083 -0.508 . . . . 74.510000000000005 109.805 -172.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -56.25 109.52 1.56 Allowed Glycine 0 CA--C 1.529 0.926 0 O-C-N 123.954 0.784 . . . . 63.439999999999998 111.855 175.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.414 ' NE2' ' HA ' ' A' ' 594' ' ' ASP . 27.7 mm-40 . . . . . 0 C--O 1.263 1.783 0 C-N-CA 125.734 1.614 . . . . 74.349999999999994 112.745 -179.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.585 0 CA-C-O 122.016 0.912 . . . . 74.530000000000001 110.708 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 9.2 p -143.09 145.59 33.01 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 114.743 -1.117 . . . . 72.019999999999996 108.13 -178.606 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -140.54 140.81 35.28 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.265 -0.643 . . . . 72.319999999999993 109.265 -179.57 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.1 p-10 -78.83 140.48 38.17 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.395 0.617 . . . . 73.239999999999995 110.656 178.289 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 39.0 pt -96.36 137.07 21.62 Favored Pre-proline 0 C--N 1.294 -1.812 0 CA-C-N 114.91 -1.041 . . . . 75.230000000000004 109.776 179.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.22 176.89 9.24 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.979 1.786 . . . . 75.310000000000002 111.924 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.57 110.27 19.69 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.856 -1.165 . . . . 64.120000000000005 107.856 177.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 29.3 m -117.84 12.3 7.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-O 120.982 0.42 . . . . 73.420000000000002 111.812 -178.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -84.72 102.25 12.85 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.486 -0.485 . . . . 61.340000000000003 109.954 -178.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 156.38 -26.07 0.54 Allowed Glycine 0 C--N 1.301 -1.385 0 C-N-CA 120.653 -0.784 . . . . 61.119999999999997 112.136 179.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.45 ' O ' HG11 ' A' ' 534' ' ' VAL . 11.4 pm0 -102.44 -173.86 2.43 Favored 'General case' 0 N--CA 1.427 -1.605 0 O-C-N 122.527 -0.396 . . . . 70.219999999999999 110.276 177.49 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.1 m -69.84 155.46 40.52 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.474 -0.935 . . . . 74.109999999999999 108.474 -179.236 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.41 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.3 p -61.64 -42.68 95.13 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 O-C-N 123.018 0.199 . . . . 75.230000000000004 111.428 -178.276 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.71 -39.82 94.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.286 0.565 . . . . 71.349999999999994 110.21 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 66.9 t -70.36 -39.69 76.85 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.452 0 CA-C-N 115.431 -0.804 . . . . 71.319999999999993 109.8 178.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.22 -44.28 92.38 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 122.276 0.23 . . . . 75.319999999999993 110.996 177.783 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 23.0 mt-30 -63.1 -41.6 99.41 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.896 -0.409 . . . . 74.409999999999997 109.896 178.035 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.42 ' O ' HG22 ' A' ' 514' ' ' VAL . 72.3 mmtt -66.31 -38.79 88.54 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.939 -0.573 . . . . 74.409999999999997 111.897 175.772 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.14 -48.45 80.04 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 122.026 0.917 . . . . 74.450000000000003 108.8 176.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -59.55 -42.3 92.06 Favored 'General case' 0 C--O 1.21 -1.011 0 CA-C-N 113.909 -1.496 . . . . 72.209999999999994 109.623 -179.255 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -60.47 -35.21 75.35 Favored 'General case' 0 N--CA 1.427 -1.608 0 C-N-CA 124.169 0.988 . . . . 74.099999999999994 111.16 -179.732 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 510' ' ' LYS . 98.1 t -64.34 -35.85 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.444 0.64 . . . . 74.230000000000004 110.832 178.342 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -101.46 5.0 41.79 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.184 -0.462 . . . . 73.209999999999994 109.931 -177.079 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -132.94 -58.29 0.08 OUTLIER Glycine 0 N--CA 1.426 -2.033 0 C-N-CA 119.89 -1.148 . . . . 72.030000000000001 114.232 -171.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 59.66 29.56 19.13 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 122.465 1.126 . . . . 73.120000000000005 108.97 -172.631 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.1 p -96.87 -165.39 1.26 Allowed 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 114.061 -1.427 . . . . 65.319999999999993 110.559 -177.754 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -107.83 138.6 43.79 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.827 -1.175 . . . . 73.219999999999999 107.827 178.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -128.93 148.5 50.93 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.297 0.57 . . . . 72.319999999999993 111.192 -179.243 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.5 m -140.25 152.41 45.91 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.016 -1.105 . . . . 75.430000000000007 108.016 176.366 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -120.38 142.13 49.45 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.02 0.438 . . . . 73.510000000000005 111.041 -176.227 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -131.94 135.94 46.98 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.465 -1.68 . . . . 61.340000000000003 106.465 176.462 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 75.0 p -104.83 139.45 39.57 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.259 1.028 . . . . 74.150000000000006 113.234 -173.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.5 p -123.95 152.99 29.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 105.858 -1.904 . . . . 54.539999999999999 105.858 176.388 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.462 ' HA ' ' HG3' ' A' ' 557' ' ' LYS . 1.1 p-10 -84.74 136.94 33.5 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.407 -0.96 . . . . 72.540000000000006 108.407 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 23.3 m -149.45 169.87 8.53 Favored Pre-proline 0 C--N 1.285 -2.203 0 N-CA-C 107.586 -1.264 . . . . 72.340000000000003 107.586 -175.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -69.93 -16.3 36.8 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 121.992 1.795 . . . . 75.109999999999999 112.385 176.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.409 ' HD2' ' N ' ' A' ' 529' ' ' ARG . 3.2 mpt_? -81.57 135.0 50.05 Favored Pre-proline 0 CA--C 1.512 -0.492 0 CA-C-N 116.499 -0.319 . . . . 74.310000000000002 110.432 179.757 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.66 156.98 20.55 Favored 'Trans proline' 0 C--O 1.257 1.446 0 C-N-CA 123.141 2.561 . . . . 74.200000000000003 112.557 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.24 104.6 0.33 Allowed 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.348 -0.842 . . . . 71.329999999999998 111.251 -176.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 151.93 -26.33 0.92 Allowed Glycine 0 N--CA 1.419 -2.494 0 C-N-CA 120.142 -1.028 . . . . 74.099999999999994 112.707 179.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -82.67 144.49 30.23 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 119.378 -0.929 . . . . 75.409999999999997 109.33 -179.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.45 HG11 ' O ' ' A' ' 503' ' ' GLN . 7.4 p -92.34 117.63 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 CA-C-O 121.822 0.82 . . . . 73.409999999999997 108.845 177.568 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.99 -30.74 70.93 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.444 -1.253 . . . . 74.349999999999994 109.932 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 156.02 -167.62 33.32 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 111.085 -0.806 . . . . 53.520000000000003 111.085 178.61 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.4 p -116.59 147.55 41.76 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.694 -0.854 . . . . 72.230000000000004 108.694 178.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -57.94 -50.32 88.75 Favored Pre-proline 0 N--CA 1.476 0.839 0 O-C-N 123.577 0.548 . . . . 74.140000000000001 111.458 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -76.29 131.0 12.43 Favored 'Trans proline' 0 N--CA 1.438 -1.76 0 N-CA-C 107.978 -1.585 . . . . 75.129999999999995 107.978 168.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -56.55 140.94 90.76 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 122.492 2.128 . . . . 73.209999999999994 111.736 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.01 137.83 58.0 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 120.702 0.287 . . . . 74.019999999999996 110.635 -178.746 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.69 -12.66 58.0 Favored Glycine 0 C--N 1.309 -0.949 0 N-CA-C 111.782 -0.527 . . . . 70.439999999999998 111.782 -176.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 26.4 m -84.35 137.31 33.49 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 122.85 -0.206 . . . . 72.530000000000001 110.567 -178.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 9.7 t -82.33 127.69 33.48 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.592 -0.892 . . . . 74.329999999999998 108.592 175.198 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.8 m -123.07 156.75 62.32 Favored Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 107.75 -1.204 . . . . 71.420000000000002 107.75 -179.053 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -65.44 137.66 51.8 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 120.834 1.023 . . . . 74.0 111.39 -179.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.8 p -64.98 -19.64 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.481 -0.781 . . . . 74.209999999999994 110.599 179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -89.33 -12.32 40.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.183 0.516 . . . . 71.120000000000005 111.456 -179.041 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 50.4 m -87.21 163.78 16.71 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.617 0.722 . . . . 74.519999999999996 111.14 178.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.3 p -98.02 137.66 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.849 0 CA-C-N 115.122 -0.945 . . . . 61.100000000000001 109.462 178.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.41 135.56 28.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.985 -0.552 . . . . 62.520000000000003 110.306 -178.571 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -103.3 119.99 39.92 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-N 115.852 -0.613 . . . . 75.450000000000003 110.817 -173.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -102.66 122.96 45.48 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 124.06 0.944 . . . . 75.010000000000005 109.235 177.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -85.13 122.28 29.11 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.895 -0.78 . . . . 71.340000000000003 108.895 174.163 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 26.5 t -98.69 134.18 38.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 108.573 -0.899 . . . . 73.319999999999993 108.573 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.633 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 23.6 m -85.06 117.77 24.23 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.92 -0.77 . . . . 63.450000000000003 108.92 176.492 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.462 ' HG3' ' HA ' ' A' ' 526' ' ' ASP . 2.6 ptpp? -96.66 133.33 41.32 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 106.612 -1.625 . . . . 72.319999999999993 106.612 166.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -60.13 -23.98 60.31 Favored Glycine 0 CA--C 1.492 -1.397 0 O-C-N 124.344 1.028 . . . . 72.010000000000005 113.167 -175.481 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . 0.492 ' OD1' ' HG3' ' A' ' 616' ' ' ARG . 45.1 t-20 79.77 -15.71 0.73 Allowed 'General case' 0 C--O 1.211 -0.951 0 C-N-CA 125.231 1.412 . . . . 75.5 108.587 179.403 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 86.3 mt-30 -112.52 141.72 45.93 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 115.563 -0.744 . . . . 74.540000000000006 112.233 -173.411 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -123.8 158.24 32.23 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.104 -1.407 . . . . 74.120000000000005 107.936 177.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.1 p -64.42 125.36 21.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.228 0.537 . . . . 72.540000000000006 110.078 177.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 563' ' ' MET . . . . . 0.522 ' SD ' HG21 ' A' ' 620' ' ' ILE . 52.1 ttp -83.88 133.52 45.91 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 109.874 -0.417 . . . . 72.450000000000003 109.874 -178.502 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.11 169.62 14.75 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.634 2.223 . . . . 75.340000000000003 110.768 174.732 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -82.48 134.11 35.21 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.276 0.56 . . . . 74.319999999999993 111.022 -178.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.5 pp -137.66 14.19 2.94 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.77 -1.105 . . . . 73.540000000000006 110.234 178.197 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 22.9 t -81.01 152.76 27.78 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.691 -1.14 . . . . 62.329999999999998 110.213 -178.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 64.21 26.14 70.24 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 114.942 0.737 . . . . 73.030000000000001 114.942 174.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 569' ' ' MET . . . . . 0.442 ' SD ' ' HG3' ' A' ' 577' ' ' ARG . 20.4 ptp -127.08 171.99 10.9 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 122.305 -0.527 . . . . 74.239999999999995 109.945 179.41 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -95.98 165.44 12.26 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.054 -1.461 . . . . 72.519999999999996 107.054 -177.07 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -61.76 -30.04 70.53 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.373 -0.603 . . . . 74.150000000000006 109.373 178.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.82 -15.91 18.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.971 -0.559 . . . . 75.439999999999998 111.671 -178.447 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.425 ' C ' ' HD2' ' A' ' 576' ' ' PRO . 38.3 t70 -101.62 -28.5 12.47 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 122.245 1.022 . . . . 74.030000000000001 108.247 176.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' A' ' 577' ' ' ARG . . . -67.91 -37.46 81.73 Favored 'General case' 0 C--O 1.212 -0.908 0 CA-C-N 114.565 -1.198 . . . . 73.200000000000003 111.275 177.307 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.478 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 23.5 tt0 -56.18 -51.13 83.2 Favored Pre-proline 0 CA--C 1.568 1.658 0 CA-C-O 119.373 -0.346 . . . . 75.329999999999998 110.973 178.269 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 85.1 Cg_exo -53.36 -37.36 81.34 Favored 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 122.095 1.863 . . . . 75.319999999999993 112.203 171.698 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.539 ' O ' ' HB3' ' A' ' 581' ' ' LEU . 1.5 mmp_? -58.62 -42.6 88.62 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.742 -0.208 . . . . 74.239999999999995 110.494 176.701 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.513 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 10.8 mp -63.47 -49.27 74.29 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 120.727 0.299 . . . . 72.299999999999997 110.993 -178.226 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -67.21 -39.69 86.32 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 113.303 0.853 . . . . 64.430000000000007 113.303 -179.229 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.06 -36.47 75.0 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.113 0.482 . . . . 72.519999999999996 111.453 -178.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . 0.539 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 2.0 tp -81.47 -10.17 59.55 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.108 -0.496 . . . . 75.340000000000003 110.109 -179.59 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 61.88 40.25 98.59 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.728 -0.949 . . . . 62.399999999999999 110.728 -178.045 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . 0.513 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 10.7 t90 -71.81 127.43 32.54 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 121.578 0.704 . . . . 75.430000000000007 109.675 -178.259 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 9.9 p -79.05 -50.05 11.68 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 114.534 -1.212 . . . . 71.420000000000002 111.807 -177.094 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -71.48 -169.47 10.43 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 116.004 1.162 . . . . 75.140000000000001 116.004 -176.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 61.7 mtm -113.76 155.94 24.73 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.105 -1.048 . . . . 72.310000000000002 108.501 -179.404 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 6.3 tt -85.14 119.82 25.96 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.039 -1.097 . . . . 70.340000000000003 108.039 179.255 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . 0.634 ' O ' ' HA ' ' A' ' 621' ' ' THR . 23.4 t70 -95.75 104.87 16.82 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.66 0.743 . . . . 63.130000000000003 109.818 -179.666 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.1 OUTLIER -90.03 129.12 36.39 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.988 -0.745 . . . . 74.519999999999996 108.988 178.155 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -83.4 -48.95 5.13 Favored Glycine 0 C--N 1.28 -2.565 0 N-CA-C 109.936 -1.265 . . . . 75.409999999999997 109.936 -178.17 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.15 142.41 38.01 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 109.114 -0.699 . . . . 73.319999999999993 109.114 179.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -115.57 125.19 52.66 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.024 -1.472 . . . . 73.25 107.024 175.444 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.89 131.47 55.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 108.816 -0.809 . . . . 74.420000000000002 108.816 -176.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.96 108.09 5.68 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.164 -1.05 . . . . 64.329999999999998 108.164 178.687 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -115.23 -55.81 2.43 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 116.088 -0.506 . . . . 75.450000000000003 110.688 -174.577 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 89.4 148.12 17.81 Favored Glycine 0 N--CA 1.422 -2.278 0 C-N-CA 120.31 -0.947 . . . . 73.430000000000007 111.358 -175.098 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.25 -32.44 60.28 Favored Glycine 0 C--N 1.304 -1.216 0 C-N-CA 123.483 0.563 . . . . 65.030000000000001 113.487 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 14.4 m -66.19 -24.44 66.63 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 124.076 0.951 . . . . 72.219999999999999 110.545 -176.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -104.29 -0.73 27.93 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.106 -0.952 . . . . 64.120000000000005 109.533 -176.634 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 60.8 m80 69.04 93.69 0.08 Allowed 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 122.135 0.969 . . . . 74.239999999999995 110.692 -174.457 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -82.2 73.28 9.24 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.553 -1.203 . . . . 75.230000000000004 110.339 -179.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -106.33 162.74 13.41 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.701 -1.136 . . . . 72.420000000000002 110.659 -176.428 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 78.8 t -67.25 130.09 32.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 N-CA-C 106.295 -1.743 . . . . 73.340000000000003 106.295 169.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.91 -34.12 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 113.091 0.775 . . . . 75.299999999999997 113.091 -174.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . 0.483 ' HB3' ' CG ' ' A' ' 623' ' ' ARG . 46.8 t80 -141.77 135.85 30.12 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.752 -0.833 . . . . 73.540000000000006 108.752 -177.301 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -133.31 144.52 49.72 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.288 -1.375 . . . . 73.329999999999998 107.288 178.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.494 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 46.3 t30 -58.91 -54.72 53.66 Favored Pre-proline 0 CA--C 1.553 1.077 0 O-C-N 123.466 0.479 . . . . 73.439999999999998 111.899 -179.235 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 94.9 Cg_endo -105.31 117.16 0.04 OUTLIER 'Trans proline' 0 CA--C 1.571 2.349 0 C-N-CA 121.502 1.468 . . . . 74.129999999999995 111.508 173.649 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.0 160.57 40.85 Favored 'Trans proline' 0 N--CA 1.482 0.821 0 C-N-CA 122.92 2.413 . . . . 74.319999999999993 112.66 -178.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -53.0 132.51 37.79 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.8 0.44 . . . . 72.239999999999995 110.928 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.07 -6.03 42.75 Favored Glycine 0 C--O 1.24 0.503 0 C-N-CA 120.695 -0.764 . . . . 50.329999999999998 111.201 -176.597 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 612' ' ' THR . . . . . 0.463 HG22 ' HB2' ' A' ' 608' ' ' PRO . 12.6 t -72.55 166.33 22.89 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 123.619 0.767 . . . . 74.409999999999997 109.69 178.832 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -104.09 118.38 5.96 Favored Glycine 0 N--CA 1.427 -1.937 0 N-CA-C 109.247 -1.541 . . . . 73.109999999999999 109.247 175.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 35.9 m -116.33 142.08 31.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.992 -0.373 . . . . 74.129999999999995 109.992 -179.643 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -57.53 169.81 0.62 Allowed 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 124.238 1.015 . . . . 75.150000000000006 112.805 -177.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . 0.492 ' HG3' ' OD1' ' A' ' 559' ' ' ASN 0.331 0.0 OUTLIER -59.29 -23.75 62.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 114.638 1.347 . . . . 75.099999999999994 114.638 178.832 . . . . . . . . 4 4 . 1 . 026 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -84.98 -8.55 58.69 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.015 -0.735 . . . . 74.430000000000007 109.015 175.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.24 12.55 58.38 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 123.682 0.658 . . . . 73.519999999999996 114.451 170.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.37 119.41 16.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 122.002 0.906 . . . . 71.140000000000001 112.076 -165.751 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.522 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.8 pp -126.82 134.84 65.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-N 114.507 -1.224 . . . . 71.319999999999993 112.592 -178.469 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 87.7 m -98.88 122.92 42.75 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.849 -0.614 . . . . 71.519999999999996 109.473 178.384 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 3.3 pp -139.1 167.01 23.02 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.092 0.404 . . . . 62.119999999999997 112.092 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . 0.483 ' CG ' ' HB3' ' A' ' 605' ' ' TYR . 18.4 ptp180 -127.79 137.8 52.52 Favored 'General case' 0 C--O 1.257 1.49 0 N-CA-C 107.69 -1.226 . . . . 75.129999999999995 107.69 175.453 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -141.07 165.37 27.74 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.389 -0.524 . . . . 62.140000000000001 111.77 -172.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -82.62 131.17 10.18 Favored Glycine 0 N--CA 1.417 -2.629 0 CA-C-N 114.97 -1.014 . . . . 74.349999999999994 110.907 175.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--N 1.276 -2.614 0 C-N-CA 125.35 1.46 . . . . 74.319999999999993 109.097 -179.734 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.719 0 CA-C-O 121.34 0.59 . . . . 73.040000000000006 111.807 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.404 ' HB ' HG22 ' A' ' 544' ' ' THR . 20.3 p -139.72 141.63 36.9 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.838 -0.619 . . . . 74.540000000000006 110.165 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 515' ' ' TYR . 0.6 OUTLIER -138.11 139.64 39.56 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 122.572 0.349 . . . . 74.209999999999994 110.659 177.543 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.4 p-10 -85.98 140.68 30.1 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.943 -0.572 . . . . 74.099999999999994 109.795 173.283 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.5 pt -98.06 136.88 20.87 Favored Pre-proline 0 C--N 1.294 -1.829 0 CA-C-N 115.347 -0.842 . . . . 64.5 111.354 -178.205 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -81.94 -178.49 4.16 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.924 1.749 . . . . 73.319999999999993 110.756 175.197 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -83.48 118.62 23.88 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.737 -0.838 . . . . 73.340000000000003 108.737 177.246 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.47 12.23 8.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 122.101 0.953 . . . . 72.319999999999993 110.145 -178.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -80.63 100.67 8.77 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.545 -1.207 . . . . 40.109999999999999 109.998 178.347 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 149.88 -30.27 1.12 Allowed Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.892 -0.671 . . . . 71.219999999999999 111.906 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -91.65 177.47 6.2 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-O 121.232 0.539 . . . . 74.319999999999993 110.211 179.192 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 27.9 m -74.22 156.18 37.53 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.454 -1.314 . . . . 70.420000000000002 107.454 177.13 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.425 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 11.4 p -56.43 -45.19 81.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 112.87 0.693 . . . . 72.239999999999995 112.87 -179.523 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -62.18 -39.69 93.52 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 120.535 -0.466 . . . . 72.030000000000001 110.171 177.902 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 78.6 t -68.87 -44.39 81.78 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.866 0 CA-C-N 115.437 -0.801 . . . . 74.329999999999998 110.04 -178.577 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.58 -45.3 91.03 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 123.216 0.607 . . . . 73.510000000000005 110.522 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.8 mt-30 -65.06 -45.64 84.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 123.31 0.382 . . . . 72.239999999999995 110.841 -179.226 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.46 ' O ' HG23 ' A' ' 514' ' ' VAL . 20.9 ptmt -67.12 -38.48 85.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.043 0.449 . . . . 74.530000000000001 110.363 179.022 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -60.86 -49.59 76.85 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 124.169 0.988 . . . . 75.450000000000003 110.081 -178.531 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -69.17 -35.4 76.26 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 115.704 -0.68 . . . . 74.310000000000002 110.524 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.428 ' N ' HD12 ' A' ' 512' ' ' LEU . 2.3 t-20 -59.89 -39.49 85.49 Favored 'General case' 0 C--O 1.204 -1.33 0 C-N-CA 123.982 0.913 . . . . 64.430000000000007 110.587 -178.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 510' ' ' LYS . 82.0 t -57.56 -32.43 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-O 121.326 0.584 . . . . 74.120000000000005 111.793 179.272 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . 0.599 ' O ' ' HG2' ' A' ' 495' ' ' LYS . 60.6 m-85 -98.24 -26.26 14.59 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.439 0.638 . . . . 74.299999999999997 110.293 179.314 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -101.36 -58.09 0.82 Allowed Glycine 0 CA--C 1.478 -2.23 0 CA-C-N 115.464 -0.789 . . . . 74.219999999999999 113.554 -167.663 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 64.86 29.59 12.46 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.135 0.969 . . . . 65.239999999999995 109.898 -174.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.7 p -88.96 -166.52 1.62 Allowed 'General case' 0 N--CA 1.422 -1.849 0 C-N-CA 125.702 1.601 . . . . 74.349999999999994 111.026 -179.516 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 13.6 mptt -107.56 143.55 35.82 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.199 -1.408 . . . . 75.209999999999994 107.199 176.187 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -131.87 151.77 51.47 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 120.904 0.383 . . . . 75.129999999999995 111.986 -179.046 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 36.7 m -132.91 156.59 46.97 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.887 -1.524 . . . . 73.340000000000003 106.887 177.369 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -129.41 144.85 51.41 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 110.03 -0.359 . . . . 73.109999999999999 110.03 177.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -137.75 127.24 24.95 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.955 -1.128 . . . . 75.530000000000001 107.955 176.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.0 m -99.3 125.27 44.91 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.053 0.454 . . . . 64.140000000000001 111.942 -175.771 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 41.9 t -121.73 151.37 25.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 106.868 -1.53 . . . . 65.549999999999997 106.868 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.418 ' C ' ' HG ' ' A' ' 527' ' ' SER . 6.8 p-10 -69.34 135.62 50.62 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 121.407 0.622 . . . . 75.439999999999998 111.507 -178.571 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 527' ' ' SER . . . . . 0.594 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 49.3 m -155.38 170.42 8.73 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 108.451 -0.944 . . . . 62.32 108.451 -178.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.87 -16.86 25.91 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 122.14 1.893 . . . . 74.430000000000007 114.031 -179.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.23 149.47 38.59 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 119.509 -0.877 . . . . 74.409999999999997 111.843 -176.521 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.95 147.65 72.77 Favored 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 123.27 2.647 . . . . 72.25 112.882 -176.078 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.702 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.65 103.86 0.37 Allowed 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 114.858 -1.065 . . . . 52.32 113.119 -174.115 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 147.04 -17.03 1.55 Allowed Glycine 0 N--CA 1.422 -2.242 0 CA-C-N 115.043 -0.981 . . . . 75.239999999999995 111.643 -178.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -82.22 141.76 32.71 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.628 -0.508 . . . . 63.240000000000002 109.628 177.843 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 41.4 t -93.32 115.84 33.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.039 -0.726 . . . . 73.340000000000003 109.039 176.438 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 535' ' ' THR . . . . . 0.425 HG22 ' HB2' ' A' ' 556' ' ' SER . 2.3 p -83.87 -17.81 39.6 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.241 -0.891 . . . . 75.549999999999997 112.357 178.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 165.88 174.86 35.79 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.185 -1.007 . . . . 73.030000000000001 112.404 178.246 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 5.7 p -117.38 152.89 34.03 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.222 -1.029 . . . . 73.340000000000003 108.222 177.359 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -67.22 -50.64 38.98 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 118.333 -1.347 . . . . 75.319999999999993 111.151 176.447 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -67.87 127.75 16.67 Favored 'Trans proline' 0 C--N 1.377 2.057 0 N-CA-C 108.043 -1.56 . . . . 74.420000000000002 108.043 170.074 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -68.92 157.39 62.04 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 122.236 1.957 . . . . 75.030000000000001 113.879 -175.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.17 136.12 56.94 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.622 -0.717 . . . . 73.299999999999997 110.444 179.646 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.51 -11.25 59.65 Favored Glycine 0 C--N 1.305 -1.155 0 N-CA-C 111.637 -0.585 . . . . 62.119999999999997 111.637 -178.491 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 543' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 28.4 m -77.87 127.98 33.24 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 122.568 -0.372 . . . . 74.409999999999997 110.945 -178.426 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 24.8 m -87.73 123.65 32.76 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 108.0 -1.111 . . . . 73.430000000000007 108.0 175.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.75 157.57 62.42 Favored Pre-proline 0 C--N 1.301 -1.503 0 N-CA-C 108.763 -0.828 . . . . 71.150000000000006 108.763 -178.826 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -63.87 140.65 74.4 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.615 1.543 . . . . 73.140000000000001 110.763 177.371 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 14.6 p -56.85 -25.62 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-O 121.455 0.645 . . . . 74.439999999999998 110.855 178.158 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.05 -15.08 52.44 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.738 -0.664 . . . . 62.32 112.008 -178.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 97.0 p -82.94 178.08 8.33 Favored 'General case' 0 C--O 1.254 1.32 0 N-CA-C 113.388 0.885 . . . . 73.519999999999996 113.388 -174.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 15.0 p -117.03 138.04 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.518 -0.765 . . . . 73.239999999999995 110.933 -176.488 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 54.9 mt -108.59 134.35 50.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.687 -0.857 . . . . 72.530000000000001 108.687 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -104.27 122.95 46.47 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.43 0.633 . . . . 74.5 112.563 179.529 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.23 119.37 34.6 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 125.487 1.515 . . . . 73.439999999999998 109.685 -179.525 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -88.82 113.81 24.76 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.656 0.741 . . . . 75.040000000000006 109.485 175.317 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.97 131.21 42.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 114.456 -1.247 . . . . 75.140000000000001 109.521 -175.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.702 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 39.1 t -77.47 117.63 19.12 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 108.261 -1.014 . . . . 73.219999999999999 108.261 176.693 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 0.4 OUTLIER -100.15 134.07 43.61 Favored 'General case' 0 N--CA 1.417 -2.118 0 N-CA-C 105.444 -2.058 . . . . 75.530000000000001 105.444 168.725 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 560' ' ' GLN . . . -64.01 -24.44 68.58 Favored Glycine 0 CA--C 1.499 -0.94 0 N-CA-C 110.484 -1.046 . . . . 75.019999999999996 110.484 179.253 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 63.5 t30 63.83 24.67 13.83 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.962 1.305 . . . . 75.030000000000001 108.438 -179.192 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 558' ' ' GLY . 97.7 mt-30 -127.52 155.57 43.56 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 114.48 -1.236 . . . . 74.5 111.234 -173.429 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -131.22 151.12 51.79 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.893 -1.049 . . . . 73.430000000000007 108.264 176.277 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.19 123.07 16.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-O 121.439 0.638 . . . . 74.519999999999996 110.317 178.777 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 563' ' ' MET . . . . . 0.525 ' SD ' HG13 ' A' ' 620' ' ' ILE . 42.9 ttp -86.45 125.63 66.96 Favored Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 115.495 -0.775 . . . . 70.409999999999997 111.014 -178.458 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.43 170.41 10.98 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.687 2.925 . . . . 71.239999999999995 112.402 176.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.94 115.51 15.71 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.46 -0.336 . . . . 71.049999999999997 110.492 -179.681 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -91.59 -16.66 26.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.87 0.843 . . . . 71.409999999999997 109.047 175.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 15.3 m -73.91 140.1 45.41 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.156 -0.929 . . . . 55.539999999999999 110.008 -179.331 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 94.17 11.42 57.47 Favored Glycine 0 C--O 1.217 -0.921 0 C-N-CA 120.713 -0.756 . . . . 62.030000000000001 114.395 177.065 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 23.9 ptp -131.83 167.6 19.27 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.329 -0.989 . . . . 71.310000000000002 108.329 176.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -88.9 170.34 10.79 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.049 -1.093 . . . . 71.230000000000004 108.049 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -65.95 -28.31 68.82 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.416 -0.957 . . . . 74.540000000000006 108.416 176.331 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.7 p -75.53 -11.85 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-N 115.297 -0.865 . . . . 73.299999999999997 110.564 -179.283 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 56.5 m-20 -98.72 -40.56 8.1 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 107.441 -1.318 . . . . 74.400000000000006 107.441 174.161 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . 0.712 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -55.83 -54.3 46.16 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-N 114.566 -1.197 . . . . 74.310000000000002 112.87 -176.636 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 40.4 mt-10 -57.77 -48.57 96.95 Favored Pre-proline 0 N--CA 1.473 0.686 0 N-CA-C 113.7 1.0 . . . . 74.140000000000001 113.7 -178.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -52.96 -38.2 79.27 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.168 1.912 . . . . 75.120000000000005 112.761 171.575 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 3.6 mmp_? -68.71 -38.89 80.6 Favored 'General case' 0 C--O 1.199 -1.554 0 N-CA-C 109.929 -0.397 . . . . 75.400000000000006 109.929 176.537 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.712 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 65.3 mt -65.26 -47.11 77.88 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 122.66 0.384 . . . . 74.200000000000003 110.634 -175.401 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 35.7 ptt85 -66.0 -35.16 79.82 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 116.29 -0.414 . . . . 74.329999999999998 111.659 176.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.44 -30.79 67.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.481 0.658 . . . . 71.340000000000003 110.619 177.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 14.1 tp -80.85 -9.05 59.86 Favored 'General case' 0 N--CA 1.425 -1.707 0 C-N-CA 124.14 0.976 . . . . 70.530000000000001 110.175 179.595 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 67.44 46.5 69.56 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.346 -0.454 . . . . 41.549999999999997 112.002 178.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 12.5 t90 -83.5 131.13 35.03 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.924 -0.399 . . . . 70.540000000000006 109.924 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 12.8 p -100.12 -26.77 13.84 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.29 1.036 . . . . 71.200000000000003 112.748 -178.193 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -82.16 -175.19 50.4 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 116.283 -0.417 . . . . 74.450000000000003 113.644 -177.069 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 70.5 mtm -107.19 149.56 27.58 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.968 -0.382 . . . . 74.450000000000003 109.968 -178.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.9 tt -91.83 130.18 37.65 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.074 -1.084 . . . . 75.129999999999995 108.074 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 621' ' ' THR . 14.0 t70 -112.19 123.42 50.22 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.266 -1.013 . . . . 64.439999999999998 108.266 176.62 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.07 133.91 48.22 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.285 0.564 . . . . 75.310000000000002 109.563 -178.595 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -74.93 -53.86 6.08 Favored Glycine 0 C--N 1.281 -2.504 0 N-CA-C 110.603 -0.999 . . . . 75.310000000000002 110.603 -179.303 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.29 141.8 35.75 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.083 -0.558 . . . . 70.299999999999997 110.485 -179.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -117.21 124.53 49.32 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 104.311 -2.477 . . . . 72.109999999999999 104.311 168.136 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.17 117.06 51.02 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 109.156 -0.683 . . . . 74.109999999999999 109.156 -175.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -73.34 123.21 23.34 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.612 0.72 . . . . 75.239999999999995 109.118 179.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -132.23 -5.31 3.42 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 114.985 -1.007 . . . . 52.350000000000001 110.433 179.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 93.71 137.01 8.26 Favored Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 120.164 -1.017 . . . . 43.32 111.907 -178.369 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.71 -32.9 62.16 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 122.956 0.312 . . . . 62.399999999999999 113.542 -179.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 47.9 t -63.62 -23.93 67.59 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.054 0.93 . . . . 71.540000000000006 110.644 -175.686 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -89.46 -1.08 57.92 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.195 -0.911 . . . . 73.109999999999999 111.879 -174.723 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 60.5 m170 60.35 86.65 0.1 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.789 0.804 . . . . 72.129999999999995 111.652 -179.225 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -88.45 85.88 6.94 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.509 1.147 . . . . 75.219999999999999 112.241 -176.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -92.41 169.57 10.46 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 113.164 -1.835 . . . . 62.509999999999998 110.258 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 96.7 t -73.07 130.28 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 105.357 -2.09 . . . . 74.519999999999996 105.357 173.42 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.6 m -105.26 -28.97 2.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 120.2 -0.6 . . . . 73.120000000000005 112.371 -173.359 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -156.1 142.43 18.4 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 109.545 -0.539 . . . . 75.25 109.545 -176.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -121.42 138.63 54.19 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.13 -1.063 . . . . 73.340000000000003 108.13 175.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . 0.465 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 3.0 t-20 -60.26 -51.91 76.93 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 123.303 0.377 . . . . 73.239999999999995 111.023 -175.591 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.465 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.5 Cg_endo -88.84 118.74 0.97 Allowed 'Trans proline' 0 N--CA 1.437 -1.829 0 N-CA-C 107.934 -1.602 . . . . 62.549999999999997 107.934 169.138 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.54 159.68 39.47 Favored 'Trans proline' 0 C--O 1.249 1.042 0 C-N-CA 122.206 1.938 . . . . 74.120000000000005 112.681 -176.208 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -62.35 139.04 58.54 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.987 -0.551 . . . . 74.129999999999995 109.872 179.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.66 -8.74 60.12 Favored Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 120.189 -1.005 . . . . 65.230000000000004 111.668 -177.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 79.5 m -80.07 138.78 37.04 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.554 -0.906 . . . . 72.329999999999998 108.554 178.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -77.19 122.85 6.29 Favored Glycine 0 N--CA 1.419 -2.499 0 N-CA-C 110.379 -1.089 . . . . 74.420000000000002 110.379 177.847 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 28.4 m -112.49 141.84 26.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 108.697 -0.853 . . . . 75.219999999999999 108.697 177.071 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 559' ' ' ASN . 34.3 p-10 -54.89 173.37 0.09 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.536 0.734 . . . . 73.409999999999997 112.654 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -57.09 -24.92 57.44 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.524 0.935 . . . . 75.329999999999998 113.524 179.568 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -84.02 -9.67 58.47 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.557 -0.857 . . . . 52.43 110.077 178.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 65.33 19.03 66.02 Favored Glycine 0 C--O 1.22 -0.778 0 N-CA-C 114.576 0.59 . . . . 52.020000000000003 114.576 165.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.2 118.5 13.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-O 122.396 1.093 . . . . 74.319999999999993 112.135 -166.624 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.525 HG13 ' SD ' ' A' ' 563' ' ' MET . 0.0 OUTLIER -130.06 133.53 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 114.183 -1.371 . . . . 75.450000000000003 111.295 -176.473 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 42.0 m -105.06 126.74 52.4 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.614 -0.884 . . . . 75.129999999999995 108.614 178.843 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.3 pp -138.13 166.76 23.32 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.164 0.431 . . . . 70.519999999999996 112.164 -176.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -128.43 136.99 51.63 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.074 -0.713 . . . . 75.540000000000006 109.074 175.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -142.0 168.08 20.59 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.612 -1.255 . . . . 74.209999999999994 107.612 -174.363 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -70.52 -124.7 0.05 OUTLIER Glycine 0 CA--C 1.538 1.494 0 C-N-CA 119.177 -1.487 . . . . 64.310000000000002 110.765 172.572 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 . . . . . 0 C--N 1.27 -2.875 0 N-CA-C 108.729 -0.841 . . . . 74.549999999999997 108.729 175.761 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 113.084 0.772 . . . . 75.109999999999999 113.084 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 7.1 p -147.19 139.55 24.65 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 122.565 0.346 . . . . 74.310000000000002 110.29 -177.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -139.42 132.95 30.33 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.584 -0.895 . . . . 72.430000000000007 108.584 179.297 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.3 p-10 -95.1 135.26 36.86 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.43 0.633 . . . . 72.299999999999997 110.847 -177.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.4 pt -81.91 127.88 70.54 Favored Pre-proline 0 C--N 1.303 -1.449 0 CA-C-N 114.667 -1.151 . . . . 75.530000000000001 111.797 -175.588 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -82.3 178.48 6.24 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.319 2.013 . . . . 74.030000000000001 111.967 178.088 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -97.47 107.82 20.41 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 122.289 1.042 . . . . 72.25 110.075 178.448 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 25.7 m -111.39 18.75 7.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 114.4 -1.273 . . . . 74.209999999999994 109.566 179.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -74.16 100.6 3.71 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.734 -1.121 . . . . 74.209999999999994 110.342 -178.546 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 155.7 -41.53 0.58 Allowed Glycine 0 N--CA 1.426 -2.023 0 C-N-CA 120.953 -0.641 . . . . 62.329999999999998 111.641 177.576 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.461 ' O ' HG12 ' A' ' 534' ' ' VAL . 19.3 mp0 -77.13 -177.46 4.53 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.45 0.643 . . . . 70.219999999999999 110.381 -179.219 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 11.4 m -75.23 155.62 36.6 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 106.428 -1.693 . . . . 75.530000000000001 106.428 174.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.423 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.4 p -62.01 -42.13 93.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 118.166 0.439 . . . . 72.340000000000003 111.66 -178.285 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.91 -42.88 98.94 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 122.854 0.462 . . . . 75.140000000000001 110.609 178.678 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 82.3 t -67.6 -49.03 74.29 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.906 0 N-CA-C 109.139 -0.689 . . . . 64.219999999999999 109.139 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . 0.439 ' CB ' HG13 ' A' ' 534' ' ' VAL . . . -59.28 -43.49 92.54 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 122.717 0.407 . . . . 75.230000000000004 111.897 -177.699 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.9 mt-30 -63.32 -44.34 95.21 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 120.757 0.313 . . . . 74.430000000000007 110.287 179.688 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -67.23 -40.22 86.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.406 -0.361 . . . . 71.219999999999999 110.155 178.51 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . 0.606 ' O ' HG11 ' A' ' 514' ' ' VAL . 9.2 m-20 -62.47 -45.66 92.04 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.316 -0.857 . . . . 73.040000000000006 111.688 -178.122 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -69.05 -37.53 78.61 Favored 'General case' 0 C--O 1.211 -0.949 0 C-N-CA 119.683 -0.807 . . . . 72.430000000000007 110.722 -179.577 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.594 ' ND2' ' H ' ' A' ' 518' ' ' THR . 2.7 t-20 -64.36 -35.66 81.61 Favored 'General case' 0 N--CA 1.421 -1.915 0 C-N-CA 124.645 1.178 . . . . 70.040000000000006 111.108 -178.455 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.606 HG11 ' O ' ' A' ' 511' ' ' ASN . 5.0 p -67.26 -31.27 52.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.944 0.402 . . . . 72.409999999999997 110.764 -178.523 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -104.51 6.22 34.6 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.625 -0.509 . . . . 75.530000000000001 109.625 -179.58 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -131.1 -53.4 0.09 OUTLIER Glycine 0 CA--C 1.477 -2.31 0 C-N-CA 119.7 -1.238 . . . . 72.420000000000002 114.399 -168.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 65.16 77.32 0.31 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 106.939 -1.504 . . . . 71.349999999999994 106.939 -173.58 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 518' ' ' THR . . . . . 0.594 ' H ' ' ND2' ' A' ' 513' ' ' ASN . 3.3 p -140.29 177.1 8.23 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 115.061 -0.972 . . . . 74.540000000000006 111.539 -170.279 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.97 132.76 53.78 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.119 -1.438 . . . . 72.519999999999996 107.119 179.185 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -130.55 154.48 47.78 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.154 0.502 . . . . 73.219999999999999 112.095 -176.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 69.6 m -140.4 160.56 39.71 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 105.969 -1.863 . . . . 72.230000000000004 105.969 174.159 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . 0.405 ' HB2' ' CG2' ' A' ' 555' ' ' VAL . 3.8 pt20 -131.11 135.98 47.98 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.695 -0.802 . . . . 75.530000000000001 111.035 -178.895 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.72 129.22 56.39 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.601 -1.259 . . . . 73.450000000000003 107.601 178.343 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.8 m -100.59 124.74 46.57 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.244 0.545 . . . . 65.219999999999999 111.842 -177.668 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.54 150.82 24.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.444 -1.317 . . . . 72.310000000000002 107.444 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -91.35 135.3 33.91 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.445 -0.576 . . . . 54.340000000000003 109.445 179.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 52.3 m -160.53 162.86 22.63 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 107.549 -1.278 . . . . 74.209999999999994 107.549 -175.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -64.15 -8.54 16.66 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.699 2.266 . . . . 75.25 113.564 178.587 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -74.07 134.49 77.58 Favored Pre-proline 0 N--CA 1.432 -1.333 0 N-CA-C 107.437 -1.32 . . . . 71.209999999999994 107.437 175.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.53 149.82 89.69 Favored 'Trans proline' 0 C--O 1.249 1.063 0 C-N-CA 122.303 2.002 . . . . 74.230000000000004 112.495 -175.789 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.26 120.09 7.53 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.357 -0.838 . . . . 75.109999999999999 111.979 -176.72 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.53 -20.77 10.12 Favored Glycine 0 N--CA 1.428 -1.872 0 CA-C-N 114.98 -1.009 . . . . 61.229999999999997 111.414 177.645 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -78.67 137.15 37.67 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.345 -0.613 . . . . 72.329999999999998 109.345 179.046 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 503' ' ' GLN . 11.5 p -99.47 120.49 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.091 0 N-CA-C 108.566 -0.901 . . . . 75.430000000000007 108.566 -179.217 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.21 -1.43 44.72 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.097 -0.956 . . . . 70.120000000000005 112.072 178.948 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 132.67 -141.57 12.95 Favored Glycine 0 N--CA 1.419 -2.447 0 N-CA-C 111.226 -0.75 . . . . 51.219999999999999 111.226 175.265 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 2.2 p -116.61 157.14 25.83 Favored 'General case' 0 C--N 1.262 -3.217 0 N-CA-C 108.547 -0.908 . . . . 74.299999999999997 108.547 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.465 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 55.1 t30 -64.92 -53.51 41.92 Favored Pre-proline 0 C--N 1.324 -0.51 0 C-N-CA 120.087 -0.645 . . . . 75.549999999999997 109.923 175.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . 0.465 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 15.8 Cg_exo -71.66 137.63 30.48 Favored 'Trans proline' 0 C--N 1.372 1.782 0 N-CA-C 107.002 -1.961 . . . . 75.129999999999995 107.002 168.488 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -55.78 139.91 84.22 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.209 1.939 . . . . 75.209999999999994 113.384 -175.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.84 132.38 51.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.39 -0.823 . . . . 74.319999999999993 110.775 -178.356 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.75 -10.17 37.96 Favored Glycine 0 C--N 1.303 -1.253 0 N-CA-C 111.668 -0.573 . . . . 72.409999999999997 111.668 -175.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 86.8 m -77.46 129.02 35.19 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 122.817 -0.225 . . . . 72.010000000000005 110.517 179.563 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 11.3 t -82.14 125.55 31.02 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.095 -1.076 . . . . 73.239999999999995 108.095 174.926 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.73 160.0 53.23 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 109.189 -0.671 . . . . 74.099999999999994 109.189 -177.707 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -65.89 143.13 71.97 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.697 1.598 . . . . 72.510000000000005 110.14 177.054 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.44 -19.72 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 CA-C-O 121.591 0.71 . . . . 74.409999999999997 110.555 178.513 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.25 -12.76 59.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.884 -0.598 . . . . 75.299999999999997 111.848 176.18 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 10.2 t -93.06 148.19 22.21 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.92 -0.77 . . . . 75.019999999999996 108.92 -179.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 9.9 p -91.79 138.71 19.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 115.836 -0.62 . . . . 73.439999999999998 111.508 -177.062 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 60.0 mt -80.72 124.28 38.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.417 -0.957 . . . . 74.319999999999993 108.417 177.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -103.65 117.9 35.48 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.305 -0.998 . . . . 71.430000000000007 108.305 -178.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.5 128.54 41.15 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.253 0.621 . . . . 75.540000000000006 111.485 -178.561 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -83.0 102.76 11.96 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 123.204 0.602 . . . . 75.25 110.061 177.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' A' ' 522' ' ' GLN . 25.9 t -95.94 123.58 48.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.407 -0.961 . . . . 74.120000000000005 108.407 -179.654 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 51.1 m -95.07 127.99 41.55 Favored 'General case' 0 N--CA 1.409 -2.481 0 CA-C-O 121.457 0.646 . . . . 73.129999999999995 111.413 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 18.2 ptpt -100.12 135.23 41.87 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 106.453 -1.684 . . . . 72.329999999999998 106.453 170.472 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -55.03 -22.88 29.86 Favored Glycine 0 CA--C 1.503 -0.676 0 O-C-N 124.698 1.249 . . . . 71.299999999999997 115.077 -172.748 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 81.73 -24.4 0.19 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.449 1.499 . . . . 71.209999999999994 109.755 -178.437 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.427 ' H ' ' C ' ' A' ' 558' ' ' GLY . 91.6 mt-30 -113.25 158.02 21.02 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.391 -0.822 . . . . 71.319999999999993 110.913 -176.852 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -127.02 150.21 49.54 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.217 -1.031 . . . . 75.430000000000007 108.217 175.359 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 31.0 t -71.28 118.14 15.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.588 -0.523 . . . . 73.450000000000003 109.588 -178.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 563' ' ' MET . . . . . 0.596 ' SD ' HG23 ' A' ' 620' ' ' ILE . 49.4 ttp -87.13 129.13 52.99 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-N 116.119 -0.491 . . . . 73.239999999999995 111.147 -176.314 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.49 169.55 22.28 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.529 2.153 . . . . 75.219999999999999 111.114 174.027 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -74.63 142.12 44.59 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.986 0.422 . . . . 73.099999999999994 110.375 179.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -135.05 15.46 3.53 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.936 0.874 . . . . 74.030000000000001 109.179 177.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 31.6 t -79.22 139.38 37.95 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.118 -0.947 . . . . 74.340000000000003 108.867 178.71 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 97.03 26.0 10.74 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.462 -0.875 . . . . 71.010000000000005 114.022 176.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.9 -175.55 3.71 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.964 -0.754 . . . . 74.530000000000001 108.964 177.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -117.06 159.07 23.11 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.65 -1.241 . . . . 75.219999999999999 107.65 -175.309 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . 0.407 ' CH2' ' HB3' ' A' ' 589' ' ' LYS . 27.2 t-105 -63.48 -24.81 67.98 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.324 0.583 . . . . 74.450000000000003 110.21 -176.398 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.0 m -66.97 -18.94 24.99 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 CA-C-N 115.025 -0.989 . . . . 63.140000000000001 110.735 179.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.535 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 22.9 t70 -101.69 -28.56 12.41 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.078 -0.712 . . . . 71.420000000000002 109.078 177.759 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -56.47 -47.52 79.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.962 0.905 . . . . 75.519999999999996 112.676 -178.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -64.25 -47.98 77.36 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 119.633 -0.827 . . . . 75.329999999999998 112.769 178.568 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -52.66 -37.2 74.65 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 121.999 1.8 . . . . 74.409999999999997 112.796 171.057 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 6.4 mmp_? -59.35 -44.27 92.7 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 109.347 -0.612 . . . . 75.409999999999997 109.347 176.446 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 1.7 tp -59.85 -49.57 77.19 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-N 115.271 -0.877 . . . . 65.120000000000005 111.44 -176.149 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -66.73 -40.93 88.55 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.712 0.634 . . . . 73.129999999999995 112.712 176.682 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.62 -37.68 73.84 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.908 0.707 . . . . 75.329999999999998 112.908 -177.257 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.89 -8.93 59.53 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 122.14 -0.35 . . . . 72.519999999999996 110.962 -174.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.26 47.03 18.7 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.145 -0.782 . . . . 43.219999999999999 111.145 -179.68 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . 0.559 ' CH2' ' HG ' ' A' ' 587' ' ' LEU . 12.4 t90 -87.18 127.86 35.14 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 121.636 0.731 . . . . 74.319999999999993 110.134 -178.689 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 27.0 m -89.1 -17.45 29.24 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 124.367 1.067 . . . . 71.340000000000003 112.947 -174.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -96.79 -171.04 34.2 Favored Glycine 0 CA--C 1.497 -1.038 0 C-N-CA 121.372 -0.442 . . . . 64.129999999999995 113.223 -176.142 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 81.4 mtp -117.73 155.85 29.27 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 120.908 0.385 . . . . 72.439999999999998 110.878 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . 0.559 ' HG ' ' CH2' ' A' ' 583' ' ' TRP . 5.0 mt -80.31 125.56 30.05 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 115.076 -0.965 . . . . 75.420000000000002 112.245 -178.48 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 621' ' ' THR . 2.4 m-20 -110.93 118.11 35.21 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.269 -1.332 . . . . 74.409999999999997 110.122 176.313 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . 0.407 ' HB3' ' CH2' ' A' ' 571' ' ' TRP . 0.0 OUTLIER -107.33 133.83 51.29 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 120.176 -0.61 . . . . 75.430000000000007 109.39 -178.961 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -78.59 -69.85 1.36 Allowed Glycine 0 C--N 1.284 -2.322 0 CA-C-N 115.354 -0.839 . . . . 65.120000000000005 111.176 -179.686 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.09 149.24 42.84 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.706 0.288 . . . . 61.130000000000003 111.508 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -96.61 124.09 40.49 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 105.925 -1.88 . . . . 74.239999999999995 105.925 170.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 40.2 t -105.76 119.99 55.9 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.5 0 CA-C-N 115.683 -0.69 . . . . 75.349999999999994 109.832 -175.601 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -73.54 107.06 5.6 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.37 -0.974 . . . . 71.109999999999999 108.37 176.506 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -107.84 -39.75 5.47 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.432 0.634 . . . . 63.329999999999998 110.014 -179.338 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 114.34 152.06 10.49 Favored Glycine 0 N--CA 1.412 -2.9 0 N-CA-C 110.674 -0.971 . . . . 65.340000000000003 110.674 -177.225 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.98 -32.66 62.74 Favored Glycine 0 C--N 1.305 -1.174 0 C-N-CA 123.287 0.47 . . . . 55.43 113.1 -179.592 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 4.3 p -69.59 -24.92 63.74 Favored 'General case' 0 N--CA 1.422 -1.859 0 C-N-CA 124.283 1.033 . . . . 41.130000000000003 111.608 -176.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -93.95 -14.18 26.25 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.602 -0.726 . . . . 73.25 109.971 -177.006 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 65.1 m80 56.69 108.73 0.01 OUTLIER 'General case' 0 C--O 1.238 0.47 0 O-C-N 124.345 1.028 . . . . 63.32 111.684 -173.691 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -73.53 75.52 1.46 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.943 -1.026 . . . . 75.519999999999996 113.404 -172.177 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -86.5 171.24 11.24 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 124.702 1.201 . . . . 74.329999999999998 109.001 177.674 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.93 129.75 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.666 -1.976 . . . . 74.120000000000005 105.666 169.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 14.5 p -96.64 -32.32 4.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 120.13 -0.628 . . . . 72.099999999999994 110.424 -174.311 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -151.3 134.94 16.32 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 116.182 -0.463 . . . . 74.109999999999999 110.62 -179.449 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -106.54 130.16 54.36 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.321 -1.362 . . . . 71.120000000000005 107.321 172.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -55.33 -55.52 38.85 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 113.654 0.983 . . . . 74.299999999999997 113.654 -176.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -87.71 131.73 2.86 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.14 1.227 . . . . 71.510000000000005 110.433 175.589 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -64.88 160.32 41.64 Favored 'Trans proline' 0 C--O 1.253 1.234 0 C-N-CA 122.642 2.228 . . . . 75.400000000000006 112.383 177.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -64.8 138.5 58.42 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.15 -0.685 . . . . 75.329999999999998 109.15 177.519 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 91.84 0.4 71.96 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 119.8 -1.19 . . . . 75.349999999999994 111.912 -179.178 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 24.0 m -90.35 146.31 24.28 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.881 -0.785 . . . . 75.319999999999993 108.881 178.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -83.56 123.2 6.06 Favored Glycine 0 N--CA 1.419 -2.45 0 N-CA-C 110.962 -0.855 . . . . 74.340000000000003 110.962 177.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.9 m -111.44 142.55 23.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 107.901 -1.148 . . . . 74.420000000000002 107.901 176.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.407 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 37.8 p30 -46.1 163.09 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 113.769 1.026 . . . . 73.030000000000001 113.769 179.077 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -57.15 -25.31 58.71 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.331 -0.85 . . . . 73.200000000000003 112.219 177.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.35 -10.96 59.75 Favored 'General case' 0 C--O 1.214 -0.802 0 C-N-CA 119.372 -0.931 . . . . 74.219999999999999 109.254 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.85 11.42 57.87 Favored Glycine 0 CA--C 1.494 -1.264 0 C-N-CA 123.455 0.55 . . . . 71.120000000000005 112.885 167.344 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.96 118.77 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.114 0 CA-C-O 122.44 1.114 . . . . 74.540000000000006 110.985 -169.638 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.596 HG23 ' SD ' ' A' ' 563' ' ' MET . 2.7 pp -124.95 133.92 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 CA-C-N 113.74 -1.573 . . . . 73.230000000000004 111.813 -177.943 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 28.3 m -99.0 130.52 45.34 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.669 -1.234 . . . . 74.209999999999994 107.669 177.369 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -138.65 162.78 33.77 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 110.145 -0.316 . . . . 71.219999999999999 110.145 -178.157 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -128.1 136.98 51.92 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.221 -1.4 . . . . 75.109999999999999 107.221 178.202 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -141.92 167.53 21.92 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.997 -0.547 . . . . 73.040000000000006 110.127 -168.432 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -64.55 -170.43 2.21 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-O 121.944 0.747 . . . . 64.299999999999997 113.633 176.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 . . . . . 0 C--N 1.28 -2.418 0 C-N-CA 124.066 0.946 . . . . 74.409999999999997 111.0 -175.91 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.58 0 CA-C-O 121.42 0.629 . . . . 74.200000000000003 111.476 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 33.2 p -136.87 148.56 47.15 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 115.5 -0.773 . . . . 74.230000000000004 110.251 -178.622 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -140.66 153.54 46.04 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.026 -0.731 . . . . 74.430000000000007 109.026 176.213 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -90.2 140.77 29.35 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.215 0.531 . . . . 71.310000000000002 110.148 -178.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 22.8 pt -101.98 112.71 65.66 Favored Pre-proline 0 C--N 1.301 -1.515 0 CA-C-N 115.592 -0.731 . . . . 74.549999999999997 110.57 177.705 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -69.65 167.68 23.6 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.439 2.092 . . . . 74.239999999999995 112.264 177.46 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -75.2 96.11 3.25 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.477 0.656 . . . . 74.239999999999995 110.207 179.183 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 31.5 m -94.81 9.33 5.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 115.259 -0.882 . . . . 75.420000000000002 110.055 177.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.71 101.04 1.99 Allowed 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 114.638 -1.165 . . . . 65.549999999999997 110.222 -179.146 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 147.41 -23.18 1.53 Allowed Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 115.455 -0.793 . . . . 71.219999999999999 111.846 178.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.418 ' O ' HG11 ' A' ' 534' ' ' VAL . 1.9 mp0 -94.06 178.47 5.64 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 108.62 -0.881 . . . . 73.400000000000006 108.62 179.518 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 24.8 m -72.05 155.33 40.43 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.487 -1.301 . . . . 74.129999999999995 107.487 176.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.46 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.7 p -61.94 -43.21 97.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 111.42 0.156 . . . . 72.019999999999996 111.42 -178.73 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.16 -39.2 93.97 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 110.088 -0.338 . . . . 74.310000000000002 110.088 -179.314 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 99.7 t -69.06 -46.93 77.71 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 CA-C-N 115.142 -0.936 . . . . 74.5 109.748 -179.72 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.59 -44.38 96.29 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 122.99 0.181 . . . . 73.209999999999994 111.251 178.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.9 mt-30 -64.14 -46.55 83.62 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 120.699 0.285 . . . . 74.430000000000007 111.233 -178.912 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.44 ' O ' HG22 ' A' ' 514' ' ' VAL . 21.2 ptmt -67.1 -38.63 85.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.028 -0.533 . . . . 72.299999999999997 110.199 -178.099 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -67.13 -43.98 81.04 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.681 -0.69 . . . . 72.420000000000002 110.648 -179.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.07 -41.33 98.06 Favored 'General case' 0 C--O 1.207 -1.16 0 N-CA-C 108.317 -0.994 . . . . 74.430000000000007 108.317 -179.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -59.64 -34.89 73.38 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 124.12 0.968 . . . . 74.329999999999998 111.054 -179.688 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 510' ' ' LYS . 97.7 t -57.66 -38.2 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-O 121.168 0.508 . . . . 70.329999999999998 111.118 178.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.43 19.81 13.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 122.123 0.963 . . . . 73.340000000000003 111.159 -178.814 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -128.81 -59.43 0.11 Allowed Glycine 0 N--CA 1.416 -2.665 0 CA-C-N 114.68 -1.146 . . . . 71.430000000000007 111.595 -177.246 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 63.95 24.56 13.67 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 122.058 0.932 . . . . 75.420000000000002 110.016 -174.708 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 6.4 p -84.18 -179.66 7.27 Favored 'General case' 0 N--CA 1.404 -2.746 0 CA-C-N 113.984 -1.462 . . . . 72.010000000000005 110.277 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 56.7 mtpt -108.43 134.23 51.52 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.448 -1.686 . . . . 72.219999999999999 106.448 179.486 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -132.89 154.28 50.54 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 112.871 0.693 . . . . 72.450000000000003 112.871 -175.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 34.2 p -140.03 156.34 46.66 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.789 -1.189 . . . . 64.310000000000002 107.789 176.3 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -124.84 145.21 49.9 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.979 -0.288 . . . . 74.450000000000003 111.186 -178.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -132.59 117.53 18.06 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.388 -0.597 . . . . 53.450000000000003 109.388 177.526 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 524' ' ' SER . . . . . 0.416 ' HA ' ' HB ' ' A' ' 555' ' ' VAL . 49.1 m -84.53 116.76 23.3 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.535 0.683 . . . . 74.310000000000002 110.157 178.58 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 44.9 t -120.96 149.81 23.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 106.435 -1.691 . . . . 72.530000000000001 106.435 -176.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -68.29 134.52 50.48 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 120.717 0.294 . . . . 54.530000000000001 110.588 -176.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 49.3 m -163.08 160.51 18.72 Favored Pre-proline 0 C--O 1.208 -1.116 0 N-CA-C 108.397 -0.964 . . . . 71.409999999999997 108.397 -179.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -73.48 3.35 4.84 Favored 'Trans proline' 0 CA--C 1.556 1.623 0 C-N-CA 122.624 2.216 . . . . 75.530000000000001 113.651 178.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . 0.477 ' HD2' ' N ' ' A' ' 529' ' ' ARG . 2.7 mpt_? -92.39 140.02 24.1 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 107.992 -1.114 . . . . 73.209999999999994 107.992 177.114 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -62.19 150.75 85.65 Favored 'Trans proline' 0 C--O 1.254 1.324 0 C-N-CA 122.847 2.365 . . . . 73.319999999999993 113.052 -176.438 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.612 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.47 110.11 1.18 Allowed 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.196 -0.911 . . . . 62.119999999999997 112.253 -174.752 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 136.86 -26.92 2.97 Favored Glycine 0 N--CA 1.433 -1.5 0 C-N-CA 120.621 -0.799 . . . . 73.049999999999997 112.394 177.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -82.03 140.57 33.84 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.044 0.45 . . . . 74.329999999999998 110.558 -178.281 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.418 HG11 ' O ' ' A' ' 503' ' ' GLN . 7.9 p -96.96 118.24 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 CA-C-O 121.687 0.756 . . . . 75.019999999999996 109.162 -179.509 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -25.77 54.46 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 114.853 -1.067 . . . . 73.209999999999994 110.999 179.275 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 162.44 -164.69 35.76 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 120.547 -0.835 . . . . 63.409999999999997 111.776 179.172 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 1.7 p -116.87 157.9 24.87 Favored 'General case' 0 C--N 1.282 -2.336 0 C-N-CA 123.184 0.594 . . . . 61.009999999999998 109.639 -178.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -58.33 -54.46 55.68 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 120.712 -0.395 . . . . 72.519999999999996 110.657 175.533 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -73.2 135.99 23.68 Favored 'Trans proline' 0 C--N 1.359 1.102 0 N-CA-C 108.337 -1.447 . . . . 70.439999999999998 108.337 168.734 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.16 140.93 94.78 Favored 'Trans proline' 0 C--O 1.245 0.852 0 C-N-CA 122.406 2.071 . . . . 71.239999999999995 112.445 -178.069 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.46 140.48 58.03 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.955 -0.566 . . . . 72.340000000000003 110.004 -179.507 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.78 -15.09 55.94 Favored Glycine 0 C--N 1.3 -1.454 0 N-CA-C 110.775 -0.93 . . . . 74.209999999999994 110.775 -175.806 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.7 m -85.16 138.22 32.52 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 122.802 0.441 . . . . 63.25 109.955 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 8.0 t -76.29 128.06 34.14 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 108.645 -0.872 . . . . 72.25 108.645 173.057 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 32.1 m -123.78 154.79 67.23 Favored Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 108.691 -0.855 . . . . 70.129999999999995 108.691 -179.078 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -64.88 134.84 41.84 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 120.693 0.929 . . . . 74.109999999999999 111.703 178.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 8.6 p -67.38 -27.46 38.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.902 -1.044 . . . . 73.200000000000003 112.907 -176.206 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -90.19 -7.04 54.57 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.534 0.683 . . . . 71.030000000000001 110.908 -175.433 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.1 t -89.79 179.14 6.06 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.131 0.491 . . . . 63.109999999999999 109.684 -178.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 12.2 p -107.6 128.7 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.261 0 CA-C-N 115.511 -0.768 . . . . 75.019999999999996 109.82 -177.605 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 60.2 mt -93.22 135.95 26.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 108.4 -0.963 . . . . 75.25 108.4 -179.691 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -103.33 117.86 35.45 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.652 -0.499 . . . . 72.540000000000006 109.652 -176.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -95.46 120.83 36.38 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 123.748 0.819 . . . . 75.540000000000006 109.464 179.187 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -88.13 110.55 20.75 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.293 0.568 . . . . 75.340000000000003 109.964 178.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 524' ' ' SER . 15.7 t -96.47 135.86 29.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 107.796 -1.187 . . . . 65.329999999999998 107.796 -178.201 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.612 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 68.7 m -89.19 124.65 34.56 Favored 'General case' 0 N--CA 1.4 -2.959 0 C-N-CA 120.375 -0.53 . . . . 71.340000000000003 110.304 176.709 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -97.79 131.21 44.5 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 104.384 -2.451 . . . . 72.540000000000006 104.384 166.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -56.14 -26.37 49.45 Favored Glycine 0 CA--C 1.491 -1.448 0 O-C-N 124.258 0.974 . . . . 72.019999999999996 112.303 -175.173 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 57.2 t30 68.38 21.64 8.23 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 123.035 1.398 . . . . 75.200000000000003 108.716 174.159 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.463 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 63.4 mt-30 -126.94 145.27 50.75 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 113.176 -1.829 . . . . 74.400000000000006 107.183 177.993 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -122.8 149.5 44.07 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 120.605 -0.438 . . . . 73.099999999999994 110.174 -177.134 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.74 115.51 7.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 O-C-N 123.83 0.706 . . . . 74.540000000000006 109.111 -178.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 563' ' ' MET . . . . . 0.504 ' SD ' HG22 ' A' ' 620' ' ' ILE . 35.7 ttp -79.85 123.24 83.87 Favored Pre-proline 0 C--N 1.306 -1.285 0 CA-C-N 115.575 -0.739 . . . . 75.299999999999997 111.747 -175.657 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . 0.426 ' HG2' ' HB2' ' A' ' 581' ' ' LEU . 20.8 Cg_exo -68.76 156.73 64.49 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.945 2.43 . . . . 73.209999999999994 110.773 174.4 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.97 123.48 28.36 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.761 0.791 . . . . 73.209999999999994 110.702 179.009 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.81 14.07 12.45 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.903 -1.517 . . . . 75.420000000000002 106.903 173.411 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 3.0 m -69.13 140.46 54.73 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 112.967 -1.924 . . . . 73.239999999999995 110.18 -177.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 73.72 70.53 1.22 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 116.276 -0.42 . . . . 61.119999999999997 113.46 177.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 22.1 ptp -174.07 172.21 3.41 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.742 -0.836 . . . . 65.010000000000005 108.742 179.28 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . 0.402 ' HB2' HG11 ' A' ' 572' ' ' VAL . 95.7 m-85 -100.36 178.66 4.69 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.478 -0.934 . . . . 74.349999999999994 108.478 178.275 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -64.76 -28.71 69.77 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.806 0.336 . . . . 74.299999999999997 110.259 -177.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . 0.402 HG11 ' HB2' ' A' ' 570' ' ' PHE . 12.7 p -58.02 -30.05 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 123.339 0.656 . . . . 62.539999999999999 111.789 179.598 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . 0.486 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 29.5 m-20 -100.81 -38.65 8.17 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 120.982 -0.287 . . . . 75.400000000000006 110.313 175.762 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.11 90.1 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.357 0.873 . . . . 73.439999999999998 113.357 -176.658 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . 0.644 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 31.4 tt0 -65.3 -50.71 57.77 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 120.42 -0.512 . . . . 64.409999999999997 111.06 -179.193 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 71.2 Cg_exo -56.19 -35.74 95.73 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 121.314 1.342 . . . . 70.299999999999997 111.911 172.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 14.5 mmt180 -64.76 -38.49 91.16 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 111.711 0.263 . . . . 72.549999999999997 111.711 178.44 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.1 pp -65.93 -46.36 78.48 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.126 -0.63 . . . . 71.329999999999998 110.561 -176.762 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . 0.468 ' N ' HD13 ' A' ' 578' ' ' LEU . 11.9 ptm180 -66.35 -39.54 89.23 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.027 -0.533 . . . . 71.450000000000003 112.058 176.045 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.56 -27.31 64.04 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 112.567 0.58 . . . . 55.439999999999998 112.567 -177.537 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . 0.426 ' HB2' ' HG2' ' A' ' 564' ' ' PRO . 2.3 pp -92.28 -8.46 45.17 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 119.867 -0.733 . . . . 75.120000000000005 110.426 -179.677 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 77.27 48.69 8.0 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 120.633 -0.794 . . . . 75.329999999999998 111.323 -178.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -84.49 127.45 34.04 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.095 -1.076 . . . . 72.319999999999993 108.095 177.54 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 3.4 p -90.35 -5.52 56.11 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 124.71 1.204 . . . . 74.5 113.114 -175.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -114.09 -168.57 16.4 Favored Glycine 0 C--N 1.302 -1.346 0 N-CA-C 111.66 -0.576 . . . . 70.5 111.66 -179.516 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 26.4 mmt -121.15 153.86 36.96 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 110.087 -0.338 . . . . 74.420000000000002 110.087 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 6.3 tt -83.26 127.32 33.54 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.608 -0.886 . . . . 73.040000000000006 108.608 -178.159 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -125.08 116.48 22.15 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.165 -0.679 . . . . 75.140000000000001 109.165 178.434 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.63 133.56 36.84 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 118.756 -1.177 . . . . 75.439999999999998 110.636 177.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -78.97 -41.58 14.05 Favored Glycine 0 C--N 1.285 -2.298 0 CA-C-N 114.603 -1.181 . . . . 74.150000000000006 112.956 -172.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -138.29 142.04 39.82 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.77 -0.455 . . . . 71.319999999999993 109.77 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -111.78 125.13 53.66 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.907 -1.516 . . . . 72.439999999999998 106.907 175.452 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.68 116.79 48.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 N-CA-C 107.902 -1.147 . . . . 73.409999999999997 107.902 179.17 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . 0.442 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 5.3 p-10 -73.96 107.12 5.98 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.022 0.915 . . . . 63.140000000000001 112.483 -176.777 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -146.68 -61.34 0.3 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.184 -1.413 . . . . 72.340000000000003 107.184 175.377 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 132.31 147.56 5.89 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 120.132 -1.033 . . . . 53.119999999999997 112.283 177.365 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.66 -33.36 62.7 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 122.745 0.212 . . . . 74.540000000000006 113.508 -178.695 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 3.3 m -62.96 -23.52 67.45 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.534 1.134 . . . . 73.230000000000004 111.092 -177.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -87.44 0.55 55.34 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 124.801 1.24 . . . . 71.150000000000006 111.111 -175.082 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 66.3 m80 71.78 32.71 1.88 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.783 1.278 . . . . 75.239999999999995 109.098 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . 0.428 ' CG ' ' HA3' ' A' ' 625' ' ' GLY . 2.2 t-20 -82.31 41.82 0.71 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 112.815 -1.993 . . . . 71.439999999999998 109.84 -175.839 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -74.22 174.45 8.74 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 126.282 1.833 . . . . 74.239999999999995 110.303 178.686 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.6 129.86 17.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.242 -1.022 . . . . 73.25 108.242 -178.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 24.7 m -106.3 -28.27 2.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.606 -0.725 . . . . 74.129999999999995 111.271 -176.67 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -156.74 141.64 17.06 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.144 -0.48 . . . . 74.150000000000006 111.081 -178.268 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -122.64 142.05 51.07 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.138 -1.43 . . . . 75.430000000000007 107.138 172.471 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -58.05 -50.09 90.02 Favored Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 113.312 0.856 . . . . 75.010000000000005 113.312 -175.077 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -89.86 128.2 1.62 Allowed 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 121.068 1.179 . . . . 63.5 110.823 174.316 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.3 151.01 65.75 Favored 'Trans proline' 0 C--O 1.247 0.936 0 C-N-CA 122.446 2.098 . . . . 71.120000000000005 112.37 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.69 135.68 57.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.332 -0.394 . . . . 72.340000000000003 110.438 178.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.09 -11.88 48.66 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.386 -0.911 . . . . 65.019999999999996 112.38 -179.714 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 4.7 t -90.09 167.91 12.39 Favored 'General case' 0 C--O 1.255 1.373 0 C-N-CA 119.682 -0.807 . . . . 75.129999999999995 109.197 -179.361 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -90.83 117.5 5.14 Favored Glycine 0 N--CA 1.427 -1.929 0 N-CA-C 111.432 -0.667 . . . . 75.030000000000001 111.432 -178.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.03 142.58 16.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 109.686 -0.487 . . . . 75.530000000000001 109.686 178.06 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.463 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 28.9 p-10 -51.07 165.16 0.13 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.26 1.024 . . . . 71.329999999999998 112.187 -179.213 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -58.8 -25.12 62.84 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.554 0.576 . . . . 75.219999999999999 112.554 -178.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -80.81 -9.23 59.83 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.66 -0.496 . . . . 71.040000000000006 109.66 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.4 -0.89 5.87 Favored Glycine 0 C--O 1.211 -1.291 0 C-N-CA 124.756 1.169 . . . . 72.519999999999996 114.247 171.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.45 119.43 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 CA-C-O 122.266 1.032 . . . . 63.119999999999997 112.051 -164.008 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.504 HG22 ' SD ' ' A' ' 563' ' ' MET . 2.5 pp -125.68 133.98 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 CA-C-N 114.288 -1.324 . . . . 75.030000000000001 109.313 -178.529 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 11.5 t -101.52 139.23 37.45 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 108.31 -0.996 . . . . 74.409999999999997 108.31 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.6 pp -138.64 168.73 19.15 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.738 -0.665 . . . . 74.239999999999995 111.215 -174.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -123.95 137.06 54.68 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.1 -1.445 . . . . 73.439999999999998 107.1 -178.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . 0.279 0.2 OUTLIER -135.85 166.17 23.93 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.207 -1.361 . . . . 74.420000000000002 108.164 -161.952 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . 0.428 ' HA3' ' CG ' ' A' ' 601' ' ' ASN . . . -84.57 -140.72 4.91 Favored Glycine 0 N--CA 1.407 -3.274 0 C-N-CA 119.286 -1.435 . . . . 62.399999999999999 110.31 166.762 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.442 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 8.3 tp-100 . . . . . 0 C--N 1.283 -2.301 0 CA-C-O 118.275 -0.869 . . . . 73.140000000000001 108.924 -179.139 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 493' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . . . . . . 0 N--CA 1.462 0.156 0 N-CA-C 112.935 0.717 . . . . 72.319999999999993 112.935 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 13.8 p -145.79 140.31 27.04 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 122.283 -0.26 . . . . 74.109999999999999 111.172 -177.053 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -141.85 154.44 45.16 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.623 -0.51 . . . . 75.310000000000002 109.623 178.068 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.4 p-10 -89.5 144.23 26.2 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.167 0.508 . . . . 74.319999999999993 111.365 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.5 pt -99.85 137.71 20.22 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 115.506 -0.77 . . . . 63.439999999999998 110.954 -179.517 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -82.21 163.67 17.42 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.111 1.874 . . . . 72.439999999999998 111.197 176.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.16 103.93 8.41 Favored 'General case' 0 CA--C 1.491 -1.312 0 CA-C-O 122.647 1.213 . . . . 74.239999999999995 109.454 176.079 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 15.0 m -106.99 63.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.437 0 CA-C-O 123.219 1.485 . . . . 74.200000000000003 110.394 -177.514 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 501' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -118.54 110.84 17.86 Favored 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 112.357 -2.201 . . . . 63.200000000000003 108.683 172.306 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 145.3 -37.4 1.31 Allowed Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 119.768 -1.206 . . . . 54.039999999999999 112.715 177.621 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 503' ' ' GLN . . . . . 0.474 ' O ' HG11 ' A' ' 534' ' ' VAL . 0.5 OUTLIER -95.79 -175.16 3.34 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.494 -0.558 . . . . 71.140000000000001 109.494 -178.614 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 24.4 m -72.02 155.38 40.38 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.34 -0.985 . . . . 75.219999999999999 108.34 176.587 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.444 ' HA ' ' HB ' ' A' ' 534' ' ' VAL . 7.1 p -61.25 -41.75 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 116.41 -0.359 . . . . 71.420000000000002 111.846 -179.398 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 506' ' ' ASP . . . . . 0.539 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 35.5 t70 -65.26 -39.98 93.35 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 110.02 -0.363 . . . . 73.25 110.02 179.166 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.58 -42.61 93.34 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 N-CA-C 109.434 -0.58 . . . . 74.430000000000007 109.434 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.26 -44.43 96.57 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 123.456 0.473 . . . . 75.439999999999998 111.275 175.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -63.01 -45.42 92.43 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 120.505 0.193 . . . . 73.340000000000003 111.284 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 32.2 mmmt -65.0 -39.49 93.53 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.514 -0.55 . . . . 74.340000000000003 109.514 178.814 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -61.27 -49.81 75.55 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.678 -1.146 . . . . 74.310000000000002 110.247 -177.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.95 -34.71 75.78 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.496 -0.774 . . . . 75.049999999999997 110.894 -177.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.41 ' ND2' ' HA ' ' A' ' 517' ' ' PHE . 1.7 t-20 -61.6 -38.01 86.02 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.79 -0.641 . . . . 65.25 110.272 179.717 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 510' ' ' LYS . 69.3 t -59.51 -33.84 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.035 0.445 . . . . 75.319999999999993 111.268 178.309 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -111.89 15.9 20.59 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.372 0.606 . . . . 74.120000000000005 109.806 -177.253 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -141.17 -60.6 0.03 OUTLIER Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 119.969 -1.11 . . . . 72.030000000000001 113.919 -172.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 517' ' ' PHE . . . . . 0.41 ' HA ' ' ND2' ' A' ' 513' ' ' ASN . 79.5 m-85 63.54 41.48 7.31 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 122.667 1.222 . . . . 64.310000000000002 109.281 -173.642 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 518' ' ' THR . . . . . 0.466 HG22 ' HA ' ' A' ' 547' ' ' VAL . 14.8 p -95.27 -171.68 2.47 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 113.58 -1.646 . . . . 74.230000000000004 110.48 -178.847 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -107.91 137.49 45.82 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.346 -1.724 . . . . 73.219999999999999 106.346 174.719 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -132.92 151.87 51.98 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 112.233 0.457 . . . . 74.120000000000005 112.233 -178.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 52.8 p -139.6 159.42 42.21 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.168 -1.049 . . . . 63.030000000000001 108.168 176.571 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -117.5 134.23 55.09 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.638 -0.425 . . . . 72.25 110.708 177.671 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -112.28 126.74 55.57 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.573 -0.899 . . . . 74.519999999999996 108.573 177.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 6.5 p -96.03 130.55 43.01 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.192 0.52 . . . . 51.420000000000002 111.601 -178.032 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 11.4 p -139.86 156.28 25.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 106.654 -1.61 . . . . 75.349999999999994 106.654 177.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 526' ' ' ASP . . . . . 0.435 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 4.1 p30 -96.24 136.44 36.72 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 120.168 -0.613 . . . . 64.540000000000006 111.921 -179.707 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.4 m -161.84 161.04 22.29 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 107.061 -1.459 . . . . 73.519999999999996 107.061 179.352 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -66.57 8.61 0.31 Allowed 'Trans proline' 0 CA--C 1.557 1.653 0 C-N-CA 122.799 2.333 . . . . 72.409999999999997 114.559 -178.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.74 132.11 47.39 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 107.0 -1.481 . . . . 74.329999999999998 107.0 174.782 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -59.85 142.49 98.7 Favored 'Trans proline' 0 C--O 1.253 1.271 0 C-N-CA 122.261 1.974 . . . . 71.109999999999999 112.486 -177.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.39 107.43 0.49 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.04 -0.982 . . . . 74.409999999999997 111.219 -177.59 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 140.1 -28.85 2.46 Favored Glycine 0 N--CA 1.429 -1.794 0 CA-C-N 115.267 -0.879 . . . . 71.120000000000005 111.009 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -76.83 125.67 29.67 Favored 'General case' 0 C--O 1.251 1.144 0 CA-C-O 121.672 0.748 . . . . 73.349999999999994 110.292 -179.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 534' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 503' ' ' GLN . 7.1 p -82.15 121.99 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.927 0 N-CA-C 107.611 -1.255 . . . . 73.409999999999997 107.611 177.429 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.74 16.85 11.39 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 113.638 -1.619 . . . . 53.030000000000001 110.361 -173.247 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 115.58 -161.68 12.77 Favored Glycine 0 N--CA 1.424 -2.124 0 N-CA-C 111.405 -0.678 . . . . 70.239999999999995 111.405 177.765 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 9.6 p -117.16 154.76 30.52 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 109.274 -0.639 . . . . 72.239999999999995 109.274 -179.184 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 538' ' ' ASN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 552' ' ' GLU . 20.9 t-20 -63.95 -53.02 52.38 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 119.735 -0.786 . . . . 64.129999999999995 110.932 173.31 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -67.11 145.99 75.09 Favored 'Trans proline' 0 C--N 1.378 2.125 0 N-CA-C 108.773 -1.279 . . . . 71.329999999999998 108.773 171.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.84 140.7 94.64 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 122.281 1.987 . . . . 70.230000000000004 112.493 -178.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.83 137.95 55.74 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.981 -0.554 . . . . 71.510000000000005 109.534 178.72 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 96.52 -14.66 63.96 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 121.001 -0.619 . . . . 72.129999999999995 111.894 -178.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 43.4 m -79.72 137.42 37.03 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-O 121.027 0.441 . . . . 64.420000000000002 110.919 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 544' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.3 t -80.78 124.45 29.07 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 121.503 0.668 . . . . 74.430000000000007 109.571 177.551 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.43 159.15 56.33 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.996 -1.113 . . . . 72.25 107.996 -178.086 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 546' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 20.7 Cg_exo -63.5 137.76 61.55 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.137 1.225 . . . . 73.230000000000004 111.323 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . 0.466 ' HA ' HG22 ' A' ' 518' ' ' THR . 12.1 p -66.21 -19.64 25.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 122.272 1.034 . . . . 63.409999999999997 109.629 179.182 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -88.42 -13.24 40.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.201 -1.363 . . . . 73.239999999999995 111.143 -177.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 92.8 p -84.25 170.43 13.72 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-O 121.17 0.51 . . . . 55.310000000000002 110.697 -177.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.6 p -104.38 124.42 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.338 0 CA-C-N 115.271 -0.877 . . . . 74.329999999999998 109.036 177.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.32 135.4 26.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.402 -0.962 . . . . 74.049999999999997 108.402 -178.206 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 552' ' ' GLU . . . . . 0.413 ' HB3' ' HB3' ' A' ' 538' ' ' ASN . 5.6 tp10 -102.55 117.57 34.98 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.795 -0.817 . . . . 74.340000000000003 108.795 -177.643 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -93.78 127.69 39.64 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.419 -0.956 . . . . 75.319999999999993 108.419 178.135 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -90.09 117.83 29.17 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.701 -0.481 . . . . 71.329999999999998 109.701 -177.529 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.51 122.18 64.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 109.095 -0.705 . . . . 74.519999999999996 109.095 -178.585 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 71.4 m -90.71 127.98 36.5 Favored 'General case' 0 N--CA 1.412 -2.33 0 C-N-CA 120.058 -0.657 . . . . 75.340000000000003 110.251 176.595 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -89.22 137.79 32.01 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 103.971 -2.603 . . . . 63.229999999999997 103.971 168.571 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.511 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -60.82 -24.25 62.24 Favored Glycine 0 C--N 1.314 -0.686 0 O-C-N 123.938 0.774 . . . . 72.200000000000003 113.553 -174.105 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 559' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 23.6 t-20 76.94 -23.96 0.23 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.83 1.652 . . . . 71.200000000000003 109.951 -179.454 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 560' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 558' ' ' GLY . 86.8 mt-30 -112.4 143.58 43.29 Favored 'General case' 0 N--CA 1.399 -2.989 0 CA-C-N 114.596 -1.184 . . . . 75.219999999999999 110.144 -174.298 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -122.99 158.57 30.2 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 114.884 -1.053 . . . . 74.450000000000003 108.686 -179.49 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 53.3 t -63.47 117.11 3.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 O-C-N 123.65 0.594 . . . . 74.200000000000003 109.658 -179.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 22.2 ttt -70.4 127.1 92.4 Favored Pre-proline 0 C--N 1.297 -1.696 0 C-N-CA 124.408 1.083 . . . . 74.230000000000004 112.706 -177.795 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.91 169.66 22.11 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.148 2.565 . . . . 64.319999999999993 111.032 172.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -90.87 126.95 36.19 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 110.089 -0.337 . . . . 70.010000000000005 110.089 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 566' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' A' ' 569' ' ' MET . 1.7 tm? -104.84 -16.38 14.91 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.836 0.827 . . . . 74.450000000000003 109.031 -175.59 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 24.0 m -72.41 143.26 48.58 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.939 -0.573 . . . . 72.319999999999993 110.596 -178.19 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 101.18 4.76 53.53 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.628 -0.796 . . . . 74.109999999999999 113.912 178.199 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 569' ' ' MET . . . . . 0.539 ' SD ' ' HA ' ' A' ' 574' ' ' ALA . 23.5 ptp -123.0 166.88 14.36 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 117.526 0.663 . . . . 74.040000000000006 109.947 179.101 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -101.54 166.32 10.78 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.692 -1.595 . . . . 71.530000000000001 106.692 -178.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 13.7 t-105 -62.58 -30.13 71.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 118.572 0.624 . . . . 62.009999999999998 109.679 179.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.2 m -71.5 -21.95 21.79 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 CA-C-N 115.923 -0.58 . . . . 74.420000000000002 111.632 -179.253 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -101.31 -27.39 13.2 Favored 'General case' 0 C--O 1.256 1.405 0 N-CA-C 109.04 -0.726 . . . . 74.329999999999998 109.04 -178.594 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 574' ' ' ALA . . . . . 0.619 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -63.52 -54.23 39.47 Favored 'General case' 0 C--O 1.207 -1.132 0 CA-C-N 114.419 -1.264 . . . . 74.319999999999993 112.284 -178.38 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -53.02 -52.19 67.73 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 114.181 1.178 . . . . 75.420000000000002 114.181 -176.442 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -54.73 -39.7 88.1 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 121.454 1.436 . . . . 73.439999999999998 112.218 174.234 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -69.12 -34.55 75.23 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.63 0.604 . . . . 74.319999999999993 112.63 176.577 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 47.8 mt -65.88 -48.37 71.74 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.596 0.712 . . . . 74.129999999999995 109.21 -177.74 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -34.62 78.29 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.197 -0.911 . . . . 71.329999999999998 111.64 178.277 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.39 -32.12 69.64 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.373 -0.376 . . . . 71.439999999999998 111.287 -177.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.4 pp -85.71 -8.74 57.99 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.499 0.666 . . . . 75.349999999999994 109.622 179.242 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 77.13 44.79 12.75 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.126 -0.943 . . . . 74.329999999999998 112.5 178.367 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -74.03 127.64 33.45 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.378 0.609 . . . . 73.129999999999995 109.688 179.218 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 2.8 p -85.06 -40.12 17.2 Favored 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 124.859 1.264 . . . . 74.340000000000003 112.928 -177.26 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -80.47 -161.05 24.09 Favored Glycine 0 C--O 1.242 0.656 0 N-CA-C 115.571 0.988 . . . . 72.239999999999995 115.571 -174.368 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 54.5 mtt -119.86 154.01 34.96 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 123.624 0.769 . . . . 74.239999999999995 109.28 -176.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 6.8 tt -83.48 123.44 29.71 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.339 0.59 . . . . 74.049999999999997 109.689 -178.453 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 588' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 621' ' ' THR . 36.6 t70 -113.7 114.29 26.17 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.898 -1.046 . . . . 74.310000000000002 108.568 -179.801 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.8 133.56 43.97 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.381 -0.927 . . . . 74.450000000000003 109.851 -179.059 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -86.81 -46.05 5.25 Favored Glycine 0 C--N 1.285 -2.302 0 CA-C-N 115.616 -0.72 . . . . 71.349999999999994 111.543 -177.461 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.67 135.01 32.78 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 110.119 -0.326 . . . . 71.430000000000007 110.119 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -116.73 127.45 54.4 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.242 -1.022 . . . . 74.329999999999998 108.242 174.246 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 99.4 t -111.28 116.83 53.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 116.452 -0.34 . . . . 74.140000000000001 110.262 -177.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 594' ' ' ASP . . . . . 0.538 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 27.6 t70 -73.77 116.77 14.76 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-O 120.82 0.343 . . . . 54.420000000000002 111.268 -177.338 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -139.77 -42.63 0.44 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.819 -0.628 . . . . 75.140000000000001 109.727 178.065 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 123.16 140.1 5.6 Favored Glycine 0 N--CA 1.426 -1.992 0 C-N-CA 120.731 -0.747 . . . . 72.439999999999998 111.842 178.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.75 -32.18 61.56 Favored Glycine 0 C--N 1.315 -0.636 0 CA-C-O 121.09 0.272 . . . . 72.430000000000007 112.552 179.593 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 4.7 p -64.02 -23.23 67.25 Favored 'General case' 0 N--CA 1.432 -1.349 0 C-N-CA 125.218 1.407 . . . . 73.030000000000001 111.563 -178.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -87.22 -0.53 56.85 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.199 -0.909 . . . . 71.310000000000002 109.9 -176.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 13.9 m170 65.26 65.39 0.58 Allowed 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 122.573 1.178 . . . . 72.129999999999995 110.954 -178.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -81.38 92.52 6.43 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 114.137 -1.392 . . . . 72.439999999999998 111.729 -179.057 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 41.3 mtm-85 -91.39 171.71 9.02 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 113.674 -1.603 . . . . 71.219999999999999 107.678 176.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . 0.467 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 86.9 t -67.67 130.26 32.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 105.497 -2.038 . . . . 75.120000000000005 105.497 169.263 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 59.4 t -101.15 -52.59 8.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 C-N-CA 120.501 -0.48 . . . . 74.0 110.813 -172.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -133.1 136.28 45.76 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.901 -0.59 . . . . 74.140000000000001 109.831 -177.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 606' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 608' ' ' PRO . 13.3 pt20 -112.29 140.13 47.26 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.441 -1.689 . . . . 75.25 106.441 175.429 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -56.74 -53.7 61.93 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 113.418 0.895 . . . . 74.310000000000002 113.418 -175.74 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 608' ' ' PRO . . . . . 0.444 ' O ' ' HG3' ' A' ' 606' ' ' GLN . 7.2 Cg_endo -91.43 134.01 1.56 Allowed 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.434 1.422 . . . . 75.209999999999994 110.459 173.526 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.07 157.69 58.98 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 121.447 1.432 . . . . 74.519999999999996 111.306 178.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.88 138.52 58.36 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 108.892 -0.781 . . . . 71.109999999999999 108.892 177.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.6 -8.76 43.99 Favored Glycine 0 C--N 1.302 -1.339 0 C-N-CA 120.679 -0.772 . . . . 73.439999999999998 111.928 -176.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 54.3 m -77.04 146.83 37.11 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.892 -0.781 . . . . 75.420000000000002 108.892 176.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -81.1 114.63 3.86 Favored Glycine 0 N--CA 1.432 -1.632 0 N-CA-C 109.818 -1.313 . . . . 61.43 109.818 174.07 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 614' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 22.0 m -108.26 141.26 23.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 116.908 0.354 . . . . 63.340000000000003 110.592 178.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 615' ' ' ASN . . . . . 0.47 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 41.3 p30 -51.57 173.15 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.219 1.562 . . . . 73.409999999999997 115.219 -177.758 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -60.91 -25.21 66.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.059 -1.428 . . . . 74.549999999999997 112.289 178.161 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -85.63 -11.1 54.72 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.2 -1.037 . . . . 75.340000000000003 108.2 -178.036 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.46 15.12 63.31 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 115.44 -0.8 . . . . 63.43 112.639 168.178 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.72 125.55 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 122.056 0.932 . . . . 74.430000000000007 111.365 -167.885 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 620' ' ' ILE . . . . . 0.401 HD11 ' HB2' ' A' ' 606' ' ' GLN . 0.0 OUTLIER -129.67 132.1 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.261 0 CA-C-N 114.193 -1.367 . . . . 72.420000000000002 109.466 -179.055 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 74.7 m -104.33 122.45 45.47 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.935 -1.135 . . . . 74.25 107.935 178.364 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.99 166.93 21.25 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.25 -0.432 . . . . 73.049999999999997 111.714 -176.177 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -127.11 136.43 52.12 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.921 -1.14 . . . . 72.430000000000007 107.921 175.616 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.467 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 3.3 p90 -142.35 165.44 27.41 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.788 -0.642 . . . . 74.340000000000003 110.969 -173.672 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -80.66 150.54 31.34 Favored Glycine 0 N--CA 1.421 -2.35 0 N-CA-C 109.748 -1.341 . . . . 63.130000000000003 109.748 175.449 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 626' ' ' GLN . . . . . 0.538 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 7.3 tt0 . . . . . 0 C--N 1.275 -2.657 0 CA-C-O 117.949 -1.024 . . . . 73.129999999999995 108.582 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.813 0 N-CA-C 109.386 -1.486 . . . . 74.409999999999997 109.386 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.28 141.73 43.87 Favored 'Trans proline' 0 C--O 1.247 0.953 0 CA-C-N 119.421 1.61 . . . . 73.150000000000006 110.128 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -105.7 6.33 31.82 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.352 -0.386 . . . . 75.340000000000003 111.382 -177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 21.8 p -134.84 147.96 50.04 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.231 -0.655 . . . . 73.230000000000004 109.231 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -148.26 143.94 27.31 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.844 -1.539 . . . . 73.530000000000001 106.844 -177.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.2 p-10 -88.93 137.88 31.92 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.028 -0.669 . . . . 70.140000000000001 109.414 178.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.9 pt -89.63 134.39 32.49 Favored Pre-proline 0 C--N 1.297 -1.691 0 CA-C-N 116.147 -0.479 . . . . 72.310000000000002 111.94 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -84.71 156.45 11.94 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.543 2.162 . . . . 74.219999999999999 110.051 171.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -88.54 121.22 30.68 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-O 122.401 1.096 . . . . 70.120000000000005 109.055 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 5.6 m -109.62 61.11 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.655 0 CA-C-N 113.999 -1.455 . . . . 72.540000000000006 109.378 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -105.73 109.95 22.08 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 112.462 -2.154 . . . . 75.530000000000001 109.426 174.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 152.57 -29.44 0.85 Allowed Glycine 0 C--N 1.305 -1.193 0 C-N-CA 119.561 -1.304 . . . . 61.409999999999997 113.124 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.408 ' O ' HG11 ' A' ' 534' ' ' VAL . 0.3 OUTLIER -107.81 -169.73 1.57 Allowed 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.856 -0.424 . . . . 70.120000000000005 109.856 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 9.7 m -70.57 155.46 40.7 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.409 -0.96 . . . . 72.120000000000005 108.409 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.1 p -60.95 -41.43 88.99 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.792 0 O-C-N 123.135 0.272 . . . . 64.239999999999995 110.915 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -59.85 -44.28 94.19 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 120.767 0.317 . . . . 73.219999999999999 110.534 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 46.3 t -69.18 -38.63 78.21 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.137 0 CA-C-N 115.529 -0.76 . . . . 75.319999999999993 109.548 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.431 ' CB ' HG12 ' A' ' 534' ' ' VAL . . . -63.68 -45.6 89.35 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.252 -0.431 . . . . 62.340000000000003 110.957 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.7 mt-30 -64.93 -41.34 95.61 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.935 -0.575 . . . . 73.019999999999996 110.552 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.495 ' O ' HG21 ' A' ' 514' ' ' VAL . 47.8 mmtm -66.11 -42.28 89.45 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 116.097 -0.501 . . . . 75.239999999999995 110.459 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -62.51 -44.89 95.25 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 116.289 -0.414 . . . . 75.540000000000006 111.493 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . 0.448 HD11 ' N ' ' A' ' 513' ' ' ASN . 3.9 pp -68.14 -35.24 77.77 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-O 121.132 0.492 . . . . 74.019999999999996 110.829 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.46 ' ND2' ' HA ' ' A' ' 517' ' ' PHE . 2.4 t-20 -59.8 -35.7 75.22 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 123.894 0.878 . . . . 73.530000000000001 109.938 176.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.495 HG21 ' O ' ' A' ' 510' ' ' LYS . 89.5 t -64.63 -33.65 64.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-O 121.251 0.548 . . . . 74.510000000000005 110.929 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -97.71 -0.78 44.85 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.463 -0.335 . . . . 70.140000000000001 110.451 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -134.96 -57.09 0.06 OUTLIER Glycine 0 CA--C 1.484 -1.868 0 C-N-CA 119.619 -1.277 . . . . 64.030000000000001 114.841 -169.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.46 ' HA ' ' ND2' ' A' ' 513' ' ' ASN . 97.6 m-85 69.24 20.56 7.45 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 122.143 0.973 . . . . 74.530000000000001 109.3 -171.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.5 p -79.37 -172.02 3.01 Favored 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 125.973 1.709 . . . . 65.450000000000003 110.65 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.0 142.09 38.66 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.758 -1.201 . . . . 75.25 107.758 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -133.14 147.9 52.1 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.142 0.496 . . . . 74.230000000000004 111.846 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 55.6 m -140.91 151.78 44.52 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.193 -1.04 . . . . 54.130000000000003 108.193 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -121.1 145.34 47.9 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 120.96 0.41 . . . . 74.430000000000007 111.683 -174.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -138.6 132.82 31.63 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.687 -0.857 . . . . 61.329999999999998 108.687 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 11.1 p -96.32 126.74 41.74 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 113.421 0.897 . . . . 74.140000000000001 113.421 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.1 p -121.18 150.85 24.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.076 -1.083 . . . . 74.439999999999998 108.076 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.98 136.14 45.09 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.493 -0.558 . . . . 75.310000000000002 109.493 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.512 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 39.4 m -159.51 168.14 12.8 Favored Pre-proline 0 C--N 1.301 -1.505 0 N-CA-C 108.117 -1.068 . . . . 65.319999999999993 108.117 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -71.75 -14.27 29.9 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.019 1.813 . . . . 64.140000000000001 111.853 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.12 140.81 95.96 Favored Pre-proline 0 C--O 1.219 -0.549 0 N-CA-C 109.297 -0.631 . . . . 75.299999999999997 109.297 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.41 146.86 86.49 Favored 'Trans proline' 0 C--O 1.252 1.213 0 C-N-CA 121.935 1.756 . . . . 73.0 111.236 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.16 113.57 1.78 Allowed 'General case' 0 C--O 1.242 0.678 0 CA-C-N 116.002 -0.544 . . . . 72.109999999999999 111.644 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 132.37 -22.9 4.12 Favored Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 115.4 -0.818 . . . . 65.209999999999994 111.551 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.01 139.49 33.25 Favored 'General case' 0 CA--C 1.493 -1.222 0 CA-C-O 121.018 0.437 . . . . 74.349999999999994 110.04 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.431 HG12 ' CB ' ' A' ' 508' ' ' ALA . 7.4 p -102.96 124.86 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.817 0 CA-C-O 121.884 0.849 . . . . 73.209999999999994 109.667 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.63 -4.93 59.24 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.697 -1.138 . . . . 65.439999999999998 112.635 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 141.53 -162.68 26.93 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 119.772 -1.204 . . . . 74.219999999999999 113.488 173.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 13.2 p -116.45 159.19 22.39 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 107.651 -1.24 . . . . 70.239999999999995 107.651 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -60.02 -53.59 63.69 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 119.103 -1.039 . . . . 71.049999999999997 112.36 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -82.21 140.73 11.19 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 121.266 1.311 . . . . 74.340000000000003 110.521 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.6 162.95 40.59 Favored 'Trans proline' 0 C--O 1.251 1.137 0 C-N-CA 122.999 2.466 . . . . 64.219999999999999 113.613 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.71 129.7 43.18 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.639 -0.71 . . . . 71.450000000000003 110.461 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.83 -5.44 34.66 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.778 -0.646 . . . . 74.420000000000002 111.536 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 99.7 m -77.1 121.02 22.99 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 122.64 -0.33 . . . . 73.140000000000001 110.238 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 4.0 t -80.3 124.1 28.55 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.887 -0.783 . . . . 74.109999999999999 108.887 176.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 32.6 m -126.45 160.07 59.91 Favored Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 107.658 -1.238 . . . . 75.230000000000004 107.658 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -63.97 138.62 63.56 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 120.942 1.095 . . . . 74.519999999999996 109.512 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.1 p -60.7 -19.86 20.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.518 0.675 . . . . 75.340000000000003 111.475 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -100.02 3.41 44.18 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.148 0.499 . . . . 62.149999999999999 110.694 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 97.4 p -83.88 171.78 12.74 Favored 'General case' 0 C--O 1.251 1.133 0 O-C-N 121.404 -0.81 . . . . 64.329999999999998 111.525 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.2 p -103.83 134.43 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 CA-C-N 115.268 -0.878 . . . . 64.329999999999998 110.394 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 55.8 mt -103.37 136.26 36.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.106 -1.072 . . . . 74.430000000000007 108.106 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.52 118.58 37.06 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.985 0.898 . . . . 65.129999999999995 111.52 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.6 118.89 32.41 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.839 -1.528 . . . . 64.5 109.786 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -86.28 102.54 14.06 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.813 0.816 . . . . 74.420000000000002 110.383 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 524' ' ' SER . 23.3 t -85.63 128.17 39.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 114.304 -1.316 . . . . 74.310000000000002 107.523 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 527' ' ' SER . 62.7 m -88.63 125.65 34.92 Favored 'General case' 0 N--CA 1.394 -3.25 0 CA-C-O 121.173 0.511 . . . . 72.439999999999998 110.823 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -101.64 134.21 45.13 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 107.275 -1.38 . . . . 75.420000000000002 107.275 173.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -63.29 -22.3 65.2 Favored Glycine 0 CA--C 1.493 -1.312 0 O-C-N 124.049 0.843 . . . . 75.430000000000007 112.365 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 79.55 2.88 2.21 Favored 'General case' 0 C--O 1.215 -0.725 0 C-N-CA 125.022 1.329 . . . . 73.409999999999997 108.674 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -113.09 150.23 32.37 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 114.998 -1.001 . . . . 73.340000000000003 112.363 -171.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -128.0 155.91 43.55 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.81 -1.181 . . . . 72.310000000000002 107.81 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 6.4 p -71.22 118.51 16.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 109.512 -0.551 . . . . 74.430000000000007 109.512 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 52.5 ttp -76.1 129.87 79.47 Favored Pre-proline 0 C--N 1.306 -1.322 0 C-N-CA 119.925 -0.71 . . . . 74.140000000000001 110.459 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.98 166.38 23.03 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.659 2.24 . . . . 61.509999999999998 111.27 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -81.03 131.85 35.33 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-O 121.368 0.604 . . . . 72.140000000000001 111.102 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.2 pp -159.82 20.3 0.17 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.58 -1.191 . . . . 74.319999999999993 110.196 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 8.3 t -79.88 147.51 31.68 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 109.11 -0.7 . . . . 74.5 109.11 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 74.84 69.16 1.43 Allowed Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 120.922 -0.656 . . . . 75.209999999999994 112.068 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -147.97 174.05 12.27 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.143 -1.058 . . . . 73.099999999999994 108.143 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -98.77 169.42 9.48 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.786 -1.561 . . . . 61.329999999999998 106.786 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -67.88 -31.67 71.63 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.94 -0.763 . . . . 73.25 108.94 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 30.3 m -78.16 -13.9 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-N 115.907 -0.588 . . . . 74.239999999999995 110.929 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.495 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 37.2 t70 -95.29 -34.19 12.27 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.402 -1.333 . . . . 72.530000000000001 107.402 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . 0.692 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -57.76 -53.55 56.91 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.529 -1.214 . . . . 72.299999999999997 111.856 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 38.0 mt-10 -51.23 -54.56 36.97 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 113.871 1.063 . . . . 72.0 113.871 -175.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -57.53 -38.3 94.36 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 121.515 1.477 . . . . 71.030000000000001 112.225 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 24.2 mmm-85 -65.08 -38.66 91.49 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.342 0.115 . . . . 72.409999999999997 110.967 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 25.7 mt -66.69 -47.93 70.86 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.947 -0.39 . . . . 71.120000000000005 109.947 -176.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 2.3 ptp180 -66.56 -34.93 78.99 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 112.558 0.577 . . . . 75.530000000000001 112.558 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.82 -34.27 77.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.249 0.547 . . . . 63.43 110.272 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 12.5 tp -82.05 -9.76 59.44 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.635 -0.711 . . . . 73.150000000000006 110.339 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 64.11 41.02 98.61 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.892 -0.594 . . . . 62.409999999999997 112.382 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . 0.438 ' CE3' HD22 ' A' ' 578' ' ' LEU . 18.2 t90 -78.55 127.24 31.87 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.919 0.39 . . . . 75.439999999999998 110.686 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 35.9 p -96.19 -22.2 17.42 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 112.988 0.736 . . . . 73.299999999999997 112.988 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -77.85 -173.09 40.16 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.353 -0.451 . . . . 75.310000000000002 113.995 -176.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 22.5 ttt -104.69 141.59 36.19 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 122.771 0.428 . . . . 62.420000000000002 110.871 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 33.9 tp -86.86 110.13 19.76 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.619 -0.882 . . . . 74.5 108.619 176.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 621' ' ' THR . 22.4 t70 -95.86 104.62 16.56 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.967 0.889 . . . . 65.430000000000007 110.26 -175.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -87.66 123.35 32.41 Favored 'General case' 0 N--CA 1.396 -3.171 0 CA-C-N 114.645 -1.161 . . . . 72.200000000000003 109.462 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -84.88 -100.04 0.66 Allowed Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.757 -0.937 . . . . 64.120000000000005 110.757 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -107.78 154.94 20.8 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 109.851 -0.426 . . . . 71.439999999999998 109.851 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -106.53 145.69 31.55 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.469 -0.937 . . . . 61.210000000000001 108.469 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 57.4 t -104.5 138.71 28.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.033 -0.729 . . . . 70.420000000000002 109.033 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . 0.406 ' HA ' ' CD ' ' A' ' 626' ' ' GLN . 3.8 p30 -73.06 124.72 26.07 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 121.388 0.613 . . . . 71.219999999999999 110.045 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -159.64 -62.07 0.07 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.724 -1.125 . . . . 70.019999999999996 108.493 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 105.77 153.24 20.92 Favored Glycine 0 N--CA 1.422 -2.264 0 C-N-CA 119.659 -1.258 . . . . 71.430000000000007 111.787 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.34 -32.2 60.36 Favored Glycine 0 C--N 1.311 -0.851 0 C-N-CA 123.511 0.577 . . . . 52.420000000000002 113.643 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 4.9 p -72.67 -25.04 61.12 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-O 121.965 0.888 . . . . 62.130000000000003 110.383 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -95.09 -0.91 53.07 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.937 -1.029 . . . . 65.400000000000006 109.495 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 39.8 m80 74.06 99.51 0.07 Allowed 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 125.051 1.34 . . . . 72.140000000000001 112.148 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -80.3 83.32 6.17 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.382 -0.827 . . . . 71.209999999999994 110.99 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -108.17 160.31 15.92 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.282 -0.872 . . . . 73.239999999999995 109.728 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 71.2 t -64.83 130.2 29.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.084 -1.45 . . . . 72.340000000000003 107.084 171.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 43.5 t -108.61 -40.33 4.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 121.524 0.678 . . . . 71.400000000000006 110.108 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -142.9 142.07 31.65 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.793 -0.817 . . . . 73.239999999999995 108.793 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -137.56 143.56 41.63 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.906 -1.516 . . . . 73.120000000000005 106.906 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.41 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 24.6 t-20 -65.84 -53.11 37.33 Favored Pre-proline 0 C--N 1.308 -1.218 0 C-N-CA 119.235 -0.986 . . . . 74.420000000000002 112.132 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.8 Cg_endo -90.64 107.93 0.33 Allowed 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.09 1.86 . . . . 73.129999999999995 110.351 173.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 607' ' ' ASN . 14.5 Cg_exo -71.13 160.37 49.34 Favored 'Trans proline' 0 C--O 1.246 0.896 0 C-N-CA 123.258 2.638 . . . . 72.099999999999994 113.411 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.85 138.54 56.17 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.351 -0.981 . . . . 64.430000000000007 108.351 175.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 96.69 -8.95 66.27 Favored Glycine 0 C--N 1.297 -1.6 0 C-N-CA 120.27 -0.967 . . . . 72.5 110.904 -175.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 24.2 m -101.88 153.17 20.09 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 108.06 -1.089 . . . . 65.340000000000003 108.06 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -74.77 127.16 9.38 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 121.242 -0.504 . . . . 71.510000000000005 112.151 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 30.9 m -119.98 142.6 34.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.898 -1.149 . . . . 74.209999999999994 107.898 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -51.7 169.14 0.07 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.708 0.803 . . . . 75.209999999999994 112.736 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -60.29 -26.17 66.3 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 120.859 0.361 . . . . 64.329999999999998 111.699 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.427 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 5.4 m-20 -83.31 -7.82 59.53 Favored 'General case' 0 C--O 1.204 -1.324 0 CA-C-N 116.069 -0.514 . . . . 74.120000000000005 110.398 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.18 19.34 68.1 Favored Glycine 0 C--O 1.22 -0.776 0 O-C-N 123.285 0.366 . . . . 71.010000000000005 112.996 171.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.79 119.4 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-O 121.913 0.863 . . . . 75.150000000000006 111.217 -167.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 48.3 pt -126.21 133.92 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 115.096 -0.957 . . . . 72.319999999999993 110.522 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 14.9 t -105.8 128.73 53.91 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.924 -1.139 . . . . 63.409999999999997 107.924 177.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.5 pp -139.24 166.69 23.87 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 114.16 1.17 . . . . 72.510000000000005 114.16 -173.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -127.68 137.04 52.37 Favored 'General case' 0 C--O 1.256 1.411 0 N-CA-C 108.173 -1.047 . . . . 75.329999999999998 108.173 175.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -142.3 166.89 23.45 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.859 -0.61 . . . . 75.140000000000001 109.617 -174.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -60.94 145.79 47.96 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 121.102 -0.571 . . . . 75.239999999999995 112.296 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.406 ' CD ' ' HA ' ' A' ' 594' ' ' ASP . 3.3 pt20 . . . . . 0 C--O 1.251 1.179 0 N-CA-C 113.885 1.068 . . . . 72.219999999999999 113.885 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.527 0 N-CA-C 110.395 -1.082 . . . . 43.049999999999997 110.395 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.65 154.47 71.36 Favored 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 122.53 2.153 . . . . 72.439999999999998 111.48 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -105.35 -25.55 12.35 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.813 0.816 . . . . 64.140000000000001 110.838 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 15.0 p -136.55 155.06 50.47 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 114.981 -1.008 . . . . 62.32 110.317 -176.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . 0.554 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 4.6 tmtt? -150.49 139.66 21.18 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.884 -0.784 . . . . 74.329999999999998 108.884 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.554 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 8.3 p-10 -78.18 129.75 35.51 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 123.633 0.773 . . . . 74.420000000000002 109.58 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.5 pt -99.03 131.65 25.0 Favored Pre-proline 0 C--N 1.304 -1.374 0 C-N-CA 120.45 -0.5 . . . . 71.329999999999998 111.689 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.08 158.54 34.0 Favored 'Trans proline' 0 C--O 1.243 0.742 0 C-N-CA 122.78 2.32 . . . . 73.430000000000007 112.167 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.436 ' HA ' ' HB1' ' A' ' 541' ' ' ALA . 5.1 p-10 -82.23 112.7 19.48 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.95 0.881 . . . . 74.540000000000006 108.979 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 31.7 m -117.41 0.95 8.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 112.973 0.731 . . . . 65.420000000000002 112.973 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -69.63 100.98 1.55 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.298 0.57 . . . . 74.239999999999995 109.917 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 138.8 -13.5 3.39 Favored Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 110.717 -0.953 . . . . 63.539999999999999 110.717 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 508' ' ' ALA . 31.7 mm-40 -82.2 -178.25 6.95 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 108.692 -0.855 . . . . 73.010000000000005 108.692 175.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.7 m -78.6 156.15 29.27 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 104.293 -2.484 . . . . 62.25 104.293 169.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.486 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 8.4 p -60.13 -42.4 89.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 119.557 1.071 . . . . 75.540000000000006 112.224 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 17.3 t70 -64.68 -43.43 93.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.945 0.402 . . . . 63.409999999999997 110.455 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 62.9 t -67.82 -39.11 81.31 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.252 0 CA-C-N 115.628 -0.714 . . . . 75.200000000000003 109.803 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' A' ' 503' ' ' GLN . . . -62.4 -45.14 94.5 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.951 -0.389 . . . . 74.549999999999997 109.951 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.8 mt-30 -62.05 -46.68 88.06 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.759 -0.655 . . . . 71.239999999999995 111.353 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.558 ' O ' HG21 ' A' ' 514' ' ' VAL 0.359 0.0 OUTLIER -67.37 -38.15 84.32 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 112.48 0.548 . . . . 74.239999999999995 112.48 177.333 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -60.71 -50.04 75.07 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 110.602 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 513' ' ' ASN . 3.8 pp -68.49 -36.06 78.4 Favored 'General case' 0 C--O 1.208 -1.098 0 C-N-CA 120.156 -0.618 . . . . 73.209999999999994 111.598 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.483 ' N ' HD12 ' A' ' 512' ' ' LEU . 3.4 t-20 -69.79 -35.19 74.66 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 112.558 0.577 . . . . 73.430000000000007 112.558 -175.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.558 HG21 ' O ' ' A' ' 510' ' ' LYS . 72.2 t -57.33 -31.1 37.24 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 CA-C-O 121.438 0.637 . . . . 73.510000000000005 110.121 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -120.22 29.17 7.63 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.771 -0.649 . . . . 74.200000000000003 109.591 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -145.84 -56.79 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.423 0 C-N-CA 120.058 -1.068 . . . . 72.239999999999995 112.181 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 62.89 33.78 14.79 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.521 1.153 . . . . 73.340000000000003 111.151 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 518' ' ' THR . . . . . 0.403 HG22 ' HA ' ' A' ' 547' ' ' VAL . 3.1 p -88.52 -171.43 3.33 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-N 113.83 -1.532 . . . . 75.019999999999996 109.047 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -111.77 142.49 44.06 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.891 -1.522 . . . . 74.219999999999999 106.891 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -132.47 148.81 52.4 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 113.201 0.815 . . . . 75.340000000000003 113.201 -174.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 51.0 m -133.06 157.66 44.7 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 106.713 -1.588 . . . . 61.219999999999999 106.713 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -125.97 126.89 45.07 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 109.693 -0.484 . . . . 73.019999999999996 109.693 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . 0.53 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -124.16 143.27 50.59 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.45 -1.315 . . . . 74.409999999999997 107.45 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 65.8 p -102.8 139.94 37.72 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.094 -1.043 . . . . 72.530000000000001 112.426 -175.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 12.1 p -131.15 151.52 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 N-CA-C 107.768 -1.197 . . . . 75.329999999999998 107.768 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -87.34 137.2 32.55 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 121.3 0.571 . . . . 72.340000000000003 110.94 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.4 m -160.08 157.51 25.25 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 106.802 -1.555 . . . . 63.530000000000001 106.802 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -64.56 2.07 1.42 Allowed 'Trans proline' 0 CA--C 1.555 1.549 0 C-N-CA 122.653 2.235 . . . . 71.299999999999997 114.076 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -96.1 144.17 27.37 Favored Pre-proline 0 N--CA 1.433 -1.319 0 N-CA-C 109.523 -0.547 . . . . 74.239999999999995 109.523 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.03 146.59 97.53 Favored 'Trans proline' 0 C--O 1.249 1.07 0 C-N-CA 123.418 2.745 . . . . 75.530000000000001 114.618 -173.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.706 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.66 113.64 2.12 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.663 -1.153 . . . . 74.25 111.064 178.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 139.91 -23.53 2.76 Favored Glycine 0 C--N 1.301 -1.368 0 N-CA-C 111.083 -0.807 . . . . 62.109999999999999 111.083 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -79.33 144.91 33.79 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.81 -0.811 . . . . 73.420000000000002 108.81 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.35 114.99 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 N-CA-C 108.288 -1.004 . . . . 75.129999999999995 108.288 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.2 -31.3 72.44 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.18 -1.373 . . . . 75.409999999999997 109.433 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 152.78 -168.34 31.71 Favored Glycine 0 N--CA 1.407 -3.244 0 N-CA-C 109.728 -1.349 . . . . 74.230000000000004 109.728 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 537' ' ' THR . . . . . 0.423 HG23 ' HG ' ' A' ' 553' ' ' LEU . 3.6 p -116.62 153.53 32.11 Favored 'General case' 0 C--N 1.268 -2.943 0 N-CA-C 107.807 -1.183 . . . . 61.100000000000001 107.807 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.466 ' HB3' ' CD ' ' A' ' 552' ' ' GLU . 54.0 t30 -67.41 -48.0 46.74 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 118.382 -1.327 . . . . 73.420000000000002 110.706 176.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.48 ' HD3' ' OE1' ' A' ' 552' ' ' GLU . 20.7 Cg_exo -71.9 129.66 15.67 Favored 'Trans proline' 0 C--N 1.374 1.882 0 N-CA-C 108.398 -1.424 . . . . 73.299999999999997 108.398 168.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.73 139.99 93.1 Favored 'Trans proline' 0 C--O 1.245 0.87 0 C-N-CA 122.955 2.437 . . . . 74.0 115.335 -174.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' A' ' 499' ' ' ASP . . . -68.27 135.85 52.58 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.297 -1.32 . . . . 74.430000000000007 110.236 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 93.54 -16.58 60.38 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 111.455 -0.658 . . . . 54.520000000000003 111.455 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 63.1 m -88.67 139.16 30.75 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 124.151 0.98 . . . . 70.519999999999996 110.821 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.1 t -73.88 128.09 34.58 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 121.529 0.68 . . . . 75.439999999999998 109.21 175.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.72 164.98 27.65 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 107.13 -1.433 . . . . 70.209999999999994 107.13 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -67.25 136.07 39.11 Favored 'Trans proline' 0 N--CA 1.442 -1.543 0 CA-C-N 120.564 1.237 . . . . 73.200000000000003 110.437 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.403 ' HA ' HG22 ' A' ' 518' ' ' THR . 9.2 p -67.49 -22.11 28.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 122.037 0.923 . . . . 64.319999999999993 109.639 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -84.26 -12.68 54.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.141 -1.391 . . . . 72.310000000000002 110.992 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 11.4 t -93.14 153.12 18.84 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-O 121.555 0.693 . . . . 70.420000000000002 110.246 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 13.2 p -94.89 134.78 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.07 0 CA-C-N 114.865 -1.061 . . . . 72.219999999999999 108.583 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 62.1 mt -102.63 135.73 38.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.553 -0.748 . . . . 71.420000000000002 109.12 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . 0.48 ' OE1' ' HD3' ' A' ' 539' ' ' PRO . 2.1 pm0 -102.93 121.61 42.87 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-O 121.764 0.793 . . . . 70.439999999999998 110.551 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . 0.423 ' HG ' HG23 ' A' ' 537' ' ' THR . 7.0 mp -98.66 122.19 41.56 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.208 -1.36 . . . . 74.439999999999998 108.369 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 2.7 mp0 -88.09 127.09 35.41 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.844 -0.616 . . . . 75.400000000000006 110.971 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 25.2 t -95.21 125.94 47.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.057 -0.974 . . . . 73.349999999999994 108.437 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.706 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 5.5 m -77.63 119.38 21.09 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.106 -1.072 . . . . 73.349999999999994 108.106 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -108.72 134.73 51.04 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 107.468 -1.308 . . . . 74.450000000000003 107.468 169.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -59.18 -23.49 57.54 Favored Glycine 0 CA--C 1.509 -0.297 0 O-C-N 124.035 0.834 . . . . 72.450000000000003 112.181 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 76.52 7.88 3.29 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.977 1.711 . . . . 74.439999999999998 108.181 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 89.0 mt-30 -126.77 146.16 50.34 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 114.889 -1.051 . . . . 72.040000000000006 110.649 -176.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . 0.44 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 53.8 p90 -124.01 152.83 42.14 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.332 -0.988 . . . . 74.430000000000007 108.332 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.47 124.4 13.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.401 0.62 . . . . 73.109999999999999 111.981 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 47.9 ttp -92.89 134.83 26.85 Favored Pre-proline 0 C--O 1.256 1.41 0 CA-C-N 115.697 -0.683 . . . . 74.129999999999995 110.057 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.73 169.07 16.82 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.884 2.389 . . . . 73.319999999999993 111.075 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.79 115.03 26.04 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.42 -0.955 . . . . 75.329999999999998 108.42 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . 0.407 ' O ' ' HG2' ' A' ' 569' ' ' MET . 91.5 mt -107.0 -0.21 23.21 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.722 0.772 . . . . 75.450000000000003 110.384 -176.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 20.6 t -79.52 153.47 29.53 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.502 -0.772 . . . . 75.329999999999998 109.317 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 82.62 25.26 51.03 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 120.22 -0.99 . . . . 71.140000000000001 114.031 177.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 569' ' ' MET . . . . . 0.411 ' O ' HG23 ' A' ' 603' ' ' VAL . 23.2 ptp -140.69 176.77 8.52 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.305 -0.998 . . . . 73.430000000000007 108.305 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -98.34 169.12 9.79 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.656 -0.868 . . . . 75.219999999999999 108.656 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -64.18 -27.62 69.19 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.579 0.704 . . . . 72.299999999999997 109.355 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.5 p -72.95 -17.32 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 CA-C-N 115.46 -0.791 . . . . 74.239999999999995 110.74 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.49 ' O ' ' HD2' ' A' ' 576' ' ' PRO . 16.5 m-20 -91.17 -38.92 12.42 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 107.97 -1.122 . . . . 74.549999999999997 107.97 175.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . 0.646 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -56.79 -52.97 62.97 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.229 -1.351 . . . . 75.439999999999998 112.068 -178.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.448 ' HB2' ' HD3' ' A' ' 576' ' ' PRO . 47.2 mt-10 -51.08 -54.02 42.26 Favored Pre-proline 0 CA--C 1.559 1.304 0 N-CA-C 113.782 1.031 . . . . 74.200000000000003 113.782 -176.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 573' ' ' ASP . 35.9 Cg_exo -61.15 -36.32 81.58 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 121.557 1.505 . . . . 74.239999999999995 112.137 177.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.444 ' HA ' ' NE ' ' A' ' 577' ' ' ARG . 3.3 mmp_? -62.84 -40.17 96.63 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.743 0.275 . . . . 71.239999999999995 111.743 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 25.0 mt -65.4 -48.92 71.2 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.333 0.587 . . . . 74.319999999999993 110.327 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -66.7 -36.84 83.45 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.704 -0.68 . . . . 65.310000000000002 112.455 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.12 -34.26 72.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.78 0.324 . . . . 43.219999999999999 111.258 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 1.5 pp -81.51 -6.22 58.75 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.396 0.617 . . . . 73.540000000000006 109.916 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.54 44.14 27.75 Favored Glycine 0 CA--C 1.498 -0.978 0 CA-C-N 115.585 -0.734 . . . . 74.430000000000007 111.988 177.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . 0.438 ' CE3' HD21 ' A' ' 578' ' ' LEU . 15.3 t90 -87.35 127.04 35.2 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 109.32 -0.622 . . . . 71.450000000000003 109.32 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 17.2 p -101.27 -21.13 14.97 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.167 -0.469 . . . . 71.450000000000003 111.94 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -73.98 -175.12 31.74 Favored Glycine 0 C--O 1.242 0.628 0 CA-C-N 116.535 -0.302 . . . . 75.230000000000004 113.459 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 53.1 mtt -106.03 144.15 33.16 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.835 -0.182 . . . . 73.439999999999998 111.016 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 37.5 tp -89.64 108.02 19.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.473 0.654 . . . . 75.319999999999993 109.413 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . 0.569 ' O ' ' HA ' ' A' ' 621' ' ' THR . 28.4 t70 -97.73 117.1 31.28 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.139 -0.937 . . . . 75.439999999999998 110.351 -176.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.98 133.55 44.2 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 119.042 -1.063 . . . . 75.439999999999998 108.987 174.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -80.42 -54.39 3.77 Favored Glycine 0 C--N 1.299 -1.527 0 N-CA-C 111.267 -0.733 . . . . 61.140000000000001 111.267 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.04 146.9 39.6 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.644 -0.502 . . . . 60.32 109.644 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -113.31 131.83 55.8 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.694 -1.595 . . . . 71.25 106.694 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 46.2 t -105.0 115.59 47.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 C-N-CA 119.891 -0.724 . . . . 73.200000000000003 109.107 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . 0.458 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 24.3 t70 -78.0 126.63 31.11 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 112.756 0.65 . . . . 72.109999999999999 112.756 -175.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -158.2 -30.62 0.08 Allowed 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.811 0.694 . . . . 71.109999999999999 111.153 174.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 108.66 144.08 10.72 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 119.45 -1.357 . . . . 34.43 112.959 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -60.67 -32.79 79.85 Favored Glycine 0 C--N 1.317 -0.506 0 C-N-CA 123.014 0.34 . . . . 52.450000000000003 113.267 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 31.3 t -62.18 -23.93 66.89 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.862 0.839 . . . . 71.219999999999999 110.326 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -86.78 -0.62 56.71 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.675 -1.148 . . . . 72.540000000000006 110.773 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 52.0 m80 66.19 38.7 4.52 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 122.137 0.97 . . . . 74.310000000000002 109.473 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -74.72 89.63 2.28 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.701 -1.59 . . . . 61.409999999999997 108.629 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -97.52 171.65 8.23 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.763 -1.562 . . . . 74.450000000000003 110.896 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 569' ' ' MET . 83.7 t -58.52 130.73 22.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.244 -1.021 . . . . 74.040000000000006 108.244 174.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 27.7 m -106.26 -30.44 2.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 120.535 -0.466 . . . . 73.420000000000002 111.901 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -149.43 135.98 19.33 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 120.258 -0.577 . . . . 74.430000000000007 110.717 -176.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -120.88 143.12 49.09 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.491 -1.67 . . . . 73.219999999999999 106.491 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.443 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 19.9 t-20 -52.61 -58.17 12.94 Favored Pre-proline 0 N--CA 1.487 1.387 0 N-CA-C 113.95 1.093 . . . . 70.430000000000007 113.95 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.1 Cg_endo -91.04 135.25 1.84 Allowed 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 121.476 1.451 . . . . 72.140000000000001 110.739 177.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -67.08 160.04 49.25 Favored 'Trans proline' 0 C--O 1.249 1.057 0 C-N-CA 121.518 1.479 . . . . 63.039999999999999 110.856 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.17 127.17 30.22 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 110.257 -0.275 . . . . 74.519999999999996 110.257 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 104.71 -5.21 43.28 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.317 -0.944 . . . . 75.530000000000001 112.251 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 73.9 m -90.63 147.35 23.36 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.861 -0.792 . . . . 61.450000000000003 108.861 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -78.72 137.89 20.12 Favored Glycine 0 N--CA 1.425 -2.043 0 C-N-CA 121.529 -0.367 . . . . 61.200000000000003 113.234 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.3 m -117.99 142.76 30.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.744 -0.836 . . . . 62.43 108.744 175.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -49.85 170.8 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.433 1.093 . . . . 75.319999999999993 113.608 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -58.9 -26.99 64.81 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.999 -0.546 . . . . 74.109999999999999 111.946 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -84.75 -7.28 59.27 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 121.22 0.533 . . . . 75.340000000000003 110.264 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.6 18.93 68.56 Favored Glycine 0 C--O 1.219 -0.838 0 CA-C-N 115.928 -0.578 . . . . 61.329999999999998 113.967 172.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.49 119.93 17.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 122.555 1.169 . . . . 71.329999999999998 112.121 -167.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.11 130.78 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 114.212 -1.358 . . . . 73.140000000000001 109.46 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 13.0 t -104.66 137.06 43.05 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.031 -1.1 . . . . 73.430000000000007 108.031 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -138.63 167.51 21.81 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.354 0.597 . . . . 73.519999999999996 112.338 -173.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -127.03 134.63 50.27 Favored 'General case' 0 C--O 1.251 1.138 0 N-CA-C 104.806 -2.294 . . . . 74.129999999999995 104.806 174.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 603' ' ' VAL . 29.3 p90 -142.94 165.33 27.65 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.627 -0.829 . . . . 75.400000000000006 112.221 -174.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -79.74 126.64 7.55 Favored Glycine 1 N--CA 1.388 -4.552 0 C-N-CA 120.65 -0.786 . . . . 54.229999999999997 111.609 173.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.458 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 9.3 tt0 . . . . . 0 C--O 1.271 2.204 0 C-N-CA 124.75 1.22 . . . . 72.430000000000007 107.812 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.022 0 N-CA-C 110.405 -1.078 . . . . 44.210000000000001 110.405 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.87 144.97 79.02 Favored 'Trans proline' 0 CA--C 1.513 -0.558 0 C-N-CA 122.181 1.921 . . . . 72.439999999999998 111.583 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -104.9 -7.1 19.58 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.852 0.834 . . . . 62.229999999999997 110.288 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 40.9 p -138.23 149.89 46.19 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.42 -1.326 . . . . 74.420000000000002 107.42 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -141.64 145.03 34.49 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.728 -1.212 . . . . 73.120000000000005 107.728 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.425 ' OD1' ' HB ' ' A' ' 544' ' ' THR . 17.2 m-20 -88.93 141.94 28.06 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.34 -0.615 . . . . 74.439999999999998 109.34 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.7 pt -101.76 123.83 42.64 Favored Pre-proline 0 C--N 1.3 -1.564 0 C-N-CA 120.609 -0.436 . . . . 74.420000000000002 110.288 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -84.58 172.39 9.18 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.383 2.055 . . . . 75.430000000000007 112.018 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -85.97 100.66 12.28 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 122.399 1.095 . . . . 74.540000000000006 109.998 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 31.4 m -89.38 1.73 7.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 114.401 -1.272 . . . . 74.340000000000003 111.261 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -64.52 100.74 0.39 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.564 -0.744 . . . . 73.0 110.079 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 158.2 -32.06 0.5 Allowed Glycine 0 C--N 1.302 -1.356 0 C-N-CA 120.797 -0.716 . . . . 61.409999999999997 111.583 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.442 ' O ' HG11 ' A' ' 534' ' ' VAL . 10.1 pm0 -102.62 -179.69 4.04 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 109.816 -0.438 . . . . 71.230000000000004 109.816 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 17.5 m -70.31 155.76 40.21 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.579 -1.267 . . . . 74.329999999999998 107.579 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.494 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 14.2 p -64.71 -40.38 88.86 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 N-CA-C 109.657 -0.497 . . . . 73.530000000000001 109.657 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . 0.593 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 11.8 t70 -58.79 -39.86 82.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.422 -0.808 . . . . 72.299999999999997 109.842 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 86.0 t -74.93 -43.55 45.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.099 -0.955 . . . . 74.25 110.61 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -58.82 -43.29 90.57 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.472 0.177 . . . . 72.129999999999995 110.739 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.2 mt-30 -64.66 -46.44 82.48 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.043 -0.526 . . . . 73.439999999999998 110.915 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 2.7 ptpp? -67.36 -38.4 84.74 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 112.802 0.667 . . . . 75.430000000000007 112.802 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 56.1 m-20 -61.98 -48.07 81.97 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.238 0.542 . . . . 74.209999999999994 110.353 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.44 -36.92 84.0 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.203 -0.908 . . . . 74.299999999999997 108.849 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 2.2 t-20 -59.4 -35.39 73.87 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 124.046 0.938 . . . . 74.329999999999998 110.534 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.512 HG21 ' O ' ' A' ' 510' ' ' LYS . 86.0 t -61.99 -33.14 56.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-O 121.286 0.565 . . . . 73.120000000000005 110.789 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -105.08 4.07 31.08 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.588 -0.523 . . . . 72.340000000000003 109.588 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -133.32 -60.96 0.08 OUTLIER Glycine 0 N--CA 1.426 -1.994 0 C-N-CA 119.987 -1.102 . . . . 72.200000000000003 114.425 -171.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.415 ' HA ' ' ND2' ' A' ' 513' ' ' ASN . 93.6 m-85 62.84 29.02 16.63 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.158 0.98 . . . . 73.420000000000002 109.102 -172.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 518' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 547' ' ' VAL . 17.2 p -85.62 -166.21 1.45 Allowed 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 126.019 1.728 . . . . 73.510000000000005 109.851 -177.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -108.55 137.68 46.11 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.312 -0.625 . . . . 74.439999999999998 109.312 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -132.2 147.37 52.41 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 116.017 -0.538 . . . . 74.329999999999998 110.203 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.1 m -140.26 145.91 37.92 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.342 -0.984 . . . . 73.120000000000005 108.342 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -117.97 135.22 54.28 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 121.371 0.605 . . . . 75.329999999999998 111.065 -175.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -123.02 126.81 47.83 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.235 -1.024 . . . . 55.210000000000001 108.235 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 22.2 m -88.14 125.87 34.83 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.297 0.57 . . . . 74.150000000000006 111.404 -176.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 10.5 p -120.31 150.67 23.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 106.611 -1.625 . . . . 74.209999999999994 106.611 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.42 ' OD1' ' HE2' ' A' ' 557' ' ' LYS . 21.1 m-20 -75.29 135.63 40.92 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 120.311 -0.556 . . . . 74.140000000000001 109.71 -174.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 73.9 m -153.11 169.57 9.52 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 108.343 -0.984 . . . . 72.219999999999999 108.343 -175.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -82.35 -17.53 7.63 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.597 1.531 . . . . 75.239999999999995 111.182 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.596 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 53.1 mtt-85 -75.51 143.68 76.26 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 116.089 -0.505 . . . . 74.040000000000006 110.273 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.97 143.18 96.59 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 123.164 2.576 . . . . 72.239999999999995 112.521 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.643 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -56.51 108.97 0.54 Allowed 'General case' 0 C--O 1.242 0.7 0 O-C-N 124.092 0.87 . . . . 64.340000000000003 112.321 -177.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 140.38 -20.0 2.8 Favored Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 115.381 -0.827 . . . . 51.020000000000003 112.494 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . 0.596 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 31.1 tt0 -82.86 144.83 29.82 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.602 -0.518 . . . . 74.25 109.602 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 503' ' ' GLN . 8.0 p -91.5 115.8 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 CA-C-O 122.094 0.949 . . . . 74.299999999999997 110.455 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.8 -30.86 69.52 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 113.671 -1.604 . . . . 74.0 110.253 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 154.82 -164.87 31.91 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 110.587 -1.005 . . . . 64.420000000000002 110.587 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 6.4 p -117.29 154.88 30.47 Favored 'General case' 0 C--N 1.288 -2.109 0 N-CA-C 109.542 -0.54 . . . . 63.100000000000001 109.542 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -63.79 -51.57 64.01 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 120.149 -0.621 . . . . 73.299999999999997 110.84 177.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -74.23 134.3 19.01 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 N-CA-C 108.644 -1.329 . . . . 63.340000000000003 108.644 170.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.45 154.4 71.85 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 122.753 2.302 . . . . 73.010000000000005 113.381 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.02 139.89 58.39 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.588 -0.733 . . . . 75.219999999999999 110.284 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 96.86 -8.8 65.76 Favored Glycine 0 C--N 1.302 -1.339 0 C-N-CA 120.595 -0.812 . . . . 65.129999999999995 111.695 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 25.2 m -82.5 133.97 35.2 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.646 -0.872 . . . . 60.329999999999998 108.646 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.425 ' HB ' ' OD1' ' A' ' 496' ' ' ASP . 15.1 t -94.64 132.79 38.98 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 108.301 -1.0 . . . . 75.209999999999994 108.301 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.17 155.2 64.96 Favored Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 107.839 -1.171 . . . . 72.319999999999993 107.839 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . 0.519 ' HG2' ' OG ' ' A' ' 549' ' ' SER . 7.6 Cg_endo -60.32 136.52 68.72 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 N-CA-C 109.421 -1.03 . . . . 73.439999999999998 109.421 176.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 518' ' ' THR . 9.7 p -66.56 -21.38 28.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.34 -0.845 . . . . 73.319999999999993 112.941 -172.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -93.35 3.69 55.2 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.766 0.793 . . . . 64.0 111.043 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 549' ' ' SER . . . . . 0.519 ' OG ' ' HG2' ' A' ' 546' ' ' PRO . 68.3 m -87.56 -174.7 4.91 Favored 'General case' 0 C--O 1.251 1.171 0 O-C-N 121.544 -0.723 . . . . 64.409999999999997 112.389 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 13.3 p -113.48 138.25 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 115.221 -0.9 . . . . 75.340000000000003 109.741 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.7 mt -102.92 137.4 31.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.76 -0.83 . . . . 73.340000000000003 108.76 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -102.43 117.49 34.83 Favored 'General case' 0 C--O 1.251 1.132 0 N-CA-C 107.999 -1.111 . . . . 74.010000000000005 107.999 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.44 129.93 55.25 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 123.343 0.402 . . . . 74.340000000000003 110.505 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -90.66 119.38 30.86 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.003 -0.544 . . . . 74.340000000000003 110.785 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 40.2 t -92.99 129.57 43.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.316 -0.994 . . . . 54.229999999999997 108.316 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.643 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 16.1 m -75.71 117.72 17.77 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 108.081 -1.081 . . . . 74.420000000000002 108.081 176.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.42 ' HE2' ' OD1' ' A' ' 526' ' ' ASP . 26.5 pttm -109.05 118.49 36.91 Favored 'General case' 0 N--CA 1.411 -2.399 0 N-CA-C 107.576 -1.268 . . . . 72.150000000000006 107.576 171.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -56.79 -23.86 46.5 Favored Glycine 0 CA--C 1.497 -1.09 0 O-C-N 124.319 1.012 . . . . 44.310000000000002 113.175 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 77.85 -3.84 2.32 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 125.331 1.452 . . . . 75.230000000000004 109.24 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.509 ' HG2' ' N ' ' A' ' 615' ' ' ASN . 63.2 mt-30 -112.58 150.21 31.67 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 115.592 -0.731 . . . . 70.299999999999997 112.831 -173.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -133.13 156.5 47.32 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.646 -1.613 . . . . 74.120000000000005 106.646 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 47.5 t -73.41 122.87 27.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.595 -0.891 . . . . 70.25 108.595 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 57.0 ttp -73.97 127.37 88.28 Favored Pre-proline 0 C--O 1.25 1.082 0 O-C-N 123.22 0.325 . . . . 74.120000000000005 111.428 -175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -61.71 169.64 6.79 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.598 2.865 . . . . 73.209999999999994 112.59 175.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -65.92 129.47 39.9 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.373 0.669 . . . . 72.019999999999996 112.766 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.7 pp -152.45 14.32 0.58 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.182 0.992 . . . . 74.209999999999994 109.075 172.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 4.2 m -79.95 140.89 36.46 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.414 -1.267 . . . . 70.420000000000002 111.995 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 53.18 43.1 63.37 Favored Glycine 0 C--O 1.223 -0.544 0 N-CA-C 115.112 0.805 . . . . 53.130000000000003 115.112 172.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 18.1 ptp -127.15 -179.65 4.97 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.874 -1.158 . . . . 75.099999999999994 107.874 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -96.24 168.96 10.27 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.665 -0.865 . . . . 75.409999999999997 108.665 -175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 37.8 t-105 -63.39 -28.08 69.74 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.445 -0.576 . . . . 73.030000000000001 109.445 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 8.9 p -75.11 -9.58 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 CA-C-N 115.695 -0.684 . . . . 74.040000000000006 110.484 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.578 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 42.6 m-20 -101.1 -42.0 6.54 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 107.858 -1.164 . . . . 61.030000000000001 107.858 173.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . 0.54 ' O ' HD13 ' A' ' 578' ' ' LEU . . . -55.54 -45.92 77.15 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.782 -1.099 . . . . 70.299999999999997 112.044 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.493 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 3.0 tm-20 -53.98 -58.46 13.33 Favored Pre-proline 0 CA--C 1.567 1.616 0 CA-C-O 118.949 -0.548 . . . . 72.25 110.533 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 57.9 Cg_exo -53.17 -32.25 58.94 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 121.978 1.785 . . . . 75.230000000000004 112.808 173.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 26.2 mmm180 -61.93 -36.25 80.81 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-O 118.659 -0.686 . . . . 75.099999999999994 112.42 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.617 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 5.4 mp -62.66 -48.54 78.88 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.708 -1.197 . . . . 74.519999999999996 110.115 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.1 -41.23 90.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.824 -0.625 . . . . 73.25 112.322 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.28 -39.54 74.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.746 0.647 . . . . 62.32 112.746 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.01 -9.02 58.46 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.926 0.394 . . . . 75.430000000000007 110.433 -175.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 72.47 48.36 24.12 Favored Glycine 0 CA--C 1.505 -0.556 0 N-CA-C 111.316 -0.713 . . . . 63.210000000000001 111.316 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . 0.617 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 8.6 t90 -85.99 133.4 33.92 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.0 0.429 . . . . 72.450000000000003 110.011 -176.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 1.3 p -86.82 -39.36 15.95 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.583 1.553 . . . . 73.430000000000007 112.826 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -79.7 -162.16 24.28 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-O 121.797 0.665 . . . . 73.120000000000005 114.279 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 61.5 mtm -122.79 152.87 40.24 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.974 -0.75 . . . . 75.530000000000001 108.974 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 4.4 tt -81.92 111.67 18.32 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.648 -1.241 . . . . 74.310000000000002 107.648 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . 0.571 ' O ' ' HA ' ' A' ' 621' ' ' THR . 33.0 t70 -95.34 107.97 20.12 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.658 0.742 . . . . 74.099999999999994 110.049 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.1 133.66 41.46 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.677 -0.861 . . . . 71.400000000000006 108.677 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.25 -69.29 1.4 Allowed Glycine 0 C--N 1.28 -2.532 0 N-CA-C 110.57 -1.012 . . . . 71.450000000000003 110.57 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -137.22 149.34 47.13 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 110.065 -0.346 . . . . 73.400000000000006 110.065 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -115.77 124.7 51.42 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.645 0.736 . . . . 75.209999999999994 109.072 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 44.2 t -106.74 153.52 7.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.758 -1.201 . . . . 73.420000000000002 107.758 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.42 126.2 29.26 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.934 0.873 . . . . 71.540000000000006 110.752 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -133.54 -48.34 0.83 Allowed 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 114.386 -1.279 . . . . 65.019999999999996 108.747 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 102.51 123.14 5.2 Favored Glycine 0 N--CA 1.422 -2.254 0 N-CA-C 111.254 -0.738 . . . . 64.450000000000003 111.254 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -60.58 -33.83 83.5 Favored Glycine 0 C--N 1.317 -0.514 0 N-CA-C 111.704 -0.559 . . . . 33.229999999999997 111.704 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.2 m -70.27 -23.88 62.96 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-O 121.819 0.819 . . . . 62.210000000000001 110.135 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -92.06 -1.58 57.13 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.195 -0.911 . . . . 74.129999999999995 110.085 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 69.82 81.73 0.17 Allowed 'General case' 0 C--O 1.244 0.772 0 CA-C-O 123.229 1.49 . . . . 74.5 111.283 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 625' ' ' GLY . 15.8 p-10 -79.77 89.31 5.21 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 113.32 -1.764 . . . . 74.439999999999998 113.056 -174.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -81.9 170.93 15.06 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.146 -0.934 . . . . 64.319999999999993 111.722 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 75.0 t -70.29 131.83 33.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 114.55 -1.205 . . . . 74.209999999999994 108.529 171.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 86.5 t -91.07 -43.92 14.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.499 0.666 . . . . 73.150000000000006 110.568 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -153.14 140.05 19.14 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.783 -0.644 . . . . 73.420000000000002 109.693 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -127.51 139.49 52.75 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.663 -1.236 . . . . 74.219999999999999 107.663 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.5 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 23.8 t-20 -58.99 -62.48 5.73 Favored Pre-proline 0 CA--C 1.555 1.153 0 CA-C-O 118.922 -0.561 . . . . 73.450000000000003 111.929 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 7.4 Cg_endo -95.74 120.44 0.24 Allowed 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 122.003 1.802 . . . . 75.239999999999995 110.027 171.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -70.34 156.82 60.99 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.437 2.091 . . . . 74.450000000000003 112.276 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.38 138.61 56.85 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.466 -0.938 . . . . 71.400000000000006 108.466 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 97.77 -2.13 60.14 Favored Glycine 0 C--N 1.301 -1.398 0 N-CA-C 110.637 -0.985 . . . . 62.240000000000002 110.637 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 26.9 m -109.54 155.52 21.28 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.281 -1.377 . . . . 73.430000000000007 107.281 175.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -78.43 138.46 21.12 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.972 -0.632 . . . . 75.439999999999998 113.393 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.89 143.05 42.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 124.068 0.947 . . . . 72.040000000000006 109.11 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.509 ' N ' ' HG2' ' A' ' 560' ' ' GLN . 30.2 p-10 -48.38 168.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.852 0.861 . . . . 70.450000000000003 113.023 175.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -57.14 -25.54 59.04 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.531 0.732 . . . . 71.120000000000005 112.806 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.95 -8.53 58.71 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 120.037 -0.665 . . . . 71.129999999999995 109.37 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.16 15.77 63.56 Favored Glycine 0 C--O 1.216 -1.024 0 CA-C-N 116.127 -0.488 . . . . 64.329999999999998 113.141 172.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.4 119.38 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-O 122.623 1.202 . . . . 73.209999999999994 112.409 -166.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.457 HG12 ' HD2' ' A' ' 608' ' ' PRO . 0.0 OUTLIER -125.62 128.25 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 CA-C-N 113.694 -1.594 . . . . 74.319999999999993 110.2 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 21.2 m -100.51 129.59 46.47 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.673 -1.149 . . . . 74.409999999999997 108.896 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.8 pp -138.92 166.24 24.99 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.742 0.645 . . . . 74.409999999999997 112.742 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -127.57 137.46 52.6 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.519 -2.03 . . . . 73.239999999999995 105.519 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -140.8 165.67 26.87 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 120.199 -0.6 . . . . 74.219999999999999 111.113 -172.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 601' ' ' ASN . . . -81.2 142.64 23.29 Favored Glycine 0 N--CA 1.412 -2.913 0 CA-C-N 115.405 -0.816 . . . . 43.149999999999999 111.125 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.402 -2.865 0 C-N-CA 124.336 1.054 . . . . 73.140000000000001 108.472 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.788 0 N-CA-C 110.098 -1.201 . . . . 43.049999999999997 110.098 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.13 142.35 24.48 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 121.949 1.766 . . . . 73.230000000000004 110.916 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -92.44 -10.54 37.61 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 122.44 1.114 . . . . 74.510000000000005 109.82 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 3.5 p -137.64 147.47 44.97 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 113.998 -1.455 . . . . 71.129999999999995 108.907 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -130.86 149.7 52.37 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.965 -0.754 . . . . 73.319999999999993 108.965 177.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.7 p-10 -87.71 135.55 33.32 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 122.986 0.514 . . . . 71.519999999999996 109.744 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 29.6 pt -88.43 130.39 45.79 Favored Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 116.586 -0.279 . . . . 75.510000000000005 110.957 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -88.44 172.75 4.81 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.629 2.219 . . . . 71.549999999999997 112.807 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -92.31 111.94 23.7 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.369 -0.832 . . . . 73.439999999999998 108.85 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 24.1 m -106.41 16.44 6.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.408 -0.815 . . . . 73.530000000000001 111.212 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -67.06 98.12 0.55 Allowed 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.822 -0.627 . . . . 73.519999999999996 111.399 -176.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 146.34 -26.03 1.7 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 115.667 -0.697 . . . . 72.519999999999996 111.637 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.425 ' O ' HG11 ' A' ' 534' ' ' VAL . 31.8 mt-30 -82.65 171.08 14.42 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.82 -0.807 . . . . 72.310000000000002 108.82 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 4.8 m -74.25 155.94 37.74 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 105.129 -2.174 . . . . 63.100000000000001 105.129 172.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.435 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.2 p -61.93 -41.94 92.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 118.648 0.658 . . . . 73.530000000000001 111.442 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . 0.534 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 17.1 t70 -62.4 -41.66 98.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.546 -0.297 . . . . 73.030000000000001 110.357 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 87.4 t -67.1 -44.15 88.26 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.247 0 CA-C-N 116.036 -0.529 . . . . 72.349999999999994 109.843 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.453 ' CB ' HG12 ' A' ' 534' ' ' VAL . . . -60.84 -39.79 90.4 Favored 'General case' 0 C--O 1.214 -0.809 0 O-C-N 123.18 0.3 . . . . 72.040000000000006 111.159 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.1 mt-30 -65.06 -43.94 90.62 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.473 -0.195 . . . . 74.439999999999998 110.473 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.537 ' O ' HG21 ' A' ' 514' ' ' VAL . 75.7 mmtt -63.95 -45.21 90.16 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.049 -0.723 . . . . 73.310000000000002 109.049 177.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -61.22 -43.06 99.49 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.279 -1.328 . . . . 75.230000000000004 110.077 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 66.3 tp -67.23 -45.81 75.66 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.14 -1.391 . . . . 74.430000000000007 109.219 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -64.88 -34.98 79.68 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 123.942 0.897 . . . . 70.150000000000006 113.155 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.537 HG21 ' O ' ' A' ' 510' ' ' LYS . 85.8 t -57.18 -33.06 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 120.928 0.394 . . . . 63.43 111.278 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -118.5 8.57 12.09 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.924 0.869 . . . . 71.329999999999998 110.267 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -114.42 -59.08 0.37 Allowed Glycine 0 N--CA 1.416 -2.688 0 CA-C-N 114.936 -1.029 . . . . 70.019999999999996 111.707 -174.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 65.53 18.72 11.36 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 122.479 1.133 . . . . 75.409999999999997 109.53 -176.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.2 p -92.54 -175.86 4.11 Favored 'General case' 0 N--CA 1.403 -2.795 0 CA-C-N 114.04 -1.436 . . . . 73.209999999999994 110.416 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -107.82 142.21 38.21 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.531 -0.914 . . . . 75.25 108.531 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -129.03 153.3 47.73 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.458 0.647 . . . . 72.400000000000006 111.427 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 71.0 m -140.12 155.71 46.87 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 107.095 -1.446 . . . . 72.099999999999994 107.095 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -124.14 123.23 39.84 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.313 0.578 . . . . 74.349999999999994 111.274 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -105.56 119.31 38.79 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.429 -0.952 . . . . 71.129999999999995 108.429 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 20.2 m -100.72 137.19 39.45 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.877 -0.329 . . . . 75.120000000000005 110.905 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.1 p -144.21 153.91 15.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.754 -1.202 . . . . 75.230000000000004 107.754 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -84.08 136.22 34.1 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.304 0.573 . . . . 74.329999999999998 110.927 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 50.6 m -159.04 171.38 7.49 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 106.394 -1.706 . . . . 64.409999999999997 106.394 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.99 -10.11 28.26 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 121.4 1.4 . . . . 62.210000000000001 112.597 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -72.59 140.14 81.46 Favored Pre-proline 0 N--CA 1.435 -1.189 0 N-CA-C 109.573 -0.529 . . . . 72.439999999999998 109.573 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.36 151.34 83.48 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.608 2.206 . . . . 72.400000000000006 113.344 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -64.96 121.55 14.91 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.187 -0.915 . . . . 74.120000000000005 111.542 -177.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 114.58 -18.91 17.02 Favored Glycine 0 C--O 1.249 1.044 0 C-N-CA 120.838 -0.696 . . . . 73.310000000000002 111.373 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -78.2 129.18 34.81 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 109.025 -0.732 . . . . 64.329999999999998 109.025 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 10.1 p -90.81 117.42 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.844 0 N-CA-C 106.78 -1.563 . . . . 74.549999999999997 106.78 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.4 m -92.94 9.74 34.25 Favored 'General case' 0 C--N 1.27 -2.886 0 CA-C-N 114.341 -1.3 . . . . 72.299999999999997 110.567 -173.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 132.7 -154.79 21.27 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 111.338 -0.705 . . . . 60.109999999999999 111.338 176.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.8 p -116.96 157.95 24.89 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.804 -0.813 . . . . 72.120000000000005 108.804 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -60.53 -55.76 41.91 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 119.004 -0.522 . . . . 72.099999999999994 111.448 176.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -70.53 144.78 50.9 Favored 'Trans proline' 0 C--N 1.367 1.533 0 N-CA-C 108.658 -1.324 . . . . 72.510000000000005 108.658 171.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -58.15 147.52 83.09 Favored 'Trans proline' 0 C--O 1.24 0.577 0 C-N-CA 122.79 2.327 . . . . 70.310000000000002 113.047 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.05 137.89 57.76 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-N 116.27 -0.423 . . . . 65.310000000000002 110.432 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.62 -19.98 48.17 Favored Glycine 0 C--N 1.31 -0.896 0 C-N-CA 120.926 -0.654 . . . . 63.340000000000003 111.948 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 35.4 m -67.46 136.79 55.19 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.705 -0.48 . . . . 74.329999999999998 109.705 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 14.8 t -96.34 133.23 40.98 Favored 'General case' 0 N--CA 1.406 -2.67 0 N-CA-C 108.984 -0.747 . . . . 74.420000000000002 108.984 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.7 m -123.39 155.88 64.67 Favored Pre-proline 0 C--N 1.296 -1.753 0 N-CA-C 108.042 -1.096 . . . . 74.439999999999998 108.042 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -63.9 138.28 62.19 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 121.385 1.39 . . . . 75.409999999999997 110.486 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 13.2 p -62.2 -19.99 23.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.611 -0.722 . . . . 75.209999999999994 111.426 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -90.18 -15.89 30.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.172 0.51 . . . . 71.409999999999997 111.507 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 60.0 m -80.39 -175.69 5.27 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 121.109 0.481 . . . . 73.439999999999998 111.723 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 12.4 p -113.19 137.61 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 115.931 -0.577 . . . . 73.340000000000003 110.168 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 70.2 mt -97.33 129.89 46.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 109.371 -0.603 . . . . 74.230000000000004 109.371 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -102.56 117.59 35.01 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.135 -0.691 . . . . 74.409999999999997 109.135 -177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.3 mp -98.59 134.84 40.97 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.813 -0.631 . . . . 74.25 110.006 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -91.82 113.63 25.95 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 116.292 -0.413 . . . . 72.219999999999999 110.365 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 524' ' ' SER . 20.1 t -106.65 126.93 62.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.421 -0.955 . . . . 75.140000000000001 108.421 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 50.5 m -95.55 143.34 26.94 Favored 'General case' 0 C--N 1.277 -2.58 0 C-N-CA 119.661 -0.816 . . . . 73.099999999999994 110.824 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 0.6 OUTLIER -105.79 144.38 32.61 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 106.163 -1.792 . . . . 74.439999999999998 106.163 168.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -55.02 -23.35 31.34 Favored Glycine 0 CA--C 1.492 -1.36 0 O-C-N 124.903 1.377 . . . . 64.120000000000005 114.624 -171.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 77.09 -27.29 0.18 Allowed 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 124.604 1.162 . . . . 74.120000000000005 110.92 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.482 ' H ' ' C ' ' A' ' 558' ' ' GLY . 72.1 mt-30 -114.1 162.18 16.81 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 114.517 -1.22 . . . . 75.329999999999998 109.665 -175.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -127.19 155.9 42.68 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 107.805 -1.183 . . . . 74.420000000000002 107.805 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 6.2 p -77.78 121.05 29.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.554 -0.536 . . . . 73.209999999999994 109.554 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 563' ' ' MET . . . . . 0.481 ' SD ' HG21 ' A' ' 620' ' ' ILE . 47.6 ttp -74.11 125.23 90.27 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 116.403 -0.362 . . . . 74.540000000000006 111.43 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -72.45 170.61 18.89 Favored 'Trans proline' 0 C--O 1.242 0.721 0 C-N-CA 123.491 2.794 . . . . 74.209999999999994 111.891 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.06 114.47 5.86 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.914 0.864 . . . . 74.420000000000002 112.703 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.5 pp -125.12 7.15 7.89 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.105 -1.407 . . . . 74.239999999999995 107.476 171.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 16.7 m -79.81 144.04 33.87 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 113.497 -1.683 . . . . 74.540000000000006 110.564 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 68.03 43.13 83.02 Favored Glycine 0 CA--C 1.521 0.413 0 O-C-N 123.686 0.616 . . . . 74.019999999999996 114.007 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 22.2 ptp -146.91 174.79 11.18 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.288 -0.634 . . . . 75.430000000000007 109.288 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -98.05 172.87 7.34 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.547 -1.279 . . . . 73.420000000000002 107.547 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -62.97 -35.63 80.79 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.708 -0.849 . . . . 75.219999999999999 108.708 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.8 -22.36 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 115.636 -0.711 . . . . 70.0 111.506 -175.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -102.18 -31.35 10.62 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-O 121.479 0.657 . . . . 75.099999999999994 110.667 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -71.41 -32.39 68.34 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.506 -0.77 . . . . 71.019999999999996 111.484 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.605 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 34.3 tt0 -64.56 -48.95 73.2 Favored Pre-proline 0 CA--C 1.56 1.336 0 CA-C-N 116.47 -0.332 . . . . 72.329999999999998 111.196 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 88.5 Cg_exo -54.69 -38.01 91.38 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 121.471 1.447 . . . . 72.430000000000007 111.76 170.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.414 ' HA ' ' NE ' ' A' ' 577' ' ' ARG . 1.4 mmp_? -58.94 -43.18 91.14 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 121.359 -0.136 . . . . 75.329999999999998 111.325 176.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.5 pp -67.05 -45.66 76.71 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.542 0.571 . . . . 73.299999999999997 112.542 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.464 ' N ' HD11 ' A' ' 578' ' ' LEU . 5.9 ptp85 -66.71 -35.04 79.18 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.478 0.547 . . . . 72.510000000000005 112.478 176.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.97 -36.56 83.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.181 0.515 . . . . 64.530000000000001 110.03 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 12.1 tp -81.26 -9.85 59.7 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.651 -0.704 . . . . 74.109999999999999 110.694 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 67.79 42.82 85.97 Favored Glycine 0 C--O 1.243 0.671 0 N-CA-C 111.883 -0.487 . . . . 74.230000000000004 111.883 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 13.7 t90 -75.19 126.49 31.13 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 120.977 0.418 . . . . 72.519999999999996 109.879 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 18.1 p -103.52 -15.44 15.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.822 -0.626 . . . . 73.25 112.084 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -83.79 -176.71 51.37 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 121.161 -0.542 . . . . 71.120000000000005 112.953 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 51.5 ttp -100.86 141.37 33.84 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 122.344 0.258 . . . . 74.430000000000007 111.286 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 8.0 tt -80.96 107.5 13.83 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.075 -1.083 . . . . 74.230000000000004 108.075 174.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 621' ' ' THR . 24.5 t70 -98.39 116.2 30.12 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.486 -0.779 . . . . 72.0 109.578 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.0 OUTLIER -106.46 134.38 49.68 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.534 -0.757 . . . . 73.140000000000001 109.192 178.61 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -70.84 -75.24 0.63 Allowed Glycine 0 C--N 1.293 -1.846 0 N-CA-C 111.116 -0.793 . . . . 72.150000000000006 111.116 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.09 121.32 15.87 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.284 -0.635 . . . . 72.439999999999998 109.284 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -84.57 137.01 33.54 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.992 -1.114 . . . . 75.349999999999994 107.992 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 47.0 t -105.76 126.75 61.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 116.223 -0.444 . . . . 72.409999999999997 110.049 -174.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . 0.458 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 9.7 p-10 -72.12 111.55 7.44 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 122.403 1.097 . . . . 63.310000000000002 111.489 -176.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -133.98 -45.68 0.79 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.356 -1.293 . . . . 51.240000000000002 109.133 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 103.44 149.36 20.79 Favored Glycine 0 N--CA 1.422 -2.261 0 C-N-CA 120.837 -0.697 . . . . 75.409999999999997 112.356 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.479 ' HA2' ' OD1' ' A' ' 601' ' ' ASN . . . -61.51 -32.58 81.74 Favored Glycine 0 C--N 1.302 -1.339 0 CA-C-N 114.981 -0.61 . . . . 72.109999999999999 112.71 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 10.6 t -71.03 -23.56 62.19 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 122.253 1.025 . . . . 75.030000000000001 109.449 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -88.58 -1.13 57.9 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.681 -1.145 . . . . 74.25 110.672 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 48.4 m80 70.29 80.7 0.17 Allowed 'General case' 0 C--O 1.244 0.792 0 CA-C-O 122.755 1.264 . . . . 72.219999999999999 110.567 -178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . 0.479 ' OD1' ' HA2' ' A' ' 597' ' ' GLY . 30.0 p-10 -87.58 78.53 8.53 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 113.812 -1.54 . . . . 74.109999999999999 111.452 -175.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -94.07 171.61 8.74 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.601 -1.181 . . . . 73.25 109.232 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . 0.446 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 96.4 t -64.93 130.75 30.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 106.829 -1.545 . . . . 73.010000000000005 106.829 170.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.8 t -96.51 -52.72 8.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 121.169 0.509 . . . . 70.530000000000001 110.535 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -147.91 150.55 34.3 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.161 -0.681 . . . . 75.239999999999995 109.161 -175.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -139.4 144.34 38.09 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.871 -1.159 . . . . 72.430000000000007 107.871 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -63.52 -51.48 66.66 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 120.444 -0.502 . . . . 74.129999999999995 111.98 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -93.13 116.67 0.32 Allowed 'Trans proline' 0 N--CA 1.442 -1.532 0 C-N-CA 121.212 1.275 . . . . 75.120000000000005 110.328 171.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.88 160.96 34.8 Favored 'Trans proline' 0 C--O 1.248 0.989 0 C-N-CA 122.857 2.371 . . . . 75.510000000000005 112.215 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.61 133.67 56.32 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.085 -0.709 . . . . 73.109999999999999 109.085 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 100.65 -0.56 55.44 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.636 -0.792 . . . . 63.109999999999999 112.265 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 35.3 m -90.18 145.76 24.78 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.555 -0.535 . . . . 72.150000000000006 109.555 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -77.28 124.21 6.82 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 110.733 -0.947 . . . . 74.430000000000007 110.733 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.9 m -125.78 143.2 40.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 108.374 -0.972 . . . . 74.420000000000002 108.374 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -48.23 163.03 0.07 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.92 0.888 . . . . 74.409999999999997 111.965 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . 0.331 0.0 OUTLIER -56.04 -24.5 39.98 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.971 1.471 . . . . 73.239999999999995 114.971 -178.387 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -83.65 -6.26 59.4 Favored 'General case' 0 C--O 1.199 -1.589 0 C-N-CA 119.256 -0.977 . . . . 75.219999999999999 112.497 175.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.83 19.52 69.61 Favored Glycine 0 CA--C 1.491 -1.441 0 CA-C-O 119.464 -0.631 . . . . 64.099999999999994 114.561 166.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.83 118.63 14.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-O 122.12 0.962 . . . . 74.239999999999995 110.419 -168.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.481 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.7 pp -129.36 133.86 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 114.708 -1.133 . . . . 73.329999999999998 111.866 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 15.4 t -102.21 122.92 45.12 Favored 'General case' 0 C--O 1.26 1.633 0 CA-C-O 121.802 0.81 . . . . 73.310000000000002 109.553 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 1.8 pt? -139.36 167.27 22.47 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.334 -0.848 . . . . 74.409999999999997 111.742 -173.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -128.22 137.08 51.86 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.262 -1.014 . . . . 75.019999999999996 108.262 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.446 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 35.0 p90 -141.28 166.63 24.24 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.788 -0.187 . . . . 64.019999999999996 111.126 -174.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -75.57 135.2 17.8 Favored Glycine 0 N--CA 1.435 -1.4 0 CA-C-O 121.69 0.605 . . . . 71.420000000000002 113.954 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.458 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 4.2 tt0 . . . . . 0 C--N 1.296 -1.755 0 N-CA-C 107.1 -1.445 . . . . 74.230000000000004 107.1 175.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.114 0 N-CA-C 110.167 -1.173 . . . . 73.099999999999994 110.167 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.13 161.46 43.16 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 122.41 2.073 . . . . 73.430000000000007 111.793 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -87.0 5.22 38.49 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.357 0.598 . . . . 73.150000000000006 111.594 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 16.1 p -139.18 141.1 37.99 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.823 -0.806 . . . . 61.240000000000002 108.823 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -143.02 148.42 36.74 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.818 0.342 . . . . 75.310000000000002 111.32 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.489 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.9 p-10 -79.1 139.08 38.17 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 115.407 -0.815 . . . . 72.349999999999994 110.209 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.4 pt -96.17 137.35 21.69 Favored Pre-proline 0 C--N 1.296 -1.722 0 CA-C-N 115.628 -0.715 . . . . 72.209999999999994 111.116 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -89.86 -177.22 1.34 Allowed 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.487 2.124 . . . . 72.420000000000002 109.829 170.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -99.9 137.28 38.57 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.919 -1.141 . . . . 73.450000000000003 107.919 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 16.7 m -110.81 17.31 7.65 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 CA-C-N 115.543 -0.753 . . . . 73.329999999999998 110.178 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -72.93 100.83 3.03 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.456 -0.793 . . . . 72.439999999999998 110.206 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 169.12 -46.43 0.22 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-N 115.379 -0.828 . . . . 72.219999999999999 111.864 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.415 ' O ' HG12 ' A' ' 534' ' ' VAL . 18.2 pm0 -98.07 -171.06 2.08 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 122.344 -0.504 . . . . 75.530000000000001 110.505 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 15.1 m -70.92 155.12 41.2 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.452 -0.944 . . . . 71.329999999999998 108.452 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 9.7 p -65.5 -41.73 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 O-C-N 123.06 0.225 . . . . 71.510000000000005 110.88 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -61.82 -37.98 86.44 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.913 -0.773 . . . . 65.120000000000005 108.913 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 95.1 t -71.02 -48.77 53.74 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.624 0 CA-C-N 115.525 -0.761 . . . . 71.430000000000007 109.684 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 511' ' ' ASN . . . -60.58 -36.73 79.25 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 122.769 0.428 . . . . 72.510000000000005 111.767 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 513' ' ' ASN . 23.8 mt-30 -65.23 -45.2 85.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.56 0.219 . . . . 61.340000000000003 110.47 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.514 ' O ' HG22 ' A' ' 514' ' ' VAL . 75.1 mmtt -66.6 -39.53 88.43 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 109.137 -0.69 . . . . 75.430000000000007 109.137 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 508' ' ' ALA . 20.3 t-20 -60.18 -47.02 87.68 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 125.771 1.628 . . . . 71.109999999999999 110.091 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -69.48 -42.06 75.32 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.761 -1.109 . . . . 71.129999999999995 108.592 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 1.0 OUTLIER -63.7 -35.59 81.07 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.421 -0.809 . . . . 75.120000000000005 111.392 -174.005 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 510' ' ' LYS . 71.4 t -57.78 -32.46 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.068 0.461 . . . . 72.239999999999995 111.737 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -115.36 4.76 14.45 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.559 0.695 . . . . 74.420000000000002 110.108 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -120.21 -57.59 0.24 Allowed Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 115.817 -0.629 . . . . 55.43 113.094 -174.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 64.76 28.96 12.9 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.89 0.876 . . . . 75.329999999999998 111.411 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 16.7 p -89.09 -166.92 1.72 Allowed 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.665 -1.152 . . . . 72.200000000000003 109.208 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -107.74 143.98 35.51 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 106.754 -1.572 . . . . 73.349999999999994 106.754 173.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -126.84 144.8 50.86 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.387 0.613 . . . . 71.099999999999994 112.327 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 73.5 m -132.81 149.92 52.22 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.651 -0.87 . . . . 72.25 108.651 176.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -123.18 131.78 53.81 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.025 0.44 . . . . 74.129999999999995 110.536 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -120.45 118.88 31.43 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.576 -0.898 . . . . 73.200000000000003 108.576 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 78.4 p -94.78 139.3 31.45 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.451 0.643 . . . . 73.310000000000002 112.203 -176.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.8 p -133.6 150.17 31.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.097 -1.075 . . . . 75.209999999999994 108.097 178.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.11 136.03 44.83 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.348 0.594 . . . . 72.319999999999993 111.281 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 74.3 m -156.01 163.2 25.59 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 106.803 -1.554 . . . . 74.030000000000001 106.803 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.52 -10.83 27.45 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.387 1.392 . . . . 72.140000000000001 112.709 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.452 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 10.2 mtm180 -84.48 152.51 60.77 Favored Pre-proline 0 N--CA 1.429 -1.483 0 N-CA-C 108.891 -0.781 . . . . 74.329999999999998 108.891 -176.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.17 149.35 70.57 Favored 'Trans proline' 0 C--O 1.246 0.893 0 C-N-CA 122.239 1.959 . . . . 73.530000000000001 114.41 -170.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.644 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -63.94 124.45 21.58 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.399 -1.273 . . . . 71.010000000000005 110.689 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 125.71 -21.65 6.26 Favored Glycine 0 C--N 1.291 -1.927 0 N-CA-C 111.049 -0.82 . . . . 50.219999999999999 111.049 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -75.0 137.59 41.64 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.584 -0.524 . . . . 63.520000000000003 109.584 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 503' ' ' GLN . 4.3 p -90.87 113.22 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.95 0 CA-C-O 122.084 0.945 . . . . 72.230000000000004 108.825 174.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -24.72 64.33 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.21 -1.359 . . . . 75.530000000000001 111.087 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 152.24 -157.42 27.25 Favored Glycine 0 N--CA 1.432 -1.617 0 N-CA-C 110.013 -1.235 . . . . 61.409999999999997 110.013 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.2 p -117.37 155.01 30.32 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 117.356 0.578 . . . . 72.519999999999996 109.903 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.447 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 25.7 t-20 -53.39 -51.7 73.27 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 119.252 -0.404 . . . . 74.219999999999999 111.902 174.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.9 Cg_endo -87.02 153.29 8.37 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 121.773 1.649 . . . . 75.420000000000002 110.453 174.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.32 160.68 48.86 Favored 'Trans proline' 0 C--O 1.26 1.58 0 C-N-CA 122.413 2.075 . . . . 72.319999999999993 112.545 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.6 131.83 46.86 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.84 -0.618 . . . . 53.310000000000002 109.712 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.74 -6.63 38.12 Favored Glycine 0 C--N 1.303 -1.256 0 C-N-CA 120.831 -0.7 . . . . 73.329999999999998 111.848 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 25.7 m -78.78 126.45 30.74 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.452 -0.574 . . . . 74.439999999999998 109.452 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 9.4 t -87.05 126.33 34.68 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.431 0.634 . . . . 73.530000000000001 109.319 176.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.67 159.49 55.38 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 107.782 -1.192 . . . . 74.25 107.782 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -66.38 137.56 47.52 Favored 'Trans proline' 0 N--CA 1.437 -1.808 0 C-N-CA 120.874 1.049 . . . . 75.239999999999995 110.354 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.41 -19.06 23.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.323 -0.853 . . . . 73.120000000000005 111.408 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -96.39 -9.8 29.11 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 112.211 0.448 . . . . 72.239999999999995 112.211 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 60.3 m -89.6 -175.99 4.86 Favored 'General case' 0 C--O 1.255 1.345 0 N-CA-C 112.871 0.693 . . . . 53.32 112.871 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.9 p -104.03 138.07 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 115.508 -0.769 . . . . 73.219999999999999 111.024 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 61.0 mt -107.55 138.34 34.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.88 -1.155 . . . . 74.209999999999994 107.88 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -102.84 126.89 50.15 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.145 0.498 . . . . 72.409999999999997 111.083 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.2 mp -108.04 134.72 50.53 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.108 -0.951 . . . . 75.349999999999994 109.281 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -89.41 134.04 34.26 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.921 -1.14 . . . . 75.409999999999997 107.921 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 524' ' ' SER . 38.3 t -116.08 131.2 69.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 110.21 -0.293 . . . . 74.340000000000003 110.21 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.644 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 2.3 m -83.79 122.03 28.11 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 107.839 -1.171 . . . . 73.329999999999998 107.839 177.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.73 140.18 30.91 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 106.725 -1.583 . . . . 74.109999999999999 106.725 171.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -57.91 -23.44 51.23 Favored Glycine 0 CA--C 1.489 -1.592 0 O-C-N 124.894 1.371 . . . . 73.409999999999997 114.282 -171.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 77.98 -19.52 0.43 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.759 1.224 . . . . 75.109999999999999 110.851 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.426 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 75.8 mt-30 -112.41 155.29 24.45 Favored 'General case' 0 N--CA 1.428 -1.549 0 O-C-N 121.502 -0.749 . . . . 73.549999999999997 112.042 -174.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -135.36 150.6 49.97 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.377 -1.342 . . . . 75.230000000000004 107.377 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 6.2 p -66.95 125.35 24.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 121.202 0.525 . . . . 73.400000000000006 111.661 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 563' ' ' MET . . . . . 0.495 ' SD ' HG22 ' A' ' 620' ' ' ILE . 51.3 ttp -88.34 131.02 43.66 Favored Pre-proline 0 C--N 1.309 -1.189 0 CA-C-N 116.095 -0.502 . . . . 72.239999999999995 109.731 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.18 169.21 17.21 Favored 'Trans proline' 0 C--O 1.244 0.803 0 C-N-CA 122.51 2.14 . . . . 74.219999999999999 110.88 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . 0.415 ' HA ' ' CB ' ' A' ' 610' ' ' ALA . 0.9 OUTLIER -79.22 127.83 32.54 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.286 1.041 . . . . 73.340000000000003 111.916 -177.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.3 pp -135.51 19.64 3.35 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 113.62 -1.627 . . . . 75.099999999999994 108.534 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 13.2 m -79.14 143.08 35.81 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 114.376 -1.284 . . . . 72.140000000000001 109.417 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 74.54 46.0 21.03 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 121.046 -0.597 . . . . 72.120000000000005 112.256 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -129.05 174.35 9.62 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 109.076 -0.712 . . . . 63.25 109.076 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -111.37 165.65 11.78 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.018 -1.845 . . . . 72.530000000000001 106.018 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 18.6 t-105 -61.75 -31.49 71.67 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.134 0.492 . . . . 74.230000000000004 110.139 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.5 p -65.37 -25.62 37.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 115.694 -0.684 . . . . 75.209999999999994 111.08 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.626 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 37.1 t70 -93.8 -26.2 17.06 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.578 -0.527 . . . . 74.400000000000006 109.578 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.19 -45.48 93.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.128 -0.942 . . . . 71.340000000000003 111.877 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.529 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 40.7 mt-10 -57.15 -52.95 70.31 Favored Pre-proline 0 CA--C 1.56 1.329 0 N-CA-C 112.547 0.573 . . . . 75.530000000000001 112.547 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.456 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 31.5 Cg_exo -61.28 -35.22 85.67 Favored 'Trans proline' 0 C--N 1.365 1.439 0 CA-C-N 120.491 1.211 . . . . 74.230000000000004 112.414 173.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.626 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 5.7 mmp_? -60.4 -44.74 95.39 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 120.934 -0.306 . . . . 73.310000000000002 110.651 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.6 pp -65.88 -47.09 76.02 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.023 -0.535 . . . . 71.430000000000007 112.203 -174.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.485 ' N ' HD12 ' A' ' 578' ' ' LEU . 16.8 ptm180 -66.64 -37.63 85.22 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.261 -0.427 . . . . 75.329999999999998 111.707 177.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.47 -35.61 73.39 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 111.822 0.305 . . . . 73.420000000000002 111.822 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.0 pp -83.97 -9.15 58.89 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 119.654 -0.818 . . . . 72.439999999999998 110.532 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 78.96 41.99 13.32 Favored Glycine 0 C--O 1.243 0.718 0 C-N-CA 121.197 -0.525 . . . . 74.150000000000006 112.211 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -78.21 128.78 34.26 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.565 -0.531 . . . . 73.519999999999996 109.565 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 5.2 p -82.18 -47.98 11.84 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 123.732 0.813 . . . . 75.129999999999995 112.092 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -68.42 -166.4 3.94 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 115.698 1.039 . . . . 43.450000000000003 115.698 -176.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 17.5 tpt -118.46 149.15 41.75 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 123.452 0.701 . . . . 60.350000000000001 109.538 -175.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 28.5 tp -80.46 117.61 21.34 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 121.252 0.548 . . . . 74.450000000000003 109.82 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 621' ' ' THR . 25.5 t70 -100.49 120.58 40.21 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 115.237 -0.892 . . . . 74.549999999999997 109.5 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.18 134.29 51.24 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.217 0.532 . . . . 72.019999999999996 109.784 178.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -86.47 -70.28 1.32 Allowed Glycine 0 C--N 1.288 -2.098 0 CA-C-N 115.396 -0.82 . . . . 73.120000000000005 112.651 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.42 154.13 47.73 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.656 0.265 . . . . 73.420000000000002 111.433 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -93.07 124.76 37.27 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.177 -0.92 . . . . 71.340000000000003 108.813 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 52.3 t -104.96 147.81 10.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 107.589 -1.263 . . . . 74.329999999999998 107.589 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . 0.475 ' HA ' ' HG2' ' A' ' 626' ' ' GLN . 10.7 p-10 -78.38 120.76 23.58 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.58 -0.896 . . . . 72.230000000000004 108.58 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -124.22 -52.39 1.74 Allowed 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.231 -0.588 . . . . 72.409999999999997 110.611 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 96.04 143.48 14.79 Favored Glycine 0 N--CA 1.427 -1.915 0 C-N-CA 119.935 -1.126 . . . . 64.230000000000004 111.697 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -60.5 -33.31 81.0 Favored Glycine 0 C--N 1.309 -0.956 0 N-CA-C 115.096 0.798 . . . . 75.129999999999995 115.096 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 33.4 t -77.14 -27.77 54.01 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 118.104 0.952 . . . . 75.450000000000003 109.528 -175.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -90.28 -3.42 57.8 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.102 -0.954 . . . . 70.129999999999995 109.947 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 34.0 m80 69.07 111.25 0.05 OUTLIER 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 114.491 -1.231 . . . . 72.219999999999999 112.486 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 625' ' ' GLY . 21.5 p-10 -79.4 65.01 4.44 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 123.306 1.527 . . . . 73.319999999999993 110.83 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -91.53 171.23 9.33 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 113.055 -1.884 . . . . 73.450000000000003 110.07 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 94.8 t -65.65 130.11 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 106.645 -1.613 . . . . 73.299999999999997 106.645 170.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 29.9 m -101.29 -36.32 4.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.152 0.501 . . . . 71.230000000000004 111.206 -176.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -144.27 135.98 25.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 116.167 -0.469 . . . . 73.209999999999994 109.965 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -126.62 137.79 53.35 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.161 -1.422 . . . . 72.040000000000006 107.161 174.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.461 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 45.0 t-20 -62.63 -59.11 13.62 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-O 118.99 -0.529 . . . . 72.430000000000007 112.162 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.0 Cg_exo -82.84 120.67 3.1 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.553 1.502 . . . . 75.319999999999993 110.065 175.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.8 148.31 64.55 Favored 'Trans proline' 0 C--O 1.243 0.758 0 C-N-CA 122.341 2.027 . . . . 74.5 112.29 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . 0.415 ' CB ' ' HA ' ' A' ' 565' ' ' ASP . . . -68.07 129.46 39.98 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.761 -0.654 . . . . 74.109999999999999 109.403 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.04 -10.4 47.82 Favored Glycine 0 C--N 1.302 -1.333 0 N-CA-C 110.219 -1.152 . . . . 73.040000000000006 110.219 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 37.1 m -101.68 161.92 13.29 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.801 -1.185 . . . . 70.010000000000005 107.801 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -82.82 135.22 13.72 Favored Glycine 0 N--CA 1.418 -2.528 0 C-N-CA 121.271 -0.49 . . . . 71.0 112.537 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.1 m -114.08 142.98 24.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 107.434 -1.321 . . . . 60.399999999999999 107.434 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.426 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 33.1 p-10 -56.37 170.86 0.32 Allowed 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 112.683 0.623 . . . . 75.540000000000006 112.683 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -56.98 -25.19 57.79 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.181 0.808 . . . . 74.120000000000005 113.181 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -87.57 -9.05 55.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.497 0.665 . . . . 73.150000000000006 109.5 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.54 14.92 63.18 Favored Glycine 0 C--O 1.217 -0.917 0 CA-C-N 115.628 -0.714 . . . . 72.430000000000007 113.406 172.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.57 119.74 17.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 122.416 1.103 . . . . 73.349999999999994 112.458 -167.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.495 HG22 ' SD ' ' A' ' 563' ' ' MET . 36.0 pt -122.42 133.32 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.975 0 CA-C-N 114.337 -1.301 . . . . 75.219999999999999 109.02 178.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 9.9 t -109.49 131.37 55.12 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.189 -1.041 . . . . 73.319999999999993 108.189 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.7 pp -138.73 165.91 25.76 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 112.873 0.694 . . . . 74.430000000000007 112.873 -175.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -128.45 137.83 52.02 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.51 -1.293 . . . . 72.109999999999999 107.51 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -133.44 163.13 30.04 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 120.161 -0.616 . . . . 73.540000000000006 111.387 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 601' ' ' ASN . . . -84.41 153.16 28.63 Favored Glycine 0 N--CA 1.42 -2.388 0 CA-C-N 115.446 -0.797 . . . . 73.340000000000003 112.507 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.475 ' HG2' ' HA ' ' A' ' 594' ' ' ASP . 1.0 OUTLIER . . . . . 0 C--O 1.271 2.202 0 N-CA-C 107.577 -1.268 . . . . 74.120000000000005 107.577 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.892 0 N-CA-C 110.901 -0.879 . . . . 43.049999999999997 110.901 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -73.21 145.01 38.23 Favored 'Trans proline' 0 C--O 1.241 0.674 0 C-N-CA 122.611 2.207 . . . . 74.319999999999993 111.699 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 66.3 24.65 10.58 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.317 1.047 . . . . 64.219999999999999 112.035 178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.406 ' HB ' HG22 ' A' ' 544' ' ' THR . 40.3 p -138.96 139.87 38.09 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.035 -0.728 . . . . 71.230000000000004 109.035 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . 0.597 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 6.1 tmtt? -134.8 143.0 46.82 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.699 -0.852 . . . . 64.109999999999999 108.699 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.597 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 9.3 p-10 -77.41 128.9 35.04 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.879 0.872 . . . . 55.25 110.712 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.7 pt -84.15 138.01 39.75 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.352 -0.84 . . . . 75.030000000000001 111.007 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.08 176.56 8.95 Favored 'Trans proline' 0 C--O 1.238 0.511 0 C-N-CA 122.666 2.244 . . . . 75.209999999999994 112.516 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -81.45 127.85 33.24 Favored 'General case' 0 C--O 1.253 1.263 0 N-CA-C 108.177 -1.046 . . . . 74.140000000000001 108.177 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.586 ' HA ' ' NE2' ' A' ' 503' ' ' GLN . 34.8 m -123.28 -16.92 4.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 113.465 0.913 . . . . 73.140000000000001 113.465 -175.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -71.11 94.84 1.16 Allowed 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 120.721 0.296 . . . . 74.430000000000007 110.897 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 153.01 -39.23 0.73 Allowed Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 120.224 -0.989 . . . . 75.439999999999998 112.224 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.586 ' NE2' ' HA ' ' A' ' 500' ' ' VAL . 15.2 pm0 -88.2 -176.91 5.56 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 119.98 -0.688 . . . . 75.049999999999997 109.685 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 14.7 m -70.84 155.3 40.97 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.435 -1.32 . . . . 74.150000000000006 107.435 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.492 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.5 p -64.39 -41.48 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 121.031 -0.267 . . . . 74.5 110.713 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 14.3 t70 -61.75 -40.88 96.68 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.596 -0.52 . . . . 73.239999999999995 109.596 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.37 -43.35 84.31 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.803 0 CA-C-N 115.576 -0.738 . . . . 72.109999999999999 109.794 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -58.37 -45.04 89.0 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 123.15 0.281 . . . . 73.450000000000003 110.6 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.2 mt-30 -63.52 -45.29 91.3 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.754 -0.657 . . . . 63.140000000000001 110.369 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.524 ' O ' HG21 ' A' ' 514' ' ' VAL . 47.0 mmtm -62.99 -43.91 97.47 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.142 -0.481 . . . . 74.530000000000001 110.535 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -64.58 -43.74 92.9 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.656 -0.702 . . . . 74.310000000000002 111.85 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.2 pp -69.22 -36.43 77.22 Favored 'General case' 0 C--O 1.207 -1.181 0 C-N-CA 120.308 -0.557 . . . . 73.310000000000002 110.63 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.435 ' ND2' ' HA ' ' A' ' 517' ' ' PHE . 2.0 t-20 -63.13 -35.79 81.45 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 123.155 0.582 . . . . 75.340000000000003 110.45 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.524 HG21 ' O ' ' A' ' 510' ' ' LYS . 89.1 t -60.84 -36.34 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.05 0.452 . . . . 75.319999999999993 110.83 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . 0.471 ' O ' ' HE3' ' A' ' 495' ' ' LYS . 84.2 m-85 -112.71 22.64 14.32 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.15 0.5 . . . . 75.25 110.024 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -144.3 -58.83 0.02 OUTLIER Glycine 0 CA--C 1.48 -2.11 0 C-N-CA 119.849 -1.167 . . . . 64.140000000000001 112.797 -176.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.435 ' HA ' ' ND2' ' A' ' 513' ' ' ASN . 96.6 m-85 66.06 23.66 11.06 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 122.93 1.347 . . . . 75.150000000000006 109.656 -173.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 518' ' ' THR . . . . . 0.479 ' C ' ' HD2' ' A' ' 519' ' ' LYS . 5.8 p -83.08 174.7 10.61 Favored 'General case' 0 N--CA 1.394 -3.233 0 CA-C-N 112.646 -2.07 . . . . 74.530000000000001 108.373 176.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.479 ' HD2' ' C ' ' A' ' 518' ' ' THR . 11.8 mptt -107.94 140.28 41.3 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 108.848 -0.797 . . . . 75.430000000000007 108.848 -177.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -125.41 154.03 42.55 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 121.16 0.505 . . . . 73.230000000000004 111.81 -172.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 32.9 p -135.59 147.17 48.6 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 107.724 -1.213 . . . . 74.340000000000003 107.724 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -119.74 119.83 34.81 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.245 0.545 . . . . 74.5 110.687 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -110.77 116.66 31.67 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.053 -1.092 . . . . 75.129999999999995 108.053 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.6 m -96.39 126.91 41.92 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.587 -0.445 . . . . 73.25 110.199 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.35 149.09 24.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 106.819 -1.549 . . . . 74.420000000000002 106.819 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.402 ' HA ' ' CG ' ' A' ' 557' ' ' LYS . 6.1 p-10 -80.18 135.85 36.37 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-O 121.186 0.517 . . . . 73.219999999999999 110.565 -176.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 43.7 m -153.0 168.91 10.55 Favored Pre-proline 0 C--N 1.293 -1.869 0 N-CA-C 106.152 -1.796 . . . . 74.120000000000005 106.152 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -75.78 -10.63 20.02 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 121.255 1.303 . . . . 73.329999999999998 111.503 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -81.01 137.2 49.91 Favored Pre-proline 0 N--CA 1.413 -2.289 0 N-CA-C 108.252 -1.018 . . . . 72.340000000000003 108.252 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -65.3 142.39 72.73 Favored 'Trans proline' 0 C--O 1.255 1.325 0 C-N-CA 123.351 2.701 . . . . 72.319999999999993 115.304 -170.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.714 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -59.58 118.2 5.8 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 114.613 -1.176 . . . . 73.219999999999999 111.739 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 136.0 -27.04 3.07 Favored Glycine 0 C--N 1.296 -1.69 0 N-CA-C 109.846 -1.302 . . . . 72.430000000000007 109.846 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -74.46 136.04 42.28 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.943 -0.629 . . . . 73.150000000000006 110.273 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 5.7 p -100.95 113.9 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.315 0 N-CA-C 108.201 -1.037 . . . . 63.140000000000001 108.201 172.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.95 -8.1 58.6 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.024 -0.534 . . . . 52.420000000000002 112.11 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 147.06 -171.86 27.66 Favored Glycine 0 N--CA 1.42 -2.408 0 C-N-CA 120.271 -0.966 . . . . 73.239999999999995 112.178 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 4.5 p -116.9 159.0 23.09 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 107.485 -1.302 . . . . 64.519999999999996 107.485 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -64.77 -47.17 75.71 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 118.33 -1.348 . . . . 74.549999999999997 112.084 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -73.58 137.07 24.6 Favored 'Trans proline' 0 C--N 1.366 1.465 0 N-CA-C 108.384 -1.429 . . . . 65.129999999999995 108.384 169.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . 0.428 ' HG2' ' OG1' ' A' ' 543' ' ' THR . 15.7 Cg_endo -59.97 140.62 93.68 Favored 'Trans proline' 0 C--O 1.246 0.89 0 C-N-CA 122.299 1.999 . . . . 73.430000000000007 112.589 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.6 132.69 54.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.758 -0.655 . . . . 63.140000000000001 109.59 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.44 -21.01 36.01 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.207 -0.757 . . . . 72.109999999999999 111.207 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 543' ' ' THR . . . . . 0.428 ' OG1' ' HG2' ' A' ' 540' ' ' PRO . 70.5 m -77.08 137.93 39.24 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.21 0.529 . . . . 72.340000000000003 110.873 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 7.1 m -84.39 123.2 29.96 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 108.628 -0.878 . . . . 73.439999999999998 108.628 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.98 157.39 63.71 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 108.424 -0.954 . . . . 73.0 108.424 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -59.99 136.26 68.27 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 121.355 1.37 . . . . 75.349999999999994 112.866 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.93 -20.54 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.671 -1.15 . . . . 75.209999999999994 111.105 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -84.13 -17.93 38.47 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.434 -1.257 . . . . 72.200000000000003 111.535 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 50.0 m -97.28 163.29 12.96 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 114.107 1.151 . . . . 61.520000000000003 114.107 -171.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.8 p -89.81 129.72 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 114.568 -1.196 . . . . 62.420000000000002 110.522 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 56.4 mt -92.74 132.13 37.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 107.697 -1.223 . . . . 73.329999999999998 107.697 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.43 117.75 35.17 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 121.509 0.671 . . . . 72.519999999999996 110.293 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.0 mp -103.96 124.51 49.13 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.884 -1.053 . . . . 74.219999999999999 108.948 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -92.46 118.79 31.32 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.412 0.625 . . . . 72.140000000000001 110.252 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.69 133.82 41.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.002 -0.999 . . . . 72.310000000000002 109.24 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.714 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 3.1 m -83.13 119.75 24.92 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.312 -1.366 . . . . 74.549999999999997 107.312 176.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.402 ' CG ' ' HA ' ' A' ' 526' ' ' ASP . 8.6 ptpp? -96.07 142.95 27.66 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.922 -1.51 . . . . 72.530000000000001 106.922 172.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -56.04 -23.47 39.37 Favored Glycine 0 C--O 1.244 0.773 0 O-C-N 124.641 1.213 . . . . 60.310000000000002 114.773 -171.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 78.55 -9.26 1.53 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 124.082 0.953 . . . . 72.319999999999993 110.364 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -112.6 156.88 21.93 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 113.387 0.884 . . . . 73.420000000000002 113.387 -170.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -130.67 157.04 43.86 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.479 -1.237 . . . . 73.209999999999994 107.915 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 97.0 t -74.72 121.49 26.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 O-C-N 123.212 0.32 . . . . 73.420000000000002 110.838 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 563' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 564' ' ' PRO . 42.8 ttm -64.84 125.81 89.74 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 123.461 0.705 . . . . 74.299999999999997 111.836 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . 0.448 ' O ' ' HG2' ' A' ' 563' ' ' MET . 16.2 Cg_exo -74.07 169.35 22.64 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.825 2.35 . . . . 74.299999999999997 110.504 172.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.87 138.42 46.27 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.41 0.624 . . . . 75.439999999999998 112.263 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -152.79 24.62 0.58 Allowed 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.786 -1.191 . . . . 71.420000000000002 107.786 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 6.2 m -78.07 141.53 38.76 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.434 -1.257 . . . . 72.430000000000007 111.371 -173.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 70.42 27.6 72.44 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 116.065 -0.516 . . . . 73.230000000000004 113.51 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 569' ' ' MET . . . . . 0.539 ' O ' ' HA ' ' A' ' 602' ' ' ARG . 27.0 ptt? -99.51 160.02 14.59 Favored 'General case' 0 CA--C 1.476 -1.884 0 C-N-CA 120.233 -0.587 . . . . 72.25 109.936 -176.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . 0.552 ' HA ' ' O ' ' A' ' 601' ' ' ASN . 6.5 m-85 -103.38 175.05 5.61 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.638 -1.986 . . . . 74.409999999999997 105.638 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -70.1 -28.49 65.44 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 118.507 -1.277 . . . . 71.530000000000001 109.579 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.9 m -73.37 -13.38 16.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.557 -0.747 . . . . 71.230000000000004 110.548 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.585 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 24.0 t70 -101.46 -28.63 12.46 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.899 -0.778 . . . . 75.25 108.899 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -59.11 -53.05 62.77 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.046 -0.979 . . . . 75.329999999999998 111.803 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -54.8 -50.5 85.59 Favored Pre-proline 0 CA--C 1.558 1.287 0 N-CA-C 113.365 0.876 . . . . 74.420000000000002 113.365 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -57.67 -28.96 83.79 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 121.336 1.357 . . . . 62.240000000000002 112.766 172.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 23.0 mmm180 -68.76 -38.9 80.41 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 121.802 -0.561 . . . . 72.040000000000006 110.805 176.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.521 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 11.0 mp -59.75 -48.05 83.22 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 120.707 0.289 . . . . 74.439999999999998 110.453 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -66.37 -38.44 87.58 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.838 -0.619 . . . . 72.219999999999999 112.411 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.03 -39.06 76.0 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.545 0.688 . . . . 73.319999999999993 111.018 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . 0.456 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 8.5 tp -83.28 -9.5 59.07 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 115.24 -0.891 . . . . 73.299999999999997 110.522 -178.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 60.87 42.35 99.57 Favored Glycine 0 CA--C 1.507 -0.466 0 N-CA-C 111.028 -0.829 . . . . 55.329999999999998 111.028 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . 0.521 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 14.6 t90 -85.21 126.74 33.9 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.469 -0.567 . . . . 71.319999999999993 109.469 -175.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 12.7 t -99.14 -16.24 18.67 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 116.127 -0.488 . . . . 54.399999999999999 110.956 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -77.15 -177.49 45.88 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 121.509 -0.377 . . . . 74.219999999999999 112.691 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 48.4 tpp -112.8 147.16 37.5 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.192 -0.67 . . . . 72.140000000000001 109.192 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.4 tt -86.91 127.87 35.06 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.42 -1.326 . . . . 64.140000000000001 107.42 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -100.07 119.11 37.8 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.547 -0.538 . . . . 75.340000000000003 109.547 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.49 133.79 46.87 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.461 -0.896 . . . . 74.219999999999999 109.91 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.36 -79.05 0.95 Allowed Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.456 -0.793 . . . . 45.240000000000002 112.091 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -137.72 145.77 42.93 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 110.047 -0.353 . . . . 74.150000000000006 110.047 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -88.15 124.63 34.0 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.729 -1.582 . . . . 74.239999999999995 106.729 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 39.1 t -104.43 126.18 59.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.531 -0.914 . . . . 73.310000000000002 108.531 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . 0.478 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 32.2 t70 -73.58 106.39 5.33 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.379 -0.528 . . . . 75.439999999999998 111.114 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -113.54 -12.33 12.92 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.142 -0.936 . . . . 75.109999999999999 109.536 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 114.49 137.6 6.52 Favored Glycine 0 N--CA 1.428 -1.855 0 N-CA-C 111.084 -0.807 . . . . 42.420000000000002 111.084 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -63.23 -38.49 96.56 Favored Glycine 0 C--N 1.318 -0.464 0 C-N-CA 121.725 -0.274 . . . . 75.299999999999997 112.887 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 33.6 t -72.79 -22.82 60.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.869 0.842 . . . . 73.409999999999997 109.414 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -86.92 -3.43 59.08 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.006 -0.997 . . . . 65.030000000000001 110.546 -175.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 70.5 m80 67.67 158.11 0.14 Allowed 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.798 1.239 . . . . 75.219999999999999 113.199 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 570' ' ' PHE . 21.1 p30 -93.77 68.16 3.9 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.592 0.71 . . . . 75.420000000000002 112.905 -179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 569' ' ' MET . 2.7 ptp180 -85.47 146.72 26.81 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 119.365 -0.934 . . . . 72.530000000000001 112.171 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 74.2 t -57.95 130.11 20.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 114.053 -1.431 . . . . 74.219999999999999 109.516 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.17 -23.02 4.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.025 0.441 . . . . 73.400000000000006 111.086 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -155.97 135.9 12.76 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.548 -0.751 . . . . 75.400000000000006 109.726 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -124.5 137.64 54.4 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.698 -1.964 . . . . 74.120000000000005 105.698 173.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.71 -53.52 35.68 Favored Pre-proline 0 C--N 1.317 -0.832 0 C-N-CA 119.066 -1.053 . . . . 72.010000000000005 112.86 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -91.94 113.76 0.34 Allowed 'Trans proline' 0 N--CA 1.438 -1.789 0 C-N-CA 121.217 1.278 . . . . 72.219999999999999 109.344 171.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -70.14 160.11 50.75 Favored 'Trans proline' 0 C--O 1.247 0.947 0 C-N-CA 122.332 2.021 . . . . 73.530000000000001 111.539 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -62.18 138.89 58.48 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 109.844 -0.428 . . . . 73.200000000000003 109.844 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 102.1 -14.74 57.01 Favored Glycine 0 C--N 1.306 -1.113 0 N-CA-C 111.579 -0.608 . . . . 62.530000000000001 111.579 -175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 6.0 m -92.05 155.03 18.37 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.881 -0.785 . . . . 71.310000000000002 108.881 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -80.01 134.22 13.31 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 121.033 -0.603 . . . . 71.140000000000001 112.496 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 13.6 m -127.06 143.13 41.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 124.226 1.01 . . . . 72.430000000000007 109.879 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -49.58 162.87 0.14 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.322 1.049 . . . . 75.129999999999995 112.971 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -59.45 -24.83 63.87 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 114.056 1.132 . . . . 75.319999999999993 114.056 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -82.71 -8.82 59.57 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 119.598 -0.841 . . . . 73.030000000000001 109.523 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.2 14.68 64.31 Favored Glycine 0 C--O 1.221 -0.68 0 C-N-CA 123.519 0.581 . . . . 72.109999999999999 113.678 173.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.29 119.9 17.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 122.099 0.952 . . . . 73.239999999999995 110.556 -168.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.414 HG22 ' HE3' ' A' ' 563' ' ' MET . 2.7 pp -128.64 134.62 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-N 115.087 -0.961 . . . . 75.400000000000006 112.768 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 10.2 t -105.11 124.69 49.97 Favored 'General case' 0 C--O 1.258 1.551 0 CA-C-N 115.355 -0.839 . . . . 65.010000000000005 109.641 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.1 pp -140.12 167.35 22.33 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.514 -0.767 . . . . 73.310000000000002 112.411 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -127.3 140.25 52.33 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.788 -0.819 . . . . 75.0 108.788 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -139.97 167.37 22.28 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.628 -0.715 . . . . 75.340000000000003 110.039 -170.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -60.1 177.15 3.33 Favored Glycine 0 CA--C 1.538 1.472 0 O-C-N 124.008 0.818 . . . . 71.349999999999994 113.847 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.478 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 5.6 tp-100 . . . . . 0 C--N 1.292 -1.921 0 C-N-CA 123.712 0.805 . . . . 73.230000000000004 108.971 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.129 0 N-CA-C 110.937 -0.865 . . . . 63.109999999999999 110.937 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.63 158.72 44.55 Favored 'Trans proline' 0 C--O 1.246 0.875 0 C-N-CA 122.349 2.032 . . . . 74.219999999999999 111.16 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -87.86 -5.15 58.74 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.895 0.855 . . . . 72.200000000000003 110.882 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 7.9 p -135.27 144.82 47.02 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.807 -1.183 . . . . 72.409999999999997 107.807 176.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -141.34 143.79 34.21 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 109.533 -0.543 . . . . 75.120000000000005 109.533 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.5 m-20 -83.02 124.73 30.7 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.036 -0.529 . . . . 72.400000000000006 110.46 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.4 pt -88.83 137.35 30.0 Favored Pre-proline 0 C--N 1.305 -1.327 0 CA-C-N 115.81 -0.632 . . . . 74.420000000000002 110.434 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.89 -177.34 3.76 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.311 2.007 . . . . 75.409999999999997 111.776 177.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -93.61 127.44 39.29 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.317 -0.994 . . . . 65.409999999999997 108.317 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.556 ' O ' ' HG2' ' A' ' 503' ' ' GLN . 28.2 m -122.06 -3.98 8.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 112.717 0.636 . . . . 73.439999999999998 112.717 -176.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -66.3 102.3 0.84 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.018 0.437 . . . . 75.420000000000002 110.423 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 141.94 -22.28 2.47 Favored Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 120.808 -0.711 . . . . 63.340000000000003 112.742 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.556 ' HG2' ' O ' ' A' ' 500' ' ' VAL . 6.3 pt20 -100.46 -179.1 4.0 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 109.091 -0.707 . . . . 75.030000000000001 109.091 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 21.1 m -74.4 155.41 38.11 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 108.495 -0.928 . . . . 73.200000000000003 108.495 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.18 -41.57 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 C-N-CA 122.697 0.399 . . . . 74.299999999999997 110.883 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . 0.484 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 28.5 t70 -59.69 -43.7 93.93 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.056 0.455 . . . . 62.140000000000001 110.162 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 90.2 t -67.99 -46.61 81.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 114.491 -1.231 . . . . 74.150000000000006 110.052 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.6 -45.79 90.86 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 123.41 0.444 . . . . 72.230000000000004 111.258 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -65.23 -44.49 88.07 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.178 -0.464 . . . . 75.329999999999998 111.745 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.557 ' O ' HG22 ' A' ' 514' ' ' VAL . 3.4 ptpp? -67.45 -39.92 85.4 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 119.632 -0.827 . . . . 64.430000000000007 111.186 176.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -62.44 -44.27 96.81 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.524 0.678 . . . . 74.200000000000003 110.918 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.65 -47.14 86.8 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-N 114.395 -1.275 . . . . 74.299999999999997 108.951 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -65.98 -35.23 80.02 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 115.439 -0.8 . . . . 70.030000000000001 112.675 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 510' ' ' LYS . 72.5 t -58.45 -33.76 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.115 0.483 . . . . 73.310000000000002 110.552 176.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -114.2 11.34 17.47 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.056 0.455 . . . . 74.439999999999998 110.117 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -127.47 -59.82 0.13 Allowed Glycine 0 CA--C 1.475 -2.416 0 C-N-CA 120.437 -0.887 . . . . 60.5 113.242 -172.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 66.25 21.55 11.03 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 121.926 0.87 . . . . 75.540000000000006 109.134 -172.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.4 p -91.48 -173.57 3.62 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 114.16 -1.382 . . . . 74.099999999999994 110.148 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 52.5 mtmt -108.11 143.85 36.28 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.384 -0.969 . . . . 75.519999999999996 108.384 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -129.17 151.08 50.23 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 120.866 0.365 . . . . 73.409999999999997 111.357 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 67.7 m -140.25 151.5 45.18 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 107.419 -1.326 . . . . 74.340000000000003 107.419 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -121.66 124.47 44.38 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.704 0.764 . . . . 74.329999999999998 112.334 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -101.43 133.05 46.66 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.999 -1.482 . . . . 75.409999999999997 106.999 175.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 22.2 m -118.37 122.12 42.06 Favored 'General case' 0 C--N 1.29 -1.978 0 C-N-CA 120.114 -0.634 . . . . 71.129999999999995 111.519 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.9 p -122.41 149.56 25.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.691 -1.226 . . . . 75.329999999999998 107.691 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.424 ' C ' ' HG ' ' A' ' 527' ' ' SER . 2.8 p30 -85.79 136.72 33.21 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 119.808 -0.757 . . . . 64.450000000000003 111.636 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.424 ' HG ' ' C ' ' A' ' 526' ' ' ASP . 53.1 m -157.47 162.22 27.75 Favored Pre-proline 0 C--N 1.302 -1.486 0 N-CA-C 106.346 -1.724 . . . . 72.329999999999998 106.346 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.13 10.26 0.42 Allowed 'Trans proline' 0 CA--C 1.556 1.578 0 C-N-CA 122.343 2.028 . . . . 74.019999999999996 114.44 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.551 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 0.6 OUTLIER -95.26 145.77 30.13 Favored Pre-proline 0 CA--C 1.506 -0.716 0 N-CA-C 107.453 -1.314 . . . . 63.329999999999998 107.453 175.724 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -64.81 148.38 89.99 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.45 2.1 . . . . 72.109999999999999 114.341 -172.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.85 113.76 2.96 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-N 114.323 -1.308 . . . . 74.040000000000006 110.742 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 126.57 -16.95 6.54 Favored Glycine 0 N--CA 1.42 -2.396 0 C-N-CA 119.918 -1.134 . . . . 64.409999999999997 111.768 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -82.92 128.18 34.21 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.28 -0.637 . . . . 75.430000000000007 109.28 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 5.3 p -94.36 112.71 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 N-CA-C 107.207 -1.405 . . . . 75.140000000000001 107.207 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 29.7 p -102.86 12.81 35.68 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 115.253 -0.885 . . . . 73.120000000000005 112.523 -172.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 169.04 172.42 35.77 Favored Glycine 0 N--CA 1.432 -1.616 0 C-N-CA 120.007 -1.092 . . . . 64.430000000000007 111.693 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 4.0 p -131.21 146.82 52.48 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.864 -0.791 . . . . 73.040000000000006 108.864 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.46 ' HB3' ' HB3' ' A' ' 552' ' ' GLU . 2.8 t-20 -64.44 -51.58 59.19 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 119.784 -0.767 . . . . 75.540000000000006 109.872 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.62 139.75 23.08 Favored 'Trans proline' 0 C--N 1.366 1.457 0 C-N-CA 120.859 1.039 . . . . 75.319999999999993 109.975 171.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -64.55 140.53 69.35 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 122.259 1.973 . . . . 75.510000000000005 112.834 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -68.15 132.54 47.38 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.452 -0.795 . . . . 72.310000000000002 109.752 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.68 -9.07 58.5 Favored Glycine 0 N--CA 1.436 -1.33 0 N-CA-C 111.187 -0.765 . . . . 73.140000000000001 111.187 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 91.3 m -86.2 136.83 33.04 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.187 0.518 . . . . 74.530000000000001 111.291 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 9.8 t -81.31 125.79 30.78 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.757 -0.831 . . . . 73.230000000000004 108.757 174.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.74 161.8 44.32 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 107.89 -1.152 . . . . 72.319999999999993 107.89 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -62.54 138.51 70.77 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 120.967 1.112 . . . . 75.439999999999998 110.768 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.87 -19.9 24.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 121.376 0.608 . . . . 75.209999999999994 111.343 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -96.17 -0.74 49.61 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 121.789 -0.569 . . . . 55.409999999999997 110.523 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 10.4 t -86.6 171.95 10.63 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.4 0.619 . . . . 63.420000000000002 109.501 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 7.6 p -115.68 137.86 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.296 0 CA-C-N 115.379 -0.828 . . . . 73.120000000000005 110.071 -177.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 3.1 mp -94.48 135.1 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 108.342 -0.985 . . . . 75.049999999999997 108.342 175.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 538' ' ' ASN . 6.3 tp10 -102.46 117.32 34.46 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.695 -1.224 . . . . 74.519999999999996 107.695 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -91.58 121.45 33.27 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.43 -0.952 . . . . 74.519999999999996 108.43 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -89.9 101.99 14.69 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.641 -1.244 . . . . 73.239999999999995 107.641 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 38.4 t -101.31 136.83 31.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-N 115.223 -0.899 . . . . 73.340000000000003 110.025 -174.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 59.7 m -91.71 128.18 37.45 Favored 'General case' 0 N--CA 1.41 -2.469 0 CA-C-N 115.973 -0.558 . . . . 72.25 109.744 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.4 ptpt -90.58 142.93 27.25 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 105.904 -1.887 . . . . 74.439999999999998 105.904 169.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -54.48 -24.07 29.74 Favored Glycine 0 CA--C 1.479 -2.182 0 O-C-N 125.145 1.528 . . . . 73.540000000000006 115.25 -168.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 74.43 -22.74 0.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.441 1.097 . . . . 74.329999999999998 110.794 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.508 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 44.3 mt-30 -113.37 148.31 36.03 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-O 121.488 0.661 . . . . 75.239999999999995 111.461 -172.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -125.53 158.02 35.58 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.886 -1.052 . . . . 74.349999999999994 108.835 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.88 125.12 22.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 121.315 0.578 . . . . 65.209999999999994 111.127 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 20.2 ttt -75.42 125.83 88.34 Favored Pre-proline 0 N--CA 1.427 -1.601 0 CA-C-N 115.356 -0.838 . . . . 73.430000000000007 110.988 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.06 169.74 20.68 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 123.039 2.493 . . . . 74.209999999999994 111.799 177.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -75.29 130.04 38.41 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.682 0.753 . . . . 61.049999999999997 112.036 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . 0.441 ' O ' ' HG2' ' A' ' 569' ' ' MET . 2.6 pp -141.27 18.26 2.24 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 123.021 1.391 . . . . 74.310000000000002 107.823 174.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 7.3 m -79.14 132.2 36.48 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 113.283 -1.781 . . . . 63.219999999999999 111.174 -173.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 64.54 39.66 96.99 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.541 -0.754 . . . . 72.450000000000003 114.29 174.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 569' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 16.0 ptp -128.89 -177.34 4.17 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 117.312 0.556 . . . . 74.319999999999993 109.933 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 601' ' ' ASN . 49.3 m-85 -93.53 163.44 13.57 Favored 'General case' 0 C--O 1.25 1.083 0 N-CA-C 108.202 -1.036 . . . . 75.239999999999995 108.202 -178.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . 0.465 ' CH2' HD12 ' A' ' 587' ' ' LEU . 16.3 t-105 -63.07 -32.16 73.47 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.166 -1.05 . . . . 71.319999999999993 108.166 174.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.75 -10.48 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.471 -0.786 . . . . 72.019999999999996 111.159 -176.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -101.36 -43.9 5.8 Favored 'General case' 0 C--O 1.256 1.401 0 N-CA-C 108.09 -1.078 . . . . 73.329999999999998 108.09 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . 0.5 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -62.82 -51.44 67.05 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.326 -1.306 . . . . 75.319999999999993 111.945 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.524 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 37.8 tt0 -51.75 -54.1 43.64 Favored Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 112.395 0.517 . . . . 75.200000000000003 112.395 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 52.9 Cg_exo -59.55 -38.29 83.47 Favored 'Trans proline' 0 C--N 1.38 2.237 0 C-N-CA 121.972 1.782 . . . . 73.430000000000007 112.721 177.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -66.76 -37.14 84.04 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 120.381 -0.528 . . . . 72.230000000000004 112.198 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.579 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 89.7 mt -66.75 -47.49 72.08 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.898 -0.592 . . . . 75.0 110.529 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -65.59 -34.52 78.43 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.635 -0.426 . . . . 74.519999999999996 111.048 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.24 -32.02 71.92 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.953 0.406 . . . . 74.310000000000002 110.943 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 578' ' ' LEU . 2.8 pp -80.89 -6.92 59.27 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.537 -0.465 . . . . 72.299999999999997 110.033 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 85.6 34.86 12.65 Favored Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 115.833 -0.621 . . . . 65.140000000000001 112.878 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . 0.422 ' CZ3' HD12 ' A' ' 578' ' ' LEU . 21.3 t90 -67.19 130.6 43.64 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.544 0.172 . . . . 75.209999999999994 111.054 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 62.8 p -103.24 -23.14 13.63 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-O 120.987 0.422 . . . . 72.549999999999997 112.023 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -75.98 -175.92 39.82 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-O 121.72 0.622 . . . . 72.349999999999994 114.359 -174.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 54.3 ttp -115.05 141.35 48.12 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.951 -0.625 . . . . 75.549999999999997 109.753 -176.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . 0.465 HD12 ' CH2' ' A' ' 571' ' ' TRP . 5.5 tt -85.64 125.68 33.34 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.061 0.457 . . . . 71.340000000000003 110.074 -175.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -95.89 104.35 16.28 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.543 -0.753 . . . . 74.120000000000005 110.333 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.16 133.51 54.25 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.138 -1.43 . . . . 72.420000000000002 107.138 173.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -111.68 -42.33 1.04 Allowed Glycine 0 C--N 1.284 -2.318 0 C-N-CA 119.874 -1.155 . . . . 74.530000000000001 113.993 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.4 135.64 33.86 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 120.569 -0.453 . . . . 63.140000000000001 111.379 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -90.86 124.44 35.17 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 105.954 -1.869 . . . . 70.0 105.954 172.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . 0.498 ' O ' ' HG2' ' A' ' 626' ' ' GLN . 46.3 t -104.81 156.26 6.02 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 N-CA-C 109.049 -0.723 . . . . 74.310000000000002 109.049 -174.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . 0.433 ' HA ' ' HG2' ' A' ' 626' ' ' GLN . 1.6 p-10 -71.49 126.94 30.99 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.298 0.571 . . . . 75.140000000000001 109.894 -176.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -148.36 -57.09 0.22 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.953 -1.021 . . . . 74.420000000000002 109.318 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 116.34 124.57 3.66 Favored Glycine 0 N--CA 1.426 -2.005 0 C-N-CA 120.638 -0.791 . . . . 71.409999999999997 111.764 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -63.64 -35.96 92.72 Favored Glycine 0 C--N 1.316 -0.542 0 N-CA-C 112.113 -0.395 . . . . 75.219999999999999 112.113 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 6.5 m -76.04 -24.02 55.15 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-O 122.014 0.911 . . . . 75.25 108.99 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -87.96 -2.41 58.59 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.607 -1.179 . . . . 73.129999999999995 109.343 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . 0.523 ' HB3' ' CE2' ' A' ' 570' ' ' PHE . 30.6 m80 81.56 125.19 0.04 OUTLIER 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.41 1.884 . . . . 74.140000000000001 111.952 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . 0.544 ' O ' ' HA ' ' A' ' 570' ' ' PHE . 8.5 p30 -73.57 96.23 2.41 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 122.597 1.189 . . . . 74.510000000000005 109.42 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 21.4 mmm-85 -100.17 151.49 21.36 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 107.351 -1.351 . . . . 74.530000000000001 107.351 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 8.1 p -65.58 131.68 31.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 106.971 -1.492 . . . . 74.329999999999998 106.971 172.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.61 -26.21 3.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 120.112 -0.635 . . . . 71.5 111.895 -174.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -155.6 138.21 15.1 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.949 -0.76 . . . . 72.519999999999996 108.949 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -133.64 139.5 46.52 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.524 -1.288 . . . . 72.5 107.524 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -71.99 -51.47 8.45 Favored Pre-proline 0 C--N 1.307 -1.246 0 C-N-CA 119.627 -0.829 . . . . 74.129999999999995 111.152 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -92.3 122.19 0.58 Allowed 'Trans proline' 0 N--CA 1.442 -1.516 0 C-N-CA 121.111 1.207 . . . . 73.209999999999994 111.332 174.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -70.35 153.35 66.29 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 121.77 1.646 . . . . 75.310000000000002 110.11 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -65.36 133.08 50.6 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.266 -0.642 . . . . 72.439999999999998 109.266 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.15 -7.68 44.27 Favored Glycine 0 C--N 1.314 -0.656 0 C-N-CA 120.786 -0.721 . . . . 73.540000000000006 111.481 -176.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 19.5 m -88.16 155.59 19.69 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.532 -0.914 . . . . 71.019999999999996 108.532 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.54 126.53 7.51 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 111.116 -0.794 . . . . 74.239999999999995 111.116 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 18.5 m -113.84 141.97 28.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.609 -0.515 . . . . 65.239999999999995 109.609 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.508 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.3 p-10 -53.4 167.94 0.18 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.682 1.193 . . . . 72.340000000000003 113.16 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -57.68 -24.66 57.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.533 -0.758 . . . . 73.450000000000003 112.98 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.436 ' OD2' ' HB ' ' A' ' 619' ' ' ILE . 28.2 t70 -82.47 -9.49 59.41 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.493 -0.483 . . . . 72.510000000000005 109.703 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.63 18.3 67.89 Favored Glycine 0 CA--C 1.506 -0.525 0 CA-C-N 116.094 -0.503 . . . . 53.049999999999997 112.649 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . 0.436 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -69.86 119.5 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-O 122.269 1.033 . . . . 73.430000000000007 111.329 -167.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.459 ' O ' HD11 ' A' ' 620' ' ' ILE . 2.6 pp -116.98 131.3 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.067 0 CA-C-N 114.703 -1.135 . . . . 74.329999999999998 111.191 177.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 54.4 m -104.68 117.88 35.19 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.549 -0.908 . . . . 73.319999999999993 108.549 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.6 pp -139.72 165.82 26.25 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.602 -0.272 . . . . 72.349999999999994 111.16 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -139.47 140.9 37.39 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.647 -0.871 . . . . 75.209999999999994 108.647 174.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -128.0 166.44 18.38 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 116.216 -0.447 . . . . 74.430000000000007 111.192 -171.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -71.77 153.34 50.08 Favored Glycine 0 N--CA 1.428 -1.864 0 CA-C-N 115.524 -0.762 . . . . 65.040000000000006 113.529 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 593' ' ' VAL . 3.4 pt20 . . . . . 0 C--N 1.299 -1.593 0 C-N-CA 123.514 0.726 . . . . 71.140000000000001 110.171 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.953 0 N-CA-C 111.101 -0.799 . . . . 60.219999999999999 111.101 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.72 142.84 36.43 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.038 1.825 . . . . 71.219999999999999 110.799 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -90.04 7.28 38.46 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.152 0.501 . . . . 70.140000000000001 109.916 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.9 p -135.55 149.41 49.43 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.65 -0.705 . . . . 74.109999999999999 110.711 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . 0.422 ' HE2' ' H ' ' A' ' 496' ' ' ASP . 0.1 OUTLIER -150.6 132.61 15.21 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.259 -1.756 . . . . 75.019999999999996 106.259 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.3 p-10 -81.47 133.1 35.35 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.149 0.5 . . . . 74.349999999999994 110.349 175.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.1 pt -86.09 138.22 34.86 Favored Pre-proline 0 C--N 1.304 -1.383 0 CA-C-N 115.465 -0.789 . . . . 74.129999999999995 111.886 -177.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.64 178.41 7.61 Favored 'Trans proline' 0 C--O 1.245 0.832 0 C-N-CA 122.408 2.072 . . . . 74.430000000000007 112.009 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -80.07 96.99 6.65 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 122.627 1.203 . . . . 73.329999999999998 110.446 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.433 ' HA ' ' NE2' ' A' ' 503' ' ' GLN . 28.5 m -95.39 -1.07 10.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 CA-C-N 115.313 -0.858 . . . . 75.349999999999994 111.828 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -76.12 107.27 8.23 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 108.738 -0.838 . . . . 64.010000000000005 108.738 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 142.71 -30.17 2.08 Favored Glycine 0 C--N 1.299 -1.494 0 C-N-CA 120.746 -0.74 . . . . 71.319999999999993 112.791 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.433 ' NE2' ' HA ' ' A' ' 500' ' ' VAL . 7.8 pt20 -100.35 -177.88 3.64 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 120.109 -0.636 . . . . 72.299999999999997 110.501 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 2.8 m -70.34 155.61 40.43 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.565 -0.532 . . . . 65.439999999999998 109.565 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.416 ' HA ' ' CG2' ' A' ' 534' ' ' VAL . 5.9 p -55.04 -46.32 77.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 123.394 0.678 . . . . 72.530000000000001 112.1 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.69 -39.18 90.51 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.898 -0.592 . . . . 65.519999999999996 110.543 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 59.9 t -73.07 -49.01 41.61 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.258 0 CA-C-N 115.337 -0.847 . . . . 74.420000000000002 109.888 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' A' ' 500' ' ' VAL . . . -58.73 -44.8 90.54 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 122.994 0.518 . . . . 73.209999999999994 110.972 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -64.99 -45.68 84.61 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.367 -0.378 . . . . 74.209999999999994 111.304 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.533 ' O ' HG23 ' A' ' 514' ' ' VAL . 17.8 ptpt -68.0 -37.86 81.97 Favored 'General case' 0 C--O 1.21 -1.0 0 C-N-CA 120.656 -0.418 . . . . 75.340000000000003 111.254 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -60.04 -48.4 81.86 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 123.4 0.437 . . . . 71.540000000000006 110.517 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . 0.432 HD11 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -68.71 -36.21 78.14 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 120.259 -0.577 . . . . 74.129999999999995 110.886 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.432 ' N ' HD11 ' A' ' 512' ' ' LEU . 1.2 t-20 -66.14 -35.59 80.88 Favored 'General case' 0 C--O 1.203 -1.376 0 C-N-CA 123.783 0.833 . . . . 75.219999999999999 110.505 -178.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 510' ' ' LYS . 75.9 t -60.94 -33.41 55.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.95 0.405 . . . . 63.310000000000002 111.11 177.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -102.51 -4.67 24.99 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.145 -0.622 . . . . 71.0 111.014 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -122.85 -50.84 0.22 Allowed Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 120.427 -0.892 . . . . 72.5 113.544 -171.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 67.5 27.18 8.02 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 122.515 1.15 . . . . 74.010000000000005 109.337 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.7 p -80.29 -167.09 1.2 Allowed 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 113.027 -1.897 . . . . 74.420000000000002 110.981 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -119.2 142.79 47.69 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.595 -1.261 . . . . 73.510000000000005 107.595 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -132.65 153.41 51.12 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 112.545 0.572 . . . . 73.549999999999997 112.545 -175.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.7 m -132.65 151.51 51.94 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.057 -1.461 . . . . 71.340000000000003 107.057 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -124.27 133.36 53.51 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 109.179 -0.674 . . . . 75.319999999999993 109.179 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -125.41 116.1 21.33 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.221 -1.029 . . . . 75.299999999999997 108.221 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 23.9 m -98.46 124.97 43.48 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.13 0.491 . . . . 75.019999999999996 111.053 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 11.0 p -126.56 154.19 36.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.799 -1.185 . . . . 74.219999999999999 107.799 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.93 135.63 35.38 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.34 0.59 . . . . 72.340000000000003 110.183 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 50.3 m -167.65 139.13 2.47 Favored Pre-proline 0 C--O 1.197 -1.68 0 N-CA-C 105.097 -2.186 . . . . 55.310000000000002 105.097 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.43 9.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.566 2.124 0 C-N-CA 123.466 2.777 . . . . 72.150000000000006 116.997 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.23 147.07 63.93 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 106.338 -1.727 . . . . 74.230000000000004 106.338 172.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.72 141.56 95.62 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.194 1.93 . . . . 75.299999999999997 112.921 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 557' ' ' LYS . . . -61.69 116.12 4.53 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 114.811 -1.086 . . . . 65.129999999999995 112.128 -176.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 121.46 -16.24 9.12 Favored Glycine 0 N--CA 1.423 -2.226 0 CA-C-N 115.044 -0.98 . . . . 74.140000000000001 111.538 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -77.47 128.28 33.95 Favored 'General case' 0 C--O 1.248 1.012 0 N-CA-C 109.328 -0.619 . . . . 74.209999999999994 109.328 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.416 ' CG2' ' HA ' ' A' ' 505' ' ' VAL . 38.0 t -86.1 112.43 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.165 0 N-CA-C 106.952 -1.499 . . . . 73.129999999999995 106.952 173.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 17.4 p -84.33 -2.42 57.04 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.594 0.712 . . . . 74.230000000000004 111.209 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.66 179.43 27.33 Favored Glycine 0 N--CA 1.419 -2.491 0 C-N-CA 120.606 -0.806 . . . . 65.540000000000006 112.435 174.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 1.6 p -116.69 158.05 24.43 Favored 'General case' 0 C--N 1.271 -2.825 0 N-CA-C 106.694 -1.595 . . . . 72.0 106.694 177.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -60.43 -49.5 89.97 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 118.794 -1.162 . . . . 73.049999999999997 112.015 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -73.61 128.8 12.97 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 N-CA-C 108.238 -1.485 . . . . 53.439999999999998 108.238 167.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.72 155.93 60.53 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 122.501 2.134 . . . . 72.519999999999996 113.126 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.05 129.63 43.08 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.245 0.618 . . . . 72.530000000000001 110.152 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.2 -15.22 54.8 Favored Glycine 0 N--CA 1.435 -1.422 0 N-CA-C 111.715 -0.554 . . . . 54.439999999999998 111.715 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 37.6 m -76.27 134.1 39.88 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.939 0.4 . . . . 70.109999999999999 111.407 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.0 t -76.53 124.06 27.02 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.45 -0.945 . . . . 72.420000000000002 108.45 173.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.04 160.72 50.77 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 108.14 -1.059 . . . . 54.340000000000003 108.14 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.48 136.84 26.89 Favored 'Trans proline' 0 N--CA 1.435 -1.952 0 CA-C-N 119.627 0.903 . . . . 72.450000000000003 110.218 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.17 -19.85 26.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.764 0.792 . . . . 74.239999999999995 110.943 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -89.64 -7.71 54.11 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.058 -0.974 . . . . 74.409999999999997 110.812 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.4 t -88.08 167.51 13.6 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.46 0.648 . . . . 73.400000000000006 109.887 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 9.8 p -108.73 121.25 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 CA-C-N 115.266 -0.879 . . . . 74.019999999999996 109.254 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 58.5 mt -87.24 133.14 30.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 115.298 -0.864 . . . . 74.409999999999997 110.045 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.15 117.6 34.91 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.763 0.792 . . . . 74.299999999999997 111.85 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.36 114.01 26.43 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 113.614 -1.63 . . . . 73.120000000000005 108.862 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -85.35 104.86 15.56 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.75 0.786 . . . . 70.340000000000003 109.766 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 23.7 t -92.96 132.8 36.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 114.667 -1.151 . . . . 71.239999999999995 108.171 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 53.0 m -105.47 135.83 46.15 Favored 'General case' 0 N--CA 1.409 -2.516 0 CA-C-O 121.244 0.545 . . . . 71.25 111.093 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.0 ptpt -116.57 128.01 55.02 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 108.107 -1.071 . . . . 73.420000000000002 108.107 174.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -58.71 -24.81 57.8 Favored Glycine 0 CA--C 1.496 -1.125 0 O-C-N 123.877 0.735 . . . . 24.120000000000001 111.37 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . 0.419 ' ND2' ' HB3' ' A' ' 616' ' ' ARG . 65.0 t30 63.88 28.03 14.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 122.846 1.308 . . . . 72.549999999999997 109.063 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.476 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 82.7 mt-30 -112.5 151.03 30.43 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 113.725 -1.58 . . . . 74.329999999999998 108.333 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -130.42 147.42 52.12 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 109.254 -0.647 . . . . 74.450000000000003 109.254 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.93 120.07 13.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 O-C-N 123.896 0.748 . . . . 73.150000000000006 109.683 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 563' ' ' MET . . . . . 0.585 ' SD ' HG23 ' A' ' 620' ' ' ILE . 42.9 ttp -83.17 129.08 62.35 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 116.26 -0.427 . . . . 72.340000000000003 111.158 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . 0.408 ' O ' ' HG2' ' A' ' 563' ' ' MET . 57.9 Cg_endo -73.76 169.57 22.05 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.547 2.165 . . . . 71.319999999999993 110.317 174.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -76.93 135.31 38.76 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.383 0.611 . . . . 73.200000000000003 111.259 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . 0.4 ' O ' ' HG2' ' A' ' 569' ' ' MET . 0.9 OUTLIER -114.53 -14.98 12.08 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.326 -0.99 . . . . 73.5 108.326 -177.259 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 33.2 t -77.47 147.39 35.92 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.585 -0.697 . . . . 75.239999999999995 110.91 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 96.26 11.01 55.37 Favored Glycine 0 CA--C 1.501 -0.798 0 CA-C-N 115.806 -0.634 . . . . 75.519999999999996 113.411 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 569' ' ' MET . . . . . 0.4 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 19.2 ptm -133.49 169.11 17.46 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.749 -0.463 . . . . 62.149999999999999 109.749 177.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -89.52 158.25 17.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.683 -0.858 . . . . 74.25 108.683 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -65.6 -25.05 67.23 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.189 -0.671 . . . . 74.340000000000003 109.189 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 23.0 m -69.22 -26.99 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 115.599 -0.728 . . . . 74.010000000000005 112.497 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.509 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 12.0 t70 -101.85 -23.45 14.17 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 108.538 -0.912 . . . . 74.230000000000004 108.538 175.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 577' ' ' ARG . . . -61.98 -46.73 87.96 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 115.531 -0.759 . . . . 71.450000000000003 112.341 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.473 ' HA ' HD12 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -60.31 -49.19 91.65 Favored Pre-proline 0 CA--C 1.565 1.532 0 C-N-CA 120.279 -0.568 . . . . 75.329999999999998 110.199 179.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 62.5 Cg_exo -52.59 -29.78 42.36 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.328 2.019 . . . . 72.019999999999996 113.328 169.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 10.4 mmm180 -62.57 -39.53 93.97 Favored 'General case' 0 C--O 1.21 -1.007 0 O-C-N 121.791 -0.568 . . . . 72.010000000000005 110.47 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.765 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 9.6 mp -58.84 -49.65 76.94 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.155 0.503 . . . . 64.109999999999999 110.615 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -66.74 -38.37 86.52 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.388 -0.823 . . . . 73.319999999999993 112.389 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.29 -35.7 73.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.982 0.42 . . . . 44.310000000000002 111.583 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 6.0 tp -81.7 -9.67 59.58 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 123.892 0.877 . . . . 64.340000000000003 110.801 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 66.05 39.8 94.89 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.905 -0.878 . . . . 61.149999999999999 110.905 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . 0.765 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 7.3 t90 -79.69 127.52 32.29 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 108.528 -0.916 . . . . 72.340000000000003 108.528 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 584' ' ' THR . . . . . 0.478 ' OG1' ' HA ' ' A' ' 617' ' ' ASP . 0.8 OUTLIER -78.62 -39.7 36.48 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 125.345 1.458 . . . . 75.319999999999993 112.78 -176.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -77.92 -162.01 17.92 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.929 -0.578 . . . . 71.030000000000001 111.759 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 65.8 mtt -133.82 160.76 36.64 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 122.426 -0.456 . . . . 72.140000000000001 109.867 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 22.7 tp -80.53 111.06 16.59 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.853 -1.166 . . . . 64.400000000000006 107.853 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 621' ' ' THR . 22.6 t70 -99.51 112.63 24.81 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.073 -0.512 . . . . 63.229999999999997 111.198 -172.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.88 133.61 34.23 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 118.848 -1.141 . . . . 74.340000000000003 109.975 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.71 -63.84 1.8 Allowed Glycine 0 C--N 1.296 -1.663 0 N-CA-C 110.998 -0.841 . . . . 60.149999999999999 110.998 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -137.04 145.12 43.64 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 121.012 0.434 . . . . 74.25 109.965 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -91.79 127.38 37.23 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.4 -1.704 . . . . 64.0 106.4 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 61.3 t -102.98 125.63 57.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 108.328 -0.99 . . . . 72.25 108.328 -175.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -72.31 107.99 5.21 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 121.491 0.662 . . . . 75.409999999999997 109.802 -173.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -123.56 -54.47 1.76 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.572 -0.74 . . . . 72.319999999999993 110.957 -175.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 104.18 147.55 17.45 Favored Glycine 0 N--CA 1.413 -2.879 0 N-CA-C 109.636 -1.386 . . . . 75.120000000000005 109.636 -173.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.74 -33.08 62.49 Favored Glycine 0 C--N 1.309 -0.921 0 N-CA-C 113.875 0.31 . . . . 53.450000000000003 113.875 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 11.8 m -68.33 -24.06 64.79 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 123.918 0.887 . . . . 73.109999999999999 110.879 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -88.6 -1.85 58.28 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.317 -0.856 . . . . 74.040000000000006 110.303 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 41.5 m80 74.5 121.23 0.04 OUTLIER 'General case' 0 C--O 1.242 0.689 0 C-N-CA 125.527 1.531 . . . . 72.230000000000004 111.952 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -82.4 63.4 6.55 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 115.493 -0.776 . . . . 72.120000000000005 111.497 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -95.55 160.5 14.48 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.397 -0.82 . . . . 75.230000000000004 109.729 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 72.7 t -71.11 130.37 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.104 0 N-CA-C 105.144 -2.169 . . . . 70.109999999999999 105.144 169.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.7 m -102.69 -28.6 3.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 120.284 -0.567 . . . . 73.230000000000004 111.763 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -157.08 135.81 11.58 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 116.62 -0.264 . . . . 74.329999999999998 111.049 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -111.62 128.95 56.21 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.731 -1.211 . . . . 72.430000000000007 107.731 170.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.43 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 8.4 t30 -57.78 -52.37 74.9 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 112.206 0.447 . . . . 75.430000000000007 112.206 -176.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 5.2 Cg_exo -83.65 122.74 3.15 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 121.823 1.682 . . . . 72.409999999999997 109.318 171.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.02 155.8 61.13 Favored 'Trans proline' 0 C--O 1.258 1.484 0 C-N-CA 122.859 2.373 . . . . 74.450000000000003 113.848 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.53 138.72 58.3 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.436 -0.802 . . . . 51.25 109.599 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 103.53 -11.64 54.04 Favored Glycine 0 C--N 1.298 -1.531 0 C-N-CA 120.438 -0.887 . . . . 74.420000000000002 111.864 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 17.2 m -83.48 141.97 31.26 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.377 -0.601 . . . . 71.319999999999993 109.377 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.69 113.9 3.75 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.109 -1.196 . . . . 54.100000000000001 110.109 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.5 m -102.01 142.67 16.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 O-C-N 122.982 -0.128 . . . . 71.329999999999998 110.667 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.476 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 0.7 OUTLIER -50.33 164.78 0.11 Allowed 'General case' 0 C--O 1.21 -0.982 0 N-CA-C 113.465 0.913 . . . . 71.010000000000005 113.465 177.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . 0.419 ' HB3' ' ND2' ' A' ' 559' ' ' ASN . 14.9 ptm180 -48.74 -27.89 3.24 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.66 1.726 . . . . 75.25 115.66 -171.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.478 ' HA ' ' OG1' ' A' ' 584' ' ' THR . 20.0 p-10 -97.2 -7.06 33.27 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.545 -0.462 . . . . 72.310000000000002 111.287 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.0 17.14 65.14 Favored Glycine 0 C--O 1.215 -1.058 0 CA-C-O 119.657 -0.524 . . . . 64.319999999999993 114.311 167.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.49 119.09 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-O 121.716 0.77 . . . . 70.409999999999997 110.768 -168.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.585 HG23 ' SD ' ' A' ' 563' ' ' MET . 2.6 pp -129.35 134.05 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-N 115.277 -0.874 . . . . 75.530000000000001 111.31 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 13.1 t -99.03 130.42 45.36 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.45 -0.795 . . . . 74.120000000000005 108.984 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -139.59 167.91 21.03 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.671 -0.695 . . . . 73.349999999999994 111.76 -174.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -127.07 140.74 52.06 Favored 'General case' 0 C--O 1.256 1.41 0 N-CA-C 109.045 -0.724 . . . . 75.25 109.045 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -139.26 165.75 26.36 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.465 -0.334 . . . . 74.010000000000005 110.354 -175.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -78.64 139.47 22.3 Favored Glycine 0 N--CA 1.434 -1.467 0 O-C-N 123.677 0.611 . . . . 61.350000000000001 113.328 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 C--N 1.288 -2.108 0 C-N-CA 125.525 1.53 . . . . 72.400000000000006 107.881 -179.301 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.005 0 N-CA-C 109.67 -1.372 . . . . 70.319999999999993 109.67 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -74.21 141.88 29.77 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.891 1.727 . . . . 74.340000000000003 109.567 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -126.4 11.94 7.5 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.512 -0.475 . . . . 64.329999999999998 110.589 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 25.9 p -140.12 145.36 37.49 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 110.043 -0.354 . . . . 74.129999999999995 110.043 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -139.64 155.51 47.37 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.428 -1.323 . . . . 73.340000000000003 107.428 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.4 p-10 -98.15 144.26 27.8 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.203 -0.599 . . . . 71.129999999999995 110.749 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.1 pt -87.09 137.42 33.05 Favored Pre-proline 0 C--N 1.295 -1.781 0 CA-C-N 115.073 -0.967 . . . . 75.150000000000006 111.592 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -85.03 -176.03 2.26 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.551 2.168 . . . . 74.120000000000005 111.053 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -86.22 114.94 23.45 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.18 0.514 . . . . 74.010000000000005 109.793 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 17.5 m -119.73 58.78 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-O 122.746 1.26 . . . . 70.230000000000004 110.422 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -118.73 107.47 13.7 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.181 -1.372 . . . . 62.530000000000001 108.677 174.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 142.42 -25.38 2.32 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 118.972 -1.585 . . . . 74.5 113.734 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -101.74 -174.68 2.65 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 117.782 0.791 . . . . 74.340000000000003 109.858 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 7.5 m -73.13 155.5 39.61 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.895 -1.15 . . . . 73.530000000000001 107.895 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.542 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.4 p -60.2 -44.72 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 111.715 0.265 . . . . 71.109999999999999 111.715 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.12 -36.11 82.96 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 120.543 -0.463 . . . . 70.239999999999995 110.084 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 68.4 t -68.9 -45.38 80.66 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.445 0 CA-C-N 115.616 -0.72 . . . . 74.200000000000003 109.257 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.424 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -60.29 -42.95 96.56 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 123.228 0.33 . . . . 72.420000000000002 110.538 177.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.542 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.7 mt-30 -63.46 -43.22 97.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.011 -0.366 . . . . 74.150000000000006 110.011 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.535 ' O ' HG21 ' A' ' 514' ' ' VAL . 46.0 mmtm -64.48 -43.91 92.67 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.443 0.639 . . . . 74.230000000000004 109.792 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -61.95 -48.26 81.21 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.109 -1.405 . . . . 75.400000000000006 110.13 -175.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . 0.4 HD11 ' N ' ' A' ' 513' ' ' ASN . 4.2 pp -69.65 -35.78 75.49 Favored 'General case' 0 C--O 1.208 -1.082 0 CA-C-N 115.509 -0.769 . . . . 75.430000000000007 110.862 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 1.7 t-20 -61.44 -35.32 77.24 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 123.925 0.89 . . . . 74.120000000000005 110.105 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 510' ' ' LYS . 97.7 t -59.18 -38.0 71.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.872 0.368 . . . . 70.310000000000002 111.298 178.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -108.22 10.26 27.89 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.628 -0.508 . . . . 62.520000000000003 109.628 -176.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -132.66 -56.74 0.08 OUTLIER Glycine 0 N--CA 1.428 -1.835 0 C-N-CA 120.074 -1.06 . . . . 75.010000000000005 113.813 -172.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 63.41 23.21 13.62 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 122.055 0.931 . . . . 72.209999999999994 110.082 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 518' ' ' THR . . . . . 0.404 HG22 ' HA ' ' A' ' 547' ' ' VAL . 1.0 OUTLIER -83.72 -174.8 5.49 Favored 'General case' 0 N--CA 1.412 -2.327 0 C-N-CA 125.984 1.714 . . . . 72.239999999999995 110.669 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.74 141.89 38.6 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.357 -1.349 . . . . 74.150000000000006 107.357 178.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -133.05 148.37 52.21 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.056 0.455 . . . . 70.150000000000006 112.192 -175.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 48.4 m -141.48 155.39 45.84 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.57 -0.9 . . . . 71.040000000000006 108.57 173.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -116.92 139.29 50.81 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.07 0.462 . . . . 75.140000000000001 111.493 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -122.37 118.71 29.07 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.333 -1.358 . . . . 74.120000000000005 107.333 176.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 11.6 m -103.93 127.32 51.46 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 120.689 -0.404 . . . . 75.340000000000003 111.493 -174.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 14.3 p -121.08 156.7 24.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.883 -1.155 . . . . 71.109999999999999 107.883 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -70.85 135.15 47.88 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-O 120.84 0.353 . . . . 75.150000000000006 110.647 -176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 65.9 m -165.04 158.07 14.05 Favored Pre-proline 0 C--N 1.31 -1.148 0 N-CA-C 107.667 -1.235 . . . . 75.230000000000004 107.667 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -66.25 -15.05 46.9 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.332 2.022 . . . . 65.209999999999994 113.257 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.66 140.22 81.32 Favored Pre-proline 0 CA--C 1.519 -0.225 0 N-CA-C 108.936 -0.765 . . . . 75.129999999999995 108.936 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.56 146.28 97.07 Favored 'Trans proline' 0 C--O 1.252 1.192 0 C-N-CA 122.764 2.31 . . . . 65.420000000000002 112.888 -175.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -59.82 110.95 1.28 Allowed 'General case' 0 C--O 1.244 0.813 0 CA-C-N 115.29 -0.868 . . . . 74.349999999999994 110.883 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 136.03 -20.86 3.56 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 120.569 -0.824 . . . . 62.329999999999998 112.129 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -82.79 132.91 35.15 Favored 'General case' 0 C--O 1.248 1.019 0 CA-C-O 121.15 0.5 . . . . 74.299999999999997 110.673 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.424 HG11 ' CB ' ' A' ' 508' ' ' ALA . 7.3 p -99.32 119.64 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.533 0 N-CA-C 107.902 -1.147 . . . . 75.340000000000003 107.902 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.5 p -98.77 12.92 34.12 Favored 'General case' 0 C--N 1.274 -2.694 0 CA-C-N 115.107 -0.951 . . . . 72.349999999999994 113.301 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 143.23 -176.93 22.43 Favored Glycine 0 CA--C 1.493 -1.296 0 C-N-CA 120.433 -0.889 . . . . 73.230000000000004 112.196 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 7.0 p -117.41 157.1 26.78 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.372 -0.973 . . . . 55.25 108.372 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.406 ' HB2' ' OE2' ' A' ' 552' ' ' GLU . 44.3 t-20 -56.5 -58.22 18.4 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 119.983 -0.687 . . . . 75.409999999999997 110.689 175.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.96 140.75 32.06 Favored 'Trans proline' 0 C--N 1.365 1.422 0 CA-C-N 120.63 1.261 . . . . 73.109999999999999 109.965 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.57 156.48 63.74 Favored 'Trans proline' 0 C--O 1.252 1.18 0 C-N-CA 122.466 2.111 . . . . 65.120000000000005 112.348 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.58 137.62 58.3 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.015 -0.539 . . . . 54.219999999999999 110.798 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.1 -16.13 50.32 Favored Glycine 0 CA--C 1.492 -1.347 0 N-CA-C 111.485 -0.646 . . . . 73.319999999999993 111.485 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 71.0 m -74.05 122.95 23.47 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 109.945 -0.391 . . . . 75.109999999999999 109.945 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.3 t -80.43 124.62 29.06 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 108.473 -0.936 . . . . 73.329999999999998 108.473 176.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.7 m -122.72 156.58 61.54 Favored Pre-proline 0 C--N 1.294 -1.835 0 N-CA-C 107.468 -1.308 . . . . 73.230000000000004 107.468 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -67.67 138.47 45.4 Favored 'Trans proline' 0 N--CA 1.436 -1.894 0 C-N-CA 121.68 1.587 . . . . 75.120000000000005 111.82 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.404 ' HA ' HG22 ' A' ' 518' ' ' THR . 7.5 p -63.79 -20.53 26.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 115.087 -0.961 . . . . 71.409999999999997 111.455 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -87.79 -17.46 31.53 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.882 0.372 . . . . 72.109999999999999 110.488 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 53.3 m -88.07 159.61 18.17 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-O 122.312 1.053 . . . . 74.310000000000002 113.304 -173.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 68.9 t -89.85 129.49 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 CA-C-N 113.204 -1.816 . . . . 73.340000000000003 110.267 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 56.0 mt -91.57 140.59 15.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.727 -1.212 . . . . 75.230000000000004 107.727 176.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . 0.406 ' OE2' ' HB2' ' A' ' 538' ' ' ASN . 21.9 tt0 -103.26 117.7 35.11 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 110.339 -0.245 . . . . 72.329999999999998 110.339 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.3 mp -99.76 123.22 43.8 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 123.851 0.72 . . . . 73.439999999999998 110.016 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -85.95 106.89 17.46 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 123.472 0.709 . . . . 71.400000000000006 109.193 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 524' ' ' SER . 42.8 t -105.63 144.96 14.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.479 -0.782 . . . . 74.129999999999995 109.492 -176.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 46.8 m -93.35 126.92 38.73 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 116.077 -0.511 . . . . 64.109999999999999 109.961 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -99.01 131.43 45.06 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 106.175 -1.787 . . . . 74.239999999999995 106.175 169.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -62.92 -24.25 66.56 Favored Glycine 0 CA--C 1.492 -1.394 0 O-C-N 124.673 1.233 . . . . 73.019999999999996 114.271 -170.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 75.15 -27.02 0.19 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.52 1.128 . . . . 70.209999999999994 111.199 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.475 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 59.9 mt-30 -111.92 163.53 14.12 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 115.713 -0.676 . . . . 73.219999999999999 110.646 -172.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -141.09 157.28 45.52 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.895 -1.048 . . . . 73.5 108.841 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.22 126.75 33.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.931 -0.396 . . . . 73.420000000000002 109.931 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 563' ' ' MET . . . . . 0.446 ' SD ' HG23 ' A' ' 620' ' ' ILE . 49.5 ttp -94.23 137.13 22.92 Favored Pre-proline 0 C--N 1.314 -0.958 0 N-CA-C 111.946 0.351 . . . . 73.140000000000001 111.946 -176.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.25 169.81 21.36 Favored 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 122.861 2.374 . . . . 73.549999999999997 111.261 173.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -84.79 140.65 31.06 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.796 -0.446 . . . . 65.420000000000002 109.796 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . 0.446 ' O ' ' HG2' ' A' ' 569' ' ' MET . 2.4 pp -138.73 16.62 2.69 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.622 0.725 . . . . 74.310000000000002 111.471 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 60.1 p -79.8 150.28 30.79 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.453 -0.573 . . . . 71.340000000000003 109.453 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . 0.41 ' O ' ' HD2' ' A' ' 602' ' ' ARG . . . 85.32 29.95 26.29 Favored Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 120.077 -1.059 . . . . 71.120000000000005 113.289 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 569' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 19.8 ptp -131.84 -176.1 3.94 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.796 -0.816 . . . . 75.400000000000006 108.796 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -109.53 165.43 11.67 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.149 -1.426 . . . . 63.310000000000002 107.149 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -64.78 -30.45 71.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.41 0.624 . . . . 74.120000000000005 109.348 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.6 p -72.37 -10.97 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.882 0.849 . . . . 74.299999999999997 109.955 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.553 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 45.8 t0 -101.7 -40.84 6.79 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.974 -1.121 . . . . 75.439999999999998 107.974 174.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.29 -42.53 95.66 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.067 -0.97 . . . . 72.049999999999997 112.817 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.678 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 32.8 tt0 -59.7 -53.24 67.57 Favored Pre-proline 0 CA--C 1.567 1.628 0 C-N-CA 120.236 -0.586 . . . . 71.530000000000001 110.977 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 80.2 Cg_exo -56.32 -32.32 87.86 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 121.812 1.675 . . . . 74.420000000000002 112.716 172.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 3.6 mmp_? -59.82 -42.47 93.57 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-O 119.39 -0.338 . . . . 75.430000000000007 111.034 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.7 pp -65.81 -47.08 76.26 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 120.71 -0.396 . . . . 75.430000000000007 111.846 -175.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.457 ' N ' HD12 ' A' ' 578' ' ' LEU . 4.5 ptp180 -65.72 -37.27 85.94 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 112.175 0.435 . . . . 75.200000000000003 112.175 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.99 -32.68 69.57 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.009 0.433 . . . . 71.420000000000002 112.038 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 14.3 tp -85.82 -9.1 57.58 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 121.424 0.631 . . . . 64.409999999999997 110.926 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 75.63 21.47 76.96 Favored Glycine 0 C--N 1.311 -0.806 0 C-N-CA 120.563 -0.827 . . . . 64.510000000000005 112.652 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 15.0 t90 -87.46 127.35 35.23 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.576 -1.268 . . . . 75.510000000000005 107.576 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 15.0 t -116.07 2.26 13.38 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 119.678 -0.809 . . . . 71.329999999999998 112.254 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -74.06 177.07 45.91 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 119.448 -1.358 . . . . 65.120000000000005 110.402 172.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 67.2 mtt -97.57 140.14 32.43 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.145 -0.622 . . . . 75.200000000000003 112.124 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 48.5 tp -88.43 116.72 26.86 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.878 -1.156 . . . . 75.120000000000005 107.878 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 621' ' ' THR . 30.6 t70 -106.66 117.49 34.18 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.066 0.46 . . . . 75.230000000000004 111.327 -176.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.14 134.55 35.19 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.971 -0.559 . . . . 74.129999999999995 110.524 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -75.51 -84.34 0.38 Allowed Glycine 0 C--N 1.294 -1.793 0 CA-C-N 115.357 -0.838 . . . . 60.329999999999998 111.812 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.05 154.5 47.1 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.343 0.116 . . . . 61.409999999999997 110.777 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -101.63 127.84 48.19 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 124.795 1.238 . . . . 74.200000000000003 108.346 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 626' ' ' GLN . 40.2 t -104.13 132.72 50.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 115.527 -0.761 . . . . 73.099999999999994 109.243 -175.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -72.4 126.82 30.78 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.202 0.525 . . . . 70.019999999999996 111.771 -175.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . 0.432 ' HB3' ' ND2' ' A' ' 601' ' ' ASN . . . -150.97 -57.9 0.16 Allowed 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.865 -1.061 . . . . 74.439999999999998 108.701 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 140.88 130.92 2.65 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 111.016 -0.834 . . . . 72.150000000000006 111.016 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.67 -31.95 61.07 Favored Glycine 0 C--O 1.22 -0.771 0 C-N-CA 122.856 0.265 . . . . 54.530000000000001 112.54 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 29.4 t -61.55 -23.61 66.08 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.033 0.933 . . . . 73.239999999999995 110.312 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -87.41 -12.2 46.91 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.503 -0.771 . . . . 75.049999999999997 110.343 -176.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 55.05 72.96 0.44 Allowed 'General case' 0 C--O 1.249 1.061 0 C-N-CA 123.956 0.902 . . . . 71.530000000000001 111.437 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . 0.432 ' ND2' ' HB3' ' A' ' 595' ' ' ALA . 45.3 m-80 -84.44 93.72 8.36 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.531 1.158 . . . . 75.150000000000006 111.213 -174.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . 0.41 ' HD2' ' O ' ' A' ' 568' ' ' GLY . 18.6 mtm180 -74.46 171.49 13.68 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 113.027 -1.897 . . . . 73.150000000000006 110.282 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 90.0 t -58.7 129.33 20.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.185 -0.672 . . . . 73.109999999999999 109.185 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 24.2 m -110.19 -27.98 2.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-O 120.972 0.415 . . . . 73.219999999999999 111.358 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -139.49 135.51 33.59 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 116.025 -0.534 . . . . 74.340000000000003 110.439 -176.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -132.66 128.77 37.75 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 104.642 -2.355 . . . . 73.140000000000001 104.642 171.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.416 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 28.5 t-20 -59.36 -55.5 45.44 Favored Pre-proline 0 N--CA 1.471 0.608 0 N-CA-C 113.232 0.826 . . . . 73.109999999999999 113.232 -175.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.449 ' HG2' HG22 ' A' ' 620' ' ' ILE . 12.4 Cg_exo -79.17 116.39 3.65 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 121.056 1.171 . . . . 73.019999999999996 109.328 171.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.71 161.27 46.64 Favored 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 123.129 2.553 . . . . 73.439999999999998 112.85 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.08 139.0 57.75 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.937 -0.574 . . . . 73.140000000000001 109.707 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 90.56 -8.05 80.41 Favored Glycine 0 C--N 1.303 -1.262 0 C-N-CA 120.402 -0.904 . . . . 62.340000000000003 112.305 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 52.6 m -90.62 151.65 21.2 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.236 -0.653 . . . . 63.409999999999997 109.236 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -76.98 130.14 10.24 Favored Glycine 0 N--CA 1.433 -1.546 0 N-CA-C 111.416 -0.674 . . . . 63.310000000000002 111.416 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.49 142.79 33.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 109.898 -0.408 . . . . 75.329999999999998 109.898 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.475 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.0 p-10 -51.42 166.94 0.1 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.646 1.179 . . . . 64.340000000000003 112.749 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -58.64 -25.8 63.08 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 113.037 0.754 . . . . 75.140000000000001 113.037 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.528 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 68.0 m-20 -86.17 -7.13 58.78 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 119.855 -0.738 . . . . 75.439999999999998 111.007 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 65.59 18.55 65.97 Favored Glycine 0 C--O 1.215 -1.052 0 O-C-N 123.448 0.467 . . . . 62.340000000000003 112.865 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.89 119.62 17.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 122.349 1.071 . . . . 72.329999999999998 111.802 -166.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.449 HG22 ' HG2' ' A' ' 608' ' ' PRO . 40.1 pt -128.21 134.37 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 CA-C-N 114.544 -1.207 . . . . 73.450000000000003 110.753 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 8.9 t -104.9 130.06 53.14 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.611 -1.255 . . . . 74.239999999999995 107.611 174.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -138.79 165.65 26.45 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.221 -0.445 . . . . 74.340000000000003 110.435 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -137.8 147.32 44.51 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.253 0.549 . . . . 74.010000000000005 110.587 175.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -136.14 165.31 26.03 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.161 -1.052 . . . . 74.340000000000003 108.161 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -86.17 -164.78 39.93 Favored Glycine 0 N--CA 1.422 -2.245 0 C-N-CA 119.77 -1.205 . . . . 72.030000000000001 112.058 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' A' ' 593' ' ' VAL . 3.1 tp-100 . . . . . 0 C--N 1.281 -2.399 0 C-N-CA 123.52 0.728 . . . . 75.5 109.45 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.029 0 N-CA-C 111.106 -0.798 . . . . 73.200000000000003 111.106 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.82 157.07 61.52 Favored 'Trans proline' 0 C--O 1.249 1.049 0 C-N-CA 122.558 2.172 . . . . 75.319999999999993 111.154 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 62.43 35.5 14.79 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.662 0.785 . . . . 73.409999999999997 111.357 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 48.8 p -133.75 155.44 49.76 Favored 'General case' 0 C--O 1.25 1.125 0 N-CA-C 107.405 -1.332 . . . . 64.109999999999999 107.405 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . 0.614 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 4.9 tmtt? -131.28 134.02 45.98 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.693 -0.854 . . . . 75.5 108.693 175.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.614 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 0.8 OUTLIER -78.05 124.05 27.57 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 124.679 1.192 . . . . 74.349999999999994 110.954 176.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.3 pt -86.77 131.52 45.04 Favored Pre-proline 0 C--N 1.295 -1.79 0 CA-C-N 115.703 -0.68 . . . . 75.430000000000007 110.846 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -93.48 176.92 1.34 Allowed 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 122.133 1.889 . . . . 71.219999999999999 111.571 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -90.22 103.36 16.04 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.273 1.035 . . . . 74.340000000000003 108.233 176.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 534' ' ' VAL . 17.9 m -92.45 23.99 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 114.595 -1.184 . . . . 72.340000000000003 111.77 -175.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -74.11 99.03 3.25 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.21 -0.45 . . . . 70.230000000000004 110.321 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 163.04 -44.0 0.34 Allowed Glycine 0 N--CA 1.428 -1.843 0 C-N-CA 119.541 -1.314 . . . . 74.329999999999998 113.004 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.418 ' O ' HG11 ' A' ' 534' ' ' VAL . 18.6 pm0 -92.75 -171.27 2.68 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 120.231 -0.588 . . . . 74.319999999999993 110.419 -177.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 6.8 m -77.77 155.22 31.3 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 108.167 -1.049 . . . . 74.129999999999995 108.167 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.413 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.9 p -63.4 -42.01 94.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 111.859 0.318 . . . . 65.530000000000001 111.859 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . 0.421 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 27.4 t70 -62.8 -39.02 92.98 Favored 'General case' 0 C--O 1.199 -1.554 0 N-CA-C 109.442 -0.577 . . . . 71.010000000000005 109.442 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 90.1 t -66.06 -44.82 91.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.74 -0.664 . . . . 74.040000000000006 109.567 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.42 ' HB2' HG12 ' A' ' 534' ' ' VAL . . . -60.78 -44.06 97.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 120.189 -0.604 . . . . 75.120000000000005 111.668 175.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.4 mt-30 -63.62 -43.38 97.01 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 122.515 0.326 . . . . 72.420000000000002 110.914 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.473 ' O ' HG23 ' A' ' 514' ' ' VAL . 32.0 mmtp -65.1 -39.82 93.69 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.997 -0.547 . . . . 74.439999999999998 110.067 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . 0.422 ' O ' ' HD1' ' A' ' 515' ' ' TYR . 5.8 m-80 -61.31 -45.97 92.22 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 116.105 -0.498 . . . . 71.540000000000006 110.633 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.26 -37.51 83.61 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.699 -0.682 . . . . 73.450000000000003 110.882 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.472 ' ND2' ' HA ' ' A' ' 517' ' ' PHE . 1.1 t-20 -65.09 -37.63 88.12 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 116.555 -0.293 . . . . 72.25 110.542 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 510' ' ' LYS . 95.3 t -62.58 -32.53 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 121.154 0.502 . . . . 70.209999999999994 111.119 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . 0.422 ' HD1' ' O ' ' A' ' 511' ' ' ASN . 97.3 m-85 -108.78 14.9 24.01 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.986 -0.446 . . . . 73.150000000000006 110.267 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -146.99 -58.36 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 119.043 -1.551 . . . . 53.240000000000002 115.056 -172.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.472 ' HA ' ' ND2' ' A' ' 513' ' ' ASN . 61.3 m-85 67.93 31.97 5.38 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.451 1.119 . . . . 62.340000000000003 108.047 -169.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 518' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 547' ' ' VAL . 12.9 p -79.91 179.04 7.79 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 113.238 -1.801 . . . . 72.319999999999993 110.479 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -108.67 138.83 44.36 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.129 -1.434 . . . . 54.5 107.129 176.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -132.73 145.54 51.11 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.162 0.506 . . . . 75.329999999999998 111.961 -176.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.1 m -141.59 150.28 41.84 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.751 -0.833 . . . . 63.030000000000001 108.751 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . 0.404 ' HB2' ' CG2' ' A' ' 555' ' ' VAL . 3.0 pt20 -119.65 149.91 41.2 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-O 120.907 0.384 . . . . 73.099999999999994 111.25 -174.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -123.47 143.01 50.43 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.215 -1.772 . . . . 61.119999999999997 106.215 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 20.0 m -118.85 130.91 56.01 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.231 0.539 . . . . 53.420000000000002 112.254 -175.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.5 p -123.75 151.01 28.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.746 -0.661 . . . . 72.5 110.05 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.478 ' C ' ' HG ' ' A' ' 527' ' ' SER . 5.8 t70 -66.17 134.11 52.07 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.104 -1.073 . . . . 74.530000000000001 108.104 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.478 ' HG ' ' C ' ' A' ' 526' ' ' ASP . 62.6 m -156.81 176.85 2.35 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-O 119.485 -0.293 . . . . 75.109999999999999 110.596 -176.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -79.45 -25.29 5.73 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 122.2 1.933 . . . . 71.409999999999997 112.777 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.87 146.74 34.45 Favored Pre-proline 0 CA--C 1.506 -0.713 0 C-N-CA 120.132 -0.627 . . . . 75.140000000000001 110.38 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.62 159.92 30.45 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 123.419 2.746 . . . . 73.140000000000001 113.947 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -63.64 99.19 0.21 Allowed 'General case' 0 C--O 1.245 0.825 0 CA-C-N 114.698 -1.137 . . . . 74.109999999999999 110.132 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 163.9 -29.94 0.24 Allowed Glycine 0 N--CA 1.414 -2.769 0 CA-C-N 114.862 -1.063 . . . . 63.310000000000002 111.127 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -71.12 130.38 41.35 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 120.36 -0.536 . . . . 75.420000000000002 110.194 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 7.2 p -96.6 119.5 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.675 0 N-CA-C 106.559 -1.645 . . . . 71.030000000000001 106.559 171.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.4 m -104.66 20.54 18.45 Favored 'General case' 0 C--N 1.261 -3.252 0 CA-C-N 114.328 -1.306 . . . . 74.209999999999994 110.715 -171.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 126.3 -168.05 18.55 Favored Glycine 0 N--CA 1.429 -1.823 0 C-N-CA 120.721 -0.752 . . . . 74.120000000000005 112.053 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 33.4 p -116.89 146.42 42.95 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.53 -1.285 . . . . 74.239999999999995 107.53 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -68.66 -46.74 34.65 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 119.102 -1.039 . . . . 72.209999999999994 111.18 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -66.53 151.23 83.38 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 120.948 1.099 . . . . 62.329999999999998 109.966 171.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -57.66 140.73 94.43 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.142 2.561 . . . . 74.219999999999999 113.722 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -68.03 129.76 40.89 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.714 -0.847 . . . . 75.439999999999998 108.714 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.53 -14.37 46.67 Favored Glycine 0 C--N 1.294 -1.786 0 N-CA-C 110.851 -0.9 . . . . 63.119999999999997 110.851 -176.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 98.7 m -75.83 127.49 33.11 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 109.563 -0.532 . . . . 75.510000000000005 109.563 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.2 t -93.85 130.25 39.96 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 108.351 -0.981 . . . . 72.540000000000006 108.351 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.01 154.15 64.46 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 108.19 -1.041 . . . . 74.129999999999995 108.19 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . 0.428 ' HG2' ' OG ' ' A' ' 549' ' ' SER . 3.2 Cg_endo -59.42 137.83 80.49 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 121.43 1.42 . . . . 73.040000000000006 111.837 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 518' ' ' THR . 12.8 p -57.02 -29.5 31.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.662 -1.154 . . . . 75.540000000000006 113.08 -176.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -90.03 3.31 53.61 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 123.266 0.627 . . . . 73.129999999999995 110.582 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 549' ' ' SER . . . . . 0.428 ' OG ' ' HG2' ' A' ' 546' ' ' PRO . 52.2 m -104.38 177.56 4.81 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 116.234 -0.439 . . . . 74.319999999999993 111.013 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 7.5 p -97.63 130.67 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 N-CA-C 113.084 0.772 . . . . 75.150000000000006 113.084 -172.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 66.1 mt -93.48 129.62 43.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 106.256 -1.757 . . . . 74.209999999999994 106.256 172.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -103.52 116.99 33.4 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.289 0.566 . . . . 70.230000000000004 110.923 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.53 133.06 50.9 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.809 -1.087 . . . . 74.420000000000002 111.346 -177.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -87.43 117.71 26.4 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.959 -0.564 . . . . 75.140000000000001 110.397 178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 524' ' ' SER . 43.3 t -108.64 126.64 65.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 109.079 -0.712 . . . . 72.0 109.079 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 74.9 m -89.24 132.07 35.06 Favored 'General case' 0 N--CA 1.408 -2.562 0 CA-C-N 115.84 -0.618 . . . . 71.540000000000006 109.43 176.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -114.05 138.62 50.15 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.327 -1.36 . . . . 74.329999999999998 107.327 174.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.566 ' O ' ' HG3' ' A' ' 560' ' ' GLN . . . -67.41 -26.82 73.51 Favored Glycine 0 CA--C 1.493 -1.324 0 N-CA-C 109.92 -1.272 . . . . 74.340000000000003 109.92 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 60.6 t30 61.14 29.3 18.75 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-O 122.757 1.265 . . . . 73.099999999999994 108.247 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.566 ' HG3' ' O ' ' A' ' 558' ' ' GLY . 91.9 mt-30 -129.33 172.2 11.73 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 113.642 -1.617 . . . . 73.450000000000003 110.755 -174.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -143.81 152.51 41.29 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.506 -1.294 . . . . 75.239999999999995 107.506 174.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 68.0 t -78.1 116.54 21.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 108.684 -0.858 . . . . 64.030000000000001 108.684 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 563' ' ' MET . . . . . 0.507 ' SD ' HG22 ' A' ' 620' ' ' ILE . 45.1 ttp -73.6 128.53 86.91 Favored Pre-proline 0 C--N 1.315 -0.912 0 CA-C-N 116.314 -0.403 . . . . 73.400000000000006 112.016 -175.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.7 170.2 18.27 Favored 'Trans proline' 0 C--O 1.242 0.705 0 C-N-CA 123.189 2.592 . . . . 70.409999999999997 112.118 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.8 128.62 37.44 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 113.054 0.761 . . . . 75.349999999999994 113.054 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.07 -9.85 3.4 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 114.81 -1.086 . . . . 75.040000000000006 108.604 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 22.6 t -79.25 151.81 30.95 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.653 -0.654 . . . . 74.310000000000002 110.645 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 62.65 52.05 51.51 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 116.004 -0.544 . . . . 55.039999999999999 114.172 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 23.6 ptp -158.4 169.69 23.9 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 107.568 -1.271 . . . . 74.430000000000007 107.568 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -88.32 167.98 13.08 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.217 -0.66 . . . . 72.340000000000003 109.217 -174.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 26.3 t-105 -64.89 -27.61 68.97 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.51 -0.922 . . . . 72.450000000000003 108.51 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.3 m -73.59 -9.99 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 115.398 -0.819 . . . . 74.030000000000001 111.371 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -96.39 -44.08 7.37 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.719 -1.215 . . . . 74.519999999999996 107.719 173.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -57.47 -44.74 85.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.764 -1.107 . . . . 72.010000000000005 112.585 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.625 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 1.6 tm-20 -57.25 -58.99 14.19 Favored Pre-proline 0 CA--C 1.571 1.777 0 C-N-CA 122.824 0.45 . . . . 74.109999999999999 111.288 -177.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -61.37 -31.89 88.92 Favored 'Trans proline' 0 C--N 1.372 1.81 0 CA-C-N 120.652 1.269 . . . . 73.430000000000007 112.323 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -68.99 -33.82 74.3 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.24 0.83 . . . . 75.030000000000001 113.24 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.6 pp -66.34 -47.15 74.41 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.238 0.542 . . . . 75.109999999999999 110.733 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.473 ' N ' HD13 ' A' ' 578' ' ' LEU . 15.1 ptm180 -65.86 -34.53 78.35 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.671 -0.695 . . . . 74.230000000000004 111.133 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.79 -38.39 88.88 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 123.375 0.67 . . . . 73.129999999999995 111.502 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.0 pp -85.98 -8.16 58.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.313 0.577 . . . . 73.129999999999995 110.751 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 82.5 39.3 11.02 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.737 -0.665 . . . . 73.340000000000003 111.706 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 12.6 t90 -87.04 126.29 34.66 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.548 -0.908 . . . . 73.030000000000001 108.548 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 1.9 p -108.24 2.96 23.1 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.967 0.729 . . . . 50.229999999999997 112.967 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -94.64 -173.38 38.15 Favored Glycine 0 N--CA 1.438 -1.186 0 N-CA-C 110.381 -1.088 . . . . 75.299999999999997 110.381 176.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 60.6 mtm -114.27 151.33 33.03 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.397 -0.594 . . . . 75.450000000000003 109.397 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.7 tt -83.07 125.18 31.19 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.962 -1.125 . . . . 72.219999999999999 107.962 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 621' ' ' THR . 30.8 t70 -104.05 123.55 47.43 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.081 0.467 . . . . 63.310000000000002 109.941 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . 0.412 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -101.39 133.44 45.99 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 108.566 -0.902 . . . . 74.019999999999996 108.566 177.22 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -77.42 -68.7 1.48 Allowed Glycine 0 C--N 1.283 -2.387 0 N-CA-C 110.505 -1.038 . . . . 72.340000000000003 110.505 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.53 142.73 37.23 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.854 -0.795 . . . . 72.109999999999999 108.854 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -83.63 134.49 34.79 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.762 -1.199 . . . . 73.329999999999998 107.762 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . 0.465 ' O ' ' HG2' ' A' ' 626' ' ' GLN . 42.8 t -104.13 141.62 19.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 107.893 -1.151 . . . . 74.219999999999999 107.893 -176.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -72.46 118.2 15.06 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 109.484 -0.561 . . . . 74.200000000000003 109.484 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -137.3 -59.76 0.68 Allowed 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 115.466 -0.788 . . . . 63.539999999999999 109.768 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 85.84 154.09 23.0 Favored Glycine 0 N--CA 1.412 -2.903 0 C-N-CA 119.07 -1.538 . . . . 44.43 109.818 -173.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.96 -33.82 75.78 Favored Glycine 0 C--N 1.284 -2.357 0 N-CA-C 114.934 0.733 . . . . 52.109999999999999 114.934 -177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 6.9 t -73.62 -24.74 60.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 117.68 0.74 . . . . 74.230000000000004 110.231 -174.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -87.92 -1.68 58.13 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.16 0.505 . . . . 75.400000000000006 109.827 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 57.0 m80 68.34 86.64 0.13 Allowed 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 124.993 1.317 . . . . 73.319999999999993 110.868 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -74.37 82.38 1.91 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 112.697 -2.047 . . . . 75.329999999999998 111.623 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -129.28 171.32 12.59 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.015 -1.448 . . . . 75.430000000000007 110.47 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . 0.454 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 70.7 t -57.94 130.77 21.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 O-C-N 123.338 0.399 . . . . 73.140000000000001 110.075 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 27.0 m -106.53 -34.1 2.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 C-N-CA 120.579 -0.448 . . . . 75.310000000000002 110.922 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -152.92 135.92 15.54 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 116.352 -0.386 . . . . 72.409999999999997 110.5 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -118.79 128.59 54.62 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.593 -1.632 . . . . 75.010000000000005 106.593 171.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.407 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 4.4 t-20 -63.09 -47.94 84.95 Favored Pre-proline 0 N--CA 1.469 0.496 0 C-N-CA 119.717 -0.793 . . . . 73.310000000000002 110.954 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.9 Cg_exo -84.64 108.66 1.26 Allowed 'Trans proline' 0 C--N 1.361 1.187 0 N-CA-C 108.17 -1.512 . . . . 75.349999999999994 108.17 168.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.38 161.02 47.54 Favored 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 123.386 2.724 . . . . 75.530000000000001 113.13 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.78 134.72 57.08 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.35 -0.611 . . . . 73.409999999999997 109.35 176.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 103.55 -5.03 47.56 Favored Glycine 0 C--N 1.304 -1.211 0 C-N-CA 120.554 -0.831 . . . . 71.150000000000006 111.508 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 59.1 m -86.36 141.36 29.25 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.725 -0.472 . . . . 75.430000000000007 109.725 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -78.33 117.36 4.63 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 110.072 -1.211 . . . . 74.120000000000005 110.072 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 28.6 m -115.48 142.2 29.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 110.167 -0.308 . . . . 74.230000000000004 110.167 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -50.08 170.15 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.961 1.304 . . . . 73.409999999999997 113.041 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -60.98 -25.64 67.0 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.85 0.685 . . . . 73.219999999999999 112.85 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.454 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 17.8 m-20 -82.84 -8.83 59.55 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 119.185 -1.006 . . . . 75.109999999999999 110.832 177.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 64.85 15.48 60.17 Favored Glycine 0 C--O 1.219 -0.826 0 C-N-CA 123.599 0.618 . . . . 75.030000000000001 114.592 168.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.71 118.37 15.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 122.612 1.196 . . . . 74.519999999999996 112.515 -164.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.507 HG22 ' SD ' ' A' ' 563' ' ' MET . 2.8 pp -128.46 134.34 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 114.012 -1.449 . . . . 71.430000000000007 111.266 -177.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 15.1 t -104.11 129.16 51.8 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.456 -0.572 . . . . 73.019999999999996 109.456 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.5 pp -139.43 167.2 22.62 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.355 0.502 . . . . 63.340000000000003 112.355 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 25.9 ptt85 -127.8 137.81 52.52 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.49 -0.559 . . . . 75.510000000000005 109.49 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.454 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 20.0 p90 -139.94 165.93 26.0 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.918 -0.583 . . . . 75.129999999999995 110.896 -173.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -76.15 134.64 16.16 Favored Glycine 0 N--CA 1.431 -1.647 0 CA-C-N 115.832 -0.622 . . . . 72.439999999999998 112.615 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 593' ' ' VAL . 2.7 pt20 . . . . . 0 C--N 1.305 -1.36 0 C-N-CA 123.768 0.827 . . . . 73.430000000000007 109.293 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.909 0 N-CA-C 110.476 -1.05 . . . . 73.299999999999997 110.476 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -67.61 142.33 58.32 Favored 'Trans proline' 0 C--O 1.241 0.63 0 C-N-CA 122.442 2.095 . . . . 75.040000000000006 110.748 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -96.54 -8.2 32.57 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.517 0.675 . . . . 70.540000000000006 111.174 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 31.2 p -137.66 147.3 44.79 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 115.338 -0.847 . . . . 72.219999999999999 109.744 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -127.68 139.86 52.44 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.614 -0.884 . . . . 75.420000000000002 108.614 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.4 p-10 -96.02 130.25 43.07 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.485 0.659 . . . . 74.219999999999999 110.414 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 34.8 pt -91.12 127.06 52.94 Favored Pre-proline 0 C--N 1.304 -1.383 0 CA-C-N 114.717 -1.129 . . . . 75.430000000000007 111.198 -176.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -84.42 -179.42 3.85 Favored 'Trans proline' 0 N--CA 1.441 -1.585 0 C-N-CA 121.632 1.555 . . . . 72.109999999999999 110.696 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -82.3 103.37 11.83 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 122.253 1.025 . . . . 75.510000000000005 110.182 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.79 7.67 9.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 114.946 -1.025 . . . . 74.430000000000007 111.384 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -80.56 102.81 10.0 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 109.054 -0.721 . . . . 60.210000000000001 109.054 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 159.05 -36.14 0.49 Allowed Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.566 -0.826 . . . . 72.439999999999998 112.131 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 16.6 pm0 -94.45 -173.08 2.95 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 109.301 -0.629 . . . . 73.409999999999997 109.301 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 27.9 m -70.1 154.89 41.37 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.856 -1.164 . . . . 72.219999999999999 107.856 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.443 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.2 p -63.02 -41.89 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 C-N-CA 120.891 -0.324 . . . . 74.010000000000005 111.049 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . 0.525 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 18.7 t70 -62.18 -43.95 97.68 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 109.645 -0.502 . . . . 60.219999999999999 109.645 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 64.0 t -66.61 -41.85 88.93 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 CA-C-N 115.79 -0.641 . . . . 75.319999999999993 109.737 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.405 ' CB ' HG13 ' A' ' 534' ' ' VAL . . . -61.15 -44.57 97.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 120.442 0.163 . . . . 63.140000000000001 110.684 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 26.3 mt-30 -65.0 -43.82 91.28 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.266 -0.425 . . . . 65.430000000000007 111.086 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.556 ' O ' HG22 ' A' ' 514' ' ' VAL . 32.7 mmtp -62.92 -47.14 84.54 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.429 -0.582 . . . . 74.430000000000007 109.429 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -63.99 -37.95 89.3 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.515 -0.766 . . . . 74.099999999999994 111.345 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.64 -46.28 69.61 Favored 'General case' 0 C--O 1.203 -1.348 0 N-CA-C 108.151 -1.055 . . . . 64.25 108.151 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -59.99 -38.13 81.7 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 124.077 0.951 . . . . 73.200000000000003 111.188 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 510' ' ' LYS . 57.7 t -57.57 -37.56 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-O 120.845 0.355 . . . . 73.230000000000004 111.326 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -110.0 0.91 18.69 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.865 0.84 . . . . 74.439999999999998 111.098 -176.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -113.5 -60.4 0.41 Allowed Glycine 0 N--CA 1.416 -2.698 0 CA-C-N 115.18 -0.918 . . . . 70.109999999999999 111.331 -174.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 70.74 16.49 6.74 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.58 1.152 . . . . 74.400000000000006 110.415 -175.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.4 p -83.05 -176.17 6.2 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-N 114.082 -1.417 . . . . 75.25 109.496 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' A' ' 519' ' ' LYS . 0.1 OUTLIER -108.69 143.14 38.18 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.29 -1.004 . . . . 71.230000000000004 108.29 177.018 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -123.1 148.61 45.46 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-O 121.428 0.633 . . . . 74.129999999999995 111.804 -175.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 16.9 p -135.31 140.26 44.97 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 107.369 -1.345 . . . . 75.219999999999999 107.369 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -117.45 127.27 53.85 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-O 121.246 0.546 . . . . 73.010000000000005 110.466 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -116.11 143.36 45.58 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.161 -1.422 . . . . 74.219999999999999 107.161 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.0 p -119.44 132.66 55.85 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 113.783 1.031 . . . . 72.109999999999999 113.783 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.64 149.97 24.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 107.902 -1.147 . . . . 74.420000000000002 107.902 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -79.61 136.86 36.95 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.923 -0.311 . . . . 71.0 110.881 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 59.9 m -163.24 155.08 15.13 Favored Pre-proline 0 C--O 1.204 -1.335 0 N-CA-C 107.106 -1.442 . . . . 74.230000000000004 107.106 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.39 -14.66 36.01 Favored 'Trans proline' 0 CA--C 1.552 1.376 0 C-N-CA 122.439 2.093 . . . . 73.25 114.587 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -70.9 145.58 91.99 Favored Pre-proline 0 C--O 1.215 -0.711 0 N-CA-C 109.529 -0.545 . . . . 75.519999999999996 109.529 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.33 144.39 91.13 Favored 'Trans proline' 0 C--O 1.26 1.59 0 C-N-CA 122.317 2.012 . . . . 73.0 112.619 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.683 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -64.14 100.34 0.32 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.246 -0.888 . . . . 63.009999999999998 111.171 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 157.43 -23.41 0.43 Allowed Glycine 0 N--CA 1.427 -1.93 0 C-N-CA 120.559 -0.829 . . . . 74.349999999999994 111.979 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -80.65 138.92 36.43 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 119.904 -0.718 . . . . 75.099999999999994 109.842 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.405 HG13 ' CB ' ' A' ' 508' ' ' ALA . 5.4 p -93.85 113.93 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 N-CA-C 107.294 -1.373 . . . . 72.239999999999995 107.294 172.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.7 m -99.62 8.74 44.15 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 113.929 -1.487 . . . . 74.319999999999993 111.186 -172.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 157.31 172.89 25.05 Favored Glycine 0 N--CA 1.428 -1.883 0 C-N-CA 119.704 -1.236 . . . . 42.43 113.245 174.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.6 p -120.52 158.27 27.65 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 105.798 -1.927 . . . . 73.319999999999993 105.798 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.409 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 3.9 t-20 -67.05 -54.33 20.83 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 117.517 -1.673 . . . . 70.230000000000004 111.368 177.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.409 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 8.2 Cg_exo -74.33 143.21 31.2 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 121.282 1.321 . . . . 71.310000000000002 109.792 174.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.74 157.99 59.61 Favored 'Trans proline' 0 C--O 1.25 1.106 0 C-N-CA 122.635 2.224 . . . . 71.319999999999993 113.284 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.28 139.59 58.08 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.806 -0.633 . . . . 64.010000000000005 110.505 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.18 -14.36 59.79 Favored Glycine 0 C--N 1.3 -1.436 0 N-CA-C 111.706 -0.557 . . . . 71.439999999999998 111.706 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 20.4 m -75.32 135.23 40.89 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 109.771 -0.455 . . . . 70.239999999999995 109.771 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.8 t -96.58 125.47 41.07 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 107.916 -1.142 . . . . 75.030000000000001 107.916 177.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.26 154.55 65.44 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 108.622 -0.881 . . . . 64.519999999999996 108.622 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.64 137.48 77.56 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.784 1.656 . . . . 70.209999999999994 112.283 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 13.5 p -65.33 -24.03 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-N 115.19 -0.913 . . . . 73.400000000000006 110.82 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -78.02 -10.02 59.4 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.559 -1.201 . . . . 73.25 111.632 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 22.9 t -94.01 -176.84 4.13 Favored 'General case' 0 C--O 1.26 1.637 0 CA-C-O 121.631 0.729 . . . . 63.539999999999999 112.176 -174.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 14.7 p -119.13 137.92 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 114.774 -1.103 . . . . 74.310000000000002 109.037 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.3 mt -108.71 138.33 36.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 109.149 -0.686 . . . . 73.439999999999998 109.149 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.53 122.06 44.17 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.689 0.757 . . . . 73.519999999999996 111.756 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.1 mp -108.08 122.23 46.45 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.212 -1.358 . . . . 74.209999999999994 108.776 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -90.63 116.23 28.35 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.916 0.865 . . . . 73.329999999999998 111.26 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.8 135.21 34.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 114.263 -1.335 . . . . 64.129999999999995 108.811 -177.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.683 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 66.4 m -86.33 129.04 34.99 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.538 -0.541 . . . . 74.400000000000006 109.538 174.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -101.03 130.05 46.98 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 105.883 -1.895 . . . . 74.319999999999993 105.883 172.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -62.22 -24.93 65.92 Favored Glycine 0 CA--C 1.5 -0.898 0 O-C-N 124.006 0.816 . . . . 74.510000000000005 114.146 -173.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . 0.484 ' OD1' ' HG3' ' A' ' 616' ' ' ARG . 49.0 t-20 71.93 -14.62 0.51 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.841 1.256 . . . . 74.439999999999998 111.363 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -111.93 149.55 31.76 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.307 -0.87 . . . . 72.150000000000006 112.856 -170.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -131.0 158.4 40.39 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.248 -1.342 . . . . 75.120000000000005 107.449 177.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.61 125.33 32.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 120.991 0.424 . . . . 72.349999999999994 111.217 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 55.2 ttp -86.6 129.51 52.64 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 110.092 -0.336 . . . . 73.239999999999995 110.092 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.07 170.46 20.07 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.363 2.708 . . . . 73.120000000000005 112.337 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.02 126.65 28.7 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 112.784 0.661 . . . . 72.310000000000002 112.784 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . 0.448 ' O ' ' HG2' ' A' ' 569' ' ' MET . 0.0 OUTLIER -132.05 7.25 4.31 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.504 1.145 . . . . 55.439999999999998 109.06 171.382 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 3.1 m -79.19 138.19 37.75 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.559 -1.201 . . . . 75.120000000000005 108.926 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 84.15 18.62 62.46 Favored Glycine 0 C--N 1.315 -0.624 0 C-N-CA 120.533 -0.841 . . . . 74.310000000000002 113.876 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 569' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 20.2 ptp -124.0 175.12 7.16 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.291 -1.003 . . . . 75.349999999999994 108.291 176.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -94.8 164.98 12.71 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.595 -1.631 . . . . 72.209999999999994 106.595 -175.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . 0.495 ' O ' ' HG3' ' A' ' 575' ' ' GLU . 10.8 t-105 -63.49 -34.16 77.17 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.781 -0.822 . . . . 73.400000000000006 108.781 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.6 p -74.23 -14.78 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.648 -0.705 . . . . 73.310000000000002 110.669 -175.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -100.98 -28.6 12.65 Favored 'General case' 0 C--O 1.263 1.814 0 CA-C-O 122.025 0.917 . . . . 54.43 108.766 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . 0.616 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -64.12 -41.67 97.14 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.486 -1.234 . . . . 51.109999999999999 109.98 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 571' ' ' TRP . 46.0 mt-10 -51.21 -56.12 22.83 Favored Pre-proline 0 CA--C 1.567 1.615 0 N-CA-C 112.519 0.562 . . . . 74.319999999999993 112.519 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -58.4 -33.34 97.76 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 121.554 1.502 . . . . 73.510000000000005 112.71 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -68.64 -34.3 75.5 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 119.487 -0.885 . . . . 71.319999999999993 111.735 176.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 41.0 mt -63.06 -48.31 79.23 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.147 0.499 . . . . 71.439999999999998 110.383 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 6.9 ptp85 -66.19 -36.83 84.1 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.136 -0.484 . . . . 75.219999999999999 111.324 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.31 77.85 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.134 -0.484 . . . . 72.5 112.097 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 1.7 pp -81.93 -8.54 59.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.158 0.504 . . . . 73.340000000000003 109.868 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 80.3 42.45 10.52 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.528 -0.76 . . . . 71.319999999999993 112.311 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . 0.429 ' CE3' HD23 ' A' ' 578' ' ' LEU . 18.1 t90 -87.31 126.59 34.94 Favored 'General case' 0 N--CA 1.427 -1.619 0 C-N-CA 120.147 -0.621 . . . . 73.519999999999996 109.888 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 26.9 p -100.95 -14.28 17.95 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.33 0.492 . . . . 74.409999999999997 112.33 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -82.96 -171.09 46.91 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 121.344 -0.455 . . . . 60.350000000000001 113.349 -177.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 92.3 mmm -117.57 147.47 42.79 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.907 -0.405 . . . . 75.030000000000001 109.907 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . 0.407 HD21 ' HG ' ' A' ' 622' ' ' LEU . 3.6 tt -93.02 129.56 38.9 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.88 0.372 . . . . 72.319999999999993 110.203 -175.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -113.96 124.85 53.16 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-N 115.911 -0.586 . . . . 73.319999999999993 109.719 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.8 133.95 34.81 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.806 -0.442 . . . . 55.329999999999998 109.806 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -84.06 -106.8 0.57 Allowed Glycine 0 C--N 1.291 -1.937 0 CA-C-N 115.829 -0.623 . . . . 70.219999999999999 112.32 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . 0.588 ' O ' ' HB2' ' A' ' 623' ' ' ARG . . . -96.14 116.58 29.21 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.948 0.404 . . . . 75.239999999999995 110.343 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -87.24 140.08 29.9 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 123.499 0.719 . . . . 74.200000000000003 110.898 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 48.4 t -122.36 128.74 75.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.313 -0.995 . . . . 74.109999999999999 108.313 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.59 122.61 21.66 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.92 0.391 . . . . 65.049999999999997 110.397 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -134.45 -43.47 0.77 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.815 -0.63 . . . . 75.519999999999996 110.596 -177.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 106.86 128.92 6.1 Favored Glycine 0 N--CA 1.433 -1.524 0 N-CA-C 111.543 -0.623 . . . . 74.25 111.543 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.17 -32.95 84.33 Favored Glycine 0 N--CA 1.46 0.235 0 CA-C-O 121.067 0.26 . . . . 54.350000000000001 112.485 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 3.0 p -64.94 -23.94 67.37 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 124.938 1.295 . . . . 72.430000000000007 110.944 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -92.23 -0.78 57.4 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.776 -0.647 . . . . 72.209999999999994 110.283 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 30.5 m170 75.01 97.23 0.07 Allowed 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 125.017 1.327 . . . . 71.239999999999995 112.29 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . 0.662 ' HB2' ' O ' ' A' ' 625' ' ' GLY . 19.2 p30 -83.2 88.85 6.91 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 114.016 -1.447 . . . . 73.310000000000002 112.748 -175.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 -91.85 155.68 18.03 Favored 'General case' 0 C--O 1.254 1.307 0 CA-C-N 114.504 -1.226 . . . . 75.319999999999993 110.818 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 88.0 t -62.86 131.89 28.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 114.955 -1.021 . . . . 75.510000000000005 108.3 172.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.74 -46.55 12.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 120.996 0.427 . . . . 73.530000000000001 110.666 -175.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -151.69 154.11 35.69 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.346 -0.983 . . . . 71.340000000000003 108.346 -176.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -142.55 149.31 38.92 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.309 -0.626 . . . . 74.150000000000006 109.309 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.481 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 50.8 t-20 -69.23 -56.45 8.59 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 120.611 -0.436 . . . . 74.140000000000001 111.265 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.8 Cg_exo -84.44 115.36 1.89 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 120.729 1.296 . . . . 74.219999999999999 108.888 173.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -70.2 157.91 58.04 Favored 'Trans proline' 0 C--O 1.248 1.017 0 C-N-CA 122.303 2.002 . . . . 75.219999999999999 112.458 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.31 137.81 56.34 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.721 -0.844 . . . . 63.409999999999997 108.721 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 96.94 -7.18 64.71 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.892 -0.671 . . . . 74.349999999999994 111.646 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 38.5 m -94.71 150.15 20.51 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.987 -0.375 . . . . 74.439999999999998 109.987 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -75.63 126.5 8.54 Favored Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 111.823 -0.511 . . . . 73.409999999999997 111.823 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.3 m -118.65 142.65 32.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 109.077 -0.712 . . . . 75.349999999999994 109.077 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -52.25 165.87 0.2 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.887 0.875 . . . . 72.099999999999994 112.035 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . 0.484 ' HG3' ' OD1' ' A' ' 559' ' ' ASN . 0.0 OUTLIER -57.82 -25.3 60.42 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.864 1.061 . . . . 75.319999999999993 113.864 -178.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.38 -10.31 59.75 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 119.95 -0.7 . . . . 72.310000000000002 109.48 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 65.34 16.1 62.19 Favored Glycine 0 CA--C 1.498 -1.019 0 CA-C-N 115.61 -0.723 . . . . 73.140000000000001 113.472 169.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.16 119.29 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 122.567 1.175 . . . . 73.219999999999999 111.067 -165.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.403 HG12 ' HD2' ' A' ' 608' ' ' PRO . 0.0 OUTLIER -129.2 132.48 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.176 0 CA-C-N 113.824 -1.535 . . . . 72.409999999999997 109.11 -176.071 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 8.9 t -114.96 133.53 55.94 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.399 -0.963 . . . . 72.239999999999995 108.399 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . 0.407 ' HG ' HD21 ' A' ' 587' ' ' LEU . 3.1 pp -138.97 166.65 23.93 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.748 -0.66 . . . . 74.400000000000006 112.073 -174.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . 0.588 ' HB2' ' O ' ' A' ' 591' ' ' ALA . 7.4 ptm180 -126.93 137.42 53.13 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 106.915 -1.513 . . . . 75.230000000000004 106.915 175.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -139.49 165.93 25.92 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 115.808 -0.633 . . . . 74.299999999999997 109.324 -171.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . 0.662 ' O ' ' HB2' ' A' ' 601' ' ' ASN . . . -72.7 140.03 28.45 Favored Glycine 0 N--CA 1.418 -2.561 0 N-CA-C 108.493 -1.843 . . . . 63.219999999999999 108.493 174.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 . . . . . 0 C--N 1.265 -3.107 0 CA-C-O 118.11 -0.947 . . . . 74.200000000000003 108.643 -179.401 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.636 0 N-CA-C 110.569 -1.012 . . . . 73.200000000000003 110.569 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -76.45 142.71 23.88 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 122.503 2.135 . . . . 75.319999999999993 110.758 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 61.57 31.22 18.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.865 0.866 . . . . 73.409999999999997 111.677 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 38.3 p -139.5 144.18 37.81 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.423 -0.584 . . . . 64.109999999999999 109.423 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . 0.531 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 4.3 tmtt? -134.93 139.38 44.91 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.05 -1.093 . . . . 75.5 108.05 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.531 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 10.5 p-10 -78.77 132.97 37.12 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 124.097 0.959 . . . . 74.349999999999994 110.051 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 42.6 pt -98.58 128.45 32.81 Favored Pre-proline 0 C--N 1.306 -1.309 0 C-N-CA 120.386 -0.526 . . . . 75.430000000000007 110.584 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.92 -163.33 0.19 Allowed 'Trans proline' 0 C--O 1.251 1.139 0 C-N-CA 122.682 2.254 . . . . 71.219999999999999 111.018 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -86.18 127.3 34.7 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.609 0.719 . . . . 74.340000000000003 109.984 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.42 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 15.9 m -122.99 62.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-O 123.359 1.552 . . . . 72.340000000000003 108.425 171.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -120.43 108.58 14.29 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 112.825 -1.988 . . . . 70.230000000000004 109.191 176.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 138.39 -25.47 2.87 Favored Glycine 0 N--CA 1.431 -1.661 0 C-N-CA 119.613 -1.279 . . . . 74.329999999999998 113.42 175.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.428 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.4 OUTLIER -101.39 -177.0 3.31 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 117.835 0.817 . . . . 74.319999999999993 109.382 179.342 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 9.1 m -74.36 155.45 38.13 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.78 -1.193 . . . . 74.129999999999995 107.78 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.5 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 8.9 p -64.3 -41.32 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-O 119.471 -0.3 . . . . 65.530000000000001 111.715 -177.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 15.5 t70 -59.56 -42.6 92.77 Favored 'General case' 0 C--O 1.213 -0.844 0 N-CA-C 108.417 -0.957 . . . . 71.010000000000005 108.417 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 76.9 t -65.34 -44.84 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 114.983 -1.008 . . . . 74.040000000000006 110.044 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.42 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -63.24 -44.98 93.68 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 111.725 0.269 . . . . 75.120000000000005 111.725 177.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.6 mt-30 -61.88 -45.26 94.55 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 122.804 0.441 . . . . 72.420000000000002 110.08 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.543 ' O ' HG23 ' A' ' 514' ' ' VAL . 31.5 mmtp -67.01 -39.28 87.05 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.631 -0.713 . . . . 74.439999999999998 110.579 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -61.49 -43.98 97.9 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 121.31 0.576 . . . . 71.540000000000006 110.492 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.57 -43.06 86.04 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.842 -1.17 . . . . 73.450000000000003 107.842 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -59.81 -36.5 76.88 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 124.035 0.934 . . . . 72.25 111.664 -177.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 510' ' ' LYS . 90.4 t -60.07 -40.48 83.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.732 0.301 . . . . 70.209999999999994 110.929 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -107.15 13.17 27.63 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.414 0.626 . . . . 73.150000000000006 110.281 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -134.65 -54.29 0.07 OUTLIER Glycine 0 N--CA 1.429 -1.801 0 C-N-CA 120.534 -0.841 . . . . 53.240000000000002 113.72 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 65.22 25.76 12.3 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.404 1.097 . . . . 62.340000000000003 109.088 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 518' ' ' THR . . . . . 0.437 HG21 ' HA ' ' A' ' 547' ' ' VAL . 6.2 p -80.77 -173.54 4.25 Favored 'General case' 0 N--CA 1.416 -2.143 0 C-N-CA 125.719 1.608 . . . . 72.319999999999993 111.602 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -108.76 138.41 45.14 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.451 -1.685 . . . . 54.5 106.451 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -132.43 149.01 52.42 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.065 0.459 . . . . 75.329999999999998 111.607 -178.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 71.3 m -141.22 150.9 43.26 Favored 'General case' 0 N--CA 1.418 -2.025 0 N-CA-C 108.515 -0.92 . . . . 63.030000000000001 108.515 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . 0.446 ' HB2' ' CG2' ' A' ' 555' ' ' VAL . 3.6 pt20 -119.56 136.63 54.27 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.036 0.446 . . . . 73.099999999999994 110.294 -178.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -120.04 137.34 54.16 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.184 -1.413 . . . . 61.119999999999997 107.184 176.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 33.8 m -106.1 134.5 49.12 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 112.295 0.48 . . . . 53.420000000000002 112.295 -175.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.6 p -131.13 153.04 38.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.357 -0.838 . . . . 72.5 109.006 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -73.24 134.92 44.45 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.24 -1.022 . . . . 74.530000000000001 108.24 177.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 65.5 m -161.13 168.04 12.3 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.513 -0.551 . . . . 75.109999999999999 109.513 -177.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -71.96 -21.91 23.78 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.055 1.837 . . . . 71.409999999999997 112.077 176.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -69.73 144.22 93.39 Favored Pre-proline 0 C--O 1.221 -0.426 0 CA-C-N 116.2 -0.455 . . . . 75.140000000000001 111.311 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.47 152.42 81.67 Favored 'Trans proline' 0 C--O 1.248 0.996 0 C-N-CA 122.586 2.191 . . . . 73.140000000000001 111.72 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -62.31 112.01 2.24 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 115.63 -0.714 . . . . 74.109999999999999 110.999 -177.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 131.53 -23.62 4.24 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 115.427 -0.806 . . . . 63.310000000000002 111.623 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -80.08 133.83 36.14 Favored 'General case' 0 C--O 1.246 0.912 0 CA-C-O 121.262 0.553 . . . . 75.420000000000002 109.768 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 503' ' ' GLN . 8.1 p -97.32 120.09 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.875 0 N-CA-C 108.094 -1.076 . . . . 71.030000000000001 108.094 -178.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 4.1 p -90.13 1.24 56.62 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.207 -0.906 . . . . 74.209999999999994 112.376 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 144.0 -161.7 27.83 Favored Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.314 -0.946 . . . . 74.120000000000005 112.321 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 3.8 p -116.97 155.14 29.65 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.807 -0.812 . . . . 74.239999999999995 108.807 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -65.31 -50.52 58.63 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.306 -0.627 . . . . 72.209999999999994 109.306 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.67 138.91 46.73 Favored 'Trans proline' 0 C--N 1.375 1.966 0 N-CA-C 108.97 -1.204 . . . . 62.329999999999998 108.97 170.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.01 143.64 91.34 Favored 'Trans proline' 0 C--O 1.243 0.725 0 C-N-CA 122.86 2.373 . . . . 74.219999999999999 113.659 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.01 131.53 47.88 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.63 -0.714 . . . . 75.439999999999998 109.745 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.22 -5.39 35.91 Favored Glycine 0 N--CA 1.434 -1.448 0 CA-C-N 115.708 -0.678 . . . . 63.119999999999997 111.465 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 5.9 t -84.97 138.16 32.65 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.233 0.54 . . . . 75.510000000000005 110.714 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 9.2 t -81.56 131.37 35.27 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.158 -1.053 . . . . 72.540000000000006 108.158 174.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.0 m -126.51 154.99 75.24 Favored Pre-proline 0 C--N 1.315 -0.935 0 N-CA-C 108.786 -0.82 . . . . 74.129999999999995 108.786 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -70.18 138.89 37.51 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.635 1.557 . . . . 73.040000000000006 111.29 176.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.437 ' HA ' HG21 ' A' ' 518' ' ' THR . 8.9 p -64.73 -19.08 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 CA-C-O 122.345 1.069 . . . . 75.540000000000006 110.608 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -86.38 -18.35 32.06 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.17 -0.923 . . . . 73.129999999999995 110.768 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 50.4 m -91.98 167.78 11.86 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.362 0.601 . . . . 74.319999999999993 111.968 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 10.7 p -97.22 138.15 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-N 115.096 -0.956 . . . . 75.150000000000006 111.051 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 56.7 mt -97.48 134.19 36.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 107.615 -1.254 . . . . 74.209999999999994 107.615 176.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -103.33 117.34 34.27 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.097 -0.705 . . . . 70.230000000000004 109.097 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.8 mp -104.42 133.13 49.82 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 120.916 0.388 . . . . 74.420000000000002 111.657 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -87.51 108.83 19.22 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 123.558 0.743 . . . . 75.140000000000001 110.853 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 522' ' ' GLN . 32.5 t -95.85 124.3 48.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.468 -0.938 . . . . 72.0 108.468 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.5 ' HB3' ' HB2' ' A' ' 527' ' ' SER . 58.0 m -88.05 133.24 34.02 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 115.972 -0.558 . . . . 71.540000000000006 110.733 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.1 ptpt -115.72 130.96 57.05 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 107.843 -1.169 . . . . 74.329999999999998 107.843 171.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 527' ' ' SER . . . -64.93 -23.75 69.6 Favored Glycine 0 CA--C 1.497 -1.061 0 N-CA-C 110.264 -1.134 . . . . 74.340000000000003 110.264 178.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 53.9 t30 70.22 -5.55 1.31 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.041 1.736 . . . . 73.099999999999994 111.051 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 77.9 mt-30 -113.54 142.72 45.62 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 115.796 -0.638 . . . . 73.450000000000003 110.572 -176.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -123.36 158.21 31.59 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.665 -0.865 . . . . 75.239999999999995 108.665 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.29 118.3 10.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 O-C-N 123.499 0.499 . . . . 64.030000000000001 109.78 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 563' ' ' MET . . . . . 0.548 ' SD ' HG22 ' A' ' 620' ' ' ILE . 35.9 ttp -79.32 136.93 56.26 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 116.219 -0.446 . . . . 73.400000000000006 111.402 -178.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.32 171.24 10.71 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.623 2.882 . . . . 70.409999999999997 111.742 172.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -82.53 129.39 34.91 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 116.529 -0.305 . . . . 75.349999999999994 111.314 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -123.05 16.5 9.99 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.258 1.028 . . . . 75.040000000000006 109.191 176.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 50.8 m -79.03 130.91 36.03 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 114.386 -1.279 . . . . 74.310000000000002 112.363 -175.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 71.12 62.53 3.49 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.45 -0.796 . . . . 55.039999999999999 114.377 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 24.4 ptp -159.86 164.84 33.26 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 109.057 -0.719 . . . . 74.430000000000007 109.057 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -92.88 174.7 7.11 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.835 -0.431 . . . . 72.340000000000003 109.835 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 35.3 t-105 -64.48 -29.64 70.68 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.885 -0.783 . . . . 72.450000000000003 108.885 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 22.1 m -74.96 -6.4 8.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.469 -0.787 . . . . 74.030000000000001 111.214 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -102.21 -44.35 5.45 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.501 -0.925 . . . . 74.519999999999996 108.501 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -64.68 -40.09 94.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.94 -1.027 . . . . 72.010000000000005 113.122 -177.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.694 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 6.0 tm-20 -66.22 -50.81 48.12 Favored Pre-proline 0 CA--C 1.564 1.482 0 N-CA-C 109.943 -0.392 . . . . 74.109999999999999 109.943 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 61.7 Cg_exo -53.12 -34.32 67.99 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 121.584 1.523 . . . . 73.430000000000007 111.646 169.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -60.88 -39.63 89.94 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.433 0.531 . . . . 75.030000000000001 112.433 175.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 3.9 pp -65.98 -44.45 84.85 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 120.184 -0.606 . . . . 75.109999999999999 110.727 -178.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.454 ' N ' HD13 ' A' ' 578' ' ' LEU . 6.6 ptm180 -66.46 -34.58 78.26 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.833 0.349 . . . . 74.230000000000004 111.69 176.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.24 -36.53 74.55 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.161 0.505 . . . . 73.129999999999995 111.35 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.5 tp -87.9 -9.22 54.33 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 123.695 0.798 . . . . 73.129999999999995 110.622 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 66.04 37.51 93.2 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.114 -0.795 . . . . 73.340000000000003 111.114 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -80.73 126.43 31.29 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.409 0.623 . . . . 73.030000000000001 110.172 -176.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 17.0 p -96.67 -18.5 19.65 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 113.313 0.857 . . . . 50.229999999999997 113.313 -174.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -80.36 -156.57 13.23 Favored Glycine 0 C--O 1.24 0.471 0 C-N-CA 121.327 -0.463 . . . . 75.299999999999997 114.115 -176.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 67.2 mtm -128.68 155.32 45.22 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.561 -0.533 . . . . 75.450000000000003 109.561 -176.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.5 tt -106.67 113.71 27.38 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.648 -1.241 . . . . 72.219999999999999 107.648 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 621' ' ' THR . 51.9 m-20 -98.65 110.1 22.75 Favored 'General case' 0 CA--C 1.478 -1.804 0 N-CA-C 109.305 -0.628 . . . . 63.310000000000002 109.305 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.0 OUTLIER -87.55 133.07 33.85 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 118.418 -1.313 . . . . 74.019999999999996 107.633 174.115 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -82.59 -55.67 2.96 Favored Glycine 0 C--N 1.29 -1.976 0 CA-C-N 115.605 -0.725 . . . . 72.340000000000003 112.04 -174.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.85 154.13 47.23 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.569 -0.53 . . . . 72.109999999999999 109.569 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 626' ' ' GLN . 10.5 m-20 -99.54 129.79 45.74 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 105.385 -2.08 . . . . 73.329999999999998 105.385 173.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 16.5 t -103.49 135.78 39.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 107.138 -1.43 . . . . 74.219999999999999 107.138 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.71 121.86 19.61 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 118.219 0.463 . . . . 74.200000000000003 111.083 -169.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -138.3 -56.99 0.65 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.547 -0.751 . . . . 63.539999999999999 110.489 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 100.06 142.31 12.96 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 109.573 -1.411 . . . . 44.43 109.573 -173.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.93 -35.4 83.02 Favored Glycine 0 C--N 1.314 -0.676 0 N-CA-C 113.914 0.326 . . . . 52.109999999999999 113.914 -176.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 9.3 t -71.85 -24.41 61.69 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.284 0.564 . . . . 74.230000000000004 110.329 -176.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -88.19 -0.55 57.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.33 -0.396 . . . . 75.400000000000006 110.734 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 50.8 m80 79.2 84.33 0.06 Allowed 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 125.426 1.49 . . . . 73.319999999999993 110.275 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -81.16 71.98 8.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 123.21 1.481 . . . . 75.329999999999998 111.182 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -115.21 172.32 7.14 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 113.233 -1.803 . . . . 75.430000000000007 110.653 -177.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . 0.428 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 63.2 t -56.54 130.79 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 109.588 -0.523 . . . . 73.140000000000001 109.588 -178.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 26.3 m -110.39 -30.04 2.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.277 -0.874 . . . . 75.310000000000002 111.488 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -156.75 135.71 11.83 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 109.68 -0.489 . . . . 72.409999999999997 109.68 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -116.17 136.24 53.19 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.601 -0.518 . . . . 75.010000000000005 109.601 173.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.406 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 9.5 t30 -56.99 -50.76 86.36 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 123.627 0.579 . . . . 73.310000000000002 111.594 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.46 ' O ' ' HE1' ' A' ' 563' ' ' MET . 57.8 Cg_endo -89.3 112.32 0.56 Allowed 'Trans proline' 0 N--CA 1.43 -2.216 0 N-CA-C 109.361 -1.053 . . . . 75.349999999999994 109.361 169.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.18 161.03 47.48 Favored 'Trans proline' 0 C--O 1.249 1.049 0 C-N-CA 122.709 2.272 . . . . 75.530000000000001 111.132 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -54.89 132.91 47.58 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 122.622 0.369 . . . . 73.409999999999997 110.316 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.64 -6.54 59.0 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.159 -1.019 . . . . 71.150000000000006 112.972 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 37.5 m -86.25 149.54 25.0 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.857 -0.423 . . . . 75.430000000000007 109.857 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.5 123.3 6.07 Favored Glycine 0 N--CA 1.433 -1.562 0 C-N-CA 121.211 -0.519 . . . . 74.120000000000005 112.478 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 35.5 m -116.28 142.31 30.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.716 -0.846 . . . . 74.230000000000004 108.716 176.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -55.74 175.31 0.09 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.922 0.889 . . . . 73.409999999999997 113.287 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -60.99 -27.0 67.98 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.5 -0.318 . . . . 73.219999999999999 111.639 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -82.34 -8.24 59.63 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.171 -0.612 . . . . 75.109999999999999 109.799 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.19 18.75 67.49 Favored Glycine 0 C--O 1.214 -1.131 0 O-C-N 123.302 0.376 . . . . 75.030000000000001 113.105 173.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.68 120.09 17.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 121.739 0.781 . . . . 74.519999999999996 111.396 -167.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.548 HG22 ' SD ' ' A' ' 563' ' ' MET . 50.7 pt -126.88 135.49 63.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 115.026 -0.988 . . . . 71.430000000000007 111.985 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 14.0 t -109.62 128.25 55.09 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.796 -0.816 . . . . 73.019999999999996 108.796 177.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 3.8 pp -139.78 168.08 20.65 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.297 -0.41 . . . . 63.340000000000003 111.631 -176.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -127.6 138.1 52.76 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.435 -0.58 . . . . 75.510000000000005 109.435 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.428 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 22.9 p90 -129.67 165.8 21.09 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 112.53 0.567 . . . . 75.129999999999995 112.53 -175.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -64.85 137.61 39.05 Favored Glycine 0 N--CA 1.423 -2.21 0 CA-C-N 114.886 -1.052 . . . . 72.439999999999998 112.488 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.459 ' HB2' ' HB3' ' A' ' 592' ' ' ASP . 10.3 tt0 . . . . . 0 C--N 1.277 -2.567 0 C-N-CA 125.431 1.492 . . . . 73.430000000000007 107.416 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.805 0 CA-C-O 119.28 -0.733 . . . . 43.049999999999997 111.274 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -76.75 141.66 22.0 Favored 'Trans proline' 0 C--O 1.25 1.082 0 C-N-CA 122.305 2.003 . . . . 74.349999999999994 112.566 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 62.11 7.25 2.08 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.903 1.681 . . . . 74.230000000000004 114.148 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.8 p -147.94 147.29 29.53 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 122.169 -0.332 . . . . 74.439999999999998 111.465 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -143.83 143.69 31.44 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 123.689 0.795 . . . . 74.329999999999998 109.443 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.8 p-10 -91.13 139.48 30.72 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.825 -0.806 . . . . 74.549999999999997 108.825 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.5 pt -97.65 132.17 25.6 Favored Pre-proline 0 C--N 1.293 -1.861 0 CA-C-N 115.463 -0.79 . . . . 75.319999999999993 111.9 -176.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -83.96 175.85 7.29 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.22 1.947 . . . . 60.229999999999997 110.187 173.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -86.55 127.09 34.86 Favored 'General case' 0 CA--C 1.489 -1.376 0 CA-C-O 122.047 0.927 . . . . 74.099999999999994 109.909 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 16.2 m -113.85 59.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 CA-C-O 122.827 1.298 . . . . 74.099999999999994 109.481 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -112.57 105.77 14.05 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 113.61 -1.632 . . . . 74.25 109.648 174.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 141.97 -17.03 2.57 Favored Glycine 0 C--N 1.313 -0.705 0 C-N-CA 118.472 -1.823 . . . . 73.329999999999998 114.61 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.428 ' O ' HG11 ' A' ' 534' ' ' VAL . 0.1 OUTLIER -112.72 -175.27 2.63 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.041 -0.726 . . . . 73.040000000000006 109.041 177.686 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 2.8 m -74.66 155.44 37.76 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 107.973 -1.121 . . . . 74.530000000000001 107.973 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.529 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 8.3 p -62.82 -42.13 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 121.123 -0.231 . . . . 74.409999999999997 111.48 -178.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.25 -34.41 78.28 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 110.06 -0.348 . . . . 75.409999999999997 110.06 -178.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 59.0 t -71.9 -44.32 67.41 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.966 0 N-CA-C 109.351 -0.611 . . . . 74.439999999999998 109.351 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -58.58 -43.68 89.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.78 0.324 . . . . 73.349999999999994 110.83 177.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.3 mt-30 -62.75 -44.24 96.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.722 -0.672 . . . . 74.319999999999993 110.445 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.505 ' O ' HG21 ' A' ' 514' ' ' VAL . 71.8 mmtt -65.86 -42.61 90.18 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.924 -0.58 . . . . 71.420000000000002 111.129 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -62.86 -47.23 84.25 Favored 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 124.06 0.85 . . . . 72.209999999999994 111.237 -176.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -68.41 -35.31 77.46 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 115.689 -0.687 . . . . 75.030000000000001 110.6 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.442 ' N ' HD12 ' A' ' 512' ' ' LEU . 4.0 t-20 -63.87 -34.0 76.95 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 115.171 -0.922 . . . . 74.519999999999996 111.431 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.505 HG21 ' O ' ' A' ' 510' ' ' LYS . 84.0 t -57.22 -32.53 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 121.164 0.507 . . . . 75.099999999999994 110.731 177.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -107.85 4.77 25.81 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.489 -0.93 . . . . 70.549999999999997 108.489 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -126.96 -60.18 0.14 Allowed Glycine 0 N--CA 1.416 -2.666 0 C-N-CA 119.547 -1.311 . . . . 75.420000000000002 114.577 -169.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 64.8 25.12 12.89 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 122.561 1.172 . . . . 70.409999999999997 108.224 -171.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.6 p -82.87 -172.88 4.36 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 113.271 -1.786 . . . . 74.319999999999993 111.007 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.477 ' HD2' ' N ' ' A' ' 519' ' ' LYS . 0.1 OUTLIER -108.71 136.56 48.1 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.537 -1.282 . . . . 74.450000000000003 107.537 179.461 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -132.26 147.22 52.4 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.121 0.486 . . . . 74.329999999999998 111.699 -177.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 64.5 m -140.74 149.24 41.89 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.637 -0.875 . . . . 71.420000000000002 108.637 176.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -117.9 140.55 49.56 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 116.255 -0.429 . . . . 63.509999999999998 110.326 -176.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -132.23 130.51 41.06 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.421 -0.955 . . . . 43.210000000000001 108.421 176.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 27.0 m -88.61 126.78 35.45 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 120.933 0.397 . . . . 73.209999999999994 111.522 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.77 150.68 25.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.216 -1.031 . . . . 73.430000000000007 108.216 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -66.91 135.02 53.2 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.453 -0.573 . . . . 64.099999999999994 109.453 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 33.4 m -154.17 165.94 16.9 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 107.935 -1.135 . . . . 73.030000000000001 107.935 -177.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -83.42 -18.47 5.87 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 120.979 1.119 . . . . 73.310000000000002 111.394 172.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.428 HH21 ' CD ' ' A' ' 533' ' ' GLU . 25.1 mtp180 -79.17 145.72 65.52 Favored Pre-proline 0 N--CA 1.437 -1.086 0 C-N-CA 124.697 1.199 . . . . 72.219999999999999 109.668 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.5 146.3 97.15 Favored 'Trans proline' 0 C--O 1.25 1.087 0 C-N-CA 123.638 2.892 . . . . 73.519999999999996 115.056 -170.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.653 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.91 105.31 0.55 Allowed 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.859 -1.064 . . . . 75.230000000000004 112.012 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 142.51 -26.22 2.28 Favored Glycine 0 C--N 1.308 -1.011 0 N-CA-C 110.656 -0.977 . . . . 74.010000000000005 110.656 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . 0.428 ' CD ' HH21 ' A' ' 529' ' ' ARG . 43.9 tt0 -80.35 136.48 36.4 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 121.227 0.536 . . . . 74.340000000000003 110.182 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 8.0 p -98.27 124.78 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.66 0 CA-C-N 115.491 -0.777 . . . . 73.010000000000005 109.104 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.43 8.95 40.28 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.827 -1.079 . . . . 75.120000000000005 113.465 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 127.82 -163.57 21.45 Favored Glycine 0 C--N 1.298 -1.57 0 C-N-CA 120.288 -0.958 . . . . 73.420000000000002 112.703 174.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 28.1 p -116.69 158.94 22.99 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.504 -0.925 . . . . 72.340000000000003 108.504 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -59.87 -57.08 29.46 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 120.134 -0.626 . . . . 71.530000000000001 110.352 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -68.81 144.68 60.09 Favored 'Trans proline' 0 C--N 1.376 1.984 0 CA-C-N 120.26 1.128 . . . . 75.5 110.72 173.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.7 157.64 60.87 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 123.063 2.508 . . . . 73.019999999999996 113.506 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.22 130.74 46.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.517 -0.765 . . . . 74.409999999999997 110.765 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.82 -12.79 41.89 Favored Glycine 0 C--N 1.303 -1.299 0 CA-C-N 116.025 -0.534 . . . . 72.340000000000003 112.236 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 45.8 m -73.83 125.72 28.79 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 110.174 -0.306 . . . . 74.519999999999996 110.174 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 11.7 t -81.39 124.36 29.34 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.38 -0.97 . . . . 65.25 108.38 176.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.2 m -123.95 159.26 57.18 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 107.903 -1.147 . . . . 75.239999999999995 107.903 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -66.69 137.66 46.59 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 120.723 0.948 . . . . 75.439999999999998 111.191 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.5 p -63.24 -23.61 33.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.233 -0.894 . . . . 72.409999999999997 112.104 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -101.7 3.17 39.42 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.744 -0.782 . . . . 72.510000000000005 110.194 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 9.9 t -95.86 -178.62 4.43 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 108.619 -0.882 . . . . 73.239999999999995 108.619 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.2 p -103.24 137.24 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 CA-C-O 121.635 0.731 . . . . 74.340000000000003 111.639 -174.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.37 128.24 50.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 106.647 -1.612 . . . . 74.439999999999998 106.647 175.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -103.4 117.5 34.62 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.613 0.72 . . . . 73.150000000000006 112.08 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.7 mp -102.04 130.65 48.66 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.368 -1.287 . . . . 74.030000000000001 110.17 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -93.58 115.85 28.35 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.752 0.787 . . . . 73.340000000000003 112.135 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 40.1 t -88.41 129.77 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 107.281 -1.378 . . . . 65.5 107.281 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.653 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 2.2 m -84.06 117.74 23.62 Favored 'General case' 0 C--N 1.271 -2.813 0 N-CA-C 108.498 -0.927 . . . . 73.319999999999993 108.498 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -94.32 125.75 39.16 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.77 -1.567 . . . . 74.219999999999999 106.77 171.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -61.85 -23.4 63.37 Favored Glycine 0 C--N 1.308 -1.011 0 N-CA-C 115.014 0.766 . . . . 73.400000000000006 115.014 -173.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 78.08 -20.3 0.39 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.87 1.268 . . . . 74.230000000000004 108.532 -175.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.497 ' H ' ' C ' ' A' ' 558' ' ' GLY . 78.3 mt-30 -112.78 148.17 35.36 Favored 'General case' 0 N--CA 1.403 -2.784 0 CA-C-N 115.376 -0.829 . . . . 75.129999999999995 111.012 -174.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -123.84 154.9 38.96 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 106.205 -1.776 . . . . 71.439999999999998 106.205 175.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 44.2 t -71.96 126.97 33.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 109.314 -0.624 . . . . 71.340000000000003 109.314 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 51.9 ttp -84.24 127.53 66.0 Favored Pre-proline 0 C--O 1.251 1.153 0 CA-C-N 116.28 -0.418 . . . . 72.030000000000001 110.19 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.73 169.53 19.92 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.707 2.271 . . . . 65.239999999999995 111.101 175.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -72.53 142.13 48.49 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.381 0.61 . . . . 71.239999999999995 111.321 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.8 pp -154.87 25.9 0.44 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.599 -1.182 . . . . 73.230000000000004 109.624 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 21.7 m -79.58 146.81 32.38 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.101 -0.954 . . . . 71.450000000000003 110.372 -177.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 63.72 53.79 35.7 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.116 -0.564 . . . . 71.239999999999995 113.098 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -130.04 173.07 11.08 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.19 -1.041 . . . . 72.409999999999997 108.19 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -108.4 172.29 6.92 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.808 -1.182 . . . . 74.219999999999999 107.808 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . 0.47 ' CZ3' HD21 ' A' ' 587' ' ' LEU . 12.8 t-105 -65.93 -32.27 73.68 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.452 -0.944 . . . . 72.420000000000002 108.452 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.59 -15.1 18.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.537 -0.756 . . . . 73.530000000000001 111.238 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.544 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 25.9 t70 -101.07 -21.56 14.96 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.608 -0.886 . . . . 63.520000000000003 108.608 177.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -68.24 -39.18 82.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.189 -0.914 . . . . 73.25 111.92 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.634 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 2.7 tm-20 -58.77 -52.31 75.66 Favored Pre-proline 0 CA--C 1.57 1.742 0 N-CA-C 109.283 -0.636 . . . . 75.439999999999998 109.283 177.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 75.1 Cg_exo -55.23 -40.66 84.55 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 121.271 1.314 . . . . 72.349999999999994 112.486 171.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 16.7 mmt180 -61.62 -38.21 86.81 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 111.906 0.336 . . . . 74.310000000000002 111.906 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.1 pp -66.5 -47.13 73.99 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.969 -0.692 . . . . 72.430000000000007 110.964 -176.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.471 ' N ' HD12 ' A' ' 578' ' ' LEU . 14.7 ptm180 -66.12 -34.85 78.99 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.528 -0.305 . . . . 75.510000000000005 110.696 176.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.31 -39.52 92.59 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.823 -0.626 . . . . 54.530000000000001 111.284 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 1.1 pp -92.51 -8.73 43.67 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.01 -0.676 . . . . 75.530000000000001 110.963 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 76.83 42.91 19.4 Favored Glycine 0 CA--C 1.517 0.165 0 N-CA-C 111.53 -0.628 . . . . 72.25 111.53 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -87.22 127.56 35.16 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 123.276 0.63 . . . . 75.400000000000006 110.145 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 5.8 m -103.99 -21.3 13.63 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.064 0.459 . . . . 73.040000000000006 111.557 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -72.56 177.97 39.7 Favored Glycine 0 C--O 1.241 0.567 0 CA-C-O 121.598 0.555 . . . . 73.109999999999999 114.472 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 586' ' ' MET . . . . . 0.423 ' O ' HG12 ' A' ' 619' ' ' ILE . 55.7 ttp -95.54 145.6 25.09 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 123.597 0.759 . . . . 61.43 110.654 -177.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . 0.47 HD21 ' CZ3' ' A' ' 571' ' ' TRP . 5.4 tt -85.64 112.44 21.01 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.438 -0.949 . . . . 73.420000000000002 108.438 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 621' ' ' THR . 25.4 t70 -101.83 105.26 16.08 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.686 0.755 . . . . 75.150000000000006 110.324 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.48 133.87 34.75 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 115.033 -0.985 . . . . 74.239999999999995 108.561 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -73.35 -63.35 2.8 Favored Glycine 0 C--N 1.288 -2.106 0 N-CA-C 110.792 -0.923 . . . . 74.209999999999994 110.792 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.16 151.3 45.15 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.462 -0.369 . . . . 65.430000000000007 111.032 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -115.6 123.49 48.57 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 104.41 -2.441 . . . . 71.040000000000006 104.41 168.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 50.7 t -112.64 120.69 63.37 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 CA-C-N 116.007 -0.542 . . . . 74.239999999999995 109.579 -174.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . 0.413 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 21.9 t70 -76.35 106.7 8.12 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 106.385 -1.709 . . . . 74.310000000000002 106.385 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -134.83 8.0 3.51 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.607 -0.437 . . . . 64.340000000000003 111.75 -175.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 117.28 95.68 1.84 Allowed Glycine 0 N--CA 1.422 -2.241 0 C-N-CA 120.194 -1.003 . . . . 74.340000000000003 111.7 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.25 -31.29 59.24 Favored Glycine 0 C--N 1.32 -0.348 0 N-CA-C 111.951 -0.46 . . . . 61.32 111.951 177.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 46.4 t -59.4 -24.6 63.6 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.185 0.994 . . . . 65.310000000000002 110.669 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -87.33 -4.22 59.05 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.568 -0.742 . . . . 74.540000000000006 111.169 -175.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 39.6 m80 63.7 94.06 0.05 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 122.102 0.953 . . . . 71.219999999999999 111.051 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . 0.494 HD21 ' N ' ' A' ' 601' ' ' ASN . 0.8 OUTLIER -85.28 87.86 7.43 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.967 0.889 . . . . 72.239999999999995 112.215 -173.249 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -90.82 169.93 10.52 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.045 -1.434 . . . . 62.210000000000001 108.996 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 85.1 t -60.45 129.83 23.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.007 -0.738 . . . . 75.019999999999996 109.007 176.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 11.7 p -112.79 -35.75 2.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 O-C-N 123.645 0.591 . . . . 73.439999999999998 111.041 -175.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -136.58 139.62 42.28 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.306 -0.406 . . . . 64.25 110.082 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -137.75 139.2 39.97 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.295 -1.372 . . . . 71.129999999999995 107.295 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -65.7 -52.81 40.54 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 113.125 0.787 . . . . 73.239999999999995 113.125 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -85.92 125.19 2.69 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 CA-C-N 120.424 1.187 . . . . 74.239999999999995 110.941 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.88 158.99 53.98 Favored 'Trans proline' 0 C--O 1.244 0.823 0 C-N-CA 122.382 2.055 . . . . 72.040000000000006 112.81 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.58 130.79 44.14 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 108.488 -0.93 . . . . 70.310000000000002 108.488 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 98.18 0.01 58.6 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 120.222 -0.989 . . . . 65.409999999999997 112.084 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 35.6 m -102.17 154.52 18.94 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.421 -0.955 . . . . 75.5 108.421 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.45 133.2 12.15 Favored Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 120.914 -0.66 . . . . 54.039999999999999 111.792 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.5 m -117.38 142.36 31.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.922 -0.77 . . . . 71.409999999999997 108.922 176.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.404 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 34.2 p30 -47.55 166.35 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 114.112 1.153 . . . . 72.049999999999997 114.112 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -61.35 -26.03 67.55 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.303 -0.862 . . . . 74.519999999999996 112.626 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -83.46 -10.89 58.08 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 119.037 -1.065 . . . . 73.209999999999994 109.481 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.73 9.77 56.73 Favored Glycine 0 CA--C 1.499 -0.946 0 N-CA-C 111.293 -0.723 . . . . 75.049999999999997 111.293 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 586' ' ' MET . 0.0 OUTLIER -70.45 118.83 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.167 0 CA-C-O 122.212 1.006 . . . . 73.129999999999995 108.615 -171.041 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.428 ' O ' HD13 ' A' ' 620' ' ' ILE . 2.7 pp -121.11 132.6 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.872 0 CA-C-N 114.02 -1.445 . . . . 75.010000000000005 110.251 -177.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 15.3 t -104.93 119.35 38.79 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.57 -0.9 . . . . 70.129999999999995 108.57 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -139.49 165.88 26.05 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.4 -0.818 . . . . 74.439999999999998 110.813 -175.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -128.82 142.32 51.01 Favored 'General case' 0 C--O 1.257 1.469 0 CA-C-O 121.279 0.561 . . . . 74.340000000000003 110.458 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -142.0 166.75 23.87 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.186 -1.413 . . . . 72.120000000000005 107.186 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -79.31 -142.94 2.55 Favored Glycine 0 C--N 1.294 -1.785 0 C-N-CA 119.107 -1.52 . . . . 64.340000000000003 113.096 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.413 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 6.5 tp-100 . . . . . 0 C--N 1.279 -2.488 0 N-CA-C 109.294 -0.632 . . . . 63.119999999999997 109.294 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.591 0 N-CA-C 110.965 -0.854 . . . . 61.219999999999999 110.965 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -76.75 161.09 33.95 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 122.661 2.24 . . . . 73.340000000000003 110.269 174.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 59.75 21.78 10.59 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.015 0.926 . . . . 73.329999999999998 112.661 176.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.0 p -139.21 143.43 38.06 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.675 -0.491 . . . . 75.400000000000006 109.675 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -131.81 143.47 50.22 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 121.197 0.523 . . . . 74.340000000000003 110.546 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 2.3 m-20 -88.32 121.85 31.18 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.897 -1.047 . . . . 72.209999999999994 109.817 -177.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.0 pt -86.62 122.56 71.7 Favored Pre-proline 0 C--N 1.302 -1.465 0 CA-C-N 116.318 -0.401 . . . . 71.310000000000002 110.637 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -85.86 -169.57 0.6 Allowed 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.294 1.996 . . . . 73.420000000000002 110.593 177.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -89.5 129.81 35.93 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.569 -0.9 . . . . 75.0 108.569 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.414 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 27.8 m -121.77 7.84 5.85 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 CA-C-N 115.208 -0.905 . . . . 74.209999999999994 109.969 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.97 103.78 4.59 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.397 -0.82 . . . . 74.129999999999995 110.119 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 161.98 -41.39 0.38 Allowed Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 115.517 -0.765 . . . . 73.329999999999998 111.195 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 14.3 pm0 -93.94 -177.51 4.36 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 108.984 -0.747 . . . . 71.540000000000006 108.984 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 7.8 m -70.56 155.4 40.77 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 108.467 -0.938 . . . . 74.25 108.467 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.474 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 11.5 p -64.87 -42.05 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 O-C-N 123.122 0.264 . . . . 74.530000000000001 110.717 -177.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -62.2 -40.72 97.04 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 109.866 -0.42 . . . . 72.519999999999996 109.866 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 84.4 t -66.14 -47.28 85.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.894 0 CA-C-N 115.271 -0.877 . . . . 74.319999999999993 109.333 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.414 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -60.9 -45.15 95.76 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 111.828 0.307 . . . . 72.439999999999998 111.828 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.5 mt-30 -64.88 -46.76 80.42 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 116.038 -0.528 . . . . 75.420000000000002 111.232 -177.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.506 ' O ' HG23 ' A' ' 514' ' ' VAL . 21.5 ptmt -67.49 -38.84 84.95 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 116.208 -0.451 . . . . 74.209999999999994 110.645 -178.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -62.87 -42.32 99.72 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.186 0.517 . . . . 72.299999999999997 111.15 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -68.71 -41.97 78.34 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.337 -0.847 . . . . 64.25 108.74 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -59.38 -40.84 87.82 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.644 1.178 . . . . 73.209999999999994 111.734 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 510' ' ' LYS . 91.6 t -57.58 -33.18 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 121.173 0.511 . . . . 74.209999999999994 111.507 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -114.84 16.42 17.3 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.621 -0.511 . . . . 74.409999999999997 109.621 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -133.94 -58.46 0.07 OUTLIER Glycine 0 N--CA 1.428 -1.879 0 C-N-CA 119.64 -1.267 . . . . 55.530000000000001 113.618 -173.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 64.07 28.2 14.22 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 122.629 1.204 . . . . 74.450000000000003 111.013 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.2 p -79.61 171.99 14.4 Favored 'General case' 0 N--CA 1.396 -3.137 0 CA-C-N 113.643 -1.617 . . . . 74.409999999999997 108.17 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.523 ' N ' ' HD2' ' A' ' 519' ' ' LYS . 10.2 mptt -107.56 136.06 47.96 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 107.549 -1.278 . . . . 74.409999999999997 107.549 -176.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -133.51 149.24 51.71 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.026 0.441 . . . . 75.310000000000002 112.145 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.7 m -138.73 142.93 38.88 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.076 -1.453 . . . . 75.019999999999996 107.076 174.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -117.54 137.75 52.36 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.62 -0.432 . . . . 75.019999999999996 111.094 -176.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -122.62 119.73 31.64 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.63 -0.878 . . . . 64.219999999999999 108.63 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 12.8 m -96.36 120.34 36.48 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.097 0.475 . . . . 74.109999999999999 111.17 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.7 p -123.82 155.31 30.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.448 -1.316 . . . . 75.400000000000006 107.448 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -75.78 136.42 40.27 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.496 0.665 . . . . 72.510000000000005 111.745 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 64.9 m -160.45 159.69 26.06 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 107.047 -1.464 . . . . 72.25 107.047 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -65.58 -9.77 23.82 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 C-N-CA 122.788 2.326 . . . . 74.219999999999999 113.561 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.436 ' HB2' ' CB ' ' A' ' 556' ' ' SER . 14.7 mmm180 -78.36 141.94 62.21 Favored Pre-proline 0 N--CA 1.436 -1.15 0 N-CA-C 107.27 -1.382 . . . . 72.549999999999997 107.27 176.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -64.43 152.2 82.5 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 122.862 2.374 . . . . 73.140000000000001 113.958 -173.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.643 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.91 111.15 1.19 Allowed 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.815 -0.629 . . . . 63.539999999999999 111.963 -178.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 123.85 -16.17 7.83 Favored Glycine 0 C--N 1.299 -1.491 0 CA-C-N 115.283 -0.871 . . . . 53.25 112.121 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.16 138.36 34.74 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.535 -0.542 . . . . 64.150000000000006 109.535 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 6.1 p -87.16 116.84 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 CA-C-O 122.136 0.969 . . . . 74.0 109.48 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.97 -27.31 60.93 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 113.976 -1.466 . . . . 74.219999999999999 109.884 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.51 -162.31 29.54 Favored Glycine 0 N--CA 1.416 -2.651 0 N-CA-C 110.583 -1.007 . . . . 73.450000000000003 110.583 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 5.3 p -117.03 157.7 25.39 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 109.481 -0.563 . . . . 72.420000000000002 109.481 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -63.94 -54.14 43.21 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 120.766 -0.374 . . . . 72.450000000000003 110.2 174.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -69.32 134.4 28.81 Favored 'Trans proline' 0 C--N 1.369 1.617 0 N-CA-C 108.679 -1.316 . . . . 74.109999999999999 108.679 170.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.57 155.96 50.12 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 122.437 2.091 . . . . 75.0 112.93 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.4 131.21 45.86 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.964 -0.562 . . . . 75.049999999999997 109.718 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.84 -7.44 38.52 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 111.459 -0.656 . . . . 73.140000000000001 111.459 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 30.1 m -80.9 137.25 36.15 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.842 -0.429 . . . . 73.420000000000002 109.842 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 5.6 t -92.04 128.32 37.84 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 107.819 -1.178 . . . . 74.200000000000003 107.819 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 29.5 m -123.95 154.85 67.83 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.74 -0.837 . . . . 73.230000000000004 108.74 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -65.56 137.94 52.46 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 121.054 1.169 . . . . 74.409999999999997 111.269 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.6 -19.76 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-O 122.219 1.009 . . . . 74.439999999999998 109.691 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -84.76 -16.05 42.91 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.148 -1.387 . . . . 71.219999999999999 110.747 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 22.8 t -94.45 -173.29 3.01 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-N 115.869 -0.605 . . . . 71.200000000000003 110.737 -175.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.2 p -118.95 138.15 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 C-N-CA 123.6 0.76 . . . . 75.129999999999995 111.207 -175.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 43.8 mt -95.0 143.9 10.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.509 -0.922 . . . . 63.439999999999998 108.509 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -103.8 117.06 33.46 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.43 -0.952 . . . . 73.450000000000003 108.43 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.95 120.6 41.86 Favored 'General case' 0 C--N 1.311 -1.071 0 O-C-N 123.735 0.647 . . . . 73.430000000000007 110.083 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -90.74 120.96 32.22 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.215 0.531 . . . . 72.150000000000006 109.991 176.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 23.9 t -105.59 137.22 36.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.216 -1.031 . . . . 74.310000000000002 108.216 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.643 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 71.2 m -89.89 133.15 34.92 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-O 120.756 0.312 . . . . 75.109999999999999 110.362 176.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 18.8 ptpt -106.1 127.18 53.01 Favored 'General case' 0 N--CA 1.406 -2.638 0 N-CA-C 104.317 -2.475 . . . . 72.239999999999995 104.317 164.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -55.42 -23.66 35.39 Favored Glycine 0 CA--C 1.506 -0.511 0 O-C-N 124.062 0.851 . . . . 75.549999999999997 114.128 -173.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 81.77 -19.13 0.44 Allowed 'General case' 0 CA--C 1.495 -1.161 0 C-N-CA 126.236 1.815 . . . . 72.430000000000007 108.903 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 85.2 mt-30 -111.83 144.91 40.36 Favored 'General case' 0 N--CA 1.407 -2.59 0 CA-C-N 115.259 -0.882 . . . . 73.209999999999994 110.528 -173.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -123.29 146.67 47.71 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 107.535 -1.284 . . . . 64.549999999999997 107.535 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 84.5 t -62.33 116.63 2.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 123.66 0.6 . . . . 74.310000000000002 109.825 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 56.3 ttp -77.59 126.63 84.24 Favored Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 116.387 -0.37 . . . . 63.439999999999998 110.686 -176.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.45 168.49 21.01 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.5 2.133 . . . . 64.109999999999999 110.95 175.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -77.66 132.13 38.07 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 113.122 0.786 . . . . 74.349999999999994 113.122 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.0 pp -140.49 16.21 2.37 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.384 -1.28 . . . . 74.439999999999998 110.07 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 71.3 p -73.89 148.3 42.41 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 116.151 -0.477 . . . . 73.040000000000006 112.227 -175.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 72.97 57.28 5.35 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 115.689 -0.687 . . . . 62.25 113.987 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -136.93 167.93 20.54 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.115 -0.698 . . . . 74.230000000000004 109.115 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -95.5 165.76 12.19 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.387 -1.338 . . . . 75.5 107.387 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -67.21 -29.04 68.6 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.356 -0.609 . . . . 71.239999999999995 109.356 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.2 p -71.78 -22.81 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.558 0.694 . . . . 73.430000000000007 109.982 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -95.97 -34.29 11.84 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.039 -0.982 . . . . 55.240000000000002 108.936 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -54.7 -53.11 59.24 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 114.973 -1.012 . . . . 73.109999999999999 112.635 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -53.82 -54.95 40.91 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 115.122 1.527 . . . . 71.439999999999998 115.122 -176.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.83 -28.11 81.17 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.413 1.409 . . . . 53.409999999999997 111.446 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -67.98 -35.12 77.82 Favored 'General case' 0 C--O 1.198 -1.646 0 CA-C-O 118.999 -0.524 . . . . 71.340000000000003 111.847 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.578 HD23 ' CZ3' ' A' ' 583' ' ' TRP . 16.6 mt -60.25 -48.95 79.55 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.406 -0.59 . . . . 73.129999999999995 109.406 -176.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -66.5 -40.82 89.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.764 -0.653 . . . . 72.230000000000004 111.492 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.76 65.43 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.132 0.492 . . . . 74.239999999999995 111.762 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.7 tp -91.87 -9.11 44.49 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 124.33 1.052 . . . . 70.319999999999993 110.022 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.65 22.35 77.31 Favored Glycine 0 C--N 1.315 -0.588 0 C-N-CA 121.112 -0.566 . . . . 53.229999999999997 112.55 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . 0.578 ' CZ3' HD23 ' A' ' 578' ' ' LEU . 16.7 t90 -87.48 127.31 35.23 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.053 -0.721 . . . . 74.120000000000005 109.053 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 14.8 p -100.11 -14.49 18.55 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 113.877 1.066 . . . . 75.540000000000006 113.877 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -80.11 -159.29 18.73 Favored Glycine 0 C--N 1.313 -0.711 0 N-CA-C 114.321 0.488 . . . . 73.319999999999993 114.321 -175.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 65.7 mtt -114.41 139.5 49.45 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.868 0.366 . . . . 71.340000000000003 111.383 -174.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 21.5 tp -80.71 101.88 9.56 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 106.709 -1.589 . . . . 61.030000000000001 106.709 177.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -98.99 117.45 33.54 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.872 -0.331 . . . . 75.219999999999999 111.036 -173.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.0 OUTLIER -91.19 133.44 35.37 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 119.587 -0.845 . . . . 70.409999999999997 110.503 -179.102 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -74.34 -72.99 0.96 Allowed Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 110.798 -0.921 . . . . 42.329999999999998 110.798 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.16 142.28 35.97 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.715 -0.846 . . . . 75.349999999999994 108.715 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -79.88 123.58 27.89 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 107.079 -1.452 . . . . 74.549999999999997 107.079 174.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 50.4 t -104.68 128.28 58.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.398 -1.334 . . . . 75.519999999999996 107.398 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -72.01 114.04 9.68 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.768 -0.827 . . . . 63.140000000000001 108.768 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -124.53 -44.29 1.99 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.918 -1.037 . . . . 70.129999999999995 111.0 -173.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 109.08 122.52 4.62 Favored Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.561 -0.828 . . . . 61.299999999999997 112.111 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -61.22 -33.63 85.04 Favored Glycine 0 C--N 1.316 -0.548 0 CA-C-N 116.001 -0.1 . . . . 72.310000000000002 113.057 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 22.8 t -70.59 -22.85 62.51 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.94 0.876 . . . . 60.340000000000003 110.377 -177.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -87.12 -1.3 57.79 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.304 -0.862 . . . . 72.140000000000001 108.935 -175.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 69.77 82.63 0.16 Allowed 'General case' 0 CA--C 1.492 -1.274 0 C-N-CA 124.59 1.156 . . . . 73.420000000000002 108.611 -173.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -79.43 79.63 5.87 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 114.16 -1.382 . . . . 75.230000000000004 111.549 -176.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -87.68 173.23 9.15 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.746 -1.57 . . . . 75.120000000000005 108.234 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 624' ' ' PHE . 91.1 t -58.68 130.4 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.322 -1.733 . . . . 74.120000000000005 106.322 168.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.2 m -101.57 -29.92 3.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 120.703 -0.399 . . . . 71.150000000000006 111.687 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -155.78 144.55 20.42 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 109.824 -0.436 . . . . 74.0 109.824 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -135.04 140.73 45.82 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.977 -1.49 . . . . 73.129999999999995 106.977 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.404 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 27.4 t-20 -66.32 -54.82 22.78 Favored Pre-proline 0 C--N 1.312 -1.046 0 C-N-CA 119.647 -0.821 . . . . 75.439999999999998 112.314 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.3 Cg_exo -84.8 119.16 2.17 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 121.996 1.797 . . . . 74.319999999999993 111.388 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.14 160.77 48.1 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 123.048 2.498 . . . . 64.209999999999994 112.252 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.07 134.94 51.46 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.657 -0.868 . . . . 62.409999999999997 108.657 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.32 -15.09 47.11 Favored Glycine 0 C--N 1.293 -1.81 0 N-CA-C 110.948 -0.861 . . . . 63.340000000000003 110.948 -175.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 37.3 m -92.61 146.77 23.41 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.042 -1.096 . . . . 74.310000000000002 108.042 178.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -78.2 130.92 10.47 Favored Glycine 0 N--CA 1.426 -1.995 0 C-N-CA 121.163 -0.541 . . . . 70.439999999999998 112.427 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 26.8 m -114.69 142.12 28.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.829 -1.174 . . . . 73.420000000000002 107.829 176.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.412 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.9 p-10 -50.92 172.85 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.149 0.98 . . . . 72.109999999999999 113.397 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -54.71 -27.14 38.46 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 113.811 1.041 . . . . 74.409999999999997 113.811 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.419 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 1.2 m-20 -94.77 -6.5 42.89 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.17 -0.612 . . . . 74.120000000000005 110.645 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.49 19.19 68.59 Favored Glycine 0 C--O 1.214 -1.118 0 CA-C-O 119.806 -0.441 . . . . 71.140000000000001 113.35 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.72 119.15 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 122.083 0.944 . . . . 74.25 110.835 -167.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 48.7 pt -125.54 134.98 65.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.89 -1.05 . . . . 63.210000000000001 110.909 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 15.1 t -100.31 125.37 46.52 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 108.461 -0.94 . . . . 73.340000000000003 108.461 177.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 1.8 pt? -139.32 165.27 27.63 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.285 -0.87 . . . . 74.319999999999993 110.288 -175.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -128.81 140.06 51.88 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.64 -0.504 . . . . 71.430000000000007 109.64 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 603' ' ' VAL . 5.2 p90 -130.97 165.16 23.76 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.862 0.363 . . . . 72.129999999999995 111.452 -174.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -76.96 141.89 26.82 Favored Glycine 0 N--CA 1.415 -2.762 0 CA-C-N 114.955 -1.021 . . . . 64.109999999999999 113.604 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 . . . . . 0 C--N 1.272 -2.798 0 N-CA-C 106.98 -1.489 . . . . 72.310000000000002 106.98 178.66 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.431 0 N-CA-C 109.973 -1.251 . . . . 72.420000000000002 109.973 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -68.2 142.09 54.43 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 122.164 1.909 . . . . 75.040000000000006 110.719 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 61.24 21.68 12.12 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.039 0.936 . . . . 72.299999999999997 112.449 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 29.5 p -139.84 145.46 38.14 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.572 -0.529 . . . . 73.540000000000006 109.572 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -128.51 137.04 51.57 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 123.396 0.435 . . . . 75.439999999999998 110.305 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.9 p-10 -84.87 124.79 32.02 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.474 0.654 . . . . 54.43 110.099 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.3 pt -84.89 125.35 71.02 Favored Pre-proline 0 C--N 1.305 -1.357 0 CA-C-N 115.673 -0.694 . . . . 72.230000000000004 111.735 -176.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -74.44 172.65 15.7 Favored 'Trans proline' 0 C--O 1.254 1.28 0 C-N-CA 122.449 2.099 . . . . 62.340000000000003 111.124 174.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -80.25 105.44 11.52 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.989 -0.55 . . . . 73.319999999999993 109.616 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 15.4 m -106.87 59.3 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-O 123.24 1.495 . . . . 75.329999999999998 110.308 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -118.0 111.49 19.01 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 112.658 -2.064 . . . . 64.310000000000002 108.127 173.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 136.22 -15.85 3.93 Favored Glycine 0 C--N 1.303 -1.289 0 C-N-CA 119.042 -1.551 . . . . 62.140000000000001 113.937 177.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.451 ' O ' HG13 ' A' ' 534' ' ' VAL . 0.4 OUTLIER -111.39 -175.46 2.71 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 117.695 0.748 . . . . 74.319999999999993 109.231 176.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 10.6 m -71.67 155.0 40.99 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.542 -0.91 . . . . 72.519999999999996 108.542 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.433 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.7 p -61.64 -42.48 94.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 111.508 0.188 . . . . 74.349999999999994 111.508 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 25.7 t70 -62.51 -41.63 98.96 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.965 -0.383 . . . . 73.239999999999995 109.965 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 68.0 t -67.46 -41.66 86.3 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.966 0 CA-C-N 115.64 -0.709 . . . . 72.129999999999995 109.476 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.495 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -61.97 -43.51 98.69 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 121.365 -0.134 . . . . 72.340000000000003 111.146 176.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 26.3 mt-30 -64.85 -43.13 94.0 Favored 'General case' 0 CA--C 1.511 -0.539 0 O-C-N 123.089 0.243 . . . . 71.420000000000002 110.811 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.55 ' O ' HG21 ' A' ' 514' ' ' VAL . 75.9 mmtt -63.77 -46.6 84.52 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.586 -0.524 . . . . 64.409999999999997 109.586 176.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -63.57 -38.63 91.84 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.733 -0.667 . . . . 73.349999999999994 111.715 -177.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.71 -45.29 83.31 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.552 -1.277 . . . . 71.409999999999997 107.552 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -59.77 -36.1 75.97 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 124.03 0.932 . . . . 75.030000000000001 110.947 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.55 HG21 ' O ' ' A' ' 510' ' ' LYS . 83.5 t -57.2 -39.5 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 122.875 0.47 . . . . 60.100000000000001 111.317 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -105.0 -8.32 18.63 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.584 0.707 . . . . 73.25 110.012 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -108.43 -59.6 0.54 Allowed Glycine 0 N--CA 1.414 -2.802 0 CA-C-N 115.574 -0.739 . . . . 73.129999999999995 112.836 -169.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 65.44 25.81 11.92 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 122.398 1.094 . . . . 75.430000000000007 109.434 -173.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 518' ' ' THR . . . . . 0.463 HG22 ' HA ' ' A' ' 547' ' ' VAL . 1.9 p -90.61 -172.99 3.59 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 113.741 -1.572 . . . . 75.510000000000005 110.239 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -108.75 142.05 39.86 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.38 -1.341 . . . . 74.209999999999994 107.38 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -132.44 153.11 51.18 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.11 0.481 . . . . 73.239999999999995 112.278 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.7 m -141.4 152.73 44.56 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.169 -1.048 . . . . 74.040000000000006 108.169 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -117.46 126.43 52.61 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.396 0.617 . . . . 62.43 111.719 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.02 130.38 56.17 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.891 -1.151 . . . . 74.019999999999996 107.891 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 18.7 p -103.87 139.58 38.86 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.323 0.582 . . . . 65.420000000000002 112.435 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.0 p -136.64 149.58 26.87 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 107.276 -1.379 . . . . 71.530000000000001 107.276 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.425 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 1.6 p-10 -87.61 136.83 32.79 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.93 -0.708 . . . . 73.200000000000003 110.521 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 50.6 m -156.27 163.79 23.67 Favored Pre-proline 0 C--N 1.293 -1.879 0 N-CA-C 106.415 -1.698 . . . . 75.239999999999995 106.415 -178.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.4 10.69 0.7 Allowed 'Trans proline' 0 CA--C 1.558 1.676 0 C-N-CA 121.935 1.757 . . . . 73.430000000000007 114.355 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.446 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 0.0 OUTLIER -96.59 140.99 22.46 Favored Pre-proline 0 C--O 1.214 -0.788 0 N-CA-C 108.686 -0.857 . . . . 74.099999999999994 108.686 177.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.1 145.88 73.15 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 123.251 2.634 . . . . 73.109999999999999 113.643 -176.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 557' ' ' LYS . . . -66.83 99.39 0.62 Allowed 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.972 -1.013 . . . . 74.349999999999994 112.781 -174.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 152.3 -26.64 0.88 Allowed Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 115.045 -0.98 . . . . 64.519999999999996 110.734 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -74.39 131.4 41.06 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.687 0.756 . . . . 70.329999999999998 110.831 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.495 HG11 ' CB ' ' A' ' 508' ' ' ALA . 12.4 p -97.97 125.65 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.063 0 N-CA-C 107.33 -1.359 . . . . 73.510000000000005 107.33 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 p -97.59 10.95 38.58 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 115.184 -0.916 . . . . 71.519999999999996 113.024 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 133.18 -165.77 23.93 Favored Glycine 0 N--CA 1.434 -1.491 0 C-N-CA 119.963 -1.113 . . . . 74.040000000000006 113.448 173.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 14.2 p -116.94 158.4 24.13 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 124.293 1.037 . . . . 73.299999999999997 108.736 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -62.14 -50.4 80.38 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 119.31 -0.956 . . . . 62.219999999999999 112.454 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -69.17 143.27 53.12 Favored 'Trans proline' 0 C--N 1.367 1.529 0 N-CA-C 108.929 -1.219 . . . . 65.340000000000003 108.929 170.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.94 144.93 89.34 Favored 'Trans proline' 0 C--O 1.253 1.229 0 C-N-CA 122.411 2.074 . . . . 72.299999999999997 112.634 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.27 137.51 58.27 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.458 -0.792 . . . . 73.329999999999998 109.629 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.52 -12.59 47.17 Favored Glycine 0 C--N 1.304 -1.242 0 N-CA-C 111.48 -0.648 . . . . 63.240000000000002 111.48 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 31.9 m -81.03 136.81 36.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.518 0.199 . . . . 74.209999999999994 110.895 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.2 t -90.59 128.32 36.55 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 108.214 -1.032 . . . . 75.030000000000001 108.214 173.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.77 153.99 67.0 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 108.907 -0.775 . . . . 65.519999999999996 108.907 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -60.54 138.19 78.61 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.76 1.64 . . . . 74.420000000000002 111.702 178.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.463 ' HA ' HG22 ' A' ' 518' ' ' THR . 8.7 p -61.27 -19.03 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 CA-C-O 122.177 0.989 . . . . 74.349999999999994 110.552 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -81.12 -15.8 54.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.638 -1.165 . . . . 75.540000000000006 111.954 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 77.6 p -92.79 157.96 16.14 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 112.905 0.706 . . . . 75.019999999999996 112.905 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.9 p -98.56 128.15 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 115.261 -0.881 . . . . 75.400000000000006 110.119 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.6 mt -98.95 136.05 31.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.508 -0.769 . . . . 73.409999999999997 109.798 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.88 125.25 50.16 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.889 0.852 . . . . 74.430000000000007 111.754 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.63 120.92 39.89 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 113.884 -1.507 . . . . 75.329999999999998 109.128 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -85.7 108.5 18.07 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.731 0.777 . . . . 63.43 112.057 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 16.2 t -90.6 129.84 40.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 114.962 -1.017 . . . . 74.439999999999998 108.307 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 67.7 m -94.69 117.99 31.01 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 109.83 -0.433 . . . . 74.040000000000006 109.83 177.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 18.2 ptpt -90.94 136.74 32.87 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.431 -1.692 . . . . 75.120000000000005 106.431 173.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -62.85 -24.39 66.55 Favored Glycine 0 CA--C 1.489 -1.561 0 O-C-N 124.233 0.958 . . . . 65.109999999999999 114.423 -171.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . 0.425 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 31.7 t-20 77.75 -24.99 0.2 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.571 1.148 . . . . 73.409999999999997 109.574 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.485 ' H ' ' C ' ' A' ' 558' ' ' GLY . 86.5 mt-30 -111.46 150.46 29.85 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 115.782 -0.645 . . . . 73.219999999999999 111.078 -174.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -132.35 149.86 52.27 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.347 -1.297 . . . . 75.420000000000002 107.622 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 63.2 t -68.25 125.72 26.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 109.833 -0.432 . . . . 73.519999999999996 109.833 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 48.1 ttp -92.18 125.63 55.88 Favored Pre-proline 0 C--N 1.308 -1.233 0 CA-C-N 116.072 -0.513 . . . . 70.310000000000002 111.184 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.81 155.01 71.57 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.957 2.438 . . . . 71.450000000000003 111.027 174.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . 0.513 ' HA ' ' CB ' ' A' ' 610' ' ' ALA . 29.4 t70 -67.03 139.42 57.63 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 114.851 1.426 . . . . 71.299999999999997 114.851 -174.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . 0.408 ' O ' ' HG2' ' A' ' 569' ' ' MET . 2.1 pt? -141.35 15.63 2.21 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.772 -1.103 . . . . 75.040000000000006 109.688 176.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 84.2 p -80.06 153.28 28.88 Favored 'General case' 0 C--O 1.251 1.161 0 C-N-CA 120.171 -0.611 . . . . 71.450000000000003 110.571 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 79.08 31.49 42.76 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.856 -0.688 . . . . 61.399999999999999 113.91 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 569' ' ' MET . . . . . 0.473 ' SD ' ' HG3' ' A' ' 577' ' ' ARG . 21.5 ptp -134.01 -179.07 5.32 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.795 -0.817 . . . . 73.109999999999999 108.795 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -101.82 167.43 10.08 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.275 -1.38 . . . . 74.540000000000006 107.275 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 -67.24 -30.01 69.8 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.678 -0.86 . . . . 74.319999999999993 108.678 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 11.5 p -72.11 -16.83 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 115.395 -0.821 . . . . 74.209999999999994 110.34 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.601 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 18.6 t70 -101.35 -39.16 7.72 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.706 -0.85 . . . . 73.140000000000001 108.706 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.7 -42.46 97.23 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 115.034 -0.984 . . . . 74.299999999999997 112.019 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.5 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 39.2 tt0 -55.4 -53.18 64.96 Favored Pre-proline 0 CA--C 1.569 1.701 0 CA-C-O 119.142 -0.456 . . . . 74.299999999999997 111.776 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 71.6 Cg_exo -55.77 -30.33 75.72 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 122.124 1.883 . . . . 74.099999999999994 112.6 171.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 11.4 mmm180 -62.81 -38.29 90.14 Favored 'General case' 0 C--O 1.202 -1.421 0 C-N-CA 120.707 -0.397 . . . . 74.439999999999998 110.816 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.73 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 10.5 mp -58.01 -49.28 77.4 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 118.001 0.364 . . . . 73.510000000000005 110.807 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -66.17 -40.87 90.8 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.62 -0.718 . . . . 73.0 112.675 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.02 -27.78 64.96 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.898 0.38 . . . . 65.129999999999995 111.735 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . 0.447 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 8.3 tp -89.73 -9.36 49.67 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 123.939 0.896 . . . . 75.049999999999997 110.545 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 68.73 32.11 73.9 Favored Glycine 0 C--O 1.243 0.672 0 C-N-CA 120.829 -0.701 . . . . 73.299999999999997 111.995 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . 0.73 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 10.9 t90 -87.03 126.78 34.97 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 107.576 -1.268 . . . . 73.230000000000004 107.576 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 4.2 p -91.78 -27.95 17.68 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 113.031 0.752 . . . . 74.230000000000004 113.031 -174.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -71.7 179.36 34.23 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 116.122 -0.49 . . . . 75.150000000000006 112.878 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 62.6 mtm -107.28 148.8 28.52 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.073 0.463 . . . . 75.319999999999993 111.056 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 29.9 tp -80.63 111.47 17.09 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 107.182 -1.414 . . . . 75.430000000000007 107.182 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . 0.543 ' O ' ' HA ' ' A' ' 621' ' ' THR . 15.3 t70 -97.94 114.92 27.15 Favored 'General case' 0 CA--C 1.485 -1.531 0 CA-C-N 116.086 -0.506 . . . . 74.109999999999999 110.237 -174.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.6 133.45 35.54 Favored 'General case' 0 C--N 1.276 -2.6 0 C-N-CA 119.853 -0.739 . . . . 74.140000000000001 109.399 177.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -83.01 -61.77 1.89 Allowed Glycine 0 C--N 1.291 -1.952 0 N-CA-C 109.884 -1.286 . . . . 74.549999999999997 109.884 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.67 149.45 43.73 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 109.348 -0.612 . . . . 65.329999999999998 109.348 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -90.06 150.14 22.21 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.221 -1.029 . . . . 61.039999999999999 108.221 176.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 19.9 t -117.44 136.7 53.75 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 108.636 -0.876 . . . . 71.209999999999994 108.636 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.59 106.97 5.59 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.709 -1.219 . . . . 54.43 107.709 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -120.42 -61.5 1.57 Allowed 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.618 -0.719 . . . . 75.409999999999997 109.342 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 89.08 151.83 24.84 Favored Glycine 0 N--CA 1.419 -2.457 0 C-N-CA 119.575 -1.298 . . . . 70.409999999999997 111.238 -176.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.4 -33.69 62.34 Favored Glycine 0 C--N 1.3 -1.441 0 N-CA-C 114.649 0.62 . . . . 73.25 114.649 -177.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 32.2 t -73.1 -24.89 60.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.95 0.881 . . . . 75.310000000000002 109.794 -176.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -99.83 -3.38 32.72 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.044 -0.98 . . . . 73.230000000000004 109.645 -177.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 56.6 m80 74.37 126.98 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.201 1.4 . . . . 72.129999999999995 112.677 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -83.74 51.07 1.93 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.249 1.023 . . . . 75.340000000000003 108.987 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 37.4 mtp180 -83.91 158.17 21.69 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.729 -1.123 . . . . 70.239999999999995 113.299 -176.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.16 131.73 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 106.136 -1.801 . . . . 74.540000000000006 106.136 167.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 44.0 t -97.47 -44.07 12.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-O 121.594 0.712 . . . . 72.329999999999998 109.512 -177.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -154.24 145.38 22.81 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.431 -0.804 . . . . 74.349999999999994 110.167 -176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -126.41 133.58 51.24 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 105.833 -1.914 . . . . 72.519999999999996 105.833 174.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -63.52 -51.09 69.47 Favored Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 112.744 0.646 . . . . 61.399999999999999 112.744 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -87.65 111.15 0.76 Allowed 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 122.002 1.801 . . . . 64.430000000000007 109.815 172.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.92 143.49 45.38 Favored 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 122.588 2.192 . . . . 73.0 113.485 -177.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . 0.513 ' CB ' ' HA ' ' A' ' 565' ' ' ASP . . . -65.82 139.85 58.35 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.81 -0.632 . . . . 72.420000000000002 109.737 176.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.45 -9.16 44.96 Favored Glycine 0 C--N 1.301 -1.365 0 N-CA-C 109.578 -1.409 . . . . 43.32 109.578 -172.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 63.0 m -108.67 154.18 22.38 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.491 -0.929 . . . . 75.109999999999999 108.491 176.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -72.74 128.54 12.59 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 111.898 -0.481 . . . . 75.430000000000007 111.898 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 30.1 m -112.7 143.14 23.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 123.666 0.786 . . . . 72.310000000000002 109.464 178.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -43.56 167.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 125.492 1.517 . . . . 71.099999999999994 113.259 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -57.29 -25.35 59.13 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 113.907 1.077 . . . . 74.230000000000004 113.907 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -93.04 -7.57 45.33 Favored 'General case' 0 C--O 1.208 -1.103 0 C-N-CA 119.327 -0.949 . . . . 75.120000000000005 108.543 -178.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 68.09 11.7 61.62 Favored Glycine 0 CA--C 1.491 -1.444 0 CA-C-N 115.557 -0.747 . . . . 64.239999999999995 111.788 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.46 118.85 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-O 122.279 1.037 . . . . 72.239999999999995 111.627 -169.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 45.0 pt -121.18 134.33 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 113.8 -1.546 . . . . 72.340000000000003 110.265 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 14.1 t -98.66 131.31 44.94 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 108.035 -1.098 . . . . 73.340000000000003 108.035 177.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -139.36 167.57 21.79 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.863 -0.608 . . . . 75.219999999999999 111.733 -174.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -126.75 136.42 52.4 Favored 'General case' 0 C--O 1.255 1.392 0 N-CA-C 107.228 -1.397 . . . . 74.409999999999997 107.228 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -141.39 163.23 33.5 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.448 -0.342 . . . . 75.420000000000002 110.603 -172.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -76.27 129.43 10.06 Favored Glycine 0 N--CA 1.416 -2.643 0 O-C-N 123.827 0.705 . . . . 74.5 111.545 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 C--N 1.299 -1.6 0 C-N-CA 123.948 0.899 . . . . 63.240000000000002 109.678 -179.503 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.076 0 N-CA-C 110.087 -1.205 . . . . 51.409999999999997 110.087 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.36 142.56 96.18 Favored 'Trans proline' 0 C--O 1.251 1.125 0 C-N-CA 122.456 2.104 . . . . 70.099999999999994 111.309 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -123.42 46.42 2.21 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.973 -0.558 . . . . 74.329999999999998 110.329 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 25.4 p -130.89 140.32 50.2 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.891 -0.411 . . . . 75.450000000000003 109.891 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . 0.559 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 8.8 tmtm? -150.56 144.22 25.17 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.724 -1.213 . . . . 75.430000000000007 107.724 172.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.559 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 9.6 p-10 -78.58 130.13 35.59 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.48 0.657 . . . . 60.210000000000001 110.808 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 29.3 pt -87.24 133.69 38.17 Favored Pre-proline 0 C--N 1.288 -2.103 0 C-N-CA 120.212 -0.595 . . . . 73.409999999999997 110.331 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -69.52 170.87 15.29 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 121.864 1.709 . . . . 75.109999999999999 111.85 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -78.01 83.23 4.32 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 122.876 1.322 . . . . 73.109999999999999 110.626 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.413 ' HB ' ' CB ' ' A' ' 508' ' ' ALA . 26.9 m -86.73 -6.82 10.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 114.399 -1.273 . . . . 75.329999999999998 112.268 -177.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.67 101.85 3.76 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.817 -0.809 . . . . 70.230000000000004 108.817 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 157.18 -38.54 0.56 Allowed Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.799 -0.715 . . . . 63.409999999999997 111.89 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 17.4 pm0 -97.54 -168.02 1.62 Allowed 'General case' 0 C--O 1.243 0.738 0 C-N-CA 120.761 -0.376 . . . . 63.409999999999997 110.006 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 14.5 m -70.15 155.35 40.76 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.21 -0.663 . . . . 74.549999999999997 109.21 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.433 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.3 p -63.18 -41.45 92.86 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.547 0 O-C-N 123.302 0.376 . . . . 73.450000000000003 110.72 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . 0.447 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 18.7 t70 -59.84 -42.91 94.64 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.891 0.377 . . . . 63.0 110.04 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 61.6 t -68.32 -45.42 82.58 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.622 0 CA-C-N 115.352 -0.84 . . . . 72.230000000000004 109.226 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.413 ' CB ' ' HB ' ' A' ' 500' ' ' VAL . . . -58.83 -45.38 90.15 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 120.638 0.256 . . . . 75.510000000000005 111.006 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.0 mt-30 -64.12 -45.64 87.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.972 -0.558 . . . . 72.430000000000007 111.237 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.557 ' O ' HG21 ' A' ' 514' ' ' VAL 0.314 0.0 OUTLIER -67.32 -37.65 83.66 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 119.632 -0.827 . . . . 73.140000000000001 111.607 177.353 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . 0.458 ' N ' ' HD3' ' A' ' 510' ' ' LYS . 7.9 m-20 -60.45 -50.2 74.53 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 116.276 -0.42 . . . . 72.230000000000004 110.723 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . 0.439 HD11 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -68.05 -36.25 79.56 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.937 -0.574 . . . . 74.129999999999995 111.239 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.439 ' N ' HD11 ' A' ' 512' ' ' LEU . 1.5 t-20 -65.9 -38.43 88.73 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 122.999 0.52 . . . . 61.210000000000001 110.528 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.557 HG21 ' O ' ' A' ' 510' ' ' LYS . 78.2 t -59.59 -32.98 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.093 0.473 . . . . 71.049999999999997 111.102 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -111.54 16.35 20.73 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.881 -0.328 . . . . 74.510000000000005 110.275 -177.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -143.01 -53.83 0.03 OUTLIER Glycine 0 CA--C 1.488 -1.62 0 C-N-CA 119.421 -1.371 . . . . 65.439999999999998 113.826 -173.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 61.46 39.37 15.09 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.652 1.215 . . . . 74.430000000000007 108.899 -174.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 518' ' ' THR . . . . . 0.481 HG23 ' HA ' ' A' ' 547' ' ' VAL . 20.3 p -91.23 -172.24 3.23 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 112.814 -1.994 . . . . 65.519999999999996 109.3 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.5 142.38 39.0 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.393 -1.336 . . . . 73.019999999999996 107.393 176.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -131.53 152.05 51.07 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.401 0.619 . . . . 74.219999999999999 112.244 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 20.4 p -140.29 146.42 38.52 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 107.962 -1.125 . . . . 73.549999999999997 107.962 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -119.79 129.47 54.47 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.237 -0.585 . . . . 74.349999999999994 110.942 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -121.01 118.7 30.5 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.945 -0.761 . . . . 74.420000000000002 108.945 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.8 m -90.78 137.09 32.63 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.132 0.491 . . . . 72.430000000000007 111.895 -176.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 47.2 t -128.89 149.06 33.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 105.793 -1.929 . . . . 73.239999999999995 105.793 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.1 135.68 36.38 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 118.327 0.512 . . . . 63.539999999999999 110.941 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 42.9 m -159.46 169.75 9.92 Favored Pre-proline 0 C--N 1.31 -1.151 0 N-CA-C 107.623 -1.251 . . . . 52.240000000000002 107.623 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -73.12 -13.78 25.97 Favored 'Trans proline' 0 C--O 1.25 1.078 0 C-N-CA 122.004 1.803 . . . . 73.430000000000007 112.838 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.491 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 48.6 mtt180 -73.35 143.05 82.41 Favored Pre-proline 0 N--CA 1.442 -0.825 0 N-CA-C 108.988 -0.745 . . . . 75.319999999999993 108.988 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.71 144.6 97.36 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 122.5 2.133 . . . . 74.329999999999998 112.034 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.78 99.21 0.08 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.367 -0.833 . . . . 71.129999999999995 111.762 -178.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 153.56 -22.4 0.73 Allowed Glycine 0 N--CA 1.423 -2.185 0 C-N-CA 120.573 -0.823 . . . . 53.140000000000001 112.154 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . 0.491 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 32.6 tt0 -79.99 138.35 37.03 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 117.239 0.52 . . . . 74.310000000000002 109.97 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 5.1 p -91.97 113.2 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 N-CA-C 108.502 -0.925 . . . . 74.329999999999998 108.502 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.54 -33.25 73.78 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.199 -1.364 . . . . 75.549999999999997 110.189 -177.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 167.91 177.78 39.44 Favored Glycine 0 N--CA 1.42 -2.401 0 CA-C-N 115.089 -0.959 . . . . 63.329999999999998 110.959 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.0 p -118.1 153.83 33.11 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 108.502 -0.925 . . . . 71.519999999999996 108.502 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -72.32 -48.01 10.08 Favored Pre-proline 0 C--N 1.318 -0.784 0 C-N-CA 118.235 -1.386 . . . . 75.340000000000003 110.246 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.52 131.5 34.03 Favored 'Trans proline' 0 C--N 1.381 2.274 0 N-CA-C 108.529 -1.373 . . . . 73.310000000000002 108.529 169.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -69.01 139.97 44.24 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 122.184 1.923 . . . . 75.319999999999993 114.732 -173.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -68.66 133.66 48.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.93 -1.032 . . . . 65.510000000000005 110.415 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 91.16 -19.29 47.45 Favored Glycine 0 C--N 1.306 -1.115 0 N-CA-C 110.839 -0.904 . . . . 73.409999999999997 110.839 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.2 m -87.82 139.46 30.5 Favored 'General case' 0 N--CA 1.413 -2.324 0 C-N-CA 123.623 0.769 . . . . 74.310000000000002 110.555 -175.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 3.4 t -72.45 124.6 25.51 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.662 -0.699 . . . . 75.120000000000005 109.323 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.72 163.82 36.68 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 107.236 -1.394 . . . . 74.219999999999999 107.236 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -76.46 135.3 16.32 Favored 'Trans proline' 0 N--CA 1.423 -2.642 0 CA-C-N 120.004 1.037 . . . . 73.519999999999996 111.715 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.481 ' HA ' HG23 ' A' ' 518' ' ' THR . 35.3 t -67.53 -24.91 31.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-N 114.122 -1.399 . . . . 62.219999999999999 110.46 176.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -78.19 -17.86 56.23 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.441 -1.254 . . . . 73.450000000000003 111.509 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 94.6 p -90.82 177.38 6.32 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.637 -0.425 . . . . 73.150000000000006 110.993 -177.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 12.9 p -109.07 126.31 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.831 0 CA-C-O 121.75 0.786 . . . . 72.209999999999994 109.908 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 63.1 mt -86.11 129.45 38.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 108.794 -0.817 . . . . 71.340000000000003 108.794 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -103.79 117.32 34.08 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.718 0.771 . . . . 75.140000000000001 110.664 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -95.45 114.03 25.75 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.653 -1.612 . . . . 73.049999999999997 108.218 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -84.32 116.39 22.99 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.922 -0.77 . . . . 74.120000000000005 108.922 176.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 524' ' ' SER . 23.9 t -104.15 131.79 52.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 115.099 -0.955 . . . . 74.349999999999994 109.244 -175.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.631 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 74.1 m -84.76 122.22 28.8 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 109.621 -0.511 . . . . 72.439999999999998 109.621 175.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.0 ptpt -93.49 141.25 28.68 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 104.672 -2.344 . . . . 74.219999999999999 104.672 169.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.575 ' O ' ' HG3' ' A' ' 560' ' ' GLN . . . -66.46 -27.17 72.95 Favored Glycine 0 CA--C 1.488 -1.649 0 C-N-CA 120.138 -1.03 . . . . 44.340000000000003 110.652 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 64.4 t30 65.27 11.84 7.58 Favored 'General case' 0 C--O 1.216 -0.689 0 C-N-CA 124.697 1.199 . . . . 63.210000000000001 109.885 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.575 ' HG3' ' O ' ' A' ' 558' ' ' GLY . 40.9 mt-30 -124.68 142.85 51.09 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 115.478 -0.783 . . . . 64.329999999999998 109.21 -176.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . 0.4 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 53.6 p90 -123.34 148.24 46.21 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.389 -0.967 . . . . 71.120000000000005 108.389 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.1 122.14 14.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.144 0.497 . . . . 72.25 111.002 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 563' ' ' MET . . . . . 0.422 ' SD ' HD12 ' A' ' 620' ' ' ILE . 56.9 ttp -97.45 122.43 55.58 Favored Pre-proline 0 C--N 1.31 -1.133 0 CA-C-N 115.885 -0.598 . . . . 74.430000000000007 110.953 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -68.15 169.81 15.88 Favored 'Trans proline' 0 C--O 1.241 0.661 0 C-N-CA 123.065 2.51 . . . . 72.040000000000006 110.843 172.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.6 142.42 38.95 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.138 0.494 . . . . 75.120000000000005 110.569 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . 0.443 ' O ' ' HG2' ' A' ' 569' ' ' MET . 2.0 pt? -126.69 5.29 6.73 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 122.206 1.003 . . . . 74.010000000000005 108.91 174.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 567' ' ' SER . . . . . 0.458 ' HA ' ' HB ' ' A' ' 603' ' ' VAL . 29.0 t -79.44 140.62 37.31 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 107.808 -1.182 . . . . 65.519999999999996 107.808 176.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 99.39 -2.46 57.6 Favored Glycine 0 C--N 1.302 -1.314 0 C-N-CA 120.018 -1.086 . . . . 74.109999999999999 112.878 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 569' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 24.0 ptp -120.06 169.35 10.29 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.561 -0.903 . . . . 73.340000000000003 108.561 177.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -92.59 171.59 8.92 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.004 -1.11 . . . . 74.319999999999993 108.004 -174.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -62.44 -32.87 73.79 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.69 -0.856 . . . . 75.209999999999994 108.69 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 30.7 m -68.9 -12.88 16.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 CA-C-N 116.076 -0.511 . . . . 74.329999999999998 112.107 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -102.27 -43.91 5.57 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 110.033 -0.358 . . . . 75.25 110.033 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -61.32 -39.5 90.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.799 -0.637 . . . . 74.109999999999999 112.235 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.646 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 44.0 tt0 -63.16 -53.36 54.87 Favored Pre-proline 0 CA--C 1.561 1.382 0 CA-C-N 116.622 -0.263 . . . . 74.120000000000005 111.494 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 92.7 Cg_exo -54.14 -40.43 81.87 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 121.547 1.498 . . . . 75.329999999999998 112.315 171.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.24 -42.49 91.2 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.479 0.18 . . . . 74.409999999999997 110.634 178.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.5 pp -66.17 -46.85 75.94 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 120.359 -0.536 . . . . 72.299999999999997 111.716 -175.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.447 ' N ' HD12 ' A' ' 578' ' ' LEU . 1.7 ptm180 -66.24 -36.23 82.46 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.792 -0.64 . . . . 75.310000000000002 111.563 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -71.17 -37.99 72.18 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 112.367 0.506 . . . . 75.5 112.367 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.0 pp -80.65 -8.66 59.7 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.22 0.533 . . . . 73.030000000000001 110.496 -176.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 85.6 32.55 18.65 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 115.46 -0.791 . . . . 71.120000000000005 112.509 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -77.02 126.2 30.57 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 107.197 -1.408 . . . . 75.349999999999994 107.197 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 2.1 p -106.08 6.42 31.07 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 112.833 0.679 . . . . 61.140000000000001 112.833 -175.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -95.68 -152.96 29.68 Favored Glycine 0 N--CA 1.436 -1.338 0 N-CA-C 110.723 -0.951 . . . . 73.430000000000007 110.723 174.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 57.6 ttp -136.87 147.0 46.23 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.03 -1.1 . . . . 71.109999999999999 108.03 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 6.0 tt -80.16 118.34 21.77 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.494 -0.928 . . . . 73.209999999999994 108.494 -177.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 621' ' ' THR . 26.5 t70 -98.76 120.61 39.48 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.641 -0.708 . . . . 71.340000000000003 109.332 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.5 133.21 43.18 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 119.194 -1.002 . . . . 73.439999999999998 108.724 176.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -85.2 -51.64 3.67 Favored Glycine 0 C--N 1.284 -2.35 0 N-CA-C 109.616 -1.394 . . . . 71.209999999999994 109.616 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -134.81 117.69 16.2 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 109.362 -0.607 . . . . 72.200000000000003 109.362 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -105.31 123.84 48.53 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.712 -1.218 . . . . 71.120000000000005 107.712 173.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 53.9 t -112.09 129.34 67.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 109.087 -0.708 . . . . 61.200000000000003 109.087 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . 0.403 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 23.3 t70 -72.67 114.47 10.84 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 108.798 -0.816 . . . . 64.530000000000001 108.798 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -124.27 -57.41 1.59 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.572 -0.74 . . . . 74.340000000000003 109.843 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 106.53 151.16 18.47 Favored Glycine 0 N--CA 1.423 -2.222 0 C-N-CA 120.062 -1.066 . . . . 72.219999999999999 110.863 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.482 ' HA2' ' OD1' ' A' ' 601' ' ' ASN . . . -58.77 -33.99 75.43 Favored Glycine 0 C--N 1.311 -0.811 0 N-CA-C 115.038 0.775 . . . . 74.450000000000003 115.038 -177.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 11.3 t -74.83 -23.91 58.53 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 122.125 0.964 . . . . 74.019999999999996 109.117 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -89.84 0.18 57.19 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.822 -1.081 . . . . 74.230000000000004 110.301 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 27.3 m170 78.41 85.67 0.07 Allowed 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 125.821 1.648 . . . . 60.310000000000002 109.789 -177.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . 0.482 ' OD1' ' HA2' ' A' ' 597' ' ' GLY . 26.0 p-10 -89.15 58.91 4.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 122.987 1.375 . . . . 75.239999999999995 110.428 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -97.16 163.59 12.86 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.893 -1.503 . . . . 74.310000000000002 108.431 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . 0.458 ' HB ' ' HA ' ' A' ' 567' ' ' SER . 92.8 t -70.17 130.52 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 104.74 -2.318 . . . . 74.030000000000001 104.74 168.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 13.4 p -103.11 -35.52 3.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 121.289 0.566 . . . . 73.530000000000001 111.133 -173.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -146.1 134.62 22.05 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 109.147 -0.686 . . . . 74.150000000000006 109.147 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -115.78 131.93 56.79 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.402 -1.703 . . . . 74.150000000000006 106.402 174.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.423 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 20.8 t-20 -58.25 -51.7 79.87 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 112.376 0.51 . . . . 73.209999999999994 112.376 -175.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.1 Cg_endo -87.13 118.97 1.44 Allowed 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.234 1.289 . . . . 75.109999999999999 109.494 172.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -64.56 159.71 43.39 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 122.549 2.166 . . . . 64.329999999999998 111.906 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.9 135.23 57.72 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.174 -0.466 . . . . 71.409999999999997 110.415 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.43 -11.94 47.3 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 111.35 -0.7 . . . . 73.129999999999995 111.35 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 34.2 m -82.1 136.75 35.14 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.592 -0.521 . . . . 75.530000000000001 109.592 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -77.33 123.13 6.36 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 110.271 -1.131 . . . . 63.020000000000003 110.271 175.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.6 m -113.62 142.38 26.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 109.643 -0.503 . . . . 71.140000000000001 109.643 178.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 559' ' ' ASN . 29.9 p30 -48.59 164.62 0.06 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.176 1.176 . . . . 74.129999999999995 114.176 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -57.74 -27.9 63.42 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.788 0.835 . . . . 73.439999999999998 112.629 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.42 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 4.4 p-10 -90.24 -9.37 48.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 119.486 -0.885 . . . . 72.430000000000007 110.459 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.11 14.86 62.1 Favored Glycine 0 CA--C 1.49 -1.503 0 C-N-CA 124.065 0.841 . . . . 65.439999999999998 114.685 163.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.05 117.66 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-O 122.566 1.174 . . . . 64.519999999999996 110.869 -167.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.422 HD12 ' SD ' ' A' ' 563' ' ' MET . 49.3 pt -129.81 135.28 61.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 113.755 -1.566 . . . . 71.239999999999995 110.37 -177.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 13.8 t -99.21 129.87 45.48 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 108.235 -1.024 . . . . 75.319999999999993 108.235 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 4.0 pp -138.76 167.13 22.65 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 116.136 -0.484 . . . . 75.340000000000003 111.462 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -128.09 136.33 51.04 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.808 -0.812 . . . . 72.349999999999994 108.808 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -142.55 165.58 27.02 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 116.187 -0.46 . . . . 75.120000000000005 111.827 -172.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -86.73 132.47 11.17 Favored Glycine 0 N--CA 1.42 -2.407 0 N-CA-C 109.221 -1.552 . . . . 40.229999999999997 109.221 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 9.9 tt0 . . . . . 0 C--N 1.279 -2.463 0 C-N-CA 123.066 0.547 . . . . 74.120000000000005 109.593 -178.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.487 0 N-CA-C 109.709 -1.356 . . . . 51.030000000000001 109.709 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -67.63 142.63 59.28 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 122.226 1.951 . . . . 64.129999999999995 110.894 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -115.88 11.11 15.44 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.599 0.714 . . . . 72.510000000000005 109.899 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 13.0 p -129.96 155.32 46.26 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 115.53 -0.759 . . . . 75.319999999999993 110.827 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -143.11 146.36 33.7 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.426 -0.806 . . . . 71.109999999999999 109.758 176.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.1 p-10 -91.56 140.03 30.12 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.094 -0.706 . . . . 73.019999999999996 109.094 177.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.4 pt -96.53 124.6 50.24 Favored Pre-proline 0 C--N 1.298 -1.664 0 CA-C-N 115.673 -0.694 . . . . 75.540000000000006 110.467 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -66.76 157.5 60.85 Favored 'Trans proline' 0 C--O 1.245 0.829 0 C-N-CA 122.475 2.117 . . . . 72.5 111.843 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -77.65 99.98 6.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.587 0.708 . . . . 63.210000000000001 109.704 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 30.3 m -105.63 11.14 8.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 114.96 -1.018 . . . . 74.120000000000005 112.169 -175.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -80.01 96.96 6.59 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.036 0.445 . . . . 70.329999999999998 110.798 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 162.38 -40.93 0.37 Allowed Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.777 -0.725 . . . . 74.319999999999993 111.914 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 16.1 pm0 -90.77 -171.89 3.19 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 110.251 -0.277 . . . . 74.549999999999997 110.251 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 28.1 m -70.1 155.0 41.23 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.818 -0.808 . . . . 72.120000000000005 108.818 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.417 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.2 p -62.48 -41.63 92.62 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 O-C-N 123.075 0.235 . . . . 75.420000000000002 110.722 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -59.4 -40.83 87.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.385 0.612 . . . . 74.299999999999997 109.645 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . 0.413 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 75.4 t -71.88 -45.95 62.61 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.608 0 CA-C-N 115.292 -0.867 . . . . 74.109999999999999 110.057 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.44 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -58.85 -44.34 90.99 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 111.917 0.34 . . . . 73.209999999999994 111.917 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.6 mt-30 -62.42 -45.79 91.53 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.295 -0.411 . . . . 64.310000000000002 110.957 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.56 ' O ' HG21 ' A' ' 514' ' ' VAL . 16.6 ptpt -67.97 -38.82 83.19 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 120.486 -0.485 . . . . 75.299999999999997 110.175 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -60.84 -47.36 86.7 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 116.056 -0.52 . . . . 74.340000000000003 110.86 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . 0.465 HD13 ' N ' ' A' ' 513' ' ' ASN . 3.9 pp -68.48 -35.73 77.95 Favored 'General case' 0 C--O 1.211 -0.923 0 CA-C-N 115.863 -0.608 . . . . 74.219999999999999 111.154 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.465 ' N ' HD13 ' A' ' 512' ' ' LEU . 4.1 t-20 -66.02 -34.86 79.06 Favored 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 123.287 0.635 . . . . 74.219999999999999 111.99 -178.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 510' ' ' LYS . 89.1 t -57.0 -32.42 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 121.491 0.663 . . . . 75.129999999999995 110.354 177.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -114.45 17.26 17.5 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.757 -0.656 . . . . 73.109999999999999 109.666 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -138.09 -55.03 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 119.923 -1.132 . . . . 63.210000000000001 113.57 -174.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 66.87 17.85 10.58 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.277 1.037 . . . . 74.340000000000003 109.922 -176.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.7 p -78.13 -170.7 2.06 Favored 'General case' 0 N--CA 1.411 -2.401 0 C-N-CA 125.481 1.512 . . . . 73.510000000000005 111.492 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -108.24 143.12 37.5 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.013 -1.477 . . . . 74.230000000000004 107.013 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -132.7 150.43 52.16 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.242 -0.583 . . . . 74.450000000000003 111.938 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.2 m -140.83 146.29 37.37 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.98 -1.489 . . . . 71.409999999999997 106.98 175.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -118.08 136.01 53.83 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 120.13 -0.628 . . . . 74.010000000000005 110.104 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -130.29 131.95 45.67 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.624 -0.88 . . . . 64.129999999999995 108.624 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 73.1 m -100.18 131.36 46.17 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.542 0.687 . . . . 71.019999999999996 112.596 -178.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.78 149.27 25.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.373 -1.714 . . . . 73.439999999999998 106.373 176.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -76.83 135.63 38.9 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 121.49 0.662 . . . . 64.430000000000007 111.674 -176.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 50.3 m -162.79 156.09 17.0 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 106.338 -1.727 . . . . 61.32 106.338 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -63.93 -3.12 5.35 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 122.762 2.308 . . . . 74.239999999999995 114.288 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -80.12 136.58 53.62 Favored Pre-proline 0 CA--C 1.51 -0.587 0 N-CA-C 106.967 -1.494 . . . . 74.409999999999997 106.967 176.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -61.6 147.94 94.2 Favored 'Trans proline' 0 C--O 1.256 1.382 0 C-N-CA 122.343 2.028 . . . . 51.32 112.701 -175.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -56.61 115.89 2.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.292 -0.867 . . . . 72.409999999999997 110.88 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 134.21 -27.78 3.24 Favored Glycine 0 N--CA 1.434 -1.436 0 C-N-CA 120.825 -0.703 . . . . 73.030000000000001 111.643 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -80.85 135.68 35.97 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-O 121.254 0.549 . . . . 74.329999999999998 110.295 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.44 HG11 ' CB ' ' A' ' 508' ' ' ALA . 7.2 p -96.67 120.78 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.722 0 N-CA-C 107.702 -1.221 . . . . 73.129999999999995 107.702 178.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.2 p -97.74 -1.23 43.85 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.167 -0.924 . . . . 74.530000000000001 113.132 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 163.23 -166.56 37.13 Favored Glycine 0 N--CA 1.423 -2.219 0 C-N-CA 120.278 -0.963 . . . . 60.020000000000003 111.52 176.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 2.4 p -135.39 152.91 51.87 Favored 'General case' 0 C--N 1.273 -2.746 0 N-CA-C 107.866 -1.161 . . . . 65.439999999999998 107.866 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.44 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 62.0 t30 -58.29 -50.83 85.93 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 119.834 -0.747 . . . . 72.239999999999995 111.201 175.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 4.8 Cg_exo -81.36 128.47 6.27 Favored 'Trans proline' 0 C--N 1.37 1.676 0 N-CA-C 107.568 -1.743 . . . . 54.130000000000003 107.568 168.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.38 140.31 88.41 Favored 'Trans proline' 0 C--O 1.245 0.846 0 C-N-CA 122.42 2.08 . . . . 75.099999999999994 113.04 -176.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.82 138.65 58.51 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.91 -0.587 . . . . 74.409999999999997 110.122 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.72 -11.58 57.8 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 120.752 -0.737 . . . . 72.510000000000005 111.294 -176.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 18.4 m -88.32 137.49 32.28 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.167 -0.309 . . . . 75.530000000000001 110.167 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 13.3 t -81.16 129.79 34.73 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 109.233 -0.655 . . . . 71.340000000000003 109.233 173.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.5 m -123.83 164.13 30.95 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 107.315 -1.365 . . . . 73.519999999999996 107.315 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -68.23 139.38 45.88 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 120.936 1.09 . . . . 63.299999999999997 110.646 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.8 p -62.6 -20.3 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 CA-C-N 115.696 -0.684 . . . . 73.140000000000001 112.296 -175.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -93.31 -7.35 45.14 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.757 0.313 . . . . 54.399999999999999 110.916 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 69.9 m -82.06 165.69 20.4 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.697 0.761 . . . . 73.540000000000006 112.624 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.2 p -102.31 137.7 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.292 0 CA-C-N 114.697 -1.138 . . . . 60.43 109.554 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 60.2 mt -101.96 132.38 48.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.076 -1.083 . . . . 72.109999999999999 108.076 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -102.8 117.95 35.75 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.218 0.532 . . . . 72.329999999999998 110.541 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -88.31 114.47 24.97 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.394 -1.275 . . . . 75.109999999999999 108.522 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -83.27 101.7 11.45 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.226 -1.028 . . . . 74.409999999999997 108.226 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 524' ' ' SER . 17.2 t -96.06 144.18 10.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 107.541 -1.281 . . . . 73.310000000000002 107.541 -177.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 67.9 m -97.8 133.82 41.79 Favored 'General case' 0 N--CA 1.394 -3.245 0 C-N-CA 119.444 -0.902 . . . . 73.5 110.694 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -97.5 129.5 44.67 Favored 'General case' 0 N--CA 1.405 -2.706 0 N-CA-C 103.882 -2.636 . . . . 75.109999999999999 103.882 168.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -60.47 -23.92 61.02 Favored Glycine 0 CA--C 1.49 -1.507 0 O-C-N 123.923 0.764 . . . . 62.119999999999997 113.599 -173.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 79.95 -15.54 0.74 Allowed 'General case' 0 C--O 1.211 -0.967 0 C-N-CA 124.946 1.298 . . . . 71.430000000000007 107.87 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.495 ' H ' ' C ' ' A' ' 558' ' ' GLY . 92.7 mt-30 -112.62 145.04 41.09 Favored 'General case' 0 N--CA 1.402 -2.832 0 CA-C-N 114.71 -1.132 . . . . 73.200000000000003 110.496 -175.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . 0.425 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 48.5 p90 -123.84 154.53 39.49 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 107.193 -1.41 . . . . 74.209999999999994 107.193 177.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.25 121.89 16.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.018 0.437 . . . . 70.450000000000003 110.864 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 563' ' ' MET . . . . . 0.601 ' SD ' HG21 ' A' ' 620' ' ' ILE . 47.4 ttp -79.23 122.73 84.53 Favored Pre-proline 0 C--N 1.316 -0.86 0 N-CA-C 109.653 -0.499 . . . . 64.310000000000002 109.653 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.77 169.62 20.71 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.214 1.942 . . . . 75.150000000000006 111.006 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -72.01 118.18 14.55 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.536 0.684 . . . . 71.219999999999999 110.424 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.9 pp -136.11 11.55 3.32 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.206 -0.907 . . . . 75.120000000000005 110.477 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 2.2 t -80.24 144.15 33.14 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.318 -0.855 . . . . 71.540000000000006 109.985 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 80.82 70.01 1.36 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.643 -0.789 . . . . 72.340000000000003 113.58 175.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -163.91 179.85 6.76 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.345 -1.354 . . . . 72.349999999999994 107.345 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -95.14 176.4 6.24 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.567 -0.531 . . . . 71.5 109.567 -178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . 0.53 ' CZ3' HD21 ' A' ' 587' ' ' LEU . 11.6 t-105 -71.56 -28.1 63.62 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.989 -1.486 . . . . 74.409999999999997 106.989 175.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 9.0 p -71.61 -6.72 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-N 115.429 -0.805 . . . . 74.140000000000001 110.264 178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 6.7 m-20 -101.11 -45.06 5.5 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.341 -0.985 . . . . 65.120000000000005 108.341 171.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -63.21 -46.0 89.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.331 -0.849 . . . . 72.319999999999993 113.25 -176.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.469 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 31.4 tt0 -64.19 -49.94 70.69 Favored Pre-proline 0 CA--C 1.561 1.376 0 N-CA-C 111.838 0.31 . . . . 74.519999999999996 111.838 -177.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 51.5 Cg_exo -61.1 -34.42 89.7 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.675 1.583 . . . . 75.439999999999998 112.279 174.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 30.6 mmm180 -68.98 -33.97 74.55 Favored 'General case' 0 C--O 1.216 -0.663 0 C-N-CA 120.147 -0.621 . . . . 75.200000000000003 110.625 176.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.441 ' HG ' ' HB3' ' A' ' 583' ' ' TRP . 5.4 tt -60.41 -48.87 79.89 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.348 0.659 . . . . 74.510000000000005 109.363 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 576' ' ' PRO . 7.7 ptm180 -66.25 -41.09 90.44 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.914 0.339 . . . . 74.409999999999997 111.914 176.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.42 -37.01 82.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.152 -0.476 . . . . 72.329999999999998 112.168 -177.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.56 -9.28 54.86 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.154 0.502 . . . . 65.329999999999998 110.02 -177.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 70.52 46.66 46.63 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.768 -0.933 . . . . 73.420000000000002 110.768 -178.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . 0.441 ' HB3' ' HG ' ' A' ' 578' ' ' LEU . 11.3 t90 -73.39 126.76 30.9 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 109.357 -0.608 . . . . 74.310000000000002 109.357 -177.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 584' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 617' ' ' ASP . 7.6 p -90.42 -24.38 20.77 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.409 -0.814 . . . . 53.240000000000002 112.101 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -85.19 -174.3 50.15 Favored Glycine 0 N--CA 1.432 -1.589 0 CA-C-N 116.076 -0.511 . . . . 61.140000000000001 113.075 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 27.4 ttt -117.33 149.04 41.14 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.967 -0.383 . . . . 74.230000000000004 109.967 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . 0.53 HD21 ' CZ3' ' A' ' 571' ' ' TRP . 6.1 tt -80.7 108.83 14.67 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.27 -1.382 . . . . 62.140000000000001 107.27 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -105.37 119.28 38.7 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.942 -0.572 . . . . 74.549999999999997 111.612 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.1 OUTLIER -111.91 133.21 54.25 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.035 -1.098 . . . . 74.310000000000002 108.035 171.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -111.01 -5.13 27.26 Favored Glycine 0 C--N 1.297 -1.625 0 C-N-CA 120.096 -1.05 . . . . 65.109999999999999 112.83 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.35 130.57 26.7 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 121.137 -0.225 . . . . 73.310000000000002 110.743 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.35 124.2 31.02 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 123.907 0.755 . . . . 75.049999999999997 109.829 176.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . 0.508 ' O ' ' HA2' ' A' ' 625' ' ' GLY . 86.9 t -104.64 131.85 52.7 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 105.22 -2.141 . . . . 74.430000000000007 105.22 171.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -82.88 122.95 28.91 Favored 'General case' 0 C--N 1.281 -2.406 0 C-N-CA 118.681 -1.208 . . . . 73.040000000000006 110.93 -177.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -147.46 -68.86 0.24 Allowed 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.002 -1.453 . . . . 73.430000000000007 108.359 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 92.75 157.8 33.85 Favored Glycine 0 N--CA 1.417 -2.628 0 C-N-CA 119.827 -1.178 . . . . 54.549999999999997 110.985 -176.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -57.99 -37.63 86.06 Favored Glycine 0 C--N 1.291 -1.931 0 N-CA-C 115.441 0.936 . . . . 75.299999999999997 115.441 -176.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 36.4 m -76.11 -24.55 54.98 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-N 118.05 0.925 . . . . 74.450000000000003 110.628 -174.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -89.13 -0.04 57.12 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.601 -1.181 . . . . 72.329999999999998 111.458 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 40.1 m80 77.6 89.79 0.07 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.619 1.2 . . . . 74.25 109.833 -176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -81.62 85.99 6.46 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 113.93 -1.487 . . . . 74.010000000000005 109.964 -171.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -111.52 170.03 8.4 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.567 0.951 . . . . 74.329999999999998 113.567 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 99.3 t -77.72 133.27 30.88 Favored 'Isoleucine or valine' 0 C--O 1.248 0.995 0 CA-C-N 114.27 -1.332 . . . . 75.439999999999998 108.05 173.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.5 m -112.21 -42.42 4.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 120.285 -0.566 . . . . 73.329999999999998 112.36 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -144.69 151.04 38.32 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.969 -0.382 . . . . 72.209999999999994 109.969 -174.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -140.06 144.67 36.97 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 123.491 0.494 . . . . 64.099999999999994 110.355 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.402 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 58.4 t30 -64.77 -51.82 55.12 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-N 116.181 -0.463 . . . . 64.239999999999995 111.734 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.4 Cg_exo -85.21 115.74 1.69 Allowed 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 121.756 1.637 . . . . 73.310000000000002 110.134 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.21 152.31 66.92 Favored 'Trans proline' 0 C--O 1.256 1.379 0 C-N-CA 122.401 2.067 . . . . 75.310000000000002 111.799 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -58.71 135.84 57.54 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.49 -0.559 . . . . 75.299999999999997 109.49 176.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 103.23 -7.36 51.61 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.571 -0.823 . . . . 60.039999999999999 111.908 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 28.0 m -93.78 144.46 25.39 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.237 -0.653 . . . . 71.450000000000003 109.237 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -70.34 131.22 22.08 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 111.952 -0.459 . . . . 73.239999999999995 111.952 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.7 m -124.56 141.64 44.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.917 -0.772 . . . . 74.420000000000002 108.917 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.411 ' N ' ' HG2' ' A' ' 560' ' ' GLN . 28.4 p-10 -51.52 171.72 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.204 1.402 . . . . 64.230000000000004 114.301 -176.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.68 -27.1 37.81 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.824 1.046 . . . . 74.230000000000004 113.824 -179.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.429 ' HA ' ' OG1' ' A' ' 584' ' ' THR . 11.0 m-20 -87.74 -8.18 56.36 Favored 'General case' 0 C--O 1.198 -1.632 0 C-N-CA 119.149 -1.02 . . . . 74.530000000000001 110.988 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.02 17.81 65.99 Favored Glycine 0 C--O 1.219 -0.784 0 C-N-CA 121.755 -0.259 . . . . 64.319999999999993 112.661 173.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.96 119.28 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 121.724 0.773 . . . . 75.239999999999995 110.726 -169.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.601 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.6 pp -123.76 133.29 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 115.29 -0.868 . . . . 64.109999999999999 112.546 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 14.2 t -102.86 122.48 44.63 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 122.118 0.961 . . . . 74.239999999999995 109.26 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -136.64 169.43 17.73 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.777 -1.101 . . . . 73.319999999999993 110.471 -173.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -125.95 135.84 52.33 Favored 'General case' 0 C--O 1.261 1.667 0 N-CA-C 107.866 -1.161 . . . . 75.109999999999999 107.866 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -142.98 169.05 18.29 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.783 -1.192 . . . . 74.310000000000002 107.783 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 593' ' ' VAL . . . -49.47 109.5 0.62 Allowed Glycine 0 CA--C 1.544 1.896 0 O-C-N 124.193 0.933 . . . . 71.340000000000003 113.549 175.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 . . . . . 0 C--O 1.253 1.277 0 C-N-CA 125.816 1.646 . . . . 71.319999999999993 112.934 176.843 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.492 0 N-CA-C 109.078 -1.609 . . . . 54.130000000000003 109.078 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -74.3 141.51 28.98 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.668 1.579 . . . . 71.140000000000001 109.906 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 59.31 15.65 4.47 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.279 1.032 . . . . 73.530000000000001 112.976 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 19.3 p -141.0 142.42 34.27 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.936 -0.478 . . . . 73.319999999999993 110.521 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -138.88 135.01 34.04 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.75 -0.833 . . . . 74.329999999999998 108.75 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.3 p-10 -83.66 144.99 29.03 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.186 0.517 . . . . 74.430000000000007 110.318 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.5 pt -90.38 116.92 67.5 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 115.13 -0.941 . . . . 65.120000000000005 111.086 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . 0.405 ' HD2' HD22 ' A' ' 512' ' ' LEU . 27.5 Cg_exo -66.2 160.57 44.3 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.484 2.122 . . . . 72.439999999999998 111.106 173.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -67.91 110.99 4.11 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.801 0.81 . . . . 74.450000000000003 110.423 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 14.2 m -130.27 65.17 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 122.757 1.265 . . . . 70.420000000000002 109.494 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -128.99 93.29 3.56 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 113.559 -1.655 . . . . 73.340000000000003 108.382 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 160.82 -38.73 0.43 Allowed Glycine 0 N--CA 1.428 -1.861 0 C-N-CA 119.905 -1.14 . . . . 54.539999999999999 112.787 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.517 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.3 OUTLIER -89.71 -170.27 2.76 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 110.231 -0.285 . . . . 74.340000000000003 110.231 -178.784 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 21.3 m -71.79 155.58 40.28 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.15 -0.685 . . . . 73.120000000000005 109.15 178.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.418 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.6 p -60.38 -41.77 88.48 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.587 0 O-C-N 123.243 0.34 . . . . 73.219999999999999 111.391 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.77 -40.7 97.34 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 109.684 -0.487 . . . . 74.450000000000003 109.684 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.03 -42.88 89.09 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.177 0 N-CA-C 109.073 -0.714 . . . . 73.299999999999997 109.073 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.416 ' HB2' HG13 ' A' ' 534' ' ' VAL . . . -59.34 -45.55 91.05 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.855 0.36 . . . . 75.340000000000003 110.959 177.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 26.0 mt-30 -65.32 -42.58 92.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.66 -0.7 . . . . 72.430000000000007 110.689 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.596 ' O ' HG21 ' A' ' 514' ' ' VAL . 45.0 mmtm -61.63 -45.69 92.97 Favored 'General case' 0 CA--C 1.495 -1.152 0 O-C-N 123.392 0.433 . . . . 71.450000000000003 110.122 177.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -61.88 -41.49 97.92 Favored 'General case' 0 N--CA 1.435 -1.221 0 O-C-N 123.821 0.701 . . . . 72.329999999999998 110.89 -176.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . 0.405 HD22 ' HD2' ' A' ' 498' ' ' PRO . 0.2 OUTLIER -68.04 -46.62 70.63 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.859 -1.064 . . . . 71.230000000000004 108.208 -179.196 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.413 ' ND2' ' HA ' ' A' ' 517' ' ' PHE . 2.1 t-20 -61.7 -35.87 79.28 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 124.001 0.92 . . . . 73.329999999999998 111.612 -174.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.596 HG21 ' O ' ' A' ' 510' ' ' LYS . 89.6 t -57.62 -38.97 67.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 O-C-N 123.269 0.356 . . . . 74.340000000000003 111.525 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -105.21 -3.73 22.57 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.458 0.647 . . . . 74.040000000000006 109.523 -176.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -116.33 -58.64 0.32 Allowed Glycine 0 N--CA 1.42 -2.4 0 CA-C-N 115.473 -0.785 . . . . 71.129999999999995 113.828 -170.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.413 ' HA ' ' ND2' ' A' ' 513' ' ' ASN . 75.6 m-85 63.31 26.78 15.2 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 122.351 1.072 . . . . 75.319999999999993 110.212 -172.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.4 p -83.46 -177.14 6.62 Favored 'General case' 0 N--CA 1.403 -2.817 0 CA-C-N 113.872 -1.513 . . . . 72.120000000000005 109.447 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -107.99 139.69 42.24 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.371 -1.344 . . . . 64.219999999999999 107.371 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -129.2 149.07 51.16 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-O 121.117 0.485 . . . . 74.310000000000002 111.255 -176.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.3 m -139.97 152.44 46.32 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 106.688 -1.597 . . . . 74.299999999999997 106.688 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -122.84 142.07 51.16 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 112.51 0.559 . . . . 73.030000000000001 112.51 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -132.26 143.33 49.84 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.086 -1.45 . . . . 73.219999999999999 107.086 176.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 80.2 p -103.14 138.11 40.41 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.427 -0.909 . . . . 74.430000000000007 111.676 -175.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.9 p -121.43 149.64 24.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 106.547 -1.649 . . . . 74.329999999999998 106.547 177.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -72.32 136.93 46.34 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.521 -0.548 . . . . 74.230000000000004 109.521 -177.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.424 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 56.6 m -153.51 160.07 31.37 Favored Pre-proline 0 C--N 1.291 -1.971 0 N-CA-C 107.768 -1.197 . . . . 73.120000000000005 107.768 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.32 -2.75 12.96 Favored 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 121.865 1.71 . . . . 74.329999999999998 113.09 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.18 152.02 38.56 Favored Pre-proline 0 N--CA 1.451 -0.412 0 N-CA-C 109.624 -0.51 . . . . 71.340000000000003 109.624 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -57.34 146.61 81.85 Favored 'Trans proline' 0 C--O 1.25 1.087 0 C-N-CA 122.96 2.44 . . . . 75.209999999999994 113.458 -177.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.697 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.16 99.83 0.11 Allowed 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 114.943 -1.026 . . . . 73.319999999999993 111.651 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 157.82 -23.09 0.4 Allowed Glycine 0 C--N 1.3 -1.464 0 CA-C-N 115.758 -0.656 . . . . 74.439999999999998 111.874 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -74.38 144.74 44.25 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.349 -0.982 . . . . 74.230000000000004 108.349 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 503' ' ' GLN . 11.0 p -91.38 118.6 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.413 0 CA-C-O 121.854 0.835 . . . . 64.430000000000007 108.779 176.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.83 -23.59 60.79 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.514 -1.221 . . . . 62.509999999999998 109.374 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 138.99 -152.8 22.41 Favored Glycine 0 N--CA 1.421 -2.305 0 N-CA-C 110.581 -1.007 . . . . 63.049999999999997 110.581 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.0 p -116.48 157.93 24.4 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 109.71 -0.478 . . . . 71.530000000000001 109.71 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -66.45 -53.68 28.79 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 120.236 -0.586 . . . . 74.129999999999995 110.261 173.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.71 149.82 79.03 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 121.319 1.346 . . . . 74.150000000000006 109.767 173.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.04 139.36 66.85 Favored 'Trans proline' 0 C--O 1.246 0.923 0 C-N-CA 121.659 1.572 . . . . 70.120000000000005 113.02 -176.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.97 137.43 55.13 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-N 115.204 -0.907 . . . . 61.399999999999999 110.178 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 93.81 -11.8 70.42 Favored Glycine 0 N--CA 1.442 -0.967 0 C-N-CA 121.092 -0.575 . . . . 61.140000000000001 111.668 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 51.8 m -88.52 137.83 31.97 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 122.745 0.418 . . . . 74.329999999999998 110.358 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.9 t -74.74 136.83 41.74 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.95 -0.568 . . . . 72.340000000000003 109.729 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.3 m -130.89 154.46 81.96 Favored Pre-proline 0 C--N 1.312 -1.064 0 N-CA-C 108.161 -1.051 . . . . 72.299999999999997 108.161 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -61.72 136.88 65.02 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.15 1.233 . . . . 71.319999999999993 111.202 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 13.3 p -65.99 -23.22 31.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.724 0.773 . . . . 74.219999999999999 111.872 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -78.06 -17.41 57.04 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.096 -0.502 . . . . 74.530000000000001 110.75 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 25.2 t -78.29 162.54 26.44 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.885 0.85 . . . . 74.239999999999995 111.499 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.8 p -98.64 137.74 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.388 0 CA-C-N 114.246 -1.343 . . . . 74.549999999999997 108.282 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 61.7 mt -100.88 137.53 28.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.168 -0.678 . . . . 74.409999999999997 109.168 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -103.24 117.78 35.29 Favored 'General case' 0 C--O 1.254 1.336 0 N-CA-C 108.816 -0.809 . . . . 73.519999999999996 108.816 -177.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -101.49 120.36 40.17 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 123.735 0.814 . . . . 71.319999999999993 109.624 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 2.8 mp0 -86.52 123.17 31.43 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 121.17 0.51 . . . . 73.430000000000007 110.795 178.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 39.6 t -96.01 132.19 40.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.781 -1.192 . . . . 71.209999999999994 107.781 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.697 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 13.0 m -79.7 117.35 20.53 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 107.033 -1.469 . . . . 75.549999999999997 107.033 176.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -107.52 128.78 54.82 Favored 'General case' 0 N--CA 1.422 -1.869 0 C-N-CA 119.566 -0.854 . . . . 75.310000000000002 108.838 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -58.61 -24.83 57.5 Favored Glycine 0 CA--C 1.501 -0.79 0 O-C-N 124.462 1.101 . . . . 74.340000000000003 113.993 -175.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 73.93 -0.16 3.44 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.995 1.318 . . . . 73.219999999999999 109.8 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.43 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 70.3 mt-30 -113.74 149.63 34.54 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 115.661 -0.699 . . . . 72.040000000000006 111.971 -174.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -124.12 158.79 31.47 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.454 -1.248 . . . . 72.409999999999997 108.351 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.15 126.94 37.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.336 0.589 . . . . 72.519999999999996 110.516 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 18.8 ttt -78.21 125.15 85.47 Favored Pre-proline 0 N--CA 1.432 -1.344 0 C-N-CA 124.542 1.137 . . . . 74.340000000000003 111.436 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.66 169.43 22.58 Favored 'Trans proline' 0 C--O 1.245 0.869 0 C-N-CA 122.805 2.336 . . . . 74.040000000000006 111.125 174.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.79 116.79 26.19 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.86 0.838 . . . . 75.510000000000005 111.36 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -117.64 9.11 13.01 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.204 -1.406 . . . . 71.439999999999998 107.204 170.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 22.0 t -80.65 147.22 30.77 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 114.211 -1.359 . . . . 71.409999999999997 107.953 176.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 66.75 56.74 11.68 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 121.357 -0.449 . . . . 63.509999999999998 112.897 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 22.9 ptp -168.49 179.76 4.23 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.165 -1.791 . . . . 75.099999999999994 106.165 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -100.1 170.45 8.47 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.06 -0.719 . . . . 74.219999999999999 109.06 -176.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . 0.401 ' CH2' HD23 ' A' ' 587' ' ' LEU . 12.1 t-105 -65.63 -27.53 68.45 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 108.569 -0.9 . . . . 74.310000000000002 108.569 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.6 p -71.16 -13.2 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 115.735 -0.666 . . . . 73.230000000000004 110.479 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -99.41 -35.87 9.77 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 109.017 -0.735 . . . . 74.439999999999998 109.017 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . 0.615 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -62.64 -39.61 94.41 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 115.323 -0.853 . . . . 74.049999999999997 110.397 177.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.403 ' HB3' ' CD ' ' A' ' 576' ' ' PRO . 2.5 tm-20 -51.3 -59.13 8.42 Favored Pre-proline 0 CA--C 1.585 2.303 0 C-N-CA 124.138 0.975 . . . . 75.340000000000003 110.57 -178.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.403 ' CD ' ' HB3' ' A' ' 575' ' ' GLU . 19.8 Cg_endo -61.57 -32.49 87.78 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 121.891 1.727 . . . . 61.409999999999997 113.013 175.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 7.6 mmp_? -61.98 -41.25 97.82 Favored 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 120.593 -0.443 . . . . 74.409999999999997 110.726 177.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 16.8 mt -65.99 -46.39 78.19 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-O 120.782 0.325 . . . . 65.219999999999999 110.465 -175.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -65.76 -39.73 91.34 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 112.472 0.545 . . . . 73.310000000000002 112.472 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -69.17 -33.61 73.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.878 0.371 . . . . 72.329999999999998 111.247 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.3 tp -81.01 -10.16 59.74 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 121.471 0.653 . . . . 74.540000000000006 110.156 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 62.0 35.6 91.65 Favored Glycine 0 C--O 1.224 -0.496 0 CA-C-N 115.961 -0.563 . . . . 65.030000000000001 112.569 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . 0.455 ' CE3' HD21 ' A' ' 578' ' ' LEU . 18.4 t90 -78.83 126.68 31.03 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.638 -0.504 . . . . 74.310000000000002 109.638 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 12.9 t -109.39 6.62 24.49 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 111.966 0.358 . . . . 72.219999999999999 111.966 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -89.11 -171.82 45.8 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 119.955 -1.117 . . . . 73.420000000000002 111.261 176.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 94.4 mmm -105.05 139.16 40.15 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 116.749 0.274 . . . . 75.010000000000005 110.375 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . 0.401 HD23 ' CH2' ' A' ' 571' ' ' TRP . 6.4 tt -80.64 110.01 15.72 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 107.354 -1.35 . . . . 74.120000000000005 107.354 176.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . 0.488 ' O ' ' HA ' ' A' ' 621' ' ' THR . 30.6 t70 -95.65 114.23 25.95 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.909 -1.041 . . . . 72.430000000000007 109.679 -178.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.9 134.78 52.28 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 108.172 -1.047 . . . . 73.409999999999997 108.172 177.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -101.07 -89.69 2.07 Favored Glycine 0 C--N 1.268 -3.197 0 CA-C-N 115.306 -0.861 . . . . 44.100000000000001 112.646 -175.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -99.63 149.15 23.58 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.025 0.44 . . . . 73.219999999999999 111.665 -176.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -93.45 139.18 31.0 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.395 -0.965 . . . . 74.549999999999997 108.395 176.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 39.5 t -105.11 153.96 6.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 109.014 -0.735 . . . . 74.420000000000002 109.014 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -73.11 119.2 17.02 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 121.599 0.714 . . . . 75.430000000000007 109.728 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -143.46 -65.35 0.38 Allowed 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.154 -1.424 . . . . 73.299999999999997 107.154 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 100.05 158.8 28.34 Favored Glycine 0 N--CA 1.4 -3.753 0 C-N-CA 119.967 -1.111 . . . . 74.349999999999994 112.074 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.23 -32.38 60.19 Favored Glycine 0 C--N 1.302 -1.324 0 C-N-CA 123.689 0.662 . . . . 61.210000000000001 113.514 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 26.8 t -69.5 -23.91 63.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 122.057 0.932 . . . . 75.239999999999995 109.828 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 55.9 mm-40 -100.96 -12.09 19.2 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.553 -0.748 . . . . 74.209999999999994 109.712 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 43.7 m80 67.11 172.69 0.26 Allowed 'General case' 0 C--O 1.242 0.658 0 C-N-CA 124.603 1.161 . . . . 75.129999999999995 111.824 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -89.55 84.85 6.39 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 112.526 0.565 . . . . 75.019999999999996 112.526 -174.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . 0.405 ' O ' ' HB2' ' A' ' 624' ' ' PHE . 48.0 mtp180 -91.08 145.96 24.24 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.09 -0.959 . . . . 75.120000000000005 110.542 176.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . 0.402 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 59.5 t -74.43 130.51 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 105.904 -1.887 . . . . 64.329999999999998 105.904 173.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 73.8 t -102.96 -59.91 3.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-O 120.738 0.304 . . . . 65.409999999999997 111.206 -173.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -144.61 141.05 29.13 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.162 -0.472 . . . . 75.140000000000001 110.037 -172.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.56 160.89 22.29 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 107.251 -1.389 . . . . 72.129999999999995 107.251 176.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.476 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 3.2 t-20 -67.03 -52.61 30.16 Favored Pre-proline 0 C--N 1.312 -1.034 0 N-CA-C 109.689 -0.486 . . . . 75.040000000000006 109.689 171.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.2 Cg_exo -87.47 122.8 1.78 Allowed 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 121.589 1.526 . . . . 71.030000000000001 110.91 173.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -67.26 158.39 57.18 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.184 1.923 . . . . 74.219999999999999 110.874 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.5 127.63 33.44 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.79 -0.448 . . . . 74.519999999999996 109.79 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.31 -0.02 40.64 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.713 -0.756 . . . . 71.5 112.091 -177.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 10.2 m -92.32 166.34 12.63 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.81 -0.811 . . . . 54.530000000000001 108.81 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -90.73 130.69 10.39 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.91 -0.662 . . . . 74.400000000000006 112.082 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.4 m -125.05 141.93 43.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.783 -0.821 . . . . 75.400000000000006 108.783 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.43 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.9 p-10 -62.42 179.28 0.33 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.437 0.902 . . . . 71.310000000000002 113.437 -175.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -61.03 -25.78 67.15 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.375 -0.375 . . . . 74.129999999999995 112.0 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.487 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 34.5 t70 -83.18 -9.45 59.16 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.091 -0.707 . . . . 75.129999999999995 109.091 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . 0.417 ' HA3' ' CD1' ' A' ' 583' ' ' TRP . . . 64.9 15.9 60.89 Favored Glycine 0 CA--C 1.492 -1.355 0 CA-C-N 115.195 -0.911 . . . . 75.129999999999995 113.704 168.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.58 119.13 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 CA-C-O 122.974 1.368 . . . . 70.129999999999995 113.255 -164.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 48.1 pt -123.47 133.09 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 CA-C-N 113.42 -1.718 . . . . 74.239999999999995 108.581 177.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 12.1 t -109.86 124.93 52.19 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.419 -0.956 . . . . 63.399999999999999 108.419 177.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.38 167.17 21.53 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 113.229 0.826 . . . . 75.099999999999994 113.229 -176.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -127.21 137.52 52.92 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.501 -1.227 . . . . 74.019999999999996 107.86 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 602' ' ' ARG . 15.1 p90 -139.35 166.7 23.85 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.486 -0.325 . . . . 71.230000000000004 111.162 -175.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -57.93 145.61 40.18 Favored Glycine 0 N--CA 1.447 -0.621 0 O-C-N 123.978 0.799 . . . . 75.430000000000007 114.412 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 . . . . . 0 C--N 1.308 -1.232 0 C-N-CA 124.391 1.076 . . . . 74.219999999999999 109.924 177.654 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.666 0 N-CA-C 110.544 -1.022 . . . . 74.439999999999998 110.544 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.03 142.23 67.37 Favored 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 122.39 2.06 . . . . 75.439999999999998 111.269 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -87.81 -4.22 58.89 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.873 0.844 . . . . 70.239999999999995 110.996 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 5.9 p -140.59 144.59 35.9 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.787 -1.19 . . . . 73.329999999999998 107.787 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -139.03 135.51 34.31 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 108.806 -0.813 . . . . 74.510000000000005 108.806 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.4 p-10 -81.53 133.99 35.46 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.885 -0.598 . . . . 70.340000000000003 109.936 177.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 498' ' ' PRO . 33.0 pt -89.63 131.23 40.52 Favored Pre-proline 0 C--N 1.291 -1.945 0 CA-C-N 115.061 -0.972 . . . . 74.129999999999995 110.993 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 3.4 Cg_exo -76.49 -174.4 2.11 Favored 'Trans proline' 0 C--O 1.251 1.144 0 C-N-CA 121.966 1.777 . . . . 73.209999999999994 110.011 174.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -85.38 117.17 24.14 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.002 0.906 . . . . 65.040000000000006 110.773 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.58 66.29 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.38 0 CA-C-O 123.277 1.513 . . . . 74.439999999999998 108.487 172.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -129.75 109.55 11.05 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 112.018 -2.355 . . . . 72.099999999999994 107.369 174.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 138.44 -20.05 3.16 Favored Glycine 0 C--N 1.299 -1.477 0 C-N-CA 119.837 -1.173 . . . . 53.409999999999997 112.956 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.43 ' O ' HG13 ' A' ' 534' ' ' VAL . 0.0 OUTLIER -107.44 -173.88 2.4 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 117.484 0.642 . . . . 72.140000000000001 110.087 178.416 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 10.0 m -75.99 155.99 34.48 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.229 -1.026 . . . . 73.019999999999996 108.229 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.44 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 6.0 p -57.5 -46.59 85.98 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 111.801 0.297 . . . . 74.319999999999993 111.801 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -64.33 -37.93 89.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.308 0.575 . . . . 75.340000000000003 110.559 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 97.7 t -68.04 -42.42 85.23 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.982 0 CA-C-N 115.231 -0.895 . . . . 74.450000000000003 109.554 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.412 ' HB3' HG11 ' A' ' 534' ' ' VAL . . . -62.34 -45.36 93.56 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 122.298 0.239 . . . . 72.329999999999998 110.87 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 22.9 mt-30 -64.89 -45.81 84.38 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.458 -0.337 . . . . 74.530000000000001 111.261 -178.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.471 ' O ' HG21 ' A' ' 514' ' ' VAL . 0.0 OUTLIER -67.27 -38.92 85.88 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 120.473 -0.491 . . . . 74.120000000000005 110.716 179.165 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -63.2 -45.61 90.88 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 121.152 0.501 . . . . 73.209999999999994 110.479 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -62.17 -42.19 99.03 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 108.172 -1.047 . . . . 73.230000000000004 108.172 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -59.7 -34.95 73.55 Favored 'General case' 0 N--CA 1.428 -1.561 0 C-N-CA 123.613 0.765 . . . . 70.230000000000004 112.54 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 510' ' ' LYS . 75.2 t -57.89 -34.44 48.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-O 121.682 0.753 . . . . 73.109999999999999 110.866 177.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -104.47 -6.49 20.61 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.49 0.662 . . . . 74.519999999999996 109.763 -177.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -114.8 -66.59 0.43 Allowed Glycine 0 N--CA 1.416 -2.686 0 CA-C-N 115.352 -0.84 . . . . 64.510000000000005 113.425 -171.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 64.31 30.01 13.51 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 122.8 1.285 . . . . 74.219999999999999 109.07 -168.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 10.7 p -88.99 -175.35 4.8 Favored 'General case' 0 N--CA 1.409 -2.516 0 CA-C-N 112.954 -1.93 . . . . 71.430000000000007 109.545 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 13.5 mptt -108.24 143.47 37.02 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.131 -1.063 . . . . 75.120000000000005 108.131 177.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -132.41 157.14 45.3 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.364 0.602 . . . . 72.219999999999999 112.493 -175.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 62.3 m -140.42 150.16 43.5 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.716 -1.216 . . . . 74.040000000000006 107.716 174.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -123.82 138.18 54.54 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 120.713 0.292 . . . . 64.349999999999994 110.493 -176.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -136.33 143.23 44.02 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.712 -0.848 . . . . 72.510000000000005 108.712 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 45.5 m -97.17 135.13 39.56 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.404 1.097 . . . . 73.099999999999994 111.906 -178.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.43 153.01 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.813 0 CA-C-N 113.028 -1.897 . . . . 72.519999999999996 107.023 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -90.58 133.92 34.75 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.774 -0.77 . . . . 70.150000000000006 109.704 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.558 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 69.0 m -162.26 162.8 19.38 Favored Pre-proline 0 C--O 1.202 -1.438 0 N-CA-C 107.926 -1.138 . . . . 73.439999999999998 107.926 177.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -68.27 -3.93 11.79 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 122.194 1.929 . . . . 75.25 113.157 177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -79.48 136.66 55.9 Favored Pre-proline 0 N--CA 1.425 -1.69 0 N-CA-C 107.948 -1.13 . . . . 74.299999999999997 107.948 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -59.34 147.98 88.6 Favored 'Trans proline' 0 C--O 1.247 0.927 0 C-N-CA 123.047 2.498 . . . . 72.310000000000002 113.391 -175.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.701 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.72 108.12 0.8 Allowed 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.391 -0.822 . . . . 73.319999999999993 111.232 -177.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 131.62 -21.05 4.54 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 115.387 -0.824 . . . . 63.350000000000001 111.203 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.65 137.21 36.32 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.638 -0.875 . . . . 72.299999999999997 108.638 178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 503' ' ' GLN . 10.3 p -91.42 121.43 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.719 0 CA-C-O 121.939 0.875 . . . . 73.340000000000003 109.207 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.5 p -79.47 -16.56 55.88 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.774 -1.103 . . . . 75.5 111.174 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 145.98 -162.7 28.35 Favored Glycine 0 N--CA 1.425 -2.082 0 C-N-CA 120.774 -0.727 . . . . 75.049999999999997 112.18 175.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.9 p -116.26 157.68 24.55 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.646 -1.242 . . . . 75.219999999999999 107.646 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.402 ' HB3' ' CD ' ' A' ' 552' ' ' GLU . 23.5 t-20 -63.38 -49.4 79.1 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 118.634 -1.226 . . . . 73.519999999999996 112.279 178.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -71.48 136.11 27.88 Favored 'Trans proline' 0 C--N 1.364 1.347 0 N-CA-C 108.705 -1.306 . . . . 70.019999999999996 108.705 170.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -66.12 159.34 50.0 Favored 'Trans proline' 0 C--O 1.248 0.984 0 C-N-CA 122.324 2.016 . . . . 74.430000000000007 113.199 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.96 139.19 58.74 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.756 -0.656 . . . . 73.319999999999993 109.86 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.81 -19.67 51.22 Favored Glycine 0 N--CA 1.432 -1.585 0 N-CA-C 111.781 -0.528 . . . . 71.219999999999999 111.781 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 17.5 m -74.13 129.06 37.1 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 110.354 -0.239 . . . . 70.25 110.354 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 14.6 t -82.7 126.76 32.73 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-O 121.578 0.704 . . . . 71.310000000000002 109.388 175.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.3 m -123.81 155.52 66.61 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 107.716 -1.216 . . . . 73.420000000000002 107.716 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -61.69 137.65 69.97 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 120.973 1.115 . . . . 75.030000000000001 111.531 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.26 -20.23 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.961 0.886 . . . . 72.420000000000002 110.655 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -87.72 -18.07 30.3 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.143 -0.935 . . . . 75.299999999999997 111.647 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 85.1 p -89.89 175.05 7.36 Favored 'General case' 0 C--O 1.252 1.235 0 N-CA-C 113.453 0.909 . . . . 73.129999999999995 113.453 -172.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 11.1 p -96.93 138.6 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 CA-C-N 114.281 -1.327 . . . . 73.540000000000006 111.175 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.4 mt -114.52 137.96 46.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.791 -1.189 . . . . 73.200000000000003 107.791 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . 0.402 ' CD ' ' HB3' ' A' ' 538' ' ' ASN . 1.7 pm0 -103.39 128.69 50.45 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.788 0.804 . . . . 72.450000000000003 112.188 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.86 122.03 42.74 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.678 -1.601 . . . . 73.530000000000001 108.876 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -88.23 113.2 23.61 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.53 0.681 . . . . 65.519999999999996 110.344 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 524' ' ' SER . 18.2 t -93.07 122.96 44.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 107.341 -1.355 . . . . 71.430000000000007 107.341 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.701 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 48.5 t -81.92 131.95 35.26 Favored 'General case' 0 N--CA 1.405 -2.681 0 N-CA-C 108.797 -0.816 . . . . 53.340000000000003 108.797 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -95.11 141.55 28.61 Favored 'General case' 0 N--CA 1.412 -2.363 0 N-CA-C 105.526 -2.028 . . . . 75.349999999999994 105.526 168.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -56.05 -23.94 41.15 Favored Glycine 0 CA--C 1.499 -0.952 0 O-C-N 124.48 1.112 . . . . 62.240000000000002 112.564 -177.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.2 t30 68.16 20.98 8.77 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-O 123.129 1.442 . . . . 74.310000000000002 109.026 174.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.533 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 66.7 mt-30 -141.79 164.54 29.93 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 113.094 -1.866 . . . . 75.120000000000005 107.117 178.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -143.23 151.65 40.84 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.785 -1.191 . . . . 75.030000000000001 107.785 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 13.6 p -70.45 132.23 33.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 121.01 0.433 . . . . 73.109999999999999 110.116 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 563' ' ' MET . . . . . 0.403 ' SD ' HG22 ' A' ' 620' ' ' ILE . 44.2 ttp -91.15 109.52 36.04 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 108.405 -0.961 . . . . 72.430000000000007 108.405 175.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.75 160.24 44.62 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.478 2.118 . . . . 73.450000000000003 110.897 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -73.8 115.06 12.79 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.971 0.891 . . . . 73.120000000000005 112.329 -178.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.7 pp -135.3 18.98 3.38 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.096 -1.411 . . . . 75.349999999999994 107.789 174.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 8.7 t -74.41 136.89 42.39 Favored 'General case' 0 N--CA 1.417 -2.08 0 CA-C-N 114.603 -1.18 . . . . 75.519999999999996 108.902 -175.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . 0.457 ' HA2' ' CZ ' ' A' ' 602' ' ' ARG . . . 113.96 50.28 0.51 Allowed Glycine 0 N--CA 1.42 -2.377 0 CA-C-N 115.546 -0.752 . . . . 73.430000000000007 111.914 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 19.8 ptp -142.17 173.36 11.59 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 120.099 -0.64 . . . . 64.340000000000003 110.246 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -98.61 175.63 5.93 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.987 -1.116 . . . . 73.0 107.987 -177.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 38.3 t-105 -68.82 -29.91 68.35 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.188 -0.671 . . . . 74.409999999999997 109.188 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.38 -15.64 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 115.579 -0.737 . . . . 64.439999999999998 110.299 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.583 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 9.0 m-20 -96.5 -44.69 7.06 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 108.44 -0.948 . . . . 73.299999999999997 108.44 176.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.98 -45.86 90.44 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.705 -1.134 . . . . 74.129999999999995 113.529 -174.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.493 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 35.4 tt0 -60.46 -50.46 85.54 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 120.664 -0.414 . . . . 70.439999999999998 111.828 -177.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 51.5 Cg_exo -58.88 -28.46 87.39 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 121.469 1.446 . . . . 74.5 111.576 173.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.667 ' O ' ' HB3' ' A' ' 581' ' ' LEU . 17.0 mmt180 -62.88 -38.45 90.92 Favored 'General case' 0 C--O 1.204 -1.324 0 CA-C-O 118.306 -0.854 . . . . 75.129999999999995 112.688 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.774 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 6.5 mp -59.38 -49.51 77.52 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.652 -1.219 . . . . 74.129999999999995 109.547 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -67.33 -42.07 84.2 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.518 -1.219 . . . . 74.019999999999996 113.515 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -71.15 -39.64 71.83 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.839 0.681 . . . . 73.349999999999994 112.839 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . 0.667 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 1.7 tp -82.97 -9.43 59.29 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.38 0.672 . . . . 71.439999999999998 111.053 -176.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 69.48 40.81 78.63 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 110.616 -0.993 . . . . 73.409999999999997 110.616 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . 0.774 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 11.3 t90 -87.46 126.45 34.9 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.217 -1.401 . . . . 74.019999999999996 107.217 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 17.4 p -86.81 -28.79 22.73 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 123.08 0.552 . . . . 71.530000000000001 112.389 -174.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -74.71 -175.5 34.99 Favored Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 115.588 -0.733 . . . . 75.219999999999999 111.636 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 23.9 mmt -123.3 155.21 37.69 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.681 -0.489 . . . . 74.040000000000006 109.681 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 47.4 tp -94.12 118.51 31.64 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 123.613 0.571 . . . . 74.340000000000003 109.578 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -118.14 122.12 42.27 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.127 -1.064 . . . . 74.530000000000001 108.127 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.34 130.02 34.79 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 106.928 -1.508 . . . . 75.209999999999994 106.928 172.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.75 -35.12 23.06 Favored Glycine 0 C--N 1.285 -2.253 0 CA-C-N 115.585 -0.734 . . . . 51.439999999999998 111.688 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.61 147.72 39.81 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 120.828 0.347 . . . . 73.129999999999995 110.8 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -100.18 123.66 44.68 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 102.814 -3.032 . . . . 75.129999999999995 102.814 170.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.89 137.41 32.7 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.611 0 N-CA-C 106.531 -1.655 . . . . 75.329999999999998 106.531 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -75.53 106.88 7.32 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 118.418 -1.313 . . . . 65.510000000000005 111.122 -178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -129.61 -64.34 0.89 Allowed 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.023 -1.473 . . . . 74.140000000000001 107.023 172.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 111.8 150.15 11.41 Favored Glycine 0 N--CA 1.42 -2.367 0 C-N-CA 120.394 -0.908 . . . . 73.409999999999997 111.111 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.95 -32.76 62.77 Favored Glycine 0 C--N 1.307 -1.083 0 C-N-CA 123.356 0.503 . . . . 72.0 113.685 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 20.3 t -72.37 -24.18 61.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.952 0.882 . . . . 74.230000000000004 109.968 -175.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -90.3 -0.98 57.87 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.301 -0.863 . . . . 75.049999999999997 109.82 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 37.1 m80 75.99 99.61 0.07 Allowed 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 124.975 1.31 . . . . 73.140000000000001 109.906 -173.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -82.75 72.28 9.83 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.615 1.197 . . . . 71.519999999999996 112.076 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . 0.457 ' CZ ' ' HA2' ' A' ' 568' ' ' GLY . 9.9 ptm180 -100.14 166.48 10.99 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.362 -1.29 . . . . 74.209999999999994 109.594 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 10.4 p -62.86 131.64 28.37 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 CA-C-N 115.995 -0.548 . . . . 73.420000000000002 109.931 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 12.9 p -109.99 -26.68 3.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 121.724 0.773 . . . . 71.129999999999995 110.276 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -154.01 135.53 14.28 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.52 -0.764 . . . . 74.340000000000003 110.188 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -127.09 136.1 51.68 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.035 -1.468 . . . . 74.209999999999994 107.035 171.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -65.68 -51.62 48.42 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 112.816 0.673 . . . . 65.400000000000006 112.816 -175.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -79.11 114.01 3.3 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.576 1.517 . . . . 75.120000000000005 108.934 172.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.06 145.19 54.66 Favored 'Trans proline' 0 C--O 1.25 1.121 0 C-N-CA 122.359 2.039 . . . . 72.530000000000001 113.046 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -63.42 132.46 51.49 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.603 -0.726 . . . . 73.040000000000006 109.227 176.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 102.65 0.03 49.34 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 110.971 -0.852 . . . . 72.25 110.971 -175.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 32.3 m -105.51 150.43 25.34 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 109.559 -0.534 . . . . 71.129999999999995 109.559 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -73.38 127.19 10.56 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 111.172 -0.771 . . . . 71.230000000000004 111.172 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.6 m -117.09 142.76 29.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 108.22 -1.03 . . . . 74.540000000000006 108.22 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.533 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 29.3 p30 -44.1 167.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.073 1.509 . . . . 74.540000000000006 115.073 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -55.08 -25.53 31.72 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.483 1.113 . . . . 73.109999999999999 113.739 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -96.27 -8.93 31.5 Favored 'General case' 0 C--O 1.207 -1.163 0 C-N-CA 120.05 -0.66 . . . . 64.200000000000003 110.105 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.64 18.96 70.66 Favored Glycine 0 C--O 1.217 -0.923 0 CA-C-O 120.044 -0.309 . . . . 74.430000000000007 113.765 167.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.93 119.74 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-O 121.82 0.819 . . . . 75.219999999999999 110.711 -171.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.403 HG22 ' SD ' ' A' ' 563' ' ' MET . 2.7 pp -127.36 133.97 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 115.132 -0.94 . . . . 75.319999999999993 110.767 -177.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.2 t -103.24 135.93 43.96 Favored 'General case' 0 C--O 1.259 1.597 0 N-CA-C 108.748 -0.834 . . . . 74.299999999999997 108.748 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.7 pp -139.2 165.99 25.7 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.815 -0.629 . . . . 75.420000000000002 111.608 -178.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -131.4 137.93 48.89 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.944 -0.761 . . . . 72.420000000000002 108.944 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -136.65 166.48 23.45 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.038 -0.528 . . . . 71.439999999999998 110.319 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -71.58 67.84 0.99 Allowed Glycine 0 CA--C 1.527 0.803 0 O-C-N 124.069 0.855 . . . . 75.400000000000006 114.925 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 . . . . . 0 C--O 1.262 1.715 0 C-N-CA 126.628 1.971 . . . . 75.530000000000001 112.064 -175.371 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.724 0 N-CA-C 110.007 -1.237 . . . . 52.539999999999999 110.007 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.15 154.02 36.85 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.099 1.866 . . . . 74.140000000000001 111.92 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -102.0 -0.16 34.16 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.26 1.029 . . . . 73.019999999999996 109.341 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 27.8 p -140.03 153.97 46.97 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.69 -1.141 . . . . 73.129999999999995 109.003 -176.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . 0.47 ' NZ ' ' HB2' ' A' ' 495' ' ' LYS . 0.0 OUTLIER -137.97 145.09 41.53 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.893 -0.41 . . . . 75.519999999999996 109.893 173.371 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 19.9 m-20 -77.89 141.89 38.8 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.849 -0.797 . . . . 63.25 108.849 173.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.6 pt -108.71 130.12 23.12 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 115.728 -0.669 . . . . 75.400000000000006 110.336 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -80.7 -177.49 3.79 Favored 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.705 2.27 . . . . 64.340000000000003 112.333 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -87.78 89.83 8.14 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 122.459 1.123 . . . . 71.120000000000005 110.521 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.0 m -80.59 -0.31 4.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-N 114.936 -1.029 . . . . 63.109999999999999 111.96 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -69.53 100.84 1.48 Allowed 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.734 -0.666 . . . . 71.140000000000001 110.494 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 156.86 -38.11 0.57 Allowed Glycine 0 C--N 1.304 -1.224 0 C-N-CA 120.808 -0.71 . . . . 64.430000000000007 111.979 178.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -92.62 -175.66 4.03 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 109.543 -0.54 . . . . 74.310000000000002 109.543 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 13.2 m -70.18 154.86 41.42 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.35 -0.981 . . . . 73.319999999999993 108.35 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.476 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.4 p -64.14 -41.33 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 C-N-CA 120.737 -0.385 . . . . 74.010000000000005 110.797 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . 0.577 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 28.1 t70 -59.69 -43.24 94.11 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 109.815 -0.439 . . . . 54.240000000000002 109.815 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 46.3 t -69.29 -41.54 81.08 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 CA-C-N 115.868 -0.606 . . . . 64.120000000000005 110.085 -178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -58.24 -44.02 88.09 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.753 0.311 . . . . 35.310000000000002 110.671 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.0 mt-30 -64.8 -44.88 88.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.027 -0.533 . . . . 75.120000000000005 110.617 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.577 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 33.4 mmtp -64.76 -40.17 94.84 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 116.19 -0.459 . . . . 75.510000000000005 110.129 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . 0.475 ' O ' HG13 ' A' ' 514' ' ' VAL . 85.9 m-20 -66.72 -40.49 88.44 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.856 -0.611 . . . . 71.230000000000004 111.585 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . 0.471 HD11 ' N ' ' A' ' 513' ' ' ASN . 4.4 pp -69.9 -41.37 74.78 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.42 -0.912 . . . . 73.319999999999993 110.776 177.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.471 ' N ' HD11 ' A' ' 512' ' ' LEU . 2.4 t-20 -64.38 -38.91 92.69 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 124.136 0.974 . . . . 74.319999999999993 111.259 -177.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 511' ' ' ASN . 9.0 p -64.06 -31.62 54.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.196 0.522 . . . . 75.230000000000004 110.876 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -112.62 23.24 13.73 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.409 -0.589 . . . . 75.400000000000006 109.409 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -146.07 -56.13 0.02 OUTLIER Glycine 0 CA--C 1.484 -1.866 0 C-N-CA 119.653 -1.26 . . . . 63.240000000000002 113.963 -174.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 65.76 26.28 11.32 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.211 1.005 . . . . 74.519999999999996 109.618 -175.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 14.7 p -82.95 -175.71 5.97 Favored 'General case' 0 N--CA 1.409 -2.489 0 CA-C-N 113.755 -1.566 . . . . 74.519999999999996 108.905 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.51 142.92 38.2 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.042 -1.095 . . . . 75.200000000000003 108.042 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -130.33 148.78 52.2 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.078 0.466 . . . . 72.099999999999994 111.332 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 32.2 m -138.32 139.99 39.33 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.058 -0.719 . . . . 74.299999999999997 109.058 176.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -118.09 138.67 52.09 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.85 0.357 . . . . 73.120000000000005 110.795 -176.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -135.02 130.42 35.65 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.268 -0.424 . . . . 71.030000000000001 109.862 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 73.9 m -88.96 129.15 35.68 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.695 0.76 . . . . 74.030000000000001 112.175 -178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.83 149.68 25.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.109 -1.811 . . . . 71.340000000000003 106.109 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -81.48 136.44 35.64 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.908 -0.717 . . . . 73.510000000000005 109.772 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 67.2 m -158.56 164.85 19.91 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 107.982 -1.118 . . . . 53.43 107.982 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -65.35 -14.78 46.77 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.251 1.968 . . . . 72.409999999999997 113.534 178.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.36 146.85 40.74 Favored Pre-proline 0 C--N 1.326 -0.413 0 C-N-CA 120.945 -0.302 . . . . 73.340000000000003 110.993 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.77 155.47 37.56 Favored 'Trans proline' 0 C--O 1.263 1.758 0 C-N-CA 123.633 2.889 . . . . 73.439999999999998 115.378 -175.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.669 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -68.71 110.4 4.28 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 113.617 -1.629 . . . . 73.340000000000003 110.602 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 137.39 -21.63 3.26 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.574 -0.822 . . . . 75.329999999999998 111.546 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -82.88 138.18 33.99 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.99 -0.745 . . . . 71.219999999999999 108.99 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 6.6 p -86.16 114.74 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.193 0 CA-C-O 122.12 0.962 . . . . 75.140000000000001 108.907 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.06 -32.57 74.34 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 113.575 -1.648 . . . . 70.340000000000003 109.681 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 153.26 -166.69 31.68 Favored Glycine 0 N--CA 1.418 -2.546 0 N-CA-C 110.102 -1.199 . . . . 65.439999999999998 110.102 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 6.6 p -116.96 157.44 25.75 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 109.448 -0.575 . . . . 65.140000000000001 109.448 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -63.45 -55.17 37.55 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 119.17 -0.443 . . . . 75.329999999999998 110.495 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -69.02 126.5 13.88 Favored 'Trans proline' 0 C--N 1.365 1.442 0 N-CA-C 108.346 -1.444 . . . . 54.420000000000002 108.346 170.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.59 155.22 67.89 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.497 2.131 . . . . 53.240000000000002 113.293 -176.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.98 130.81 47.32 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.925 -0.58 . . . . 55.32 110.294 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.85 -4.82 42.44 Favored Glycine 0 C--N 1.303 -1.258 0 C-N-CA 120.205 -0.998 . . . . 74.230000000000004 111.725 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 25.3 m -88.16 133.28 34.05 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.467 -0.568 . . . . 74.549999999999997 109.467 178.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 0.2 OUTLIER -86.71 123.9 32.39 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 106.84 -1.541 . . . . 75.030000000000001 106.84 174.74 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.67 155.06 63.53 Favored Pre-proline 0 C--N 1.295 -1.798 0 N-CA-C 108.454 -0.943 . . . . 73.040000000000006 108.454 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -64.34 138.3 59.94 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 121.552 1.501 . . . . 74.430000000000007 111.636 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.31 -19.96 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 CA-C-O 122.168 0.985 . . . . 71.099999999999994 109.858 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -91.12 -8.38 48.94 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.785 -1.098 . . . . 73.439999999999998 111.687 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 15.1 t -89.79 -175.64 4.7 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-O 121.282 0.563 . . . . 63.210000000000001 110.416 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.1 p -118.89 137.65 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-N 115.869 -0.605 . . . . 72.409999999999997 109.511 -177.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 59.8 mt -97.55 132.56 41.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.883 -0.784 . . . . 73.310000000000002 108.883 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -103.12 116.1 31.84 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.416 -1.327 . . . . 72.219999999999999 107.416 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.84 125.8 52.36 Favored 'General case' 0 C--N 1.312 -1.035 0 O-C-N 123.625 0.578 . . . . 75.219999999999999 111.0 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -93.09 121.66 34.66 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.699 -0.682 . . . . 74.519999999999996 109.293 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 15.1 t -104.37 137.4 33.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 107.447 -1.316 . . . . 71.450000000000003 107.447 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.669 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 24.5 p -88.08 139.53 30.42 Favored 'General case' 0 N--CA 1.413 -2.315 0 C-N-CA 119.92 -0.712 . . . . 74.239999999999995 109.839 178.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -108.41 145.03 35.2 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 105.299 -2.112 . . . . 73.219999999999999 105.299 167.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 559' ' ' ASN . . . -54.68 -22.58 25.98 Favored Glycine 0 CA--C 1.506 -0.516 0 O-C-N 124.72 1.262 . . . . 62.340000000000003 114.743 -174.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 558' ' ' GLY . 18.9 t-20 82.79 -16.4 0.59 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.816 1.246 . . . . 62.140000000000001 109.678 -178.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.443 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 86.9 mt-30 -113.48 157.33 22.12 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.283 -0.871 . . . . 73.239999999999995 111.383 -176.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -136.8 157.85 45.81 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.278 -1.379 . . . . 74.239999999999995 107.278 176.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.97 119.3 23.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.434 -0.58 . . . . 74.420000000000002 109.434 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 54.8 ttp -79.98 133.46 58.02 Favored Pre-proline 0 C--N 1.311 -1.077 0 C-N-CA 120.817 -0.353 . . . . 75.409999999999997 110.088 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.95 169.67 17.33 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.71 2.273 . . . . 74.540000000000006 111.525 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -89.62 119.87 30.42 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 113.219 0.822 . . . . 75.310000000000002 113.219 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.36 12.73 3.02 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.504 -1.225 . . . . 63.340000000000003 109.272 173.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 84.5 p -69.03 153.41 43.83 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 115.69 -0.686 . . . . 75.329999999999998 112.824 -173.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 86.13 56.66 2.26 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.793 -0.923 . . . . 44.329999999999998 110.793 -178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 569' ' ' MET . . . . . 0.467 ' O ' ' HA ' ' A' ' 602' ' ' ARG . 14.4 ptm -142.49 177.04 8.55 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.01 -0.367 . . . . 73.439999999999998 110.01 -175.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -95.5 160.63 14.42 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 106.69 -1.596 . . . . 75.310000000000002 106.69 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . 0.452 ' CZ3' ' HB3' ' A' ' 589' ' ' LYS . 19.3 t-105 -66.49 -32.32 73.61 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.482 -0.932 . . . . 75.209999999999994 108.482 176.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.1 m -76.2 -13.53 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.284 -0.871 . . . . 62.32 111.159 -174.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -96.96 -27.23 14.73 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.779 -1.193 . . . . 73.310000000000002 107.779 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -68.82 -40.33 79.57 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.25 -0.886 . . . . 70.310000000000002 111.773 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.633 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 44.9 mt-10 -55.36 -55.6 38.07 Favored Pre-proline 0 CA--C 1.567 1.606 0 N-CA-C 112.725 0.639 . . . . 75.019999999999996 112.725 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.5 -30.38 79.75 Favored 'Trans proline' 0 C--N 1.364 1.391 0 CA-C-N 120.707 1.288 . . . . 71.219999999999999 112.606 172.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -68.73 -36.36 78.31 Favored 'General case' 0 N--CA 1.435 -1.197 0 O-C-N 122.091 -0.38 . . . . 62.420000000000002 111.009 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.3 pp -64.51 -45.97 84.96 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 120.728 0.299 . . . . 74.019999999999996 110.655 -178.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.522 ' N ' HD11 ' A' ' 578' ' ' LEU . 8.5 ptm180 -65.93 -34.84 79.04 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.358 -0.383 . . . . 73.219999999999999 111.242 175.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.24 -39.31 82.32 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 116.41 -0.359 . . . . 63.240000000000002 111.548 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.93 -9.66 42.32 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.555 -0.458 . . . . 75.209999999999994 111.399 -177.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 79.43 42.37 11.85 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.071 -0.585 . . . . 73.230000000000004 112.339 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . 0.434 ' CH2' ' HG ' ' A' ' 587' ' ' LEU . 10.0 t90 -81.46 127.26 32.62 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.799 -0.815 . . . . 74.450000000000003 108.799 178.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 22.5 m -83.19 -29.63 28.42 Favored 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 113.083 0.771 . . . . 55.109999999999999 113.083 -176.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -90.72 -175.62 44.3 Favored Glycine 0 C--N 1.315 -0.611 0 CA-C-N 116.555 -0.293 . . . . 72.329999999999998 112.905 -177.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 70.1 mtm -117.73 163.33 16.65 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.368 -0.604 . . . . 65.140000000000001 109.368 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . 0.434 ' HG ' ' CH2' ' A' ' 583' ' ' TRP . 5.1 mp -84.26 131.14 34.76 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 109.703 -0.48 . . . . 71.439999999999998 109.703 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -101.86 116.07 31.9 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 108.831 -0.803 . . . . 73.329999999999998 108.831 177.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . 0.452 ' HB3' ' CZ3' ' A' ' 571' ' ' TRP . 0.0 OUTLIER -95.08 134.23 38.02 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.659 0.742 . . . . 74.239999999999995 112.204 -175.077 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -95.58 -145.0 18.03 Favored Glycine 0 C--N 1.29 -1.982 0 N-CA-C 109.264 -1.534 . . . . 74.109999999999999 109.264 174.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -74.49 126.16 30.16 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 117.309 0.554 . . . . 73.340000000000003 110.547 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -69.75 144.21 52.8 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 123.913 0.758 . . . . 72.010000000000005 109.703 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 58.6 t -106.68 143.44 17.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-N 115.272 -0.877 . . . . 73.420000000000002 109.638 -174.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -74.94 107.0 6.73 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.968 -0.753 . . . . 63.009999999999998 108.968 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -126.98 -53.88 1.4 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 116.057 -0.52 . . . . 72.540000000000006 110.125 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 101.81 129.44 6.68 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.963 -0.855 . . . . 72.310000000000002 110.963 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.68 -43.11 91.55 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 116.539 0.169 . . . . 72.439999999999998 113.224 -177.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 35.3 t -68.7 -24.68 64.52 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.323 0.583 . . . . 73.109999999999999 110.65 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -93.53 -1.75 55.16 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 116.088 -0.505 . . . . 75.510000000000005 110.593 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 42.2 m170 80.55 98.33 0.06 Allowed 'General case' 0 C--O 1.246 0.892 0 C-N-CA 125.437 1.495 . . . . 72.329999999999998 113.216 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -73.08 90.39 1.53 Allowed 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 114.091 -1.413 . . . . 73.409999999999997 109.952 177.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 569' ' ' MET . 19.6 mtm180 -107.94 171.14 7.57 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.865 -0.607 . . . . 75.349999999999994 110.003 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 14.7 p -73.4 137.97 22.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.751 -0.833 . . . . 72.219999999999999 108.751 175.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 33.5 m -107.26 -29.19 2.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 119.752 -0.779 . . . . 73.519999999999996 110.865 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -156.55 139.17 15.03 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.65 -0.705 . . . . 74.310000000000002 109.464 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -133.02 141.96 48.55 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.057 -1.831 . . . . 70.150000000000006 106.057 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.479 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 23.7 t-20 -62.14 -60.36 10.37 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-O 118.923 -0.561 . . . . 74.200000000000003 112.483 -177.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 6.3 Cg_exo -87.98 109.26 0.62 Allowed 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 121.752 1.635 . . . . 72.430000000000007 109.844 173.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -71.11 160.63 48.58 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 123.225 2.616 . . . . 71.409999999999997 113.112 -178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.02 132.67 47.7 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.821 -0.807 . . . . 65.420000000000002 108.821 175.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 103.18 -11.88 55.32 Favored Glycine 0 C--N 1.302 -1.336 0 N-CA-C 110.852 -0.899 . . . . 44.539999999999999 110.852 -175.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 44.8 m -100.27 159.5 15.07 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.787 -0.82 . . . . 72.540000000000006 108.787 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -76.86 120.61 5.72 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 112.036 -0.426 . . . . 71.129999999999995 112.036 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.7 m -112.42 143.32 22.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 107.793 -1.188 . . . . 72.019999999999996 107.793 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.443 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.2 p-10 -52.99 168.8 0.11 Allowed 'General case' 0 C--O 1.216 -0.704 0 C-N-CA 123.534 0.734 . . . . 74.120000000000005 112.184 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . 0.267 0.0 OUTLIER -60.91 -24.95 66.4 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 113.642 0.978 . . . . 74.340000000000003 113.642 -176.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -80.97 -9.2 59.87 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 119.686 -0.806 . . . . 73.219999999999999 109.522 176.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.18 18.9 67.66 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 112.008 -0.437 . . . . 75.239999999999995 112.008 175.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.49 119.34 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-O 122.379 1.085 . . . . 75.519999999999996 111.694 -166.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.467 ' O ' HD11 ' A' ' 620' ' ' ILE . 2.8 pp -118.17 132.19 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 CA-C-N 114.77 -1.105 . . . . 72.329999999999998 110.352 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 12.9 t -99.19 128.76 45.37 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.007 -1.479 . . . . 73.140000000000001 107.007 174.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.1 166.64 23.97 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 112.599 0.592 . . . . 74.230000000000004 112.599 -172.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -126.21 134.88 51.11 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 105.231 -2.137 . . . . 75.010000000000005 105.231 173.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -142.29 166.05 25.74 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.912 -0.585 . . . . 71.209999999999994 110.571 -169.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -63.45 130.49 40.72 Favored Glycine 0 N--CA 1.433 -1.546 0 O-C-N 124.203 0.939 . . . . 53.049999999999997 111.956 175.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 . . . . . 0 C--N 1.301 -1.501 0 C-N-CA 126.162 1.785 . . . . 75.230000000000004 114.446 -178.878 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.685 0 N-CA-C 110.382 -1.087 . . . . 61.549999999999997 110.382 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -68.58 142.92 55.06 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.134 1.89 . . . . 75.530000000000001 111.475 178.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -117.61 9.59 13.17 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.995 -0.548 . . . . 62.310000000000002 110.816 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.451 ' HB ' ' OG1' ' A' ' 544' ' ' THR . 33.9 p -137.49 144.87 42.43 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.389 -0.596 . . . . 75.5 109.389 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -141.93 148.9 39.42 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 123.493 0.717 . . . . 74.230000000000004 109.343 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 14.3 m-20 -89.58 131.17 35.72 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 120.942 0.401 . . . . 73.030000000000001 110.759 -175.07 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.0 pt -90.77 128.05 49.81 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 116.048 -0.524 . . . . 75.400000000000006 110.579 178.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.27 -177.57 2.17 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.706 2.271 . . . . 70.409999999999997 112.463 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -81.26 99.84 8.84 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.789 -0.641 . . . . 71.310000000000002 109.556 177.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.1 m -102.13 -3.31 9.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.301 -0.863 . . . . 73.310000000000002 111.442 -179.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -64.87 103.65 0.74 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.836 -0.62 . . . . 52.450000000000003 110.219 -178.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 145.87 -24.08 1.79 Allowed Glycine 0 C--N 1.295 -1.707 0 CA-C-N 115.476 -0.784 . . . . 74.219999999999999 111.984 178.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.421 ' O ' HG12 ' A' ' 534' ' ' VAL . 2.2 mp0 -92.04 -179.24 5.22 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.124 -1.065 . . . . 74.109999999999999 108.124 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 31.5 m -75.85 155.17 35.57 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.457 -1.683 . . . . 61.399999999999999 106.457 175.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.556 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.2 p -61.29 -43.19 96.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 118.103 0.41 . . . . 73.329999999999998 111.438 -177.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . 0.54 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 25.6 t70 -63.17 -41.29 99.21 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.415 -0.357 . . . . 75.400000000000006 110.176 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 94.5 t -68.04 -42.99 85.69 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.984 0 CA-C-N 115.386 -0.825 . . . . 64.310000000000002 110.33 -178.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.412 ' CB ' HG13 ' A' ' 534' ' ' VAL . . . -62.5 -44.38 96.53 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 121.12 -0.232 . . . . 73.439999999999998 110.532 178.582 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 21.5 mt-30 -64.54 -46.5 82.56 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 116.437 -0.347 . . . . 74.150000000000006 110.676 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.54 ' HG3' ' O ' ' A' ' 506' ' ' ASP 0.359 0.0 OUTLIER -65.68 -37.0 85.27 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 112.386 0.513 . . . . 72.400000000000006 112.386 179.468 . . . . . . . . 4 4 . 1 . 021 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -60.55 -47.4 86.36 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.445 -0.576 . . . . 75.450000000000003 109.445 178.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.54 -37.66 80.16 Favored 'General case' 0 C--O 1.205 -1.275 0 CA-C-N 115.457 -0.792 . . . . 70.25 109.743 177.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -59.74 -34.44 72.95 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 123.884 0.874 . . . . 73.239999999999995 111.745 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.507 HG21 ' O ' ' A' ' 510' ' ' LYS . 73.6 t -56.57 -31.33 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 O-C-N 123.645 0.591 . . . . 60.149999999999999 110.524 176.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -114.08 5.92 16.2 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.095 -0.706 . . . . 74.340000000000003 109.095 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -124.42 -62.09 0.18 Allowed Glycine 0 CA--C 1.481 -2.06 0 C-N-CA 120.342 -0.932 . . . . 73.420000000000002 113.988 -169.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 61.07 32.66 19.74 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 122.144 0.973 . . . . 75.420000000000002 109.071 -172.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.9 p -87.02 -178.43 6.27 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.377 -1.283 . . . . 75.239999999999995 111.331 -177.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -108.22 143.11 37.49 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.98 -1.119 . . . . 74.329999999999998 107.98 178.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -125.3 146.14 49.69 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.745 0.307 . . . . 74.430000000000007 110.71 -174.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 56.3 p -126.92 141.07 51.9 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 106.18 -1.785 . . . . 74.319999999999993 106.18 171.043 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -129.72 122.57 29.15 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.299 0.571 . . . . 74.319999999999993 110.996 -174.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -118.09 125.31 50.04 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.632 -0.713 . . . . 74.209999999999994 109.493 -179.041 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 40.3 m -85.78 130.44 34.55 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-O 121.558 0.694 . . . . 55.030000000000001 111.287 -179.188 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.4 p -121.05 149.14 24.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 107.146 -1.427 . . . . 75.140000000000001 107.146 178.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.402 ' C ' ' HG ' ' A' ' 527' ' ' SER . 9.1 p-10 -80.63 135.44 36.05 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.164 -0.615 . . . . 75.420000000000002 109.762 -177.069 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.402 ' HG ' ' C ' ' A' ' 526' ' ' ASP . 70.8 m -159.75 165.27 18.3 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 108.1 -1.074 . . . . 74.099999999999994 108.1 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -71.5 -8.08 22.55 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.103 1.869 . . . . 73.310000000000002 112.549 177.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.464 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 16.0 mtm180 -81.57 141.71 48.96 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 123.48 0.712 . . . . 71.409999999999997 109.866 178.106 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.61 153.67 59.89 Favored 'Trans proline' 0 C--O 1.249 1.056 0 C-N-CA 123.431 2.754 . . . . 75.200000000000003 113.596 -174.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.689 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -68.37 105.98 2.35 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.192 -0.913 . . . . 71.310000000000002 110.576 -177.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 139.44 -17.13 3.11 Favored Glycine 0 N--CA 1.434 -1.5 0 CA-C-N 115.293 -0.867 . . . . 72.230000000000004 112.162 -179.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -81.33 130.05 34.87 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 109.594 -0.521 . . . . 75.200000000000003 109.594 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.431 ' HB ' ' HA ' ' A' ' 505' ' ' VAL . 7.8 p -81.36 118.01 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.252 0 CA-C-O 122.612 1.196 . . . . 74.329999999999998 108.871 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 m -80.07 -17.73 51.91 Favored 'General case' 0 C--N 1.269 -2.905 0 CA-C-N 112.938 -1.937 . . . . 74.010000000000005 110.177 -175.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 139.93 -163.12 26.3 Favored Glycine 0 N--CA 1.41 -3.034 0 C-N-CA 120.544 -0.836 . . . . 65.530000000000001 111.234 176.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.6 p -117.37 157.92 25.32 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 109.194 -0.669 . . . . 73.109999999999999 109.194 -179.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -66.61 -54.52 22.71 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 120.364 -0.535 . . . . 62.350000000000001 110.002 175.438 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -67.93 138.85 45.52 Favored 'Trans proline' 0 C--N 1.373 1.844 0 N-CA-C 109.395 -1.04 . . . . 74.230000000000004 109.395 170.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -62.9 155.39 60.49 Favored 'Trans proline' 0 C--O 1.244 0.801 0 C-N-CA 122.763 2.309 . . . . 71.230000000000004 113.106 -177.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.89 134.61 53.38 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.264 -0.426 . . . . 64.25 109.904 179.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.31 -5.53 57.45 Favored Glycine 0 C--N 1.303 -1.283 0 N-CA-C 111.344 -0.702 . . . . 54.450000000000003 111.344 -177.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 20.6 m -88.72 135.25 33.61 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.516 -0.55 . . . . 73.0 109.516 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 14.5 t -82.44 132.98 35.2 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.503 -0.925 . . . . 64.420000000000002 108.503 175.062 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.1 m -123.6 156.4 64.59 Favored Pre-proline 0 C--N 1.294 -1.834 0 N-CA-C 107.269 -1.382 . . . . 71.030000000000001 107.269 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.3 135.37 26.71 Favored 'Trans proline' 0 N--CA 1.433 -2.064 0 CA-C-N 119.833 0.976 . . . . 72.010000000000005 111.219 -178.061 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.68 -22.24 28.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 122.496 1.141 . . . . 75.040000000000006 108.838 177.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -79.9 -18.12 51.39 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 113.113 -1.858 . . . . 71.209999999999994 110.188 -175.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 18.7 t -102.07 -166.6 1.31 Allowed 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.612 -0.722 . . . . 73.310000000000002 109.512 -176.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 8.7 p -117.09 137.67 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.398 0 CA-C-N 115.162 -0.926 . . . . 73.5 109.196 -177.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.0 mt -91.68 141.37 14.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.324 -0.991 . . . . 74.400000000000006 108.324 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -102.29 116.93 33.68 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 108.506 -0.924 . . . . 73.430000000000007 108.506 -177.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.78 121.11 43.74 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.785 0.834 . . . . 70.340000000000003 109.921 -179.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -88.35 122.76 32.22 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.922 -0.769 . . . . 62.340000000000003 108.922 174.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 524' ' ' SER . 25.4 t -110.2 134.66 51.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 108.763 -0.828 . . . . 75.340000000000003 108.763 -178.269 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.689 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 75.5 m -81.57 131.1 35.26 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 120.093 -0.643 . . . . 74.150000000000006 109.885 176.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -99.69 131.78 45.46 Favored 'General case' 0 N--CA 1.411 -2.407 0 N-CA-C 104.28 -2.489 . . . . 72.510000000000005 104.28 166.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -60.17 -26.01 63.09 Favored Glycine 0 CA--C 1.49 -1.517 0 O-C-N 124.13 0.893 . . . . 73.439999999999998 112.924 -173.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 71.77 -15.44 0.45 Allowed 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 125.191 1.396 . . . . 74.310000000000002 110.721 178.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 558' ' ' GLY . 89.9 mt-30 -113.18 144.34 42.84 Favored 'General case' 0 N--CA 1.416 -2.167 0 C-N-CA 123.37 0.668 . . . . 75.209999999999994 111.754 -174.371 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -123.31 146.69 47.7 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.678 -1.23 . . . . 73.209999999999994 107.678 177.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.81 117.97 12.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.417 0.627 . . . . 75.099999999999994 110.504 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 51.9 ttp -81.11 120.51 78.82 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 115.626 -0.715 . . . . 73.0 110.246 -177.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.76 169.78 12.49 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 123.156 2.571 . . . . 65.299999999999997 111.917 176.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -65.53 115.49 5.81 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 122.195 0.998 . . . . 72.310000000000002 112.634 -178.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.2 pp -131.37 6.19 4.46 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 113.81 -1.541 . . . . 74.140000000000001 107.784 170.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 14.5 m -80.08 142.09 35.2 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 113.627 -1.624 . . . . 72.519999999999996 109.499 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . 0.489 ' H ' ' CG1' ' A' ' 603' ' ' VAL . . . 80.64 48.17 6.38 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 121.353 -0.451 . . . . 73.319999999999993 112.839 178.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 21.6 ptp -152.31 -174.71 4.98 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 109.331 -0.618 . . . . 74.239999999999995 109.331 178.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -95.08 166.65 11.82 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.637 -0.875 . . . . 72.150000000000006 108.637 -173.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 -66.58 -29.06 69.03 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.998 -0.742 . . . . 75.319999999999993 108.998 178.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.9 p -73.89 -12.36 15.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 CA-C-O 121.968 0.89 . . . . 74.299999999999997 109.948 -178.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -101.49 -29.48 11.96 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 115.725 -0.671 . . . . 64.430000000000007 111.146 173.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.46 -47.77 82.55 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.75 0.657 . . . . 71.140000000000001 111.166 179.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.479 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 43.1 mt-10 -55.5 -51.81 77.0 Favored Pre-proline 0 CA--C 1.56 1.348 0 N-CA-C 113.463 0.912 . . . . 72.430000000000007 113.463 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.439 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 31.9 Cg_exo -61.86 -40.24 45.93 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.613 1.542 . . . . 73.409999999999997 113.128 174.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -60.76 -40.58 93.04 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 111.4 0.148 . . . . 73.319999999999993 111.4 179.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.543 HD13 ' N ' ' A' ' 579' ' ' ARG . 4.3 pp -65.97 -46.58 77.54 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.543 -0.463 . . . . 72.239999999999995 112.029 -176.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.543 ' N ' HD13 ' A' ' 578' ' ' LEU . 15.1 ptp180 -66.82 -36.1 81.6 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.503 -0.317 . . . . 74.219999999999999 111.611 178.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.1 -30.67 67.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.255 0.55 . . . . 72.439999999999998 110.53 178.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 11.4 tp -81.43 -9.73 59.66 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.294 0.569 . . . . 62.299999999999997 110.452 177.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 76.5 26.71 62.73 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.445 -0.884 . . . . 75.030000000000001 112.062 179.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . 0.409 ' CD1' ' HA3' ' A' ' 618' ' ' GLY . 16.0 t90 -87.33 126.49 34.88 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 107.705 -1.22 . . . . 71.340000000000003 107.705 176.192 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 41.7 p -115.24 0.49 13.54 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 112.918 0.711 . . . . 72.239999999999995 112.918 -175.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -81.5 -173.88 48.58 Favored Glycine 0 C--O 1.248 0.996 0 C-N-CA 120.499 -0.857 . . . . 64.450000000000003 112.011 178.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 65.8 mtt -100.27 147.91 25.24 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 120.853 0.359 . . . . 74.010000000000005 110.729 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.1 tt -91.56 122.49 34.18 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.346 -1.353 . . . . 75.219999999999999 107.346 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . 0.538 ' O ' ' HA ' ' A' ' 621' ' ' THR . 32.3 t70 -98.65 119.87 38.11 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.231 -0.655 . . . . 75.439999999999998 109.231 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.88 135.05 53.02 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 116.181 -0.463 . . . . 65.530000000000001 110.035 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -73.01 -88.4 0.17 Allowed Glycine 0 C--N 1.297 -1.609 0 N-CA-C 110.727 -0.949 . . . . 64.010000000000005 110.727 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.7 154.12 47.4 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.778 -0.452 . . . . 73.340000000000003 109.778 177.192 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 624' ' ' PHE . 3.3 p30 -100.49 132.54 45.82 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.62 -0.881 . . . . 75.439999999999998 108.62 174.254 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 46.3 t -105.08 139.09 27.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 108.651 -0.87 . . . . 75.299999999999997 108.651 -176.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . 0.54 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 7.3 p-10 -71.53 110.9 6.41 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 122.185 0.993 . . . . 73.219999999999999 111.884 -173.316 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -113.24 -55.78 2.48 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.008 -0.996 . . . . 64.120000000000005 108.469 179.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 139.18 141.7 4.14 Favored Glycine 0 N--CA 1.416 -2.64 0 CA-C-N 115.613 -0.721 . . . . 71.209999999999994 111.465 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -59.77 -36.05 88.52 Favored Glycine 0 N--CA 1.446 -0.686 0 O-C-N 123.844 0.379 . . . . 73.299999999999997 112.744 -178.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 15.1 m -67.07 -24.7 66.0 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 123.053 0.541 . . . . 75.540000000000006 111.269 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -92.81 -12.75 30.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.867 0.365 . . . . 75.120000000000005 110.759 -178.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 23.2 m170 67.71 145.83 0.04 OUTLIER 'General case' 0 C--O 1.246 0.889 0 N-CA-C 114.914 1.45 . . . . 75.450000000000003 114.914 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -77.68 89.15 3.96 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 114.11 -1.405 . . . . 74.140000000000001 111.027 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -101.13 154.34 18.82 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.651 -1.24 . . . . 73.400000000000006 107.651 176.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . 0.489 ' CG1' ' H ' ' A' ' 568' ' ' GLY . 8.8 p -67.87 141.96 17.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.402 -0.962 . . . . 72.239999999999995 108.402 176.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.51 -53.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.726 -0.842 . . . . 74.200000000000003 108.726 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -149.0 145.65 27.42 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.779 -0.823 . . . . 75.420000000000002 108.779 -178.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -129.19 136.26 49.91 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.543 -1.28 . . . . 74.109999999999999 107.543 173.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.45 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 48.7 t30 -55.4 -54.1 54.81 Favored Pre-proline 0 C--N 1.314 -0.959 0 N-CA-C 112.697 0.629 . . . . 74.409999999999997 112.697 -178.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.8 Cg_endo -87.72 107.2 0.6 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 121.579 1.519 . . . . 75.230000000000004 109.47 173.53 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.29 160.8 47.76 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 123.308 2.672 . . . . 71.420000000000002 113.362 -177.407 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.64 130.07 44.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.149 -0.478 . . . . 71.25 109.772 177.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.3 -3.08 40.18 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.707 -0.758 . . . . 70.439999999999998 112.833 -178.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 2.1 t -101.88 162.99 12.49 Favored 'General case' 0 C--O 1.25 1.104 0 N-CA-C 108.329 -0.989 . . . . 75.120000000000005 108.329 178.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -85.13 127.81 8.39 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 120.657 -0.782 . . . . 72.129999999999995 111.726 179.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 32.7 m -112.04 141.65 26.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.801 -0.814 . . . . 65.540000000000006 108.801 177.243 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -56.47 176.27 0.09 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.631 1.173 . . . . 73.319999999999993 114.025 -175.481 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -56.93 -27.98 61.56 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.881 0.872 . . . . 74.310000000000002 112.504 -177.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.438 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 6.5 m-20 -94.25 -6.11 45.31 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 120.629 -0.428 . . . . 75.120000000000005 110.592 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . 0.409 ' HA3' ' CD1' ' A' ' 583' ' ' TRP . . . 66.19 17.93 66.51 Favored Glycine 0 CA--C 1.497 -1.053 0 C-N-CA 124.088 0.851 . . . . 51.130000000000003 113.993 170.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.21 119.24 15.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 122.312 1.053 . . . . 73.430000000000007 111.767 -165.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 45.0 pt -122.18 134.56 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 114.679 -1.146 . . . . 74.129999999999995 110.141 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 9.7 t -105.8 129.85 53.9 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.447 -0.945 . . . . 74.329999999999998 108.447 177.571 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.5 pp -138.86 166.03 25.49 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 113.037 0.754 . . . . 73.310000000000002 113.037 -176.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -128.11 137.33 52.08 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.085 -1.45 . . . . 74.239999999999995 107.085 176.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 592' ' ' ASP . 3.0 p90 -140.09 166.1 25.57 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.316 -0.554 . . . . 74.420000000000002 111.909 -172.321 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -76.27 169.39 54.87 Favored Glycine 0 N--CA 1.429 -1.817 0 CA-C-N 115.621 -0.718 . . . . 52.420000000000002 113.136 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.54 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 27.0 tt0 . . . . . 0 C--N 1.274 -2.717 0 N-CA-C 106.919 -1.511 . . . . 75.319999999999993 106.919 178.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.222 0 N-CA-C 110.194 -1.162 . . . . 63.409999999999997 110.194 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -72.24 149.55 51.63 Favored 'Trans proline' 0 C--O 1.243 0.759 0 C-N-CA 121.934 1.756 . . . . 74.230000000000004 111.463 178.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 61.76 6.02 1.49 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.302 1.441 . . . . 64.129999999999995 113.687 177.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 14.1 p -138.01 139.57 39.7 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 109.079 -0.712 . . . . 75.150000000000006 109.079 179.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 516' ' ' GLY . 74.7 mmtt -123.27 134.01 54.13 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-O 121.007 0.432 . . . . 75.430000000000007 110.311 -175.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -95.78 127.77 42.09 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.091 -0.959 . . . . 74.209999999999994 109.135 178.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 498' ' ' PRO . 27.0 pt -106.2 122.87 40.8 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 115.976 -0.556 . . . . 74.519999999999996 111.217 -178.556 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 11.3 Cg_exo -72.41 -175.45 1.79 Allowed 'Trans proline' 0 C--O 1.248 0.992 0 C-N-CA 122.165 1.91 . . . . 73.329999999999998 110.477 175.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -79.71 89.98 5.19 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.617 1.199 . . . . 52.340000000000003 110.565 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.29 -11.01 12.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.001 -1.454 . . . . 74.430000000000007 110.178 177.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -67.38 103.15 1.22 Allowed 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 114.53 -1.214 . . . . 72.519999999999996 109.12 178.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 148.86 -30.92 1.22 Allowed Glycine 0 C--N 1.293 -1.816 0 C-N-CA 120.493 -0.86 . . . . 73.109999999999999 112.095 178.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.401 ' O ' HG12 ' A' ' 534' ' ' VAL . 10.0 pt20 -94.76 -169.83 2.1 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 120.009 -0.677 . . . . 74.239999999999995 110.14 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 2.9 m -74.16 156.08 37.71 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.785 -0.82 . . . . 73.430000000000007 108.785 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.539 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.7 p -57.91 -47.76 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 O-C-N 123.464 0.477 . . . . 73.219999999999999 112.152 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -65.24 -36.69 84.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 120.565 -0.454 . . . . 74.030000000000001 110.012 -178.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.79 -41.92 85.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.831 0 CA-C-N 115.907 -0.588 . . . . 74.340000000000003 109.523 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -65.39 -45.24 84.76 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.749 -0.205 . . . . 72.409999999999997 110.912 177.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.5 mt-30 -63.97 -45.75 87.69 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 123.395 0.435 . . . . 74.510000000000005 110.759 -178.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.52 ' O ' HG21 ' A' ' 514' ' ' VAL . 0.1 OUTLIER -67.34 -39.35 85.78 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 116.154 -0.476 . . . . 64.230000000000004 110.007 -178.229 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -62.62 -46.89 86.16 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 123.39 0.431 . . . . 71.439999999999998 111.013 -179.332 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.3 pp -68.5 -35.81 78.03 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 115.83 -0.623 . . . . 71.209999999999994 110.995 -178.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -63.3 -35.98 82.17 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 123.512 0.725 . . . . 72.439999999999998 110.315 179.016 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.52 HG21 ' O ' ' A' ' 510' ' ' LYS . 85.0 t -63.47 -32.47 56.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.884 0 CA-C-O 121.127 0.489 . . . . 75.209999999999994 110.838 177.107 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . 0.43 ' O ' ' HD2' ' A' ' 495' ' ' LYS . 11.1 m-85 -103.32 3.65 35.57 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.928 -0.397 . . . . 71.310000000000002 109.928 -178.052 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . 0.432 ' O ' ' HE3' ' A' ' 495' ' ' LYS . . . -134.88 -54.99 0.07 OUTLIER Glycine 0 N--CA 1.416 -2.634 0 C-N-CA 118.803 -1.665 . . . . 74.439999999999998 115.019 -169.094 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 66.1 20.82 11.21 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.94 0.876 . . . . 74.329999999999998 109.032 -172.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.8 p -81.6 -174.87 5.23 Favored 'General case' 0 N--CA 1.407 -2.59 0 CA-C-N 114.155 -1.384 . . . . 73.400000000000006 110.462 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.69 138.99 42.92 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.951 -1.129 . . . . 72.299999999999997 107.951 -178.204 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 18.9 p90 -130.02 152.56 49.35 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 123.303 0.377 . . . . 72.219999999999999 110.588 -178.464 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 11.1 p -140.83 144.69 35.5 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 107.888 -1.153 . . . . 73.319999999999993 107.888 177.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -117.71 136.68 53.19 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.112 -0.635 . . . . 71.409999999999997 111.084 -178.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -132.29 129.85 40.1 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.013 -1.106 . . . . 73.319999999999993 108.013 177.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 32.6 t -99.73 135.03 41.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.443 0.64 . . . . 73.340000000000003 110.716 -177.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.7 p -135.21 150.99 29.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 107.747 -1.205 . . . . 75.019999999999996 107.747 178.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -82.79 135.67 34.9 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.398 0.618 . . . . 74.209999999999994 111.308 -178.012 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 72.4 m -164.23 160.2 16.36 Favored Pre-proline 0 C--N 1.308 -1.217 0 N-CA-C 106.32 -1.733 . . . . 75.540000000000006 106.32 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -64.29 -4.6 8.19 Favored 'Trans proline' 0 CA--C 1.553 1.471 0 C-N-CA 122.576 2.184 . . . . 62.450000000000003 114.084 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -70.69 130.08 89.18 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 107.755 -1.202 . . . . 73.409999999999997 107.755 173.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.8 148.13 76.83 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 122.417 2.078 . . . . 74.150000000000006 112.283 -176.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.25 111.52 1.1 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.303 -0.862 . . . . 75.400000000000006 111.614 -176.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 123.88 -16.76 7.75 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 115.397 -0.82 . . . . 71.030000000000001 112.143 178.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.69 129.42 34.96 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.216 -0.661 . . . . 72.209999999999994 109.216 179.505 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 503' ' ' GLN . 6.5 p -87.38 115.35 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 CA-C-O 121.459 0.647 . . . . 73.219999999999999 109.345 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -31.74 72.71 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.109 -0.951 . . . . 74.239999999999995 110.04 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 164.15 -174.61 40.27 Favored Glycine 0 N--CA 1.416 -2.656 0 CA-C-N 115.243 -0.89 . . . . 63.439999999999998 111.309 179.079 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 5.8 p -116.36 153.21 32.42 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 108.215 -1.032 . . . . 72.409999999999997 108.215 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -61.9 -47.57 91.08 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 119.47 -0.892 . . . . 72.420000000000002 111.431 179.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -67.82 120.32 7.32 Favored 'Trans proline' 0 C--N 1.367 1.551 0 N-CA-C 107.216 -1.878 . . . . 74.099999999999994 107.216 165.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.21 142.57 97.35 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.887 2.391 . . . . 75.420000000000002 113.687 -174.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.57 129.89 43.31 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.855 -0.612 . . . . 71.420000000000002 110.253 178.072 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.69 -7.05 49.34 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 111.386 -0.686 . . . . 54.030000000000001 111.386 -178.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 24.0 m -89.33 137.11 32.61 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 122.729 -0.277 . . . . 72.519999999999996 110.507 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 8.8 t -88.7 125.35 34.81 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 107.028 -1.471 . . . . 74.430000000000007 107.028 171.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 36.0 m -122.87 159.77 52.15 Favored Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 109.416 -0.587 . . . . 74.420000000000002 109.416 -175.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -66.92 139.91 53.22 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.92 1.746 . . . . 72.5 111.031 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.5 p -61.2 -20.85 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 CA-C-O 121.591 0.71 . . . . 73.019999999999996 110.378 178.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -77.87 -19.04 55.51 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.222 -0.899 . . . . 71.120000000000005 112.105 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 78.5 p -83.21 174.0 11.15 Favored 'General case' 0 C--O 1.247 0.958 0 N-CA-C 112.635 0.605 . . . . 64.120000000000005 112.635 -176.223 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.6 p -113.52 137.92 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 109.133 -0.691 . . . . 74.209999999999994 109.133 -178.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 59.8 mt -103.95 115.39 45.8 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 N-CA-C 107.706 -1.22 . . . . 72.230000000000004 107.706 178.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -103.73 129.18 51.06 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.399 -0.92 . . . . 72.5 110.556 178.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.78 126.91 43.37 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 114.314 -1.312 . . . . 73.299999999999997 110.259 -177.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -88.15 111.94 22.16 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 107.058 -1.46 . . . . 61.409999999999997 107.058 173.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 524' ' ' SER . 22.2 t -97.52 132.68 41.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 107.207 -1.405 . . . . 72.209999999999994 107.207 -178.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 72.3 m -94.7 134.03 37.73 Favored 'General case' 0 N--CA 1.404 -2.772 0 C-N-CA 119.36 -0.936 . . . . 74.150000000000006 111.684 177.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.441 ' HZ2' ' HB3' ' A' ' 557' ' ' LYS . 0.4 OUTLIER -98.0 133.88 41.86 Favored 'General case' 0 N--CA 1.402 -2.859 0 N-CA-C 104.637 -2.357 . . . . 72.420000000000002 104.637 168.886 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -54.32 -23.27 25.63 Favored Glycine 0 N--CA 1.468 0.822 0 O-C-N 124.493 1.12 . . . . 73.340000000000003 114.842 -171.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 81.06 -23.85 0.21 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.988 1.715 . . . . 72.25 109.253 -177.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.47 ' H ' ' C ' ' A' ' 558' ' ' GLY . 77.6 mt-30 -110.75 161.44 15.77 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 115.208 -0.905 . . . . 75.299999999999997 109.922 -172.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . 0.414 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 47.5 p90 -137.56 155.44 49.22 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 107.793 -1.188 . . . . 71.409999999999997 107.793 177.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.14 118.65 14.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 O-C-N 123.751 0.657 . . . . 74.120000000000005 110.188 179.177 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 40.2 ttp -85.86 128.48 58.22 Favored Pre-proline 0 C--N 1.298 -1.633 0 CA-C-N 116.026 -0.533 . . . . 73.400000000000006 110.495 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.54 169.96 14.69 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.183 2.589 . . . . 74.340000000000003 111.514 175.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -66.09 124.11 21.71 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.742 0.782 . . . . 72.530000000000001 112.355 -179.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 8.9 tt -115.76 3.91 13.91 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.746 -1.576 . . . . 72.420000000000002 106.746 174.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 14.3 m -76.39 131.42 39.12 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.055 -1.429 . . . . 74.25 109.123 179.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 74.22 61.06 3.33 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.989 -0.624 . . . . 74.140000000000001 113.44 176.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 569' ' ' MET . . . . . 0.456 ' HB2' ' HB2' ' A' ' 573' ' ' ASP . 20.1 ptp -162.66 173.12 14.31 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.696 -0.853 . . . . 73.140000000000001 108.696 177.528 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -101.15 175.73 5.49 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.864 -0.791 . . . . 75.439999999999998 108.864 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -61.64 -34.89 76.48 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.169 -1.049 . . . . 74.409999999999997 108.169 177.34 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 31.6 m -69.29 -10.25 13.22 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 115.386 -0.825 . . . . 73.209999999999994 112.084 -179.171 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 569' ' ' MET . 16.0 m-20 -101.87 -44.22 5.58 Favored 'General case' 0 C--O 1.248 1.02 0 N-CA-C 108.946 -0.761 . . . . 64.349999999999994 108.946 174.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . 0.423 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -62.0 -53.22 58.64 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 114.173 -1.376 . . . . 70.239999999999995 112.107 -175.741 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.436 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 33.8 tt0 -56.93 -47.83 98.42 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 123.396 0.435 . . . . 73.129999999999995 111.993 -176.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 73.8 Cg_exo -52.72 -44.74 45.51 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.242 1.961 . . . . 75.510000000000005 113.411 172.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -64.64 -37.92 89.21 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.705 -0.479 . . . . 75.409999999999997 109.705 178.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.588 HD12 ' CZ3' ' A' ' 583' ' ' TRP . 78.5 mt -67.38 -48.29 67.83 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.564 -0.744 . . . . 65.140000000000001 111.679 -178.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -65.85 -34.18 77.56 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 120.953 0.406 . . . . 73.209999999999994 111.086 177.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -69.95 -30.81 68.28 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.208 -0.451 . . . . 73.129999999999995 110.409 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 578' ' ' LEU . 3.1 pp -81.34 -8.54 59.76 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 119.751 -0.779 . . . . 73.219999999999999 111.244 177.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 80.08 54.43 3.85 Favored Glycine 0 CA--C 1.504 -0.648 0 N-CA-C 110.824 -0.911 . . . . 65.439999999999998 110.824 -178.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . 0.588 ' CZ3' HD12 ' A' ' 578' ' ' LEU . 14.0 t90 -80.45 127.89 32.94 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.758 0.313 . . . . 73.109999999999999 111.361 -178.651 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 32.0 p -106.59 -12.95 15.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.508 -0.314 . . . . 75.540000000000006 111.727 179.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -85.95 -175.18 49.95 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 121.055 -0.593 . . . . 51.229999999999997 112.809 -175.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 64.1 mtt -118.91 149.28 41.84 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.674 0.273 . . . . 75.219999999999999 110.27 -178.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 7.7 tt -87.91 130.17 35.0 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-O 121.212 0.53 . . . . 75.239999999999995 111.08 -175.494 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 621' ' ' THR . 18.9 t70 -117.59 121.76 41.8 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.041 -0.981 . . . . 72.439999999999998 109.172 175.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.4 133.48 49.22 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.743 -1.206 . . . . 75.329999999999998 107.743 174.351 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -85.75 -26.39 35.26 Favored Glycine 0 C--N 1.294 -1.804 0 C-N-CA 120.784 -0.722 . . . . 65.239999999999995 112.548 -176.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.42 139.76 37.18 Favored 'General case' 0 N--CA 1.42 -1.973 0 C-N-CA 120.847 -0.341 . . . . 75.209999999999994 110.905 -178.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -116.11 124.45 50.4 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 105.046 -2.205 . . . . 61.310000000000002 105.046 171.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 58.6 t -115.29 117.44 55.62 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 N-CA-C 108.659 -0.867 . . . . 74.409999999999997 108.659 -177.05 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -73.69 106.65 5.53 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.617 0.722 . . . . 71.140000000000001 109.838 -179.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -123.51 -58.37 1.61 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.976 -1.011 . . . . 75.349999999999994 108.899 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 131.8 148.23 6.1 Favored Glycine 0 N--CA 1.431 -1.648 0 N-CA-C 110.717 -0.953 . . . . 72.540000000000006 110.717 178.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.99 -33.95 88.62 Favored Glycine 0 C--N 1.314 -0.676 0 N-CA-C 112.468 -0.253 . . . . 73.310000000000002 112.468 -178.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 23.4 t -75.14 -23.51 57.85 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.199 1.0 . . . . 72.420000000000002 108.661 -179.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -87.81 -3.02 58.97 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.713 -1.13 . . . . 64.140000000000001 110.236 -178.178 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 47.4 m80 69.73 95.44 0.07 Allowed 'General case' 0 C--O 1.247 0.925 0 C-N-CA 124.987 1.315 . . . . 71.340000000000003 112.977 175.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -83.93 80.22 9.23 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 109.044 -0.724 . . . . 70.400000000000006 109.044 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -98.48 159.8 14.71 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.535 -0.757 . . . . 62.520000000000003 109.964 -179.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 59.6 t -70.84 130.2 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 107.331 -1.359 . . . . 74.420000000000002 107.331 176.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 31.5 m -108.84 -29.8 2.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 123.574 0.546 . . . . 73.540000000000006 111.516 -176.207 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -155.91 139.27 15.75 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 120.74 0.305 . . . . 74.030000000000001 110.252 -179.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -121.19 128.38 52.4 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.516 -0.766 . . . . 62.509999999999998 109.19 173.609 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -56.6 -51.1 83.81 Favored Pre-proline 0 N--CA 1.475 0.816 0 O-C-N 123.846 0.716 . . . . 71.140000000000001 110.799 178.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -77.07 111.81 3.29 Favored 'Trans proline' 0 C--N 1.371 1.756 0 N-CA-C 108.495 -1.387 . . . . 61.340000000000003 108.495 168.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.93 155.19 62.51 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.78 2.32 . . . . 75.140000000000001 113.491 -177.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.58 130.76 44.02 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.378 -0.828 . . . . 61.549999999999997 109.876 177.335 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.18 -5.88 59.42 Favored Glycine 0 C--N 1.305 -1.159 0 N-CA-C 111.245 -0.742 . . . . 64.129999999999995 111.245 -177.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 28.8 m -101.66 156.11 17.69 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.889 -0.782 . . . . 73.140000000000001 108.889 -179.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -80.28 135.07 14.28 Favored Glycine 0 N--CA 1.422 -2.274 0 CA-C-N 116.363 -0.381 . . . . 71.25 112.431 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.3 m -120.74 142.98 34.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 107.777 -1.194 . . . . 75.349999999999994 107.777 175.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.407 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 29.4 p-10 -48.97 163.47 0.08 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.766 0.826 . . . . 71.519999999999996 112.144 -179.098 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -58.67 -27.7 65.03 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.43 0.53 . . . . 71.420000000000002 112.43 -175.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -81.15 -7.18 59.51 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 119.931 -0.708 . . . . 74.519999999999996 111.138 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.35 19.66 68.76 Favored Glycine 0 CA--C 1.492 -1.374 0 CA-C-O 119.831 -0.427 . . . . 74.030000000000001 113.445 169.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.88 119.27 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-O 121.834 0.826 . . . . 74.430000000000007 109.69 -168.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 39.4 pt -118.84 133.84 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 CA-C-N 114.857 -1.065 . . . . 74.340000000000003 112.258 -176.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 8.8 t -110.84 118.24 35.58 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 107.327 -1.36 . . . . 64.200000000000003 107.327 174.702 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.54 168.95 18.68 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.578 -0.737 . . . . 75.129999999999995 111.476 -173.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -125.95 135.76 52.23 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-O 122.53 1.157 . . . . 74.219999999999999 110.026 175.482 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -142.9 169.63 17.2 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 105.114 -2.18 . . . . 74.219999999999999 105.114 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -52.33 -128.08 0.0 OUTLIER Glycine 0 CA--C 1.559 2.802 0 N-CA-C 115.878 1.111 . . . . 71.099999999999994 115.878 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 . . . . . 0 C--N 1.277 -2.554 0 O-C-N 120.805 -1.409 . . . . 64.120000000000005 110.561 -176.292 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.845 0 N-CA-C 110.248 -1.141 . . . . 53.119999999999997 110.248 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.41 143.07 51.31 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.062 1.841 . . . . 74.519999999999996 111.511 178.438 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -91.41 -5.76 53.9 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.461 0.648 . . . . 65.109999999999999 111.114 -178.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 44.9 p -136.02 147.01 47.76 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.244 -0.889 . . . . 64.209999999999994 108.987 178.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -135.77 145.84 46.98 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.151 0.5 . . . . 75.439999999999998 110.272 176.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.0 m-20 -79.87 126.83 31.5 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.077 -0.965 . . . . 74.450000000000003 108.992 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.5 pt -91.93 131.12 36.17 Favored Pre-proline 0 C--N 1.306 -1.313 0 C-N-CA 120.455 -0.498 . . . . 74.349999999999994 110.746 178.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -83.39 177.06 6.72 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.371 2.047 . . . . 72.310000000000002 111.626 177.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -88.44 122.71 32.23 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.289 0.566 . . . . 74.439999999999998 109.942 178.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.27 8.28 6.36 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-N 115.234 -0.893 . . . . 74.319999999999993 110.803 -179.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -78.13 99.86 6.35 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 116.024 -0.535 . . . . 74.299999999999997 110.953 -177.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 157.55 -37.67 0.55 Allowed Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.667 -0.778 . . . . 65.530000000000001 111.945 178.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -89.46 -172.04 3.45 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 122.534 -0.392 . . . . 74.430000000000007 109.983 -178.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 3.6 m -71.2 155.53 40.63 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.618 -0.882 . . . . 72.230000000000004 108.618 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.49 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.7 p -62.65 -43.56 98.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 O-C-N 123.109 0.256 . . . . 74.230000000000004 111.584 -178.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.17 -37.89 88.78 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.061 -0.256 . . . . 74.430000000000007 110.526 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 66.0 t -67.59 -45.92 84.06 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.375 0 N-CA-C 109.272 -0.64 . . . . 75.129999999999995 109.272 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.88 92.16 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.553 0.216 . . . . 74.319999999999993 111.43 179.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.2 mt-30 -63.84 -45.88 87.53 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.098 -0.501 . . . . 74.109999999999999 111.028 -178.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.539 ' O ' HG21 ' A' ' 514' ' ' VAL . 13.7 ptmm? -67.54 -37.97 83.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.335 -0.393 . . . . 73.420000000000002 111.086 179.325 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -61.18 -48.86 79.61 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 116.059 -0.519 . . . . 73.340000000000003 110.631 -179.566 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.4 pp -68.17 -35.47 78.09 Favored 'General case' 0 C--O 1.209 -1.046 0 CA-C-N 115.945 -0.57 . . . . 73.099999999999994 110.619 -178.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -59.95 -35.73 75.57 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 123.951 0.9 . . . . 72.450000000000003 110.751 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.539 HG21 ' O ' ' A' ' 510' ' ' LYS . 98.8 t -58.28 -35.03 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 122.763 0.425 . . . . 74.349999999999994 111.862 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -112.28 -1.38 15.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.567 0.699 . . . . 75.239999999999995 109.959 -177.612 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -113.37 -60.2 0.41 Allowed Glycine 0 N--CA 1.421 -2.35 0 CA-C-N 115.321 -0.854 . . . . 71.140000000000001 113.033 -171.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 63.0 27.09 15.79 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.519 1.152 . . . . 75.239999999999995 109.293 -174.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.3 p -85.43 -170.03 2.93 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 113.914 -1.494 . . . . 75.140000000000001 109.722 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -107.95 139.41 42.61 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.466 -1.309 . . . . 73.409999999999997 107.466 174.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -130.7 149.49 52.32 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.149 0.5 . . . . 72.040000000000006 111.224 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.7 p -140.8 157.67 45.07 Favored 'General case' 0 N--CA 1.405 -2.693 0 N-CA-C 107.142 -1.429 . . . . 71.430000000000007 107.142 178.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -125.57 141.17 52.17 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 120.711 -0.396 . . . . 71.430000000000007 110.094 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -131.63 143.16 50.11 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.249 -1.389 . . . . 62.420000000000002 107.249 178.173 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.9 m -105.47 139.64 39.79 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.071 -0.651 . . . . 73.400000000000006 111.839 -175.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.47 149.54 33.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 109.218 -0.66 . . . . 71.219999999999999 109.218 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.407 ' C ' ' HG ' ' A' ' 527' ' ' SER . 10.1 t70 -68.28 134.79 50.92 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.445 -0.576 . . . . 71.549999999999997 109.445 177.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' A' ' 556' ' ' SER . 74.1 m -160.22 166.59 15.47 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 109.885 -0.413 . . . . 54.509999999999998 109.885 179.534 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -78.1 -6.91 16.08 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.976 1.784 . . . . 53.210000000000001 113.03 175.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.451 ' HG2' ' OE2' ' A' ' 533' ' ' GLU . 3.3 mpt_? -88.52 149.32 44.09 Favored Pre-proline 0 CA--C 1.516 -0.352 0 N-CA-C 109.769 -0.456 . . . . 75.310000000000002 109.769 -179.351 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.47 147.01 86.55 Favored 'Trans proline' 0 C--O 1.258 1.488 0 C-N-CA 122.668 2.245 . . . . 73.310000000000002 112.792 -178.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.91 106.9 0.63 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.054 -0.975 . . . . 74.209999999999994 110.759 -179.282 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 152.1 -31.58 0.88 Allowed Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 110.193 -1.163 . . . . 73.299999999999997 110.193 -178.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . 0.451 ' OE2' ' HG2' ' A' ' 529' ' ' ARG . 34.1 tt0 -76.98 139.1 40.0 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.154 0.502 . . . . 73.420000000000002 109.977 178.148 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.25 118.44 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.462 0 N-CA-C 108.132 -1.062 . . . . 70.209999999999994 108.132 174.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.4 p -79.51 -11.33 59.9 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.43 -0.804 . . . . 73.530000000000001 112.56 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.87 -168.17 29.36 Favored Glycine 0 CA--C 1.481 -2.087 0 C-N-CA 120.119 -1.039 . . . . 73.140000000000001 112.404 175.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 12.6 p -116.68 158.18 24.21 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 107.469 -1.308 . . . . 75.200000000000003 107.469 179.188 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -63.21 -49.44 80.07 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 118.505 -1.278 . . . . 73.140000000000001 111.995 176.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -70.24 149.25 63.57 Favored 'Trans proline' 0 C--N 1.369 1.647 0 CA-C-N 120.486 1.209 . . . . 74.340000000000003 110.447 173.103 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.5 144.85 51.24 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.706 2.271 . . . . 74.340000000000003 113.167 -178.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -68.41 129.73 40.79 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.428 -0.582 . . . . 73.409999999999997 109.428 176.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.35 -10.82 50.8 Favored Glycine 0 C--N 1.309 -0.938 0 N-CA-C 110.94 -0.864 . . . . 71.400000000000006 110.94 -176.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 92.3 m -88.09 137.11 32.62 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 109.985 -0.376 . . . . 65.340000000000003 109.985 178.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.1 t -86.36 132.28 34.0 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.688 -0.856 . . . . 71.219999999999999 108.688 175.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.89 155.98 74.7 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 108.289 -1.004 . . . . 74.519999999999996 108.289 -179.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -58.48 137.11 78.57 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.551 1.501 . . . . 73.230000000000004 111.289 178.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.63 -23.85 34.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 123.701 0.801 . . . . 73.209999999999994 113.016 -174.088 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -97.38 -0.11 46.91 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 120.317 -0.553 . . . . 74.420000000000002 111.857 -177.2 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 89.4 p -78.08 170.94 15.77 Favored 'General case' 0 C--O 1.256 1.429 0 C-N-CA 119.63 -0.828 . . . . 74.200000000000003 110.96 -178.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.8 p -110.24 115.75 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-O 121.934 0.874 . . . . 75.25 109.839 -178.256 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 52.1 mt -85.55 130.82 35.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 114.94 -1.027 . . . . 74.010000000000005 108.579 -177.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.55 120.73 41.44 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.727 0.775 . . . . 73.420000000000002 111.182 178.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.1 mp -99.2 124.09 43.99 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 113.983 -1.462 . . . . 74.549999999999997 109.338 178.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 2.9 mp0 -88.28 117.73 27.39 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.436 -0.802 . . . . 71.230000000000004 111.04 -179.087 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 32.0 t -93.23 126.41 45.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.004 -0.998 . . . . 74.319999999999993 108.35 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 17.0 p -82.04 117.87 22.57 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 109.489 -0.56 . . . . 43.210000000000001 109.489 178.402 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -97.68 137.46 36.54 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 108.432 -0.951 . . . . 72.230000000000004 108.432 174.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -63.02 -22.3 64.64 Favored Glycine 0 CA--C 1.5 -0.894 0 O-C-N 124.174 0.921 . . . . 55.109999999999999 111.846 177.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 81.01 -5.92 1.65 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.684 1.593 . . . . 75.439999999999998 109.282 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 42.5 mt-30 -111.93 144.3 41.5 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 115.655 -0.702 . . . . 73.049999999999997 111.517 -172.117 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . 0.458 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 55.1 p90 -123.69 154.59 39.19 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.68 -1.146 . . . . 74.299999999999997 108.052 178.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.32 117.82 5.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.031 0.443 . . . . 75.040000000000006 110.492 177.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 50.8 ttp -81.56 130.91 59.75 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.953 -0.567 . . . . 63.399999999999999 111.889 -176.077 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -65.58 169.46 12.76 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.988 2.458 . . . . 75.129999999999995 111.068 172.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -87.14 143.13 27.44 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.215 0.531 . . . . 71.409999999999997 111.582 -177.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -133.03 25.21 4.26 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.155 -1.794 . . . . 73.310000000000002 106.155 176.131 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 4.4 m -75.61 148.69 38.59 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 113.13 -1.85 . . . . 73.239999999999995 111.909 -174.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 70.09 59.04 5.69 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.254 -0.885 . . . . 64.540000000000006 114.066 173.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 569' ' ' MET . . . . . 0.441 ' SD ' ' HG3' ' A' ' 577' ' ' ARG . 23.0 ptp -159.55 175.07 13.69 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-N 117.335 0.568 . . . . 74.230000000000004 111.079 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -97.79 176.13 5.92 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.102 -1.073 . . . . 75.129999999999995 108.102 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . 0.417 ' CZ3' HD22 ' A' ' 587' ' ' LEU . 23.1 t-105 -64.19 -33.91 76.87 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.723 -0.843 . . . . 74.439999999999998 108.723 173.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.72 -14.65 18.57 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 CA-C-N 115.762 -0.653 . . . . 74.129999999999995 111.765 -178.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.415 ' CB ' ' HB2' ' A' ' 569' ' ' MET . 14.5 m-20 -93.66 -41.14 9.87 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.172 -1.047 . . . . 62.039999999999999 108.172 174.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -52.67 -47.63 67.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.961 -1.018 . . . . 62.119999999999997 113.067 -177.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 578' ' ' LEU 0.255 32.0 mt-10 -60.18 -56.16 38.22 Favored Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 114.059 1.133 . . . . 72.319999999999993 114.059 179.416 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -58.72 -31.1 94.25 Favored 'Trans proline' 0 C--N 1.365 1.4 0 C-N-CA 121.392 1.395 . . . . 72.040000000000006 112.874 174.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.441 ' HG3' ' SD ' ' A' ' 569' ' ' MET . 2.8 mmp_? -66.2 -45.37 81.01 Favored 'General case' 0 C--O 1.209 -1.07 0 C-N-CA 121.314 -0.154 . . . . 71.340000000000003 110.626 176.116 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.3 pp -66.12 -39.75 90.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.263 0.468 . . . . 73.010000000000005 112.263 -174.192 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.406 ' N ' HD12 ' A' ' 578' ' ' LEU . 15.2 ptm180 -66.33 -39.6 89.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.388 -0.369 . . . . 72.549999999999997 111.072 176.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.24 -34.56 73.0 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 121.055 0.455 . . . . 71.409999999999997 110.876 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 28.6 tp -81.22 -9.15 59.83 Favored 'General case' 0 N--CA 1.42 -1.929 0 C-N-CA 123.939 0.895 . . . . 71.230000000000004 110.808 -179.261 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 65.62 36.53 92.54 Favored Glycine 0 C--N 1.315 -0.601 0 CA-C-N 116.199 -0.455 . . . . 75.349999999999994 112.079 178.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -78.38 127.13 31.76 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 107.825 -1.176 . . . . 72.109999999999999 107.825 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 10.2 m -94.37 -20.03 20.11 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.979 0.418 . . . . 70.530000000000001 111.671 -176.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -83.4 175.59 52.51 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 121.094 -0.574 . . . . 71.530000000000001 113.397 -178.029 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 586' ' ' MET . . . . . 0.434 ' HA ' ' HE3' ' A' ' 586' ' ' MET . 10.4 mmt -101.31 155.27 18.14 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.396 -0.594 . . . . 72.230000000000004 109.396 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . 0.417 HD22 ' CZ3' ' A' ' 571' ' ' TRP . 6.1 tt -89.88 118.2 29.27 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.904 -0.589 . . . . 74.530000000000001 109.761 -176.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 621' ' ' THR . 26.4 t70 -95.91 117.47 30.67 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 109.017 -0.735 . . . . 73.400000000000006 109.017 178.043 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.31 135.47 52.95 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.693 -0.685 . . . . 75.340000000000003 110.572 -178.716 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -70.21 -87.65 0.11 Allowed Glycine 0 C--N 1.296 -1.67 0 CA-C-N 115.313 -0.858 . . . . 74.299999999999997 111.076 -179.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.29 154.16 47.88 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 122.728 -0.278 . . . . 73.5 110.371 177.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.9 128.24 35.97 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 107.76 -1.2 . . . . 73.049999999999997 107.76 176.146 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 81.7 t -104.01 135.91 39.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 109.688 -0.486 . . . . 72.150000000000006 109.688 -179.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.95 107.32 11.62 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 122.062 0.934 . . . . 60.049999999999997 111.327 -177.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -119.35 -44.97 2.55 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.757 -1.111 . . . . 72.340000000000003 109.317 177.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 103.84 143.35 12.51 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.076 -1.059 . . . . 73.239999999999995 111.718 179.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.37 -37.4 87.54 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 114.228 0.451 . . . . 63.219999999999999 114.228 -177.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 23.0 t -77.35 -23.62 50.84 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.43 0.633 . . . . 71.400000000000006 109.573 -176.264 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -91.08 -5.01 55.8 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.412 -0.813 . . . . 72.019999999999996 109.84 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 32.9 m170 66.31 97.13 0.05 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.406 1.082 . . . . 74.319999999999993 112.474 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . 0.56 ' HB3' ' C ' ' A' ' 625' ' ' GLY . 62.2 m-80 -70.93 85.3 0.69 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.902 -1.045 . . . . 72.340000000000003 111.973 -177.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -110.33 172.52 6.82 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.9 -0.591 . . . . 72.420000000000002 111.253 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 13.0 p -57.53 134.98 21.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 CA-C-N 116.064 -0.516 . . . . 73.310000000000002 110.37 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 29.6 m -108.6 -34.72 2.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 116.235 -0.439 . . . . 64.019999999999996 111.137 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -156.22 142.11 18.01 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.449 -0.341 . . . . 75.319999999999993 110.203 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -129.03 134.67 48.22 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.162 -1.792 . . . . 64.209999999999994 106.162 173.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.512 ' O ' ' HD3' ' A' ' 609' ' ' PRO . 4.4 t-20 -67.21 -49.48 44.36 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 119.623 -0.831 . . . . 72.25 111.786 -176.202 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.428 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.7 Cg_endo -90.62 105.05 0.3 Allowed 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 121.567 1.511 . . . . 74.519999999999996 109.522 170.331 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 607' ' ' ASN . 19.0 Cg_exo -68.67 160.75 48.19 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 122.682 2.255 . . . . 73.340000000000003 111.448 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -57.67 130.03 44.57 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.257 -0.429 . . . . 75.109999999999999 110.35 178.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.3 -9.83 46.19 Favored Glycine 0 C--N 1.31 -0.869 0 C-N-CA 120.542 -0.837 . . . . 65.540000000000006 111.882 -176.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 34.4 m -87.3 151.28 23.26 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.824 -0.806 . . . . 73.439999999999998 108.824 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -75.96 131.9 12.35 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 120.702 -0.761 . . . . 73.219999999999999 111.855 177.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 29.4 m -125.63 143.4 39.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.134 -1.061 . . . . 73.200000000000003 108.134 176.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -54.25 176.29 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.729 0.812 . . . . 64.519999999999996 113.152 -177.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -55.58 -27.61 50.28 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.883 0.873 . . . . 73.109999999999999 112.761 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.454 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 1.0 OUTLIER -85.79 -6.55 59.09 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 120.897 -0.321 . . . . 74.030000000000001 111.083 178.119 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.77 20.52 72.36 Favored Glycine 0 CA--C 1.496 -1.116 0 C-N-CA 121.511 -0.376 . . . . 73.140000000000001 112.507 173.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.52 119.75 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 CA-C-O 122.595 1.188 . . . . 74.219999999999999 111.194 -168.685 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.64 132.38 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 CA-C-N 113.926 -1.488 . . . . 74.510000000000005 108.651 -177.801 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 10.1 t -106.37 124.25 49.3 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-N 115.48 -0.782 . . . . 75.219999999999999 109.551 -178.347 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -138.69 166.25 24.86 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.754 -0.657 . . . . 74.0 111.501 -176.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -128.89 137.52 51.49 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.127 -1.064 . . . . 74.310000000000002 108.127 175.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -139.74 165.44 27.27 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 116.367 -0.379 . . . . 74.25 111.032 -171.115 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . 0.56 ' C ' ' HB3' ' A' ' 601' ' ' ASN . . . -66.52 139.54 37.47 Favored Glycine 0 N--CA 1.427 -1.937 0 O-C-N 124.088 0.867 . . . . 53.130000000000003 111.524 175.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 . . . . . 0 C--N 1.306 -1.32 0 C-N-CA 126.306 1.843 . . . . 74.420000000000002 114.676 -177.138 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.398 0 N-CA-C 110.235 -1.146 . . . . 60.340000000000003 110.235 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -75.93 142.78 25.51 Favored 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 121.644 1.563 . . . . 65.400000000000006 111.746 178.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -95.49 20.2 9.86 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.897 0.856 . . . . 73.400000000000006 109.852 -179.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 25.4 p -129.71 158.41 39.45 Favored 'General case' 0 N--CA 1.409 -2.525 0 N-CA-C 107.257 -1.386 . . . . 75.140000000000001 107.257 -179.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -149.03 142.47 25.27 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 108.211 -1.033 . . . . 73.040000000000006 108.211 179.368 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.04 134.65 35.37 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.278 0.561 . . . . 70.140000000000001 110.638 179.195 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 39.5 pt -85.03 137.96 37.29 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 114.972 -1.013 . . . . 74.129999999999995 111.953 -177.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.99 166.14 29.84 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.741 2.294 . . . . 72.409999999999997 113.776 178.426 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -88.21 44.76 1.22 Allowed 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 125.158 1.383 . . . . 75.439999999999998 111.223 -177.427 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 17.2 m -72.05 14.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 114.516 1.302 . . . . 74.439999999999998 114.516 -175.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -79.66 101.63 8.48 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.351 -0.611 . . . . 75.409999999999997 109.351 178.2 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 150.79 -31.09 1.01 Allowed Glycine 0 C--N 1.297 -1.602 0 N-CA-C 110.951 -0.86 . . . . 71.099999999999994 110.951 -179.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -81.61 -177.26 6.46 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 109.103 -0.703 . . . . 74.299999999999997 109.103 177.537 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 2.4 m -71.5 155.94 40.01 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 107.451 -1.314 . . . . 73.310000000000002 107.451 176.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.421 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.5 p -63.27 -42.0 94.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 117.737 0.244 . . . . 71.239999999999995 110.999 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 23.4 t70 -59.77 -43.77 94.19 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.258 0.551 . . . . 74.340000000000003 110.045 178.482 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 95.8 t -67.74 -44.81 85.52 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.126 0 CA-C-N 114.868 -1.06 . . . . 73.510000000000005 109.871 -178.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.35 -45.19 94.33 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 123.104 0.253 . . . . 61.25 111.458 179.092 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 27.2 mt-30 -62.27 -46.79 87.22 Favored 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 123.404 0.44 . . . . 73.099999999999994 110.996 -179.25 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.492 ' O ' HG23 ' A' ' 514' ' ' VAL 0.321 20.4 pttp -68.79 -37.55 79.35 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 112.375 0.509 . . . . 71.129999999999995 112.375 178.359 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -61.03 -49.5 77.17 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 120.771 0.319 . . . . 71.109999999999999 110.501 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . 0.407 HD11 ' N ' ' A' ' 513' ' ' ASN . 4.2 pp -65.85 -35.75 81.55 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-N 116.071 -0.513 . . . . 75.230000000000004 110.962 -178.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.407 ' N ' HD11 ' A' ' 512' ' ' LEU . 1.7 t-20 -62.9 -36.17 82.49 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 123.085 0.554 . . . . 75.230000000000004 110.669 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 510' ' ' LYS . 93.9 t -63.08 -34.27 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 121.261 0.553 . . . . 73.340000000000003 110.829 177.516 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -106.58 12.2 29.7 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.221 0.534 . . . . 73.400000000000006 110.371 -176.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -141.45 -54.05 0.04 OUTLIER Glycine 0 CA--C 1.488 -1.596 0 C-N-CA 119.935 -1.126 . . . . 70.140000000000001 114.023 -172.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 66.66 20.49 10.73 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.811 0.815 . . . . 74.530000000000001 110.032 -173.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.2 p -76.12 -178.48 4.47 Favored 'General case' 0 N--CA 1.415 -2.219 0 C-N-CA 125.449 1.499 . . . . 75.430000000000007 109.371 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -107.62 142.98 36.71 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 108.168 -1.049 . . . . 75.109999999999999 108.168 175.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -126.54 147.46 49.86 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.301 0.572 . . . . 73.340000000000003 111.977 -176.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 13.6 p -133.75 146.65 50.95 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 114.537 -1.211 . . . . 74.319999999999993 107.763 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -121.67 136.5 54.94 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 120.96 0.409 . . . . 74.439999999999998 111.245 -177.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -122.54 122.09 38.06 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.838 -0.801 . . . . 73.349999999999994 108.838 178.018 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.1 m -87.48 134.79 33.55 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.834 0.35 . . . . 71.0 110.891 -177.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 556' ' ' SER . 47.6 t -136.55 150.14 27.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 106.086 -1.82 . . . . 72.150000000000006 106.086 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -99.21 135.82 40.06 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.655 -0.869 . . . . 71.099999999999994 108.655 175.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 66.7 m -162.58 171.4 6.52 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 107.289 -1.374 . . . . 73.450000000000003 107.289 -176.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.92 -15.05 44.98 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 121.935 1.757 . . . . 74.239999999999995 113.104 177.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.43 135.65 94.79 Favored Pre-proline 0 C--O 1.224 -0.268 0 N-CA-C 108.472 -0.936 . . . . 75.530000000000001 108.472 176.207 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.8 149.84 86.44 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.575 2.183 . . . . 74.239999999999995 113.392 -175.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 557' ' ' LYS . . . -59.77 106.89 0.53 Allowed 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 115.146 -0.934 . . . . 44.200000000000003 111.679 -178.657 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 124.09 -14.4 7.9 Favored Glycine 0 N--CA 1.424 -2.161 0 CA-C-N 115.129 -0.941 . . . . 63.140000000000001 111.578 179.151 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -82.45 130.75 35.17 Favored 'General case' 0 C--O 1.258 1.541 0 N-CA-C 108.873 -0.788 . . . . 75.129999999999995 108.873 179.485 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 7.0 p -81.67 117.87 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.833 0 N-CA-C 107.509 -1.293 . . . . 65.340000000000003 107.509 176.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.3 m -72.79 -27.13 61.81 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 113.533 -1.667 . . . . 74.239999999999995 109.311 -175.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 153.15 -166.46 31.56 Favored Glycine 0 N--CA 1.412 -2.929 0 N-CA-C 110.086 -1.206 . . . . 61.229999999999997 110.086 177.097 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.0 p -116.2 157.85 24.22 Favored 'General case' 0 C--N 1.267 -3.002 0 N-CA-C 106.88 -1.526 . . . . 75.329999999999998 106.88 178.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -62.68 -51.11 74.58 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 118.469 -1.292 . . . . 73.319999999999993 111.439 177.229 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -73.07 147.13 42.47 Favored 'Trans proline' 0 C--N 1.369 1.606 0 CA-C-N 120.191 1.104 . . . . 73.040000000000006 110.173 173.332 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.55 145.1 75.36 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.497 2.131 . . . . 74.019999999999996 111.679 -179.207 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.11 142.0 57.83 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 110.128 -0.323 . . . . 73.430000000000007 110.128 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.19 -21.86 43.83 Favored Glycine 0 C--N 1.313 -0.701 0 N-CA-C 111.635 -0.586 . . . . 73.140000000000001 111.635 -177.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 47.1 m -71.53 137.3 47.99 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 122.872 0.469 . . . . 74.299999999999997 111.354 -177.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 12.4 t -84.44 126.29 33.12 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 109.254 -0.647 . . . . 73.150000000000006 109.254 176.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.63 157.96 73.51 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 106.973 -1.491 . . . . 73.319999999999993 106.973 177.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -59.43 135.31 64.15 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 CA-C-N 120.639 1.264 . . . . 74.349999999999994 111.81 -179.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.84 -19.89 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-N 114.95 -1.023 . . . . 74.340000000000003 112.835 -174.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -92.4 -17.55 24.46 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.796 -0.638 . . . . 74.310000000000002 112.038 -178.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 99.0 p -78.4 179.41 7.01 Favored 'General case' 0 C--O 1.253 1.288 0 N-CA-C 112.506 0.558 . . . . 70.230000000000004 112.506 -174.067 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.3 p -109.85 128.42 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.809 0 CA-C-O 121.513 0.673 . . . . 75.340000000000003 110.41 -178.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 47.8 mt -98.0 138.86 21.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.286 -1.005 . . . . 71.319999999999993 108.286 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.6 120.29 40.6 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.717 0.77 . . . . 73.450000000000003 112.224 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.7 mp -102.18 122.13 43.57 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 113.853 -1.521 . . . . 71.409999999999997 108.644 178.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -85.87 122.68 30.27 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 115.433 -0.803 . . . . 73.109999999999999 108.996 179.14 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.13 125.33 68.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.514 -0.921 . . . . 71.430000000000007 108.514 -176.203 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 525' ' ' VAL . 67.9 m -97.29 147.63 23.95 Favored 'General case' 0 C--N 1.285 -2.237 0 C-N-CA 119.515 -0.874 . . . . 54.539999999999999 111.973 179.026 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.4 ptpt -111.57 141.39 45.21 Favored 'General case' 0 N--CA 1.404 -2.74 0 N-CA-C 105.323 -2.103 . . . . 74.420000000000002 105.323 169.243 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -54.71 -22.09 24.45 Favored Glycine 0 C--O 1.242 0.633 0 O-C-N 124.441 1.088 . . . . 72.530000000000001 114.52 -174.488 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 88.14 -22.35 0.14 Allowed 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 126.576 1.95 . . . . 51.399999999999999 107.594 -176.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.476 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 77.6 mt-30 -112.99 146.92 38.21 Favored 'General case' 0 N--CA 1.405 -2.676 0 CA-C-N 114.468 -1.242 . . . . 72.010000000000005 111.298 -175.677 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -124.65 153.32 42.45 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 107.282 -1.377 . . . . 75.540000000000006 107.282 176.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.99 121.61 22.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 109.556 -0.535 . . . . 75.120000000000005 109.556 -179.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 54.3 ttp -79.53 130.1 69.33 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 116.292 -0.413 . . . . 73.400000000000006 110.318 -177.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.69 168.97 9.23 Favored 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.782 2.321 . . . . 73.420000000000002 110.881 174.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.2 129.9 34.79 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.739 0.78 . . . . 71.420000000000002 110.42 -179.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . 0.483 ' O ' ' HG2' ' A' ' 569' ' ' MET . 3.1 pp -126.74 10.33 7.12 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.148 -1.387 . . . . 75.299999999999997 108.677 176.086 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 567' ' ' SER . . . . . 0.433 ' HB3' ' OE1' ' A' ' 606' ' ' GLN . 1.6 p -79.06 131.71 36.36 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 114.548 -1.206 . . . . 72.25 110.959 -179.332 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 87.85 37.03 8.1 Favored Glycine 0 N--CA 1.428 -1.888 0 C-N-CA 120.809 -0.71 . . . . 74.540000000000006 113.178 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 569' ' ' MET . . . . . 0.483 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 22.4 ptp -142.73 174.72 10.39 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 117.654 0.727 . . . . 72.430000000000007 109.422 177.424 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -99.45 177.8 5.07 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.037 -0.727 . . . . 73.430000000000007 109.037 -177.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -72.59 -26.01 61.54 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.671 -0.863 . . . . 75.530000000000001 108.671 -178.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.2 p -71.57 -14.84 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-N 115.3 -0.863 . . . . 73.519999999999996 109.75 178.151 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 10.9 m-20 -94.33 -39.14 10.64 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.103 -0.703 . . . . 72.140000000000001 109.103 175.547 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -55.83 -46.48 78.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.653 -0.703 . . . . 73.340000000000003 112.429 -178.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.516 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 11.9 mm-40 -54.0 -58.08 15.06 Favored Pre-proline 0 CA--C 1.573 1.864 0 N-CA-C 112.757 0.651 . . . . 71.049999999999997 112.757 -179.552 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -61.54 -36.0 78.87 Favored 'Trans proline' 0 C--N 1.369 1.648 0 CA-C-N 120.727 1.295 . . . . 75.219999999999999 113.066 175.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.497 ' HA ' ' NE ' ' A' ' 577' ' ' ARG . 9.0 mmp_? -63.4 -39.63 95.03 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.762 -0.375 . . . . 73.129999999999995 111.058 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.517 HD11 ' N ' ' A' ' 579' ' ' ARG . 4.3 pp -65.92 -47.31 75.16 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 112.664 0.616 . . . . 74.349999999999994 112.664 -176.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.517 ' N ' HD11 ' A' ' 578' ' ' LEU . 5.8 ptp180 -66.44 -35.14 79.54 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 111.711 0.263 . . . . 75.439999999999998 111.711 177.636 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -71.12 -38.92 72.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.313 0.486 . . . . 71.0 112.313 -178.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 1.3 pp -82.38 -8.98 59.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.463 0.649 . . . . 73.140000000000001 110.219 -178.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 82.91 35.96 17.07 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.607 -0.724 . . . . 60.409999999999997 112.261 177.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -87.35 127.49 35.2 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 108.506 -0.924 . . . . 75.200000000000003 108.506 177.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 24.4 p -106.1 -10.33 16.56 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.39 0.885 . . . . 73.239999999999995 113.39 -176.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -84.36 -170.37 46.75 Favored Glycine 0 C--N 1.323 -0.182 0 C-N-CA 120.754 -0.736 . . . . 60.439999999999998 113.909 -177.34 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 69.6 mtm -102.8 145.42 29.79 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 123.003 0.521 . . . . 73.530000000000001 111.679 -175.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 28.2 tp -94.76 125.67 39.57 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.555 -0.906 . . . . 75.409999999999997 108.555 177.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 621' ' ' THR . 23.5 t70 -113.63 121.18 43.39 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.85 -0.613 . . . . 74.129999999999995 109.804 -177.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.78 133.82 45.92 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.86 -1.136 . . . . 75.230000000000004 110.134 175.655 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -79.25 -65.59 1.78 Allowed Glycine 0 N--CA 1.428 -1.883 0 C-N-CA 120.65 -0.786 . . . . 64.540000000000006 111.68 179.33 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.24 140.99 35.91 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 120.762 0.315 . . . . 70.420000000000002 110.742 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 624' ' ' PHE . 9.5 p-10 -110.49 124.76 52.4 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 105.339 -2.097 . . . . 62.329999999999998 105.339 170.201 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 73.8 t -104.59 137.6 32.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 120.909 -0.316 . . . . 72.25 110.75 -173.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.73 108.04 4.85 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 109.153 -0.684 . . . . 65.25 109.153 -174.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -127.07 -36.13 2.19 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 120.791 0.329 . . . . 73.219999999999999 110.895 -179.642 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 104.83 146.75 15.46 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 119.823 -1.179 . . . . 64.140000000000001 112.324 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.34 -32.2 60.33 Favored Glycine 0 C--N 1.314 -0.659 0 C-N-CA 123.909 0.766 . . . . 73.209999999999994 114.147 -178.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.3 t -59.46 -23.27 62.58 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.276 1.43 . . . . 74.239999999999995 110.99 -176.212 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -86.42 -9.63 55.91 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.472 -0.785 . . . . 74.120000000000005 111.713 -173.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 55.14 70.87 0.58 Allowed 'General case' 0 C--O 1.245 0.839 0 CA-C-O 122.371 1.081 . . . . 73.349999999999994 109.104 -174.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -77.97 89.83 4.15 Favored 'General case' 0 CA--C 1.481 -1.687 0 CA-C-N 113.699 -1.591 . . . . 75.540000000000006 113.675 -171.159 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -84.86 172.1 11.68 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 113.844 -1.526 . . . . 70.450000000000003 107.413 176.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.09 131.66 26.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 107.436 -1.32 . . . . 74.25 107.436 171.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 30.4 m -107.76 -27.12 3.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 112.53 0.566 . . . . 75.450000000000003 112.53 -174.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -147.48 141.37 25.83 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 109.194 -0.669 . . . . 72.230000000000004 109.194 -178.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . 0.433 ' OE1' ' HB3' ' A' ' 567' ' ' SER . 18.0 pt20 -140.42 146.19 38.0 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.547 -0.908 . . . . 65.430000000000007 108.547 177.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.491 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 22.0 t-20 -61.38 -61.52 7.73 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 112.648 0.61 . . . . 75.329999999999998 112.648 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.4 Cg_endo -91.87 120.55 0.56 Allowed 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 122.027 1.818 . . . . 71.239999999999995 109.458 175.189 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.33 160.6 46.92 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 122.348 2.032 . . . . 71.430000000000007 112.278 178.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -59.99 127.38 31.6 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.03 -0.532 . . . . 74.25 109.87 178.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 101.05 -1.34 54.93 Favored Glycine 0 C--N 1.309 -0.93 0 C-N-CA 120.039 -1.076 . . . . 55.439999999999998 112.084 -178.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 54.6 m -95.39 146.76 24.15 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.903 -0.406 . . . . 72.420000000000002 109.903 178.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -74.47 123.8 7.85 Favored Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 115.912 -0.586 . . . . 72.150000000000006 112.175 177.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 19.1 m -107.08 142.53 19.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.949 -0.76 . . . . 71.310000000000002 108.949 176.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.476 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.7 p-10 -51.85 174.82 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.756 1.222 . . . . 75.109999999999999 113.353 -177.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -54.04 -32.25 53.92 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.7 0.63 . . . . 75.409999999999997 112.7 -179.238 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.456 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 37.4 t70 -85.75 -7.52 58.72 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 120.991 0.424 . . . . 74.340000000000003 109.994 -177.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.12 19.73 70.37 Favored Glycine 0 CA--C 1.499 -0.965 0 CA-C-N 116.077 -0.51 . . . . 72.530000000000001 112.558 174.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.05 120.94 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-O 122.68 1.229 . . . . 74.099999999999994 111.511 -166.26 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.409 HG12 ' HD2' ' A' ' 608' ' ' PRO . 0.0 OUTLIER -128.83 132.17 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 0 CA-C-N 113.605 -1.634 . . . . 74.209999999999994 108.725 -179.015 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 6.6 t -113.03 137.42 51.45 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.334 -0.987 . . . . 51.109999999999999 108.334 178.493 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.4 pp -138.6 165.72 26.19 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 113.66 0.985 . . . . 74.340000000000003 113.66 -173.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -128.9 137.41 51.41 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.555 -1.276 . . . . 75.25 107.555 176.534 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 592' ' ' ASP . 50.2 p90 -141.3 165.64 26.95 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 120.797 0.332 . . . . 73.439999999999998 110.812 -175.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -88.05 146.78 19.93 Favored Glycine 0 N--CA 1.423 -2.215 0 C-N-CA 120.329 -0.939 . . . . 72.129999999999995 111.363 177.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 C--N 1.281 -2.373 0 N-CA-C 107.214 -1.402 . . . . 74.099999999999994 107.214 177.976 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.027 0 N-CA-C 110.475 -1.05 . . . . 72.049999999999997 110.475 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.31 147.58 29.39 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.902 1.735 . . . . 60.240000000000002 112.187 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -98.17 22.11 9.95 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.125 0.964 . . . . 55.210000000000001 108.854 178.499 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 13.8 p -135.74 140.53 44.44 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-N 114.556 -1.202 . . . . 73.400000000000006 107.825 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -130.12 142.49 50.59 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 120.946 0.403 . . . . 74.230000000000004 111.331 -179.395 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.5 p-10 -78.96 124.2 28.02 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.949 -1.023 . . . . 71.109999999999999 109.184 176.229 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.7 pt -77.97 133.38 65.55 Favored Pre-proline 0 C--N 1.302 -1.49 0 CA-C-N 115.78 -0.645 . . . . 74.209999999999994 111.532 -177.062 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.89 -174.85 2.4 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.349 2.033 . . . . 72.209999999999994 111.26 174.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -98.67 122.96 42.56 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.098 0.475 . . . . 73.200000000000003 110.034 179.137 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 508' ' ' ALA . 17.0 m -124.86 49.73 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-O 122.245 1.022 . . . . 73.200000000000003 110.206 178.041 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -107.31 108.54 19.98 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.076 -0.965 . . . . 73.129999999999995 109.368 176.076 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 136.69 -17.13 3.72 Favored Glycine 0 C--N 1.304 -1.218 0 C-N-CA 120.323 -0.942 . . . . 63.140000000000001 111.971 177.27 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -91.79 179.12 5.71 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.412 -0.959 . . . . 63.399999999999999 108.412 178.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 21.1 m -75.05 155.55 37.11 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 105.455 -2.054 . . . . 71.239999999999995 105.455 171.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.501 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 9.2 p -62.23 -43.79 98.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 118.794 0.725 . . . . 74.510000000000005 111.642 -176.624 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 20.5 t70 -63.56 -40.3 96.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.74 0.305 . . . . 71.25 110.477 179.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 58.5 t -70.23 -39.81 77.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.33 0 CA-C-N 116.146 -0.479 . . . . 75.299999999999997 109.991 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' A' ' 500' ' ' VAL . . . -60.9 -44.76 96.68 Favored 'General case' 0 C--O 1.209 -1.069 0 N-CA-C 109.671 -0.492 . . . . 71.019999999999996 109.671 176.569 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 22.8 mt-30 -64.81 -42.69 94.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.157 -0.474 . . . . 61.219999999999999 110.715 -179.216 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.509 ' O ' HG22 ' A' ' 514' ' ' VAL . 75.3 mmtt -66.46 -42.67 87.2 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.252 -0.431 . . . . 75.209999999999994 110.49 177.792 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -67.62 -38.05 83.36 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.621 0.724 . . . . 74.140000000000001 111.08 -177.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.43 -46.49 86.09 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.565 -1.198 . . . . 74.439999999999998 108.343 177.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -61.09 -33.83 73.97 Favored 'General case' 0 N--CA 1.423 -1.823 0 C-N-CA 124.088 0.955 . . . . 65.329999999999998 112.937 -178.129 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 510' ' ' LYS . 65.9 t -56.58 -34.26 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.199 0.523 . . . . 74.209999999999994 110.54 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -110.96 -2.21 16.08 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.584 0.707 . . . . 72.400000000000006 110.147 -178.359 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -110.33 -63.54 0.52 Allowed Glycine 0 N--CA 1.414 -2.802 0 CA-C-N 115.439 -0.8 . . . . 74.0 112.366 -173.354 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 64.82 21.95 12.44 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 122.426 1.108 . . . . 74.25 109.503 -172.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.3 p -89.19 -169.89 2.68 Favored 'General case' 0 N--CA 1.408 -2.54 0 CA-C-N 113.367 -1.742 . . . . 73.040000000000006 110.417 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -111.79 141.13 45.8 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 109.173 -0.677 . . . . 72.439999999999998 109.173 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -132.48 151.11 52.02 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.657 0.741 . . . . 73.019999999999996 112.25 -175.121 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 55.1 p -138.82 157.18 46.54 Favored 'General case' 0 N--CA 1.403 -2.803 0 N-CA-C 106.62 -1.622 . . . . 71.530000000000001 106.62 178.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -131.44 147.11 52.52 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 109.524 -0.547 . . . . 73.450000000000003 109.524 -178.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -142.45 143.29 32.53 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.27 -1.381 . . . . 62.039999999999999 107.27 175.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 18.3 m -103.15 136.1 43.58 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-O 121.442 0.639 . . . . 73.420000000000002 112.07 -174.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 10.8 p -124.11 154.02 30.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 106.285 -1.746 . . . . 74.400000000000006 106.285 175.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.447 ' C ' ' HG ' ' A' ' 527' ' ' SER . 6.0 p-10 -91.52 135.88 33.53 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 120.078 -0.649 . . . . 73.540000000000006 111.146 -178.228 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.524 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 57.4 m -163.64 165.13 14.35 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 107.163 -1.421 . . . . 54.340000000000003 107.163 -178.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -66.72 -7.95 19.78 Favored 'Trans proline' 0 CA--C 1.549 1.24 0 C-N-CA 122.177 1.918 . . . . 74.129999999999995 113.962 179.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.426 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 0.0 OUTLIER -74.12 127.51 87.85 Favored Pre-proline 0 C--O 1.238 0.482 0 N-CA-C 107.898 -1.149 . . . . 72.409999999999997 107.898 176.555 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.9 145.66 83.39 Favored 'Trans proline' 0 C--O 1.25 1.12 0 C-N-CA 122.888 2.392 . . . . 74.239999999999995 112.911 -177.18 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -54.56 117.96 3.78 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.739 -1.119 . . . . 72.0 111.806 -177.186 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 127.62 -24.74 5.17 Favored Glycine 0 N--CA 1.428 -1.839 0 CA-C-N 115.227 -0.897 . . . . 73.239999999999995 111.458 178.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -83.11 138.5 33.65 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.91 -0.404 . . . . 71.219999999999999 109.91 178.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.431 HG13 ' CB ' ' A' ' 508' ' ' ALA . 4.3 p -101.25 116.78 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 CA-C-O 121.902 0.858 . . . . 74.430000000000007 109.361 -177.403 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.1 p -81.04 -8.68 59.82 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.575 -1.193 . . . . 74.409999999999997 112.809 -178.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.65 -164.96 29.14 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.471 -0.871 . . . . 70.140000000000001 112.487 175.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 21.8 p -116.77 158.5 23.79 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.423 -1.325 . . . . 73.099999999999994 107.423 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -63.54 -56.82 23.16 Favored Pre-proline 0 C--O 1.241 0.626 0 C-N-CA 118.184 -1.406 . . . . 72.299999999999997 112.172 176.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.14 137.34 40.36 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 120.822 1.014 . . . . 72.239999999999995 109.628 173.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.38 148.03 93.05 Favored 'Trans proline' 0 C--O 1.25 1.106 0 C-N-CA 122.464 2.109 . . . . 62.539999999999999 112.422 -178.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.35 143.07 50.61 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.009 -0.541 . . . . 74.040000000000006 110.31 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.66 -18.73 54.65 Favored Glycine 0 C--N 1.303 -1.283 0 N-CA-C 111.549 -0.62 . . . . 40.109999999999999 111.549 -177.348 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 53.3 m -73.26 136.85 44.64 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.533 0.206 . . . . 70.510000000000005 110.772 -179.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 13.5 t -88.59 134.53 33.85 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.502 -0.555 . . . . 75.010000000000005 109.502 177.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.49 155.92 80.69 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 107.847 -1.168 . . . . 75.540000000000006 107.847 177.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -59.09 141.68 98.45 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.598 1.532 . . . . 73.109999999999999 111.17 177.12 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 8.3 p -60.16 -19.79 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 CA-C-N 115.627 -0.715 . . . . 75.150000000000006 111.619 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -98.92 -5.15 31.27 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 121.539 0.685 . . . . 75.439999999999998 111.107 178.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 34.2 t -72.82 151.61 41.94 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 121.185 0.516 . . . . 73.400000000000006 110.273 -178.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.9 p -98.24 121.2 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.983 0 CA-C-N 115.358 -0.837 . . . . 73.120000000000005 109.015 179.273 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 54.9 mt -92.79 139.51 17.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.76 -0.83 . . . . 75.319999999999993 108.76 -177.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -103.71 123.42 46.99 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.756 0.789 . . . . 62.130000000000003 111.82 178.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.3 mp -103.57 126.95 51.03 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.409 -1.268 . . . . 72.129999999999995 108.832 177.159 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -90.13 116.01 27.81 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.566 0.698 . . . . 72.0 110.804 -178.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 524' ' ' SER . 25.6 t -90.72 129.21 41.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 107.704 -1.221 . . . . 74.299999999999997 107.704 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 43.4 t -87.48 125.09 34.1 Favored 'General case' 0 N--CA 1.403 -2.798 0 N-CA-C 108.6 -0.889 . . . . 73.209999999999994 108.6 177.114 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -105.46 139.31 40.28 Favored 'General case' 0 N--CA 1.406 -2.667 0 N-CA-C 106.706 -1.59 . . . . 74.310000000000002 106.706 169.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -58.18 -21.9 48.21 Favored Glycine 0 C--N 1.312 -0.769 0 O-C-N 124.295 0.997 . . . . 71.450000000000003 112.126 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 24.5 t-20 90.43 -2.74 0.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 126.771 2.028 . . . . 73.120000000000005 107.796 -179.468 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.424 ' HG2' ' N ' ' A' ' 615' ' ' ASN . 98.0 mt-30 -112.82 147.73 36.32 Favored 'General case' 0 N--CA 1.405 -2.724 0 CA-C-N 114.135 -1.393 . . . . 72.310000000000002 112.64 -169.33 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -123.31 158.34 31.21 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 114.19 -1.368 . . . . 73.319999999999993 107.496 177.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.84 120.31 13.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 121.114 0.483 . . . . 64.319999999999993 111.368 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 22.2 ttt -70.52 123.62 89.38 Favored Pre-proline 0 N--CA 1.434 -1.243 0 C-N-CA 123.86 0.864 . . . . 75.409999999999997 111.335 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -67.25 169.32 15.57 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.316 2.677 . . . . 63.520000000000003 112.16 176.248 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -87.43 124.31 33.29 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.088 0.471 . . . . 64.310000000000002 111.753 -177.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . 0.528 ' O ' HD21 ' A' ' 566' ' ' LEU . 9.5 tt -133.66 18.93 3.89 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 122.533 1.158 . . . . 72.349999999999994 108.35 -177.704 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 77.2 p -77.46 143.76 38.29 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 121.496 -0.752 . . . . 73.109999999999999 112.36 -174.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 65.24 42.76 96.12 Favored Glycine 0 N--CA 1.453 -0.182 0 CA-C-N 115.693 -0.685 . . . . 72.319999999999993 114.642 174.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 22.7 ptp -137.57 177.5 7.82 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.042 -0.725 . . . . 74.349999999999994 109.042 177.193 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -94.42 178.24 5.68 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.616 -0.513 . . . . 74.430000000000007 109.616 -178.044 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . 0.434 ' CZ3' HD22 ' A' ' 587' ' ' LEU . 18.9 t-105 -68.97 -30.22 68.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.786 -1.191 . . . . 74.540000000000006 107.786 175.919 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.0 p -74.94 -9.21 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-N 115.203 -0.908 . . . . 65.329999999999998 110.388 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.622 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 15.3 m-20 -99.25 -37.49 9.25 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 108.519 -0.919 . . . . 72.299999999999997 108.519 173.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -59.46 -43.95 93.08 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.108 -0.951 . . . . 74.310000000000002 111.926 179.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.602 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 33.3 mt-10 -57.66 -52.43 74.38 Favored Pre-proline 0 CA--C 1.556 1.187 0 N-CA-C 113.941 1.089 . . . . 74.239999999999995 113.941 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.3 -33.76 98.0 Favored 'Trans proline' 0 C--N 1.364 1.349 0 CA-C-N 120.438 1.192 . . . . 62.520000000000003 112.993 173.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.622 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 9.3 mmp_? -64.29 -45.55 87.48 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 109.57 -0.53 . . . . 72.140000000000001 109.57 178.101 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.3 pp -66.11 -44.04 85.45 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.833 -0.621 . . . . 65.340000000000003 112.162 -172.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -66.67 -37.83 85.56 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.161 -0.472 . . . . 74.299999999999997 110.928 178.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -71.28 -37.12 71.9 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 112.008 0.373 . . . . 73.439999999999998 112.008 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.0 pp -83.76 -9.35 58.88 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 120.532 -0.467 . . . . 74.129999999999995 110.794 -179.022 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 75.95 44.96 17.62 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 121.232 -0.509 . . . . 72.430000000000007 112.467 179.033 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -75.96 127.46 33.03 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.968 -0.753 . . . . 63.539999999999999 108.968 178.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 1.3 p -86.72 -32.68 20.32 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 124.303 1.041 . . . . 75.129999999999995 113.006 -178.068 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -82.91 -169.35 44.37 Favored Glycine 0 C--N 1.311 -0.836 0 N-CA-C 113.951 0.341 . . . . 73.420000000000002 113.951 -178.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 85.3 mtp -115.55 150.38 36.68 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 110.216 -0.29 . . . . 73.329999999999998 110.216 -178.408 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . 0.434 HD22 ' CZ3' ' A' ' 571' ' ' TRP . 2.3 tt -80.43 130.23 35.03 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.228 -1.027 . . . . 72.400000000000006 108.228 -179.563 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -126.77 122.63 35.34 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.611 -0.722 . . . . 72.349999999999994 110.933 -178.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.0 OUTLIER -101.94 128.48 48.33 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 118.302 -1.359 . . . . 74.150000000000006 109.109 173.311 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -76.96 -38.3 30.94 Favored Glycine 0 N--CA 1.428 -1.885 0 C-N-CA 120.763 -0.732 . . . . 70.420000000000002 112.444 -176.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -136.74 147.66 46.83 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 121.012 0.434 . . . . 72.409999999999997 110.714 -177.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -99.18 125.79 44.83 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.002 -1.481 . . . . 71.400000000000006 107.002 176.04 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 59.5 t -104.19 131.23 53.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 107.911 -1.144 . . . . 72.319999999999993 107.911 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . 0.414 ' HA ' ' NE2' ' A' ' 626' ' ' GLN . 6.8 p-10 -74.34 117.78 16.55 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.824 0.821 . . . . 73.239999999999995 110.285 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -141.82 -62.84 0.45 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.487 -1.233 . . . . 73.140000000000001 109.356 -179.222 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 95.22 160.72 33.72 Favored Glycine 0 N--CA 1.407 -3.279 0 N-CA-C 110.655 -0.978 . . . . 62.020000000000003 110.655 -178.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.6 -33.04 61.97 Favored Glycine 0 C--N 1.292 -1.864 0 CA-C-N 115.031 -0.584 . . . . 51.009999999999998 113.735 -178.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 35.3 t -70.25 -29.19 65.93 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 109.647 -0.501 . . . . 75.519999999999996 109.647 -178.076 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -95.69 -2.28 48.31 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.493 -0.322 . . . . 73.519999999999996 110.991 -178.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 73.24 116.45 0.05 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.966 1.307 . . . . 75.140000000000001 111.268 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -78.4 61.69 2.87 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.736 0.779 . . . . 70.420000000000002 110.781 -179.025 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -87.07 160.09 18.7 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.712 -0.676 . . . . 75.019999999999996 109.402 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . 0.488 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 99.5 t -63.6 130.23 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 106.904 -1.517 . . . . 72.439999999999998 106.904 170.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.7 t -96.31 -47.45 12.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.384 0.611 . . . . 63.210000000000001 109.504 -175.173 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -150.58 144.43 25.27 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 106.925 -1.509 . . . . 73.040000000000006 106.925 -178.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -128.64 143.99 51.06 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.325 -0.991 . . . . 73.049999999999997 108.325 178.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.429 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 3.3 t-20 -60.18 -54.62 53.43 Favored Pre-proline 0 CA--C 1.553 1.067 0 N-CA-C 112.504 0.557 . . . . 75.409999999999997 112.504 -179.412 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 9.3 Cg_endo -94.24 123.44 0.41 Allowed 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 121.929 1.753 . . . . 72.349999999999994 111.954 178.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -67.67 153.46 76.01 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 122.168 1.912 . . . . 62.409999999999997 110.747 175.05 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.4 139.46 58.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.744 0.307 . . . . 62.299999999999997 110.275 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.14 -11.69 62.03 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 120.317 -0.944 . . . . 72.230000000000004 111.993 -178.368 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 90.6 m -76.58 146.34 38.38 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.763 -0.829 . . . . 65.319999999999993 108.763 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -73.81 122.69 7.75 Favored Glycine 0 N--CA 1.42 -2.415 0 C-N-CA 119.654 -1.26 . . . . 71.200000000000003 110.531 175.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.7 m -114.08 141.57 29.79 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 108.676 -0.861 . . . . 74.340000000000003 108.676 176.407 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.424 ' N ' ' HG2' ' A' ' 560' ' ' GLN . 33.4 p-10 -52.0 168.42 0.09 Allowed 'General case' 0 C--O 1.209 -1.072 0 C-N-CA 124.457 1.103 . . . . 75.030000000000001 112.696 -176.423 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -58.15 -24.77 60.1 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.819 0.674 . . . . 74.340000000000003 112.819 -176.486 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -88.56 -8.55 54.56 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 109.402 -0.592 . . . . 73.230000000000004 109.402 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.12 16.08 63.92 Favored Glycine 0 CA--C 1.502 -0.757 0 CA-C-N 116.016 -0.538 . . . . 64.230000000000004 113.95 171.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.17 119.31 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 122.208 1.004 . . . . 73.5 110.927 -167.165 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.417 ' O ' HD12 ' A' ' 620' ' ' ILE . 2.8 pp -129.0 134.05 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 114.477 -1.238 . . . . 73.310000000000002 110.673 -177.351 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 11.9 t -110.03 133.02 53.64 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.7 -0.852 . . . . 75.450000000000003 108.7 179.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 3.2 pp -138.78 168.75 19.12 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.69 -0.686 . . . . 75.400000000000006 110.788 -175.384 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -126.92 135.82 51.44 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.343 -0.984 . . . . 73.409999999999997 108.343 174.253 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.488 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 2.1 p90 -142.41 168.23 20.23 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.083 -0.508 . . . . 74.510000000000005 109.805 -172.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -56.25 109.52 1.56 Allowed Glycine 0 CA--C 1.529 0.926 0 O-C-N 123.954 0.784 . . . . 63.439999999999998 111.855 175.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.414 ' NE2' ' HA ' ' A' ' 594' ' ' ASP . 27.7 mm-40 . . . . . 0 C--O 1.263 1.783 0 C-N-CA 125.734 1.614 . . . . 74.349999999999994 112.745 -179.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.345 0 N-CA-C 110.979 -0.848 . . . . 75.019999999999996 110.979 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.21 146.37 95.96 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.009 2.473 . . . . 72.230000000000004 112.343 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -92.36 -11.78 34.07 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 122.016 0.912 . . . . 74.530000000000001 110.708 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 9.2 p -143.09 145.59 33.01 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 114.743 -1.117 . . . . 72.019999999999996 108.13 -178.606 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -140.54 140.81 35.28 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.265 -0.643 . . . . 72.319999999999993 109.265 -179.57 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.1 p-10 -78.83 140.48 38.17 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.395 0.617 . . . . 73.239999999999995 110.656 178.289 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 39.0 pt -96.36 137.07 21.62 Favored Pre-proline 0 C--N 1.294 -1.812 0 CA-C-N 114.91 -1.041 . . . . 75.230000000000004 109.776 179.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.22 176.89 9.24 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.979 1.786 . . . . 75.310000000000002 111.924 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.57 110.27 19.69 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.856 -1.165 . . . . 64.120000000000005 107.856 177.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 29.3 m -117.84 12.3 7.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-O 120.982 0.42 . . . . 73.420000000000002 111.812 -178.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -84.72 102.25 12.85 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.486 -0.485 . . . . 61.340000000000003 109.954 -178.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 156.38 -26.07 0.54 Allowed Glycine 0 C--N 1.301 -1.385 0 C-N-CA 120.653 -0.784 . . . . 61.119999999999997 112.136 179.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.45 ' O ' HG11 ' A' ' 534' ' ' VAL . 11.4 pm0 -102.44 -173.86 2.43 Favored 'General case' 0 N--CA 1.427 -1.605 0 O-C-N 122.527 -0.396 . . . . 70.219999999999999 110.276 177.49 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.1 m -69.84 155.46 40.52 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.474 -0.935 . . . . 74.109999999999999 108.474 -179.236 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.41 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.3 p -61.64 -42.68 95.13 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 O-C-N 123.018 0.199 . . . . 75.230000000000004 111.428 -178.276 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.71 -39.82 94.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.286 0.565 . . . . 71.349999999999994 110.21 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 66.9 t -70.36 -39.69 76.85 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.452 0 CA-C-N 115.431 -0.804 . . . . 71.319999999999993 109.8 178.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.22 -44.28 92.38 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 122.276 0.23 . . . . 75.319999999999993 110.996 177.783 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 23.0 mt-30 -63.1 -41.6 99.41 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.896 -0.409 . . . . 74.409999999999997 109.896 178.035 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.42 ' O ' HG22 ' A' ' 514' ' ' VAL . 72.3 mmtt -66.31 -38.79 88.54 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.939 -0.573 . . . . 74.409999999999997 111.897 175.772 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.14 -48.45 80.04 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 122.026 0.917 . . . . 74.450000000000003 108.8 176.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -59.55 -42.3 92.06 Favored 'General case' 0 C--O 1.21 -1.011 0 CA-C-N 113.909 -1.496 . . . . 72.209999999999994 109.623 -179.255 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -60.47 -35.21 75.35 Favored 'General case' 0 N--CA 1.427 -1.608 0 C-N-CA 124.169 0.988 . . . . 74.099999999999994 111.16 -179.732 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 510' ' ' LYS . 98.1 t -64.34 -35.85 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.444 0.64 . . . . 74.230000000000004 110.832 178.342 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -101.46 5.0 41.79 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.184 -0.462 . . . . 73.209999999999994 109.931 -177.079 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -132.94 -58.29 0.08 OUTLIER Glycine 0 N--CA 1.426 -2.033 0 C-N-CA 119.89 -1.148 . . . . 72.030000000000001 114.232 -171.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 59.66 29.56 19.13 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 122.465 1.126 . . . . 73.120000000000005 108.97 -172.631 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.1 p -96.87 -165.39 1.26 Allowed 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 114.061 -1.427 . . . . 65.319999999999993 110.559 -177.754 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -107.83 138.6 43.79 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.827 -1.175 . . . . 73.219999999999999 107.827 178.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -128.93 148.5 50.93 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.297 0.57 . . . . 72.319999999999993 111.192 -179.243 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.5 m -140.25 152.41 45.91 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.016 -1.105 . . . . 75.430000000000007 108.016 176.366 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -120.38 142.13 49.45 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.02 0.438 . . . . 73.510000000000005 111.041 -176.227 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -131.94 135.94 46.98 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.465 -1.68 . . . . 61.340000000000003 106.465 176.462 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 75.0 p -104.83 139.45 39.57 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.259 1.028 . . . . 74.150000000000006 113.234 -173.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.5 p -123.95 152.99 29.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 105.858 -1.904 . . . . 54.539999999999999 105.858 176.388 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.462 ' HA ' ' HG3' ' A' ' 557' ' ' LYS . 1.1 p-10 -84.74 136.94 33.5 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.407 -0.96 . . . . 72.540000000000006 108.407 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 23.3 m -149.45 169.87 8.53 Favored Pre-proline 0 C--N 1.285 -2.203 0 N-CA-C 107.586 -1.264 . . . . 72.340000000000003 107.586 -175.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -69.93 -16.3 36.8 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 121.992 1.795 . . . . 75.109999999999999 112.385 176.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.409 ' HD2' ' N ' ' A' ' 529' ' ' ARG . 3.2 mpt_? -81.57 135.0 50.05 Favored Pre-proline 0 CA--C 1.512 -0.492 0 CA-C-N 116.499 -0.319 . . . . 74.310000000000002 110.432 179.757 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.66 156.98 20.55 Favored 'Trans proline' 0 C--O 1.257 1.446 0 C-N-CA 123.141 2.561 . . . . 74.200000000000003 112.557 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.24 104.6 0.33 Allowed 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.348 -0.842 . . . . 71.329999999999998 111.251 -176.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 151.93 -26.33 0.92 Allowed Glycine 0 N--CA 1.419 -2.494 0 C-N-CA 120.142 -1.028 . . . . 74.099999999999994 112.707 179.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -82.67 144.49 30.23 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 119.378 -0.929 . . . . 75.409999999999997 109.33 -179.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.45 HG11 ' O ' ' A' ' 503' ' ' GLN . 7.4 p -92.34 117.63 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 CA-C-O 121.822 0.82 . . . . 73.409999999999997 108.845 177.568 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.99 -30.74 70.93 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.444 -1.253 . . . . 74.349999999999994 109.932 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 156.02 -167.62 33.32 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 111.085 -0.806 . . . . 53.520000000000003 111.085 178.61 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.4 p -116.59 147.55 41.76 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.694 -0.854 . . . . 72.230000000000004 108.694 178.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -57.94 -50.32 88.75 Favored Pre-proline 0 N--CA 1.476 0.839 0 O-C-N 123.577 0.548 . . . . 74.140000000000001 111.458 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -76.29 131.0 12.43 Favored 'Trans proline' 0 N--CA 1.438 -1.76 0 N-CA-C 107.978 -1.585 . . . . 75.129999999999995 107.978 168.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -56.55 140.94 90.76 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 122.492 2.128 . . . . 73.209999999999994 111.736 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.01 137.83 58.0 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 120.702 0.287 . . . . 74.019999999999996 110.635 -178.746 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.69 -12.66 58.0 Favored Glycine 0 C--N 1.309 -0.949 0 N-CA-C 111.782 -0.527 . . . . 70.439999999999998 111.782 -176.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 26.4 m -84.35 137.31 33.49 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 122.85 -0.206 . . . . 72.530000000000001 110.567 -178.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 9.7 t -82.33 127.69 33.48 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.592 -0.892 . . . . 74.329999999999998 108.592 175.198 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.8 m -123.07 156.75 62.32 Favored Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 107.75 -1.204 . . . . 71.420000000000002 107.75 -179.053 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -65.44 137.66 51.8 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 120.834 1.023 . . . . 74.0 111.39 -179.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.8 p -64.98 -19.64 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.481 -0.781 . . . . 74.209999999999994 110.599 179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -89.33 -12.32 40.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.183 0.516 . . . . 71.120000000000005 111.456 -179.041 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 50.4 m -87.21 163.78 16.71 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.617 0.722 . . . . 74.519999999999996 111.14 178.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.3 p -98.02 137.66 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.849 0 CA-C-N 115.122 -0.945 . . . . 61.100000000000001 109.462 178.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.41 135.56 28.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.985 -0.552 . . . . 62.520000000000003 110.306 -178.571 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -103.3 119.99 39.92 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-N 115.852 -0.613 . . . . 75.450000000000003 110.817 -173.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -102.66 122.96 45.48 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 124.06 0.944 . . . . 75.010000000000005 109.235 177.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -85.13 122.28 29.11 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.895 -0.78 . . . . 71.340000000000003 108.895 174.163 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 26.5 t -98.69 134.18 38.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 108.573 -0.899 . . . . 73.319999999999993 108.573 179.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.633 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 23.6 m -85.06 117.77 24.23 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.92 -0.77 . . . . 63.450000000000003 108.92 176.492 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.462 ' HG3' ' HA ' ' A' ' 526' ' ' ASP . 2.6 ptpp? -96.66 133.33 41.32 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 106.612 -1.625 . . . . 72.319999999999993 106.612 166.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -60.13 -23.98 60.31 Favored Glycine 0 CA--C 1.492 -1.397 0 O-C-N 124.344 1.028 . . . . 72.010000000000005 113.167 -175.481 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . 0.492 ' OD1' ' HG3' ' A' ' 616' ' ' ARG . 45.1 t-20 79.77 -15.71 0.73 Allowed 'General case' 0 C--O 1.211 -0.951 0 C-N-CA 125.231 1.412 . . . . 75.5 108.587 179.403 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 86.3 mt-30 -112.52 141.72 45.93 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 115.563 -0.744 . . . . 74.540000000000006 112.233 -173.411 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -123.8 158.24 32.23 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.104 -1.407 . . . . 74.120000000000005 107.936 177.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.1 p -64.42 125.36 21.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.228 0.537 . . . . 72.540000000000006 110.078 177.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 563' ' ' MET . . . . . 0.522 ' SD ' HG21 ' A' ' 620' ' ' ILE . 52.1 ttp -83.88 133.52 45.91 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 109.874 -0.417 . . . . 72.450000000000003 109.874 -178.502 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.11 169.62 14.75 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.634 2.223 . . . . 75.340000000000003 110.768 174.732 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -82.48 134.11 35.21 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.276 0.56 . . . . 74.319999999999993 111.022 -178.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.5 pp -137.66 14.19 2.94 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.77 -1.105 . . . . 73.540000000000006 110.234 178.197 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 22.9 t -81.01 152.76 27.78 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.691 -1.14 . . . . 62.329999999999998 110.213 -178.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 64.21 26.14 70.24 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 114.942 0.737 . . . . 73.030000000000001 114.942 174.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 569' ' ' MET . . . . . 0.442 ' SD ' ' HG3' ' A' ' 577' ' ' ARG . 20.4 ptp -127.08 171.99 10.9 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 122.305 -0.527 . . . . 74.239999999999995 109.945 179.41 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -95.98 165.44 12.26 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.054 -1.461 . . . . 72.519999999999996 107.054 -177.07 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -61.76 -30.04 70.53 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.373 -0.603 . . . . 74.150000000000006 109.373 178.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.82 -15.91 18.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.971 -0.559 . . . . 75.439999999999998 111.671 -178.447 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.425 ' C ' ' HD2' ' A' ' 576' ' ' PRO . 38.3 t70 -101.62 -28.5 12.47 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 122.245 1.022 . . . . 74.030000000000001 108.247 176.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . 0.51 ' O ' ' HB2' ' A' ' 577' ' ' ARG . . . -67.91 -37.46 81.73 Favored 'General case' 0 C--O 1.212 -0.908 0 CA-C-N 114.565 -1.198 . . . . 73.200000000000003 111.275 177.307 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.478 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 23.5 tt0 -56.18 -51.13 83.2 Favored Pre-proline 0 CA--C 1.568 1.658 0 CA-C-O 119.373 -0.346 . . . . 75.329999999999998 110.973 178.269 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 85.1 Cg_exo -53.36 -37.36 81.34 Favored 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 122.095 1.863 . . . . 75.319999999999993 112.203 171.698 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.539 ' O ' ' HB3' ' A' ' 581' ' ' LEU . 1.5 mmp_? -58.62 -42.6 88.62 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.742 -0.208 . . . . 74.239999999999995 110.494 176.701 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.513 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 10.8 mp -63.47 -49.27 74.29 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 120.727 0.299 . . . . 72.299999999999997 110.993 -178.226 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -67.21 -39.69 86.32 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 113.303 0.853 . . . . 64.430000000000007 113.303 -179.229 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.06 -36.47 75.0 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.113 0.482 . . . . 72.519999999999996 111.453 -178.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . 0.539 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 2.0 tp -81.47 -10.17 59.55 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.108 -0.496 . . . . 75.340000000000003 110.109 -179.59 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 61.88 40.25 98.59 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.728 -0.949 . . . . 62.399999999999999 110.728 -178.045 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . 0.513 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 10.7 t90 -71.81 127.43 32.54 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 121.578 0.704 . . . . 75.430000000000007 109.675 -178.259 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 9.9 p -79.05 -50.05 11.68 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 114.534 -1.212 . . . . 71.420000000000002 111.807 -177.094 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -71.48 -169.47 10.43 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 116.004 1.162 . . . . 75.140000000000001 116.004 -176.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 61.7 mtm -113.76 155.94 24.73 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.105 -1.048 . . . . 72.310000000000002 108.501 -179.404 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 6.3 tt -85.14 119.82 25.96 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.039 -1.097 . . . . 70.340000000000003 108.039 179.255 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . 0.634 ' O ' ' HA ' ' A' ' 621' ' ' THR . 23.4 t70 -95.75 104.87 16.82 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.66 0.743 . . . . 63.130000000000003 109.818 -179.666 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.1 OUTLIER -90.03 129.12 36.39 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.988 -0.745 . . . . 74.519999999999996 108.988 178.155 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -83.4 -48.95 5.13 Favored Glycine 0 C--N 1.28 -2.565 0 N-CA-C 109.936 -1.265 . . . . 75.409999999999997 109.936 -178.17 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.15 142.41 38.01 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 109.114 -0.699 . . . . 73.319999999999993 109.114 179.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -115.57 125.19 52.66 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.024 -1.472 . . . . 73.25 107.024 175.444 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.89 131.47 55.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 108.816 -0.809 . . . . 74.420000000000002 108.816 -176.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.96 108.09 5.68 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.164 -1.05 . . . . 64.329999999999998 108.164 178.687 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -115.23 -55.81 2.43 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 116.088 -0.506 . . . . 75.450000000000003 110.688 -174.577 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 89.4 148.12 17.81 Favored Glycine 0 N--CA 1.422 -2.278 0 C-N-CA 120.31 -0.947 . . . . 73.430000000000007 111.358 -175.098 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.25 -32.44 60.28 Favored Glycine 0 C--N 1.304 -1.216 0 C-N-CA 123.483 0.563 . . . . 65.030000000000001 113.487 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 14.4 m -66.19 -24.44 66.63 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 124.076 0.951 . . . . 72.219999999999999 110.545 -176.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -104.29 -0.73 27.93 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.106 -0.952 . . . . 64.120000000000005 109.533 -176.634 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 60.8 m80 69.04 93.69 0.08 Allowed 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 122.135 0.969 . . . . 74.239999999999995 110.692 -174.457 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -82.2 73.28 9.24 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.553 -1.203 . . . . 75.230000000000004 110.339 -179.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -106.33 162.74 13.41 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.701 -1.136 . . . . 72.420000000000002 110.659 -176.428 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 78.8 t -67.25 130.09 32.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 N-CA-C 106.295 -1.743 . . . . 73.340000000000003 106.295 169.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.91 -34.12 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 113.091 0.775 . . . . 75.299999999999997 113.091 -174.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . 0.483 ' HB3' ' CG ' ' A' ' 623' ' ' ARG . 46.8 t80 -141.77 135.85 30.12 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.752 -0.833 . . . . 73.540000000000006 108.752 -177.301 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -133.31 144.52 49.72 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.288 -1.375 . . . . 73.329999999999998 107.288 178.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.494 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 46.3 t30 -58.91 -54.72 53.66 Favored Pre-proline 0 CA--C 1.553 1.077 0 O-C-N 123.466 0.479 . . . . 73.439999999999998 111.899 -179.235 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 94.9 Cg_endo -105.31 117.16 0.04 OUTLIER 'Trans proline' 0 CA--C 1.571 2.349 0 C-N-CA 121.502 1.468 . . . . 74.129999999999995 111.508 173.649 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.0 160.57 40.85 Favored 'Trans proline' 0 N--CA 1.482 0.821 0 C-N-CA 122.92 2.413 . . . . 74.319999999999993 112.66 -178.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -53.0 132.51 37.79 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.8 0.44 . . . . 72.239999999999995 110.928 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.07 -6.03 42.75 Favored Glycine 0 C--O 1.24 0.503 0 C-N-CA 120.695 -0.764 . . . . 50.329999999999998 111.201 -176.597 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 612' ' ' THR . . . . . 0.463 HG22 ' HB2' ' A' ' 608' ' ' PRO . 12.6 t -72.55 166.33 22.89 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 123.619 0.767 . . . . 74.409999999999997 109.69 178.832 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -104.09 118.38 5.96 Favored Glycine 0 N--CA 1.427 -1.937 0 N-CA-C 109.247 -1.541 . . . . 73.109999999999999 109.247 175.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 35.9 m -116.33 142.08 31.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.992 -0.373 . . . . 74.129999999999995 109.992 -179.643 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -57.53 169.81 0.62 Allowed 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 124.238 1.015 . . . . 75.150000000000006 112.805 -177.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . 0.492 ' HG3' ' OD1' ' A' ' 559' ' ' ASN 0.331 0.0 OUTLIER -59.29 -23.75 62.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 114.638 1.347 . . . . 75.099999999999994 114.638 178.832 . . . . . . . . 4 4 . 1 . 026 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -84.98 -8.55 58.69 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.015 -0.735 . . . . 74.430000000000007 109.015 175.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.24 12.55 58.38 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 123.682 0.658 . . . . 73.519999999999996 114.451 170.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.37 119.41 16.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 122.002 0.906 . . . . 71.140000000000001 112.076 -165.751 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.522 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.8 pp -126.82 134.84 65.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-N 114.507 -1.224 . . . . 71.319999999999993 112.592 -178.469 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 87.7 m -98.88 122.92 42.75 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.849 -0.614 . . . . 71.519999999999996 109.473 178.384 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 3.3 pp -139.1 167.01 23.02 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.092 0.404 . . . . 62.119999999999997 112.092 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . 0.483 ' CG ' ' HB3' ' A' ' 605' ' ' TYR . 18.4 ptp180 -127.79 137.8 52.52 Favored 'General case' 0 C--O 1.257 1.49 0 N-CA-C 107.69 -1.226 . . . . 75.129999999999995 107.69 175.453 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -141.07 165.37 27.74 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.389 -0.524 . . . . 62.140000000000001 111.77 -172.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -82.62 131.17 10.18 Favored Glycine 0 N--CA 1.417 -2.629 0 CA-C-N 114.97 -1.014 . . . . 74.349999999999994 110.907 175.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--N 1.276 -2.614 0 C-N-CA 125.35 1.46 . . . . 74.319999999999993 109.097 -179.734 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.499 0 N-CA-C 110.526 -1.03 . . . . 63.030000000000001 110.526 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.23 142.23 37.3 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.25 1.966 . . . . 73.510000000000005 109.652 178.775 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -90.73 -5.47 55.68 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.34 0.59 . . . . 73.040000000000006 111.807 -176.461 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.404 ' HB ' HG22 ' A' ' 544' ' ' THR . 20.3 p -139.72 141.63 36.9 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.838 -0.619 . . . . 74.540000000000006 110.165 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 515' ' ' TYR . 0.6 OUTLIER -138.11 139.64 39.56 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 122.572 0.349 . . . . 74.209999999999994 110.659 177.543 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.4 p-10 -85.98 140.68 30.1 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.943 -0.572 . . . . 74.099999999999994 109.795 173.283 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.5 pt -98.06 136.88 20.87 Favored Pre-proline 0 C--N 1.294 -1.829 0 CA-C-N 115.347 -0.842 . . . . 64.5 111.354 -178.205 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -81.94 -178.49 4.16 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.924 1.749 . . . . 73.319999999999993 110.756 175.197 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -83.48 118.62 23.88 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.737 -0.838 . . . . 73.340000000000003 108.737 177.246 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.47 12.23 8.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 122.101 0.953 . . . . 72.319999999999993 110.145 -178.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -80.63 100.67 8.77 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.545 -1.207 . . . . 40.109999999999999 109.998 178.347 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 149.88 -30.27 1.12 Allowed Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.892 -0.671 . . . . 71.219999999999999 111.906 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -91.65 177.47 6.2 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-O 121.232 0.539 . . . . 74.319999999999993 110.211 179.192 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 27.9 m -74.22 156.18 37.53 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.454 -1.314 . . . . 70.420000000000002 107.454 177.13 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.425 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 11.4 p -56.43 -45.19 81.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 112.87 0.693 . . . . 72.239999999999995 112.87 -179.523 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -62.18 -39.69 93.52 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 120.535 -0.466 . . . . 72.030000000000001 110.171 177.902 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 78.6 t -68.87 -44.39 81.78 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.866 0 CA-C-N 115.437 -0.801 . . . . 74.329999999999998 110.04 -178.577 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -63.58 -45.3 91.03 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 123.216 0.607 . . . . 73.510000000000005 110.522 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.8 mt-30 -65.06 -45.64 84.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 123.31 0.382 . . . . 72.239999999999995 110.841 -179.226 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.46 ' O ' HG23 ' A' ' 514' ' ' VAL . 20.9 ptmt -67.12 -38.48 85.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.043 0.449 . . . . 74.530000000000001 110.363 179.022 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -60.86 -49.59 76.85 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 124.169 0.988 . . . . 75.450000000000003 110.081 -178.531 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -69.17 -35.4 76.26 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 115.704 -0.68 . . . . 74.310000000000002 110.524 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.428 ' N ' HD12 ' A' ' 512' ' ' LEU . 2.3 t-20 -59.89 -39.49 85.49 Favored 'General case' 0 C--O 1.204 -1.33 0 C-N-CA 123.982 0.913 . . . . 64.430000000000007 110.587 -178.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 510' ' ' LYS . 82.0 t -57.56 -32.43 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-O 121.326 0.584 . . . . 74.120000000000005 111.793 179.272 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . 0.599 ' O ' ' HG2' ' A' ' 495' ' ' LYS . 60.6 m-85 -98.24 -26.26 14.59 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.439 0.638 . . . . 74.299999999999997 110.293 179.314 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -101.36 -58.09 0.82 Allowed Glycine 0 CA--C 1.478 -2.23 0 CA-C-N 115.464 -0.789 . . . . 74.219999999999999 113.554 -167.663 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 64.86 29.59 12.46 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.135 0.969 . . . . 65.239999999999995 109.898 -174.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.7 p -88.96 -166.52 1.62 Allowed 'General case' 0 N--CA 1.422 -1.849 0 C-N-CA 125.702 1.601 . . . . 74.349999999999994 111.026 -179.516 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 13.6 mptt -107.56 143.55 35.82 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.199 -1.408 . . . . 75.209999999999994 107.199 176.187 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -131.87 151.77 51.47 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 120.904 0.383 . . . . 75.129999999999995 111.986 -179.046 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 36.7 m -132.91 156.59 46.97 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.887 -1.524 . . . . 73.340000000000003 106.887 177.369 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -129.41 144.85 51.41 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 110.03 -0.359 . . . . 73.109999999999999 110.03 177.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -137.75 127.24 24.95 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.955 -1.128 . . . . 75.530000000000001 107.955 176.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 15.0 m -99.3 125.27 44.91 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.053 0.454 . . . . 64.140000000000001 111.942 -175.771 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 41.9 t -121.73 151.37 25.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 106.868 -1.53 . . . . 65.549999999999997 106.868 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.418 ' C ' ' HG ' ' A' ' 527' ' ' SER . 6.8 p-10 -69.34 135.62 50.62 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 121.407 0.622 . . . . 75.439999999999998 111.507 -178.571 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 527' ' ' SER . . . . . 0.594 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 49.3 m -155.38 170.42 8.73 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 108.451 -0.944 . . . . 62.32 108.451 -178.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.87 -16.86 25.91 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 122.14 1.893 . . . . 74.430000000000007 114.031 -179.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.23 149.47 38.59 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 119.509 -0.877 . . . . 74.409999999999997 111.843 -176.521 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.95 147.65 72.77 Favored 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 123.27 2.647 . . . . 72.25 112.882 -176.078 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.702 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.65 103.86 0.37 Allowed 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 114.858 -1.065 . . . . 52.32 113.119 -174.115 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 147.04 -17.03 1.55 Allowed Glycine 0 N--CA 1.422 -2.242 0 CA-C-N 115.043 -0.981 . . . . 75.239999999999995 111.643 -178.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -82.22 141.76 32.71 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.628 -0.508 . . . . 63.240000000000002 109.628 177.843 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 41.4 t -93.32 115.84 33.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.039 -0.726 . . . . 73.340000000000003 109.039 176.438 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 535' ' ' THR . . . . . 0.425 HG22 ' HB2' ' A' ' 556' ' ' SER . 2.3 p -83.87 -17.81 39.6 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.241 -0.891 . . . . 75.549999999999997 112.357 178.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 165.88 174.86 35.79 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.185 -1.007 . . . . 73.030000000000001 112.404 178.246 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 5.7 p -117.38 152.89 34.03 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.222 -1.029 . . . . 73.340000000000003 108.222 177.359 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -67.22 -50.64 38.98 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 118.333 -1.347 . . . . 75.319999999999993 111.151 176.447 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -67.87 127.75 16.67 Favored 'Trans proline' 0 C--N 1.377 2.057 0 N-CA-C 108.043 -1.56 . . . . 74.420000000000002 108.043 170.074 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -68.92 157.39 62.04 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 122.236 1.957 . . . . 75.030000000000001 113.879 -175.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.17 136.12 56.94 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.622 -0.717 . . . . 73.299999999999997 110.444 179.646 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.51 -11.25 59.65 Favored Glycine 0 C--N 1.305 -1.155 0 N-CA-C 111.637 -0.585 . . . . 62.119999999999997 111.637 -178.491 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 543' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 28.4 m -77.87 127.98 33.24 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 122.568 -0.372 . . . . 74.409999999999997 110.945 -178.426 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 24.8 m -87.73 123.65 32.76 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 108.0 -1.111 . . . . 73.430000000000007 108.0 175.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.75 157.57 62.42 Favored Pre-proline 0 C--N 1.301 -1.503 0 N-CA-C 108.763 -0.828 . . . . 71.150000000000006 108.763 -178.826 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -63.87 140.65 74.4 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.615 1.543 . . . . 73.140000000000001 110.763 177.371 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 14.6 p -56.85 -25.62 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-O 121.455 0.645 . . . . 74.439999999999998 110.855 178.158 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.05 -15.08 52.44 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.738 -0.664 . . . . 62.32 112.008 -178.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 97.0 p -82.94 178.08 8.33 Favored 'General case' 0 C--O 1.254 1.32 0 N-CA-C 113.388 0.885 . . . . 73.519999999999996 113.388 -174.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 15.0 p -117.03 138.04 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.518 -0.765 . . . . 73.239999999999995 110.933 -176.488 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 54.9 mt -108.59 134.35 50.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.687 -0.857 . . . . 72.530000000000001 108.687 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -104.27 122.95 46.47 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.43 0.633 . . . . 74.5 112.563 179.529 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.23 119.37 34.6 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 125.487 1.515 . . . . 73.439999999999998 109.685 -179.525 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -88.82 113.81 24.76 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.656 0.741 . . . . 75.040000000000006 109.485 175.317 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.97 131.21 42.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 114.456 -1.247 . . . . 75.140000000000001 109.521 -175.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.702 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 39.1 t -77.47 117.63 19.12 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 108.261 -1.014 . . . . 73.219999999999999 108.261 176.693 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 0.4 OUTLIER -100.15 134.07 43.61 Favored 'General case' 0 N--CA 1.417 -2.118 0 N-CA-C 105.444 -2.058 . . . . 75.530000000000001 105.444 168.725 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 560' ' ' GLN . . . -64.01 -24.44 68.58 Favored Glycine 0 CA--C 1.499 -0.94 0 N-CA-C 110.484 -1.046 . . . . 75.019999999999996 110.484 179.253 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 63.5 t30 63.83 24.67 13.83 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.962 1.305 . . . . 75.030000000000001 108.438 -179.192 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 558' ' ' GLY . 97.7 mt-30 -127.52 155.57 43.56 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 114.48 -1.236 . . . . 74.5 111.234 -173.429 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -131.22 151.12 51.79 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.893 -1.049 . . . . 73.430000000000007 108.264 176.277 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.19 123.07 16.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-O 121.439 0.638 . . . . 74.519999999999996 110.317 178.777 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 563' ' ' MET . . . . . 0.525 ' SD ' HG13 ' A' ' 620' ' ' ILE . 42.9 ttp -86.45 125.63 66.96 Favored Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 115.495 -0.775 . . . . 70.409999999999997 111.014 -178.458 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.43 170.41 10.98 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.687 2.925 . . . . 71.239999999999995 112.402 176.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.94 115.51 15.71 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.46 -0.336 . . . . 71.049999999999997 110.492 -179.681 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -91.59 -16.66 26.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.87 0.843 . . . . 71.409999999999997 109.047 175.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 15.3 m -73.91 140.1 45.41 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.156 -0.929 . . . . 55.539999999999999 110.008 -179.331 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 94.17 11.42 57.47 Favored Glycine 0 C--O 1.217 -0.921 0 C-N-CA 120.713 -0.756 . . . . 62.030000000000001 114.395 177.065 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 23.9 ptp -131.83 167.6 19.27 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.329 -0.989 . . . . 71.310000000000002 108.329 176.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -88.9 170.34 10.79 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.049 -1.093 . . . . 71.230000000000004 108.049 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -65.95 -28.31 68.82 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.416 -0.957 . . . . 74.540000000000006 108.416 176.331 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.7 p -75.53 -11.85 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-N 115.297 -0.865 . . . . 73.299999999999997 110.564 -179.283 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 56.5 m-20 -98.72 -40.56 8.1 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 107.441 -1.318 . . . . 74.400000000000006 107.441 174.161 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . 0.712 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -55.83 -54.3 46.16 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-N 114.566 -1.197 . . . . 74.310000000000002 112.87 -176.636 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 40.4 mt-10 -57.77 -48.57 96.95 Favored Pre-proline 0 N--CA 1.473 0.686 0 N-CA-C 113.7 1.0 . . . . 74.140000000000001 113.7 -178.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -52.96 -38.2 79.27 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.168 1.912 . . . . 75.120000000000005 112.761 171.575 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 3.6 mmp_? -68.71 -38.89 80.6 Favored 'General case' 0 C--O 1.199 -1.554 0 N-CA-C 109.929 -0.397 . . . . 75.400000000000006 109.929 176.537 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.712 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 65.3 mt -65.26 -47.11 77.88 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 122.66 0.384 . . . . 74.200000000000003 110.634 -175.401 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 35.7 ptt85 -66.0 -35.16 79.82 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 116.29 -0.414 . . . . 74.329999999999998 111.659 176.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.44 -30.79 67.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.481 0.658 . . . . 71.340000000000003 110.619 177.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 14.1 tp -80.85 -9.05 59.86 Favored 'General case' 0 N--CA 1.425 -1.707 0 C-N-CA 124.14 0.976 . . . . 70.530000000000001 110.175 179.595 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 67.44 46.5 69.56 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.346 -0.454 . . . . 41.549999999999997 112.002 178.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 12.5 t90 -83.5 131.13 35.03 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.924 -0.399 . . . . 70.540000000000006 109.924 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 12.8 p -100.12 -26.77 13.84 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.29 1.036 . . . . 71.200000000000003 112.748 -178.193 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -82.16 -175.19 50.4 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 116.283 -0.417 . . . . 74.450000000000003 113.644 -177.069 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 70.5 mtm -107.19 149.56 27.58 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.968 -0.382 . . . . 74.450000000000003 109.968 -178.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.9 tt -91.83 130.18 37.65 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.074 -1.084 . . . . 75.129999999999995 108.074 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 621' ' ' THR . 14.0 t70 -112.19 123.42 50.22 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.266 -1.013 . . . . 64.439999999999998 108.266 176.62 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.07 133.91 48.22 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.285 0.564 . . . . 75.310000000000002 109.563 -178.595 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -74.93 -53.86 6.08 Favored Glycine 0 C--N 1.281 -2.504 0 N-CA-C 110.603 -0.999 . . . . 75.310000000000002 110.603 -179.303 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.29 141.8 35.75 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.083 -0.558 . . . . 70.299999999999997 110.485 -179.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -117.21 124.53 49.32 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 104.311 -2.477 . . . . 72.109999999999999 104.311 168.136 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.17 117.06 51.02 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 109.156 -0.683 . . . . 74.109999999999999 109.156 -175.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -73.34 123.21 23.34 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.612 0.72 . . . . 75.239999999999995 109.118 179.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -132.23 -5.31 3.42 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 114.985 -1.007 . . . . 52.350000000000001 110.433 179.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 93.71 137.01 8.26 Favored Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 120.164 -1.017 . . . . 43.32 111.907 -178.369 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.71 -32.9 62.16 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 122.956 0.312 . . . . 62.399999999999999 113.542 -179.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 47.9 t -63.62 -23.93 67.59 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.054 0.93 . . . . 71.540000000000006 110.644 -175.686 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -89.46 -1.08 57.92 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.195 -0.911 . . . . 73.109999999999999 111.879 -174.723 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 60.5 m170 60.35 86.65 0.1 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.789 0.804 . . . . 72.129999999999995 111.652 -179.225 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -88.45 85.88 6.94 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.509 1.147 . . . . 75.219999999999999 112.241 -176.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -92.41 169.57 10.46 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 113.164 -1.835 . . . . 62.509999999999998 110.258 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 96.7 t -73.07 130.28 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 105.357 -2.09 . . . . 74.519999999999996 105.357 173.42 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.6 m -105.26 -28.97 2.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 120.2 -0.6 . . . . 73.120000000000005 112.371 -173.359 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -156.1 142.43 18.4 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 109.545 -0.539 . . . . 75.25 109.545 -176.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -121.42 138.63 54.19 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.13 -1.063 . . . . 73.340000000000003 108.13 175.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . 0.465 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 3.0 t-20 -60.26 -51.91 76.93 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 123.303 0.377 . . . . 73.239999999999995 111.023 -175.591 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.465 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.5 Cg_endo -88.84 118.74 0.97 Allowed 'Trans proline' 0 N--CA 1.437 -1.829 0 N-CA-C 107.934 -1.602 . . . . 62.549999999999997 107.934 169.138 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.54 159.68 39.47 Favored 'Trans proline' 0 C--O 1.249 1.042 0 C-N-CA 122.206 1.938 . . . . 74.120000000000005 112.681 -176.208 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -62.35 139.04 58.54 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.987 -0.551 . . . . 74.129999999999995 109.872 179.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.66 -8.74 60.12 Favored Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 120.189 -1.005 . . . . 65.230000000000004 111.668 -177.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 79.5 m -80.07 138.78 37.04 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.554 -0.906 . . . . 72.329999999999998 108.554 178.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -77.19 122.85 6.29 Favored Glycine 0 N--CA 1.419 -2.499 0 N-CA-C 110.379 -1.089 . . . . 74.420000000000002 110.379 177.847 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 28.4 m -112.49 141.84 26.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 108.697 -0.853 . . . . 75.219999999999999 108.697 177.071 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 559' ' ' ASN . 34.3 p-10 -54.89 173.37 0.09 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.536 0.734 . . . . 73.409999999999997 112.654 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -57.09 -24.92 57.44 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.524 0.935 . . . . 75.329999999999998 113.524 179.568 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -84.02 -9.67 58.47 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.557 -0.857 . . . . 52.43 110.077 178.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 65.33 19.03 66.02 Favored Glycine 0 C--O 1.22 -0.778 0 N-CA-C 114.576 0.59 . . . . 52.020000000000003 114.576 165.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.2 118.5 13.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-O 122.396 1.093 . . . . 74.319999999999993 112.135 -166.624 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.525 HG13 ' SD ' ' A' ' 563' ' ' MET . 0.0 OUTLIER -130.06 133.53 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 114.183 -1.371 . . . . 75.450000000000003 111.295 -176.473 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 42.0 m -105.06 126.74 52.4 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.614 -0.884 . . . . 75.129999999999995 108.614 178.843 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.3 pp -138.13 166.76 23.32 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.164 0.431 . . . . 70.519999999999996 112.164 -176.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -128.43 136.99 51.63 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.074 -0.713 . . . . 75.540000000000006 109.074 175.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -142.0 168.08 20.59 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.612 -1.255 . . . . 74.209999999999994 107.612 -174.363 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -70.52 -124.7 0.05 OUTLIER Glycine 0 CA--C 1.538 1.494 0 C-N-CA 119.177 -1.487 . . . . 64.310000000000002 110.765 172.572 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 . . . . . 0 C--N 1.27 -2.875 0 N-CA-C 108.729 -0.841 . . . . 74.549999999999997 108.729 175.761 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.693 0 N-CA-C 110.104 -1.198 . . . . 73.120000000000005 110.104 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -76.18 142.02 23.96 Favored 'Trans proline' 0 C--O 1.247 0.973 0 CA-C-N 119.631 1.715 . . . . 74.230000000000004 109.533 174.65 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 60.1 10.83 2.42 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.699 1.2 . . . . 75.109999999999999 113.084 179.302 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 7.1 p -147.19 139.55 24.65 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 122.565 0.346 . . . . 74.310000000000002 110.29 -177.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -139.42 132.95 30.33 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.584 -0.895 . . . . 72.430000000000007 108.584 179.297 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.3 p-10 -95.1 135.26 36.86 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.43 0.633 . . . . 72.299999999999997 110.847 -177.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.4 pt -81.91 127.88 70.54 Favored Pre-proline 0 C--N 1.303 -1.449 0 CA-C-N 114.667 -1.151 . . . . 75.530000000000001 111.797 -175.588 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -82.3 178.48 6.24 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.319 2.013 . . . . 74.030000000000001 111.967 178.088 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -97.47 107.82 20.41 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 122.289 1.042 . . . . 72.25 110.075 178.448 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 25.7 m -111.39 18.75 7.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 114.4 -1.273 . . . . 74.209999999999994 109.566 179.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -74.16 100.6 3.71 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.734 -1.121 . . . . 74.209999999999994 110.342 -178.546 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 155.7 -41.53 0.58 Allowed Glycine 0 N--CA 1.426 -2.023 0 C-N-CA 120.953 -0.641 . . . . 62.329999999999998 111.641 177.576 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.461 ' O ' HG12 ' A' ' 534' ' ' VAL . 19.3 mp0 -77.13 -177.46 4.53 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.45 0.643 . . . . 70.219999999999999 110.381 -179.219 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 11.4 m -75.23 155.62 36.6 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 106.428 -1.693 . . . . 75.530000000000001 106.428 174.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.423 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.4 p -62.01 -42.13 93.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 118.166 0.439 . . . . 72.340000000000003 111.66 -178.285 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.91 -42.88 98.94 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 122.854 0.462 . . . . 75.140000000000001 110.609 178.678 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 82.3 t -67.6 -49.03 74.29 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.906 0 N-CA-C 109.139 -0.689 . . . . 64.219999999999999 109.139 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . 0.439 ' CB ' HG13 ' A' ' 534' ' ' VAL . . . -59.28 -43.49 92.54 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 122.717 0.407 . . . . 75.230000000000004 111.897 -177.699 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.9 mt-30 -63.32 -44.34 95.21 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 120.757 0.313 . . . . 74.430000000000007 110.287 179.688 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -67.23 -40.22 86.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.406 -0.361 . . . . 71.219999999999999 110.155 178.51 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . 0.606 ' O ' HG11 ' A' ' 514' ' ' VAL . 9.2 m-20 -62.47 -45.66 92.04 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.316 -0.857 . . . . 73.040000000000006 111.688 -178.122 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -69.05 -37.53 78.61 Favored 'General case' 0 C--O 1.211 -0.949 0 C-N-CA 119.683 -0.807 . . . . 72.430000000000007 110.722 -179.577 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.594 ' ND2' ' H ' ' A' ' 518' ' ' THR . 2.7 t-20 -64.36 -35.66 81.61 Favored 'General case' 0 N--CA 1.421 -1.915 0 C-N-CA 124.645 1.178 . . . . 70.040000000000006 111.108 -178.455 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.606 HG11 ' O ' ' A' ' 511' ' ' ASN . 5.0 p -67.26 -31.27 52.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.944 0.402 . . . . 72.409999999999997 110.764 -178.523 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -104.51 6.22 34.6 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.625 -0.509 . . . . 75.530000000000001 109.625 -179.58 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -131.1 -53.4 0.09 OUTLIER Glycine 0 CA--C 1.477 -2.31 0 C-N-CA 119.7 -1.238 . . . . 72.420000000000002 114.399 -168.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 65.16 77.32 0.31 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 106.939 -1.504 . . . . 71.349999999999994 106.939 -173.58 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 518' ' ' THR . . . . . 0.594 ' H ' ' ND2' ' A' ' 513' ' ' ASN . 3.3 p -140.29 177.1 8.23 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 115.061 -0.972 . . . . 74.540000000000006 111.539 -170.279 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.97 132.76 53.78 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.119 -1.438 . . . . 72.519999999999996 107.119 179.185 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -130.55 154.48 47.78 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.154 0.502 . . . . 73.219999999999999 112.095 -176.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 69.6 m -140.4 160.56 39.71 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 105.969 -1.863 . . . . 72.230000000000004 105.969 174.159 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . 0.405 ' HB2' ' CG2' ' A' ' 555' ' ' VAL . 3.8 pt20 -131.11 135.98 47.98 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.695 -0.802 . . . . 75.530000000000001 111.035 -178.895 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.72 129.22 56.39 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.601 -1.259 . . . . 73.450000000000003 107.601 178.343 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.8 m -100.59 124.74 46.57 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.244 0.545 . . . . 65.219999999999999 111.842 -177.668 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.54 150.82 24.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.444 -1.317 . . . . 72.310000000000002 107.444 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -91.35 135.3 33.91 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.445 -0.576 . . . . 54.340000000000003 109.445 179.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 52.3 m -160.53 162.86 22.63 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 107.549 -1.278 . . . . 74.209999999999994 107.549 -175.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -64.15 -8.54 16.66 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.699 2.266 . . . . 75.25 113.564 178.587 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -74.07 134.49 77.58 Favored Pre-proline 0 N--CA 1.432 -1.333 0 N-CA-C 107.437 -1.32 . . . . 71.209999999999994 107.437 175.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.53 149.82 89.69 Favored 'Trans proline' 0 C--O 1.249 1.063 0 C-N-CA 122.303 2.002 . . . . 74.230000000000004 112.495 -175.789 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.26 120.09 7.53 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.357 -0.838 . . . . 75.109999999999999 111.979 -176.72 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.53 -20.77 10.12 Favored Glycine 0 N--CA 1.428 -1.872 0 CA-C-N 114.98 -1.009 . . . . 61.229999999999997 111.414 177.645 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -78.67 137.15 37.67 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.345 -0.613 . . . . 72.329999999999998 109.345 179.046 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 503' ' ' GLN . 11.5 p -99.47 120.49 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.091 0 N-CA-C 108.566 -0.901 . . . . 75.430000000000007 108.566 -179.217 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.21 -1.43 44.72 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.097 -0.956 . . . . 70.120000000000005 112.072 178.948 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 132.67 -141.57 12.95 Favored Glycine 0 N--CA 1.419 -2.447 0 N-CA-C 111.226 -0.75 . . . . 51.219999999999999 111.226 175.265 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 2.2 p -116.61 157.14 25.83 Favored 'General case' 0 C--N 1.262 -3.217 0 N-CA-C 108.547 -0.908 . . . . 74.299999999999997 108.547 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.465 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 55.1 t30 -64.92 -53.51 41.92 Favored Pre-proline 0 C--N 1.324 -0.51 0 C-N-CA 120.087 -0.645 . . . . 75.549999999999997 109.923 175.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . 0.465 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 15.8 Cg_exo -71.66 137.63 30.48 Favored 'Trans proline' 0 C--N 1.372 1.782 0 N-CA-C 107.002 -1.961 . . . . 75.129999999999995 107.002 168.488 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -55.78 139.91 84.22 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.209 1.939 . . . . 75.209999999999994 113.384 -175.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.84 132.38 51.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.39 -0.823 . . . . 74.319999999999993 110.775 -178.356 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.75 -10.17 37.96 Favored Glycine 0 C--N 1.303 -1.253 0 N-CA-C 111.668 -0.573 . . . . 72.409999999999997 111.668 -175.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 86.8 m -77.46 129.02 35.19 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 122.817 -0.225 . . . . 72.010000000000005 110.517 179.563 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 11.3 t -82.14 125.55 31.02 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.095 -1.076 . . . . 73.239999999999995 108.095 174.926 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.73 160.0 53.23 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 109.189 -0.671 . . . . 74.099999999999994 109.189 -177.707 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -65.89 143.13 71.97 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.697 1.598 . . . . 72.510000000000005 110.14 177.054 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.44 -19.72 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 CA-C-O 121.591 0.71 . . . . 74.409999999999997 110.555 178.513 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.25 -12.76 59.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.884 -0.598 . . . . 75.299999999999997 111.848 176.18 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 10.2 t -93.06 148.19 22.21 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.92 -0.77 . . . . 75.019999999999996 108.92 -179.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 9.9 p -91.79 138.71 19.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 115.836 -0.62 . . . . 73.439999999999998 111.508 -177.062 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 60.0 mt -80.72 124.28 38.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.417 -0.957 . . . . 74.319999999999993 108.417 177.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -103.65 117.9 35.48 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.305 -0.998 . . . . 71.430000000000007 108.305 -178.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.5 128.54 41.15 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.253 0.621 . . . . 75.540000000000006 111.485 -178.561 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -83.0 102.76 11.96 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 123.204 0.602 . . . . 75.25 110.061 177.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' A' ' 522' ' ' GLN . 25.9 t -95.94 123.58 48.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.407 -0.961 . . . . 74.120000000000005 108.407 -179.654 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 51.1 m -95.07 127.99 41.55 Favored 'General case' 0 N--CA 1.409 -2.481 0 CA-C-O 121.457 0.646 . . . . 73.129999999999995 111.413 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 18.2 ptpt -100.12 135.23 41.87 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 106.453 -1.684 . . . . 72.329999999999998 106.453 170.472 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -55.03 -22.88 29.86 Favored Glycine 0 CA--C 1.503 -0.676 0 O-C-N 124.698 1.249 . . . . 71.299999999999997 115.077 -172.748 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 81.73 -24.4 0.19 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.449 1.499 . . . . 71.209999999999994 109.755 -178.437 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.427 ' H ' ' C ' ' A' ' 558' ' ' GLY . 91.6 mt-30 -113.25 158.02 21.02 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.391 -0.822 . . . . 71.319999999999993 110.913 -176.852 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -127.02 150.21 49.54 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.217 -1.031 . . . . 75.430000000000007 108.217 175.359 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 31.0 t -71.28 118.14 15.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.588 -0.523 . . . . 73.450000000000003 109.588 -178.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 563' ' ' MET . . . . . 0.596 ' SD ' HG23 ' A' ' 620' ' ' ILE . 49.4 ttp -87.13 129.13 52.99 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-N 116.119 -0.491 . . . . 73.239999999999995 111.147 -176.314 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.49 169.55 22.28 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.529 2.153 . . . . 75.219999999999999 111.114 174.027 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -74.63 142.12 44.59 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.986 0.422 . . . . 73.099999999999994 110.375 179.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -135.05 15.46 3.53 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.936 0.874 . . . . 74.030000000000001 109.179 177.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 31.6 t -79.22 139.38 37.95 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.118 -0.947 . . . . 74.340000000000003 108.867 178.71 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 97.03 26.0 10.74 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.462 -0.875 . . . . 71.010000000000005 114.022 176.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.9 -175.55 3.71 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.964 -0.754 . . . . 74.530000000000001 108.964 177.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -117.06 159.07 23.11 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.65 -1.241 . . . . 75.219999999999999 107.65 -175.309 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . 0.407 ' CH2' ' HB3' ' A' ' 589' ' ' LYS . 27.2 t-105 -63.48 -24.81 67.98 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.324 0.583 . . . . 74.450000000000003 110.21 -176.398 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.0 m -66.97 -18.94 24.99 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 CA-C-N 115.025 -0.989 . . . . 63.140000000000001 110.735 179.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.535 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 22.9 t70 -101.69 -28.56 12.41 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.078 -0.712 . . . . 71.420000000000002 109.078 177.759 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -56.47 -47.52 79.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.962 0.905 . . . . 75.519999999999996 112.676 -178.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -64.25 -47.98 77.36 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 119.633 -0.827 . . . . 75.329999999999998 112.769 178.568 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -52.66 -37.2 74.65 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 121.999 1.8 . . . . 74.409999999999997 112.796 171.057 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 6.4 mmp_? -59.35 -44.27 92.7 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 109.347 -0.612 . . . . 75.409999999999997 109.347 176.446 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 1.7 tp -59.85 -49.57 77.19 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-N 115.271 -0.877 . . . . 65.120000000000005 111.44 -176.149 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -66.73 -40.93 88.55 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.712 0.634 . . . . 73.129999999999995 112.712 176.682 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.62 -37.68 73.84 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.908 0.707 . . . . 75.329999999999998 112.908 -177.257 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.89 -8.93 59.53 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 122.14 -0.35 . . . . 72.519999999999996 110.962 -174.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.26 47.03 18.7 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.145 -0.782 . . . . 43.219999999999999 111.145 -179.68 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . 0.559 ' CH2' ' HG ' ' A' ' 587' ' ' LEU . 12.4 t90 -87.18 127.86 35.14 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 121.636 0.731 . . . . 74.319999999999993 110.134 -178.689 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 27.0 m -89.1 -17.45 29.24 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 124.367 1.067 . . . . 71.340000000000003 112.947 -174.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -96.79 -171.04 34.2 Favored Glycine 0 CA--C 1.497 -1.038 0 C-N-CA 121.372 -0.442 . . . . 64.129999999999995 113.223 -176.142 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 81.4 mtp -117.73 155.85 29.27 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 120.908 0.385 . . . . 72.439999999999998 110.878 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . 0.559 ' HG ' ' CH2' ' A' ' 583' ' ' TRP . 5.0 mt -80.31 125.56 30.05 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 115.076 -0.965 . . . . 75.420000000000002 112.245 -178.48 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 621' ' ' THR . 2.4 m-20 -110.93 118.11 35.21 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.269 -1.332 . . . . 74.409999999999997 110.122 176.313 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . 0.407 ' HB3' ' CH2' ' A' ' 571' ' ' TRP . 0.0 OUTLIER -107.33 133.83 51.29 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 120.176 -0.61 . . . . 75.430000000000007 109.39 -178.961 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -78.59 -69.85 1.36 Allowed Glycine 0 C--N 1.284 -2.322 0 CA-C-N 115.354 -0.839 . . . . 65.120000000000005 111.176 -179.686 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.09 149.24 42.84 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.706 0.288 . . . . 61.130000000000003 111.508 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -96.61 124.09 40.49 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 105.925 -1.88 . . . . 74.239999999999995 105.925 170.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 40.2 t -105.76 119.99 55.9 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.5 0 CA-C-N 115.683 -0.69 . . . . 75.349999999999994 109.832 -175.601 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -73.54 107.06 5.6 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.37 -0.974 . . . . 71.109999999999999 108.37 176.506 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -107.84 -39.75 5.47 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.432 0.634 . . . . 63.329999999999998 110.014 -179.338 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 114.34 152.06 10.49 Favored Glycine 0 N--CA 1.412 -2.9 0 N-CA-C 110.674 -0.971 . . . . 65.340000000000003 110.674 -177.225 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.98 -32.66 62.74 Favored Glycine 0 C--N 1.305 -1.174 0 C-N-CA 123.287 0.47 . . . . 55.43 113.1 -179.592 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 4.3 p -69.59 -24.92 63.74 Favored 'General case' 0 N--CA 1.422 -1.859 0 C-N-CA 124.283 1.033 . . . . 41.130000000000003 111.608 -176.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -93.95 -14.18 26.25 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.602 -0.726 . . . . 73.25 109.971 -177.006 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 65.1 m80 56.69 108.73 0.01 OUTLIER 'General case' 0 C--O 1.238 0.47 0 O-C-N 124.345 1.028 . . . . 63.32 111.684 -173.691 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -73.53 75.52 1.46 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.943 -1.026 . . . . 75.519999999999996 113.404 -172.177 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -86.5 171.24 11.24 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 124.702 1.201 . . . . 74.329999999999998 109.001 177.674 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.93 129.75 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.666 -1.976 . . . . 74.120000000000005 105.666 169.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 14.5 p -96.64 -32.32 4.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 120.13 -0.628 . . . . 72.099999999999994 110.424 -174.311 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -151.3 134.94 16.32 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 116.182 -0.463 . . . . 74.109999999999999 110.62 -179.449 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -106.54 130.16 54.36 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.321 -1.362 . . . . 71.120000000000005 107.321 172.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -55.33 -55.52 38.85 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 113.654 0.983 . . . . 74.299999999999997 113.654 -176.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -87.71 131.73 2.86 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.14 1.227 . . . . 71.510000000000005 110.433 175.589 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -64.88 160.32 41.64 Favored 'Trans proline' 0 C--O 1.253 1.234 0 C-N-CA 122.642 2.228 . . . . 75.400000000000006 112.383 177.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -64.8 138.5 58.42 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.15 -0.685 . . . . 75.329999999999998 109.15 177.519 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 91.84 0.4 71.96 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 119.8 -1.19 . . . . 75.349999999999994 111.912 -179.178 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 24.0 m -90.35 146.31 24.28 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.881 -0.785 . . . . 75.319999999999993 108.881 178.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -83.56 123.2 6.06 Favored Glycine 0 N--CA 1.419 -2.45 0 N-CA-C 110.962 -0.855 . . . . 74.340000000000003 110.962 177.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.9 m -111.44 142.55 23.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 107.901 -1.148 . . . . 74.420000000000002 107.901 176.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.407 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 37.8 p30 -46.1 163.09 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 113.769 1.026 . . . . 73.030000000000001 113.769 179.077 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -57.15 -25.31 58.71 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.331 -0.85 . . . . 73.200000000000003 112.219 177.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.35 -10.96 59.75 Favored 'General case' 0 C--O 1.214 -0.802 0 C-N-CA 119.372 -0.931 . . . . 74.219999999999999 109.254 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.85 11.42 57.87 Favored Glycine 0 CA--C 1.494 -1.264 0 C-N-CA 123.455 0.55 . . . . 71.120000000000005 112.885 167.344 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.96 118.77 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.114 0 CA-C-O 122.44 1.114 . . . . 74.540000000000006 110.985 -169.638 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.596 HG23 ' SD ' ' A' ' 563' ' ' MET . 2.7 pp -124.95 133.92 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 CA-C-N 113.74 -1.573 . . . . 73.230000000000004 111.813 -177.943 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 28.3 m -99.0 130.52 45.34 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.669 -1.234 . . . . 74.209999999999994 107.669 177.369 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -138.65 162.78 33.77 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 110.145 -0.316 . . . . 71.219999999999999 110.145 -178.157 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -128.1 136.98 51.92 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.221 -1.4 . . . . 75.109999999999999 107.221 178.202 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -141.92 167.53 21.92 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.997 -0.547 . . . . 73.040000000000006 110.127 -168.432 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -64.55 -170.43 2.21 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-O 121.944 0.747 . . . . 64.299999999999997 113.633 176.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 . . . . . 0 C--N 1.28 -2.418 0 C-N-CA 124.066 0.946 . . . . 74.409999999999997 111.0 -175.91 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.652 0 N-CA-C 110.319 -1.112 . . . . 65.239999999999995 110.319 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.84 145.33 90.41 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.743 2.295 . . . . 71.099999999999994 111.844 179.118 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -84.45 -10.6 57.36 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.42 0.629 . . . . 74.200000000000003 111.476 -176.307 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 33.2 p -136.87 148.56 47.15 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 115.5 -0.773 . . . . 74.230000000000004 110.251 -178.622 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -140.66 153.54 46.04 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.026 -0.731 . . . . 74.430000000000007 109.026 176.213 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -90.2 140.77 29.35 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.215 0.531 . . . . 71.310000000000002 110.148 -178.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 22.8 pt -101.98 112.71 65.66 Favored Pre-proline 0 C--N 1.301 -1.515 0 CA-C-N 115.592 -0.731 . . . . 74.549999999999997 110.57 177.705 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -69.65 167.68 23.6 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.439 2.092 . . . . 74.239999999999995 112.264 177.46 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -75.2 96.11 3.25 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.477 0.656 . . . . 74.239999999999995 110.207 179.183 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 31.5 m -94.81 9.33 5.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 115.259 -0.882 . . . . 75.420000000000002 110.055 177.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.71 101.04 1.99 Allowed 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 114.638 -1.165 . . . . 65.549999999999997 110.222 -179.146 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 147.41 -23.18 1.53 Allowed Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 115.455 -0.793 . . . . 71.219999999999999 111.846 178.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.418 ' O ' HG11 ' A' ' 534' ' ' VAL . 1.9 mp0 -94.06 178.47 5.64 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 108.62 -0.881 . . . . 73.400000000000006 108.62 179.518 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 24.8 m -72.05 155.33 40.43 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.487 -1.301 . . . . 74.129999999999995 107.487 176.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.46 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.7 p -61.94 -43.21 97.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 111.42 0.156 . . . . 72.019999999999996 111.42 -178.73 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.16 -39.2 93.97 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 110.088 -0.338 . . . . 74.310000000000002 110.088 -179.314 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 99.7 t -69.06 -46.93 77.71 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 CA-C-N 115.142 -0.936 . . . . 74.5 109.748 -179.72 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.59 -44.38 96.29 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 122.99 0.181 . . . . 73.209999999999994 111.251 178.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.9 mt-30 -64.14 -46.55 83.62 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 120.699 0.285 . . . . 74.430000000000007 111.233 -178.912 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.44 ' O ' HG22 ' A' ' 514' ' ' VAL . 21.2 ptmt -67.1 -38.63 85.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.028 -0.533 . . . . 72.299999999999997 110.199 -178.099 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -67.13 -43.98 81.04 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.681 -0.69 . . . . 72.420000000000002 110.648 -179.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.07 -41.33 98.06 Favored 'General case' 0 C--O 1.207 -1.16 0 N-CA-C 108.317 -0.994 . . . . 74.430000000000007 108.317 -179.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -59.64 -34.89 73.38 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 124.12 0.968 . . . . 74.329999999999998 111.054 -179.688 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 510' ' ' LYS . 97.7 t -57.66 -38.2 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-O 121.168 0.508 . . . . 70.329999999999998 111.118 178.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.43 19.81 13.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 122.123 0.963 . . . . 73.340000000000003 111.159 -178.814 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -128.81 -59.43 0.11 Allowed Glycine 0 N--CA 1.416 -2.665 0 CA-C-N 114.68 -1.146 . . . . 71.430000000000007 111.595 -177.246 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 63.95 24.56 13.67 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 122.058 0.932 . . . . 75.420000000000002 110.016 -174.708 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 6.4 p -84.18 -179.66 7.27 Favored 'General case' 0 N--CA 1.404 -2.746 0 CA-C-N 113.984 -1.462 . . . . 72.010000000000005 110.277 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 56.7 mtpt -108.43 134.23 51.52 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.448 -1.686 . . . . 72.219999999999999 106.448 179.486 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -132.89 154.28 50.54 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 112.871 0.693 . . . . 72.450000000000003 112.871 -175.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 34.2 p -140.03 156.34 46.66 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.789 -1.189 . . . . 64.310000000000002 107.789 176.3 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -124.84 145.21 49.9 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.979 -0.288 . . . . 74.450000000000003 111.186 -178.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -132.59 117.53 18.06 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.388 -0.597 . . . . 53.450000000000003 109.388 177.526 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 524' ' ' SER . . . . . 0.416 ' HA ' ' HB ' ' A' ' 555' ' ' VAL . 49.1 m -84.53 116.76 23.3 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.535 0.683 . . . . 74.310000000000002 110.157 178.58 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 44.9 t -120.96 149.81 23.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 106.435 -1.691 . . . . 72.530000000000001 106.435 -176.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -68.29 134.52 50.48 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 120.717 0.294 . . . . 54.530000000000001 110.588 -176.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 49.3 m -163.08 160.51 18.72 Favored Pre-proline 0 C--O 1.208 -1.116 0 N-CA-C 108.397 -0.964 . . . . 71.409999999999997 108.397 -179.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -73.48 3.35 4.84 Favored 'Trans proline' 0 CA--C 1.556 1.623 0 C-N-CA 122.624 2.216 . . . . 75.530000000000001 113.651 178.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . 0.477 ' HD2' ' N ' ' A' ' 529' ' ' ARG . 2.7 mpt_? -92.39 140.02 24.1 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 107.992 -1.114 . . . . 73.209999999999994 107.992 177.114 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -62.19 150.75 85.65 Favored 'Trans proline' 0 C--O 1.254 1.324 0 C-N-CA 122.847 2.365 . . . . 73.319999999999993 113.052 -176.438 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.612 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.47 110.11 1.18 Allowed 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.196 -0.911 . . . . 62.119999999999997 112.253 -174.752 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 136.86 -26.92 2.97 Favored Glycine 0 N--CA 1.433 -1.5 0 C-N-CA 120.621 -0.799 . . . . 73.049999999999997 112.394 177.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -82.03 140.57 33.84 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.044 0.45 . . . . 74.329999999999998 110.558 -178.281 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.418 HG11 ' O ' ' A' ' 503' ' ' GLN . 7.9 p -96.96 118.24 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 CA-C-O 121.687 0.756 . . . . 75.019999999999996 109.162 -179.509 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -25.77 54.46 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 114.853 -1.067 . . . . 73.209999999999994 110.999 179.275 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 162.44 -164.69 35.76 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 120.547 -0.835 . . . . 63.409999999999997 111.776 179.172 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 1.7 p -116.87 157.9 24.87 Favored 'General case' 0 C--N 1.282 -2.336 0 C-N-CA 123.184 0.594 . . . . 61.009999999999998 109.639 -178.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -58.33 -54.46 55.68 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 120.712 -0.395 . . . . 72.519999999999996 110.657 175.533 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -73.2 135.99 23.68 Favored 'Trans proline' 0 C--N 1.359 1.102 0 N-CA-C 108.337 -1.447 . . . . 70.439999999999998 108.337 168.734 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.16 140.93 94.78 Favored 'Trans proline' 0 C--O 1.245 0.852 0 C-N-CA 122.406 2.071 . . . . 71.239999999999995 112.445 -178.069 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.46 140.48 58.03 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.955 -0.566 . . . . 72.340000000000003 110.004 -179.507 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.78 -15.09 55.94 Favored Glycine 0 C--N 1.3 -1.454 0 N-CA-C 110.775 -0.93 . . . . 74.209999999999994 110.775 -175.806 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.7 m -85.16 138.22 32.52 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 122.802 0.441 . . . . 63.25 109.955 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 8.0 t -76.29 128.06 34.14 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 108.645 -0.872 . . . . 72.25 108.645 173.057 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 32.1 m -123.78 154.79 67.23 Favored Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 108.691 -0.855 . . . . 70.129999999999995 108.691 -179.078 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -64.88 134.84 41.84 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 120.693 0.929 . . . . 74.109999999999999 111.703 178.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 8.6 p -67.38 -27.46 38.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.902 -1.044 . . . . 73.200000000000003 112.907 -176.206 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -90.19 -7.04 54.57 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.534 0.683 . . . . 71.030000000000001 110.908 -175.433 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.1 t -89.79 179.14 6.06 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.131 0.491 . . . . 63.109999999999999 109.684 -178.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 12.2 p -107.6 128.7 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.261 0 CA-C-N 115.511 -0.768 . . . . 75.019999999999996 109.82 -177.605 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 60.2 mt -93.22 135.95 26.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 108.4 -0.963 . . . . 75.25 108.4 -179.691 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -103.33 117.86 35.45 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.652 -0.499 . . . . 72.540000000000006 109.652 -176.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -95.46 120.83 36.38 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 123.748 0.819 . . . . 75.540000000000006 109.464 179.187 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -88.13 110.55 20.75 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.293 0.568 . . . . 75.340000000000003 109.964 178.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 524' ' ' SER . 15.7 t -96.47 135.86 29.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 107.796 -1.187 . . . . 65.329999999999998 107.796 -178.201 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.612 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 68.7 m -89.19 124.65 34.56 Favored 'General case' 0 N--CA 1.4 -2.959 0 C-N-CA 120.375 -0.53 . . . . 71.340000000000003 110.304 176.709 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -97.79 131.21 44.5 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 104.384 -2.451 . . . . 72.540000000000006 104.384 166.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -56.14 -26.37 49.45 Favored Glycine 0 CA--C 1.491 -1.448 0 O-C-N 124.258 0.974 . . . . 72.019999999999996 112.303 -175.173 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 57.2 t30 68.38 21.64 8.23 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 123.035 1.398 . . . . 75.200000000000003 108.716 174.159 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.463 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 63.4 mt-30 -126.94 145.27 50.75 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 113.176 -1.829 . . . . 74.400000000000006 107.183 177.993 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -122.8 149.5 44.07 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 120.605 -0.438 . . . . 73.099999999999994 110.174 -177.134 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.74 115.51 7.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 O-C-N 123.83 0.706 . . . . 74.540000000000006 109.111 -178.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 563' ' ' MET . . . . . 0.504 ' SD ' HG22 ' A' ' 620' ' ' ILE . 35.7 ttp -79.85 123.24 83.87 Favored Pre-proline 0 C--N 1.306 -1.285 0 CA-C-N 115.575 -0.739 . . . . 75.299999999999997 111.747 -175.657 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . 0.426 ' HG2' ' HB2' ' A' ' 581' ' ' LEU . 20.8 Cg_exo -68.76 156.73 64.49 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.945 2.43 . . . . 73.209999999999994 110.773 174.4 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.97 123.48 28.36 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.761 0.791 . . . . 73.209999999999994 110.702 179.009 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.81 14.07 12.45 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.903 -1.517 . . . . 75.420000000000002 106.903 173.411 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 3.0 m -69.13 140.46 54.73 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 112.967 -1.924 . . . . 73.239999999999995 110.18 -177.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 73.72 70.53 1.22 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 116.276 -0.42 . . . . 61.119999999999997 113.46 177.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 22.1 ptp -174.07 172.21 3.41 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.742 -0.836 . . . . 65.010000000000005 108.742 179.28 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . 0.402 ' HB2' HG11 ' A' ' 572' ' ' VAL . 95.7 m-85 -100.36 178.66 4.69 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.478 -0.934 . . . . 74.349999999999994 108.478 178.275 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -64.76 -28.71 69.77 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.806 0.336 . . . . 74.299999999999997 110.259 -177.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . 0.402 HG11 ' HB2' ' A' ' 570' ' ' PHE . 12.7 p -58.02 -30.05 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 123.339 0.656 . . . . 62.539999999999999 111.789 179.598 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . 0.486 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 29.5 m-20 -100.81 -38.65 8.17 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 120.982 -0.287 . . . . 75.400000000000006 110.313 175.762 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.11 90.1 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.357 0.873 . . . . 73.439999999999998 113.357 -176.658 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . 0.644 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 31.4 tt0 -65.3 -50.71 57.77 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 120.42 -0.512 . . . . 64.409999999999997 111.06 -179.193 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 71.2 Cg_exo -56.19 -35.74 95.73 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 121.314 1.342 . . . . 70.299999999999997 111.911 172.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 14.5 mmt180 -64.76 -38.49 91.16 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 111.711 0.263 . . . . 72.549999999999997 111.711 178.44 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.1 pp -65.93 -46.36 78.48 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.126 -0.63 . . . . 71.329999999999998 110.561 -176.762 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . 0.468 ' N ' HD13 ' A' ' 578' ' ' LEU . 11.9 ptm180 -66.35 -39.54 89.23 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.027 -0.533 . . . . 71.450000000000003 112.058 176.045 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.56 -27.31 64.04 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 112.567 0.58 . . . . 55.439999999999998 112.567 -177.537 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . 0.426 ' HB2' ' HG2' ' A' ' 564' ' ' PRO . 2.3 pp -92.28 -8.46 45.17 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 119.867 -0.733 . . . . 75.120000000000005 110.426 -179.677 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 77.27 48.69 8.0 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 120.633 -0.794 . . . . 75.329999999999998 111.323 -178.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -84.49 127.45 34.04 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.095 -1.076 . . . . 72.319999999999993 108.095 177.54 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 3.4 p -90.35 -5.52 56.11 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 124.71 1.204 . . . . 74.5 113.114 -175.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -114.09 -168.57 16.4 Favored Glycine 0 C--N 1.302 -1.346 0 N-CA-C 111.66 -0.576 . . . . 70.5 111.66 -179.516 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 26.4 mmt -121.15 153.86 36.96 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 110.087 -0.338 . . . . 74.420000000000002 110.087 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 6.3 tt -83.26 127.32 33.54 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.608 -0.886 . . . . 73.040000000000006 108.608 -178.159 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -125.08 116.48 22.15 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.165 -0.679 . . . . 75.140000000000001 109.165 178.434 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.63 133.56 36.84 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 118.756 -1.177 . . . . 75.439999999999998 110.636 177.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -78.97 -41.58 14.05 Favored Glycine 0 C--N 1.285 -2.298 0 CA-C-N 114.603 -1.181 . . . . 74.150000000000006 112.956 -172.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -138.29 142.04 39.82 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.77 -0.455 . . . . 71.319999999999993 109.77 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -111.78 125.13 53.66 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.907 -1.516 . . . . 72.439999999999998 106.907 175.452 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.68 116.79 48.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 N-CA-C 107.902 -1.147 . . . . 73.409999999999997 107.902 179.17 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . 0.442 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 5.3 p-10 -73.96 107.12 5.98 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.022 0.915 . . . . 63.140000000000001 112.483 -176.777 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -146.68 -61.34 0.3 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.184 -1.413 . . . . 72.340000000000003 107.184 175.377 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 132.31 147.56 5.89 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 120.132 -1.033 . . . . 53.119999999999997 112.283 177.365 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.66 -33.36 62.7 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 122.745 0.212 . . . . 74.540000000000006 113.508 -178.695 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 3.3 m -62.96 -23.52 67.45 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.534 1.134 . . . . 73.230000000000004 111.092 -177.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -87.44 0.55 55.34 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 124.801 1.24 . . . . 71.150000000000006 111.111 -175.082 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 66.3 m80 71.78 32.71 1.88 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.783 1.278 . . . . 75.239999999999995 109.098 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . 0.428 ' CG ' ' HA3' ' A' ' 625' ' ' GLY . 2.2 t-20 -82.31 41.82 0.71 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 112.815 -1.993 . . . . 71.439999999999998 109.84 -175.839 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -74.22 174.45 8.74 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 126.282 1.833 . . . . 74.239999999999995 110.303 178.686 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.6 129.86 17.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.242 -1.022 . . . . 73.25 108.242 -178.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 24.7 m -106.3 -28.27 2.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.606 -0.725 . . . . 74.129999999999995 111.271 -176.67 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -156.74 141.64 17.06 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.144 -0.48 . . . . 74.150000000000006 111.081 -178.268 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -122.64 142.05 51.07 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.138 -1.43 . . . . 75.430000000000007 107.138 172.471 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -58.05 -50.09 90.02 Favored Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 113.312 0.856 . . . . 75.010000000000005 113.312 -175.077 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -89.86 128.2 1.62 Allowed 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 121.068 1.179 . . . . 63.5 110.823 174.316 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.3 151.01 65.75 Favored 'Trans proline' 0 C--O 1.247 0.936 0 C-N-CA 122.446 2.098 . . . . 71.120000000000005 112.37 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.69 135.68 57.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.332 -0.394 . . . . 72.340000000000003 110.438 178.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.09 -11.88 48.66 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.386 -0.911 . . . . 65.019999999999996 112.38 -179.714 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 4.7 t -90.09 167.91 12.39 Favored 'General case' 0 C--O 1.255 1.373 0 C-N-CA 119.682 -0.807 . . . . 75.129999999999995 109.197 -179.361 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -90.83 117.5 5.14 Favored Glycine 0 N--CA 1.427 -1.929 0 N-CA-C 111.432 -0.667 . . . . 75.030000000000001 111.432 -178.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.03 142.58 16.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 109.686 -0.487 . . . . 75.530000000000001 109.686 178.06 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.463 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 28.9 p-10 -51.07 165.16 0.13 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.26 1.024 . . . . 71.329999999999998 112.187 -179.213 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -58.8 -25.12 62.84 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.554 0.576 . . . . 75.219999999999999 112.554 -178.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -80.81 -9.23 59.83 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.66 -0.496 . . . . 71.040000000000006 109.66 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.4 -0.89 5.87 Favored Glycine 0 C--O 1.211 -1.291 0 C-N-CA 124.756 1.169 . . . . 72.519999999999996 114.247 171.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.45 119.43 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 CA-C-O 122.266 1.032 . . . . 63.119999999999997 112.051 -164.008 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.504 HG22 ' SD ' ' A' ' 563' ' ' MET . 2.5 pp -125.68 133.98 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 CA-C-N 114.288 -1.324 . . . . 75.030000000000001 109.313 -178.529 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 11.5 t -101.52 139.23 37.45 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 108.31 -0.996 . . . . 74.409999999999997 108.31 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.6 pp -138.64 168.73 19.15 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.738 -0.665 . . . . 74.239999999999995 111.215 -174.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -123.95 137.06 54.68 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.1 -1.445 . . . . 73.439999999999998 107.1 -178.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . 0.279 0.2 OUTLIER -135.85 166.17 23.93 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.207 -1.361 . . . . 74.420000000000002 108.164 -161.952 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . 0.428 ' HA3' ' CG ' ' A' ' 601' ' ' ASN . . . -84.57 -140.72 4.91 Favored Glycine 0 N--CA 1.407 -3.274 0 C-N-CA 119.286 -1.435 . . . . 62.399999999999999 110.31 166.762 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.442 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 8.3 tp-100 . . . . . 0 C--N 1.283 -2.301 0 CA-C-O 118.275 -0.869 . . . . 73.140000000000001 108.924 -179.139 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.94 0 N-CA-C 110.558 -1.017 . . . . 60.340000000000003 110.558 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.64 156.48 65.87 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 122.396 2.064 . . . . 74.239999999999995 112.681 -177.653 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 493' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . 71.84 2.23 4.21 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 125.346 1.459 . . . . 72.319999999999993 112.935 177.296 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 13.8 p -145.79 140.31 27.04 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 122.283 -0.26 . . . . 74.109999999999999 111.172 -177.053 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -141.85 154.44 45.16 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.623 -0.51 . . . . 75.310000000000002 109.623 178.068 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.4 p-10 -89.5 144.23 26.2 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.167 0.508 . . . . 74.319999999999993 111.365 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.5 pt -99.85 137.71 20.22 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 115.506 -0.77 . . . . 63.439999999999998 110.954 -179.517 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -82.21 163.67 17.42 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.111 1.874 . . . . 72.439999999999998 111.197 176.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.16 103.93 8.41 Favored 'General case' 0 CA--C 1.491 -1.312 0 CA-C-O 122.647 1.213 . . . . 74.239999999999995 109.454 176.079 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 15.0 m -106.99 63.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.437 0 CA-C-O 123.219 1.485 . . . . 74.200000000000003 110.394 -177.514 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 501' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -118.54 110.84 17.86 Favored 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 112.357 -2.201 . . . . 63.200000000000003 108.683 172.306 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 145.3 -37.4 1.31 Allowed Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 119.768 -1.206 . . . . 54.039999999999999 112.715 177.621 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 503' ' ' GLN . . . . . 0.474 ' O ' HG11 ' A' ' 534' ' ' VAL . 0.5 OUTLIER -95.79 -175.16 3.34 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.494 -0.558 . . . . 71.140000000000001 109.494 -178.614 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 24.4 m -72.02 155.38 40.38 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.34 -0.985 . . . . 75.219999999999999 108.34 176.587 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.444 ' HA ' ' HB ' ' A' ' 534' ' ' VAL . 7.1 p -61.25 -41.75 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 116.41 -0.359 . . . . 71.420000000000002 111.846 -179.398 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 506' ' ' ASP . . . . . 0.539 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 35.5 t70 -65.26 -39.98 93.35 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 110.02 -0.363 . . . . 73.25 110.02 179.166 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.58 -42.61 93.34 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 N-CA-C 109.434 -0.58 . . . . 74.430000000000007 109.434 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.26 -44.43 96.57 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 123.456 0.473 . . . . 75.439999999999998 111.275 175.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -63.01 -45.42 92.43 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 120.505 0.193 . . . . 73.340000000000003 111.284 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 32.2 mmmt -65.0 -39.49 93.53 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.514 -0.55 . . . . 74.340000000000003 109.514 178.814 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -61.27 -49.81 75.55 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.678 -1.146 . . . . 74.310000000000002 110.247 -177.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.95 -34.71 75.78 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.496 -0.774 . . . . 75.049999999999997 110.894 -177.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.41 ' ND2' ' HA ' ' A' ' 517' ' ' PHE . 1.7 t-20 -61.6 -38.01 86.02 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.79 -0.641 . . . . 65.25 110.272 179.717 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 510' ' ' LYS . 69.3 t -59.51 -33.84 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.035 0.445 . . . . 75.319999999999993 111.268 178.309 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -111.89 15.9 20.59 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.372 0.606 . . . . 74.120000000000005 109.806 -177.253 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -141.17 -60.6 0.03 OUTLIER Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 119.969 -1.11 . . . . 72.030000000000001 113.919 -172.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 517' ' ' PHE . . . . . 0.41 ' HA ' ' ND2' ' A' ' 513' ' ' ASN . 79.5 m-85 63.54 41.48 7.31 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 122.667 1.222 . . . . 64.310000000000002 109.281 -173.642 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 518' ' ' THR . . . . . 0.466 HG22 ' HA ' ' A' ' 547' ' ' VAL . 14.8 p -95.27 -171.68 2.47 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 113.58 -1.646 . . . . 74.230000000000004 110.48 -178.847 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -107.91 137.49 45.82 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.346 -1.724 . . . . 73.219999999999999 106.346 174.719 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -132.92 151.87 51.98 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 112.233 0.457 . . . . 74.120000000000005 112.233 -178.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 52.8 p -139.6 159.42 42.21 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.168 -1.049 . . . . 63.030000000000001 108.168 176.571 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -117.5 134.23 55.09 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.638 -0.425 . . . . 72.25 110.708 177.671 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -112.28 126.74 55.57 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.573 -0.899 . . . . 74.519999999999996 108.573 177.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 6.5 p -96.03 130.55 43.01 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.192 0.52 . . . . 51.420000000000002 111.601 -178.032 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 11.4 p -139.86 156.28 25.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 106.654 -1.61 . . . . 75.349999999999994 106.654 177.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 526' ' ' ASP . . . . . 0.435 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 4.1 p30 -96.24 136.44 36.72 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 120.168 -0.613 . . . . 64.540000000000006 111.921 -179.707 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.4 m -161.84 161.04 22.29 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 107.061 -1.459 . . . . 73.519999999999996 107.061 179.352 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -66.57 8.61 0.31 Allowed 'Trans proline' 0 CA--C 1.557 1.653 0 C-N-CA 122.799 2.333 . . . . 72.409999999999997 114.559 -178.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.74 132.11 47.39 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 107.0 -1.481 . . . . 74.329999999999998 107.0 174.782 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -59.85 142.49 98.7 Favored 'Trans proline' 0 C--O 1.253 1.271 0 C-N-CA 122.261 1.974 . . . . 71.109999999999999 112.486 -177.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.39 107.43 0.49 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.04 -0.982 . . . . 74.409999999999997 111.219 -177.59 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 140.1 -28.85 2.46 Favored Glycine 0 N--CA 1.429 -1.794 0 CA-C-N 115.267 -0.879 . . . . 71.120000000000005 111.009 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -76.83 125.67 29.67 Favored 'General case' 0 C--O 1.251 1.144 0 CA-C-O 121.672 0.748 . . . . 73.349999999999994 110.292 -179.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 534' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 503' ' ' GLN . 7.1 p -82.15 121.99 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.927 0 N-CA-C 107.611 -1.255 . . . . 73.409999999999997 107.611 177.429 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.74 16.85 11.39 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 113.638 -1.619 . . . . 53.030000000000001 110.361 -173.247 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 115.58 -161.68 12.77 Favored Glycine 0 N--CA 1.424 -2.124 0 N-CA-C 111.405 -0.678 . . . . 70.239999999999995 111.405 177.765 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 9.6 p -117.16 154.76 30.52 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 109.274 -0.639 . . . . 72.239999999999995 109.274 -179.184 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 538' ' ' ASN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 552' ' ' GLU . 20.9 t-20 -63.95 -53.02 52.38 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 119.735 -0.786 . . . . 64.129999999999995 110.932 173.31 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -67.11 145.99 75.09 Favored 'Trans proline' 0 C--N 1.378 2.125 0 N-CA-C 108.773 -1.279 . . . . 71.329999999999998 108.773 171.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.84 140.7 94.64 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 122.281 1.987 . . . . 70.230000000000004 112.493 -178.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.83 137.95 55.74 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.981 -0.554 . . . . 71.510000000000005 109.534 178.72 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 96.52 -14.66 63.96 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 121.001 -0.619 . . . . 72.129999999999995 111.894 -178.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 43.4 m -79.72 137.42 37.03 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-O 121.027 0.441 . . . . 64.420000000000002 110.919 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 544' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.3 t -80.78 124.45 29.07 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 121.503 0.668 . . . . 74.430000000000007 109.571 177.551 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.43 159.15 56.33 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.996 -1.113 . . . . 72.25 107.996 -178.086 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 546' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 20.7 Cg_exo -63.5 137.76 61.55 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.137 1.225 . . . . 73.230000000000004 111.323 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . 0.466 ' HA ' HG22 ' A' ' 518' ' ' THR . 12.1 p -66.21 -19.64 25.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 122.272 1.034 . . . . 63.409999999999997 109.629 179.182 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -88.42 -13.24 40.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.201 -1.363 . . . . 73.239999999999995 111.143 -177.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 92.8 p -84.25 170.43 13.72 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-O 121.17 0.51 . . . . 55.310000000000002 110.697 -177.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.6 p -104.38 124.42 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.338 0 CA-C-N 115.271 -0.877 . . . . 74.329999999999998 109.036 177.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.32 135.4 26.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.402 -0.962 . . . . 74.049999999999997 108.402 -178.206 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 552' ' ' GLU . . . . . 0.413 ' HB3' ' HB3' ' A' ' 538' ' ' ASN . 5.6 tp10 -102.55 117.57 34.98 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.795 -0.817 . . . . 74.340000000000003 108.795 -177.643 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -93.78 127.69 39.64 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.419 -0.956 . . . . 75.319999999999993 108.419 178.135 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -90.09 117.83 29.17 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.701 -0.481 . . . . 71.329999999999998 109.701 -177.529 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.51 122.18 64.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 109.095 -0.705 . . . . 74.519999999999996 109.095 -178.585 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 71.4 m -90.71 127.98 36.5 Favored 'General case' 0 N--CA 1.412 -2.33 0 C-N-CA 120.058 -0.657 . . . . 75.340000000000003 110.251 176.595 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -89.22 137.79 32.01 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 103.971 -2.603 . . . . 63.229999999999997 103.971 168.571 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.511 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -60.82 -24.25 62.24 Favored Glycine 0 C--N 1.314 -0.686 0 O-C-N 123.938 0.774 . . . . 72.200000000000003 113.553 -174.105 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 559' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 23.6 t-20 76.94 -23.96 0.23 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.83 1.652 . . . . 71.200000000000003 109.951 -179.454 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 558' ' ' GLY . 86.8 mt-30 -112.4 143.58 43.29 Favored 'General case' 0 N--CA 1.399 -2.989 0 CA-C-N 114.596 -1.184 . . . . 75.219999999999999 110.144 -174.298 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -122.99 158.57 30.2 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 114.884 -1.053 . . . . 74.450000000000003 108.686 -179.49 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 53.3 t -63.47 117.11 3.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 O-C-N 123.65 0.594 . . . . 74.200000000000003 109.658 -179.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 22.2 ttt -70.4 127.1 92.4 Favored Pre-proline 0 C--N 1.297 -1.696 0 C-N-CA 124.408 1.083 . . . . 74.230000000000004 112.706 -177.795 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.91 169.66 22.11 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.148 2.565 . . . . 64.319999999999993 111.032 172.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -90.87 126.95 36.19 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 110.089 -0.337 . . . . 70.010000000000005 110.089 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 566' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' A' ' 569' ' ' MET . 1.7 tm? -104.84 -16.38 14.91 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.836 0.827 . . . . 74.450000000000003 109.031 -175.59 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 24.0 m -72.41 143.26 48.58 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.939 -0.573 . . . . 72.319999999999993 110.596 -178.19 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 101.18 4.76 53.53 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.628 -0.796 . . . . 74.109999999999999 113.912 178.199 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 569' ' ' MET . . . . . 0.539 ' SD ' ' HA ' ' A' ' 574' ' ' ALA . 23.5 ptp -123.0 166.88 14.36 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 117.526 0.663 . . . . 74.040000000000006 109.947 179.101 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -101.54 166.32 10.78 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.692 -1.595 . . . . 71.530000000000001 106.692 -178.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 13.7 t-105 -62.58 -30.13 71.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 118.572 0.624 . . . . 62.009999999999998 109.679 179.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.2 m -71.5 -21.95 21.79 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 CA-C-N 115.923 -0.58 . . . . 74.420000000000002 111.632 -179.253 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -101.31 -27.39 13.2 Favored 'General case' 0 C--O 1.256 1.405 0 N-CA-C 109.04 -0.726 . . . . 74.329999999999998 109.04 -178.594 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 574' ' ' ALA . . . . . 0.619 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -63.52 -54.23 39.47 Favored 'General case' 0 C--O 1.207 -1.132 0 CA-C-N 114.419 -1.264 . . . . 74.319999999999993 112.284 -178.38 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -53.02 -52.19 67.73 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 114.181 1.178 . . . . 75.420000000000002 114.181 -176.442 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -54.73 -39.7 88.1 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 121.454 1.436 . . . . 73.439999999999998 112.218 174.234 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -69.12 -34.55 75.23 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.63 0.604 . . . . 74.319999999999993 112.63 176.577 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 47.8 mt -65.88 -48.37 71.74 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.596 0.712 . . . . 74.129999999999995 109.21 -177.74 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -34.62 78.29 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.197 -0.911 . . . . 71.329999999999998 111.64 178.277 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.39 -32.12 69.64 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.373 -0.376 . . . . 71.439999999999998 111.287 -177.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.4 pp -85.71 -8.74 57.99 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.499 0.666 . . . . 75.349999999999994 109.622 179.242 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 77.13 44.79 12.75 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.126 -0.943 . . . . 74.329999999999998 112.5 178.367 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -74.03 127.64 33.45 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.378 0.609 . . . . 73.129999999999995 109.688 179.218 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 2.8 p -85.06 -40.12 17.2 Favored 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 124.859 1.264 . . . . 74.340000000000003 112.928 -177.26 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -80.47 -161.05 24.09 Favored Glycine 0 C--O 1.242 0.656 0 N-CA-C 115.571 0.988 . . . . 72.239999999999995 115.571 -174.368 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 54.5 mtt -119.86 154.01 34.96 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 123.624 0.769 . . . . 74.239999999999995 109.28 -176.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 6.8 tt -83.48 123.44 29.71 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.339 0.59 . . . . 74.049999999999997 109.689 -178.453 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 588' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 621' ' ' THR . 36.6 t70 -113.7 114.29 26.17 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.898 -1.046 . . . . 74.310000000000002 108.568 -179.801 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.8 133.56 43.97 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.381 -0.927 . . . . 74.450000000000003 109.851 -179.059 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -86.81 -46.05 5.25 Favored Glycine 0 C--N 1.285 -2.302 0 CA-C-N 115.616 -0.72 . . . . 71.349999999999994 111.543 -177.461 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.67 135.01 32.78 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 110.119 -0.326 . . . . 71.430000000000007 110.119 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -116.73 127.45 54.4 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.242 -1.022 . . . . 74.329999999999998 108.242 174.246 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 99.4 t -111.28 116.83 53.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 116.452 -0.34 . . . . 74.140000000000001 110.262 -177.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 594' ' ' ASP . . . . . 0.538 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 27.6 t70 -73.77 116.77 14.76 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-O 120.82 0.343 . . . . 54.420000000000002 111.268 -177.338 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -139.77 -42.63 0.44 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.819 -0.628 . . . . 75.140000000000001 109.727 178.065 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 123.16 140.1 5.6 Favored Glycine 0 N--CA 1.426 -1.992 0 C-N-CA 120.731 -0.747 . . . . 72.439999999999998 111.842 178.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.75 -32.18 61.56 Favored Glycine 0 C--N 1.315 -0.636 0 CA-C-O 121.09 0.272 . . . . 72.430000000000007 112.552 179.593 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 4.7 p -64.02 -23.23 67.25 Favored 'General case' 0 N--CA 1.432 -1.349 0 C-N-CA 125.218 1.407 . . . . 73.030000000000001 111.563 -178.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -87.22 -0.53 56.85 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.199 -0.909 . . . . 71.310000000000002 109.9 -176.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 13.9 m170 65.26 65.39 0.58 Allowed 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 122.573 1.178 . . . . 72.129999999999995 110.954 -178.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -81.38 92.52 6.43 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 114.137 -1.392 . . . . 72.439999999999998 111.729 -179.057 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 41.3 mtm-85 -91.39 171.71 9.02 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 113.674 -1.603 . . . . 71.219999999999999 107.678 176.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . 0.467 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 86.9 t -67.67 130.26 32.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 105.497 -2.038 . . . . 75.120000000000005 105.497 169.263 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 59.4 t -101.15 -52.59 8.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 C-N-CA 120.501 -0.48 . . . . 74.0 110.813 -172.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -133.1 136.28 45.76 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.901 -0.59 . . . . 74.140000000000001 109.831 -177.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 606' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 608' ' ' PRO . 13.3 pt20 -112.29 140.13 47.26 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.441 -1.689 . . . . 75.25 106.441 175.429 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -56.74 -53.7 61.93 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 113.418 0.895 . . . . 74.310000000000002 113.418 -175.74 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 608' ' ' PRO . . . . . 0.444 ' O ' ' HG3' ' A' ' 606' ' ' GLN . 7.2 Cg_endo -91.43 134.01 1.56 Allowed 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.434 1.422 . . . . 75.209999999999994 110.459 173.526 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.07 157.69 58.98 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 121.447 1.432 . . . . 74.519999999999996 111.306 178.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.88 138.52 58.36 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 108.892 -0.781 . . . . 71.109999999999999 108.892 177.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.6 -8.76 43.99 Favored Glycine 0 C--N 1.302 -1.339 0 C-N-CA 120.679 -0.772 . . . . 73.439999999999998 111.928 -176.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 54.3 m -77.04 146.83 37.11 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.892 -0.781 . . . . 75.420000000000002 108.892 176.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -81.1 114.63 3.86 Favored Glycine 0 N--CA 1.432 -1.632 0 N-CA-C 109.818 -1.313 . . . . 61.43 109.818 174.07 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 614' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 22.0 m -108.26 141.26 23.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 116.908 0.354 . . . . 63.340000000000003 110.592 178.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 615' ' ' ASN . . . . . 0.47 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 41.3 p30 -51.57 173.15 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.219 1.562 . . . . 73.409999999999997 115.219 -177.758 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -60.91 -25.21 66.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.059 -1.428 . . . . 74.549999999999997 112.289 178.161 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -85.63 -11.1 54.72 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.2 -1.037 . . . . 75.340000000000003 108.2 -178.036 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.46 15.12 63.31 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 115.44 -0.8 . . . . 63.43 112.639 168.178 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.72 125.55 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 122.056 0.932 . . . . 74.430000000000007 111.365 -167.885 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 620' ' ' ILE . . . . . 0.401 HD11 ' HB2' ' A' ' 606' ' ' GLN . 0.0 OUTLIER -129.67 132.1 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.261 0 CA-C-N 114.193 -1.367 . . . . 72.420000000000002 109.466 -179.055 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 74.7 m -104.33 122.45 45.47 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.935 -1.135 . . . . 74.25 107.935 178.364 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.99 166.93 21.25 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.25 -0.432 . . . . 73.049999999999997 111.714 -176.177 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -127.11 136.43 52.12 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.921 -1.14 . . . . 72.430000000000007 107.921 175.616 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.467 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 3.3 p90 -142.35 165.44 27.41 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.788 -0.642 . . . . 74.340000000000003 110.969 -173.672 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -80.66 150.54 31.34 Favored Glycine 0 N--CA 1.421 -2.35 0 N-CA-C 109.748 -1.341 . . . . 63.130000000000003 109.748 175.449 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 626' ' ' GLN . . . . . 0.538 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 7.3 tt0 . . . . . 0 C--N 1.275 -2.657 0 CA-C-O 117.949 -1.024 . . . . 73.129999999999995 108.582 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.9 0 CA-C-O 120.854 0.359 . . . . 75.34 111.382 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 21.8 p -134.84 147.96 50.04 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.231 -0.655 . . . . 73.23 109.231 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -148.26 143.94 27.31 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.844 -1.539 . . . . 73.33 106.844 -177.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.2 p-10 -88.93 137.88 31.92 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.028 -0.669 . . . . 70.14 109.414 178.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 497' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 498' ' ' PRO . 40.9 pt -89.63 134.39 32.49 Favored Pre-proline 0 C--N 1.297 -1.691 0 CA-C-N 116.147 -0.479 . . . . 62.32 111.94 -177.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 3.9 Cg_exo -84.71 156.45 11.94 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.543 2.162 . . . . 74.22 110.051 171.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -88.54 121.22 30.68 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-O 122.401 1.096 . . . . 70.12 109.055 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.403 ' CG2' ' HB1' ' A' ' 508' ' ' ALA . 5.6 m -109.62 61.11 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.655 0 CA-C-N 113.999 -1.455 . . . . 65.12 109.378 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -105.73 109.95 22.08 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 112.462 -2.154 . . . . 75.53 109.426 174.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 152.57 -29.44 0.85 Allowed Glycine 0 C--N 1.305 -1.193 0 C-N-CA 119.561 -1.304 . . . . 61.41 113.124 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.428 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.3 OUTLIER -107.81 -169.73 1.57 Allowed 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.856 -0.424 . . . . 70.12 109.856 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.413 ' HB ' HG23 ' A' ' 507' ' ' VAL . 9.7 m -70.57 155.46 40.7 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.409 -0.96 . . . . 72.12 108.409 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.443 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.1 p -60.95 -41.43 88.99 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.792 0 O-C-N 123.135 0.272 . . . . 63.21 110.915 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -59.85 -44.28 94.19 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 120.767 0.317 . . . . 73.22 110.534 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.413 HG23 ' HB ' ' A' ' 504' ' ' THR . 46.3 t -69.18 -38.63 78.21 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.137 0 CA-C-N 115.529 -0.76 . . . . 63.43 109.548 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.452 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -63.68 -45.6 89.35 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.252 -0.431 . . . . 60.22 110.957 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.7 mt-30 -64.93 -41.34 95.61 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.935 -0.575 . . . . 73.02 110.552 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.504 ' O ' HG23 ' A' ' 514' ' ' VAL . 47.8 mmtm -66.11 -42.28 89.45 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 116.097 -0.501 . . . . 73.24 110.459 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -62.51 -44.89 95.25 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 116.289 -0.414 . . . . 75.54 111.493 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 513' ' ' ASN . 3.9 pp -68.14 -35.24 77.77 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-O 121.132 0.492 . . . . 74.02 110.829 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.46 ' N ' HD12 ' A' ' 512' ' ' LEU . 52.3 t30 -59.8 -35.7 75.22 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 123.894 0.878 . . . . 72.52 109.938 176.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 510' ' ' LYS . 89.5 t -64.63 -33.65 64.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-O 121.251 0.548 . . . . 74.51 110.929 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -97.71 -0.78 44.85 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.463 -0.335 . . . . 70.14 110.451 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -134.96 -57.09 0.06 OUTLIER Glycine 0 CA--C 1.484 -1.868 0 C-N-CA 119.619 -1.277 . . . . 64.01 114.841 -169.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 69.24 20.56 7.45 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 122.143 0.973 . . . . 74.53 109.3 -171.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.5 p -79.37 -172.02 3.01 Favored 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 125.973 1.709 . . . . 52.1 110.65 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.0 142.09 38.66 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.758 -1.201 . . . . 75.25 107.758 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -133.14 147.9 52.1 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.142 0.496 . . . . 72.21 111.846 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 55.6 m -140.91 151.78 44.52 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.193 -1.04 . . . . 54.13 108.193 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -121.1 145.34 47.9 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 120.96 0.41 . . . . 74.43 111.683 -174.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -138.6 132.82 31.63 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.687 -0.857 . . . . 41.02 108.687 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.525 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 11.1 p -96.32 126.74 41.74 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 113.421 0.897 . . . . 74.14 113.421 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.1 p -121.18 150.85 24.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.076 -1.083 . . . . 64.14 108.076 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.98 136.14 45.09 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.493 -0.558 . . . . 75.31 109.493 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.544 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 39.4 m -159.51 168.14 12.8 Favored Pre-proline 0 C--N 1.301 -1.505 0 N-CA-C 108.117 -1.068 . . . . 64.32 108.117 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -71.75 -14.27 29.9 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.019 1.813 . . . . 64.14 111.853 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.12 140.81 95.96 Favored Pre-proline 0 C--O 1.219 -0.549 0 N-CA-C 109.297 -0.631 . . . . 73.22 109.297 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.41 146.86 86.49 Favored 'Trans proline' 0 C--O 1.252 1.213 0 C-N-CA 121.935 1.756 . . . . 44.23 111.236 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.16 113.57 1.78 Allowed 'General case' 0 C--O 1.242 0.678 0 CA-C-N 116.002 -0.544 . . . . 53.24 111.644 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 132.37 -22.9 4.12 Favored Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 115.4 -0.818 . . . . 53.24 111.551 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.01 139.49 33.25 Favored 'General case' 0 CA--C 1.493 -1.222 0 CA-C-O 121.018 0.437 . . . . 74.35 110.04 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.505 HG22 ' H ' ' A' ' 536' ' ' GLY . 7.4 p -102.96 124.86 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.817 0 CA-C-O 121.884 0.849 . . . . 73.21 109.667 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.63 -4.93 59.24 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.697 -1.138 . . . . 65.44 112.635 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.505 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 141.53 -162.68 26.93 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 119.772 -1.204 . . . . 62.14 113.488 173.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 13.2 p -116.45 159.19 22.39 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 107.651 -1.24 . . . . 70.24 107.651 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -60.02 -53.59 63.69 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 119.103 -1.039 . . . . 71.05 112.36 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -82.21 140.73 11.19 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 121.266 1.311 . . . . 43.0 110.521 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.6 162.95 40.59 Favored 'Trans proline' 0 C--O 1.251 1.137 0 C-N-CA 122.999 2.466 . . . . 62.35 113.613 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.71 129.7 43.18 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.639 -0.71 . . . . 52.34 110.461 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.83 -5.44 34.66 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.778 -0.646 . . . . 74.42 111.536 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 99.7 m -77.1 121.02 22.99 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 122.64 -0.33 . . . . 73.14 110.238 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 4.0 t -80.3 124.1 28.55 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.887 -0.783 . . . . 74.11 108.887 176.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 32.6 m -126.45 160.07 59.91 Favored Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 107.658 -1.238 . . . . 64.31 107.658 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -63.97 138.62 63.56 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 120.942 1.095 . . . . 73.11 109.512 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.1 p -60.7 -19.86 20.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.518 0.675 . . . . 75.34 111.475 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -100.02 3.41 44.18 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.148 0.499 . . . . 62.15 110.694 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 97.4 p -83.88 171.78 12.74 Favored 'General case' 0 C--O 1.251 1.133 0 O-C-N 121.404 -0.81 . . . . 45.01 111.525 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.2 p -103.83 134.43 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 CA-C-N 115.268 -0.878 . . . . 64.22 110.394 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 55.8 mt -103.37 136.26 36.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.106 -1.072 . . . . 72.44 108.106 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.52 118.58 37.06 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.985 0.898 . . . . 63.13 111.52 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.6 118.89 32.41 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.839 -1.528 . . . . 43.02 109.786 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -86.28 102.54 14.06 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.813 0.816 . . . . 54.15 110.383 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 524' ' ' SER . 23.3 t -85.63 128.17 39.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 114.304 -1.316 . . . . 60.23 107.523 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' ' 527' ' ' SER . 62.7 m -88.63 125.65 34.92 Favored 'General case' 0 N--CA 1.394 -3.25 0 CA-C-O 121.173 0.511 . . . . 60.45 110.823 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -101.64 134.21 45.13 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 107.275 -1.38 . . . . 61.45 107.275 173.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -63.29 -22.3 65.2 Favored Glycine 0 CA--C 1.493 -1.312 0 O-C-N 124.049 0.843 . . . . 75.43 112.365 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 79.55 2.88 2.21 Favored 'General case' 0 C--O 1.215 -0.725 0 C-N-CA 125.022 1.329 . . . . 73.41 108.674 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.403 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 90.6 mt-30 -113.09 150.23 32.37 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 114.998 -1.001 . . . . 73.34 112.363 -171.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -128.0 155.91 43.55 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.81 -1.181 . . . . 71.34 107.81 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 6.4 p -71.22 118.51 16.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 109.512 -0.551 . . . . 72.51 109.512 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 52.5 ttp -76.1 129.87 79.47 Favored Pre-proline 0 C--N 1.306 -1.322 0 C-N-CA 119.925 -0.71 . . . . 54.54 110.459 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.98 166.38 23.03 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.659 2.24 . . . . 51.1 111.27 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 565' ' ' ASP . . . . . 0.419 ' HA ' ' CB ' ' A' ' 610' ' ' ALA . 2.2 p-10 -81.03 131.85 35.33 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-O 121.368 0.604 . . . . 72.14 111.102 -175.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.2 pp -159.82 20.3 0.17 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.58 -1.191 . . . . 65.14 110.196 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 8.3 t -79.88 147.51 31.68 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 109.11 -0.7 . . . . 74.5 109.11 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 74.84 69.16 1.43 Allowed Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 120.922 -0.656 . . . . 75.21 112.068 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -147.97 174.05 12.27 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.143 -1.058 . . . . 73.1 108.143 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -98.77 169.42 9.48 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.786 -1.561 . . . . 61.33 106.786 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -67.88 -31.67 71.63 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.94 -0.763 . . . . 73.25 108.94 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 30.3 m -78.16 -13.9 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-N 115.907 -0.588 . . . . 65.23 110.929 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 37.2 t70 -95.29 -34.19 12.27 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.402 -1.333 . . . . 71.32 107.402 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 574' ' ' ALA . . . . . 0.725 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -57.76 -53.55 56.91 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.529 -1.214 . . . . 72.3 111.856 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 38.0 mt-10 -51.23 -54.56 36.97 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 113.871 1.063 . . . . 72.0 113.871 -175.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -57.53 -38.3 94.36 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 121.515 1.477 . . . . 64.5 112.225 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 24.2 mmm-85 -65.08 -38.66 91.49 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.342 0.115 . . . . 65.24 110.967 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 25.7 mt -66.69 -47.93 70.86 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.947 -0.39 . . . . 44.1 109.947 -176.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 2.3 ptp180 -66.56 -34.93 78.99 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 112.558 0.577 . . . . 74.32 112.558 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.82 -34.27 77.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.249 0.547 . . . . 63.43 110.272 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 12.5 tp -82.05 -9.76 59.44 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.635 -0.711 . . . . 73.15 110.339 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 64.11 41.02 98.61 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.892 -0.594 . . . . 62.41 112.382 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.469 ' CE3' HD22 ' A' ' 578' ' ' LEU . 18.2 t90 -78.55 127.24 31.87 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.919 0.39 . . . . 75.44 110.686 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 35.9 p -96.19 -22.2 17.42 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 112.988 0.736 . . . . 73.3 112.988 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 585' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -77.85 -173.09 40.16 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.353 -0.451 . . . . 55.15 113.995 -176.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 22.5 ttt -104.69 141.59 36.19 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 122.771 0.428 . . . . 42.3 110.871 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 33.9 tp -86.86 110.13 19.76 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.619 -0.882 . . . . 62.43 108.619 176.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.543 ' O ' ' HA ' ' A' ' 621' ' ' THR . 22.4 t70 -95.86 104.62 16.56 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.967 0.889 . . . . 62.11 110.26 -175.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -87.66 123.35 32.41 Favored 'General case' 0 N--CA 1.396 -3.171 0 CA-C-N 114.645 -1.161 . . . . 72.2 109.462 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -84.88 -100.04 0.66 Allowed Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.757 -0.937 . . . . 64.12 110.757 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -107.78 154.94 20.8 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 109.851 -0.426 . . . . 45.24 109.851 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 592' ' ' ASP . . . . . 0.422 ' OD1' ' HB3' ' A' ' 626' ' ' GLN . 3.0 p30 -106.53 145.69 31.55 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.469 -0.937 . . . . 61.21 108.469 174.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 57.4 t -104.5 138.71 28.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.033 -0.729 . . . . 70.42 109.033 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 594' ' ' ASP . . . . . 0.448 ' HA ' ' CD ' ' A' ' 626' ' ' GLN . 3.8 p30 -73.06 124.72 26.07 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 121.388 0.613 . . . . 55.35 110.045 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -159.64 -62.07 0.07 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.724 -1.125 . . . . 34.13 108.493 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 105.77 153.24 20.92 Favored Glycine 0 N--CA 1.422 -2.264 0 C-N-CA 119.659 -1.258 . . . . 65.51 111.787 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.34 -32.2 60.36 Favored Glycine 0 C--N 1.311 -0.851 0 C-N-CA 123.511 0.577 . . . . 52.42 113.643 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 4.9 p -72.67 -25.04 61.12 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-O 121.965 0.888 . . . . 62.13 110.383 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -95.09 -0.91 53.07 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.937 -1.029 . . . . 65.4 109.495 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 39.8 m80 74.06 99.51 0.07 Allowed 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 125.051 1.34 . . . . 72.14 112.148 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -80.3 83.32 6.17 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.382 -0.827 . . . . 71.21 110.99 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -108.17 160.31 15.92 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.282 -0.872 . . . . 73.24 109.728 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 71.2 t -64.83 130.2 29.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.084 -1.45 . . . . 52.21 107.084 171.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 43.5 t -108.61 -40.33 4.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 121.524 0.678 . . . . 70.3 110.108 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -142.9 142.07 31.65 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.793 -0.817 . . . . 73.24 108.793 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -137.56 143.56 41.63 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.906 -1.516 . . . . 72.04 106.906 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.431 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 24.6 t-20 -65.84 -53.11 37.33 Favored Pre-proline 0 C--N 1.308 -1.218 0 C-N-CA 119.235 -0.986 . . . . 61.23 112.132 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.8 Cg_endo -90.64 107.93 0.33 Allowed 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.09 1.86 . . . . 73.13 110.351 173.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -71.13 160.37 49.34 Favored 'Trans proline' 0 C--O 1.246 0.896 0 C-N-CA 123.258 2.638 . . . . 72.1 113.411 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 610' ' ' ALA . . . . . 0.419 ' CB ' ' HA ' ' A' ' 565' ' ' ASP . . . -67.85 138.54 56.17 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.351 -0.981 . . . . 64.13 108.351 175.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 96.69 -8.95 66.27 Favored Glycine 0 C--N 1.297 -1.6 0 C-N-CA 120.27 -0.967 . . . . 72.5 110.904 -175.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 24.2 m -101.88 153.17 20.09 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 108.06 -1.089 . . . . 65.34 108.06 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -74.77 127.16 9.38 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 121.242 -0.504 . . . . 71.51 112.151 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 30.9 m -119.98 142.6 34.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.898 -1.149 . . . . 74.21 107.898 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.403 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 33.9 p-10 -51.7 169.14 0.07 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.708 0.803 . . . . 75.21 112.736 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -60.29 -26.17 66.3 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 120.859 0.361 . . . . 64.33 111.699 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.433 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 5.4 m-20 -83.31 -7.82 59.53 Favored 'General case' 0 C--O 1.204 -1.324 0 CA-C-N 116.069 -0.514 . . . . 70.31 110.398 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.18 19.34 68.1 Favored Glycine 0 C--O 1.22 -0.776 0 O-C-N 123.285 0.366 . . . . 71.01 112.996 171.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.79 119.4 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-O 121.913 0.863 . . . . 54.04 111.217 -167.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 48.3 pt -126.21 133.92 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 115.096 -0.957 . . . . 71.22 110.522 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 14.9 t -105.8 128.73 53.91 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.924 -1.139 . . . . 41.0 107.924 177.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.5 pp -139.24 166.69 23.87 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 114.16 1.17 . . . . 72.51 114.16 -173.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -127.68 137.04 52.37 Favored 'General case' 0 C--O 1.256 1.411 0 N-CA-C 108.173 -1.047 . . . . 75.33 108.173 175.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -142.3 166.89 23.45 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.859 -0.61 . . . . 72.43 109.617 -174.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -60.94 145.79 47.96 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 121.102 -0.571 . . . . 75.24 112.296 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.448 ' CD ' ' HA ' ' A' ' 594' ' ' ASP . 3.3 pt20 . . . . . 0 C--O 1.251 1.179 0 N-CA-C 113.885 1.068 . . . . 72.15 113.885 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.874 0 CA-C-O 121.813 0.816 . . . . 51.22 110.838 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 15.0 p -136.55 155.06 50.47 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 114.981 -1.008 . . . . 62.32 110.317 -176.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.57 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 4.6 tmtt? -150.49 139.66 21.18 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.884 -0.784 . . . . 74.33 108.884 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.57 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 8.3 p-10 -78.18 129.75 35.51 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 123.633 0.773 . . . . 64.43 109.58 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.5 pt -99.03 131.65 25.0 Favored Pre-proline 0 C--N 1.304 -1.374 0 C-N-CA 120.45 -0.5 . . . . 71.33 111.689 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.08 158.54 34.0 Favored 'Trans proline' 0 C--O 1.243 0.742 0 C-N-CA 122.78 2.32 . . . . 53.33 112.167 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 499' ' ' ASP . . . . . 0.53 ' HA ' ' HB1' ' A' ' 541' ' ' ALA . 5.1 p-10 -82.23 112.7 19.48 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.95 0.881 . . . . 72.12 108.979 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 31.7 m -117.41 0.95 8.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 112.973 0.731 . . . . 65.42 112.973 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -69.63 100.98 1.55 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.298 0.57 . . . . 63.4 109.917 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 138.8 -13.5 3.39 Favored Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 110.717 -0.953 . . . . 61.22 110.717 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 508' ' ' ALA . 31.7 mm-40 -82.2 -178.25 6.95 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 108.692 -0.855 . . . . 71.35 108.692 175.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.7 m -78.6 156.15 29.27 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 104.293 -2.484 . . . . 62.25 104.293 169.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.473 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 8.4 p -60.13 -42.4 89.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 119.557 1.071 . . . . 75.54 112.224 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 506' ' ' ASP . . . . . 0.418 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 17.3 t70 -64.68 -43.43 93.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.945 0.402 . . . . 63.41 110.455 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 62.9 t -67.82 -39.11 81.31 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.252 0 CA-C-N 115.628 -0.714 . . . . 71.24 109.803 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 503' ' ' GLN . . . -62.4 -45.14 94.5 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.951 -0.389 . . . . 74.55 109.951 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 98.0 mt-30 -62.05 -46.68 88.06 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.759 -0.655 . . . . 71.24 111.353 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.567 ' O ' HG23 ' A' ' 514' ' ' VAL 0.359 0.0 OUTLIER -67.37 -38.15 84.32 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 112.48 0.548 . . . . 62.1 112.48 177.333 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -60.71 -50.04 75.07 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.602 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 513' ' ' ASN . 3.8 pp -68.49 -36.06 78.4 Favored 'General case' 0 C--O 1.208 -1.098 0 C-N-CA 120.156 -0.618 . . . . 72.43 111.598 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.487 ' N ' HD12 ' A' ' 512' ' ' LEU . 3.4 t-20 -69.79 -35.19 74.66 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 112.558 0.577 . . . . 73.43 112.558 -175.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 510' ' ' LYS . 72.2 t -57.33 -31.1 37.24 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 CA-C-O 121.438 0.637 . . . . 71.12 110.121 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -120.22 29.17 7.63 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.771 -0.649 . . . . 74.2 109.591 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -145.84 -56.79 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.423 0 C-N-CA 120.058 -1.068 . . . . 53.11 112.181 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 62.89 33.78 14.79 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.521 1.153 . . . . 73.34 111.151 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 547' ' ' VAL . 3.1 p -88.52 -171.43 3.33 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-N 113.83 -1.532 . . . . 53.53 109.047 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -111.77 142.49 44.06 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.891 -1.522 . . . . 74.11 106.891 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -132.47 148.81 52.4 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 113.201 0.815 . . . . 75.34 113.201 -174.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 51.0 m -133.06 157.66 44.7 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 106.713 -1.588 . . . . 61.22 106.713 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -125.97 126.89 45.07 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 109.693 -0.484 . . . . 63.41 109.693 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 523' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -124.16 143.27 50.59 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.45 -1.315 . . . . 64.54 107.45 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 65.8 p -102.8 139.94 37.72 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.094 -1.043 . . . . 72.43 112.426 -175.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 12.1 p -131.15 151.52 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 N-CA-C 107.768 -1.197 . . . . 75.33 107.768 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -87.34 137.2 32.55 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 121.3 0.571 . . . . 72.34 110.94 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.4 m -160.08 157.51 25.25 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 106.802 -1.555 . . . . 63.53 106.802 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -64.56 2.07 1.42 Allowed 'Trans proline' 0 CA--C 1.555 1.549 0 C-N-CA 122.653 2.235 . . . . 71.3 114.076 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -96.1 144.17 27.37 Favored Pre-proline 0 N--CA 1.433 -1.319 0 N-CA-C 109.523 -0.547 . . . . 60.23 109.523 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.03 146.59 97.53 Favored 'Trans proline' 0 C--O 1.249 1.07 0 C-N-CA 123.418 2.745 . . . . 74.34 114.618 -173.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.66 113.64 2.12 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.663 -1.153 . . . . 74.25 111.064 178.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 139.91 -23.53 2.76 Favored Glycine 0 C--N 1.301 -1.368 0 N-CA-C 111.083 -0.807 . . . . 62.11 111.083 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -79.33 144.91 33.79 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.81 -0.811 . . . . 73.42 108.81 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.449 HG11 ' HB2' ' A' ' 508' ' ' ALA . 7.7 p -94.35 114.99 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 N-CA-C 108.288 -1.004 . . . . 71.35 108.288 173.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.2 -31.3 72.44 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.18 -1.373 . . . . 63.24 109.433 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 152.78 -168.34 31.71 Favored Glycine 0 N--CA 1.407 -3.244 0 N-CA-C 109.728 -1.349 . . . . 74.23 109.728 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 537' ' ' THR . . . . . 0.511 HG22 ' HG ' ' A' ' 553' ' ' LEU . 3.6 p -116.62 153.53 32.11 Favored 'General case' 0 C--N 1.268 -2.943 0 N-CA-C 107.807 -1.183 . . . . 52.44 107.807 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.455 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 54.0 t30 -67.41 -48.0 46.74 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 118.382 -1.327 . . . . 64.24 110.706 176.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.495 ' HD3' ' OE1' ' A' ' 552' ' ' GLU . 20.7 Cg_exo -71.9 129.66 15.67 Favored 'Trans proline' 0 C--N 1.374 1.882 0 N-CA-C 108.398 -1.424 . . . . 73.24 108.398 168.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.73 139.99 93.1 Favored 'Trans proline' 0 C--O 1.245 0.87 0 C-N-CA 122.955 2.437 . . . . 74.0 115.335 -174.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 541' ' ' ALA . . . . . 0.53 ' HB1' ' HA ' ' A' ' 499' ' ' ASP . . . -68.27 135.85 52.58 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.297 -1.32 . . . . 74.43 110.236 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 93.54 -16.58 60.38 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 111.455 -0.658 . . . . 54.52 111.455 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 63.1 m -88.67 139.16 30.75 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 124.151 0.98 . . . . 52.01 110.821 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.1 t -73.88 128.09 34.58 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 121.529 0.68 . . . . 75.44 109.21 175.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.72 164.98 27.65 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 107.13 -1.433 . . . . 64.42 107.13 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -67.25 136.07 39.11 Favored 'Trans proline' 0 N--CA 1.442 -1.543 0 CA-C-N 120.564 1.237 . . . . 73.2 110.437 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.444 ' HA ' HG22 ' A' ' 518' ' ' THR . 9.2 p -67.49 -22.11 28.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 122.037 0.923 . . . . 45.21 109.639 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -84.26 -12.68 54.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.141 -1.391 . . . . 61.44 110.992 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 11.4 t -93.14 153.12 18.84 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-O 121.555 0.693 . . . . 70.42 110.246 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 13.2 p -94.89 134.78 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.07 0 CA-C-N 114.865 -1.061 . . . . 72.22 108.583 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 62.1 mt -102.63 135.73 38.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.553 -0.748 . . . . 71.23 109.12 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 552' ' ' GLU . . . . . 0.495 ' OE1' ' HD3' ' A' ' 539' ' ' PRO . 2.1 pm0 -102.93 121.61 42.87 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-O 121.764 0.793 . . . . 64.44 110.551 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.511 ' HG ' HG22 ' A' ' 537' ' ' THR . 7.0 mp -98.66 122.19 41.56 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.208 -1.36 . . . . 74.44 108.369 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.549 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 2.7 mp0 -88.09 127.09 35.41 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.844 -0.616 . . . . 75.4 110.971 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 25.2 t -95.21 125.94 47.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.057 -0.974 . . . . 73.35 108.437 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.716 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 5.5 m -77.63 119.38 21.09 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.106 -1.072 . . . . 62.31 108.106 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -108.72 134.73 51.04 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 107.468 -1.308 . . . . 74.45 107.468 169.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -59.18 -23.49 57.54 Favored Glycine 0 CA--C 1.509 -0.297 0 O-C-N 124.035 0.834 . . . . 25.33 112.181 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 76.52 7.88 3.29 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.977 1.711 . . . . 74.44 108.181 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 89.0 mt-30 -126.77 146.16 50.34 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 114.889 -1.051 . . . . 72.04 110.649 -176.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 561' ' ' PHE . . . . . 0.447 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 53.8 p90 -124.01 152.83 42.14 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.332 -0.988 . . . . 74.43 108.332 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.47 124.4 13.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.401 0.62 . . . . 73.11 111.981 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 47.9 ttp -92.89 134.83 26.85 Favored Pre-proline 0 C--O 1.256 1.41 0 CA-C-N 115.697 -0.683 . . . . 74.13 110.057 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.73 169.07 16.82 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.884 2.389 . . . . 62.32 111.075 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.79 115.03 26.04 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.42 -0.955 . . . . 72.34 108.42 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 566' ' ' LEU . . . . . 0.419 ' O ' ' HG2' ' A' ' 569' ' ' MET . 91.5 mt -107.0 -0.21 23.21 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.722 0.772 . . . . 72.54 110.384 -176.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 20.6 t -79.52 153.47 29.53 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.502 -0.772 . . . . 75.33 109.317 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 568' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' A' ' 602' ' ' ARG . . . 82.62 25.26 51.03 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 120.22 -0.99 . . . . 71.14 114.031 177.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 569' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 23.2 ptp -140.69 176.77 8.52 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.305 -0.998 . . . . 72.02 108.305 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -98.34 169.12 9.79 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.656 -0.868 . . . . 50.45 108.656 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -64.18 -27.62 69.19 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.579 0.704 . . . . 71.32 109.355 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.5 p -72.95 -17.32 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 CA-C-N 115.46 -0.791 . . . . 72.15 110.74 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.489 ' O ' ' HD2' ' A' ' 576' ' ' PRO . 16.5 m-20 -91.17 -38.92 12.42 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 107.97 -1.122 . . . . 74.55 107.97 175.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 574' ' ' ALA . . . . . 0.678 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -56.79 -52.97 62.97 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.229 -1.351 . . . . 75.44 112.068 -178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.493 ' HB2' ' HD3' ' A' ' 576' ' ' PRO . 47.2 mt-10 -51.08 -54.02 42.26 Favored Pre-proline 0 CA--C 1.559 1.304 0 N-CA-C 113.782 1.031 . . . . 72.03 113.782 -176.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.493 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 35.9 Cg_exo -61.15 -36.32 81.58 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 121.557 1.505 . . . . 74.24 112.137 177.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.457 ' NE ' ' HA ' ' A' ' 577' ' ' ARG . 3.3 mmp_? -62.84 -40.17 96.63 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.743 0.275 . . . . 71.24 111.743 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 25.0 mt -65.4 -48.92 71.2 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.333 0.587 . . . . 73.12 110.327 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -66.7 -36.84 83.45 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.704 -0.68 . . . . 62.54 112.455 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.12 -34.26 72.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.78 0.324 . . . . 43.22 111.258 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' A' ' 583' ' ' TRP . 1.5 pp -81.51 -6.22 58.75 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.396 0.617 . . . . 72.51 109.916 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.54 44.14 27.75 Favored Glycine 0 CA--C 1.498 -0.978 0 CA-C-N 115.585 -0.734 . . . . 74.43 111.988 177.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.464 ' CE3' HD22 ' A' ' 578' ' ' LEU . 15.3 t90 -87.35 127.04 35.2 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 109.32 -0.622 . . . . 71.45 109.32 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 17.2 p -101.27 -21.13 14.97 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.167 -0.469 . . . . 71.45 111.94 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -73.98 -175.12 31.74 Favored Glycine 0 C--O 1.242 0.628 0 CA-C-N 116.535 -0.302 . . . . 75.23 113.459 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 53.1 mtt -106.03 144.15 33.16 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.835 -0.182 . . . . 73.44 111.016 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 37.5 tp -89.64 108.02 19.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.473 0.654 . . . . 75.32 109.413 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' A' ' 621' ' ' THR . 28.4 t70 -97.73 117.1 31.28 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.139 -0.937 . . . . 75.44 110.351 -176.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.98 133.55 44.2 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 119.042 -1.063 . . . . 75.44 108.987 174.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -80.42 -54.39 3.77 Favored Glycine 0 C--N 1.299 -1.527 0 N-CA-C 111.267 -0.733 . . . . 50.21 111.267 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.04 146.9 39.6 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.644 -0.502 . . . . 60.32 109.644 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -113.31 131.83 55.8 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.694 -1.595 . . . . 61.51 106.694 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 46.2 t -105.0 115.59 47.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 C-N-CA 119.891 -0.724 . . . . 73.2 109.107 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 594' ' ' ASP . . . . . 0.494 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 24.3 t70 -78.0 126.63 31.11 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 112.756 0.65 . . . . 72.11 112.756 -175.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 595' ' ' ALA . . . . . 0.445 ' HB3' ' ND2' ' A' ' 601' ' ' ASN . . . -158.2 -30.62 0.08 Allowed 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.811 0.694 . . . . 53.41 111.153 174.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 108.66 144.08 10.72 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 119.45 -1.357 . . . . 24.2 112.959 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -60.67 -32.79 79.85 Favored Glycine 0 C--N 1.317 -0.506 0 C-N-CA 123.014 0.34 . . . . 52.33 113.267 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 31.3 t -62.18 -23.93 66.89 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.862 0.839 . . . . 71.22 110.326 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -86.78 -0.62 56.71 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.675 -1.148 . . . . 71.43 110.773 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 52.0 m80 66.19 38.7 4.52 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 122.137 0.97 . . . . 74.31 109.473 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 601' ' ' ASN . . . . . 0.445 ' ND2' ' HB3' ' A' ' 595' ' ' ALA . 15.4 t30 -74.72 89.63 2.28 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.701 -1.59 . . . . 60.42 108.629 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.407 ' HD3' ' HA2' ' A' ' 568' ' ' GLY . 16.6 ptp180 -97.52 171.65 8.23 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.763 -1.562 . . . . 74.45 110.896 -175.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 569' ' ' MET . 83.7 t -58.52 130.73 22.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.244 -1.021 . . . . 70.33 108.244 174.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 27.7 m -106.26 -30.44 2.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 120.535 -0.466 . . . . 73.42 111.901 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -149.43 135.98 19.33 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 120.258 -0.577 . . . . 74.43 110.717 -176.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -120.88 143.12 49.09 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.491 -1.67 . . . . 70.34 106.491 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.493 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 19.9 t-20 -52.61 -58.17 12.94 Favored Pre-proline 0 N--CA 1.487 1.387 0 N-CA-C 113.95 1.093 . . . . 70.43 113.95 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.1 Cg_endo -91.04 135.25 1.84 Allowed 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 121.476 1.451 . . . . 65.35 110.739 177.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -67.08 160.04 49.25 Favored 'Trans proline' 0 C--O 1.249 1.057 0 C-N-CA 121.518 1.479 . . . . 63.04 110.856 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.17 127.17 30.22 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 110.257 -0.275 . . . . 74.04 110.257 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 104.71 -5.21 43.28 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.317 -0.944 . . . . 73.31 112.251 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 73.9 m -90.63 147.35 23.36 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.861 -0.792 . . . . 61.45 108.861 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 613' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -78.72 137.89 20.12 Favored Glycine 0 N--CA 1.425 -2.043 0 C-N-CA 121.529 -0.367 . . . . 43.34 113.234 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.3 m -117.99 142.76 30.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.744 -0.836 . . . . 53.11 108.744 175.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -49.85 170.8 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.433 1.093 . . . . 51.03 113.608 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -58.9 -26.99 64.81 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.999 -0.546 . . . . 65.34 111.946 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -84.75 -7.28 59.27 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 121.22 0.533 . . . . 75.34 110.264 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.6 18.93 68.56 Favored Glycine 0 C--O 1.219 -0.838 0 CA-C-N 115.928 -0.578 . . . . 61.33 113.967 172.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.49 119.93 17.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 122.555 1.169 . . . . 71.33 112.121 -167.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.11 130.78 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 114.212 -1.358 . . . . 60.14 109.46 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.605 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 13.0 t -104.66 137.06 43.05 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.031 -1.1 . . . . 73.43 108.031 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -138.63 167.51 21.81 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.354 0.597 . . . . 73.52 112.338 -173.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -127.03 134.63 50.27 Favored 'General case' 0 C--O 1.251 1.138 0 N-CA-C 104.806 -2.294 . . . . 74.13 104.806 174.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.407 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 29.3 p90 -142.94 165.33 27.65 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.627 -0.829 . . . . 75.4 112.221 -174.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -79.74 126.64 7.55 Favored Glycine 1 N--CA 1.388 -4.552 0 C-N-CA 120.65 -0.786 . . . . 21.41 111.609 173.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.494 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 58.3 tt0 . . . . . 0 C--O 1.271 2.204 0 C-N-CA 124.75 1.22 . . . . 72.43 107.812 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.625 0 CA-C-O 121.852 0.834 . . . . 62.23 110.288 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 40.9 p -138.23 149.89 46.19 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.42 -1.326 . . . . 74.42 107.42 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -141.64 145.03 34.49 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.728 -1.212 . . . . 73.12 107.728 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 17.2 m-20 -88.93 141.94 28.06 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.34 -0.615 . . . . 74.44 109.34 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.7 pt -101.76 123.83 42.64 Favored Pre-proline 0 C--N 1.3 -1.564 0 C-N-CA 120.609 -0.436 . . . . 73.32 110.288 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -84.58 172.39 9.18 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.383 2.055 . . . . 75.43 112.018 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -85.97 100.66 12.28 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 122.399 1.095 . . . . 73.34 109.998 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 31.4 m -89.38 1.73 7.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 114.401 -1.272 . . . . 74.34 111.261 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -64.52 100.74 0.39 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.564 -0.744 . . . . 61.23 110.079 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 158.2 -32.06 0.5 Allowed Glycine 0 C--N 1.302 -1.356 0 C-N-CA 120.797 -0.716 . . . . 61.41 111.583 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.461 ' O ' HG12 ' A' ' 534' ' ' VAL . 10.1 pm0 -102.62 -179.69 4.04 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 109.816 -0.438 . . . . 71.23 109.816 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 17.5 m -70.31 155.76 40.21 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.579 -1.267 . . . . 74.33 107.579 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.494 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 14.2 p -64.71 -40.38 88.86 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 N-CA-C 109.657 -0.497 . . . . 73.53 109.657 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 506' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 11.8 t70 -58.79 -39.86 82.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.422 -0.808 . . . . 70.31 109.842 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 86.0 t -74.93 -43.55 45.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.099 -0.955 . . . . 74.25 110.61 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -58.82 -43.29 90.57 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.472 0.177 . . . . 72.13 110.739 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.2 mt-30 -64.66 -46.44 82.48 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.043 -0.526 . . . . 73.44 110.915 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.594 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 2.7 ptpp? -67.36 -38.4 84.74 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 112.802 0.667 . . . . 75.43 112.802 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 56.1 m-20 -61.98 -48.07 81.97 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.238 0.542 . . . . 74.21 110.353 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.44 -36.92 84.0 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.203 -0.908 . . . . 64.31 108.849 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 45.9 t30 -59.4 -35.39 73.87 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 124.046 0.938 . . . . 74.33 110.534 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 510' ' ' LYS . 86.0 t -61.99 -33.14 56.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-O 121.286 0.565 . . . . 72.15 110.789 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -105.08 4.07 31.08 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.588 -0.523 . . . . 72.34 109.588 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -133.32 -60.96 0.08 OUTLIER Glycine 0 N--CA 1.426 -1.994 0 C-N-CA 119.987 -1.102 . . . . 72.2 114.425 -171.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 62.84 29.02 16.63 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.158 0.98 . . . . 71.23 109.102 -172.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 547' ' ' VAL . 17.2 p -85.62 -166.21 1.45 Allowed 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 126.019 1.728 . . . . 73.51 109.851 -177.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -108.55 137.68 46.11 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.312 -0.625 . . . . 65.4 109.312 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -132.2 147.37 52.41 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 116.017 -0.538 . . . . 64.04 110.203 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.1 m -140.26 145.91 37.92 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.342 -0.984 . . . . 73.12 108.342 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -117.97 135.22 54.28 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 121.371 0.605 . . . . 73.14 111.065 -175.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -123.02 126.81 47.83 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.235 -1.024 . . . . 52.43 108.235 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 22.2 m -88.14 125.87 34.83 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.297 0.57 . . . . 73.15 111.404 -176.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 10.5 p -120.31 150.67 23.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 106.611 -1.625 . . . . 62.02 106.611 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.416 ' OD1' ' HE2' ' A' ' 557' ' ' LYS . 21.1 m-20 -75.29 135.63 40.92 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 120.311 -0.556 . . . . 74.14 109.71 -174.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 73.9 m -153.11 169.57 9.52 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 108.343 -0.984 . . . . 72.22 108.343 -175.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -82.35 -17.53 7.63 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.597 1.531 . . . . 64.11 111.182 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.605 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 53.1 mtt-85 -75.51 143.68 76.26 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 116.089 -0.505 . . . . 73.42 110.273 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.97 143.18 96.59 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 123.164 2.576 . . . . 63.22 112.521 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -56.51 108.97 0.54 Allowed 'General case' 0 C--O 1.242 0.7 0 O-C-N 124.092 0.87 . . . . 64.34 112.321 -177.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 140.38 -20.0 2.8 Favored Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 115.381 -0.827 . . . . 31.31 112.494 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 533' ' ' GLU . . . . . 0.605 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 31.1 tt0 -82.86 144.83 29.82 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.602 -0.518 . . . . 74.14 109.602 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 503' ' ' GLN . 8.0 p -91.5 115.8 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 CA-C-O 122.094 0.949 . . . . 74.3 110.455 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.8 -30.86 69.52 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 113.671 -1.604 . . . . 61.44 110.253 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 154.82 -164.87 31.91 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 110.587 -1.005 . . . . 64.42 110.587 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 6.4 p -117.29 154.88 30.47 Favored 'General case' 0 C--N 1.288 -2.109 0 N-CA-C 109.542 -0.54 . . . . 62.13 109.542 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.452 ' HB2' HE22 ' A' ' 554' ' ' GLN . 9.7 t30 -63.79 -51.57 64.01 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 120.149 -0.621 . . . . 70.31 110.84 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -74.23 134.3 19.01 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 N-CA-C 108.644 -1.329 . . . . 63.12 108.644 170.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.45 154.4 71.85 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 122.753 2.302 . . . . 73.01 113.381 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.02 139.89 58.39 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.588 -0.733 . . . . 55.51 110.284 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 96.86 -8.8 65.76 Favored Glycine 0 C--N 1.302 -1.339 0 C-N-CA 120.595 -0.812 . . . . 65.13 111.695 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 25.2 m -82.5 133.97 35.2 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.646 -0.872 . . . . 60.33 108.646 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.1 t -94.64 132.79 38.98 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 108.301 -1.0 . . . . 71.14 108.301 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.17 155.2 64.96 Favored Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 107.839 -1.171 . . . . 72.32 107.839 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.525 ' HG2' ' OG ' ' A' ' 549' ' ' SER . 7.6 Cg_endo -60.32 136.52 68.72 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 N-CA-C 109.421 -1.03 . . . . 73.44 109.421 176.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.572 ' O ' HG22 ' A' ' 518' ' ' THR . 9.7 p -66.56 -21.38 28.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.34 -0.845 . . . . 62.12 112.941 -172.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -93.35 3.69 55.2 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.766 0.793 . . . . 54.31 111.043 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 549' ' ' SER . . . . . 0.525 ' OG ' ' HG2' ' A' ' 546' ' ' PRO . 68.3 m -87.56 -174.7 4.91 Favored 'General case' 0 C--O 1.251 1.171 0 O-C-N 121.544 -0.723 . . . . 54.3 112.389 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 13.3 p -113.48 138.25 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 115.221 -0.9 . . . . 75.34 109.741 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.7 mt -102.92 137.4 31.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.76 -0.83 . . . . 73.34 108.76 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -102.43 117.49 34.83 Favored 'General case' 0 C--O 1.251 1.132 0 N-CA-C 107.999 -1.111 . . . . 74.01 107.999 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.44 129.93 55.25 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 123.343 0.402 . . . . 64.44 110.505 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.452 HE22 ' HB2' ' A' ' 538' ' ' ASN . 2.9 mp0 -90.66 119.38 30.86 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.003 -0.544 . . . . 74.34 110.785 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 40.2 t -92.99 129.57 43.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.316 -0.994 . . . . 54.23 108.316 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.658 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 16.1 m -75.71 117.72 17.77 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 108.081 -1.081 . . . . 74.2 108.081 176.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.416 ' HE2' ' OD1' ' A' ' 526' ' ' ASP . 26.5 pttm -109.05 118.49 36.91 Favored 'General case' 0 N--CA 1.411 -2.399 0 N-CA-C 107.576 -1.268 . . . . 72.15 107.576 171.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -56.79 -23.86 46.5 Favored Glycine 0 CA--C 1.497 -1.09 0 O-C-N 124.319 1.012 . . . . 32.41 113.175 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 77.85 -3.84 2.32 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 125.331 1.452 . . . . 75.23 109.24 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.549 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 63.2 mt-30 -112.58 150.21 31.67 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 115.592 -0.731 . . . . 61.45 112.831 -173.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -133.13 156.5 47.32 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.646 -1.613 . . . . 74.12 106.646 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 47.5 t -73.41 122.87 27.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.595 -0.891 . . . . 63.4 108.595 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.421 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 57.0 ttp -73.97 127.37 88.28 Favored Pre-proline 0 C--O 1.25 1.082 0 O-C-N 123.22 0.325 . . . . 62.1 111.428 -175.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 564' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 51.9 Cg_exo -61.71 169.64 6.79 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.598 2.865 . . . . 70.05 112.59 175.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -65.92 129.47 39.9 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.373 0.669 . . . . 63.05 112.766 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.7 pp -152.45 14.32 0.58 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.182 0.992 . . . . 74.11 109.075 172.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 4.2 m -79.95 140.89 36.46 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.414 -1.267 . . . . 70.3 111.995 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 53.18 43.1 63.37 Favored Glycine 0 C--O 1.223 -0.544 0 N-CA-C 115.112 0.805 . . . . 52.43 115.112 172.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 18.1 ptp -127.15 -179.65 4.97 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.874 -1.158 . . . . 75.1 107.874 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 570' ' ' PHE . . . . . 0.426 ' HB2' HG12 ' A' ' 572' ' ' VAL . 21.7 m-85 -96.24 168.96 10.27 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.665 -0.865 . . . . 74.31 108.665 -175.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 37.8 t-105 -63.39 -28.08 69.74 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.445 -0.576 . . . . 73.03 109.445 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 572' ' ' VAL . . . . . 0.426 HG12 ' HB2' ' A' ' 570' ' ' PHE . 8.9 p -75.11 -9.58 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 CA-C-N 115.695 -0.684 . . . . 74.04 110.484 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.587 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 42.6 m-20 -101.1 -42.0 6.54 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 107.858 -1.164 . . . . 52.24 107.858 173.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 574' ' ' ALA . . . . . 0.55 ' O ' HD12 ' A' ' 578' ' ' LEU . . . -55.54 -45.92 77.15 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.782 -1.099 . . . . 62.43 112.044 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.563 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 3.0 tm-20 -53.98 -58.46 13.33 Favored Pre-proline 0 CA--C 1.567 1.616 0 CA-C-O 118.949 -0.548 . . . . 72.25 110.533 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 57.9 Cg_exo -53.17 -32.25 58.94 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 121.978 1.785 . . . . 72.54 112.808 173.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 26.2 mmm180 -61.93 -36.25 80.81 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-O 118.659 -0.686 . . . . 75.1 112.42 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.632 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 5.4 mp -62.66 -48.54 78.88 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.708 -1.197 . . . . 73.23 110.115 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 576' ' ' PRO . 0.7 OUTLIER -66.1 -41.23 90.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.824 -0.625 . . . . 71.33 112.322 178.556 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.28 -39.54 74.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.746 0.647 . . . . 62.1 112.746 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.01 -9.02 58.46 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.926 0.394 . . . . 64.22 110.433 -175.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 72.47 48.36 24.12 Favored Glycine 0 CA--C 1.505 -0.556 0 N-CA-C 111.316 -0.713 . . . . 63.04 111.316 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.632 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 8.6 t90 -85.99 133.4 33.92 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.0 0.429 . . . . 72.45 110.011 -176.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 1.3 p -86.82 -39.36 15.95 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.583 1.553 . . . . 64.31 112.826 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -79.7 -162.16 24.28 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-O 121.797 0.665 . . . . 64.5 114.279 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 61.5 mtm -122.79 152.87 40.24 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.974 -0.75 . . . . 75.53 108.974 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 4.4 tt -81.92 111.67 18.32 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.648 -1.241 . . . . 71.02 107.648 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 621' ' ' THR . 33.0 t70 -95.34 107.97 20.12 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.658 0.742 . . . . 71.05 110.049 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.504 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.3 OUTLIER -97.1 133.66 41.46 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.677 -0.861 . . . . 65.25 108.677 178.451 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.25 -69.29 1.4 Allowed Glycine 0 C--N 1.28 -2.532 0 N-CA-C 110.57 -1.012 . . . . 71.45 110.57 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -137.22 149.34 47.13 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 110.065 -0.346 . . . . 73.4 110.065 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -115.77 124.7 51.42 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.645 0.736 . . . . 75.21 109.072 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 44.2 t -106.74 153.52 7.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.758 -1.201 . . . . 73.42 107.758 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.42 126.2 29.26 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.934 0.873 . . . . 71.32 110.752 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -133.54 -48.34 0.83 Allowed 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 114.386 -1.279 . . . . 62.31 108.747 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 102.51 123.14 5.2 Favored Glycine 0 N--CA 1.422 -2.254 0 N-CA-C 111.254 -0.738 . . . . 64.45 111.254 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -60.58 -33.83 83.5 Favored Glycine 0 C--N 1.317 -0.514 0 N-CA-C 111.704 -0.559 . . . . 14.31 111.704 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.2 m -70.27 -23.88 62.96 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-O 121.819 0.819 . . . . 62.21 110.135 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -92.06 -1.58 57.13 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.195 -0.911 . . . . 74.13 110.085 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 69.82 81.73 0.17 Allowed 'General case' 0 C--O 1.244 0.772 0 CA-C-O 123.229 1.49 . . . . 72.21 111.283 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 601' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 625' ' ' GLY . 15.8 p-10 -79.77 89.31 5.21 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 113.32 -1.764 . . . . 72.25 113.056 -174.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -81.9 170.93 15.06 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.146 -0.934 . . . . 61.41 111.722 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 75.0 t -70.29 131.83 33.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 114.55 -1.205 . . . . 64.42 108.529 171.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 86.5 t -91.07 -43.92 14.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.499 0.666 . . . . 72.43 110.568 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -153.14 140.05 19.14 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.783 -0.644 . . . . 64.34 109.693 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -127.51 139.49 52.75 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.663 -1.236 . . . . 74.22 107.663 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.59 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 23.8 t-20 -58.99 -62.48 5.73 Favored Pre-proline 0 CA--C 1.555 1.153 0 CA-C-O 118.922 -0.561 . . . . 73.45 111.929 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.625 ' HD2' HG12 ' A' ' 620' ' ' ILE . 7.4 Cg_endo -95.74 120.44 0.24 Allowed 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 122.003 1.802 . . . . 75.24 110.027 171.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 609' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 19.0 Cg_exo -70.34 156.82 60.99 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.437 2.091 . . . . 74.45 112.276 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.38 138.61 56.85 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.466 -0.938 . . . . 53.34 108.466 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 97.77 -2.13 60.14 Favored Glycine 0 C--N 1.301 -1.398 0 N-CA-C 110.637 -0.985 . . . . 30.41 110.637 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 26.9 m -109.54 155.52 21.28 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.281 -1.377 . . . . 63.04 107.281 175.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -78.43 138.46 21.12 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.972 -0.632 . . . . 75.44 113.393 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.89 143.05 42.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 124.068 0.947 . . . . 72.04 109.11 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.549 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.2 p-10 -48.38 168.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.852 0.861 . . . . 70.45 113.023 175.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -57.14 -25.54 59.04 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.531 0.732 . . . . 71.12 112.806 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.95 -8.53 58.71 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 120.037 -0.665 . . . . 71.13 109.37 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.16 15.77 63.56 Favored Glycine 0 C--O 1.216 -1.024 0 CA-C-N 116.127 -0.488 . . . . 64.33 113.141 172.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.4 119.38 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-O 122.623 1.202 . . . . 70.3 112.409 -166.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.625 HG12 ' HD2' ' A' ' 608' ' ' PRO . 0.0 OUTLIER -125.62 128.25 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 CA-C-N 113.694 -1.594 . . . . 74.31 110.2 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 21.2 m -100.51 129.59 46.47 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.673 -1.149 . . . . 74.41 108.896 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.8 pp -138.92 166.24 24.99 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.742 0.645 . . . . 74.41 112.742 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -127.57 137.46 52.6 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.519 -2.03 . . . . 72.33 105.519 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -140.8 165.67 26.87 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 120.199 -0.6 . . . . 74.22 111.113 -172.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 625' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 601' ' ' ASN . . . -81.2 142.64 23.29 Favored Glycine 0 N--CA 1.412 -2.913 0 CA-C-N 115.405 -0.816 . . . . 43.15 111.125 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? . . . . . 0 N--CA 1.402 -2.865 0 C-N-CA 124.336 1.054 . . . . 72.01 108.472 178.484 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.669 0 CA-C-O 122.44 1.114 . . . . 74.51 109.82 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 3.5 p -137.64 147.47 44.97 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 113.998 -1.455 . . . . 52.01 108.907 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -130.86 149.7 52.37 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.965 -0.754 . . . . 73.32 108.965 177.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.7 p-10 -87.71 135.55 33.32 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 122.986 0.514 . . . . 71.33 109.744 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 29.6 pt -88.43 130.39 45.79 Favored Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 116.586 -0.279 . . . . 75.51 110.957 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -88.44 172.75 4.81 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.629 2.219 . . . . 71.55 112.807 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -92.31 111.94 23.7 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.369 -0.832 . . . . 73.44 108.85 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 24.1 m -106.41 16.44 6.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.408 -0.815 . . . . 72.1 111.212 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -67.06 98.12 0.55 Allowed 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.822 -0.627 . . . . 73.52 111.399 -176.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 146.34 -26.03 1.7 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 115.667 -0.697 . . . . 31.0 111.637 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.447 ' O ' HG12 ' A' ' 534' ' ' VAL . 31.8 mt-30 -82.65 171.08 14.42 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.82 -0.807 . . . . 64.22 108.82 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 4.8 m -74.25 155.94 37.74 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 105.129 -2.174 . . . . 63.1 105.129 172.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.433 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.2 p -61.93 -41.94 92.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 118.648 0.658 . . . . 73.53 111.442 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 506' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 17.1 t70 -62.4 -41.66 98.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.546 -0.297 . . . . 65.54 110.357 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 87.4 t -67.1 -44.15 88.26 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.247 0 CA-C-N 116.036 -0.529 . . . . 72.35 109.843 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.477 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -60.84 -39.79 90.4 Favored 'General case' 0 C--O 1.214 -0.809 0 O-C-N 123.18 0.3 . . . . 72.04 111.159 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 98.6 mt-30 -65.06 -43.94 90.62 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.473 -0.195 . . . . 74.44 110.473 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 75.7 mmtt -63.95 -45.21 90.16 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.049 -0.723 . . . . 73.31 109.049 177.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -61.22 -43.06 99.49 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.279 -1.328 . . . . 75.13 110.077 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 66.3 tp -67.23 -45.81 75.66 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.14 -1.391 . . . . 74.43 109.219 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -64.88 -34.98 79.68 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 123.942 0.897 . . . . 63.3 113.155 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 510' ' ' LYS . 85.8 t -57.18 -33.06 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 120.928 0.394 . . . . 63.43 111.278 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -118.5 8.57 12.09 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.924 0.869 . . . . 71.33 110.267 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -114.42 -59.08 0.37 Allowed Glycine 0 N--CA 1.416 -2.688 0 CA-C-N 114.936 -1.029 . . . . 70.02 111.707 -174.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 65.53 18.72 11.36 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 122.479 1.133 . . . . 75.41 109.53 -176.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.2 p -92.54 -175.86 4.11 Favored 'General case' 0 N--CA 1.403 -2.795 0 CA-C-N 114.04 -1.436 . . . . 55.53 110.416 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -107.82 142.21 38.21 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.531 -0.914 . . . . 75.25 108.531 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -129.03 153.3 47.73 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.458 0.647 . . . . 72.4 111.427 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 71.0 m -140.12 155.71 46.87 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 107.095 -1.446 . . . . 72.1 107.095 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -124.14 123.23 39.84 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.313 0.578 . . . . 72.12 111.274 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -105.56 119.31 38.79 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.429 -0.952 . . . . 71.13 108.429 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 20.2 m -100.72 137.19 39.45 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.877 -0.329 . . . . 75.12 110.905 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.1 p -144.21 153.91 15.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.754 -1.202 . . . . 54.42 107.754 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.435 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 3.3 p30 -84.08 136.22 34.1 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.304 0.573 . . . . 63.03 110.927 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.441 ' HB3' ' HD2' ' A' ' 528' ' ' PRO . 50.6 m -159.04 171.38 7.49 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 106.394 -1.706 . . . . 63.12 106.394 -177.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 528' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 527' ' ' SER . 37.3 Cg_endo -68.99 -10.11 28.26 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 121.4 1.4 . . . . 62.21 112.597 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.414 ' HB2' ' CB ' ' A' ' 556' ' ' SER . 23.5 mmm180 -72.59 140.14 81.46 Favored Pre-proline 0 N--CA 1.435 -1.189 0 N-CA-C 109.573 -0.529 . . . . 72.44 109.573 177.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.36 151.34 83.48 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.608 2.206 . . . . 72.4 113.344 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -64.96 121.55 14.91 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.187 -0.915 . . . . 74.12 111.542 -177.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 114.58 -18.91 17.02 Favored Glycine 0 C--O 1.249 1.044 0 C-N-CA 120.838 -0.696 . . . . 73.31 111.373 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -78.2 129.18 34.81 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 109.025 -0.732 . . . . 64.33 109.025 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 10.1 p -90.81 117.42 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.844 0 N-CA-C 106.78 -1.563 . . . . 42.11 106.78 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.4 m -92.94 9.74 34.25 Favored 'General case' 0 C--N 1.27 -2.886 0 CA-C-N 114.341 -1.3 . . . . 51.14 110.567 -173.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.411 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 132.7 -154.79 21.27 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 111.338 -0.705 . . . . 34.32 111.338 176.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.8 p -116.96 157.95 24.89 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.804 -0.813 . . . . 52.03 108.804 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.403 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 11.9 t-20 -60.53 -55.76 41.91 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 119.004 -0.522 . . . . 54.44 111.448 176.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 16.3 Cg_exo -70.53 144.78 50.9 Favored 'Trans proline' 0 C--N 1.367 1.533 0 N-CA-C 108.658 -1.324 . . . . 72.51 108.658 171.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -58.15 147.52 83.09 Favored 'Trans proline' 0 C--O 1.24 0.577 0 C-N-CA 122.79 2.327 . . . . 70.31 113.047 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.05 137.89 57.76 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-N 116.27 -0.423 . . . . 63.02 110.432 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.62 -19.98 48.17 Favored Glycine 0 C--N 1.31 -0.896 0 C-N-CA 120.926 -0.654 . . . . 42.32 111.948 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 35.4 m -67.46 136.79 55.19 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.705 -0.48 . . . . 74.33 109.705 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 14.8 t -96.34 133.23 40.98 Favored 'General case' 0 N--CA 1.406 -2.67 0 N-CA-C 108.984 -0.747 . . . . 74.42 108.984 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.7 m -123.39 155.88 64.67 Favored Pre-proline 0 C--N 1.296 -1.753 0 N-CA-C 108.042 -1.096 . . . . 71.43 108.042 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -63.9 138.28 62.19 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 121.385 1.39 . . . . 65.43 110.486 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 13.2 p -62.2 -19.99 23.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.611 -0.722 . . . . 75.21 111.426 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -90.18 -15.89 30.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.172 0.51 . . . . 43.55 111.507 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 60.0 m -80.39 -175.69 5.27 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 121.109 0.481 . . . . 73.44 111.723 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 12.4 p -113.19 137.61 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 115.931 -0.577 . . . . 73.34 110.168 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 70.2 mt -97.33 129.89 46.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 109.371 -0.603 . . . . 73.12 109.371 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -102.56 117.59 35.01 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.135 -0.691 . . . . 74.41 109.135 -177.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.3 mp -98.59 134.84 40.97 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.813 -0.631 . . . . 74.25 110.006 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -91.82 113.63 25.95 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 116.292 -0.413 . . . . 71.41 110.365 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 524' ' ' SER . 20.1 t -106.65 126.93 62.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.421 -0.955 . . . . 65.0 108.421 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.556 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 50.5 m -95.55 143.34 26.94 Favored 'General case' 0 C--N 1.277 -2.58 0 C-N-CA 119.661 -0.816 . . . . 73.1 110.824 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 0.6 OUTLIER -105.79 144.38 32.61 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 106.163 -1.792 . . . . 74.44 106.163 168.715 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -55.02 -23.35 31.34 Favored Glycine 0 CA--C 1.492 -1.36 0 O-C-N 124.903 1.377 . . . . 64.12 114.624 -171.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 559' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 4.3 t30 77.09 -27.29 0.18 Allowed 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 124.604 1.162 . . . . 74.12 110.92 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' A' ' 558' ' ' GLY . 72.1 mt-30 -114.1 162.18 16.81 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 114.517 -1.22 . . . . 74.42 109.665 -175.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -127.19 155.9 42.68 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 107.805 -1.183 . . . . 74.42 107.805 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 6.2 p -77.78 121.05 29.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.554 -0.536 . . . . 63.31 109.554 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.497 ' SD ' HG21 ' A' ' 620' ' ' ILE . 47.6 ttp -74.11 125.23 90.27 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 116.403 -0.362 . . . . 74.54 111.43 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -72.45 170.61 18.89 Favored 'Trans proline' 0 C--O 1.242 0.721 0 C-N-CA 123.491 2.794 . . . . 72.52 111.891 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.06 114.47 5.86 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.914 0.864 . . . . 74.42 112.703 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.5 pp -125.12 7.15 7.89 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.105 -1.407 . . . . 72.53 107.476 171.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 16.7 m -79.81 144.04 33.87 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 113.497 -1.683 . . . . 74.54 110.564 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 68.03 43.13 83.02 Favored Glycine 0 CA--C 1.521 0.413 0 O-C-N 123.686 0.616 . . . . 74.02 114.007 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 22.2 ptp -146.91 174.79 11.18 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.288 -0.634 . . . . 64.5 109.288 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -98.05 172.87 7.34 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.547 -1.279 . . . . 64.55 107.547 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -62.97 -35.63 80.79 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.708 -0.849 . . . . 75.14 108.708 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.8 -22.36 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 115.636 -0.711 . . . . 61.43 111.506 -175.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.403 ' C ' ' HD2' ' A' ' 576' ' ' PRO . 28.4 t70 -102.18 -31.35 10.62 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-O 121.479 0.657 . . . . 71.3 110.667 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -71.41 -32.39 68.34 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.506 -0.77 . . . . 63.21 111.484 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.615 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 34.3 tt0 -64.56 -48.95 73.2 Favored Pre-proline 0 CA--C 1.56 1.336 0 CA-C-N 116.47 -0.332 . . . . 52.21 111.196 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 88.5 Cg_exo -54.69 -38.01 91.38 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 121.471 1.447 . . . . 33.31 111.76 170.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.439 ' NE ' ' HA ' ' A' ' 577' ' ' ARG . 1.4 mmp_? -58.94 -43.18 91.14 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 121.359 -0.136 . . . . 50.13 111.325 176.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.5 pp -67.05 -45.66 76.71 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.542 0.571 . . . . 73.3 112.542 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.47 ' N ' HD12 ' A' ' 578' ' ' LEU . 5.9 ptp85 -66.71 -35.04 79.18 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.478 0.547 . . . . 72.44 112.478 176.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.97 -36.56 83.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.181 0.515 . . . . 64.53 110.03 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 12.1 tp -81.26 -9.85 59.7 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.651 -0.704 . . . . 63.33 110.694 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 67.79 42.82 85.97 Favored Glycine 0 C--O 1.243 0.671 0 N-CA-C 111.883 -0.487 . . . . 73.41 111.883 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.406 ' HE3' ' CB ' ' A' ' 578' ' ' LEU . 13.7 t90 -75.19 126.49 31.13 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 120.977 0.418 . . . . 61.05 109.879 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 18.1 p -103.52 -15.44 15.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.822 -0.626 . . . . 73.25 112.084 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -83.79 -176.71 51.37 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 121.161 -0.542 . . . . 65.13 112.953 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 51.5 ttp -100.86 141.37 33.84 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 122.344 0.258 . . . . 74.43 111.286 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 8.0 tt -80.96 107.5 13.83 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.075 -1.083 . . . . 74.23 108.075 174.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.545 ' O ' ' HA ' ' A' ' 621' ' ' THR . 24.5 t70 -98.39 116.2 30.12 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.486 -0.779 . . . . 72.0 109.578 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -106.46 134.38 49.68 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.534 -0.757 . . . . 54.2 109.192 178.61 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -70.84 -75.24 0.63 Allowed Glycine 0 C--N 1.293 -1.846 0 N-CA-C 111.116 -0.793 . . . . 72.15 111.116 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.09 121.32 15.87 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.284 -0.635 . . . . 72.44 109.284 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -84.57 137.01 33.54 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.992 -1.114 . . . . 53.34 107.992 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 47.0 t -105.76 126.75 61.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 116.223 -0.444 . . . . 72.41 110.049 -174.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 594' ' ' ASP . . . . . 0.507 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 9.7 p-10 -72.12 111.55 7.44 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 122.403 1.097 . . . . 63.31 111.489 -176.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -133.98 -45.68 0.79 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.356 -1.293 . . . . 42.22 109.133 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 103.44 149.36 20.79 Favored Glycine 0 N--CA 1.422 -2.261 0 C-N-CA 120.837 -0.697 . . . . 62.33 112.356 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.494 ' HA2' ' OD1' ' A' ' 601' ' ' ASN . . . -61.51 -32.58 81.74 Favored Glycine 0 C--N 1.302 -1.339 0 CA-C-N 114.981 -0.61 . . . . 62.5 112.71 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 10.6 t -71.03 -23.56 62.19 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 122.253 1.025 . . . . 75.03 109.449 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -88.58 -1.13 57.9 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.681 -1.145 . . . . 74.25 110.672 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 48.4 m80 70.29 80.7 0.17 Allowed 'General case' 0 C--O 1.244 0.792 0 CA-C-O 122.755 1.264 . . . . 72.22 110.567 -178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 601' ' ' ASN . . . . . 0.494 ' OD1' ' HA2' ' A' ' 597' ' ' GLY . 30.0 p-10 -87.58 78.53 8.53 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 113.812 -1.54 . . . . 74.11 111.452 -175.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -94.07 171.61 8.74 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.601 -1.181 . . . . 73.25 109.232 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 96.4 t -64.93 130.75 30.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 106.829 -1.545 . . . . 54.55 106.829 170.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.8 t -96.51 -52.72 8.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 121.169 0.509 . . . . 70.53 110.535 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -147.91 150.55 34.3 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.161 -0.681 . . . . 73.21 109.161 -175.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -139.4 144.34 38.09 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.871 -1.159 . . . . 63.15 107.871 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.403 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 9.6 t30 -63.52 -51.48 66.66 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 120.444 -0.502 . . . . 72.34 111.98 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 57.6 Cg_endo -93.13 116.67 0.32 Allowed 'Trans proline' 0 N--CA 1.442 -1.532 0 C-N-CA 121.212 1.275 . . . . 75.12 110.328 171.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.88 160.96 34.8 Favored 'Trans proline' 0 C--O 1.248 0.989 0 C-N-CA 122.857 2.371 . . . . 75.51 112.215 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.61 133.67 56.32 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.085 -0.709 . . . . 73.11 109.085 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 100.65 -0.56 55.44 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.636 -0.792 . . . . 63.11 112.265 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 35.3 m -90.18 145.76 24.78 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.555 -0.535 . . . . 72.15 109.555 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -77.28 124.21 6.82 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 110.733 -0.947 . . . . 41.43 110.733 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.9 m -125.78 143.2 40.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 108.374 -0.972 . . . . 63.42 108.374 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.431 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.4 p-10 -48.23 163.03 0.07 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.92 0.888 . . . . 74.41 111.965 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . 0.331 0.0 OUTLIER -56.04 -24.5 39.98 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.971 1.471 . . . . 64.22 114.971 -178.387 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -83.65 -6.26 59.4 Favored 'General case' 0 C--O 1.199 -1.589 0 C-N-CA 119.256 -0.977 . . . . 75.22 112.497 175.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.83 19.52 69.61 Favored Glycine 0 CA--C 1.491 -1.441 0 CA-C-O 119.464 -0.631 . . . . 64.1 114.561 166.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.83 118.63 14.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-O 122.12 0.962 . . . . 72.31 110.419 -168.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.497 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.7 pp -129.36 133.86 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 114.708 -1.133 . . . . 41.41 111.866 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 15.4 t -102.21 122.92 45.12 Favored 'General case' 0 C--O 1.26 1.633 0 CA-C-O 121.802 0.81 . . . . 73.31 109.553 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 1.8 pt? -139.36 167.27 22.47 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.334 -0.848 . . . . 74.41 111.742 -173.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -128.22 137.08 51.86 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.262 -1.014 . . . . 71.22 108.262 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.463 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 35.0 p90 -141.28 166.63 24.24 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.788 -0.187 . . . . 64.02 111.126 -174.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -75.57 135.2 17.8 Favored Glycine 0 N--CA 1.435 -1.4 0 CA-C-O 121.69 0.605 . . . . 71.42 113.954 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.507 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 4.2 tt0 . . . . . 0 C--N 1.296 -1.755 0 N-CA-C 107.1 -1.445 . . . . 74.23 107.1 175.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.193 0 CA-C-O 121.357 0.598 . . . . 61.43 111.594 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 16.1 p -139.18 141.1 37.99 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.823 -0.806 . . . . 61.24 108.823 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -143.02 148.42 36.74 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.818 0.342 . . . . 43.52 111.32 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.9 p-10 -79.1 139.08 38.17 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 115.407 -0.815 . . . . 72.35 110.209 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.4 pt -96.17 137.35 21.69 Favored Pre-proline 0 C--N 1.296 -1.722 0 CA-C-N 115.628 -0.715 . . . . 72.21 111.116 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -89.86 -177.22 1.34 Allowed 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.487 2.124 . . . . 72.42 109.829 170.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -99.9 137.28 38.57 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.919 -1.141 . . . . 73.45 107.919 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.502 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 16.7 m -110.81 17.31 7.65 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 CA-C-N 115.543 -0.753 . . . . 51.13 110.178 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -72.93 100.83 3.03 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.456 -0.793 . . . . 72.44 110.206 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 169.12 -46.43 0.22 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-N 115.379 -0.828 . . . . 63.32 111.864 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.431 ' O ' HG12 ' A' ' 534' ' ' VAL . 18.2 pm0 -98.07 -171.06 2.08 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 122.344 -0.504 . . . . 75.04 110.505 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 15.1 m -70.92 155.12 41.2 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.452 -0.944 . . . . 71.33 108.452 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 9.7 p -65.5 -41.73 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 O-C-N 123.06 0.225 . . . . 63.05 110.88 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -61.82 -37.98 86.44 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.913 -0.773 . . . . 65.12 108.913 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 95.1 t -71.02 -48.77 53.74 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.624 0 CA-C-N 115.525 -0.761 . . . . 53.35 109.684 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.502 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -60.58 -36.73 79.25 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 122.769 0.428 . . . . 72.51 111.767 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.422 ' O ' ' HB2' ' A' ' 513' ' ' ASN . 99.2 mt-30 -65.23 -45.2 85.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.56 0.219 . . . . 53.22 110.47 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.524 ' O ' HG23 ' A' ' 514' ' ' VAL . 75.1 mmtt -66.6 -39.53 88.43 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 109.137 -0.69 . . . . 74.14 109.137 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 511' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' A' ' 508' ' ' ALA . 20.3 t-20 -60.18 -47.02 87.68 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 125.771 1.628 . . . . 71.11 110.091 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -69.48 -42.06 75.32 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.761 -1.109 . . . . 71.13 108.592 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 14.3 t30 -63.7 -35.59 81.07 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.421 -0.809 . . . . 75.12 111.392 -174.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 510' ' ' LYS . 71.4 t -57.78 -32.46 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.068 0.461 . . . . 63.45 111.737 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -115.36 4.76 14.45 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.559 0.695 . . . . 74.42 110.108 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -120.21 -57.59 0.24 Allowed Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 115.817 -0.629 . . . . 53.03 113.094 -174.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 64.76 28.96 12.9 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.89 0.876 . . . . 73.11 111.411 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 16.7 p -89.09 -166.92 1.72 Allowed 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.665 -1.152 . . . . 72.2 109.208 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -107.74 143.98 35.51 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 106.754 -1.572 . . . . 73.35 106.754 173.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -126.84 144.8 50.86 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.387 0.613 . . . . 62.3 112.327 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 73.5 m -132.81 149.92 52.22 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.651 -0.87 . . . . 72.25 108.651 176.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 522' ' ' GLN . . . . . 0.405 ' HB2' ' CG2' ' A' ' 555' ' ' VAL . 14.1 pt20 -123.18 131.78 53.81 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.025 0.44 . . . . 74.13 110.536 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -120.45 118.88 31.43 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.576 -0.898 . . . . 73.2 108.576 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 78.4 p -94.78 139.3 31.45 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.451 0.643 . . . . 73.31 112.203 -176.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.8 p -133.6 150.17 31.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.097 -1.075 . . . . 75.21 108.097 178.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.11 136.03 44.83 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.348 0.594 . . . . 72.32 111.281 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 74.3 m -156.01 163.2 25.59 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 106.803 -1.554 . . . . 74.03 106.803 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.52 -10.83 27.45 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.387 1.392 . . . . 65.12 112.709 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.455 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 10.2 mtm180 -84.48 152.51 60.77 Favored Pre-proline 0 N--CA 1.429 -1.483 0 N-CA-C 108.891 -0.781 . . . . 74.33 108.891 -176.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.17 149.35 70.57 Favored 'Trans proline' 0 C--O 1.246 0.893 0 C-N-CA 122.239 1.959 . . . . 73.53 114.41 -170.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -63.94 124.45 21.58 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.399 -1.273 . . . . 71.01 110.689 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 125.71 -21.65 6.26 Favored Glycine 0 C--N 1.291 -1.927 0 N-CA-C 111.049 -0.82 . . . . 50.22 111.049 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -75.0 137.59 41.64 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.584 -0.524 . . . . 44.5 109.584 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 503' ' ' GLN . 4.3 p -90.87 113.22 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.95 0 CA-C-O 122.084 0.945 . . . . 72.23 108.825 174.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -24.72 64.33 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.21 -1.359 . . . . 74.42 111.087 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 152.24 -157.42 27.25 Favored Glycine 0 N--CA 1.432 -1.617 0 N-CA-C 110.013 -1.235 . . . . 43.45 110.013 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.2 p -117.37 155.01 30.32 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 117.356 0.578 . . . . 60.34 109.903 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.495 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 25.7 t-20 -53.39 -51.7 73.27 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 119.252 -0.404 . . . . 74.22 111.902 174.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.9 Cg_endo -87.02 153.29 8.37 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 121.773 1.649 . . . . 75.42 110.453 174.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.32 160.68 48.86 Favored 'Trans proline' 0 C--O 1.26 1.58 0 C-N-CA 122.413 2.075 . . . . 72.32 112.545 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.6 131.83 46.86 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.84 -0.618 . . . . 53.31 109.712 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.74 -6.63 38.12 Favored Glycine 0 C--N 1.303 -1.256 0 C-N-CA 120.831 -0.7 . . . . 73.33 111.848 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 25.7 m -78.78 126.45 30.74 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.452 -0.574 . . . . 74.44 109.452 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 9.4 t -87.05 126.33 34.68 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.431 0.634 . . . . 64.1 109.319 176.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.67 159.49 55.38 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 107.782 -1.192 . . . . 74.25 107.782 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -66.38 137.56 47.52 Favored 'Trans proline' 0 N--CA 1.437 -1.808 0 C-N-CA 120.874 1.049 . . . . 75.24 110.354 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.41 -19.06 23.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.323 -0.853 . . . . 54.34 111.408 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -96.39 -9.8 29.11 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 112.211 0.448 . . . . 55.55 112.211 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 60.3 m -89.6 -175.99 4.86 Favored 'General case' 0 C--O 1.255 1.345 0 N-CA-C 112.871 0.693 . . . . 53.32 112.871 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.9 p -104.03 138.07 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 115.508 -0.769 . . . . 72.22 111.024 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 61.0 mt -107.55 138.34 34.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.88 -1.155 . . . . 74.21 107.88 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 552' ' ' GLU . . . . . 0.417 ' HG2' ' NE2' ' A' ' 554' ' ' GLN . 25.1 tt0 -102.84 126.89 50.15 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.145 0.498 . . . . 72.41 111.083 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.2 mp -108.04 134.72 50.53 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.108 -0.951 . . . . 70.51 109.281 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.417 ' NE2' ' HG2' ' A' ' 552' ' ' GLU . 25.0 mm-40 -89.41 134.04 34.26 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.921 -1.14 . . . . 75.41 107.921 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 524' ' ' SER . 38.3 t -116.08 131.2 69.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 110.21 -0.293 . . . . 72.34 110.21 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.655 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 2.3 m -83.79 122.03 28.11 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 107.839 -1.171 . . . . 73.33 107.839 177.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.73 140.18 30.91 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 106.725 -1.583 . . . . 63.04 106.725 171.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -57.91 -23.44 51.23 Favored Glycine 0 CA--C 1.489 -1.592 0 O-C-N 124.894 1.371 . . . . 73.41 114.282 -171.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 77.98 -19.52 0.43 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.759 1.224 . . . . 75.11 110.851 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.487 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 75.8 mt-30 -112.41 155.29 24.45 Favored 'General case' 0 N--CA 1.428 -1.549 0 O-C-N 121.502 -0.749 . . . . 72.43 112.042 -174.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -135.36 150.6 49.97 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.377 -1.342 . . . . 75.23 107.377 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 6.2 p -66.95 125.35 24.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 121.202 0.525 . . . . 73.4 111.661 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.504 ' SD ' HG21 ' A' ' 620' ' ' ILE . 51.3 ttp -88.34 131.02 43.66 Favored Pre-proline 0 C--N 1.309 -1.189 0 CA-C-N 116.095 -0.502 . . . . 55.4 109.731 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.18 169.21 17.21 Favored 'Trans proline' 0 C--O 1.244 0.803 0 C-N-CA 122.51 2.14 . . . . 63.05 110.88 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 565' ' ' ASP . . . . . 0.469 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 0.9 OUTLIER -79.22 127.83 32.54 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.286 1.041 . . . . 72.44 111.916 -177.225 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.3 pp -135.51 19.64 3.35 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 113.62 -1.627 . . . . 75.1 108.534 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 13.2 m -79.14 143.08 35.81 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 114.376 -1.284 . . . . 60.33 109.417 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 74.54 46.0 21.03 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 121.046 -0.597 . . . . 53.0 112.256 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -129.05 174.35 9.62 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 109.076 -0.712 . . . . 52.42 109.076 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -111.37 165.65 11.78 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.018 -1.845 . . . . 63.22 106.018 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 18.6 t-105 -61.75 -31.49 71.67 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.134 0.492 . . . . 74.23 110.139 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.5 p -65.37 -25.62 37.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 115.694 -0.684 . . . . 73.03 111.08 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.633 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 37.1 t70 -93.8 -26.2 17.06 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.578 -0.527 . . . . 74.4 109.578 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.19 -45.48 93.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.128 -0.942 . . . . 71.34 111.877 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.542 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 40.7 mt-10 -57.15 -52.95 70.31 Favored Pre-proline 0 CA--C 1.56 1.329 0 N-CA-C 112.547 0.573 . . . . 75.53 112.547 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 31.5 Cg_exo -61.28 -35.22 85.67 Favored 'Trans proline' 0 C--N 1.365 1.439 0 CA-C-N 120.491 1.211 . . . . 74.23 112.414 173.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 5.7 mmp_? -60.4 -44.74 95.39 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 120.934 -0.306 . . . . 73.31 110.651 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.6 pp -65.88 -47.09 76.02 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.023 -0.535 . . . . 71.33 112.203 -174.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.5 ' N ' HD12 ' A' ' 578' ' ' LEU . 16.8 ptm180 -66.64 -37.63 85.22 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.261 -0.427 . . . . 75.33 111.707 177.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.47 -35.61 73.39 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 111.822 0.305 . . . . 73.42 111.822 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.0 pp -83.97 -9.15 58.89 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 119.654 -0.818 . . . . 63.43 110.532 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 78.96 41.99 13.32 Favored Glycine 0 C--O 1.243 0.718 0 C-N-CA 121.197 -0.525 . . . . 73.14 112.211 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -78.21 128.78 34.26 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.565 -0.531 . . . . 73.52 109.565 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 5.2 p -82.18 -47.98 11.84 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 123.732 0.813 . . . . 64.54 112.092 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -68.42 -166.4 3.94 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 115.698 1.039 . . . . 43.45 115.698 -176.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 17.5 tpt -118.46 149.15 41.75 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 123.452 0.701 . . . . 53.33 109.538 -175.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 28.5 tp -80.46 117.61 21.34 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 121.252 0.548 . . . . 65.25 109.82 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 621' ' ' THR . 25.5 t70 -100.49 120.58 40.21 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 115.237 -0.892 . . . . 74.55 109.5 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.493 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.3 OUTLIER -108.18 134.29 51.24 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.217 0.532 . . . . 64.1 109.784 178.046 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -86.47 -70.28 1.32 Allowed Glycine 0 C--N 1.288 -2.098 0 CA-C-N 115.396 -0.82 . . . . 73.12 112.651 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.42 154.13 47.73 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.656 0.265 . . . . 63.45 111.433 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -93.07 124.76 37.27 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.177 -0.92 . . . . 71.34 108.813 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 52.3 t -104.96 147.81 10.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 107.589 -1.263 . . . . 72.42 107.589 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 594' ' ' ASP . . . . . 0.495 ' HA ' ' HG2' ' A' ' 626' ' ' GLN . 10.7 p-10 -78.38 120.76 23.58 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.58 -0.896 . . . . 72.23 108.58 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -124.22 -52.39 1.74 Allowed 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.231 -0.588 . . . . 65.44 110.611 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 96.04 143.48 14.79 Favored Glycine 0 N--CA 1.427 -1.915 0 C-N-CA 119.935 -1.126 . . . . 64.23 111.697 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -60.5 -33.31 81.0 Favored Glycine 0 C--N 1.309 -0.956 0 N-CA-C 115.096 0.798 . . . . 72.53 115.096 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 33.4 t -77.14 -27.77 54.01 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 118.104 0.952 . . . . 72.12 109.528 -175.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -90.28 -3.42 57.8 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.102 -0.954 . . . . 70.13 109.947 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 34.0 m80 69.07 111.25 0.05 OUTLIER 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 114.491 -1.231 . . . . 72.22 112.486 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 601' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 625' ' ' GLY . 21.5 p-10 -79.4 65.01 4.44 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 123.306 1.527 . . . . 73.32 110.83 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -91.53 171.23 9.33 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 113.055 -1.884 . . . . 51.01 110.07 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 94.8 t -65.65 130.11 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 106.645 -1.613 . . . . 73.3 106.645 170.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 29.9 m -101.29 -36.32 4.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.152 0.501 . . . . 63.23 111.206 -176.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -144.27 135.98 25.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 116.167 -0.469 . . . . 62.42 109.965 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -126.62 137.79 53.35 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.161 -1.422 . . . . 41.4 107.161 174.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.523 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 45.0 t-20 -62.63 -59.11 13.62 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-O 118.99 -0.529 . . . . 72.43 112.162 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.0 Cg_exo -82.84 120.67 3.1 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.553 1.502 . . . . 75.23 110.065 175.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 609' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 14.6 Cg_exo -69.8 148.31 64.55 Favored 'Trans proline' 0 C--O 1.243 0.758 0 C-N-CA 122.341 2.027 . . . . 65.33 112.29 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 610' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -68.07 129.46 39.98 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.761 -0.654 . . . . 74.11 109.403 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.04 -10.4 47.82 Favored Glycine 0 C--N 1.302 -1.333 0 N-CA-C 110.219 -1.152 . . . . 60.25 110.219 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 37.1 m -101.68 161.92 13.29 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.801 -1.185 . . . . 70.01 107.801 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -82.82 135.22 13.72 Favored Glycine 0 N--CA 1.418 -2.528 0 C-N-CA 121.271 -0.49 . . . . 52.33 112.537 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.1 m -114.08 142.98 24.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 107.434 -1.321 . . . . 60.4 107.434 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.487 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 33.1 p-10 -56.37 170.86 0.32 Allowed 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 112.683 0.623 . . . . 75.54 112.683 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -56.98 -25.19 57.79 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.181 0.808 . . . . 73.42 113.181 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -87.57 -9.05 55.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.497 0.665 . . . . 73.15 109.5 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.54 14.92 63.18 Favored Glycine 0 C--O 1.217 -0.917 0 CA-C-N 115.628 -0.714 . . . . 70.32 113.406 172.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.57 119.74 17.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 122.416 1.103 . . . . 61.13 112.458 -167.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.504 HG21 ' SD ' ' A' ' 563' ' ' MET . 36.0 pt -122.42 133.32 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.975 0 CA-C-N 114.337 -1.301 . . . . 44.01 109.02 178.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 9.9 t -109.49 131.37 55.12 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.189 -1.041 . . . . 73.32 108.189 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.7 pp -138.73 165.91 25.76 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 112.873 0.694 . . . . 73.13 112.873 -175.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -128.45 137.83 52.02 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.51 -1.293 . . . . 72.11 107.51 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -133.44 163.13 30.04 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 120.161 -0.616 . . . . 73.54 111.387 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 625' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 601' ' ' ASN . . . -84.41 153.16 28.63 Favored Glycine 0 N--CA 1.42 -2.388 0 CA-C-N 115.446 -0.797 . . . . 64.15 112.507 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.495 ' HG2' ' HA ' ' A' ' 594' ' ' ASP . 8.0 pt20 . . . . . 0 C--O 1.271 2.202 0 N-CA-C 107.577 -1.268 . . . . 51.35 107.577 176.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 120.989 0.423 . . . . 63.35 112.035 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.44 ' HB ' HG22 ' A' ' 544' ' ' THR . 40.3 p -138.96 139.87 38.09 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.035 -0.728 . . . . 52.35 109.035 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.612 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 6.1 tmtt? -134.8 143.0 46.82 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.699 -0.852 . . . . 64.11 108.699 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.612 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 9.3 p-10 -77.41 128.9 35.04 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.879 0.872 . . . . 42.55 110.712 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.7 pt -84.15 138.01 39.75 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.352 -0.84 . . . . 75.03 111.007 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.08 176.56 8.95 Favored 'Trans proline' 0 C--O 1.238 0.511 0 C-N-CA 122.666 2.244 . . . . 75.21 112.516 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -81.45 127.85 33.24 Favored 'General case' 0 C--O 1.253 1.263 0 N-CA-C 108.177 -1.046 . . . . 64.4 108.177 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.585 ' HA ' ' NE2' ' A' ' 503' ' ' GLN . 34.8 m -123.28 -16.92 4.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 113.465 0.913 . . . . 73.04 113.465 -175.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -71.11 94.84 1.16 Allowed 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 120.721 0.296 . . . . 54.21 110.897 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 153.01 -39.23 0.73 Allowed Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 120.224 -0.989 . . . . 65.24 112.224 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.585 ' NE2' ' HA ' ' A' ' 500' ' ' VAL . 15.2 pm0 -88.2 -176.91 5.56 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 119.98 -0.688 . . . . 61.2 109.685 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 14.7 m -70.84 155.3 40.97 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.435 -1.32 . . . . 74.15 107.435 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.484 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.5 p -64.39 -41.48 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 121.031 -0.267 . . . . 74.5 110.713 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 506' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 14.3 t70 -61.75 -40.88 96.68 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.596 -0.52 . . . . 73.24 109.596 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.37 -43.35 84.31 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.803 0 CA-C-N 115.576 -0.738 . . . . 55.33 109.794 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.519 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -58.37 -45.04 89.0 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 123.15 0.281 . . . . 73.22 110.6 176.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.2 mt-30 -63.52 -45.29 91.3 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.754 -0.657 . . . . 63.14 110.369 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.533 ' O ' HG23 ' A' ' 514' ' ' VAL . 47.0 mmtm -62.99 -43.91 97.47 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.142 -0.481 . . . . 54.32 110.535 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -64.58 -43.74 92.9 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.656 -0.702 . . . . 74.31 111.85 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.2 pp -69.22 -36.43 77.22 Favored 'General case' 0 C--O 1.207 -1.181 0 C-N-CA 120.308 -0.557 . . . . 73.31 110.63 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.429 ' N ' HD12 ' A' ' 512' ' ' LEU . 39.8 t30 -63.13 -35.79 81.45 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 123.155 0.582 . . . . 75.34 110.45 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 510' ' ' LYS . 89.1 t -60.84 -36.34 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.05 0.452 . . . . 75.32 110.83 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 515' ' ' TYR . . . . . 0.461 ' O ' ' HE3' ' A' ' 495' ' ' LYS . 84.2 m-85 -112.71 22.64 14.32 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.15 0.5 . . . . 75.25 110.024 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -144.3 -58.83 0.02 OUTLIER Glycine 0 CA--C 1.48 -2.11 0 C-N-CA 119.849 -1.167 . . . . 64.14 112.797 -176.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 66.06 23.66 11.06 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 122.93 1.347 . . . . 72.1 109.656 -173.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.496 ' C ' ' HD2' ' A' ' 519' ' ' LYS . 5.8 p -83.08 174.7 10.61 Favored 'General case' 0 N--CA 1.394 -3.233 0 CA-C-N 112.646 -2.07 . . . . 71.2 108.373 176.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.496 ' HD2' ' C ' ' A' ' 518' ' ' THR . 11.8 mptt -107.94 140.28 41.3 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 108.848 -0.797 . . . . 75.43 108.848 -177.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -125.41 154.03 42.55 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 121.16 0.505 . . . . 71.14 111.81 -172.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 32.9 p -135.59 147.17 48.6 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 107.724 -1.213 . . . . 74.34 107.724 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -119.74 119.83 34.81 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.245 0.545 . . . . 72.45 110.687 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -110.77 116.66 31.67 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.053 -1.092 . . . . 75.13 108.053 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.6 m -96.39 126.91 41.92 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.587 -0.445 . . . . 72.03 110.199 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.35 149.09 24.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 106.819 -1.549 . . . . 74.42 106.819 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.501 ' HB2' HD22 ' A' ' 559' ' ' ASN . 6.1 p-10 -80.18 135.85 36.37 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-O 121.186 0.517 . . . . 73.22 110.565 -176.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 43.7 m -153.0 168.91 10.55 Favored Pre-proline 0 C--N 1.293 -1.869 0 N-CA-C 106.152 -1.796 . . . . 71.25 106.152 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -75.78 -10.63 20.02 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 121.255 1.303 . . . . 73.33 111.503 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.48 ' HA ' ' HD3' ' A' ' 530' ' ' PRO . 17.9 mtp180 -81.01 137.2 49.91 Favored Pre-proline 0 N--CA 1.413 -2.289 0 N-CA-C 108.252 -1.018 . . . . 72.34 108.252 -178.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 530' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 529' ' ' ARG . 15.9 Cg_exo -65.3 142.39 72.73 Favored 'Trans proline' 0 C--O 1.255 1.325 0 C-N-CA 123.351 2.701 . . . . 53.31 115.304 -170.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.729 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -59.58 118.2 5.8 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 114.613 -1.176 . . . . 62.53 111.739 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 136.0 -27.04 3.07 Favored Glycine 0 C--N 1.296 -1.69 0 N-CA-C 109.846 -1.302 . . . . 63.52 109.846 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -74.46 136.04 42.28 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.943 -0.629 . . . . 63.54 110.273 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 5.7 p -100.95 113.9 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.315 0 N-CA-C 108.201 -1.037 . . . . 63.14 108.201 172.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.95 -8.1 58.6 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.024 -0.534 . . . . 52.42 112.11 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 147.06 -171.86 27.66 Favored Glycine 0 N--CA 1.42 -2.408 0 C-N-CA 120.271 -0.966 . . . . 73.24 112.178 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 4.5 p -116.9 159.0 23.09 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 107.485 -1.302 . . . . 64.52 107.485 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -64.77 -47.17 75.71 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 118.33 -1.348 . . . . 74.55 112.084 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -73.58 137.07 24.6 Favored 'Trans proline' 0 C--N 1.366 1.465 0 N-CA-C 108.384 -1.429 . . . . 65.13 108.384 169.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 540' ' ' PRO . . . . . 0.434 ' HG2' ' OG1' ' A' ' 543' ' ' THR . 15.7 Cg_endo -59.97 140.62 93.68 Favored 'Trans proline' 0 C--O 1.246 0.89 0 C-N-CA 122.299 1.999 . . . . 62.14 112.589 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.6 132.69 54.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.758 -0.655 . . . . 63.14 109.59 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.44 -21.01 36.01 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.207 -0.757 . . . . 71.34 111.207 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.434 ' OG1' ' HG2' ' A' ' 540' ' ' PRO . 70.5 m -77.08 137.93 39.24 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.21 0.529 . . . . 43.41 110.873 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 7.1 m -84.39 123.2 29.96 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 108.628 -0.878 . . . . 62.01 108.628 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.98 157.39 63.71 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 108.424 -0.954 . . . . 63.42 108.424 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -59.99 136.26 68.27 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 121.355 1.37 . . . . 75.35 112.866 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.93 -20.54 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.671 -1.15 . . . . 73.43 111.105 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -84.13 -17.93 38.47 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.434 -1.257 . . . . 72.2 111.535 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 50.0 m -97.28 163.29 12.96 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 114.107 1.151 . . . . 61.52 114.107 -171.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.8 p -89.81 129.72 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 114.568 -1.196 . . . . 61.04 110.522 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 56.4 mt -92.74 132.13 37.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 107.697 -1.223 . . . . 73.33 107.697 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.43 117.75 35.17 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 121.509 0.671 . . . . 72.52 110.293 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.0 mp -103.96 124.51 49.13 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.884 -1.053 . . . . 74.22 108.948 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -92.46 118.79 31.32 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.412 0.625 . . . . 72.14 110.252 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.69 133.82 41.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.002 -0.999 . . . . 72.31 109.24 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.729 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 3.1 m -83.13 119.75 24.92 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.312 -1.366 . . . . 74.55 107.312 176.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.456 ' HG3' ' HA ' ' A' ' 526' ' ' ASP . 8.6 ptpp? -96.07 142.95 27.66 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.922 -1.51 . . . . 72.53 106.922 172.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -56.04 -23.47 39.37 Favored Glycine 0 C--O 1.244 0.773 0 O-C-N 124.641 1.213 . . . . 60.31 114.773 -171.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 559' ' ' ASN . . . . . 0.501 HD22 ' HB2' ' A' ' 526' ' ' ASP . 24.0 t-20 78.55 -9.26 1.53 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 124.082 0.953 . . . . 72.32 110.364 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -112.6 156.88 21.93 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 113.387 0.884 . . . . 73.42 113.387 -170.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -130.67 157.04 43.86 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.479 -1.237 . . . . 71.41 107.915 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 97.0 t -74.72 121.49 26.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 O-C-N 123.212 0.32 . . . . 64.42 110.838 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 564' ' ' PRO . 42.8 ttm -64.84 125.81 89.74 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 123.461 0.705 . . . . 64.13 111.836 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 564' ' ' PRO . . . . . 0.464 ' O ' ' HG2' ' A' ' 563' ' ' MET . 16.2 Cg_exo -74.07 169.35 22.64 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.825 2.35 . . . . 74.3 110.504 172.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.87 138.42 46.27 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.41 0.624 . . . . 75.44 112.263 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -152.79 24.62 0.58 Allowed 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.786 -1.191 . . . . 71.42 107.786 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 6.2 m -78.07 141.53 38.76 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.434 -1.257 . . . . 72.43 111.371 -173.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 70.42 27.6 72.44 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 116.065 -0.516 . . . . 73.23 113.51 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 569' ' ' MET . . . . . 0.523 ' O ' ' HA ' ' A' ' 602' ' ' ARG . 27.0 ptt? -99.51 160.02 14.59 Favored 'General case' 0 CA--C 1.476 -1.884 0 C-N-CA 120.233 -0.587 . . . . 62.53 109.936 -176.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 570' ' ' PHE . . . . . 0.587 ' HA ' ' O ' ' A' ' 601' ' ' ASN . 6.5 m-85 -103.38 175.05 5.61 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.638 -1.986 . . . . 74.41 105.638 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -70.1 -28.49 65.44 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 118.507 -1.277 . . . . 71.53 109.579 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.9 m -73.37 -13.38 16.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.557 -0.747 . . . . 71.23 110.548 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.597 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 24.0 t70 -101.46 -28.63 12.46 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.899 -0.778 . . . . 74.22 108.899 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -59.11 -53.05 62.77 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.046 -0.979 . . . . 75.33 111.803 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -54.8 -50.5 85.59 Favored Pre-proline 0 CA--C 1.558 1.287 0 N-CA-C 113.365 0.876 . . . . 74.42 113.365 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -57.67 -28.96 83.79 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 121.336 1.357 . . . . 62.24 112.766 172.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.597 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 23.0 mmm180 -68.76 -38.9 80.41 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 121.802 -0.561 . . . . 72.04 110.805 176.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.541 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 11.0 mp -59.75 -48.05 83.22 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 120.707 0.289 . . . . 74.44 110.453 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -66.37 -38.44 87.58 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.838 -0.619 . . . . 72.22 112.411 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.03 -39.06 76.0 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.545 0.688 . . . . 61.25 111.018 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.457 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 8.5 tp -83.28 -9.5 59.07 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 115.24 -0.891 . . . . 73.3 110.522 -178.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 60.87 42.35 99.57 Favored Glycine 0 CA--C 1.507 -0.466 0 N-CA-C 111.028 -0.829 . . . . 34.45 111.028 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.541 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 14.6 t90 -85.21 126.74 33.9 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.469 -0.567 . . . . 71.32 109.469 -175.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 12.7 t -99.14 -16.24 18.67 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 116.127 -0.488 . . . . 52.1 110.956 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 585' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -77.15 -177.49 45.88 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 121.509 -0.377 . . . . 74.22 112.691 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 48.4 tpp -112.8 147.16 37.5 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.192 -0.67 . . . . 72.14 109.192 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.4 tt -86.91 127.87 35.06 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.42 -1.326 . . . . 64.14 107.42 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 621' ' ' THR . 31.3 t70 -100.07 119.11 37.8 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.547 -0.538 . . . . 74.05 109.547 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.49 133.79 46.87 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.461 -0.896 . . . . 60.3 109.91 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.36 -79.05 0.95 Allowed Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.456 -0.793 . . . . 45.24 112.091 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -137.72 145.77 42.93 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 110.047 -0.353 . . . . 74.15 110.047 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -88.15 124.63 34.0 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.729 -1.582 . . . . 74.24 106.729 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 39.1 t -104.43 126.18 59.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.531 -0.914 . . . . 62.34 108.531 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 594' ' ' ASP . . . . . 0.525 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 32.2 t70 -73.58 106.39 5.33 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.379 -0.528 . . . . 75.44 111.114 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -113.54 -12.33 12.92 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.142 -0.936 . . . . 75.11 109.536 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 114.49 137.6 6.52 Favored Glycine 0 N--CA 1.428 -1.855 0 N-CA-C 111.084 -0.807 . . . . 42.42 111.084 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -63.23 -38.49 96.56 Favored Glycine 0 C--N 1.318 -0.464 0 C-N-CA 121.725 -0.274 . . . . 75.3 112.887 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 33.6 t -72.79 -22.82 60.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.869 0.842 . . . . 61.14 109.414 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -86.92 -3.43 59.08 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.006 -0.997 . . . . 65.03 110.546 -175.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 70.5 m80 67.67 158.11 0.14 Allowed 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.798 1.239 . . . . 75.22 113.199 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 601' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 570' ' ' PHE . 21.1 p30 -93.77 68.16 3.9 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.592 0.71 . . . . 64.52 112.905 -179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.523 ' HA ' ' O ' ' A' ' 569' ' ' MET . 2.7 ptp180 -85.47 146.72 26.81 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 119.365 -0.934 . . . . 72.53 112.171 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 74.2 t -57.95 130.11 20.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 114.053 -1.431 . . . . 72.34 109.516 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.17 -23.02 4.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.025 0.441 . . . . 73.4 111.086 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -155.97 135.9 12.76 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.548 -0.751 . . . . 75.4 109.726 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -124.5 137.64 54.4 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.698 -1.964 . . . . 74.12 105.698 173.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.41 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 28.6 t-20 -65.71 -53.52 35.68 Favored Pre-proline 0 C--N 1.317 -0.832 0 C-N-CA 119.066 -1.053 . . . . 70.42 112.86 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 5.3 Cg_endo -91.94 113.76 0.34 Allowed 'Trans proline' 0 N--CA 1.438 -1.789 0 C-N-CA 121.217 1.278 . . . . 64.33 109.344 171.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -70.14 160.11 50.75 Favored 'Trans proline' 0 C--O 1.247 0.947 0 C-N-CA 122.332 2.021 . . . . 64.13 111.539 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -62.18 138.89 58.48 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 109.844 -0.428 . . . . 73.2 109.844 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 102.1 -14.74 57.01 Favored Glycine 0 C--N 1.306 -1.113 0 N-CA-C 111.579 -0.608 . . . . 62.53 111.579 -175.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 6.0 m -92.05 155.03 18.37 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.881 -0.785 . . . . 71.31 108.881 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -80.01 134.22 13.31 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 121.033 -0.603 . . . . 71.14 112.496 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 13.6 m -127.06 143.13 41.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 124.226 1.01 . . . . 61.31 109.879 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.413 HD21 HG22 ' A' ' 619' ' ' ILE . 29.2 p-10 -49.58 162.87 0.14 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.322 1.049 . . . . 72.41 112.971 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -59.45 -24.83 63.87 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 114.056 1.132 . . . . 75.31 114.056 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.403 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 28.9 t70 -82.71 -8.82 59.57 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 119.598 -0.841 . . . . 73.03 109.523 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.2 14.68 64.31 Favored Glycine 0 C--O 1.221 -0.68 0 C-N-CA 123.519 0.581 . . . . 72.11 113.678 173.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 619' ' ' ILE . . . . . 0.413 HG22 HD21 ' A' ' 615' ' ' ASN . 0.1 OUTLIER -70.29 119.9 17.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 122.099 0.952 . . . . 63.32 110.556 -168.696 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.423 ' O ' HD12 ' A' ' 620' ' ' ILE . 2.7 pp -128.64 134.62 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-N 115.087 -0.961 . . . . 75.4 112.768 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 10.2 t -105.11 124.69 49.97 Favored 'General case' 0 C--O 1.258 1.551 0 CA-C-N 115.355 -0.839 . . . . 45.53 109.641 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.1 pp -140.12 167.35 22.33 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.514 -0.767 . . . . 62.04 112.411 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -127.3 140.25 52.33 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.788 -0.819 . . . . 75.0 108.788 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -139.97 167.37 22.28 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.628 -0.715 . . . . 55.44 110.039 -170.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -60.1 177.15 3.33 Favored Glycine 0 CA--C 1.538 1.472 0 O-C-N 124.008 0.818 . . . . 71.35 113.847 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.525 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 35.9 tp60 . . . . . 0 C--N 1.292 -1.921 0 C-N-CA 123.712 0.805 . . . . 73.23 108.971 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.231 0 CA-C-O 121.895 0.855 . . . . 72.2 110.882 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 7.9 p -135.27 144.82 47.02 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.807 -1.183 . . . . 72.41 107.807 176.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -141.34 143.79 34.21 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 109.533 -0.543 . . . . 75.12 109.533 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.5 m-20 -83.02 124.73 30.7 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.036 -0.529 . . . . 72.4 110.46 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.4 pt -88.83 137.35 30.0 Favored Pre-proline 0 C--N 1.305 -1.327 0 CA-C-N 115.81 -0.632 . . . . 74.42 110.434 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.89 -177.34 3.76 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.311 2.007 . . . . 73.24 111.776 177.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -93.61 127.44 39.29 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.317 -0.994 . . . . 44.11 108.317 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.555 ' O ' ' HG2' ' A' ' 503' ' ' GLN . 28.2 m -122.06 -3.98 8.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 112.717 0.636 . . . . 73.44 112.717 -176.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -66.3 102.3 0.84 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.018 0.437 . . . . 75.42 110.423 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 141.94 -22.28 2.47 Favored Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 120.808 -0.711 . . . . 63.34 112.742 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.555 ' HG2' ' O ' ' A' ' 500' ' ' VAL . 6.3 pt20 -100.46 -179.1 4.0 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 109.091 -0.707 . . . . 65.22 109.091 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 21.1 m -74.4 155.41 38.11 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 108.495 -0.928 . . . . 73.2 108.495 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.18 -41.57 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 C-N-CA 122.697 0.399 . . . . 62.23 110.883 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 506' ' ' ASP . . . . . 0.497 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 28.5 t70 -59.69 -43.7 93.93 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.056 0.455 . . . . 61.23 110.162 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 90.2 t -67.99 -46.61 81.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 114.491 -1.231 . . . . 72.43 110.052 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.423 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -59.6 -45.79 90.86 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 123.41 0.444 . . . . 70.4 111.258 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -65.23 -44.49 88.07 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.178 -0.464 . . . . 75.25 111.745 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.567 ' O ' HG23 ' A' ' 514' ' ' VAL . 3.4 ptpp? -67.45 -39.92 85.4 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 119.632 -0.827 . . . . 64.43 111.186 176.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -62.44 -44.27 96.81 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.524 0.678 . . . . 73.2 110.918 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.65 -47.14 86.8 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-N 114.395 -1.275 . . . . 74.3 108.951 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -65.98 -35.23 80.02 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 115.439 -0.8 . . . . 64.33 112.675 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 510' ' ' LYS . 72.5 t -58.45 -33.76 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.115 0.483 . . . . 71.24 110.552 176.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -114.2 11.34 17.47 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.056 0.455 . . . . 74.25 110.117 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -127.47 -59.82 0.13 Allowed Glycine 0 CA--C 1.475 -2.416 0 C-N-CA 120.437 -0.887 . . . . 60.5 113.242 -172.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 66.25 21.55 11.03 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 121.926 0.87 . . . . 73.15 109.134 -172.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.4 p -91.48 -173.57 3.62 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 114.16 -1.382 . . . . 62.42 110.148 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 52.5 mtmt -108.11 143.85 36.28 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.384 -0.969 . . . . 75.52 108.384 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -129.17 151.08 50.23 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 120.866 0.365 . . . . 73.41 111.357 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 67.7 m -140.25 151.5 45.18 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 107.419 -1.326 . . . . 74.34 107.419 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -121.66 124.47 44.38 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.704 0.764 . . . . 64.0 112.334 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -101.43 133.05 46.66 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.999 -1.482 . . . . 75.15 106.999 175.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 22.2 m -118.37 122.12 42.06 Favored 'General case' 0 C--N 1.29 -1.978 0 C-N-CA 120.114 -0.634 . . . . 71.13 111.519 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.9 p -122.41 149.56 25.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.691 -1.226 . . . . 75.33 107.691 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -85.79 136.72 33.21 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 119.808 -0.757 . . . . 64.45 111.636 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 53.1 m -157.47 162.22 27.75 Favored Pre-proline 0 C--N 1.302 -1.486 0 N-CA-C 106.346 -1.724 . . . . 72.33 106.346 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.13 10.26 0.42 Allowed 'Trans proline' 0 CA--C 1.556 1.578 0 C-N-CA 122.343 2.028 . . . . 74.02 114.44 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.552 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 0.6 OUTLIER -95.26 145.77 30.13 Favored Pre-proline 0 CA--C 1.506 -0.716 0 N-CA-C 107.453 -1.314 . . . . 63.33 107.453 175.724 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -64.81 148.38 89.99 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.45 2.1 . . . . 72.11 114.341 -172.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.458 ' HB2' ' H ' ' A' ' 558' ' ' GLY . . . -61.85 113.76 2.96 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-N 114.323 -1.308 . . . . 74.04 110.742 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 126.57 -16.95 6.54 Favored Glycine 0 N--CA 1.42 -2.396 0 C-N-CA 119.918 -1.134 . . . . 64.21 111.768 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -82.92 128.18 34.21 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.28 -0.637 . . . . 75.43 109.28 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 5.3 p -94.36 112.71 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 N-CA-C 107.207 -1.405 . . . . 73.11 107.207 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 29.7 p -102.86 12.81 35.68 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 115.253 -0.885 . . . . 73.12 112.523 -172.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 169.04 172.42 35.77 Favored Glycine 0 N--CA 1.432 -1.616 0 C-N-CA 120.007 -1.092 . . . . 64.43 111.693 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 4.0 p -131.21 146.82 52.48 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.864 -0.791 . . . . 72.33 108.864 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 552' ' ' GLU . 2.8 t-20 -64.44 -51.58 59.19 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 119.784 -0.767 . . . . 75.54 109.872 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 58.8 Cg_endo -75.62 139.75 23.08 Favored 'Trans proline' 0 C--N 1.366 1.457 0 C-N-CA 120.859 1.039 . . . . 65.14 109.975 171.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 540' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 25.2 Cg_exo -64.55 140.53 69.35 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 122.259 1.973 . . . . 54.34 112.834 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -68.15 132.54 47.38 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.452 -0.795 . . . . 72.31 109.752 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.68 -9.07 58.5 Favored Glycine 0 N--CA 1.436 -1.33 0 N-CA-C 111.187 -0.765 . . . . 51.02 111.187 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 91.3 m -86.2 136.83 33.04 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.187 0.518 . . . . 71.25 111.291 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 9.8 t -81.31 125.79 30.78 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.757 -0.831 . . . . 73.21 108.757 174.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.74 161.8 44.32 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 107.89 -1.152 . . . . 72.32 107.89 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -62.54 138.51 70.77 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 120.967 1.112 . . . . 41.42 110.768 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.87 -19.9 24.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 121.376 0.608 . . . . 75.21 111.343 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -96.17 -0.74 49.61 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 121.789 -0.569 . . . . 55.41 110.523 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 10.4 t -86.6 171.95 10.63 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.4 0.619 . . . . 51.14 109.501 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 7.6 p -115.68 137.86 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.296 0 CA-C-N 115.379 -0.828 . . . . 73.12 110.071 -177.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 3.1 mp -94.48 135.1 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 108.342 -0.985 . . . . 75.05 108.342 175.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 552' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 538' ' ' ASN . 6.3 tp10 -102.46 117.32 34.46 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.695 -1.224 . . . . 72.34 107.695 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -91.58 121.45 33.27 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.43 -0.952 . . . . 72.12 108.43 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -89.9 101.99 14.69 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.641 -1.244 . . . . 73.24 107.641 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 524' ' ' SER . 38.4 t -101.31 136.83 31.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-N 115.223 -0.899 . . . . 73.01 110.025 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 59.7 m -91.71 128.18 37.45 Favored 'General case' 0 N--CA 1.41 -2.469 0 CA-C-N 115.973 -0.558 . . . . 71.03 109.744 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -90.58 142.93 27.25 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 105.904 -1.887 . . . . 74.44 105.904 169.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -54.48 -24.07 29.74 Favored Glycine 0 CA--C 1.479 -2.182 0 O-C-N 125.145 1.528 . . . . 35.31 115.25 -168.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 74.43 -22.74 0.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.441 1.097 . . . . 73.33 110.794 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.583 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 44.3 mt-30 -113.37 148.31 36.03 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-O 121.488 0.661 . . . . 61.23 111.461 -172.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -125.53 158.02 35.58 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.886 -1.052 . . . . 63.52 108.835 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.88 125.12 22.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 121.315 0.578 . . . . 65.21 111.127 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 20.2 ttt -75.42 125.83 88.34 Favored Pre-proline 0 N--CA 1.427 -1.601 0 CA-C-N 115.356 -0.838 . . . . 73.43 110.988 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.06 169.74 20.68 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 123.039 2.493 . . . . 64.14 111.799 177.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -75.29 130.04 38.41 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.682 0.753 . . . . 61.05 112.036 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 566' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 569' ' ' MET . 2.6 pp -141.27 18.26 2.24 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 123.021 1.391 . . . . 74.31 107.823 174.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 7.3 m -79.14 132.2 36.48 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 113.283 -1.781 . . . . 60.41 111.174 -173.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 568' ' ' GLY . . . . . 0.408 ' H ' ' CG1' ' A' ' 603' ' ' VAL . . . 64.54 39.66 96.99 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.541 -0.754 . . . . 72.45 114.29 174.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 569' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 16.0 ptp -128.89 -177.34 4.17 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 117.312 0.556 . . . . 55.4 109.933 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 570' ' ' PHE . . . . . 0.554 ' HA ' ' O ' ' A' ' 601' ' ' ASN . 49.3 m-85 -93.53 163.44 13.57 Favored 'General case' 0 C--O 1.25 1.083 0 N-CA-C 108.202 -1.036 . . . . 75.24 108.202 -178.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 571' ' ' TRP . . . . . 0.474 ' CH2' HD13 ' A' ' 587' ' ' LEU . 16.3 t-105 -63.07 -32.16 73.47 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.166 -1.05 . . . . 64.14 108.166 174.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.75 -10.48 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.471 -0.786 . . . . 63.42 111.159 -176.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -101.36 -43.9 5.8 Favored 'General case' 0 C--O 1.256 1.401 0 N-CA-C 108.09 -1.078 . . . . 73.33 108.09 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 574' ' ' ALA . . . . . 0.517 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -62.82 -51.44 67.05 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.326 -1.306 . . . . 74.22 111.945 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.562 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 37.8 tt0 -51.75 -54.1 43.64 Favored Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 112.395 0.517 . . . . 75.2 112.395 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 52.9 Cg_exo -59.55 -38.29 83.47 Favored 'Trans proline' 0 C--N 1.38 2.237 0 C-N-CA 121.972 1.782 . . . . 73.43 112.721 177.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -66.76 -37.14 84.04 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 120.381 -0.528 . . . . 72.23 112.198 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.585 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 89.7 mt -66.75 -47.49 72.08 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.898 -0.592 . . . . 75.0 110.529 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -65.59 -34.52 78.43 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.635 -0.426 . . . . 71.15 111.048 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.24 -32.02 71.92 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.953 0.406 . . . . 74.31 110.943 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 578' ' ' LEU . 2.8 pp -80.89 -6.92 59.27 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.537 -0.465 . . . . 72.3 110.033 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 85.6 34.86 12.65 Favored Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 115.833 -0.621 . . . . 65.14 112.878 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.43 ' CZ3' HD13 ' A' ' 578' ' ' LEU . 21.3 t90 -67.19 130.6 43.64 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.544 0.172 . . . . 75.21 111.054 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 62.8 p -103.24 -23.14 13.63 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-O 120.987 0.422 . . . . 72.55 112.023 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -75.98 -175.92 39.82 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-O 121.72 0.622 . . . . 62.33 114.359 -174.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 54.3 ttp -115.05 141.35 48.12 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.951 -0.625 . . . . 74.43 109.753 -176.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 587' ' ' LEU . . . . . 0.474 HD13 ' CH2' ' A' ' 571' ' ' TRP . 5.5 tt -85.64 125.68 33.34 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.061 0.457 . . . . 64.1 110.074 -175.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -95.89 104.35 16.28 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.543 -0.753 . . . . 74.12 110.333 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.467 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -112.16 133.51 54.25 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.138 -1.43 . . . . 62.54 107.138 173.209 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -111.68 -42.33 1.04 Allowed Glycine 0 C--N 1.284 -2.318 0 C-N-CA 119.874 -1.155 . . . . 74.53 113.993 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.4 135.64 33.86 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 120.569 -0.453 . . . . 63.14 111.379 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -90.86 124.44 35.17 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 105.954 -1.869 . . . . 70.0 105.954 172.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 593' ' ' VAL . . . . . 0.491 ' O ' ' HG2' ' A' ' 626' ' ' GLN . 46.3 t -104.81 156.26 6.02 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 N-CA-C 109.049 -0.723 . . . . 74.31 109.049 -174.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 594' ' ' ASP . . . . . 0.448 ' HA ' ' HG2' ' A' ' 626' ' ' GLN . 1.6 p-10 -71.49 126.94 30.99 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.298 0.571 . . . . 73.1 109.894 -176.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -148.36 -57.09 0.22 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.953 -1.021 . . . . 74.42 109.318 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 116.34 124.57 3.66 Favored Glycine 0 N--CA 1.426 -2.005 0 C-N-CA 120.638 -0.791 . . . . 65.33 111.764 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -63.64 -35.96 92.72 Favored Glycine 0 C--N 1.316 -0.542 0 N-CA-C 112.113 -0.395 . . . . 75.2 112.113 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 6.5 m -76.04 -24.02 55.15 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-O 122.014 0.911 . . . . 64.11 108.99 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -87.96 -2.41 58.59 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.607 -1.179 . . . . 73.13 109.343 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 600' ' ' HIS . . . . . 0.539 ' HB3' ' CE2' ' A' ' 570' ' ' PHE . 30.6 m80 81.56 125.19 0.04 OUTLIER 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.41 1.884 . . . . 74.14 111.952 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 601' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 570' ' ' PHE . 8.5 p30 -73.57 96.23 2.41 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 122.597 1.189 . . . . 74.51 109.42 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 21.4 mmm-85 -100.17 151.49 21.36 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 107.351 -1.351 . . . . 74.53 107.351 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.408 ' CG1' ' H ' ' A' ' 568' ' ' GLY . 8.1 p -65.58 131.68 31.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 106.971 -1.492 . . . . 55.22 106.971 172.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.61 -26.21 3.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 120.112 -0.635 . . . . 71.5 111.895 -174.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -155.6 138.21 15.1 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.949 -0.76 . . . . 72.45 108.949 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -133.64 139.5 46.52 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.524 -1.288 . . . . 72.5 107.524 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.43 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 26.3 t-20 -71.99 -51.47 8.45 Favored Pre-proline 0 C--N 1.307 -1.246 0 C-N-CA 119.627 -0.829 . . . . 74.13 111.152 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 74.6 Cg_endo -92.3 122.19 0.58 Allowed 'Trans proline' 0 N--CA 1.442 -1.516 0 C-N-CA 121.111 1.207 . . . . 73.21 111.332 174.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -70.35 153.35 66.29 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 121.77 1.646 . . . . 75.31 110.11 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -65.36 133.08 50.6 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.266 -0.642 . . . . 60.33 109.266 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.15 -7.68 44.27 Favored Glycine 0 C--N 1.314 -0.656 0 C-N-CA 120.786 -0.721 . . . . 73.54 111.481 -176.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 19.5 m -88.16 155.59 19.69 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.532 -0.914 . . . . 71.02 108.532 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.54 126.53 7.51 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 111.116 -0.794 . . . . 74.24 111.116 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 18.5 m -113.84 141.97 28.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.609 -0.515 . . . . 63.15 109.609 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.583 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.3 p-10 -53.4 167.94 0.18 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.682 1.193 . . . . 72.34 113.16 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -57.68 -24.66 57.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.533 -0.758 . . . . 73.45 112.98 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.451 ' OD2' ' HB ' ' A' ' 619' ' ' ILE . 28.2 t70 -82.47 -9.49 59.41 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.493 -0.483 . . . . 72.51 109.703 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.63 18.3 67.89 Favored Glycine 0 CA--C 1.506 -0.525 0 CA-C-N 116.094 -0.503 . . . . 53.05 112.649 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 619' ' ' ILE . . . . . 0.451 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -69.86 119.5 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-O 122.269 1.033 . . . . 73.43 111.329 -167.788 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.447 ' O ' HD12 ' A' ' 620' ' ' ILE . 2.6 pp -116.98 131.3 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.067 0 CA-C-N 114.703 -1.135 . . . . 72.54 111.191 177.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 54.4 m -104.68 117.88 35.19 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.549 -0.908 . . . . 73.32 108.549 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.6 pp -139.72 165.82 26.25 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.602 -0.272 . . . . 72.35 111.16 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -139.47 140.9 37.39 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.647 -0.871 . . . . 74.35 108.647 174.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -128.0 166.44 18.38 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 116.216 -0.447 . . . . 74.43 111.192 -171.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -71.77 153.34 50.08 Favored Glycine 0 N--CA 1.428 -1.864 0 CA-C-N 115.524 -0.762 . . . . 65.04 113.529 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 593' ' ' VAL . 13.0 pt20 . . . . . 0 C--N 1.299 -1.593 0 C-N-CA 123.514 0.726 . . . . 51.1 110.171 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.595 0 CA-C-O 121.152 0.501 . . . . 63.11 109.916 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.9 p -135.55 149.41 49.43 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.65 -0.705 . . . . 74.11 110.711 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.452 ' HE2' ' H ' ' A' ' 496' ' ' ASP . 0.1 OUTLIER -150.6 132.61 15.21 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.259 -1.756 . . . . 65.52 106.259 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.3 p-10 -81.47 133.1 35.35 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.149 0.5 . . . . 74.35 110.349 175.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.1 pt -86.09 138.22 34.86 Favored Pre-proline 0 C--N 1.304 -1.383 0 CA-C-N 115.465 -0.789 . . . . 74.13 111.886 -177.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.64 178.41 7.61 Favored 'Trans proline' 0 C--O 1.245 0.832 0 C-N-CA 122.408 2.072 . . . . 74.43 112.009 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -80.07 96.99 6.65 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 122.627 1.203 . . . . 73.33 110.446 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.64 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 28.5 m -95.39 -1.07 10.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 CA-C-N 115.313 -0.858 . . . . 65.1 111.828 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -76.12 107.27 8.23 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 108.738 -0.838 . . . . 43.43 108.738 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 142.71 -30.17 2.08 Favored Glycine 0 C--N 1.299 -1.494 0 C-N-CA 120.746 -0.74 . . . . 62.42 112.791 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -100.35 -177.88 3.64 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 120.109 -0.636 . . . . 70.42 110.501 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.407 ' HB ' HG23 ' A' ' 507' ' ' VAL . 2.8 m -70.34 155.61 40.43 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.565 -0.532 . . . . 65.44 109.565 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.432 ' HA ' ' CG2' ' A' ' 534' ' ' VAL . 5.9 p -55.04 -46.32 77.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 123.394 0.678 . . . . 71.44 112.1 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.69 -39.18 90.51 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.898 -0.592 . . . . 64.55 110.543 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.407 HG23 ' HB ' ' A' ' 504' ' ' THR . 59.9 t -73.07 -49.01 41.61 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.258 0 CA-C-N 115.337 -0.847 . . . . 74.21 109.888 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.64 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -58.73 -44.8 90.54 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 122.994 0.518 . . . . 62.34 110.972 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -64.99 -45.68 84.61 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.367 -0.378 . . . . 74.21 111.304 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.543 ' O ' HG23 ' A' ' 514' ' ' VAL . 17.8 ptpt -68.0 -37.86 81.97 Favored 'General case' 0 C--O 1.21 -1.0 0 C-N-CA 120.656 -0.418 . . . . 72.5 111.254 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.04 -48.4 81.86 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 123.4 0.437 . . . . 71.13 110.517 -177.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -68.71 -36.21 78.14 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 120.259 -0.577 . . . . 74.13 110.886 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.444 ' N ' HD12 ' A' ' 512' ' ' LEU . 17.0 t30 -66.14 -35.59 80.88 Favored 'General case' 0 C--O 1.203 -1.376 0 C-N-CA 123.783 0.833 . . . . 75.22 110.505 -178.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 510' ' ' LYS . 75.9 t -60.94 -33.41 55.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.95 0.405 . . . . 63.14 111.11 177.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -102.51 -4.67 24.99 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.145 -0.622 . . . . 71.0 111.014 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -122.85 -50.84 0.22 Allowed Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 120.427 -0.892 . . . . 64.05 113.544 -171.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 67.5 27.18 8.02 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 122.515 1.15 . . . . 74.01 109.337 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.7 p -80.29 -167.09 1.2 Allowed 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 113.027 -1.897 . . . . 63.12 110.981 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -119.2 142.79 47.69 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.595 -1.261 . . . . 71.31 107.595 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -132.65 153.41 51.12 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 112.545 0.572 . . . . 71.53 112.545 -175.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.7 m -132.65 151.51 51.94 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.057 -1.461 . . . . 71.34 107.057 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -124.27 133.36 53.51 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 109.179 -0.674 . . . . 64.14 109.179 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -125.41 116.1 21.33 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.221 -1.029 . . . . 62.44 108.221 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 23.9 m -98.46 124.97 43.48 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.13 0.491 . . . . 73.15 111.053 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 11.0 p -126.56 154.19 36.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.799 -1.185 . . . . 74.22 107.799 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.93 135.63 35.38 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.34 0.59 . . . . 71.2 110.183 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 50.3 m -167.65 139.13 2.47 Favored Pre-proline 0 C--O 1.197 -1.68 0 N-CA-C 105.097 -2.186 . . . . 43.54 105.097 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.43 9.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.566 2.124 0 C-N-CA 123.466 2.777 . . . . 72.15 116.997 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.23 147.07 63.93 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 106.338 -1.727 . . . . 74.23 106.338 172.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.72 141.56 95.62 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.194 1.93 . . . . 75.3 112.921 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 557' ' ' LYS . . . -61.69 116.12 4.53 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 114.811 -1.086 . . . . 65.13 112.128 -176.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 121.46 -16.24 9.12 Favored Glycine 0 N--CA 1.423 -2.226 0 CA-C-N 115.044 -0.98 . . . . 71.44 111.538 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -77.47 128.28 33.95 Favored 'General case' 0 C--O 1.248 1.012 0 N-CA-C 109.328 -0.619 . . . . 74.21 109.328 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.432 ' CG2' ' HA ' ' A' ' 505' ' ' VAL . 38.0 t -86.1 112.43 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.165 0 N-CA-C 106.952 -1.499 . . . . 53.45 106.952 173.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 17.4 p -84.33 -2.42 57.04 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.594 0.712 . . . . 64.02 111.209 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.66 179.43 27.33 Favored Glycine 0 N--CA 1.419 -2.491 0 C-N-CA 120.606 -0.806 . . . . 65.54 112.435 174.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 1.6 p -116.69 158.05 24.43 Favored 'General case' 0 C--N 1.271 -2.825 0 N-CA-C 106.694 -1.595 . . . . 54.13 106.694 177.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -60.43 -49.5 89.97 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 118.794 -1.162 . . . . 71.43 112.015 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 38.8 Cg_endo -73.61 128.8 12.97 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 N-CA-C 108.238 -1.485 . . . . 33.33 108.238 167.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 540' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 24.9 Cg_exo -63.72 155.93 60.53 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 122.501 2.134 . . . . 64.44 113.126 -177.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.05 129.63 43.08 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.245 0.618 . . . . 65.15 110.152 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.2 -15.22 54.8 Favored Glycine 0 N--CA 1.435 -1.422 0 N-CA-C 111.715 -0.554 . . . . 54.44 111.715 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 37.6 m -76.27 134.1 39.88 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.939 0.4 . . . . 70.11 111.407 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.0 t -76.53 124.06 27.02 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.45 -0.945 . . . . 64.31 108.45 173.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.04 160.72 50.77 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 108.14 -1.059 . . . . 54.34 108.14 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.48 136.84 26.89 Favored 'Trans proline' 0 N--CA 1.435 -1.952 0 CA-C-N 119.627 0.903 . . . . 72.01 110.218 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.17 -19.85 26.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.764 0.792 . . . . 74.24 110.943 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -89.64 -7.71 54.11 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.058 -0.974 . . . . 74.41 110.812 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.4 t -88.08 167.51 13.6 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.46 0.648 . . . . 70.15 109.887 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 9.8 p -108.73 121.25 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 CA-C-N 115.266 -0.879 . . . . 74.02 109.254 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 58.5 mt -87.24 133.14 30.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 115.298 -0.864 . . . . 74.41 110.045 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.15 117.6 34.91 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.763 0.792 . . . . 73.32 111.85 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.404 HD12 HG11 ' A' ' 534' ' ' VAL . 3.4 mm? -92.36 114.01 26.43 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 113.614 -1.63 . . . . 73.12 108.862 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -85.35 104.86 15.56 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.75 0.786 . . . . 61.55 109.766 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 524' ' ' SER . 23.7 t -92.96 132.8 36.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 114.667 -1.151 . . . . 71.15 108.171 -177.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 53.0 m -105.47 135.83 46.15 Favored 'General case' 0 N--CA 1.409 -2.516 0 CA-C-O 121.244 0.545 . . . . 42.34 111.093 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.0 ptpt -116.57 128.01 55.02 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 108.107 -1.071 . . . . 64.42 108.107 174.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -58.71 -24.81 57.8 Favored Glycine 0 CA--C 1.496 -1.125 0 O-C-N 123.877 0.735 . . . . 21.2 111.37 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 559' ' ' ASN . . . . . 0.425 ' ND2' ' HB3' ' A' ' 616' ' ' ARG . 65.0 t30 63.88 28.03 14.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 122.846 1.308 . . . . 64.14 109.063 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.517 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 82.7 mt-30 -112.5 151.03 30.43 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 113.725 -1.58 . . . . 74.33 108.333 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -130.42 147.42 52.12 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 109.254 -0.647 . . . . 74.45 109.254 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.93 120.07 13.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 O-C-N 123.896 0.748 . . . . 73.15 109.683 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.615 ' SD ' HG21 ' A' ' 620' ' ' ILE . 42.9 ttp -83.17 129.08 62.35 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 116.26 -0.427 . . . . 62.33 111.158 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 564' ' ' PRO . . . . . 0.426 ' O ' ' HG2' ' A' ' 563' ' ' MET . 57.9 Cg_endo -73.76 169.57 22.05 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.547 2.165 . . . . 71.32 110.317 174.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -76.93 135.31 38.76 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.383 0.611 . . . . 73.2 111.259 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 566' ' ' LEU . . . . . 0.415 ' O ' ' HG2' ' A' ' 569' ' ' MET . 0.9 OUTLIER -114.53 -14.98 12.08 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.326 -0.99 . . . . 62.14 108.326 -177.259 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 567' ' ' SER . . . . . 0.404 ' HA ' ' HB ' ' A' ' 603' ' ' VAL . 33.2 t -77.47 147.39 35.92 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.585 -0.697 . . . . 70.13 110.91 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 96.26 11.01 55.37 Favored Glycine 0 CA--C 1.501 -0.798 0 CA-C-N 115.806 -0.634 . . . . 75.52 113.411 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 569' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 19.2 ptm -133.49 169.11 17.46 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.749 -0.463 . . . . 62.15 109.749 177.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 570' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 601' ' ' ASN . 10.9 m-85 -89.52 158.25 17.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.683 -0.858 . . . . 74.25 108.683 -176.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 571' ' ' TRP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 29.0 t-105 -65.6 -25.05 67.23 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.189 -0.671 . . . . 74.34 109.189 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 23.0 m -69.22 -26.99 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 115.599 -0.728 . . . . 51.22 112.497 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 12.0 t70 -101.85 -23.45 14.17 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 108.538 -0.912 . . . . 74.23 108.538 175.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 574' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 577' ' ' ARG . . . -61.98 -46.73 87.96 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 115.531 -0.759 . . . . 54.5 112.341 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.476 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 0.9 OUTLIER -60.31 -49.19 91.65 Favored Pre-proline 0 CA--C 1.565 1.532 0 C-N-CA 120.279 -0.568 . . . . 62.3 110.199 179.422 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 62.5 Cg_exo -52.59 -29.78 42.36 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.328 2.019 . . . . 72.02 113.328 169.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 10.4 mmm180 -62.57 -39.53 93.97 Favored 'General case' 0 C--O 1.21 -1.007 0 O-C-N 121.791 -0.568 . . . . 41.32 110.47 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.788 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 9.6 mp -58.84 -49.65 76.94 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.155 0.503 . . . . 62.22 110.615 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' A' ' 576' ' ' PRO . 14.4 ptp180 -66.74 -38.37 86.52 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.388 -0.823 . . . . 64.23 112.389 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.29 -35.7 73.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.982 0.42 . . . . 42.31 111.583 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 6.0 tp -81.7 -9.67 59.58 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 123.892 0.877 . . . . 64.22 110.801 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 66.05 39.8 94.89 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.905 -0.878 . . . . 43.24 110.905 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.788 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 7.3 t90 -79.69 127.52 32.29 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 108.528 -0.916 . . . . 72.31 108.528 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 584' ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' ' 617' ' ' ASP . 0.8 OUTLIER -78.62 -39.7 36.48 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 125.345 1.458 . . . . 75.32 112.78 -176.693 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -77.92 -162.01 17.92 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.929 -0.578 . . . . 71.03 111.759 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 65.8 mtt -133.82 160.76 36.64 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 122.426 -0.456 . . . . 72.14 109.867 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 22.7 tp -80.53 111.06 16.59 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.853 -1.166 . . . . 64.4 107.853 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 621' ' ' THR . 22.6 t70 -99.51 112.63 24.81 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.073 -0.512 . . . . 63.23 111.198 -172.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.88 133.61 34.23 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 118.848 -1.141 . . . . 45.32 109.975 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.71 -63.84 1.8 Allowed Glycine 0 C--N 1.296 -1.663 0 N-CA-C 110.998 -0.841 . . . . 60.15 110.998 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -137.04 145.12 43.64 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 121.012 0.434 . . . . 71.45 109.965 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -91.79 127.38 37.23 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.4 -1.704 . . . . 62.34 106.4 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 61.3 t -102.98 125.63 57.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 108.328 -0.99 . . . . 60.43 108.328 -175.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -72.31 107.99 5.21 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 121.491 0.662 . . . . 75.41 109.802 -173.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -123.56 -54.47 1.76 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.572 -0.74 . . . . 72.32 110.957 -175.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 104.18 147.55 17.45 Favored Glycine 0 N--CA 1.413 -2.879 0 N-CA-C 109.636 -1.386 . . . . 70.4 109.636 -173.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.74 -33.08 62.49 Favored Glycine 0 C--N 1.309 -0.921 0 N-CA-C 113.875 0.31 . . . . 52.13 113.875 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 11.8 m -68.33 -24.06 64.79 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 123.918 0.887 . . . . 73.1 110.879 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -88.6 -1.85 58.28 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.317 -0.856 . . . . 73.53 110.303 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 41.5 m80 74.5 121.23 0.04 OUTLIER 'General case' 0 C--O 1.242 0.689 0 C-N-CA 125.527 1.531 . . . . 64.52 111.952 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 601' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 570' ' ' PHE . 21.2 m120 -82.4 63.4 6.55 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 115.493 -0.776 . . . . 72.12 111.497 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -95.55 160.5 14.48 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.397 -0.82 . . . . 75.23 109.729 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.411 HG11 HD12 ' A' ' 622' ' ' LEU . 72.7 t -71.11 130.37 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.104 0 N-CA-C 105.144 -2.169 . . . . 70.11 105.144 169.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.7 m -102.69 -28.6 3.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 120.284 -0.567 . . . . 73.23 111.763 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -157.08 135.81 11.58 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 116.62 -0.264 . . . . 70.21 111.049 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -111.62 128.95 56.21 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.731 -1.211 . . . . 72.43 107.731 170.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.472 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 8.4 t30 -57.78 -52.37 74.9 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 112.206 0.447 . . . . 63.24 112.206 -176.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 5.2 Cg_exo -83.65 122.74 3.15 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 121.823 1.682 . . . . 72.4 109.318 171.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.02 155.8 61.13 Favored 'Trans proline' 0 C--O 1.258 1.484 0 C-N-CA 122.859 2.373 . . . . 74.45 113.848 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.53 138.72 58.3 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.436 -0.802 . . . . 51.25 109.599 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 103.53 -11.64 54.04 Favored Glycine 0 C--N 1.298 -1.531 0 C-N-CA 120.438 -0.887 . . . . 74.42 111.864 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 17.2 m -83.48 141.97 31.26 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.377 -0.601 . . . . 71.32 109.377 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.69 113.9 3.75 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.109 -1.196 . . . . 22.34 110.109 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.5 m -102.01 142.67 16.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 O-C-N 122.982 -0.128 . . . . 71.33 110.667 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.517 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 0.7 OUTLIER -50.33 164.78 0.11 Allowed 'General case' 0 C--O 1.21 -0.982 0 N-CA-C 113.465 0.913 . . . . 44.21 113.465 177.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 616' ' ' ARG . . . . . 0.425 ' HB3' ' ND2' ' A' ' 559' ' ' ASN . 14.9 ptm180 -48.74 -27.89 3.24 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.66 1.726 . . . . 75.25 115.66 -171.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.477 ' HA ' ' OG1' ' A' ' 584' ' ' THR . 20.0 p-10 -97.2 -7.06 33.27 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.545 -0.462 . . . . 72.31 111.287 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.0 17.14 65.14 Favored Glycine 0 C--O 1.215 -1.058 0 CA-C-O 119.657 -0.524 . . . . 62.43 114.311 167.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.49 119.09 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-O 121.716 0.77 . . . . 70.41 110.768 -168.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.615 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.6 pp -129.35 134.05 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-N 115.277 -0.874 . . . . 74.25 111.31 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 13.1 t -99.03 130.42 45.36 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.45 -0.795 . . . . 74.12 108.984 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.411 HD12 HG11 ' A' ' 603' ' ' VAL . 1.7 pt? -139.59 167.91 21.03 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.671 -0.695 . . . . 65.41 111.76 -174.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -127.07 140.74 52.06 Favored 'General case' 0 C--O 1.256 1.41 0 N-CA-C 109.045 -0.724 . . . . 72.14 109.045 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -139.26 165.75 26.36 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.465 -0.334 . . . . 63.51 110.354 -175.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -78.64 139.47 22.3 Favored Glycine 0 N--CA 1.434 -1.467 0 O-C-N 123.677 0.611 . . . . 32.44 113.328 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 C--N 1.288 -2.108 0 C-N-CA 125.525 1.53 . . . . 72.4 107.881 -179.301 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.744 0 CA-C-O 121.044 0.449 . . . . 64.33 110.589 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.437 HG22 ' HA ' ' A' ' 546' ' ' PRO . 25.9 p -140.12 145.36 37.49 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 110.043 -0.354 . . . . 74.13 110.043 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -139.64 155.51 47.37 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.428 -1.323 . . . . 73.24 107.428 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.596 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.4 p-10 -98.15 144.26 27.8 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.203 -0.599 . . . . 64.34 110.749 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.1 pt -87.09 137.42 33.05 Favored Pre-proline 0 C--N 1.295 -1.781 0 CA-C-N 115.073 -0.967 . . . . 75.15 111.592 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -85.03 -176.03 2.26 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.551 2.168 . . . . 74.12 111.053 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -86.22 114.94 23.45 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.18 0.514 . . . . 72.33 109.793 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.529 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 17.5 m -119.73 58.78 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-O 122.746 1.26 . . . . 61.34 110.422 175.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -118.73 107.47 13.7 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.181 -1.372 . . . . 53.42 108.677 174.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 142.42 -25.38 2.32 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 118.972 -1.585 . . . . 44.1 113.734 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -101.74 -174.68 2.65 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 117.782 0.791 . . . . 43.12 109.858 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.448 ' HB ' HG23 ' A' ' 507' ' ' VAL . 7.5 m -73.13 155.5 39.61 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.895 -1.15 . . . . 73.53 107.895 178.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.542 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.4 p -60.2 -44.72 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 111.715 0.265 . . . . 64.24 111.715 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.12 -36.11 82.96 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 120.543 -0.463 . . . . 54.13 110.084 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.448 HG23 ' HB ' ' A' ' 504' ' ' THR . 68.4 t -68.9 -45.38 80.66 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.445 0 CA-C-N 115.616 -0.72 . . . . 74.2 109.257 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.529 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -60.29 -42.95 96.56 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 123.228 0.33 . . . . 72.42 110.538 177.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.542 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 96.0 mt-30 -63.46 -43.22 97.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.011 -0.366 . . . . 74.15 110.011 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 514' ' ' VAL . 46.0 mmtm -64.48 -43.91 92.67 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.443 0.639 . . . . 70.31 109.792 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -61.95 -48.26 81.21 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.109 -1.405 . . . . 75.4 110.13 -175.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.2 pp -69.65 -35.78 75.49 Favored 'General case' 0 C--O 1.208 -1.082 0 CA-C-N 115.509 -0.769 . . . . 75.43 110.862 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 33.4 t30 -61.44 -35.32 77.24 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 123.925 0.89 . . . . 74.12 110.105 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 510' ' ' LYS . 97.7 t -59.18 -38.0 71.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.872 0.368 . . . . 70.31 111.298 178.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -108.22 10.26 27.89 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.628 -0.508 . . . . 62.52 109.628 -176.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -132.66 -56.74 0.08 OUTLIER Glycine 0 N--CA 1.428 -1.835 0 C-N-CA 120.074 -1.06 . . . . 75.01 113.813 -172.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 63.41 23.21 13.62 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 122.055 0.931 . . . . 72.21 110.082 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.479 HG22 ' HA ' ' A' ' 547' ' ' VAL . 1.0 OUTLIER -83.72 -174.8 5.49 Favored 'General case' 0 N--CA 1.412 -2.327 0 C-N-CA 125.984 1.714 . . . . 63.23 110.669 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 0.4 OUTLIER -107.74 141.89 38.6 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.357 -1.349 . . . . 74.15 107.357 178.107 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -133.05 148.37 52.21 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.056 0.455 . . . . 70.15 112.192 -175.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 48.4 m -141.48 155.39 45.84 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.57 -0.9 . . . . 65.24 108.57 173.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -116.92 139.29 50.81 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.07 0.462 . . . . 75.14 111.493 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -122.37 118.71 29.07 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.333 -1.358 . . . . 70.23 107.333 176.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 11.6 m -103.93 127.32 51.46 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 120.689 -0.404 . . . . 61.04 111.493 -174.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 14.3 p -121.08 156.7 24.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.883 -1.155 . . . . 63.52 107.883 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -70.85 135.15 47.88 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-O 120.84 0.353 . . . . 75.15 110.647 -176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 65.9 m -165.04 158.07 14.05 Favored Pre-proline 0 C--N 1.31 -1.148 0 N-CA-C 107.667 -1.235 . . . . 74.14 107.667 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -66.25 -15.05 46.9 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.332 2.022 . . . . 65.21 113.257 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.66 140.22 81.32 Favored Pre-proline 0 CA--C 1.519 -0.225 0 N-CA-C 108.936 -0.765 . . . . 70.23 108.936 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.56 146.28 97.07 Favored 'Trans proline' 0 C--O 1.252 1.192 0 C-N-CA 122.764 2.31 . . . . 65.42 112.888 -175.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -59.82 110.95 1.28 Allowed 'General case' 0 C--O 1.244 0.813 0 CA-C-N 115.29 -0.868 . . . . 74.35 110.883 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 136.03 -20.86 3.56 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 120.569 -0.824 . . . . 62.33 112.129 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -82.79 132.91 35.15 Favored 'General case' 0 C--O 1.248 1.019 0 CA-C-O 121.15 0.5 . . . . 74.12 110.673 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.44 HG11 ' CB ' ' A' ' 508' ' ' ALA . 7.3 p -99.32 119.64 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.533 0 N-CA-C 107.902 -1.147 . . . . 75.34 107.902 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.5 p -98.77 12.92 34.12 Favored 'General case' 0 C--N 1.274 -2.694 0 CA-C-N 115.107 -0.951 . . . . 72.35 113.301 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 143.23 -176.93 22.43 Favored Glycine 0 CA--C 1.493 -1.296 0 C-N-CA 120.433 -0.889 . . . . 73.23 112.196 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 7.0 p -117.41 157.1 26.78 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.372 -0.973 . . . . 55.25 108.372 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.409 ' HB2' ' OE2' ' A' ' 552' ' ' GLU . 44.3 t-20 -56.5 -58.22 18.4 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 119.983 -0.687 . . . . 71.34 110.689 175.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.96 140.75 32.06 Favored 'Trans proline' 0 C--N 1.365 1.422 0 CA-C-N 120.63 1.261 . . . . 73.11 109.965 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.57 156.48 63.74 Favored 'Trans proline' 0 C--O 1.252 1.18 0 C-N-CA 122.466 2.111 . . . . 65.12 112.348 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.58 137.62 58.3 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.015 -0.539 . . . . 54.22 110.798 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.1 -16.13 50.32 Favored Glycine 0 CA--C 1.492 -1.347 0 N-CA-C 111.485 -0.646 . . . . 51.32 111.485 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 71.0 m -74.05 122.95 23.47 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 109.945 -0.391 . . . . 74.04 109.945 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.3 t -80.43 124.62 29.06 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 108.473 -0.936 . . . . 70.34 108.473 176.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.7 m -122.72 156.58 61.54 Favored Pre-proline 0 C--N 1.294 -1.835 0 N-CA-C 107.468 -1.308 . . . . 73.23 107.468 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.437 ' HA ' HG22 ' A' ' 494' ' ' THR . 5.2 Cg_exo -67.67 138.47 45.4 Favored 'Trans proline' 0 N--CA 1.436 -1.894 0 C-N-CA 121.68 1.587 . . . . 75.12 111.82 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.479 ' HA ' HG22 ' A' ' 518' ' ' THR . 7.5 p -63.79 -20.53 26.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 115.087 -0.961 . . . . 51.1 111.455 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -87.79 -17.46 31.53 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.882 0.372 . . . . 72.11 110.488 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 53.3 m -88.07 159.61 18.17 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-O 122.312 1.053 . . . . 53.23 113.304 -173.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 68.9 t -89.85 129.49 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 CA-C-N 113.204 -1.816 . . . . 64.22 110.267 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 56.0 mt -91.57 140.59 15.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.727 -1.212 . . . . 51.3 107.727 176.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 552' ' ' GLU . . . . . 0.409 ' OE2' ' HB2' ' A' ' 538' ' ' ASN . 21.9 tt0 -103.26 117.7 35.11 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 110.339 -0.245 . . . . 72.33 110.339 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.3 mp -99.76 123.22 43.8 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 123.851 0.72 . . . . 55.21 110.016 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -85.95 106.89 17.46 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 123.472 0.709 . . . . 65.21 109.193 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 524' ' ' SER . 42.8 t -105.63 144.96 14.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.479 -0.782 . . . . 74.13 109.492 -176.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.549 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 46.8 m -93.35 126.92 38.73 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 116.077 -0.511 . . . . 64.11 109.961 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -99.01 131.43 45.06 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 106.175 -1.787 . . . . 74.24 106.175 169.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -62.92 -24.25 66.56 Favored Glycine 0 CA--C 1.492 -1.394 0 O-C-N 124.673 1.233 . . . . 70.25 114.271 -170.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 75.15 -27.02 0.19 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.52 1.128 . . . . 70.21 111.199 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.516 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 59.9 mt-30 -111.92 163.53 14.12 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 115.713 -0.676 . . . . 73.22 110.646 -172.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -141.09 157.28 45.52 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.895 -1.048 . . . . 71.51 108.841 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.22 126.75 33.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.931 -0.396 . . . . 72.52 109.931 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.454 ' SD ' HG21 ' A' ' 620' ' ' ILE . 49.5 ttp -94.23 137.13 22.92 Favored Pre-proline 0 C--N 1.314 -0.958 0 N-CA-C 111.946 0.351 . . . . 73.14 111.946 -176.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.25 169.81 21.36 Favored 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 122.861 2.374 . . . . 73.55 111.261 173.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -84.79 140.65 31.06 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.796 -0.446 . . . . 65.42 109.796 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 566' ' ' LEU . . . . . 0.448 ' O ' ' HG2' ' A' ' 569' ' ' MET . 2.4 pp -138.73 16.62 2.69 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.622 0.725 . . . . 74.31 111.471 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 60.1 p -79.8 150.28 30.79 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.453 -0.573 . . . . 71.34 109.453 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 568' ' ' GLY . . . . . 0.408 ' O ' ' HD2' ' A' ' 602' ' ' ARG . . . 85.32 29.95 26.29 Favored Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 120.077 -1.059 . . . . 71.12 113.289 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 569' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 19.8 ptp -131.84 -176.1 3.94 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.796 -0.816 . . . . 75.4 108.796 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -109.53 165.43 11.67 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.149 -1.426 . . . . 54.11 107.149 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -64.78 -30.45 71.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.41 0.624 . . . . 74.12 109.348 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.6 p -72.37 -10.97 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.882 0.849 . . . . 74.3 109.955 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 45.8 t0 -101.7 -40.84 6.79 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.974 -1.121 . . . . 75.44 107.974 174.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.29 -42.53 95.66 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.067 -0.97 . . . . 71.13 112.817 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.691 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 32.8 tt0 -59.7 -53.24 67.57 Favored Pre-proline 0 CA--C 1.567 1.628 0 C-N-CA 120.236 -0.586 . . . . 64.32 110.977 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 80.2 Cg_exo -56.32 -32.32 87.86 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 121.812 1.675 . . . . 72.0 112.716 172.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 3.6 mmp_? -59.82 -42.47 93.57 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-O 119.39 -0.338 . . . . 73.22 111.034 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.7 pp -65.81 -47.08 76.26 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 120.71 -0.396 . . . . 75.43 111.846 -175.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.462 ' N ' HD12 ' A' ' 578' ' ' LEU . 4.5 ptp180 -65.72 -37.27 85.94 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 112.175 0.435 . . . . 72.04 112.175 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.99 -32.68 69.57 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.009 0.433 . . . . 70.22 112.038 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 14.3 tp -85.82 -9.1 57.58 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 121.424 0.631 . . . . 64.41 110.926 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 75.63 21.47 76.96 Favored Glycine 0 C--N 1.311 -0.806 0 C-N-CA 120.563 -0.827 . . . . 63.31 112.652 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 15.0 t90 -87.46 127.35 35.23 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.576 -1.268 . . . . 75.44 107.576 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 15.0 t -116.07 2.26 13.38 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 119.678 -0.809 . . . . 54.34 112.254 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 585' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -74.06 177.07 45.91 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 119.448 -1.358 . . . . 43.5 110.402 172.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 67.2 mtt -97.57 140.14 32.43 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.145 -0.622 . . . . 73.12 112.124 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 48.5 tp -88.43 116.72 26.86 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.878 -1.156 . . . . 63.3 107.878 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 621' ' ' THR . 30.6 t70 -106.66 117.49 34.18 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.066 0.46 . . . . 71.1 111.327 -176.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.496 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.2 OUTLIER -93.14 134.55 35.19 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.971 -0.559 . . . . 71.23 110.524 177.886 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -75.51 -84.34 0.38 Allowed Glycine 0 C--N 1.294 -1.793 0 CA-C-N 115.357 -0.838 . . . . 60.33 111.812 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.05 154.5 47.1 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.343 0.116 . . . . 61.32 110.777 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -101.63 127.84 48.19 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 124.795 1.238 . . . . 65.53 108.346 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 593' ' ' VAL . . . . . 0.542 ' O ' ' HB2' ' A' ' 626' ' ' GLN . 40.2 t -104.13 132.72 50.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 115.527 -0.761 . . . . 72.41 109.243 -175.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -72.4 126.82 30.78 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.202 0.525 . . . . 64.22 111.771 -175.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 595' ' ' ALA . . . . . 0.429 ' HB3' ' ND2' ' A' ' 601' ' ' ASN . . . -150.97 -57.9 0.16 Allowed 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.865 -1.061 . . . . 62.2 108.701 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 140.88 130.92 2.65 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 111.016 -0.834 . . . . 63.21 111.016 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.67 -31.95 61.07 Favored Glycine 0 C--O 1.22 -0.771 0 C-N-CA 122.856 0.265 . . . . 44.11 112.54 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 29.4 t -61.55 -23.61 66.08 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.033 0.933 . . . . 73.24 110.312 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -87.41 -12.2 46.91 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.503 -0.771 . . . . 74.12 110.343 -176.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 55.05 72.96 0.44 Allowed 'General case' 0 C--O 1.249 1.061 0 C-N-CA 123.956 0.902 . . . . 71.53 111.437 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 601' ' ' ASN . . . . . 0.449 ' HB3' ' HA3' ' A' ' 625' ' ' GLY . 45.3 m-80 -84.44 93.72 8.36 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.531 1.158 . . . . 71.45 111.213 -174.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.408 ' HD2' ' O ' ' A' ' 568' ' ' GLY . 18.6 mtm180 -74.46 171.49 13.68 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 113.027 -1.897 . . . . 51.02 110.282 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 90.0 t -58.7 129.33 20.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.185 -0.672 . . . . 73.11 109.185 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 24.2 m -110.19 -27.98 2.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-O 120.972 0.415 . . . . 73.22 111.358 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -139.49 135.51 33.59 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 116.025 -0.534 . . . . 65.1 110.439 -176.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -132.66 128.77 37.75 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 104.642 -2.355 . . . . 72.04 104.642 171.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 28.5 t-20 -59.36 -55.5 45.44 Favored Pre-proline 0 N--CA 1.471 0.608 0 N-CA-C 113.232 0.826 . . . . 73.11 113.232 -175.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.486 ' HG2' HG22 ' A' ' 620' ' ' ILE . 12.4 Cg_exo -79.17 116.39 3.65 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 121.056 1.171 . . . . 73.02 109.328 171.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.71 161.27 46.64 Favored 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 123.129 2.553 . . . . 73.44 112.85 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.08 139.0 57.75 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.937 -0.574 . . . . 61.13 109.707 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 90.56 -8.05 80.41 Favored Glycine 0 C--N 1.303 -1.262 0 C-N-CA 120.402 -0.904 . . . . 62.34 112.305 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 52.6 m -90.62 151.65 21.2 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.236 -0.653 . . . . 63.13 109.236 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -76.98 130.14 10.24 Favored Glycine 0 N--CA 1.433 -1.546 0 N-CA-C 111.416 -0.674 . . . . 63.31 111.416 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.49 142.79 33.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 109.898 -0.408 . . . . 75.33 109.898 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.516 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.0 p-10 -51.42 166.94 0.1 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.646 1.179 . . . . 64.34 112.749 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -58.64 -25.8 63.08 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 113.037 0.754 . . . . 75.14 113.037 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.536 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 68.0 m-20 -86.17 -7.13 58.78 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 119.855 -0.738 . . . . 45.04 111.007 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 65.59 18.55 65.97 Favored Glycine 0 C--O 1.215 -1.052 0 O-C-N 123.448 0.467 . . . . 52.31 112.865 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.89 119.62 17.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 122.349 1.071 . . . . 61.2 111.802 -166.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.486 HG22 ' HG2' ' A' ' 608' ' ' PRO . 40.1 pt -128.21 134.37 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 CA-C-N 114.544 -1.207 . . . . 62.13 110.753 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 8.9 t -104.9 130.06 53.14 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.611 -1.255 . . . . 74.03 107.611 174.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -138.79 165.65 26.45 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.221 -0.445 . . . . 63.21 110.435 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -137.8 147.32 44.51 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.253 0.549 . . . . 74.01 110.587 175.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -136.14 165.31 26.03 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.161 -1.052 . . . . 74.34 108.161 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 625' ' ' GLY . . . . . 0.449 ' HA3' ' HB3' ' A' ' 601' ' ' ASN . . . -86.17 -164.78 39.93 Favored Glycine 0 N--CA 1.422 -2.245 0 C-N-CA 119.77 -1.205 . . . . 72.03 112.058 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.542 ' HB2' ' O ' ' A' ' 593' ' ' VAL . 3.1 tp-100 . . . . . 0 C--N 1.281 -2.399 0 C-N-CA 123.52 0.728 . . . . 75.5 109.45 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.708 0 CA-C-O 121.518 0.675 . . . . 73.13 111.357 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 48.8 p -133.75 155.44 49.76 Favored 'General case' 0 C--O 1.25 1.125 0 N-CA-C 107.405 -1.332 . . . . 64.11 107.405 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.625 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 4.9 tmtt? -131.28 134.02 45.98 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.693 -0.854 . . . . 75.5 108.693 175.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.625 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 0.8 OUTLIER -78.05 124.05 27.57 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 124.679 1.192 . . . . 74.35 110.954 176.805 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.3 pt -86.77 131.52 45.04 Favored Pre-proline 0 C--N 1.295 -1.79 0 CA-C-N 115.703 -0.68 . . . . 75.43 110.846 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -93.48 176.92 1.34 Allowed 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 122.133 1.889 . . . . 41.43 111.571 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -90.22 103.36 16.04 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.273 1.035 . . . . 54.31 108.233 176.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 534' ' ' VAL . 17.9 m -92.45 23.99 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 114.595 -1.184 . . . . 70.03 111.77 -175.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -74.11 99.03 3.25 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.21 -0.45 . . . . 51.43 110.321 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 163.04 -44.0 0.34 Allowed Glycine 0 N--CA 1.428 -1.843 0 C-N-CA 119.541 -1.314 . . . . 74.33 113.004 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.418 ' O ' HG12 ' A' ' 534' ' ' VAL . 18.6 pm0 -92.75 -171.27 2.68 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 120.231 -0.588 . . . . 74.32 110.419 -177.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.449 ' HB ' HG23 ' A' ' 507' ' ' VAL . 6.8 m -77.77 155.22 31.3 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 108.167 -1.049 . . . . 74.13 108.167 177.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.463 ' HA ' ' HB ' ' A' ' 534' ' ' VAL . 7.9 p -63.4 -42.01 94.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 111.859 0.318 . . . . 54.14 111.859 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 506' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 27.4 t70 -62.8 -39.02 92.98 Favored 'General case' 0 C--O 1.199 -1.554 0 N-CA-C 109.442 -0.577 . . . . 71.01 109.442 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.449 HG23 ' HB ' ' A' ' 504' ' ' THR . 90.1 t -66.06 -44.82 91.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.74 -0.664 . . . . 73.54 109.567 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.484 ' HB2' HG11 ' A' ' 534' ' ' VAL . . . -60.78 -44.06 97.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 120.189 -0.604 . . . . 75.12 111.668 175.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 98.2 mt-30 -63.62 -43.38 97.01 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 122.515 0.326 . . . . 72.42 110.914 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.484 ' O ' HG23 ' A' ' 514' ' ' VAL . 32.0 mmtp -65.1 -39.82 93.69 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.997 -0.547 . . . . 73.14 110.067 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 511' ' ' ASN . . . . . 0.42 ' O ' ' HD1' ' A' ' 515' ' ' TYR . 5.8 m-80 -61.31 -45.97 92.22 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 116.105 -0.498 . . . . 52.54 110.633 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.26 -37.51 83.61 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.699 -0.682 . . . . 73.45 110.882 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -65.09 -37.63 88.12 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 116.555 -0.293 . . . . 72.25 110.542 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 510' ' ' LYS . 95.3 t -62.58 -32.53 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 121.154 0.502 . . . . 54.14 111.119 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 515' ' ' TYR . . . . . 0.42 ' HD1' ' O ' ' A' ' 511' ' ' ASN . 97.3 m-85 -108.78 14.9 24.01 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.986 -0.446 . . . . 73.15 110.267 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -146.99 -58.36 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 119.043 -1.551 . . . . 52.13 115.056 -172.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 67.93 31.97 5.38 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.451 1.119 . . . . 62.34 108.047 -169.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.509 HG22 ' HA ' ' A' ' 547' ' ' VAL . 12.9 p -79.91 179.04 7.79 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 113.238 -1.801 . . . . 72.32 110.479 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -108.67 138.83 44.36 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.129 -1.434 . . . . 54.23 107.129 176.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -132.73 145.54 51.11 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.162 0.506 . . . . 75.33 111.961 -176.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.1 m -141.59 150.28 41.84 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.751 -0.833 . . . . 63.03 108.751 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 522' ' ' GLN . . . . . 0.42 ' HB2' ' CG2' ' A' ' 555' ' ' VAL . 14.0 pt20 -119.65 149.91 41.2 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-O 120.907 0.384 . . . . 71.44 111.25 -174.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -123.47 143.01 50.43 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.215 -1.772 . . . . 61.12 106.215 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 20.0 m -118.85 130.91 56.01 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.231 0.539 . . . . 53.32 112.254 -175.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.5 p -123.75 151.01 28.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.746 -0.661 . . . . 72.5 110.05 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.17 134.11 52.07 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.104 -1.073 . . . . 74.53 108.104 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 62.6 m -156.81 176.85 2.35 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-O 119.485 -0.293 . . . . 75.11 110.596 -176.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -79.45 -25.29 5.73 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 122.2 1.933 . . . . 71.41 112.777 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.87 146.74 34.45 Favored Pre-proline 0 CA--C 1.506 -0.713 0 C-N-CA 120.132 -0.627 . . . . 75.14 110.38 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.62 159.92 30.45 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 123.419 2.746 . . . . 64.42 113.947 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -63.64 99.19 0.21 Allowed 'General case' 0 C--O 1.245 0.825 0 CA-C-N 114.698 -1.137 . . . . 74.11 110.132 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 163.9 -29.94 0.24 Allowed Glycine 0 N--CA 1.414 -2.769 0 CA-C-N 114.862 -1.063 . . . . 63.31 111.127 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -71.12 130.38 41.35 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 120.36 -0.536 . . . . 75.42 110.194 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 7.2 p -96.6 119.5 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.675 0 N-CA-C 106.559 -1.645 . . . . 54.12 106.559 171.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.4 m -104.66 20.54 18.45 Favored 'General case' 0 C--N 1.261 -3.252 0 CA-C-N 114.328 -1.306 . . . . 74.21 110.715 -171.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 126.3 -168.05 18.55 Favored Glycine 0 N--CA 1.429 -1.823 0 C-N-CA 120.721 -0.752 . . . . 64.2 112.053 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 33.4 p -116.89 146.42 42.95 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.53 -1.285 . . . . 74.24 107.53 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -68.66 -46.74 34.65 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 119.102 -1.039 . . . . 61.24 111.18 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 27.3 Cg_exo -66.53 151.23 83.38 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 120.948 1.099 . . . . 62.33 109.966 171.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 540' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 46.1 Cg_exo -57.66 140.73 94.43 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.142 2.561 . . . . 74.22 113.722 -177.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -68.03 129.76 40.89 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.714 -0.847 . . . . 74.1 108.714 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.53 -14.37 46.67 Favored Glycine 0 C--N 1.294 -1.786 0 N-CA-C 110.851 -0.9 . . . . 23.31 110.851 -176.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 98.7 m -75.83 127.49 33.11 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 109.563 -0.532 . . . . 75.51 109.563 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.2 t -93.85 130.25 39.96 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 108.351 -0.981 . . . . 70.13 108.351 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.01 154.15 64.46 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 108.19 -1.041 . . . . 74.13 108.19 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.425 ' HG2' ' OG ' ' A' ' 549' ' ' SER . 3.2 Cg_endo -59.42 137.83 80.49 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 121.43 1.42 . . . . 62.23 111.837 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.509 ' HA ' HG22 ' A' ' 518' ' ' THR . 12.8 p -57.02 -29.5 31.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.662 -1.154 . . . . 74.14 113.08 -176.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -90.03 3.31 53.61 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 123.266 0.627 . . . . 72.4 110.582 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 549' ' ' SER . . . . . 0.425 ' OG ' ' HG2' ' A' ' 546' ' ' PRO . 52.2 m -104.38 177.56 4.81 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 116.234 -0.439 . . . . 74.32 111.013 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 7.5 p -97.63 130.67 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 N-CA-C 113.084 0.772 . . . . 75.15 113.084 -172.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 66.1 mt -93.48 129.62 43.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 106.256 -1.757 . . . . 72.3 106.256 172.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -103.52 116.99 33.4 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.289 0.566 . . . . 70.23 110.923 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.53 133.06 50.9 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.809 -1.087 . . . . 74.42 111.346 -177.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -87.43 117.71 26.4 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.959 -0.564 . . . . 75.14 110.397 178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 524' ' ' SER . 43.3 t -108.64 126.64 65.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 109.079 -0.712 . . . . 71.13 109.079 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 74.9 m -89.24 132.07 35.06 Favored 'General case' 0 N--CA 1.408 -2.562 0 CA-C-N 115.84 -0.618 . . . . 71.54 109.43 176.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.5 ptpt -114.05 138.62 50.15 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.327 -1.36 . . . . 74.33 107.327 174.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.574 ' O ' ' HG3' ' A' ' 560' ' ' GLN . . . -67.41 -26.82 73.51 Favored Glycine 0 CA--C 1.493 -1.324 0 N-CA-C 109.92 -1.272 . . . . 72.01 109.92 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 60.6 t30 61.14 29.3 18.75 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-O 122.757 1.265 . . . . 52.55 108.247 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 558' ' ' GLY . 91.9 mt-30 -129.33 172.2 11.73 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 113.642 -1.617 . . . . 73.45 110.755 -174.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -143.81 152.51 41.29 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.506 -1.294 . . . . 75.24 107.506 174.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 68.0 t -78.1 116.54 21.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 108.684 -0.858 . . . . 63.5 108.684 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.517 ' SD ' HG21 ' A' ' 620' ' ' ILE . 45.1 ttp -73.6 128.53 86.91 Favored Pre-proline 0 C--N 1.315 -0.912 0 CA-C-N 116.314 -0.403 . . . . 73.4 112.016 -175.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.7 170.2 18.27 Favored 'Trans proline' 0 C--O 1.242 0.705 0 C-N-CA 123.189 2.592 . . . . 70.41 112.118 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 565' ' ' ASP . . . . . 0.418 ' HA ' ' HB2' ' A' ' 610' ' ' ALA . 14.8 t70 -60.8 128.62 37.44 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 113.054 0.761 . . . . 75.35 113.054 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 566' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 566' ' ' LEU . 0.8 OUTLIER -132.07 -9.85 3.4 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 114.81 -1.086 . . . . 75.04 108.604 178.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 22.6 t -79.25 151.81 30.95 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.653 -0.654 . . . . 74.31 110.645 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 62.65 52.05 51.51 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 116.004 -0.544 . . . . 55.04 114.172 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 23.6 ptp -158.4 169.69 23.9 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 107.568 -1.271 . . . . 74.43 107.568 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -88.32 167.98 13.08 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.217 -0.66 . . . . 72.34 109.217 -174.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 26.3 t-105 -64.89 -27.61 68.97 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.51 -0.922 . . . . 72.45 108.51 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.3 m -73.59 -9.99 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 115.398 -0.819 . . . . 41.1 111.371 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 9.6 m-20 -96.39 -44.08 7.37 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.719 -1.215 . . . . 74.52 107.719 173.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -57.47 -44.74 85.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.764 -1.107 . . . . 70.35 112.585 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.633 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 1.6 tm-20 -57.25 -58.99 14.19 Favored Pre-proline 0 CA--C 1.571 1.777 0 C-N-CA 122.824 0.45 . . . . 74.11 111.288 -177.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -61.37 -31.89 88.92 Favored 'Trans proline' 0 C--N 1.372 1.81 0 CA-C-N 120.652 1.269 . . . . 65.44 112.323 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 26.3 mmt180 -68.99 -33.82 74.3 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.24 0.83 . . . . 71.42 113.24 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.6 pp -66.34 -47.15 74.41 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.238 0.542 . . . . 72.03 110.733 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.481 ' N ' HD12 ' A' ' 578' ' ' LEU . 15.1 ptm180 -65.86 -34.53 78.35 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.671 -0.695 . . . . 63.12 111.133 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.79 -38.39 88.88 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 123.375 0.67 . . . . 73.13 111.502 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.491 HD11 ' HB2' ' A' ' 583' ' ' TRP . 2.0 pp -85.98 -8.16 58.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.313 0.577 . . . . 71.02 110.751 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 82.5 39.3 11.02 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.737 -0.665 . . . . 35.12 111.706 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.491 ' HB2' HD11 ' A' ' 581' ' ' LEU . 12.6 t90 -87.04 126.29 34.66 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.548 -0.908 . . . . 72.45 108.548 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 1.9 p -108.24 2.96 23.1 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.967 0.729 . . . . 50.23 112.967 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 585' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -94.64 -173.38 38.15 Favored Glycine 0 N--CA 1.438 -1.186 0 N-CA-C 110.381 -1.088 . . . . 75.3 110.381 176.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 60.6 mtm -114.27 151.33 33.03 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.397 -0.594 . . . . 75.45 109.397 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.7 tt -83.07 125.18 31.19 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.962 -1.125 . . . . 62.31 107.962 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 621' ' ' THR . 30.8 t70 -104.05 123.55 47.43 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.081 0.467 . . . . 53.34 109.941 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.562 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -101.39 133.44 45.99 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 108.566 -0.902 . . . . 74.02 108.566 177.22 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -77.42 -68.7 1.48 Allowed Glycine 0 C--N 1.283 -2.387 0 N-CA-C 110.505 -1.038 . . . . 72.33 110.505 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.53 142.73 37.23 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.854 -0.795 . . . . 63.44 108.854 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -83.63 134.49 34.79 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.762 -1.199 . . . . 73.33 107.762 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 593' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 626' ' ' GLN . 42.8 t -104.13 141.62 19.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 107.893 -1.151 . . . . 73.21 107.893 -176.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 594' ' ' ASP . . . . . 0.405 ' HA ' ' HG2' ' A' ' 626' ' ' GLN . 16.5 t70 -72.46 118.2 15.06 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 109.484 -0.561 . . . . 65.45 109.484 -177.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -137.3 -59.76 0.68 Allowed 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 115.466 -0.788 . . . . 63.54 109.768 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 85.84 154.09 23.0 Favored Glycine 0 N--CA 1.412 -2.903 0 C-N-CA 119.07 -1.538 . . . . 44.43 109.818 -173.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.96 -33.82 75.78 Favored Glycine 0 C--N 1.284 -2.357 0 N-CA-C 114.934 0.733 . . . . 52.11 114.934 -177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 6.9 t -73.62 -24.74 60.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 117.68 0.74 . . . . 74.23 110.231 -174.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -87.92 -1.68 58.13 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.16 0.505 . . . . 75.4 109.827 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 57.0 m80 68.34 86.64 0.13 Allowed 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 124.993 1.317 . . . . 73.32 110.868 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -74.37 82.38 1.91 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 112.697 -2.047 . . . . 64.11 111.623 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -129.28 171.32 12.59 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.015 -1.448 . . . . 74.12 110.47 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.47 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 70.7 t -57.94 130.77 21.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 O-C-N 123.338 0.399 . . . . 54.31 110.075 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 27.0 m -106.53 -34.1 2.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 C-N-CA 120.579 -0.448 . . . . 64.31 110.922 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -152.92 135.92 15.54 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 116.352 -0.386 . . . . 64.22 110.5 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -118.79 128.59 54.62 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.593 -1.632 . . . . 75.01 106.593 171.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.436 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 4.4 t-20 -63.09 -47.94 84.95 Favored Pre-proline 0 N--CA 1.469 0.496 0 C-N-CA 119.717 -0.793 . . . . 73.31 110.954 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.9 Cg_exo -84.64 108.66 1.26 Allowed 'Trans proline' 0 C--N 1.361 1.187 0 N-CA-C 108.17 -1.512 . . . . 54.24 108.17 168.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.38 161.02 47.54 Favored 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 123.386 2.724 . . . . 75.53 113.13 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 610' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 565' ' ' ASP . . . -61.78 134.72 57.08 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.35 -0.611 . . . . 61.55 109.35 176.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 103.55 -5.03 47.56 Favored Glycine 0 C--N 1.304 -1.211 0 C-N-CA 120.554 -0.831 . . . . 71.15 111.508 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 59.1 m -86.36 141.36 29.25 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.725 -0.472 . . . . 74.45 109.725 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -78.33 117.36 4.63 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 110.072 -1.211 . . . . 74.12 110.072 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 28.6 m -115.48 142.2 29.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 110.167 -0.308 . . . . 74.23 110.167 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.428 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.6 p-10 -50.08 170.15 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.961 1.304 . . . . 73.41 113.041 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -60.98 -25.64 67.0 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.85 0.685 . . . . 71.1 112.85 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.465 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 17.8 m-20 -82.84 -8.83 59.55 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 119.185 -1.006 . . . . 55.13 110.832 177.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 64.85 15.48 60.17 Favored Glycine 0 C--O 1.219 -0.826 0 C-N-CA 123.599 0.618 . . . . 75.03 114.592 168.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.71 118.37 15.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 122.612 1.196 . . . . 72.33 112.515 -164.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.517 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.8 pp -128.46 134.34 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 114.012 -1.449 . . . . 71.43 111.266 -177.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 15.1 t -104.11 129.16 51.8 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.456 -0.572 . . . . 44.12 109.456 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.5 pp -139.43 167.2 22.62 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.355 0.502 . . . . 63.31 112.355 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 25.9 ptt85 -127.8 137.81 52.52 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.49 -0.559 . . . . 73.02 109.49 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.47 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 20.0 p90 -139.94 165.93 26.0 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.918 -0.583 . . . . 75.13 110.896 -173.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -76.15 134.64 16.16 Favored Glycine 0 N--CA 1.431 -1.647 0 CA-C-N 115.832 -0.622 . . . . 42.12 112.615 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 593' ' ' VAL . 12.9 pt20 . . . . . 0 C--N 1.305 -1.36 0 C-N-CA 123.768 0.827 . . . . 65.24 109.293 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.702 0 CA-C-O 121.517 0.675 . . . . 40.11 111.174 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 31.2 p -137.66 147.3 44.79 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 115.338 -0.847 . . . . 72.22 109.744 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -127.68 139.86 52.44 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.614 -0.884 . . . . 71.1 108.614 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.4 p-10 -96.02 130.25 43.07 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.485 0.659 . . . . 74.22 110.414 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 34.8 pt -91.12 127.06 52.94 Favored Pre-proline 0 C--N 1.304 -1.383 0 CA-C-N 114.717 -1.129 . . . . 75.43 111.198 -176.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -84.42 -179.42 3.85 Favored 'Trans proline' 0 N--CA 1.441 -1.585 0 C-N-CA 121.632 1.555 . . . . 64.33 110.696 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -82.3 103.37 11.83 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 122.253 1.025 . . . . 72.33 110.182 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.414 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 26.8 m -100.79 7.67 9.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 114.946 -1.025 . . . . 74.21 111.384 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.426 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -80.56 102.81 10.0 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 109.054 -0.721 . . . . 60.15 109.054 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 159.05 -36.14 0.49 Allowed Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.566 -0.826 . . . . 61.25 112.131 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 16.6 pm0 -94.45 -173.08 2.95 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 109.301 -0.629 . . . . 73.41 109.301 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 27.9 m -70.1 154.89 41.37 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.856 -1.164 . . . . 72.22 107.856 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.438 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.2 p -63.02 -41.89 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 C-N-CA 120.891 -0.324 . . . . 74.01 111.049 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 506' ' ' ASP . . . . . 0.539 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 18.7 t70 -62.18 -43.95 97.68 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 109.645 -0.502 . . . . 60.22 109.645 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 64.0 t -66.61 -41.85 88.93 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 CA-C-N 115.79 -0.641 . . . . 60.33 109.737 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.427 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -61.15 -44.57 97.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 120.442 0.163 . . . . 62.43 110.684 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 26.3 mt-30 -65.0 -43.82 91.28 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.266 -0.425 . . . . 65.43 111.086 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.566 ' O ' HG23 ' A' ' 514' ' ' VAL . 32.7 mmtp -62.92 -47.14 84.54 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.429 -0.582 . . . . 74.43 109.429 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -63.99 -37.95 89.3 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.515 -0.766 . . . . 74.1 111.345 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.64 -46.28 69.61 Favored 'General case' 0 C--O 1.203 -1.348 0 N-CA-C 108.151 -1.055 . . . . 64.25 108.151 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -59.99 -38.13 81.7 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 124.077 0.951 . . . . 73.2 111.188 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 510' ' ' LYS . 57.7 t -57.57 -37.56 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-O 120.845 0.355 . . . . 72.15 111.326 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -110.0 0.91 18.69 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.865 0.84 . . . . 74.44 111.098 -176.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -113.5 -60.4 0.41 Allowed Glycine 0 N--CA 1.416 -2.698 0 CA-C-N 115.18 -0.918 . . . . 70.11 111.331 -174.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 70.74 16.49 6.74 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.58 1.152 . . . . 74.4 110.415 -175.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 547' ' ' VAL . 4.4 p -83.05 -176.17 6.2 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-N 114.082 -1.417 . . . . 75.25 109.496 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 0.1 OUTLIER -108.69 143.14 38.18 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.29 -1.004 . . . . 61.0 108.29 177.018 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -123.1 148.61 45.46 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-O 121.428 0.633 . . . . 74.13 111.804 -175.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 16.9 p -135.31 140.26 44.97 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 107.369 -1.345 . . . . 71.31 107.369 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -117.45 127.27 53.85 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-O 121.246 0.546 . . . . 73.01 110.466 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -116.11 143.36 45.58 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.161 -1.422 . . . . 74.22 107.161 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.0 p -119.44 132.66 55.85 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 113.783 1.031 . . . . 72.11 113.783 -175.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.64 149.97 24.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 107.902 -1.147 . . . . 63.41 107.902 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -79.61 136.86 36.95 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.923 -0.311 . . . . 33.04 110.881 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.436 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 59.9 m -163.24 155.08 15.13 Favored Pre-proline 0 C--O 1.204 -1.335 0 N-CA-C 107.106 -1.442 . . . . 43.45 107.106 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.39 -14.66 36.01 Favored 'Trans proline' 0 CA--C 1.552 1.376 0 C-N-CA 122.439 2.093 . . . . 73.25 114.587 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -70.9 145.58 91.99 Favored Pre-proline 0 C--O 1.215 -0.711 0 N-CA-C 109.529 -0.545 . . . . 75.52 109.529 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.33 144.39 91.13 Favored 'Trans proline' 0 C--O 1.26 1.59 0 C-N-CA 122.317 2.012 . . . . 65.43 112.619 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.693 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -64.14 100.34 0.32 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.246 -0.888 . . . . 63.01 111.171 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 157.43 -23.41 0.43 Allowed Glycine 0 N--CA 1.427 -1.93 0 C-N-CA 120.559 -0.829 . . . . 74.35 111.979 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -80.65 138.92 36.43 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 119.904 -0.718 . . . . 75.1 109.842 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.427 HG11 ' CB ' ' A' ' 508' ' ' ALA . 5.4 p -93.85 113.93 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 N-CA-C 107.294 -1.373 . . . . 72.24 107.294 172.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.7 m -99.62 8.74 44.15 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 113.929 -1.487 . . . . 74.32 111.186 -172.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.426 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 157.31 172.89 25.05 Favored Glycine 0 N--CA 1.428 -1.883 0 C-N-CA 119.704 -1.236 . . . . 42.43 113.245 174.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.6 p -120.52 158.27 27.65 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 105.798 -1.927 . . . . 73.32 105.798 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 51.6 t30 -67.05 -54.33 20.83 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 117.517 -1.673 . . . . 70.23 111.368 177.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 8.2 Cg_exo -74.33 143.21 31.2 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 121.282 1.321 . . . . 61.51 109.792 174.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.74 157.99 59.61 Favored 'Trans proline' 0 C--O 1.25 1.106 0 C-N-CA 122.635 2.224 . . . . 71.12 113.284 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.28 139.59 58.08 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.806 -0.633 . . . . 42.43 110.505 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.18 -14.36 59.79 Favored Glycine 0 C--N 1.3 -1.436 0 N-CA-C 111.706 -0.557 . . . . 71.44 111.706 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 20.4 m -75.32 135.23 40.89 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 109.771 -0.455 . . . . 54.44 109.771 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.8 t -96.58 125.47 41.07 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 107.916 -1.142 . . . . 75.03 107.916 177.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.26 154.55 65.44 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 108.622 -0.881 . . . . 64.52 108.622 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.64 137.48 77.56 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.784 1.656 . . . . 60.03 112.283 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.45 ' HA ' HG22 ' A' ' 518' ' ' THR . 13.5 p -65.33 -24.03 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-N 115.19 -0.913 . . . . 62.03 110.82 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -78.02 -10.02 59.4 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.559 -1.201 . . . . 73.25 111.632 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 22.9 t -94.01 -176.84 4.13 Favored 'General case' 0 C--O 1.26 1.637 0 CA-C-O 121.631 0.729 . . . . 61.35 112.176 -174.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 14.7 p -119.13 137.92 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 114.774 -1.103 . . . . 54.54 109.037 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.3 mt -108.71 138.33 36.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 109.149 -0.686 . . . . 73.44 109.149 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.53 122.06 44.17 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.689 0.757 . . . . 73.21 111.756 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.1 mp -108.08 122.23 46.45 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.212 -1.358 . . . . 63.11 108.776 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -90.63 116.23 28.35 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.916 0.865 . . . . 73.33 111.26 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 524' ' ' SER . 21.3 t -98.8 135.21 34.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 114.263 -1.335 . . . . 41.23 108.811 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.693 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 66.4 m -86.33 129.04 34.99 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.538 -0.541 . . . . 74.4 109.538 174.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -101.03 130.05 46.98 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 105.883 -1.895 . . . . 72.15 105.883 172.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -62.22 -24.93 65.92 Favored Glycine 0 CA--C 1.5 -0.898 0 O-C-N 124.006 0.816 . . . . 74.51 114.146 -173.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 559' ' ' ASN . . . . . 0.486 ' OD1' ' HG3' ' A' ' 616' ' ' ARG . 49.0 t-20 71.93 -14.62 0.51 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.841 1.256 . . . . 74.44 111.363 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -111.93 149.55 31.76 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.307 -0.87 . . . . 72.15 112.856 -170.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -131.0 158.4 40.39 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.248 -1.342 . . . . 71.13 107.449 177.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.61 125.33 32.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 120.991 0.424 . . . . 62.22 111.217 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 55.2 ttp -86.6 129.51 52.64 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 110.092 -0.336 . . . . 72.13 110.092 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.07 170.46 20.07 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.363 2.708 . . . . 72.42 112.337 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.02 126.65 28.7 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 112.784 0.661 . . . . 72.31 112.784 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 566' ' ' LEU . . . . . 0.464 ' O ' ' HG2' ' A' ' 569' ' ' MET . 0.0 OUTLIER -132.05 7.25 4.31 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.504 1.145 . . . . 55.44 109.06 171.382 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 3.1 m -79.19 138.19 37.75 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.559 -1.201 . . . . 75.12 108.926 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 84.15 18.62 62.46 Favored Glycine 0 C--N 1.315 -0.624 0 C-N-CA 120.533 -0.841 . . . . 74.31 113.876 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 569' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 20.2 ptp -124.0 175.12 7.16 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.291 -1.003 . . . . 75.11 108.291 176.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -94.8 164.98 12.71 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.595 -1.631 . . . . 63.12 106.595 -175.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 571' ' ' TRP . . . . . 0.504 ' O ' ' HG3' ' A' ' 575' ' ' GLU . 10.8 t-105 -63.49 -34.16 77.17 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.781 -0.822 . . . . 73.4 108.781 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.6 p -74.23 -14.78 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.648 -0.705 . . . . 73.31 110.669 -175.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -100.98 -28.6 12.65 Favored 'General case' 0 C--O 1.263 1.814 0 CA-C-O 122.025 0.917 . . . . 54.43 108.766 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 574' ' ' ALA . . . . . 0.643 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -64.12 -41.67 97.14 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.486 -1.234 . . . . 51.11 109.98 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 571' ' ' TRP . 46.0 mt-10 -51.21 -56.12 22.83 Favored Pre-proline 0 CA--C 1.567 1.615 0 N-CA-C 112.519 0.562 . . . . 74.32 112.519 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -58.4 -33.34 97.76 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 121.554 1.502 . . . . 71.42 112.71 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -68.64 -34.3 75.5 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 119.487 -0.885 . . . . 71.32 111.735 176.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 41.0 mt -63.06 -48.31 79.23 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.147 0.499 . . . . 63.22 110.383 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 6.9 ptp85 -66.19 -36.83 84.1 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.136 -0.484 . . . . 75.22 111.324 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.31 77.85 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.134 -0.484 . . . . 54.02 112.097 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' A' ' 583' ' ' TRP . 1.7 pp -81.93 -8.54 59.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.158 0.504 . . . . 73.34 109.868 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 80.3 42.45 10.52 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.528 -0.76 . . . . 71.32 112.311 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.457 ' CE3' HD22 ' A' ' 578' ' ' LEU . 18.1 t90 -87.31 126.59 34.94 Favored 'General case' 0 N--CA 1.427 -1.619 0 C-N-CA 120.147 -0.621 . . . . 73.52 109.888 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 26.9 p -100.95 -14.28 17.95 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.33 0.492 . . . . 74.41 112.33 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -82.96 -171.09 46.91 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 121.344 -0.455 . . . . 42.43 113.349 -177.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 92.3 mmm -117.57 147.47 42.79 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.907 -0.405 . . . . 62.51 109.907 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 587' ' ' LEU . . . . . 0.455 HD21 ' HG ' ' A' ' 622' ' ' LEU . 3.6 tt -93.02 129.56 38.9 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.88 0.372 . . . . 53.23 110.203 -175.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -113.96 124.85 53.16 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-N 115.911 -0.586 . . . . 72.14 109.719 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.485 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.3 OUTLIER -90.8 133.95 34.81 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.806 -0.442 . . . . 55.33 109.806 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -84.06 -106.8 0.57 Allowed Glycine 0 C--N 1.291 -1.937 0 CA-C-N 115.829 -0.623 . . . . 54.1 112.32 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 591' ' ' ALA . . . . . 0.605 ' O ' ' HB2' ' A' ' 623' ' ' ARG . . . -96.14 116.58 29.21 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.948 0.404 . . . . 74.32 110.343 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -87.24 140.08 29.9 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 123.499 0.719 . . . . 71.34 110.898 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 48.4 t -122.36 128.74 75.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.313 -0.995 . . . . 61.43 108.313 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.59 122.61 21.66 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.92 0.391 . . . . 65.05 110.397 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -134.45 -43.47 0.77 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.815 -0.63 . . . . 71.11 110.596 -177.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 106.86 128.92 6.1 Favored Glycine 0 N--CA 1.433 -1.524 0 N-CA-C 111.543 -0.623 . . . . 55.32 111.543 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.17 -32.95 84.33 Favored Glycine 0 N--CA 1.46 0.235 0 CA-C-O 121.067 0.26 . . . . 54.35 112.485 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 3.0 p -64.94 -23.94 67.37 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 124.938 1.295 . . . . 55.23 110.944 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -92.23 -0.78 57.4 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.776 -0.647 . . . . 72.21 110.283 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 30.5 m170 75.01 97.23 0.07 Allowed 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 125.017 1.327 . . . . 71.24 112.29 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 601' ' ' ASN . . . . . 0.683 ' HB2' ' O ' ' A' ' 625' ' ' GLY . 19.2 p30 -83.2 88.85 6.91 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 114.016 -1.447 . . . . 60.22 112.748 -175.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 -91.85 155.68 18.03 Favored 'General case' 0 C--O 1.254 1.307 0 CA-C-N 114.504 -1.226 . . . . 75.32 110.818 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 88.0 t -62.86 131.89 28.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 114.955 -1.021 . . . . 70.44 108.3 172.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.74 -46.55 12.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 120.996 0.427 . . . . 63.43 110.666 -175.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -151.69 154.11 35.69 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.346 -0.983 . . . . 71.15 108.346 -176.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -142.55 149.31 38.92 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.309 -0.626 . . . . 74.15 109.309 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.524 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 50.8 t-20 -69.23 -56.45 8.59 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 120.611 -0.436 . . . . 64.44 111.265 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.8 Cg_exo -84.44 115.36 1.89 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 120.729 1.296 . . . . 42.25 108.888 173.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -70.2 157.91 58.04 Favored 'Trans proline' 0 C--O 1.248 1.017 0 C-N-CA 122.303 2.002 . . . . 70.15 112.458 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.31 137.81 56.34 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.721 -0.844 . . . . 63.41 108.721 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 96.94 -7.18 64.71 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.892 -0.671 . . . . 74.35 111.646 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 38.5 m -94.71 150.15 20.51 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.987 -0.375 . . . . 74.44 109.987 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -75.63 126.5 8.54 Favored Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 111.823 -0.511 . . . . 54.14 111.823 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.3 m -118.65 142.65 32.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 109.077 -0.712 . . . . 75.35 109.077 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -52.25 165.87 0.2 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.887 0.875 . . . . 72.1 112.035 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 616' ' ' ARG . . . . . 0.486 ' HG3' ' OD1' ' A' ' 559' ' ' ASN . 0.0 OUTLIER -57.82 -25.3 60.42 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.864 1.061 . . . . 75.25 113.864 -178.853 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.38 -10.31 59.75 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 119.95 -0.7 . . . . 72.31 109.48 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 65.34 16.1 62.19 Favored Glycine 0 CA--C 1.498 -1.019 0 CA-C-N 115.61 -0.723 . . . . 73.14 113.472 169.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.16 119.29 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 122.567 1.175 . . . . 73.22 111.067 -165.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.415 HG12 ' HD2' ' A' ' 608' ' ' PRO . 0.0 OUTLIER -129.2 132.48 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.176 0 CA-C-N 113.824 -1.535 . . . . 72.41 109.11 -176.071 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 8.9 t -114.96 133.53 55.94 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.399 -0.963 . . . . 65.2 108.399 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.455 ' HG ' HD21 ' A' ' 587' ' ' LEU . 3.1 pp -138.97 166.65 23.93 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.748 -0.66 . . . . 41.25 112.073 -174.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 623' ' ' ARG . . . . . 0.605 ' HB2' ' O ' ' A' ' 591' ' ' ALA . 7.4 ptm180 -126.93 137.42 53.13 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 106.915 -1.513 . . . . 74.24 106.915 175.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -139.49 165.93 25.92 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 115.808 -0.633 . . . . 74.3 109.324 -171.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 625' ' ' GLY . . . . . 0.683 ' O ' ' HB2' ' A' ' 601' ' ' ASN . . . -72.7 140.03 28.45 Favored Glycine 0 N--CA 1.418 -2.561 0 N-CA-C 108.493 -1.843 . . . . 63.22 108.493 174.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 . . . . . 0 C--N 1.265 -3.107 0 CA-C-O 118.11 -0.947 . . . . 72.45 108.643 -179.401 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.443 0 CA-C-O 121.133 0.492 . . . . 73.13 111.677 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 38.3 p -139.5 144.18 37.81 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.423 -0.584 . . . . 64.11 109.423 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.545 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 4.3 tmtt? -134.93 139.38 44.91 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.05 -1.093 . . . . 75.5 108.05 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.545 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 10.5 p-10 -78.77 132.97 37.12 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 124.097 0.959 . . . . 74.35 110.051 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 42.6 pt -98.58 128.45 32.81 Favored Pre-proline 0 C--N 1.306 -1.309 0 C-N-CA 120.386 -0.526 . . . . 75.43 110.584 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.92 -163.33 0.19 Allowed 'Trans proline' 0 C--O 1.251 1.139 0 C-N-CA 122.682 2.254 . . . . 41.43 111.018 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -86.18 127.3 34.7 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.609 0.719 . . . . 54.31 109.984 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.511 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 15.9 m -122.99 62.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-O 123.359 1.552 . . . . 70.03 108.425 171.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -120.43 108.58 14.29 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 112.825 -1.988 . . . . 51.43 109.191 176.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 138.39 -25.47 2.87 Favored Glycine 0 N--CA 1.431 -1.661 0 C-N-CA 119.613 -1.279 . . . . 74.33 113.42 175.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.453 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.4 OUTLIER -101.39 -177.0 3.31 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 117.835 0.817 . . . . 74.32 109.382 179.342 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.414 ' HB ' HG23 ' A' ' 507' ' ' VAL . 9.1 m -74.36 155.45 38.13 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.78 -1.193 . . . . 74.13 107.78 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 8.9 p -64.3 -41.32 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-O 119.471 -0.3 . . . . 54.14 111.715 -177.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 506' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 15.5 t70 -59.56 -42.6 92.77 Favored 'General case' 0 C--O 1.213 -0.844 0 N-CA-C 108.417 -0.957 . . . . 71.01 108.417 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.414 HG23 ' HB ' ' A' ' 504' ' ' THR . 76.9 t -65.34 -44.84 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 114.983 -1.008 . . . . 73.54 110.044 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.511 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -63.24 -44.98 93.68 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 111.725 0.269 . . . . 75.12 111.725 177.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.6 mt-30 -61.88 -45.26 94.55 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 122.804 0.441 . . . . 72.42 110.08 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 514' ' ' VAL . 31.5 mmtp -67.01 -39.28 87.05 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.631 -0.713 . . . . 73.14 110.579 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -61.49 -43.98 97.9 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 121.31 0.576 . . . . 52.54 110.492 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.57 -43.06 86.04 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.842 -1.17 . . . . 73.45 107.842 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -59.81 -36.5 76.88 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 124.035 0.934 . . . . 72.25 111.664 -177.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 510' ' ' LYS . 90.4 t -60.07 -40.48 83.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.732 0.301 . . . . 54.14 110.929 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -107.15 13.17 27.63 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.414 0.626 . . . . 73.15 110.281 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -134.65 -54.29 0.07 OUTLIER Glycine 0 N--CA 1.429 -1.801 0 C-N-CA 120.534 -0.841 . . . . 52.13 113.72 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 65.22 25.76 12.3 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.404 1.097 . . . . 62.34 109.088 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.485 HG22 ' HA ' ' A' ' 547' ' ' VAL . 6.2 p -80.77 -173.54 4.25 Favored 'General case' 0 N--CA 1.416 -2.143 0 C-N-CA 125.719 1.608 . . . . 72.32 111.602 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -108.76 138.41 45.14 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.451 -1.685 . . . . 54.23 106.451 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -132.43 149.01 52.42 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.065 0.459 . . . . 75.33 111.607 -178.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 71.3 m -141.22 150.9 43.26 Favored 'General case' 0 N--CA 1.418 -2.025 0 N-CA-C 108.515 -0.92 . . . . 63.03 108.515 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 522' ' ' GLN . . . . . 0.46 ' HB2' ' CG2' ' A' ' 555' ' ' VAL . 14.2 pt20 -119.56 136.63 54.27 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.036 0.446 . . . . 71.44 110.294 -178.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -120.04 137.34 54.16 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.184 -1.413 . . . . 61.12 107.184 176.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 33.8 m -106.1 134.5 49.12 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 112.295 0.48 . . . . 53.32 112.295 -175.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.6 p -131.13 153.04 38.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.357 -0.838 . . . . 72.5 109.006 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -73.24 134.92 44.45 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.24 -1.022 . . . . 74.53 108.24 177.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.571 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 65.5 m -161.13 168.04 12.3 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.513 -0.551 . . . . 75.11 109.513 -177.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -71.96 -21.91 23.78 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.055 1.837 . . . . 71.41 112.077 176.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -69.73 144.22 93.39 Favored Pre-proline 0 C--O 1.221 -0.426 0 CA-C-N 116.2 -0.455 . . . . 75.14 111.311 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.47 152.42 81.67 Favored 'Trans proline' 0 C--O 1.248 0.996 0 C-N-CA 122.586 2.191 . . . . 64.42 111.72 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 557' ' ' LYS . . . -62.31 112.01 2.24 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 115.63 -0.714 . . . . 74.11 110.999 -177.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 131.53 -23.62 4.24 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 115.427 -0.806 . . . . 63.31 111.623 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -80.08 133.83 36.14 Favored 'General case' 0 C--O 1.246 0.912 0 CA-C-O 121.262 0.553 . . . . 75.42 109.768 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 503' ' ' GLN . 8.1 p -97.32 120.09 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.875 0 N-CA-C 108.094 -1.076 . . . . 54.12 108.094 -178.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 4.1 p -90.13 1.24 56.62 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.207 -0.906 . . . . 74.21 112.376 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.445 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 144.0 -161.7 27.83 Favored Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.314 -0.946 . . . . 64.2 112.321 175.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 3.8 p -116.97 155.14 29.65 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.807 -0.812 . . . . 74.24 108.807 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -65.31 -50.52 58.63 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.306 -0.627 . . . . 61.24 109.306 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.67 138.91 46.73 Favored 'Trans proline' 0 C--N 1.375 1.966 0 N-CA-C 108.97 -1.204 . . . . 62.33 108.97 170.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.01 143.64 91.34 Favored 'Trans proline' 0 C--O 1.243 0.725 0 C-N-CA 122.86 2.373 . . . . 74.22 113.659 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.01 131.53 47.88 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.63 -0.714 . . . . 74.1 109.745 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.22 -5.39 35.91 Favored Glycine 0 N--CA 1.434 -1.448 0 CA-C-N 115.708 -0.678 . . . . 23.31 111.465 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 5.9 t -84.97 138.16 32.65 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.233 0.54 . . . . 75.51 110.714 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 9.2 t -81.56 131.37 35.27 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.158 -1.053 . . . . 70.13 108.158 174.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.0 m -126.51 154.99 75.24 Favored Pre-proline 0 C--N 1.315 -0.935 0 N-CA-C 108.786 -0.82 . . . . 74.13 108.786 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -70.18 138.89 37.51 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.635 1.557 . . . . 62.23 111.29 176.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.485 ' HA ' HG22 ' A' ' 518' ' ' THR . 8.9 p -64.73 -19.08 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 CA-C-O 122.345 1.069 . . . . 74.14 110.608 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -86.38 -18.35 32.06 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.17 -0.923 . . . . 72.4 110.768 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 50.4 m -91.98 167.78 11.86 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.362 0.601 . . . . 74.32 111.968 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 10.7 p -97.22 138.15 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-N 115.096 -0.956 . . . . 75.15 111.051 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 56.7 mt -97.48 134.19 36.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 107.615 -1.254 . . . . 72.3 107.615 176.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -103.33 117.34 34.27 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.097 -0.705 . . . . 70.23 109.097 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.8 mp -104.42 133.13 49.82 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 120.916 0.388 . . . . 74.42 111.657 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -87.51 108.83 19.22 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 123.558 0.743 . . . . 75.14 110.853 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 522' ' ' GLN . 32.5 t -95.85 124.3 48.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.468 -0.938 . . . . 71.13 108.468 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.571 ' HB3' ' HB2' ' A' ' 527' ' ' SER . 58.0 m -88.05 133.24 34.02 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 115.972 -0.558 . . . . 71.54 110.733 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.1 ptpt -115.72 130.96 57.05 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 107.843 -1.169 . . . . 74.33 107.843 171.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 527' ' ' SER . . . -64.93 -23.75 69.6 Favored Glycine 0 CA--C 1.497 -1.061 0 N-CA-C 110.264 -1.134 . . . . 72.01 110.264 178.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 53.9 t30 70.22 -5.55 1.31 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.041 1.736 . . . . 52.55 111.051 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 77.9 mt-30 -113.54 142.72 45.62 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 115.796 -0.638 . . . . 73.45 110.572 -176.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -123.36 158.21 31.59 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.665 -0.865 . . . . 75.24 108.665 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.29 118.3 10.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 O-C-N 123.499 0.499 . . . . 63.5 109.78 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.556 ' SD ' HG21 ' A' ' 620' ' ' ILE . 35.9 ttp -79.32 136.93 56.26 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 116.219 -0.446 . . . . 73.4 111.402 -178.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.32 171.24 10.71 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.623 2.882 . . . . 70.41 111.742 172.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -82.53 129.39 34.91 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 116.529 -0.305 . . . . 75.35 111.314 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -123.05 16.5 9.99 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.258 1.028 . . . . 75.04 109.191 176.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 50.8 m -79.03 130.91 36.03 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 114.386 -1.279 . . . . 74.31 112.363 -175.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 568' ' ' GLY . . . . . 0.426 ' HA2' ' HD3' ' A' ' 602' ' ' ARG . . . 71.12 62.53 3.49 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.45 -0.796 . . . . 55.04 114.377 176.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 24.4 ptp -159.86 164.84 33.26 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 109.057 -0.719 . . . . 74.43 109.057 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -92.88 174.7 7.11 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.835 -0.431 . . . . 72.34 109.835 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 35.3 t-105 -64.48 -29.64 70.68 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.885 -0.783 . . . . 72.45 108.885 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 22.1 m -74.96 -6.4 8.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.469 -0.787 . . . . 41.1 111.214 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -102.21 -44.35 5.45 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.501 -0.925 . . . . 74.52 108.501 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -64.68 -40.09 94.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.94 -1.027 . . . . 70.35 113.122 -177.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.711 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 6.0 tm-20 -66.22 -50.81 48.12 Favored Pre-proline 0 CA--C 1.564 1.482 0 N-CA-C 109.943 -0.392 . . . . 74.11 109.943 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 61.7 Cg_exo -53.12 -34.32 67.99 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 121.584 1.523 . . . . 65.44 111.646 169.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -60.88 -39.63 89.94 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.433 0.531 . . . . 71.42 112.433 175.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.711 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 3.9 pp -65.98 -44.45 84.85 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 120.184 -0.606 . . . . 72.03 110.727 -178.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.461 ' N ' HD12 ' A' ' 578' ' ' LEU . 6.6 ptm180 -66.46 -34.58 78.26 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.833 0.349 . . . . 63.12 111.69 176.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.24 -36.53 74.55 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.161 0.505 . . . . 73.13 111.35 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.5 tp -87.9 -9.22 54.33 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 123.695 0.798 . . . . 71.02 110.622 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 66.04 37.51 93.2 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.114 -0.795 . . . . 35.12 111.114 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -80.73 126.43 31.29 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.409 0.623 . . . . 72.45 110.172 -176.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 17.0 p -96.67 -18.5 19.65 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 113.313 0.857 . . . . 50.23 113.313 -174.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -80.36 -156.57 13.23 Favored Glycine 0 C--O 1.24 0.471 0 C-N-CA 121.327 -0.463 . . . . 75.3 114.115 -176.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 67.2 mtm -128.68 155.32 45.22 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.561 -0.533 . . . . 75.45 109.561 -176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.5 tt -106.67 113.71 27.38 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.648 -1.241 . . . . 62.31 107.648 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 621' ' ' THR . 51.9 m-20 -98.65 110.1 22.75 Favored 'General case' 0 CA--C 1.478 -1.804 0 N-CA-C 109.305 -0.628 . . . . 53.34 109.305 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.0 OUTLIER -87.55 133.07 33.85 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 118.418 -1.313 . . . . 74.02 107.633 174.115 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -82.59 -55.67 2.96 Favored Glycine 0 C--N 1.29 -1.976 0 CA-C-N 115.605 -0.725 . . . . 72.33 112.04 -174.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.85 154.13 47.23 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.569 -0.53 . . . . 63.44 109.569 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 592' ' ' ASP . . . . . 0.554 ' HB3' ' HB2' ' A' ' 626' ' ' GLN . 10.5 m-20 -99.54 129.79 45.74 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 105.385 -2.08 . . . . 73.33 105.385 173.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 16.5 t -103.49 135.78 39.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 107.138 -1.43 . . . . 73.21 107.138 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.71 121.86 19.61 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 118.219 0.463 . . . . 65.45 111.083 -169.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -138.3 -56.99 0.65 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.547 -0.751 . . . . 63.54 110.489 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 100.06 142.31 12.96 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 109.573 -1.411 . . . . 44.43 109.573 -173.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.93 -35.4 83.02 Favored Glycine 0 C--N 1.314 -0.676 0 N-CA-C 113.914 0.326 . . . . 52.11 113.914 -176.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 9.3 t -71.85 -24.41 61.69 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.284 0.564 . . . . 74.23 110.329 -176.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -88.19 -0.55 57.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.33 -0.396 . . . . 75.4 110.734 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 50.8 m80 79.2 84.33 0.06 Allowed 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 125.426 1.49 . . . . 73.32 110.275 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -81.16 71.98 8.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 123.21 1.481 . . . . 64.11 111.182 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.426 ' HD3' ' HA2' ' A' ' 568' ' ' GLY . 4.6 ppt_? -115.21 172.32 7.14 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 113.233 -1.803 . . . . 74.12 110.653 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.448 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 63.2 t -56.54 130.79 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 109.588 -0.523 . . . . 54.31 109.588 -178.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 26.3 m -110.39 -30.04 2.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.277 -0.874 . . . . 64.31 111.488 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -156.75 135.71 11.83 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 109.68 -0.489 . . . . 64.22 109.68 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -116.17 136.24 53.19 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.601 -0.518 . . . . 75.01 109.601 173.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.447 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 9.5 t30 -56.99 -50.76 86.36 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 123.627 0.579 . . . . 73.31 111.594 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.496 ' O ' ' HE1' ' A' ' 563' ' ' MET . 57.8 Cg_endo -89.3 112.32 0.56 Allowed 'Trans proline' 0 N--CA 1.43 -2.216 0 N-CA-C 109.361 -1.053 . . . . 54.24 109.361 169.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.18 161.03 47.48 Favored 'Trans proline' 0 C--O 1.249 1.049 0 C-N-CA 122.709 2.272 . . . . 75.53 111.132 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -54.89 132.91 47.58 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 122.622 0.369 . . . . 61.55 110.316 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.64 -6.54 59.0 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.159 -1.019 . . . . 71.15 112.972 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 37.5 m -86.25 149.54 25.0 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.857 -0.423 . . . . 74.45 109.857 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.5 123.3 6.07 Favored Glycine 0 N--CA 1.433 -1.562 0 C-N-CA 121.211 -0.519 . . . . 74.12 112.478 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 35.5 m -116.28 142.31 30.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.716 -0.846 . . . . 74.23 108.716 176.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -55.74 175.31 0.09 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.922 0.889 . . . . 73.41 113.287 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -60.99 -27.0 67.98 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.5 -0.318 . . . . 71.1 111.639 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -82.34 -8.24 59.63 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.171 -0.612 . . . . 55.13 109.799 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.19 18.75 67.49 Favored Glycine 0 C--O 1.214 -1.131 0 O-C-N 123.302 0.376 . . . . 75.03 113.105 173.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.68 120.09 17.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 121.739 0.781 . . . . 72.33 111.396 -167.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.556 HG21 ' SD ' ' A' ' 563' ' ' MET . 50.7 pt -126.88 135.49 63.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 115.026 -0.988 . . . . 71.43 111.985 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 14.0 t -109.62 128.25 55.09 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.796 -0.816 . . . . 44.12 108.796 177.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 3.8 pp -139.78 168.08 20.65 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.297 -0.41 . . . . 63.31 111.631 -176.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -127.6 138.1 52.76 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.435 -0.58 . . . . 73.02 109.435 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.448 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 22.9 p90 -129.67 165.8 21.09 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 112.53 0.567 . . . . 75.13 112.53 -175.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -64.85 137.61 39.05 Favored Glycine 0 N--CA 1.423 -2.21 0 CA-C-N 114.886 -1.052 . . . . 42.12 112.488 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.554 ' HB2' ' HB3' ' A' ' 592' ' ' ASP . 62.6 tt0 . . . . . 0 C--N 1.277 -2.567 0 C-N-CA 125.431 1.492 . . . . 65.24 107.416 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 114.148 1.166 . . . . 74.23 114.148 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.8 p -147.94 147.29 29.53 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 122.169 -0.332 . . . . 74.44 111.465 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -143.83 143.69 31.44 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 123.689 0.795 . . . . 74.33 109.443 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.8 p-10 -91.13 139.48 30.72 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.825 -0.806 . . . . 74.55 108.825 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.5 pt -97.65 132.17 25.6 Favored Pre-proline 0 C--N 1.293 -1.861 0 CA-C-N 115.463 -0.79 . . . . 75.32 111.9 -176.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -83.96 175.85 7.29 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.22 1.947 . . . . 60.23 110.187 173.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -86.55 127.09 34.86 Favored 'General case' 0 CA--C 1.489 -1.376 0 CA-C-O 122.047 0.927 . . . . 70.21 109.909 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.437 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 16.2 m -113.85 59.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 CA-C-O 122.827 1.298 . . . . 64.53 109.481 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -112.57 105.77 14.05 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 113.61 -1.632 . . . . 72.32 109.648 174.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 141.97 -17.03 2.57 Favored Glycine 0 C--N 1.313 -0.705 0 C-N-CA 118.472 -1.823 . . . . 71.11 114.61 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.442 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.1 OUTLIER -112.72 -175.27 2.63 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.041 -0.726 . . . . 73.04 109.041 177.686 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.412 ' HB ' HG23 ' A' ' 507' ' ' VAL . 2.8 m -74.66 155.44 37.76 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 107.973 -1.121 . . . . 74.53 107.973 178.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.527 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 8.3 p -62.82 -42.13 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 121.123 -0.231 . . . . 52.45 111.48 -178.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.25 -34.41 78.28 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 110.06 -0.348 . . . . 71.43 110.06 -178.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.412 HG23 ' HB ' ' A' ' 504' ' ' THR . 59.0 t -71.9 -44.32 67.41 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.966 0 N-CA-C 109.351 -0.611 . . . . 74.44 109.351 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.443 ' HB2' HG11 ' A' ' 534' ' ' VAL . . . -58.58 -43.68 89.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.78 0.324 . . . . 72.35 110.83 177.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 97.2 mt-30 -62.75 -44.24 96.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.722 -0.672 . . . . 74.32 110.445 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 514' ' ' VAL . 71.8 mmtt -65.86 -42.61 90.18 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.924 -0.58 . . . . 64.12 111.129 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -62.86 -47.23 84.25 Favored 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 124.06 0.85 . . . . 72.21 111.237 -176.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -68.41 -35.31 77.46 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 115.689 -0.687 . . . . 75.03 110.6 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.45 ' N ' HD12 ' A' ' 512' ' ' LEU . 4.0 t-20 -63.87 -34.0 76.95 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 115.171 -0.922 . . . . 74.52 111.431 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 510' ' ' LYS . 84.0 t -57.22 -32.53 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 121.164 0.507 . . . . 75.1 110.731 177.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -107.85 4.77 25.81 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.489 -0.93 . . . . 70.55 108.489 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -126.96 -60.18 0.14 Allowed Glycine 0 N--CA 1.416 -2.666 0 C-N-CA 119.547 -1.311 . . . . 51.42 114.577 -169.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 64.8 25.12 12.89 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 122.561 1.172 . . . . 65.31 108.224 -171.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.6 p -82.87 -172.88 4.36 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 113.271 -1.786 . . . . 23.32 111.007 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 519' ' ' LYS . 0.1 OUTLIER -108.71 136.56 48.1 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.537 -1.282 . . . . 74.45 107.537 179.461 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -132.26 147.22 52.4 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.121 0.486 . . . . 74.33 111.699 -177.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 64.5 m -140.74 149.24 41.89 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.637 -0.875 . . . . 71.31 108.637 176.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -117.9 140.55 49.56 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 116.255 -0.429 . . . . 63.51 110.326 -176.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -132.23 130.51 41.06 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.421 -0.955 . . . . 43.21 108.421 176.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 27.0 m -88.61 126.78 35.45 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 120.933 0.397 . . . . 64.43 111.522 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.77 150.68 25.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.216 -1.031 . . . . 72.02 108.216 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -66.91 135.02 53.2 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.453 -0.573 . . . . 62.14 109.453 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 33.4 m -154.17 165.94 16.9 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 107.935 -1.135 . . . . 72.22 107.935 -177.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -83.42 -18.47 5.87 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 120.979 1.119 . . . . 73.31 111.394 172.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.444 HH21 ' CD ' ' A' ' 533' ' ' GLU . 25.1 mtp180 -79.17 145.72 65.52 Favored Pre-proline 0 N--CA 1.437 -1.086 0 C-N-CA 124.697 1.199 . . . . 72.22 109.668 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.5 146.3 97.15 Favored 'Trans proline' 0 C--O 1.25 1.087 0 C-N-CA 123.638 2.892 . . . . 73.52 115.056 -170.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.91 105.31 0.55 Allowed 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.859 -1.064 . . . . 75.23 112.012 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 142.51 -26.22 2.28 Favored Glycine 0 C--N 1.308 -1.011 0 N-CA-C 110.656 -0.977 . . . . 74.01 110.656 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 533' ' ' GLU . . . . . 0.444 ' CD ' HH21 ' A' ' 529' ' ' ARG . 43.9 tt0 -80.35 136.48 36.4 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 121.227 0.536 . . . . 74.34 110.182 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 536' ' ' GLY . 8.0 p -98.27 124.78 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.66 0 CA-C-N 115.491 -0.777 . . . . 63.0 109.104 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.43 8.95 40.28 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.827 -1.079 . . . . 63.02 113.465 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.498 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 127.82 -163.57 21.45 Favored Glycine 0 C--N 1.298 -1.57 0 C-N-CA 120.288 -0.958 . . . . 73.42 112.703 174.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 28.1 p -116.69 158.94 22.99 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.504 -0.925 . . . . 72.34 108.504 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -59.87 -57.08 29.46 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 120.134 -0.626 . . . . 60.5 110.352 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -68.81 144.68 60.09 Favored 'Trans proline' 0 C--N 1.376 1.984 0 CA-C-N 120.26 1.128 . . . . 75.5 110.72 173.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.7 157.64 60.87 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 123.063 2.508 . . . . 72.24 113.506 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.22 130.74 46.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.517 -0.765 . . . . 43.35 110.765 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.82 -12.79 41.89 Favored Glycine 0 C--N 1.303 -1.299 0 CA-C-N 116.025 -0.534 . . . . 72.34 112.236 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 45.8 m -73.83 125.72 28.79 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 110.174 -0.306 . . . . 74.52 110.174 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 11.7 t -81.39 124.36 29.34 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.38 -0.97 . . . . 65.25 108.38 176.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.2 m -123.95 159.26 57.18 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 107.903 -1.147 . . . . 75.24 107.903 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -66.69 137.66 46.59 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 120.723 0.948 . . . . 75.42 111.191 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.5 p -63.24 -23.61 33.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.233 -0.894 . . . . 71.45 112.104 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -101.7 3.17 39.42 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.744 -0.782 . . . . 72.51 110.194 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 9.9 t -95.86 -178.62 4.43 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 108.619 -0.882 . . . . 64.31 108.619 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.2 p -103.24 137.24 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 CA-C-O 121.635 0.731 . . . . 74.34 111.639 -174.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.37 128.24 50.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 106.647 -1.612 . . . . 74.44 106.647 175.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -103.4 117.5 34.62 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.613 0.72 . . . . 71.33 112.08 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.7 mp -102.04 130.65 48.66 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.368 -1.287 . . . . 73.31 110.17 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -93.58 115.85 28.35 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.752 0.787 . . . . 73.34 112.135 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 40.1 t -88.41 129.77 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 107.281 -1.378 . . . . 54.42 107.281 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.664 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 2.2 m -84.06 117.74 23.62 Favored 'General case' 0 C--N 1.271 -2.813 0 N-CA-C 108.498 -0.927 . . . . 73.32 108.498 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -94.32 125.75 39.16 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.77 -1.567 . . . . 72.33 106.77 171.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -61.85 -23.4 63.37 Favored Glycine 0 C--N 1.308 -1.011 0 N-CA-C 115.014 0.766 . . . . 73.4 115.014 -173.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 78.08 -20.3 0.39 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.87 1.268 . . . . 74.23 108.532 -175.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.472 ' H ' ' C ' ' A' ' 558' ' ' GLY . 78.3 mt-30 -112.78 148.17 35.36 Favored 'General case' 0 N--CA 1.403 -2.784 0 CA-C-N 115.376 -0.829 . . . . 75.13 111.012 -174.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -123.84 154.9 38.96 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 106.205 -1.776 . . . . 64.44 106.205 175.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 44.2 t -71.96 126.97 33.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 109.314 -0.624 . . . . 65.43 109.314 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.439 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 51.9 ttp -84.24 127.53 66.0 Favored Pre-proline 0 C--O 1.251 1.153 0 CA-C-N 116.28 -0.418 . . . . 72.03 110.19 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 564' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 11.9 Cg_exo -70.73 169.53 19.92 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.707 2.271 . . . . 65.24 111.101 175.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -72.53 142.13 48.49 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.381 0.61 . . . . 71.21 111.321 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.8 pp -154.87 25.9 0.44 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.599 -1.182 . . . . 64.4 109.624 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 21.7 m -79.58 146.81 32.38 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.101 -0.954 . . . . 53.14 110.372 -177.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 63.72 53.79 35.7 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.116 -0.564 . . . . 71.24 113.098 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -130.04 173.07 11.08 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.19 -1.041 . . . . 72.41 108.19 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -108.4 172.29 6.92 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.808 -1.182 . . . . 74.22 107.808 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 571' ' ' TRP . . . . . 0.521 ' CZ3' HD22 ' A' ' 587' ' ' LEU . 12.8 t-105 -65.93 -32.27 73.68 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.452 -0.944 . . . . 71.43 108.452 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.59 -15.1 18.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.537 -0.756 . . . . 73.53 111.238 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.557 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 25.9 t70 -101.07 -21.56 14.96 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.608 -0.886 . . . . 63.52 108.608 177.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -68.24 -39.18 82.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.189 -0.914 . . . . 61.53 111.92 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.644 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 2.7 tm-20 -58.77 -52.31 75.66 Favored Pre-proline 0 CA--C 1.57 1.742 0 N-CA-C 109.283 -0.636 . . . . 60.44 109.283 177.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 75.1 Cg_exo -55.23 -40.66 84.55 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 121.271 1.314 . . . . 72.35 112.486 171.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.557 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 16.7 mmt180 -61.62 -38.21 86.81 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 111.906 0.336 . . . . 62.02 111.906 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.1 pp -66.5 -47.13 73.99 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.969 -0.692 . . . . 40.35 110.964 -176.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.478 ' N ' HD12 ' A' ' 578' ' ' LEU . 14.7 ptm180 -66.12 -34.85 78.99 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.528 -0.305 . . . . 73.24 110.696 176.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.31 -39.52 92.59 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.823 -0.626 . . . . 45.41 111.284 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.423 HD11 ' HB2' ' A' ' 583' ' ' TRP . 1.1 pp -92.51 -8.73 43.67 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.01 -0.676 . . . . 71.34 110.963 -178.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 76.83 42.91 19.4 Favored Glycine 0 CA--C 1.517 0.165 0 N-CA-C 111.53 -0.628 . . . . 51.2 111.53 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.423 ' HB2' HD11 ' A' ' 581' ' ' LEU . 16.2 t90 -87.22 127.56 35.16 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 123.276 0.63 . . . . 75.4 110.145 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 5.8 m -103.99 -21.3 13.63 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.064 0.459 . . . . 73.04 111.557 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -72.56 177.97 39.7 Favored Glycine 0 C--O 1.241 0.567 0 CA-C-O 121.598 0.555 . . . . 73.11 114.472 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 586' ' ' MET . . . . . 0.434 ' O ' HG12 ' A' ' 619' ' ' ILE . 55.7 ttp -95.54 145.6 25.09 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 123.597 0.759 . . . . 61.43 110.654 -177.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 587' ' ' LEU . . . . . 0.521 HD22 ' CZ3' ' A' ' 571' ' ' TRP . 5.4 tt -85.64 112.44 21.01 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.438 -0.949 . . . . 73.42 108.438 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 621' ' ' THR . 25.4 t70 -101.83 105.26 16.08 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.686 0.755 . . . . 75.15 110.324 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.482 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.1 OUTLIER -90.48 133.87 34.75 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 115.033 -0.985 . . . . 74.24 108.561 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -73.35 -63.35 2.8 Favored Glycine 0 C--N 1.288 -2.106 0 N-CA-C 110.792 -0.923 . . . . 72.43 110.792 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.16 151.3 45.15 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.462 -0.369 . . . . 45.42 111.032 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -115.6 123.49 48.57 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 104.41 -2.441 . . . . 71.04 104.41 168.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 50.7 t -112.64 120.69 63.37 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 CA-C-N 116.007 -0.542 . . . . 52.52 109.579 -174.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 594' ' ' ASP . . . . . 0.446 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 21.9 t70 -76.35 106.7 8.12 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 106.385 -1.709 . . . . 70.12 106.385 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -134.83 8.0 3.51 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.607 -0.437 . . . . 44.44 111.75 -175.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 117.28 95.68 1.84 Allowed Glycine 0 N--CA 1.422 -2.241 0 C-N-CA 120.194 -1.003 . . . . 50.15 111.7 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.25 -31.29 59.24 Favored Glycine 0 C--N 1.32 -0.348 0 N-CA-C 111.951 -0.46 . . . . 32.14 111.951 177.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 46.4 t -59.4 -24.6 63.6 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.185 0.994 . . . . 54.22 110.669 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -87.33 -4.22 59.05 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.568 -0.742 . . . . 71.23 111.169 -175.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 39.6 m80 63.7 94.06 0.05 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 122.102 0.953 . . . . 71.22 111.051 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 601' ' ' ASN . . . . . 0.494 ' N ' HD22 ' A' ' 601' ' ' ASN . 0.8 OUTLIER -85.28 87.86 7.43 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.967 0.889 . . . . 72.24 112.215 -173.249 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -90.82 169.93 10.52 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.045 -1.434 . . . . 55.33 108.996 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.412 HG11 HD12 ' A' ' 622' ' ' LEU . 85.1 t -60.45 129.83 23.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.007 -0.738 . . . . 71.31 109.007 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 11.7 p -112.79 -35.75 2.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 O-C-N 123.645 0.591 . . . . 51.44 111.041 -175.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -136.58 139.62 42.28 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.306 -0.406 . . . . 63.15 110.082 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -137.75 139.2 39.97 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.295 -1.372 . . . . 71.13 107.295 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -65.7 -52.81 40.54 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 113.125 0.787 . . . . 73.24 113.125 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 609' ' ' PRO . 34.0 Cg_endo -85.92 125.19 2.69 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 CA-C-N 120.424 1.187 . . . . 53.01 110.941 176.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 609' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 11.6 Cg_exo -70.88 158.99 53.98 Favored 'Trans proline' 0 C--O 1.244 0.823 0 C-N-CA 122.382 2.055 . . . . 72.04 112.81 178.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.58 130.79 44.14 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 108.488 -0.93 . . . . 70.31 108.488 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 98.18 0.01 58.6 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 120.222 -0.989 . . . . 65.41 112.084 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 35.6 m -102.17 154.52 18.94 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.421 -0.955 . . . . 75.5 108.421 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.45 133.2 12.15 Favored Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 120.914 -0.66 . . . . 54.04 111.792 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.5 m -117.38 142.36 31.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.922 -0.77 . . . . 71.41 108.922 176.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.455 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 34.2 p30 -47.55 166.35 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 114.112 1.153 . . . . 64.53 114.112 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -61.35 -26.03 67.55 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.303 -0.862 . . . . 74.52 112.626 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -83.46 -10.89 58.08 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 119.037 -1.065 . . . . 72.11 109.481 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.73 9.77 56.73 Favored Glycine 0 CA--C 1.499 -0.946 0 N-CA-C 111.293 -0.723 . . . . 22.34 111.293 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 619' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 586' ' ' MET . 0.0 OUTLIER -70.45 118.83 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.167 0 CA-C-O 122.212 1.006 . . . . 73.13 108.615 -171.041 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.44 ' O ' HD12 ' A' ' 620' ' ' ILE . 2.7 pp -121.11 132.6 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.872 0 CA-C-N 114.02 -1.445 . . . . 52.44 110.251 -177.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 15.3 t -104.93 119.35 38.79 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.57 -0.9 . . . . 61.45 108.57 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.442 HD21 HD21 ' A' ' 587' ' ' LEU . 1.3 pt? -139.49 165.88 26.05 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.4 -0.818 . . . . 61.23 110.813 -175.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -128.82 142.32 51.01 Favored 'General case' 0 C--O 1.257 1.469 0 CA-C-O 121.279 0.561 . . . . 74.13 110.458 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -142.0 166.75 23.87 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.186 -1.413 . . . . 53.31 107.186 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -79.31 -142.94 2.55 Favored Glycine 0 C--N 1.294 -1.785 0 C-N-CA 119.107 -1.52 . . . . 64.34 113.096 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.446 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 6.5 tp-100 . . . . . 0 C--N 1.279 -2.488 0 N-CA-C 109.294 -0.632 . . . . 60.0 109.294 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 112.661 0.615 . . . . 73.33 112.661 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.0 p -139.21 143.43 38.06 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.675 -0.491 . . . . 75.4 109.675 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -131.81 143.47 50.22 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 121.197 0.523 . . . . 73.22 110.546 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 2.3 m-20 -88.32 121.85 31.18 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.897 -1.047 . . . . 72.21 109.817 -177.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.0 pt -86.62 122.56 71.7 Favored Pre-proline 0 C--N 1.302 -1.465 0 CA-C-N 116.318 -0.401 . . . . 71.31 110.637 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -85.86 -169.57 0.6 Allowed 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.294 1.996 . . . . 73.42 110.593 177.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -89.5 129.81 35.93 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.569 -0.9 . . . . 75.0 108.569 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.504 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 27.8 m -121.77 7.84 5.85 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 CA-C-N 115.208 -0.905 . . . . 71.13 109.969 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.97 103.78 4.59 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.397 -0.82 . . . . 74.13 110.119 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 161.98 -41.39 0.38 Allowed Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 115.517 -0.765 . . . . 44.54 111.195 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 14.3 pm0 -93.94 -177.51 4.36 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 108.984 -0.747 . . . . 71.54 108.984 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 7.8 m -70.56 155.4 40.77 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 108.467 -0.938 . . . . 73.34 108.467 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.472 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 11.5 p -64.87 -42.05 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 O-C-N 123.122 0.264 . . . . 74.53 110.717 -177.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -62.2 -40.72 97.04 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 109.866 -0.42 . . . . 72.52 109.866 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 84.4 t -66.14 -47.28 85.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.894 0 CA-C-N 115.271 -0.877 . . . . 60.35 109.333 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.504 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -60.9 -45.15 95.76 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 111.828 0.307 . . . . 72.44 111.828 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.5 mt-30 -64.88 -46.76 80.42 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 116.038 -0.528 . . . . 75.42 111.232 -177.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.515 ' O ' HG23 ' A' ' 514' ' ' VAL . 21.5 ptmt -67.49 -38.84 84.95 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 116.208 -0.451 . . . . 73.53 110.645 -178.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -62.87 -42.32 99.72 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.186 0.517 . . . . 61.13 111.15 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -68.71 -41.97 78.34 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.337 -0.847 . . . . 64.25 108.74 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -59.38 -40.84 87.82 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.644 1.178 . . . . 73.21 111.734 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 510' ' ' LYS . 91.6 t -57.58 -33.18 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 121.173 0.511 . . . . 74.21 111.507 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -114.84 16.42 17.3 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.621 -0.511 . . . . 73.2 109.621 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -133.94 -58.46 0.07 OUTLIER Glycine 0 N--CA 1.428 -1.879 0 C-N-CA 119.64 -1.267 . . . . 32.12 113.618 -173.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 64.07 28.2 14.22 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 122.629 1.204 . . . . 72.32 111.013 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.2 p -79.61 171.99 14.4 Favored 'General case' 0 N--CA 1.396 -3.137 0 CA-C-N 113.643 -1.617 . . . . 74.41 108.17 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.535 ' HD2' ' N ' ' A' ' 519' ' ' LYS . 10.2 mptt -107.56 136.06 47.96 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 107.549 -1.278 . . . . 73.53 107.549 -176.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -133.51 149.24 51.71 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.026 0.441 . . . . 72.1 112.145 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.7 m -138.73 142.93 38.88 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.076 -1.453 . . . . 63.03 107.076 174.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -117.54 137.75 52.36 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.62 -0.432 . . . . 72.23 111.094 -176.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -122.62 119.73 31.64 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.63 -0.878 . . . . 64.22 108.63 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 12.8 m -96.36 120.34 36.48 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.097 0.475 . . . . 74.11 111.17 -176.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.7 p -123.82 155.31 30.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.448 -1.316 . . . . 74.43 107.448 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.443 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 4.3 p30 -75.78 136.42 40.27 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.496 0.665 . . . . 72.51 111.745 -178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 64.9 m -160.45 159.69 26.06 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 107.047 -1.464 . . . . 52.35 107.047 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -65.58 -9.77 23.82 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 C-N-CA 122.788 2.326 . . . . 74.22 113.561 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.449 ' HB2' ' CB ' ' A' ' 556' ' ' SER . 14.7 mmm180 -78.36 141.94 62.21 Favored Pre-proline 0 N--CA 1.436 -1.15 0 N-CA-C 107.27 -1.382 . . . . 72.55 107.27 176.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -64.43 152.2 82.5 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 122.862 2.374 . . . . 73.14 113.958 -173.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.649 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.91 111.15 1.19 Allowed 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.815 -0.629 . . . . 63.54 111.963 -178.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 123.85 -16.17 7.83 Favored Glycine 0 C--N 1.299 -1.491 0 CA-C-N 115.283 -0.871 . . . . 52.04 112.121 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.16 138.36 34.74 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.535 -0.542 . . . . 64.15 109.535 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 6.1 p -87.16 116.84 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 CA-C-O 122.136 0.969 . . . . 74.0 109.48 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.97 -27.31 60.93 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 113.976 -1.466 . . . . 74.22 109.884 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.51 -162.31 29.54 Favored Glycine 0 N--CA 1.416 -2.651 0 N-CA-C 110.583 -1.007 . . . . 64.4 110.583 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 5.3 p -117.03 157.7 25.39 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 109.481 -0.563 . . . . 63.42 109.481 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.484 ' HB2' HE22 ' A' ' 554' ' ' GLN . 7.7 t30 -63.94 -54.14 43.21 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 120.766 -0.374 . . . . 72.45 110.2 174.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -69.32 134.4 28.81 Favored 'Trans proline' 0 C--N 1.369 1.617 0 N-CA-C 108.679 -1.316 . . . . 72.12 108.679 170.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.57 155.96 50.12 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 122.437 2.091 . . . . 51.22 112.93 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.4 131.21 45.86 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.964 -0.562 . . . . 73.51 109.718 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.84 -7.44 38.52 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 111.459 -0.656 . . . . 73.14 111.459 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 30.1 m -80.9 137.25 36.15 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.842 -0.429 . . . . 70.03 109.842 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 5.6 t -92.04 128.32 37.84 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 107.819 -1.178 . . . . 73.04 107.819 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 29.5 m -123.95 154.85 67.83 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.74 -0.837 . . . . 62.11 108.74 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -65.56 137.94 52.46 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 121.054 1.169 . . . . 74.41 111.269 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.6 -19.76 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-O 122.219 1.009 . . . . 74.34 109.691 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -84.76 -16.05 42.91 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.148 -1.387 . . . . 71.22 110.747 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 22.8 t -94.45 -173.29 3.01 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-N 115.869 -0.605 . . . . 71.2 110.737 -175.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.2 p -118.95 138.15 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 C-N-CA 123.6 0.76 . . . . 75.13 111.207 -175.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 43.8 mt -95.0 143.9 10.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.509 -0.922 . . . . 42.22 108.509 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -103.8 117.06 33.46 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.43 -0.952 . . . . 73.45 108.43 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.95 120.6 41.86 Favored 'General case' 0 C--N 1.311 -1.071 0 O-C-N 123.735 0.647 . . . . 71.44 110.083 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.484 HE22 ' HB2' ' A' ' 538' ' ' ASN . 2.6 mp0 -90.74 120.96 32.22 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.215 0.531 . . . . 63.34 109.991 176.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.459 HG22 HG21 ' A' ' 505' ' ' VAL . 23.9 t -105.59 137.22 36.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.216 -1.031 . . . . 74.31 108.216 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.649 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 71.2 m -89.89 133.15 34.92 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-O 120.756 0.312 . . . . 74.3 110.362 176.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 18.8 ptpt -106.1 127.18 53.01 Favored 'General case' 0 N--CA 1.406 -2.638 0 N-CA-C 104.317 -2.475 . . . . 72.24 104.317 164.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -55.42 -23.66 35.39 Favored Glycine 0 CA--C 1.506 -0.511 0 O-C-N 124.062 0.851 . . . . 55.14 114.128 -173.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 559' ' ' ASN . . . . . 0.443 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 19.6 t-20 81.77 -19.13 0.44 Allowed 'General case' 0 CA--C 1.495 -1.161 0 C-N-CA 126.236 1.815 . . . . 44.25 108.903 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.483 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 85.2 mt-30 -111.83 144.91 40.36 Favored 'General case' 0 N--CA 1.407 -2.59 0 CA-C-N 115.259 -0.882 . . . . 73.21 110.528 -173.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -123.29 146.67 47.71 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 107.535 -1.284 . . . . 64.21 107.535 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 84.5 t -62.33 116.63 2.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 123.66 0.6 . . . . 71.4 109.825 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.415 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 56.3 ttp -77.59 126.63 84.24 Favored Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 116.387 -0.37 . . . . 50.53 110.686 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 564' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 16.1 Cg_exo -69.45 168.49 21.01 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.5 2.133 . . . . 61.0 110.95 175.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -77.66 132.13 38.07 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 113.122 0.786 . . . . 74.21 113.122 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.0 pp -140.49 16.21 2.37 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.384 -1.28 . . . . 74.44 110.07 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 71.3 p -73.89 148.3 42.41 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 116.151 -0.477 . . . . 73.04 112.227 -175.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 72.97 57.28 5.35 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 115.689 -0.687 . . . . 61.33 113.987 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -136.93 167.93 20.54 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.115 -0.698 . . . . 72.43 109.115 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -95.5 165.76 12.19 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.387 -1.338 . . . . 75.5 107.387 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -67.21 -29.04 68.6 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.356 -0.609 . . . . 64.34 109.356 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.2 p -71.78 -22.81 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.558 0.694 . . . . 71.11 109.982 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -95.97 -34.29 11.84 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.039 -0.982 . . . . 55.24 108.936 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -54.7 -53.11 59.24 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 114.973 -1.012 . . . . 73.11 112.635 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.426 ' HB2' ' HD3' ' A' ' 576' ' ' PRO . 38.2 mt-10 -53.82 -54.95 40.91 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 115.122 1.527 . . . . 71.44 115.122 -176.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 24.5 Cg_exo -61.83 -28.11 81.17 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.413 1.409 . . . . 53.41 111.446 175.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -67.98 -35.12 77.82 Favored 'General case' 0 C--O 1.198 -1.646 0 CA-C-O 118.999 -0.524 . . . . 70.42 111.847 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.592 HD22 ' CE3' ' A' ' 583' ' ' TRP . 16.6 mt -60.25 -48.95 79.55 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.406 -0.59 . . . . 71.32 109.406 -176.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -66.5 -40.82 89.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.764 -0.653 . . . . 62.42 111.492 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.76 65.43 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.132 0.492 . . . . 74.24 111.762 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.7 tp -91.87 -9.11 44.49 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 124.33 1.052 . . . . 65.42 110.022 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.65 22.35 77.31 Favored Glycine 0 C--N 1.315 -0.588 0 C-N-CA 121.112 -0.566 . . . . 53.23 112.55 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.592 ' CE3' HD22 ' A' ' 578' ' ' LEU . 16.7 t90 -87.48 127.31 35.23 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.053 -0.721 . . . . 74.12 109.053 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 14.8 p -100.11 -14.49 18.55 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 113.877 1.066 . . . . 75.54 113.877 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 585' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -80.11 -159.29 18.73 Favored Glycine 0 C--N 1.313 -0.711 0 N-CA-C 114.321 0.488 . . . . 73.32 114.321 -175.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 65.7 mtt -114.41 139.5 49.45 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.868 0.366 . . . . 71.34 111.383 -174.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 21.5 tp -80.71 101.88 9.56 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 106.709 -1.589 . . . . 51.2 106.709 177.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 621' ' ' THR . 31.0 t70 -98.99 117.45 33.54 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.872 -0.331 . . . . 75.22 111.036 -173.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.0 OUTLIER -91.19 133.44 35.37 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 119.587 -0.845 . . . . 70.41 110.503 -179.102 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -74.34 -72.99 0.96 Allowed Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 110.798 -0.921 . . . . 42.33 110.798 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.16 142.28 35.97 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.715 -0.846 . . . . 75.35 108.715 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -79.88 123.58 27.89 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 107.079 -1.452 . . . . 74.55 107.079 174.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 50.4 t -104.68 128.28 58.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.398 -1.334 . . . . 72.25 107.398 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -72.01 114.04 9.68 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.768 -0.827 . . . . 54.52 108.768 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -124.53 -44.29 1.99 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.918 -1.037 . . . . 51.13 111.0 -173.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 109.08 122.52 4.62 Favored Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.561 -0.828 . . . . 44.32 112.111 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -61.22 -33.63 85.04 Favored Glycine 0 C--N 1.316 -0.548 0 CA-C-N 116.001 -0.1 . . . . 72.31 113.057 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 22.8 t -70.59 -22.85 62.51 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.94 0.876 . . . . 53.3 110.377 -177.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -87.12 -1.3 57.79 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.304 -0.862 . . . . 70.54 108.935 -175.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 69.77 82.63 0.16 Allowed 'General case' 0 CA--C 1.492 -1.274 0 C-N-CA 124.59 1.156 . . . . 73.42 108.611 -173.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -79.43 79.63 5.87 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 114.16 -1.382 . . . . 75.23 111.549 -176.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -87.68 173.23 9.15 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.746 -1.57 . . . . 73.21 108.234 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.489 HG11 HD12 ' A' ' 622' ' ' LEU . 91.1 t -58.68 130.4 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.322 -1.733 . . . . 74.12 106.322 168.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.2 m -101.57 -29.92 3.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 120.703 -0.399 . . . . 64.51 111.687 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -155.78 144.55 20.42 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 109.824 -0.436 . . . . 64.33 109.824 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -135.04 140.73 45.82 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.977 -1.49 . . . . 73.13 106.977 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.43 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 27.4 t-20 -66.32 -54.82 22.78 Favored Pre-proline 0 C--N 1.312 -1.046 0 C-N-CA 119.647 -0.821 . . . . 75.44 112.314 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.3 Cg_exo -84.8 119.16 2.17 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 121.996 1.797 . . . . 35.2 111.388 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.14 160.77 48.1 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 123.048 2.498 . . . . 53.05 112.252 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.07 134.94 51.46 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.657 -0.868 . . . . 62.41 108.657 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.32 -15.09 47.11 Favored Glycine 0 C--N 1.293 -1.81 0 N-CA-C 110.948 -0.861 . . . . 62.34 110.948 -175.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 37.3 m -92.61 146.77 23.41 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.042 -1.096 . . . . 64.35 108.042 178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -78.2 130.92 10.47 Favored Glycine 0 N--CA 1.426 -1.995 0 C-N-CA 121.163 -0.541 . . . . 70.44 112.427 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 26.8 m -114.69 142.12 28.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.829 -1.174 . . . . 65.31 107.829 176.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.483 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.9 p-10 -50.92 172.85 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.149 0.98 . . . . 64.4 113.397 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -54.71 -27.14 38.46 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 113.811 1.041 . . . . 74.41 113.811 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.422 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 1.2 m-20 -94.77 -6.5 42.89 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.17 -0.612 . . . . 62.11 110.645 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.49 19.19 68.59 Favored Glycine 0 C--O 1.214 -1.118 0 CA-C-O 119.806 -0.441 . . . . 71.14 113.35 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.72 119.15 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 122.083 0.944 . . . . 64.22 110.835 -167.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.415 HG22 ' HG2' ' A' ' 608' ' ' PRO . 48.7 pt -125.54 134.98 65.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.89 -1.05 . . . . 43.23 110.909 -176.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 15.1 t -100.31 125.37 46.52 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 108.461 -0.94 . . . . 73.34 108.461 177.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 1.8 pt? -139.32 165.27 27.63 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.285 -0.87 . . . . 73.42 110.288 -175.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -128.81 140.06 51.88 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.64 -0.504 . . . . 71.43 109.64 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 603' ' ' VAL . 5.2 p90 -130.97 165.16 23.76 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.862 0.363 . . . . 71.52 111.452 -174.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -76.96 141.89 26.82 Favored Glycine 0 N--CA 1.415 -2.762 0 CA-C-N 114.955 -1.021 . . . . 64.11 113.604 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 . . . . . 0 C--N 1.272 -2.798 0 N-CA-C 106.98 -1.489 . . . . 72.31 106.98 178.66 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 112.449 0.537 . . . . 72.3 112.449 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 546' ' ' PRO . 29.5 p -139.84 145.46 38.14 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.572 -0.529 . . . . 54.42 109.572 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -128.51 137.04 51.57 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 123.396 0.435 . . . . 74.32 110.305 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.587 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.9 p-10 -84.87 124.79 32.02 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.474 0.654 . . . . 54.43 110.099 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 497' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 498' ' ' PRO . 37.3 pt -84.89 125.35 71.02 Favored Pre-proline 0 C--N 1.305 -1.357 0 CA-C-N 115.673 -0.694 . . . . 63.35 111.735 -176.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 8.2 Cg_exo -74.44 172.65 15.7 Favored 'Trans proline' 0 C--O 1.254 1.28 0 C-N-CA 122.449 2.099 . . . . 62.34 111.124 174.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -80.25 105.44 11.52 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.989 -0.55 . . . . 73.32 109.616 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.432 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 15.4 m -106.87 59.3 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-O 123.24 1.495 . . . . 75.33 110.308 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -118.0 111.49 19.01 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 112.658 -2.064 . . . . 61.44 108.127 173.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 136.22 -15.85 3.93 Favored Glycine 0 C--N 1.303 -1.289 0 C-N-CA 119.042 -1.551 . . . . 61.22 113.937 177.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.469 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.4 OUTLIER -111.39 -175.46 2.71 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 117.695 0.748 . . . . 73.11 109.231 176.703 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 10.6 m -71.67 155.0 40.99 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.542 -0.91 . . . . 72.52 108.542 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.435 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.7 p -61.64 -42.48 94.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 111.508 0.188 . . . . 73.2 111.508 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 506' ' ' ASP . . . . . 0.433 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 25.7 t70 -62.51 -41.63 98.96 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.965 -0.383 . . . . 73.24 109.965 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 68.0 t -67.46 -41.66 86.3 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.966 0 CA-C-N 115.64 -0.709 . . . . 71.32 109.476 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.514 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -61.97 -43.51 98.69 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 121.365 -0.134 . . . . 72.34 111.146 176.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 26.3 mt-30 -64.85 -43.13 94.0 Favored 'General case' 0 CA--C 1.511 -0.539 0 O-C-N 123.089 0.243 . . . . 71.42 110.811 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.556 ' O ' HG23 ' A' ' 514' ' ' VAL . 75.9 mmtt -63.77 -46.6 84.52 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.586 -0.524 . . . . 64.41 109.586 176.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -63.57 -38.63 91.84 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.733 -0.667 . . . . 73.35 111.715 -177.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.71 -45.29 83.31 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.552 -1.277 . . . . 62.24 107.552 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -59.77 -36.1 75.97 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 124.03 0.932 . . . . 75.03 110.947 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 510' ' ' LYS . 83.5 t -57.2 -39.5 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 122.875 0.47 . . . . 51.24 111.317 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -105.0 -8.32 18.63 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.584 0.707 . . . . 73.25 110.012 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -108.43 -59.6 0.54 Allowed Glycine 0 N--CA 1.414 -2.802 0 CA-C-N 115.574 -0.739 . . . . 52.14 112.836 -169.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 65.44 25.81 11.92 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 122.398 1.094 . . . . 75.22 109.434 -173.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 547' ' ' VAL . 1.9 p -90.61 -172.99 3.59 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 113.741 -1.572 . . . . 75.51 110.239 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -108.75 142.05 39.86 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.38 -1.341 . . . . 72.42 107.38 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -132.44 153.11 51.18 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.11 0.481 . . . . 73.24 112.278 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.7 m -141.4 152.73 44.56 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.169 -1.048 . . . . 74.04 108.169 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -117.46 126.43 52.61 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.396 0.617 . . . . 60.41 111.719 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.02 130.38 56.17 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.891 -1.151 . . . . 65.13 107.891 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 18.7 p -103.87 139.58 38.86 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.323 0.582 . . . . 63.04 112.435 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.0 p -136.64 149.58 26.87 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 107.276 -1.379 . . . . 71.53 107.276 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 1.6 p-10 -87.61 136.83 32.79 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.93 -0.708 . . . . 73.2 110.521 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 50.6 m -156.27 163.79 23.67 Favored Pre-proline 0 C--N 1.293 -1.879 0 N-CA-C 106.415 -1.698 . . . . 75.24 106.415 -178.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.4 10.69 0.7 Allowed 'Trans proline' 0 CA--C 1.558 1.676 0 C-N-CA 121.935 1.757 . . . . 73.43 114.355 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.459 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 0.0 OUTLIER -96.59 140.99 22.46 Favored Pre-proline 0 C--O 1.214 -0.788 0 N-CA-C 108.686 -0.857 . . . . 74.1 108.686 177.524 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.1 145.88 73.15 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 123.251 2.634 . . . . 62.53 113.643 -176.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -66.83 99.39 0.62 Allowed 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.972 -1.013 . . . . 71.44 112.781 -174.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 152.3 -26.64 0.88 Allowed Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 115.045 -0.98 . . . . 64.52 110.734 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -74.39 131.4 41.06 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.687 0.756 . . . . 70.33 110.831 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.514 HG11 ' CB ' ' A' ' 508' ' ' ALA . 12.4 p -97.97 125.65 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.063 0 N-CA-C 107.33 -1.359 . . . . 73.51 107.33 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 p -97.59 10.95 38.58 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 115.184 -0.916 . . . . 65.44 113.024 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.466 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 133.18 -165.77 23.93 Favored Glycine 0 N--CA 1.434 -1.491 0 C-N-CA 119.963 -1.113 . . . . 74.04 113.448 173.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 14.2 p -116.94 158.4 24.13 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 124.293 1.037 . . . . 53.41 108.736 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.442 ' HB2' HE22 ' A' ' 554' ' ' GLN . 9.4 t30 -62.14 -50.4 80.38 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 119.31 -0.956 . . . . 61.41 112.454 178.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -69.17 143.27 53.12 Favored 'Trans proline' 0 C--N 1.367 1.529 0 N-CA-C 108.929 -1.219 . . . . 55.03 108.929 170.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.94 144.93 89.34 Favored 'Trans proline' 0 C--O 1.253 1.229 0 C-N-CA 122.411 2.074 . . . . 55.43 112.634 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.27 137.51 58.27 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.458 -0.792 . . . . 73.33 109.629 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.52 -12.59 47.17 Favored Glycine 0 C--N 1.304 -1.242 0 N-CA-C 111.48 -0.648 . . . . 63.24 111.48 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.417 ' O ' HG12 ' A' ' 497' ' ' ILE . 31.9 m -81.03 136.81 36.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.518 0.199 . . . . 61.13 110.895 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.2 t -90.59 128.32 36.55 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 108.214 -1.032 . . . . 41.3 108.214 173.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.77 153.99 67.0 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 108.907 -0.775 . . . . 52.13 108.907 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.457 ' HA ' HG22 ' A' ' 494' ' ' THR . 14.9 Cg_endo -60.54 138.19 78.61 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.76 1.64 . . . . 74.42 111.702 178.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.545 ' HA ' HG22 ' A' ' 518' ' ' THR . 8.7 p -61.27 -19.03 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 CA-C-O 122.177 0.989 . . . . 33.2 110.552 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -81.12 -15.8 54.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.638 -1.165 . . . . 75.54 111.954 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 77.6 p -92.79 157.96 16.14 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 112.905 0.706 . . . . 64.42 112.905 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.9 p -98.56 128.15 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 115.261 -0.881 . . . . 75.4 110.119 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.6 mt -98.95 136.05 31.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.508 -0.769 . . . . 62.1 109.798 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.88 125.25 50.16 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.889 0.852 . . . . 73.0 111.754 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.63 120.92 39.89 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 113.884 -1.507 . . . . 74.33 109.128 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.442 HE22 ' HB2' ' A' ' 538' ' ' ASN . 2.6 mp0 -85.7 108.5 18.07 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.731 0.777 . . . . 63.43 112.057 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 16.2 t -90.6 129.84 40.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 114.962 -1.017 . . . . 63.44 108.307 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 67.7 m -94.69 117.99 31.01 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 109.83 -0.433 . . . . 44.13 109.83 177.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.401 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 18.2 ptpt -90.94 136.74 32.87 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.431 -1.692 . . . . 75.12 106.431 173.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -62.85 -24.39 66.55 Favored Glycine 0 CA--C 1.489 -1.561 0 O-C-N 124.233 0.958 . . . . 65.11 114.423 -171.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 559' ' ' ASN . . . . . 0.457 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 31.7 t-20 77.75 -24.99 0.2 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.571 1.148 . . . . 64.24 109.574 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.444 ' H ' ' C ' ' A' ' 558' ' ' GLY . 86.5 mt-30 -111.46 150.46 29.85 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 115.782 -0.645 . . . . 63.4 111.078 -174.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -132.35 149.86 52.27 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.347 -1.297 . . . . 75.42 107.622 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 63.2 t -68.25 125.72 26.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 109.833 -0.432 . . . . 71.14 109.833 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 48.1 ttp -92.18 125.63 55.88 Favored Pre-proline 0 C--N 1.308 -1.233 0 CA-C-N 116.072 -0.513 . . . . 60.21 111.184 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.81 155.01 71.57 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.957 2.438 . . . . 71.45 111.027 174.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 565' ' ' ASP . . . . . 0.524 ' HA ' ' CB ' ' A' ' 610' ' ' ALA . 29.4 t70 -67.03 139.42 57.63 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 114.851 1.426 . . . . 65.52 114.851 -174.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 566' ' ' LEU . . . . . 0.417 ' O ' ' HG2' ' A' ' 569' ' ' MET . 2.1 pt? -141.35 15.63 2.21 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.772 -1.103 . . . . 63.43 109.688 176.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 84.2 p -80.06 153.28 28.88 Favored 'General case' 0 C--O 1.251 1.161 0 C-N-CA 120.171 -0.611 . . . . 65.31 110.571 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 79.08 31.49 42.76 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.856 -0.688 . . . . 52.22 113.91 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 569' ' ' MET . . . . . 0.487 ' SD ' ' HG3' ' A' ' 577' ' ' ARG . 21.5 ptp -134.01 -179.07 5.32 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.795 -0.817 . . . . 24.02 108.795 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -101.82 167.43 10.08 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.275 -1.38 . . . . 74.54 107.275 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 -67.24 -30.01 69.8 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.678 -0.86 . . . . 73.12 108.678 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 11.5 p -72.11 -16.83 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 115.395 -0.821 . . . . 74.21 110.34 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.613 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 18.6 t70 -101.35 -39.16 7.72 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.706 -0.85 . . . . 73.14 108.706 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.7 -42.46 97.23 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 115.034 -0.984 . . . . 55.44 112.019 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.539 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 39.2 tt0 -55.4 -53.18 64.96 Favored Pre-proline 0 CA--C 1.569 1.701 0 CA-C-O 119.142 -0.456 . . . . 72.01 111.776 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 71.6 Cg_exo -55.77 -30.33 75.72 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 122.124 1.883 . . . . 74.1 112.6 171.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 11.4 mmm180 -62.81 -38.29 90.14 Favored 'General case' 0 C--O 1.202 -1.421 0 C-N-CA 120.707 -0.397 . . . . 74.44 110.816 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.741 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 10.5 mp -58.01 -49.28 77.4 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 118.001 0.364 . . . . 72.41 110.807 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -66.17 -40.87 90.8 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.62 -0.718 . . . . 72.33 112.675 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.02 -27.78 64.96 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.898 0.38 . . . . 33.35 111.735 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 8.3 tp -89.73 -9.36 49.67 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 123.939 0.896 . . . . 55.04 110.545 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 68.73 32.11 73.9 Favored Glycine 0 C--O 1.243 0.672 0 C-N-CA 120.829 -0.701 . . . . 72.52 111.995 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.741 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 10.9 t90 -87.03 126.78 34.97 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 107.576 -1.268 . . . . 73.04 107.576 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 4.2 p -91.78 -27.95 17.68 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 113.031 0.752 . . . . 62.41 113.031 -174.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -71.7 179.36 34.23 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 116.122 -0.49 . . . . 75.15 112.878 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 62.6 mtm -107.28 148.8 28.52 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.073 0.463 . . . . 74.34 111.056 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 29.9 tp -80.63 111.47 17.09 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 107.182 -1.414 . . . . 75.41 107.182 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.58 ' O ' ' HA ' ' A' ' 621' ' ' THR . 15.3 t70 -97.94 114.92 27.15 Favored 'General case' 0 CA--C 1.485 -1.531 0 CA-C-N 116.086 -0.506 . . . . 74.11 110.237 -174.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.468 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.1 OUTLIER -91.6 133.45 35.54 Favored 'General case' 0 C--N 1.276 -2.6 0 C-N-CA 119.853 -0.739 . . . . 72.2 109.399 177.67 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -83.01 -61.77 1.89 Allowed Glycine 0 C--N 1.291 -1.952 0 N-CA-C 109.884 -1.286 . . . . 74.55 109.884 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.67 149.45 43.73 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 109.348 -0.612 . . . . 52.55 109.348 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -90.06 150.14 22.21 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.221 -1.029 . . . . 61.04 108.221 176.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 19.9 t -117.44 136.7 53.75 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 108.636 -0.876 . . . . 55.2 108.636 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.59 106.97 5.59 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.709 -1.219 . . . . 54.43 107.709 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -120.42 -61.5 1.57 Allowed 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.618 -0.719 . . . . 75.41 109.342 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 89.08 151.83 24.84 Favored Glycine 0 N--CA 1.419 -2.457 0 C-N-CA 119.575 -1.298 . . . . 70.32 111.238 -176.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.4 -33.69 62.34 Favored Glycine 0 C--N 1.3 -1.441 0 N-CA-C 114.649 0.62 . . . . 73.25 114.649 -177.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 32.2 t -73.1 -24.89 60.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.95 0.881 . . . . 75.31 109.794 -176.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -99.83 -3.38 32.72 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.044 -0.98 . . . . 65.12 109.645 -177.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 56.6 m80 74.37 126.98 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.201 1.4 . . . . 72.13 112.677 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -83.74 51.07 1.93 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.249 1.023 . . . . 72.22 108.987 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.402 ' HE ' ' HB3' ' A' ' 602' ' ' ARG . 37.4 mtp180 -83.91 158.17 21.69 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.729 -1.123 . . . . 52.31 113.299 -176.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.16 131.73 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 106.136 -1.801 . . . . 61.32 106.136 167.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 44.0 t -97.47 -44.07 12.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-O 121.594 0.712 . . . . 64.52 109.512 -177.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -154.24 145.38 22.81 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.431 -0.804 . . . . 74.35 110.167 -176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -126.41 133.58 51.24 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 105.833 -1.914 . . . . 72.52 105.833 174.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.408 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 65.7 t30 -63.52 -51.09 69.47 Favored Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 112.744 0.646 . . . . 41.1 112.744 -174.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.5 Cg_exo -87.65 111.15 0.76 Allowed 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 122.002 1.801 . . . . 64.43 109.815 172.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.92 143.49 45.38 Favored 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 122.588 2.192 . . . . 73.0 113.485 -177.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 610' ' ' ALA . . . . . 0.524 ' CB ' ' HA ' ' A' ' 565' ' ' ASP . . . -65.82 139.85 58.35 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.81 -0.632 . . . . 72.42 109.737 176.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.45 -9.16 44.96 Favored Glycine 0 C--N 1.301 -1.365 0 N-CA-C 109.578 -1.409 . . . . 43.32 109.578 -172.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 63.0 m -108.67 154.18 22.38 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.491 -0.929 . . . . 75.11 108.491 176.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -72.74 128.54 12.59 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 111.898 -0.481 . . . . 75.43 111.898 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 30.1 m -112.7 143.14 23.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 123.666 0.786 . . . . 70.31 109.464 178.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.437 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 9.4 p30 -43.56 167.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 125.492 1.517 . . . . 71.1 113.259 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -57.29 -25.35 59.13 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 113.907 1.077 . . . . 74.23 113.907 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -93.04 -7.57 45.33 Favored 'General case' 0 C--O 1.208 -1.103 0 C-N-CA 119.327 -0.949 . . . . 75.12 108.543 -178.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 68.09 11.7 61.62 Favored Glycine 0 CA--C 1.491 -1.444 0 CA-C-N 115.557 -0.747 . . . . 64.24 111.788 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.46 118.85 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-O 122.279 1.037 . . . . 51.44 111.627 -169.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 45.0 pt -121.18 134.33 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 113.8 -1.546 . . . . 51.31 110.265 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 14.1 t -98.66 131.31 44.94 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 108.035 -1.098 . . . . 73.34 108.035 177.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -139.36 167.57 21.79 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.863 -0.608 . . . . 71.22 111.733 -174.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -126.75 136.42 52.4 Favored 'General case' 0 C--O 1.255 1.392 0 N-CA-C 107.228 -1.397 . . . . 71.02 107.228 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -141.39 163.23 33.5 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.448 -0.342 . . . . 75.42 110.603 -172.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -76.27 129.43 10.06 Favored Glycine 0 N--CA 1.416 -2.643 0 O-C-N 123.827 0.705 . . . . 63.21 111.545 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 . . . . . 0 C--N 1.299 -1.6 0 C-N-CA 123.948 0.899 . . . . 63.24 109.678 -179.503 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.374 0 CA-C-O 120.861 0.362 . . . . 64.24 110.329 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 25.4 p -130.89 140.32 50.2 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.891 -0.411 . . . . 71.44 109.891 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.564 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 8.8 tmtm? -150.56 144.22 25.17 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.724 -1.213 . . . . 75.43 107.724 172.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.564 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 9.6 p-10 -78.58 130.13 35.59 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.48 0.657 . . . . 60.21 110.808 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 29.3 pt -87.24 133.69 38.17 Favored Pre-proline 0 C--N 1.288 -2.103 0 C-N-CA 120.212 -0.595 . . . . 73.41 110.331 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -69.52 170.87 15.29 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 121.864 1.709 . . . . 74.12 111.85 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -78.01 83.23 4.32 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 122.876 1.322 . . . . 73.11 110.626 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.434 ' HB ' ' CB ' ' A' ' 508' ' ' ALA . 26.9 m -86.73 -6.82 10.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 114.399 -1.273 . . . . 72.13 112.268 -177.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.67 101.85 3.76 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.817 -0.809 . . . . 61.3 108.817 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 157.18 -38.54 0.56 Allowed Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.799 -0.715 . . . . 50.45 111.89 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 17.4 pm0 -97.54 -168.02 1.62 Allowed 'General case' 0 C--O 1.243 0.738 0 C-N-CA 120.761 -0.376 . . . . 63.41 110.006 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.402 ' HB ' HG23 ' A' ' 507' ' ' VAL . 14.5 m -70.15 155.35 40.76 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.21 -0.663 . . . . 74.55 109.21 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.427 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.3 p -63.18 -41.45 92.86 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.547 0 O-C-N 123.302 0.376 . . . . 65.51 110.72 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 506' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 18.7 t70 -59.84 -42.91 94.64 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.891 0.377 . . . . 63.0 110.04 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.402 HG23 ' HB ' ' A' ' 504' ' ' THR . 61.6 t -68.32 -45.42 82.58 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.622 0 CA-C-N 115.352 -0.84 . . . . 62.41 109.226 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.434 ' CB ' ' HB ' ' A' ' 500' ' ' VAL . . . -58.83 -45.38 90.15 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 120.638 0.256 . . . . 75.51 111.006 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 97.8 mt-30 -64.12 -45.64 87.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.972 -0.558 . . . . 72.43 111.237 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.563 ' O ' HG23 ' A' ' 514' ' ' VAL 0.314 0.0 OUTLIER -67.32 -37.65 83.66 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 119.632 -0.827 . . . . 73.14 111.607 177.353 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 511' ' ' ASN . . . . . 0.456 ' N ' ' HD3' ' A' ' 510' ' ' LYS . 7.9 m-20 -60.45 -50.2 74.53 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 116.276 -0.42 . . . . 62.51 110.723 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.451 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -68.05 -36.25 79.56 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.937 -0.574 . . . . 71.02 111.239 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.451 ' N ' HD12 ' A' ' 512' ' ' LEU . 26.8 t30 -65.9 -38.43 88.73 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 122.999 0.52 . . . . 41.34 110.528 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 510' ' ' LYS . 78.2 t -59.59 -32.98 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.093 0.473 . . . . 64.02 111.102 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -111.54 16.35 20.73 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.881 -0.328 . . . . 74.24 110.275 -177.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -143.01 -53.83 0.03 OUTLIER Glycine 0 CA--C 1.488 -1.62 0 C-N-CA 119.421 -1.371 . . . . 43.05 113.826 -173.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 61.46 39.37 15.09 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.652 1.215 . . . . 74.43 108.899 -174.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 547' ' ' VAL . 20.3 p -91.23 -172.24 3.23 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 112.814 -1.994 . . . . 65.45 109.3 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.5 142.38 39.0 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.393 -1.336 . . . . 71.23 107.393 176.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -131.53 152.05 51.07 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.401 0.619 . . . . 74.22 112.244 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 20.4 p -140.29 146.42 38.52 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 107.962 -1.125 . . . . 71.1 107.962 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -119.79 129.47 54.47 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.237 -0.585 . . . . 74.35 110.942 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -121.01 118.7 30.5 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.945 -0.761 . . . . 72.02 108.945 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.8 m -90.78 137.09 32.63 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.132 0.491 . . . . 53.42 111.895 -176.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 47.2 t -128.89 149.06 33.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 105.793 -1.929 . . . . 62.21 105.793 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.1 135.68 36.38 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 118.327 0.512 . . . . 63.54 110.941 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 42.9 m -159.46 169.75 9.92 Favored Pre-proline 0 C--N 1.31 -1.151 0 N-CA-C 107.623 -1.251 . . . . 52.24 107.623 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -73.12 -13.78 25.97 Favored 'Trans proline' 0 C--O 1.25 1.078 0 C-N-CA 122.004 1.803 . . . . 73.43 112.838 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.516 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 48.6 mtt180 -73.35 143.05 82.41 Favored Pre-proline 0 N--CA 1.442 -0.825 0 N-CA-C 108.988 -0.745 . . . . 74.13 108.988 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.71 144.6 97.36 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 122.5 2.133 . . . . 74.33 112.034 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.642 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.78 99.21 0.08 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.367 -0.833 . . . . 62.42 111.762 -178.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 153.56 -22.4 0.73 Allowed Glycine 0 N--CA 1.423 -2.185 0 C-N-CA 120.573 -0.823 . . . . 53.14 112.154 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 533' ' ' GLU . . . . . 0.516 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 32.6 tt0 -79.99 138.35 37.03 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 117.239 0.52 . . . . 74.04 109.97 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 5.1 p -91.97 113.2 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 N-CA-C 108.502 -0.925 . . . . 74.31 108.502 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.54 -33.25 73.78 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.199 -1.364 . . . . 72.42 110.189 -177.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 167.91 177.78 39.44 Favored Glycine 0 N--CA 1.42 -2.401 0 CA-C-N 115.089 -0.959 . . . . 63.33 110.959 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 537' ' ' THR . . . . . 0.425 HG22 HD13 ' A' ' 553' ' ' LEU . 10.0 p -118.1 153.83 33.11 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 108.502 -0.925 . . . . 71.52 108.502 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -72.32 -48.01 10.08 Favored Pre-proline 0 C--N 1.318 -0.784 0 C-N-CA 118.235 -1.386 . . . . 75.34 110.246 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 32.3 Cg_exo -62.52 131.5 34.03 Favored 'Trans proline' 0 C--N 1.381 2.274 0 N-CA-C 108.529 -1.373 . . . . 61.3 108.529 169.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 540' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 8.3 Cg_exo -69.01 139.97 44.24 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 122.184 1.923 . . . . 75.32 114.732 -173.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -68.66 133.66 48.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.93 -1.032 . . . . 65.51 110.415 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 91.16 -19.29 47.45 Favored Glycine 0 C--N 1.306 -1.115 0 N-CA-C 110.839 -0.904 . . . . 53.42 110.839 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.2 m -87.82 139.46 30.5 Favored 'General case' 0 N--CA 1.413 -2.324 0 C-N-CA 123.623 0.769 . . . . 74.31 110.555 -175.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 3.4 t -72.45 124.6 25.51 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.662 -0.699 . . . . 64.24 109.323 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.72 163.82 36.68 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 107.236 -1.394 . . . . 73.34 107.236 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -76.46 135.3 16.32 Favored 'Trans proline' 0 N--CA 1.423 -2.642 0 CA-C-N 120.004 1.037 . . . . 72.1 111.715 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.711 ' HA ' HG22 ' A' ' 518' ' ' THR . 35.3 t -67.53 -24.91 31.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-N 114.122 -1.399 . . . . 61.43 110.46 176.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -78.19 -17.86 56.23 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.441 -1.254 . . . . 73.45 111.509 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 94.6 p -90.82 177.38 6.32 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.637 -0.425 . . . . 73.15 110.993 -177.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 12.9 p -109.07 126.31 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.831 0 CA-C-O 121.75 0.786 . . . . 72.21 109.908 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 63.1 mt -86.11 129.45 38.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 108.794 -0.817 . . . . 63.05 108.794 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -103.79 117.32 34.08 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.718 0.771 . . . . 75.14 110.664 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.425 HD13 HG22 ' A' ' 537' ' ' THR . 2.7 mm? -95.45 114.03 25.75 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.653 -1.612 . . . . 73.05 108.218 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -84.32 116.39 22.99 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.922 -0.77 . . . . 74.12 108.922 176.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 524' ' ' SER . 23.9 t -104.15 131.79 52.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 115.099 -0.955 . . . . 61.13 109.244 -175.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 74.1 m -84.76 122.22 28.8 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 109.621 -0.511 . . . . 43.13 109.621 175.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.0 ptpt -93.49 141.25 28.68 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 104.672 -2.344 . . . . 74.22 104.672 169.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.584 ' O ' ' HG3' ' A' ' 560' ' ' GLN . . . -66.46 -27.17 72.95 Favored Glycine 0 CA--C 1.488 -1.649 0 C-N-CA 120.138 -1.03 . . . . 44.34 110.652 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 559' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 64.4 t30 65.27 11.84 7.58 Favored 'General case' 0 C--O 1.216 -0.689 0 C-N-CA 124.697 1.199 . . . . 63.21 109.885 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.584 ' HG3' ' O ' ' A' ' 558' ' ' GLY . 40.9 mt-30 -124.68 142.85 51.09 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 115.478 -0.783 . . . . 51.44 109.21 -176.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 561' ' ' PHE . . . . . 0.407 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 53.6 p90 -123.34 148.24 46.21 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.389 -0.967 . . . . 71.12 108.389 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.1 122.14 14.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.144 0.497 . . . . 72.25 111.002 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.432 ' SD ' HD13 ' A' ' 620' ' ' ILE . 56.9 ttp -97.45 122.43 55.58 Favored Pre-proline 0 C--N 1.31 -1.133 0 CA-C-N 115.885 -0.598 . . . . 74.23 110.953 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -68.15 169.81 15.88 Favored 'Trans proline' 0 C--O 1.241 0.661 0 C-N-CA 123.065 2.51 . . . . 72.04 110.843 172.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 565' ' ' ASP . . . . . 0.443 ' HB3' ' HB2' ' A' ' 610' ' ' ALA . 5.8 p-10 -77.6 142.42 38.95 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.138 0.494 . . . . 75.12 110.569 -178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 566' ' ' LEU . . . . . 0.461 ' O ' ' HG2' ' A' ' 569' ' ' MET . 2.0 pt? -126.69 5.29 6.73 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 122.206 1.003 . . . . 73.21 108.91 174.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 567' ' ' SER . . . . . 0.485 ' HA ' ' HB ' ' A' ' 603' ' ' VAL . 29.0 t -79.44 140.62 37.31 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 107.808 -1.182 . . . . 64.2 107.808 176.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 99.39 -2.46 57.6 Favored Glycine 0 C--N 1.302 -1.314 0 C-N-CA 120.018 -1.086 . . . . 74.11 112.878 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 569' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 24.0 ptp -120.06 169.35 10.29 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.561 -0.903 . . . . 73.34 108.561 177.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -92.59 171.59 8.92 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.004 -1.11 . . . . 70.42 108.004 -174.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -62.44 -32.87 73.79 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.69 -0.856 . . . . 74.13 108.69 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 30.7 m -68.9 -12.88 16.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 CA-C-N 116.076 -0.511 . . . . 43.14 112.107 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -102.27 -43.91 5.57 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 110.033 -0.358 . . . . 75.25 110.033 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -61.32 -39.5 90.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.799 -0.637 . . . . 74.11 112.235 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.658 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 44.0 tt0 -63.16 -53.36 54.87 Favored Pre-proline 0 CA--C 1.561 1.382 0 CA-C-N 116.622 -0.263 . . . . 74.12 111.494 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 92.7 Cg_exo -54.14 -40.43 81.87 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 121.547 1.498 . . . . 75.33 112.315 171.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.423 ' HE ' ' HA ' ' A' ' 577' ' ' ARG . 0.3 OUTLIER -59.24 -42.49 91.2 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.479 0.18 . . . . 64.32 110.634 178.428 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.5 pp -66.17 -46.85 75.94 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 120.359 -0.536 . . . . 62.23 111.716 -175.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.451 ' N ' HD12 ' A' ' 578' ' ' LEU . 1.7 ptm180 -66.24 -36.23 82.46 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.792 -0.64 . . . . 64.33 111.563 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -71.17 -37.99 72.18 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 112.367 0.506 . . . . 63.31 112.367 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.0 pp -80.65 -8.66 59.7 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.22 0.533 . . . . 72.43 110.496 -176.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 85.6 32.55 18.65 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 115.46 -0.791 . . . . 71.12 112.509 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -77.02 126.2 30.57 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 107.197 -1.408 . . . . 73.44 107.197 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 2.1 p -106.08 6.42 31.07 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 112.833 0.679 . . . . 54.11 112.833 -175.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 585' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -95.68 -152.96 29.68 Favored Glycine 0 N--CA 1.436 -1.338 0 N-CA-C 110.723 -0.951 . . . . 73.43 110.723 174.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 57.6 ttp -136.87 147.0 46.23 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.03 -1.1 . . . . 71.11 108.03 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 587' ' ' LEU . . . . . 0.448 HD21 HD11 ' A' ' 622' ' ' LEU . 6.0 tt -80.16 118.34 21.77 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.494 -0.928 . . . . 62.3 108.494 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 621' ' ' THR . 26.5 t70 -98.76 120.61 39.48 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.641 -0.708 . . . . 71.34 109.332 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.485 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.1 OUTLIER -98.5 133.21 43.18 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 119.194 -1.002 . . . . 73.31 108.724 176.447 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -85.2 -51.64 3.67 Favored Glycine 0 C--N 1.284 -2.35 0 N-CA-C 109.616 -1.394 . . . . 71.21 109.616 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -134.81 117.69 16.2 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 109.362 -0.607 . . . . 62.42 109.362 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -105.31 123.84 48.53 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.712 -1.218 . . . . 62.43 107.712 173.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 53.9 t -112.09 129.34 67.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 109.087 -0.708 . . . . 55.33 109.087 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 594' ' ' ASP . . . . . 0.42 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 23.3 t70 -72.67 114.47 10.84 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 108.798 -0.816 . . . . 61.31 108.798 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -124.27 -57.41 1.59 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.572 -0.74 . . . . 55.34 109.843 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 106.53 151.16 18.47 Favored Glycine 0 N--CA 1.423 -2.222 0 C-N-CA 120.062 -1.066 . . . . 60.31 110.863 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.498 ' HA2' ' OD1' ' A' ' 601' ' ' ASN . . . -58.77 -33.99 75.43 Favored Glycine 0 C--N 1.311 -0.811 0 N-CA-C 115.038 0.775 . . . . 43.32 115.038 -177.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 11.3 t -74.83 -23.91 58.53 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 122.125 0.964 . . . . 74.02 109.117 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -89.84 0.18 57.19 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.822 -1.081 . . . . 73.44 110.301 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 27.3 m170 78.41 85.67 0.07 Allowed 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 125.821 1.648 . . . . 60.31 109.789 -177.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 601' ' ' ASN . . . . . 0.498 ' OD1' ' HA2' ' A' ' 597' ' ' GLY . 26.0 p-10 -89.15 58.91 4.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 122.987 1.375 . . . . 75.24 110.428 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -97.16 163.59 12.86 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.893 -1.503 . . . . 74.31 108.431 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.485 ' HB ' ' HA ' ' A' ' 567' ' ' SER . 92.8 t -70.17 130.52 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 104.74 -2.318 . . . . 71.13 104.74 168.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 13.4 p -103.11 -35.52 3.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 121.289 0.566 . . . . 73.53 111.133 -173.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -146.1 134.62 22.05 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 109.147 -0.686 . . . . 74.15 109.147 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -115.78 131.93 56.79 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.402 -1.703 . . . . 74.15 106.402 174.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.453 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 20.8 t-20 -58.25 -51.7 79.87 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 112.376 0.51 . . . . 73.21 112.376 -175.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.1 Cg_endo -87.13 118.97 1.44 Allowed 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.234 1.289 . . . . 74.23 109.494 172.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -64.56 159.71 43.39 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 122.549 2.166 . . . . 64.3 111.906 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 610' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 565' ' ' ASP . . . -60.9 135.23 57.72 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.174 -0.466 . . . . 71.41 110.415 177.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.43 -11.94 47.3 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 111.35 -0.7 . . . . 73.13 111.35 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 34.2 m -82.1 136.75 35.14 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.592 -0.521 . . . . 75.53 109.592 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 613' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -77.33 123.13 6.36 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 110.271 -1.131 . . . . 63.02 110.271 175.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.6 m -113.62 142.38 26.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 109.643 -0.503 . . . . 64.12 109.643 178.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 559' ' ' ASN . 29.9 p30 -48.59 164.62 0.06 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.176 1.176 . . . . 74.04 114.176 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -57.74 -27.9 63.42 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.788 0.835 . . . . 72.33 112.629 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.444 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 4.4 p-10 -90.24 -9.37 48.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 119.486 -0.885 . . . . 72.43 110.459 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.11 14.86 62.1 Favored Glycine 0 CA--C 1.49 -1.503 0 C-N-CA 124.065 0.841 . . . . 61.34 114.685 163.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.05 117.66 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-O 122.566 1.174 . . . . 44.14 110.869 -167.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.432 HD13 ' SD ' ' A' ' 563' ' ' MET . 49.3 pt -129.81 135.28 61.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 113.755 -1.566 . . . . 71.24 110.37 -177.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 13.8 t -99.21 129.87 45.48 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 108.235 -1.024 . . . . 75.32 108.235 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.448 HD11 HD21 ' A' ' 587' ' ' LEU . 4.0 pp -138.76 167.13 22.65 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 116.136 -0.484 . . . . 75.34 111.462 -178.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -128.09 136.33 51.04 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.808 -0.812 . . . . 71.42 108.808 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.422 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 18.8 p90 -142.55 165.58 27.02 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 116.187 -0.46 . . . . 75.12 111.827 -172.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -86.73 132.47 11.17 Favored Glycine 0 N--CA 1.42 -2.407 0 N-CA-C 109.221 -1.552 . . . . 40.23 109.221 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.42 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 65.5 tt0 . . . . . 0 C--N 1.279 -2.463 0 C-N-CA 123.066 0.547 . . . . 38.01 109.593 -178.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.605 0 CA-C-O 121.599 0.714 . . . . 72.51 109.899 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 13.0 p -129.96 155.32 46.26 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 115.53 -0.759 . . . . 72.23 110.827 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -143.11 146.36 33.7 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.426 -0.806 . . . . 53.33 109.758 176.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.565 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.1 p-10 -91.56 140.03 30.12 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.094 -0.706 . . . . 73.02 109.094 177.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.4 pt -96.53 124.6 50.24 Favored Pre-proline 0 C--N 1.298 -1.664 0 CA-C-N 115.673 -0.694 . . . . 70.21 110.467 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -66.76 157.5 60.85 Favored 'Trans proline' 0 C--O 1.245 0.829 0 C-N-CA 122.475 2.117 . . . . 65.24 111.843 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 499' ' ' ASP . . . . . 0.429 ' HA ' ' HB1' ' A' ' 541' ' ' ALA . 27.1 t70 -77.65 99.98 6.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.587 0.708 . . . . 63.21 109.704 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 30.3 m -105.63 11.14 8.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 114.96 -1.018 . . . . 74.12 112.169 -175.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -80.01 96.96 6.59 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.036 0.445 . . . . 53.31 110.798 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 162.38 -40.93 0.37 Allowed Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.777 -0.725 . . . . 74.32 111.914 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 16.1 pm0 -90.77 -171.89 3.19 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 110.251 -0.277 . . . . 74.55 110.251 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 28.1 m -70.1 155.0 41.23 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.818 -0.808 . . . . 52.21 108.818 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.42 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.2 p -62.48 -41.63 92.62 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 O-C-N 123.075 0.235 . . . . 44.44 110.722 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -59.4 -40.83 87.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.385 0.612 . . . . 74.3 109.645 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.436 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 75.4 t -71.88 -45.95 62.61 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.608 0 CA-C-N 115.292 -0.867 . . . . 74.11 110.057 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.463 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -58.85 -44.34 90.99 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 111.917 0.34 . . . . 73.21 111.917 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.6 mt-30 -62.42 -45.79 91.53 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.295 -0.411 . . . . 43.32 110.957 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.568 ' O ' HG23 ' A' ' 514' ' ' VAL . 16.6 ptpt -67.97 -38.82 83.19 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 120.486 -0.485 . . . . 75.3 110.175 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -60.84 -47.36 86.7 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 116.056 -0.52 . . . . 74.34 110.86 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 513' ' ' ASN . 3.9 pp -68.48 -35.73 77.95 Favored 'General case' 0 C--O 1.211 -0.923 0 CA-C-N 115.863 -0.608 . . . . 64.2 111.154 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.48 ' N ' HD12 ' A' ' 512' ' ' LEU . 4.1 t-20 -66.02 -34.86 79.06 Favored 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 123.287 0.635 . . . . 74.22 111.99 -178.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 510' ' ' LYS . 89.1 t -57.0 -32.42 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 121.491 0.663 . . . . 65.41 110.354 177.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -114.45 17.26 17.5 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.757 -0.656 . . . . 70.14 109.666 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -138.09 -55.03 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 119.923 -1.132 . . . . 63.21 113.57 -174.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 66.87 17.85 10.58 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.277 1.037 . . . . 73.35 109.922 -176.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.7 p -78.13 -170.7 2.06 Favored 'General case' 0 N--CA 1.411 -2.401 0 C-N-CA 125.481 1.512 . . . . 65.32 111.492 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -108.24 143.12 37.5 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.013 -1.477 . . . . 74.23 107.013 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -132.7 150.43 52.16 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.242 -0.583 . . . . 74.45 111.938 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.2 m -140.83 146.29 37.37 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.98 -1.489 . . . . 71.41 106.98 175.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -118.08 136.01 53.83 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 120.13 -0.628 . . . . 74.01 110.104 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -130.29 131.95 45.67 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.624 -0.88 . . . . 55.1 108.624 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 73.1 m -100.18 131.36 46.17 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.542 0.687 . . . . 71.02 112.596 -178.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 556' ' ' SER . 7.4 p -121.78 149.27 25.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.373 -1.714 . . . . 72.52 106.373 176.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -76.83 135.63 38.9 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 121.49 0.662 . . . . 61.22 111.674 -176.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 50.3 m -162.79 156.09 17.0 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 106.338 -1.727 . . . . 61.32 106.338 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -63.93 -3.12 5.35 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 122.762 2.308 . . . . 74.24 114.288 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -80.12 136.58 53.62 Favored Pre-proline 0 CA--C 1.51 -0.587 0 N-CA-C 106.967 -1.494 . . . . 65.54 106.967 176.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -61.6 147.94 94.2 Favored 'Trans proline' 0 C--O 1.256 1.382 0 C-N-CA 122.343 2.028 . . . . 50.31 112.701 -175.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -56.61 115.89 2.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.292 -0.867 . . . . 61.51 110.88 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 134.21 -27.78 3.24 Favored Glycine 0 N--CA 1.434 -1.436 0 C-N-CA 120.825 -0.703 . . . . 45.33 111.643 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -80.85 135.68 35.97 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-O 121.254 0.549 . . . . 74.33 110.295 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.463 HG11 ' CB ' ' A' ' 508' ' ' ALA . 7.2 p -96.67 120.78 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.722 0 N-CA-C 107.702 -1.221 . . . . 73.13 107.702 178.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.2 p -97.74 -1.23 43.85 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.167 -0.924 . . . . 74.53 113.132 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 163.23 -166.56 37.13 Favored Glycine 0 N--CA 1.423 -2.219 0 C-N-CA 120.278 -0.963 . . . . 53.24 111.52 176.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 2.4 p -135.39 152.91 51.87 Favored 'General case' 0 C--N 1.273 -2.746 0 N-CA-C 107.866 -1.161 . . . . 65.44 107.866 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.48 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 62.0 t30 -58.29 -50.83 85.93 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 119.834 -0.747 . . . . 72.24 111.201 175.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 4.8 Cg_exo -81.36 128.47 6.27 Favored 'Trans proline' 0 C--N 1.37 1.676 0 N-CA-C 107.568 -1.743 . . . . 44.11 107.568 168.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.38 140.31 88.41 Favored 'Trans proline' 0 C--O 1.245 0.846 0 C-N-CA 122.42 2.08 . . . . 75.1 113.04 -176.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 541' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' A' ' 499' ' ' ASP . . . -64.82 138.65 58.51 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.91 -0.587 . . . . 71.55 110.122 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.72 -11.58 57.8 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 120.752 -0.737 . . . . 71.15 111.294 -176.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 18.4 m -88.32 137.49 32.28 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.167 -0.309 . . . . 75.53 110.167 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 13.3 t -81.16 129.79 34.73 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 109.233 -0.655 . . . . 51.1 109.233 173.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.5 m -123.83 164.13 30.95 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 107.315 -1.365 . . . . 73.52 107.315 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -68.23 139.38 45.88 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 120.936 1.09 . . . . 63.03 110.646 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.8 p -62.6 -20.3 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 CA-C-N 115.696 -0.684 . . . . 70.12 112.296 -175.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -93.31 -7.35 45.14 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.757 0.313 . . . . 54.4 110.916 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 69.9 m -82.06 165.69 20.4 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.697 0.761 . . . . 73.54 112.624 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.2 p -102.31 137.7 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.292 0 CA-C-N 114.697 -1.138 . . . . 54.14 109.554 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 60.2 mt -101.96 132.38 48.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.076 -1.083 . . . . 63.4 108.076 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -102.8 117.95 35.75 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.218 0.532 . . . . 61.41 110.541 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.421 HD12 HG21 ' A' ' 534' ' ' VAL . 3.6 mm? -88.31 114.47 24.97 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.394 -1.275 . . . . 72.31 108.522 178.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -83.27 101.7 11.45 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.226 -1.028 . . . . 74.41 108.226 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 524' ' ' SER . 17.2 t -96.06 144.18 10.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 107.541 -1.281 . . . . 73.31 107.541 -177.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 67.9 m -97.8 133.82 41.79 Favored 'General case' 0 N--CA 1.394 -3.245 0 C-N-CA 119.444 -0.902 . . . . 65.04 110.694 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -97.5 129.5 44.67 Favored 'General case' 0 N--CA 1.405 -2.706 0 N-CA-C 103.882 -2.636 . . . . 63.42 103.882 168.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -60.47 -23.92 61.02 Favored Glycine 0 CA--C 1.49 -1.507 0 O-C-N 123.923 0.764 . . . . 62.12 113.599 -173.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 79.95 -15.54 0.74 Allowed 'General case' 0 C--O 1.211 -0.967 0 C-N-CA 124.946 1.298 . . . . 71.43 107.87 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.469 ' H ' ' C ' ' A' ' 558' ' ' GLY . 92.7 mt-30 -112.62 145.04 41.09 Favored 'General case' 0 N--CA 1.402 -2.832 0 CA-C-N 114.71 -1.132 . . . . 73.2 110.496 -175.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 561' ' ' PHE . . . . . 0.43 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 48.5 p90 -123.84 154.53 39.49 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 107.193 -1.41 . . . . 71.01 107.193 177.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.25 121.89 16.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.018 0.437 . . . . 70.45 110.864 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.617 ' SD ' HG21 ' A' ' 620' ' ' ILE . 47.4 ttp -79.23 122.73 84.53 Favored Pre-proline 0 C--N 1.316 -0.86 0 N-CA-C 109.653 -0.499 . . . . 63.54 109.653 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.77 169.62 20.71 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.214 1.942 . . . . 72.31 111.006 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -72.01 118.18 14.55 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.536 0.684 . . . . 54.14 110.424 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.9 pp -136.11 11.55 3.32 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.206 -0.907 . . . . 75.12 110.477 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 2.2 t -80.24 144.15 33.14 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.318 -0.855 . . . . 65.34 109.985 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 80.82 70.01 1.36 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.643 -0.789 . . . . 42.14 113.58 175.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -163.91 179.85 6.76 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.345 -1.354 . . . . 72.35 107.345 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 570' ' ' PHE . . . . . 0.457 ' HB2' HG12 ' A' ' 572' ' ' VAL . 26.1 m-85 -95.14 176.4 6.24 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.567 -0.531 . . . . 71.5 109.567 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 571' ' ' TRP . . . . . 0.554 ' CZ3' HD22 ' A' ' 587' ' ' LEU . 11.6 t-105 -71.56 -28.1 63.62 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.989 -1.486 . . . . 74.41 106.989 175.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 572' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 570' ' ' PHE . 9.0 p -71.61 -6.72 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-N 115.429 -0.805 . . . . 72.31 110.264 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 6.7 m-20 -101.11 -45.06 5.5 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.341 -0.985 . . . . 65.12 108.341 171.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -63.21 -46.0 89.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.331 -0.849 . . . . 72.32 113.25 -176.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.501 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 31.4 tt0 -64.19 -49.94 70.69 Favored Pre-proline 0 CA--C 1.561 1.376 0 N-CA-C 111.838 0.31 . . . . 74.52 111.838 -177.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 51.5 Cg_exo -61.1 -34.42 89.7 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.675 1.583 . . . . 75.44 112.279 174.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 30.6 mmm180 -68.98 -33.97 74.55 Favored 'General case' 0 C--O 1.216 -0.663 0 C-N-CA 120.147 -0.621 . . . . 75.2 110.625 176.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.523 ' HG ' ' HB3' ' A' ' 583' ' ' TRP . 5.4 tt -60.41 -48.87 79.89 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.348 0.659 . . . . 74.51 109.363 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 576' ' ' PRO . 7.7 ptm180 -66.25 -41.09 90.44 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.914 0.339 . . . . 73.44 111.914 176.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.42 -37.01 82.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.152 -0.476 . . . . 72.33 112.168 -177.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.56 -9.28 54.86 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.154 0.502 . . . . 65.33 110.02 -177.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 70.52 46.66 46.63 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.768 -0.933 . . . . 71.13 110.768 -178.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.523 ' HB3' ' HG ' ' A' ' 578' ' ' LEU . 11.3 t90 -73.39 126.76 30.9 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 109.357 -0.608 . . . . 74.31 109.357 -177.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 584' ' ' THR . . . . . 0.432 ' OG1' ' HA ' ' A' ' 617' ' ' ASP . 7.6 p -90.42 -24.38 20.77 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.409 -0.814 . . . . 53.24 112.101 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -85.19 -174.3 50.15 Favored Glycine 0 N--CA 1.432 -1.589 0 CA-C-N 116.076 -0.511 . . . . 61.14 113.075 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 27.4 ttt -117.33 149.04 41.14 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.967 -0.383 . . . . 60.44 109.967 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 587' ' ' LEU . . . . . 0.554 HD22 ' CZ3' ' A' ' 571' ' ' TRP . 6.1 tt -80.7 108.83 14.67 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.27 -1.382 . . . . 62.14 107.27 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.411 ' O ' ' HA ' ' A' ' 621' ' ' THR . 21.8 t70 -105.37 119.28 38.7 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.942 -0.572 . . . . 74.55 111.612 -177.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.1 OUTLIER -111.91 133.21 54.25 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.035 -1.098 . . . . 74.22 108.035 171.86 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -111.01 -5.13 27.26 Favored Glycine 0 C--N 1.297 -1.625 0 C-N-CA 120.096 -1.05 . . . . 65.11 112.83 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.35 130.57 26.7 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 121.137 -0.225 . . . . 73.11 110.743 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.35 124.2 31.02 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 123.907 0.755 . . . . 62.54 109.829 176.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 593' ' ' VAL . . . . . 0.508 ' O ' ' HA2' ' A' ' 625' ' ' GLY . 86.9 t -104.64 131.85 52.7 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 105.22 -2.141 . . . . 71.52 105.22 171.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -82.88 122.95 28.91 Favored 'General case' 0 C--N 1.281 -2.406 0 C-N-CA 118.681 -1.208 . . . . 72.33 110.93 -177.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -147.46 -68.86 0.24 Allowed 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.002 -1.453 . . . . 72.23 108.359 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 92.75 157.8 33.85 Favored Glycine 0 N--CA 1.417 -2.628 0 C-N-CA 119.827 -1.178 . . . . 54.21 110.985 -176.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -57.99 -37.63 86.06 Favored Glycine 0 C--N 1.291 -1.931 0 N-CA-C 115.441 0.936 . . . . 61.35 115.441 -176.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 36.4 m -76.11 -24.55 54.98 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-N 118.05 0.925 . . . . 74.45 110.628 -174.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -89.13 -0.04 57.12 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.601 -1.181 . . . . 72.33 111.458 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 40.1 m80 77.6 89.79 0.07 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.619 1.2 . . . . 74.25 109.833 -176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -81.62 85.99 6.46 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 113.93 -1.487 . . . . 74.01 109.964 -171.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -111.52 170.03 8.4 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.567 0.951 . . . . 70.11 113.567 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.419 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 99.3 t -77.72 133.27 30.88 Favored 'Isoleucine or valine' 0 C--O 1.248 0.995 0 CA-C-N 114.27 -1.332 . . . . 72.11 108.05 173.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.5 m -112.21 -42.42 4.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 120.285 -0.566 . . . . 71.53 112.36 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -144.69 151.04 38.32 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.969 -0.382 . . . . 72.21 109.969 -174.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 606' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 622' ' ' LEU . 16.4 pt20 -140.06 144.67 36.97 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 123.491 0.494 . . . . 50.24 110.355 177.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.43 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 58.4 t30 -64.77 -51.82 55.12 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-N 116.181 -0.463 . . . . 61.23 111.734 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.4 Cg_exo -85.21 115.74 1.69 Allowed 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 121.756 1.637 . . . . 73.31 110.134 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 609' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 11.5 Cg_exo -70.21 152.31 66.92 Favored 'Trans proline' 0 C--O 1.256 1.379 0 C-N-CA 122.401 2.067 . . . . 74.11 111.799 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -58.71 135.84 57.54 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.49 -0.559 . . . . 75.3 109.49 176.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 103.23 -7.36 51.61 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.571 -0.823 . . . . 60.04 111.908 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 28.0 m -93.78 144.46 25.39 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.237 -0.653 . . . . 63.41 109.237 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 613' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -70.34 131.22 22.08 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 111.952 -0.459 . . . . 73.24 111.952 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.7 m -124.56 141.64 44.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.917 -0.772 . . . . 74.42 108.917 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.414 ' N ' ' HG2' ' A' ' 560' ' ' GLN . 28.4 p-10 -51.52 171.72 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.204 1.402 . . . . 64.23 114.301 -176.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.68 -27.1 37.81 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.824 1.046 . . . . 52.22 113.824 -179.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.432 ' HA ' ' OG1' ' A' ' 584' ' ' THR . 11.0 m-20 -87.74 -8.18 56.36 Favored 'General case' 0 C--O 1.198 -1.632 0 C-N-CA 119.149 -1.02 . . . . 74.53 110.988 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.02 17.81 65.99 Favored Glycine 0 C--O 1.219 -0.784 0 C-N-CA 121.755 -0.259 . . . . 60.21 112.661 173.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.96 119.28 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 121.724 0.773 . . . . 72.21 110.726 -169.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.617 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.6 pp -123.76 133.29 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 115.29 -0.868 . . . . 64.11 112.546 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 14.2 t -102.86 122.48 44.63 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 122.118 0.961 . . . . 74.24 109.26 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -136.64 169.43 17.73 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.777 -1.101 . . . . 71.42 110.471 -173.944 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -125.95 135.84 52.33 Favored 'General case' 0 C--O 1.261 1.667 0 N-CA-C 107.866 -1.161 . . . . 75.11 107.866 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.419 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 3.7 p90 -142.98 169.05 18.29 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.783 -1.192 . . . . 74.31 107.783 -175.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 625' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 593' ' ' VAL . . . -49.47 109.5 0.62 Allowed Glycine 0 CA--C 1.544 1.896 0 O-C-N 124.193 0.933 . . . . 61.55 113.549 175.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 . . . . . 0 C--O 1.253 1.277 0 C-N-CA 125.816 1.646 . . . . 64.25 112.934 176.843 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.69 0 N-CA-C 112.976 0.732 . . . . 73.53 112.976 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 19.3 p -141.0 142.42 34.27 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.936 -0.478 . . . . 73.32 110.521 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -138.88 135.01 34.04 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.75 -0.833 . . . . 64.5 108.75 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.631 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.3 p-10 -83.66 144.99 29.03 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.186 0.517 . . . . 74.43 110.318 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.5 pt -90.38 116.92 67.5 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 115.13 -0.941 . . . . 62.42 111.086 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 498' ' ' PRO . . . . . 0.487 ' HD2' HD22 ' A' ' 512' ' ' LEU . 27.5 Cg_exo -66.2 160.57 44.3 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.484 2.122 . . . . 72.44 111.106 173.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -67.91 110.99 4.11 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.801 0.81 . . . . 74.45 110.423 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 14.2 m -130.27 65.17 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 122.757 1.265 . . . . 63.54 109.494 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -128.99 93.29 3.56 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 113.559 -1.655 . . . . 73.34 108.382 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 160.82 -38.73 0.43 Allowed Glycine 0 N--CA 1.428 -1.861 0 C-N-CA 119.905 -1.14 . . . . 54.54 112.787 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.555 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.3 OUTLIER -89.71 -170.27 2.76 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 110.231 -0.285 . . . . 74.34 110.231 -178.784 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.52 ' HB ' HG23 ' A' ' 507' ' ' VAL . 21.3 m -71.79 155.58 40.28 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.15 -0.685 . . . . 62.41 109.15 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.6 p -60.38 -41.77 88.48 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.587 0 O-C-N 123.243 0.34 . . . . 73.22 111.391 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.77 -40.7 97.34 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 109.684 -0.487 . . . . 74.45 109.684 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 507' ' ' VAL . . . . . 0.52 HG23 ' HB ' ' A' ' 504' ' ' THR . 47.8 t -67.03 -42.88 89.09 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.177 0 N-CA-C 109.073 -0.714 . . . . 64.02 109.073 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.609 ' HB2' HG11 ' A' ' 534' ' ' VAL . . . -59.34 -45.55 91.05 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.855 0.36 . . . . 75.34 110.959 177.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 26.0 mt-30 -65.32 -42.58 92.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.66 -0.7 . . . . 55.3 110.689 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.61 ' O ' HG23 ' A' ' 514' ' ' VAL . 45.0 mmtm -61.63 -45.69 92.97 Favored 'General case' 0 CA--C 1.495 -1.152 0 O-C-N 123.392 0.433 . . . . 65.13 110.122 177.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -61.88 -41.49 97.92 Favored 'General case' 0 N--CA 1.435 -1.221 0 O-C-N 123.821 0.701 . . . . 72.33 110.89 -176.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.487 HD22 ' HD2' ' A' ' 498' ' ' PRO . 0.2 OUTLIER -68.04 -46.62 70.63 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.859 -1.064 . . . . 63.12 108.208 -179.196 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -61.7 -35.87 79.28 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 124.001 0.92 . . . . 64.15 111.612 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 510' ' ' LYS . 89.6 t -57.62 -38.97 67.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 O-C-N 123.269 0.356 . . . . 74.34 111.525 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -105.21 -3.73 22.57 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.458 0.647 . . . . 74.04 109.523 -176.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -116.33 -58.64 0.32 Allowed Glycine 0 N--CA 1.42 -2.4 0 CA-C-N 115.473 -0.785 . . . . 71.13 113.828 -170.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 63.31 26.78 15.2 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 122.351 1.072 . . . . 75.32 110.212 -172.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.4 p -83.46 -177.14 6.62 Favored 'General case' 0 N--CA 1.403 -2.817 0 CA-C-N 113.872 -1.513 . . . . 71.11 109.447 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -107.99 139.69 42.24 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.371 -1.344 . . . . 64.13 107.371 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -129.2 149.07 51.16 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-O 121.117 0.485 . . . . 63.13 111.255 -176.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.3 m -139.97 152.44 46.32 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 106.688 -1.597 . . . . 71.03 106.688 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -122.84 142.07 51.16 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 112.51 0.559 . . . . 71.22 112.51 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 523' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -132.26 143.33 49.84 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.086 -1.45 . . . . 63.01 107.086 176.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 80.2 p -103.14 138.11 40.41 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.427 -0.909 . . . . 63.0 111.676 -175.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.9 p -121.43 149.64 24.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 106.547 -1.649 . . . . 71.14 106.547 177.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -72.32 136.93 46.34 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.521 -0.548 . . . . 74.23 109.521 -177.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.468 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 56.6 m -153.51 160.07 31.37 Favored Pre-proline 0 C--N 1.291 -1.971 0 N-CA-C 107.768 -1.197 . . . . 73.12 107.768 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.32 -2.75 12.96 Favored 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 121.865 1.71 . . . . 73.32 113.09 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.18 152.02 38.56 Favored Pre-proline 0 N--CA 1.451 -0.412 0 N-CA-C 109.624 -0.51 . . . . 71.34 109.624 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -57.34 146.61 81.85 Favored 'Trans proline' 0 C--O 1.25 1.087 0 C-N-CA 122.96 2.44 . . . . 72.43 113.458 -177.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.708 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.16 99.83 0.11 Allowed 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 114.943 -1.026 . . . . 73.32 111.651 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 157.82 -23.09 0.4 Allowed Glycine 0 C--N 1.3 -1.464 0 CA-C-N 115.758 -0.656 . . . . 74.44 111.874 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -74.38 144.74 44.25 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.349 -0.982 . . . . 74.23 108.349 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.609 HG11 ' HB2' ' A' ' 508' ' ' ALA . 11.0 p -91.38 118.6 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.413 0 CA-C-O 121.854 0.835 . . . . 64.43 108.779 176.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.83 -23.59 60.79 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.514 -1.221 . . . . 61.44 109.374 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 138.99 -152.8 22.41 Favored Glycine 0 N--CA 1.421 -2.305 0 N-CA-C 110.581 -1.007 . . . . 63.05 110.581 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.0 p -116.48 157.93 24.4 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 109.71 -0.478 . . . . 71.21 109.71 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.461 ' HB2' HE22 ' A' ' 554' ' ' GLN . 26.5 t-20 -66.45 -53.68 28.79 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 120.236 -0.586 . . . . 74.13 110.261 173.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 37.0 Cg_endo -67.71 149.82 79.03 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 121.319 1.346 . . . . 62.23 109.767 173.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 540' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 23.5 Cg_exo -64.04 139.36 66.85 Favored 'Trans proline' 0 C--O 1.246 0.923 0 C-N-CA 121.659 1.572 . . . . 70.12 113.02 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.97 137.43 55.13 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-N 115.204 -0.907 . . . . 61.4 110.178 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 93.81 -11.8 70.42 Favored Glycine 0 N--CA 1.442 -0.967 0 C-N-CA 121.092 -0.575 . . . . 61.14 111.668 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 51.8 m -88.52 137.83 31.97 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 122.745 0.418 . . . . 72.12 110.358 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.9 t -74.74 136.83 41.74 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.95 -0.568 . . . . 62.1 109.729 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.3 m -130.89 154.46 81.96 Favored Pre-proline 0 C--N 1.312 -1.064 0 N-CA-C 108.161 -1.051 . . . . 64.32 108.161 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -61.72 136.88 65.02 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.15 1.233 . . . . 54.4 111.202 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 13.3 p -65.99 -23.22 31.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.724 0.773 . . . . 64.14 111.872 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -78.06 -17.41 57.04 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.096 -0.502 . . . . 74.53 110.75 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 25.2 t -78.29 162.54 26.44 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.885 0.85 . . . . 74.24 111.499 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.8 p -98.64 137.74 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.388 0 CA-C-N 114.246 -1.343 . . . . 74.55 108.282 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 61.7 mt -100.88 137.53 28.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.168 -0.678 . . . . 74.41 109.168 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -103.24 117.78 35.29 Favored 'General case' 0 C--O 1.254 1.336 0 N-CA-C 108.816 -0.809 . . . . 73.52 108.816 -177.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -101.49 120.36 40.17 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 123.735 0.814 . . . . 71.32 109.624 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.461 HE22 ' HB2' ' A' ' 538' ' ' ASN . 2.8 mp0 -86.52 123.17 31.43 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 121.17 0.51 . . . . 73.43 110.795 178.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 39.6 t -96.01 132.19 40.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.781 -1.192 . . . . 61.15 107.781 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.708 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 13.0 m -79.7 117.35 20.53 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 107.033 -1.469 . . . . 52.14 107.033 176.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 21.3 pttm -107.52 128.78 54.82 Favored 'General case' 0 N--CA 1.422 -1.869 0 C-N-CA 119.566 -0.854 . . . . 72.32 108.838 173.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 527' ' ' SER . . . -58.61 -24.83 57.5 Favored Glycine 0 CA--C 1.501 -0.79 0 O-C-N 124.462 1.101 . . . . 74.34 113.993 -175.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 73.93 -0.16 3.44 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.995 1.318 . . . . 73.22 109.8 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.478 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 70.3 mt-30 -113.74 149.63 34.54 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 115.661 -0.699 . . . . 72.04 111.971 -174.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -124.12 158.79 31.47 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.454 -1.248 . . . . 64.3 108.351 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.15 126.94 37.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.336 0.589 . . . . 53.45 110.516 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 18.8 ttt -78.21 125.15 85.47 Favored Pre-proline 0 N--CA 1.432 -1.344 0 C-N-CA 124.542 1.137 . . . . 52.44 111.436 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.66 169.43 22.58 Favored 'Trans proline' 0 C--O 1.245 0.869 0 C-N-CA 122.805 2.336 . . . . 74.04 111.125 174.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.79 116.79 26.19 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.86 0.838 . . . . 75.51 111.36 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 566' ' ' LEU . . . . . 0.441 ' H ' HD23 ' A' ' 566' ' ' LEU . 2.1 pt? -117.64 9.11 13.01 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.204 -1.406 . . . . 70.22 107.204 170.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 22.0 t -80.65 147.22 30.77 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 114.211 -1.359 . . . . 62.41 107.953 176.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 66.75 56.74 11.68 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 121.357 -0.449 . . . . 55.14 112.897 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 22.9 ptp -168.49 179.76 4.23 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.165 -1.791 . . . . 75.1 106.165 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 570' ' ' PHE . . . . . 0.457 ' HB2' HG12 ' A' ' 572' ' ' VAL . 52.3 m-85 -100.1 170.45 8.47 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.06 -0.719 . . . . 73.24 109.06 -176.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 571' ' ' TRP . . . . . 0.427 ' CH2' HD22 ' A' ' 587' ' ' LEU . 12.1 t-105 -65.63 -27.53 68.45 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 108.569 -0.9 . . . . 52.43 108.569 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 572' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 570' ' ' PHE . 14.6 p -71.16 -13.2 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 115.735 -0.666 . . . . 73.23 110.479 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -99.41 -35.87 9.77 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 109.017 -0.735 . . . . 73.31 109.017 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 574' ' ' ALA . . . . . 0.64 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -62.64 -39.61 94.41 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 115.323 -0.853 . . . . 74.05 110.397 177.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.416 ' HB3' ' CD ' ' A' ' 576' ' ' PRO . 2.5 tm-20 -51.3 -59.13 8.42 Favored Pre-proline 0 CA--C 1.585 2.303 0 C-N-CA 124.138 0.975 . . . . 75.34 110.57 -178.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.416 ' CD ' ' HB3' ' A' ' 575' ' ' GLU . 19.8 Cg_endo -61.57 -32.49 87.78 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 121.891 1.727 . . . . 61.41 113.013 175.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 7.6 mmp_? -61.98 -41.25 97.82 Favored 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 120.593 -0.443 . . . . 74.41 110.726 177.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 16.8 mt -65.99 -46.39 78.19 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-O 120.782 0.325 . . . . 62.21 110.465 -175.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -65.76 -39.73 91.34 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 112.472 0.545 . . . . 73.05 112.472 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -69.17 -33.61 73.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.878 0.371 . . . . 62.4 111.247 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.3 tp -81.01 -10.16 59.74 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 121.471 0.653 . . . . 55.35 110.156 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 62.0 35.6 91.65 Favored Glycine 0 C--O 1.224 -0.496 0 CA-C-N 115.961 -0.563 . . . . 54.31 112.569 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.477 ' CE3' HD22 ' A' ' 578' ' ' LEU . 18.4 t90 -78.83 126.68 31.03 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.638 -0.504 . . . . 74.14 109.638 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 12.9 t -109.39 6.62 24.49 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 111.966 0.358 . . . . 63.22 111.966 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 585' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -89.11 -171.82 45.8 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 119.955 -1.117 . . . . 73.42 111.261 176.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 94.4 mmm -105.05 139.16 40.15 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 116.749 0.274 . . . . 61.32 110.375 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 587' ' ' LEU . . . . . 0.427 HD22 ' CH2' ' A' ' 571' ' ' TRP . 6.4 tt -80.64 110.01 15.72 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 107.354 -1.35 . . . . 74.12 107.354 176.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.509 ' O ' ' HA ' ' A' ' 621' ' ' THR . 30.6 t70 -95.65 114.23 25.95 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.909 -1.041 . . . . 72.21 109.679 -178.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.452 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -110.9 134.78 52.28 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 108.172 -1.047 . . . . 73.04 108.172 177.862 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -101.07 -89.69 2.07 Favored Glycine 0 C--N 1.268 -3.197 0 CA-C-N 115.306 -0.861 . . . . 43.43 112.646 -175.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -99.63 149.15 23.58 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.025 0.44 . . . . 73.22 111.665 -176.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -93.45 139.18 31.0 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.395 -0.965 . . . . 71.04 108.395 176.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 39.5 t -105.11 153.96 6.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 109.014 -0.735 . . . . 74.42 109.014 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -73.11 119.2 17.02 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 121.599 0.714 . . . . 75.43 109.728 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -143.46 -65.35 0.38 Allowed 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.154 -1.424 . . . . 73.3 107.154 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 100.05 158.8 28.34 Favored Glycine 0 N--CA 1.4 -3.753 0 C-N-CA 119.967 -1.111 . . . . 70.53 112.074 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.23 -32.38 60.19 Favored Glycine 0 C--N 1.302 -1.324 0 C-N-CA 123.689 0.662 . . . . 45.45 113.514 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 26.8 t -69.5 -23.91 63.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 122.057 0.932 . . . . 61.2 109.828 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 55.9 mm-40 -100.96 -12.09 19.2 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.553 -0.748 . . . . 73.12 109.712 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 43.7 m80 67.11 172.69 0.26 Allowed 'General case' 0 C--O 1.242 0.658 0 C-N-CA 124.603 1.161 . . . . 75.13 111.824 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -89.55 84.85 6.39 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 112.526 0.565 . . . . 72.21 112.526 -174.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 624' ' ' PHE . 48.0 mtp180 -91.08 145.96 24.24 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.09 -0.959 . . . . 73.54 110.542 176.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.403 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 59.5 t -74.43 130.51 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 105.904 -1.887 . . . . 53.41 105.904 173.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 73.8 t -102.96 -59.91 3.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-O 120.738 0.304 . . . . 65.41 111.206 -173.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -144.61 141.05 29.13 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.162 -0.472 . . . . 74.15 110.037 -172.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.56 160.89 22.29 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 107.251 -1.389 . . . . 71.34 107.251 176.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.526 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 3.2 t-20 -67.03 -52.61 30.16 Favored Pre-proline 0 C--N 1.312 -1.034 0 N-CA-C 109.689 -0.486 . . . . 75.04 109.689 171.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.2 Cg_exo -87.47 122.8 1.78 Allowed 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 121.589 1.526 . . . . 63.14 110.91 173.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -67.26 158.39 57.18 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.184 1.923 . . . . 31.4 110.874 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.5 127.63 33.44 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.79 -0.448 . . . . 73.43 109.79 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.31 -0.02 40.64 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.713 -0.756 . . . . 71.5 112.091 -177.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 10.2 m -92.32 166.34 12.63 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.81 -0.811 . . . . 54.33 108.81 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -90.73 130.69 10.39 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.91 -0.662 . . . . 74.4 112.082 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.4 m -125.05 141.93 43.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.783 -0.821 . . . . 75.34 108.783 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.478 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.9 p-10 -62.42 179.28 0.33 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.437 0.902 . . . . 60.11 113.437 -175.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -61.03 -25.78 67.15 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.375 -0.375 . . . . 70.13 112.0 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.497 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 34.5 t70 -83.18 -9.45 59.16 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.091 -0.707 . . . . 75.13 109.091 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 618' ' ' GLY . . . . . 0.418 ' HA3' ' CD1' ' A' ' 583' ' ' TRP . . . 64.9 15.9 60.89 Favored Glycine 0 CA--C 1.492 -1.355 0 CA-C-N 115.195 -0.911 . . . . 73.54 113.704 168.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.58 119.13 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 CA-C-O 122.974 1.368 . . . . 70.13 113.255 -164.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.448 HG22 ' HG2' ' A' ' 608' ' ' PRO . 48.1 pt -123.47 133.09 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 CA-C-N 113.42 -1.718 . . . . 61.04 108.581 177.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 12.1 t -109.86 124.93 52.19 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.419 -0.956 . . . . 63.4 108.419 177.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.38 167.17 21.53 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 113.229 0.826 . . . . 75.1 113.229 -176.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -127.21 137.52 52.92 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.501 -1.227 . . . . 74.02 107.86 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 602' ' ' ARG . 15.1 p90 -139.35 166.7 23.85 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.486 -0.325 . . . . 64.21 111.162 -175.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -57.93 145.61 40.18 Favored Glycine 0 N--CA 1.447 -0.621 0 O-C-N 123.978 0.799 . . . . 75.43 114.412 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 . . . . . 0 C--N 1.308 -1.232 0 C-N-CA 124.391 1.076 . . . . 73.11 109.924 177.654 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.479 0 CA-C-O 121.873 0.844 . . . . 70.24 110.996 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 5.9 p -140.59 144.59 35.9 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.787 -1.19 . . . . 61.34 107.787 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -139.03 135.51 34.31 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 108.806 -0.813 . . . . 74.51 108.806 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.563 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.4 p-10 -81.53 133.99 35.46 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.885 -0.598 . . . . 52.31 109.936 177.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.0 pt -89.63 131.23 40.52 Favored Pre-proline 0 C--N 1.291 -1.945 0 CA-C-N 115.061 -0.972 . . . . 71.23 110.993 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.49 -174.4 2.11 Favored 'Trans proline' 0 C--O 1.251 1.144 0 C-N-CA 121.966 1.777 . . . . 73.21 110.011 174.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -85.38 117.17 24.14 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.002 0.906 . . . . 65.04 110.773 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.466 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 16.6 m -117.58 66.29 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.38 0 CA-C-O 123.277 1.513 . . . . 72.25 108.487 172.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -129.75 109.55 11.05 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 112.018 -2.355 . . . . 72.1 107.369 174.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 138.44 -20.05 3.16 Favored Glycine 0 C--N 1.299 -1.477 0 C-N-CA 119.837 -1.173 . . . . 41.22 112.956 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.471 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.0 OUTLIER -107.44 -173.88 2.4 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 117.484 0.642 . . . . 72.14 110.087 178.416 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 10.0 m -75.99 155.99 34.48 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.229 -1.026 . . . . 63.01 108.229 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.444 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 6.0 p -57.5 -46.59 85.98 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 111.801 0.297 . . . . 74.32 111.801 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -64.33 -37.93 89.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.308 0.575 . . . . 65.22 110.559 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 97.7 t -68.04 -42.42 85.23 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.982 0 CA-C-N 115.231 -0.895 . . . . 73.33 109.554 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.519 ' HB2' HG11 ' A' ' 534' ' ' VAL . . . -62.34 -45.36 93.56 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 122.298 0.239 . . . . 71.43 110.87 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 22.9 mt-30 -64.89 -45.81 84.38 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.458 -0.337 . . . . 74.53 111.261 -178.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.473 ' O ' HG23 ' A' ' 514' ' ' VAL . 0.0 OUTLIER -67.27 -38.92 85.88 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 120.473 -0.491 . . . . 74.12 110.716 179.165 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -63.2 -45.61 90.88 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 121.152 0.501 . . . . 73.21 110.479 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -62.17 -42.19 99.03 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 108.172 -1.047 . . . . 65.14 108.172 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -59.7 -34.95 73.55 Favored 'General case' 0 N--CA 1.428 -1.561 0 C-N-CA 123.613 0.765 . . . . 70.23 112.54 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 510' ' ' LYS . 75.2 t -57.89 -34.44 48.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-O 121.682 0.753 . . . . 72.45 110.866 177.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -104.47 -6.49 20.61 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.49 0.662 . . . . 74.52 109.763 -177.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -114.8 -66.59 0.43 Allowed Glycine 0 N--CA 1.416 -2.686 0 CA-C-N 115.352 -0.84 . . . . 52.42 113.425 -171.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 64.31 30.01 13.51 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 122.8 1.285 . . . . 74.22 109.07 -168.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 10.7 p -88.99 -175.35 4.8 Favored 'General case' 0 N--CA 1.409 -2.516 0 CA-C-N 112.954 -1.93 . . . . 71.43 109.545 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 13.5 mptt -108.24 143.47 37.02 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.131 -1.063 . . . . 73.1 108.131 177.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -132.41 157.14 45.3 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.364 0.602 . . . . 72.22 112.493 -175.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 62.3 m -140.42 150.16 43.5 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.716 -1.216 . . . . 50.42 107.716 174.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -123.82 138.18 54.54 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 120.713 0.292 . . . . 64.35 110.493 -176.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -136.33 143.23 44.02 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.712 -0.848 . . . . 72.51 108.712 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 45.5 m -97.17 135.13 39.56 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.404 1.097 . . . . 63.45 111.906 -178.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.43 153.01 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.813 0 CA-C-N 113.028 -1.897 . . . . 53.32 107.023 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -90.58 133.92 34.75 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.774 -0.77 . . . . 70.15 109.704 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.572 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 69.0 m -162.26 162.8 19.38 Favored Pre-proline 0 C--O 1.202 -1.438 0 N-CA-C 107.926 -1.138 . . . . 73.44 107.926 177.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -68.27 -3.93 11.79 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 122.194 1.929 . . . . 74.04 113.157 177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.402 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 25.2 mmm180 -79.48 136.66 55.9 Favored Pre-proline 0 N--CA 1.425 -1.69 0 N-CA-C 107.948 -1.13 . . . . 73.24 107.948 178.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -59.34 147.98 88.6 Favored 'Trans proline' 0 C--O 1.247 0.927 0 C-N-CA 123.047 2.498 . . . . 72.31 113.391 -175.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.709 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.72 108.12 0.8 Allowed 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.391 -0.822 . . . . 52.11 111.232 -177.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 131.62 -21.05 4.54 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 115.387 -0.824 . . . . 45.32 111.203 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.65 137.21 36.32 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.638 -0.875 . . . . 64.0 108.638 178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.519 HG11 ' HB2' ' A' ' 508' ' ' ALA . 10.3 p -91.42 121.43 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.719 0 CA-C-O 121.939 0.875 . . . . 63.22 109.207 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.474 HG23 ' HB2' ' A' ' 556' ' ' SER . 2.5 p -79.47 -16.56 55.88 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.774 -1.103 . . . . 75.5 111.174 176.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.405 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 145.98 -162.7 28.35 Favored Glycine 0 N--CA 1.425 -2.082 0 C-N-CA 120.774 -0.727 . . . . 75.05 112.18 175.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.9 p -116.26 157.68 24.55 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.646 -1.242 . . . . 72.34 107.646 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.405 ' HB3' ' CD ' ' A' ' 552' ' ' GLU . 23.5 t-20 -63.38 -49.4 79.1 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 118.634 -1.226 . . . . 73.52 112.279 178.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -71.48 136.11 27.88 Favored 'Trans proline' 0 C--N 1.364 1.347 0 N-CA-C 108.705 -1.306 . . . . 70.02 108.705 170.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -66.12 159.34 50.0 Favored 'Trans proline' 0 C--O 1.248 0.984 0 C-N-CA 122.324 2.016 . . . . 74.43 113.199 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.96 139.19 58.74 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.756 -0.656 . . . . 71.31 109.86 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.81 -19.67 51.22 Favored Glycine 0 N--CA 1.432 -1.585 0 N-CA-C 111.781 -0.528 . . . . 71.22 111.781 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 17.5 m -74.13 129.06 37.1 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 110.354 -0.239 . . . . 64.23 110.354 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 14.6 t -82.7 126.76 32.73 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-O 121.578 0.704 . . . . 51.0 109.388 175.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.3 m -123.81 155.52 66.61 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 107.716 -1.216 . . . . 64.4 107.716 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -61.69 137.65 69.97 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 120.973 1.115 . . . . 75.03 111.531 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.26 -20.23 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.961 0.886 . . . . 61.34 110.655 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -87.72 -18.07 30.3 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.143 -0.935 . . . . 75.3 111.647 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 85.1 p -89.89 175.05 7.36 Favored 'General case' 0 C--O 1.252 1.235 0 N-CA-C 113.453 0.909 . . . . 73.13 113.453 -172.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 11.1 p -96.93 138.6 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 CA-C-N 114.281 -1.327 . . . . 73.54 111.175 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.4 mt -114.52 137.96 46.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.791 -1.189 . . . . 71.53 107.791 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 552' ' ' GLU . . . . . 0.405 ' CD ' ' HB3' ' A' ' 538' ' ' ASN . 1.7 pm0 -103.39 128.69 50.45 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.788 0.804 . . . . 72.45 112.188 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.86 122.03 42.74 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.678 -1.601 . . . . 72.4 108.876 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -88.23 113.2 23.61 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.53 0.681 . . . . 62.41 110.344 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 524' ' ' SER . 18.2 t -93.07 122.96 44.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 107.341 -1.355 . . . . 71.43 107.341 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.709 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 48.5 t -81.92 131.95 35.26 Favored 'General case' 0 N--CA 1.405 -2.681 0 N-CA-C 108.797 -0.816 . . . . 51.54 108.797 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -95.11 141.55 28.61 Favored 'General case' 0 N--CA 1.412 -2.363 0 N-CA-C 105.526 -2.028 . . . . 75.35 105.526 168.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -56.05 -23.94 41.15 Favored Glycine 0 CA--C 1.499 -0.952 0 O-C-N 124.48 1.112 . . . . 44.13 112.564 -177.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.2 t30 68.16 20.98 8.77 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-O 123.129 1.442 . . . . 74.31 109.026 174.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.589 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 66.7 mt-30 -141.79 164.54 29.93 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 113.094 -1.866 . . . . 75.12 107.117 178.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -143.23 151.65 40.84 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.785 -1.191 . . . . 65.01 107.785 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 13.6 p -70.45 132.23 33.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 121.01 0.433 . . . . 73.11 110.116 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.415 ' SD ' HG21 ' A' ' 620' ' ' ILE . 44.2 ttp -91.15 109.52 36.04 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 108.405 -0.961 . . . . 72.43 108.405 175.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.75 160.24 44.62 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.478 2.118 . . . . 73.45 110.897 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -73.8 115.06 12.79 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.971 0.891 . . . . 73.12 112.329 -178.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.7 pp -135.3 18.98 3.38 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.096 -1.411 . . . . 75.35 107.789 174.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 8.7 t -74.41 136.89 42.39 Favored 'General case' 0 N--CA 1.417 -2.08 0 CA-C-N 114.603 -1.18 . . . . 75.52 108.902 -175.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 568' ' ' GLY . . . . . 0.473 ' HA2' ' CZ ' ' A' ' 602' ' ' ARG . . . 113.96 50.28 0.51 Allowed Glycine 0 N--CA 1.42 -2.377 0 CA-C-N 115.546 -0.752 . . . . 73.43 111.914 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 19.8 ptp -142.17 173.36 11.59 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 120.099 -0.64 . . . . 64.34 110.246 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -98.61 175.63 5.93 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.987 -1.116 . . . . 73.0 107.987 -177.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 38.3 t-105 -68.82 -29.91 68.35 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.188 -0.671 . . . . 74.41 109.188 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.38 -15.64 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 115.579 -0.737 . . . . 55.42 110.299 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.595 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 9.0 m-20 -96.5 -44.69 7.06 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 108.44 -0.948 . . . . 64.24 108.44 176.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.98 -45.86 90.44 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.705 -1.134 . . . . 74.13 113.529 -174.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.514 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 35.4 tt0 -60.46 -50.46 85.54 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 120.664 -0.414 . . . . 61.34 111.828 -177.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 51.5 Cg_exo -58.88 -28.46 87.39 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 121.469 1.446 . . . . 74.5 111.576 173.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.672 ' O ' ' HB3' ' A' ' 581' ' ' LEU . 17.0 mmt180 -62.88 -38.45 90.92 Favored 'General case' 0 C--O 1.204 -1.324 0 CA-C-O 118.306 -0.854 . . . . 74.2 112.688 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.793 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 6.5 mp -59.38 -49.51 77.52 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.652 -1.219 . . . . 71.03 109.547 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -67.33 -42.07 84.2 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.518 -1.219 . . . . 74.02 113.515 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -71.15 -39.64 71.83 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.839 0.681 . . . . 62.31 112.839 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.672 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 1.7 tp -82.97 -9.43 59.29 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.38 0.672 . . . . 63.25 111.053 -176.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 69.48 40.81 78.63 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 110.616 -0.993 . . . . 63.04 110.616 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.793 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 11.3 t90 -87.46 126.45 34.9 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.217 -1.401 . . . . 74.02 107.217 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 17.4 p -86.81 -28.79 22.73 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 123.08 0.552 . . . . 53.44 112.389 -174.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -74.71 -175.5 34.99 Favored Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 115.588 -0.733 . . . . 75.22 111.636 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 23.9 mmt -123.3 155.21 37.69 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.681 -0.489 . . . . 74.04 109.681 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 47.4 tp -94.12 118.51 31.64 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 123.613 0.571 . . . . 74.34 109.578 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -118.14 122.12 42.27 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.127 -1.064 . . . . 74.53 108.127 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.3 OUTLIER -87.34 130.02 34.79 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 106.928 -1.508 . . . . 62.44 106.928 172.14 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.75 -35.12 23.06 Favored Glycine 0 C--N 1.285 -2.253 0 CA-C-N 115.585 -0.734 . . . . 51.44 111.688 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.61 147.72 39.81 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 120.828 0.347 . . . . 72.24 110.8 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -100.18 123.66 44.68 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 102.814 -3.032 . . . . 75.13 102.814 170.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.89 137.41 32.7 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.611 0 N-CA-C 106.531 -1.655 . . . . 73.54 106.531 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -75.53 106.88 7.32 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 118.418 -1.313 . . . . 65.51 111.122 -178.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 595' ' ' ALA . . . . . 0.447 ' HB3' ' HA3' ' A' ' 625' ' ' GLY . . . -129.61 -64.34 0.89 Allowed 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.023 -1.473 . . . . 74.14 107.023 172.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 111.8 150.15 11.41 Favored Glycine 0 N--CA 1.42 -2.367 0 C-N-CA 120.394 -0.908 . . . . 73.41 111.111 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.95 -32.76 62.77 Favored Glycine 0 C--N 1.307 -1.083 0 C-N-CA 123.356 0.503 . . . . 72.0 113.685 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 20.3 t -72.37 -24.18 61.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.952 0.882 . . . . 74.23 109.968 -175.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -90.3 -0.98 57.87 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.301 -0.863 . . . . 75.05 109.82 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 37.1 m80 75.99 99.61 0.07 Allowed 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 124.975 1.31 . . . . 71.01 109.906 -173.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -82.75 72.28 9.83 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.615 1.197 . . . . 62.52 112.076 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.473 ' CZ ' ' HA2' ' A' ' 568' ' ' GLY . 9.9 ptm180 -100.14 166.48 10.99 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.362 -1.29 . . . . 73.22 109.594 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.41 ' CG1' ' H ' ' A' ' 568' ' ' GLY . 10.4 p -62.86 131.64 28.37 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 CA-C-N 115.995 -0.548 . . . . 73.42 109.931 177.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 12.9 p -109.99 -26.68 3.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 121.724 0.773 . . . . 71.13 110.276 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -154.01 135.53 14.28 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.52 -0.764 . . . . 74.34 110.188 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -127.09 136.1 51.68 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.035 -1.468 . . . . 74.21 107.035 171.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.405 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 28.5 t-20 -65.68 -51.62 48.42 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 112.816 0.673 . . . . 65.4 112.816 -175.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 8.1 Cg_exo -79.11 114.01 3.3 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.576 1.517 . . . . 75.12 108.934 172.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.06 145.19 54.66 Favored 'Trans proline' 0 C--O 1.25 1.121 0 C-N-CA 122.359 2.039 . . . . 72.53 113.046 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -63.42 132.46 51.49 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.603 -0.726 . . . . 73.04 109.227 176.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 102.65 0.03 49.34 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 110.971 -0.852 . . . . 72.25 110.971 -175.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 32.3 m -105.51 150.43 25.34 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 109.559 -0.534 . . . . 71.13 109.559 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -73.38 127.19 10.56 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 111.172 -0.771 . . . . 71.23 111.172 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.6 m -117.09 142.76 29.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 108.22 -1.03 . . . . 74.24 108.22 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.589 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 29.3 p30 -44.1 167.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.073 1.509 . . . . 40.42 115.073 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -55.08 -25.53 31.72 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.483 1.113 . . . . 55.22 113.739 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -96.27 -8.93 31.5 Favored 'General case' 0 C--O 1.207 -1.163 0 C-N-CA 120.05 -0.66 . . . . 64.2 110.105 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.64 18.96 70.66 Favored Glycine 0 C--O 1.217 -0.923 0 CA-C-O 120.044 -0.309 . . . . 74.43 113.765 167.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.93 119.74 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-O 121.82 0.819 . . . . 73.03 110.711 -171.19 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.415 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.7 pp -127.36 133.97 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 115.132 -0.94 . . . . 52.43 110.767 -177.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.2 t -103.24 135.93 43.96 Favored 'General case' 0 C--O 1.259 1.597 0 N-CA-C 108.748 -0.834 . . . . 74.3 108.748 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 2.7 pp -139.2 165.99 25.7 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.815 -0.629 . . . . 62.54 111.608 -178.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -131.4 137.93 48.89 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.944 -0.761 . . . . 72.42 108.944 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -136.65 166.48 23.45 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.038 -0.528 . . . . 71.44 110.319 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 625' ' ' GLY . . . . . 0.447 ' HA3' ' HB3' ' A' ' 595' ' ' ALA . . . -71.58 67.84 0.99 Allowed Glycine 0 CA--C 1.527 0.803 0 O-C-N 124.069 0.855 . . . . 75.4 114.925 -175.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 . . . . . 0 C--O 1.262 1.715 0 C-N-CA 126.628 1.971 . . . . 75.53 112.064 -175.371 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.508 0 CA-C-O 122.26 1.029 . . . . 73.02 109.341 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.404 ' HB ' HG22 ' A' ' 544' ' ' THR . 27.8 p -140.03 153.97 46.97 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.69 -1.141 . . . . 73.13 109.003 -176.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.479 ' HB2' ' NZ ' ' A' ' 495' ' ' LYS . 0.0 OUTLIER -137.97 145.09 41.53 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.893 -0.41 . . . . 75.52 109.893 173.371 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 19.9 m-20 -77.89 141.89 38.8 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.849 -0.797 . . . . 63.25 108.849 173.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.6 pt -108.71 130.12 23.12 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 115.728 -0.669 . . . . 65.52 110.336 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -80.7 -177.49 3.79 Favored 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.705 2.27 . . . . 63.45 112.333 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -87.78 89.83 8.14 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 122.459 1.123 . . . . 64.32 110.521 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.0 m -80.59 -0.31 4.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-N 114.936 -1.029 . . . . 61.11 111.96 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -69.53 100.84 1.48 Allowed 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.734 -0.666 . . . . 71.14 110.494 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 156.86 -38.11 0.57 Allowed Glycine 0 C--N 1.304 -1.224 0 C-N-CA 120.808 -0.71 . . . . 64.43 111.979 178.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -92.62 -175.66 4.03 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 109.543 -0.54 . . . . 74.31 109.543 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 13.2 m -70.18 154.86 41.42 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.35 -0.981 . . . . 63.14 108.35 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.475 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.4 p -64.14 -41.33 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 C-N-CA 120.737 -0.385 . . . . 73.54 110.797 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 506' ' ' ASP . . . . . 0.589 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 28.1 t70 -59.69 -43.24 94.11 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 109.815 -0.439 . . . . 54.24 109.815 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 46.3 t -69.29 -41.54 81.08 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 CA-C-N 115.868 -0.606 . . . . 61.14 110.085 -178.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -58.24 -44.02 88.09 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.753 0.311 . . . . 35.31 110.671 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.0 mt-30 -64.8 -44.88 88.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.027 -0.533 . . . . 74.51 110.617 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 33.4 mmtp -64.76 -40.17 94.84 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 116.19 -0.459 . . . . 72.44 110.129 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 511' ' ' ASN . . . . . 0.481 ' O ' HG12 ' A' ' 514' ' ' VAL . 85.9 m-20 -66.72 -40.49 88.44 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.856 -0.611 . . . . 71.23 111.585 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.4 pp -69.9 -41.37 74.78 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.42 -0.912 . . . . 41.31 110.776 177.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.482 ' N ' HD12 ' A' ' 512' ' ' LEU . 44.9 t30 -64.38 -38.91 92.69 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 124.136 0.974 . . . . 74.32 111.259 -177.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 511' ' ' ASN . 9.0 p -64.06 -31.62 54.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.196 0.522 . . . . 74.32 110.876 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -112.62 23.24 13.73 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.409 -0.589 . . . . 74.25 109.409 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -146.07 -56.13 0.02 OUTLIER Glycine 0 CA--C 1.484 -1.866 0 C-N-CA 119.653 -1.26 . . . . 51.35 113.963 -174.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 65.76 26.28 11.32 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.211 1.005 . . . . 74.52 109.618 -175.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 14.7 p -82.95 -175.71 5.97 Favored 'General case' 0 N--CA 1.409 -2.489 0 CA-C-N 113.755 -1.566 . . . . 74.52 108.905 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.51 142.92 38.2 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.042 -1.095 . . . . 75.2 108.042 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -130.33 148.78 52.2 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.078 0.466 . . . . 61.41 111.332 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 32.2 m -138.32 139.99 39.33 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.058 -0.719 . . . . 53.3 109.058 176.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -118.09 138.67 52.09 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.85 0.357 . . . . 73.12 110.795 -176.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -135.02 130.42 35.65 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.268 -0.424 . . . . 52.55 109.862 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 73.9 m -88.96 129.15 35.68 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.695 0.76 . . . . 71.41 112.175 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.83 149.68 25.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.109 -1.811 . . . . 54.53 106.109 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -81.48 136.44 35.64 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.908 -0.717 . . . . 73.51 109.772 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 67.2 m -158.56 164.85 19.91 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 107.982 -1.118 . . . . 53.43 107.982 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -65.35 -14.78 46.77 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.251 1.968 . . . . 63.01 113.534 178.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.435 HH21 HG23 ' A' ' 535' ' ' THR . 0.4 OUTLIER -87.36 146.85 40.74 Favored Pre-proline 0 C--N 1.326 -0.413 0 C-N-CA 120.945 -0.302 . . . . 65.35 110.993 -179.149 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.77 155.47 37.56 Favored 'Trans proline' 0 C--O 1.263 1.758 0 C-N-CA 123.633 2.889 . . . . 72.33 115.378 -175.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.681 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -68.71 110.4 4.28 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 113.617 -1.629 . . . . 70.24 110.602 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 137.39 -21.63 3.26 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.574 -0.822 . . . . 75.33 111.546 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -82.88 138.18 33.99 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.99 -0.745 . . . . 71.22 108.99 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 6.6 p -86.16 114.74 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.193 0 CA-C-O 122.12 0.962 . . . . 75.14 108.907 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.435 HG23 HH21 ' A' ' 529' ' ' ARG . 0.5 OUTLIER -65.06 -32.57 74.34 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 113.575 -1.648 . . . . 70.34 109.681 -179.007 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 153.26 -166.69 31.68 Favored Glycine 0 N--CA 1.418 -2.546 0 N-CA-C 110.102 -1.199 . . . . 65.44 110.102 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 6.6 p -116.96 157.44 25.75 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 109.448 -0.575 . . . . 54.42 109.448 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -63.45 -55.17 37.55 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 119.17 -0.443 . . . . 75.33 110.495 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -69.02 126.5 13.88 Favored 'Trans proline' 0 C--N 1.365 1.442 0 N-CA-C 108.346 -1.444 . . . . 54.42 108.346 170.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.59 155.22 67.89 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.497 2.131 . . . . 53.24 113.293 -176.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.98 130.81 47.32 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.925 -0.58 . . . . 55.32 110.294 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.85 -4.82 42.44 Favored Glycine 0 C--N 1.303 -1.258 0 C-N-CA 120.205 -0.998 . . . . 74.23 111.725 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 25.3 m -88.16 133.28 34.05 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.467 -0.568 . . . . 74.55 109.467 178.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 0.2 OUTLIER -86.71 123.9 32.39 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 106.84 -1.541 . . . . 75.03 106.84 174.74 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.67 155.06 63.53 Favored Pre-proline 0 C--N 1.295 -1.798 0 N-CA-C 108.454 -0.943 . . . . 63.14 108.454 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -64.34 138.3 59.94 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 121.552 1.501 . . . . 74.43 111.636 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.31 -19.96 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 CA-C-O 122.168 0.985 . . . . 71.1 109.858 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -91.12 -8.38 48.94 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.785 -1.098 . . . . 73.44 111.687 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 15.1 t -89.79 -175.64 4.7 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-O 121.282 0.563 . . . . 53.53 110.416 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.1 p -118.89 137.65 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-N 115.869 -0.605 . . . . 72.41 109.511 -177.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 59.8 mt -97.55 132.56 41.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.883 -0.784 . . . . 63.32 108.883 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -103.12 116.1 31.84 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.416 -1.327 . . . . 72.22 107.416 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.84 125.8 52.36 Favored 'General case' 0 C--N 1.312 -1.035 0 O-C-N 123.625 0.578 . . . . 55.22 111.0 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -93.09 121.66 34.66 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.699 -0.682 . . . . 71.13 109.293 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.446 HG22 HG21 ' A' ' 505' ' ' VAL . 15.1 t -104.37 137.4 33.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 107.447 -1.316 . . . . 64.51 107.447 -178.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.681 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 24.5 p -88.08 139.53 30.42 Favored 'General case' 0 N--CA 1.413 -2.315 0 C-N-CA 119.92 -0.712 . . . . 74.24 109.839 178.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -108.41 145.03 35.2 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 105.299 -2.112 . . . . 73.22 105.299 167.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 559' ' ' ASN . . . -54.68 -22.58 25.98 Favored Glycine 0 CA--C 1.506 -0.516 0 O-C-N 124.72 1.262 . . . . 62.34 114.743 -174.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 559' ' ' ASN . . . . . 0.428 ' HB3' ' O ' ' A' ' 558' ' ' GLY . 18.9 t-20 82.79 -16.4 0.59 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.816 1.246 . . . . 62.03 109.678 -178.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.518 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 86.9 mt-30 -113.48 157.33 22.12 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.283 -0.871 . . . . 71.1 111.383 -176.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -136.8 157.85 45.81 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.278 -1.379 . . . . 74.24 107.278 176.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.97 119.3 23.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.434 -0.58 . . . . 74.42 109.434 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 54.8 ttp -79.98 133.46 58.02 Favored Pre-proline 0 C--N 1.311 -1.077 0 C-N-CA 120.817 -0.353 . . . . 75.41 110.088 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.95 169.67 17.33 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.71 2.273 . . . . 74.54 111.525 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 565' ' ' ASP . . . . . 0.445 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 24.6 t70 -89.62 119.87 30.42 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 113.219 0.822 . . . . 75.31 113.219 -178.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.36 12.73 3.02 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.504 -1.225 . . . . 51.34 109.272 173.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 84.5 p -69.03 153.41 43.83 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 115.69 -0.686 . . . . 73.02 112.824 -173.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 568' ' ' GLY . . . . . 0.444 ' H ' ' CG1' ' A' ' 603' ' ' VAL . . . 86.13 56.66 2.26 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.793 -0.923 . . . . 44.33 110.793 -178.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 569' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 602' ' ' ARG . 14.4 ptm -142.49 177.04 8.55 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.01 -0.367 . . . . 73.44 110.01 -175.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -95.5 160.63 14.42 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 106.69 -1.596 . . . . 75.31 106.69 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 571' ' ' TRP . . . . . 0.46 ' CZ3' ' HB3' ' A' ' 589' ' ' LYS . 19.3 t-105 -66.49 -32.32 73.61 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.482 -0.932 . . . . 75.21 108.482 176.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.1 m -76.2 -13.53 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.284 -0.871 . . . . 62.32 111.159 -174.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -96.96 -27.23 14.73 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.779 -1.193 . . . . 62.31 107.779 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -68.82 -40.33 79.57 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.25 -0.886 . . . . 70.31 111.773 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.639 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 44.9 mt-10 -55.36 -55.6 38.07 Favored Pre-proline 0 CA--C 1.567 1.606 0 N-CA-C 112.725 0.639 . . . . 71.13 112.725 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.5 -30.38 79.75 Favored 'Trans proline' 0 C--N 1.364 1.391 0 CA-C-N 120.707 1.288 . . . . 63.11 112.606 172.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -68.73 -36.36 78.31 Favored 'General case' 0 N--CA 1.435 -1.197 0 O-C-N 122.091 -0.38 . . . . 61.23 111.009 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.3 pp -64.51 -45.97 84.96 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 120.728 0.299 . . . . 73.54 110.655 -178.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.529 ' N ' HD12 ' A' ' 578' ' ' LEU . 8.5 ptm180 -65.93 -34.84 79.04 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.358 -0.383 . . . . 73.22 111.242 175.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.24 -39.31 82.32 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 116.41 -0.359 . . . . 63.24 111.548 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' A' ' 583' ' ' TRP . 1.5 pp -91.93 -9.66 42.32 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.555 -0.458 . . . . 75.21 111.399 -177.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 79.43 42.37 11.85 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.071 -0.585 . . . . 72.35 112.339 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.473 ' CH2' ' HG ' ' A' ' 587' ' ' LEU . 10.0 t90 -81.46 127.26 32.62 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.799 -0.815 . . . . 74.45 108.799 178.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 22.5 m -83.19 -29.63 28.42 Favored 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 113.083 0.771 . . . . 55.11 113.083 -176.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -90.72 -175.62 44.3 Favored Glycine 0 C--N 1.315 -0.611 0 CA-C-N 116.555 -0.293 . . . . 72.33 112.905 -177.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 70.1 mtm -117.73 163.33 16.65 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.368 -0.604 . . . . 63.23 109.368 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 587' ' ' LEU . . . . . 0.473 ' HG ' ' CH2' ' A' ' 583' ' ' TRP . 5.1 mp -84.26 131.14 34.76 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 109.703 -0.48 . . . . 71.44 109.703 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 621' ' ' THR . 32.8 t70 -101.86 116.07 31.9 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 108.831 -0.803 . . . . 73.33 108.831 177.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.46 ' HB3' ' CZ3' ' A' ' 571' ' ' TRP . 0.0 OUTLIER -95.08 134.23 38.02 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.659 0.742 . . . . 63.11 112.204 -175.077 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -95.58 -145.0 18.03 Favored Glycine 0 C--N 1.29 -1.982 0 N-CA-C 109.264 -1.534 . . . . 63.22 109.264 174.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -74.49 126.16 30.16 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 117.309 0.554 . . . . 73.12 110.547 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -69.75 144.21 52.8 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 123.913 0.758 . . . . 72.01 109.703 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 58.6 t -106.68 143.44 17.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-N 115.272 -0.877 . . . . 71.31 109.638 -174.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -74.94 107.0 6.73 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.968 -0.753 . . . . 63.01 108.968 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -126.98 -53.88 1.4 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 116.057 -0.52 . . . . 65.3 110.125 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 101.81 129.44 6.68 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.963 -0.855 . . . . 72.31 110.963 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.68 -43.11 91.55 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 116.539 0.169 . . . . 72.44 113.224 -177.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 35.3 t -68.7 -24.68 64.52 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.323 0.583 . . . . 62.2 110.65 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -93.53 -1.75 55.16 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 116.088 -0.505 . . . . 75.51 110.593 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 42.2 m170 80.55 98.33 0.06 Allowed 'General case' 0 C--O 1.246 0.892 0 C-N-CA 125.437 1.495 . . . . 71.32 113.216 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -73.08 90.39 1.53 Allowed 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 114.091 -1.413 . . . . 73.41 109.952 177.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 569' ' ' MET . 19.6 mtm180 -107.94 171.14 7.57 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.865 -0.607 . . . . 73.12 110.003 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.444 ' CG1' ' H ' ' A' ' 568' ' ' GLY . 14.7 p -73.4 137.97 22.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.751 -0.833 . . . . 72.22 108.751 175.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 33.5 m -107.26 -29.19 2.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 119.752 -0.779 . . . . 73.52 110.865 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -156.55 139.17 15.03 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.65 -0.705 . . . . 74.31 109.464 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -133.02 141.96 48.55 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.057 -1.831 . . . . 70.15 106.057 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.536 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 23.7 t-20 -62.14 -60.36 10.37 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-O 118.923 -0.561 . . . . 74.2 112.483 -177.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.536 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 6.3 Cg_exo -87.98 109.26 0.62 Allowed 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 121.752 1.635 . . . . 54.43 109.844 173.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 609' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 7.1 Cg_exo -71.11 160.63 48.58 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 123.225 2.616 . . . . 62.12 113.112 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 610' ' ' ALA . . . . . 0.445 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -68.02 132.67 47.7 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.821 -0.807 . . . . 65.42 108.821 175.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 103.18 -11.88 55.32 Favored Glycine 0 C--N 1.302 -1.336 0 N-CA-C 110.852 -0.899 . . . . 44.54 110.852 -175.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 44.8 m -100.27 159.5 15.07 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.787 -0.82 . . . . 72.54 108.787 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -76.86 120.61 5.72 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 112.036 -0.426 . . . . 71.13 112.036 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.7 m -112.42 143.32 22.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 107.793 -1.188 . . . . 53.41 107.793 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.518 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.2 p-10 -52.99 168.8 0.11 Allowed 'General case' 0 C--O 1.216 -0.704 0 C-N-CA 123.534 0.734 . . . . 74.12 112.184 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . 0.267 0.0 OUTLIER -60.91 -24.95 66.4 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 113.642 0.978 . . . . 73.04 113.642 -176.864 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -80.97 -9.2 59.87 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 119.686 -0.806 . . . . 55.44 109.522 176.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.18 18.9 67.66 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 112.008 -0.437 . . . . 75.24 112.008 175.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.49 119.34 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-O 122.379 1.085 . . . . 62.31 111.694 -166.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.469 ' O ' HD12 ' A' ' 620' ' ' ILE . 2.8 pp -118.17 132.19 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 CA-C-N 114.77 -1.105 . . . . 72.33 110.352 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 12.9 t -99.19 128.76 45.37 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.007 -1.479 . . . . 65.42 107.007 174.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.1 166.64 23.97 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 112.599 0.592 . . . . 74.23 112.599 -172.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -126.21 134.88 51.11 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 105.231 -2.137 . . . . 53.34 105.231 173.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -142.29 166.05 25.74 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.912 -0.585 . . . . 71.21 110.571 -169.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -63.45 130.49 40.72 Favored Glycine 0 N--CA 1.433 -1.546 0 O-C-N 124.203 0.939 . . . . 42.32 111.956 175.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 . . . . . 0 C--N 1.301 -1.501 0 C-N-CA 126.162 1.785 . . . . 64.34 114.446 -178.878 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.985 0 CA-C-O 120.96 0.409 . . . . 43.51 110.816 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.449 ' HB ' ' OG1' ' A' ' 544' ' ' THR . 33.9 p -137.49 144.87 42.43 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.389 -0.596 . . . . 75.5 109.389 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -141.93 148.9 39.42 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 123.493 0.717 . . . . 70.31 109.343 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 14.3 m-20 -89.58 131.17 35.72 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 120.942 0.401 . . . . 73.03 110.759 -175.07 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.0 pt -90.77 128.05 49.81 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 116.048 -0.524 . . . . 74.11 110.579 178.28 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.27 -177.57 2.17 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.706 2.271 . . . . 43.53 112.463 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -81.26 99.84 8.84 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.789 -0.641 . . . . 71.31 109.556 177.105 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.49 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 27.1 m -102.13 -3.31 9.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.301 -0.863 . . . . 34.11 111.442 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -64.87 103.65 0.74 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.836 -0.62 . . . . 51.24 110.219 -178.33 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 145.87 -24.08 1.79 Allowed Glycine 0 C--N 1.295 -1.707 0 CA-C-N 115.476 -0.784 . . . . 74.22 111.984 178.499 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.456 ' O ' HG12 ' A' ' 534' ' ' VAL . 2.2 mp0 -92.04 -179.24 5.22 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.124 -1.065 . . . . 70.31 108.124 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 31.5 m -75.85 155.17 35.57 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.457 -1.683 . . . . 61.4 106.457 175.568 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.551 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.2 p -61.29 -43.19 96.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 118.103 0.41 . . . . 73.33 111.438 -177.828 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 506' ' ' ASP . . . . . 0.546 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 25.6 t70 -63.17 -41.29 99.21 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.415 -0.357 . . . . 73.23 110.176 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 94.5 t -68.04 -42.99 85.69 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.984 0 CA-C-N 115.386 -0.825 . . . . 44.21 110.33 -178.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.49 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -62.5 -44.38 96.53 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 121.12 -0.232 . . . . 73.44 110.532 178.582 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.551 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 93.1 mt-30 -64.54 -46.5 82.56 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 116.437 -0.347 . . . . 74.15 110.676 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 506' ' ' ASP 0.359 0.0 OUTLIER -65.68 -37.0 85.27 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 112.386 0.513 . . . . 72.4 112.386 179.468 . . . . . . . . 4 4 . 1 . 021 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -60.55 -47.4 86.36 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.445 -0.576 . . . . 75.45 109.445 178.518 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.54 -37.66 80.16 Favored 'General case' 0 C--O 1.205 -1.275 0 CA-C-N 115.457 -0.792 . . . . 70.25 109.743 177.718 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -59.74 -34.44 72.95 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 123.884 0.874 . . . . 73.24 111.745 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.6 t -56.57 -31.33 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 O-C-N 123.645 0.591 . . . . 42.52 110.524 176.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -114.08 5.92 16.2 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.095 -0.706 . . . . 70.24 109.095 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -124.42 -62.09 0.18 Allowed Glycine 0 CA--C 1.481 -2.06 0 C-N-CA 120.342 -0.932 . . . . 64.01 113.988 -169.296 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 61.07 32.66 19.74 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 122.144 0.973 . . . . 75.42 109.071 -172.732 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 547' ' ' VAL . 4.9 p -87.02 -178.43 6.27 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.377 -1.283 . . . . 75.24 111.331 -177.265 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -108.22 143.11 37.49 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.98 -1.119 . . . . 64.54 107.98 178.132 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -125.3 146.14 49.69 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.745 0.307 . . . . 74.43 110.71 -174.751 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 56.3 p -126.92 141.07 51.9 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 106.18 -1.785 . . . . 72.0 106.18 171.043 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -129.72 122.57 29.15 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.299 0.571 . . . . 71.44 110.996 -174.119 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -118.09 125.31 50.04 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.632 -0.713 . . . . 42.5 109.493 -179.041 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 40.3 m -85.78 130.44 34.55 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-O 121.558 0.694 . . . . 55.03 111.287 -179.188 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.4 p -121.05 149.14 24.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 107.146 -1.427 . . . . 75.14 107.146 178.54 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -80.63 135.44 36.05 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.164 -0.615 . . . . 75.42 109.762 -177.069 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.8 m -159.75 165.27 18.3 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 108.1 -1.074 . . . . 74.1 108.1 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -71.5 -8.08 22.55 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.103 1.869 . . . . 72.51 112.549 177.443 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.471 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 16.0 mtm180 -81.57 141.71 48.96 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 123.48 0.712 . . . . 71.41 109.866 178.106 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.61 153.67 59.89 Favored 'Trans proline' 0 C--O 1.249 1.056 0 C-N-CA 123.431 2.754 . . . . 75.2 113.596 -174.497 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.687 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -68.37 105.98 2.35 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.192 -0.913 . . . . 64.02 110.576 -177.605 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 139.44 -17.13 3.11 Favored Glycine 0 N--CA 1.434 -1.5 0 CA-C-N 115.293 -0.867 . . . . 72.23 112.162 -179.208 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -81.33 130.05 34.87 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 109.594 -0.521 . . . . 75.2 109.594 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.496 ' HB ' ' HA ' ' A' ' 505' ' ' VAL . 7.8 p -81.36 118.01 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.252 0 CA-C-O 122.612 1.196 . . . . 74.33 108.871 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 m -80.07 -17.73 51.91 Favored 'General case' 0 C--N 1.269 -2.905 0 CA-C-N 112.938 -1.937 . . . . 61.22 110.177 -175.789 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 139.93 -163.12 26.3 Favored Glycine 0 N--CA 1.41 -3.034 0 C-N-CA 120.544 -0.836 . . . . 44.04 111.234 176.807 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 537' ' ' THR . . . . . 0.415 HG22 HD13 ' A' ' 553' ' ' LEU . 11.6 p -117.37 157.92 25.32 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 109.194 -0.669 . . . . 72.04 109.194 -179.502 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.433 ' HB2' HE22 ' A' ' 554' ' ' GLN . 3.8 t-20 -66.61 -54.52 22.71 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 120.364 -0.535 . . . . 62.35 110.002 175.438 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.422 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 23.1 Cg_endo -67.93 138.85 45.52 Favored 'Trans proline' 0 C--N 1.373 1.844 0 N-CA-C 109.395 -1.04 . . . . 61.45 109.395 170.47 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 540' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 38.0 Cg_exo -62.9 155.39 60.49 Favored 'Trans proline' 0 C--O 1.244 0.801 0 C-N-CA 122.763 2.309 . . . . 71.23 113.106 -177.479 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.89 134.61 53.38 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.264 -0.426 . . . . 64.25 109.904 179.119 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.31 -5.53 57.45 Favored Glycine 0 C--N 1.303 -1.283 0 N-CA-C 111.344 -0.702 . . . . 34.05 111.344 -177.784 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 20.6 m -88.72 135.25 33.61 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.516 -0.55 . . . . 72.43 109.516 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 14.5 t -82.44 132.98 35.2 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.503 -0.925 . . . . 52.33 108.503 175.062 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.1 m -123.6 156.4 64.59 Favored Pre-proline 0 C--N 1.294 -1.834 0 N-CA-C 107.269 -1.382 . . . . 71.03 107.269 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.3 135.37 26.71 Favored 'Trans proline' 0 N--CA 1.433 -2.064 0 CA-C-N 119.833 0.976 . . . . 51.25 111.219 -178.061 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.416 ' HA ' HG22 ' A' ' 518' ' ' THR . 8.3 p -67.68 -22.24 28.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 122.496 1.141 . . . . 62.13 108.838 177.304 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -79.9 -18.12 51.39 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 113.113 -1.858 . . . . 71.21 110.188 -175.737 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 18.7 t -102.07 -166.6 1.31 Allowed 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.612 -0.722 . . . . 52.12 109.512 -176.249 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 8.7 p -117.09 137.67 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.398 0 CA-C-N 115.162 -0.926 . . . . 73.5 109.196 -177.5 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.0 mt -91.68 141.37 14.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.324 -0.991 . . . . 74.4 108.324 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -102.29 116.93 33.68 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 108.506 -0.924 . . . . 73.43 108.506 -177.567 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.415 HD13 HG22 ' A' ' 537' ' ' THR . 3.2 mm? -106.78 121.11 43.74 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.785 0.834 . . . . 70.34 109.921 -179.316 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.433 HE22 ' HB2' ' A' ' 538' ' ' ASN . 2.9 mp0 -88.35 122.76 32.22 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.922 -0.769 . . . . 62.34 108.922 174.777 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 524' ' ' SER . 25.4 t -110.2 134.66 51.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 108.763 -0.828 . . . . 72.24 108.763 -178.269 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.687 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 75.5 m -81.57 131.1 35.26 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 120.093 -0.643 . . . . 74.15 109.885 176.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -99.69 131.78 45.46 Favored 'General case' 0 N--CA 1.411 -2.407 0 N-CA-C 104.28 -2.489 . . . . 64.33 104.28 166.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -60.17 -26.01 63.09 Favored Glycine 0 CA--C 1.49 -1.517 0 O-C-N 124.13 0.893 . . . . 65.44 112.924 -173.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 71.77 -15.44 0.45 Allowed 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 125.191 1.396 . . . . 74.31 110.721 178.315 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.466 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 89.9 mt-30 -113.18 144.34 42.84 Favored 'General case' 0 N--CA 1.416 -2.167 0 C-N-CA 123.37 0.668 . . . . 61.01 111.754 -174.371 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -123.31 146.69 47.7 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.678 -1.23 . . . . 73.21 107.678 177.692 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.81 117.97 12.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.417 0.627 . . . . 74.12 110.504 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 51.9 ttp -81.11 120.51 78.82 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 115.626 -0.715 . . . . 63.41 110.246 -177.598 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.76 169.78 12.49 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 123.156 2.571 . . . . 61.54 111.917 176.127 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -65.53 115.49 5.81 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 122.195 0.998 . . . . 72.31 112.634 -178.777 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.2 pp -131.37 6.19 4.46 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 113.81 -1.541 . . . . 74.14 107.784 170.589 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 14.5 m -80.08 142.09 35.2 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 113.627 -1.624 . . . . 72.52 109.499 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 568' ' ' GLY . . . . . 0.549 ' H ' ' CG1' ' A' ' 603' ' ' VAL . . . 80.64 48.17 6.38 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 121.353 -0.451 . . . . 73.32 112.839 178.064 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 21.6 ptp -152.31 -174.71 4.98 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 109.331 -0.618 . . . . 71.31 109.331 178.731 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -95.08 166.65 11.82 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.637 -0.875 . . . . 71.4 108.637 -173.064 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 -66.58 -29.06 69.03 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.998 -0.742 . . . . 53.22 108.998 178.387 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.9 p -73.89 -12.36 15.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 CA-C-O 121.968 0.89 . . . . 63.02 109.948 -178.647 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -101.49 -29.48 11.96 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 115.725 -0.671 . . . . 64.43 111.146 173.727 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.46 -47.77 82.55 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.75 0.657 . . . . 71.14 111.166 179.032 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.492 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 43.1 mt-10 -55.5 -51.81 77.0 Favored Pre-proline 0 CA--C 1.56 1.348 0 N-CA-C 113.463 0.912 . . . . 72.43 113.463 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 31.9 Cg_exo -61.86 -40.24 45.93 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.613 1.542 . . . . 73.41 113.128 174.72 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.425 ' NE ' ' HA ' ' A' ' 577' ' ' ARG . 3.3 mmp_? -60.76 -40.58 93.04 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 111.4 0.148 . . . . 63.45 111.4 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 579' ' ' ARG . 4.3 pp -65.97 -46.58 77.54 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.543 -0.463 . . . . 72.24 112.029 -176.724 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.551 ' N ' HD12 ' A' ' 578' ' ' LEU . 15.1 ptp180 -66.82 -36.1 81.6 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.503 -0.317 . . . . 74.22 111.611 178.752 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.1 -30.67 67.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.255 0.55 . . . . 50.12 110.53 178.349 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 11.4 tp -81.43 -9.73 59.66 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.294 0.569 . . . . 62.3 110.452 177.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 76.5 26.71 62.73 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.445 -0.884 . . . . 75.03 112.062 179.44 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.414 ' CD1' ' HA3' ' A' ' 618' ' ' GLY . 16.0 t90 -87.33 126.49 34.88 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 107.705 -1.22 . . . . 71.34 107.705 176.192 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 41.7 p -115.24 0.49 13.54 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 112.918 0.711 . . . . 72.24 112.918 -175.101 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 585' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -81.5 -173.88 48.58 Favored Glycine 0 C--O 1.248 0.996 0 C-N-CA 120.499 -0.857 . . . . 54.42 112.011 178.828 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 65.8 mtt -100.27 147.91 25.24 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 120.853 0.359 . . . . 74.01 110.729 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.1 tt -91.56 122.49 34.18 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.346 -1.353 . . . . 74.34 107.346 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.561 ' O ' ' HA ' ' A' ' 621' ' ' THR . 32.3 t70 -98.65 119.87 38.11 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.231 -0.655 . . . . 64.34 109.231 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.49 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -111.88 135.05 53.02 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 116.181 -0.463 . . . . 64.12 110.035 179.953 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -73.01 -88.4 0.17 Allowed Glycine 0 C--N 1.297 -1.609 0 N-CA-C 110.727 -0.949 . . . . 64.01 110.727 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.7 154.12 47.4 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.778 -0.452 . . . . 73.34 109.778 177.192 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 592' ' ' ASP . . . . . 0.524 ' HA ' ' O ' ' A' ' 624' ' ' PHE . 3.3 p30 -100.49 132.54 45.82 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.62 -0.881 . . . . 75.44 108.62 174.254 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 46.3 t -105.08 139.09 27.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 108.651 -0.87 . . . . 75.3 108.651 -176.125 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 594' ' ' ASP . . . . . 0.605 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 7.3 p-10 -71.53 110.9 6.41 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 122.185 0.993 . . . . 73.22 111.884 -173.316 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -113.24 -55.78 2.48 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.008 -0.996 . . . . 64.12 108.469 179.017 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 139.18 141.7 4.14 Favored Glycine 0 N--CA 1.416 -2.64 0 CA-C-N 115.613 -0.721 . . . . 71.21 111.465 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -59.77 -36.05 88.52 Favored Glycine 0 N--CA 1.446 -0.686 0 O-C-N 123.844 0.379 . . . . 73.3 112.744 -178.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 15.1 m -67.07 -24.7 66.0 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 123.053 0.541 . . . . 62.33 111.269 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -92.81 -12.75 30.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.867 0.365 . . . . 75.12 110.759 -178.464 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 23.2 m170 67.71 145.83 0.04 OUTLIER 'General case' 0 C--O 1.246 0.889 0 N-CA-C 114.914 1.45 . . . . 75.45 114.914 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -77.68 89.15 3.96 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 114.11 -1.405 . . . . 74.14 111.027 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -101.13 154.34 18.82 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.651 -1.24 . . . . 73.34 107.651 176.376 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.549 ' CG1' ' H ' ' A' ' 568' ' ' GLY . 8.8 p -67.87 141.96 17.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.402 -0.962 . . . . 72.24 108.402 176.545 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.51 -53.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.726 -0.842 . . . . 73.2 108.726 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -149.0 145.65 27.42 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.779 -0.823 . . . . 75.42 108.779 -178.256 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -129.19 136.26 49.91 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.543 -1.28 . . . . 74.11 107.543 173.576 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.494 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 48.7 t30 -55.4 -54.1 54.81 Favored Pre-proline 0 C--N 1.314 -0.959 0 N-CA-C 112.697 0.629 . . . . 71.13 112.697 -178.508 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.8 Cg_endo -87.72 107.2 0.6 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 121.579 1.519 . . . . 75.23 109.47 173.53 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.29 160.8 47.76 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 123.308 2.672 . . . . 71.42 113.362 -177.407 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.64 130.07 44.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.149 -0.478 . . . . 65.12 109.772 177.234 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.3 -3.08 40.18 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.707 -0.758 . . . . 63.13 112.833 -178.354 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 2.1 t -101.88 162.99 12.49 Favored 'General case' 0 C--O 1.25 1.104 0 N-CA-C 108.329 -0.989 . . . . 75.12 108.329 178.529 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -85.13 127.81 8.39 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 120.657 -0.782 . . . . 72.13 111.726 179.495 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 32.7 m -112.04 141.65 26.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.801 -0.814 . . . . 53.0 108.801 177.243 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.466 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 33.7 p-10 -56.47 176.27 0.09 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.631 1.173 . . . . 60.21 114.025 -175.481 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -56.93 -27.98 61.56 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.881 0.872 . . . . 72.43 112.504 -177.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.448 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 6.5 m-20 -94.25 -6.11 45.31 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 120.629 -0.428 . . . . 75.12 110.592 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 618' ' ' GLY . . . . . 0.414 ' HA3' ' CD1' ' A' ' 583' ' ' TRP . . . 66.19 17.93 66.51 Favored Glycine 0 CA--C 1.497 -1.053 0 C-N-CA 124.088 0.851 . . . . 31.2 113.993 170.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.21 119.24 15.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 122.312 1.053 . . . . 71.41 111.767 -165.762 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 45.0 pt -122.18 134.56 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 114.679 -1.146 . . . . 71.32 110.141 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 9.7 t -105.8 129.85 53.9 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.447 -0.945 . . . . 62.23 108.447 177.571 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.5 pp -138.86 166.03 25.49 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 113.037 0.754 . . . . 60.35 113.037 -176.586 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -128.11 137.33 52.08 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.085 -1.45 . . . . 73.23 107.085 176.346 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 592' ' ' ASP . 3.0 p90 -140.09 166.1 25.57 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.316 -0.554 . . . . 74.1 111.909 -172.321 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -76.27 169.39 54.87 Favored Glycine 0 N--CA 1.429 -1.817 0 CA-C-N 115.621 -0.718 . . . . 52.42 113.136 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.605 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 27.0 tt0 . . . . . 0 C--N 1.274 -2.717 0 N-CA-C 106.919 -1.511 . . . . 75.32 106.919 178.463 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 113.687 0.995 . . . . 64.13 113.687 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 14.1 p -138.01 139.57 39.7 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 109.079 -0.712 . . . . 73.24 109.079 179.554 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.444 ' HE3' ' O ' ' A' ' 516' ' ' GLY . 74.7 mmtt -123.27 134.01 54.13 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-O 121.007 0.432 . . . . 71.14 110.311 -175.726 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.4 p-10 -95.78 127.77 42.09 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.091 -0.959 . . . . 74.21 109.135 178.441 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 27.0 pt -106.2 122.87 40.8 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 115.976 -0.556 . . . . 64.41 111.217 -178.556 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.41 -175.45 1.79 Allowed 'Trans proline' 0 C--O 1.248 0.992 0 C-N-CA 122.165 1.91 . . . . 73.33 110.477 175.904 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 499' ' ' ASP . . . . . 0.404 ' HA ' ' HB1' ' A' ' 541' ' ' ALA . 9.1 p-10 -79.71 89.98 5.19 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.617 1.199 . . . . 51.14 110.565 178.41 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.29 -11.01 12.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.001 -1.454 . . . . 52.32 110.178 177.212 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.413 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -67.38 103.15 1.22 Allowed 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 114.53 -1.214 . . . . 72.52 109.12 178.388 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 148.86 -30.92 1.22 Allowed Glycine 0 C--N 1.293 -1.816 0 C-N-CA 120.493 -0.86 . . . . 54.52 112.095 178.56 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.42 ' O ' HG12 ' A' ' 534' ' ' VAL . 10.0 pt20 -94.76 -169.83 2.1 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 120.009 -0.677 . . . . 74.24 110.14 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 2.9 m -74.16 156.08 37.71 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.785 -0.82 . . . . 73.43 108.785 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.532 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.7 p -57.91 -47.76 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 O-C-N 123.464 0.477 . . . . 72.13 112.152 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -65.24 -36.69 84.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 120.565 -0.454 . . . . 32.23 110.012 -178.749 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.79 -41.92 85.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.831 0 CA-C-N 115.907 -0.588 . . . . 74.34 109.523 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -65.39 -45.24 84.76 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.749 -0.205 . . . . 70.21 110.912 177.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.5 mt-30 -63.97 -45.75 87.69 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 123.395 0.435 . . . . 65.44 110.759 -178.788 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.532 ' O ' HG23 ' A' ' 514' ' ' VAL . 0.1 OUTLIER -67.34 -39.35 85.78 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 116.154 -0.476 . . . . 62.42 110.007 -178.229 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -62.62 -46.89 86.16 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 123.39 0.431 . . . . 63.42 111.013 -179.332 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.3 pp -68.5 -35.81 78.03 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 115.83 -0.623 . . . . 62.45 110.995 -178.328 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.402 ' N ' HD12 ' A' ' 512' ' ' LEU . 41.1 t30 -63.3 -35.98 82.17 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 123.512 0.725 . . . . 72.44 110.315 179.016 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 510' ' ' LYS . 85.0 t -63.47 -32.47 56.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.884 0 CA-C-O 121.127 0.489 . . . . 75.21 110.838 177.107 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 515' ' ' TYR . . . . . 0.435 ' O ' ' HD2' ' A' ' 495' ' ' LYS . 11.1 m-85 -103.32 3.65 35.57 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.928 -0.397 . . . . 64.24 109.928 -178.052 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 516' ' ' GLY . . . . . 0.444 ' O ' ' HE3' ' A' ' 495' ' ' LYS . . . -134.88 -54.99 0.07 OUTLIER Glycine 0 N--CA 1.416 -2.634 0 C-N-CA 118.803 -1.665 . . . . 74.44 115.019 -169.094 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 66.1 20.82 11.21 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.94 0.876 . . . . 74.33 109.032 -172.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.8 p -81.6 -174.87 5.23 Favored 'General case' 0 N--CA 1.407 -2.59 0 CA-C-N 114.155 -1.384 . . . . 63.43 110.462 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.69 138.99 42.92 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.951 -1.129 . . . . 72.3 107.951 -178.204 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 520' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 18.9 p90 -130.02 152.56 49.35 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 123.303 0.377 . . . . 72.22 110.588 -178.464 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 11.1 p -140.83 144.69 35.5 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 107.888 -1.153 . . . . 73.32 107.888 177.714 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -117.71 136.68 53.19 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.112 -0.635 . . . . 71.41 111.084 -178.116 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -132.29 129.85 40.1 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.013 -1.106 . . . . 72.44 108.013 177.65 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 32.6 t -99.73 135.03 41.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.443 0.64 . . . . 73.34 110.716 -177.0 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 556' ' ' SER . 8.7 p -135.21 150.99 29.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 107.747 -1.205 . . . . 75.02 107.747 178.092 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -82.79 135.67 34.9 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.398 0.618 . . . . 74.21 111.308 -178.012 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 72.4 m -164.23 160.2 16.36 Favored Pre-proline 0 C--N 1.308 -1.217 0 N-CA-C 106.32 -1.733 . . . . 75.54 106.32 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -64.29 -4.6 8.19 Favored 'Trans proline' 0 CA--C 1.553 1.471 0 C-N-CA 122.576 2.184 . . . . 62.45 114.084 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -70.69 130.08 89.18 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 107.755 -1.202 . . . . 73.13 107.755 173.636 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.8 148.13 76.83 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 122.417 2.078 . . . . 73.11 112.283 -176.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.25 111.52 1.1 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.303 -0.862 . . . . 75.4 111.614 -176.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 123.88 -16.76 7.75 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 115.397 -0.82 . . . . 71.03 112.143 178.556 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.69 129.42 34.96 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.216 -0.661 . . . . 71.43 109.216 179.505 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 503' ' ' GLN . 6.5 p -87.38 115.35 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 CA-C-O 121.459 0.647 . . . . 72.42 109.345 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -31.74 72.71 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.109 -0.951 . . . . 74.24 110.04 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 164.15 -174.61 40.27 Favored Glycine 0 N--CA 1.416 -2.656 0 CA-C-N 115.243 -0.89 . . . . 63.44 111.309 179.079 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 537' ' ' THR . . . . . 0.449 HG22 ' HG ' ' A' ' 553' ' ' LEU . 5.8 p -116.36 153.21 32.42 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 108.215 -1.032 . . . . 63.22 108.215 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -61.9 -47.57 91.08 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 119.47 -0.892 . . . . 72.42 111.431 179.536 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -67.82 120.32 7.32 Favored 'Trans proline' 0 C--N 1.367 1.551 0 N-CA-C 107.216 -1.878 . . . . 74.0 107.216 165.668 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.21 142.57 97.35 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.887 2.391 . . . . 75.42 113.687 -174.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 541' ' ' ALA . . . . . 0.404 ' HB1' ' HA ' ' A' ' 499' ' ' ASP . . . -61.57 129.89 43.31 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.855 -0.612 . . . . 71.42 110.253 178.072 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.69 -7.05 49.34 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 111.386 -0.686 . . . . 54.03 111.386 -178.091 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 24.0 m -89.33 137.11 32.61 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 122.729 -0.277 . . . . 70.31 110.507 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.8 t -88.7 125.35 34.81 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 107.028 -1.471 . . . . 64.25 107.028 171.627 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 36.0 m -122.87 159.77 52.15 Favored Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 109.416 -0.587 . . . . 73.14 109.416 -175.089 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -66.92 139.91 53.22 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.92 1.746 . . . . 72.11 111.031 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.5 p -61.2 -20.85 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 CA-C-O 121.591 0.71 . . . . 73.02 110.378 178.364 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -77.87 -19.04 55.51 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.222 -0.899 . . . . 71.12 112.105 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 78.5 p -83.21 174.0 11.15 Favored 'General case' 0 C--O 1.247 0.958 0 N-CA-C 112.635 0.605 . . . . 64.12 112.635 -176.223 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.6 p -113.52 137.92 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 109.133 -0.691 . . . . 72.12 109.133 -178.973 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 59.8 mt -103.95 115.39 45.8 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 N-CA-C 107.706 -1.22 . . . . 72.23 107.706 178.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -103.73 129.18 51.06 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.399 -0.92 . . . . 72.5 110.556 178.391 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.449 ' HG ' HG22 ' A' ' 537' ' ' THR . 7.4 mp -97.78 126.91 43.37 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 114.314 -1.312 . . . . 72.21 110.259 -177.809 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -88.15 111.94 22.16 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 107.058 -1.46 . . . . 61.41 107.058 173.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 524' ' ' SER . 22.2 t -97.52 132.68 41.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 107.207 -1.405 . . . . 65.42 107.207 -178.91 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 72.3 m -94.7 134.03 37.73 Favored 'General case' 0 N--CA 1.404 -2.772 0 C-N-CA 119.36 -0.936 . . . . 74.15 111.684 177.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.0 133.88 41.86 Favored 'General case' 0 N--CA 1.402 -2.859 0 N-CA-C 104.637 -2.357 . . . . 72.42 104.637 168.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -54.32 -23.27 25.63 Favored Glycine 0 N--CA 1.468 0.822 0 O-C-N 124.493 1.12 . . . . 73.34 114.842 -171.9 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 81.06 -23.85 0.21 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.988 1.715 . . . . 72.04 109.253 -177.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.463 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 77.6 mt-30 -110.75 161.44 15.77 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 115.208 -0.905 . . . . 75.3 109.922 -172.485 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 561' ' ' PHE . . . . . 0.422 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 47.5 p90 -137.56 155.44 49.22 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 107.793 -1.188 . . . . 71.41 107.793 177.796 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.14 118.65 14.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 O-C-N 123.751 0.657 . . . . 74.12 110.188 179.177 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 40.2 ttp -85.86 128.48 58.22 Favored Pre-proline 0 C--N 1.298 -1.633 0 CA-C-N 116.026 -0.533 . . . . 70.43 110.495 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.54 169.96 14.69 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.183 2.589 . . . . 71.45 111.514 175.689 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 565' ' ' ASP . . . . . 0.42 ' HA ' ' HB2' ' A' ' 610' ' ' ALA . 5.8 p-10 -66.09 124.11 21.71 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.742 0.782 . . . . 72.53 112.355 -179.777 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 8.9 tt -115.76 3.91 13.91 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.746 -1.576 . . . . 65.31 106.746 174.377 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 14.3 m -76.39 131.42 39.12 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.055 -1.429 . . . . 74.11 109.123 179.354 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 74.22 61.06 3.33 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.989 -0.624 . . . . 71.31 113.44 176.768 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 569' ' ' MET . . . . . 0.529 ' HB2' ' HB2' ' A' ' 573' ' ' ASP . 20.1 ptp -162.66 173.12 14.31 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.696 -0.853 . . . . 73.14 108.696 177.528 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -101.15 175.73 5.49 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.864 -0.791 . . . . 75.44 108.864 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -61.64 -34.89 76.48 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.169 -1.049 . . . . 74.41 108.169 177.34 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 31.6 m -69.29 -10.25 13.22 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 115.386 -0.825 . . . . 63.23 112.084 -179.171 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 569' ' ' MET . 16.0 m-20 -101.87 -44.22 5.58 Favored 'General case' 0 C--O 1.248 1.02 0 N-CA-C 108.946 -0.761 . . . . 62.04 108.946 174.622 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 574' ' ' ALA . . . . . 0.444 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -62.0 -53.22 58.64 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 114.173 -1.376 . . . . 62.13 112.107 -175.741 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.45 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 33.8 tt0 -56.93 -47.83 98.42 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 123.396 0.435 . . . . 73.13 111.993 -176.667 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.465 ' HA ' ' HG2' ' A' ' 579' ' ' ARG . 73.8 Cg_exo -52.72 -44.74 45.51 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.242 1.961 . . . . 73.33 113.411 172.733 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -64.64 -37.92 89.21 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.705 -0.479 . . . . 74.24 109.705 178.252 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.599 HD13 ' CZ3' ' A' ' 583' ' ' TRP . 78.5 mt -67.38 -48.29 67.83 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.564 -0.744 . . . . 65.14 111.679 -178.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.465 ' HG2' ' HA ' ' A' ' 576' ' ' PRO . 16.9 ptp180 -65.85 -34.18 77.56 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 120.953 0.406 . . . . 73.21 111.086 177.962 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -69.95 -30.81 68.28 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.208 -0.451 . . . . 73.13 110.409 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 578' ' ' LEU . 3.1 pp -81.34 -8.54 59.76 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 119.751 -0.779 . . . . 64.04 111.244 177.938 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 80.08 54.43 3.85 Favored Glycine 0 CA--C 1.504 -0.648 0 N-CA-C 110.824 -0.911 . . . . 65.44 110.824 -178.647 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.599 ' CZ3' HD13 ' A' ' 578' ' ' LEU . 14.0 t90 -80.45 127.89 32.94 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.758 0.313 . . . . 72.31 111.361 -178.651 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 32.0 p -106.59 -12.95 15.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.508 -0.314 . . . . 55.13 111.727 179.296 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -85.95 -175.18 49.95 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 121.055 -0.593 . . . . 51.23 112.809 -175.481 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 64.1 mtt -118.91 149.28 41.84 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.674 0.273 . . . . 73.51 110.27 -178.903 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 7.7 tt -87.91 130.17 35.0 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-O 121.212 0.53 . . . . 54.33 111.08 -175.494 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.558 ' O ' ' HA ' ' A' ' 621' ' ' THR . 18.9 t70 -117.59 121.76 41.8 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.041 -0.981 . . . . 72.44 109.172 175.841 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.3 OUTLIER -104.4 133.48 49.22 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.743 -1.206 . . . . 75.33 107.743 174.351 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -85.75 -26.39 35.26 Favored Glycine 0 C--N 1.294 -1.804 0 C-N-CA 120.784 -0.722 . . . . 65.24 112.548 -176.627 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.42 139.76 37.18 Favored 'General case' 0 N--CA 1.42 -1.973 0 C-N-CA 120.847 -0.341 . . . . 70.42 110.905 -178.345 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -116.11 124.45 50.4 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 105.046 -2.205 . . . . 61.31 105.046 171.282 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 593' ' ' VAL . . . . . 0.416 ' HB ' ' HA2' ' A' ' 625' ' ' GLY . 58.6 t -115.29 117.44 55.62 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 N-CA-C 108.659 -0.867 . . . . 70.32 108.659 -177.05 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -73.69 106.65 5.53 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.617 0.722 . . . . 71.14 109.838 -179.1 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -123.51 -58.37 1.61 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.976 -1.011 . . . . 75.35 108.899 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 131.8 148.23 6.1 Favored Glycine 0 N--CA 1.431 -1.648 0 N-CA-C 110.717 -0.953 . . . . 72.54 110.717 178.747 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.99 -33.95 88.62 Favored Glycine 0 C--N 1.314 -0.676 0 N-CA-C 112.468 -0.253 . . . . 73.31 112.468 -178.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 23.4 t -75.14 -23.51 57.85 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.199 1.0 . . . . 72.11 108.661 -179.461 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -87.81 -3.02 58.97 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.713 -1.13 . . . . 61.44 110.236 -178.178 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 47.4 m80 69.73 95.44 0.07 Allowed 'General case' 0 C--O 1.247 0.925 0 C-N-CA 124.987 1.315 . . . . 71.34 112.977 175.405 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -83.93 80.22 9.23 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 109.044 -0.724 . . . . 45.02 109.044 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -98.48 159.8 14.71 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.535 -0.757 . . . . 62.52 109.964 -179.018 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 59.6 t -70.84 130.2 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 107.331 -1.359 . . . . 74.42 107.331 176.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 31.5 m -108.84 -29.8 2.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 123.574 0.546 . . . . 64.05 111.516 -176.207 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -155.91 139.27 15.75 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 120.74 0.305 . . . . 74.03 110.252 -179.573 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -121.19 128.38 52.4 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.516 -0.766 . . . . 61.4 109.19 173.609 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -56.6 -51.1 83.81 Favored Pre-proline 0 N--CA 1.475 0.816 0 O-C-N 123.846 0.716 . . . . 71.14 110.799 178.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -77.07 111.81 3.29 Favored 'Trans proline' 0 C--N 1.371 1.756 0 N-CA-C 108.495 -1.387 . . . . 52.34 108.495 168.363 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.93 155.19 62.51 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.78 2.32 . . . . 44.52 113.491 -177.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 610' ' ' ALA . . . . . 0.42 ' HB2' ' HA ' ' A' ' 565' ' ' ASP . . . -67.58 130.76 44.02 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.378 -0.828 . . . . 61.55 109.876 177.335 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.18 -5.88 59.42 Favored Glycine 0 C--N 1.305 -1.159 0 N-CA-C 111.245 -0.742 . . . . 44.33 111.245 -177.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 28.8 m -101.66 156.11 17.69 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.889 -0.782 . . . . 54.32 108.889 -179.591 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 613' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -80.28 135.07 14.28 Favored Glycine 0 N--CA 1.422 -2.274 0 CA-C-N 116.363 -0.381 . . . . 63.4 112.431 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.3 m -120.74 142.98 34.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 107.777 -1.194 . . . . 75.35 107.777 175.754 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.463 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 29.4 p-10 -48.97 163.47 0.08 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.766 0.826 . . . . 71.52 112.144 -179.098 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -58.67 -27.7 65.03 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.43 0.53 . . . . 71.42 112.43 -175.737 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -81.15 -7.18 59.51 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 119.931 -0.708 . . . . 73.15 111.138 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.35 19.66 68.76 Favored Glycine 0 CA--C 1.492 -1.374 0 CA-C-O 119.831 -0.427 . . . . 62.23 113.445 169.179 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.88 119.27 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-O 121.834 0.826 . . . . 74.43 109.69 -168.761 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 39.4 pt -118.84 133.84 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 CA-C-N 114.857 -1.065 . . . . 74.34 112.258 -176.728 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 8.8 t -110.84 118.24 35.58 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 107.327 -1.36 . . . . 64.2 107.327 174.702 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -138.54 168.95 18.68 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.578 -0.737 . . . . 64.24 111.476 -173.938 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -125.95 135.76 52.23 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-O 122.53 1.157 . . . . 53.54 110.026 175.482 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -142.9 169.63 17.2 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 105.114 -2.18 . . . . 74.14 105.114 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 625' ' ' GLY . . . . . 0.416 ' HA2' ' HB ' ' A' ' 593' ' ' VAL . . . -52.33 -128.08 0.0 OUTLIER Glycine 0 CA--C 1.559 2.802 0 N-CA-C 115.878 1.111 . . . . 31.41 115.878 178.767 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 . . . . . 0 C--N 1.277 -2.554 0 O-C-N 120.805 -1.409 . . . . 52.42 110.561 -176.292 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.607 0 CA-C-O 121.461 0.648 . . . . 65.11 111.114 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 44.9 p -136.02 147.01 47.76 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.244 -0.889 . . . . 64.21 108.987 178.764 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -135.77 145.84 46.98 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.151 0.5 . . . . 75.44 110.272 176.684 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.0 m-20 -79.87 126.83 31.5 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.077 -0.965 . . . . 74.45 108.992 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.5 pt -91.93 131.12 36.17 Favored Pre-proline 0 C--N 1.306 -1.313 0 C-N-CA 120.455 -0.498 . . . . 72.03 110.746 178.969 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -83.39 177.06 6.72 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.371 2.047 . . . . 61.32 111.626 177.904 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -88.44 122.71 32.23 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.289 0.566 . . . . 74.44 109.942 178.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.458 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 27.8 m -120.27 8.28 6.36 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-N 115.234 -0.893 . . . . 74.32 110.803 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -78.13 99.86 6.35 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 116.024 -0.535 . . . . 74.3 110.953 -177.598 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 157.55 -37.67 0.55 Allowed Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.667 -0.778 . . . . 61.03 111.945 178.637 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -89.46 -172.04 3.45 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 122.534 -0.392 . . . . 74.43 109.983 -178.912 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 3.6 m -71.2 155.53 40.63 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.618 -0.882 . . . . 71.02 108.618 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.49 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.7 p -62.65 -43.56 98.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 O-C-N 123.109 0.256 . . . . 62.14 111.584 -178.933 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.17 -37.89 88.78 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.061 -0.256 . . . . 74.43 110.526 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 66.0 t -67.59 -45.92 84.06 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.375 0 N-CA-C 109.272 -0.64 . . . . 75.13 109.272 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.458 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -59.17 -44.88 92.16 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.553 0.216 . . . . 74.32 111.43 179.465 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.2 mt-30 -63.84 -45.88 87.53 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.098 -0.501 . . . . 74.11 111.028 -178.859 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.549 ' O ' HG23 ' A' ' 514' ' ' VAL . 13.7 ptmm? -67.54 -37.97 83.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.335 -0.393 . . . . 73.24 111.086 179.325 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -61.18 -48.86 79.61 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 116.059 -0.519 . . . . 73.34 110.631 -179.566 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.4 pp -68.17 -35.47 78.09 Favored 'General case' 0 C--O 1.209 -1.046 0 CA-C-N 115.945 -0.57 . . . . 73.1 110.619 -178.633 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -59.95 -35.73 75.57 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 123.951 0.9 . . . . 62.2 110.751 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 510' ' ' LYS . 98.8 t -58.28 -35.03 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 122.763 0.425 . . . . 64.34 111.862 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -112.28 -1.38 15.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.567 0.699 . . . . 63.11 109.959 -177.612 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -113.37 -60.2 0.41 Allowed Glycine 0 N--CA 1.421 -2.35 0 CA-C-N 115.321 -0.854 . . . . 71.14 113.033 -171.105 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 63.0 27.09 15.79 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.519 1.152 . . . . 75.24 109.293 -174.865 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.3 p -85.43 -170.03 2.93 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 113.914 -1.494 . . . . 53.43 109.722 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -107.95 139.41 42.61 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.466 -1.309 . . . . 73.41 107.466 174.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -130.7 149.49 52.32 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.149 0.5 . . . . 72.04 111.224 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.7 p -140.8 157.67 45.07 Favored 'General case' 0 N--CA 1.405 -2.693 0 N-CA-C 107.142 -1.429 . . . . 71.43 107.142 178.366 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -125.57 141.17 52.17 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 120.711 -0.396 . . . . 71.43 110.094 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 523' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -131.63 143.16 50.11 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.249 -1.389 . . . . 51.41 107.249 178.173 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.9 m -105.47 139.64 39.79 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.071 -0.651 . . . . 54.23 111.839 -175.216 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.47 149.54 33.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 109.218 -0.66 . . . . 71.22 109.218 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.28 134.79 50.92 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.445 -0.576 . . . . 71.55 109.445 177.695 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 556' ' ' SER . 74.1 m -160.22 166.59 15.47 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 109.885 -0.413 . . . . 54.33 109.885 179.534 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -78.1 -6.91 16.08 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.976 1.784 . . . . 45.35 113.03 175.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.449 ' HG2' ' OE2' ' A' ' 533' ' ' GLU . 3.3 mpt_? -88.52 149.32 44.09 Favored Pre-proline 0 CA--C 1.516 -0.352 0 N-CA-C 109.769 -0.456 . . . . 72.2 109.769 -179.351 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.47 147.01 86.55 Favored 'Trans proline' 0 C--O 1.258 1.488 0 C-N-CA 122.668 2.245 . . . . 73.31 112.792 -178.752 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.91 106.9 0.63 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.054 -0.975 . . . . 74.21 110.759 -179.282 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 152.1 -31.58 0.88 Allowed Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 110.193 -1.163 . . . . 72.24 110.193 -178.692 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 533' ' ' GLU . . . . . 0.449 ' OE2' ' HG2' ' A' ' 529' ' ' ARG . 34.1 tt0 -76.98 139.1 40.0 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.154 0.502 . . . . 72.54 109.977 178.148 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.25 118.44 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.462 0 N-CA-C 108.132 -1.062 . . . . 70.21 108.132 174.964 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.4 p -79.51 -11.33 59.9 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.43 -0.804 . . . . 73.43 112.56 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.87 -168.17 29.36 Favored Glycine 0 CA--C 1.481 -2.087 0 C-N-CA 120.119 -1.039 . . . . 61.52 112.404 175.154 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 537' ' ' THR . . . . . 0.489 HG22 ' HG ' ' A' ' 553' ' ' LEU . 12.6 p -116.68 158.18 24.21 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 107.469 -1.308 . . . . 53.54 107.469 179.188 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -63.21 -49.44 80.07 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 118.505 -1.278 . . . . 72.24 111.995 176.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 18.9 Cg_exo -70.24 149.25 63.57 Favored 'Trans proline' 0 C--N 1.369 1.647 0 CA-C-N 120.486 1.209 . . . . 62.53 110.447 173.103 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 540' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 13.8 Cg_exo -70.5 144.85 51.24 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.706 2.271 . . . . 74.34 113.167 -178.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -68.41 129.73 40.79 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.428 -0.582 . . . . 73.41 109.428 176.801 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.35 -10.82 50.8 Favored Glycine 0 C--N 1.309 -0.938 0 N-CA-C 110.94 -0.864 . . . . 52.24 110.94 -176.758 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 92.3 m -88.09 137.11 32.62 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 109.985 -0.376 . . . . 54.42 109.985 178.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.1 t -86.36 132.28 34.0 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.688 -0.856 . . . . 71.22 108.688 175.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.89 155.98 74.7 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 108.289 -1.004 . . . . 74.11 108.289 -179.594 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.407 ' HG2' ' HB3' ' A' ' 549' ' ' SER . 10.1 Cg_endo -58.48 137.11 78.57 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.551 1.501 . . . . 60.14 111.289 178.267 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.63 -23.85 34.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 123.701 0.801 . . . . 73.21 113.016 -174.088 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -97.38 -0.11 46.91 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 120.317 -0.553 . . . . 74.42 111.857 -177.2 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 549' ' ' SER . . . . . 0.407 ' HB3' ' HG2' ' A' ' 546' ' ' PRO . 89.4 p -78.08 170.94 15.77 Favored 'General case' 0 C--O 1.256 1.429 0 C-N-CA 119.63 -0.828 . . . . 72.14 110.96 -178.614 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.8 p -110.24 115.75 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-O 121.934 0.874 . . . . 43.03 109.839 -178.256 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 52.1 mt -85.55 130.82 35.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 114.94 -1.027 . . . . 61.41 108.579 -177.579 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 552' ' ' GLU . . . . . 0.413 ' OE1' ' HD3' ' A' ' 539' ' ' PRO . 0.4 OUTLIER -103.55 120.73 41.44 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.727 0.775 . . . . 63.1 111.182 178.873 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.489 ' HG ' HG22 ' A' ' 537' ' ' THR . 7.1 mp -99.2 124.09 43.99 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 113.983 -1.462 . . . . 73.21 109.338 178.66 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 2.9 mp0 -88.28 117.73 27.39 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.436 -0.802 . . . . 62.35 111.04 -179.087 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 32.0 t -93.23 126.41 45.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.004 -0.998 . . . . 60.03 108.35 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 527' ' ' SER . 17.0 p -82.04 117.87 22.57 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 109.489 -0.56 . . . . 30.24 109.489 178.402 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -97.68 137.46 36.54 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 108.432 -0.951 . . . . 72.23 108.432 174.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -63.02 -22.3 64.64 Favored Glycine 0 CA--C 1.5 -0.894 0 O-C-N 124.174 0.921 . . . . 35.34 111.846 177.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 81.01 -5.92 1.65 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.684 1.593 . . . . 75.44 109.282 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 42.5 mt-30 -111.93 144.3 41.5 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 115.655 -0.702 . . . . 65.23 111.517 -172.117 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 561' ' ' PHE . . . . . 0.468 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 55.1 p90 -123.69 154.59 39.19 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.68 -1.146 . . . . 74.3 108.052 178.872 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.32 117.82 5.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.031 0.443 . . . . 75.04 110.492 177.637 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.446 ' HB2' HG22 ' A' ' 614' ' ' VAL . 50.8 ttp -81.56 130.91 59.75 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.953 -0.567 . . . . 50.22 111.889 -176.077 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -65.58 169.46 12.76 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.988 2.458 . . . . 75.13 111.068 172.6 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -87.14 143.13 27.44 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.215 0.531 . . . . 64.15 111.582 -177.435 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 566' ' ' LEU . . . . . 0.414 ' H ' HD23 ' A' ' 566' ' ' LEU . 2.1 pt? -133.03 25.21 4.26 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.155 -1.794 . . . . 73.31 106.155 176.131 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 4.4 m -75.61 148.69 38.59 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 113.13 -1.85 . . . . 71.53 111.909 -174.242 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 70.09 59.04 5.69 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.254 -0.885 . . . . 64.54 114.066 173.472 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 569' ' ' MET . . . . . 0.464 ' HB2' ' HB2' ' A' ' 573' ' ' ASP . 23.0 ptp -159.55 175.07 13.69 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-N 117.335 0.568 . . . . 74.23 111.079 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -97.79 176.13 5.92 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.102 -1.073 . . . . 75.13 108.102 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 571' ' ' TRP . . . . . 0.493 ' CZ3' HD22 ' A' ' 587' ' ' LEU . 23.1 t-105 -64.19 -33.91 76.87 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.723 -0.843 . . . . 74.44 108.723 173.867 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.72 -14.65 18.57 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 CA-C-N 115.762 -0.653 . . . . 74.13 111.765 -178.498 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 569' ' ' MET . 14.5 m-20 -93.66 -41.14 9.87 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.172 -1.047 . . . . 62.04 108.172 174.804 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -52.67 -47.63 67.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.961 -1.018 . . . . 53.51 113.067 -177.312 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.502 ' O ' ' HG ' ' A' ' 578' ' ' LEU 0.255 32.0 mt-10 -60.18 -56.16 38.22 Favored Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 114.059 1.133 . . . . 72.32 114.059 179.416 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -58.72 -31.1 94.25 Favored 'Trans proline' 0 C--N 1.365 1.4 0 C-N-CA 121.392 1.395 . . . . 70.14 112.874 174.808 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.453 ' HG3' ' SD ' ' A' ' 569' ' ' MET . 2.8 mmp_? -66.2 -45.37 81.01 Favored 'General case' 0 C--O 1.209 -1.07 0 C-N-CA 121.314 -0.154 . . . . 71.34 110.626 176.116 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.3 pp -66.12 -39.75 90.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.263 0.468 . . . . 73.01 112.263 -174.192 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.414 ' N ' HD12 ' A' ' 578' ' ' LEU . 15.2 ptm180 -66.33 -39.6 89.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.388 -0.369 . . . . 71.33 111.072 176.648 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.24 -34.56 73.0 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 121.055 0.455 . . . . 71.41 110.876 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 28.6 tp -81.22 -9.15 59.83 Favored 'General case' 0 N--CA 1.42 -1.929 0 C-N-CA 123.939 0.895 . . . . 71.23 110.808 -179.261 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 65.62 36.53 92.54 Favored Glycine 0 C--N 1.315 -0.601 0 CA-C-N 116.199 -0.455 . . . . 75.35 112.079 178.661 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -78.38 127.13 31.76 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 107.825 -1.176 . . . . 72.11 107.825 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 10.2 m -94.37 -20.03 20.11 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.979 0.418 . . . . 70.53 111.671 -176.36 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 585' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -83.4 175.59 52.51 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 121.094 -0.574 . . . . 71.53 113.397 -178.029 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 10.4 mmt -101.31 155.27 18.14 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.396 -0.594 . . . . 72.23 109.396 -179.516 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 587' ' ' LEU . . . . . 0.493 HD22 ' CZ3' ' A' ' 571' ' ' TRP . 6.1 tt -89.88 118.2 29.27 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.904 -0.589 . . . . 71.43 109.761 -176.977 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 621' ' ' THR . 26.4 t70 -95.91 117.47 30.67 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 109.017 -0.735 . . . . 73.4 109.017 178.043 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.416 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -112.31 135.47 52.95 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.693 -0.685 . . . . 71.23 110.572 -178.716 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -70.21 -87.65 0.11 Allowed Glycine 0 C--N 1.296 -1.67 0 CA-C-N 115.313 -0.858 . . . . 74.3 111.076 -179.679 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.29 154.16 47.88 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 122.728 -0.278 . . . . 73.5 110.371 177.653 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.9 128.24 35.97 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 107.76 -1.2 . . . . 72.32 107.76 176.146 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 81.7 t -104.01 135.91 39.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 109.688 -0.486 . . . . 72.15 109.688 -179.216 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.95 107.32 11.62 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 122.062 0.934 . . . . 60.05 111.327 -177.507 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -119.35 -44.97 2.55 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.757 -1.111 . . . . 72.34 109.317 177.299 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 103.84 143.35 12.51 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.076 -1.059 . . . . 73.24 111.718 179.585 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.37 -37.4 87.54 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 114.228 0.451 . . . . 51.25 114.228 -177.233 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 23.0 t -77.35 -23.62 50.84 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.43 0.633 . . . . 71.4 109.573 -176.264 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -91.08 -5.01 55.8 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.412 -0.813 . . . . 72.02 109.84 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 32.9 m170 66.31 97.13 0.05 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.406 1.082 . . . . 74.32 112.474 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 601' ' ' ASN . . . . . 0.57 ' HB3' ' C ' ' A' ' 625' ' ' GLY . 62.2 m-80 -70.93 85.3 0.69 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.902 -1.045 . . . . 72.34 111.973 -177.782 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -110.33 172.52 6.82 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.9 -0.591 . . . . 72.42 111.253 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 13.0 p -57.53 134.98 21.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 CA-C-N 116.064 -0.516 . . . . 73.31 110.37 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 29.6 m -108.6 -34.72 2.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 116.235 -0.439 . . . . 55.51 111.137 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -156.22 142.11 18.01 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.449 -0.341 . . . . 75.32 110.203 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 606' ' ' GLN . . . . . 0.409 ' HB2' HD11 ' A' ' 620' ' ' ILE . 20.4 pt20 -129.03 134.67 48.22 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.162 -1.792 . . . . 54.11 106.162 173.708 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 609' ' ' PRO . 4.4 t-20 -67.21 -49.48 44.36 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 119.623 -0.831 . . . . 53.23 111.786 -176.202 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.7 Cg_endo -90.62 105.05 0.3 Allowed 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 121.567 1.511 . . . . 72.11 109.522 170.331 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 609' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 607' ' ' ASN . 19.0 Cg_exo -68.67 160.75 48.19 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 122.682 2.255 . . . . 73.34 111.448 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -57.67 130.03 44.57 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.257 -0.429 . . . . 75.11 110.35 178.839 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.3 -9.83 46.19 Favored Glycine 0 C--N 1.31 -0.869 0 C-N-CA 120.542 -0.837 . . . . 65.54 111.882 -176.652 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 34.4 m -87.3 151.28 23.26 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.824 -0.806 . . . . 73.44 108.824 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 613' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -75.96 131.9 12.35 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 120.702 -0.761 . . . . 73.22 111.855 177.432 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 563' ' ' MET . 29.4 m -125.63 143.4 39.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.134 -1.061 . . . . 61.11 108.134 176.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -54.25 176.29 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.729 0.812 . . . . 35.55 113.152 -177.333 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -55.58 -27.61 50.28 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.883 0.873 . . . . 72.1 112.761 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.459 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 1.0 OUTLIER -85.79 -6.55 59.09 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 120.897 -0.321 . . . . 72.22 111.083 178.119 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.77 20.52 72.36 Favored Glycine 0 CA--C 1.496 -1.116 0 C-N-CA 121.511 -0.376 . . . . 73.14 112.507 173.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.52 119.75 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 CA-C-O 122.595 1.188 . . . . 74.22 111.194 -168.685 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' A' ' 606' ' ' GLN . 0.0 OUTLIER -126.64 132.38 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 CA-C-N 113.926 -1.488 . . . . 72.44 108.651 -177.801 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 10.1 t -106.37 124.25 49.3 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-N 115.48 -0.782 . . . . 64.01 109.551 -178.347 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.404 HD21 HD21 ' A' ' 587' ' ' LEU . 2.1 pt? -138.69 166.25 24.86 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.754 -0.657 . . . . 73.21 111.501 -176.722 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -128.89 137.52 51.49 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.127 -1.064 . . . . 73.33 108.127 175.873 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -139.74 165.44 27.27 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 116.367 -0.379 . . . . 74.25 111.032 -171.115 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 625' ' ' GLY . . . . . 0.57 ' C ' ' HB3' ' A' ' 601' ' ' ASN . . . -66.52 139.54 37.47 Favored Glycine 0 N--CA 1.427 -1.937 0 O-C-N 124.088 0.867 . . . . 53.13 111.524 175.867 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 . . . . . 0 C--N 1.306 -1.32 0 C-N-CA 126.306 1.843 . . . . 74.42 114.676 -177.138 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.547 0 CA-C-O 121.897 0.856 . . . . 55.24 109.852 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 25.4 p -129.71 158.41 39.45 Favored 'General case' 0 N--CA 1.409 -2.525 0 N-CA-C 107.257 -1.386 . . . . 75.14 107.257 -179.345 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -149.03 142.47 25.27 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 108.211 -1.033 . . . . 73.04 108.211 179.368 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.04 134.65 35.37 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.278 0.561 . . . . 70.14 110.638 179.195 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 39.5 pt -85.03 137.96 37.29 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 114.972 -1.013 . . . . 70.12 111.953 -177.677 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.99 166.14 29.84 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.741 2.294 . . . . 61.14 113.776 178.426 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -88.21 44.76 1.22 Allowed 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 125.158 1.383 . . . . 44.04 111.223 -177.427 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 17.2 m -72.05 14.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 114.516 1.302 . . . . 55.24 114.516 -175.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.419 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -79.66 101.63 8.48 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.351 -0.611 . . . . 52.44 109.351 178.2 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 150.79 -31.09 1.01 Allowed Glycine 0 C--N 1.297 -1.602 0 N-CA-C 110.951 -0.86 . . . . 32.21 110.951 -179.6 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.424 ' O ' HG12 ' A' ' 534' ' ' VAL . 18.1 mp0 -81.61 -177.26 6.46 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 109.103 -0.703 . . . . 74.3 109.103 177.537 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 2.4 m -71.5 155.94 40.01 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 107.451 -1.314 . . . . 70.14 107.451 176.708 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.424 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.5 p -63.27 -42.0 94.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 117.737 0.244 . . . . 71.24 110.999 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 506' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 23.4 t70 -59.77 -43.77 94.19 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.258 0.551 . . . . 74.34 110.045 178.482 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 95.8 t -67.74 -44.81 85.52 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.126 0 CA-C-N 114.868 -1.06 . . . . 65.2 109.871 -178.687 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.35 -45.19 94.33 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 123.104 0.253 . . . . 54.13 111.458 179.092 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 96.4 mt-30 -62.27 -46.79 87.22 Favored 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 123.404 0.44 . . . . 62.22 110.996 -179.25 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.502 ' O ' HG23 ' A' ' 514' ' ' VAL 0.321 20.4 pttp -68.79 -37.55 79.35 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 112.375 0.509 . . . . 62.14 112.375 178.359 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -61.03 -49.5 77.17 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 120.771 0.319 . . . . 71.11 110.501 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.416 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.2 pp -65.85 -35.75 81.55 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-N 116.071 -0.513 . . . . 74.04 110.962 -178.825 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.416 ' N ' HD12 ' A' ' 512' ' ' LEU . 34.3 t30 -62.9 -36.17 82.49 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 123.085 0.554 . . . . 71.44 110.669 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 510' ' ' LYS . 93.9 t -63.08 -34.27 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 121.261 0.553 . . . . 63.25 110.829 177.516 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -106.58 12.2 29.7 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.221 0.534 . . . . 70.32 110.371 -176.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -141.45 -54.05 0.04 OUTLIER Glycine 0 CA--C 1.488 -1.596 0 C-N-CA 119.935 -1.126 . . . . 22.11 114.023 -172.67 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 66.66 20.49 10.73 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.811 0.815 . . . . 74.51 110.032 -173.921 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.2 p -76.12 -178.48 4.47 Favored 'General case' 0 N--CA 1.415 -2.219 0 C-N-CA 125.449 1.499 . . . . 75.43 109.371 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 34.5 mtmm -107.62 142.98 36.71 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 108.168 -1.049 . . . . 73.33 108.168 175.935 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -126.54 147.46 49.86 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.301 0.572 . . . . 71.32 111.977 -176.481 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 13.6 p -133.75 146.65 50.95 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 114.537 -1.211 . . . . 74.32 107.763 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -121.67 136.5 54.94 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 120.96 0.409 . . . . 74.44 111.245 -177.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -122.54 122.09 38.06 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.838 -0.801 . . . . 73.35 108.838 178.018 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.1 m -87.48 134.79 33.55 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.834 0.35 . . . . 71.0 110.891 -177.362 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 556' ' ' SER . 47.6 t -136.55 150.14 27.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 106.086 -1.82 . . . . 72.15 106.086 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -99.21 135.82 40.06 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.655 -0.869 . . . . 71.1 108.655 175.722 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 66.7 m -162.58 171.4 6.52 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 107.289 -1.374 . . . . 52.25 107.289 -176.742 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.92 -15.05 44.98 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 121.935 1.757 . . . . 74.24 113.104 177.651 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.43 135.65 94.79 Favored Pre-proline 0 C--O 1.224 -0.268 0 N-CA-C 108.472 -0.936 . . . . 75.53 108.472 176.207 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.8 149.84 86.44 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.575 2.183 . . . . 74.24 113.392 -175.732 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 557' ' ' LYS . . . -59.77 106.89 0.53 Allowed 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 115.146 -0.934 . . . . 44.2 111.679 -178.657 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 124.09 -14.4 7.9 Favored Glycine 0 N--CA 1.424 -2.161 0 CA-C-N 115.129 -0.941 . . . . 63.14 111.578 179.151 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -82.45 130.75 35.17 Favored 'General case' 0 C--O 1.258 1.541 0 N-CA-C 108.873 -0.788 . . . . 53.32 108.873 179.485 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 503' ' ' GLN . 7.0 p -81.67 117.87 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.833 0 N-CA-C 107.509 -1.293 . . . . 65.34 107.509 176.905 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.3 m -72.79 -27.13 61.81 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 113.533 -1.667 . . . . 74.24 109.311 -175.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 153.15 -166.46 31.56 Favored Glycine 0 N--CA 1.412 -2.929 0 N-CA-C 110.086 -1.206 . . . . 42.12 110.086 177.097 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.0 p -116.2 157.85 24.22 Favored 'General case' 0 C--N 1.267 -3.002 0 N-CA-C 106.88 -1.526 . . . . 75.33 106.88 178.772 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -62.68 -51.11 74.58 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 118.469 -1.292 . . . . 73.32 111.439 177.229 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -73.07 147.13 42.47 Favored 'Trans proline' 0 C--N 1.369 1.606 0 CA-C-N 120.191 1.104 . . . . 73.04 110.173 173.332 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.55 145.1 75.36 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.497 2.131 . . . . 72.45 111.679 -179.207 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.11 142.0 57.83 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 110.128 -0.323 . . . . 73.43 110.128 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.19 -21.86 43.83 Favored Glycine 0 C--N 1.313 -0.701 0 N-CA-C 111.635 -0.586 . . . . 51.43 111.635 -177.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 47.1 m -71.53 137.3 47.99 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 122.872 0.469 . . . . 74.3 111.354 -177.821 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 12.4 t -84.44 126.29 33.12 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 109.254 -0.647 . . . . 73.15 109.254 176.439 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.63 157.96 73.51 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 106.973 -1.491 . . . . 73.32 106.973 177.982 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 10.0 Cg_endo -59.43 135.31 64.15 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 CA-C-N 120.639 1.264 . . . . 72.32 111.81 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.84 -19.89 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-N 114.95 -1.023 . . . . 74.34 112.835 -174.561 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -92.4 -17.55 24.46 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.796 -0.638 . . . . 74.31 112.038 -178.021 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 99.0 p -78.4 179.41 7.01 Favored 'General case' 0 C--O 1.253 1.288 0 N-CA-C 112.506 0.558 . . . . 70.23 112.506 -174.067 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 14.3 p -109.85 128.42 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.809 0 CA-C-O 121.513 0.673 . . . . 75.34 110.41 -178.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 47.8 mt -98.0 138.86 21.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.286 -1.005 . . . . 71.32 108.286 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.6 120.29 40.6 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.717 0.77 . . . . 63.31 112.224 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.7 mp -102.18 122.13 43.57 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 113.853 -1.521 . . . . 71.41 108.644 178.727 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -85.87 122.68 30.27 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 115.433 -0.803 . . . . 65.25 108.996 179.14 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.13 125.33 68.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.514 -0.921 . . . . 62.11 108.514 -176.203 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 525' ' ' VAL . 67.9 m -97.29 147.63 23.95 Favored 'General case' 0 C--N 1.285 -2.237 0 C-N-CA 119.515 -0.874 . . . . 54.54 111.973 179.026 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.4 ptpt -111.57 141.39 45.21 Favored 'General case' 0 N--CA 1.404 -2.74 0 N-CA-C 105.323 -2.103 . . . . 74.42 105.323 169.243 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -54.71 -22.09 24.45 Favored Glycine 0 C--O 1.242 0.633 0 O-C-N 124.441 1.088 . . . . 62.05 114.52 -174.488 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 88.14 -22.35 0.14 Allowed 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 126.576 1.95 . . . . 43.33 107.594 -176.72 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.56 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 77.6 mt-30 -112.99 146.92 38.21 Favored 'General case' 0 N--CA 1.405 -2.676 0 CA-C-N 114.468 -1.242 . . . . 72.01 111.298 -175.677 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -124.65 153.32 42.45 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 107.282 -1.377 . . . . 75.54 107.282 176.577 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.99 121.61 22.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 109.556 -0.535 . . . . 75.12 109.556 -179.78 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 54.3 ttp -79.53 130.1 69.33 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 116.292 -0.413 . . . . 73.4 110.318 -177.955 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.69 168.97 9.23 Favored 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.782 2.321 . . . . 73.42 110.881 174.279 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.2 129.9 34.79 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.739 0.78 . . . . 71.42 110.42 -179.457 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 566' ' ' LEU . . . . . 0.495 ' O ' ' HG2' ' A' ' 569' ' ' MET . 3.1 pp -126.74 10.33 7.12 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.148 -1.387 . . . . 72.52 108.677 176.086 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 567' ' ' SER . . . . . 0.438 ' HB3' ' OE1' ' A' ' 606' ' ' GLN . 1.6 p -79.06 131.71 36.36 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 114.548 -1.206 . . . . 65.02 110.959 -179.332 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 568' ' ' GLY . . . . . 0.468 ' H ' HG12 ' A' ' 603' ' ' VAL . . . 87.85 37.03 8.1 Favored Glycine 0 N--CA 1.428 -1.888 0 C-N-CA 120.809 -0.71 . . . . 74.54 113.178 179.431 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 569' ' ' MET . . . . . 0.495 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 22.4 ptp -142.73 174.72 10.39 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 117.654 0.727 . . . . 72.01 109.422 177.424 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -99.45 177.8 5.07 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.037 -0.727 . . . . 73.43 109.037 -177.341 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -72.59 -26.01 61.54 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.671 -0.863 . . . . 75.53 108.671 -178.72 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.2 p -71.57 -14.84 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-N 115.3 -0.863 . . . . 72.04 109.75 178.151 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 10.9 m-20 -94.33 -39.14 10.64 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.103 -0.703 . . . . 30.14 109.103 175.547 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -55.83 -46.48 78.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.653 -0.703 . . . . 61.54 112.429 -178.512 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.538 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 11.9 mm-40 -54.0 -58.08 15.06 Favored Pre-proline 0 CA--C 1.573 1.864 0 N-CA-C 112.757 0.651 . . . . 63.41 112.757 -179.552 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -61.54 -36.0 78.87 Favored 'Trans proline' 0 C--N 1.369 1.648 0 CA-C-N 120.727 1.295 . . . . 75.22 113.066 175.863 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.524 ' NE ' ' HA ' ' A' ' 577' ' ' ARG . 9.0 mmp_? -63.4 -39.63 95.03 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.762 -0.375 . . . . 73.13 111.058 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.3 pp -65.92 -47.31 75.16 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 112.664 0.616 . . . . 74.35 112.664 -176.799 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.514 ' N ' HD12 ' A' ' 578' ' ' LEU . 5.8 ptp180 -66.44 -35.14 79.54 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 111.711 0.263 . . . . 75.44 111.711 177.636 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -71.12 -38.92 72.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.313 0.486 . . . . 71.0 112.313 -178.901 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 583' ' ' TRP . 1.3 pp -82.38 -8.98 59.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.463 0.649 . . . . 53.51 110.219 -178.124 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 82.91 35.96 17.07 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.607 -0.724 . . . . 32.13 112.261 177.967 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.454 ' HB2' HD11 ' A' ' 581' ' ' LEU . 18.9 t90 -87.35 127.49 35.2 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 108.506 -0.924 . . . . 72.54 108.506 177.462 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 24.4 p -106.1 -10.33 16.56 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.39 0.885 . . . . 73.24 113.39 -176.821 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 585' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -84.36 -170.37 46.75 Favored Glycine 0 C--N 1.323 -0.182 0 C-N-CA 120.754 -0.736 . . . . 60.44 113.909 -177.34 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 69.6 mtm -102.8 145.42 29.79 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 123.003 0.521 . . . . 70.14 111.679 -175.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 28.2 tp -94.76 125.67 39.57 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.555 -0.906 . . . . 75.41 108.555 177.93 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 621' ' ' THR . 23.5 t70 -113.63 121.18 43.39 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.85 -0.613 . . . . 74.13 109.804 -177.723 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.78 133.82 45.92 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.86 -1.136 . . . . 62.41 110.134 175.655 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -79.25 -65.59 1.78 Allowed Glycine 0 N--CA 1.428 -1.883 0 C-N-CA 120.65 -0.786 . . . . 64.54 111.68 179.33 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.24 140.99 35.91 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 120.762 0.315 . . . . 70.42 110.742 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 592' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 624' ' ' PHE . 9.5 p-10 -110.49 124.76 52.4 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 105.339 -2.097 . . . . 54.1 105.339 170.201 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 73.8 t -104.59 137.6 32.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 120.909 -0.316 . . . . 63.14 110.75 -173.348 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.73 108.04 4.85 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 109.153 -0.684 . . . . 65.25 109.153 -174.704 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -127.07 -36.13 2.19 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 120.791 0.329 . . . . 45.13 110.895 -179.642 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 104.83 146.75 15.46 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 119.823 -1.179 . . . . 64.14 112.324 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.34 -32.2 60.33 Favored Glycine 0 C--N 1.314 -0.659 0 C-N-CA 123.909 0.766 . . . . 71.55 114.147 -178.1 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.3 t -59.46 -23.27 62.58 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.276 1.43 . . . . 74.24 110.99 -176.212 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -86.42 -9.63 55.91 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.472 -0.785 . . . . 74.12 111.713 -173.841 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 55.14 70.87 0.58 Allowed 'General case' 0 C--O 1.245 0.839 0 CA-C-O 122.371 1.081 . . . . 73.35 109.104 -174.881 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -77.97 89.83 4.15 Favored 'General case' 0 CA--C 1.481 -1.687 0 CA-C-N 113.699 -1.591 . . . . 75.54 113.675 -171.159 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -84.86 172.1 11.68 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 113.844 -1.526 . . . . 70.45 107.413 176.634 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.468 HG12 ' H ' ' A' ' 568' ' ' GLY . 7.1 p -61.09 131.66 26.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 107.436 -1.32 . . . . 74.2 107.436 171.6 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 30.4 m -107.76 -27.12 3.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 112.53 0.566 . . . . 75.45 112.53 -174.004 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -147.48 141.37 25.83 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 109.194 -0.669 . . . . 72.13 109.194 -178.283 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 606' ' ' GLN . . . . . 0.438 ' OE1' ' HB3' ' A' ' 567' ' ' SER . 18.0 pt20 -140.42 146.19 38.0 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.547 -0.908 . . . . 65.43 108.547 177.966 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.563 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 22.0 t-20 -61.38 -61.52 7.73 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 112.648 0.61 . . . . 75.33 112.648 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.4 Cg_endo -91.87 120.55 0.56 Allowed 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 122.027 1.818 . . . . 64.31 109.458 175.189 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.33 160.6 46.92 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 122.348 2.032 . . . . 71.4 112.278 178.284 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -59.99 127.38 31.6 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.03 -0.532 . . . . 74.25 109.87 178.13 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 101.05 -1.34 54.93 Favored Glycine 0 C--N 1.309 -0.93 0 C-N-CA 120.039 -1.076 . . . . 55.44 112.084 -178.012 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 54.6 m -95.39 146.76 24.15 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.903 -0.406 . . . . 72.42 109.903 178.516 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -74.47 123.8 7.85 Favored Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 115.912 -0.586 . . . . 63.03 112.175 177.624 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 19.1 m -107.08 142.53 19.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.949 -0.76 . . . . 71.31 108.949 176.808 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.56 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.7 p-10 -51.85 174.82 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.756 1.222 . . . . 62.21 113.353 -177.758 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -54.04 -32.25 53.92 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.7 0.63 . . . . 73.3 112.7 -179.238 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.459 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 37.4 t70 -85.75 -7.52 58.72 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 120.991 0.424 . . . . 64.24 109.994 -177.58 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.12 19.73 70.37 Favored Glycine 0 CA--C 1.499 -0.965 0 CA-C-N 116.077 -0.51 . . . . 72.53 112.558 174.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.05 120.94 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-O 122.68 1.229 . . . . 71.25 111.511 -166.26 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.527 HG12 ' HD2' ' A' ' 608' ' ' PRO . 0.0 OUTLIER -128.83 132.17 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 0 CA-C-N 113.605 -1.634 . . . . 63.34 108.725 -179.015 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 6.6 t -113.03 137.42 51.45 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.334 -0.987 . . . . 50.05 108.334 178.493 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.4 pp -138.6 165.72 26.19 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 113.66 0.985 . . . . 74.14 113.66 -173.559 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -128.9 137.41 51.41 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.555 -1.276 . . . . 74.53 107.555 176.534 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 592' ' ' ASP . 50.2 p90 -141.3 165.64 26.95 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 120.797 0.332 . . . . 73.44 110.812 -175.743 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -88.05 146.78 19.93 Favored Glycine 0 N--CA 1.423 -2.215 0 C-N-CA 120.329 -0.939 . . . . 65.35 111.363 177.963 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 C--N 1.281 -2.373 0 N-CA-C 107.214 -1.402 . . . . 74.1 107.214 177.976 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 122.125 0.964 . . . . 55.21 108.854 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 546' ' ' PRO . 13.8 p -135.74 140.53 44.44 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-N 114.556 -1.202 . . . . 72.1 107.825 179.661 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -130.12 142.49 50.59 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 120.946 0.403 . . . . 74.23 111.331 -179.395 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.5 p-10 -78.96 124.2 28.02 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.949 -1.023 . . . . 71.11 109.184 176.229 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.7 pt -77.97 133.38 65.55 Favored Pre-proline 0 C--N 1.302 -1.49 0 CA-C-N 115.78 -0.645 . . . . 54.54 111.532 -177.062 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.89 -174.85 2.4 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.349 2.033 . . . . 53.21 111.26 174.634 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -98.67 122.96 42.56 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.098 0.475 . . . . 73.2 110.034 179.137 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.633 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 17.0 m -124.86 49.73 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-O 122.245 1.022 . . . . 71.44 110.206 178.041 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -107.31 108.54 19.98 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.076 -0.965 . . . . 24.14 109.368 176.076 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 136.69 -17.13 3.72 Favored Glycine 0 C--N 1.304 -1.218 0 C-N-CA 120.323 -0.942 . . . . 63.14 111.971 177.27 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -91.79 179.12 5.71 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.412 -0.959 . . . . 52.13 108.412 178.689 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 21.1 m -75.05 155.55 37.11 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 105.455 -2.054 . . . . 71.24 105.455 171.774 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.499 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 9.2 p -62.23 -43.79 98.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 118.794 0.725 . . . . 63.32 111.642 -176.624 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 506' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 20.5 t70 -63.56 -40.3 96.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.74 0.305 . . . . 54.34 110.477 179.565 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 58.5 t -70.23 -39.81 77.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.33 0 CA-C-N 116.146 -0.479 . . . . 65.02 109.991 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.633 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -60.9 -44.76 96.68 Favored 'General case' 0 C--O 1.209 -1.069 0 N-CA-C 109.671 -0.492 . . . . 41.33 109.671 176.569 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 97.0 mt-30 -64.81 -42.69 94.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.157 -0.474 . . . . 61.22 110.715 -179.216 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.522 ' O ' HG23 ' A' ' 514' ' ' VAL . 75.3 mmtt -66.46 -42.67 87.2 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.252 -0.431 . . . . 75.14 110.49 177.792 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -67.62 -38.05 83.36 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.621 0.724 . . . . 70.45 111.08 -177.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.43 -46.49 86.09 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.565 -1.198 . . . . 72.32 108.343 177.409 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -61.09 -33.83 73.97 Favored 'General case' 0 N--CA 1.423 -1.823 0 C-N-CA 124.088 0.955 . . . . 61.02 112.937 -178.129 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 510' ' ' LYS . 65.9 t -56.58 -34.26 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.199 0.523 . . . . 73.11 110.54 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -110.96 -2.21 16.08 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.584 0.707 . . . . 72.4 110.147 -178.359 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -110.33 -63.54 0.52 Allowed Glycine 0 N--CA 1.414 -2.802 0 CA-C-N 115.439 -0.8 . . . . 74.0 112.366 -173.354 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 64.82 21.95 12.44 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 122.426 1.108 . . . . 74.25 109.503 -172.082 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.3 p -89.19 -169.89 2.68 Favored 'General case' 0 N--CA 1.408 -2.54 0 CA-C-N 113.367 -1.742 . . . . 73.04 110.417 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -111.79 141.13 45.8 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 109.173 -0.677 . . . . 70.52 109.173 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -132.48 151.11 52.02 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.657 0.741 . . . . 73.02 112.25 -175.121 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 55.1 p -138.82 157.18 46.54 Favored 'General case' 0 N--CA 1.403 -2.803 0 N-CA-C 106.62 -1.622 . . . . 44.21 106.62 178.937 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -131.44 147.11 52.52 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 109.524 -0.547 . . . . 73.45 109.524 -178.701 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -142.45 143.29 32.53 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.27 -1.381 . . . . 62.04 107.27 175.961 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 18.3 m -103.15 136.1 43.58 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-O 121.442 0.639 . . . . 70.02 112.07 -174.889 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 10.8 p -124.11 154.02 30.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 106.285 -1.746 . . . . 73.31 106.285 175.722 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.522 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 6.0 p-10 -91.52 135.88 33.53 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 120.078 -0.649 . . . . 51.05 111.146 -178.228 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.537 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 57.4 m -163.64 165.13 14.35 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 107.163 -1.421 . . . . 42.52 107.163 -178.929 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -66.72 -7.95 19.78 Favored 'Trans proline' 0 CA--C 1.549 1.24 0 C-N-CA 122.177 1.918 . . . . 73.04 113.962 179.606 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.442 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 0.0 OUTLIER -74.12 127.51 87.85 Favored Pre-proline 0 C--O 1.238 0.482 0 N-CA-C 107.898 -1.149 . . . . 72.12 107.898 176.555 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.9 145.66 83.39 Favored 'Trans proline' 0 C--O 1.25 1.12 0 C-N-CA 122.888 2.392 . . . . 74.24 112.911 -177.18 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -54.56 117.96 3.78 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.739 -1.119 . . . . 64.51 111.806 -177.186 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 127.62 -24.74 5.17 Favored Glycine 0 N--CA 1.428 -1.839 0 CA-C-N 115.227 -0.897 . . . . 73.24 111.458 178.713 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -83.11 138.5 33.65 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.91 -0.404 . . . . 71.22 109.91 178.915 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.452 HG11 ' CB ' ' A' ' 508' ' ' ALA . 4.3 p -101.25 116.78 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 CA-C-O 121.902 0.858 . . . . 62.34 109.361 -177.403 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.1 p -81.04 -8.68 59.82 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.575 -1.193 . . . . 65.23 112.809 -178.724 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.65 -164.96 29.14 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.471 -0.871 . . . . 61.01 112.487 175.398 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 21.8 p -116.77 158.5 23.79 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.423 -1.325 . . . . 65.45 107.423 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -63.54 -56.82 23.16 Favored Pre-proline 0 C--O 1.241 0.626 0 C-N-CA 118.184 -1.406 . . . . 72.3 112.172 176.59 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.14 137.34 40.36 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 120.822 1.014 . . . . 65.33 109.628 173.903 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.38 148.03 93.05 Favored 'Trans proline' 0 C--O 1.25 1.106 0 C-N-CA 122.464 2.109 . . . . 62.54 112.422 -178.415 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.35 143.07 50.61 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.009 -0.541 . . . . 63.23 110.31 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.66 -18.73 54.65 Favored Glycine 0 C--N 1.303 -1.283 0 N-CA-C 111.549 -0.62 . . . . 40.11 111.549 -177.348 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 53.3 m -73.26 136.85 44.64 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.533 0.206 . . . . 70.51 110.772 -179.372 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 13.5 t -88.59 134.53 33.85 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.502 -0.555 . . . . 62.1 109.502 177.849 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.49 155.92 80.69 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 107.847 -1.168 . . . . 75.54 107.847 177.526 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.456 ' HA ' HG22 ' A' ' 494' ' ' THR . 23.1 Cg_exo -59.09 141.68 98.45 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.598 1.532 . . . . 51.45 111.17 177.12 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 8.3 p -60.16 -19.79 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 CA-C-N 115.627 -0.715 . . . . 72.25 111.619 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -98.92 -5.15 31.27 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 121.539 0.685 . . . . 75.44 111.107 178.826 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 34.2 t -72.82 151.61 41.94 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 121.185 0.516 . . . . 73.13 110.273 -178.748 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.9 p -98.24 121.2 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.983 0 CA-C-N 115.358 -0.837 . . . . 73.12 109.015 179.273 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 54.9 mt -92.79 139.51 17.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.76 -0.83 . . . . 71.42 108.76 -177.58 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -103.71 123.42 46.99 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.756 0.789 . . . . 62.13 111.82 178.722 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.3 mp -103.57 126.95 51.03 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.409 -1.268 . . . . 71.35 108.832 177.159 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -90.13 116.01 27.81 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.566 0.698 . . . . 72.0 110.804 -178.82 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 524' ' ' SER . 25.6 t -90.72 129.21 41.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 107.704 -1.221 . . . . 73.02 107.704 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 43.4 t -87.48 125.09 34.1 Favored 'General case' 0 N--CA 1.403 -2.798 0 N-CA-C 108.6 -0.889 . . . . 65.42 108.6 177.114 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 3.2 ptpp? -105.46 139.31 40.28 Favored 'General case' 0 N--CA 1.406 -2.667 0 N-CA-C 106.706 -1.59 . . . . 63.03 106.706 169.288 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -58.18 -21.9 48.21 Favored Glycine 0 C--N 1.312 -0.769 0 O-C-N 124.295 0.997 . . . . 71.45 112.126 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 559' ' ' ASN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 24.5 t-20 90.43 -2.74 0.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 126.771 2.028 . . . . 71.31 107.796 -179.468 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.426 ' HG2' ' N ' ' A' ' 615' ' ' ASN . 98.0 mt-30 -112.82 147.73 36.32 Favored 'General case' 0 N--CA 1.405 -2.724 0 CA-C-N 114.135 -1.393 . . . . 72.31 112.64 -169.33 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -123.31 158.34 31.21 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 114.19 -1.368 . . . . 73.25 107.496 177.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.84 120.31 13.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 121.114 0.483 . . . . 52.23 111.368 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 22.2 ttt -70.52 123.62 89.38 Favored Pre-proline 0 N--CA 1.434 -1.243 0 C-N-CA 123.86 0.864 . . . . 72.43 111.335 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -67.25 169.32 15.57 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.316 2.677 . . . . 53.34 112.16 176.248 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -87.43 124.31 33.29 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.088 0.471 . . . . 64.31 111.753 -177.944 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 566' ' ' LEU . . . . . 0.534 ' O ' HD23 ' A' ' 566' ' ' LEU . 9.5 tt -133.66 18.93 3.89 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 122.533 1.158 . . . . 72.35 108.35 -177.704 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 77.2 p -77.46 143.76 38.29 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 121.496 -0.752 . . . . 54.33 112.36 -174.735 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 65.24 42.76 96.12 Favored Glycine 0 N--CA 1.453 -0.182 0 CA-C-N 115.693 -0.685 . . . . 72.32 114.642 174.661 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 22.7 ptp -137.57 177.5 7.82 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.042 -0.725 . . . . 44.1 109.042 177.193 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -94.42 178.24 5.68 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.616 -0.513 . . . . 70.32 109.616 -178.044 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 571' ' ' TRP . . . . . 0.438 ' CZ3' HD22 ' A' ' 587' ' ' LEU . 18.9 t-105 -68.97 -30.22 68.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.786 -1.191 . . . . 74.22 107.786 175.919 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.0 p -74.94 -9.21 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-N 115.203 -0.908 . . . . 35.44 110.388 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.635 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 15.3 m-20 -99.25 -37.49 9.25 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 108.519 -0.919 . . . . 72.3 108.519 173.782 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -59.46 -43.95 93.08 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.108 -0.951 . . . . 54.14 111.926 179.587 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.616 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 33.3 mt-10 -57.66 -52.43 74.38 Favored Pre-proline 0 CA--C 1.556 1.187 0 N-CA-C 113.941 1.089 . . . . 74.24 113.941 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.3 -33.76 98.0 Favored 'Trans proline' 0 C--N 1.364 1.349 0 CA-C-N 120.438 1.192 . . . . 61.32 112.993 173.793 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.635 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 9.3 mmp_? -64.29 -45.55 87.48 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 109.57 -0.53 . . . . 71.41 109.57 178.101 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.3 pp -66.11 -44.04 85.45 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.833 -0.621 . . . . 60.24 112.162 -172.956 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -66.67 -37.83 85.56 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.161 -0.472 . . . . 64.12 110.928 178.353 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -71.28 -37.12 71.9 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 112.008 0.373 . . . . 73.44 112.008 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.0 pp -83.76 -9.35 58.88 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 120.532 -0.467 . . . . 73.44 110.794 -179.022 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 75.95 44.96 17.62 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 121.232 -0.509 . . . . 72.43 112.467 179.033 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -75.96 127.46 33.03 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.968 -0.753 . . . . 63.54 108.968 178.99 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 1.3 p -86.72 -32.68 20.32 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 124.303 1.041 . . . . 75.13 113.006 -178.068 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -82.91 -169.35 44.37 Favored Glycine 0 C--N 1.311 -0.836 0 N-CA-C 113.951 0.341 . . . . 73.42 113.951 -178.075 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 85.3 mtp -115.55 150.38 36.68 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 110.216 -0.29 . . . . 61.34 110.216 -178.408 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 587' ' ' LEU . . . . . 0.438 HD22 ' CZ3' ' A' ' 571' ' ' TRP . 2.3 tt -80.43 130.23 35.03 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.228 -1.027 . . . . 72.4 108.228 -179.563 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 621' ' ' THR . 21.3 t70 -126.77 122.63 35.34 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.611 -0.722 . . . . 72.35 110.933 -178.974 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.0 OUTLIER -101.94 128.48 48.33 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 118.302 -1.359 . . . . 70.11 109.109 173.311 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -76.96 -38.3 30.94 Favored Glycine 0 N--CA 1.428 -1.885 0 C-N-CA 120.763 -0.732 . . . . 70.42 112.444 -176.29 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -136.74 147.66 46.83 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 121.012 0.434 . . . . 72.41 110.714 -177.73 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -99.18 125.79 44.83 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.002 -1.481 . . . . 70.3 107.002 176.04 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 59.5 t -104.19 131.23 53.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 107.911 -1.144 . . . . 72.32 107.911 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -74.34 117.78 16.55 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.824 0.821 . . . . 73.03 110.285 179.376 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -141.82 -62.84 0.45 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.487 -1.233 . . . . 73.14 109.356 -179.222 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 95.22 160.72 33.72 Favored Glycine 0 N--CA 1.407 -3.279 0 N-CA-C 110.655 -0.978 . . . . 62.02 110.655 -178.537 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.6 -33.04 61.97 Favored Glycine 0 C--N 1.292 -1.864 0 CA-C-N 115.031 -0.584 . . . . 43.51 113.735 -178.629 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 35.3 t -70.25 -29.19 65.93 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 109.647 -0.501 . . . . 52.41 109.647 -178.076 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -95.69 -2.28 48.31 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.493 -0.322 . . . . 73.52 110.991 -178.599 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 73.24 116.45 0.05 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.966 1.307 . . . . 75.14 111.268 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -78.4 61.69 2.87 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.736 0.779 . . . . 70.42 110.781 -179.025 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -87.07 160.09 18.7 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.712 -0.676 . . . . 75.02 109.402 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.484 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 99.5 t -63.6 130.23 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 106.904 -1.517 . . . . 64.35 106.904 170.677 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.7 t -96.31 -47.45 12.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.384 0.611 . . . . 63.21 109.504 -175.173 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -150.58 144.43 25.27 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 106.925 -1.509 . . . . 73.04 106.925 -178.283 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -128.64 143.99 51.06 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.325 -0.991 . . . . 65.42 108.325 178.842 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.47 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 3.3 t-20 -60.18 -54.62 53.43 Favored Pre-proline 0 CA--C 1.553 1.067 0 N-CA-C 112.504 0.557 . . . . 74.25 112.504 -179.412 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 9.3 Cg_endo -94.24 123.44 0.41 Allowed 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 121.929 1.753 . . . . 72.35 111.954 178.899 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -67.67 153.46 76.01 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 122.168 1.912 . . . . 62.03 110.747 175.05 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.4 139.46 58.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.744 0.307 . . . . 60.12 110.275 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.14 -11.69 62.03 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 120.317 -0.944 . . . . 52.14 111.993 -178.368 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 90.6 m -76.58 146.34 38.38 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.763 -0.829 . . . . 62.02 108.763 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -73.81 122.69 7.75 Favored Glycine 0 N--CA 1.42 -2.415 0 C-N-CA 119.654 -1.26 . . . . 71.2 110.531 175.899 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.7 m -114.08 141.57 29.79 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 108.676 -0.861 . . . . 54.4 108.676 176.407 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.426 ' N ' ' HG2' ' A' ' 560' ' ' GLN . 33.4 p-10 -52.0 168.42 0.09 Allowed 'General case' 0 C--O 1.209 -1.072 0 C-N-CA 124.457 1.103 . . . . 72.31 112.696 -176.423 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -58.15 -24.77 60.1 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.819 0.674 . . . . 72.12 112.819 -176.486 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -88.56 -8.55 54.56 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 109.402 -0.592 . . . . 61.5 109.402 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.12 16.08 63.92 Favored Glycine 0 CA--C 1.502 -0.757 0 CA-C-N 116.016 -0.538 . . . . 64.23 113.95 171.211 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.17 119.31 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 122.208 1.004 . . . . 73.5 110.927 -167.165 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.425 ' O ' HD12 ' A' ' 620' ' ' ILE . 2.8 pp -129.0 134.05 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 114.477 -1.238 . . . . 73.31 110.673 -177.351 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 11.9 t -110.03 133.02 53.64 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.7 -0.852 . . . . 75.45 108.7 179.294 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 3.2 pp -138.78 168.75 19.12 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.69 -0.686 . . . . 75.22 110.788 -175.384 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -126.92 135.82 51.44 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.343 -0.984 . . . . 63.33 108.343 174.253 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.484 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 2.1 p90 -142.41 168.23 20.23 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.083 -0.508 . . . . 74.51 109.805 -172.941 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -56.25 109.52 1.56 Allowed Glycine 0 CA--C 1.529 0.926 0 O-C-N 123.954 0.784 . . . . 63.44 111.855 175.768 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 . . . . . 0 C--O 1.263 1.783 0 C-N-CA 125.734 1.614 . . . . 74.35 112.745 -179.392 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.585 0 CA-C-O 122.016 0.912 . . . . 64.23 110.708 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 9.2 p -143.09 145.59 33.01 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 114.743 -1.117 . . . . 72.02 108.13 -178.606 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -140.54 140.81 35.28 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.265 -0.643 . . . . 44.52 109.265 -179.57 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.578 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.1 p-10 -78.83 140.48 38.17 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.395 0.617 . . . . 72.41 110.656 178.289 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 39.0 pt -96.36 137.07 21.62 Favored Pre-proline 0 C--N 1.294 -1.812 0 CA-C-N 114.91 -1.041 . . . . 75.23 109.776 179.185 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.22 176.89 9.24 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.979 1.786 . . . . 54.45 111.924 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.57 110.27 19.69 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.856 -1.165 . . . . 64.12 107.856 177.785 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 29.3 m -117.84 12.3 7.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-O 120.982 0.42 . . . . 73.42 111.812 -178.847 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -84.72 102.25 12.85 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.486 -0.485 . . . . 61.34 109.954 -178.24 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 156.38 -26.07 0.54 Allowed Glycine 0 C--N 1.301 -1.385 0 C-N-CA 120.653 -0.784 . . . . 42.35 112.136 179.826 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.47 ' O ' HG12 ' A' ' 534' ' ' VAL . 11.4 pm0 -102.44 -173.86 2.43 Favored 'General case' 0 N--CA 1.427 -1.605 0 O-C-N 122.527 -0.396 . . . . 63.53 110.276 177.49 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.1 m -69.84 155.46 40.52 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.474 -0.935 . . . . 62.32 108.474 -179.236 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.507 HG21 HG22 ' A' ' 555' ' ' VAL . 7.3 p -61.64 -42.68 95.13 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 O-C-N 123.018 0.199 . . . . 64.45 111.428 -178.276 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.71 -39.82 94.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.286 0.565 . . . . 71.35 110.21 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 66.9 t -70.36 -39.69 76.85 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.452 0 CA-C-N 115.431 -0.804 . . . . 71.32 109.8 178.759 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.22 -44.28 92.38 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 122.276 0.23 . . . . 62.11 110.996 177.783 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 97.3 mt-30 -63.1 -41.6 99.41 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.896 -0.409 . . . . 74.41 109.896 178.035 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 514' ' ' VAL . 72.3 mmtt -66.31 -38.79 88.54 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.939 -0.573 . . . . 74.21 111.897 175.772 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.14 -48.45 80.04 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 122.026 0.917 . . . . 74.45 108.8 176.91 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.426 HD11 HD12 ' A' ' 551' ' ' ILE . 2.2 tm? -59.55 -42.3 92.06 Favored 'General case' 0 C--O 1.21 -1.011 0 CA-C-N 113.909 -1.496 . . . . 72.21 109.623 -179.255 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -60.47 -35.21 75.35 Favored 'General case' 0 N--CA 1.427 -1.608 0 C-N-CA 124.169 0.988 . . . . 65.23 111.16 -179.732 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 510' ' ' LYS . 98.1 t -64.34 -35.85 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.444 0.64 . . . . 71.32 110.832 178.342 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -101.46 5.0 41.79 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.184 -0.462 . . . . 52.42 109.931 -177.079 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -132.94 -58.29 0.08 OUTLIER Glycine 0 N--CA 1.426 -2.033 0 C-N-CA 119.89 -1.148 . . . . 63.31 114.232 -171.863 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 59.66 29.56 19.13 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 122.465 1.126 . . . . 73.12 108.97 -172.631 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.1 p -96.87 -165.39 1.26 Allowed 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 114.061 -1.427 . . . . 65.32 110.559 -177.754 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -107.83 138.6 43.79 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.827 -1.175 . . . . 73.22 107.827 178.489 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -128.93 148.5 50.93 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.297 0.57 . . . . 72.32 111.192 -179.243 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.5 m -140.25 152.41 45.91 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.016 -1.105 . . . . 75.43 108.016 176.366 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -120.38 142.13 49.45 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.02 0.438 . . . . 62.02 111.041 -176.227 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -131.94 135.94 46.98 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.465 -1.68 . . . . 54.13 106.465 176.462 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 75.0 p -104.83 139.45 39.57 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.259 1.028 . . . . 74.15 113.234 -173.815 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.5 p -123.95 152.99 29.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 105.858 -1.904 . . . . 53.32 105.858 176.388 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.585 ' HA ' ' HG3' ' A' ' 557' ' ' LYS . 1.1 p-10 -84.74 136.94 33.5 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.407 -0.96 . . . . 65.21 108.407 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 23.3 m -149.45 169.87 8.53 Favored Pre-proline 0 C--N 1.285 -2.203 0 N-CA-C 107.586 -1.264 . . . . 43.22 107.586 -175.507 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -69.93 -16.3 36.8 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 121.992 1.795 . . . . 34.3 112.385 176.804 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.412 ' N ' ' HD2' ' A' ' 529' ' ' ARG . 3.2 mpt_? -81.57 135.0 50.05 Favored Pre-proline 0 CA--C 1.512 -0.492 0 CA-C-N 116.499 -0.319 . . . . 74.31 110.432 179.757 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.66 156.98 20.55 Favored 'Trans proline' 0 C--O 1.257 1.446 0 C-N-CA 123.141 2.561 . . . . 72.52 112.557 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.24 104.6 0.33 Allowed 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.348 -0.842 . . . . 71.33 111.251 -176.872 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 151.93 -26.33 0.92 Allowed Glycine 0 N--CA 1.419 -2.494 0 C-N-CA 120.142 -1.028 . . . . 74.1 112.707 179.711 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -82.67 144.49 30.23 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 119.378 -0.929 . . . . 75.41 109.33 -179.595 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 503' ' ' GLN . 7.4 p -92.34 117.63 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 CA-C-O 121.822 0.82 . . . . 72.43 108.845 177.568 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.99 -30.74 70.93 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.444 -1.253 . . . . 74.35 109.932 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 156.02 -167.62 33.32 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 111.085 -0.806 . . . . 43.11 111.085 178.61 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 537' ' ' THR . . . . . 0.462 HG22 HD13 ' A' ' 553' ' ' LEU . 11.4 p -116.59 147.55 41.76 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.694 -0.854 . . . . 72.23 108.694 178.846 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -57.94 -50.32 88.75 Favored Pre-proline 0 N--CA 1.476 0.839 0 O-C-N 123.577 0.548 . . . . 74.14 111.458 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -76.29 131.0 12.43 Favored 'Trans proline' 0 N--CA 1.438 -1.76 0 N-CA-C 107.978 -1.585 . . . . 75.13 107.978 168.747 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -56.55 140.94 90.76 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 122.492 2.128 . . . . 71.12 111.736 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.01 137.83 58.0 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 120.702 0.287 . . . . 43.42 110.635 -178.746 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.69 -12.66 58.0 Favored Glycine 0 C--N 1.309 -0.949 0 N-CA-C 111.782 -0.527 . . . . 61.41 111.782 -176.985 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 26.4 m -84.35 137.31 33.49 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 122.85 -0.206 . . . . 62.32 110.567 -178.772 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 9.7 t -82.33 127.69 33.48 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.592 -0.892 . . . . 74.22 108.592 175.198 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.8 m -123.07 156.75 62.32 Favored Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 107.75 -1.204 . . . . 63.34 107.75 -179.053 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -65.44 137.66 51.8 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 120.834 1.023 . . . . 74.0 111.39 -179.205 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.8 p -64.98 -19.64 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.481 -0.781 . . . . 71.52 110.599 179.902 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -89.33 -12.32 40.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.183 0.516 . . . . 63.1 111.456 -179.041 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 50.4 m -87.21 163.78 16.71 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.617 0.722 . . . . 74.52 111.14 178.901 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.3 p -98.02 137.66 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.849 0 CA-C-N 115.122 -0.945 . . . . 55.14 109.462 178.139 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 551' ' ' ILE . . . . . 0.426 HD12 HD11 ' A' ' 512' ' ' LEU . 78.4 mt -94.41 135.56 28.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.985 -0.552 . . . . 62.52 110.306 -178.571 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -103.3 119.99 39.92 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-N 115.852 -0.613 . . . . 65.52 110.817 -173.914 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.462 HD13 HG22 ' A' ' 537' ' ' THR . 3.5 mm? -102.66 122.96 45.48 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 124.06 0.944 . . . . 75.01 109.235 177.978 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -85.13 122.28 29.11 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.895 -0.78 . . . . 71.34 108.895 174.163 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.507 HG22 HG21 ' A' ' 505' ' ' VAL . 26.5 t -98.69 134.18 38.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 108.573 -0.899 . . . . 43.0 108.573 179.482 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.638 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 23.6 m -85.06 117.77 24.23 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.92 -0.77 . . . . 54.14 108.92 176.492 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.585 ' HG3' ' HA ' ' A' ' 526' ' ' ASP . 2.6 ptpp? -96.66 133.33 41.32 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 106.612 -1.625 . . . . 72.32 106.612 166.956 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -60.13 -23.98 60.31 Favored Glycine 0 CA--C 1.492 -1.397 0 O-C-N 124.344 1.028 . . . . 72.01 113.167 -175.481 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 559' ' ' ASN . . . . . 0.497 ' OD1' ' HG3' ' A' ' 616' ' ' ARG . 45.1 t-20 79.77 -15.71 0.73 Allowed 'General case' 0 C--O 1.211 -0.951 0 C-N-CA 125.231 1.412 . . . . 75.5 108.587 179.403 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 86.3 mt-30 -112.52 141.72 45.93 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 115.563 -0.744 . . . . 71.11 112.233 -173.411 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -123.8 158.24 32.23 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.104 -1.407 . . . . 74.12 107.936 177.827 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.1 p -64.42 125.36 21.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.228 0.537 . . . . 72.54 110.078 177.895 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.529 ' SD ' HG21 ' A' ' 620' ' ' ILE . 52.1 ttp -83.88 133.52 45.91 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 109.874 -0.417 . . . . 72.45 109.874 -178.502 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.11 169.62 14.75 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.634 2.223 . . . . 63.3 110.768 174.732 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -82.48 134.11 35.21 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.276 0.56 . . . . 74.32 111.022 -178.74 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.5 pp -137.66 14.19 2.94 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.77 -1.105 . . . . 71.12 110.234 178.197 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 22.9 t -81.01 152.76 27.78 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.691 -1.14 . . . . 52.4 110.213 -178.826 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 64.21 26.14 70.24 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 114.942 0.737 . . . . 70.03 114.942 174.349 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 569' ' ' MET . . . . . 0.452 ' SD ' ' HG3' ' A' ' 577' ' ' ARG . 20.4 ptp -127.08 171.99 10.9 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 122.305 -0.527 . . . . 71.31 109.945 179.41 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -95.98 165.44 12.26 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.054 -1.461 . . . . 64.04 107.054 -177.07 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -61.76 -30.04 70.53 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.373 -0.603 . . . . 63.43 109.373 178.924 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.82 -15.91 18.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.971 -0.559 . . . . 73.22 111.671 -178.447 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.431 ' C ' ' HD2' ' A' ' 576' ' ' PRO . 38.3 t70 -101.62 -28.5 12.47 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 122.245 1.022 . . . . 74.03 108.247 176.952 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 574' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 577' ' ' ARG . . . -67.91 -37.46 81.73 Favored 'General case' 0 C--O 1.212 -0.908 0 CA-C-N 114.565 -1.198 . . . . 73.2 111.275 177.307 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.526 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 23.5 tt0 -56.18 -51.13 83.2 Favored Pre-proline 0 CA--C 1.568 1.658 0 CA-C-O 119.373 -0.346 . . . . 75.33 110.973 178.269 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 85.1 Cg_exo -53.36 -37.36 81.34 Favored 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 122.095 1.863 . . . . 75.32 112.203 171.698 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.541 ' O ' ' HB3' ' A' ' 581' ' ' LEU . 1.5 mmp_? -58.62 -42.6 88.62 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.742 -0.208 . . . . 74.24 110.494 176.701 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.538 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 10.8 mp -63.47 -49.27 74.29 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 120.727 0.299 . . . . 71.42 110.993 -178.226 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -67.21 -39.69 86.32 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 113.303 0.853 . . . . 62.41 113.303 -179.229 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.06 -36.47 75.0 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.113 0.482 . . . . 33.4 111.453 -178.83 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.541 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 2.0 tp -81.47 -10.17 59.55 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.108 -0.496 . . . . 74.43 110.109 -179.59 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 61.88 40.25 98.59 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.728 -0.949 . . . . 52.12 110.728 -178.045 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.538 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 10.7 t90 -71.81 127.43 32.54 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 121.578 0.704 . . . . 75.43 109.675 -178.259 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 9.9 p -79.05 -50.05 11.68 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 114.534 -1.212 . . . . 71.42 111.807 -177.094 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -71.48 -169.47 10.43 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 116.004 1.162 . . . . 65.44 116.004 -176.091 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 61.7 mtm -113.76 155.94 24.73 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.105 -1.048 . . . . 72.31 108.501 -179.404 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 6.3 tt -85.14 119.82 25.96 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.039 -1.097 . . . . 70.34 108.039 179.255 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.647 ' O ' ' HA ' ' A' ' 621' ' ' THR . 23.4 t70 -95.75 104.87 16.82 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.66 0.743 . . . . 63.13 109.818 -179.666 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.505 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.1 OUTLIER -90.03 129.12 36.39 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.988 -0.745 . . . . 70.42 108.988 178.155 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -83.4 -48.95 5.13 Favored Glycine 0 C--N 1.28 -2.565 0 N-CA-C 109.936 -1.265 . . . . 53.24 109.936 -178.17 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.15 142.41 38.01 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 109.114 -0.699 . . . . 60.53 109.114 179.782 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -115.57 125.19 52.66 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.024 -1.472 . . . . 71.13 107.024 175.444 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.89 131.47 55.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 108.816 -0.809 . . . . 74.42 108.816 -176.77 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.96 108.09 5.68 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.164 -1.05 . . . . 64.33 108.164 178.687 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -115.23 -55.81 2.43 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 116.088 -0.506 . . . . 71.02 110.688 -174.577 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 89.4 148.12 17.81 Favored Glycine 0 N--CA 1.422 -2.278 0 C-N-CA 120.31 -0.947 . . . . 73.43 111.358 -175.098 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.25 -32.44 60.28 Favored Glycine 0 C--N 1.304 -1.216 0 C-N-CA 123.483 0.563 . . . . 65.03 113.487 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 14.4 m -66.19 -24.44 66.63 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 124.076 0.951 . . . . 72.22 110.545 -176.869 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -104.29 -0.73 27.93 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.106 -0.952 . . . . 53.33 109.533 -176.634 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 60.8 m80 69.04 93.69 0.08 Allowed 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 122.135 0.969 . . . . 74.24 110.692 -174.457 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -82.2 73.28 9.24 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.553 -1.203 . . . . 75.23 110.339 -179.099 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -106.33 162.74 13.41 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.701 -1.136 . . . . 71.1 110.659 -176.428 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 78.8 t -67.25 130.09 32.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 N-CA-C 106.295 -1.743 . . . . 73.34 106.295 169.759 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.91 -34.12 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 113.091 0.775 . . . . 73.51 113.091 -174.28 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 605' ' ' TYR . . . . . 0.496 ' HB3' ' CG ' ' A' ' 623' ' ' ARG . 46.8 t80 -141.77 135.85 30.12 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.752 -0.833 . . . . 73.54 108.752 -177.301 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -133.31 144.52 49.72 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.288 -1.375 . . . . 73.33 107.288 178.738 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.565 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 46.3 t30 -58.91 -54.72 53.66 Favored Pre-proline 0 CA--C 1.553 1.077 0 O-C-N 123.466 0.479 . . . . 73.11 111.899 -179.235 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 94.9 Cg_endo -105.31 117.16 0.04 OUTLIER 'Trans proline' 0 CA--C 1.571 2.349 0 C-N-CA 121.502 1.468 . . . . 73.31 111.508 173.649 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.0 160.57 40.85 Favored 'Trans proline' 0 N--CA 1.482 0.821 0 C-N-CA 122.92 2.413 . . . . 74.23 112.66 -178.489 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -53.0 132.51 37.79 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.8 0.44 . . . . 72.24 110.928 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.07 -6.03 42.75 Favored Glycine 0 C--O 1.24 0.503 0 C-N-CA 120.695 -0.764 . . . . 50.33 111.201 -176.597 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 612' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 608' ' ' PRO . 12.6 t -72.55 166.33 22.89 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 123.619 0.767 . . . . 74.41 109.69 178.832 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -104.09 118.38 5.96 Favored Glycine 0 N--CA 1.427 -1.937 0 N-CA-C 109.247 -1.541 . . . . 73.11 109.247 175.322 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 35.9 m -116.33 142.08 31.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.992 -0.373 . . . . 72.33 109.992 -179.643 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -57.53 169.81 0.62 Allowed 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 124.238 1.015 . . . . 65.42 112.805 -177.775 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 616' ' ' ARG . . . . . 0.497 ' HG3' ' OD1' ' A' ' 559' ' ' ASN 0.331 0.0 OUTLIER -59.29 -23.75 62.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 114.638 1.347 . . . . 75.1 114.638 178.832 . . . . . . . . 4 4 . 1 . 026 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -84.98 -8.55 58.69 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.015 -0.735 . . . . 74.43 109.015 175.867 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.24 12.55 58.38 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 123.682 0.658 . . . . 73.52 114.451 170.184 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.37 119.41 16.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 122.002 0.906 . . . . 71.14 112.076 -165.751 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.529 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.8 pp -126.82 134.84 65.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-N 114.507 -1.224 . . . . 54.35 112.592 -178.469 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.647 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 87.7 m -98.88 122.92 42.75 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.849 -0.614 . . . . 70.11 109.473 178.384 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 3.3 pp -139.1 167.01 23.02 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.092 0.404 . . . . 61.41 112.092 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 623' ' ' ARG . . . . . 0.496 ' CG ' ' HB3' ' A' ' 605' ' ' TYR . 18.4 ptp180 -127.79 137.8 52.52 Favored 'General case' 0 C--O 1.257 1.49 0 N-CA-C 107.69 -1.226 . . . . 75.13 107.69 175.453 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -141.07 165.37 27.74 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.389 -0.524 . . . . 62.14 111.77 -172.393 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -82.62 131.17 10.18 Favored Glycine 0 N--CA 1.417 -2.629 0 CA-C-N 114.97 -1.014 . . . . 74.21 110.907 175.772 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 . . . . . 0 C--N 1.276 -2.614 0 C-N-CA 125.35 1.46 . . . . 74.32 109.097 -179.734 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.719 0 CA-C-O 121.34 0.59 . . . . 73.04 111.807 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.458 ' HB ' HG22 ' A' ' 544' ' ' THR . 20.3 p -139.72 141.63 36.9 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.838 -0.619 . . . . 73.33 110.165 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 495' ' ' LYS . . . . . 0.61 ' HG2' ' O ' ' A' ' 515' ' ' TYR . 0.6 OUTLIER -138.11 139.64 39.56 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 122.572 0.349 . . . . 74.21 110.659 177.543 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.645 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.4 p-10 -85.98 140.68 30.1 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.943 -0.572 . . . . 61.45 109.795 173.283 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.5 pt -98.06 136.88 20.87 Favored Pre-proline 0 C--N 1.294 -1.829 0 CA-C-N 115.347 -0.842 . . . . 64.5 111.354 -178.205 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -81.94 -178.49 4.16 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.924 1.749 . . . . 73.32 110.756 175.197 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -83.48 118.62 23.88 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.737 -0.838 . . . . 73.34 108.737 177.246 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.475 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 27.1 m -110.47 12.23 8.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 122.101 0.953 . . . . 72.32 110.145 -178.817 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -80.63 100.67 8.77 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.545 -1.207 . . . . 21.21 109.998 178.347 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 149.88 -30.27 1.12 Allowed Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.892 -0.671 . . . . 53.21 111.906 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -91.65 177.47 6.2 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-O 121.232 0.539 . . . . 72.33 110.211 179.192 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 27.9 m -74.22 156.18 37.53 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.454 -1.314 . . . . 70.42 107.454 177.13 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.453 ' HA ' HG23 ' A' ' 534' ' ' VAL . 11.4 p -56.43 -45.19 81.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 112.87 0.693 . . . . 64.2 112.87 -179.523 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -62.18 -39.69 93.52 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 120.535 -0.466 . . . . 72.03 110.171 177.902 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 78.6 t -68.87 -44.39 81.78 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.866 0 CA-C-N 115.437 -0.801 . . . . 70.54 110.04 -178.577 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.475 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -63.58 -45.3 91.03 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 123.216 0.607 . . . . 55.31 110.522 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 97.4 mt-30 -65.06 -45.64 84.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 123.31 0.382 . . . . 72.24 110.841 -179.226 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.469 ' O ' HG23 ' A' ' 514' ' ' VAL . 20.9 ptmt -67.12 -38.48 85.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.043 0.449 . . . . 63.45 110.363 179.022 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -60.86 -49.59 76.85 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 124.169 0.988 . . . . 75.45 110.081 -178.531 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -69.17 -35.4 76.26 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 115.704 -0.68 . . . . 72.44 110.524 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.44 ' N ' HD12 ' A' ' 512' ' ' LEU . 45.3 t30 -59.89 -39.49 85.49 Favored 'General case' 0 C--O 1.204 -1.33 0 C-N-CA 123.982 0.913 . . . . 64.43 110.587 -178.998 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 510' ' ' LYS . 82.0 t -57.56 -32.43 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-O 121.326 0.584 . . . . 74.12 111.793 179.272 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 515' ' ' TYR . . . . . 0.61 ' O ' ' HG2' ' A' ' 495' ' ' LYS . 60.6 m-85 -98.24 -26.26 14.59 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.439 0.638 . . . . 74.3 110.293 179.314 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -101.36 -58.09 0.82 Allowed Glycine 0 CA--C 1.478 -2.23 0 CA-C-N 115.464 -0.789 . . . . 74.22 113.554 -167.663 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 64.86 29.59 12.46 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.135 0.969 . . . . 64.44 109.898 -174.917 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.7 p -88.96 -166.52 1.62 Allowed 'General case' 0 N--CA 1.422 -1.849 0 C-N-CA 125.702 1.601 . . . . 52.31 111.026 -179.516 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 13.6 mptt -107.56 143.55 35.82 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.199 -1.408 . . . . 73.44 107.199 176.187 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -131.87 151.77 51.47 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 120.904 0.383 . . . . 71.22 111.986 -179.046 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 36.7 m -132.91 156.59 46.97 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.887 -1.524 . . . . 70.32 106.887 177.369 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -129.41 144.85 51.41 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 110.03 -0.359 . . . . 62.41 110.03 177.844 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -137.75 127.24 24.95 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.955 -1.128 . . . . 71.55 107.955 176.973 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 15.0 m -99.3 125.27 44.91 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.053 0.454 . . . . 64.14 111.942 -175.771 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 41.9 t -121.73 151.37 25.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 106.868 -1.53 . . . . 63.43 106.868 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.34 135.62 50.62 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 121.407 0.622 . . . . 73.1 111.507 -178.571 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 527' ' ' SER . . . . . 0.614 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 49.3 m -155.38 170.42 8.73 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 108.451 -0.944 . . . . 61.32 108.451 -178.916 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.87 -16.86 25.91 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 122.14 1.893 . . . . 74.43 114.031 -179.696 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.23 149.47 38.59 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 119.509 -0.877 . . . . 74.41 111.843 -176.521 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.95 147.65 72.77 Favored 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 123.27 2.647 . . . . 72.25 112.882 -176.078 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.715 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.65 103.86 0.37 Allowed 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 114.858 -1.065 . . . . 50.35 113.119 -174.115 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 147.04 -17.03 1.55 Allowed Glycine 0 N--CA 1.422 -2.242 0 CA-C-N 115.043 -0.981 . . . . 62.44 111.643 -178.958 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -82.22 141.76 32.71 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.628 -0.508 . . . . 63.24 109.628 177.843 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.453 HG23 ' HA ' ' A' ' 505' ' ' VAL . 41.4 t -93.32 115.84 33.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.039 -0.726 . . . . 73.34 109.039 176.438 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 535' ' ' THR . . . . . 0.581 HG23 ' HB2' ' A' ' 556' ' ' SER . 2.3 p -83.87 -17.81 39.6 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.241 -0.891 . . . . 73.23 112.357 178.965 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 165.88 174.86 35.79 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.185 -1.007 . . . . 73.03 112.404 178.246 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 5.7 p -117.38 152.89 34.03 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.222 -1.029 . . . . 73.24 108.222 177.359 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -67.22 -50.64 38.98 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 118.333 -1.347 . . . . 75.32 111.151 176.447 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -67.87 127.75 16.67 Favored 'Trans proline' 0 C--N 1.377 2.057 0 N-CA-C 108.043 -1.56 . . . . 61.34 108.043 170.074 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -68.92 157.39 62.04 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 122.236 1.957 . . . . 75.03 113.879 -175.909 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.17 136.12 56.94 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.622 -0.717 . . . . 73.3 110.444 179.646 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.51 -11.25 59.65 Favored Glycine 0 C--N 1.305 -1.155 0 N-CA-C 111.637 -0.585 . . . . 21.11 111.637 -178.491 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 28.4 m -77.87 127.98 33.24 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 122.568 -0.372 . . . . 52.02 110.945 -178.426 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.645 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 24.8 m -87.73 123.65 32.76 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 108.0 -1.111 . . . . 72.41 108.0 175.858 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.75 157.57 62.42 Favored Pre-proline 0 C--N 1.301 -1.503 0 N-CA-C 108.763 -0.828 . . . . 71.15 108.763 -178.826 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -63.87 140.65 74.4 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.615 1.543 . . . . 73.14 110.763 177.371 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 14.6 p -56.85 -25.62 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-O 121.455 0.645 . . . . 64.53 110.855 178.158 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.05 -15.08 52.44 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.738 -0.664 . . . . 62.32 112.008 -178.706 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 97.0 p -82.94 178.08 8.33 Favored 'General case' 0 C--O 1.254 1.32 0 N-CA-C 113.388 0.885 . . . . 63.44 113.388 -174.633 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 15.0 p -117.03 138.04 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.518 -0.765 . . . . 70.01 110.933 -176.488 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 54.9 mt -108.59 134.35 50.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.687 -0.857 . . . . 52.52 108.687 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -104.27 122.95 46.47 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.43 0.633 . . . . 73.03 112.563 179.529 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.23 119.37 34.6 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 125.487 1.515 . . . . 72.44 109.685 -179.525 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -88.82 113.81 24.76 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.656 0.741 . . . . 75.04 109.485 175.317 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 524' ' ' SER . 42.8 t -94.97 131.21 42.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 114.456 -1.247 . . . . 75.14 109.521 -175.754 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.715 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 39.1 t -77.47 117.63 19.12 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 108.261 -1.014 . . . . 62.33 108.261 176.693 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.15 134.07 43.61 Favored 'General case' 0 N--CA 1.417 -2.118 0 N-CA-C 105.444 -2.058 . . . . 74.14 105.444 168.725 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' A' ' 560' ' ' GLN . . . -64.01 -24.44 68.58 Favored Glycine 0 CA--C 1.499 -0.94 0 N-CA-C 110.484 -1.046 . . . . 75.02 110.484 179.253 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 559' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 63.5 t30 63.83 24.67 13.83 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.962 1.305 . . . . 65.54 108.438 -179.192 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 558' ' ' GLY . 97.7 mt-30 -127.52 155.57 43.56 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 114.48 -1.236 . . . . 74.5 111.234 -173.429 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -131.22 151.12 51.79 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.893 -1.049 . . . . 73.43 108.264 176.277 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.19 123.07 16.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-O 121.439 0.638 . . . . 62.53 110.317 178.777 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.536 ' SD ' HG13 ' A' ' 620' ' ' ILE . 42.9 ttp -86.45 125.63 66.96 Favored Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 115.495 -0.775 . . . . 62.45 111.014 -178.458 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 564' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 24.1 Cg_exo -65.43 170.41 10.98 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.687 2.925 . . . . 55.3 112.402 176.591 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.94 115.51 15.71 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.46 -0.336 . . . . 71.05 110.492 -179.681 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -91.59 -16.66 26.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.87 0.843 . . . . 70.24 109.047 175.601 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 15.3 m -73.91 140.1 45.41 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.156 -0.929 . . . . 42.23 110.008 -179.331 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 94.17 11.42 57.47 Favored Glycine 0 C--O 1.217 -0.921 0 C-N-CA 120.713 -0.756 . . . . 62.03 114.395 177.065 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 569' ' ' MET . . . . . 0.443 ' HB2' ' HB2' ' A' ' 573' ' ' ASP . 23.9 ptp -131.83 167.6 19.27 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.329 -0.989 . . . . 70.02 108.329 176.759 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -88.9 170.34 10.79 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.049 -1.093 . . . . 62.33 108.049 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -65.95 -28.31 68.82 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.416 -0.957 . . . . 74.54 108.416 176.331 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.7 p -75.53 -11.85 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-N 115.297 -0.865 . . . . 73.3 110.564 -179.283 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 56.5 m-20 -98.72 -40.56 8.1 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 107.441 -1.318 . . . . 74.4 107.441 174.161 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 574' ' ' ALA . . . . . 0.73 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -55.83 -54.3 46.16 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-N 114.566 -1.197 . . . . 74.31 112.87 -176.636 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 40.4 mt-10 -57.77 -48.57 96.95 Favored Pre-proline 0 N--CA 1.473 0.686 0 N-CA-C 113.7 1.0 . . . . 64.4 113.7 -178.787 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -52.96 -38.2 79.27 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.168 1.912 . . . . 75.12 112.761 171.575 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 3.6 mmp_? -68.71 -38.89 80.6 Favored 'General case' 0 C--O 1.199 -1.554 0 N-CA-C 109.929 -0.397 . . . . 71.31 109.929 176.537 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.73 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 65.3 mt -65.26 -47.11 77.88 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 122.66 0.384 . . . . 74.2 110.634 -175.401 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 35.7 ptt85 -66.0 -35.16 79.82 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 116.29 -0.414 . . . . 74.32 111.659 176.924 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.44 -30.79 67.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.481 0.658 . . . . 71.34 110.619 177.503 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 14.1 tp -80.85 -9.05 59.86 Favored 'General case' 0 N--CA 1.425 -1.707 0 C-N-CA 124.14 0.976 . . . . 70.53 110.175 179.595 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 67.44 46.5 69.56 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.346 -0.454 . . . . 41.55 112.002 178.84 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.422 ' CE3' HD22 ' A' ' 578' ' ' LEU . 12.5 t90 -83.5 131.13 35.03 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.924 -0.399 . . . . 65.54 109.924 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 12.8 p -100.12 -26.77 13.84 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.29 1.036 . . . . 71.14 112.748 -178.193 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -82.16 -175.19 50.4 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 116.283 -0.417 . . . . 74.45 113.644 -177.069 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 70.5 mtm -107.19 149.56 27.58 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.968 -0.382 . . . . 73.22 109.968 -178.514 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.9 tt -91.83 130.18 37.65 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.074 -1.084 . . . . 75.13 108.074 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 621' ' ' THR . 14.0 t70 -112.19 123.42 50.22 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.266 -1.013 . . . . 64.44 108.266 176.62 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.531 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -104.07 133.91 48.22 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.285 0.564 . . . . 75.31 109.563 -178.595 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -74.93 -53.86 6.08 Favored Glycine 0 C--N 1.281 -2.504 0 N-CA-C 110.603 -0.999 . . . . 75.31 110.603 -179.303 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.29 141.8 35.75 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.083 -0.558 . . . . 54.4 110.485 -179.58 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -117.21 124.53 49.32 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 104.311 -2.477 . . . . 72.11 104.311 168.136 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.17 117.06 51.02 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 109.156 -0.683 . . . . 54.21 109.156 -175.695 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 594' ' ' ASP . . . . . 0.43 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 4.8 p-10 -73.34 123.21 23.34 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.612 0.72 . . . . 70.55 109.118 179.707 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -132.23 -5.31 3.42 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 114.985 -1.007 . . . . 52.35 110.433 179.942 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 93.71 137.01 8.26 Favored Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 120.164 -1.017 . . . . 43.32 111.907 -178.369 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.71 -32.9 62.16 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 122.956 0.312 . . . . 52.25 113.542 -179.282 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 47.9 t -63.62 -23.93 67.59 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.054 0.93 . . . . 71.54 110.644 -175.686 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -89.46 -1.08 57.92 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.195 -0.911 . . . . 64.44 111.879 -174.723 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 60.5 m170 60.35 86.65 0.1 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.789 0.804 . . . . 60.52 111.652 -179.225 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -88.45 85.88 6.94 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.509 1.147 . . . . 63.13 112.241 -176.59 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 602' ' ' ARG . . . . . 0.41 ' HG2' ' H ' ' A' ' 602' ' ' ARG . 5.5 ptp180 -92.41 169.57 10.46 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 113.164 -1.835 . . . . 61.15 110.258 -179.799 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 96.7 t -73.07 130.28 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 105.357 -2.09 . . . . 74.52 105.357 173.42 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.6 m -105.26 -28.97 2.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 120.2 -0.6 . . . . 51.25 112.371 -173.359 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -156.1 142.43 18.4 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 109.545 -0.539 . . . . 75.25 109.545 -176.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -121.42 138.63 54.19 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.13 -1.063 . . . . 73.34 108.13 175.421 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.523 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 56.6 t30 -60.26 -51.91 76.93 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 123.303 0.377 . . . . 55.44 111.023 -175.591 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.5 Cg_endo -88.84 118.74 0.97 Allowed 'Trans proline' 0 N--CA 1.437 -1.829 0 N-CA-C 107.934 -1.602 . . . . 62.04 107.934 169.138 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 609' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 28.1 Cg_exo -63.54 159.68 39.47 Favored 'Trans proline' 0 C--O 1.249 1.042 0 C-N-CA 122.206 1.938 . . . . 74.12 112.681 -176.208 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -62.35 139.04 58.54 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.987 -0.551 . . . . 74.13 109.872 179.269 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.66 -8.74 60.12 Favored Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 120.189 -1.005 . . . . 65.23 111.668 -177.619 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 79.5 m -80.07 138.78 37.04 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.554 -0.906 . . . . 72.33 108.554 178.744 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -77.19 122.85 6.29 Favored Glycine 0 N--CA 1.419 -2.499 0 N-CA-C 110.379 -1.089 . . . . 53.25 110.379 177.847 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 28.4 m -112.49 141.84 26.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 108.697 -0.853 . . . . 51.01 108.697 177.071 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 559' ' ' ASN . 34.3 p-10 -54.89 173.37 0.09 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.536 0.734 . . . . 73.41 112.654 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -57.09 -24.92 57.44 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.524 0.935 . . . . 64.34 113.524 179.568 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -84.02 -9.67 58.47 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.557 -0.857 . . . . 52.43 110.077 178.679 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 65.33 19.03 66.02 Favored Glycine 0 C--O 1.22 -0.778 0 N-CA-C 114.576 0.59 . . . . 52.02 114.576 165.817 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.2 118.5 13.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-O 122.396 1.093 . . . . 63.1 112.135 -166.624 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.536 HG13 ' SD ' ' A' ' 563' ' ' MET . 0.0 OUTLIER -130.06 133.53 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 114.183 -1.371 . . . . 75.45 111.295 -176.473 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 42.0 m -105.06 126.74 52.4 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.614 -0.884 . . . . 72.24 108.614 178.843 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.3 pp -138.13 166.76 23.32 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.164 0.431 . . . . 70.22 112.164 -176.742 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -128.43 136.99 51.63 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.074 -0.713 . . . . 72.24 109.074 175.249 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -142.0 168.08 20.59 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.612 -1.255 . . . . 74.03 107.612 -174.363 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -70.52 -124.7 0.05 OUTLIER Glycine 0 CA--C 1.538 1.494 0 C-N-CA 119.177 -1.487 . . . . 64.31 110.765 172.572 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 48.2 tt0 . . . . . 0 C--N 1.27 -2.875 0 N-CA-C 108.729 -0.841 . . . . 74.55 108.729 175.761 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 113.084 0.772 . . . . 34.32 113.084 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 7.1 p -147.19 139.55 24.65 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 122.565 0.346 . . . . 74.31 110.29 -177.595 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -139.42 132.95 30.33 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.584 -0.895 . . . . 62.43 108.584 179.297 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.3 p-10 -95.1 135.26 36.86 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.43 0.633 . . . . 72.3 110.847 -177.937 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.4 pt -81.91 127.88 70.54 Favored Pre-proline 0 C--N 1.303 -1.449 0 CA-C-N 114.667 -1.151 . . . . 75.53 111.797 -175.588 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -82.3 178.48 6.24 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.319 2.013 . . . . 73.14 111.967 178.088 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -97.47 107.82 20.41 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 122.289 1.042 . . . . 64.22 110.075 178.448 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.441 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 25.7 m -111.39 18.75 7.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 114.4 -1.273 . . . . 74.21 109.566 179.389 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -74.16 100.6 3.71 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.734 -1.121 . . . . 50.42 110.342 -178.546 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 155.7 -41.53 0.58 Allowed Glycine 0 N--CA 1.426 -2.023 0 C-N-CA 120.953 -0.641 . . . . 53.15 111.641 177.576 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.483 ' O ' HG12 ' A' ' 534' ' ' VAL . 19.3 mp0 -77.13 -177.46 4.53 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.45 0.643 . . . . 70.22 110.381 -179.219 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 11.4 m -75.23 155.62 36.6 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 106.428 -1.693 . . . . 75.53 106.428 174.599 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.43 HG21 HG22 ' A' ' 555' ' ' VAL . 7.4 p -62.01 -42.13 93.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 118.166 0.439 . . . . 72.34 111.66 -178.285 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.91 -42.88 98.94 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 122.854 0.462 . . . . 65.14 110.609 178.678 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 82.3 t -67.6 -49.03 74.29 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.906 0 N-CA-C 109.139 -0.689 . . . . 64.22 109.139 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.461 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -59.28 -43.49 92.54 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 122.717 0.407 . . . . 75.23 111.897 -177.699 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.9 mt-30 -63.32 -44.34 95.21 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 120.757 0.313 . . . . 73.53 110.287 179.688 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.48 ' HA ' ' HE2' ' A' ' 510' ' ' LYS . 11.2 mmpt? -67.23 -40.22 86.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.406 -0.361 . . . . 64.2 110.155 178.51 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 511' ' ' ASN . . . . . 0.613 ' O ' HG12 ' A' ' 514' ' ' VAL . 9.2 m-20 -62.47 -45.66 92.04 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.316 -0.857 . . . . 73.04 111.688 -178.122 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 512' ' ' LEU . . . . . 0.458 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -69.05 -37.53 78.61 Favored 'General case' 0 C--O 1.211 -0.949 0 C-N-CA 119.683 -0.807 . . . . 55.41 110.722 -179.577 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.458 ' N ' HD12 ' A' ' 512' ' ' LEU . 49.1 t30 -64.36 -35.66 81.61 Favored 'General case' 0 N--CA 1.421 -1.915 0 C-N-CA 124.645 1.178 . . . . 70.04 111.108 -178.455 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 511' ' ' ASN . 5.0 p -67.26 -31.27 52.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.944 0.402 . . . . 72.41 110.764 -178.523 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -104.51 6.22 34.6 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.625 -0.509 . . . . 75.53 109.625 -179.58 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -131.1 -53.4 0.09 OUTLIER Glycine 0 CA--C 1.477 -2.31 0 C-N-CA 119.7 -1.238 . . . . 72.42 114.399 -168.902 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 65.16 77.32 0.31 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 106.939 -1.504 . . . . 71.35 106.939 -173.58 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.3 p -140.29 177.1 8.23 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 115.061 -0.972 . . . . 72.33 111.539 -170.279 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.97 132.76 53.78 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.119 -1.438 . . . . 71.11 107.119 179.185 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -130.55 154.48 47.78 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.154 0.502 . . . . 73.22 112.095 -176.704 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 69.6 m -140.4 160.56 39.71 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 105.969 -1.863 . . . . 72.23 105.969 174.159 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 522' ' ' GLN . . . . . 0.416 ' HB2' ' CG2' ' A' ' 555' ' ' VAL . 3.8 pt20 -131.11 135.98 47.98 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.695 -0.802 . . . . 75.53 111.035 -178.895 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.72 129.22 56.39 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.601 -1.259 . . . . 70.45 107.601 178.343 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.8 m -100.59 124.74 46.57 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.244 0.545 . . . . 64.32 111.842 -177.668 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.54 150.82 24.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.444 -1.317 . . . . 72.31 107.444 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -91.35 135.3 33.91 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.445 -0.576 . . . . 54.34 109.445 179.484 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 52.3 m -160.53 162.86 22.63 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 107.549 -1.278 . . . . 74.21 107.549 -175.932 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -64.15 -8.54 16.66 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.699 2.266 . . . . 75.25 113.564 178.587 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -74.07 134.49 77.58 Favored Pre-proline 0 N--CA 1.432 -1.333 0 N-CA-C 107.437 -1.32 . . . . 70.12 107.437 175.878 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.53 149.82 89.69 Favored 'Trans proline' 0 C--O 1.249 1.063 0 C-N-CA 122.303 2.002 . . . . 72.14 112.495 -175.789 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.26 120.09 7.53 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.357 -0.838 . . . . 62.41 111.979 -176.72 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.53 -20.77 10.12 Favored Glycine 0 N--CA 1.428 -1.872 0 CA-C-N 114.98 -1.009 . . . . 61.23 111.414 177.645 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -78.67 137.15 37.67 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.345 -0.613 . . . . 72.31 109.345 179.046 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.499 HG22 ' H ' ' A' ' 536' ' ' GLY . 11.5 p -99.47 120.49 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.091 0 N-CA-C 108.566 -0.901 . . . . 75.43 108.566 -179.217 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.21 -1.43 44.72 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.097 -0.956 . . . . 70.12 112.072 178.948 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.499 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 132.67 -141.57 12.95 Favored Glycine 0 N--CA 1.419 -2.447 0 N-CA-C 111.226 -0.75 . . . . 32.2 111.226 175.265 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 2.2 p -116.61 157.14 25.83 Favored 'General case' 0 C--N 1.262 -3.217 0 N-CA-C 108.547 -0.908 . . . . 74.3 108.547 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.515 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 55.1 t30 -64.92 -53.51 41.92 Favored Pre-proline 0 C--N 1.324 -0.51 0 C-N-CA 120.087 -0.645 . . . . 72.11 109.923 175.953 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 15.8 Cg_exo -71.66 137.63 30.48 Favored 'Trans proline' 0 C--N 1.372 1.782 0 N-CA-C 107.002 -1.961 . . . . 64.03 107.002 168.488 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -55.78 139.91 84.22 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.209 1.939 . . . . 75.21 113.384 -175.66 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.84 132.38 51.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.39 -0.823 . . . . 74.32 110.775 -178.356 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.75 -10.17 37.96 Favored Glycine 0 C--N 1.303 -1.253 0 N-CA-C 111.668 -0.573 . . . . 55.11 111.668 -175.747 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 86.8 m -77.46 129.02 35.19 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 122.817 -0.225 . . . . 72.01 110.517 179.563 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 11.3 t -82.14 125.55 31.02 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.095 -1.076 . . . . 61.54 108.095 174.926 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.73 160.0 53.23 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 109.189 -0.671 . . . . 54.05 109.189 -177.707 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -65.89 143.13 71.97 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.697 1.598 . . . . 72.51 110.14 177.054 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.44 -19.72 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 CA-C-O 121.591 0.71 . . . . 74.41 110.555 178.513 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.25 -12.76 59.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.884 -0.598 . . . . 75.3 111.848 176.18 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 10.2 t -93.06 148.19 22.21 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.92 -0.77 . . . . 75.02 108.92 -179.813 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 9.9 p -91.79 138.71 19.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 115.836 -0.62 . . . . 61.4 111.508 -177.062 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 60.0 mt -80.72 124.28 38.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.417 -0.957 . . . . 73.11 108.417 177.336 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -103.65 117.9 35.48 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.305 -0.998 . . . . 71.43 108.305 -178.227 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.5 128.54 41.15 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.253 0.621 . . . . 55.44 111.485 -178.561 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -83.0 102.76 11.96 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 123.204 0.602 . . . . 64.35 110.061 177.363 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.43 HG22 HG21 ' A' ' 505' ' ' VAL . 25.9 t -95.94 123.58 48.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.407 -0.961 . . . . 73.44 108.407 -179.654 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 51.1 m -95.07 127.99 41.55 Favored 'General case' 0 N--CA 1.409 -2.481 0 CA-C-O 121.457 0.646 . . . . 73.13 111.413 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -100.12 135.23 41.87 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 106.453 -1.684 . . . . 72.33 106.453 170.472 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -55.03 -22.88 29.86 Favored Glycine 0 CA--C 1.503 -0.676 0 O-C-N 124.698 1.249 . . . . 43.54 115.077 -172.748 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 81.73 -24.4 0.19 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.449 1.499 . . . . 71.21 109.755 -178.437 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.5 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 91.6 mt-30 -113.25 158.02 21.02 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.391 -0.822 . . . . 71.05 110.913 -176.852 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -127.02 150.21 49.54 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.217 -1.031 . . . . 74.45 108.217 175.359 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 31.0 t -71.28 118.14 15.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.588 -0.523 . . . . 62.13 109.588 -178.784 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.6 ' SD ' HG21 ' A' ' 620' ' ' ILE . 49.4 ttp -87.13 129.13 52.99 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-N 116.119 -0.491 . . . . 65.41 111.147 -176.314 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.49 169.55 22.28 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.529 2.153 . . . . 73.44 111.114 174.027 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -74.63 142.12 44.59 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.986 0.422 . . . . 73.1 110.375 179.168 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -135.05 15.46 3.53 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.936 0.874 . . . . 74.03 109.179 177.777 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 31.6 t -79.22 139.38 37.95 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.118 -0.947 . . . . 74.34 108.867 178.71 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 97.03 26.0 10.74 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.462 -0.875 . . . . 71.01 114.022 176.926 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.9 -175.55 3.71 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.964 -0.754 . . . . 74.53 108.964 177.928 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -117.06 159.07 23.11 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.65 -1.241 . . . . 75.22 107.65 -175.309 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 571' ' ' TRP . . . . . 0.415 ' CH2' ' HB3' ' A' ' 589' ' ' LYS . 27.2 t-105 -63.48 -24.81 67.98 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.324 0.583 . . . . 74.45 110.21 -176.398 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.0 m -66.97 -18.94 24.99 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 CA-C-N 115.025 -0.989 . . . . 62.33 110.735 179.247 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.547 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 22.9 t70 -101.69 -28.56 12.41 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.078 -0.712 . . . . 71.42 109.078 177.759 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -56.47 -47.52 79.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.962 0.905 . . . . 75.52 112.676 -178.727 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -64.25 -47.98 77.36 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 119.633 -0.827 . . . . 74.22 112.769 178.568 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -52.66 -37.2 74.65 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 121.999 1.8 . . . . 74.41 112.796 171.057 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 6.4 mmp_? -59.35 -44.27 92.7 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 109.347 -0.612 . . . . 70.52 109.347 176.446 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 583' ' ' TRP . 1.7 tp -59.85 -49.57 77.19 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-N 115.271 -0.877 . . . . 65.12 111.44 -176.149 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -66.73 -40.93 88.55 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.712 0.634 . . . . 73.13 112.712 176.682 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.62 -37.68 73.84 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.908 0.707 . . . . 75.33 112.908 -177.257 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.414 HD11 ' HB2' ' A' ' 583' ' ' TRP . 0.7 OUTLIER -82.89 -8.93 59.53 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 122.14 -0.35 . . . . 72.52 110.962 -174.918 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.26 47.03 18.7 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.145 -0.782 . . . . 43.22 111.145 -179.68 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 583' ' ' TRP . . . . . 0.528 ' HB3' HD12 ' A' ' 578' ' ' LEU . 12.4 t90 -87.18 127.86 35.14 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 121.636 0.731 . . . . 72.13 110.134 -178.689 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 27.0 m -89.1 -17.45 29.24 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 124.367 1.067 . . . . 71.34 112.947 -174.95 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -96.79 -171.04 34.2 Favored Glycine 0 CA--C 1.497 -1.038 0 C-N-CA 121.372 -0.442 . . . . 64.13 113.223 -176.142 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 81.4 mtp -117.73 155.85 29.27 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 120.908 0.385 . . . . 72.44 110.878 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 587' ' ' LEU . . . . . 0.523 ' HG ' ' CH2' ' A' ' 583' ' ' TRP . 5.0 mt -80.31 125.56 30.05 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 115.076 -0.965 . . . . 75.42 112.245 -178.48 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 621' ' ' THR . 2.4 m-20 -110.93 118.11 35.21 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.269 -1.332 . . . . 74.41 110.122 176.313 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.415 ' HB3' ' CH2' ' A' ' 571' ' ' TRP . 0.0 OUTLIER -107.33 133.83 51.29 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 120.176 -0.61 . . . . 75.43 109.39 -178.961 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -78.59 -69.85 1.36 Allowed Glycine 0 C--N 1.284 -2.322 0 CA-C-N 115.354 -0.839 . . . . 64.2 111.176 -179.686 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.09 149.24 42.84 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.706 0.288 . . . . 61.13 111.508 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -96.61 124.09 40.49 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 105.925 -1.88 . . . . 74.24 105.925 170.898 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 40.2 t -105.76 119.99 55.9 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.5 0 CA-C-N 115.683 -0.69 . . . . 75.35 109.832 -175.601 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -73.54 107.06 5.6 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.37 -0.974 . . . . 54.1 108.37 176.506 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -107.84 -39.75 5.47 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.432 0.634 . . . . 63.33 110.014 -179.338 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 114.34 152.06 10.49 Favored Glycine 0 N--CA 1.412 -2.9 0 N-CA-C 110.674 -0.971 . . . . 43.01 110.674 -177.225 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.98 -32.66 62.74 Favored Glycine 0 C--N 1.305 -1.174 0 C-N-CA 123.287 0.47 . . . . 35.25 113.1 -179.592 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 4.3 p -69.59 -24.92 63.74 Favored 'General case' 0 N--CA 1.422 -1.859 0 C-N-CA 124.283 1.033 . . . . 41.13 111.608 -176.466 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -93.95 -14.18 26.25 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.602 -0.726 . . . . 73.25 109.971 -177.006 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 65.1 m80 56.69 108.73 0.01 OUTLIER 'General case' 0 C--O 1.238 0.47 0 O-C-N 124.345 1.028 . . . . 63.32 111.684 -173.691 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 601' ' ' ASN . . . . . 0.401 ' HB3' ' HA3' ' A' ' 625' ' ' GLY . 48.1 m-80 -73.53 75.52 1.46 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.943 -1.026 . . . . 75.52 113.404 -172.177 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -86.5 171.24 11.24 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 124.702 1.201 . . . . 74.33 109.001 177.674 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.93 129.75 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.666 -1.976 . . . . 61.42 105.666 169.728 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 14.5 p -96.64 -32.32 4.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 120.13 -0.628 . . . . 64.34 110.424 -174.311 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -151.3 134.94 16.32 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 116.182 -0.463 . . . . 70.35 110.62 -179.449 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -106.54 130.16 54.36 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.321 -1.362 . . . . 71.12 107.321 172.935 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.432 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 24.2 t-20 -55.33 -55.52 38.85 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 113.654 0.983 . . . . 74.3 113.654 -176.695 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.3 Cg_endo -87.71 131.73 2.86 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.14 1.227 . . . . 53.41 110.433 175.589 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 609' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 38.5 Cg_exo -64.88 160.32 41.64 Favored 'Trans proline' 0 C--O 1.253 1.234 0 C-N-CA 122.642 2.228 . . . . 75.4 112.383 177.964 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -64.8 138.5 58.42 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.15 -0.685 . . . . 61.25 109.15 177.519 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 91.84 0.4 71.96 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 119.8 -1.19 . . . . 75.35 111.912 -179.178 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 24.0 m -90.35 146.31 24.28 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.881 -0.785 . . . . 52.1 108.881 178.575 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -83.56 123.2 6.06 Favored Glycine 0 N--CA 1.419 -2.45 0 N-CA-C 110.962 -0.855 . . . . 74.34 110.962 177.623 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.9 m -111.44 142.55 23.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 107.901 -1.148 . . . . 62.32 107.901 176.787 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.5 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 37.8 p30 -46.1 163.09 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 113.769 1.026 . . . . 72.44 113.769 179.077 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -57.15 -25.31 58.71 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.331 -0.85 . . . . 73.2 112.219 177.617 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.35 -10.96 59.75 Favored 'General case' 0 C--O 1.214 -0.802 0 C-N-CA 119.372 -0.931 . . . . 74.22 109.254 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.85 11.42 57.87 Favored Glycine 0 CA--C 1.494 -1.264 0 C-N-CA 123.455 0.55 . . . . 71.12 112.885 167.344 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.96 118.77 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.114 0 CA-C-O 122.44 1.114 . . . . 74.21 110.985 -169.638 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.6 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.7 pp -124.95 133.92 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 CA-C-N 113.74 -1.573 . . . . 62.45 111.813 -177.943 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 28.3 m -99.0 130.52 45.34 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.669 -1.234 . . . . 72.43 107.669 177.369 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.404 HD23 ' H ' ' A' ' 622' ' ' LEU . 2.0 pt? -138.65 162.78 33.77 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 110.145 -0.316 . . . . 62.11 110.145 -178.157 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -128.1 136.98 51.92 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.221 -1.4 . . . . 75.11 107.221 178.202 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -141.92 167.53 21.92 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.997 -0.547 . . . . 72.31 110.127 -168.432 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 625' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 601' ' ' ASN . . . -64.55 -170.43 2.21 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-O 121.944 0.747 . . . . 64.3 113.633 176.555 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 . . . . . 0 C--N 1.28 -2.418 0 C-N-CA 124.066 0.946 . . . . 74.11 111.0 -175.91 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.58 0 CA-C-O 121.42 0.629 . . . . 74.2 111.476 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 33.2 p -136.87 148.56 47.15 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 115.5 -0.773 . . . . 74.23 110.251 -178.622 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -140.66 153.54 46.04 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.026 -0.731 . . . . 74.33 109.026 176.213 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -90.2 140.77 29.35 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.215 0.531 . . . . 71.31 110.148 -178.85 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 22.8 pt -101.98 112.71 65.66 Favored Pre-proline 0 C--N 1.301 -1.515 0 CA-C-N 115.592 -0.731 . . . . 74.55 110.57 177.705 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -69.65 167.68 23.6 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.439 2.092 . . . . 74.24 112.264 177.46 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -75.2 96.11 3.25 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.477 0.656 . . . . 74.24 110.207 179.183 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 31.5 m -94.81 9.33 5.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 115.259 -0.882 . . . . 63.32 110.055 177.323 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.71 101.04 1.99 Allowed 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 114.638 -1.165 . . . . 61.12 110.222 -179.146 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 147.41 -23.18 1.53 Allowed Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 115.455 -0.793 . . . . 71.22 111.846 178.918 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.432 ' O ' HG12 ' A' ' 534' ' ' VAL . 1.9 mp0 -94.06 178.47 5.64 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 108.62 -0.881 . . . . 72.44 108.62 179.518 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 24.8 m -72.05 155.33 40.43 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.487 -1.301 . . . . 74.13 107.487 176.71 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.454 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.7 p -61.94 -43.21 97.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 111.42 0.156 . . . . 72.02 111.42 -178.73 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.16 -39.2 93.97 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 110.088 -0.338 . . . . 74.31 110.088 -179.314 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 99.7 t -69.06 -46.93 77.71 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 CA-C-N 115.142 -0.936 . . . . 63.02 109.748 -179.72 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.59 -44.38 96.29 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 122.99 0.181 . . . . 73.21 111.251 178.924 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 509' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 98.5 mt-30 -64.14 -46.55 83.62 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 120.699 0.285 . . . . 74.43 111.233 -178.912 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.451 ' O ' HG23 ' A' ' 514' ' ' VAL . 21.2 ptmt -67.1 -38.63 85.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.028 -0.533 . . . . 64.43 110.199 -178.099 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -67.13 -43.98 81.04 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.681 -0.69 . . . . 72.42 110.648 -179.788 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.07 -41.33 98.06 Favored 'General case' 0 C--O 1.207 -1.16 0 N-CA-C 108.317 -0.994 . . . . 74.14 108.317 -179.408 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -59.64 -34.89 73.38 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 124.12 0.968 . . . . 74.33 111.054 -179.688 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 510' ' ' LYS . 97.7 t -57.66 -38.2 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-O 121.168 0.508 . . . . 70.33 111.118 178.997 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.43 19.81 13.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 122.123 0.963 . . . . 64.42 111.159 -178.814 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -128.81 -59.43 0.11 Allowed Glycine 0 N--CA 1.416 -2.665 0 CA-C-N 114.68 -1.146 . . . . 63.03 111.595 -177.246 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 63.95 24.56 13.67 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 122.058 0.932 . . . . 75.42 110.016 -174.708 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 6.4 p -84.18 -179.66 7.27 Favored 'General case' 0 N--CA 1.404 -2.746 0 CA-C-N 113.984 -1.462 . . . . 63.01 110.277 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 519' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 56.7 mtpt -108.43 134.23 51.52 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.448 -1.686 . . . . 61.42 106.448 179.486 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -132.89 154.28 50.54 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 112.871 0.693 . . . . 72.45 112.871 -175.411 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 34.2 p -140.03 156.34 46.66 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.789 -1.189 . . . . 64.31 107.789 176.3 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -124.84 145.21 49.9 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.979 -0.288 . . . . 74.45 111.186 -178.939 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -132.59 117.53 18.06 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.388 -0.597 . . . . 42.24 109.388 177.526 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 524' ' ' SER . . . . . 0.455 ' HA ' ' HB ' ' A' ' 555' ' ' VAL . 49.1 m -84.53 116.76 23.3 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.535 0.683 . . . . 74.31 110.157 178.58 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 44.9 t -120.96 149.81 23.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 106.435 -1.691 . . . . 72.53 106.435 -176.519 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -68.29 134.52 50.48 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 120.717 0.294 . . . . 54.53 110.588 -176.833 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 49.3 m -163.08 160.51 18.72 Favored Pre-proline 0 C--O 1.208 -1.116 0 N-CA-C 108.397 -0.964 . . . . 71.41 108.397 -179.726 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -73.48 3.35 4.84 Favored 'Trans proline' 0 CA--C 1.556 1.623 0 C-N-CA 122.624 2.216 . . . . 72.32 113.651 178.875 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 529' ' ' ARG . . . . . 0.477 ' N ' ' HD2' ' A' ' 529' ' ' ARG . 2.7 mpt_? -92.39 140.02 24.1 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 107.992 -1.114 . . . . 71.25 107.992 177.114 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -62.19 150.75 85.65 Favored 'Trans proline' 0 C--O 1.254 1.324 0 C-N-CA 122.847 2.365 . . . . 63.35 113.052 -176.438 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.625 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.47 110.11 1.18 Allowed 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.196 -0.911 . . . . 62.12 112.253 -174.752 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 136.86 -26.92 2.97 Favored Glycine 0 N--CA 1.433 -1.5 0 C-N-CA 120.621 -0.799 . . . . 73.05 112.394 177.838 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -82.03 140.57 33.84 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.044 0.45 . . . . 74.33 110.558 -178.281 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 503' ' ' GLN . 7.9 p -96.96 118.24 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 CA-C-O 121.687 0.756 . . . . 75.02 109.162 -179.509 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -25.77 54.46 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 114.853 -1.067 . . . . 60.3 110.999 179.275 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 162.44 -164.69 35.76 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 120.547 -0.835 . . . . 63.41 111.776 179.172 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 1.7 p -116.87 157.9 24.87 Favored 'General case' 0 C--N 1.282 -2.336 0 C-N-CA 123.184 0.594 . . . . 61.01 109.639 -178.793 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.432 ' HB2' HE22 ' A' ' 554' ' ' GLN . 25.0 t-20 -58.33 -54.46 55.68 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 120.712 -0.395 . . . . 72.52 110.657 175.533 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -73.2 135.99 23.68 Favored 'Trans proline' 0 C--N 1.359 1.102 0 N-CA-C 108.337 -1.447 . . . . 70.44 108.337 168.734 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.16 140.93 94.78 Favored 'Trans proline' 0 C--O 1.245 0.852 0 C-N-CA 122.406 2.071 . . . . 64.35 112.445 -178.069 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.46 140.48 58.03 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.955 -0.566 . . . . 71.13 110.004 -179.507 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.78 -15.09 55.94 Favored Glycine 0 C--N 1.3 -1.454 0 N-CA-C 110.775 -0.93 . . . . 74.21 110.775 -175.806 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.7 m -85.16 138.22 32.52 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 122.802 0.441 . . . . 63.24 109.955 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 8.0 t -76.29 128.06 34.14 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 108.645 -0.872 . . . . 71.52 108.645 173.057 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 32.1 m -123.78 154.79 67.23 Favored Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 108.691 -0.855 . . . . 64.3 108.691 -179.078 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -64.88 134.84 41.84 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 120.693 0.929 . . . . 74.11 111.703 178.958 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 8.6 p -67.38 -27.46 38.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.902 -1.044 . . . . 72.35 112.907 -176.206 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -90.19 -7.04 54.57 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.534 0.683 . . . . 63.33 110.908 -175.433 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.1 t -89.79 179.14 6.06 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.131 0.491 . . . . 63.11 109.684 -178.355 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 12.2 p -107.6 128.7 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.261 0 CA-C-N 115.511 -0.768 . . . . 73.05 109.82 -177.605 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 60.2 mt -93.22 135.95 26.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 108.4 -0.963 . . . . 75.25 108.4 -179.691 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -103.33 117.86 35.45 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.652 -0.499 . . . . 72.54 109.652 -176.687 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.426 HD12 HG21 ' A' ' 534' ' ' VAL . 3.6 mm? -95.46 120.83 36.38 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 123.748 0.819 . . . . 75.54 109.464 179.187 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 554' ' ' GLN . . . . . 0.432 HE22 ' HB2' ' A' ' 538' ' ' ASN . 2.8 mp0 -88.13 110.55 20.75 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.293 0.568 . . . . 75.34 109.964 178.61 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 555' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 524' ' ' SER . 15.7 t -96.47 135.86 29.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 107.796 -1.187 . . . . 65.33 107.796 -178.201 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.625 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 68.7 m -89.19 124.65 34.56 Favored 'General case' 0 N--CA 1.4 -2.959 0 C-N-CA 120.375 -0.53 . . . . 51.43 110.304 176.709 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -97.79 131.21 44.5 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 104.384 -2.451 . . . . 61.25 104.384 166.87 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -56.14 -26.37 49.45 Favored Glycine 0 CA--C 1.491 -1.448 0 O-C-N 124.258 0.974 . . . . 51.33 112.303 -175.173 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 57.2 t30 68.38 21.64 8.23 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 123.035 1.398 . . . . 75.2 108.716 174.159 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.5 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 63.4 mt-30 -126.94 145.27 50.75 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 113.176 -1.829 . . . . 73.44 107.183 177.993 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -122.8 149.5 44.07 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 120.605 -0.438 . . . . 62.2 110.174 -177.134 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.74 115.51 7.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 O-C-N 123.83 0.706 . . . . 71.03 109.111 -178.711 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.516 ' SD ' HG21 ' A' ' 620' ' ' ILE . 35.7 ttp -79.85 123.24 83.87 Favored Pre-proline 0 C--N 1.306 -1.285 0 CA-C-N 115.575 -0.739 . . . . 73.41 111.747 -175.657 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 564' ' ' PRO . . . . . 0.456 ' HG2' ' HB2' ' A' ' 581' ' ' LEU . 20.8 Cg_exo -68.76 156.73 64.49 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.945 2.43 . . . . 73.21 110.773 174.4 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.97 123.48 28.36 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.761 0.791 . . . . 64.41 110.702 179.009 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 566' ' ' LEU . . . . . 0.466 ' H ' HD13 ' A' ' 566' ' ' LEU . 0.0 OUTLIER -119.81 14.07 12.45 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.903 -1.517 . . . . 75.42 106.903 173.411 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 3.0 m -69.13 140.46 54.73 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 112.967 -1.924 . . . . 73.24 110.18 -177.541 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 73.72 70.53 1.22 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 116.276 -0.42 . . . . 55.4 113.46 177.937 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 22.1 ptp -174.07 172.21 3.41 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.742 -0.836 . . . . 65.01 108.742 179.28 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 570' ' ' PHE . . . . . 0.452 ' HB2' HG12 ' A' ' 572' ' ' VAL . 95.7 m-85 -100.36 178.66 4.69 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.478 -0.934 . . . . 74.35 108.478 178.275 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 571' ' ' TRP . . . . . 0.413 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 11.7 t-105 -64.76 -28.71 69.77 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.806 0.336 . . . . 72.3 110.259 -177.449 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 572' ' ' VAL . . . . . 0.452 HG12 ' HB2' ' A' ' 570' ' ' PHE . 12.7 p -58.02 -30.05 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 123.339 0.656 . . . . 62.11 111.789 179.598 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 573' ' ' ASP . . . . . 0.503 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 29.5 m-20 -100.81 -38.65 8.17 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 120.982 -0.287 . . . . 75.4 110.313 175.762 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 574' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -58.73 -43.11 90.1 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.357 0.873 . . . . 73.44 113.357 -176.658 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 575' ' ' GLU . . . . . 0.664 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 31.4 tt0 -65.3 -50.71 57.77 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 120.42 -0.512 . . . . 64.41 111.06 -179.193 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 576' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 71.2 Cg_exo -56.19 -35.74 95.73 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 121.314 1.342 . . . . 70.3 111.911 172.903 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 577' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 14.5 mmt180 -64.76 -38.49 91.16 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 111.711 0.263 . . . . 72.55 111.711 178.44 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.1 pp -65.93 -46.36 78.48 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.126 -0.63 . . . . 64.22 110.561 -176.762 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 579' ' ' ARG . . . . . 0.475 ' N ' HD12 ' A' ' 578' ' ' LEU . 11.9 ptm180 -66.35 -39.54 89.23 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.027 -0.533 . . . . 71.13 112.058 176.045 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.56 -27.31 64.04 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 112.567 0.58 . . . . 55.44 112.567 -177.537 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 581' ' ' LEU . . . . . 0.456 ' HB2' ' HG2' ' A' ' 564' ' ' PRO . 2.3 pp -92.28 -8.46 45.17 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 119.867 -0.733 . . . . 74.23 110.426 -179.677 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 77.27 48.69 8.0 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 120.633 -0.794 . . . . 75.33 111.323 -178.148 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -84.49 127.45 34.04 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.095 -1.076 . . . . 71.34 108.095 177.54 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 3.4 p -90.35 -5.52 56.11 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 124.71 1.204 . . . . 62.11 113.114 -175.948 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -114.09 -168.57 16.4 Favored Glycine 0 C--N 1.302 -1.346 0 N-CA-C 111.66 -0.576 . . . . 70.5 111.66 -179.516 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 26.4 mmt -121.15 153.86 36.96 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 110.087 -0.338 . . . . 71.31 110.087 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 6.3 tt -83.26 127.32 33.54 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.608 -0.886 . . . . 73.04 108.608 -178.159 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -125.08 116.48 22.15 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.165 -0.679 . . . . 74.23 109.165 178.434 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.63 133.56 36.84 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 118.756 -1.177 . . . . 74.31 110.636 177.821 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -78.97 -41.58 14.05 Favored Glycine 0 C--N 1.285 -2.298 0 CA-C-N 114.603 -1.181 . . . . 72.24 112.956 -172.908 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -138.29 142.04 39.82 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.77 -0.455 . . . . 71.32 109.77 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -111.78 125.13 53.66 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.907 -1.516 . . . . 72.44 106.907 175.452 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.68 116.79 48.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 N-CA-C 107.902 -1.147 . . . . 72.21 107.902 179.17 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 594' ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 5.3 p-10 -73.96 107.12 5.98 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.022 0.915 . . . . 61.13 112.483 -176.777 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -146.68 -61.34 0.3 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.184 -1.413 . . . . 70.21 107.184 175.377 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 132.31 147.56 5.89 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 120.132 -1.033 . . . . 53.12 112.283 177.365 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.66 -33.36 62.7 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 122.745 0.212 . . . . 53.03 113.508 -178.695 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 3.3 m -62.96 -23.52 67.45 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.534 1.134 . . . . 73.23 111.092 -177.936 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -87.44 0.55 55.34 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 124.801 1.24 . . . . 70.54 111.111 -175.082 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 66.3 m80 71.78 32.71 1.88 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.783 1.278 . . . . 75.24 109.098 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 601' ' ' ASN . . . . . 0.441 ' CG ' ' HA3' ' A' ' 625' ' ' GLY . 2.2 t-20 -82.31 41.82 0.71 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 112.815 -1.993 . . . . 55.53 109.84 -175.839 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -74.22 174.45 8.74 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 126.282 1.833 . . . . 73.23 110.303 178.686 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.6 129.86 17.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.242 -1.022 . . . . 73.03 108.242 -178.925 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 24.7 m -106.3 -28.27 2.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.606 -0.725 . . . . 54.03 111.271 -176.67 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -156.74 141.64 17.06 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.144 -0.48 . . . . 74.15 111.081 -178.268 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -122.64 142.05 51.07 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.138 -1.43 . . . . 75.43 107.138 172.471 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -58.05 -50.09 90.02 Favored Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 113.312 0.856 . . . . 51.34 113.312 -175.077 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -89.86 128.2 1.62 Allowed 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 121.068 1.179 . . . . 63.11 110.823 174.316 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.3 151.01 65.75 Favored 'Trans proline' 0 C--O 1.247 0.936 0 C-N-CA 122.446 2.098 . . . . 71.12 112.37 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.69 135.68 57.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.332 -0.394 . . . . 61.22 110.438 178.821 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.09 -11.88 48.66 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.386 -0.911 . . . . 65.02 112.38 -179.714 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 4.7 t -90.09 167.91 12.39 Favored 'General case' 0 C--O 1.255 1.373 0 C-N-CA 119.682 -0.807 . . . . 75.13 109.197 -179.361 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -90.83 117.5 5.14 Favored Glycine 0 N--CA 1.427 -1.929 0 N-CA-C 111.432 -0.667 . . . . 75.03 111.432 -178.826 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.03 142.58 16.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 109.686 -0.487 . . . . 75.53 109.686 178.06 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.5 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 28.9 p-10 -51.07 165.16 0.13 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.26 1.024 . . . . 63.22 112.187 -179.213 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -58.8 -25.12 62.84 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.554 0.576 . . . . 75.22 112.554 -178.148 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -80.81 -9.23 59.83 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.66 -0.496 . . . . 71.04 109.66 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.4 -0.89 5.87 Favored Glycine 0 C--O 1.211 -1.291 0 C-N-CA 124.756 1.169 . . . . 72.31 114.247 171.84 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.45 119.43 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 CA-C-O 122.266 1.032 . . . . 54.43 112.051 -164.008 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.516 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.5 pp -125.68 133.98 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 CA-C-N 114.288 -1.324 . . . . 70.32 109.313 -178.529 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 11.5 t -101.52 139.23 37.45 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 108.31 -0.996 . . . . 65.45 108.31 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.6 pp -138.64 168.73 19.15 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.738 -0.665 . . . . 44.21 111.215 -174.839 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -123.95 137.06 54.68 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.1 -1.445 . . . . 73.44 107.1 -178.967 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . 0.279 0.2 OUTLIER -135.85 166.17 23.93 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.207 -1.361 . . . . 63.44 108.164 -161.952 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 625' ' ' GLY . . . . . 0.441 ' HA3' ' CG ' ' A' ' 601' ' ' ASN . . . -84.57 -140.72 4.91 Favored Glycine 0 N--CA 1.407 -3.274 0 C-N-CA 119.286 -1.435 . . . . 62.4 110.31 166.762 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.471 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 53.8 tp60 . . . . . 0 C--N 1.283 -2.301 0 CA-C-O 118.275 -0.869 . . . . 73.14 108.924 -179.139 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 493' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . . . . . . 0 N--CA 1.462 0.156 0 N-CA-C 112.935 0.717 . . . . 71.12 112.935 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 13.8 p -145.79 140.31 27.04 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 122.283 -0.26 . . . . 74.11 111.172 -177.053 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -141.85 154.44 45.16 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.623 -0.51 . . . . 71.23 109.623 178.068 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 496' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.4 p-10 -89.5 144.23 26.2 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.167 0.508 . . . . 74.32 111.365 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.5 pt -99.85 137.71 20.22 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 115.506 -0.77 . . . . 52.31 110.954 -179.517 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -82.21 163.67 17.42 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.111 1.874 . . . . 63.04 111.197 176.812 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.16 103.93 8.41 Favored 'General case' 0 CA--C 1.491 -1.312 0 CA-C-O 122.647 1.213 . . . . 74.24 109.454 176.079 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.486 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 15.0 m -106.99 63.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.437 0 CA-C-O 123.219 1.485 . . . . 73.34 110.394 -177.514 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 501' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -118.54 110.84 17.86 Favored 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 112.357 -2.201 . . . . 63.2 108.683 172.306 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 145.3 -37.4 1.31 Allowed Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 119.768 -1.206 . . . . 51.21 112.715 177.621 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 503' ' ' GLN . . . . . 0.492 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.5 OUTLIER -95.79 -175.16 3.34 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.494 -0.558 . . . . 71.14 109.494 -178.614 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 24.4 m -72.02 155.38 40.38 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.34 -0.985 . . . . 63.42 108.34 176.587 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.501 ' HA ' ' HB ' ' A' ' 534' ' ' VAL . 7.1 p -61.25 -41.75 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 116.41 -0.359 . . . . 64.24 111.846 -179.398 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 506' ' ' ASP . . . . . 0.551 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 35.5 t70 -65.26 -39.98 93.35 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 110.02 -0.363 . . . . 72.2 110.02 179.166 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.58 -42.61 93.34 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 N-CA-C 109.434 -0.58 . . . . 72.52 109.434 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 508' ' ' ALA . . . . . 0.486 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -62.26 -44.43 96.57 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 123.456 0.473 . . . . 61.31 111.275 175.895 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -63.01 -45.42 92.43 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 120.505 0.193 . . . . 73.34 111.284 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 32.2 mmmt -65.0 -39.49 93.53 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.514 -0.55 . . . . 74.32 109.514 178.814 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -61.27 -49.81 75.55 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.678 -1.146 . . . . 74.31 110.247 -177.702 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.95 -34.71 75.78 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.496 -0.774 . . . . 75.05 110.894 -177.991 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -61.6 -38.01 86.02 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.79 -0.641 . . . . 65.25 110.272 179.717 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 510' ' ' LYS . 69.3 t -59.51 -33.84 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.035 0.445 . . . . 75.32 111.268 178.309 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -111.89 15.9 20.59 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.372 0.606 . . . . 74.12 109.806 -177.253 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -141.17 -60.6 0.03 OUTLIER Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 119.969 -1.11 . . . . 72.03 113.919 -172.834 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 63.54 41.48 7.31 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 122.667 1.222 . . . . 62.11 109.281 -173.642 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 518' ' ' THR . . . . . 0.558 HG22 ' HA ' ' A' ' 547' ' ' VAL . 14.8 p -95.27 -171.68 2.47 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 113.58 -1.646 . . . . 70.21 110.48 -178.847 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -107.91 137.49 45.82 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.346 -1.724 . . . . 72.0 106.346 174.719 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -132.92 151.87 51.98 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 112.233 0.457 . . . . 72.14 112.233 -178.866 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 52.8 p -139.6 159.42 42.21 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.168 -1.049 . . . . 61.32 108.168 176.571 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -117.5 134.23 55.09 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.638 -0.425 . . . . 71.51 110.708 177.671 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -112.28 126.74 55.57 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.573 -0.899 . . . . 73.32 108.573 177.931 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 6.5 p -96.03 130.55 43.01 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.192 0.52 . . . . 51.42 111.601 -178.032 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 11.4 p -139.86 156.28 25.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 106.654 -1.61 . . . . 75.35 106.654 177.194 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 526' ' ' ASP . . . . . 0.492 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 4.1 p30 -96.24 136.44 36.72 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 120.168 -0.613 . . . . 61.44 111.921 -179.707 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.4 m -161.84 161.04 22.29 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 107.061 -1.459 . . . . 60.3 107.061 179.352 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -66.57 8.61 0.31 Allowed 'Trans proline' 0 CA--C 1.557 1.653 0 C-N-CA 122.799 2.333 . . . . 72.41 114.559 -178.957 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.74 132.11 47.39 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 107.0 -1.481 . . . . 73.53 107.0 174.782 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -59.85 142.49 98.7 Favored 'Trans proline' 0 C--O 1.253 1.271 0 C-N-CA 122.261 1.974 . . . . 71.11 112.486 -177.733 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.39 107.43 0.49 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.04 -0.982 . . . . 63.51 111.219 -177.59 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 140.1 -28.85 2.46 Favored Glycine 0 N--CA 1.429 -1.794 0 CA-C-N 115.267 -0.879 . . . . 71.12 111.009 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -76.83 125.67 29.67 Favored 'General case' 0 C--O 1.251 1.144 0 CA-C-O 121.672 0.748 . . . . 65.11 110.292 -179.79 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 534' ' ' VAL . . . . . 0.501 ' HB ' ' HA ' ' A' ' 505' ' ' VAL . 7.1 p -82.15 121.99 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.927 0 N-CA-C 107.611 -1.255 . . . . 72.21 107.611 177.429 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.74 16.85 11.39 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 113.638 -1.619 . . . . 53.03 110.361 -173.247 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.449 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 115.58 -161.68 12.77 Favored Glycine 0 N--CA 1.424 -2.124 0 N-CA-C 111.405 -0.678 . . . . 70.24 111.405 177.765 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 537' ' ' THR . . . . . 0.403 HG22 HD13 ' A' ' 553' ' ' LEU . 9.6 p -117.16 154.76 30.52 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 109.274 -0.639 . . . . 72.24 109.274 -179.184 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 538' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 552' ' ' GLU . 20.9 t-20 -63.95 -53.02 52.38 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 119.735 -0.786 . . . . 64.13 110.932 173.31 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 539' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 26.0 Cg_exo -67.11 145.99 75.09 Favored 'Trans proline' 0 C--N 1.378 2.125 0 N-CA-C 108.773 -1.279 . . . . 64.44 108.773 171.931 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.84 140.7 94.64 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 122.281 1.987 . . . . 63.24 112.493 -178.827 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.83 137.95 55.74 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.981 -0.554 . . . . 71.51 109.534 178.72 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 96.52 -14.66 63.96 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 121.001 -0.619 . . . . 72.13 111.894 -178.506 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 43.4 m -79.72 137.42 37.03 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-O 121.027 0.441 . . . . 60.23 110.919 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 544' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.3 t -80.78 124.45 29.07 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 121.503 0.668 . . . . 74.43 109.571 177.551 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.43 159.15 56.33 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.996 -1.113 . . . . 72.02 107.996 -178.086 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 546' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 20.7 Cg_exo -63.5 137.76 61.55 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.137 1.225 . . . . 73.23 111.323 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 547' ' ' VAL . . . . . 0.558 ' HA ' HG22 ' A' ' 518' ' ' THR . 12.1 p -66.21 -19.64 25.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 122.272 1.034 . . . . 63.41 109.629 179.182 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -88.42 -13.24 40.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.201 -1.363 . . . . 73.24 111.143 -177.78 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 92.8 p -84.25 170.43 13.72 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-O 121.17 0.51 . . . . 55.31 110.697 -177.864 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.6 p -104.38 124.42 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.338 0 CA-C-N 115.271 -0.877 . . . . 74.33 109.036 177.878 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.32 135.4 26.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.402 -0.962 . . . . 63.14 108.402 -178.206 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 552' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 538' ' ' ASN . 5.6 tp10 -102.55 117.57 34.98 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.795 -0.817 . . . . 63.25 108.795 -177.643 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.403 HD13 HG22 ' A' ' 537' ' ' THR . 3.7 mm? -93.78 127.69 39.64 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.419 -0.956 . . . . 75.32 108.419 178.135 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -90.09 117.83 29.17 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.701 -0.481 . . . . 60.24 109.701 -177.529 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.51 122.18 64.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 109.095 -0.705 . . . . 45.5 109.095 -178.585 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 71.4 m -90.71 127.98 36.5 Favored 'General case' 0 N--CA 1.412 -2.33 0 C-N-CA 120.058 -0.657 . . . . 75.03 110.251 176.595 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -89.22 137.79 32.01 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 103.971 -2.603 . . . . 60.02 103.971 168.571 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -60.82 -24.25 62.24 Favored Glycine 0 C--N 1.314 -0.686 0 O-C-N 123.938 0.774 . . . . 62.24 113.553 -174.105 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 559' ' ' ASN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 23.6 t-20 76.94 -23.96 0.23 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.83 1.652 . . . . 71.2 109.951 -179.454 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 560' ' ' GLN . . . . . 0.589 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 86.8 mt-30 -112.4 143.58 43.29 Favored 'General case' 0 N--CA 1.399 -2.989 0 CA-C-N 114.596 -1.184 . . . . 72.01 110.144 -174.298 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -122.99 158.57 30.2 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 114.884 -1.053 . . . . 74.45 108.686 -179.49 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 53.3 t -63.47 117.11 3.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 O-C-N 123.65 0.594 . . . . 71.14 109.658 -179.567 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 563' ' ' MET . . . . . 0.615 ' HE3' HG13 ' A' ' 620' ' ' ILE . 22.2 ttt -70.4 127.1 92.4 Favored Pre-proline 0 C--N 1.297 -1.696 0 C-N-CA 124.408 1.083 . . . . 74.23 112.706 -177.795 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.91 169.66 22.11 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.148 2.565 . . . . 64.32 111.032 172.894 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -90.87 126.95 36.19 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 110.089 -0.337 . . . . 70.01 110.089 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 566' ' ' LEU . . . . . 0.467 ' O ' ' HG2' ' A' ' 569' ' ' MET . 1.7 tm? -104.84 -16.38 14.91 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.836 0.827 . . . . 74.45 109.031 -175.59 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 24.0 m -72.41 143.26 48.58 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.939 -0.573 . . . . 72.32 110.596 -178.19 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 101.18 4.76 53.53 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.628 -0.796 . . . . 62.52 113.912 178.199 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 569' ' ' MET . . . . . 0.532 ' SD ' ' HA ' ' A' ' 574' ' ' ALA . 23.5 ptp -123.0 166.88 14.36 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 117.526 0.663 . . . . 74.04 109.947 179.101 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -101.54 166.32 10.78 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.692 -1.595 . . . . 63.1 106.692 -178.591 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 13.7 t-105 -62.58 -30.13 71.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 118.572 0.624 . . . . 52.51 109.679 179.737 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.2 m -71.5 -21.95 21.79 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 CA-C-N 115.923 -0.58 . . . . 74.42 111.632 -179.253 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -101.31 -27.39 13.2 Favored 'General case' 0 C--O 1.256 1.405 0 N-CA-C 109.04 -0.726 . . . . 74.33 109.04 -178.594 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 574' ' ' ALA . . . . . 0.64 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -63.52 -54.23 39.47 Favored 'General case' 0 C--O 1.207 -1.132 0 CA-C-N 114.419 -1.264 . . . . 34.11 112.284 -178.38 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -53.02 -52.19 67.73 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 114.181 1.178 . . . . 74.53 114.181 -176.442 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -54.73 -39.7 88.1 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 121.454 1.436 . . . . 61.41 112.218 174.234 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -69.12 -34.55 75.23 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.63 0.604 . . . . 74.32 112.63 176.577 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 47.8 mt -65.88 -48.37 71.74 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.596 0.712 . . . . 74.13 109.21 -177.74 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -34.62 78.29 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.197 -0.911 . . . . 63.11 111.64 178.277 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.39 -32.12 69.64 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.373 -0.376 . . . . 71.44 111.287 -177.987 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.4 pp -85.71 -8.74 57.99 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.499 0.666 . . . . 75.21 109.622 179.242 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 77.13 44.79 12.75 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.126 -0.943 . . . . 53.4 112.5 178.367 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -74.03 127.64 33.45 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.378 0.609 . . . . 71.54 109.688 179.218 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 2.8 p -85.06 -40.12 17.2 Favored 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 124.859 1.264 . . . . 63.21 112.928 -177.26 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -80.47 -161.05 24.09 Favored Glycine 0 C--O 1.242 0.656 0 N-CA-C 115.571 0.988 . . . . 72.24 115.571 -174.368 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 54.5 mtt -119.86 154.01 34.96 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 123.624 0.769 . . . . 74.13 109.28 -176.386 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 6.8 tt -83.48 123.44 29.71 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.339 0.59 . . . . 74.05 109.689 -178.453 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 588' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 621' ' ' THR . 36.6 t70 -113.7 114.29 26.17 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.898 -1.046 . . . . 74.31 108.568 -179.801 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 589' ' ' LYS . . . . . 0.475 ' HD2' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -99.8 133.56 43.97 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.381 -0.927 . . . . 73.22 109.851 -179.059 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -86.81 -46.05 5.25 Favored Glycine 0 C--N 1.285 -2.302 0 CA-C-N 115.616 -0.72 . . . . 35.21 111.543 -177.461 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.67 135.01 32.78 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 110.119 -0.326 . . . . 71.43 110.119 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -116.73 127.45 54.4 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.242 -1.022 . . . . 74.33 108.242 174.246 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 99.4 t -111.28 116.83 53.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 116.452 -0.34 . . . . 73.33 110.262 -177.96 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 594' ' ' ASP . . . . . 0.593 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 27.6 t70 -73.77 116.77 14.76 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-O 120.82 0.343 . . . . 54.42 111.268 -177.338 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -139.77 -42.63 0.44 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.819 -0.628 . . . . 72.23 109.727 178.065 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 123.16 140.1 5.6 Favored Glycine 0 N--CA 1.426 -1.992 0 C-N-CA 120.731 -0.747 . . . . 43.14 111.842 178.827 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.75 -32.18 61.56 Favored Glycine 0 C--N 1.315 -0.636 0 CA-C-O 121.09 0.272 . . . . 72.43 112.552 179.593 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 4.7 p -64.02 -23.23 67.25 Favored 'General case' 0 N--CA 1.432 -1.349 0 C-N-CA 125.218 1.407 . . . . 64.44 111.563 -178.866 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -87.22 -0.53 56.85 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.199 -0.909 . . . . 71.31 109.9 -176.927 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 13.9 m170 65.26 65.39 0.58 Allowed 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 122.573 1.178 . . . . 72.13 110.954 -178.737 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -81.38 92.52 6.43 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 114.137 -1.392 . . . . 72.44 111.729 -179.057 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 41.3 mtm-85 -91.39 171.71 9.02 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 113.674 -1.603 . . . . 53.41 107.678 176.772 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 603' ' ' VAL . . . . . 0.48 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 86.9 t -67.67 130.26 32.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 105.497 -2.038 . . . . 75.12 105.497 169.263 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 59.4 t -101.15 -52.59 8.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 C-N-CA 120.501 -0.48 . . . . 44.44 110.813 -172.194 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -133.1 136.28 45.76 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.901 -0.59 . . . . 72.24 109.831 -177.88 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 606' ' ' GLN . . . . . 0.466 ' HB2' HD11 ' A' ' 620' ' ' ILE . 13.3 pt20 -112.29 140.13 47.26 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.441 -1.689 . . . . 71.02 106.441 175.429 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 607' ' ' ASN . . . . . 0.423 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 11.6 t30 -56.74 -53.7 61.93 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 113.418 0.895 . . . . 74.31 113.418 -175.74 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 608' ' ' PRO . . . . . 0.446 ' O ' ' HG3' ' A' ' 606' ' ' GLN . 7.2 Cg_endo -91.43 134.01 1.56 Allowed 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.434 1.422 . . . . 75.21 110.459 173.526 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.07 157.69 58.98 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 121.447 1.432 . . . . 44.22 111.306 178.188 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.88 138.52 58.36 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 108.892 -0.781 . . . . 42.02 108.892 177.811 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.6 -8.76 43.99 Favored Glycine 0 C--N 1.302 -1.339 0 C-N-CA 120.679 -0.772 . . . . 73.44 111.928 -176.155 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 54.3 m -77.04 146.83 37.11 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.892 -0.781 . . . . 73.21 108.892 176.629 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -81.1 114.63 3.86 Favored Glycine 0 N--CA 1.432 -1.632 0 N-CA-C 109.818 -1.313 . . . . 52.34 109.818 174.07 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 614' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 22.0 m -108.26 141.26 23.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 116.908 0.354 . . . . 63.34 110.592 178.945 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 615' ' ' ASN . . . . . 0.589 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 41.3 p30 -51.57 173.15 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.219 1.562 . . . . 72.53 115.219 -177.758 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -60.91 -25.21 66.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.059 -1.428 . . . . 70.01 112.289 178.161 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -85.63 -11.1 54.72 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.2 -1.037 . . . . 75.12 108.2 -178.036 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.46 15.12 63.31 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 115.44 -0.8 . . . . 63.43 112.639 168.178 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.72 125.55 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 122.056 0.932 . . . . 74.43 111.365 -167.885 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 620' ' ' ILE . . . . . 0.615 HG13 ' HE3' ' A' ' 563' ' ' MET . 0.0 OUTLIER -129.67 132.1 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.261 0 CA-C-N 114.193 -1.367 . . . . 72.42 109.466 -179.055 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 74.7 m -104.33 122.45 45.47 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.935 -1.135 . . . . 65.31 107.935 178.364 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 622' ' ' LEU . . . . . 0.423 HD13 ' H ' ' A' ' 622' ' ' LEU . 0.0 OUTLIER -132.99 166.93 21.25 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.25 -0.432 . . . . 73.05 111.714 -176.177 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -127.11 136.43 52.12 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.921 -1.14 . . . . 70.31 107.921 175.616 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.48 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 3.3 p90 -142.35 165.44 27.41 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.788 -0.642 . . . . 52.23 110.969 -173.672 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -80.66 150.54 31.34 Favored Glycine 0 N--CA 1.421 -2.35 0 N-CA-C 109.748 -1.341 . . . . 53.03 109.748 175.449 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 626' ' ' GLN . . . . . 0.593 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 42.0 tt0 . . . . . 0 C--N 1.275 -2.657 0 CA-C-O 117.949 -1.024 . . . . 54.53 108.582 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.813 0 N-CA-C 109.386 -1.486 . . . . 43.05 109.386 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.28 141.73 43.87 Favored 'Trans proline' 0 C--O 1.247 0.953 0 CA-C-N 119.421 1.61 . . . . 73.15 110.128 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -105.7 6.33 31.82 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.352 -0.386 . . . . 75.34 111.382 -177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 21.8 p -134.84 147.96 50.04 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.231 -0.655 . . . . 73.23 109.231 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -148.26 143.94 27.31 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.844 -1.539 . . . . 73.33 106.844 -177.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.2 p-10 -88.93 137.88 31.92 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.028 -0.669 . . . . 70.14 109.414 178.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 497' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 498' ' ' PRO . 40.9 pt -89.63 134.39 32.49 Favored Pre-proline 0 C--N 1.297 -1.691 0 CA-C-N 116.147 -0.479 . . . . 62.32 111.94 -177.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 3.9 Cg_exo -84.71 156.45 11.94 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.543 2.162 . . . . 74.22 110.051 171.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -88.54 121.22 30.68 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-O 122.401 1.096 . . . . 70.12 109.055 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.403 ' CG2' ' HB1' ' A' ' 508' ' ' ALA . 5.6 m -109.62 61.11 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.655 0 CA-C-N 113.999 -1.455 . . . . 65.12 109.378 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -105.73 109.95 22.08 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 112.462 -2.154 . . . . 75.53 109.426 174.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 152.57 -29.44 0.85 Allowed Glycine 0 C--N 1.305 -1.193 0 C-N-CA 119.561 -1.304 . . . . 61.41 113.124 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.428 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.3 OUTLIER -107.81 -169.73 1.57 Allowed 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.856 -0.424 . . . . 70.12 109.856 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.413 ' HB ' HG23 ' A' ' 507' ' ' VAL . 9.7 m -70.57 155.46 40.7 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.409 -0.96 . . . . 72.12 108.409 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.443 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.1 p -60.95 -41.43 88.99 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.792 0 O-C-N 123.135 0.272 . . . . 63.21 110.915 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -59.85 -44.28 94.19 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 120.767 0.317 . . . . 73.22 110.534 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.413 HG23 ' HB ' ' A' ' 504' ' ' THR . 46.3 t -69.18 -38.63 78.21 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.137 0 CA-C-N 115.529 -0.76 . . . . 63.43 109.548 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.452 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -63.68 -45.6 89.35 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.252 -0.431 . . . . 60.22 110.957 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.7 mt-30 -64.93 -41.34 95.61 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.935 -0.575 . . . . 73.02 110.552 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.504 ' O ' HG23 ' A' ' 514' ' ' VAL . 47.8 mmtm -66.11 -42.28 89.45 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 116.097 -0.501 . . . . 73.24 110.459 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -62.51 -44.89 95.25 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 116.289 -0.414 . . . . 75.54 111.493 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 513' ' ' ASN . 3.9 pp -68.14 -35.24 77.77 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-O 121.132 0.492 . . . . 74.02 110.829 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.46 ' N ' HD12 ' A' ' 512' ' ' LEU . 52.3 t30 -59.8 -35.7 75.22 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 123.894 0.878 . . . . 72.52 109.938 176.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 510' ' ' LYS . 89.5 t -64.63 -33.65 64.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-O 121.251 0.548 . . . . 74.51 110.929 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -97.71 -0.78 44.85 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.463 -0.335 . . . . 70.14 110.451 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -134.96 -57.09 0.06 OUTLIER Glycine 0 CA--C 1.484 -1.868 0 C-N-CA 119.619 -1.277 . . . . 64.01 114.841 -169.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 69.24 20.56 7.45 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 122.143 0.973 . . . . 74.53 109.3 -171.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.5 p -79.37 -172.02 3.01 Favored 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 125.973 1.709 . . . . 52.1 110.65 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.0 142.09 38.66 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.758 -1.201 . . . . 75.25 107.758 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -133.14 147.9 52.1 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.142 0.496 . . . . 72.21 111.846 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 55.6 m -140.91 151.78 44.52 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.193 -1.04 . . . . 54.13 108.193 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -121.1 145.34 47.9 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 120.96 0.41 . . . . 74.43 111.683 -174.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -138.6 132.82 31.63 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.687 -0.857 . . . . 41.02 108.687 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.525 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 11.1 p -96.32 126.74 41.74 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 113.421 0.897 . . . . 74.14 113.421 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.1 p -121.18 150.85 24.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.076 -1.083 . . . . 64.14 108.076 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.98 136.14 45.09 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.493 -0.558 . . . . 75.31 109.493 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.544 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 39.4 m -159.51 168.14 12.8 Favored Pre-proline 0 C--N 1.301 -1.505 0 N-CA-C 108.117 -1.068 . . . . 64.32 108.117 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -71.75 -14.27 29.9 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.019 1.813 . . . . 64.14 111.853 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.12 140.81 95.96 Favored Pre-proline 0 C--O 1.219 -0.549 0 N-CA-C 109.297 -0.631 . . . . 73.22 109.297 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.41 146.86 86.49 Favored 'Trans proline' 0 C--O 1.252 1.213 0 C-N-CA 121.935 1.756 . . . . 44.23 111.236 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.16 113.57 1.78 Allowed 'General case' 0 C--O 1.242 0.678 0 CA-C-N 116.002 -0.544 . . . . 53.24 111.644 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 132.37 -22.9 4.12 Favored Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 115.4 -0.818 . . . . 53.24 111.551 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.01 139.49 33.25 Favored 'General case' 0 CA--C 1.493 -1.222 0 CA-C-O 121.018 0.437 . . . . 74.35 110.04 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.505 HG22 ' H ' ' A' ' 536' ' ' GLY . 7.4 p -102.96 124.86 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.817 0 CA-C-O 121.884 0.849 . . . . 73.21 109.667 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.63 -4.93 59.24 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.697 -1.138 . . . . 65.44 112.635 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.505 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 141.53 -162.68 26.93 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 119.772 -1.204 . . . . 62.14 113.488 173.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 13.2 p -116.45 159.19 22.39 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 107.651 -1.24 . . . . 70.24 107.651 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -60.02 -53.59 63.69 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 119.103 -1.039 . . . . 71.05 112.36 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -82.21 140.73 11.19 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 121.266 1.311 . . . . 43.0 110.521 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.6 162.95 40.59 Favored 'Trans proline' 0 C--O 1.251 1.137 0 C-N-CA 122.999 2.466 . . . . 62.35 113.613 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.71 129.7 43.18 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.639 -0.71 . . . . 52.34 110.461 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.83 -5.44 34.66 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.778 -0.646 . . . . 74.42 111.536 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 99.7 m -77.1 121.02 22.99 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 122.64 -0.33 . . . . 73.14 110.238 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 4.0 t -80.3 124.1 28.55 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.887 -0.783 . . . . 74.11 108.887 176.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 32.6 m -126.45 160.07 59.91 Favored Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 107.658 -1.238 . . . . 64.31 107.658 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -63.97 138.62 63.56 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 120.942 1.095 . . . . 73.11 109.512 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.1 p -60.7 -19.86 20.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.518 0.675 . . . . 75.34 111.475 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -100.02 3.41 44.18 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.148 0.499 . . . . 62.15 110.694 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 97.4 p -83.88 171.78 12.74 Favored 'General case' 0 C--O 1.251 1.133 0 O-C-N 121.404 -0.81 . . . . 45.01 111.525 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.2 p -103.83 134.43 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 CA-C-N 115.268 -0.878 . . . . 64.22 110.394 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 55.8 mt -103.37 136.26 36.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.106 -1.072 . . . . 72.44 108.106 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.52 118.58 37.06 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.985 0.898 . . . . 63.13 111.52 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.6 118.89 32.41 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.839 -1.528 . . . . 43.02 109.786 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -86.28 102.54 14.06 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.813 0.816 . . . . 54.15 110.383 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 524' ' ' SER . 23.3 t -85.63 128.17 39.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 114.304 -1.316 . . . . 60.23 107.523 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' ' 527' ' ' SER . 62.7 m -88.63 125.65 34.92 Favored 'General case' 0 N--CA 1.394 -3.25 0 CA-C-O 121.173 0.511 . . . . 60.45 110.823 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -101.64 134.21 45.13 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 107.275 -1.38 . . . . 61.45 107.275 173.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -63.29 -22.3 65.2 Favored Glycine 0 CA--C 1.493 -1.312 0 O-C-N 124.049 0.843 . . . . 75.43 112.365 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 79.55 2.88 2.21 Favored 'General case' 0 C--O 1.215 -0.725 0 C-N-CA 125.022 1.329 . . . . 73.41 108.674 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.403 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 90.6 mt-30 -113.09 150.23 32.37 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 114.998 -1.001 . . . . 73.34 112.363 -171.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -128.0 155.91 43.55 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.81 -1.181 . . . . 71.34 107.81 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 6.4 p -71.22 118.51 16.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 109.512 -0.551 . . . . 72.51 109.512 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 52.5 ttp -76.1 129.87 79.47 Favored Pre-proline 0 C--N 1.306 -1.322 0 C-N-CA 119.925 -0.71 . . . . 54.54 110.459 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.98 166.38 23.03 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.659 2.24 . . . . 51.1 111.27 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 565' ' ' ASP . . . . . 0.419 ' HA ' ' CB ' ' A' ' 610' ' ' ALA . 2.2 p-10 -81.03 131.85 35.33 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-O 121.368 0.604 . . . . 72.14 111.102 -175.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.2 pp -159.82 20.3 0.17 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.58 -1.191 . . . . 65.14 110.196 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 8.3 t -79.88 147.51 31.68 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 109.11 -0.7 . . . . 74.5 109.11 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 74.84 69.16 1.43 Allowed Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 120.922 -0.656 . . . . 75.21 112.068 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -147.97 174.05 12.27 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.143 -1.058 . . . . 73.1 108.143 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -98.77 169.42 9.48 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.786 -1.561 . . . . 61.33 106.786 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -67.88 -31.67 71.63 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.94 -0.763 . . . . 73.25 108.94 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 30.3 m -78.16 -13.9 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-N 115.907 -0.588 . . . . 65.23 110.929 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 37.2 t70 -95.29 -34.19 12.27 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.402 -1.333 . . . . 71.32 107.402 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 574' ' ' ALA . . . . . 0.725 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -57.76 -53.55 56.91 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.529 -1.214 . . . . 72.3 111.856 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 38.0 mt-10 -51.23 -54.56 36.97 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 113.871 1.063 . . . . 72.0 113.871 -175.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -57.53 -38.3 94.36 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 121.515 1.477 . . . . 64.5 112.225 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 24.2 mmm-85 -65.08 -38.66 91.49 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.342 0.115 . . . . 65.24 110.967 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 25.7 mt -66.69 -47.93 70.86 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.947 -0.39 . . . . 44.1 109.947 -176.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 2.3 ptp180 -66.56 -34.93 78.99 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 112.558 0.577 . . . . 74.32 112.558 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.82 -34.27 77.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.249 0.547 . . . . 63.43 110.272 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 12.5 tp -82.05 -9.76 59.44 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.635 -0.711 . . . . 73.15 110.339 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 64.11 41.02 98.61 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.892 -0.594 . . . . 62.41 112.382 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.469 ' CE3' HD22 ' A' ' 578' ' ' LEU . 18.2 t90 -78.55 127.24 31.87 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.919 0.39 . . . . 75.44 110.686 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 35.9 p -96.19 -22.2 17.42 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 112.988 0.736 . . . . 73.3 112.988 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 585' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -77.85 -173.09 40.16 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.353 -0.451 . . . . 55.15 113.995 -176.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 22.5 ttt -104.69 141.59 36.19 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 122.771 0.428 . . . . 42.3 110.871 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 33.9 tp -86.86 110.13 19.76 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.619 -0.882 . . . . 62.43 108.619 176.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.543 ' O ' ' HA ' ' A' ' 621' ' ' THR . 22.4 t70 -95.86 104.62 16.56 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.967 0.889 . . . . 62.11 110.26 -175.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -87.66 123.35 32.41 Favored 'General case' 0 N--CA 1.396 -3.171 0 CA-C-N 114.645 -1.161 . . . . 72.2 109.462 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -84.88 -100.04 0.66 Allowed Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.757 -0.937 . . . . 64.12 110.757 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -107.78 154.94 20.8 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 109.851 -0.426 . . . . 45.24 109.851 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 592' ' ' ASP . . . . . 0.422 ' OD1' ' HB3' ' A' ' 626' ' ' GLN . 3.0 p30 -106.53 145.69 31.55 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.469 -0.937 . . . . 61.21 108.469 174.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 57.4 t -104.5 138.71 28.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.033 -0.729 . . . . 70.42 109.033 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 594' ' ' ASP . . . . . 0.448 ' HA ' ' CD ' ' A' ' 626' ' ' GLN . 3.8 p30 -73.06 124.72 26.07 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 121.388 0.613 . . . . 55.35 110.045 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -159.64 -62.07 0.07 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.724 -1.125 . . . . 34.13 108.493 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 105.77 153.24 20.92 Favored Glycine 0 N--CA 1.422 -2.264 0 C-N-CA 119.659 -1.258 . . . . 65.51 111.787 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.34 -32.2 60.36 Favored Glycine 0 C--N 1.311 -0.851 0 C-N-CA 123.511 0.577 . . . . 52.42 113.643 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 4.9 p -72.67 -25.04 61.12 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-O 121.965 0.888 . . . . 62.13 110.383 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -95.09 -0.91 53.07 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.937 -1.029 . . . . 65.4 109.495 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 39.8 m80 74.06 99.51 0.07 Allowed 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 125.051 1.34 . . . . 72.14 112.148 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -80.3 83.32 6.17 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.382 -0.827 . . . . 71.21 110.99 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -108.17 160.31 15.92 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.282 -0.872 . . . . 73.24 109.728 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 71.2 t -64.83 130.2 29.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.084 -1.45 . . . . 52.21 107.084 171.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 43.5 t -108.61 -40.33 4.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 121.524 0.678 . . . . 70.3 110.108 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -142.9 142.07 31.65 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.793 -0.817 . . . . 73.24 108.793 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -137.56 143.56 41.63 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.906 -1.516 . . . . 72.04 106.906 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.431 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 24.6 t-20 -65.84 -53.11 37.33 Favored Pre-proline 0 C--N 1.308 -1.218 0 C-N-CA 119.235 -0.986 . . . . 61.23 112.132 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.8 Cg_endo -90.64 107.93 0.33 Allowed 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.09 1.86 . . . . 73.13 110.351 173.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -71.13 160.37 49.34 Favored 'Trans proline' 0 C--O 1.246 0.896 0 C-N-CA 123.258 2.638 . . . . 72.1 113.411 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 610' ' ' ALA . . . . . 0.419 ' CB ' ' HA ' ' A' ' 565' ' ' ASP . . . -67.85 138.54 56.17 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.351 -0.981 . . . . 64.13 108.351 175.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 96.69 -8.95 66.27 Favored Glycine 0 C--N 1.297 -1.6 0 C-N-CA 120.27 -0.967 . . . . 72.5 110.904 -175.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 24.2 m -101.88 153.17 20.09 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 108.06 -1.089 . . . . 65.34 108.06 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -74.77 127.16 9.38 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 121.242 -0.504 . . . . 71.51 112.151 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 30.9 m -119.98 142.6 34.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.898 -1.149 . . . . 74.21 107.898 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.403 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 33.9 p-10 -51.7 169.14 0.07 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.708 0.803 . . . . 75.21 112.736 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -60.29 -26.17 66.3 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 120.859 0.361 . . . . 64.33 111.699 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.433 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 5.4 m-20 -83.31 -7.82 59.53 Favored 'General case' 0 C--O 1.204 -1.324 0 CA-C-N 116.069 -0.514 . . . . 70.31 110.398 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.18 19.34 68.1 Favored Glycine 0 C--O 1.22 -0.776 0 O-C-N 123.285 0.366 . . . . 71.01 112.996 171.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.79 119.4 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-O 121.913 0.863 . . . . 54.04 111.217 -167.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 48.3 pt -126.21 133.92 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 115.096 -0.957 . . . . 71.22 110.522 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 14.9 t -105.8 128.73 53.91 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.924 -1.139 . . . . 41.0 107.924 177.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.5 pp -139.24 166.69 23.87 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 114.16 1.17 . . . . 72.51 114.16 -173.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -127.68 137.04 52.37 Favored 'General case' 0 C--O 1.256 1.411 0 N-CA-C 108.173 -1.047 . . . . 75.33 108.173 175.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -142.3 166.89 23.45 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.859 -0.61 . . . . 72.43 109.617 -174.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -60.94 145.79 47.96 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 121.102 -0.571 . . . . 75.24 112.296 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.448 ' CD ' ' HA ' ' A' ' 594' ' ' ASP . 3.3 pt20 . . . . . 0 C--O 1.251 1.179 0 N-CA-C 113.885 1.068 . . . . 72.15 113.885 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.527 0 N-CA-C 110.395 -1.082 . . . . 43.05 110.395 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.65 154.47 71.36 Favored 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 122.53 2.153 . . . . 63.21 111.48 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -105.35 -25.55 12.35 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.813 0.816 . . . . 51.22 110.838 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 15.0 p -136.55 155.06 50.47 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 114.981 -1.008 . . . . 62.32 110.317 -176.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.57 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 4.6 tmtt? -150.49 139.66 21.18 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.884 -0.784 . . . . 74.33 108.884 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.57 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 8.3 p-10 -78.18 129.75 35.51 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 123.633 0.773 . . . . 64.43 109.58 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.5 pt -99.03 131.65 25.0 Favored Pre-proline 0 C--N 1.304 -1.374 0 C-N-CA 120.45 -0.5 . . . . 71.33 111.689 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.08 158.54 34.0 Favored 'Trans proline' 0 C--O 1.243 0.742 0 C-N-CA 122.78 2.32 . . . . 53.33 112.167 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.53 ' HA ' ' HB1' ' A' ' 541' ' ' ALA . 5.1 p-10 -82.23 112.7 19.48 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.95 0.881 . . . . 72.12 108.979 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 31.7 m -117.41 0.95 8.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 112.973 0.731 . . . . 65.42 112.973 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -69.63 100.98 1.55 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.298 0.57 . . . . 63.4 109.917 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 138.8 -13.5 3.39 Favored Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 110.717 -0.953 . . . . 61.22 110.717 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 508' ' ' ALA . 31.7 mm-40 -82.2 -178.25 6.95 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 108.692 -0.855 . . . . 71.35 108.692 175.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.7 m -78.6 156.15 29.27 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 104.293 -2.484 . . . . 62.25 104.293 169.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.473 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 8.4 p -60.13 -42.4 89.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 119.557 1.071 . . . . 75.54 112.224 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 506' ' ' ASP . . . . . 0.418 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 17.3 t70 -64.68 -43.43 93.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.945 0.402 . . . . 63.41 110.455 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 62.9 t -67.82 -39.11 81.31 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.252 0 CA-C-N 115.628 -0.714 . . . . 71.24 109.803 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 503' ' ' GLN . . . -62.4 -45.14 94.5 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.951 -0.389 . . . . 74.55 109.951 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 98.0 mt-30 -62.05 -46.68 88.06 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.759 -0.655 . . . . 71.24 111.353 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.567 ' O ' HG23 ' A' ' 514' ' ' VAL 0.359 0.0 OUTLIER -67.37 -38.15 84.32 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 112.48 0.548 . . . . 62.1 112.48 177.333 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -60.71 -50.04 75.07 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.602 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 513' ' ' ASN . 3.8 pp -68.49 -36.06 78.4 Favored 'General case' 0 C--O 1.208 -1.098 0 C-N-CA 120.156 -0.618 . . . . 72.43 111.598 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.487 ' N ' HD12 ' A' ' 512' ' ' LEU . 3.4 t-20 -69.79 -35.19 74.66 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 112.558 0.577 . . . . 73.43 112.558 -175.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 510' ' ' LYS . 72.2 t -57.33 -31.1 37.24 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 CA-C-O 121.438 0.637 . . . . 71.12 110.121 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -120.22 29.17 7.63 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.771 -0.649 . . . . 74.2 109.591 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -145.84 -56.79 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.423 0 C-N-CA 120.058 -1.068 . . . . 53.11 112.181 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 62.89 33.78 14.79 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.521 1.153 . . . . 73.34 111.151 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 547' ' ' VAL . 3.1 p -88.52 -171.43 3.33 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-N 113.83 -1.532 . . . . 53.53 109.047 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -111.77 142.49 44.06 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.891 -1.522 . . . . 74.11 106.891 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -132.47 148.81 52.4 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 113.201 0.815 . . . . 75.34 113.201 -174.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 51.0 m -133.06 157.66 44.7 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 106.713 -1.588 . . . . 61.22 106.713 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -125.97 126.89 45.07 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 109.693 -0.484 . . . . 63.41 109.693 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 523' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -124.16 143.27 50.59 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.45 -1.315 . . . . 64.54 107.45 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 65.8 p -102.8 139.94 37.72 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.094 -1.043 . . . . 72.43 112.426 -175.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 12.1 p -131.15 151.52 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 N-CA-C 107.768 -1.197 . . . . 75.33 107.768 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -87.34 137.2 32.55 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 121.3 0.571 . . . . 72.34 110.94 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.4 m -160.08 157.51 25.25 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 106.802 -1.555 . . . . 63.53 106.802 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -64.56 2.07 1.42 Allowed 'Trans proline' 0 CA--C 1.555 1.549 0 C-N-CA 122.653 2.235 . . . . 71.3 114.076 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -96.1 144.17 27.37 Favored Pre-proline 0 N--CA 1.433 -1.319 0 N-CA-C 109.523 -0.547 . . . . 60.23 109.523 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.03 146.59 97.53 Favored 'Trans proline' 0 C--O 1.249 1.07 0 C-N-CA 123.418 2.745 . . . . 74.34 114.618 -173.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.66 113.64 2.12 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.663 -1.153 . . . . 74.25 111.064 178.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 139.91 -23.53 2.76 Favored Glycine 0 C--N 1.301 -1.368 0 N-CA-C 111.083 -0.807 . . . . 62.11 111.083 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -79.33 144.91 33.79 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.81 -0.811 . . . . 73.42 108.81 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.449 HG11 ' HB2' ' A' ' 508' ' ' ALA . 7.7 p -94.35 114.99 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 N-CA-C 108.288 -1.004 . . . . 71.35 108.288 173.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.2 -31.3 72.44 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.18 -1.373 . . . . 63.24 109.433 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 152.78 -168.34 31.71 Favored Glycine 0 N--CA 1.407 -3.244 0 N-CA-C 109.728 -1.349 . . . . 74.23 109.728 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 537' ' ' THR . . . . . 0.511 HG22 ' HG ' ' A' ' 553' ' ' LEU . 3.6 p -116.62 153.53 32.11 Favored 'General case' 0 C--N 1.268 -2.943 0 N-CA-C 107.807 -1.183 . . . . 52.44 107.807 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.455 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 54.0 t30 -67.41 -48.0 46.74 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 118.382 -1.327 . . . . 64.24 110.706 176.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.495 ' HD3' ' OE1' ' A' ' 552' ' ' GLU . 20.7 Cg_exo -71.9 129.66 15.67 Favored 'Trans proline' 0 C--N 1.374 1.882 0 N-CA-C 108.398 -1.424 . . . . 73.24 108.398 168.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.73 139.99 93.1 Favored 'Trans proline' 0 C--O 1.245 0.87 0 C-N-CA 122.955 2.437 . . . . 74.0 115.335 -174.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 541' ' ' ALA . . . . . 0.53 ' HB1' ' HA ' ' A' ' 499' ' ' ASP . . . -68.27 135.85 52.58 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.297 -1.32 . . . . 74.43 110.236 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 93.54 -16.58 60.38 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 111.455 -0.658 . . . . 54.52 111.455 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 63.1 m -88.67 139.16 30.75 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 124.151 0.98 . . . . 52.01 110.821 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.1 t -73.88 128.09 34.58 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 121.529 0.68 . . . . 75.44 109.21 175.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.72 164.98 27.65 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 107.13 -1.433 . . . . 64.42 107.13 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -67.25 136.07 39.11 Favored 'Trans proline' 0 N--CA 1.442 -1.543 0 CA-C-N 120.564 1.237 . . . . 73.2 110.437 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.444 ' HA ' HG22 ' A' ' 518' ' ' THR . 9.2 p -67.49 -22.11 28.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 122.037 0.923 . . . . 45.21 109.639 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -84.26 -12.68 54.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.141 -1.391 . . . . 61.44 110.992 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 11.4 t -93.14 153.12 18.84 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-O 121.555 0.693 . . . . 70.42 110.246 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 13.2 p -94.89 134.78 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.07 0 CA-C-N 114.865 -1.061 . . . . 72.22 108.583 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 62.1 mt -102.63 135.73 38.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.553 -0.748 . . . . 71.23 109.12 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 552' ' ' GLU . . . . . 0.495 ' OE1' ' HD3' ' A' ' 539' ' ' PRO . 2.1 pm0 -102.93 121.61 42.87 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-O 121.764 0.793 . . . . 64.44 110.551 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.511 ' HG ' HG22 ' A' ' 537' ' ' THR . 7.0 mp -98.66 122.19 41.56 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.208 -1.36 . . . . 74.44 108.369 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.549 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 2.7 mp0 -88.09 127.09 35.41 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.844 -0.616 . . . . 75.4 110.971 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 25.2 t -95.21 125.94 47.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.057 -0.974 . . . . 73.35 108.437 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.716 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 5.5 m -77.63 119.38 21.09 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.106 -1.072 . . . . 62.31 108.106 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -108.72 134.73 51.04 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 107.468 -1.308 . . . . 74.45 107.468 169.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -59.18 -23.49 57.54 Favored Glycine 0 CA--C 1.509 -0.297 0 O-C-N 124.035 0.834 . . . . 25.33 112.181 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 76.52 7.88 3.29 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.977 1.711 . . . . 74.44 108.181 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 89.0 mt-30 -126.77 146.16 50.34 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 114.889 -1.051 . . . . 72.04 110.649 -176.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 561' ' ' PHE . . . . . 0.447 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 53.8 p90 -124.01 152.83 42.14 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.332 -0.988 . . . . 74.43 108.332 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.47 124.4 13.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.401 0.62 . . . . 73.11 111.981 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 47.9 ttp -92.89 134.83 26.85 Favored Pre-proline 0 C--O 1.256 1.41 0 CA-C-N 115.697 -0.683 . . . . 74.13 110.057 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.73 169.07 16.82 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.884 2.389 . . . . 62.32 111.075 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.79 115.03 26.04 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.42 -0.955 . . . . 72.34 108.42 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 566' ' ' LEU . . . . . 0.419 ' O ' ' HG2' ' A' ' 569' ' ' MET . 91.5 mt -107.0 -0.21 23.21 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.722 0.772 . . . . 72.54 110.384 -176.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 20.6 t -79.52 153.47 29.53 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.502 -0.772 . . . . 75.33 109.317 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 568' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' A' ' 602' ' ' ARG . . . 82.62 25.26 51.03 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 120.22 -0.99 . . . . 71.14 114.031 177.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 569' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 23.2 ptp -140.69 176.77 8.52 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.305 -0.998 . . . . 72.02 108.305 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -98.34 169.12 9.79 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.656 -0.868 . . . . 50.45 108.656 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -64.18 -27.62 69.19 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.579 0.704 . . . . 71.32 109.355 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.5 p -72.95 -17.32 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 CA-C-N 115.46 -0.791 . . . . 72.15 110.74 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.489 ' O ' ' HD2' ' A' ' 576' ' ' PRO . 16.5 m-20 -91.17 -38.92 12.42 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 107.97 -1.122 . . . . 74.55 107.97 175.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 574' ' ' ALA . . . . . 0.678 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -56.79 -52.97 62.97 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.229 -1.351 . . . . 75.44 112.068 -178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.493 ' HB2' ' HD3' ' A' ' 576' ' ' PRO . 47.2 mt-10 -51.08 -54.02 42.26 Favored Pre-proline 0 CA--C 1.559 1.304 0 N-CA-C 113.782 1.031 . . . . 72.03 113.782 -176.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.493 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 35.9 Cg_exo -61.15 -36.32 81.58 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 121.557 1.505 . . . . 74.24 112.137 177.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.457 ' NE ' ' HA ' ' A' ' 577' ' ' ARG . 3.3 mmp_? -62.84 -40.17 96.63 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.743 0.275 . . . . 71.24 111.743 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 25.0 mt -65.4 -48.92 71.2 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.333 0.587 . . . . 73.12 110.327 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -66.7 -36.84 83.45 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.704 -0.68 . . . . 62.54 112.455 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.12 -34.26 72.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.78 0.324 . . . . 43.22 111.258 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' A' ' 583' ' ' TRP . 1.5 pp -81.51 -6.22 58.75 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.396 0.617 . . . . 72.51 109.916 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.54 44.14 27.75 Favored Glycine 0 CA--C 1.498 -0.978 0 CA-C-N 115.585 -0.734 . . . . 74.43 111.988 177.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.464 ' CE3' HD22 ' A' ' 578' ' ' LEU . 15.3 t90 -87.35 127.04 35.2 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 109.32 -0.622 . . . . 71.45 109.32 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 17.2 p -101.27 -21.13 14.97 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.167 -0.469 . . . . 71.45 111.94 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -73.98 -175.12 31.74 Favored Glycine 0 C--O 1.242 0.628 0 CA-C-N 116.535 -0.302 . . . . 75.23 113.459 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 53.1 mtt -106.03 144.15 33.16 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.835 -0.182 . . . . 73.44 111.016 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 37.5 tp -89.64 108.02 19.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.473 0.654 . . . . 75.32 109.413 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' A' ' 621' ' ' THR . 28.4 t70 -97.73 117.1 31.28 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.139 -0.937 . . . . 75.44 110.351 -176.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.98 133.55 44.2 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 119.042 -1.063 . . . . 75.44 108.987 174.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -80.42 -54.39 3.77 Favored Glycine 0 C--N 1.299 -1.527 0 N-CA-C 111.267 -0.733 . . . . 50.21 111.267 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.04 146.9 39.6 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.644 -0.502 . . . . 60.32 109.644 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -113.31 131.83 55.8 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.694 -1.595 . . . . 61.51 106.694 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 46.2 t -105.0 115.59 47.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 C-N-CA 119.891 -0.724 . . . . 73.2 109.107 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 594' ' ' ASP . . . . . 0.494 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 24.3 t70 -78.0 126.63 31.11 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 112.756 0.65 . . . . 72.11 112.756 -175.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 595' ' ' ALA . . . . . 0.445 ' HB3' ' ND2' ' A' ' 601' ' ' ASN . . . -158.2 -30.62 0.08 Allowed 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.811 0.694 . . . . 53.41 111.153 174.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 108.66 144.08 10.72 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 119.45 -1.357 . . . . 24.2 112.959 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -60.67 -32.79 79.85 Favored Glycine 0 C--N 1.317 -0.506 0 C-N-CA 123.014 0.34 . . . . 52.33 113.267 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 31.3 t -62.18 -23.93 66.89 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.862 0.839 . . . . 71.22 110.326 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -86.78 -0.62 56.71 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.675 -1.148 . . . . 71.43 110.773 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 52.0 m80 66.19 38.7 4.52 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 122.137 0.97 . . . . 74.31 109.473 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 601' ' ' ASN . . . . . 0.445 ' ND2' ' HB3' ' A' ' 595' ' ' ALA . 15.4 t30 -74.72 89.63 2.28 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.701 -1.59 . . . . 60.42 108.629 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.407 ' HD3' ' HA2' ' A' ' 568' ' ' GLY . 16.6 ptp180 -97.52 171.65 8.23 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.763 -1.562 . . . . 74.45 110.896 -175.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 569' ' ' MET . 83.7 t -58.52 130.73 22.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.244 -1.021 . . . . 70.33 108.244 174.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 27.7 m -106.26 -30.44 2.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 120.535 -0.466 . . . . 73.42 111.901 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -149.43 135.98 19.33 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 120.258 -0.577 . . . . 74.43 110.717 -176.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -120.88 143.12 49.09 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.491 -1.67 . . . . 70.34 106.491 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.493 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 19.9 t-20 -52.61 -58.17 12.94 Favored Pre-proline 0 N--CA 1.487 1.387 0 N-CA-C 113.95 1.093 . . . . 70.43 113.95 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.1 Cg_endo -91.04 135.25 1.84 Allowed 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 121.476 1.451 . . . . 65.35 110.739 177.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -67.08 160.04 49.25 Favored 'Trans proline' 0 C--O 1.249 1.057 0 C-N-CA 121.518 1.479 . . . . 63.04 110.856 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.17 127.17 30.22 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 110.257 -0.275 . . . . 74.04 110.257 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 104.71 -5.21 43.28 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.317 -0.944 . . . . 73.31 112.251 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 73.9 m -90.63 147.35 23.36 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.861 -0.792 . . . . 61.45 108.861 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 613' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -78.72 137.89 20.12 Favored Glycine 0 N--CA 1.425 -2.043 0 C-N-CA 121.529 -0.367 . . . . 43.34 113.234 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.3 m -117.99 142.76 30.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.744 -0.836 . . . . 53.11 108.744 175.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -49.85 170.8 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.433 1.093 . . . . 51.03 113.608 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -58.9 -26.99 64.81 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.999 -0.546 . . . . 65.34 111.946 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -84.75 -7.28 59.27 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 121.22 0.533 . . . . 75.34 110.264 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.6 18.93 68.56 Favored Glycine 0 C--O 1.219 -0.838 0 CA-C-N 115.928 -0.578 . . . . 61.33 113.967 172.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.49 119.93 17.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 122.555 1.169 . . . . 71.33 112.121 -167.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.11 130.78 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 114.212 -1.358 . . . . 60.14 109.46 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.605 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 13.0 t -104.66 137.06 43.05 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.031 -1.1 . . . . 73.43 108.031 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -138.63 167.51 21.81 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.354 0.597 . . . . 73.52 112.338 -173.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -127.03 134.63 50.27 Favored 'General case' 0 C--O 1.251 1.138 0 N-CA-C 104.806 -2.294 . . . . 74.13 104.806 174.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.407 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 29.3 p90 -142.94 165.33 27.65 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.627 -0.829 . . . . 75.4 112.221 -174.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -79.74 126.64 7.55 Favored Glycine 1 N--CA 1.388 -4.552 0 C-N-CA 120.65 -0.786 . . . . 21.41 111.609 173.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.494 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 58.3 tt0 . . . . . 0 C--O 1.271 2.204 0 C-N-CA 124.75 1.22 . . . . 72.43 107.812 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.022 0 N-CA-C 110.405 -1.078 . . . . 43.05 110.405 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.87 144.97 79.02 Favored 'Trans proline' 0 CA--C 1.513 -0.558 0 C-N-CA 122.181 1.921 . . . . 72.44 111.583 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -104.9 -7.1 19.58 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.852 0.834 . . . . 62.23 110.288 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 40.9 p -138.23 149.89 46.19 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.42 -1.326 . . . . 74.42 107.42 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -141.64 145.03 34.49 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.728 -1.212 . . . . 73.12 107.728 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 17.2 m-20 -88.93 141.94 28.06 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.34 -0.615 . . . . 74.44 109.34 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.7 pt -101.76 123.83 42.64 Favored Pre-proline 0 C--N 1.3 -1.564 0 C-N-CA 120.609 -0.436 . . . . 73.32 110.288 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -84.58 172.39 9.18 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.383 2.055 . . . . 75.43 112.018 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -85.97 100.66 12.28 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 122.399 1.095 . . . . 73.34 109.998 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 31.4 m -89.38 1.73 7.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 114.401 -1.272 . . . . 74.34 111.261 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -64.52 100.74 0.39 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.564 -0.744 . . . . 61.23 110.079 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 158.2 -32.06 0.5 Allowed Glycine 0 C--N 1.302 -1.356 0 C-N-CA 120.797 -0.716 . . . . 61.41 111.583 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.461 ' O ' HG12 ' A' ' 534' ' ' VAL . 10.1 pm0 -102.62 -179.69 4.04 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 109.816 -0.438 . . . . 71.23 109.816 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 17.5 m -70.31 155.76 40.21 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.579 -1.267 . . . . 74.33 107.579 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.494 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 14.2 p -64.71 -40.38 88.86 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 N-CA-C 109.657 -0.497 . . . . 73.53 109.657 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 506' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 11.8 t70 -58.79 -39.86 82.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.422 -0.808 . . . . 70.31 109.842 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 86.0 t -74.93 -43.55 45.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.099 -0.955 . . . . 74.25 110.61 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -58.82 -43.29 90.57 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.472 0.177 . . . . 72.13 110.739 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.2 mt-30 -64.66 -46.44 82.48 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.043 -0.526 . . . . 73.44 110.915 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.594 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 2.7 ptpp? -67.36 -38.4 84.74 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 112.802 0.667 . . . . 75.43 112.802 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 56.1 m-20 -61.98 -48.07 81.97 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.238 0.542 . . . . 74.21 110.353 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.44 -36.92 84.0 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.203 -0.908 . . . . 64.31 108.849 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 45.9 t30 -59.4 -35.39 73.87 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 124.046 0.938 . . . . 74.33 110.534 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 510' ' ' LYS . 86.0 t -61.99 -33.14 56.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-O 121.286 0.565 . . . . 72.15 110.789 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -105.08 4.07 31.08 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.588 -0.523 . . . . 72.34 109.588 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -133.32 -60.96 0.08 OUTLIER Glycine 0 N--CA 1.426 -1.994 0 C-N-CA 119.987 -1.102 . . . . 72.2 114.425 -171.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 62.84 29.02 16.63 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.158 0.98 . . . . 71.23 109.102 -172.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 547' ' ' VAL . 17.2 p -85.62 -166.21 1.45 Allowed 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 126.019 1.728 . . . . 73.51 109.851 -177.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -108.55 137.68 46.11 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.312 -0.625 . . . . 65.4 109.312 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -132.2 147.37 52.41 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 116.017 -0.538 . . . . 64.04 110.203 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.1 m -140.26 145.91 37.92 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.342 -0.984 . . . . 73.12 108.342 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -117.97 135.22 54.28 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 121.371 0.605 . . . . 73.14 111.065 -175.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -123.02 126.81 47.83 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.235 -1.024 . . . . 52.43 108.235 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 22.2 m -88.14 125.87 34.83 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.297 0.57 . . . . 73.15 111.404 -176.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 10.5 p -120.31 150.67 23.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 106.611 -1.625 . . . . 62.02 106.611 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.416 ' OD1' ' HE2' ' A' ' 557' ' ' LYS . 21.1 m-20 -75.29 135.63 40.92 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 120.311 -0.556 . . . . 74.14 109.71 -174.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 73.9 m -153.11 169.57 9.52 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 108.343 -0.984 . . . . 72.22 108.343 -175.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -82.35 -17.53 7.63 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.597 1.531 . . . . 64.11 111.182 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.605 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 53.1 mtt-85 -75.51 143.68 76.26 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 116.089 -0.505 . . . . 73.42 110.273 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.97 143.18 96.59 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 123.164 2.576 . . . . 63.22 112.521 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -56.51 108.97 0.54 Allowed 'General case' 0 C--O 1.242 0.7 0 O-C-N 124.092 0.87 . . . . 64.34 112.321 -177.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 140.38 -20.0 2.8 Favored Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 115.381 -0.827 . . . . 31.31 112.494 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 533' ' ' GLU . . . . . 0.605 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 31.1 tt0 -82.86 144.83 29.82 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.602 -0.518 . . . . 74.14 109.602 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 503' ' ' GLN . 8.0 p -91.5 115.8 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 CA-C-O 122.094 0.949 . . . . 74.3 110.455 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.8 -30.86 69.52 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 113.671 -1.604 . . . . 61.44 110.253 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 154.82 -164.87 31.91 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 110.587 -1.005 . . . . 64.42 110.587 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 6.4 p -117.29 154.88 30.47 Favored 'General case' 0 C--N 1.288 -2.109 0 N-CA-C 109.542 -0.54 . . . . 62.13 109.542 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.452 ' HB2' HE22 ' A' ' 554' ' ' GLN . 9.7 t30 -63.79 -51.57 64.01 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 120.149 -0.621 . . . . 70.31 110.84 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -74.23 134.3 19.01 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 N-CA-C 108.644 -1.329 . . . . 63.12 108.644 170.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.45 154.4 71.85 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 122.753 2.302 . . . . 73.01 113.381 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.02 139.89 58.39 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.588 -0.733 . . . . 55.51 110.284 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 96.86 -8.8 65.76 Favored Glycine 0 C--N 1.302 -1.339 0 C-N-CA 120.595 -0.812 . . . . 65.13 111.695 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 25.2 m -82.5 133.97 35.2 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.646 -0.872 . . . . 60.33 108.646 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.1 t -94.64 132.79 38.98 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 108.301 -1.0 . . . . 71.14 108.301 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.17 155.2 64.96 Favored Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 107.839 -1.171 . . . . 72.32 107.839 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.525 ' HG2' ' OG ' ' A' ' 549' ' ' SER . 7.6 Cg_endo -60.32 136.52 68.72 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 N-CA-C 109.421 -1.03 . . . . 73.44 109.421 176.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.572 ' O ' HG22 ' A' ' 518' ' ' THR . 9.7 p -66.56 -21.38 28.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.34 -0.845 . . . . 62.12 112.941 -172.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -93.35 3.69 55.2 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.766 0.793 . . . . 54.31 111.043 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 549' ' ' SER . . . . . 0.525 ' OG ' ' HG2' ' A' ' 546' ' ' PRO . 68.3 m -87.56 -174.7 4.91 Favored 'General case' 0 C--O 1.251 1.171 0 O-C-N 121.544 -0.723 . . . . 54.3 112.389 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 13.3 p -113.48 138.25 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 115.221 -0.9 . . . . 75.34 109.741 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.7 mt -102.92 137.4 31.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.76 -0.83 . . . . 73.34 108.76 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -102.43 117.49 34.83 Favored 'General case' 0 C--O 1.251 1.132 0 N-CA-C 107.999 -1.111 . . . . 74.01 107.999 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.44 129.93 55.25 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 123.343 0.402 . . . . 64.44 110.505 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.452 HE22 ' HB2' ' A' ' 538' ' ' ASN . 2.9 mp0 -90.66 119.38 30.86 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.003 -0.544 . . . . 74.34 110.785 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 40.2 t -92.99 129.57 43.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.316 -0.994 . . . . 54.23 108.316 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.658 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 16.1 m -75.71 117.72 17.77 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 108.081 -1.081 . . . . 74.2 108.081 176.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.416 ' HE2' ' OD1' ' A' ' 526' ' ' ASP . 26.5 pttm -109.05 118.49 36.91 Favored 'General case' 0 N--CA 1.411 -2.399 0 N-CA-C 107.576 -1.268 . . . . 72.15 107.576 171.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -56.79 -23.86 46.5 Favored Glycine 0 CA--C 1.497 -1.09 0 O-C-N 124.319 1.012 . . . . 32.41 113.175 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 77.85 -3.84 2.32 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 125.331 1.452 . . . . 75.23 109.24 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.549 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 63.2 mt-30 -112.58 150.21 31.67 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 115.592 -0.731 . . . . 61.45 112.831 -173.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -133.13 156.5 47.32 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.646 -1.613 . . . . 74.12 106.646 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 47.5 t -73.41 122.87 27.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.595 -0.891 . . . . 63.4 108.595 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.421 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 57.0 ttp -73.97 127.37 88.28 Favored Pre-proline 0 C--O 1.25 1.082 0 O-C-N 123.22 0.325 . . . . 62.1 111.428 -175.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 564' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 51.9 Cg_exo -61.71 169.64 6.79 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.598 2.865 . . . . 70.05 112.59 175.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -65.92 129.47 39.9 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.373 0.669 . . . . 63.05 112.766 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.7 pp -152.45 14.32 0.58 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.182 0.992 . . . . 74.11 109.075 172.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 4.2 m -79.95 140.89 36.46 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.414 -1.267 . . . . 70.3 111.995 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 53.18 43.1 63.37 Favored Glycine 0 C--O 1.223 -0.544 0 N-CA-C 115.112 0.805 . . . . 52.43 115.112 172.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 18.1 ptp -127.15 -179.65 4.97 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.874 -1.158 . . . . 75.1 107.874 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 570' ' ' PHE . . . . . 0.426 ' HB2' HG12 ' A' ' 572' ' ' VAL . 21.7 m-85 -96.24 168.96 10.27 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.665 -0.865 . . . . 74.31 108.665 -175.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 37.8 t-105 -63.39 -28.08 69.74 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.445 -0.576 . . . . 73.03 109.445 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 572' ' ' VAL . . . . . 0.426 HG12 ' HB2' ' A' ' 570' ' ' PHE . 8.9 p -75.11 -9.58 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 CA-C-N 115.695 -0.684 . . . . 74.04 110.484 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.587 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 42.6 m-20 -101.1 -42.0 6.54 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 107.858 -1.164 . . . . 52.24 107.858 173.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 574' ' ' ALA . . . . . 0.55 ' O ' HD12 ' A' ' 578' ' ' LEU . . . -55.54 -45.92 77.15 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.782 -1.099 . . . . 62.43 112.044 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.563 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 3.0 tm-20 -53.98 -58.46 13.33 Favored Pre-proline 0 CA--C 1.567 1.616 0 CA-C-O 118.949 -0.548 . . . . 72.25 110.533 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 57.9 Cg_exo -53.17 -32.25 58.94 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 121.978 1.785 . . . . 72.54 112.808 173.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 26.2 mmm180 -61.93 -36.25 80.81 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-O 118.659 -0.686 . . . . 75.1 112.42 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.632 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 5.4 mp -62.66 -48.54 78.88 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.708 -1.197 . . . . 73.23 110.115 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 576' ' ' PRO . 0.7 OUTLIER -66.1 -41.23 90.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.824 -0.625 . . . . 71.33 112.322 178.556 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.28 -39.54 74.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.746 0.647 . . . . 62.1 112.746 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.01 -9.02 58.46 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.926 0.394 . . . . 64.22 110.433 -175.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 72.47 48.36 24.12 Favored Glycine 0 CA--C 1.505 -0.556 0 N-CA-C 111.316 -0.713 . . . . 63.04 111.316 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.632 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 8.6 t90 -85.99 133.4 33.92 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.0 0.429 . . . . 72.45 110.011 -176.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 1.3 p -86.82 -39.36 15.95 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.583 1.553 . . . . 64.31 112.826 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -79.7 -162.16 24.28 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-O 121.797 0.665 . . . . 64.5 114.279 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 61.5 mtm -122.79 152.87 40.24 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.974 -0.75 . . . . 75.53 108.974 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 4.4 tt -81.92 111.67 18.32 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.648 -1.241 . . . . 71.02 107.648 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 621' ' ' THR . 33.0 t70 -95.34 107.97 20.12 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.658 0.742 . . . . 71.05 110.049 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.504 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.3 OUTLIER -97.1 133.66 41.46 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.677 -0.861 . . . . 65.25 108.677 178.451 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.25 -69.29 1.4 Allowed Glycine 0 C--N 1.28 -2.532 0 N-CA-C 110.57 -1.012 . . . . 71.45 110.57 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -137.22 149.34 47.13 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 110.065 -0.346 . . . . 73.4 110.065 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -115.77 124.7 51.42 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.645 0.736 . . . . 75.21 109.072 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 44.2 t -106.74 153.52 7.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.758 -1.201 . . . . 73.42 107.758 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.42 126.2 29.26 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.934 0.873 . . . . 71.32 110.752 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -133.54 -48.34 0.83 Allowed 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 114.386 -1.279 . . . . 62.31 108.747 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 102.51 123.14 5.2 Favored Glycine 0 N--CA 1.422 -2.254 0 N-CA-C 111.254 -0.738 . . . . 64.45 111.254 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -60.58 -33.83 83.5 Favored Glycine 0 C--N 1.317 -0.514 0 N-CA-C 111.704 -0.559 . . . . 14.31 111.704 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.2 m -70.27 -23.88 62.96 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-O 121.819 0.819 . . . . 62.21 110.135 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -92.06 -1.58 57.13 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.195 -0.911 . . . . 74.13 110.085 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 69.82 81.73 0.17 Allowed 'General case' 0 C--O 1.244 0.772 0 CA-C-O 123.229 1.49 . . . . 72.21 111.283 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 601' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 625' ' ' GLY . 15.8 p-10 -79.77 89.31 5.21 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 113.32 -1.764 . . . . 72.25 113.056 -174.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -81.9 170.93 15.06 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.146 -0.934 . . . . 61.41 111.722 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 75.0 t -70.29 131.83 33.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 114.55 -1.205 . . . . 64.42 108.529 171.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 86.5 t -91.07 -43.92 14.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.499 0.666 . . . . 72.43 110.568 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -153.14 140.05 19.14 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.783 -0.644 . . . . 64.34 109.693 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -127.51 139.49 52.75 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.663 -1.236 . . . . 74.22 107.663 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.59 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 23.8 t-20 -58.99 -62.48 5.73 Favored Pre-proline 0 CA--C 1.555 1.153 0 CA-C-O 118.922 -0.561 . . . . 73.45 111.929 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.625 ' HD2' HG12 ' A' ' 620' ' ' ILE . 7.4 Cg_endo -95.74 120.44 0.24 Allowed 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 122.003 1.802 . . . . 75.24 110.027 171.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 609' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 19.0 Cg_exo -70.34 156.82 60.99 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.437 2.091 . . . . 74.45 112.276 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.38 138.61 56.85 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.466 -0.938 . . . . 53.34 108.466 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 97.77 -2.13 60.14 Favored Glycine 0 C--N 1.301 -1.398 0 N-CA-C 110.637 -0.985 . . . . 30.41 110.637 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 26.9 m -109.54 155.52 21.28 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.281 -1.377 . . . . 63.04 107.281 175.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -78.43 138.46 21.12 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.972 -0.632 . . . . 75.44 113.393 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.89 143.05 42.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 124.068 0.947 . . . . 72.04 109.11 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.549 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.2 p-10 -48.38 168.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.852 0.861 . . . . 70.45 113.023 175.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -57.14 -25.54 59.04 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.531 0.732 . . . . 71.12 112.806 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.95 -8.53 58.71 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 120.037 -0.665 . . . . 71.13 109.37 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.16 15.77 63.56 Favored Glycine 0 C--O 1.216 -1.024 0 CA-C-N 116.127 -0.488 . . . . 64.33 113.141 172.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.4 119.38 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-O 122.623 1.202 . . . . 70.3 112.409 -166.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.625 HG12 ' HD2' ' A' ' 608' ' ' PRO . 0.0 OUTLIER -125.62 128.25 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 CA-C-N 113.694 -1.594 . . . . 74.31 110.2 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 21.2 m -100.51 129.59 46.47 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.673 -1.149 . . . . 74.41 108.896 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.8 pp -138.92 166.24 24.99 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.742 0.645 . . . . 74.41 112.742 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -127.57 137.46 52.6 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.519 -2.03 . . . . 72.33 105.519 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -140.8 165.67 26.87 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 120.199 -0.6 . . . . 74.22 111.113 -172.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 625' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 601' ' ' ASN . . . -81.2 142.64 23.29 Favored Glycine 0 N--CA 1.412 -2.913 0 CA-C-N 115.405 -0.816 . . . . 43.15 111.125 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? . . . . . 0 N--CA 1.402 -2.865 0 C-N-CA 124.336 1.054 . . . . 72.01 108.472 178.484 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.788 0 N-CA-C 110.098 -1.201 . . . . 43.05 110.098 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.13 142.35 24.48 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 121.949 1.766 . . . . 73.23 110.916 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -92.44 -10.54 37.61 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 122.44 1.114 . . . . 74.51 109.82 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 3.5 p -137.64 147.47 44.97 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 113.998 -1.455 . . . . 52.01 108.907 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -130.86 149.7 52.37 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.965 -0.754 . . . . 73.32 108.965 177.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.7 p-10 -87.71 135.55 33.32 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 122.986 0.514 . . . . 71.33 109.744 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 29.6 pt -88.43 130.39 45.79 Favored Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 116.586 -0.279 . . . . 75.51 110.957 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -88.44 172.75 4.81 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.629 2.219 . . . . 71.55 112.807 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -92.31 111.94 23.7 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.369 -0.832 . . . . 73.44 108.85 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 24.1 m -106.41 16.44 6.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.408 -0.815 . . . . 72.1 111.212 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -67.06 98.12 0.55 Allowed 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.822 -0.627 . . . . 73.52 111.399 -176.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 146.34 -26.03 1.7 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 115.667 -0.697 . . . . 31.0 111.637 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.447 ' O ' HG12 ' A' ' 534' ' ' VAL . 31.8 mt-30 -82.65 171.08 14.42 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.82 -0.807 . . . . 64.22 108.82 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 4.8 m -74.25 155.94 37.74 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 105.129 -2.174 . . . . 63.1 105.129 172.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.433 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.2 p -61.93 -41.94 92.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 118.648 0.658 . . . . 73.53 111.442 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 506' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 17.1 t70 -62.4 -41.66 98.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.546 -0.297 . . . . 65.54 110.357 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 87.4 t -67.1 -44.15 88.26 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.247 0 CA-C-N 116.036 -0.529 . . . . 72.35 109.843 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.477 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -60.84 -39.79 90.4 Favored 'General case' 0 C--O 1.214 -0.809 0 O-C-N 123.18 0.3 . . . . 72.04 111.159 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 98.6 mt-30 -65.06 -43.94 90.62 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.473 -0.195 . . . . 74.44 110.473 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 75.7 mmtt -63.95 -45.21 90.16 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.049 -0.723 . . . . 73.31 109.049 177.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -61.22 -43.06 99.49 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.279 -1.328 . . . . 75.13 110.077 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 66.3 tp -67.23 -45.81 75.66 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.14 -1.391 . . . . 74.43 109.219 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -64.88 -34.98 79.68 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 123.942 0.897 . . . . 63.3 113.155 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 510' ' ' LYS . 85.8 t -57.18 -33.06 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 120.928 0.394 . . . . 63.43 111.278 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -118.5 8.57 12.09 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.924 0.869 . . . . 71.33 110.267 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -114.42 -59.08 0.37 Allowed Glycine 0 N--CA 1.416 -2.688 0 CA-C-N 114.936 -1.029 . . . . 70.02 111.707 -174.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 65.53 18.72 11.36 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 122.479 1.133 . . . . 75.41 109.53 -176.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.2 p -92.54 -175.86 4.11 Favored 'General case' 0 N--CA 1.403 -2.795 0 CA-C-N 114.04 -1.436 . . . . 55.53 110.416 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -107.82 142.21 38.21 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.531 -0.914 . . . . 75.25 108.531 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -129.03 153.3 47.73 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.458 0.647 . . . . 72.4 111.427 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 71.0 m -140.12 155.71 46.87 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 107.095 -1.446 . . . . 72.1 107.095 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -124.14 123.23 39.84 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.313 0.578 . . . . 72.12 111.274 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -105.56 119.31 38.79 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.429 -0.952 . . . . 71.13 108.429 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 20.2 m -100.72 137.19 39.45 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.877 -0.329 . . . . 75.12 110.905 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.1 p -144.21 153.91 15.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.754 -1.202 . . . . 54.42 107.754 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.435 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 3.3 p30 -84.08 136.22 34.1 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.304 0.573 . . . . 63.03 110.927 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.441 ' HB3' ' HD2' ' A' ' 528' ' ' PRO . 50.6 m -159.04 171.38 7.49 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 106.394 -1.706 . . . . 63.12 106.394 -177.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 528' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 527' ' ' SER . 37.3 Cg_endo -68.99 -10.11 28.26 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 121.4 1.4 . . . . 62.21 112.597 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.414 ' HB2' ' CB ' ' A' ' 556' ' ' SER . 23.5 mmm180 -72.59 140.14 81.46 Favored Pre-proline 0 N--CA 1.435 -1.189 0 N-CA-C 109.573 -0.529 . . . . 72.44 109.573 177.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.36 151.34 83.48 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.608 2.206 . . . . 72.4 113.344 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -64.96 121.55 14.91 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.187 -0.915 . . . . 74.12 111.542 -177.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 114.58 -18.91 17.02 Favored Glycine 0 C--O 1.249 1.044 0 C-N-CA 120.838 -0.696 . . . . 73.31 111.373 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -78.2 129.18 34.81 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 109.025 -0.732 . . . . 64.33 109.025 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 10.1 p -90.81 117.42 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.844 0 N-CA-C 106.78 -1.563 . . . . 42.11 106.78 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.4 m -92.94 9.74 34.25 Favored 'General case' 0 C--N 1.27 -2.886 0 CA-C-N 114.341 -1.3 . . . . 51.14 110.567 -173.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.411 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 132.7 -154.79 21.27 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 111.338 -0.705 . . . . 34.32 111.338 176.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.8 p -116.96 157.95 24.89 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.804 -0.813 . . . . 52.03 108.804 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.403 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 11.9 t-20 -60.53 -55.76 41.91 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 119.004 -0.522 . . . . 54.44 111.448 176.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 16.3 Cg_exo -70.53 144.78 50.9 Favored 'Trans proline' 0 C--N 1.367 1.533 0 N-CA-C 108.658 -1.324 . . . . 72.51 108.658 171.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -58.15 147.52 83.09 Favored 'Trans proline' 0 C--O 1.24 0.577 0 C-N-CA 122.79 2.327 . . . . 70.31 113.047 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.05 137.89 57.76 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-N 116.27 -0.423 . . . . 63.02 110.432 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.62 -19.98 48.17 Favored Glycine 0 C--N 1.31 -0.896 0 C-N-CA 120.926 -0.654 . . . . 42.32 111.948 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 35.4 m -67.46 136.79 55.19 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.705 -0.48 . . . . 74.33 109.705 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 14.8 t -96.34 133.23 40.98 Favored 'General case' 0 N--CA 1.406 -2.67 0 N-CA-C 108.984 -0.747 . . . . 74.42 108.984 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.7 m -123.39 155.88 64.67 Favored Pre-proline 0 C--N 1.296 -1.753 0 N-CA-C 108.042 -1.096 . . . . 71.43 108.042 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -63.9 138.28 62.19 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 121.385 1.39 . . . . 65.43 110.486 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 13.2 p -62.2 -19.99 23.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.611 -0.722 . . . . 75.21 111.426 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -90.18 -15.89 30.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.172 0.51 . . . . 43.55 111.507 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 60.0 m -80.39 -175.69 5.27 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 121.109 0.481 . . . . 73.44 111.723 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 12.4 p -113.19 137.61 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 115.931 -0.577 . . . . 73.34 110.168 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 70.2 mt -97.33 129.89 46.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 109.371 -0.603 . . . . 73.12 109.371 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -102.56 117.59 35.01 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.135 -0.691 . . . . 74.41 109.135 -177.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.3 mp -98.59 134.84 40.97 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.813 -0.631 . . . . 74.25 110.006 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -91.82 113.63 25.95 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 116.292 -0.413 . . . . 71.41 110.365 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 524' ' ' SER . 20.1 t -106.65 126.93 62.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.421 -0.955 . . . . 65.0 108.421 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.556 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 50.5 m -95.55 143.34 26.94 Favored 'General case' 0 C--N 1.277 -2.58 0 C-N-CA 119.661 -0.816 . . . . 73.1 110.824 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 0.6 OUTLIER -105.79 144.38 32.61 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 106.163 -1.792 . . . . 74.44 106.163 168.715 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -55.02 -23.35 31.34 Favored Glycine 0 CA--C 1.492 -1.36 0 O-C-N 124.903 1.377 . . . . 64.12 114.624 -171.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 559' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 4.3 t30 77.09 -27.29 0.18 Allowed 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 124.604 1.162 . . . . 74.12 110.92 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' A' ' 558' ' ' GLY . 72.1 mt-30 -114.1 162.18 16.81 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 114.517 -1.22 . . . . 74.42 109.665 -175.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -127.19 155.9 42.68 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 107.805 -1.183 . . . . 74.42 107.805 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 6.2 p -77.78 121.05 29.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.554 -0.536 . . . . 63.31 109.554 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.497 ' SD ' HG21 ' A' ' 620' ' ' ILE . 47.6 ttp -74.11 125.23 90.27 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 116.403 -0.362 . . . . 74.54 111.43 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -72.45 170.61 18.89 Favored 'Trans proline' 0 C--O 1.242 0.721 0 C-N-CA 123.491 2.794 . . . . 72.52 111.891 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.06 114.47 5.86 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.914 0.864 . . . . 74.42 112.703 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.5 pp -125.12 7.15 7.89 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.105 -1.407 . . . . 72.53 107.476 171.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 16.7 m -79.81 144.04 33.87 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 113.497 -1.683 . . . . 74.54 110.564 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 68.03 43.13 83.02 Favored Glycine 0 CA--C 1.521 0.413 0 O-C-N 123.686 0.616 . . . . 74.02 114.007 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 22.2 ptp -146.91 174.79 11.18 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.288 -0.634 . . . . 64.5 109.288 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -98.05 172.87 7.34 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.547 -1.279 . . . . 64.55 107.547 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -62.97 -35.63 80.79 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.708 -0.849 . . . . 75.14 108.708 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.8 -22.36 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 115.636 -0.711 . . . . 61.43 111.506 -175.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.403 ' C ' ' HD2' ' A' ' 576' ' ' PRO . 28.4 t70 -102.18 -31.35 10.62 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-O 121.479 0.657 . . . . 71.3 110.667 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -71.41 -32.39 68.34 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.506 -0.77 . . . . 63.21 111.484 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.615 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 34.3 tt0 -64.56 -48.95 73.2 Favored Pre-proline 0 CA--C 1.56 1.336 0 CA-C-N 116.47 -0.332 . . . . 52.21 111.196 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 88.5 Cg_exo -54.69 -38.01 91.38 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 121.471 1.447 . . . . 33.31 111.76 170.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.439 ' NE ' ' HA ' ' A' ' 577' ' ' ARG . 1.4 mmp_? -58.94 -43.18 91.14 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 121.359 -0.136 . . . . 50.13 111.325 176.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.5 pp -67.05 -45.66 76.71 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.542 0.571 . . . . 73.3 112.542 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.47 ' N ' HD12 ' A' ' 578' ' ' LEU . 5.9 ptp85 -66.71 -35.04 79.18 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.478 0.547 . . . . 72.44 112.478 176.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.97 -36.56 83.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.181 0.515 . . . . 64.53 110.03 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 12.1 tp -81.26 -9.85 59.7 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.651 -0.704 . . . . 63.33 110.694 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 67.79 42.82 85.97 Favored Glycine 0 C--O 1.243 0.671 0 N-CA-C 111.883 -0.487 . . . . 73.41 111.883 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.406 ' HE3' ' CB ' ' A' ' 578' ' ' LEU . 13.7 t90 -75.19 126.49 31.13 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 120.977 0.418 . . . . 61.05 109.879 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 18.1 p -103.52 -15.44 15.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.822 -0.626 . . . . 73.25 112.084 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -83.79 -176.71 51.37 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 121.161 -0.542 . . . . 65.13 112.953 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 51.5 ttp -100.86 141.37 33.84 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 122.344 0.258 . . . . 74.43 111.286 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 8.0 tt -80.96 107.5 13.83 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.075 -1.083 . . . . 74.23 108.075 174.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.545 ' O ' ' HA ' ' A' ' 621' ' ' THR . 24.5 t70 -98.39 116.2 30.12 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.486 -0.779 . . . . 72.0 109.578 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -106.46 134.38 49.68 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.534 -0.757 . . . . 54.2 109.192 178.61 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -70.84 -75.24 0.63 Allowed Glycine 0 C--N 1.293 -1.846 0 N-CA-C 111.116 -0.793 . . . . 72.15 111.116 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.09 121.32 15.87 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.284 -0.635 . . . . 72.44 109.284 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -84.57 137.01 33.54 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.992 -1.114 . . . . 53.34 107.992 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 47.0 t -105.76 126.75 61.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 116.223 -0.444 . . . . 72.41 110.049 -174.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 594' ' ' ASP . . . . . 0.507 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 9.7 p-10 -72.12 111.55 7.44 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 122.403 1.097 . . . . 63.31 111.489 -176.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -133.98 -45.68 0.79 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.356 -1.293 . . . . 42.22 109.133 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 103.44 149.36 20.79 Favored Glycine 0 N--CA 1.422 -2.261 0 C-N-CA 120.837 -0.697 . . . . 62.33 112.356 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.494 ' HA2' ' OD1' ' A' ' 601' ' ' ASN . . . -61.51 -32.58 81.74 Favored Glycine 0 C--N 1.302 -1.339 0 CA-C-N 114.981 -0.61 . . . . 62.5 112.71 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 10.6 t -71.03 -23.56 62.19 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 122.253 1.025 . . . . 75.03 109.449 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -88.58 -1.13 57.9 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.681 -1.145 . . . . 74.25 110.672 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 48.4 m80 70.29 80.7 0.17 Allowed 'General case' 0 C--O 1.244 0.792 0 CA-C-O 122.755 1.264 . . . . 72.22 110.567 -178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 601' ' ' ASN . . . . . 0.494 ' OD1' ' HA2' ' A' ' 597' ' ' GLY . 30.0 p-10 -87.58 78.53 8.53 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 113.812 -1.54 . . . . 74.11 111.452 -175.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -94.07 171.61 8.74 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.601 -1.181 . . . . 73.25 109.232 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 96.4 t -64.93 130.75 30.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 106.829 -1.545 . . . . 54.55 106.829 170.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.8 t -96.51 -52.72 8.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 121.169 0.509 . . . . 70.53 110.535 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -147.91 150.55 34.3 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.161 -0.681 . . . . 73.21 109.161 -175.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -139.4 144.34 38.09 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.871 -1.159 . . . . 63.15 107.871 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.403 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 9.6 t30 -63.52 -51.48 66.66 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 120.444 -0.502 . . . . 72.34 111.98 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 57.6 Cg_endo -93.13 116.67 0.32 Allowed 'Trans proline' 0 N--CA 1.442 -1.532 0 C-N-CA 121.212 1.275 . . . . 75.12 110.328 171.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.88 160.96 34.8 Favored 'Trans proline' 0 C--O 1.248 0.989 0 C-N-CA 122.857 2.371 . . . . 75.51 112.215 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.61 133.67 56.32 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.085 -0.709 . . . . 73.11 109.085 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 100.65 -0.56 55.44 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.636 -0.792 . . . . 63.11 112.265 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 35.3 m -90.18 145.76 24.78 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.555 -0.535 . . . . 72.15 109.555 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -77.28 124.21 6.82 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 110.733 -0.947 . . . . 41.43 110.733 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.9 m -125.78 143.2 40.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 108.374 -0.972 . . . . 63.42 108.374 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.431 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.4 p-10 -48.23 163.03 0.07 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.92 0.888 . . . . 74.41 111.965 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . 0.331 0.0 OUTLIER -56.04 -24.5 39.98 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.971 1.471 . . . . 64.22 114.971 -178.387 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -83.65 -6.26 59.4 Favored 'General case' 0 C--O 1.199 -1.589 0 C-N-CA 119.256 -0.977 . . . . 75.22 112.497 175.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.83 19.52 69.61 Favored Glycine 0 CA--C 1.491 -1.441 0 CA-C-O 119.464 -0.631 . . . . 64.1 114.561 166.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.83 118.63 14.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-O 122.12 0.962 . . . . 72.31 110.419 -168.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.497 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.7 pp -129.36 133.86 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 114.708 -1.133 . . . . 41.41 111.866 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 15.4 t -102.21 122.92 45.12 Favored 'General case' 0 C--O 1.26 1.633 0 CA-C-O 121.802 0.81 . . . . 73.31 109.553 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 1.8 pt? -139.36 167.27 22.47 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.334 -0.848 . . . . 74.41 111.742 -173.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -128.22 137.08 51.86 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.262 -1.014 . . . . 71.22 108.262 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.463 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 35.0 p90 -141.28 166.63 24.24 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.788 -0.187 . . . . 64.02 111.126 -174.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -75.57 135.2 17.8 Favored Glycine 0 N--CA 1.435 -1.4 0 CA-C-O 121.69 0.605 . . . . 71.42 113.954 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.507 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 4.2 tt0 . . . . . 0 C--N 1.296 -1.755 0 N-CA-C 107.1 -1.445 . . . . 74.23 107.1 175.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.114 0 N-CA-C 110.167 -1.173 . . . . 43.05 110.167 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.13 161.46 43.16 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 122.41 2.073 . . . . 73.43 111.793 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -87.0 5.22 38.49 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.357 0.598 . . . . 61.43 111.594 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 16.1 p -139.18 141.1 37.99 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.823 -0.806 . . . . 61.24 108.823 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -143.02 148.42 36.74 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.818 0.342 . . . . 43.52 111.32 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.9 p-10 -79.1 139.08 38.17 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 115.407 -0.815 . . . . 72.35 110.209 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.4 pt -96.17 137.35 21.69 Favored Pre-proline 0 C--N 1.296 -1.722 0 CA-C-N 115.628 -0.715 . . . . 72.21 111.116 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -89.86 -177.22 1.34 Allowed 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.487 2.124 . . . . 72.42 109.829 170.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -99.9 137.28 38.57 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.919 -1.141 . . . . 73.45 107.919 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.502 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 16.7 m -110.81 17.31 7.65 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 CA-C-N 115.543 -0.753 . . . . 51.13 110.178 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -72.93 100.83 3.03 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.456 -0.793 . . . . 72.44 110.206 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 169.12 -46.43 0.22 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-N 115.379 -0.828 . . . . 63.32 111.864 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.431 ' O ' HG12 ' A' ' 534' ' ' VAL . 18.2 pm0 -98.07 -171.06 2.08 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 122.344 -0.504 . . . . 75.04 110.505 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 15.1 m -70.92 155.12 41.2 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.452 -0.944 . . . . 71.33 108.452 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 9.7 p -65.5 -41.73 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 O-C-N 123.06 0.225 . . . . 63.05 110.88 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -61.82 -37.98 86.44 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.913 -0.773 . . . . 65.12 108.913 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 95.1 t -71.02 -48.77 53.74 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.624 0 CA-C-N 115.525 -0.761 . . . . 53.35 109.684 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.502 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -60.58 -36.73 79.25 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 122.769 0.428 . . . . 72.51 111.767 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.422 ' O ' ' HB2' ' A' ' 513' ' ' ASN . 99.2 mt-30 -65.23 -45.2 85.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.56 0.219 . . . . 53.22 110.47 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.524 ' O ' HG23 ' A' ' 514' ' ' VAL . 75.1 mmtt -66.6 -39.53 88.43 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 109.137 -0.69 . . . . 74.14 109.137 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 511' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' A' ' 508' ' ' ALA . 20.3 t-20 -60.18 -47.02 87.68 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 125.771 1.628 . . . . 71.11 110.091 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -69.48 -42.06 75.32 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.761 -1.109 . . . . 71.13 108.592 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 14.3 t30 -63.7 -35.59 81.07 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.421 -0.809 . . . . 75.12 111.392 -174.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 510' ' ' LYS . 71.4 t -57.78 -32.46 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.068 0.461 . . . . 63.45 111.737 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -115.36 4.76 14.45 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.559 0.695 . . . . 74.42 110.108 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -120.21 -57.59 0.24 Allowed Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 115.817 -0.629 . . . . 53.03 113.094 -174.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 64.76 28.96 12.9 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.89 0.876 . . . . 73.11 111.411 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 16.7 p -89.09 -166.92 1.72 Allowed 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.665 -1.152 . . . . 72.2 109.208 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -107.74 143.98 35.51 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 106.754 -1.572 . . . . 73.35 106.754 173.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -126.84 144.8 50.86 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.387 0.613 . . . . 62.3 112.327 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 73.5 m -132.81 149.92 52.22 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.651 -0.87 . . . . 72.25 108.651 176.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 522' ' ' GLN . . . . . 0.405 ' HB2' ' CG2' ' A' ' 555' ' ' VAL . 14.1 pt20 -123.18 131.78 53.81 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.025 0.44 . . . . 74.13 110.536 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -120.45 118.88 31.43 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.576 -0.898 . . . . 73.2 108.576 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 78.4 p -94.78 139.3 31.45 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.451 0.643 . . . . 73.31 112.203 -176.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.8 p -133.6 150.17 31.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.097 -1.075 . . . . 75.21 108.097 178.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.11 136.03 44.83 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.348 0.594 . . . . 72.32 111.281 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 74.3 m -156.01 163.2 25.59 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 106.803 -1.554 . . . . 74.03 106.803 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.52 -10.83 27.45 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.387 1.392 . . . . 65.12 112.709 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.455 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 10.2 mtm180 -84.48 152.51 60.77 Favored Pre-proline 0 N--CA 1.429 -1.483 0 N-CA-C 108.891 -0.781 . . . . 74.33 108.891 -176.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.17 149.35 70.57 Favored 'Trans proline' 0 C--O 1.246 0.893 0 C-N-CA 122.239 1.959 . . . . 73.53 114.41 -170.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -63.94 124.45 21.58 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.399 -1.273 . . . . 71.01 110.689 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 125.71 -21.65 6.26 Favored Glycine 0 C--N 1.291 -1.927 0 N-CA-C 111.049 -0.82 . . . . 50.22 111.049 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -75.0 137.59 41.64 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.584 -0.524 . . . . 44.5 109.584 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 503' ' ' GLN . 4.3 p -90.87 113.22 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.95 0 CA-C-O 122.084 0.945 . . . . 72.23 108.825 174.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -24.72 64.33 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.21 -1.359 . . . . 74.42 111.087 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 152.24 -157.42 27.25 Favored Glycine 0 N--CA 1.432 -1.617 0 N-CA-C 110.013 -1.235 . . . . 43.45 110.013 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.2 p -117.37 155.01 30.32 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 117.356 0.578 . . . . 60.34 109.903 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.495 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 25.7 t-20 -53.39 -51.7 73.27 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 119.252 -0.404 . . . . 74.22 111.902 174.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.9 Cg_endo -87.02 153.29 8.37 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 121.773 1.649 . . . . 75.42 110.453 174.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.32 160.68 48.86 Favored 'Trans proline' 0 C--O 1.26 1.58 0 C-N-CA 122.413 2.075 . . . . 72.32 112.545 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.6 131.83 46.86 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.84 -0.618 . . . . 53.31 109.712 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.74 -6.63 38.12 Favored Glycine 0 C--N 1.303 -1.256 0 C-N-CA 120.831 -0.7 . . . . 73.33 111.848 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 25.7 m -78.78 126.45 30.74 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.452 -0.574 . . . . 74.44 109.452 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 9.4 t -87.05 126.33 34.68 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.431 0.634 . . . . 64.1 109.319 176.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.67 159.49 55.38 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 107.782 -1.192 . . . . 74.25 107.782 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -66.38 137.56 47.52 Favored 'Trans proline' 0 N--CA 1.437 -1.808 0 C-N-CA 120.874 1.049 . . . . 75.24 110.354 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.41 -19.06 23.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.323 -0.853 . . . . 54.34 111.408 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -96.39 -9.8 29.11 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 112.211 0.448 . . . . 55.55 112.211 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 60.3 m -89.6 -175.99 4.86 Favored 'General case' 0 C--O 1.255 1.345 0 N-CA-C 112.871 0.693 . . . . 53.32 112.871 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.9 p -104.03 138.07 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 115.508 -0.769 . . . . 72.22 111.024 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 61.0 mt -107.55 138.34 34.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.88 -1.155 . . . . 74.21 107.88 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 552' ' ' GLU . . . . . 0.417 ' HG2' ' NE2' ' A' ' 554' ' ' GLN . 25.1 tt0 -102.84 126.89 50.15 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.145 0.498 . . . . 72.41 111.083 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.2 mp -108.04 134.72 50.53 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.108 -0.951 . . . . 70.51 109.281 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.417 ' NE2' ' HG2' ' A' ' 552' ' ' GLU . 25.0 mm-40 -89.41 134.04 34.26 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.921 -1.14 . . . . 75.41 107.921 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 524' ' ' SER . 38.3 t -116.08 131.2 69.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 110.21 -0.293 . . . . 72.34 110.21 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.655 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 2.3 m -83.79 122.03 28.11 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 107.839 -1.171 . . . . 73.33 107.839 177.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.73 140.18 30.91 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 106.725 -1.583 . . . . 63.04 106.725 171.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -57.91 -23.44 51.23 Favored Glycine 0 CA--C 1.489 -1.592 0 O-C-N 124.894 1.371 . . . . 73.41 114.282 -171.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 77.98 -19.52 0.43 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.759 1.224 . . . . 75.11 110.851 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.487 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 75.8 mt-30 -112.41 155.29 24.45 Favored 'General case' 0 N--CA 1.428 -1.549 0 O-C-N 121.502 -0.749 . . . . 72.43 112.042 -174.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -135.36 150.6 49.97 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.377 -1.342 . . . . 75.23 107.377 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 6.2 p -66.95 125.35 24.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 121.202 0.525 . . . . 73.4 111.661 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.504 ' SD ' HG21 ' A' ' 620' ' ' ILE . 51.3 ttp -88.34 131.02 43.66 Favored Pre-proline 0 C--N 1.309 -1.189 0 CA-C-N 116.095 -0.502 . . . . 55.4 109.731 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.18 169.21 17.21 Favored 'Trans proline' 0 C--O 1.244 0.803 0 C-N-CA 122.51 2.14 . . . . 63.05 110.88 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 565' ' ' ASP . . . . . 0.469 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 0.9 OUTLIER -79.22 127.83 32.54 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.286 1.041 . . . . 72.44 111.916 -177.225 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.3 pp -135.51 19.64 3.35 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 113.62 -1.627 . . . . 75.1 108.534 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 13.2 m -79.14 143.08 35.81 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 114.376 -1.284 . . . . 60.33 109.417 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 74.54 46.0 21.03 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 121.046 -0.597 . . . . 53.0 112.256 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -129.05 174.35 9.62 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 109.076 -0.712 . . . . 52.42 109.076 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -111.37 165.65 11.78 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.018 -1.845 . . . . 63.22 106.018 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 18.6 t-105 -61.75 -31.49 71.67 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.134 0.492 . . . . 74.23 110.139 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.5 p -65.37 -25.62 37.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 115.694 -0.684 . . . . 73.03 111.08 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.633 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 37.1 t70 -93.8 -26.2 17.06 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.578 -0.527 . . . . 74.4 109.578 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.19 -45.48 93.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.128 -0.942 . . . . 71.34 111.877 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.542 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 40.7 mt-10 -57.15 -52.95 70.31 Favored Pre-proline 0 CA--C 1.56 1.329 0 N-CA-C 112.547 0.573 . . . . 75.53 112.547 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 31.5 Cg_exo -61.28 -35.22 85.67 Favored 'Trans proline' 0 C--N 1.365 1.439 0 CA-C-N 120.491 1.211 . . . . 74.23 112.414 173.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 5.7 mmp_? -60.4 -44.74 95.39 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 120.934 -0.306 . . . . 73.31 110.651 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.6 pp -65.88 -47.09 76.02 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.023 -0.535 . . . . 71.33 112.203 -174.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.5 ' N ' HD12 ' A' ' 578' ' ' LEU . 16.8 ptm180 -66.64 -37.63 85.22 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.261 -0.427 . . . . 75.33 111.707 177.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.47 -35.61 73.39 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 111.822 0.305 . . . . 73.42 111.822 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.0 pp -83.97 -9.15 58.89 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 119.654 -0.818 . . . . 63.43 110.532 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 78.96 41.99 13.32 Favored Glycine 0 C--O 1.243 0.718 0 C-N-CA 121.197 -0.525 . . . . 73.14 112.211 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -78.21 128.78 34.26 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.565 -0.531 . . . . 73.52 109.565 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 5.2 p -82.18 -47.98 11.84 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 123.732 0.813 . . . . 64.54 112.092 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -68.42 -166.4 3.94 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 115.698 1.039 . . . . 43.45 115.698 -176.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 17.5 tpt -118.46 149.15 41.75 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 123.452 0.701 . . . . 53.33 109.538 -175.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 28.5 tp -80.46 117.61 21.34 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 121.252 0.548 . . . . 65.25 109.82 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 621' ' ' THR . 25.5 t70 -100.49 120.58 40.21 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 115.237 -0.892 . . . . 74.55 109.5 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.493 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.3 OUTLIER -108.18 134.29 51.24 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.217 0.532 . . . . 64.1 109.784 178.046 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -86.47 -70.28 1.32 Allowed Glycine 0 C--N 1.288 -2.098 0 CA-C-N 115.396 -0.82 . . . . 73.12 112.651 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.42 154.13 47.73 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.656 0.265 . . . . 63.45 111.433 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -93.07 124.76 37.27 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.177 -0.92 . . . . 71.34 108.813 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 52.3 t -104.96 147.81 10.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 107.589 -1.263 . . . . 72.42 107.589 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 594' ' ' ASP . . . . . 0.495 ' HA ' ' HG2' ' A' ' 626' ' ' GLN . 10.7 p-10 -78.38 120.76 23.58 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.58 -0.896 . . . . 72.23 108.58 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -124.22 -52.39 1.74 Allowed 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.231 -0.588 . . . . 65.44 110.611 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 96.04 143.48 14.79 Favored Glycine 0 N--CA 1.427 -1.915 0 C-N-CA 119.935 -1.126 . . . . 64.23 111.697 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -60.5 -33.31 81.0 Favored Glycine 0 C--N 1.309 -0.956 0 N-CA-C 115.096 0.798 . . . . 72.53 115.096 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 33.4 t -77.14 -27.77 54.01 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 118.104 0.952 . . . . 72.12 109.528 -175.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -90.28 -3.42 57.8 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.102 -0.954 . . . . 70.13 109.947 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 34.0 m80 69.07 111.25 0.05 OUTLIER 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 114.491 -1.231 . . . . 72.22 112.486 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 601' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 625' ' ' GLY . 21.5 p-10 -79.4 65.01 4.44 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 123.306 1.527 . . . . 73.32 110.83 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -91.53 171.23 9.33 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 113.055 -1.884 . . . . 51.01 110.07 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 94.8 t -65.65 130.11 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 106.645 -1.613 . . . . 73.3 106.645 170.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 29.9 m -101.29 -36.32 4.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.152 0.501 . . . . 63.23 111.206 -176.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -144.27 135.98 25.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 116.167 -0.469 . . . . 62.42 109.965 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -126.62 137.79 53.35 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.161 -1.422 . . . . 41.4 107.161 174.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.523 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 45.0 t-20 -62.63 -59.11 13.62 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-O 118.99 -0.529 . . . . 72.43 112.162 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.0 Cg_exo -82.84 120.67 3.1 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.553 1.502 . . . . 75.23 110.065 175.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 609' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 14.6 Cg_exo -69.8 148.31 64.55 Favored 'Trans proline' 0 C--O 1.243 0.758 0 C-N-CA 122.341 2.027 . . . . 65.33 112.29 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 610' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -68.07 129.46 39.98 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.761 -0.654 . . . . 74.11 109.403 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.04 -10.4 47.82 Favored Glycine 0 C--N 1.302 -1.333 0 N-CA-C 110.219 -1.152 . . . . 60.25 110.219 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 37.1 m -101.68 161.92 13.29 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.801 -1.185 . . . . 70.01 107.801 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -82.82 135.22 13.72 Favored Glycine 0 N--CA 1.418 -2.528 0 C-N-CA 121.271 -0.49 . . . . 52.33 112.537 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.1 m -114.08 142.98 24.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 107.434 -1.321 . . . . 60.4 107.434 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.487 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 33.1 p-10 -56.37 170.86 0.32 Allowed 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 112.683 0.623 . . . . 75.54 112.683 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -56.98 -25.19 57.79 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.181 0.808 . . . . 73.42 113.181 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -87.57 -9.05 55.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.497 0.665 . . . . 73.15 109.5 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.54 14.92 63.18 Favored Glycine 0 C--O 1.217 -0.917 0 CA-C-N 115.628 -0.714 . . . . 70.32 113.406 172.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.57 119.74 17.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 122.416 1.103 . . . . 61.13 112.458 -167.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.504 HG21 ' SD ' ' A' ' 563' ' ' MET . 36.0 pt -122.42 133.32 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.975 0 CA-C-N 114.337 -1.301 . . . . 44.01 109.02 178.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 9.9 t -109.49 131.37 55.12 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.189 -1.041 . . . . 73.32 108.189 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.7 pp -138.73 165.91 25.76 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 112.873 0.694 . . . . 73.13 112.873 -175.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -128.45 137.83 52.02 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.51 -1.293 . . . . 72.11 107.51 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -133.44 163.13 30.04 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 120.161 -0.616 . . . . 73.54 111.387 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 625' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 601' ' ' ASN . . . -84.41 153.16 28.63 Favored Glycine 0 N--CA 1.42 -2.388 0 CA-C-N 115.446 -0.797 . . . . 64.15 112.507 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.495 ' HG2' ' HA ' ' A' ' 594' ' ' ASP . 8.0 pt20 . . . . . 0 C--O 1.271 2.202 0 N-CA-C 107.577 -1.268 . . . . 51.35 107.577 176.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 491' ' ' GLY . . . . . 0.418 ' HA3' ' HD3' ' A' ' 492' ' ' PRO . . . . . . . . 0 N--CA 1.469 0.892 0 N-CA-C 110.901 -0.879 . . . . 43.05 110.901 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.418 ' HD3' ' HA3' ' A' ' 491' ' ' GLY . 12.6 Cg_exo -73.21 145.01 38.23 Favored 'Trans proline' 0 C--O 1.241 0.674 0 C-N-CA 122.611 2.207 . . . . 74.32 111.699 177.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 66.3 24.65 10.58 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.317 1.047 . . . . 63.35 112.035 178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.44 ' HB ' HG22 ' A' ' 544' ' ' THR . 40.3 p -138.96 139.87 38.09 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.035 -0.728 . . . . 52.35 109.035 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.612 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 6.1 tmtt? -134.8 143.0 46.82 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.699 -0.852 . . . . 64.11 108.699 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.612 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 9.3 p-10 -77.41 128.9 35.04 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.879 0.872 . . . . 42.55 110.712 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.7 pt -84.15 138.01 39.75 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.352 -0.84 . . . . 75.03 111.007 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.08 176.56 8.95 Favored 'Trans proline' 0 C--O 1.238 0.511 0 C-N-CA 122.666 2.244 . . . . 75.21 112.516 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -81.45 127.85 33.24 Favored 'General case' 0 C--O 1.253 1.263 0 N-CA-C 108.177 -1.046 . . . . 64.4 108.177 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.585 ' HA ' ' NE2' ' A' ' 503' ' ' GLN . 34.8 m -123.28 -16.92 4.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 113.465 0.913 . . . . 73.04 113.465 -175.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -71.11 94.84 1.16 Allowed 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 120.721 0.296 . . . . 54.21 110.897 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 153.01 -39.23 0.73 Allowed Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 120.224 -0.989 . . . . 65.24 112.224 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.585 ' NE2' ' HA ' ' A' ' 500' ' ' VAL . 15.2 pm0 -88.2 -176.91 5.56 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 119.98 -0.688 . . . . 61.2 109.685 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 14.7 m -70.84 155.3 40.97 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.435 -1.32 . . . . 74.15 107.435 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.484 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.5 p -64.39 -41.48 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 121.031 -0.267 . . . . 74.5 110.713 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 506' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 14.3 t70 -61.75 -40.88 96.68 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.596 -0.52 . . . . 73.24 109.596 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.37 -43.35 84.31 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.803 0 CA-C-N 115.576 -0.738 . . . . 55.33 109.794 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.519 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -58.37 -45.04 89.0 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 123.15 0.281 . . . . 73.22 110.6 176.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.2 mt-30 -63.52 -45.29 91.3 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.754 -0.657 . . . . 63.14 110.369 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.533 ' O ' HG23 ' A' ' 514' ' ' VAL . 47.0 mmtm -62.99 -43.91 97.47 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.142 -0.481 . . . . 54.32 110.535 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -64.58 -43.74 92.9 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.656 -0.702 . . . . 74.31 111.85 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.2 pp -69.22 -36.43 77.22 Favored 'General case' 0 C--O 1.207 -1.181 0 C-N-CA 120.308 -0.557 . . . . 73.31 110.63 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.429 ' N ' HD12 ' A' ' 512' ' ' LEU . 39.8 t30 -63.13 -35.79 81.45 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 123.155 0.582 . . . . 75.34 110.45 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 510' ' ' LYS . 89.1 t -60.84 -36.34 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.05 0.452 . . . . 75.32 110.83 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 515' ' ' TYR . . . . . 0.461 ' O ' ' HE3' ' A' ' 495' ' ' LYS . 84.2 m-85 -112.71 22.64 14.32 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.15 0.5 . . . . 75.25 110.024 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -144.3 -58.83 0.02 OUTLIER Glycine 0 CA--C 1.48 -2.11 0 C-N-CA 119.849 -1.167 . . . . 64.14 112.797 -176.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 66.06 23.66 11.06 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 122.93 1.347 . . . . 72.1 109.656 -173.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.496 ' C ' ' HD2' ' A' ' 519' ' ' LYS . 5.8 p -83.08 174.7 10.61 Favored 'General case' 0 N--CA 1.394 -3.233 0 CA-C-N 112.646 -2.07 . . . . 71.2 108.373 176.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.496 ' HD2' ' C ' ' A' ' 518' ' ' THR . 11.8 mptt -107.94 140.28 41.3 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 108.848 -0.797 . . . . 75.43 108.848 -177.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -125.41 154.03 42.55 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 121.16 0.505 . . . . 71.14 111.81 -172.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 32.9 p -135.59 147.17 48.6 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 107.724 -1.213 . . . . 74.34 107.724 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -119.74 119.83 34.81 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.245 0.545 . . . . 72.45 110.687 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -110.77 116.66 31.67 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.053 -1.092 . . . . 75.13 108.053 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.6 m -96.39 126.91 41.92 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.587 -0.445 . . . . 72.03 110.199 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.35 149.09 24.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 106.819 -1.549 . . . . 74.42 106.819 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.501 ' HB2' HD22 ' A' ' 559' ' ' ASN . 6.1 p-10 -80.18 135.85 36.37 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-O 121.186 0.517 . . . . 73.22 110.565 -176.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 43.7 m -153.0 168.91 10.55 Favored Pre-proline 0 C--N 1.293 -1.869 0 N-CA-C 106.152 -1.796 . . . . 71.25 106.152 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -75.78 -10.63 20.02 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 121.255 1.303 . . . . 73.33 111.503 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.48 ' HA ' ' HD3' ' A' ' 530' ' ' PRO . 17.9 mtp180 -81.01 137.2 49.91 Favored Pre-proline 0 N--CA 1.413 -2.289 0 N-CA-C 108.252 -1.018 . . . . 72.34 108.252 -178.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 530' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 529' ' ' ARG . 15.9 Cg_exo -65.3 142.39 72.73 Favored 'Trans proline' 0 C--O 1.255 1.325 0 C-N-CA 123.351 2.701 . . . . 53.31 115.304 -170.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.729 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -59.58 118.2 5.8 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 114.613 -1.176 . . . . 62.53 111.739 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 136.0 -27.04 3.07 Favored Glycine 0 C--N 1.296 -1.69 0 N-CA-C 109.846 -1.302 . . . . 63.52 109.846 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -74.46 136.04 42.28 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.943 -0.629 . . . . 63.54 110.273 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 5.7 p -100.95 113.9 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.315 0 N-CA-C 108.201 -1.037 . . . . 63.14 108.201 172.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.95 -8.1 58.6 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.024 -0.534 . . . . 52.42 112.11 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 147.06 -171.86 27.66 Favored Glycine 0 N--CA 1.42 -2.408 0 C-N-CA 120.271 -0.966 . . . . 73.24 112.178 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 4.5 p -116.9 159.0 23.09 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 107.485 -1.302 . . . . 64.52 107.485 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -64.77 -47.17 75.71 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 118.33 -1.348 . . . . 74.55 112.084 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -73.58 137.07 24.6 Favored 'Trans proline' 0 C--N 1.366 1.465 0 N-CA-C 108.384 -1.429 . . . . 65.13 108.384 169.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 540' ' ' PRO . . . . . 0.434 ' HG2' ' OG1' ' A' ' 543' ' ' THR . 15.7 Cg_endo -59.97 140.62 93.68 Favored 'Trans proline' 0 C--O 1.246 0.89 0 C-N-CA 122.299 1.999 . . . . 62.14 112.589 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.6 132.69 54.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.758 -0.655 . . . . 63.14 109.59 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.44 -21.01 36.01 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.207 -0.757 . . . . 71.34 111.207 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.434 ' OG1' ' HG2' ' A' ' 540' ' ' PRO . 70.5 m -77.08 137.93 39.24 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.21 0.529 . . . . 43.41 110.873 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 7.1 m -84.39 123.2 29.96 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 108.628 -0.878 . . . . 62.01 108.628 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.98 157.39 63.71 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 108.424 -0.954 . . . . 63.42 108.424 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -59.99 136.26 68.27 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 121.355 1.37 . . . . 75.35 112.866 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.93 -20.54 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.671 -1.15 . . . . 73.43 111.105 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -84.13 -17.93 38.47 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.434 -1.257 . . . . 72.2 111.535 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 50.0 m -97.28 163.29 12.96 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 114.107 1.151 . . . . 61.52 114.107 -171.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.8 p -89.81 129.72 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 114.568 -1.196 . . . . 61.04 110.522 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 56.4 mt -92.74 132.13 37.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 107.697 -1.223 . . . . 73.33 107.697 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.43 117.75 35.17 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 121.509 0.671 . . . . 72.52 110.293 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.0 mp -103.96 124.51 49.13 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.884 -1.053 . . . . 74.22 108.948 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -92.46 118.79 31.32 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.412 0.625 . . . . 72.14 110.252 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.69 133.82 41.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.002 -0.999 . . . . 72.31 109.24 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.729 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 3.1 m -83.13 119.75 24.92 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.312 -1.366 . . . . 74.55 107.312 176.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.456 ' HG3' ' HA ' ' A' ' 526' ' ' ASP . 8.6 ptpp? -96.07 142.95 27.66 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.922 -1.51 . . . . 72.53 106.922 172.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -56.04 -23.47 39.37 Favored Glycine 0 C--O 1.244 0.773 0 O-C-N 124.641 1.213 . . . . 60.31 114.773 -171.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 559' ' ' ASN . . . . . 0.501 HD22 ' HB2' ' A' ' 526' ' ' ASP . 24.0 t-20 78.55 -9.26 1.53 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 124.082 0.953 . . . . 72.32 110.364 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -112.6 156.88 21.93 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 113.387 0.884 . . . . 73.42 113.387 -170.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -130.67 157.04 43.86 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.479 -1.237 . . . . 71.41 107.915 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 97.0 t -74.72 121.49 26.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 O-C-N 123.212 0.32 . . . . 64.42 110.838 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 564' ' ' PRO . 42.8 ttm -64.84 125.81 89.74 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 123.461 0.705 . . . . 64.13 111.836 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 564' ' ' PRO . . . . . 0.464 ' O ' ' HG2' ' A' ' 563' ' ' MET . 16.2 Cg_exo -74.07 169.35 22.64 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.825 2.35 . . . . 74.3 110.504 172.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.87 138.42 46.27 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.41 0.624 . . . . 75.44 112.263 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -152.79 24.62 0.58 Allowed 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.786 -1.191 . . . . 71.42 107.786 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 6.2 m -78.07 141.53 38.76 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.434 -1.257 . . . . 72.43 111.371 -173.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 70.42 27.6 72.44 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 116.065 -0.516 . . . . 73.23 113.51 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 569' ' ' MET . . . . . 0.523 ' O ' ' HA ' ' A' ' 602' ' ' ARG . 27.0 ptt? -99.51 160.02 14.59 Favored 'General case' 0 CA--C 1.476 -1.884 0 C-N-CA 120.233 -0.587 . . . . 62.53 109.936 -176.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 570' ' ' PHE . . . . . 0.587 ' HA ' ' O ' ' A' ' 601' ' ' ASN . 6.5 m-85 -103.38 175.05 5.61 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.638 -1.986 . . . . 74.41 105.638 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -70.1 -28.49 65.44 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 118.507 -1.277 . . . . 71.53 109.579 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.9 m -73.37 -13.38 16.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.557 -0.747 . . . . 71.23 110.548 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.597 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 24.0 t70 -101.46 -28.63 12.46 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.899 -0.778 . . . . 74.22 108.899 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -59.11 -53.05 62.77 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.046 -0.979 . . . . 75.33 111.803 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -54.8 -50.5 85.59 Favored Pre-proline 0 CA--C 1.558 1.287 0 N-CA-C 113.365 0.876 . . . . 74.42 113.365 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -57.67 -28.96 83.79 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 121.336 1.357 . . . . 62.24 112.766 172.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.597 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 23.0 mmm180 -68.76 -38.9 80.41 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 121.802 -0.561 . . . . 72.04 110.805 176.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.541 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 11.0 mp -59.75 -48.05 83.22 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 120.707 0.289 . . . . 74.44 110.453 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -66.37 -38.44 87.58 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.838 -0.619 . . . . 72.22 112.411 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.03 -39.06 76.0 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.545 0.688 . . . . 61.25 111.018 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.457 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 8.5 tp -83.28 -9.5 59.07 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 115.24 -0.891 . . . . 73.3 110.522 -178.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 60.87 42.35 99.57 Favored Glycine 0 CA--C 1.507 -0.466 0 N-CA-C 111.028 -0.829 . . . . 34.45 111.028 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.541 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 14.6 t90 -85.21 126.74 33.9 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.469 -0.567 . . . . 71.32 109.469 -175.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 12.7 t -99.14 -16.24 18.67 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 116.127 -0.488 . . . . 52.1 110.956 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 585' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -77.15 -177.49 45.88 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 121.509 -0.377 . . . . 74.22 112.691 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 48.4 tpp -112.8 147.16 37.5 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.192 -0.67 . . . . 72.14 109.192 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.4 tt -86.91 127.87 35.06 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.42 -1.326 . . . . 64.14 107.42 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 621' ' ' THR . 31.3 t70 -100.07 119.11 37.8 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.547 -0.538 . . . . 74.05 109.547 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.49 133.79 46.87 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.461 -0.896 . . . . 60.3 109.91 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.36 -79.05 0.95 Allowed Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.456 -0.793 . . . . 45.24 112.091 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -137.72 145.77 42.93 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 110.047 -0.353 . . . . 74.15 110.047 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -88.15 124.63 34.0 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.729 -1.582 . . . . 74.24 106.729 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 39.1 t -104.43 126.18 59.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.531 -0.914 . . . . 62.34 108.531 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 594' ' ' ASP . . . . . 0.525 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 32.2 t70 -73.58 106.39 5.33 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.379 -0.528 . . . . 75.44 111.114 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -113.54 -12.33 12.92 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.142 -0.936 . . . . 75.11 109.536 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 114.49 137.6 6.52 Favored Glycine 0 N--CA 1.428 -1.855 0 N-CA-C 111.084 -0.807 . . . . 42.42 111.084 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -63.23 -38.49 96.56 Favored Glycine 0 C--N 1.318 -0.464 0 C-N-CA 121.725 -0.274 . . . . 75.3 112.887 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 33.6 t -72.79 -22.82 60.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.869 0.842 . . . . 61.14 109.414 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -86.92 -3.43 59.08 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.006 -0.997 . . . . 65.03 110.546 -175.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 70.5 m80 67.67 158.11 0.14 Allowed 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.798 1.239 . . . . 75.22 113.199 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 601' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 570' ' ' PHE . 21.1 p30 -93.77 68.16 3.9 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.592 0.71 . . . . 64.52 112.905 -179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.523 ' HA ' ' O ' ' A' ' 569' ' ' MET . 2.7 ptp180 -85.47 146.72 26.81 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 119.365 -0.934 . . . . 72.53 112.171 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 74.2 t -57.95 130.11 20.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 114.053 -1.431 . . . . 72.34 109.516 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.17 -23.02 4.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.025 0.441 . . . . 73.4 111.086 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -155.97 135.9 12.76 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.548 -0.751 . . . . 75.4 109.726 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -124.5 137.64 54.4 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.698 -1.964 . . . . 74.12 105.698 173.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.41 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 28.6 t-20 -65.71 -53.52 35.68 Favored Pre-proline 0 C--N 1.317 -0.832 0 C-N-CA 119.066 -1.053 . . . . 70.42 112.86 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 5.3 Cg_endo -91.94 113.76 0.34 Allowed 'Trans proline' 0 N--CA 1.438 -1.789 0 C-N-CA 121.217 1.278 . . . . 64.33 109.344 171.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -70.14 160.11 50.75 Favored 'Trans proline' 0 C--O 1.247 0.947 0 C-N-CA 122.332 2.021 . . . . 64.13 111.539 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -62.18 138.89 58.48 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 109.844 -0.428 . . . . 73.2 109.844 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 102.1 -14.74 57.01 Favored Glycine 0 C--N 1.306 -1.113 0 N-CA-C 111.579 -0.608 . . . . 62.53 111.579 -175.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 6.0 m -92.05 155.03 18.37 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.881 -0.785 . . . . 71.31 108.881 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -80.01 134.22 13.31 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 121.033 -0.603 . . . . 71.14 112.496 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 13.6 m -127.06 143.13 41.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 124.226 1.01 . . . . 61.31 109.879 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.413 HD21 HG22 ' A' ' 619' ' ' ILE . 29.2 p-10 -49.58 162.87 0.14 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.322 1.049 . . . . 72.41 112.971 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -59.45 -24.83 63.87 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 114.056 1.132 . . . . 75.31 114.056 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.403 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 28.9 t70 -82.71 -8.82 59.57 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 119.598 -0.841 . . . . 73.03 109.523 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.2 14.68 64.31 Favored Glycine 0 C--O 1.221 -0.68 0 C-N-CA 123.519 0.581 . . . . 72.11 113.678 173.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 619' ' ' ILE . . . . . 0.413 HG22 HD21 ' A' ' 615' ' ' ASN . 0.1 OUTLIER -70.29 119.9 17.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 122.099 0.952 . . . . 63.32 110.556 -168.696 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.423 ' O ' HD12 ' A' ' 620' ' ' ILE . 2.7 pp -128.64 134.62 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-N 115.087 -0.961 . . . . 75.4 112.768 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 10.2 t -105.11 124.69 49.97 Favored 'General case' 0 C--O 1.258 1.551 0 CA-C-N 115.355 -0.839 . . . . 45.53 109.641 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.1 pp -140.12 167.35 22.33 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.514 -0.767 . . . . 62.04 112.411 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -127.3 140.25 52.33 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.788 -0.819 . . . . 75.0 108.788 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -139.97 167.37 22.28 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.628 -0.715 . . . . 55.44 110.039 -170.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -60.1 177.15 3.33 Favored Glycine 0 CA--C 1.538 1.472 0 O-C-N 124.008 0.818 . . . . 71.35 113.847 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.525 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 35.9 tp60 . . . . . 0 C--N 1.292 -1.921 0 C-N-CA 123.712 0.805 . . . . 73.23 108.971 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 491' ' ' GLY . . . . . 0.411 ' HA2' ' HD3' ' A' ' 492' ' ' PRO . . . . . . . . 0 CA--C 1.496 -1.129 0 N-CA-C 110.937 -0.865 . . . . 62.23 110.937 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 492' ' ' PRO . . . . . 0.411 ' HD3' ' HA2' ' A' ' 491' ' ' GLY . 24.5 Cg_exo -63.63 158.72 44.55 Favored 'Trans proline' 0 C--O 1.246 0.875 0 C-N-CA 122.349 2.032 . . . . 74.22 111.16 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -87.86 -5.15 58.74 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.895 0.855 . . . . 72.2 110.882 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 7.9 p -135.27 144.82 47.02 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.807 -1.183 . . . . 72.41 107.807 176.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -141.34 143.79 34.21 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 109.533 -0.543 . . . . 75.12 109.533 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.5 m-20 -83.02 124.73 30.7 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.036 -0.529 . . . . 72.4 110.46 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.4 pt -88.83 137.35 30.0 Favored Pre-proline 0 C--N 1.305 -1.327 0 CA-C-N 115.81 -0.632 . . . . 74.42 110.434 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.89 -177.34 3.76 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.311 2.007 . . . . 73.24 111.776 177.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -93.61 127.44 39.29 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.317 -0.994 . . . . 44.11 108.317 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.555 ' O ' ' HG2' ' A' ' 503' ' ' GLN . 28.2 m -122.06 -3.98 8.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 112.717 0.636 . . . . 73.44 112.717 -176.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -66.3 102.3 0.84 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.018 0.437 . . . . 75.42 110.423 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 141.94 -22.28 2.47 Favored Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 120.808 -0.711 . . . . 63.34 112.742 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.555 ' HG2' ' O ' ' A' ' 500' ' ' VAL . 6.3 pt20 -100.46 -179.1 4.0 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 109.091 -0.707 . . . . 65.22 109.091 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 21.1 m -74.4 155.41 38.11 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 108.495 -0.928 . . . . 73.2 108.495 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.18 -41.57 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 C-N-CA 122.697 0.399 . . . . 62.23 110.883 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 506' ' ' ASP . . . . . 0.497 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 28.5 t70 -59.69 -43.7 93.93 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.056 0.455 . . . . 61.23 110.162 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 90.2 t -67.99 -46.61 81.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 114.491 -1.231 . . . . 72.43 110.052 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.423 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -59.6 -45.79 90.86 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 123.41 0.444 . . . . 70.4 111.258 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -65.23 -44.49 88.07 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.178 -0.464 . . . . 75.25 111.745 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.567 ' O ' HG23 ' A' ' 514' ' ' VAL . 3.4 ptpp? -67.45 -39.92 85.4 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 119.632 -0.827 . . . . 64.43 111.186 176.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -62.44 -44.27 96.81 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.524 0.678 . . . . 73.2 110.918 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.65 -47.14 86.8 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-N 114.395 -1.275 . . . . 74.3 108.951 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -65.98 -35.23 80.02 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 115.439 -0.8 . . . . 64.33 112.675 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 510' ' ' LYS . 72.5 t -58.45 -33.76 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.115 0.483 . . . . 71.24 110.552 176.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -114.2 11.34 17.47 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.056 0.455 . . . . 74.25 110.117 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -127.47 -59.82 0.13 Allowed Glycine 0 CA--C 1.475 -2.416 0 C-N-CA 120.437 -0.887 . . . . 60.5 113.242 -172.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 66.25 21.55 11.03 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 121.926 0.87 . . . . 73.15 109.134 -172.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.4 p -91.48 -173.57 3.62 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 114.16 -1.382 . . . . 62.42 110.148 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 52.5 mtmt -108.11 143.85 36.28 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.384 -0.969 . . . . 75.52 108.384 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -129.17 151.08 50.23 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 120.866 0.365 . . . . 73.41 111.357 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 67.7 m -140.25 151.5 45.18 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 107.419 -1.326 . . . . 74.34 107.419 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -121.66 124.47 44.38 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.704 0.764 . . . . 64.0 112.334 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -101.43 133.05 46.66 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.999 -1.482 . . . . 75.15 106.999 175.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 22.2 m -118.37 122.12 42.06 Favored 'General case' 0 C--N 1.29 -1.978 0 C-N-CA 120.114 -0.634 . . . . 71.13 111.519 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.9 p -122.41 149.56 25.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.691 -1.226 . . . . 75.33 107.691 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -85.79 136.72 33.21 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 119.808 -0.757 . . . . 64.45 111.636 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 53.1 m -157.47 162.22 27.75 Favored Pre-proline 0 C--N 1.302 -1.486 0 N-CA-C 106.346 -1.724 . . . . 72.33 106.346 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.13 10.26 0.42 Allowed 'Trans proline' 0 CA--C 1.556 1.578 0 C-N-CA 122.343 2.028 . . . . 74.02 114.44 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.552 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 0.6 OUTLIER -95.26 145.77 30.13 Favored Pre-proline 0 CA--C 1.506 -0.716 0 N-CA-C 107.453 -1.314 . . . . 63.33 107.453 175.724 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -64.81 148.38 89.99 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.45 2.1 . . . . 72.11 114.341 -172.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.458 ' HB2' ' H ' ' A' ' 558' ' ' GLY . . . -61.85 113.76 2.96 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-N 114.323 -1.308 . . . . 74.04 110.742 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 126.57 -16.95 6.54 Favored Glycine 0 N--CA 1.42 -2.396 0 C-N-CA 119.918 -1.134 . . . . 64.21 111.768 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -82.92 128.18 34.21 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.28 -0.637 . . . . 75.43 109.28 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 5.3 p -94.36 112.71 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 N-CA-C 107.207 -1.405 . . . . 73.11 107.207 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 29.7 p -102.86 12.81 35.68 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 115.253 -0.885 . . . . 73.12 112.523 -172.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 169.04 172.42 35.77 Favored Glycine 0 N--CA 1.432 -1.616 0 C-N-CA 120.007 -1.092 . . . . 64.43 111.693 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 4.0 p -131.21 146.82 52.48 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.864 -0.791 . . . . 72.33 108.864 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 552' ' ' GLU . 2.8 t-20 -64.44 -51.58 59.19 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 119.784 -0.767 . . . . 75.54 109.872 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 58.8 Cg_endo -75.62 139.75 23.08 Favored 'Trans proline' 0 C--N 1.366 1.457 0 C-N-CA 120.859 1.039 . . . . 65.14 109.975 171.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 540' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 25.2 Cg_exo -64.55 140.53 69.35 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 122.259 1.973 . . . . 54.34 112.834 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -68.15 132.54 47.38 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.452 -0.795 . . . . 72.31 109.752 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.68 -9.07 58.5 Favored Glycine 0 N--CA 1.436 -1.33 0 N-CA-C 111.187 -0.765 . . . . 51.02 111.187 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 91.3 m -86.2 136.83 33.04 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.187 0.518 . . . . 71.25 111.291 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 9.8 t -81.31 125.79 30.78 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.757 -0.831 . . . . 73.21 108.757 174.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.74 161.8 44.32 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 107.89 -1.152 . . . . 72.32 107.89 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -62.54 138.51 70.77 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 120.967 1.112 . . . . 41.42 110.768 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.87 -19.9 24.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 121.376 0.608 . . . . 75.21 111.343 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -96.17 -0.74 49.61 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 121.789 -0.569 . . . . 55.41 110.523 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 10.4 t -86.6 171.95 10.63 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.4 0.619 . . . . 51.14 109.501 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 7.6 p -115.68 137.86 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.296 0 CA-C-N 115.379 -0.828 . . . . 73.12 110.071 -177.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 3.1 mp -94.48 135.1 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 108.342 -0.985 . . . . 75.05 108.342 175.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 552' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 538' ' ' ASN . 6.3 tp10 -102.46 117.32 34.46 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.695 -1.224 . . . . 72.34 107.695 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -91.58 121.45 33.27 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.43 -0.952 . . . . 72.12 108.43 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -89.9 101.99 14.69 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.641 -1.244 . . . . 73.24 107.641 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 524' ' ' SER . 38.4 t -101.31 136.83 31.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-N 115.223 -0.899 . . . . 73.01 110.025 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 59.7 m -91.71 128.18 37.45 Favored 'General case' 0 N--CA 1.41 -2.469 0 CA-C-N 115.973 -0.558 . . . . 71.03 109.744 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -90.58 142.93 27.25 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 105.904 -1.887 . . . . 74.44 105.904 169.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -54.48 -24.07 29.74 Favored Glycine 0 CA--C 1.479 -2.182 0 O-C-N 125.145 1.528 . . . . 35.31 115.25 -168.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 74.43 -22.74 0.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.441 1.097 . . . . 73.33 110.794 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.583 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 44.3 mt-30 -113.37 148.31 36.03 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-O 121.488 0.661 . . . . 61.23 111.461 -172.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -125.53 158.02 35.58 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.886 -1.052 . . . . 63.52 108.835 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.88 125.12 22.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 121.315 0.578 . . . . 65.21 111.127 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 20.2 ttt -75.42 125.83 88.34 Favored Pre-proline 0 N--CA 1.427 -1.601 0 CA-C-N 115.356 -0.838 . . . . 73.43 110.988 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.06 169.74 20.68 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 123.039 2.493 . . . . 64.14 111.799 177.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -75.29 130.04 38.41 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.682 0.753 . . . . 61.05 112.036 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 566' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 569' ' ' MET . 2.6 pp -141.27 18.26 2.24 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 123.021 1.391 . . . . 74.31 107.823 174.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 7.3 m -79.14 132.2 36.48 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 113.283 -1.781 . . . . 60.41 111.174 -173.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 568' ' ' GLY . . . . . 0.408 ' H ' ' CG1' ' A' ' 603' ' ' VAL . . . 64.54 39.66 96.99 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.541 -0.754 . . . . 72.45 114.29 174.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 569' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 16.0 ptp -128.89 -177.34 4.17 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 117.312 0.556 . . . . 55.4 109.933 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 570' ' ' PHE . . . . . 0.554 ' HA ' ' O ' ' A' ' 601' ' ' ASN . 49.3 m-85 -93.53 163.44 13.57 Favored 'General case' 0 C--O 1.25 1.083 0 N-CA-C 108.202 -1.036 . . . . 75.24 108.202 -178.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 571' ' ' TRP . . . . . 0.474 ' CH2' HD13 ' A' ' 587' ' ' LEU . 16.3 t-105 -63.07 -32.16 73.47 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.166 -1.05 . . . . 64.14 108.166 174.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.75 -10.48 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.471 -0.786 . . . . 63.42 111.159 -176.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -101.36 -43.9 5.8 Favored 'General case' 0 C--O 1.256 1.401 0 N-CA-C 108.09 -1.078 . . . . 73.33 108.09 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 574' ' ' ALA . . . . . 0.517 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -62.82 -51.44 67.05 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.326 -1.306 . . . . 74.22 111.945 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.562 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 37.8 tt0 -51.75 -54.1 43.64 Favored Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 112.395 0.517 . . . . 75.2 112.395 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 52.9 Cg_exo -59.55 -38.29 83.47 Favored 'Trans proline' 0 C--N 1.38 2.237 0 C-N-CA 121.972 1.782 . . . . 73.43 112.721 177.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -66.76 -37.14 84.04 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 120.381 -0.528 . . . . 72.23 112.198 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.585 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 89.7 mt -66.75 -47.49 72.08 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.898 -0.592 . . . . 75.0 110.529 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -65.59 -34.52 78.43 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.635 -0.426 . . . . 71.15 111.048 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.24 -32.02 71.92 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.953 0.406 . . . . 74.31 110.943 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 578' ' ' LEU . 2.8 pp -80.89 -6.92 59.27 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.537 -0.465 . . . . 72.3 110.033 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 85.6 34.86 12.65 Favored Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 115.833 -0.621 . . . . 65.14 112.878 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.43 ' CZ3' HD13 ' A' ' 578' ' ' LEU . 21.3 t90 -67.19 130.6 43.64 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.544 0.172 . . . . 75.21 111.054 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 62.8 p -103.24 -23.14 13.63 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-O 120.987 0.422 . . . . 72.55 112.023 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -75.98 -175.92 39.82 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-O 121.72 0.622 . . . . 62.33 114.359 -174.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 54.3 ttp -115.05 141.35 48.12 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.951 -0.625 . . . . 74.43 109.753 -176.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 587' ' ' LEU . . . . . 0.474 HD13 ' CH2' ' A' ' 571' ' ' TRP . 5.5 tt -85.64 125.68 33.34 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.061 0.457 . . . . 64.1 110.074 -175.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -95.89 104.35 16.28 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.543 -0.753 . . . . 74.12 110.333 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.467 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -112.16 133.51 54.25 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.138 -1.43 . . . . 62.54 107.138 173.209 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -111.68 -42.33 1.04 Allowed Glycine 0 C--N 1.284 -2.318 0 C-N-CA 119.874 -1.155 . . . . 74.53 113.993 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.4 135.64 33.86 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 120.569 -0.453 . . . . 63.14 111.379 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -90.86 124.44 35.17 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 105.954 -1.869 . . . . 70.0 105.954 172.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 593' ' ' VAL . . . . . 0.491 ' O ' ' HG2' ' A' ' 626' ' ' GLN . 46.3 t -104.81 156.26 6.02 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 N-CA-C 109.049 -0.723 . . . . 74.31 109.049 -174.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 594' ' ' ASP . . . . . 0.448 ' HA ' ' HG2' ' A' ' 626' ' ' GLN . 1.6 p-10 -71.49 126.94 30.99 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.298 0.571 . . . . 73.1 109.894 -176.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -148.36 -57.09 0.22 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.953 -1.021 . . . . 74.42 109.318 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 116.34 124.57 3.66 Favored Glycine 0 N--CA 1.426 -2.005 0 C-N-CA 120.638 -0.791 . . . . 65.33 111.764 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -63.64 -35.96 92.72 Favored Glycine 0 C--N 1.316 -0.542 0 N-CA-C 112.113 -0.395 . . . . 75.2 112.113 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 6.5 m -76.04 -24.02 55.15 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-O 122.014 0.911 . . . . 64.11 108.99 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -87.96 -2.41 58.59 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.607 -1.179 . . . . 73.13 109.343 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 600' ' ' HIS . . . . . 0.539 ' HB3' ' CE2' ' A' ' 570' ' ' PHE . 30.6 m80 81.56 125.19 0.04 OUTLIER 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.41 1.884 . . . . 74.14 111.952 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 601' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 570' ' ' PHE . 8.5 p30 -73.57 96.23 2.41 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 122.597 1.189 . . . . 74.51 109.42 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 21.4 mmm-85 -100.17 151.49 21.36 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 107.351 -1.351 . . . . 74.53 107.351 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.408 ' CG1' ' H ' ' A' ' 568' ' ' GLY . 8.1 p -65.58 131.68 31.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 106.971 -1.492 . . . . 55.22 106.971 172.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.61 -26.21 3.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 120.112 -0.635 . . . . 71.5 111.895 -174.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -155.6 138.21 15.1 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.949 -0.76 . . . . 72.45 108.949 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -133.64 139.5 46.52 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.524 -1.288 . . . . 72.5 107.524 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.43 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 26.3 t-20 -71.99 -51.47 8.45 Favored Pre-proline 0 C--N 1.307 -1.246 0 C-N-CA 119.627 -0.829 . . . . 74.13 111.152 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 74.6 Cg_endo -92.3 122.19 0.58 Allowed 'Trans proline' 0 N--CA 1.442 -1.516 0 C-N-CA 121.111 1.207 . . . . 73.21 111.332 174.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -70.35 153.35 66.29 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 121.77 1.646 . . . . 75.31 110.11 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -65.36 133.08 50.6 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.266 -0.642 . . . . 60.33 109.266 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.15 -7.68 44.27 Favored Glycine 0 C--N 1.314 -0.656 0 C-N-CA 120.786 -0.721 . . . . 73.54 111.481 -176.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 19.5 m -88.16 155.59 19.69 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.532 -0.914 . . . . 71.02 108.532 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.54 126.53 7.51 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 111.116 -0.794 . . . . 74.24 111.116 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 18.5 m -113.84 141.97 28.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.609 -0.515 . . . . 63.15 109.609 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.583 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.3 p-10 -53.4 167.94 0.18 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.682 1.193 . . . . 72.34 113.16 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -57.68 -24.66 57.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.533 -0.758 . . . . 73.45 112.98 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.451 ' OD2' ' HB ' ' A' ' 619' ' ' ILE . 28.2 t70 -82.47 -9.49 59.41 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.493 -0.483 . . . . 72.51 109.703 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.63 18.3 67.89 Favored Glycine 0 CA--C 1.506 -0.525 0 CA-C-N 116.094 -0.503 . . . . 53.05 112.649 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 619' ' ' ILE . . . . . 0.451 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -69.86 119.5 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-O 122.269 1.033 . . . . 73.43 111.329 -167.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.447 ' O ' HD12 ' A' ' 620' ' ' ILE . 2.6 pp -116.98 131.3 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.067 0 CA-C-N 114.703 -1.135 . . . . 72.54 111.191 177.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 54.4 m -104.68 117.88 35.19 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.549 -0.908 . . . . 73.32 108.549 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.6 pp -139.72 165.82 26.25 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.602 -0.272 . . . . 72.35 111.16 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -139.47 140.9 37.39 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.647 -0.871 . . . . 74.35 108.647 174.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -128.0 166.44 18.38 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 116.216 -0.447 . . . . 74.43 111.192 -171.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -71.77 153.34 50.08 Favored Glycine 0 N--CA 1.428 -1.864 0 CA-C-N 115.524 -0.762 . . . . 65.04 113.529 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 593' ' ' VAL . 13.0 pt20 . . . . . 0 C--N 1.299 -1.593 0 C-N-CA 123.514 0.726 . . . . 51.1 110.171 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.953 0 N-CA-C 111.101 -0.799 . . . . 43.05 111.101 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.72 142.84 36.43 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.038 1.825 . . . . 62.33 110.799 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -90.04 7.28 38.46 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.152 0.501 . . . . 63.11 109.916 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.9 p -135.55 149.41 49.43 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.65 -0.705 . . . . 74.11 110.711 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.452 ' HE2' ' H ' ' A' ' 496' ' ' ASP . 0.1 OUTLIER -150.6 132.61 15.21 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.259 -1.756 . . . . 65.52 106.259 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.3 p-10 -81.47 133.1 35.35 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.149 0.5 . . . . 74.35 110.349 175.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.1 pt -86.09 138.22 34.86 Favored Pre-proline 0 C--N 1.304 -1.383 0 CA-C-N 115.465 -0.789 . . . . 74.13 111.886 -177.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.64 178.41 7.61 Favored 'Trans proline' 0 C--O 1.245 0.832 0 C-N-CA 122.408 2.072 . . . . 74.43 112.009 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -80.07 96.99 6.65 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 122.627 1.203 . . . . 73.33 110.446 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.64 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 28.5 m -95.39 -1.07 10.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 CA-C-N 115.313 -0.858 . . . . 65.1 111.828 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -76.12 107.27 8.23 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 108.738 -0.838 . . . . 43.43 108.738 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 142.71 -30.17 2.08 Favored Glycine 0 C--N 1.299 -1.494 0 C-N-CA 120.746 -0.74 . . . . 62.42 112.791 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -100.35 -177.88 3.64 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 120.109 -0.636 . . . . 70.42 110.501 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.407 ' HB ' HG23 ' A' ' 507' ' ' VAL . 2.8 m -70.34 155.61 40.43 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.565 -0.532 . . . . 65.44 109.565 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.432 ' HA ' ' CG2' ' A' ' 534' ' ' VAL . 5.9 p -55.04 -46.32 77.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 123.394 0.678 . . . . 71.44 112.1 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.69 -39.18 90.51 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.898 -0.592 . . . . 64.55 110.543 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.407 HG23 ' HB ' ' A' ' 504' ' ' THR . 59.9 t -73.07 -49.01 41.61 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.258 0 CA-C-N 115.337 -0.847 . . . . 74.21 109.888 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.64 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -58.73 -44.8 90.54 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 122.994 0.518 . . . . 62.34 110.972 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -64.99 -45.68 84.61 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.367 -0.378 . . . . 74.21 111.304 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.543 ' O ' HG23 ' A' ' 514' ' ' VAL . 17.8 ptpt -68.0 -37.86 81.97 Favored 'General case' 0 C--O 1.21 -1.0 0 C-N-CA 120.656 -0.418 . . . . 72.5 111.254 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.04 -48.4 81.86 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 123.4 0.437 . . . . 71.13 110.517 -177.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -68.71 -36.21 78.14 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 120.259 -0.577 . . . . 74.13 110.886 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.444 ' N ' HD12 ' A' ' 512' ' ' LEU . 17.0 t30 -66.14 -35.59 80.88 Favored 'General case' 0 C--O 1.203 -1.376 0 C-N-CA 123.783 0.833 . . . . 75.22 110.505 -178.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 510' ' ' LYS . 75.9 t -60.94 -33.41 55.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.95 0.405 . . . . 63.14 111.11 177.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -102.51 -4.67 24.99 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.145 -0.622 . . . . 71.0 111.014 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -122.85 -50.84 0.22 Allowed Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 120.427 -0.892 . . . . 64.05 113.544 -171.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 67.5 27.18 8.02 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 122.515 1.15 . . . . 74.01 109.337 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.7 p -80.29 -167.09 1.2 Allowed 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 113.027 -1.897 . . . . 63.12 110.981 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -119.2 142.79 47.69 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.595 -1.261 . . . . 71.31 107.595 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -132.65 153.41 51.12 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 112.545 0.572 . . . . 71.53 112.545 -175.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.7 m -132.65 151.51 51.94 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.057 -1.461 . . . . 71.34 107.057 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -124.27 133.36 53.51 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 109.179 -0.674 . . . . 64.14 109.179 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -125.41 116.1 21.33 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.221 -1.029 . . . . 62.44 108.221 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 23.9 m -98.46 124.97 43.48 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.13 0.491 . . . . 73.15 111.053 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 11.0 p -126.56 154.19 36.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.799 -1.185 . . . . 74.22 107.799 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.93 135.63 35.38 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.34 0.59 . . . . 71.2 110.183 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 50.3 m -167.65 139.13 2.47 Favored Pre-proline 0 C--O 1.197 -1.68 0 N-CA-C 105.097 -2.186 . . . . 43.54 105.097 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.43 9.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.566 2.124 0 C-N-CA 123.466 2.777 . . . . 72.15 116.997 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.23 147.07 63.93 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 106.338 -1.727 . . . . 74.23 106.338 172.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.72 141.56 95.62 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.194 1.93 . . . . 75.3 112.921 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 557' ' ' LYS . . . -61.69 116.12 4.53 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 114.811 -1.086 . . . . 65.13 112.128 -176.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 121.46 -16.24 9.12 Favored Glycine 0 N--CA 1.423 -2.226 0 CA-C-N 115.044 -0.98 . . . . 71.44 111.538 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -77.47 128.28 33.95 Favored 'General case' 0 C--O 1.248 1.012 0 N-CA-C 109.328 -0.619 . . . . 74.21 109.328 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.432 ' CG2' ' HA ' ' A' ' 505' ' ' VAL . 38.0 t -86.1 112.43 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.165 0 N-CA-C 106.952 -1.499 . . . . 53.45 106.952 173.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 17.4 p -84.33 -2.42 57.04 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.594 0.712 . . . . 64.02 111.209 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.66 179.43 27.33 Favored Glycine 0 N--CA 1.419 -2.491 0 C-N-CA 120.606 -0.806 . . . . 65.54 112.435 174.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 1.6 p -116.69 158.05 24.43 Favored 'General case' 0 C--N 1.271 -2.825 0 N-CA-C 106.694 -1.595 . . . . 54.13 106.694 177.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -60.43 -49.5 89.97 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 118.794 -1.162 . . . . 71.43 112.015 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 38.8 Cg_endo -73.61 128.8 12.97 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 N-CA-C 108.238 -1.485 . . . . 33.33 108.238 167.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 540' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 24.9 Cg_exo -63.72 155.93 60.53 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 122.501 2.134 . . . . 64.44 113.126 -177.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.05 129.63 43.08 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.245 0.618 . . . . 65.15 110.152 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.2 -15.22 54.8 Favored Glycine 0 N--CA 1.435 -1.422 0 N-CA-C 111.715 -0.554 . . . . 54.44 111.715 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 37.6 m -76.27 134.1 39.88 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.939 0.4 . . . . 70.11 111.407 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.0 t -76.53 124.06 27.02 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.45 -0.945 . . . . 64.31 108.45 173.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.04 160.72 50.77 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 108.14 -1.059 . . . . 54.34 108.14 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.48 136.84 26.89 Favored 'Trans proline' 0 N--CA 1.435 -1.952 0 CA-C-N 119.627 0.903 . . . . 72.01 110.218 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.17 -19.85 26.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.764 0.792 . . . . 74.24 110.943 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -89.64 -7.71 54.11 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.058 -0.974 . . . . 74.41 110.812 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.4 t -88.08 167.51 13.6 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.46 0.648 . . . . 70.15 109.887 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 9.8 p -108.73 121.25 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 CA-C-N 115.266 -0.879 . . . . 74.02 109.254 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 58.5 mt -87.24 133.14 30.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 115.298 -0.864 . . . . 74.41 110.045 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.15 117.6 34.91 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.763 0.792 . . . . 73.32 111.85 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.404 HD12 HG11 ' A' ' 534' ' ' VAL . 3.4 mm? -92.36 114.01 26.43 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 113.614 -1.63 . . . . 73.12 108.862 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -85.35 104.86 15.56 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.75 0.786 . . . . 61.55 109.766 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 524' ' ' SER . 23.7 t -92.96 132.8 36.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 114.667 -1.151 . . . . 71.15 108.171 -177.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 53.0 m -105.47 135.83 46.15 Favored 'General case' 0 N--CA 1.409 -2.516 0 CA-C-O 121.244 0.545 . . . . 42.34 111.093 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.0 ptpt -116.57 128.01 55.02 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 108.107 -1.071 . . . . 64.42 108.107 174.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -58.71 -24.81 57.8 Favored Glycine 0 CA--C 1.496 -1.125 0 O-C-N 123.877 0.735 . . . . 21.2 111.37 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 559' ' ' ASN . . . . . 0.425 ' ND2' ' HB3' ' A' ' 616' ' ' ARG . 65.0 t30 63.88 28.03 14.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 122.846 1.308 . . . . 64.14 109.063 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.517 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 82.7 mt-30 -112.5 151.03 30.43 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 113.725 -1.58 . . . . 74.33 108.333 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -130.42 147.42 52.12 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 109.254 -0.647 . . . . 74.45 109.254 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.93 120.07 13.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 O-C-N 123.896 0.748 . . . . 73.15 109.683 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.615 ' SD ' HG21 ' A' ' 620' ' ' ILE . 42.9 ttp -83.17 129.08 62.35 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 116.26 -0.427 . . . . 62.33 111.158 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 564' ' ' PRO . . . . . 0.426 ' O ' ' HG2' ' A' ' 563' ' ' MET . 57.9 Cg_endo -73.76 169.57 22.05 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.547 2.165 . . . . 71.32 110.317 174.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -76.93 135.31 38.76 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.383 0.611 . . . . 73.2 111.259 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 566' ' ' LEU . . . . . 0.415 ' O ' ' HG2' ' A' ' 569' ' ' MET . 0.9 OUTLIER -114.53 -14.98 12.08 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.326 -0.99 . . . . 62.14 108.326 -177.259 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 567' ' ' SER . . . . . 0.404 ' HA ' ' HB ' ' A' ' 603' ' ' VAL . 33.2 t -77.47 147.39 35.92 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.585 -0.697 . . . . 70.13 110.91 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 96.26 11.01 55.37 Favored Glycine 0 CA--C 1.501 -0.798 0 CA-C-N 115.806 -0.634 . . . . 75.52 113.411 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 569' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 19.2 ptm -133.49 169.11 17.46 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.749 -0.463 . . . . 62.15 109.749 177.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 570' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 601' ' ' ASN . 10.9 m-85 -89.52 158.25 17.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.683 -0.858 . . . . 74.25 108.683 -176.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 571' ' ' TRP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 29.0 t-105 -65.6 -25.05 67.23 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.189 -0.671 . . . . 74.34 109.189 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 23.0 m -69.22 -26.99 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 115.599 -0.728 . . . . 51.22 112.497 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 12.0 t70 -101.85 -23.45 14.17 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 108.538 -0.912 . . . . 74.23 108.538 175.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 574' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 577' ' ' ARG . . . -61.98 -46.73 87.96 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 115.531 -0.759 . . . . 54.5 112.341 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.476 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 0.9 OUTLIER -60.31 -49.19 91.65 Favored Pre-proline 0 CA--C 1.565 1.532 0 C-N-CA 120.279 -0.568 . . . . 62.3 110.199 179.422 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 62.5 Cg_exo -52.59 -29.78 42.36 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.328 2.019 . . . . 72.02 113.328 169.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 10.4 mmm180 -62.57 -39.53 93.97 Favored 'General case' 0 C--O 1.21 -1.007 0 O-C-N 121.791 -0.568 . . . . 41.32 110.47 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.788 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 9.6 mp -58.84 -49.65 76.94 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.155 0.503 . . . . 62.22 110.615 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' A' ' 576' ' ' PRO . 14.4 ptp180 -66.74 -38.37 86.52 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.388 -0.823 . . . . 64.23 112.389 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.29 -35.7 73.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.982 0.42 . . . . 42.31 111.583 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 6.0 tp -81.7 -9.67 59.58 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 123.892 0.877 . . . . 64.22 110.801 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 66.05 39.8 94.89 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.905 -0.878 . . . . 43.24 110.905 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.788 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 7.3 t90 -79.69 127.52 32.29 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 108.528 -0.916 . . . . 72.31 108.528 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 584' ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' ' 617' ' ' ASP . 0.8 OUTLIER -78.62 -39.7 36.48 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 125.345 1.458 . . . . 75.32 112.78 -176.693 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -77.92 -162.01 17.92 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.929 -0.578 . . . . 71.03 111.759 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 65.8 mtt -133.82 160.76 36.64 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 122.426 -0.456 . . . . 72.14 109.867 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 22.7 tp -80.53 111.06 16.59 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.853 -1.166 . . . . 64.4 107.853 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 621' ' ' THR . 22.6 t70 -99.51 112.63 24.81 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.073 -0.512 . . . . 63.23 111.198 -172.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.88 133.61 34.23 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 118.848 -1.141 . . . . 45.32 109.975 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.71 -63.84 1.8 Allowed Glycine 0 C--N 1.296 -1.663 0 N-CA-C 110.998 -0.841 . . . . 60.15 110.998 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -137.04 145.12 43.64 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 121.012 0.434 . . . . 71.45 109.965 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -91.79 127.38 37.23 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.4 -1.704 . . . . 62.34 106.4 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 61.3 t -102.98 125.63 57.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 108.328 -0.99 . . . . 60.43 108.328 -175.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -72.31 107.99 5.21 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 121.491 0.662 . . . . 75.41 109.802 -173.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -123.56 -54.47 1.76 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.572 -0.74 . . . . 72.32 110.957 -175.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 104.18 147.55 17.45 Favored Glycine 0 N--CA 1.413 -2.879 0 N-CA-C 109.636 -1.386 . . . . 70.4 109.636 -173.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.74 -33.08 62.49 Favored Glycine 0 C--N 1.309 -0.921 0 N-CA-C 113.875 0.31 . . . . 52.13 113.875 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 11.8 m -68.33 -24.06 64.79 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 123.918 0.887 . . . . 73.1 110.879 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -88.6 -1.85 58.28 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.317 -0.856 . . . . 73.53 110.303 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 41.5 m80 74.5 121.23 0.04 OUTLIER 'General case' 0 C--O 1.242 0.689 0 C-N-CA 125.527 1.531 . . . . 64.52 111.952 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 601' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 570' ' ' PHE . 21.2 m120 -82.4 63.4 6.55 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 115.493 -0.776 . . . . 72.12 111.497 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -95.55 160.5 14.48 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.397 -0.82 . . . . 75.23 109.729 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.411 HG11 HD12 ' A' ' 622' ' ' LEU . 72.7 t -71.11 130.37 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.104 0 N-CA-C 105.144 -2.169 . . . . 70.11 105.144 169.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.7 m -102.69 -28.6 3.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 120.284 -0.567 . . . . 73.23 111.763 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -157.08 135.81 11.58 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 116.62 -0.264 . . . . 70.21 111.049 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -111.62 128.95 56.21 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.731 -1.211 . . . . 72.43 107.731 170.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.472 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 8.4 t30 -57.78 -52.37 74.9 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 112.206 0.447 . . . . 63.24 112.206 -176.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 5.2 Cg_exo -83.65 122.74 3.15 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 121.823 1.682 . . . . 72.4 109.318 171.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.02 155.8 61.13 Favored 'Trans proline' 0 C--O 1.258 1.484 0 C-N-CA 122.859 2.373 . . . . 74.45 113.848 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.53 138.72 58.3 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.436 -0.802 . . . . 51.25 109.599 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 103.53 -11.64 54.04 Favored Glycine 0 C--N 1.298 -1.531 0 C-N-CA 120.438 -0.887 . . . . 74.42 111.864 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 17.2 m -83.48 141.97 31.26 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.377 -0.601 . . . . 71.32 109.377 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.69 113.9 3.75 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.109 -1.196 . . . . 22.34 110.109 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.5 m -102.01 142.67 16.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 O-C-N 122.982 -0.128 . . . . 71.33 110.667 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.517 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 0.7 OUTLIER -50.33 164.78 0.11 Allowed 'General case' 0 C--O 1.21 -0.982 0 N-CA-C 113.465 0.913 . . . . 44.21 113.465 177.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 616' ' ' ARG . . . . . 0.425 ' HB3' ' ND2' ' A' ' 559' ' ' ASN . 14.9 ptm180 -48.74 -27.89 3.24 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.66 1.726 . . . . 75.25 115.66 -171.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.477 ' HA ' ' OG1' ' A' ' 584' ' ' THR . 20.0 p-10 -97.2 -7.06 33.27 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.545 -0.462 . . . . 72.31 111.287 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.0 17.14 65.14 Favored Glycine 0 C--O 1.215 -1.058 0 CA-C-O 119.657 -0.524 . . . . 62.43 114.311 167.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.49 119.09 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-O 121.716 0.77 . . . . 70.41 110.768 -168.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.615 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.6 pp -129.35 134.05 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-N 115.277 -0.874 . . . . 74.25 111.31 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 13.1 t -99.03 130.42 45.36 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.45 -0.795 . . . . 74.12 108.984 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.411 HD12 HG11 ' A' ' 603' ' ' VAL . 1.7 pt? -139.59 167.91 21.03 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.671 -0.695 . . . . 65.41 111.76 -174.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -127.07 140.74 52.06 Favored 'General case' 0 C--O 1.256 1.41 0 N-CA-C 109.045 -0.724 . . . . 72.14 109.045 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -139.26 165.75 26.36 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.465 -0.334 . . . . 63.51 110.354 -175.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -78.64 139.47 22.3 Favored Glycine 0 N--CA 1.434 -1.467 0 O-C-N 123.677 0.611 . . . . 32.44 113.328 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 C--N 1.288 -2.108 0 C-N-CA 125.525 1.53 . . . . 72.4 107.881 -179.301 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.005 0 N-CA-C 109.67 -1.372 . . . . 43.05 109.67 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -74.21 141.88 29.77 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.891 1.727 . . . . 74.34 109.567 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -126.4 11.94 7.5 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.512 -0.475 . . . . 64.33 110.589 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.437 HG22 ' HA ' ' A' ' 546' ' ' PRO . 25.9 p -140.12 145.36 37.49 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 110.043 -0.354 . . . . 74.13 110.043 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -139.64 155.51 47.37 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.428 -1.323 . . . . 73.24 107.428 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.596 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.4 p-10 -98.15 144.26 27.8 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.203 -0.599 . . . . 64.34 110.749 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.1 pt -87.09 137.42 33.05 Favored Pre-proline 0 C--N 1.295 -1.781 0 CA-C-N 115.073 -0.967 . . . . 75.15 111.592 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -85.03 -176.03 2.26 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.551 2.168 . . . . 74.12 111.053 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -86.22 114.94 23.45 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.18 0.514 . . . . 72.33 109.793 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.529 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 17.5 m -119.73 58.78 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-O 122.746 1.26 . . . . 61.34 110.422 175.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -118.73 107.47 13.7 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.181 -1.372 . . . . 53.42 108.677 174.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 142.42 -25.38 2.32 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 118.972 -1.585 . . . . 44.1 113.734 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -101.74 -174.68 2.65 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 117.782 0.791 . . . . 43.12 109.858 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.448 ' HB ' HG23 ' A' ' 507' ' ' VAL . 7.5 m -73.13 155.5 39.61 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.895 -1.15 . . . . 73.53 107.895 178.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.542 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.4 p -60.2 -44.72 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 111.715 0.265 . . . . 64.24 111.715 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.12 -36.11 82.96 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 120.543 -0.463 . . . . 54.13 110.084 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.448 HG23 ' HB ' ' A' ' 504' ' ' THR . 68.4 t -68.9 -45.38 80.66 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.445 0 CA-C-N 115.616 -0.72 . . . . 74.2 109.257 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.529 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -60.29 -42.95 96.56 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 123.228 0.33 . . . . 72.42 110.538 177.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.542 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 96.0 mt-30 -63.46 -43.22 97.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.011 -0.366 . . . . 74.15 110.011 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 514' ' ' VAL . 46.0 mmtm -64.48 -43.91 92.67 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.443 0.639 . . . . 70.31 109.792 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -61.95 -48.26 81.21 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.109 -1.405 . . . . 75.4 110.13 -175.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.2 pp -69.65 -35.78 75.49 Favored 'General case' 0 C--O 1.208 -1.082 0 CA-C-N 115.509 -0.769 . . . . 75.43 110.862 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 33.4 t30 -61.44 -35.32 77.24 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 123.925 0.89 . . . . 74.12 110.105 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 510' ' ' LYS . 97.7 t -59.18 -38.0 71.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.872 0.368 . . . . 70.31 111.298 178.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -108.22 10.26 27.89 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.628 -0.508 . . . . 62.52 109.628 -176.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -132.66 -56.74 0.08 OUTLIER Glycine 0 N--CA 1.428 -1.835 0 C-N-CA 120.074 -1.06 . . . . 75.01 113.813 -172.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 63.41 23.21 13.62 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 122.055 0.931 . . . . 72.21 110.082 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.479 HG22 ' HA ' ' A' ' 547' ' ' VAL . 1.0 OUTLIER -83.72 -174.8 5.49 Favored 'General case' 0 N--CA 1.412 -2.327 0 C-N-CA 125.984 1.714 . . . . 63.23 110.669 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 0.4 OUTLIER -107.74 141.89 38.6 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.357 -1.349 . . . . 74.15 107.357 178.107 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -133.05 148.37 52.21 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.056 0.455 . . . . 70.15 112.192 -175.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 48.4 m -141.48 155.39 45.84 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.57 -0.9 . . . . 65.24 108.57 173.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -116.92 139.29 50.81 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.07 0.462 . . . . 75.14 111.493 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -122.37 118.71 29.07 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.333 -1.358 . . . . 70.23 107.333 176.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 11.6 m -103.93 127.32 51.46 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 120.689 -0.404 . . . . 61.04 111.493 -174.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 14.3 p -121.08 156.7 24.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.883 -1.155 . . . . 63.52 107.883 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -70.85 135.15 47.88 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-O 120.84 0.353 . . . . 75.15 110.647 -176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 65.9 m -165.04 158.07 14.05 Favored Pre-proline 0 C--N 1.31 -1.148 0 N-CA-C 107.667 -1.235 . . . . 74.14 107.667 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -66.25 -15.05 46.9 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.332 2.022 . . . . 65.21 113.257 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.66 140.22 81.32 Favored Pre-proline 0 CA--C 1.519 -0.225 0 N-CA-C 108.936 -0.765 . . . . 70.23 108.936 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.56 146.28 97.07 Favored 'Trans proline' 0 C--O 1.252 1.192 0 C-N-CA 122.764 2.31 . . . . 65.42 112.888 -175.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -59.82 110.95 1.28 Allowed 'General case' 0 C--O 1.244 0.813 0 CA-C-N 115.29 -0.868 . . . . 74.35 110.883 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 136.03 -20.86 3.56 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 120.569 -0.824 . . . . 62.33 112.129 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -82.79 132.91 35.15 Favored 'General case' 0 C--O 1.248 1.019 0 CA-C-O 121.15 0.5 . . . . 74.12 110.673 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.44 HG11 ' CB ' ' A' ' 508' ' ' ALA . 7.3 p -99.32 119.64 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.533 0 N-CA-C 107.902 -1.147 . . . . 75.34 107.902 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.5 p -98.77 12.92 34.12 Favored 'General case' 0 C--N 1.274 -2.694 0 CA-C-N 115.107 -0.951 . . . . 72.35 113.301 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 143.23 -176.93 22.43 Favored Glycine 0 CA--C 1.493 -1.296 0 C-N-CA 120.433 -0.889 . . . . 73.23 112.196 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 7.0 p -117.41 157.1 26.78 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.372 -0.973 . . . . 55.25 108.372 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.409 ' HB2' ' OE2' ' A' ' 552' ' ' GLU . 44.3 t-20 -56.5 -58.22 18.4 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 119.983 -0.687 . . . . 71.34 110.689 175.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.96 140.75 32.06 Favored 'Trans proline' 0 C--N 1.365 1.422 0 CA-C-N 120.63 1.261 . . . . 73.11 109.965 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.57 156.48 63.74 Favored 'Trans proline' 0 C--O 1.252 1.18 0 C-N-CA 122.466 2.111 . . . . 65.12 112.348 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.58 137.62 58.3 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.015 -0.539 . . . . 54.22 110.798 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.1 -16.13 50.32 Favored Glycine 0 CA--C 1.492 -1.347 0 N-CA-C 111.485 -0.646 . . . . 51.32 111.485 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 71.0 m -74.05 122.95 23.47 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 109.945 -0.391 . . . . 74.04 109.945 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.3 t -80.43 124.62 29.06 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 108.473 -0.936 . . . . 70.34 108.473 176.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.7 m -122.72 156.58 61.54 Favored Pre-proline 0 C--N 1.294 -1.835 0 N-CA-C 107.468 -1.308 . . . . 73.23 107.468 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.437 ' HA ' HG22 ' A' ' 494' ' ' THR . 5.2 Cg_exo -67.67 138.47 45.4 Favored 'Trans proline' 0 N--CA 1.436 -1.894 0 C-N-CA 121.68 1.587 . . . . 75.12 111.82 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.479 ' HA ' HG22 ' A' ' 518' ' ' THR . 7.5 p -63.79 -20.53 26.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 115.087 -0.961 . . . . 51.1 111.455 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -87.79 -17.46 31.53 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.882 0.372 . . . . 72.11 110.488 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 53.3 m -88.07 159.61 18.17 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-O 122.312 1.053 . . . . 53.23 113.304 -173.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 68.9 t -89.85 129.49 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 CA-C-N 113.204 -1.816 . . . . 64.22 110.267 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 56.0 mt -91.57 140.59 15.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.727 -1.212 . . . . 51.3 107.727 176.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 552' ' ' GLU . . . . . 0.409 ' OE2' ' HB2' ' A' ' 538' ' ' ASN . 21.9 tt0 -103.26 117.7 35.11 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 110.339 -0.245 . . . . 72.33 110.339 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.3 mp -99.76 123.22 43.8 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 123.851 0.72 . . . . 55.21 110.016 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -85.95 106.89 17.46 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 123.472 0.709 . . . . 65.21 109.193 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 524' ' ' SER . 42.8 t -105.63 144.96 14.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.479 -0.782 . . . . 74.13 109.492 -176.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.549 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 46.8 m -93.35 126.92 38.73 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 116.077 -0.511 . . . . 64.11 109.961 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -99.01 131.43 45.06 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 106.175 -1.787 . . . . 74.24 106.175 169.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -62.92 -24.25 66.56 Favored Glycine 0 CA--C 1.492 -1.394 0 O-C-N 124.673 1.233 . . . . 70.25 114.271 -170.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 75.15 -27.02 0.19 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.52 1.128 . . . . 70.21 111.199 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.516 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 59.9 mt-30 -111.92 163.53 14.12 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 115.713 -0.676 . . . . 73.22 110.646 -172.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -141.09 157.28 45.52 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.895 -1.048 . . . . 71.51 108.841 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.22 126.75 33.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.931 -0.396 . . . . 72.52 109.931 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.454 ' SD ' HG21 ' A' ' 620' ' ' ILE . 49.5 ttp -94.23 137.13 22.92 Favored Pre-proline 0 C--N 1.314 -0.958 0 N-CA-C 111.946 0.351 . . . . 73.14 111.946 -176.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.25 169.81 21.36 Favored 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 122.861 2.374 . . . . 73.55 111.261 173.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -84.79 140.65 31.06 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.796 -0.446 . . . . 65.42 109.796 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 566' ' ' LEU . . . . . 0.448 ' O ' ' HG2' ' A' ' 569' ' ' MET . 2.4 pp -138.73 16.62 2.69 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.622 0.725 . . . . 74.31 111.471 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 60.1 p -79.8 150.28 30.79 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.453 -0.573 . . . . 71.34 109.453 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 568' ' ' GLY . . . . . 0.408 ' O ' ' HD2' ' A' ' 602' ' ' ARG . . . 85.32 29.95 26.29 Favored Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 120.077 -1.059 . . . . 71.12 113.289 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 569' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 19.8 ptp -131.84 -176.1 3.94 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.796 -0.816 . . . . 75.4 108.796 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -109.53 165.43 11.67 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.149 -1.426 . . . . 54.11 107.149 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -64.78 -30.45 71.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.41 0.624 . . . . 74.12 109.348 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.6 p -72.37 -10.97 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.882 0.849 . . . . 74.3 109.955 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 45.8 t0 -101.7 -40.84 6.79 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.974 -1.121 . . . . 75.44 107.974 174.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.29 -42.53 95.66 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.067 -0.97 . . . . 71.13 112.817 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.691 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 32.8 tt0 -59.7 -53.24 67.57 Favored Pre-proline 0 CA--C 1.567 1.628 0 C-N-CA 120.236 -0.586 . . . . 64.32 110.977 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 80.2 Cg_exo -56.32 -32.32 87.86 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 121.812 1.675 . . . . 72.0 112.716 172.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 3.6 mmp_? -59.82 -42.47 93.57 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-O 119.39 -0.338 . . . . 73.22 111.034 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.7 pp -65.81 -47.08 76.26 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 120.71 -0.396 . . . . 75.43 111.846 -175.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.462 ' N ' HD12 ' A' ' 578' ' ' LEU . 4.5 ptp180 -65.72 -37.27 85.94 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 112.175 0.435 . . . . 72.04 112.175 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.99 -32.68 69.57 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.009 0.433 . . . . 70.22 112.038 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 14.3 tp -85.82 -9.1 57.58 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 121.424 0.631 . . . . 64.41 110.926 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 75.63 21.47 76.96 Favored Glycine 0 C--N 1.311 -0.806 0 C-N-CA 120.563 -0.827 . . . . 63.31 112.652 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 15.0 t90 -87.46 127.35 35.23 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.576 -1.268 . . . . 75.44 107.576 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 15.0 t -116.07 2.26 13.38 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 119.678 -0.809 . . . . 54.34 112.254 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 585' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -74.06 177.07 45.91 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 119.448 -1.358 . . . . 43.5 110.402 172.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 67.2 mtt -97.57 140.14 32.43 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.145 -0.622 . . . . 73.12 112.124 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 48.5 tp -88.43 116.72 26.86 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.878 -1.156 . . . . 63.3 107.878 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 621' ' ' THR . 30.6 t70 -106.66 117.49 34.18 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.066 0.46 . . . . 71.1 111.327 -176.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.496 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.2 OUTLIER -93.14 134.55 35.19 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.971 -0.559 . . . . 71.23 110.524 177.886 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -75.51 -84.34 0.38 Allowed Glycine 0 C--N 1.294 -1.793 0 CA-C-N 115.357 -0.838 . . . . 60.33 111.812 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.05 154.5 47.1 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.343 0.116 . . . . 61.32 110.777 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -101.63 127.84 48.19 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 124.795 1.238 . . . . 65.53 108.346 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 593' ' ' VAL . . . . . 0.542 ' O ' ' HB2' ' A' ' 626' ' ' GLN . 40.2 t -104.13 132.72 50.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 115.527 -0.761 . . . . 72.41 109.243 -175.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -72.4 126.82 30.78 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.202 0.525 . . . . 64.22 111.771 -175.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 595' ' ' ALA . . . . . 0.429 ' HB3' ' ND2' ' A' ' 601' ' ' ASN . . . -150.97 -57.9 0.16 Allowed 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.865 -1.061 . . . . 62.2 108.701 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 140.88 130.92 2.65 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 111.016 -0.834 . . . . 63.21 111.016 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.67 -31.95 61.07 Favored Glycine 0 C--O 1.22 -0.771 0 C-N-CA 122.856 0.265 . . . . 44.11 112.54 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 29.4 t -61.55 -23.61 66.08 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.033 0.933 . . . . 73.24 110.312 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -87.41 -12.2 46.91 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.503 -0.771 . . . . 74.12 110.343 -176.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 55.05 72.96 0.44 Allowed 'General case' 0 C--O 1.249 1.061 0 C-N-CA 123.956 0.902 . . . . 71.53 111.437 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 601' ' ' ASN . . . . . 0.449 ' HB3' ' HA3' ' A' ' 625' ' ' GLY . 45.3 m-80 -84.44 93.72 8.36 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.531 1.158 . . . . 71.45 111.213 -174.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.408 ' HD2' ' O ' ' A' ' 568' ' ' GLY . 18.6 mtm180 -74.46 171.49 13.68 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 113.027 -1.897 . . . . 51.02 110.282 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 90.0 t -58.7 129.33 20.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.185 -0.672 . . . . 73.11 109.185 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 24.2 m -110.19 -27.98 2.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-O 120.972 0.415 . . . . 73.22 111.358 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -139.49 135.51 33.59 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 116.025 -0.534 . . . . 65.1 110.439 -176.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -132.66 128.77 37.75 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 104.642 -2.355 . . . . 72.04 104.642 171.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 28.5 t-20 -59.36 -55.5 45.44 Favored Pre-proline 0 N--CA 1.471 0.608 0 N-CA-C 113.232 0.826 . . . . 73.11 113.232 -175.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.486 ' HG2' HG22 ' A' ' 620' ' ' ILE . 12.4 Cg_exo -79.17 116.39 3.65 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 121.056 1.171 . . . . 73.02 109.328 171.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.71 161.27 46.64 Favored 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 123.129 2.553 . . . . 73.44 112.85 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.08 139.0 57.75 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.937 -0.574 . . . . 61.13 109.707 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 90.56 -8.05 80.41 Favored Glycine 0 C--N 1.303 -1.262 0 C-N-CA 120.402 -0.904 . . . . 62.34 112.305 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 52.6 m -90.62 151.65 21.2 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.236 -0.653 . . . . 63.13 109.236 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -76.98 130.14 10.24 Favored Glycine 0 N--CA 1.433 -1.546 0 N-CA-C 111.416 -0.674 . . . . 63.31 111.416 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.49 142.79 33.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 109.898 -0.408 . . . . 75.33 109.898 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.516 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.0 p-10 -51.42 166.94 0.1 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.646 1.179 . . . . 64.34 112.749 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -58.64 -25.8 63.08 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 113.037 0.754 . . . . 75.14 113.037 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.536 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 68.0 m-20 -86.17 -7.13 58.78 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 119.855 -0.738 . . . . 45.04 111.007 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 65.59 18.55 65.97 Favored Glycine 0 C--O 1.215 -1.052 0 O-C-N 123.448 0.467 . . . . 52.31 112.865 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.89 119.62 17.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 122.349 1.071 . . . . 61.2 111.802 -166.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.486 HG22 ' HG2' ' A' ' 608' ' ' PRO . 40.1 pt -128.21 134.37 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 CA-C-N 114.544 -1.207 . . . . 62.13 110.753 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 8.9 t -104.9 130.06 53.14 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.611 -1.255 . . . . 74.03 107.611 174.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -138.79 165.65 26.45 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.221 -0.445 . . . . 63.21 110.435 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -137.8 147.32 44.51 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.253 0.549 . . . . 74.01 110.587 175.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -136.14 165.31 26.03 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.161 -1.052 . . . . 74.34 108.161 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 625' ' ' GLY . . . . . 0.449 ' HA3' ' HB3' ' A' ' 601' ' ' ASN . . . -86.17 -164.78 39.93 Favored Glycine 0 N--CA 1.422 -2.245 0 C-N-CA 119.77 -1.205 . . . . 72.03 112.058 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.542 ' HB2' ' O ' ' A' ' 593' ' ' VAL . 3.1 tp-100 . . . . . 0 C--N 1.281 -2.399 0 C-N-CA 123.52 0.728 . . . . 75.5 109.45 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.029 0 N-CA-C 111.106 -0.798 . . . . 73.2 111.106 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.82 157.07 61.52 Favored 'Trans proline' 0 C--O 1.249 1.049 0 C-N-CA 122.558 2.172 . . . . 73.0 111.154 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 62.43 35.5 14.79 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.662 0.785 . . . . 73.13 111.357 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 48.8 p -133.75 155.44 49.76 Favored 'General case' 0 C--O 1.25 1.125 0 N-CA-C 107.405 -1.332 . . . . 64.11 107.405 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.625 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 4.9 tmtt? -131.28 134.02 45.98 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.693 -0.854 . . . . 75.5 108.693 175.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.625 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 0.8 OUTLIER -78.05 124.05 27.57 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 124.679 1.192 . . . . 74.35 110.954 176.805 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.3 pt -86.77 131.52 45.04 Favored Pre-proline 0 C--N 1.295 -1.79 0 CA-C-N 115.703 -0.68 . . . . 75.43 110.846 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -93.48 176.92 1.34 Allowed 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 122.133 1.889 . . . . 41.43 111.571 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -90.22 103.36 16.04 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.273 1.035 . . . . 54.31 108.233 176.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 534' ' ' VAL . 17.9 m -92.45 23.99 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 114.595 -1.184 . . . . 70.03 111.77 -175.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -74.11 99.03 3.25 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.21 -0.45 . . . . 51.43 110.321 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 163.04 -44.0 0.34 Allowed Glycine 0 N--CA 1.428 -1.843 0 C-N-CA 119.541 -1.314 . . . . 74.33 113.004 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.418 ' O ' HG12 ' A' ' 534' ' ' VAL . 18.6 pm0 -92.75 -171.27 2.68 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 120.231 -0.588 . . . . 74.32 110.419 -177.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.449 ' HB ' HG23 ' A' ' 507' ' ' VAL . 6.8 m -77.77 155.22 31.3 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 108.167 -1.049 . . . . 74.13 108.167 177.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.463 ' HA ' ' HB ' ' A' ' 534' ' ' VAL . 7.9 p -63.4 -42.01 94.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 111.859 0.318 . . . . 54.14 111.859 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 506' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 27.4 t70 -62.8 -39.02 92.98 Favored 'General case' 0 C--O 1.199 -1.554 0 N-CA-C 109.442 -0.577 . . . . 71.01 109.442 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.449 HG23 ' HB ' ' A' ' 504' ' ' THR . 90.1 t -66.06 -44.82 91.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.74 -0.664 . . . . 73.54 109.567 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.484 ' HB2' HG11 ' A' ' 534' ' ' VAL . . . -60.78 -44.06 97.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 120.189 -0.604 . . . . 75.12 111.668 175.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 98.2 mt-30 -63.62 -43.38 97.01 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 122.515 0.326 . . . . 72.42 110.914 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.484 ' O ' HG23 ' A' ' 514' ' ' VAL . 32.0 mmtp -65.1 -39.82 93.69 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.997 -0.547 . . . . 73.14 110.067 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 511' ' ' ASN . . . . . 0.42 ' O ' ' HD1' ' A' ' 515' ' ' TYR . 5.8 m-80 -61.31 -45.97 92.22 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 116.105 -0.498 . . . . 52.54 110.633 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.26 -37.51 83.61 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.699 -0.682 . . . . 73.45 110.882 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -65.09 -37.63 88.12 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 116.555 -0.293 . . . . 72.25 110.542 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 510' ' ' LYS . 95.3 t -62.58 -32.53 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 121.154 0.502 . . . . 54.14 111.119 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 515' ' ' TYR . . . . . 0.42 ' HD1' ' O ' ' A' ' 511' ' ' ASN . 97.3 m-85 -108.78 14.9 24.01 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.986 -0.446 . . . . 73.15 110.267 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -146.99 -58.36 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 119.043 -1.551 . . . . 52.13 115.056 -172.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 67.93 31.97 5.38 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.451 1.119 . . . . 62.34 108.047 -169.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.509 HG22 ' HA ' ' A' ' 547' ' ' VAL . 12.9 p -79.91 179.04 7.79 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 113.238 -1.801 . . . . 72.32 110.479 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -108.67 138.83 44.36 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.129 -1.434 . . . . 54.23 107.129 176.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -132.73 145.54 51.11 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.162 0.506 . . . . 75.33 111.961 -176.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.1 m -141.59 150.28 41.84 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.751 -0.833 . . . . 63.03 108.751 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 522' ' ' GLN . . . . . 0.42 ' HB2' ' CG2' ' A' ' 555' ' ' VAL . 14.0 pt20 -119.65 149.91 41.2 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-O 120.907 0.384 . . . . 71.44 111.25 -174.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -123.47 143.01 50.43 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.215 -1.772 . . . . 61.12 106.215 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 20.0 m -118.85 130.91 56.01 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.231 0.539 . . . . 53.32 112.254 -175.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.5 p -123.75 151.01 28.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.746 -0.661 . . . . 72.5 110.05 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.17 134.11 52.07 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.104 -1.073 . . . . 74.53 108.104 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 62.6 m -156.81 176.85 2.35 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-O 119.485 -0.293 . . . . 75.11 110.596 -176.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -79.45 -25.29 5.73 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 122.2 1.933 . . . . 71.41 112.777 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.87 146.74 34.45 Favored Pre-proline 0 CA--C 1.506 -0.713 0 C-N-CA 120.132 -0.627 . . . . 75.14 110.38 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.62 159.92 30.45 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 123.419 2.746 . . . . 64.42 113.947 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -63.64 99.19 0.21 Allowed 'General case' 0 C--O 1.245 0.825 0 CA-C-N 114.698 -1.137 . . . . 74.11 110.132 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 163.9 -29.94 0.24 Allowed Glycine 0 N--CA 1.414 -2.769 0 CA-C-N 114.862 -1.063 . . . . 63.31 111.127 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -71.12 130.38 41.35 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 120.36 -0.536 . . . . 75.42 110.194 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 7.2 p -96.6 119.5 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.675 0 N-CA-C 106.559 -1.645 . . . . 54.12 106.559 171.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.4 m -104.66 20.54 18.45 Favored 'General case' 0 C--N 1.261 -3.252 0 CA-C-N 114.328 -1.306 . . . . 74.21 110.715 -171.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 126.3 -168.05 18.55 Favored Glycine 0 N--CA 1.429 -1.823 0 C-N-CA 120.721 -0.752 . . . . 64.2 112.053 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 33.4 p -116.89 146.42 42.95 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.53 -1.285 . . . . 74.24 107.53 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -68.66 -46.74 34.65 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 119.102 -1.039 . . . . 61.24 111.18 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 27.3 Cg_exo -66.53 151.23 83.38 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 120.948 1.099 . . . . 62.33 109.966 171.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 540' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 46.1 Cg_exo -57.66 140.73 94.43 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.142 2.561 . . . . 74.22 113.722 -177.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -68.03 129.76 40.89 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.714 -0.847 . . . . 74.1 108.714 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.53 -14.37 46.67 Favored Glycine 0 C--N 1.294 -1.786 0 N-CA-C 110.851 -0.9 . . . . 23.31 110.851 -176.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 98.7 m -75.83 127.49 33.11 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 109.563 -0.532 . . . . 75.51 109.563 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.2 t -93.85 130.25 39.96 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 108.351 -0.981 . . . . 70.13 108.351 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.01 154.15 64.46 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 108.19 -1.041 . . . . 74.13 108.19 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.425 ' HG2' ' OG ' ' A' ' 549' ' ' SER . 3.2 Cg_endo -59.42 137.83 80.49 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 121.43 1.42 . . . . 62.23 111.837 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.509 ' HA ' HG22 ' A' ' 518' ' ' THR . 12.8 p -57.02 -29.5 31.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.662 -1.154 . . . . 74.14 113.08 -176.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -90.03 3.31 53.61 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 123.266 0.627 . . . . 72.4 110.582 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 549' ' ' SER . . . . . 0.425 ' OG ' ' HG2' ' A' ' 546' ' ' PRO . 52.2 m -104.38 177.56 4.81 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 116.234 -0.439 . . . . 74.32 111.013 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 7.5 p -97.63 130.67 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 N-CA-C 113.084 0.772 . . . . 75.15 113.084 -172.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 66.1 mt -93.48 129.62 43.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 106.256 -1.757 . . . . 72.3 106.256 172.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -103.52 116.99 33.4 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.289 0.566 . . . . 70.23 110.923 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.53 133.06 50.9 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.809 -1.087 . . . . 74.42 111.346 -177.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -87.43 117.71 26.4 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.959 -0.564 . . . . 75.14 110.397 178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 524' ' ' SER . 43.3 t -108.64 126.64 65.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 109.079 -0.712 . . . . 71.13 109.079 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 74.9 m -89.24 132.07 35.06 Favored 'General case' 0 N--CA 1.408 -2.562 0 CA-C-N 115.84 -0.618 . . . . 71.54 109.43 176.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.5 ptpt -114.05 138.62 50.15 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.327 -1.36 . . . . 74.33 107.327 174.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.574 ' O ' ' HG3' ' A' ' 560' ' ' GLN . . . -67.41 -26.82 73.51 Favored Glycine 0 CA--C 1.493 -1.324 0 N-CA-C 109.92 -1.272 . . . . 72.01 109.92 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 60.6 t30 61.14 29.3 18.75 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-O 122.757 1.265 . . . . 52.55 108.247 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 558' ' ' GLY . 91.9 mt-30 -129.33 172.2 11.73 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 113.642 -1.617 . . . . 73.45 110.755 -174.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -143.81 152.51 41.29 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.506 -1.294 . . . . 75.24 107.506 174.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 68.0 t -78.1 116.54 21.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 108.684 -0.858 . . . . 63.5 108.684 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.517 ' SD ' HG21 ' A' ' 620' ' ' ILE . 45.1 ttp -73.6 128.53 86.91 Favored Pre-proline 0 C--N 1.315 -0.912 0 CA-C-N 116.314 -0.403 . . . . 73.4 112.016 -175.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.7 170.2 18.27 Favored 'Trans proline' 0 C--O 1.242 0.705 0 C-N-CA 123.189 2.592 . . . . 70.41 112.118 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 565' ' ' ASP . . . . . 0.418 ' HA ' ' HB2' ' A' ' 610' ' ' ALA . 14.8 t70 -60.8 128.62 37.44 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 113.054 0.761 . . . . 75.35 113.054 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 566' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 566' ' ' LEU . 0.8 OUTLIER -132.07 -9.85 3.4 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 114.81 -1.086 . . . . 75.04 108.604 178.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 22.6 t -79.25 151.81 30.95 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.653 -0.654 . . . . 74.31 110.645 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 62.65 52.05 51.51 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 116.004 -0.544 . . . . 55.04 114.172 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 23.6 ptp -158.4 169.69 23.9 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 107.568 -1.271 . . . . 74.43 107.568 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -88.32 167.98 13.08 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.217 -0.66 . . . . 72.34 109.217 -174.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 26.3 t-105 -64.89 -27.61 68.97 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.51 -0.922 . . . . 72.45 108.51 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.3 m -73.59 -9.99 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 115.398 -0.819 . . . . 41.1 111.371 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 9.6 m-20 -96.39 -44.08 7.37 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.719 -1.215 . . . . 74.52 107.719 173.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -57.47 -44.74 85.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.764 -1.107 . . . . 70.35 112.585 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.633 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 1.6 tm-20 -57.25 -58.99 14.19 Favored Pre-proline 0 CA--C 1.571 1.777 0 C-N-CA 122.824 0.45 . . . . 74.11 111.288 -177.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -61.37 -31.89 88.92 Favored 'Trans proline' 0 C--N 1.372 1.81 0 CA-C-N 120.652 1.269 . . . . 65.44 112.323 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 26.3 mmt180 -68.99 -33.82 74.3 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.24 0.83 . . . . 71.42 113.24 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.6 pp -66.34 -47.15 74.41 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.238 0.542 . . . . 72.03 110.733 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.481 ' N ' HD12 ' A' ' 578' ' ' LEU . 15.1 ptm180 -65.86 -34.53 78.35 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.671 -0.695 . . . . 63.12 111.133 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.79 -38.39 88.88 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 123.375 0.67 . . . . 73.13 111.502 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.491 HD11 ' HB2' ' A' ' 583' ' ' TRP . 2.0 pp -85.98 -8.16 58.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.313 0.577 . . . . 71.02 110.751 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 82.5 39.3 11.02 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.737 -0.665 . . . . 35.12 111.706 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.491 ' HB2' HD11 ' A' ' 581' ' ' LEU . 12.6 t90 -87.04 126.29 34.66 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.548 -0.908 . . . . 72.45 108.548 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 1.9 p -108.24 2.96 23.1 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.967 0.729 . . . . 50.23 112.967 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 585' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -94.64 -173.38 38.15 Favored Glycine 0 N--CA 1.438 -1.186 0 N-CA-C 110.381 -1.088 . . . . 75.3 110.381 176.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 60.6 mtm -114.27 151.33 33.03 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.397 -0.594 . . . . 75.45 109.397 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.7 tt -83.07 125.18 31.19 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.962 -1.125 . . . . 62.31 107.962 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 621' ' ' THR . 30.8 t70 -104.05 123.55 47.43 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.081 0.467 . . . . 53.34 109.941 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.562 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -101.39 133.44 45.99 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 108.566 -0.902 . . . . 74.02 108.566 177.22 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -77.42 -68.7 1.48 Allowed Glycine 0 C--N 1.283 -2.387 0 N-CA-C 110.505 -1.038 . . . . 72.33 110.505 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.53 142.73 37.23 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.854 -0.795 . . . . 63.44 108.854 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -83.63 134.49 34.79 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.762 -1.199 . . . . 73.33 107.762 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 593' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 626' ' ' GLN . 42.8 t -104.13 141.62 19.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 107.893 -1.151 . . . . 73.21 107.893 -176.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 594' ' ' ASP . . . . . 0.405 ' HA ' ' HG2' ' A' ' 626' ' ' GLN . 16.5 t70 -72.46 118.2 15.06 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 109.484 -0.561 . . . . 65.45 109.484 -177.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -137.3 -59.76 0.68 Allowed 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 115.466 -0.788 . . . . 63.54 109.768 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 85.84 154.09 23.0 Favored Glycine 0 N--CA 1.412 -2.903 0 C-N-CA 119.07 -1.538 . . . . 44.43 109.818 -173.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.96 -33.82 75.78 Favored Glycine 0 C--N 1.284 -2.357 0 N-CA-C 114.934 0.733 . . . . 52.11 114.934 -177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 6.9 t -73.62 -24.74 60.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 117.68 0.74 . . . . 74.23 110.231 -174.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -87.92 -1.68 58.13 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.16 0.505 . . . . 75.4 109.827 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 57.0 m80 68.34 86.64 0.13 Allowed 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 124.993 1.317 . . . . 73.32 110.868 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -74.37 82.38 1.91 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 112.697 -2.047 . . . . 64.11 111.623 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -129.28 171.32 12.59 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.015 -1.448 . . . . 74.12 110.47 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.47 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 70.7 t -57.94 130.77 21.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 O-C-N 123.338 0.399 . . . . 54.31 110.075 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 27.0 m -106.53 -34.1 2.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 C-N-CA 120.579 -0.448 . . . . 64.31 110.922 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -152.92 135.92 15.54 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 116.352 -0.386 . . . . 64.22 110.5 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -118.79 128.59 54.62 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.593 -1.632 . . . . 75.01 106.593 171.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.436 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 4.4 t-20 -63.09 -47.94 84.95 Favored Pre-proline 0 N--CA 1.469 0.496 0 C-N-CA 119.717 -0.793 . . . . 73.31 110.954 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.9 Cg_exo -84.64 108.66 1.26 Allowed 'Trans proline' 0 C--N 1.361 1.187 0 N-CA-C 108.17 -1.512 . . . . 54.24 108.17 168.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.38 161.02 47.54 Favored 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 123.386 2.724 . . . . 75.53 113.13 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 610' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 565' ' ' ASP . . . -61.78 134.72 57.08 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.35 -0.611 . . . . 61.55 109.35 176.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 103.55 -5.03 47.56 Favored Glycine 0 C--N 1.304 -1.211 0 C-N-CA 120.554 -0.831 . . . . 71.15 111.508 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 59.1 m -86.36 141.36 29.25 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.725 -0.472 . . . . 74.45 109.725 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -78.33 117.36 4.63 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 110.072 -1.211 . . . . 74.12 110.072 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 28.6 m -115.48 142.2 29.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 110.167 -0.308 . . . . 74.23 110.167 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.428 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.6 p-10 -50.08 170.15 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.961 1.304 . . . . 73.41 113.041 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -60.98 -25.64 67.0 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.85 0.685 . . . . 71.1 112.85 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.465 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 17.8 m-20 -82.84 -8.83 59.55 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 119.185 -1.006 . . . . 55.13 110.832 177.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 64.85 15.48 60.17 Favored Glycine 0 C--O 1.219 -0.826 0 C-N-CA 123.599 0.618 . . . . 75.03 114.592 168.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.71 118.37 15.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 122.612 1.196 . . . . 72.33 112.515 -164.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.517 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.8 pp -128.46 134.34 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 114.012 -1.449 . . . . 71.43 111.266 -177.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 15.1 t -104.11 129.16 51.8 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.456 -0.572 . . . . 44.12 109.456 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.5 pp -139.43 167.2 22.62 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.355 0.502 . . . . 63.31 112.355 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 25.9 ptt85 -127.8 137.81 52.52 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.49 -0.559 . . . . 73.02 109.49 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.47 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 20.0 p90 -139.94 165.93 26.0 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.918 -0.583 . . . . 75.13 110.896 -173.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -76.15 134.64 16.16 Favored Glycine 0 N--CA 1.431 -1.647 0 CA-C-N 115.832 -0.622 . . . . 42.12 112.615 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 593' ' ' VAL . 12.9 pt20 . . . . . 0 C--N 1.305 -1.36 0 C-N-CA 123.768 0.827 . . . . 65.24 109.293 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.909 0 N-CA-C 110.476 -1.05 . . . . 43.05 110.476 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -67.61 142.33 58.32 Favored 'Trans proline' 0 C--O 1.241 0.63 0 C-N-CA 122.442 2.095 . . . . 64.04 110.748 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -96.54 -8.2 32.57 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.517 0.675 . . . . 40.11 111.174 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 31.2 p -137.66 147.3 44.79 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 115.338 -0.847 . . . . 72.22 109.744 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -127.68 139.86 52.44 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.614 -0.884 . . . . 71.1 108.614 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.4 p-10 -96.02 130.25 43.07 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.485 0.659 . . . . 74.22 110.414 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 34.8 pt -91.12 127.06 52.94 Favored Pre-proline 0 C--N 1.304 -1.383 0 CA-C-N 114.717 -1.129 . . . . 75.43 111.198 -176.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -84.42 -179.42 3.85 Favored 'Trans proline' 0 N--CA 1.441 -1.585 0 C-N-CA 121.632 1.555 . . . . 64.33 110.696 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -82.3 103.37 11.83 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 122.253 1.025 . . . . 72.33 110.182 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.414 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 26.8 m -100.79 7.67 9.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 114.946 -1.025 . . . . 74.21 111.384 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.426 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -80.56 102.81 10.0 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 109.054 -0.721 . . . . 60.15 109.054 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 159.05 -36.14 0.49 Allowed Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.566 -0.826 . . . . 61.25 112.131 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 16.6 pm0 -94.45 -173.08 2.95 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 109.301 -0.629 . . . . 73.41 109.301 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 27.9 m -70.1 154.89 41.37 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.856 -1.164 . . . . 72.22 107.856 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.438 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.2 p -63.02 -41.89 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 C-N-CA 120.891 -0.324 . . . . 74.01 111.049 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 506' ' ' ASP . . . . . 0.539 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 18.7 t70 -62.18 -43.95 97.68 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 109.645 -0.502 . . . . 60.22 109.645 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 64.0 t -66.61 -41.85 88.93 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 CA-C-N 115.79 -0.641 . . . . 60.33 109.737 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.427 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -61.15 -44.57 97.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 120.442 0.163 . . . . 62.43 110.684 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 26.3 mt-30 -65.0 -43.82 91.28 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.266 -0.425 . . . . 65.43 111.086 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.566 ' O ' HG23 ' A' ' 514' ' ' VAL . 32.7 mmtp -62.92 -47.14 84.54 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.429 -0.582 . . . . 74.43 109.429 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -63.99 -37.95 89.3 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.515 -0.766 . . . . 74.1 111.345 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.64 -46.28 69.61 Favored 'General case' 0 C--O 1.203 -1.348 0 N-CA-C 108.151 -1.055 . . . . 64.25 108.151 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -59.99 -38.13 81.7 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 124.077 0.951 . . . . 73.2 111.188 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 510' ' ' LYS . 57.7 t -57.57 -37.56 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-O 120.845 0.355 . . . . 72.15 111.326 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -110.0 0.91 18.69 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.865 0.84 . . . . 74.44 111.098 -176.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -113.5 -60.4 0.41 Allowed Glycine 0 N--CA 1.416 -2.698 0 CA-C-N 115.18 -0.918 . . . . 70.11 111.331 -174.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 70.74 16.49 6.74 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.58 1.152 . . . . 74.4 110.415 -175.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 547' ' ' VAL . 4.4 p -83.05 -176.17 6.2 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-N 114.082 -1.417 . . . . 75.25 109.496 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 0.1 OUTLIER -108.69 143.14 38.18 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.29 -1.004 . . . . 61.0 108.29 177.018 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -123.1 148.61 45.46 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-O 121.428 0.633 . . . . 74.13 111.804 -175.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 16.9 p -135.31 140.26 44.97 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 107.369 -1.345 . . . . 71.31 107.369 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -117.45 127.27 53.85 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-O 121.246 0.546 . . . . 73.01 110.466 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -116.11 143.36 45.58 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.161 -1.422 . . . . 74.22 107.161 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.0 p -119.44 132.66 55.85 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 113.783 1.031 . . . . 72.11 113.783 -175.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.64 149.97 24.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 107.902 -1.147 . . . . 63.41 107.902 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -79.61 136.86 36.95 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.923 -0.311 . . . . 33.04 110.881 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.436 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 59.9 m -163.24 155.08 15.13 Favored Pre-proline 0 C--O 1.204 -1.335 0 N-CA-C 107.106 -1.442 . . . . 43.45 107.106 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.39 -14.66 36.01 Favored 'Trans proline' 0 CA--C 1.552 1.376 0 C-N-CA 122.439 2.093 . . . . 73.25 114.587 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -70.9 145.58 91.99 Favored Pre-proline 0 C--O 1.215 -0.711 0 N-CA-C 109.529 -0.545 . . . . 75.52 109.529 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.33 144.39 91.13 Favored 'Trans proline' 0 C--O 1.26 1.59 0 C-N-CA 122.317 2.012 . . . . 65.43 112.619 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.693 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -64.14 100.34 0.32 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.246 -0.888 . . . . 63.01 111.171 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 157.43 -23.41 0.43 Allowed Glycine 0 N--CA 1.427 -1.93 0 C-N-CA 120.559 -0.829 . . . . 74.35 111.979 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -80.65 138.92 36.43 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 119.904 -0.718 . . . . 75.1 109.842 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.427 HG11 ' CB ' ' A' ' 508' ' ' ALA . 5.4 p -93.85 113.93 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 N-CA-C 107.294 -1.373 . . . . 72.24 107.294 172.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.7 m -99.62 8.74 44.15 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 113.929 -1.487 . . . . 74.32 111.186 -172.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.426 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 157.31 172.89 25.05 Favored Glycine 0 N--CA 1.428 -1.883 0 C-N-CA 119.704 -1.236 . . . . 42.43 113.245 174.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.6 p -120.52 158.27 27.65 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 105.798 -1.927 . . . . 73.32 105.798 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 51.6 t30 -67.05 -54.33 20.83 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 117.517 -1.673 . . . . 70.23 111.368 177.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 8.2 Cg_exo -74.33 143.21 31.2 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 121.282 1.321 . . . . 61.51 109.792 174.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.74 157.99 59.61 Favored 'Trans proline' 0 C--O 1.25 1.106 0 C-N-CA 122.635 2.224 . . . . 71.12 113.284 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.28 139.59 58.08 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.806 -0.633 . . . . 42.43 110.505 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.18 -14.36 59.79 Favored Glycine 0 C--N 1.3 -1.436 0 N-CA-C 111.706 -0.557 . . . . 71.44 111.706 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 20.4 m -75.32 135.23 40.89 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 109.771 -0.455 . . . . 54.44 109.771 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.8 t -96.58 125.47 41.07 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 107.916 -1.142 . . . . 75.03 107.916 177.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.26 154.55 65.44 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 108.622 -0.881 . . . . 64.52 108.622 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.64 137.48 77.56 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.784 1.656 . . . . 60.03 112.283 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.45 ' HA ' HG22 ' A' ' 518' ' ' THR . 13.5 p -65.33 -24.03 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-N 115.19 -0.913 . . . . 62.03 110.82 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -78.02 -10.02 59.4 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.559 -1.201 . . . . 73.25 111.632 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 22.9 t -94.01 -176.84 4.13 Favored 'General case' 0 C--O 1.26 1.637 0 CA-C-O 121.631 0.729 . . . . 61.35 112.176 -174.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 14.7 p -119.13 137.92 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 114.774 -1.103 . . . . 54.54 109.037 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.3 mt -108.71 138.33 36.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 109.149 -0.686 . . . . 73.44 109.149 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.53 122.06 44.17 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.689 0.757 . . . . 73.21 111.756 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.1 mp -108.08 122.23 46.45 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.212 -1.358 . . . . 63.11 108.776 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -90.63 116.23 28.35 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.916 0.865 . . . . 73.33 111.26 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 524' ' ' SER . 21.3 t -98.8 135.21 34.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 114.263 -1.335 . . . . 41.23 108.811 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.693 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 66.4 m -86.33 129.04 34.99 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.538 -0.541 . . . . 74.4 109.538 174.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -101.03 130.05 46.98 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 105.883 -1.895 . . . . 72.15 105.883 172.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -62.22 -24.93 65.92 Favored Glycine 0 CA--C 1.5 -0.898 0 O-C-N 124.006 0.816 . . . . 74.51 114.146 -173.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 559' ' ' ASN . . . . . 0.486 ' OD1' ' HG3' ' A' ' 616' ' ' ARG . 49.0 t-20 71.93 -14.62 0.51 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.841 1.256 . . . . 74.44 111.363 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -111.93 149.55 31.76 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.307 -0.87 . . . . 72.15 112.856 -170.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -131.0 158.4 40.39 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.248 -1.342 . . . . 71.13 107.449 177.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.61 125.33 32.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 120.991 0.424 . . . . 62.22 111.217 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 55.2 ttp -86.6 129.51 52.64 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 110.092 -0.336 . . . . 72.13 110.092 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.07 170.46 20.07 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.363 2.708 . . . . 72.42 112.337 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.02 126.65 28.7 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 112.784 0.661 . . . . 72.31 112.784 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 566' ' ' LEU . . . . . 0.464 ' O ' ' HG2' ' A' ' 569' ' ' MET . 0.0 OUTLIER -132.05 7.25 4.31 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.504 1.145 . . . . 55.44 109.06 171.382 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 3.1 m -79.19 138.19 37.75 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.559 -1.201 . . . . 75.12 108.926 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 84.15 18.62 62.46 Favored Glycine 0 C--N 1.315 -0.624 0 C-N-CA 120.533 -0.841 . . . . 74.31 113.876 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 569' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 20.2 ptp -124.0 175.12 7.16 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.291 -1.003 . . . . 75.11 108.291 176.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -94.8 164.98 12.71 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.595 -1.631 . . . . 63.12 106.595 -175.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 571' ' ' TRP . . . . . 0.504 ' O ' ' HG3' ' A' ' 575' ' ' GLU . 10.8 t-105 -63.49 -34.16 77.17 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.781 -0.822 . . . . 73.4 108.781 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.6 p -74.23 -14.78 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.648 -0.705 . . . . 73.31 110.669 -175.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -100.98 -28.6 12.65 Favored 'General case' 0 C--O 1.263 1.814 0 CA-C-O 122.025 0.917 . . . . 54.43 108.766 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 574' ' ' ALA . . . . . 0.643 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -64.12 -41.67 97.14 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.486 -1.234 . . . . 51.11 109.98 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 571' ' ' TRP . 46.0 mt-10 -51.21 -56.12 22.83 Favored Pre-proline 0 CA--C 1.567 1.615 0 N-CA-C 112.519 0.562 . . . . 74.32 112.519 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -58.4 -33.34 97.76 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 121.554 1.502 . . . . 71.42 112.71 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -68.64 -34.3 75.5 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 119.487 -0.885 . . . . 71.32 111.735 176.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 41.0 mt -63.06 -48.31 79.23 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.147 0.499 . . . . 63.22 110.383 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 6.9 ptp85 -66.19 -36.83 84.1 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.136 -0.484 . . . . 75.22 111.324 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.31 77.85 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.134 -0.484 . . . . 54.02 112.097 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' A' ' 583' ' ' TRP . 1.7 pp -81.93 -8.54 59.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.158 0.504 . . . . 73.34 109.868 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 80.3 42.45 10.52 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.528 -0.76 . . . . 71.32 112.311 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.457 ' CE3' HD22 ' A' ' 578' ' ' LEU . 18.1 t90 -87.31 126.59 34.94 Favored 'General case' 0 N--CA 1.427 -1.619 0 C-N-CA 120.147 -0.621 . . . . 73.52 109.888 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 26.9 p -100.95 -14.28 17.95 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.33 0.492 . . . . 74.41 112.33 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -82.96 -171.09 46.91 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 121.344 -0.455 . . . . 42.43 113.349 -177.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 92.3 mmm -117.57 147.47 42.79 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.907 -0.405 . . . . 62.51 109.907 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 587' ' ' LEU . . . . . 0.455 HD21 ' HG ' ' A' ' 622' ' ' LEU . 3.6 tt -93.02 129.56 38.9 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.88 0.372 . . . . 53.23 110.203 -175.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -113.96 124.85 53.16 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-N 115.911 -0.586 . . . . 72.14 109.719 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.485 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.3 OUTLIER -90.8 133.95 34.81 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.806 -0.442 . . . . 55.33 109.806 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -84.06 -106.8 0.57 Allowed Glycine 0 C--N 1.291 -1.937 0 CA-C-N 115.829 -0.623 . . . . 54.1 112.32 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 591' ' ' ALA . . . . . 0.605 ' O ' ' HB2' ' A' ' 623' ' ' ARG . . . -96.14 116.58 29.21 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.948 0.404 . . . . 74.32 110.343 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -87.24 140.08 29.9 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 123.499 0.719 . . . . 71.34 110.898 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 48.4 t -122.36 128.74 75.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.313 -0.995 . . . . 61.43 108.313 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.59 122.61 21.66 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.92 0.391 . . . . 65.05 110.397 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -134.45 -43.47 0.77 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.815 -0.63 . . . . 71.11 110.596 -177.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 106.86 128.92 6.1 Favored Glycine 0 N--CA 1.433 -1.524 0 N-CA-C 111.543 -0.623 . . . . 55.32 111.543 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.17 -32.95 84.33 Favored Glycine 0 N--CA 1.46 0.235 0 CA-C-O 121.067 0.26 . . . . 54.35 112.485 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 3.0 p -64.94 -23.94 67.37 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 124.938 1.295 . . . . 55.23 110.944 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -92.23 -0.78 57.4 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.776 -0.647 . . . . 72.21 110.283 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 30.5 m170 75.01 97.23 0.07 Allowed 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 125.017 1.327 . . . . 71.24 112.29 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 601' ' ' ASN . . . . . 0.683 ' HB2' ' O ' ' A' ' 625' ' ' GLY . 19.2 p30 -83.2 88.85 6.91 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 114.016 -1.447 . . . . 60.22 112.748 -175.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 -91.85 155.68 18.03 Favored 'General case' 0 C--O 1.254 1.307 0 CA-C-N 114.504 -1.226 . . . . 75.32 110.818 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 88.0 t -62.86 131.89 28.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 114.955 -1.021 . . . . 70.44 108.3 172.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.74 -46.55 12.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 120.996 0.427 . . . . 63.43 110.666 -175.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -151.69 154.11 35.69 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.346 -0.983 . . . . 71.15 108.346 -176.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -142.55 149.31 38.92 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.309 -0.626 . . . . 74.15 109.309 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.524 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 50.8 t-20 -69.23 -56.45 8.59 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 120.611 -0.436 . . . . 64.44 111.265 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.8 Cg_exo -84.44 115.36 1.89 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 120.729 1.296 . . . . 42.25 108.888 173.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -70.2 157.91 58.04 Favored 'Trans proline' 0 C--O 1.248 1.017 0 C-N-CA 122.303 2.002 . . . . 70.15 112.458 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.31 137.81 56.34 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.721 -0.844 . . . . 63.41 108.721 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 96.94 -7.18 64.71 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.892 -0.671 . . . . 74.35 111.646 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 38.5 m -94.71 150.15 20.51 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.987 -0.375 . . . . 74.44 109.987 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -75.63 126.5 8.54 Favored Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 111.823 -0.511 . . . . 54.14 111.823 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.3 m -118.65 142.65 32.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 109.077 -0.712 . . . . 75.35 109.077 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -52.25 165.87 0.2 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.887 0.875 . . . . 72.1 112.035 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 616' ' ' ARG . . . . . 0.486 ' HG3' ' OD1' ' A' ' 559' ' ' ASN . 0.0 OUTLIER -57.82 -25.3 60.42 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.864 1.061 . . . . 75.25 113.864 -178.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.38 -10.31 59.75 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 119.95 -0.7 . . . . 72.31 109.48 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 65.34 16.1 62.19 Favored Glycine 0 CA--C 1.498 -1.019 0 CA-C-N 115.61 -0.723 . . . . 73.14 113.472 169.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.16 119.29 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 122.567 1.175 . . . . 73.22 111.067 -165.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.415 HG12 ' HD2' ' A' ' 608' ' ' PRO . 0.0 OUTLIER -129.2 132.48 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.176 0 CA-C-N 113.824 -1.535 . . . . 72.41 109.11 -176.071 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 8.9 t -114.96 133.53 55.94 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.399 -0.963 . . . . 65.2 108.399 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.455 ' HG ' HD21 ' A' ' 587' ' ' LEU . 3.1 pp -138.97 166.65 23.93 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.748 -0.66 . . . . 41.25 112.073 -174.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 623' ' ' ARG . . . . . 0.605 ' HB2' ' O ' ' A' ' 591' ' ' ALA . 7.4 ptm180 -126.93 137.42 53.13 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 106.915 -1.513 . . . . 74.24 106.915 175.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -139.49 165.93 25.92 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 115.808 -0.633 . . . . 74.3 109.324 -171.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 625' ' ' GLY . . . . . 0.683 ' O ' ' HB2' ' A' ' 601' ' ' ASN . . . -72.7 140.03 28.45 Favored Glycine 0 N--CA 1.418 -2.561 0 N-CA-C 108.493 -1.843 . . . . 63.22 108.493 174.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 . . . . . 0 C--N 1.265 -3.107 0 CA-C-O 118.11 -0.947 . . . . 72.45 108.643 -179.401 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.636 0 N-CA-C 110.569 -1.012 . . . . 73.2 110.569 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -76.45 142.71 23.88 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 122.503 2.135 . . . . 73.0 110.758 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 61.57 31.22 18.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.865 0.866 . . . . 73.13 111.677 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 38.3 p -139.5 144.18 37.81 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.423 -0.584 . . . . 64.11 109.423 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.545 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 4.3 tmtt? -134.93 139.38 44.91 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.05 -1.093 . . . . 75.5 108.05 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.545 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 10.5 p-10 -78.77 132.97 37.12 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 124.097 0.959 . . . . 74.35 110.051 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 42.6 pt -98.58 128.45 32.81 Favored Pre-proline 0 C--N 1.306 -1.309 0 C-N-CA 120.386 -0.526 . . . . 75.43 110.584 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.92 -163.33 0.19 Allowed 'Trans proline' 0 C--O 1.251 1.139 0 C-N-CA 122.682 2.254 . . . . 41.43 111.018 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -86.18 127.3 34.7 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.609 0.719 . . . . 54.31 109.984 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.511 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 15.9 m -122.99 62.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-O 123.359 1.552 . . . . 70.03 108.425 171.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -120.43 108.58 14.29 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 112.825 -1.988 . . . . 51.43 109.191 176.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 138.39 -25.47 2.87 Favored Glycine 0 N--CA 1.431 -1.661 0 C-N-CA 119.613 -1.279 . . . . 74.33 113.42 175.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.453 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.4 OUTLIER -101.39 -177.0 3.31 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 117.835 0.817 . . . . 74.32 109.382 179.342 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.414 ' HB ' HG23 ' A' ' 507' ' ' VAL . 9.1 m -74.36 155.45 38.13 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.78 -1.193 . . . . 74.13 107.78 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 8.9 p -64.3 -41.32 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-O 119.471 -0.3 . . . . 54.14 111.715 -177.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 506' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 15.5 t70 -59.56 -42.6 92.77 Favored 'General case' 0 C--O 1.213 -0.844 0 N-CA-C 108.417 -0.957 . . . . 71.01 108.417 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.414 HG23 ' HB ' ' A' ' 504' ' ' THR . 76.9 t -65.34 -44.84 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 114.983 -1.008 . . . . 73.54 110.044 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.511 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -63.24 -44.98 93.68 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 111.725 0.269 . . . . 75.12 111.725 177.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.6 mt-30 -61.88 -45.26 94.55 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 122.804 0.441 . . . . 72.42 110.08 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 514' ' ' VAL . 31.5 mmtp -67.01 -39.28 87.05 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.631 -0.713 . . . . 73.14 110.579 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -61.49 -43.98 97.9 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 121.31 0.576 . . . . 52.54 110.492 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.57 -43.06 86.04 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.842 -1.17 . . . . 73.45 107.842 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -59.81 -36.5 76.88 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 124.035 0.934 . . . . 72.25 111.664 -177.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 510' ' ' LYS . 90.4 t -60.07 -40.48 83.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.732 0.301 . . . . 54.14 110.929 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -107.15 13.17 27.63 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.414 0.626 . . . . 73.15 110.281 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -134.65 -54.29 0.07 OUTLIER Glycine 0 N--CA 1.429 -1.801 0 C-N-CA 120.534 -0.841 . . . . 52.13 113.72 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 65.22 25.76 12.3 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.404 1.097 . . . . 62.34 109.088 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.485 HG22 ' HA ' ' A' ' 547' ' ' VAL . 6.2 p -80.77 -173.54 4.25 Favored 'General case' 0 N--CA 1.416 -2.143 0 C-N-CA 125.719 1.608 . . . . 72.32 111.602 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -108.76 138.41 45.14 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.451 -1.685 . . . . 54.23 106.451 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -132.43 149.01 52.42 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.065 0.459 . . . . 75.33 111.607 -178.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 71.3 m -141.22 150.9 43.26 Favored 'General case' 0 N--CA 1.418 -2.025 0 N-CA-C 108.515 -0.92 . . . . 63.03 108.515 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 522' ' ' GLN . . . . . 0.46 ' HB2' ' CG2' ' A' ' 555' ' ' VAL . 14.2 pt20 -119.56 136.63 54.27 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.036 0.446 . . . . 71.44 110.294 -178.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -120.04 137.34 54.16 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.184 -1.413 . . . . 61.12 107.184 176.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 33.8 m -106.1 134.5 49.12 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 112.295 0.48 . . . . 53.32 112.295 -175.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.6 p -131.13 153.04 38.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.357 -0.838 . . . . 72.5 109.006 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -73.24 134.92 44.45 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.24 -1.022 . . . . 74.53 108.24 177.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.571 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 65.5 m -161.13 168.04 12.3 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.513 -0.551 . . . . 75.11 109.513 -177.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -71.96 -21.91 23.78 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.055 1.837 . . . . 71.41 112.077 176.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -69.73 144.22 93.39 Favored Pre-proline 0 C--O 1.221 -0.426 0 CA-C-N 116.2 -0.455 . . . . 75.14 111.311 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.47 152.42 81.67 Favored 'Trans proline' 0 C--O 1.248 0.996 0 C-N-CA 122.586 2.191 . . . . 64.42 111.72 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 557' ' ' LYS . . . -62.31 112.01 2.24 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 115.63 -0.714 . . . . 74.11 110.999 -177.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 131.53 -23.62 4.24 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 115.427 -0.806 . . . . 63.31 111.623 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -80.08 133.83 36.14 Favored 'General case' 0 C--O 1.246 0.912 0 CA-C-O 121.262 0.553 . . . . 75.42 109.768 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 503' ' ' GLN . 8.1 p -97.32 120.09 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.875 0 N-CA-C 108.094 -1.076 . . . . 54.12 108.094 -178.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 4.1 p -90.13 1.24 56.62 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.207 -0.906 . . . . 74.21 112.376 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.445 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 144.0 -161.7 27.83 Favored Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.314 -0.946 . . . . 64.2 112.321 175.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 3.8 p -116.97 155.14 29.65 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.807 -0.812 . . . . 74.24 108.807 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -65.31 -50.52 58.63 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.306 -0.627 . . . . 61.24 109.306 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.67 138.91 46.73 Favored 'Trans proline' 0 C--N 1.375 1.966 0 N-CA-C 108.97 -1.204 . . . . 62.33 108.97 170.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.01 143.64 91.34 Favored 'Trans proline' 0 C--O 1.243 0.725 0 C-N-CA 122.86 2.373 . . . . 74.22 113.659 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.01 131.53 47.88 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.63 -0.714 . . . . 74.1 109.745 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.22 -5.39 35.91 Favored Glycine 0 N--CA 1.434 -1.448 0 CA-C-N 115.708 -0.678 . . . . 23.31 111.465 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 5.9 t -84.97 138.16 32.65 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.233 0.54 . . . . 75.51 110.714 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 9.2 t -81.56 131.37 35.27 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.158 -1.053 . . . . 70.13 108.158 174.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.0 m -126.51 154.99 75.24 Favored Pre-proline 0 C--N 1.315 -0.935 0 N-CA-C 108.786 -0.82 . . . . 74.13 108.786 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -70.18 138.89 37.51 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.635 1.557 . . . . 62.23 111.29 176.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.485 ' HA ' HG22 ' A' ' 518' ' ' THR . 8.9 p -64.73 -19.08 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 CA-C-O 122.345 1.069 . . . . 74.14 110.608 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -86.38 -18.35 32.06 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.17 -0.923 . . . . 72.4 110.768 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 50.4 m -91.98 167.78 11.86 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.362 0.601 . . . . 74.32 111.968 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 10.7 p -97.22 138.15 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-N 115.096 -0.956 . . . . 75.15 111.051 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 56.7 mt -97.48 134.19 36.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 107.615 -1.254 . . . . 72.3 107.615 176.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -103.33 117.34 34.27 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.097 -0.705 . . . . 70.23 109.097 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.8 mp -104.42 133.13 49.82 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 120.916 0.388 . . . . 74.42 111.657 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -87.51 108.83 19.22 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 123.558 0.743 . . . . 75.14 110.853 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 522' ' ' GLN . 32.5 t -95.85 124.3 48.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.468 -0.938 . . . . 71.13 108.468 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.571 ' HB3' ' HB2' ' A' ' 527' ' ' SER . 58.0 m -88.05 133.24 34.02 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 115.972 -0.558 . . . . 71.54 110.733 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.1 ptpt -115.72 130.96 57.05 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 107.843 -1.169 . . . . 74.33 107.843 171.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 527' ' ' SER . . . -64.93 -23.75 69.6 Favored Glycine 0 CA--C 1.497 -1.061 0 N-CA-C 110.264 -1.134 . . . . 72.01 110.264 178.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 53.9 t30 70.22 -5.55 1.31 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.041 1.736 . . . . 52.55 111.051 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 77.9 mt-30 -113.54 142.72 45.62 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 115.796 -0.638 . . . . 73.45 110.572 -176.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -123.36 158.21 31.59 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.665 -0.865 . . . . 75.24 108.665 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.29 118.3 10.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 O-C-N 123.499 0.499 . . . . 63.5 109.78 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.556 ' SD ' HG21 ' A' ' 620' ' ' ILE . 35.9 ttp -79.32 136.93 56.26 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 116.219 -0.446 . . . . 73.4 111.402 -178.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.32 171.24 10.71 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.623 2.882 . . . . 70.41 111.742 172.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -82.53 129.39 34.91 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 116.529 -0.305 . . . . 75.35 111.314 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -123.05 16.5 9.99 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.258 1.028 . . . . 75.04 109.191 176.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 50.8 m -79.03 130.91 36.03 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 114.386 -1.279 . . . . 74.31 112.363 -175.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 568' ' ' GLY . . . . . 0.426 ' HA2' ' HD3' ' A' ' 602' ' ' ARG . . . 71.12 62.53 3.49 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.45 -0.796 . . . . 55.04 114.377 176.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 24.4 ptp -159.86 164.84 33.26 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 109.057 -0.719 . . . . 74.43 109.057 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -92.88 174.7 7.11 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.835 -0.431 . . . . 72.34 109.835 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 35.3 t-105 -64.48 -29.64 70.68 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.885 -0.783 . . . . 72.45 108.885 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 22.1 m -74.96 -6.4 8.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.469 -0.787 . . . . 41.1 111.214 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -102.21 -44.35 5.45 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.501 -0.925 . . . . 74.52 108.501 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -64.68 -40.09 94.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.94 -1.027 . . . . 70.35 113.122 -177.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.711 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 6.0 tm-20 -66.22 -50.81 48.12 Favored Pre-proline 0 CA--C 1.564 1.482 0 N-CA-C 109.943 -0.392 . . . . 74.11 109.943 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 61.7 Cg_exo -53.12 -34.32 67.99 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 121.584 1.523 . . . . 65.44 111.646 169.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -60.88 -39.63 89.94 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.433 0.531 . . . . 71.42 112.433 175.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.711 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 3.9 pp -65.98 -44.45 84.85 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 120.184 -0.606 . . . . 72.03 110.727 -178.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.461 ' N ' HD12 ' A' ' 578' ' ' LEU . 6.6 ptm180 -66.46 -34.58 78.26 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.833 0.349 . . . . 63.12 111.69 176.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.24 -36.53 74.55 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.161 0.505 . . . . 73.13 111.35 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.5 tp -87.9 -9.22 54.33 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 123.695 0.798 . . . . 71.02 110.622 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 66.04 37.51 93.2 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.114 -0.795 . . . . 35.12 111.114 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -80.73 126.43 31.29 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.409 0.623 . . . . 72.45 110.172 -176.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 17.0 p -96.67 -18.5 19.65 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 113.313 0.857 . . . . 50.23 113.313 -174.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -80.36 -156.57 13.23 Favored Glycine 0 C--O 1.24 0.471 0 C-N-CA 121.327 -0.463 . . . . 75.3 114.115 -176.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 67.2 mtm -128.68 155.32 45.22 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.561 -0.533 . . . . 75.45 109.561 -176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.5 tt -106.67 113.71 27.38 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.648 -1.241 . . . . 62.31 107.648 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 621' ' ' THR . 51.9 m-20 -98.65 110.1 22.75 Favored 'General case' 0 CA--C 1.478 -1.804 0 N-CA-C 109.305 -0.628 . . . . 53.34 109.305 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.0 OUTLIER -87.55 133.07 33.85 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 118.418 -1.313 . . . . 74.02 107.633 174.115 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -82.59 -55.67 2.96 Favored Glycine 0 C--N 1.29 -1.976 0 CA-C-N 115.605 -0.725 . . . . 72.33 112.04 -174.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.85 154.13 47.23 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.569 -0.53 . . . . 63.44 109.569 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 592' ' ' ASP . . . . . 0.554 ' HB3' ' HB2' ' A' ' 626' ' ' GLN . 10.5 m-20 -99.54 129.79 45.74 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 105.385 -2.08 . . . . 73.33 105.385 173.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 16.5 t -103.49 135.78 39.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 107.138 -1.43 . . . . 73.21 107.138 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.71 121.86 19.61 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 118.219 0.463 . . . . 65.45 111.083 -169.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -138.3 -56.99 0.65 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.547 -0.751 . . . . 63.54 110.489 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 100.06 142.31 12.96 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 109.573 -1.411 . . . . 44.43 109.573 -173.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.93 -35.4 83.02 Favored Glycine 0 C--N 1.314 -0.676 0 N-CA-C 113.914 0.326 . . . . 52.11 113.914 -176.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 9.3 t -71.85 -24.41 61.69 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.284 0.564 . . . . 74.23 110.329 -176.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -88.19 -0.55 57.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.33 -0.396 . . . . 75.4 110.734 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 50.8 m80 79.2 84.33 0.06 Allowed 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 125.426 1.49 . . . . 73.32 110.275 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -81.16 71.98 8.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 123.21 1.481 . . . . 64.11 111.182 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.426 ' HD3' ' HA2' ' A' ' 568' ' ' GLY . 4.6 ppt_? -115.21 172.32 7.14 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 113.233 -1.803 . . . . 74.12 110.653 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.448 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 63.2 t -56.54 130.79 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 109.588 -0.523 . . . . 54.31 109.588 -178.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 26.3 m -110.39 -30.04 2.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.277 -0.874 . . . . 64.31 111.488 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -156.75 135.71 11.83 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 109.68 -0.489 . . . . 64.22 109.68 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -116.17 136.24 53.19 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.601 -0.518 . . . . 75.01 109.601 173.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.447 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 9.5 t30 -56.99 -50.76 86.36 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 123.627 0.579 . . . . 73.31 111.594 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.496 ' O ' ' HE1' ' A' ' 563' ' ' MET . 57.8 Cg_endo -89.3 112.32 0.56 Allowed 'Trans proline' 0 N--CA 1.43 -2.216 0 N-CA-C 109.361 -1.053 . . . . 54.24 109.361 169.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.18 161.03 47.48 Favored 'Trans proline' 0 C--O 1.249 1.049 0 C-N-CA 122.709 2.272 . . . . 75.53 111.132 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -54.89 132.91 47.58 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 122.622 0.369 . . . . 61.55 110.316 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.64 -6.54 59.0 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.159 -1.019 . . . . 71.15 112.972 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 37.5 m -86.25 149.54 25.0 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.857 -0.423 . . . . 74.45 109.857 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.5 123.3 6.07 Favored Glycine 0 N--CA 1.433 -1.562 0 C-N-CA 121.211 -0.519 . . . . 74.12 112.478 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 35.5 m -116.28 142.31 30.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.716 -0.846 . . . . 74.23 108.716 176.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -55.74 175.31 0.09 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.922 0.889 . . . . 73.41 113.287 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -60.99 -27.0 67.98 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.5 -0.318 . . . . 71.1 111.639 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -82.34 -8.24 59.63 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.171 -0.612 . . . . 55.13 109.799 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.19 18.75 67.49 Favored Glycine 0 C--O 1.214 -1.131 0 O-C-N 123.302 0.376 . . . . 75.03 113.105 173.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.68 120.09 17.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 121.739 0.781 . . . . 72.33 111.396 -167.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.556 HG21 ' SD ' ' A' ' 563' ' ' MET . 50.7 pt -126.88 135.49 63.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 115.026 -0.988 . . . . 71.43 111.985 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 14.0 t -109.62 128.25 55.09 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.796 -0.816 . . . . 44.12 108.796 177.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 3.8 pp -139.78 168.08 20.65 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.297 -0.41 . . . . 63.31 111.631 -176.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -127.6 138.1 52.76 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.435 -0.58 . . . . 73.02 109.435 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.448 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 22.9 p90 -129.67 165.8 21.09 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 112.53 0.567 . . . . 75.13 112.53 -175.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -64.85 137.61 39.05 Favored Glycine 0 N--CA 1.423 -2.21 0 CA-C-N 114.886 -1.052 . . . . 42.12 112.488 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.554 ' HB2' ' HB3' ' A' ' 592' ' ' ASP . 62.6 tt0 . . . . . 0 C--N 1.277 -2.567 0 C-N-CA 125.431 1.492 . . . . 65.24 107.416 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.805 0 CA-C-O 119.28 -0.733 . . . . 43.05 111.274 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -76.75 141.66 22.0 Favored 'Trans proline' 0 C--O 1.25 1.082 0 C-N-CA 122.305 2.003 . . . . 74.35 112.566 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 62.11 7.25 2.08 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.903 1.681 . . . . 74.23 114.148 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.8 p -147.94 147.29 29.53 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 122.169 -0.332 . . . . 74.44 111.465 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -143.83 143.69 31.44 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 123.689 0.795 . . . . 74.33 109.443 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.8 p-10 -91.13 139.48 30.72 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.825 -0.806 . . . . 74.55 108.825 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.5 pt -97.65 132.17 25.6 Favored Pre-proline 0 C--N 1.293 -1.861 0 CA-C-N 115.463 -0.79 . . . . 75.32 111.9 -176.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -83.96 175.85 7.29 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.22 1.947 . . . . 60.23 110.187 173.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -86.55 127.09 34.86 Favored 'General case' 0 CA--C 1.489 -1.376 0 CA-C-O 122.047 0.927 . . . . 70.21 109.909 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.437 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 16.2 m -113.85 59.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 CA-C-O 122.827 1.298 . . . . 64.53 109.481 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -112.57 105.77 14.05 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 113.61 -1.632 . . . . 72.32 109.648 174.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 141.97 -17.03 2.57 Favored Glycine 0 C--N 1.313 -0.705 0 C-N-CA 118.472 -1.823 . . . . 71.11 114.61 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.442 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.1 OUTLIER -112.72 -175.27 2.63 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.041 -0.726 . . . . 73.04 109.041 177.686 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.412 ' HB ' HG23 ' A' ' 507' ' ' VAL . 2.8 m -74.66 155.44 37.76 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 107.973 -1.121 . . . . 74.53 107.973 178.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.527 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 8.3 p -62.82 -42.13 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 121.123 -0.231 . . . . 52.45 111.48 -178.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.25 -34.41 78.28 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 110.06 -0.348 . . . . 71.43 110.06 -178.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.412 HG23 ' HB ' ' A' ' 504' ' ' THR . 59.0 t -71.9 -44.32 67.41 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.966 0 N-CA-C 109.351 -0.611 . . . . 74.44 109.351 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.443 ' HB2' HG11 ' A' ' 534' ' ' VAL . . . -58.58 -43.68 89.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.78 0.324 . . . . 72.35 110.83 177.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 97.2 mt-30 -62.75 -44.24 96.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.722 -0.672 . . . . 74.32 110.445 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 514' ' ' VAL . 71.8 mmtt -65.86 -42.61 90.18 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.924 -0.58 . . . . 64.12 111.129 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -62.86 -47.23 84.25 Favored 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 124.06 0.85 . . . . 72.21 111.237 -176.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -68.41 -35.31 77.46 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 115.689 -0.687 . . . . 75.03 110.6 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.45 ' N ' HD12 ' A' ' 512' ' ' LEU . 4.0 t-20 -63.87 -34.0 76.95 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 115.171 -0.922 . . . . 74.52 111.431 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 510' ' ' LYS . 84.0 t -57.22 -32.53 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 121.164 0.507 . . . . 75.1 110.731 177.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -107.85 4.77 25.81 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.489 -0.93 . . . . 70.55 108.489 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -126.96 -60.18 0.14 Allowed Glycine 0 N--CA 1.416 -2.666 0 C-N-CA 119.547 -1.311 . . . . 51.42 114.577 -169.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 64.8 25.12 12.89 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 122.561 1.172 . . . . 65.31 108.224 -171.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.6 p -82.87 -172.88 4.36 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 113.271 -1.786 . . . . 23.32 111.007 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 519' ' ' LYS . 0.1 OUTLIER -108.71 136.56 48.1 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.537 -1.282 . . . . 74.45 107.537 179.461 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -132.26 147.22 52.4 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.121 0.486 . . . . 74.33 111.699 -177.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 64.5 m -140.74 149.24 41.89 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.637 -0.875 . . . . 71.31 108.637 176.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -117.9 140.55 49.56 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 116.255 -0.429 . . . . 63.51 110.326 -176.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -132.23 130.51 41.06 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.421 -0.955 . . . . 43.21 108.421 176.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 27.0 m -88.61 126.78 35.45 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 120.933 0.397 . . . . 64.43 111.522 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.77 150.68 25.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.216 -1.031 . . . . 72.02 108.216 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -66.91 135.02 53.2 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.453 -0.573 . . . . 62.14 109.453 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 33.4 m -154.17 165.94 16.9 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 107.935 -1.135 . . . . 72.22 107.935 -177.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -83.42 -18.47 5.87 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 120.979 1.119 . . . . 73.31 111.394 172.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.444 HH21 ' CD ' ' A' ' 533' ' ' GLU . 25.1 mtp180 -79.17 145.72 65.52 Favored Pre-proline 0 N--CA 1.437 -1.086 0 C-N-CA 124.697 1.199 . . . . 72.22 109.668 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.5 146.3 97.15 Favored 'Trans proline' 0 C--O 1.25 1.087 0 C-N-CA 123.638 2.892 . . . . 73.52 115.056 -170.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.91 105.31 0.55 Allowed 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.859 -1.064 . . . . 75.23 112.012 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 142.51 -26.22 2.28 Favored Glycine 0 C--N 1.308 -1.011 0 N-CA-C 110.656 -0.977 . . . . 74.01 110.656 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 533' ' ' GLU . . . . . 0.444 ' CD ' HH21 ' A' ' 529' ' ' ARG . 43.9 tt0 -80.35 136.48 36.4 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 121.227 0.536 . . . . 74.34 110.182 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 536' ' ' GLY . 8.0 p -98.27 124.78 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.66 0 CA-C-N 115.491 -0.777 . . . . 63.0 109.104 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.43 8.95 40.28 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.827 -1.079 . . . . 63.02 113.465 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.498 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 127.82 -163.57 21.45 Favored Glycine 0 C--N 1.298 -1.57 0 C-N-CA 120.288 -0.958 . . . . 73.42 112.703 174.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 28.1 p -116.69 158.94 22.99 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.504 -0.925 . . . . 72.34 108.504 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -59.87 -57.08 29.46 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 120.134 -0.626 . . . . 60.5 110.352 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -68.81 144.68 60.09 Favored 'Trans proline' 0 C--N 1.376 1.984 0 CA-C-N 120.26 1.128 . . . . 75.5 110.72 173.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.7 157.64 60.87 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 123.063 2.508 . . . . 72.24 113.506 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.22 130.74 46.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.517 -0.765 . . . . 43.35 110.765 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.82 -12.79 41.89 Favored Glycine 0 C--N 1.303 -1.299 0 CA-C-N 116.025 -0.534 . . . . 72.34 112.236 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 45.8 m -73.83 125.72 28.79 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 110.174 -0.306 . . . . 74.52 110.174 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 11.7 t -81.39 124.36 29.34 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.38 -0.97 . . . . 65.25 108.38 176.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.2 m -123.95 159.26 57.18 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 107.903 -1.147 . . . . 75.24 107.903 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -66.69 137.66 46.59 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 120.723 0.948 . . . . 75.42 111.191 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.5 p -63.24 -23.61 33.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.233 -0.894 . . . . 71.45 112.104 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -101.7 3.17 39.42 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.744 -0.782 . . . . 72.51 110.194 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 9.9 t -95.86 -178.62 4.43 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 108.619 -0.882 . . . . 64.31 108.619 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.2 p -103.24 137.24 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 CA-C-O 121.635 0.731 . . . . 74.34 111.639 -174.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.37 128.24 50.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 106.647 -1.612 . . . . 74.44 106.647 175.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -103.4 117.5 34.62 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.613 0.72 . . . . 71.33 112.08 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.7 mp -102.04 130.65 48.66 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.368 -1.287 . . . . 73.31 110.17 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -93.58 115.85 28.35 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.752 0.787 . . . . 73.34 112.135 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 40.1 t -88.41 129.77 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 107.281 -1.378 . . . . 54.42 107.281 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.664 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 2.2 m -84.06 117.74 23.62 Favored 'General case' 0 C--N 1.271 -2.813 0 N-CA-C 108.498 -0.927 . . . . 73.32 108.498 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -94.32 125.75 39.16 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.77 -1.567 . . . . 72.33 106.77 171.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -61.85 -23.4 63.37 Favored Glycine 0 C--N 1.308 -1.011 0 N-CA-C 115.014 0.766 . . . . 73.4 115.014 -173.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 78.08 -20.3 0.39 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.87 1.268 . . . . 74.23 108.532 -175.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.472 ' H ' ' C ' ' A' ' 558' ' ' GLY . 78.3 mt-30 -112.78 148.17 35.36 Favored 'General case' 0 N--CA 1.403 -2.784 0 CA-C-N 115.376 -0.829 . . . . 75.13 111.012 -174.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -123.84 154.9 38.96 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 106.205 -1.776 . . . . 64.44 106.205 175.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 44.2 t -71.96 126.97 33.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 109.314 -0.624 . . . . 65.43 109.314 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.439 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 51.9 ttp -84.24 127.53 66.0 Favored Pre-proline 0 C--O 1.251 1.153 0 CA-C-N 116.28 -0.418 . . . . 72.03 110.19 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 564' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 11.9 Cg_exo -70.73 169.53 19.92 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.707 2.271 . . . . 65.24 111.101 175.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -72.53 142.13 48.49 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.381 0.61 . . . . 71.21 111.321 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.8 pp -154.87 25.9 0.44 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.599 -1.182 . . . . 64.4 109.624 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 21.7 m -79.58 146.81 32.38 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.101 -0.954 . . . . 53.14 110.372 -177.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 63.72 53.79 35.7 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.116 -0.564 . . . . 71.24 113.098 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -130.04 173.07 11.08 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.19 -1.041 . . . . 72.41 108.19 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -108.4 172.29 6.92 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.808 -1.182 . . . . 74.22 107.808 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 571' ' ' TRP . . . . . 0.521 ' CZ3' HD22 ' A' ' 587' ' ' LEU . 12.8 t-105 -65.93 -32.27 73.68 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.452 -0.944 . . . . 71.43 108.452 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.59 -15.1 18.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.537 -0.756 . . . . 73.53 111.238 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.557 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 25.9 t70 -101.07 -21.56 14.96 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.608 -0.886 . . . . 63.52 108.608 177.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -68.24 -39.18 82.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.189 -0.914 . . . . 61.53 111.92 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.644 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 2.7 tm-20 -58.77 -52.31 75.66 Favored Pre-proline 0 CA--C 1.57 1.742 0 N-CA-C 109.283 -0.636 . . . . 60.44 109.283 177.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 75.1 Cg_exo -55.23 -40.66 84.55 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 121.271 1.314 . . . . 72.35 112.486 171.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.557 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 16.7 mmt180 -61.62 -38.21 86.81 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 111.906 0.336 . . . . 62.02 111.906 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.1 pp -66.5 -47.13 73.99 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.969 -0.692 . . . . 40.35 110.964 -176.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.478 ' N ' HD12 ' A' ' 578' ' ' LEU . 14.7 ptm180 -66.12 -34.85 78.99 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.528 -0.305 . . . . 73.24 110.696 176.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.31 -39.52 92.59 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.823 -0.626 . . . . 45.41 111.284 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.423 HD11 ' HB2' ' A' ' 583' ' ' TRP . 1.1 pp -92.51 -8.73 43.67 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.01 -0.676 . . . . 71.34 110.963 -178.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 76.83 42.91 19.4 Favored Glycine 0 CA--C 1.517 0.165 0 N-CA-C 111.53 -0.628 . . . . 51.2 111.53 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.423 ' HB2' HD11 ' A' ' 581' ' ' LEU . 16.2 t90 -87.22 127.56 35.16 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 123.276 0.63 . . . . 75.4 110.145 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 5.8 m -103.99 -21.3 13.63 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.064 0.459 . . . . 73.04 111.557 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -72.56 177.97 39.7 Favored Glycine 0 C--O 1.241 0.567 0 CA-C-O 121.598 0.555 . . . . 73.11 114.472 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 586' ' ' MET . . . . . 0.434 ' O ' HG12 ' A' ' 619' ' ' ILE . 55.7 ttp -95.54 145.6 25.09 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 123.597 0.759 . . . . 61.43 110.654 -177.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 587' ' ' LEU . . . . . 0.521 HD22 ' CZ3' ' A' ' 571' ' ' TRP . 5.4 tt -85.64 112.44 21.01 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.438 -0.949 . . . . 73.42 108.438 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 621' ' ' THR . 25.4 t70 -101.83 105.26 16.08 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.686 0.755 . . . . 75.15 110.324 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.482 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.1 OUTLIER -90.48 133.87 34.75 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 115.033 -0.985 . . . . 74.24 108.561 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -73.35 -63.35 2.8 Favored Glycine 0 C--N 1.288 -2.106 0 N-CA-C 110.792 -0.923 . . . . 72.43 110.792 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.16 151.3 45.15 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.462 -0.369 . . . . 45.42 111.032 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -115.6 123.49 48.57 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 104.41 -2.441 . . . . 71.04 104.41 168.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 50.7 t -112.64 120.69 63.37 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 CA-C-N 116.007 -0.542 . . . . 52.52 109.579 -174.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 594' ' ' ASP . . . . . 0.446 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 21.9 t70 -76.35 106.7 8.12 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 106.385 -1.709 . . . . 70.12 106.385 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -134.83 8.0 3.51 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.607 -0.437 . . . . 44.44 111.75 -175.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 117.28 95.68 1.84 Allowed Glycine 0 N--CA 1.422 -2.241 0 C-N-CA 120.194 -1.003 . . . . 50.15 111.7 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.25 -31.29 59.24 Favored Glycine 0 C--N 1.32 -0.348 0 N-CA-C 111.951 -0.46 . . . . 32.14 111.951 177.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 46.4 t -59.4 -24.6 63.6 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.185 0.994 . . . . 54.22 110.669 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -87.33 -4.22 59.05 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.568 -0.742 . . . . 71.23 111.169 -175.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 39.6 m80 63.7 94.06 0.05 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 122.102 0.953 . . . . 71.22 111.051 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 601' ' ' ASN . . . . . 0.494 ' N ' HD22 ' A' ' 601' ' ' ASN . 0.8 OUTLIER -85.28 87.86 7.43 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.967 0.889 . . . . 72.24 112.215 -173.249 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -90.82 169.93 10.52 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.045 -1.434 . . . . 55.33 108.996 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.412 HG11 HD12 ' A' ' 622' ' ' LEU . 85.1 t -60.45 129.83 23.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.007 -0.738 . . . . 71.31 109.007 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 11.7 p -112.79 -35.75 2.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 O-C-N 123.645 0.591 . . . . 51.44 111.041 -175.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -136.58 139.62 42.28 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.306 -0.406 . . . . 63.15 110.082 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -137.75 139.2 39.97 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.295 -1.372 . . . . 71.13 107.295 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -65.7 -52.81 40.54 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 113.125 0.787 . . . . 73.24 113.125 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 609' ' ' PRO . 34.0 Cg_endo -85.92 125.19 2.69 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 CA-C-N 120.424 1.187 . . . . 53.01 110.941 176.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 609' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 11.6 Cg_exo -70.88 158.99 53.98 Favored 'Trans proline' 0 C--O 1.244 0.823 0 C-N-CA 122.382 2.055 . . . . 72.04 112.81 178.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.58 130.79 44.14 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 108.488 -0.93 . . . . 70.31 108.488 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 98.18 0.01 58.6 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 120.222 -0.989 . . . . 65.41 112.084 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 35.6 m -102.17 154.52 18.94 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.421 -0.955 . . . . 75.5 108.421 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.45 133.2 12.15 Favored Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 120.914 -0.66 . . . . 54.04 111.792 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.5 m -117.38 142.36 31.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.922 -0.77 . . . . 71.41 108.922 176.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.455 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 34.2 p30 -47.55 166.35 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 114.112 1.153 . . . . 64.53 114.112 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -61.35 -26.03 67.55 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.303 -0.862 . . . . 74.52 112.626 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -83.46 -10.89 58.08 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 119.037 -1.065 . . . . 72.11 109.481 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.73 9.77 56.73 Favored Glycine 0 CA--C 1.499 -0.946 0 N-CA-C 111.293 -0.723 . . . . 22.34 111.293 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 619' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 586' ' ' MET . 0.0 OUTLIER -70.45 118.83 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.167 0 CA-C-O 122.212 1.006 . . . . 73.13 108.615 -171.041 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.44 ' O ' HD12 ' A' ' 620' ' ' ILE . 2.7 pp -121.11 132.6 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.872 0 CA-C-N 114.02 -1.445 . . . . 52.44 110.251 -177.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 15.3 t -104.93 119.35 38.79 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.57 -0.9 . . . . 61.45 108.57 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.442 HD21 HD21 ' A' ' 587' ' ' LEU . 1.3 pt? -139.49 165.88 26.05 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.4 -0.818 . . . . 61.23 110.813 -175.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -128.82 142.32 51.01 Favored 'General case' 0 C--O 1.257 1.469 0 CA-C-O 121.279 0.561 . . . . 74.13 110.458 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -142.0 166.75 23.87 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.186 -1.413 . . . . 53.31 107.186 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -79.31 -142.94 2.55 Favored Glycine 0 C--N 1.294 -1.785 0 C-N-CA 119.107 -1.52 . . . . 64.34 113.096 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.446 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 6.5 tp-100 . . . . . 0 C--N 1.279 -2.488 0 N-CA-C 109.294 -0.632 . . . . 60.0 109.294 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.591 0 N-CA-C 110.965 -0.854 . . . . 43.05 110.965 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -76.75 161.09 33.95 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 122.661 2.24 . . . . 70.54 110.269 174.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 59.75 21.78 10.59 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.015 0.926 . . . . 73.33 112.661 176.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.0 p -139.21 143.43 38.06 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.675 -0.491 . . . . 75.4 109.675 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -131.81 143.47 50.22 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 121.197 0.523 . . . . 73.22 110.546 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 2.3 m-20 -88.32 121.85 31.18 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.897 -1.047 . . . . 72.21 109.817 -177.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.0 pt -86.62 122.56 71.7 Favored Pre-proline 0 C--N 1.302 -1.465 0 CA-C-N 116.318 -0.401 . . . . 71.31 110.637 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -85.86 -169.57 0.6 Allowed 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.294 1.996 . . . . 73.42 110.593 177.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -89.5 129.81 35.93 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.569 -0.9 . . . . 75.0 108.569 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.504 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 27.8 m -121.77 7.84 5.85 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 CA-C-N 115.208 -0.905 . . . . 71.13 109.969 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.97 103.78 4.59 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.397 -0.82 . . . . 74.13 110.119 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 161.98 -41.39 0.38 Allowed Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 115.517 -0.765 . . . . 44.54 111.195 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 14.3 pm0 -93.94 -177.51 4.36 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 108.984 -0.747 . . . . 71.54 108.984 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 7.8 m -70.56 155.4 40.77 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 108.467 -0.938 . . . . 73.34 108.467 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.472 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 11.5 p -64.87 -42.05 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 O-C-N 123.122 0.264 . . . . 74.53 110.717 -177.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -62.2 -40.72 97.04 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 109.866 -0.42 . . . . 72.52 109.866 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 84.4 t -66.14 -47.28 85.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.894 0 CA-C-N 115.271 -0.877 . . . . 60.35 109.333 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.504 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -60.9 -45.15 95.76 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 111.828 0.307 . . . . 72.44 111.828 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.5 mt-30 -64.88 -46.76 80.42 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 116.038 -0.528 . . . . 75.42 111.232 -177.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.515 ' O ' HG23 ' A' ' 514' ' ' VAL . 21.5 ptmt -67.49 -38.84 84.95 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 116.208 -0.451 . . . . 73.53 110.645 -178.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -62.87 -42.32 99.72 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.186 0.517 . . . . 61.13 111.15 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -68.71 -41.97 78.34 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.337 -0.847 . . . . 64.25 108.74 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -59.38 -40.84 87.82 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.644 1.178 . . . . 73.21 111.734 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 510' ' ' LYS . 91.6 t -57.58 -33.18 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 121.173 0.511 . . . . 74.21 111.507 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -114.84 16.42 17.3 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.621 -0.511 . . . . 73.2 109.621 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -133.94 -58.46 0.07 OUTLIER Glycine 0 N--CA 1.428 -1.879 0 C-N-CA 119.64 -1.267 . . . . 32.12 113.618 -173.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 64.07 28.2 14.22 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 122.629 1.204 . . . . 72.32 111.013 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.2 p -79.61 171.99 14.4 Favored 'General case' 0 N--CA 1.396 -3.137 0 CA-C-N 113.643 -1.617 . . . . 74.41 108.17 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.535 ' HD2' ' N ' ' A' ' 519' ' ' LYS . 10.2 mptt -107.56 136.06 47.96 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 107.549 -1.278 . . . . 73.53 107.549 -176.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -133.51 149.24 51.71 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.026 0.441 . . . . 72.1 112.145 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.7 m -138.73 142.93 38.88 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.076 -1.453 . . . . 63.03 107.076 174.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -117.54 137.75 52.36 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.62 -0.432 . . . . 72.23 111.094 -176.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -122.62 119.73 31.64 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.63 -0.878 . . . . 64.22 108.63 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 12.8 m -96.36 120.34 36.48 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.097 0.475 . . . . 74.11 111.17 -176.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.7 p -123.82 155.31 30.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.448 -1.316 . . . . 74.43 107.448 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.443 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 4.3 p30 -75.78 136.42 40.27 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.496 0.665 . . . . 72.51 111.745 -178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 64.9 m -160.45 159.69 26.06 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 107.047 -1.464 . . . . 52.35 107.047 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -65.58 -9.77 23.82 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 C-N-CA 122.788 2.326 . . . . 74.22 113.561 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.449 ' HB2' ' CB ' ' A' ' 556' ' ' SER . 14.7 mmm180 -78.36 141.94 62.21 Favored Pre-proline 0 N--CA 1.436 -1.15 0 N-CA-C 107.27 -1.382 . . . . 72.55 107.27 176.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -64.43 152.2 82.5 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 122.862 2.374 . . . . 73.14 113.958 -173.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.649 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.91 111.15 1.19 Allowed 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.815 -0.629 . . . . 63.54 111.963 -178.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 123.85 -16.17 7.83 Favored Glycine 0 C--N 1.299 -1.491 0 CA-C-N 115.283 -0.871 . . . . 52.04 112.121 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.16 138.36 34.74 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.535 -0.542 . . . . 64.15 109.535 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 6.1 p -87.16 116.84 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 CA-C-O 122.136 0.969 . . . . 74.0 109.48 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.97 -27.31 60.93 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 113.976 -1.466 . . . . 74.22 109.884 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.51 -162.31 29.54 Favored Glycine 0 N--CA 1.416 -2.651 0 N-CA-C 110.583 -1.007 . . . . 64.4 110.583 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 5.3 p -117.03 157.7 25.39 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 109.481 -0.563 . . . . 63.42 109.481 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.484 ' HB2' HE22 ' A' ' 554' ' ' GLN . 7.7 t30 -63.94 -54.14 43.21 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 120.766 -0.374 . . . . 72.45 110.2 174.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -69.32 134.4 28.81 Favored 'Trans proline' 0 C--N 1.369 1.617 0 N-CA-C 108.679 -1.316 . . . . 72.12 108.679 170.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.57 155.96 50.12 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 122.437 2.091 . . . . 51.22 112.93 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.4 131.21 45.86 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.964 -0.562 . . . . 73.51 109.718 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.84 -7.44 38.52 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 111.459 -0.656 . . . . 73.14 111.459 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 30.1 m -80.9 137.25 36.15 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.842 -0.429 . . . . 70.03 109.842 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 5.6 t -92.04 128.32 37.84 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 107.819 -1.178 . . . . 73.04 107.819 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 29.5 m -123.95 154.85 67.83 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.74 -0.837 . . . . 62.11 108.74 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -65.56 137.94 52.46 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 121.054 1.169 . . . . 74.41 111.269 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.6 -19.76 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-O 122.219 1.009 . . . . 74.34 109.691 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -84.76 -16.05 42.91 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.148 -1.387 . . . . 71.22 110.747 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 22.8 t -94.45 -173.29 3.01 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-N 115.869 -0.605 . . . . 71.2 110.737 -175.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.2 p -118.95 138.15 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 C-N-CA 123.6 0.76 . . . . 75.13 111.207 -175.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 43.8 mt -95.0 143.9 10.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.509 -0.922 . . . . 42.22 108.509 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -103.8 117.06 33.46 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.43 -0.952 . . . . 73.45 108.43 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.95 120.6 41.86 Favored 'General case' 0 C--N 1.311 -1.071 0 O-C-N 123.735 0.647 . . . . 71.44 110.083 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.484 HE22 ' HB2' ' A' ' 538' ' ' ASN . 2.6 mp0 -90.74 120.96 32.22 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.215 0.531 . . . . 63.34 109.991 176.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.459 HG22 HG21 ' A' ' 505' ' ' VAL . 23.9 t -105.59 137.22 36.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.216 -1.031 . . . . 74.31 108.216 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.649 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 71.2 m -89.89 133.15 34.92 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-O 120.756 0.312 . . . . 74.3 110.362 176.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 18.8 ptpt -106.1 127.18 53.01 Favored 'General case' 0 N--CA 1.406 -2.638 0 N-CA-C 104.317 -2.475 . . . . 72.24 104.317 164.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -55.42 -23.66 35.39 Favored Glycine 0 CA--C 1.506 -0.511 0 O-C-N 124.062 0.851 . . . . 55.14 114.128 -173.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 559' ' ' ASN . . . . . 0.443 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 19.6 t-20 81.77 -19.13 0.44 Allowed 'General case' 0 CA--C 1.495 -1.161 0 C-N-CA 126.236 1.815 . . . . 44.25 108.903 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.483 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 85.2 mt-30 -111.83 144.91 40.36 Favored 'General case' 0 N--CA 1.407 -2.59 0 CA-C-N 115.259 -0.882 . . . . 73.21 110.528 -173.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -123.29 146.67 47.71 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 107.535 -1.284 . . . . 64.21 107.535 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 84.5 t -62.33 116.63 2.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 123.66 0.6 . . . . 71.4 109.825 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.415 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 56.3 ttp -77.59 126.63 84.24 Favored Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 116.387 -0.37 . . . . 50.53 110.686 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 564' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 16.1 Cg_exo -69.45 168.49 21.01 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.5 2.133 . . . . 61.0 110.95 175.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -77.66 132.13 38.07 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 113.122 0.786 . . . . 74.21 113.122 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.0 pp -140.49 16.21 2.37 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.384 -1.28 . . . . 74.44 110.07 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 71.3 p -73.89 148.3 42.41 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 116.151 -0.477 . . . . 73.04 112.227 -175.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 72.97 57.28 5.35 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 115.689 -0.687 . . . . 61.33 113.987 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -136.93 167.93 20.54 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.115 -0.698 . . . . 72.43 109.115 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -95.5 165.76 12.19 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.387 -1.338 . . . . 75.5 107.387 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -67.21 -29.04 68.6 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.356 -0.609 . . . . 64.34 109.356 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.2 p -71.78 -22.81 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.558 0.694 . . . . 71.11 109.982 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -95.97 -34.29 11.84 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.039 -0.982 . . . . 55.24 108.936 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -54.7 -53.11 59.24 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 114.973 -1.012 . . . . 73.11 112.635 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.426 ' HB2' ' HD3' ' A' ' 576' ' ' PRO . 38.2 mt-10 -53.82 -54.95 40.91 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 115.122 1.527 . . . . 71.44 115.122 -176.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 24.5 Cg_exo -61.83 -28.11 81.17 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.413 1.409 . . . . 53.41 111.446 175.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -67.98 -35.12 77.82 Favored 'General case' 0 C--O 1.198 -1.646 0 CA-C-O 118.999 -0.524 . . . . 70.42 111.847 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.592 HD22 ' CE3' ' A' ' 583' ' ' TRP . 16.6 mt -60.25 -48.95 79.55 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.406 -0.59 . . . . 71.32 109.406 -176.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -66.5 -40.82 89.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.764 -0.653 . . . . 62.42 111.492 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.76 65.43 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.132 0.492 . . . . 74.24 111.762 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.7 tp -91.87 -9.11 44.49 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 124.33 1.052 . . . . 65.42 110.022 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.65 22.35 77.31 Favored Glycine 0 C--N 1.315 -0.588 0 C-N-CA 121.112 -0.566 . . . . 53.23 112.55 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.592 ' CE3' HD22 ' A' ' 578' ' ' LEU . 16.7 t90 -87.48 127.31 35.23 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.053 -0.721 . . . . 74.12 109.053 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 14.8 p -100.11 -14.49 18.55 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 113.877 1.066 . . . . 75.54 113.877 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 585' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -80.11 -159.29 18.73 Favored Glycine 0 C--N 1.313 -0.711 0 N-CA-C 114.321 0.488 . . . . 73.32 114.321 -175.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 65.7 mtt -114.41 139.5 49.45 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.868 0.366 . . . . 71.34 111.383 -174.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 21.5 tp -80.71 101.88 9.56 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 106.709 -1.589 . . . . 51.2 106.709 177.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 621' ' ' THR . 31.0 t70 -98.99 117.45 33.54 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.872 -0.331 . . . . 75.22 111.036 -173.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.0 OUTLIER -91.19 133.44 35.37 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 119.587 -0.845 . . . . 70.41 110.503 -179.102 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -74.34 -72.99 0.96 Allowed Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 110.798 -0.921 . . . . 42.33 110.798 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.16 142.28 35.97 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.715 -0.846 . . . . 75.35 108.715 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -79.88 123.58 27.89 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 107.079 -1.452 . . . . 74.55 107.079 174.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 50.4 t -104.68 128.28 58.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.398 -1.334 . . . . 72.25 107.398 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -72.01 114.04 9.68 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.768 -0.827 . . . . 54.52 108.768 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -124.53 -44.29 1.99 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.918 -1.037 . . . . 51.13 111.0 -173.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 109.08 122.52 4.62 Favored Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.561 -0.828 . . . . 44.32 112.111 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -61.22 -33.63 85.04 Favored Glycine 0 C--N 1.316 -0.548 0 CA-C-N 116.001 -0.1 . . . . 72.31 113.057 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 22.8 t -70.59 -22.85 62.51 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.94 0.876 . . . . 53.3 110.377 -177.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -87.12 -1.3 57.79 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.304 -0.862 . . . . 70.54 108.935 -175.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 69.77 82.63 0.16 Allowed 'General case' 0 CA--C 1.492 -1.274 0 C-N-CA 124.59 1.156 . . . . 73.42 108.611 -173.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -79.43 79.63 5.87 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 114.16 -1.382 . . . . 75.23 111.549 -176.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -87.68 173.23 9.15 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.746 -1.57 . . . . 73.21 108.234 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.489 HG11 HD12 ' A' ' 622' ' ' LEU . 91.1 t -58.68 130.4 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.322 -1.733 . . . . 74.12 106.322 168.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.2 m -101.57 -29.92 3.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 120.703 -0.399 . . . . 64.51 111.687 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -155.78 144.55 20.42 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 109.824 -0.436 . . . . 64.33 109.824 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -135.04 140.73 45.82 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.977 -1.49 . . . . 73.13 106.977 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.43 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 27.4 t-20 -66.32 -54.82 22.78 Favored Pre-proline 0 C--N 1.312 -1.046 0 C-N-CA 119.647 -0.821 . . . . 75.44 112.314 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.3 Cg_exo -84.8 119.16 2.17 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 121.996 1.797 . . . . 35.2 111.388 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.14 160.77 48.1 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 123.048 2.498 . . . . 53.05 112.252 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.07 134.94 51.46 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.657 -0.868 . . . . 62.41 108.657 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.32 -15.09 47.11 Favored Glycine 0 C--N 1.293 -1.81 0 N-CA-C 110.948 -0.861 . . . . 62.34 110.948 -175.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 37.3 m -92.61 146.77 23.41 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.042 -1.096 . . . . 64.35 108.042 178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -78.2 130.92 10.47 Favored Glycine 0 N--CA 1.426 -1.995 0 C-N-CA 121.163 -0.541 . . . . 70.44 112.427 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 26.8 m -114.69 142.12 28.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.829 -1.174 . . . . 65.31 107.829 176.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.483 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.9 p-10 -50.92 172.85 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.149 0.98 . . . . 64.4 113.397 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -54.71 -27.14 38.46 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 113.811 1.041 . . . . 74.41 113.811 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.422 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 1.2 m-20 -94.77 -6.5 42.89 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.17 -0.612 . . . . 62.11 110.645 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.49 19.19 68.59 Favored Glycine 0 C--O 1.214 -1.118 0 CA-C-O 119.806 -0.441 . . . . 71.14 113.35 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.72 119.15 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 122.083 0.944 . . . . 64.22 110.835 -167.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.415 HG22 ' HG2' ' A' ' 608' ' ' PRO . 48.7 pt -125.54 134.98 65.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.89 -1.05 . . . . 43.23 110.909 -176.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 15.1 t -100.31 125.37 46.52 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 108.461 -0.94 . . . . 73.34 108.461 177.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 1.8 pt? -139.32 165.27 27.63 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.285 -0.87 . . . . 73.42 110.288 -175.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -128.81 140.06 51.88 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.64 -0.504 . . . . 71.43 109.64 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 603' ' ' VAL . 5.2 p90 -130.97 165.16 23.76 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.862 0.363 . . . . 71.52 111.452 -174.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -76.96 141.89 26.82 Favored Glycine 0 N--CA 1.415 -2.762 0 CA-C-N 114.955 -1.021 . . . . 64.11 113.604 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 . . . . . 0 C--N 1.272 -2.798 0 N-CA-C 106.98 -1.489 . . . . 72.31 106.98 178.66 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.431 0 N-CA-C 109.973 -1.251 . . . . 72.42 109.973 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -68.2 142.09 54.43 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 122.164 1.909 . . . . 62.21 110.719 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 61.24 21.68 12.12 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.039 0.936 . . . . 72.3 112.449 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 546' ' ' PRO . 29.5 p -139.84 145.46 38.14 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.572 -0.529 . . . . 54.42 109.572 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -128.51 137.04 51.57 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 123.396 0.435 . . . . 74.32 110.305 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.587 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.9 p-10 -84.87 124.79 32.02 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.474 0.654 . . . . 54.43 110.099 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 497' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 498' ' ' PRO . 37.3 pt -84.89 125.35 71.02 Favored Pre-proline 0 C--N 1.305 -1.357 0 CA-C-N 115.673 -0.694 . . . . 63.35 111.735 -176.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 8.2 Cg_exo -74.44 172.65 15.7 Favored 'Trans proline' 0 C--O 1.254 1.28 0 C-N-CA 122.449 2.099 . . . . 62.34 111.124 174.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -80.25 105.44 11.52 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.989 -0.55 . . . . 73.32 109.616 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.432 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 15.4 m -106.87 59.3 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-O 123.24 1.495 . . . . 75.33 110.308 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -118.0 111.49 19.01 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 112.658 -2.064 . . . . 61.44 108.127 173.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 136.22 -15.85 3.93 Favored Glycine 0 C--N 1.303 -1.289 0 C-N-CA 119.042 -1.551 . . . . 61.22 113.937 177.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.469 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.4 OUTLIER -111.39 -175.46 2.71 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 117.695 0.748 . . . . 73.11 109.231 176.703 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 10.6 m -71.67 155.0 40.99 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.542 -0.91 . . . . 72.52 108.542 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.435 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.7 p -61.64 -42.48 94.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 111.508 0.188 . . . . 73.2 111.508 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 506' ' ' ASP . . . . . 0.433 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 25.7 t70 -62.51 -41.63 98.96 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.965 -0.383 . . . . 73.24 109.965 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 68.0 t -67.46 -41.66 86.3 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.966 0 CA-C-N 115.64 -0.709 . . . . 71.32 109.476 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.514 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -61.97 -43.51 98.69 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 121.365 -0.134 . . . . 72.34 111.146 176.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 26.3 mt-30 -64.85 -43.13 94.0 Favored 'General case' 0 CA--C 1.511 -0.539 0 O-C-N 123.089 0.243 . . . . 71.42 110.811 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.556 ' O ' HG23 ' A' ' 514' ' ' VAL . 75.9 mmtt -63.77 -46.6 84.52 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.586 -0.524 . . . . 64.41 109.586 176.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -63.57 -38.63 91.84 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.733 -0.667 . . . . 73.35 111.715 -177.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.71 -45.29 83.31 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.552 -1.277 . . . . 62.24 107.552 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -59.77 -36.1 75.97 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 124.03 0.932 . . . . 75.03 110.947 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 510' ' ' LYS . 83.5 t -57.2 -39.5 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 122.875 0.47 . . . . 51.24 111.317 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -105.0 -8.32 18.63 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.584 0.707 . . . . 73.25 110.012 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -108.43 -59.6 0.54 Allowed Glycine 0 N--CA 1.414 -2.802 0 CA-C-N 115.574 -0.739 . . . . 52.14 112.836 -169.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 65.44 25.81 11.92 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 122.398 1.094 . . . . 75.22 109.434 -173.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 547' ' ' VAL . 1.9 p -90.61 -172.99 3.59 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 113.741 -1.572 . . . . 75.51 110.239 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -108.75 142.05 39.86 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.38 -1.341 . . . . 72.42 107.38 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -132.44 153.11 51.18 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.11 0.481 . . . . 73.24 112.278 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.7 m -141.4 152.73 44.56 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.169 -1.048 . . . . 74.04 108.169 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -117.46 126.43 52.61 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.396 0.617 . . . . 60.41 111.719 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.02 130.38 56.17 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.891 -1.151 . . . . 65.13 107.891 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 18.7 p -103.87 139.58 38.86 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.323 0.582 . . . . 63.04 112.435 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.0 p -136.64 149.58 26.87 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 107.276 -1.379 . . . . 71.53 107.276 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 1.6 p-10 -87.61 136.83 32.79 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.93 -0.708 . . . . 73.2 110.521 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 50.6 m -156.27 163.79 23.67 Favored Pre-proline 0 C--N 1.293 -1.879 0 N-CA-C 106.415 -1.698 . . . . 75.24 106.415 -178.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.4 10.69 0.7 Allowed 'Trans proline' 0 CA--C 1.558 1.676 0 C-N-CA 121.935 1.757 . . . . 73.43 114.355 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.459 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 0.0 OUTLIER -96.59 140.99 22.46 Favored Pre-proline 0 C--O 1.214 -0.788 0 N-CA-C 108.686 -0.857 . . . . 74.1 108.686 177.524 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.1 145.88 73.15 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 123.251 2.634 . . . . 62.53 113.643 -176.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -66.83 99.39 0.62 Allowed 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.972 -1.013 . . . . 71.44 112.781 -174.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 152.3 -26.64 0.88 Allowed Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 115.045 -0.98 . . . . 64.52 110.734 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -74.39 131.4 41.06 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.687 0.756 . . . . 70.33 110.831 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.514 HG11 ' CB ' ' A' ' 508' ' ' ALA . 12.4 p -97.97 125.65 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.063 0 N-CA-C 107.33 -1.359 . . . . 73.51 107.33 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 p -97.59 10.95 38.58 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 115.184 -0.916 . . . . 65.44 113.024 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.466 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 133.18 -165.77 23.93 Favored Glycine 0 N--CA 1.434 -1.491 0 C-N-CA 119.963 -1.113 . . . . 74.04 113.448 173.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 14.2 p -116.94 158.4 24.13 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 124.293 1.037 . . . . 53.41 108.736 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.442 ' HB2' HE22 ' A' ' 554' ' ' GLN . 9.4 t30 -62.14 -50.4 80.38 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 119.31 -0.956 . . . . 61.41 112.454 178.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -69.17 143.27 53.12 Favored 'Trans proline' 0 C--N 1.367 1.529 0 N-CA-C 108.929 -1.219 . . . . 55.03 108.929 170.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.94 144.93 89.34 Favored 'Trans proline' 0 C--O 1.253 1.229 0 C-N-CA 122.411 2.074 . . . . 55.43 112.634 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.27 137.51 58.27 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.458 -0.792 . . . . 73.33 109.629 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.52 -12.59 47.17 Favored Glycine 0 C--N 1.304 -1.242 0 N-CA-C 111.48 -0.648 . . . . 63.24 111.48 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.417 ' O ' HG12 ' A' ' 497' ' ' ILE . 31.9 m -81.03 136.81 36.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.518 0.199 . . . . 61.13 110.895 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.2 t -90.59 128.32 36.55 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 108.214 -1.032 . . . . 41.3 108.214 173.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.77 153.99 67.0 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 108.907 -0.775 . . . . 52.13 108.907 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.457 ' HA ' HG22 ' A' ' 494' ' ' THR . 14.9 Cg_endo -60.54 138.19 78.61 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.76 1.64 . . . . 74.42 111.702 178.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.545 ' HA ' HG22 ' A' ' 518' ' ' THR . 8.7 p -61.27 -19.03 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 CA-C-O 122.177 0.989 . . . . 33.2 110.552 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -81.12 -15.8 54.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.638 -1.165 . . . . 75.54 111.954 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 77.6 p -92.79 157.96 16.14 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 112.905 0.706 . . . . 64.42 112.905 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.9 p -98.56 128.15 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 115.261 -0.881 . . . . 75.4 110.119 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.6 mt -98.95 136.05 31.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.508 -0.769 . . . . 62.1 109.798 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.88 125.25 50.16 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.889 0.852 . . . . 73.0 111.754 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.63 120.92 39.89 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 113.884 -1.507 . . . . 74.33 109.128 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.442 HE22 ' HB2' ' A' ' 538' ' ' ASN . 2.6 mp0 -85.7 108.5 18.07 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.731 0.777 . . . . 63.43 112.057 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 16.2 t -90.6 129.84 40.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 114.962 -1.017 . . . . 63.44 108.307 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 67.7 m -94.69 117.99 31.01 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 109.83 -0.433 . . . . 44.13 109.83 177.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.401 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 18.2 ptpt -90.94 136.74 32.87 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.431 -1.692 . . . . 75.12 106.431 173.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -62.85 -24.39 66.55 Favored Glycine 0 CA--C 1.489 -1.561 0 O-C-N 124.233 0.958 . . . . 65.11 114.423 -171.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 559' ' ' ASN . . . . . 0.457 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 31.7 t-20 77.75 -24.99 0.2 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.571 1.148 . . . . 64.24 109.574 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.444 ' H ' ' C ' ' A' ' 558' ' ' GLY . 86.5 mt-30 -111.46 150.46 29.85 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 115.782 -0.645 . . . . 63.4 111.078 -174.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -132.35 149.86 52.27 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.347 -1.297 . . . . 75.42 107.622 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 63.2 t -68.25 125.72 26.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 109.833 -0.432 . . . . 71.14 109.833 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 48.1 ttp -92.18 125.63 55.88 Favored Pre-proline 0 C--N 1.308 -1.233 0 CA-C-N 116.072 -0.513 . . . . 60.21 111.184 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.81 155.01 71.57 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.957 2.438 . . . . 71.45 111.027 174.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 565' ' ' ASP . . . . . 0.524 ' HA ' ' CB ' ' A' ' 610' ' ' ALA . 29.4 t70 -67.03 139.42 57.63 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 114.851 1.426 . . . . 65.52 114.851 -174.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 566' ' ' LEU . . . . . 0.417 ' O ' ' HG2' ' A' ' 569' ' ' MET . 2.1 pt? -141.35 15.63 2.21 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.772 -1.103 . . . . 63.43 109.688 176.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 84.2 p -80.06 153.28 28.88 Favored 'General case' 0 C--O 1.251 1.161 0 C-N-CA 120.171 -0.611 . . . . 65.31 110.571 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 79.08 31.49 42.76 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.856 -0.688 . . . . 52.22 113.91 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 569' ' ' MET . . . . . 0.487 ' SD ' ' HG3' ' A' ' 577' ' ' ARG . 21.5 ptp -134.01 -179.07 5.32 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.795 -0.817 . . . . 24.02 108.795 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -101.82 167.43 10.08 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.275 -1.38 . . . . 74.54 107.275 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 -67.24 -30.01 69.8 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.678 -0.86 . . . . 73.12 108.678 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 11.5 p -72.11 -16.83 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 115.395 -0.821 . . . . 74.21 110.34 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.613 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 18.6 t70 -101.35 -39.16 7.72 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.706 -0.85 . . . . 73.14 108.706 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.7 -42.46 97.23 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 115.034 -0.984 . . . . 55.44 112.019 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.539 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 39.2 tt0 -55.4 -53.18 64.96 Favored Pre-proline 0 CA--C 1.569 1.701 0 CA-C-O 119.142 -0.456 . . . . 72.01 111.776 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 71.6 Cg_exo -55.77 -30.33 75.72 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 122.124 1.883 . . . . 74.1 112.6 171.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 11.4 mmm180 -62.81 -38.29 90.14 Favored 'General case' 0 C--O 1.202 -1.421 0 C-N-CA 120.707 -0.397 . . . . 74.44 110.816 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.741 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 10.5 mp -58.01 -49.28 77.4 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 118.001 0.364 . . . . 72.41 110.807 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -66.17 -40.87 90.8 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.62 -0.718 . . . . 72.33 112.675 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.02 -27.78 64.96 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.898 0.38 . . . . 33.35 111.735 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 8.3 tp -89.73 -9.36 49.67 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 123.939 0.896 . . . . 55.04 110.545 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 68.73 32.11 73.9 Favored Glycine 0 C--O 1.243 0.672 0 C-N-CA 120.829 -0.701 . . . . 72.52 111.995 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.741 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 10.9 t90 -87.03 126.78 34.97 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 107.576 -1.268 . . . . 73.04 107.576 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 4.2 p -91.78 -27.95 17.68 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 113.031 0.752 . . . . 62.41 113.031 -174.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -71.7 179.36 34.23 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 116.122 -0.49 . . . . 75.15 112.878 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 62.6 mtm -107.28 148.8 28.52 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.073 0.463 . . . . 74.34 111.056 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 29.9 tp -80.63 111.47 17.09 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 107.182 -1.414 . . . . 75.41 107.182 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.58 ' O ' ' HA ' ' A' ' 621' ' ' THR . 15.3 t70 -97.94 114.92 27.15 Favored 'General case' 0 CA--C 1.485 -1.531 0 CA-C-N 116.086 -0.506 . . . . 74.11 110.237 -174.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.468 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.1 OUTLIER -91.6 133.45 35.54 Favored 'General case' 0 C--N 1.276 -2.6 0 C-N-CA 119.853 -0.739 . . . . 72.2 109.399 177.67 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -83.01 -61.77 1.89 Allowed Glycine 0 C--N 1.291 -1.952 0 N-CA-C 109.884 -1.286 . . . . 74.55 109.884 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.67 149.45 43.73 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 109.348 -0.612 . . . . 52.55 109.348 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -90.06 150.14 22.21 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.221 -1.029 . . . . 61.04 108.221 176.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 19.9 t -117.44 136.7 53.75 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 108.636 -0.876 . . . . 55.2 108.636 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.59 106.97 5.59 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.709 -1.219 . . . . 54.43 107.709 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -120.42 -61.5 1.57 Allowed 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.618 -0.719 . . . . 75.41 109.342 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 89.08 151.83 24.84 Favored Glycine 0 N--CA 1.419 -2.457 0 C-N-CA 119.575 -1.298 . . . . 70.32 111.238 -176.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.4 -33.69 62.34 Favored Glycine 0 C--N 1.3 -1.441 0 N-CA-C 114.649 0.62 . . . . 73.25 114.649 -177.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 32.2 t -73.1 -24.89 60.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.95 0.881 . . . . 75.31 109.794 -176.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -99.83 -3.38 32.72 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.044 -0.98 . . . . 65.12 109.645 -177.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 56.6 m80 74.37 126.98 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.201 1.4 . . . . 72.13 112.677 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -83.74 51.07 1.93 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.249 1.023 . . . . 72.22 108.987 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.402 ' HE ' ' HB3' ' A' ' 602' ' ' ARG . 37.4 mtp180 -83.91 158.17 21.69 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.729 -1.123 . . . . 52.31 113.299 -176.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.16 131.73 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 106.136 -1.801 . . . . 61.32 106.136 167.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 44.0 t -97.47 -44.07 12.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-O 121.594 0.712 . . . . 64.52 109.512 -177.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -154.24 145.38 22.81 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.431 -0.804 . . . . 74.35 110.167 -176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -126.41 133.58 51.24 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 105.833 -1.914 . . . . 72.52 105.833 174.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.408 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 65.7 t30 -63.52 -51.09 69.47 Favored Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 112.744 0.646 . . . . 41.1 112.744 -174.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.5 Cg_exo -87.65 111.15 0.76 Allowed 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 122.002 1.801 . . . . 64.43 109.815 172.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.92 143.49 45.38 Favored 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 122.588 2.192 . . . . 73.0 113.485 -177.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 610' ' ' ALA . . . . . 0.524 ' CB ' ' HA ' ' A' ' 565' ' ' ASP . . . -65.82 139.85 58.35 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.81 -0.632 . . . . 72.42 109.737 176.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.45 -9.16 44.96 Favored Glycine 0 C--N 1.301 -1.365 0 N-CA-C 109.578 -1.409 . . . . 43.32 109.578 -172.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 63.0 m -108.67 154.18 22.38 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.491 -0.929 . . . . 75.11 108.491 176.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -72.74 128.54 12.59 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 111.898 -0.481 . . . . 75.43 111.898 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 30.1 m -112.7 143.14 23.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 123.666 0.786 . . . . 70.31 109.464 178.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.437 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 9.4 p30 -43.56 167.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 125.492 1.517 . . . . 71.1 113.259 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -57.29 -25.35 59.13 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 113.907 1.077 . . . . 74.23 113.907 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -93.04 -7.57 45.33 Favored 'General case' 0 C--O 1.208 -1.103 0 C-N-CA 119.327 -0.949 . . . . 75.12 108.543 -178.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 68.09 11.7 61.62 Favored Glycine 0 CA--C 1.491 -1.444 0 CA-C-N 115.557 -0.747 . . . . 64.24 111.788 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.46 118.85 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-O 122.279 1.037 . . . . 51.44 111.627 -169.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 45.0 pt -121.18 134.33 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 113.8 -1.546 . . . . 51.31 110.265 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 14.1 t -98.66 131.31 44.94 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 108.035 -1.098 . . . . 73.34 108.035 177.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -139.36 167.57 21.79 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.863 -0.608 . . . . 71.22 111.733 -174.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -126.75 136.42 52.4 Favored 'General case' 0 C--O 1.255 1.392 0 N-CA-C 107.228 -1.397 . . . . 71.02 107.228 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -141.39 163.23 33.5 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.448 -0.342 . . . . 75.42 110.603 -172.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -76.27 129.43 10.06 Favored Glycine 0 N--CA 1.416 -2.643 0 O-C-N 123.827 0.705 . . . . 63.21 111.545 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 . . . . . 0 C--N 1.299 -1.6 0 C-N-CA 123.948 0.899 . . . . 63.24 109.678 -179.503 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.076 0 N-CA-C 110.087 -1.205 . . . . 43.05 110.087 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.36 142.56 96.18 Favored 'Trans proline' 0 C--O 1.251 1.125 0 C-N-CA 122.456 2.104 . . . . 42.31 111.309 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -123.42 46.42 2.21 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.973 -0.558 . . . . 64.24 110.329 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 25.4 p -130.89 140.32 50.2 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.891 -0.411 . . . . 71.44 109.891 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.564 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 8.8 tmtm? -150.56 144.22 25.17 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.724 -1.213 . . . . 75.43 107.724 172.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.564 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 9.6 p-10 -78.58 130.13 35.59 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.48 0.657 . . . . 60.21 110.808 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 29.3 pt -87.24 133.69 38.17 Favored Pre-proline 0 C--N 1.288 -2.103 0 C-N-CA 120.212 -0.595 . . . . 73.41 110.331 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -69.52 170.87 15.29 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 121.864 1.709 . . . . 74.12 111.85 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -78.01 83.23 4.32 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 122.876 1.322 . . . . 73.11 110.626 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.434 ' HB ' ' CB ' ' A' ' 508' ' ' ALA . 26.9 m -86.73 -6.82 10.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 114.399 -1.273 . . . . 72.13 112.268 -177.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.67 101.85 3.76 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.817 -0.809 . . . . 61.3 108.817 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 157.18 -38.54 0.56 Allowed Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.799 -0.715 . . . . 50.45 111.89 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 17.4 pm0 -97.54 -168.02 1.62 Allowed 'General case' 0 C--O 1.243 0.738 0 C-N-CA 120.761 -0.376 . . . . 63.41 110.006 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.402 ' HB ' HG23 ' A' ' 507' ' ' VAL . 14.5 m -70.15 155.35 40.76 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.21 -0.663 . . . . 74.55 109.21 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.427 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.3 p -63.18 -41.45 92.86 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.547 0 O-C-N 123.302 0.376 . . . . 65.51 110.72 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 506' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 18.7 t70 -59.84 -42.91 94.64 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.891 0.377 . . . . 63.0 110.04 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.402 HG23 ' HB ' ' A' ' 504' ' ' THR . 61.6 t -68.32 -45.42 82.58 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.622 0 CA-C-N 115.352 -0.84 . . . . 62.41 109.226 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.434 ' CB ' ' HB ' ' A' ' 500' ' ' VAL . . . -58.83 -45.38 90.15 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 120.638 0.256 . . . . 75.51 111.006 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 97.8 mt-30 -64.12 -45.64 87.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.972 -0.558 . . . . 72.43 111.237 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.563 ' O ' HG23 ' A' ' 514' ' ' VAL 0.314 0.0 OUTLIER -67.32 -37.65 83.66 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 119.632 -0.827 . . . . 73.14 111.607 177.353 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 511' ' ' ASN . . . . . 0.456 ' N ' ' HD3' ' A' ' 510' ' ' LYS . 7.9 m-20 -60.45 -50.2 74.53 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 116.276 -0.42 . . . . 62.51 110.723 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.451 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -68.05 -36.25 79.56 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.937 -0.574 . . . . 71.02 111.239 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.451 ' N ' HD12 ' A' ' 512' ' ' LEU . 26.8 t30 -65.9 -38.43 88.73 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 122.999 0.52 . . . . 41.34 110.528 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 510' ' ' LYS . 78.2 t -59.59 -32.98 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.093 0.473 . . . . 64.02 111.102 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -111.54 16.35 20.73 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.881 -0.328 . . . . 74.24 110.275 -177.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -143.01 -53.83 0.03 OUTLIER Glycine 0 CA--C 1.488 -1.62 0 C-N-CA 119.421 -1.371 . . . . 43.05 113.826 -173.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 61.46 39.37 15.09 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.652 1.215 . . . . 74.43 108.899 -174.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 547' ' ' VAL . 20.3 p -91.23 -172.24 3.23 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 112.814 -1.994 . . . . 65.45 109.3 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.5 142.38 39.0 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.393 -1.336 . . . . 71.23 107.393 176.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -131.53 152.05 51.07 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.401 0.619 . . . . 74.22 112.244 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 20.4 p -140.29 146.42 38.52 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 107.962 -1.125 . . . . 71.1 107.962 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -119.79 129.47 54.47 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.237 -0.585 . . . . 74.35 110.942 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -121.01 118.7 30.5 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.945 -0.761 . . . . 72.02 108.945 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.8 m -90.78 137.09 32.63 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.132 0.491 . . . . 53.42 111.895 -176.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 47.2 t -128.89 149.06 33.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 105.793 -1.929 . . . . 62.21 105.793 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.1 135.68 36.38 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 118.327 0.512 . . . . 63.54 110.941 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 42.9 m -159.46 169.75 9.92 Favored Pre-proline 0 C--N 1.31 -1.151 0 N-CA-C 107.623 -1.251 . . . . 52.24 107.623 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -73.12 -13.78 25.97 Favored 'Trans proline' 0 C--O 1.25 1.078 0 C-N-CA 122.004 1.803 . . . . 73.43 112.838 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.516 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 48.6 mtt180 -73.35 143.05 82.41 Favored Pre-proline 0 N--CA 1.442 -0.825 0 N-CA-C 108.988 -0.745 . . . . 74.13 108.988 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.71 144.6 97.36 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 122.5 2.133 . . . . 74.33 112.034 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.642 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.78 99.21 0.08 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.367 -0.833 . . . . 62.42 111.762 -178.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 153.56 -22.4 0.73 Allowed Glycine 0 N--CA 1.423 -2.185 0 C-N-CA 120.573 -0.823 . . . . 53.14 112.154 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 533' ' ' GLU . . . . . 0.516 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 32.6 tt0 -79.99 138.35 37.03 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 117.239 0.52 . . . . 74.04 109.97 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 5.1 p -91.97 113.2 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 N-CA-C 108.502 -0.925 . . . . 74.31 108.502 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.54 -33.25 73.78 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.199 -1.364 . . . . 72.42 110.189 -177.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 167.91 177.78 39.44 Favored Glycine 0 N--CA 1.42 -2.401 0 CA-C-N 115.089 -0.959 . . . . 63.33 110.959 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 537' ' ' THR . . . . . 0.425 HG22 HD13 ' A' ' 553' ' ' LEU . 10.0 p -118.1 153.83 33.11 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 108.502 -0.925 . . . . 71.52 108.502 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -72.32 -48.01 10.08 Favored Pre-proline 0 C--N 1.318 -0.784 0 C-N-CA 118.235 -1.386 . . . . 75.34 110.246 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 32.3 Cg_exo -62.52 131.5 34.03 Favored 'Trans proline' 0 C--N 1.381 2.274 0 N-CA-C 108.529 -1.373 . . . . 61.3 108.529 169.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 540' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 8.3 Cg_exo -69.01 139.97 44.24 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 122.184 1.923 . . . . 75.32 114.732 -173.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -68.66 133.66 48.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.93 -1.032 . . . . 65.51 110.415 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 91.16 -19.29 47.45 Favored Glycine 0 C--N 1.306 -1.115 0 N-CA-C 110.839 -0.904 . . . . 53.42 110.839 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.2 m -87.82 139.46 30.5 Favored 'General case' 0 N--CA 1.413 -2.324 0 C-N-CA 123.623 0.769 . . . . 74.31 110.555 -175.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 3.4 t -72.45 124.6 25.51 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.662 -0.699 . . . . 64.24 109.323 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.72 163.82 36.68 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 107.236 -1.394 . . . . 73.34 107.236 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -76.46 135.3 16.32 Favored 'Trans proline' 0 N--CA 1.423 -2.642 0 CA-C-N 120.004 1.037 . . . . 72.1 111.715 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.711 ' HA ' HG22 ' A' ' 518' ' ' THR . 35.3 t -67.53 -24.91 31.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-N 114.122 -1.399 . . . . 61.43 110.46 176.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -78.19 -17.86 56.23 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.441 -1.254 . . . . 73.45 111.509 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 94.6 p -90.82 177.38 6.32 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.637 -0.425 . . . . 73.15 110.993 -177.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 12.9 p -109.07 126.31 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.831 0 CA-C-O 121.75 0.786 . . . . 72.21 109.908 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 63.1 mt -86.11 129.45 38.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 108.794 -0.817 . . . . 63.05 108.794 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -103.79 117.32 34.08 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.718 0.771 . . . . 75.14 110.664 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.425 HD13 HG22 ' A' ' 537' ' ' THR . 2.7 mm? -95.45 114.03 25.75 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.653 -1.612 . . . . 73.05 108.218 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -84.32 116.39 22.99 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.922 -0.77 . . . . 74.12 108.922 176.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 524' ' ' SER . 23.9 t -104.15 131.79 52.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 115.099 -0.955 . . . . 61.13 109.244 -175.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 74.1 m -84.76 122.22 28.8 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 109.621 -0.511 . . . . 43.13 109.621 175.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.0 ptpt -93.49 141.25 28.68 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 104.672 -2.344 . . . . 74.22 104.672 169.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.584 ' O ' ' HG3' ' A' ' 560' ' ' GLN . . . -66.46 -27.17 72.95 Favored Glycine 0 CA--C 1.488 -1.649 0 C-N-CA 120.138 -1.03 . . . . 44.34 110.652 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 559' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 64.4 t30 65.27 11.84 7.58 Favored 'General case' 0 C--O 1.216 -0.689 0 C-N-CA 124.697 1.199 . . . . 63.21 109.885 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.584 ' HG3' ' O ' ' A' ' 558' ' ' GLY . 40.9 mt-30 -124.68 142.85 51.09 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 115.478 -0.783 . . . . 51.44 109.21 -176.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 561' ' ' PHE . . . . . 0.407 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 53.6 p90 -123.34 148.24 46.21 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.389 -0.967 . . . . 71.12 108.389 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.1 122.14 14.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.144 0.497 . . . . 72.25 111.002 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.432 ' SD ' HD13 ' A' ' 620' ' ' ILE . 56.9 ttp -97.45 122.43 55.58 Favored Pre-proline 0 C--N 1.31 -1.133 0 CA-C-N 115.885 -0.598 . . . . 74.23 110.953 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -68.15 169.81 15.88 Favored 'Trans proline' 0 C--O 1.241 0.661 0 C-N-CA 123.065 2.51 . . . . 72.04 110.843 172.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 565' ' ' ASP . . . . . 0.443 ' HB3' ' HB2' ' A' ' 610' ' ' ALA . 5.8 p-10 -77.6 142.42 38.95 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.138 0.494 . . . . 75.12 110.569 -178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 566' ' ' LEU . . . . . 0.461 ' O ' ' HG2' ' A' ' 569' ' ' MET . 2.0 pt? -126.69 5.29 6.73 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 122.206 1.003 . . . . 73.21 108.91 174.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 567' ' ' SER . . . . . 0.485 ' HA ' ' HB ' ' A' ' 603' ' ' VAL . 29.0 t -79.44 140.62 37.31 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 107.808 -1.182 . . . . 64.2 107.808 176.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 99.39 -2.46 57.6 Favored Glycine 0 C--N 1.302 -1.314 0 C-N-CA 120.018 -1.086 . . . . 74.11 112.878 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 569' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 24.0 ptp -120.06 169.35 10.29 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.561 -0.903 . . . . 73.34 108.561 177.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -92.59 171.59 8.92 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.004 -1.11 . . . . 70.42 108.004 -174.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -62.44 -32.87 73.79 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.69 -0.856 . . . . 74.13 108.69 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 30.7 m -68.9 -12.88 16.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 CA-C-N 116.076 -0.511 . . . . 43.14 112.107 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -102.27 -43.91 5.57 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 110.033 -0.358 . . . . 75.25 110.033 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -61.32 -39.5 90.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.799 -0.637 . . . . 74.11 112.235 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.658 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 44.0 tt0 -63.16 -53.36 54.87 Favored Pre-proline 0 CA--C 1.561 1.382 0 CA-C-N 116.622 -0.263 . . . . 74.12 111.494 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 92.7 Cg_exo -54.14 -40.43 81.87 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 121.547 1.498 . . . . 75.33 112.315 171.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.423 ' HE ' ' HA ' ' A' ' 577' ' ' ARG . 0.3 OUTLIER -59.24 -42.49 91.2 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.479 0.18 . . . . 64.32 110.634 178.428 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.5 pp -66.17 -46.85 75.94 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 120.359 -0.536 . . . . 62.23 111.716 -175.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.451 ' N ' HD12 ' A' ' 578' ' ' LEU . 1.7 ptm180 -66.24 -36.23 82.46 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.792 -0.64 . . . . 64.33 111.563 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -71.17 -37.99 72.18 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 112.367 0.506 . . . . 63.31 112.367 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.0 pp -80.65 -8.66 59.7 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.22 0.533 . . . . 72.43 110.496 -176.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 85.6 32.55 18.65 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 115.46 -0.791 . . . . 71.12 112.509 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -77.02 126.2 30.57 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 107.197 -1.408 . . . . 73.44 107.197 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 2.1 p -106.08 6.42 31.07 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 112.833 0.679 . . . . 54.11 112.833 -175.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 585' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -95.68 -152.96 29.68 Favored Glycine 0 N--CA 1.436 -1.338 0 N-CA-C 110.723 -0.951 . . . . 73.43 110.723 174.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 57.6 ttp -136.87 147.0 46.23 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.03 -1.1 . . . . 71.11 108.03 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 587' ' ' LEU . . . . . 0.448 HD21 HD11 ' A' ' 622' ' ' LEU . 6.0 tt -80.16 118.34 21.77 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.494 -0.928 . . . . 62.3 108.494 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 621' ' ' THR . 26.5 t70 -98.76 120.61 39.48 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.641 -0.708 . . . . 71.34 109.332 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.485 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.1 OUTLIER -98.5 133.21 43.18 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 119.194 -1.002 . . . . 73.31 108.724 176.447 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -85.2 -51.64 3.67 Favored Glycine 0 C--N 1.284 -2.35 0 N-CA-C 109.616 -1.394 . . . . 71.21 109.616 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -134.81 117.69 16.2 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 109.362 -0.607 . . . . 62.42 109.362 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -105.31 123.84 48.53 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.712 -1.218 . . . . 62.43 107.712 173.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 53.9 t -112.09 129.34 67.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 109.087 -0.708 . . . . 55.33 109.087 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 594' ' ' ASP . . . . . 0.42 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 23.3 t70 -72.67 114.47 10.84 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 108.798 -0.816 . . . . 61.31 108.798 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -124.27 -57.41 1.59 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.572 -0.74 . . . . 55.34 109.843 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 106.53 151.16 18.47 Favored Glycine 0 N--CA 1.423 -2.222 0 C-N-CA 120.062 -1.066 . . . . 60.31 110.863 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.498 ' HA2' ' OD1' ' A' ' 601' ' ' ASN . . . -58.77 -33.99 75.43 Favored Glycine 0 C--N 1.311 -0.811 0 N-CA-C 115.038 0.775 . . . . 43.32 115.038 -177.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 11.3 t -74.83 -23.91 58.53 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 122.125 0.964 . . . . 74.02 109.117 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -89.84 0.18 57.19 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.822 -1.081 . . . . 73.44 110.301 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 27.3 m170 78.41 85.67 0.07 Allowed 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 125.821 1.648 . . . . 60.31 109.789 -177.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 601' ' ' ASN . . . . . 0.498 ' OD1' ' HA2' ' A' ' 597' ' ' GLY . 26.0 p-10 -89.15 58.91 4.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 122.987 1.375 . . . . 75.24 110.428 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -97.16 163.59 12.86 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.893 -1.503 . . . . 74.31 108.431 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.485 ' HB ' ' HA ' ' A' ' 567' ' ' SER . 92.8 t -70.17 130.52 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 104.74 -2.318 . . . . 71.13 104.74 168.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 13.4 p -103.11 -35.52 3.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 121.289 0.566 . . . . 73.53 111.133 -173.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -146.1 134.62 22.05 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 109.147 -0.686 . . . . 74.15 109.147 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -115.78 131.93 56.79 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.402 -1.703 . . . . 74.15 106.402 174.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.453 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 20.8 t-20 -58.25 -51.7 79.87 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 112.376 0.51 . . . . 73.21 112.376 -175.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.1 Cg_endo -87.13 118.97 1.44 Allowed 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.234 1.289 . . . . 74.23 109.494 172.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -64.56 159.71 43.39 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 122.549 2.166 . . . . 64.3 111.906 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 610' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 565' ' ' ASP . . . -60.9 135.23 57.72 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.174 -0.466 . . . . 71.41 110.415 177.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.43 -11.94 47.3 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 111.35 -0.7 . . . . 73.13 111.35 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 34.2 m -82.1 136.75 35.14 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.592 -0.521 . . . . 75.53 109.592 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 613' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -77.33 123.13 6.36 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 110.271 -1.131 . . . . 63.02 110.271 175.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.6 m -113.62 142.38 26.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 109.643 -0.503 . . . . 64.12 109.643 178.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 559' ' ' ASN . 29.9 p30 -48.59 164.62 0.06 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.176 1.176 . . . . 74.04 114.176 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -57.74 -27.9 63.42 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.788 0.835 . . . . 72.33 112.629 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.444 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 4.4 p-10 -90.24 -9.37 48.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 119.486 -0.885 . . . . 72.43 110.459 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.11 14.86 62.1 Favored Glycine 0 CA--C 1.49 -1.503 0 C-N-CA 124.065 0.841 . . . . 61.34 114.685 163.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.05 117.66 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-O 122.566 1.174 . . . . 44.14 110.869 -167.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.432 HD13 ' SD ' ' A' ' 563' ' ' MET . 49.3 pt -129.81 135.28 61.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 113.755 -1.566 . . . . 71.24 110.37 -177.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 13.8 t -99.21 129.87 45.48 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 108.235 -1.024 . . . . 75.32 108.235 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.448 HD11 HD21 ' A' ' 587' ' ' LEU . 4.0 pp -138.76 167.13 22.65 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 116.136 -0.484 . . . . 75.34 111.462 -178.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -128.09 136.33 51.04 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.808 -0.812 . . . . 71.42 108.808 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.422 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 18.8 p90 -142.55 165.58 27.02 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 116.187 -0.46 . . . . 75.12 111.827 -172.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -86.73 132.47 11.17 Favored Glycine 0 N--CA 1.42 -2.407 0 N-CA-C 109.221 -1.552 . . . . 40.23 109.221 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.42 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 65.5 tt0 . . . . . 0 C--N 1.279 -2.463 0 C-N-CA 123.066 0.547 . . . . 38.01 109.593 -178.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.487 0 N-CA-C 109.709 -1.356 . . . . 51.03 109.709 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -67.63 142.63 59.28 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 122.226 1.951 . . . . 64.13 110.894 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -115.88 11.11 15.44 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.599 0.714 . . . . 72.51 109.899 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 13.0 p -129.96 155.32 46.26 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 115.53 -0.759 . . . . 72.23 110.827 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -143.11 146.36 33.7 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.426 -0.806 . . . . 53.33 109.758 176.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.565 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.1 p-10 -91.56 140.03 30.12 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.094 -0.706 . . . . 73.02 109.094 177.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.4 pt -96.53 124.6 50.24 Favored Pre-proline 0 C--N 1.298 -1.664 0 CA-C-N 115.673 -0.694 . . . . 70.21 110.467 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -66.76 157.5 60.85 Favored 'Trans proline' 0 C--O 1.245 0.829 0 C-N-CA 122.475 2.117 . . . . 65.24 111.843 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.429 ' HA ' ' HB1' ' A' ' 541' ' ' ALA . 27.1 t70 -77.65 99.98 6.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.587 0.708 . . . . 63.21 109.704 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 30.3 m -105.63 11.14 8.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 114.96 -1.018 . . . . 74.12 112.169 -175.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -80.01 96.96 6.59 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.036 0.445 . . . . 53.31 110.798 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 162.38 -40.93 0.37 Allowed Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.777 -0.725 . . . . 74.32 111.914 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 16.1 pm0 -90.77 -171.89 3.19 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 110.251 -0.277 . . . . 74.55 110.251 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 28.1 m -70.1 155.0 41.23 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.818 -0.808 . . . . 52.21 108.818 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.42 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.2 p -62.48 -41.63 92.62 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 O-C-N 123.075 0.235 . . . . 44.44 110.722 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -59.4 -40.83 87.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.385 0.612 . . . . 74.3 109.645 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.436 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 75.4 t -71.88 -45.95 62.61 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.608 0 CA-C-N 115.292 -0.867 . . . . 74.11 110.057 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.463 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -58.85 -44.34 90.99 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 111.917 0.34 . . . . 73.21 111.917 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.6 mt-30 -62.42 -45.79 91.53 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.295 -0.411 . . . . 43.32 110.957 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.568 ' O ' HG23 ' A' ' 514' ' ' VAL . 16.6 ptpt -67.97 -38.82 83.19 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 120.486 -0.485 . . . . 75.3 110.175 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -60.84 -47.36 86.7 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 116.056 -0.52 . . . . 74.34 110.86 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 513' ' ' ASN . 3.9 pp -68.48 -35.73 77.95 Favored 'General case' 0 C--O 1.211 -0.923 0 CA-C-N 115.863 -0.608 . . . . 64.2 111.154 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.48 ' N ' HD12 ' A' ' 512' ' ' LEU . 4.1 t-20 -66.02 -34.86 79.06 Favored 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 123.287 0.635 . . . . 74.22 111.99 -178.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 510' ' ' LYS . 89.1 t -57.0 -32.42 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 121.491 0.663 . . . . 65.41 110.354 177.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -114.45 17.26 17.5 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.757 -0.656 . . . . 70.14 109.666 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -138.09 -55.03 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 119.923 -1.132 . . . . 63.21 113.57 -174.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 66.87 17.85 10.58 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.277 1.037 . . . . 73.35 109.922 -176.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.7 p -78.13 -170.7 2.06 Favored 'General case' 0 N--CA 1.411 -2.401 0 C-N-CA 125.481 1.512 . . . . 65.32 111.492 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -108.24 143.12 37.5 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.013 -1.477 . . . . 74.23 107.013 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -132.7 150.43 52.16 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.242 -0.583 . . . . 74.45 111.938 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.2 m -140.83 146.29 37.37 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.98 -1.489 . . . . 71.41 106.98 175.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -118.08 136.01 53.83 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 120.13 -0.628 . . . . 74.01 110.104 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -130.29 131.95 45.67 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.624 -0.88 . . . . 55.1 108.624 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 73.1 m -100.18 131.36 46.17 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.542 0.687 . . . . 71.02 112.596 -178.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 556' ' ' SER . 7.4 p -121.78 149.27 25.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.373 -1.714 . . . . 72.52 106.373 176.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -76.83 135.63 38.9 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 121.49 0.662 . . . . 61.22 111.674 -176.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 50.3 m -162.79 156.09 17.0 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 106.338 -1.727 . . . . 61.32 106.338 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -63.93 -3.12 5.35 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 122.762 2.308 . . . . 74.24 114.288 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -80.12 136.58 53.62 Favored Pre-proline 0 CA--C 1.51 -0.587 0 N-CA-C 106.967 -1.494 . . . . 65.54 106.967 176.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -61.6 147.94 94.2 Favored 'Trans proline' 0 C--O 1.256 1.382 0 C-N-CA 122.343 2.028 . . . . 50.31 112.701 -175.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -56.61 115.89 2.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.292 -0.867 . . . . 61.51 110.88 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 134.21 -27.78 3.24 Favored Glycine 0 N--CA 1.434 -1.436 0 C-N-CA 120.825 -0.703 . . . . 45.33 111.643 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -80.85 135.68 35.97 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-O 121.254 0.549 . . . . 74.33 110.295 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.463 HG11 ' CB ' ' A' ' 508' ' ' ALA . 7.2 p -96.67 120.78 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.722 0 N-CA-C 107.702 -1.221 . . . . 73.13 107.702 178.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.2 p -97.74 -1.23 43.85 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.167 -0.924 . . . . 74.53 113.132 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 163.23 -166.56 37.13 Favored Glycine 0 N--CA 1.423 -2.219 0 C-N-CA 120.278 -0.963 . . . . 53.24 111.52 176.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 2.4 p -135.39 152.91 51.87 Favored 'General case' 0 C--N 1.273 -2.746 0 N-CA-C 107.866 -1.161 . . . . 65.44 107.866 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.48 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 62.0 t30 -58.29 -50.83 85.93 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 119.834 -0.747 . . . . 72.24 111.201 175.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 4.8 Cg_exo -81.36 128.47 6.27 Favored 'Trans proline' 0 C--N 1.37 1.676 0 N-CA-C 107.568 -1.743 . . . . 44.11 107.568 168.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.38 140.31 88.41 Favored 'Trans proline' 0 C--O 1.245 0.846 0 C-N-CA 122.42 2.08 . . . . 75.1 113.04 -176.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 541' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' A' ' 499' ' ' ASP . . . -64.82 138.65 58.51 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.91 -0.587 . . . . 71.55 110.122 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.72 -11.58 57.8 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 120.752 -0.737 . . . . 71.15 111.294 -176.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 18.4 m -88.32 137.49 32.28 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.167 -0.309 . . . . 75.53 110.167 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 13.3 t -81.16 129.79 34.73 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 109.233 -0.655 . . . . 51.1 109.233 173.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.5 m -123.83 164.13 30.95 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 107.315 -1.365 . . . . 73.52 107.315 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -68.23 139.38 45.88 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 120.936 1.09 . . . . 63.03 110.646 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.8 p -62.6 -20.3 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 CA-C-N 115.696 -0.684 . . . . 70.12 112.296 -175.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -93.31 -7.35 45.14 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.757 0.313 . . . . 54.4 110.916 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 69.9 m -82.06 165.69 20.4 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.697 0.761 . . . . 73.54 112.624 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.2 p -102.31 137.7 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.292 0 CA-C-N 114.697 -1.138 . . . . 54.14 109.554 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 60.2 mt -101.96 132.38 48.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.076 -1.083 . . . . 63.4 108.076 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -102.8 117.95 35.75 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.218 0.532 . . . . 61.41 110.541 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.421 HD12 HG21 ' A' ' 534' ' ' VAL . 3.6 mm? -88.31 114.47 24.97 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.394 -1.275 . . . . 72.31 108.522 178.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -83.27 101.7 11.45 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.226 -1.028 . . . . 74.41 108.226 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 524' ' ' SER . 17.2 t -96.06 144.18 10.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 107.541 -1.281 . . . . 73.31 107.541 -177.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 67.9 m -97.8 133.82 41.79 Favored 'General case' 0 N--CA 1.394 -3.245 0 C-N-CA 119.444 -0.902 . . . . 65.04 110.694 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -97.5 129.5 44.67 Favored 'General case' 0 N--CA 1.405 -2.706 0 N-CA-C 103.882 -2.636 . . . . 63.42 103.882 168.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -60.47 -23.92 61.02 Favored Glycine 0 CA--C 1.49 -1.507 0 O-C-N 123.923 0.764 . . . . 62.12 113.599 -173.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 79.95 -15.54 0.74 Allowed 'General case' 0 C--O 1.211 -0.967 0 C-N-CA 124.946 1.298 . . . . 71.43 107.87 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.469 ' H ' ' C ' ' A' ' 558' ' ' GLY . 92.7 mt-30 -112.62 145.04 41.09 Favored 'General case' 0 N--CA 1.402 -2.832 0 CA-C-N 114.71 -1.132 . . . . 73.2 110.496 -175.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 561' ' ' PHE . . . . . 0.43 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 48.5 p90 -123.84 154.53 39.49 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 107.193 -1.41 . . . . 71.01 107.193 177.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.25 121.89 16.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.018 0.437 . . . . 70.45 110.864 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.617 ' SD ' HG21 ' A' ' 620' ' ' ILE . 47.4 ttp -79.23 122.73 84.53 Favored Pre-proline 0 C--N 1.316 -0.86 0 N-CA-C 109.653 -0.499 . . . . 63.54 109.653 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.77 169.62 20.71 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.214 1.942 . . . . 72.31 111.006 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -72.01 118.18 14.55 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.536 0.684 . . . . 54.14 110.424 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.9 pp -136.11 11.55 3.32 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.206 -0.907 . . . . 75.12 110.477 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 2.2 t -80.24 144.15 33.14 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.318 -0.855 . . . . 65.34 109.985 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 80.82 70.01 1.36 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.643 -0.789 . . . . 42.14 113.58 175.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -163.91 179.85 6.76 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.345 -1.354 . . . . 72.35 107.345 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 570' ' ' PHE . . . . . 0.457 ' HB2' HG12 ' A' ' 572' ' ' VAL . 26.1 m-85 -95.14 176.4 6.24 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.567 -0.531 . . . . 71.5 109.567 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 571' ' ' TRP . . . . . 0.554 ' CZ3' HD22 ' A' ' 587' ' ' LEU . 11.6 t-105 -71.56 -28.1 63.62 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.989 -1.486 . . . . 74.41 106.989 175.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 572' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 570' ' ' PHE . 9.0 p -71.61 -6.72 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-N 115.429 -0.805 . . . . 72.31 110.264 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 6.7 m-20 -101.11 -45.06 5.5 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.341 -0.985 . . . . 65.12 108.341 171.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -63.21 -46.0 89.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.331 -0.849 . . . . 72.32 113.25 -176.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.501 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 31.4 tt0 -64.19 -49.94 70.69 Favored Pre-proline 0 CA--C 1.561 1.376 0 N-CA-C 111.838 0.31 . . . . 74.52 111.838 -177.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 51.5 Cg_exo -61.1 -34.42 89.7 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.675 1.583 . . . . 75.44 112.279 174.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 30.6 mmm180 -68.98 -33.97 74.55 Favored 'General case' 0 C--O 1.216 -0.663 0 C-N-CA 120.147 -0.621 . . . . 75.2 110.625 176.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.523 ' HG ' ' HB3' ' A' ' 583' ' ' TRP . 5.4 tt -60.41 -48.87 79.89 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.348 0.659 . . . . 74.51 109.363 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 576' ' ' PRO . 7.7 ptm180 -66.25 -41.09 90.44 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.914 0.339 . . . . 73.44 111.914 176.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.42 -37.01 82.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.152 -0.476 . . . . 72.33 112.168 -177.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.56 -9.28 54.86 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.154 0.502 . . . . 65.33 110.02 -177.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 70.52 46.66 46.63 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.768 -0.933 . . . . 71.13 110.768 -178.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.523 ' HB3' ' HG ' ' A' ' 578' ' ' LEU . 11.3 t90 -73.39 126.76 30.9 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 109.357 -0.608 . . . . 74.31 109.357 -177.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 584' ' ' THR . . . . . 0.432 ' OG1' ' HA ' ' A' ' 617' ' ' ASP . 7.6 p -90.42 -24.38 20.77 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.409 -0.814 . . . . 53.24 112.101 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -85.19 -174.3 50.15 Favored Glycine 0 N--CA 1.432 -1.589 0 CA-C-N 116.076 -0.511 . . . . 61.14 113.075 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 27.4 ttt -117.33 149.04 41.14 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.967 -0.383 . . . . 60.44 109.967 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 587' ' ' LEU . . . . . 0.554 HD22 ' CZ3' ' A' ' 571' ' ' TRP . 6.1 tt -80.7 108.83 14.67 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.27 -1.382 . . . . 62.14 107.27 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.411 ' O ' ' HA ' ' A' ' 621' ' ' THR . 21.8 t70 -105.37 119.28 38.7 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.942 -0.572 . . . . 74.55 111.612 -177.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.1 OUTLIER -111.91 133.21 54.25 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.035 -1.098 . . . . 74.22 108.035 171.86 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -111.01 -5.13 27.26 Favored Glycine 0 C--N 1.297 -1.625 0 C-N-CA 120.096 -1.05 . . . . 65.11 112.83 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.35 130.57 26.7 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 121.137 -0.225 . . . . 73.11 110.743 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.35 124.2 31.02 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 123.907 0.755 . . . . 62.54 109.829 176.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 593' ' ' VAL . . . . . 0.508 ' O ' ' HA2' ' A' ' 625' ' ' GLY . 86.9 t -104.64 131.85 52.7 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 105.22 -2.141 . . . . 71.52 105.22 171.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -82.88 122.95 28.91 Favored 'General case' 0 C--N 1.281 -2.406 0 C-N-CA 118.681 -1.208 . . . . 72.33 110.93 -177.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -147.46 -68.86 0.24 Allowed 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.002 -1.453 . . . . 72.23 108.359 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 92.75 157.8 33.85 Favored Glycine 0 N--CA 1.417 -2.628 0 C-N-CA 119.827 -1.178 . . . . 54.21 110.985 -176.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -57.99 -37.63 86.06 Favored Glycine 0 C--N 1.291 -1.931 0 N-CA-C 115.441 0.936 . . . . 61.35 115.441 -176.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 36.4 m -76.11 -24.55 54.98 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-N 118.05 0.925 . . . . 74.45 110.628 -174.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -89.13 -0.04 57.12 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.601 -1.181 . . . . 72.33 111.458 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 40.1 m80 77.6 89.79 0.07 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.619 1.2 . . . . 74.25 109.833 -176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -81.62 85.99 6.46 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 113.93 -1.487 . . . . 74.01 109.964 -171.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -111.52 170.03 8.4 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.567 0.951 . . . . 70.11 113.567 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.419 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 99.3 t -77.72 133.27 30.88 Favored 'Isoleucine or valine' 0 C--O 1.248 0.995 0 CA-C-N 114.27 -1.332 . . . . 72.11 108.05 173.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.5 m -112.21 -42.42 4.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 120.285 -0.566 . . . . 71.53 112.36 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -144.69 151.04 38.32 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.969 -0.382 . . . . 72.21 109.969 -174.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 606' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 622' ' ' LEU . 16.4 pt20 -140.06 144.67 36.97 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 123.491 0.494 . . . . 50.24 110.355 177.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.43 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 58.4 t30 -64.77 -51.82 55.12 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-N 116.181 -0.463 . . . . 61.23 111.734 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.4 Cg_exo -85.21 115.74 1.69 Allowed 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 121.756 1.637 . . . . 73.31 110.134 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 609' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 11.5 Cg_exo -70.21 152.31 66.92 Favored 'Trans proline' 0 C--O 1.256 1.379 0 C-N-CA 122.401 2.067 . . . . 74.11 111.799 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -58.71 135.84 57.54 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.49 -0.559 . . . . 75.3 109.49 176.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 103.23 -7.36 51.61 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.571 -0.823 . . . . 60.04 111.908 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 28.0 m -93.78 144.46 25.39 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.237 -0.653 . . . . 63.41 109.237 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 613' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -70.34 131.22 22.08 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 111.952 -0.459 . . . . 73.24 111.952 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.7 m -124.56 141.64 44.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.917 -0.772 . . . . 74.42 108.917 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.414 ' N ' ' HG2' ' A' ' 560' ' ' GLN . 28.4 p-10 -51.52 171.72 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.204 1.402 . . . . 64.23 114.301 -176.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.68 -27.1 37.81 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.824 1.046 . . . . 52.22 113.824 -179.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.432 ' HA ' ' OG1' ' A' ' 584' ' ' THR . 11.0 m-20 -87.74 -8.18 56.36 Favored 'General case' 0 C--O 1.198 -1.632 0 C-N-CA 119.149 -1.02 . . . . 74.53 110.988 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.02 17.81 65.99 Favored Glycine 0 C--O 1.219 -0.784 0 C-N-CA 121.755 -0.259 . . . . 60.21 112.661 173.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.96 119.28 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 121.724 0.773 . . . . 72.21 110.726 -169.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.617 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.6 pp -123.76 133.29 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 115.29 -0.868 . . . . 64.11 112.546 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 14.2 t -102.86 122.48 44.63 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 122.118 0.961 . . . . 74.24 109.26 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -136.64 169.43 17.73 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.777 -1.101 . . . . 71.42 110.471 -173.944 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -125.95 135.84 52.33 Favored 'General case' 0 C--O 1.261 1.667 0 N-CA-C 107.866 -1.161 . . . . 75.11 107.866 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.419 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 3.7 p90 -142.98 169.05 18.29 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.783 -1.192 . . . . 74.31 107.783 -175.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 625' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 593' ' ' VAL . . . -49.47 109.5 0.62 Allowed Glycine 0 CA--C 1.544 1.896 0 O-C-N 124.193 0.933 . . . . 61.55 113.549 175.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 . . . . . 0 C--O 1.253 1.277 0 C-N-CA 125.816 1.646 . . . . 64.25 112.934 176.843 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 491' ' ' GLY . . . . . 0.563 ' N ' ' HG1' ' A' ' 494' ' ' THR . . . . . . . . 0 CA--C 1.49 -1.492 0 N-CA-C 109.078 -1.609 . . . . 54.13 109.078 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -74.3 141.51 28.98 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.668 1.579 . . . . 61.44 109.906 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 59.31 15.65 4.47 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.279 1.032 . . . . 73.53 112.976 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.563 ' HG1' ' N ' ' A' ' 491' ' ' GLY . 19.3 p -141.0 142.42 34.27 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.936 -0.478 . . . . 73.32 110.521 -177.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -138.88 135.01 34.04 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.75 -0.833 . . . . 64.5 108.75 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.631 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.3 p-10 -83.66 144.99 29.03 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.186 0.517 . . . . 74.43 110.318 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.5 pt -90.38 116.92 67.5 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 115.13 -0.941 . . . . 62.42 111.086 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 498' ' ' PRO . . . . . 0.487 ' HD2' HD22 ' A' ' 512' ' ' LEU . 27.5 Cg_exo -66.2 160.57 44.3 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.484 2.122 . . . . 72.44 111.106 173.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -67.91 110.99 4.11 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.801 0.81 . . . . 74.45 110.423 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 14.2 m -130.27 65.17 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 122.757 1.265 . . . . 63.54 109.494 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -128.99 93.29 3.56 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 113.559 -1.655 . . . . 73.34 108.382 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 160.82 -38.73 0.43 Allowed Glycine 0 N--CA 1.428 -1.861 0 C-N-CA 119.905 -1.14 . . . . 54.54 112.787 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.555 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.3 OUTLIER -89.71 -170.27 2.76 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 110.231 -0.285 . . . . 74.34 110.231 -178.784 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.52 ' HB ' HG23 ' A' ' 507' ' ' VAL . 21.3 m -71.79 155.58 40.28 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.15 -0.685 . . . . 62.41 109.15 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.6 p -60.38 -41.77 88.48 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.587 0 O-C-N 123.243 0.34 . . . . 73.22 111.391 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.77 -40.7 97.34 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 109.684 -0.487 . . . . 74.45 109.684 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 507' ' ' VAL . . . . . 0.52 HG23 ' HB ' ' A' ' 504' ' ' THR . 47.8 t -67.03 -42.88 89.09 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.177 0 N-CA-C 109.073 -0.714 . . . . 64.02 109.073 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.609 ' HB2' HG11 ' A' ' 534' ' ' VAL . . . -59.34 -45.55 91.05 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.855 0.36 . . . . 75.34 110.959 177.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 26.0 mt-30 -65.32 -42.58 92.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.66 -0.7 . . . . 55.3 110.689 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.61 ' O ' HG23 ' A' ' 514' ' ' VAL . 45.0 mmtm -61.63 -45.69 92.97 Favored 'General case' 0 CA--C 1.495 -1.152 0 O-C-N 123.392 0.433 . . . . 65.13 110.122 177.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -61.88 -41.49 97.92 Favored 'General case' 0 N--CA 1.435 -1.221 0 O-C-N 123.821 0.701 . . . . 72.33 110.89 -176.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.487 HD22 ' HD2' ' A' ' 498' ' ' PRO . 0.2 OUTLIER -68.04 -46.62 70.63 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.859 -1.064 . . . . 63.12 108.208 -179.196 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -61.7 -35.87 79.28 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 124.001 0.92 . . . . 64.15 111.612 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 510' ' ' LYS . 89.6 t -57.62 -38.97 67.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 O-C-N 123.269 0.356 . . . . 74.34 111.525 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -105.21 -3.73 22.57 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.458 0.647 . . . . 74.04 109.523 -176.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -116.33 -58.64 0.32 Allowed Glycine 0 N--CA 1.42 -2.4 0 CA-C-N 115.473 -0.785 . . . . 71.13 113.828 -170.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 63.31 26.78 15.2 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 122.351 1.072 . . . . 75.32 110.212 -172.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.4 p -83.46 -177.14 6.62 Favored 'General case' 0 N--CA 1.403 -2.817 0 CA-C-N 113.872 -1.513 . . . . 71.11 109.447 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -107.99 139.69 42.24 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.371 -1.344 . . . . 64.13 107.371 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -129.2 149.07 51.16 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-O 121.117 0.485 . . . . 63.13 111.255 -176.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.3 m -139.97 152.44 46.32 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 106.688 -1.597 . . . . 71.03 106.688 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -122.84 142.07 51.16 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 112.51 0.559 . . . . 71.22 112.51 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 523' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -132.26 143.33 49.84 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.086 -1.45 . . . . 63.01 107.086 176.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 80.2 p -103.14 138.11 40.41 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.427 -0.909 . . . . 63.0 111.676 -175.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.9 p -121.43 149.64 24.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 106.547 -1.649 . . . . 71.14 106.547 177.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -72.32 136.93 46.34 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.521 -0.548 . . . . 74.23 109.521 -177.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.468 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 56.6 m -153.51 160.07 31.37 Favored Pre-proline 0 C--N 1.291 -1.971 0 N-CA-C 107.768 -1.197 . . . . 73.12 107.768 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.32 -2.75 12.96 Favored 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 121.865 1.71 . . . . 73.32 113.09 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.18 152.02 38.56 Favored Pre-proline 0 N--CA 1.451 -0.412 0 N-CA-C 109.624 -0.51 . . . . 71.34 109.624 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -57.34 146.61 81.85 Favored 'Trans proline' 0 C--O 1.25 1.087 0 C-N-CA 122.96 2.44 . . . . 72.43 113.458 -177.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.708 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.16 99.83 0.11 Allowed 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 114.943 -1.026 . . . . 73.32 111.651 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 157.82 -23.09 0.4 Allowed Glycine 0 C--N 1.3 -1.464 0 CA-C-N 115.758 -0.656 . . . . 74.44 111.874 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -74.38 144.74 44.25 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.349 -0.982 . . . . 74.23 108.349 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.609 HG11 ' HB2' ' A' ' 508' ' ' ALA . 11.0 p -91.38 118.6 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.413 0 CA-C-O 121.854 0.835 . . . . 64.43 108.779 176.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.83 -23.59 60.79 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.514 -1.221 . . . . 61.44 109.374 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 138.99 -152.8 22.41 Favored Glycine 0 N--CA 1.421 -2.305 0 N-CA-C 110.581 -1.007 . . . . 63.05 110.581 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.0 p -116.48 157.93 24.4 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 109.71 -0.478 . . . . 71.21 109.71 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.461 ' HB2' HE22 ' A' ' 554' ' ' GLN . 26.5 t-20 -66.45 -53.68 28.79 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 120.236 -0.586 . . . . 74.13 110.261 173.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 37.0 Cg_endo -67.71 149.82 79.03 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 121.319 1.346 . . . . 62.23 109.767 173.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 540' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 23.5 Cg_exo -64.04 139.36 66.85 Favored 'Trans proline' 0 C--O 1.246 0.923 0 C-N-CA 121.659 1.572 . . . . 70.12 113.02 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.97 137.43 55.13 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-N 115.204 -0.907 . . . . 61.4 110.178 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 93.81 -11.8 70.42 Favored Glycine 0 N--CA 1.442 -0.967 0 C-N-CA 121.092 -0.575 . . . . 61.14 111.668 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 51.8 m -88.52 137.83 31.97 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 122.745 0.418 . . . . 72.12 110.358 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.9 t -74.74 136.83 41.74 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.95 -0.568 . . . . 62.1 109.729 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.3 m -130.89 154.46 81.96 Favored Pre-proline 0 C--N 1.312 -1.064 0 N-CA-C 108.161 -1.051 . . . . 64.32 108.161 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -61.72 136.88 65.02 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.15 1.233 . . . . 54.4 111.202 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 13.3 p -65.99 -23.22 31.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.724 0.773 . . . . 64.14 111.872 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -78.06 -17.41 57.04 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.096 -0.502 . . . . 74.53 110.75 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 25.2 t -78.29 162.54 26.44 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.885 0.85 . . . . 74.24 111.499 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.8 p -98.64 137.74 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.388 0 CA-C-N 114.246 -1.343 . . . . 74.55 108.282 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 61.7 mt -100.88 137.53 28.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.168 -0.678 . . . . 74.41 109.168 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -103.24 117.78 35.29 Favored 'General case' 0 C--O 1.254 1.336 0 N-CA-C 108.816 -0.809 . . . . 73.52 108.816 -177.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -101.49 120.36 40.17 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 123.735 0.814 . . . . 71.32 109.624 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.461 HE22 ' HB2' ' A' ' 538' ' ' ASN . 2.8 mp0 -86.52 123.17 31.43 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 121.17 0.51 . . . . 73.43 110.795 178.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 39.6 t -96.01 132.19 40.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.781 -1.192 . . . . 61.15 107.781 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.708 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 13.0 m -79.7 117.35 20.53 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 107.033 -1.469 . . . . 52.14 107.033 176.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 21.3 pttm -107.52 128.78 54.82 Favored 'General case' 0 N--CA 1.422 -1.869 0 C-N-CA 119.566 -0.854 . . . . 72.32 108.838 173.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 527' ' ' SER . . . -58.61 -24.83 57.5 Favored Glycine 0 CA--C 1.501 -0.79 0 O-C-N 124.462 1.101 . . . . 74.34 113.993 -175.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 73.93 -0.16 3.44 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.995 1.318 . . . . 73.22 109.8 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.478 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 70.3 mt-30 -113.74 149.63 34.54 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 115.661 -0.699 . . . . 72.04 111.971 -174.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -124.12 158.79 31.47 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.454 -1.248 . . . . 64.3 108.351 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.15 126.94 37.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.336 0.589 . . . . 53.45 110.516 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 18.8 ttt -78.21 125.15 85.47 Favored Pre-proline 0 N--CA 1.432 -1.344 0 C-N-CA 124.542 1.137 . . . . 52.44 111.436 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.66 169.43 22.58 Favored 'Trans proline' 0 C--O 1.245 0.869 0 C-N-CA 122.805 2.336 . . . . 74.04 111.125 174.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.79 116.79 26.19 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.86 0.838 . . . . 75.51 111.36 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 566' ' ' LEU . . . . . 0.441 ' H ' HD23 ' A' ' 566' ' ' LEU . 2.1 pt? -117.64 9.11 13.01 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.204 -1.406 . . . . 70.22 107.204 170.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 22.0 t -80.65 147.22 30.77 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 114.211 -1.359 . . . . 62.41 107.953 176.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 66.75 56.74 11.68 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 121.357 -0.449 . . . . 55.14 112.897 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 22.9 ptp -168.49 179.76 4.23 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.165 -1.791 . . . . 75.1 106.165 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 570' ' ' PHE . . . . . 0.457 ' HB2' HG12 ' A' ' 572' ' ' VAL . 52.3 m-85 -100.1 170.45 8.47 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.06 -0.719 . . . . 73.24 109.06 -176.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 571' ' ' TRP . . . . . 0.427 ' CH2' HD22 ' A' ' 587' ' ' LEU . 12.1 t-105 -65.63 -27.53 68.45 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 108.569 -0.9 . . . . 52.43 108.569 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 572' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 570' ' ' PHE . 14.6 p -71.16 -13.2 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 115.735 -0.666 . . . . 73.23 110.479 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -99.41 -35.87 9.77 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 109.017 -0.735 . . . . 73.31 109.017 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 574' ' ' ALA . . . . . 0.64 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -62.64 -39.61 94.41 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 115.323 -0.853 . . . . 74.05 110.397 177.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.416 ' HB3' ' CD ' ' A' ' 576' ' ' PRO . 2.5 tm-20 -51.3 -59.13 8.42 Favored Pre-proline 0 CA--C 1.585 2.303 0 C-N-CA 124.138 0.975 . . . . 75.34 110.57 -178.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.416 ' CD ' ' HB3' ' A' ' 575' ' ' GLU . 19.8 Cg_endo -61.57 -32.49 87.78 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 121.891 1.727 . . . . 61.41 113.013 175.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 7.6 mmp_? -61.98 -41.25 97.82 Favored 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 120.593 -0.443 . . . . 74.41 110.726 177.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 16.8 mt -65.99 -46.39 78.19 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-O 120.782 0.325 . . . . 62.21 110.465 -175.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -65.76 -39.73 91.34 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 112.472 0.545 . . . . 73.05 112.472 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -69.17 -33.61 73.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.878 0.371 . . . . 62.4 111.247 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.3 tp -81.01 -10.16 59.74 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 121.471 0.653 . . . . 55.35 110.156 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 62.0 35.6 91.65 Favored Glycine 0 C--O 1.224 -0.496 0 CA-C-N 115.961 -0.563 . . . . 54.31 112.569 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.477 ' CE3' HD22 ' A' ' 578' ' ' LEU . 18.4 t90 -78.83 126.68 31.03 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.638 -0.504 . . . . 74.14 109.638 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 12.9 t -109.39 6.62 24.49 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 111.966 0.358 . . . . 63.22 111.966 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 585' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -89.11 -171.82 45.8 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 119.955 -1.117 . . . . 73.42 111.261 176.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 94.4 mmm -105.05 139.16 40.15 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 116.749 0.274 . . . . 61.32 110.375 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 587' ' ' LEU . . . . . 0.427 HD22 ' CH2' ' A' ' 571' ' ' TRP . 6.4 tt -80.64 110.01 15.72 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 107.354 -1.35 . . . . 74.12 107.354 176.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.509 ' O ' ' HA ' ' A' ' 621' ' ' THR . 30.6 t70 -95.65 114.23 25.95 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.909 -1.041 . . . . 72.21 109.679 -178.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.452 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -110.9 134.78 52.28 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 108.172 -1.047 . . . . 73.04 108.172 177.862 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -101.07 -89.69 2.07 Favored Glycine 0 C--N 1.268 -3.197 0 CA-C-N 115.306 -0.861 . . . . 43.43 112.646 -175.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -99.63 149.15 23.58 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.025 0.44 . . . . 73.22 111.665 -176.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -93.45 139.18 31.0 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.395 -0.965 . . . . 71.04 108.395 176.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 39.5 t -105.11 153.96 6.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 109.014 -0.735 . . . . 74.42 109.014 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -73.11 119.2 17.02 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 121.599 0.714 . . . . 75.43 109.728 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -143.46 -65.35 0.38 Allowed 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.154 -1.424 . . . . 73.3 107.154 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 100.05 158.8 28.34 Favored Glycine 0 N--CA 1.4 -3.753 0 C-N-CA 119.967 -1.111 . . . . 70.53 112.074 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.23 -32.38 60.19 Favored Glycine 0 C--N 1.302 -1.324 0 C-N-CA 123.689 0.662 . . . . 45.45 113.514 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 26.8 t -69.5 -23.91 63.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 122.057 0.932 . . . . 61.2 109.828 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 55.9 mm-40 -100.96 -12.09 19.2 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.553 -0.748 . . . . 73.12 109.712 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 43.7 m80 67.11 172.69 0.26 Allowed 'General case' 0 C--O 1.242 0.658 0 C-N-CA 124.603 1.161 . . . . 75.13 111.824 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -89.55 84.85 6.39 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 112.526 0.565 . . . . 72.21 112.526 -174.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 624' ' ' PHE . 48.0 mtp180 -91.08 145.96 24.24 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.09 -0.959 . . . . 73.54 110.542 176.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.403 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 59.5 t -74.43 130.51 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 105.904 -1.887 . . . . 53.41 105.904 173.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 73.8 t -102.96 -59.91 3.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-O 120.738 0.304 . . . . 65.41 111.206 -173.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -144.61 141.05 29.13 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.162 -0.472 . . . . 74.15 110.037 -172.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.56 160.89 22.29 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 107.251 -1.389 . . . . 71.34 107.251 176.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.526 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 3.2 t-20 -67.03 -52.61 30.16 Favored Pre-proline 0 C--N 1.312 -1.034 0 N-CA-C 109.689 -0.486 . . . . 75.04 109.689 171.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.2 Cg_exo -87.47 122.8 1.78 Allowed 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 121.589 1.526 . . . . 63.14 110.91 173.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -67.26 158.39 57.18 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.184 1.923 . . . . 31.4 110.874 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.5 127.63 33.44 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.79 -0.448 . . . . 73.43 109.79 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.31 -0.02 40.64 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.713 -0.756 . . . . 71.5 112.091 -177.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 10.2 m -92.32 166.34 12.63 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.81 -0.811 . . . . 54.33 108.81 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -90.73 130.69 10.39 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.91 -0.662 . . . . 74.4 112.082 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.4 m -125.05 141.93 43.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.783 -0.821 . . . . 75.34 108.783 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.478 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.9 p-10 -62.42 179.28 0.33 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.437 0.902 . . . . 60.11 113.437 -175.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -61.03 -25.78 67.15 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.375 -0.375 . . . . 70.13 112.0 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.497 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 34.5 t70 -83.18 -9.45 59.16 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.091 -0.707 . . . . 75.13 109.091 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 618' ' ' GLY . . . . . 0.418 ' HA3' ' CD1' ' A' ' 583' ' ' TRP . . . 64.9 15.9 60.89 Favored Glycine 0 CA--C 1.492 -1.355 0 CA-C-N 115.195 -0.911 . . . . 73.54 113.704 168.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.58 119.13 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 CA-C-O 122.974 1.368 . . . . 70.13 113.255 -164.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.448 HG22 ' HG2' ' A' ' 608' ' ' PRO . 48.1 pt -123.47 133.09 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 CA-C-N 113.42 -1.718 . . . . 61.04 108.581 177.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 12.1 t -109.86 124.93 52.19 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.419 -0.956 . . . . 63.4 108.419 177.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.38 167.17 21.53 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 113.229 0.826 . . . . 75.1 113.229 -176.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -127.21 137.52 52.92 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.501 -1.227 . . . . 74.02 107.86 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 602' ' ' ARG . 15.1 p90 -139.35 166.7 23.85 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.486 -0.325 . . . . 64.21 111.162 -175.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -57.93 145.61 40.18 Favored Glycine 0 N--CA 1.447 -0.621 0 O-C-N 123.978 0.799 . . . . 75.43 114.412 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 . . . . . 0 C--N 1.308 -1.232 0 C-N-CA 124.391 1.076 . . . . 73.11 109.924 177.654 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.666 0 N-CA-C 110.544 -1.022 . . . . 43.23 110.544 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.03 142.23 67.37 Favored 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 122.39 2.06 . . . . 75.43 111.269 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -87.81 -4.22 58.89 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.873 0.844 . . . . 70.24 110.996 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 5.9 p -140.59 144.59 35.9 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.787 -1.19 . . . . 61.34 107.787 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -139.03 135.51 34.31 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 108.806 -0.813 . . . . 74.51 108.806 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.563 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.4 p-10 -81.53 133.99 35.46 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.885 -0.598 . . . . 52.31 109.936 177.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.0 pt -89.63 131.23 40.52 Favored Pre-proline 0 C--N 1.291 -1.945 0 CA-C-N 115.061 -0.972 . . . . 71.23 110.993 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.49 -174.4 2.11 Favored 'Trans proline' 0 C--O 1.251 1.144 0 C-N-CA 121.966 1.777 . . . . 73.21 110.011 174.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -85.38 117.17 24.14 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.002 0.906 . . . . 65.04 110.773 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.466 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 16.6 m -117.58 66.29 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.38 0 CA-C-O 123.277 1.513 . . . . 72.25 108.487 172.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -129.75 109.55 11.05 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 112.018 -2.355 . . . . 72.1 107.369 174.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 138.44 -20.05 3.16 Favored Glycine 0 C--N 1.299 -1.477 0 C-N-CA 119.837 -1.173 . . . . 41.22 112.956 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.471 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.0 OUTLIER -107.44 -173.88 2.4 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 117.484 0.642 . . . . 72.14 110.087 178.416 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 10.0 m -75.99 155.99 34.48 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.229 -1.026 . . . . 63.01 108.229 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.444 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 6.0 p -57.5 -46.59 85.98 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 111.801 0.297 . . . . 74.32 111.801 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -64.33 -37.93 89.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.308 0.575 . . . . 65.22 110.559 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 97.7 t -68.04 -42.42 85.23 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.982 0 CA-C-N 115.231 -0.895 . . . . 73.33 109.554 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.519 ' HB2' HG11 ' A' ' 534' ' ' VAL . . . -62.34 -45.36 93.56 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 122.298 0.239 . . . . 71.43 110.87 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 22.9 mt-30 -64.89 -45.81 84.38 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.458 -0.337 . . . . 74.53 111.261 -178.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.473 ' O ' HG23 ' A' ' 514' ' ' VAL . 0.0 OUTLIER -67.27 -38.92 85.88 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 120.473 -0.491 . . . . 74.12 110.716 179.165 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -63.2 -45.61 90.88 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 121.152 0.501 . . . . 73.21 110.479 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -62.17 -42.19 99.03 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 108.172 -1.047 . . . . 65.14 108.172 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -59.7 -34.95 73.55 Favored 'General case' 0 N--CA 1.428 -1.561 0 C-N-CA 123.613 0.765 . . . . 70.23 112.54 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 510' ' ' LYS . 75.2 t -57.89 -34.44 48.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-O 121.682 0.753 . . . . 72.45 110.866 177.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -104.47 -6.49 20.61 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.49 0.662 . . . . 74.52 109.763 -177.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -114.8 -66.59 0.43 Allowed Glycine 0 N--CA 1.416 -2.686 0 CA-C-N 115.352 -0.84 . . . . 52.42 113.425 -171.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 64.31 30.01 13.51 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 122.8 1.285 . . . . 74.22 109.07 -168.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 10.7 p -88.99 -175.35 4.8 Favored 'General case' 0 N--CA 1.409 -2.516 0 CA-C-N 112.954 -1.93 . . . . 71.43 109.545 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 13.5 mptt -108.24 143.47 37.02 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.131 -1.063 . . . . 73.1 108.131 177.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -132.41 157.14 45.3 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.364 0.602 . . . . 72.22 112.493 -175.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 62.3 m -140.42 150.16 43.5 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.716 -1.216 . . . . 50.42 107.716 174.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -123.82 138.18 54.54 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 120.713 0.292 . . . . 64.35 110.493 -176.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -136.33 143.23 44.02 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.712 -0.848 . . . . 72.51 108.712 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 45.5 m -97.17 135.13 39.56 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.404 1.097 . . . . 63.45 111.906 -178.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.43 153.01 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.813 0 CA-C-N 113.028 -1.897 . . . . 53.32 107.023 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -90.58 133.92 34.75 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.774 -0.77 . . . . 70.15 109.704 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.572 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 69.0 m -162.26 162.8 19.38 Favored Pre-proline 0 C--O 1.202 -1.438 0 N-CA-C 107.926 -1.138 . . . . 73.44 107.926 177.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -68.27 -3.93 11.79 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 122.194 1.929 . . . . 74.04 113.157 177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.402 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 25.2 mmm180 -79.48 136.66 55.9 Favored Pre-proline 0 N--CA 1.425 -1.69 0 N-CA-C 107.948 -1.13 . . . . 73.24 107.948 178.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -59.34 147.98 88.6 Favored 'Trans proline' 0 C--O 1.247 0.927 0 C-N-CA 123.047 2.498 . . . . 72.31 113.391 -175.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.709 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.72 108.12 0.8 Allowed 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.391 -0.822 . . . . 52.11 111.232 -177.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 131.62 -21.05 4.54 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 115.387 -0.824 . . . . 45.32 111.203 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.65 137.21 36.32 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.638 -0.875 . . . . 64.0 108.638 178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.519 HG11 ' HB2' ' A' ' 508' ' ' ALA . 10.3 p -91.42 121.43 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.719 0 CA-C-O 121.939 0.875 . . . . 63.22 109.207 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.474 HG23 ' HB2' ' A' ' 556' ' ' SER . 2.5 p -79.47 -16.56 55.88 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.774 -1.103 . . . . 75.5 111.174 176.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.405 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 145.98 -162.7 28.35 Favored Glycine 0 N--CA 1.425 -2.082 0 C-N-CA 120.774 -0.727 . . . . 75.05 112.18 175.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.9 p -116.26 157.68 24.55 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.646 -1.242 . . . . 72.34 107.646 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.405 ' HB3' ' CD ' ' A' ' 552' ' ' GLU . 23.5 t-20 -63.38 -49.4 79.1 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 118.634 -1.226 . . . . 73.52 112.279 178.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -71.48 136.11 27.88 Favored 'Trans proline' 0 C--N 1.364 1.347 0 N-CA-C 108.705 -1.306 . . . . 70.02 108.705 170.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -66.12 159.34 50.0 Favored 'Trans proline' 0 C--O 1.248 0.984 0 C-N-CA 122.324 2.016 . . . . 74.43 113.199 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.96 139.19 58.74 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.756 -0.656 . . . . 71.31 109.86 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.81 -19.67 51.22 Favored Glycine 0 N--CA 1.432 -1.585 0 N-CA-C 111.781 -0.528 . . . . 71.22 111.781 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 17.5 m -74.13 129.06 37.1 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 110.354 -0.239 . . . . 64.23 110.354 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 14.6 t -82.7 126.76 32.73 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-O 121.578 0.704 . . . . 51.0 109.388 175.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.3 m -123.81 155.52 66.61 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 107.716 -1.216 . . . . 64.4 107.716 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -61.69 137.65 69.97 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 120.973 1.115 . . . . 75.03 111.531 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.26 -20.23 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.961 0.886 . . . . 61.34 110.655 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -87.72 -18.07 30.3 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.143 -0.935 . . . . 75.3 111.647 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 85.1 p -89.89 175.05 7.36 Favored 'General case' 0 C--O 1.252 1.235 0 N-CA-C 113.453 0.909 . . . . 73.13 113.453 -172.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 11.1 p -96.93 138.6 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 CA-C-N 114.281 -1.327 . . . . 73.54 111.175 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.4 mt -114.52 137.96 46.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.791 -1.189 . . . . 71.53 107.791 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 552' ' ' GLU . . . . . 0.405 ' CD ' ' HB3' ' A' ' 538' ' ' ASN . 1.7 pm0 -103.39 128.69 50.45 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.788 0.804 . . . . 72.45 112.188 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.86 122.03 42.74 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.678 -1.601 . . . . 72.4 108.876 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -88.23 113.2 23.61 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.53 0.681 . . . . 62.41 110.344 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 524' ' ' SER . 18.2 t -93.07 122.96 44.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 107.341 -1.355 . . . . 71.43 107.341 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.709 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 48.5 t -81.92 131.95 35.26 Favored 'General case' 0 N--CA 1.405 -2.681 0 N-CA-C 108.797 -0.816 . . . . 51.54 108.797 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -95.11 141.55 28.61 Favored 'General case' 0 N--CA 1.412 -2.363 0 N-CA-C 105.526 -2.028 . . . . 75.35 105.526 168.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -56.05 -23.94 41.15 Favored Glycine 0 CA--C 1.499 -0.952 0 O-C-N 124.48 1.112 . . . . 44.13 112.564 -177.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.2 t30 68.16 20.98 8.77 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-O 123.129 1.442 . . . . 74.31 109.026 174.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.589 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 66.7 mt-30 -141.79 164.54 29.93 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 113.094 -1.866 . . . . 75.12 107.117 178.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -143.23 151.65 40.84 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.785 -1.191 . . . . 65.01 107.785 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 13.6 p -70.45 132.23 33.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 121.01 0.433 . . . . 73.11 110.116 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.415 ' SD ' HG21 ' A' ' 620' ' ' ILE . 44.2 ttp -91.15 109.52 36.04 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 108.405 -0.961 . . . . 72.43 108.405 175.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.75 160.24 44.62 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.478 2.118 . . . . 73.45 110.897 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -73.8 115.06 12.79 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.971 0.891 . . . . 73.12 112.329 -178.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.7 pp -135.3 18.98 3.38 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.096 -1.411 . . . . 75.35 107.789 174.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 8.7 t -74.41 136.89 42.39 Favored 'General case' 0 N--CA 1.417 -2.08 0 CA-C-N 114.603 -1.18 . . . . 75.52 108.902 -175.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 568' ' ' GLY . . . . . 0.473 ' HA2' ' CZ ' ' A' ' 602' ' ' ARG . . . 113.96 50.28 0.51 Allowed Glycine 0 N--CA 1.42 -2.377 0 CA-C-N 115.546 -0.752 . . . . 73.43 111.914 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 19.8 ptp -142.17 173.36 11.59 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 120.099 -0.64 . . . . 64.34 110.246 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -98.61 175.63 5.93 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.987 -1.116 . . . . 73.0 107.987 -177.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 38.3 t-105 -68.82 -29.91 68.35 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.188 -0.671 . . . . 74.41 109.188 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.38 -15.64 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 115.579 -0.737 . . . . 55.42 110.299 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.595 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 9.0 m-20 -96.5 -44.69 7.06 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 108.44 -0.948 . . . . 64.24 108.44 176.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.98 -45.86 90.44 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.705 -1.134 . . . . 74.13 113.529 -174.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.514 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 35.4 tt0 -60.46 -50.46 85.54 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 120.664 -0.414 . . . . 61.34 111.828 -177.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 51.5 Cg_exo -58.88 -28.46 87.39 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 121.469 1.446 . . . . 74.5 111.576 173.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.672 ' O ' ' HB3' ' A' ' 581' ' ' LEU . 17.0 mmt180 -62.88 -38.45 90.92 Favored 'General case' 0 C--O 1.204 -1.324 0 CA-C-O 118.306 -0.854 . . . . 74.2 112.688 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.793 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 6.5 mp -59.38 -49.51 77.52 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.652 -1.219 . . . . 71.03 109.547 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -67.33 -42.07 84.2 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.518 -1.219 . . . . 74.02 113.515 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -71.15 -39.64 71.83 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.839 0.681 . . . . 62.31 112.839 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.672 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 1.7 tp -82.97 -9.43 59.29 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.38 0.672 . . . . 63.25 111.053 -176.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 69.48 40.81 78.63 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 110.616 -0.993 . . . . 63.04 110.616 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.793 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 11.3 t90 -87.46 126.45 34.9 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.217 -1.401 . . . . 74.02 107.217 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 17.4 p -86.81 -28.79 22.73 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 123.08 0.552 . . . . 53.44 112.389 -174.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -74.71 -175.5 34.99 Favored Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 115.588 -0.733 . . . . 75.22 111.636 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 23.9 mmt -123.3 155.21 37.69 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.681 -0.489 . . . . 74.04 109.681 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 47.4 tp -94.12 118.51 31.64 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 123.613 0.571 . . . . 74.34 109.578 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -118.14 122.12 42.27 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.127 -1.064 . . . . 74.53 108.127 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.3 OUTLIER -87.34 130.02 34.79 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 106.928 -1.508 . . . . 62.44 106.928 172.14 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.75 -35.12 23.06 Favored Glycine 0 C--N 1.285 -2.253 0 CA-C-N 115.585 -0.734 . . . . 51.44 111.688 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.61 147.72 39.81 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 120.828 0.347 . . . . 72.24 110.8 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -100.18 123.66 44.68 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 102.814 -3.032 . . . . 75.13 102.814 170.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.89 137.41 32.7 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.611 0 N-CA-C 106.531 -1.655 . . . . 73.54 106.531 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -75.53 106.88 7.32 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 118.418 -1.313 . . . . 65.51 111.122 -178.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 595' ' ' ALA . . . . . 0.447 ' HB3' ' HA3' ' A' ' 625' ' ' GLY . . . -129.61 -64.34 0.89 Allowed 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.023 -1.473 . . . . 74.14 107.023 172.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 111.8 150.15 11.41 Favored Glycine 0 N--CA 1.42 -2.367 0 C-N-CA 120.394 -0.908 . . . . 73.41 111.111 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.95 -32.76 62.77 Favored Glycine 0 C--N 1.307 -1.083 0 C-N-CA 123.356 0.503 . . . . 72.0 113.685 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 20.3 t -72.37 -24.18 61.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.952 0.882 . . . . 74.23 109.968 -175.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -90.3 -0.98 57.87 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.301 -0.863 . . . . 75.05 109.82 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 37.1 m80 75.99 99.61 0.07 Allowed 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 124.975 1.31 . . . . 71.01 109.906 -173.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -82.75 72.28 9.83 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.615 1.197 . . . . 62.52 112.076 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.473 ' CZ ' ' HA2' ' A' ' 568' ' ' GLY . 9.9 ptm180 -100.14 166.48 10.99 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.362 -1.29 . . . . 73.22 109.594 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.41 ' CG1' ' H ' ' A' ' 568' ' ' GLY . 10.4 p -62.86 131.64 28.37 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 CA-C-N 115.995 -0.548 . . . . 73.42 109.931 177.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 12.9 p -109.99 -26.68 3.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 121.724 0.773 . . . . 71.13 110.276 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -154.01 135.53 14.28 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.52 -0.764 . . . . 74.34 110.188 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -127.09 136.1 51.68 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.035 -1.468 . . . . 74.21 107.035 171.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.405 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 28.5 t-20 -65.68 -51.62 48.42 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 112.816 0.673 . . . . 65.4 112.816 -175.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 8.1 Cg_exo -79.11 114.01 3.3 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.576 1.517 . . . . 75.12 108.934 172.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.06 145.19 54.66 Favored 'Trans proline' 0 C--O 1.25 1.121 0 C-N-CA 122.359 2.039 . . . . 72.53 113.046 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -63.42 132.46 51.49 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.603 -0.726 . . . . 73.04 109.227 176.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 102.65 0.03 49.34 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 110.971 -0.852 . . . . 72.25 110.971 -175.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 32.3 m -105.51 150.43 25.34 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 109.559 -0.534 . . . . 71.13 109.559 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -73.38 127.19 10.56 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 111.172 -0.771 . . . . 71.23 111.172 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.6 m -117.09 142.76 29.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 108.22 -1.03 . . . . 74.24 108.22 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.589 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 29.3 p30 -44.1 167.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.073 1.509 . . . . 40.42 115.073 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -55.08 -25.53 31.72 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.483 1.113 . . . . 55.22 113.739 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -96.27 -8.93 31.5 Favored 'General case' 0 C--O 1.207 -1.163 0 C-N-CA 120.05 -0.66 . . . . 64.2 110.105 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.64 18.96 70.66 Favored Glycine 0 C--O 1.217 -0.923 0 CA-C-O 120.044 -0.309 . . . . 74.43 113.765 167.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.93 119.74 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-O 121.82 0.819 . . . . 73.03 110.711 -171.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.415 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.7 pp -127.36 133.97 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 115.132 -0.94 . . . . 52.43 110.767 -177.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.2 t -103.24 135.93 43.96 Favored 'General case' 0 C--O 1.259 1.597 0 N-CA-C 108.748 -0.834 . . . . 74.3 108.748 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 2.7 pp -139.2 165.99 25.7 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.815 -0.629 . . . . 62.54 111.608 -178.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -131.4 137.93 48.89 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.944 -0.761 . . . . 72.42 108.944 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -136.65 166.48 23.45 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.038 -0.528 . . . . 71.44 110.319 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 625' ' ' GLY . . . . . 0.447 ' HA3' ' HB3' ' A' ' 595' ' ' ALA . . . -71.58 67.84 0.99 Allowed Glycine 0 CA--C 1.527 0.803 0 O-C-N 124.069 0.855 . . . . 75.4 114.925 -175.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 . . . . . 0 C--O 1.262 1.715 0 C-N-CA 126.628 1.971 . . . . 75.53 112.064 -175.371 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.724 0 N-CA-C 110.007 -1.237 . . . . 45.41 110.007 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.15 154.02 36.85 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.099 1.866 . . . . 74.14 111.92 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -102.0 -0.16 34.16 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.26 1.029 . . . . 73.02 109.341 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.404 ' HB ' HG22 ' A' ' 544' ' ' THR . 27.8 p -140.03 153.97 46.97 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.69 -1.141 . . . . 73.13 109.003 -176.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.479 ' HB2' ' NZ ' ' A' ' 495' ' ' LYS . 0.0 OUTLIER -137.97 145.09 41.53 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.893 -0.41 . . . . 75.52 109.893 173.371 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 19.9 m-20 -77.89 141.89 38.8 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.849 -0.797 . . . . 63.25 108.849 173.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.6 pt -108.71 130.12 23.12 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 115.728 -0.669 . . . . 65.52 110.336 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -80.7 -177.49 3.79 Favored 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.705 2.27 . . . . 63.45 112.333 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -87.78 89.83 8.14 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 122.459 1.123 . . . . 64.32 110.521 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.0 m -80.59 -0.31 4.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-N 114.936 -1.029 . . . . 61.11 111.96 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -69.53 100.84 1.48 Allowed 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.734 -0.666 . . . . 71.14 110.494 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 156.86 -38.11 0.57 Allowed Glycine 0 C--N 1.304 -1.224 0 C-N-CA 120.808 -0.71 . . . . 64.43 111.979 178.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -92.62 -175.66 4.03 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 109.543 -0.54 . . . . 74.31 109.543 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 13.2 m -70.18 154.86 41.42 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.35 -0.981 . . . . 63.14 108.35 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.475 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.4 p -64.14 -41.33 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 C-N-CA 120.737 -0.385 . . . . 73.54 110.797 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 506' ' ' ASP . . . . . 0.589 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 28.1 t70 -59.69 -43.24 94.11 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 109.815 -0.439 . . . . 54.24 109.815 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 46.3 t -69.29 -41.54 81.08 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 CA-C-N 115.868 -0.606 . . . . 61.14 110.085 -178.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -58.24 -44.02 88.09 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.753 0.311 . . . . 35.31 110.671 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.0 mt-30 -64.8 -44.88 88.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.027 -0.533 . . . . 74.51 110.617 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 33.4 mmtp -64.76 -40.17 94.84 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 116.19 -0.459 . . . . 72.44 110.129 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 511' ' ' ASN . . . . . 0.481 ' O ' HG12 ' A' ' 514' ' ' VAL . 85.9 m-20 -66.72 -40.49 88.44 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.856 -0.611 . . . . 71.23 111.585 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.4 pp -69.9 -41.37 74.78 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.42 -0.912 . . . . 41.31 110.776 177.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.482 ' N ' HD12 ' A' ' 512' ' ' LEU . 44.9 t30 -64.38 -38.91 92.69 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 124.136 0.974 . . . . 74.32 111.259 -177.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 511' ' ' ASN . 9.0 p -64.06 -31.62 54.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.196 0.522 . . . . 74.32 110.876 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -112.62 23.24 13.73 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.409 -0.589 . . . . 74.25 109.409 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -146.07 -56.13 0.02 OUTLIER Glycine 0 CA--C 1.484 -1.866 0 C-N-CA 119.653 -1.26 . . . . 51.35 113.963 -174.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 65.76 26.28 11.32 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.211 1.005 . . . . 74.52 109.618 -175.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 14.7 p -82.95 -175.71 5.97 Favored 'General case' 0 N--CA 1.409 -2.489 0 CA-C-N 113.755 -1.566 . . . . 74.52 108.905 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.51 142.92 38.2 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.042 -1.095 . . . . 75.2 108.042 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -130.33 148.78 52.2 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.078 0.466 . . . . 61.41 111.332 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 32.2 m -138.32 139.99 39.33 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.058 -0.719 . . . . 53.3 109.058 176.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -118.09 138.67 52.09 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.85 0.357 . . . . 73.12 110.795 -176.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -135.02 130.42 35.65 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.268 -0.424 . . . . 52.55 109.862 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 73.9 m -88.96 129.15 35.68 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.695 0.76 . . . . 71.41 112.175 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.83 149.68 25.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.109 -1.811 . . . . 54.53 106.109 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -81.48 136.44 35.64 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.908 -0.717 . . . . 73.51 109.772 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 67.2 m -158.56 164.85 19.91 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 107.982 -1.118 . . . . 53.43 107.982 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -65.35 -14.78 46.77 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.251 1.968 . . . . 63.01 113.534 178.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.435 HH21 HG23 ' A' ' 535' ' ' THR . 0.4 OUTLIER -87.36 146.85 40.74 Favored Pre-proline 0 C--N 1.326 -0.413 0 C-N-CA 120.945 -0.302 . . . . 65.35 110.993 -179.149 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.77 155.47 37.56 Favored 'Trans proline' 0 C--O 1.263 1.758 0 C-N-CA 123.633 2.889 . . . . 72.33 115.378 -175.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.681 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -68.71 110.4 4.28 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 113.617 -1.629 . . . . 70.24 110.602 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 137.39 -21.63 3.26 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.574 -0.822 . . . . 75.33 111.546 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -82.88 138.18 33.99 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.99 -0.745 . . . . 71.22 108.99 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 6.6 p -86.16 114.74 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.193 0 CA-C-O 122.12 0.962 . . . . 75.14 108.907 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.435 HG23 HH21 ' A' ' 529' ' ' ARG . 0.5 OUTLIER -65.06 -32.57 74.34 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 113.575 -1.648 . . . . 70.34 109.681 -179.007 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 153.26 -166.69 31.68 Favored Glycine 0 N--CA 1.418 -2.546 0 N-CA-C 110.102 -1.199 . . . . 65.44 110.102 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 6.6 p -116.96 157.44 25.75 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 109.448 -0.575 . . . . 54.42 109.448 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -63.45 -55.17 37.55 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 119.17 -0.443 . . . . 75.33 110.495 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -69.02 126.5 13.88 Favored 'Trans proline' 0 C--N 1.365 1.442 0 N-CA-C 108.346 -1.444 . . . . 54.42 108.346 170.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.59 155.22 67.89 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.497 2.131 . . . . 53.24 113.293 -176.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.98 130.81 47.32 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.925 -0.58 . . . . 55.32 110.294 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.85 -4.82 42.44 Favored Glycine 0 C--N 1.303 -1.258 0 C-N-CA 120.205 -0.998 . . . . 74.23 111.725 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 25.3 m -88.16 133.28 34.05 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.467 -0.568 . . . . 74.55 109.467 178.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 0.2 OUTLIER -86.71 123.9 32.39 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 106.84 -1.541 . . . . 75.03 106.84 174.74 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.67 155.06 63.53 Favored Pre-proline 0 C--N 1.295 -1.798 0 N-CA-C 108.454 -0.943 . . . . 63.14 108.454 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -64.34 138.3 59.94 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 121.552 1.501 . . . . 74.43 111.636 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.31 -19.96 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 CA-C-O 122.168 0.985 . . . . 71.1 109.858 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -91.12 -8.38 48.94 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.785 -1.098 . . . . 73.44 111.687 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 15.1 t -89.79 -175.64 4.7 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-O 121.282 0.563 . . . . 53.53 110.416 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.1 p -118.89 137.65 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-N 115.869 -0.605 . . . . 72.41 109.511 -177.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 59.8 mt -97.55 132.56 41.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.883 -0.784 . . . . 63.32 108.883 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -103.12 116.1 31.84 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.416 -1.327 . . . . 72.22 107.416 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.84 125.8 52.36 Favored 'General case' 0 C--N 1.312 -1.035 0 O-C-N 123.625 0.578 . . . . 55.22 111.0 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -93.09 121.66 34.66 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.699 -0.682 . . . . 71.13 109.293 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.446 HG22 HG21 ' A' ' 505' ' ' VAL . 15.1 t -104.37 137.4 33.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 107.447 -1.316 . . . . 64.51 107.447 -178.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.681 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 24.5 p -88.08 139.53 30.42 Favored 'General case' 0 N--CA 1.413 -2.315 0 C-N-CA 119.92 -0.712 . . . . 74.24 109.839 178.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -108.41 145.03 35.2 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 105.299 -2.112 . . . . 73.22 105.299 167.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 559' ' ' ASN . . . -54.68 -22.58 25.98 Favored Glycine 0 CA--C 1.506 -0.516 0 O-C-N 124.72 1.262 . . . . 62.34 114.743 -174.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 559' ' ' ASN . . . . . 0.428 ' HB3' ' O ' ' A' ' 558' ' ' GLY . 18.9 t-20 82.79 -16.4 0.59 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.816 1.246 . . . . 62.03 109.678 -178.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.518 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 86.9 mt-30 -113.48 157.33 22.12 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.283 -0.871 . . . . 71.1 111.383 -176.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -136.8 157.85 45.81 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.278 -1.379 . . . . 74.24 107.278 176.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.97 119.3 23.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.434 -0.58 . . . . 74.42 109.434 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 54.8 ttp -79.98 133.46 58.02 Favored Pre-proline 0 C--N 1.311 -1.077 0 C-N-CA 120.817 -0.353 . . . . 75.41 110.088 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.95 169.67 17.33 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.71 2.273 . . . . 74.54 111.525 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 565' ' ' ASP . . . . . 0.445 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 24.6 t70 -89.62 119.87 30.42 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 113.219 0.822 . . . . 75.31 113.219 -178.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.36 12.73 3.02 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.504 -1.225 . . . . 51.34 109.272 173.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 84.5 p -69.03 153.41 43.83 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 115.69 -0.686 . . . . 73.02 112.824 -173.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 568' ' ' GLY . . . . . 0.444 ' H ' ' CG1' ' A' ' 603' ' ' VAL . . . 86.13 56.66 2.26 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.793 -0.923 . . . . 44.33 110.793 -178.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 569' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 602' ' ' ARG . 14.4 ptm -142.49 177.04 8.55 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.01 -0.367 . . . . 73.44 110.01 -175.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -95.5 160.63 14.42 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 106.69 -1.596 . . . . 75.31 106.69 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 571' ' ' TRP . . . . . 0.46 ' CZ3' ' HB3' ' A' ' 589' ' ' LYS . 19.3 t-105 -66.49 -32.32 73.61 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.482 -0.932 . . . . 75.21 108.482 176.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.1 m -76.2 -13.53 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.284 -0.871 . . . . 62.32 111.159 -174.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -96.96 -27.23 14.73 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.779 -1.193 . . . . 62.31 107.779 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -68.82 -40.33 79.57 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.25 -0.886 . . . . 70.31 111.773 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.639 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 44.9 mt-10 -55.36 -55.6 38.07 Favored Pre-proline 0 CA--C 1.567 1.606 0 N-CA-C 112.725 0.639 . . . . 71.13 112.725 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.5 -30.38 79.75 Favored 'Trans proline' 0 C--N 1.364 1.391 0 CA-C-N 120.707 1.288 . . . . 63.11 112.606 172.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -68.73 -36.36 78.31 Favored 'General case' 0 N--CA 1.435 -1.197 0 O-C-N 122.091 -0.38 . . . . 61.23 111.009 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.3 pp -64.51 -45.97 84.96 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 120.728 0.299 . . . . 73.54 110.655 -178.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.529 ' N ' HD12 ' A' ' 578' ' ' LEU . 8.5 ptm180 -65.93 -34.84 79.04 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.358 -0.383 . . . . 73.22 111.242 175.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.24 -39.31 82.32 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 116.41 -0.359 . . . . 63.24 111.548 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' A' ' 583' ' ' TRP . 1.5 pp -91.93 -9.66 42.32 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.555 -0.458 . . . . 75.21 111.399 -177.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 79.43 42.37 11.85 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.071 -0.585 . . . . 72.35 112.339 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.473 ' CH2' ' HG ' ' A' ' 587' ' ' LEU . 10.0 t90 -81.46 127.26 32.62 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.799 -0.815 . . . . 74.45 108.799 178.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 22.5 m -83.19 -29.63 28.42 Favored 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 113.083 0.771 . . . . 55.11 113.083 -176.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -90.72 -175.62 44.3 Favored Glycine 0 C--N 1.315 -0.611 0 CA-C-N 116.555 -0.293 . . . . 72.33 112.905 -177.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 70.1 mtm -117.73 163.33 16.65 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.368 -0.604 . . . . 63.23 109.368 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 587' ' ' LEU . . . . . 0.473 ' HG ' ' CH2' ' A' ' 583' ' ' TRP . 5.1 mp -84.26 131.14 34.76 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 109.703 -0.48 . . . . 71.44 109.703 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 621' ' ' THR . 32.8 t70 -101.86 116.07 31.9 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 108.831 -0.803 . . . . 73.33 108.831 177.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.46 ' HB3' ' CZ3' ' A' ' 571' ' ' TRP . 0.0 OUTLIER -95.08 134.23 38.02 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.659 0.742 . . . . 63.11 112.204 -175.077 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -95.58 -145.0 18.03 Favored Glycine 0 C--N 1.29 -1.982 0 N-CA-C 109.264 -1.534 . . . . 63.22 109.264 174.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -74.49 126.16 30.16 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 117.309 0.554 . . . . 73.12 110.547 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -69.75 144.21 52.8 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 123.913 0.758 . . . . 72.01 109.703 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 58.6 t -106.68 143.44 17.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-N 115.272 -0.877 . . . . 71.31 109.638 -174.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -74.94 107.0 6.73 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.968 -0.753 . . . . 63.01 108.968 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -126.98 -53.88 1.4 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 116.057 -0.52 . . . . 65.3 110.125 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 101.81 129.44 6.68 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.963 -0.855 . . . . 72.31 110.963 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.68 -43.11 91.55 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 116.539 0.169 . . . . 72.44 113.224 -177.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 35.3 t -68.7 -24.68 64.52 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.323 0.583 . . . . 62.2 110.65 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -93.53 -1.75 55.16 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 116.088 -0.505 . . . . 75.51 110.593 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 42.2 m170 80.55 98.33 0.06 Allowed 'General case' 0 C--O 1.246 0.892 0 C-N-CA 125.437 1.495 . . . . 71.32 113.216 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -73.08 90.39 1.53 Allowed 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 114.091 -1.413 . . . . 73.41 109.952 177.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 569' ' ' MET . 19.6 mtm180 -107.94 171.14 7.57 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.865 -0.607 . . . . 73.12 110.003 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.444 ' CG1' ' H ' ' A' ' 568' ' ' GLY . 14.7 p -73.4 137.97 22.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.751 -0.833 . . . . 72.22 108.751 175.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 33.5 m -107.26 -29.19 2.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 119.752 -0.779 . . . . 73.52 110.865 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -156.55 139.17 15.03 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.65 -0.705 . . . . 74.31 109.464 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -133.02 141.96 48.55 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.057 -1.831 . . . . 70.15 106.057 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.536 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 23.7 t-20 -62.14 -60.36 10.37 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-O 118.923 -0.561 . . . . 74.2 112.483 -177.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.536 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 6.3 Cg_exo -87.98 109.26 0.62 Allowed 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 121.752 1.635 . . . . 54.43 109.844 173.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 609' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 7.1 Cg_exo -71.11 160.63 48.58 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 123.225 2.616 . . . . 62.12 113.112 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 610' ' ' ALA . . . . . 0.445 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -68.02 132.67 47.7 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.821 -0.807 . . . . 65.42 108.821 175.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 103.18 -11.88 55.32 Favored Glycine 0 C--N 1.302 -1.336 0 N-CA-C 110.852 -0.899 . . . . 44.54 110.852 -175.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 44.8 m -100.27 159.5 15.07 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.787 -0.82 . . . . 72.54 108.787 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -76.86 120.61 5.72 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 112.036 -0.426 . . . . 71.13 112.036 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.7 m -112.42 143.32 22.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 107.793 -1.188 . . . . 53.41 107.793 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.518 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.2 p-10 -52.99 168.8 0.11 Allowed 'General case' 0 C--O 1.216 -0.704 0 C-N-CA 123.534 0.734 . . . . 74.12 112.184 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . 0.267 0.0 OUTLIER -60.91 -24.95 66.4 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 113.642 0.978 . . . . 73.04 113.642 -176.864 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -80.97 -9.2 59.87 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 119.686 -0.806 . . . . 55.44 109.522 176.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.18 18.9 67.66 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 112.008 -0.437 . . . . 75.24 112.008 175.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.49 119.34 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-O 122.379 1.085 . . . . 62.31 111.694 -166.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.469 ' O ' HD12 ' A' ' 620' ' ' ILE . 2.8 pp -118.17 132.19 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 CA-C-N 114.77 -1.105 . . . . 72.33 110.352 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 12.9 t -99.19 128.76 45.37 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.007 -1.479 . . . . 65.42 107.007 174.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.1 166.64 23.97 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 112.599 0.592 . . . . 74.23 112.599 -172.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -126.21 134.88 51.11 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 105.231 -2.137 . . . . 53.34 105.231 173.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -142.29 166.05 25.74 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.912 -0.585 . . . . 71.21 110.571 -169.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -63.45 130.49 40.72 Favored Glycine 0 N--CA 1.433 -1.546 0 O-C-N 124.203 0.939 . . . . 42.32 111.956 175.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 . . . . . 0 C--N 1.301 -1.501 0 C-N-CA 126.162 1.785 . . . . 64.34 114.446 -178.878 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.685 0 N-CA-C 110.382 -1.087 . . . . 61.55 110.382 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -68.58 142.92 55.06 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.134 1.89 . . . . 71.44 111.475 178.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -117.61 9.59 13.17 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.995 -0.548 . . . . 43.51 110.816 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.449 ' HB ' ' OG1' ' A' ' 544' ' ' THR . 33.9 p -137.49 144.87 42.43 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.389 -0.596 . . . . 75.5 109.389 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -141.93 148.9 39.42 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 123.493 0.717 . . . . 70.31 109.343 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 14.3 m-20 -89.58 131.17 35.72 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 120.942 0.401 . . . . 73.03 110.759 -175.07 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.0 pt -90.77 128.05 49.81 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 116.048 -0.524 . . . . 74.11 110.579 178.28 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.27 -177.57 2.17 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.706 2.271 . . . . 43.53 112.463 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -81.26 99.84 8.84 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.789 -0.641 . . . . 71.31 109.556 177.105 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.49 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 27.1 m -102.13 -3.31 9.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.301 -0.863 . . . . 34.11 111.442 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -64.87 103.65 0.74 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.836 -0.62 . . . . 51.24 110.219 -178.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 145.87 -24.08 1.79 Allowed Glycine 0 C--N 1.295 -1.707 0 CA-C-N 115.476 -0.784 . . . . 74.22 111.984 178.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.456 ' O ' HG12 ' A' ' 534' ' ' VAL . 2.2 mp0 -92.04 -179.24 5.22 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.124 -1.065 . . . . 70.31 108.124 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 31.5 m -75.85 155.17 35.57 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.457 -1.683 . . . . 61.4 106.457 175.568 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.551 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.2 p -61.29 -43.19 96.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 118.103 0.41 . . . . 73.33 111.438 -177.828 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 506' ' ' ASP . . . . . 0.546 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 25.6 t70 -63.17 -41.29 99.21 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.415 -0.357 . . . . 73.23 110.176 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 94.5 t -68.04 -42.99 85.69 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.984 0 CA-C-N 115.386 -0.825 . . . . 44.21 110.33 -178.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.49 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -62.5 -44.38 96.53 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 121.12 -0.232 . . . . 73.44 110.532 178.582 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.551 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 93.1 mt-30 -64.54 -46.5 82.56 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 116.437 -0.347 . . . . 74.15 110.676 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 506' ' ' ASP 0.359 0.0 OUTLIER -65.68 -37.0 85.27 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 112.386 0.513 . . . . 72.4 112.386 179.468 . . . . . . . . 4 4 . 1 . 021 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -60.55 -47.4 86.36 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.445 -0.576 . . . . 75.45 109.445 178.518 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.54 -37.66 80.16 Favored 'General case' 0 C--O 1.205 -1.275 0 CA-C-N 115.457 -0.792 . . . . 70.25 109.743 177.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -59.74 -34.44 72.95 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 123.884 0.874 . . . . 73.24 111.745 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.6 t -56.57 -31.33 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 O-C-N 123.645 0.591 . . . . 42.52 110.524 176.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -114.08 5.92 16.2 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.095 -0.706 . . . . 70.24 109.095 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -124.42 -62.09 0.18 Allowed Glycine 0 CA--C 1.481 -2.06 0 C-N-CA 120.342 -0.932 . . . . 64.01 113.988 -169.296 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 61.07 32.66 19.74 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 122.144 0.973 . . . . 75.42 109.071 -172.732 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 547' ' ' VAL . 4.9 p -87.02 -178.43 6.27 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.377 -1.283 . . . . 75.24 111.331 -177.265 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -108.22 143.11 37.49 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.98 -1.119 . . . . 64.54 107.98 178.132 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -125.3 146.14 49.69 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.745 0.307 . . . . 74.43 110.71 -174.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 56.3 p -126.92 141.07 51.9 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 106.18 -1.785 . . . . 72.0 106.18 171.043 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -129.72 122.57 29.15 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.299 0.571 . . . . 71.44 110.996 -174.119 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -118.09 125.31 50.04 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.632 -0.713 . . . . 42.5 109.493 -179.041 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 40.3 m -85.78 130.44 34.55 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-O 121.558 0.694 . . . . 55.03 111.287 -179.188 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.4 p -121.05 149.14 24.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 107.146 -1.427 . . . . 75.14 107.146 178.54 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -80.63 135.44 36.05 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.164 -0.615 . . . . 75.42 109.762 -177.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.8 m -159.75 165.27 18.3 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 108.1 -1.074 . . . . 74.1 108.1 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -71.5 -8.08 22.55 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.103 1.869 . . . . 72.51 112.549 177.443 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.471 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 16.0 mtm180 -81.57 141.71 48.96 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 123.48 0.712 . . . . 71.41 109.866 178.106 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.61 153.67 59.89 Favored 'Trans proline' 0 C--O 1.249 1.056 0 C-N-CA 123.431 2.754 . . . . 75.2 113.596 -174.497 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.687 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -68.37 105.98 2.35 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.192 -0.913 . . . . 64.02 110.576 -177.605 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 139.44 -17.13 3.11 Favored Glycine 0 N--CA 1.434 -1.5 0 CA-C-N 115.293 -0.867 . . . . 72.23 112.162 -179.208 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -81.33 130.05 34.87 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 109.594 -0.521 . . . . 75.2 109.594 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.496 ' HB ' ' HA ' ' A' ' 505' ' ' VAL . 7.8 p -81.36 118.01 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.252 0 CA-C-O 122.612 1.196 . . . . 74.33 108.871 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 m -80.07 -17.73 51.91 Favored 'General case' 0 C--N 1.269 -2.905 0 CA-C-N 112.938 -1.937 . . . . 61.22 110.177 -175.789 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 139.93 -163.12 26.3 Favored Glycine 0 N--CA 1.41 -3.034 0 C-N-CA 120.544 -0.836 . . . . 44.04 111.234 176.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 537' ' ' THR . . . . . 0.415 HG22 HD13 ' A' ' 553' ' ' LEU . 11.6 p -117.37 157.92 25.32 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 109.194 -0.669 . . . . 72.04 109.194 -179.502 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.433 ' HB2' HE22 ' A' ' 554' ' ' GLN . 3.8 t-20 -66.61 -54.52 22.71 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 120.364 -0.535 . . . . 62.35 110.002 175.438 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.422 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 23.1 Cg_endo -67.93 138.85 45.52 Favored 'Trans proline' 0 C--N 1.373 1.844 0 N-CA-C 109.395 -1.04 . . . . 61.45 109.395 170.47 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 540' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 38.0 Cg_exo -62.9 155.39 60.49 Favored 'Trans proline' 0 C--O 1.244 0.801 0 C-N-CA 122.763 2.309 . . . . 71.23 113.106 -177.479 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.89 134.61 53.38 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.264 -0.426 . . . . 64.25 109.904 179.119 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.31 -5.53 57.45 Favored Glycine 0 C--N 1.303 -1.283 0 N-CA-C 111.344 -0.702 . . . . 34.05 111.344 -177.784 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 20.6 m -88.72 135.25 33.61 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.516 -0.55 . . . . 72.43 109.516 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 14.5 t -82.44 132.98 35.2 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.503 -0.925 . . . . 52.33 108.503 175.062 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.1 m -123.6 156.4 64.59 Favored Pre-proline 0 C--N 1.294 -1.834 0 N-CA-C 107.269 -1.382 . . . . 71.03 107.269 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.3 135.37 26.71 Favored 'Trans proline' 0 N--CA 1.433 -2.064 0 CA-C-N 119.833 0.976 . . . . 51.25 111.219 -178.061 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.416 ' HA ' HG22 ' A' ' 518' ' ' THR . 8.3 p -67.68 -22.24 28.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 122.496 1.141 . . . . 62.13 108.838 177.304 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -79.9 -18.12 51.39 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 113.113 -1.858 . . . . 71.21 110.188 -175.737 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 18.7 t -102.07 -166.6 1.31 Allowed 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.612 -0.722 . . . . 52.12 109.512 -176.249 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 8.7 p -117.09 137.67 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.398 0 CA-C-N 115.162 -0.926 . . . . 73.5 109.196 -177.5 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.0 mt -91.68 141.37 14.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.324 -0.991 . . . . 74.4 108.324 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -102.29 116.93 33.68 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 108.506 -0.924 . . . . 73.43 108.506 -177.567 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.415 HD13 HG22 ' A' ' 537' ' ' THR . 3.2 mm? -106.78 121.11 43.74 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.785 0.834 . . . . 70.34 109.921 -179.316 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.433 HE22 ' HB2' ' A' ' 538' ' ' ASN . 2.9 mp0 -88.35 122.76 32.22 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.922 -0.769 . . . . 62.34 108.922 174.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 524' ' ' SER . 25.4 t -110.2 134.66 51.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 108.763 -0.828 . . . . 72.24 108.763 -178.269 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.687 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 75.5 m -81.57 131.1 35.26 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 120.093 -0.643 . . . . 74.15 109.885 176.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -99.69 131.78 45.46 Favored 'General case' 0 N--CA 1.411 -2.407 0 N-CA-C 104.28 -2.489 . . . . 64.33 104.28 166.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -60.17 -26.01 63.09 Favored Glycine 0 CA--C 1.49 -1.517 0 O-C-N 124.13 0.893 . . . . 65.44 112.924 -173.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 71.77 -15.44 0.45 Allowed 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 125.191 1.396 . . . . 74.31 110.721 178.315 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.466 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 89.9 mt-30 -113.18 144.34 42.84 Favored 'General case' 0 N--CA 1.416 -2.167 0 C-N-CA 123.37 0.668 . . . . 61.01 111.754 -174.371 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -123.31 146.69 47.7 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.678 -1.23 . . . . 73.21 107.678 177.692 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.81 117.97 12.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.417 0.627 . . . . 74.12 110.504 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 51.9 ttp -81.11 120.51 78.82 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 115.626 -0.715 . . . . 63.41 110.246 -177.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.76 169.78 12.49 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 123.156 2.571 . . . . 61.54 111.917 176.127 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -65.53 115.49 5.81 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 122.195 0.998 . . . . 72.31 112.634 -178.777 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.2 pp -131.37 6.19 4.46 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 113.81 -1.541 . . . . 74.14 107.784 170.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 14.5 m -80.08 142.09 35.2 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 113.627 -1.624 . . . . 72.52 109.499 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 568' ' ' GLY . . . . . 0.549 ' H ' ' CG1' ' A' ' 603' ' ' VAL . . . 80.64 48.17 6.38 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 121.353 -0.451 . . . . 73.32 112.839 178.064 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 21.6 ptp -152.31 -174.71 4.98 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 109.331 -0.618 . . . . 71.31 109.331 178.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -95.08 166.65 11.82 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.637 -0.875 . . . . 71.4 108.637 -173.064 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 -66.58 -29.06 69.03 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.998 -0.742 . . . . 53.22 108.998 178.387 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.9 p -73.89 -12.36 15.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 CA-C-O 121.968 0.89 . . . . 63.02 109.948 -178.647 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -101.49 -29.48 11.96 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 115.725 -0.671 . . . . 64.43 111.146 173.727 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.46 -47.77 82.55 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.75 0.657 . . . . 71.14 111.166 179.032 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.492 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 43.1 mt-10 -55.5 -51.81 77.0 Favored Pre-proline 0 CA--C 1.56 1.348 0 N-CA-C 113.463 0.912 . . . . 72.43 113.463 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 31.9 Cg_exo -61.86 -40.24 45.93 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.613 1.542 . . . . 73.41 113.128 174.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.425 ' NE ' ' HA ' ' A' ' 577' ' ' ARG . 3.3 mmp_? -60.76 -40.58 93.04 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 111.4 0.148 . . . . 63.45 111.4 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 579' ' ' ARG . 4.3 pp -65.97 -46.58 77.54 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.543 -0.463 . . . . 72.24 112.029 -176.724 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.551 ' N ' HD12 ' A' ' 578' ' ' LEU . 15.1 ptp180 -66.82 -36.1 81.6 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.503 -0.317 . . . . 74.22 111.611 178.752 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.1 -30.67 67.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.255 0.55 . . . . 50.12 110.53 178.349 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 11.4 tp -81.43 -9.73 59.66 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.294 0.569 . . . . 62.3 110.452 177.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 76.5 26.71 62.73 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.445 -0.884 . . . . 75.03 112.062 179.44 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.414 ' CD1' ' HA3' ' A' ' 618' ' ' GLY . 16.0 t90 -87.33 126.49 34.88 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 107.705 -1.22 . . . . 71.34 107.705 176.192 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 41.7 p -115.24 0.49 13.54 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 112.918 0.711 . . . . 72.24 112.918 -175.101 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 585' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -81.5 -173.88 48.58 Favored Glycine 0 C--O 1.248 0.996 0 C-N-CA 120.499 -0.857 . . . . 54.42 112.011 178.828 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 65.8 mtt -100.27 147.91 25.24 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 120.853 0.359 . . . . 74.01 110.729 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.1 tt -91.56 122.49 34.18 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.346 -1.353 . . . . 74.34 107.346 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.561 ' O ' ' HA ' ' A' ' 621' ' ' THR . 32.3 t70 -98.65 119.87 38.11 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.231 -0.655 . . . . 64.34 109.231 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.49 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -111.88 135.05 53.02 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 116.181 -0.463 . . . . 64.12 110.035 179.953 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -73.01 -88.4 0.17 Allowed Glycine 0 C--N 1.297 -1.609 0 N-CA-C 110.727 -0.949 . . . . 64.01 110.727 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.7 154.12 47.4 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.778 -0.452 . . . . 73.34 109.778 177.192 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 592' ' ' ASP . . . . . 0.524 ' HA ' ' O ' ' A' ' 624' ' ' PHE . 3.3 p30 -100.49 132.54 45.82 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.62 -0.881 . . . . 75.44 108.62 174.254 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 46.3 t -105.08 139.09 27.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 108.651 -0.87 . . . . 75.3 108.651 -176.125 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 594' ' ' ASP . . . . . 0.605 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 7.3 p-10 -71.53 110.9 6.41 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 122.185 0.993 . . . . 73.22 111.884 -173.316 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -113.24 -55.78 2.48 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.008 -0.996 . . . . 64.12 108.469 179.017 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 139.18 141.7 4.14 Favored Glycine 0 N--CA 1.416 -2.64 0 CA-C-N 115.613 -0.721 . . . . 71.21 111.465 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -59.77 -36.05 88.52 Favored Glycine 0 N--CA 1.446 -0.686 0 O-C-N 123.844 0.379 . . . . 73.3 112.744 -178.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 15.1 m -67.07 -24.7 66.0 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 123.053 0.541 . . . . 62.33 111.269 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -92.81 -12.75 30.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.867 0.365 . . . . 75.12 110.759 -178.464 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 23.2 m170 67.71 145.83 0.04 OUTLIER 'General case' 0 C--O 1.246 0.889 0 N-CA-C 114.914 1.45 . . . . 75.45 114.914 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -77.68 89.15 3.96 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 114.11 -1.405 . . . . 74.14 111.027 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -101.13 154.34 18.82 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.651 -1.24 . . . . 73.34 107.651 176.376 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.549 ' CG1' ' H ' ' A' ' 568' ' ' GLY . 8.8 p -67.87 141.96 17.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.402 -0.962 . . . . 72.24 108.402 176.545 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.51 -53.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.726 -0.842 . . . . 73.2 108.726 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -149.0 145.65 27.42 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.779 -0.823 . . . . 75.42 108.779 -178.256 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -129.19 136.26 49.91 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.543 -1.28 . . . . 74.11 107.543 173.576 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.494 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 48.7 t30 -55.4 -54.1 54.81 Favored Pre-proline 0 C--N 1.314 -0.959 0 N-CA-C 112.697 0.629 . . . . 71.13 112.697 -178.508 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.8 Cg_endo -87.72 107.2 0.6 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 121.579 1.519 . . . . 75.23 109.47 173.53 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.29 160.8 47.76 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 123.308 2.672 . . . . 71.42 113.362 -177.407 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.64 130.07 44.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.149 -0.478 . . . . 65.12 109.772 177.234 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.3 -3.08 40.18 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.707 -0.758 . . . . 63.13 112.833 -178.354 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 2.1 t -101.88 162.99 12.49 Favored 'General case' 0 C--O 1.25 1.104 0 N-CA-C 108.329 -0.989 . . . . 75.12 108.329 178.529 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -85.13 127.81 8.39 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 120.657 -0.782 . . . . 72.13 111.726 179.495 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 32.7 m -112.04 141.65 26.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.801 -0.814 . . . . 53.0 108.801 177.243 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.466 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 33.7 p-10 -56.47 176.27 0.09 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.631 1.173 . . . . 60.21 114.025 -175.481 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -56.93 -27.98 61.56 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.881 0.872 . . . . 72.43 112.504 -177.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.448 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 6.5 m-20 -94.25 -6.11 45.31 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 120.629 -0.428 . . . . 75.12 110.592 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 618' ' ' GLY . . . . . 0.414 ' HA3' ' CD1' ' A' ' 583' ' ' TRP . . . 66.19 17.93 66.51 Favored Glycine 0 CA--C 1.497 -1.053 0 C-N-CA 124.088 0.851 . . . . 31.2 113.993 170.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.21 119.24 15.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 122.312 1.053 . . . . 71.41 111.767 -165.762 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 45.0 pt -122.18 134.56 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 114.679 -1.146 . . . . 71.32 110.141 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 9.7 t -105.8 129.85 53.9 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.447 -0.945 . . . . 62.23 108.447 177.571 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.5 pp -138.86 166.03 25.49 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 113.037 0.754 . . . . 60.35 113.037 -176.586 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -128.11 137.33 52.08 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.085 -1.45 . . . . 73.23 107.085 176.346 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 592' ' ' ASP . 3.0 p90 -140.09 166.1 25.57 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.316 -0.554 . . . . 74.1 111.909 -172.321 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -76.27 169.39 54.87 Favored Glycine 0 N--CA 1.429 -1.817 0 CA-C-N 115.621 -0.718 . . . . 52.42 113.136 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.605 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 27.0 tt0 . . . . . 0 C--N 1.274 -2.717 0 N-CA-C 106.919 -1.511 . . . . 75.32 106.919 178.463 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.222 0 N-CA-C 110.194 -1.162 . . . . 63.41 110.194 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -72.24 149.55 51.63 Favored 'Trans proline' 0 C--O 1.243 0.759 0 C-N-CA 121.934 1.756 . . . . 74.23 111.463 178.586 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 61.76 6.02 1.49 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.302 1.441 . . . . 64.13 113.687 177.72 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 14.1 p -138.01 139.57 39.7 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 109.079 -0.712 . . . . 73.24 109.079 179.554 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.444 ' HE3' ' O ' ' A' ' 516' ' ' GLY . 74.7 mmtt -123.27 134.01 54.13 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-O 121.007 0.432 . . . . 71.14 110.311 -175.726 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.4 p-10 -95.78 127.77 42.09 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.091 -0.959 . . . . 74.21 109.135 178.441 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 27.0 pt -106.2 122.87 40.8 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 115.976 -0.556 . . . . 64.41 111.217 -178.556 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.41 -175.45 1.79 Allowed 'Trans proline' 0 C--O 1.248 0.992 0 C-N-CA 122.165 1.91 . . . . 73.33 110.477 175.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.404 ' HA ' ' HB1' ' A' ' 541' ' ' ALA . 9.1 p-10 -79.71 89.98 5.19 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.617 1.199 . . . . 51.14 110.565 178.41 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.29 -11.01 12.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.001 -1.454 . . . . 52.32 110.178 177.212 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.413 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -67.38 103.15 1.22 Allowed 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 114.53 -1.214 . . . . 72.52 109.12 178.388 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 148.86 -30.92 1.22 Allowed Glycine 0 C--N 1.293 -1.816 0 C-N-CA 120.493 -0.86 . . . . 54.52 112.095 178.56 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.42 ' O ' HG12 ' A' ' 534' ' ' VAL . 10.0 pt20 -94.76 -169.83 2.1 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 120.009 -0.677 . . . . 74.24 110.14 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 2.9 m -74.16 156.08 37.71 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.785 -0.82 . . . . 73.43 108.785 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.532 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.7 p -57.91 -47.76 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 O-C-N 123.464 0.477 . . . . 72.13 112.152 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -65.24 -36.69 84.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 120.565 -0.454 . . . . 32.23 110.012 -178.749 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.79 -41.92 85.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.831 0 CA-C-N 115.907 -0.588 . . . . 74.34 109.523 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -65.39 -45.24 84.76 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.749 -0.205 . . . . 70.21 110.912 177.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.5 mt-30 -63.97 -45.75 87.69 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 123.395 0.435 . . . . 65.44 110.759 -178.788 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.532 ' O ' HG23 ' A' ' 514' ' ' VAL . 0.1 OUTLIER -67.34 -39.35 85.78 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 116.154 -0.476 . . . . 62.42 110.007 -178.229 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -62.62 -46.89 86.16 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 123.39 0.431 . . . . 63.42 111.013 -179.332 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.3 pp -68.5 -35.81 78.03 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 115.83 -0.623 . . . . 62.45 110.995 -178.328 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.402 ' N ' HD12 ' A' ' 512' ' ' LEU . 41.1 t30 -63.3 -35.98 82.17 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 123.512 0.725 . . . . 72.44 110.315 179.016 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 510' ' ' LYS . 85.0 t -63.47 -32.47 56.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.884 0 CA-C-O 121.127 0.489 . . . . 75.21 110.838 177.107 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 515' ' ' TYR . . . . . 0.435 ' O ' ' HD2' ' A' ' 495' ' ' LYS . 11.1 m-85 -103.32 3.65 35.57 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.928 -0.397 . . . . 64.24 109.928 -178.052 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 516' ' ' GLY . . . . . 0.444 ' O ' ' HE3' ' A' ' 495' ' ' LYS . . . -134.88 -54.99 0.07 OUTLIER Glycine 0 N--CA 1.416 -2.634 0 C-N-CA 118.803 -1.665 . . . . 74.44 115.019 -169.094 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 66.1 20.82 11.21 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.94 0.876 . . . . 74.33 109.032 -172.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.8 p -81.6 -174.87 5.23 Favored 'General case' 0 N--CA 1.407 -2.59 0 CA-C-N 114.155 -1.384 . . . . 63.43 110.462 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.69 138.99 42.92 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.951 -1.129 . . . . 72.3 107.951 -178.204 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 520' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 18.9 p90 -130.02 152.56 49.35 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 123.303 0.377 . . . . 72.22 110.588 -178.464 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 11.1 p -140.83 144.69 35.5 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 107.888 -1.153 . . . . 73.32 107.888 177.714 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -117.71 136.68 53.19 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.112 -0.635 . . . . 71.41 111.084 -178.116 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -132.29 129.85 40.1 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.013 -1.106 . . . . 72.44 108.013 177.65 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 32.6 t -99.73 135.03 41.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.443 0.64 . . . . 73.34 110.716 -177.0 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 556' ' ' SER . 8.7 p -135.21 150.99 29.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 107.747 -1.205 . . . . 75.02 107.747 178.092 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -82.79 135.67 34.9 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.398 0.618 . . . . 74.21 111.308 -178.012 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 72.4 m -164.23 160.2 16.36 Favored Pre-proline 0 C--N 1.308 -1.217 0 N-CA-C 106.32 -1.733 . . . . 75.54 106.32 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -64.29 -4.6 8.19 Favored 'Trans proline' 0 CA--C 1.553 1.471 0 C-N-CA 122.576 2.184 . . . . 62.45 114.084 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -70.69 130.08 89.18 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 107.755 -1.202 . . . . 73.13 107.755 173.636 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.8 148.13 76.83 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 122.417 2.078 . . . . 73.11 112.283 -176.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.25 111.52 1.1 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.303 -0.862 . . . . 75.4 111.614 -176.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 123.88 -16.76 7.75 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 115.397 -0.82 . . . . 71.03 112.143 178.556 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.69 129.42 34.96 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.216 -0.661 . . . . 71.43 109.216 179.505 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 503' ' ' GLN . 6.5 p -87.38 115.35 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 CA-C-O 121.459 0.647 . . . . 72.42 109.345 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -31.74 72.71 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.109 -0.951 . . . . 74.24 110.04 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 164.15 -174.61 40.27 Favored Glycine 0 N--CA 1.416 -2.656 0 CA-C-N 115.243 -0.89 . . . . 63.44 111.309 179.079 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 537' ' ' THR . . . . . 0.449 HG22 ' HG ' ' A' ' 553' ' ' LEU . 5.8 p -116.36 153.21 32.42 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 108.215 -1.032 . . . . 63.22 108.215 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -61.9 -47.57 91.08 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 119.47 -0.892 . . . . 72.42 111.431 179.536 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -67.82 120.32 7.32 Favored 'Trans proline' 0 C--N 1.367 1.551 0 N-CA-C 107.216 -1.878 . . . . 74.0 107.216 165.668 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.21 142.57 97.35 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.887 2.391 . . . . 75.42 113.687 -174.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 541' ' ' ALA . . . . . 0.404 ' HB1' ' HA ' ' A' ' 499' ' ' ASP . . . -61.57 129.89 43.31 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.855 -0.612 . . . . 71.42 110.253 178.072 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.69 -7.05 49.34 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 111.386 -0.686 . . . . 54.03 111.386 -178.091 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 24.0 m -89.33 137.11 32.61 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 122.729 -0.277 . . . . 70.31 110.507 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.8 t -88.7 125.35 34.81 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 107.028 -1.471 . . . . 64.25 107.028 171.627 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 36.0 m -122.87 159.77 52.15 Favored Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 109.416 -0.587 . . . . 73.14 109.416 -175.089 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -66.92 139.91 53.22 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.92 1.746 . . . . 72.11 111.031 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.5 p -61.2 -20.85 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 CA-C-O 121.591 0.71 . . . . 73.02 110.378 178.364 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -77.87 -19.04 55.51 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.222 -0.899 . . . . 71.12 112.105 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 78.5 p -83.21 174.0 11.15 Favored 'General case' 0 C--O 1.247 0.958 0 N-CA-C 112.635 0.605 . . . . 64.12 112.635 -176.223 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.6 p -113.52 137.92 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 109.133 -0.691 . . . . 72.12 109.133 -178.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 59.8 mt -103.95 115.39 45.8 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 N-CA-C 107.706 -1.22 . . . . 72.23 107.706 178.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -103.73 129.18 51.06 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.399 -0.92 . . . . 72.5 110.556 178.391 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.449 ' HG ' HG22 ' A' ' 537' ' ' THR . 7.4 mp -97.78 126.91 43.37 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 114.314 -1.312 . . . . 72.21 110.259 -177.809 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -88.15 111.94 22.16 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 107.058 -1.46 . . . . 61.41 107.058 173.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 524' ' ' SER . 22.2 t -97.52 132.68 41.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 107.207 -1.405 . . . . 65.42 107.207 -178.91 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 72.3 m -94.7 134.03 37.73 Favored 'General case' 0 N--CA 1.404 -2.772 0 C-N-CA 119.36 -0.936 . . . . 74.15 111.684 177.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.0 133.88 41.86 Favored 'General case' 0 N--CA 1.402 -2.859 0 N-CA-C 104.637 -2.357 . . . . 72.42 104.637 168.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -54.32 -23.27 25.63 Favored Glycine 0 N--CA 1.468 0.822 0 O-C-N 124.493 1.12 . . . . 73.34 114.842 -171.9 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 81.06 -23.85 0.21 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.988 1.715 . . . . 72.04 109.253 -177.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.463 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 77.6 mt-30 -110.75 161.44 15.77 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 115.208 -0.905 . . . . 75.3 109.922 -172.485 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 561' ' ' PHE . . . . . 0.422 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 47.5 p90 -137.56 155.44 49.22 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 107.793 -1.188 . . . . 71.41 107.793 177.796 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.14 118.65 14.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 O-C-N 123.751 0.657 . . . . 74.12 110.188 179.177 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 40.2 ttp -85.86 128.48 58.22 Favored Pre-proline 0 C--N 1.298 -1.633 0 CA-C-N 116.026 -0.533 . . . . 70.43 110.495 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.54 169.96 14.69 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.183 2.589 . . . . 71.45 111.514 175.689 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 565' ' ' ASP . . . . . 0.42 ' HA ' ' HB2' ' A' ' 610' ' ' ALA . 5.8 p-10 -66.09 124.11 21.71 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.742 0.782 . . . . 72.53 112.355 -179.777 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 8.9 tt -115.76 3.91 13.91 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.746 -1.576 . . . . 65.31 106.746 174.377 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 14.3 m -76.39 131.42 39.12 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.055 -1.429 . . . . 74.11 109.123 179.354 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 74.22 61.06 3.33 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.989 -0.624 . . . . 71.31 113.44 176.768 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 569' ' ' MET . . . . . 0.529 ' HB2' ' HB2' ' A' ' 573' ' ' ASP . 20.1 ptp -162.66 173.12 14.31 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.696 -0.853 . . . . 73.14 108.696 177.528 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -101.15 175.73 5.49 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.864 -0.791 . . . . 75.44 108.864 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -61.64 -34.89 76.48 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.169 -1.049 . . . . 74.41 108.169 177.34 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 31.6 m -69.29 -10.25 13.22 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 115.386 -0.825 . . . . 63.23 112.084 -179.171 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 569' ' ' MET . 16.0 m-20 -101.87 -44.22 5.58 Favored 'General case' 0 C--O 1.248 1.02 0 N-CA-C 108.946 -0.761 . . . . 62.04 108.946 174.622 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 574' ' ' ALA . . . . . 0.444 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -62.0 -53.22 58.64 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 114.173 -1.376 . . . . 62.13 112.107 -175.741 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.45 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 33.8 tt0 -56.93 -47.83 98.42 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 123.396 0.435 . . . . 73.13 111.993 -176.667 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.465 ' HA ' ' HG2' ' A' ' 579' ' ' ARG . 73.8 Cg_exo -52.72 -44.74 45.51 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.242 1.961 . . . . 73.33 113.411 172.733 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -64.64 -37.92 89.21 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.705 -0.479 . . . . 74.24 109.705 178.252 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.599 HD13 ' CZ3' ' A' ' 583' ' ' TRP . 78.5 mt -67.38 -48.29 67.83 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.564 -0.744 . . . . 65.14 111.679 -178.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.465 ' HG2' ' HA ' ' A' ' 576' ' ' PRO . 16.9 ptp180 -65.85 -34.18 77.56 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 120.953 0.406 . . . . 73.21 111.086 177.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -69.95 -30.81 68.28 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.208 -0.451 . . . . 73.13 110.409 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 578' ' ' LEU . 3.1 pp -81.34 -8.54 59.76 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 119.751 -0.779 . . . . 64.04 111.244 177.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 80.08 54.43 3.85 Favored Glycine 0 CA--C 1.504 -0.648 0 N-CA-C 110.824 -0.911 . . . . 65.44 110.824 -178.647 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.599 ' CZ3' HD13 ' A' ' 578' ' ' LEU . 14.0 t90 -80.45 127.89 32.94 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.758 0.313 . . . . 72.31 111.361 -178.651 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 32.0 p -106.59 -12.95 15.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.508 -0.314 . . . . 55.13 111.727 179.296 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -85.95 -175.18 49.95 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 121.055 -0.593 . . . . 51.23 112.809 -175.481 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 64.1 mtt -118.91 149.28 41.84 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.674 0.273 . . . . 73.51 110.27 -178.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 7.7 tt -87.91 130.17 35.0 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-O 121.212 0.53 . . . . 54.33 111.08 -175.494 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.558 ' O ' ' HA ' ' A' ' 621' ' ' THR . 18.9 t70 -117.59 121.76 41.8 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.041 -0.981 . . . . 72.44 109.172 175.841 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.3 OUTLIER -104.4 133.48 49.22 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.743 -1.206 . . . . 75.33 107.743 174.351 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -85.75 -26.39 35.26 Favored Glycine 0 C--N 1.294 -1.804 0 C-N-CA 120.784 -0.722 . . . . 65.24 112.548 -176.627 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.42 139.76 37.18 Favored 'General case' 0 N--CA 1.42 -1.973 0 C-N-CA 120.847 -0.341 . . . . 70.42 110.905 -178.345 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -116.11 124.45 50.4 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 105.046 -2.205 . . . . 61.31 105.046 171.282 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 593' ' ' VAL . . . . . 0.416 ' HB ' ' HA2' ' A' ' 625' ' ' GLY . 58.6 t -115.29 117.44 55.62 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 N-CA-C 108.659 -0.867 . . . . 70.32 108.659 -177.05 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -73.69 106.65 5.53 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.617 0.722 . . . . 71.14 109.838 -179.1 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -123.51 -58.37 1.61 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.976 -1.011 . . . . 75.35 108.899 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 131.8 148.23 6.1 Favored Glycine 0 N--CA 1.431 -1.648 0 N-CA-C 110.717 -0.953 . . . . 72.54 110.717 178.747 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.99 -33.95 88.62 Favored Glycine 0 C--N 1.314 -0.676 0 N-CA-C 112.468 -0.253 . . . . 73.31 112.468 -178.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 23.4 t -75.14 -23.51 57.85 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.199 1.0 . . . . 72.11 108.661 -179.461 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -87.81 -3.02 58.97 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.713 -1.13 . . . . 61.44 110.236 -178.178 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 47.4 m80 69.73 95.44 0.07 Allowed 'General case' 0 C--O 1.247 0.925 0 C-N-CA 124.987 1.315 . . . . 71.34 112.977 175.405 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -83.93 80.22 9.23 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 109.044 -0.724 . . . . 45.02 109.044 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -98.48 159.8 14.71 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.535 -0.757 . . . . 62.52 109.964 -179.018 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 59.6 t -70.84 130.2 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 107.331 -1.359 . . . . 74.42 107.331 176.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 31.5 m -108.84 -29.8 2.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 123.574 0.546 . . . . 64.05 111.516 -176.207 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -155.91 139.27 15.75 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 120.74 0.305 . . . . 74.03 110.252 -179.573 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -121.19 128.38 52.4 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.516 -0.766 . . . . 61.4 109.19 173.609 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -56.6 -51.1 83.81 Favored Pre-proline 0 N--CA 1.475 0.816 0 O-C-N 123.846 0.716 . . . . 71.14 110.799 178.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -77.07 111.81 3.29 Favored 'Trans proline' 0 C--N 1.371 1.756 0 N-CA-C 108.495 -1.387 . . . . 52.34 108.495 168.363 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.93 155.19 62.51 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.78 2.32 . . . . 44.52 113.491 -177.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 610' ' ' ALA . . . . . 0.42 ' HB2' ' HA ' ' A' ' 565' ' ' ASP . . . -67.58 130.76 44.02 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.378 -0.828 . . . . 61.55 109.876 177.335 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.18 -5.88 59.42 Favored Glycine 0 C--N 1.305 -1.159 0 N-CA-C 111.245 -0.742 . . . . 44.33 111.245 -177.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 28.8 m -101.66 156.11 17.69 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.889 -0.782 . . . . 54.32 108.889 -179.591 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 613' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -80.28 135.07 14.28 Favored Glycine 0 N--CA 1.422 -2.274 0 CA-C-N 116.363 -0.381 . . . . 63.4 112.431 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.3 m -120.74 142.98 34.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 107.777 -1.194 . . . . 75.35 107.777 175.754 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.463 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 29.4 p-10 -48.97 163.47 0.08 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.766 0.826 . . . . 71.52 112.144 -179.098 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -58.67 -27.7 65.03 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.43 0.53 . . . . 71.42 112.43 -175.737 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -81.15 -7.18 59.51 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 119.931 -0.708 . . . . 73.15 111.138 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.35 19.66 68.76 Favored Glycine 0 CA--C 1.492 -1.374 0 CA-C-O 119.831 -0.427 . . . . 62.23 113.445 169.179 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.88 119.27 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-O 121.834 0.826 . . . . 74.43 109.69 -168.761 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 39.4 pt -118.84 133.84 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 CA-C-N 114.857 -1.065 . . . . 74.34 112.258 -176.728 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 8.8 t -110.84 118.24 35.58 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 107.327 -1.36 . . . . 64.2 107.327 174.702 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -138.54 168.95 18.68 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.578 -0.737 . . . . 64.24 111.476 -173.938 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -125.95 135.76 52.23 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-O 122.53 1.157 . . . . 53.54 110.026 175.482 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -142.9 169.63 17.2 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 105.114 -2.18 . . . . 74.14 105.114 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 625' ' ' GLY . . . . . 0.416 ' HA2' ' HB ' ' A' ' 593' ' ' VAL . . . -52.33 -128.08 0.0 OUTLIER Glycine 0 CA--C 1.559 2.802 0 N-CA-C 115.878 1.111 . . . . 31.41 115.878 178.767 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 . . . . . 0 C--N 1.277 -2.554 0 O-C-N 120.805 -1.409 . . . . 52.42 110.561 -176.292 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.845 0 N-CA-C 110.248 -1.141 . . . . 44.24 110.248 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.41 143.07 51.31 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.062 1.841 . . . . 74.52 111.511 178.438 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -91.41 -5.76 53.9 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.461 0.648 . . . . 65.11 111.114 -178.177 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 44.9 p -136.02 147.01 47.76 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.244 -0.889 . . . . 64.21 108.987 178.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -135.77 145.84 46.98 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.151 0.5 . . . . 75.44 110.272 176.684 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.0 m-20 -79.87 126.83 31.5 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.077 -0.965 . . . . 74.45 108.992 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.5 pt -91.93 131.12 36.17 Favored Pre-proline 0 C--N 1.306 -1.313 0 C-N-CA 120.455 -0.498 . . . . 72.03 110.746 178.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -83.39 177.06 6.72 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.371 2.047 . . . . 61.32 111.626 177.904 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -88.44 122.71 32.23 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.289 0.566 . . . . 74.44 109.942 178.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.458 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 27.8 m -120.27 8.28 6.36 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-N 115.234 -0.893 . . . . 74.32 110.803 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -78.13 99.86 6.35 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 116.024 -0.535 . . . . 74.3 110.953 -177.598 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 157.55 -37.67 0.55 Allowed Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.667 -0.778 . . . . 61.03 111.945 178.637 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -89.46 -172.04 3.45 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 122.534 -0.392 . . . . 74.43 109.983 -178.912 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 3.6 m -71.2 155.53 40.63 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.618 -0.882 . . . . 71.02 108.618 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.49 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.7 p -62.65 -43.56 98.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 O-C-N 123.109 0.256 . . . . 62.14 111.584 -178.933 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.17 -37.89 88.78 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.061 -0.256 . . . . 74.43 110.526 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 66.0 t -67.59 -45.92 84.06 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.375 0 N-CA-C 109.272 -0.64 . . . . 75.13 109.272 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.458 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -59.17 -44.88 92.16 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.553 0.216 . . . . 74.32 111.43 179.465 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.2 mt-30 -63.84 -45.88 87.53 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.098 -0.501 . . . . 74.11 111.028 -178.859 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.549 ' O ' HG23 ' A' ' 514' ' ' VAL . 13.7 ptmm? -67.54 -37.97 83.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.335 -0.393 . . . . 73.24 111.086 179.325 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -61.18 -48.86 79.61 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 116.059 -0.519 . . . . 73.34 110.631 -179.566 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.4 pp -68.17 -35.47 78.09 Favored 'General case' 0 C--O 1.209 -1.046 0 CA-C-N 115.945 -0.57 . . . . 73.1 110.619 -178.633 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -59.95 -35.73 75.57 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 123.951 0.9 . . . . 62.2 110.751 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 510' ' ' LYS . 98.8 t -58.28 -35.03 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 122.763 0.425 . . . . 64.34 111.862 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -112.28 -1.38 15.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.567 0.699 . . . . 63.11 109.959 -177.612 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -113.37 -60.2 0.41 Allowed Glycine 0 N--CA 1.421 -2.35 0 CA-C-N 115.321 -0.854 . . . . 71.14 113.033 -171.105 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 63.0 27.09 15.79 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.519 1.152 . . . . 75.24 109.293 -174.865 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.3 p -85.43 -170.03 2.93 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 113.914 -1.494 . . . . 53.43 109.722 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -107.95 139.41 42.61 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.466 -1.309 . . . . 73.41 107.466 174.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -130.7 149.49 52.32 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.149 0.5 . . . . 72.04 111.224 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.7 p -140.8 157.67 45.07 Favored 'General case' 0 N--CA 1.405 -2.693 0 N-CA-C 107.142 -1.429 . . . . 71.43 107.142 178.366 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -125.57 141.17 52.17 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 120.711 -0.396 . . . . 71.43 110.094 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 523' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -131.63 143.16 50.11 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.249 -1.389 . . . . 51.41 107.249 178.173 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.9 m -105.47 139.64 39.79 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.071 -0.651 . . . . 54.23 111.839 -175.216 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.47 149.54 33.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 109.218 -0.66 . . . . 71.22 109.218 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.28 134.79 50.92 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.445 -0.576 . . . . 71.55 109.445 177.695 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 556' ' ' SER . 74.1 m -160.22 166.59 15.47 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 109.885 -0.413 . . . . 54.33 109.885 179.534 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -78.1 -6.91 16.08 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.976 1.784 . . . . 45.35 113.03 175.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.449 ' HG2' ' OE2' ' A' ' 533' ' ' GLU . 3.3 mpt_? -88.52 149.32 44.09 Favored Pre-proline 0 CA--C 1.516 -0.352 0 N-CA-C 109.769 -0.456 . . . . 72.2 109.769 -179.351 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.47 147.01 86.55 Favored 'Trans proline' 0 C--O 1.258 1.488 0 C-N-CA 122.668 2.245 . . . . 73.31 112.792 -178.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.91 106.9 0.63 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.054 -0.975 . . . . 74.21 110.759 -179.282 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 152.1 -31.58 0.88 Allowed Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 110.193 -1.163 . . . . 72.24 110.193 -178.692 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 533' ' ' GLU . . . . . 0.449 ' OE2' ' HG2' ' A' ' 529' ' ' ARG . 34.1 tt0 -76.98 139.1 40.0 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.154 0.502 . . . . 72.54 109.977 178.148 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.25 118.44 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.462 0 N-CA-C 108.132 -1.062 . . . . 70.21 108.132 174.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.4 p -79.51 -11.33 59.9 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.43 -0.804 . . . . 73.43 112.56 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.87 -168.17 29.36 Favored Glycine 0 CA--C 1.481 -2.087 0 C-N-CA 120.119 -1.039 . . . . 61.52 112.404 175.154 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 537' ' ' THR . . . . . 0.489 HG22 ' HG ' ' A' ' 553' ' ' LEU . 12.6 p -116.68 158.18 24.21 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 107.469 -1.308 . . . . 53.54 107.469 179.188 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -63.21 -49.44 80.07 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 118.505 -1.278 . . . . 72.24 111.995 176.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 18.9 Cg_exo -70.24 149.25 63.57 Favored 'Trans proline' 0 C--N 1.369 1.647 0 CA-C-N 120.486 1.209 . . . . 62.53 110.447 173.103 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 540' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 13.8 Cg_exo -70.5 144.85 51.24 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.706 2.271 . . . . 74.34 113.167 -178.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -68.41 129.73 40.79 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.428 -0.582 . . . . 73.41 109.428 176.801 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.35 -10.82 50.8 Favored Glycine 0 C--N 1.309 -0.938 0 N-CA-C 110.94 -0.864 . . . . 52.24 110.94 -176.758 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 92.3 m -88.09 137.11 32.62 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 109.985 -0.376 . . . . 54.42 109.985 178.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.1 t -86.36 132.28 34.0 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.688 -0.856 . . . . 71.22 108.688 175.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.89 155.98 74.7 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 108.289 -1.004 . . . . 74.11 108.289 -179.594 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.407 ' HG2' ' HB3' ' A' ' 549' ' ' SER . 10.1 Cg_endo -58.48 137.11 78.57 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.551 1.501 . . . . 60.14 111.289 178.267 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.63 -23.85 34.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 123.701 0.801 . . . . 73.21 113.016 -174.088 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -97.38 -0.11 46.91 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 120.317 -0.553 . . . . 74.42 111.857 -177.2 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 549' ' ' SER . . . . . 0.407 ' HB3' ' HG2' ' A' ' 546' ' ' PRO . 89.4 p -78.08 170.94 15.77 Favored 'General case' 0 C--O 1.256 1.429 0 C-N-CA 119.63 -0.828 . . . . 72.14 110.96 -178.614 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.8 p -110.24 115.75 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-O 121.934 0.874 . . . . 43.03 109.839 -178.256 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 52.1 mt -85.55 130.82 35.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 114.94 -1.027 . . . . 61.41 108.579 -177.579 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 552' ' ' GLU . . . . . 0.413 ' OE1' ' HD3' ' A' ' 539' ' ' PRO . 0.4 OUTLIER -103.55 120.73 41.44 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.727 0.775 . . . . 63.1 111.182 178.873 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.489 ' HG ' HG22 ' A' ' 537' ' ' THR . 7.1 mp -99.2 124.09 43.99 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 113.983 -1.462 . . . . 73.21 109.338 178.66 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 2.9 mp0 -88.28 117.73 27.39 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.436 -0.802 . . . . 62.35 111.04 -179.087 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 32.0 t -93.23 126.41 45.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.004 -0.998 . . . . 60.03 108.35 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 527' ' ' SER . 17.0 p -82.04 117.87 22.57 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 109.489 -0.56 . . . . 30.24 109.489 178.402 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -97.68 137.46 36.54 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 108.432 -0.951 . . . . 72.23 108.432 174.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -63.02 -22.3 64.64 Favored Glycine 0 CA--C 1.5 -0.894 0 O-C-N 124.174 0.921 . . . . 35.34 111.846 177.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 81.01 -5.92 1.65 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.684 1.593 . . . . 75.44 109.282 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 42.5 mt-30 -111.93 144.3 41.5 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 115.655 -0.702 . . . . 65.23 111.517 -172.117 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 561' ' ' PHE . . . . . 0.468 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 55.1 p90 -123.69 154.59 39.19 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.68 -1.146 . . . . 74.3 108.052 178.872 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.32 117.82 5.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.031 0.443 . . . . 75.04 110.492 177.637 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.446 ' HB2' HG22 ' A' ' 614' ' ' VAL . 50.8 ttp -81.56 130.91 59.75 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.953 -0.567 . . . . 50.22 111.889 -176.077 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -65.58 169.46 12.76 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.988 2.458 . . . . 75.13 111.068 172.6 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -87.14 143.13 27.44 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.215 0.531 . . . . 64.15 111.582 -177.435 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 566' ' ' LEU . . . . . 0.414 ' H ' HD23 ' A' ' 566' ' ' LEU . 2.1 pt? -133.03 25.21 4.26 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.155 -1.794 . . . . 73.31 106.155 176.131 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 4.4 m -75.61 148.69 38.59 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 113.13 -1.85 . . . . 71.53 111.909 -174.242 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 70.09 59.04 5.69 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.254 -0.885 . . . . 64.54 114.066 173.472 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 569' ' ' MET . . . . . 0.464 ' HB2' ' HB2' ' A' ' 573' ' ' ASP . 23.0 ptp -159.55 175.07 13.69 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-N 117.335 0.568 . . . . 74.23 111.079 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -97.79 176.13 5.92 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.102 -1.073 . . . . 75.13 108.102 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 571' ' ' TRP . . . . . 0.493 ' CZ3' HD22 ' A' ' 587' ' ' LEU . 23.1 t-105 -64.19 -33.91 76.87 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.723 -0.843 . . . . 74.44 108.723 173.867 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.72 -14.65 18.57 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 CA-C-N 115.762 -0.653 . . . . 74.13 111.765 -178.498 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 569' ' ' MET . 14.5 m-20 -93.66 -41.14 9.87 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.172 -1.047 . . . . 62.04 108.172 174.804 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -52.67 -47.63 67.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.961 -1.018 . . . . 53.51 113.067 -177.312 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.502 ' O ' ' HG ' ' A' ' 578' ' ' LEU 0.255 32.0 mt-10 -60.18 -56.16 38.22 Favored Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 114.059 1.133 . . . . 72.32 114.059 179.416 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -58.72 -31.1 94.25 Favored 'Trans proline' 0 C--N 1.365 1.4 0 C-N-CA 121.392 1.395 . . . . 70.14 112.874 174.808 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.453 ' HG3' ' SD ' ' A' ' 569' ' ' MET . 2.8 mmp_? -66.2 -45.37 81.01 Favored 'General case' 0 C--O 1.209 -1.07 0 C-N-CA 121.314 -0.154 . . . . 71.34 110.626 176.116 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.3 pp -66.12 -39.75 90.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.263 0.468 . . . . 73.01 112.263 -174.192 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.414 ' N ' HD12 ' A' ' 578' ' ' LEU . 15.2 ptm180 -66.33 -39.6 89.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.388 -0.369 . . . . 71.33 111.072 176.648 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.24 -34.56 73.0 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 121.055 0.455 . . . . 71.41 110.876 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 28.6 tp -81.22 -9.15 59.83 Favored 'General case' 0 N--CA 1.42 -1.929 0 C-N-CA 123.939 0.895 . . . . 71.23 110.808 -179.261 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 65.62 36.53 92.54 Favored Glycine 0 C--N 1.315 -0.601 0 CA-C-N 116.199 -0.455 . . . . 75.35 112.079 178.661 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -78.38 127.13 31.76 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 107.825 -1.176 . . . . 72.11 107.825 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 10.2 m -94.37 -20.03 20.11 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.979 0.418 . . . . 70.53 111.671 -176.36 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 585' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -83.4 175.59 52.51 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 121.094 -0.574 . . . . 71.53 113.397 -178.029 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 10.4 mmt -101.31 155.27 18.14 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.396 -0.594 . . . . 72.23 109.396 -179.516 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 587' ' ' LEU . . . . . 0.493 HD22 ' CZ3' ' A' ' 571' ' ' TRP . 6.1 tt -89.88 118.2 29.27 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.904 -0.589 . . . . 71.43 109.761 -176.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 621' ' ' THR . 26.4 t70 -95.91 117.47 30.67 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 109.017 -0.735 . . . . 73.4 109.017 178.043 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.416 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -112.31 135.47 52.95 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.693 -0.685 . . . . 71.23 110.572 -178.716 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -70.21 -87.65 0.11 Allowed Glycine 0 C--N 1.296 -1.67 0 CA-C-N 115.313 -0.858 . . . . 74.3 111.076 -179.679 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.29 154.16 47.88 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 122.728 -0.278 . . . . 73.5 110.371 177.653 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.9 128.24 35.97 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 107.76 -1.2 . . . . 72.32 107.76 176.146 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 81.7 t -104.01 135.91 39.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 109.688 -0.486 . . . . 72.15 109.688 -179.216 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.95 107.32 11.62 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 122.062 0.934 . . . . 60.05 111.327 -177.507 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -119.35 -44.97 2.55 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.757 -1.111 . . . . 72.34 109.317 177.299 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 103.84 143.35 12.51 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.076 -1.059 . . . . 73.24 111.718 179.585 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.37 -37.4 87.54 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 114.228 0.451 . . . . 51.25 114.228 -177.233 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 23.0 t -77.35 -23.62 50.84 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.43 0.633 . . . . 71.4 109.573 -176.264 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -91.08 -5.01 55.8 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.412 -0.813 . . . . 72.02 109.84 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 32.9 m170 66.31 97.13 0.05 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.406 1.082 . . . . 74.32 112.474 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 601' ' ' ASN . . . . . 0.57 ' HB3' ' C ' ' A' ' 625' ' ' GLY . 62.2 m-80 -70.93 85.3 0.69 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.902 -1.045 . . . . 72.34 111.973 -177.782 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -110.33 172.52 6.82 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.9 -0.591 . . . . 72.42 111.253 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 13.0 p -57.53 134.98 21.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 CA-C-N 116.064 -0.516 . . . . 73.31 110.37 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 29.6 m -108.6 -34.72 2.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 116.235 -0.439 . . . . 55.51 111.137 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -156.22 142.11 18.01 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.449 -0.341 . . . . 75.32 110.203 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 606' ' ' GLN . . . . . 0.409 ' HB2' HD11 ' A' ' 620' ' ' ILE . 20.4 pt20 -129.03 134.67 48.22 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.162 -1.792 . . . . 54.11 106.162 173.708 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 609' ' ' PRO . 4.4 t-20 -67.21 -49.48 44.36 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 119.623 -0.831 . . . . 53.23 111.786 -176.202 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.7 Cg_endo -90.62 105.05 0.3 Allowed 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 121.567 1.511 . . . . 72.11 109.522 170.331 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 609' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 607' ' ' ASN . 19.0 Cg_exo -68.67 160.75 48.19 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 122.682 2.255 . . . . 73.34 111.448 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -57.67 130.03 44.57 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.257 -0.429 . . . . 75.11 110.35 178.839 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.3 -9.83 46.19 Favored Glycine 0 C--N 1.31 -0.869 0 C-N-CA 120.542 -0.837 . . . . 65.54 111.882 -176.652 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 34.4 m -87.3 151.28 23.26 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.824 -0.806 . . . . 73.44 108.824 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 613' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -75.96 131.9 12.35 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 120.702 -0.761 . . . . 73.22 111.855 177.432 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 563' ' ' MET . 29.4 m -125.63 143.4 39.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.134 -1.061 . . . . 61.11 108.134 176.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -54.25 176.29 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.729 0.812 . . . . 35.55 113.152 -177.333 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -55.58 -27.61 50.28 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.883 0.873 . . . . 72.1 112.761 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.459 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 1.0 OUTLIER -85.79 -6.55 59.09 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 120.897 -0.321 . . . . 72.22 111.083 178.119 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.77 20.52 72.36 Favored Glycine 0 CA--C 1.496 -1.116 0 C-N-CA 121.511 -0.376 . . . . 73.14 112.507 173.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.52 119.75 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 CA-C-O 122.595 1.188 . . . . 74.22 111.194 -168.685 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' A' ' 606' ' ' GLN . 0.0 OUTLIER -126.64 132.38 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 CA-C-N 113.926 -1.488 . . . . 72.44 108.651 -177.801 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 10.1 t -106.37 124.25 49.3 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-N 115.48 -0.782 . . . . 64.01 109.551 -178.347 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.404 HD21 HD21 ' A' ' 587' ' ' LEU . 2.1 pt? -138.69 166.25 24.86 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.754 -0.657 . . . . 73.21 111.501 -176.722 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -128.89 137.52 51.49 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.127 -1.064 . . . . 73.33 108.127 175.873 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -139.74 165.44 27.27 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 116.367 -0.379 . . . . 74.25 111.032 -171.115 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 625' ' ' GLY . . . . . 0.57 ' C ' ' HB3' ' A' ' 601' ' ' ASN . . . -66.52 139.54 37.47 Favored Glycine 0 N--CA 1.427 -1.937 0 O-C-N 124.088 0.867 . . . . 53.13 111.524 175.867 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 . . . . . 0 C--N 1.306 -1.32 0 C-N-CA 126.306 1.843 . . . . 74.42 114.676 -177.138 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.398 0 N-CA-C 110.235 -1.146 . . . . 43.05 110.235 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -75.93 142.78 25.51 Favored 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 121.644 1.563 . . . . 62.04 111.746 178.658 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -95.49 20.2 9.86 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.897 0.856 . . . . 55.24 109.852 -179.271 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 25.4 p -129.71 158.41 39.45 Favored 'General case' 0 N--CA 1.409 -2.525 0 N-CA-C 107.257 -1.386 . . . . 75.14 107.257 -179.345 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -149.03 142.47 25.27 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 108.211 -1.033 . . . . 73.04 108.211 179.368 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.04 134.65 35.37 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.278 0.561 . . . . 70.14 110.638 179.195 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 39.5 pt -85.03 137.96 37.29 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 114.972 -1.013 . . . . 70.12 111.953 -177.677 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.99 166.14 29.84 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.741 2.294 . . . . 61.14 113.776 178.426 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -88.21 44.76 1.22 Allowed 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 125.158 1.383 . . . . 44.04 111.223 -177.427 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 17.2 m -72.05 14.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 114.516 1.302 . . . . 55.24 114.516 -175.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.419 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -79.66 101.63 8.48 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.351 -0.611 . . . . 52.44 109.351 178.2 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 150.79 -31.09 1.01 Allowed Glycine 0 C--N 1.297 -1.602 0 N-CA-C 110.951 -0.86 . . . . 32.21 110.951 -179.6 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.424 ' O ' HG12 ' A' ' 534' ' ' VAL . 18.1 mp0 -81.61 -177.26 6.46 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 109.103 -0.703 . . . . 74.3 109.103 177.537 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 2.4 m -71.5 155.94 40.01 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 107.451 -1.314 . . . . 70.14 107.451 176.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.424 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.5 p -63.27 -42.0 94.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 117.737 0.244 . . . . 71.24 110.999 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 506' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 23.4 t70 -59.77 -43.77 94.19 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.258 0.551 . . . . 74.34 110.045 178.482 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 95.8 t -67.74 -44.81 85.52 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.126 0 CA-C-N 114.868 -1.06 . . . . 65.2 109.871 -178.687 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.35 -45.19 94.33 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 123.104 0.253 . . . . 54.13 111.458 179.092 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 96.4 mt-30 -62.27 -46.79 87.22 Favored 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 123.404 0.44 . . . . 62.22 110.996 -179.25 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.502 ' O ' HG23 ' A' ' 514' ' ' VAL 0.321 20.4 pttp -68.79 -37.55 79.35 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 112.375 0.509 . . . . 62.14 112.375 178.359 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -61.03 -49.5 77.17 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 120.771 0.319 . . . . 71.11 110.501 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.416 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.2 pp -65.85 -35.75 81.55 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-N 116.071 -0.513 . . . . 74.04 110.962 -178.825 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.416 ' N ' HD12 ' A' ' 512' ' ' LEU . 34.3 t30 -62.9 -36.17 82.49 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 123.085 0.554 . . . . 71.44 110.669 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 510' ' ' LYS . 93.9 t -63.08 -34.27 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 121.261 0.553 . . . . 63.25 110.829 177.516 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -106.58 12.2 29.7 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.221 0.534 . . . . 70.32 110.371 -176.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -141.45 -54.05 0.04 OUTLIER Glycine 0 CA--C 1.488 -1.596 0 C-N-CA 119.935 -1.126 . . . . 22.11 114.023 -172.67 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 66.66 20.49 10.73 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.811 0.815 . . . . 74.51 110.032 -173.921 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.2 p -76.12 -178.48 4.47 Favored 'General case' 0 N--CA 1.415 -2.219 0 C-N-CA 125.449 1.499 . . . . 75.43 109.371 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 34.5 mtmm -107.62 142.98 36.71 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 108.168 -1.049 . . . . 73.33 108.168 175.935 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -126.54 147.46 49.86 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.301 0.572 . . . . 71.32 111.977 -176.481 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 13.6 p -133.75 146.65 50.95 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 114.537 -1.211 . . . . 74.32 107.763 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -121.67 136.5 54.94 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 120.96 0.409 . . . . 74.44 111.245 -177.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -122.54 122.09 38.06 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.838 -0.801 . . . . 73.35 108.838 178.018 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.1 m -87.48 134.79 33.55 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.834 0.35 . . . . 71.0 110.891 -177.362 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 556' ' ' SER . 47.6 t -136.55 150.14 27.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 106.086 -1.82 . . . . 72.15 106.086 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -99.21 135.82 40.06 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.655 -0.869 . . . . 71.1 108.655 175.722 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 66.7 m -162.58 171.4 6.52 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 107.289 -1.374 . . . . 52.25 107.289 -176.742 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.92 -15.05 44.98 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 121.935 1.757 . . . . 74.24 113.104 177.651 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.43 135.65 94.79 Favored Pre-proline 0 C--O 1.224 -0.268 0 N-CA-C 108.472 -0.936 . . . . 75.53 108.472 176.207 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.8 149.84 86.44 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.575 2.183 . . . . 74.24 113.392 -175.732 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 557' ' ' LYS . . . -59.77 106.89 0.53 Allowed 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 115.146 -0.934 . . . . 44.2 111.679 -178.657 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 124.09 -14.4 7.9 Favored Glycine 0 N--CA 1.424 -2.161 0 CA-C-N 115.129 -0.941 . . . . 63.14 111.578 179.151 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -82.45 130.75 35.17 Favored 'General case' 0 C--O 1.258 1.541 0 N-CA-C 108.873 -0.788 . . . . 53.32 108.873 179.485 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 503' ' ' GLN . 7.0 p -81.67 117.87 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.833 0 N-CA-C 107.509 -1.293 . . . . 65.34 107.509 176.905 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.3 m -72.79 -27.13 61.81 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 113.533 -1.667 . . . . 74.24 109.311 -175.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 153.15 -166.46 31.56 Favored Glycine 0 N--CA 1.412 -2.929 0 N-CA-C 110.086 -1.206 . . . . 42.12 110.086 177.097 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.0 p -116.2 157.85 24.22 Favored 'General case' 0 C--N 1.267 -3.002 0 N-CA-C 106.88 -1.526 . . . . 75.33 106.88 178.772 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -62.68 -51.11 74.58 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 118.469 -1.292 . . . . 73.32 111.439 177.229 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -73.07 147.13 42.47 Favored 'Trans proline' 0 C--N 1.369 1.606 0 CA-C-N 120.191 1.104 . . . . 73.04 110.173 173.332 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.55 145.1 75.36 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.497 2.131 . . . . 72.45 111.679 -179.207 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.11 142.0 57.83 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 110.128 -0.323 . . . . 73.43 110.128 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.19 -21.86 43.83 Favored Glycine 0 C--N 1.313 -0.701 0 N-CA-C 111.635 -0.586 . . . . 51.43 111.635 -177.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 47.1 m -71.53 137.3 47.99 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 122.872 0.469 . . . . 74.3 111.354 -177.821 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 12.4 t -84.44 126.29 33.12 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 109.254 -0.647 . . . . 73.15 109.254 176.439 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.63 157.96 73.51 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 106.973 -1.491 . . . . 73.32 106.973 177.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 10.0 Cg_endo -59.43 135.31 64.15 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 CA-C-N 120.639 1.264 . . . . 72.32 111.81 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.84 -19.89 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-N 114.95 -1.023 . . . . 74.34 112.835 -174.561 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -92.4 -17.55 24.46 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.796 -0.638 . . . . 74.31 112.038 -178.021 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 99.0 p -78.4 179.41 7.01 Favored 'General case' 0 C--O 1.253 1.288 0 N-CA-C 112.506 0.558 . . . . 70.23 112.506 -174.067 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 14.3 p -109.85 128.42 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.809 0 CA-C-O 121.513 0.673 . . . . 75.34 110.41 -178.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 47.8 mt -98.0 138.86 21.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.286 -1.005 . . . . 71.32 108.286 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.6 120.29 40.6 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.717 0.77 . . . . 63.31 112.224 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.7 mp -102.18 122.13 43.57 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 113.853 -1.521 . . . . 71.41 108.644 178.727 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -85.87 122.68 30.27 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 115.433 -0.803 . . . . 65.25 108.996 179.14 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.13 125.33 68.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.514 -0.921 . . . . 62.11 108.514 -176.203 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 525' ' ' VAL . 67.9 m -97.29 147.63 23.95 Favored 'General case' 0 C--N 1.285 -2.237 0 C-N-CA 119.515 -0.874 . . . . 54.54 111.973 179.026 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.4 ptpt -111.57 141.39 45.21 Favored 'General case' 0 N--CA 1.404 -2.74 0 N-CA-C 105.323 -2.103 . . . . 74.42 105.323 169.243 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -54.71 -22.09 24.45 Favored Glycine 0 C--O 1.242 0.633 0 O-C-N 124.441 1.088 . . . . 62.05 114.52 -174.488 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 88.14 -22.35 0.14 Allowed 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 126.576 1.95 . . . . 43.33 107.594 -176.72 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.56 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 77.6 mt-30 -112.99 146.92 38.21 Favored 'General case' 0 N--CA 1.405 -2.676 0 CA-C-N 114.468 -1.242 . . . . 72.01 111.298 -175.677 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -124.65 153.32 42.45 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 107.282 -1.377 . . . . 75.54 107.282 176.577 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.99 121.61 22.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 109.556 -0.535 . . . . 75.12 109.556 -179.78 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 54.3 ttp -79.53 130.1 69.33 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 116.292 -0.413 . . . . 73.4 110.318 -177.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.69 168.97 9.23 Favored 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.782 2.321 . . . . 73.42 110.881 174.279 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.2 129.9 34.79 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.739 0.78 . . . . 71.42 110.42 -179.457 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 566' ' ' LEU . . . . . 0.495 ' O ' ' HG2' ' A' ' 569' ' ' MET . 3.1 pp -126.74 10.33 7.12 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.148 -1.387 . . . . 72.52 108.677 176.086 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 567' ' ' SER . . . . . 0.438 ' HB3' ' OE1' ' A' ' 606' ' ' GLN . 1.6 p -79.06 131.71 36.36 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 114.548 -1.206 . . . . 65.02 110.959 -179.332 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 568' ' ' GLY . . . . . 0.468 ' H ' HG12 ' A' ' 603' ' ' VAL . . . 87.85 37.03 8.1 Favored Glycine 0 N--CA 1.428 -1.888 0 C-N-CA 120.809 -0.71 . . . . 74.54 113.178 179.431 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 569' ' ' MET . . . . . 0.495 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 22.4 ptp -142.73 174.72 10.39 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 117.654 0.727 . . . . 72.01 109.422 177.424 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -99.45 177.8 5.07 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.037 -0.727 . . . . 73.43 109.037 -177.341 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -72.59 -26.01 61.54 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.671 -0.863 . . . . 75.53 108.671 -178.72 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.2 p -71.57 -14.84 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-N 115.3 -0.863 . . . . 72.04 109.75 178.151 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 10.9 m-20 -94.33 -39.14 10.64 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.103 -0.703 . . . . 30.14 109.103 175.547 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -55.83 -46.48 78.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.653 -0.703 . . . . 61.54 112.429 -178.512 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.538 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 11.9 mm-40 -54.0 -58.08 15.06 Favored Pre-proline 0 CA--C 1.573 1.864 0 N-CA-C 112.757 0.651 . . . . 63.41 112.757 -179.552 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -61.54 -36.0 78.87 Favored 'Trans proline' 0 C--N 1.369 1.648 0 CA-C-N 120.727 1.295 . . . . 75.22 113.066 175.863 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.524 ' NE ' ' HA ' ' A' ' 577' ' ' ARG . 9.0 mmp_? -63.4 -39.63 95.03 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.762 -0.375 . . . . 73.13 111.058 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.3 pp -65.92 -47.31 75.16 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 112.664 0.616 . . . . 74.35 112.664 -176.799 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.514 ' N ' HD12 ' A' ' 578' ' ' LEU . 5.8 ptp180 -66.44 -35.14 79.54 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 111.711 0.263 . . . . 75.44 111.711 177.636 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -71.12 -38.92 72.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.313 0.486 . . . . 71.0 112.313 -178.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 583' ' ' TRP . 1.3 pp -82.38 -8.98 59.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.463 0.649 . . . . 53.51 110.219 -178.124 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 82.91 35.96 17.07 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.607 -0.724 . . . . 32.13 112.261 177.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.454 ' HB2' HD11 ' A' ' 581' ' ' LEU . 18.9 t90 -87.35 127.49 35.2 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 108.506 -0.924 . . . . 72.54 108.506 177.462 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 24.4 p -106.1 -10.33 16.56 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.39 0.885 . . . . 73.24 113.39 -176.821 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 585' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -84.36 -170.37 46.75 Favored Glycine 0 C--N 1.323 -0.182 0 C-N-CA 120.754 -0.736 . . . . 60.44 113.909 -177.34 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 69.6 mtm -102.8 145.42 29.79 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 123.003 0.521 . . . . 70.14 111.679 -175.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 28.2 tp -94.76 125.67 39.57 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.555 -0.906 . . . . 75.41 108.555 177.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 621' ' ' THR . 23.5 t70 -113.63 121.18 43.39 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.85 -0.613 . . . . 74.13 109.804 -177.723 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.78 133.82 45.92 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.86 -1.136 . . . . 62.41 110.134 175.655 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -79.25 -65.59 1.78 Allowed Glycine 0 N--CA 1.428 -1.883 0 C-N-CA 120.65 -0.786 . . . . 64.54 111.68 179.33 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.24 140.99 35.91 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 120.762 0.315 . . . . 70.42 110.742 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 592' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 624' ' ' PHE . 9.5 p-10 -110.49 124.76 52.4 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 105.339 -2.097 . . . . 54.1 105.339 170.201 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 73.8 t -104.59 137.6 32.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 120.909 -0.316 . . . . 63.14 110.75 -173.348 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.73 108.04 4.85 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 109.153 -0.684 . . . . 65.25 109.153 -174.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -127.07 -36.13 2.19 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 120.791 0.329 . . . . 45.13 110.895 -179.642 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 104.83 146.75 15.46 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 119.823 -1.179 . . . . 64.14 112.324 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.34 -32.2 60.33 Favored Glycine 0 C--N 1.314 -0.659 0 C-N-CA 123.909 0.766 . . . . 71.55 114.147 -178.1 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.3 t -59.46 -23.27 62.58 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.276 1.43 . . . . 74.24 110.99 -176.212 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -86.42 -9.63 55.91 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.472 -0.785 . . . . 74.12 111.713 -173.841 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 55.14 70.87 0.58 Allowed 'General case' 0 C--O 1.245 0.839 0 CA-C-O 122.371 1.081 . . . . 73.35 109.104 -174.881 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -77.97 89.83 4.15 Favored 'General case' 0 CA--C 1.481 -1.687 0 CA-C-N 113.699 -1.591 . . . . 75.54 113.675 -171.159 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -84.86 172.1 11.68 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 113.844 -1.526 . . . . 70.45 107.413 176.634 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.468 HG12 ' H ' ' A' ' 568' ' ' GLY . 7.1 p -61.09 131.66 26.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 107.436 -1.32 . . . . 74.2 107.436 171.6 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 30.4 m -107.76 -27.12 3.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 112.53 0.566 . . . . 75.45 112.53 -174.004 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -147.48 141.37 25.83 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 109.194 -0.669 . . . . 72.13 109.194 -178.283 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 606' ' ' GLN . . . . . 0.438 ' OE1' ' HB3' ' A' ' 567' ' ' SER . 18.0 pt20 -140.42 146.19 38.0 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.547 -0.908 . . . . 65.43 108.547 177.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.563 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 22.0 t-20 -61.38 -61.52 7.73 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 112.648 0.61 . . . . 75.33 112.648 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.4 Cg_endo -91.87 120.55 0.56 Allowed 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 122.027 1.818 . . . . 64.31 109.458 175.189 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.33 160.6 46.92 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 122.348 2.032 . . . . 71.4 112.278 178.284 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -59.99 127.38 31.6 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.03 -0.532 . . . . 74.25 109.87 178.13 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 101.05 -1.34 54.93 Favored Glycine 0 C--N 1.309 -0.93 0 C-N-CA 120.039 -1.076 . . . . 55.44 112.084 -178.012 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 54.6 m -95.39 146.76 24.15 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.903 -0.406 . . . . 72.42 109.903 178.516 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -74.47 123.8 7.85 Favored Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 115.912 -0.586 . . . . 63.03 112.175 177.624 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 19.1 m -107.08 142.53 19.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.949 -0.76 . . . . 71.31 108.949 176.808 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.56 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.7 p-10 -51.85 174.82 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.756 1.222 . . . . 62.21 113.353 -177.758 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -54.04 -32.25 53.92 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.7 0.63 . . . . 73.3 112.7 -179.238 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.459 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 37.4 t70 -85.75 -7.52 58.72 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 120.991 0.424 . . . . 64.24 109.994 -177.58 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.12 19.73 70.37 Favored Glycine 0 CA--C 1.499 -0.965 0 CA-C-N 116.077 -0.51 . . . . 72.53 112.558 174.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.05 120.94 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-O 122.68 1.229 . . . . 71.25 111.511 -166.26 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.527 HG12 ' HD2' ' A' ' 608' ' ' PRO . 0.0 OUTLIER -128.83 132.17 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 0 CA-C-N 113.605 -1.634 . . . . 63.34 108.725 -179.015 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 6.6 t -113.03 137.42 51.45 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.334 -0.987 . . . . 50.05 108.334 178.493 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.4 pp -138.6 165.72 26.19 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 113.66 0.985 . . . . 74.14 113.66 -173.559 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -128.9 137.41 51.41 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.555 -1.276 . . . . 74.53 107.555 176.534 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 592' ' ' ASP . 50.2 p90 -141.3 165.64 26.95 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 120.797 0.332 . . . . 73.44 110.812 -175.743 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -88.05 146.78 19.93 Favored Glycine 0 N--CA 1.423 -2.215 0 C-N-CA 120.329 -0.939 . . . . 65.35 111.363 177.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 C--N 1.281 -2.373 0 N-CA-C 107.214 -1.402 . . . . 74.1 107.214 177.976 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.027 0 N-CA-C 110.475 -1.05 . . . . 72.05 110.475 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.31 147.58 29.39 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.902 1.735 . . . . 51.01 112.187 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -98.17 22.11 9.95 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.125 0.964 . . . . 55.21 108.854 178.499 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 546' ' ' PRO . 13.8 p -135.74 140.53 44.44 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-N 114.556 -1.202 . . . . 72.1 107.825 179.661 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -130.12 142.49 50.59 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 120.946 0.403 . . . . 74.23 111.331 -179.395 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.5 p-10 -78.96 124.2 28.02 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.949 -1.023 . . . . 71.11 109.184 176.229 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.7 pt -77.97 133.38 65.55 Favored Pre-proline 0 C--N 1.302 -1.49 0 CA-C-N 115.78 -0.645 . . . . 54.54 111.532 -177.062 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.89 -174.85 2.4 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.349 2.033 . . . . 53.21 111.26 174.634 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -98.67 122.96 42.56 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.098 0.475 . . . . 73.2 110.034 179.137 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.633 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 17.0 m -124.86 49.73 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-O 122.245 1.022 . . . . 71.44 110.206 178.041 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -107.31 108.54 19.98 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.076 -0.965 . . . . 24.14 109.368 176.076 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 136.69 -17.13 3.72 Favored Glycine 0 C--N 1.304 -1.218 0 C-N-CA 120.323 -0.942 . . . . 63.14 111.971 177.27 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -91.79 179.12 5.71 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.412 -0.959 . . . . 52.13 108.412 178.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 21.1 m -75.05 155.55 37.11 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 105.455 -2.054 . . . . 71.24 105.455 171.774 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.499 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 9.2 p -62.23 -43.79 98.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 118.794 0.725 . . . . 63.32 111.642 -176.624 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 506' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 20.5 t70 -63.56 -40.3 96.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.74 0.305 . . . . 54.34 110.477 179.565 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 58.5 t -70.23 -39.81 77.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.33 0 CA-C-N 116.146 -0.479 . . . . 65.02 109.991 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.633 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -60.9 -44.76 96.68 Favored 'General case' 0 C--O 1.209 -1.069 0 N-CA-C 109.671 -0.492 . . . . 41.33 109.671 176.569 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 97.0 mt-30 -64.81 -42.69 94.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.157 -0.474 . . . . 61.22 110.715 -179.216 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.522 ' O ' HG23 ' A' ' 514' ' ' VAL . 75.3 mmtt -66.46 -42.67 87.2 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.252 -0.431 . . . . 75.14 110.49 177.792 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -67.62 -38.05 83.36 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.621 0.724 . . . . 70.45 111.08 -177.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.43 -46.49 86.09 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.565 -1.198 . . . . 72.32 108.343 177.409 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -61.09 -33.83 73.97 Favored 'General case' 0 N--CA 1.423 -1.823 0 C-N-CA 124.088 0.955 . . . . 61.02 112.937 -178.129 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 510' ' ' LYS . 65.9 t -56.58 -34.26 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.199 0.523 . . . . 73.11 110.54 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -110.96 -2.21 16.08 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.584 0.707 . . . . 72.4 110.147 -178.359 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -110.33 -63.54 0.52 Allowed Glycine 0 N--CA 1.414 -2.802 0 CA-C-N 115.439 -0.8 . . . . 74.0 112.366 -173.354 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 64.82 21.95 12.44 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 122.426 1.108 . . . . 74.25 109.503 -172.082 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.3 p -89.19 -169.89 2.68 Favored 'General case' 0 N--CA 1.408 -2.54 0 CA-C-N 113.367 -1.742 . . . . 73.04 110.417 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -111.79 141.13 45.8 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 109.173 -0.677 . . . . 70.52 109.173 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -132.48 151.11 52.02 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.657 0.741 . . . . 73.02 112.25 -175.121 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 55.1 p -138.82 157.18 46.54 Favored 'General case' 0 N--CA 1.403 -2.803 0 N-CA-C 106.62 -1.622 . . . . 44.21 106.62 178.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -131.44 147.11 52.52 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 109.524 -0.547 . . . . 73.45 109.524 -178.701 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -142.45 143.29 32.53 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.27 -1.381 . . . . 62.04 107.27 175.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 18.3 m -103.15 136.1 43.58 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-O 121.442 0.639 . . . . 70.02 112.07 -174.889 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 10.8 p -124.11 154.02 30.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 106.285 -1.746 . . . . 73.31 106.285 175.722 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.522 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 6.0 p-10 -91.52 135.88 33.53 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 120.078 -0.649 . . . . 51.05 111.146 -178.228 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.537 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 57.4 m -163.64 165.13 14.35 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 107.163 -1.421 . . . . 42.52 107.163 -178.929 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -66.72 -7.95 19.78 Favored 'Trans proline' 0 CA--C 1.549 1.24 0 C-N-CA 122.177 1.918 . . . . 73.04 113.962 179.606 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.442 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 0.0 OUTLIER -74.12 127.51 87.85 Favored Pre-proline 0 C--O 1.238 0.482 0 N-CA-C 107.898 -1.149 . . . . 72.12 107.898 176.555 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.9 145.66 83.39 Favored 'Trans proline' 0 C--O 1.25 1.12 0 C-N-CA 122.888 2.392 . . . . 74.24 112.911 -177.18 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -54.56 117.96 3.78 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.739 -1.119 . . . . 64.51 111.806 -177.186 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 127.62 -24.74 5.17 Favored Glycine 0 N--CA 1.428 -1.839 0 CA-C-N 115.227 -0.897 . . . . 73.24 111.458 178.713 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -83.11 138.5 33.65 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.91 -0.404 . . . . 71.22 109.91 178.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.452 HG11 ' CB ' ' A' ' 508' ' ' ALA . 4.3 p -101.25 116.78 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 CA-C-O 121.902 0.858 . . . . 62.34 109.361 -177.403 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.1 p -81.04 -8.68 59.82 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.575 -1.193 . . . . 65.23 112.809 -178.724 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.65 -164.96 29.14 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.471 -0.871 . . . . 61.01 112.487 175.398 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 21.8 p -116.77 158.5 23.79 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.423 -1.325 . . . . 65.45 107.423 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -63.54 -56.82 23.16 Favored Pre-proline 0 C--O 1.241 0.626 0 C-N-CA 118.184 -1.406 . . . . 72.3 112.172 176.59 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.14 137.34 40.36 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 120.822 1.014 . . . . 65.33 109.628 173.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.38 148.03 93.05 Favored 'Trans proline' 0 C--O 1.25 1.106 0 C-N-CA 122.464 2.109 . . . . 62.54 112.422 -178.415 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.35 143.07 50.61 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.009 -0.541 . . . . 63.23 110.31 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.66 -18.73 54.65 Favored Glycine 0 C--N 1.303 -1.283 0 N-CA-C 111.549 -0.62 . . . . 40.11 111.549 -177.348 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 53.3 m -73.26 136.85 44.64 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.533 0.206 . . . . 70.51 110.772 -179.372 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 13.5 t -88.59 134.53 33.85 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.502 -0.555 . . . . 62.1 109.502 177.849 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.49 155.92 80.69 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 107.847 -1.168 . . . . 75.54 107.847 177.526 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.456 ' HA ' HG22 ' A' ' 494' ' ' THR . 23.1 Cg_exo -59.09 141.68 98.45 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.598 1.532 . . . . 51.45 111.17 177.12 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 8.3 p -60.16 -19.79 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 CA-C-N 115.627 -0.715 . . . . 72.25 111.619 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -98.92 -5.15 31.27 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 121.539 0.685 . . . . 75.44 111.107 178.826 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 34.2 t -72.82 151.61 41.94 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 121.185 0.516 . . . . 73.13 110.273 -178.748 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.9 p -98.24 121.2 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.983 0 CA-C-N 115.358 -0.837 . . . . 73.12 109.015 179.273 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 54.9 mt -92.79 139.51 17.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.76 -0.83 . . . . 71.42 108.76 -177.58 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -103.71 123.42 46.99 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.756 0.789 . . . . 62.13 111.82 178.722 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.3 mp -103.57 126.95 51.03 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.409 -1.268 . . . . 71.35 108.832 177.159 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -90.13 116.01 27.81 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.566 0.698 . . . . 72.0 110.804 -178.82 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 524' ' ' SER . 25.6 t -90.72 129.21 41.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 107.704 -1.221 . . . . 73.02 107.704 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 43.4 t -87.48 125.09 34.1 Favored 'General case' 0 N--CA 1.403 -2.798 0 N-CA-C 108.6 -0.889 . . . . 65.42 108.6 177.114 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 3.2 ptpp? -105.46 139.31 40.28 Favored 'General case' 0 N--CA 1.406 -2.667 0 N-CA-C 106.706 -1.59 . . . . 63.03 106.706 169.288 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -58.18 -21.9 48.21 Favored Glycine 0 C--N 1.312 -0.769 0 O-C-N 124.295 0.997 . . . . 71.45 112.126 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 559' ' ' ASN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 24.5 t-20 90.43 -2.74 0.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 126.771 2.028 . . . . 71.31 107.796 -179.468 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.426 ' HG2' ' N ' ' A' ' 615' ' ' ASN . 98.0 mt-30 -112.82 147.73 36.32 Favored 'General case' 0 N--CA 1.405 -2.724 0 CA-C-N 114.135 -1.393 . . . . 72.31 112.64 -169.33 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -123.31 158.34 31.21 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 114.19 -1.368 . . . . 73.25 107.496 177.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.84 120.31 13.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 121.114 0.483 . . . . 52.23 111.368 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 22.2 ttt -70.52 123.62 89.38 Favored Pre-proline 0 N--CA 1.434 -1.243 0 C-N-CA 123.86 0.864 . . . . 72.43 111.335 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -67.25 169.32 15.57 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.316 2.677 . . . . 53.34 112.16 176.248 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -87.43 124.31 33.29 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.088 0.471 . . . . 64.31 111.753 -177.944 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 566' ' ' LEU . . . . . 0.534 ' O ' HD23 ' A' ' 566' ' ' LEU . 9.5 tt -133.66 18.93 3.89 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 122.533 1.158 . . . . 72.35 108.35 -177.704 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 77.2 p -77.46 143.76 38.29 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 121.496 -0.752 . . . . 54.33 112.36 -174.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 65.24 42.76 96.12 Favored Glycine 0 N--CA 1.453 -0.182 0 CA-C-N 115.693 -0.685 . . . . 72.32 114.642 174.661 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 22.7 ptp -137.57 177.5 7.82 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.042 -0.725 . . . . 44.1 109.042 177.193 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -94.42 178.24 5.68 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.616 -0.513 . . . . 70.32 109.616 -178.044 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 571' ' ' TRP . . . . . 0.438 ' CZ3' HD22 ' A' ' 587' ' ' LEU . 18.9 t-105 -68.97 -30.22 68.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.786 -1.191 . . . . 74.22 107.786 175.919 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.0 p -74.94 -9.21 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-N 115.203 -0.908 . . . . 35.44 110.388 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.635 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 15.3 m-20 -99.25 -37.49 9.25 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 108.519 -0.919 . . . . 72.3 108.519 173.782 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -59.46 -43.95 93.08 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.108 -0.951 . . . . 54.14 111.926 179.587 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.616 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 33.3 mt-10 -57.66 -52.43 74.38 Favored Pre-proline 0 CA--C 1.556 1.187 0 N-CA-C 113.941 1.089 . . . . 74.24 113.941 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.3 -33.76 98.0 Favored 'Trans proline' 0 C--N 1.364 1.349 0 CA-C-N 120.438 1.192 . . . . 61.32 112.993 173.793 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.635 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 9.3 mmp_? -64.29 -45.55 87.48 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 109.57 -0.53 . . . . 71.41 109.57 178.101 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.3 pp -66.11 -44.04 85.45 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.833 -0.621 . . . . 60.24 112.162 -172.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -66.67 -37.83 85.56 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.161 -0.472 . . . . 64.12 110.928 178.353 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -71.28 -37.12 71.9 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 112.008 0.373 . . . . 73.44 112.008 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.0 pp -83.76 -9.35 58.88 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 120.532 -0.467 . . . . 73.44 110.794 -179.022 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 75.95 44.96 17.62 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 121.232 -0.509 . . . . 72.43 112.467 179.033 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -75.96 127.46 33.03 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.968 -0.753 . . . . 63.54 108.968 178.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 1.3 p -86.72 -32.68 20.32 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 124.303 1.041 . . . . 75.13 113.006 -178.068 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -82.91 -169.35 44.37 Favored Glycine 0 C--N 1.311 -0.836 0 N-CA-C 113.951 0.341 . . . . 73.42 113.951 -178.075 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 85.3 mtp -115.55 150.38 36.68 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 110.216 -0.29 . . . . 61.34 110.216 -178.408 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 587' ' ' LEU . . . . . 0.438 HD22 ' CZ3' ' A' ' 571' ' ' TRP . 2.3 tt -80.43 130.23 35.03 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.228 -1.027 . . . . 72.4 108.228 -179.563 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 621' ' ' THR . 21.3 t70 -126.77 122.63 35.34 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.611 -0.722 . . . . 72.35 110.933 -178.974 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.0 OUTLIER -101.94 128.48 48.33 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 118.302 -1.359 . . . . 70.11 109.109 173.311 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -76.96 -38.3 30.94 Favored Glycine 0 N--CA 1.428 -1.885 0 C-N-CA 120.763 -0.732 . . . . 70.42 112.444 -176.29 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -136.74 147.66 46.83 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 121.012 0.434 . . . . 72.41 110.714 -177.73 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -99.18 125.79 44.83 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.002 -1.481 . . . . 70.3 107.002 176.04 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 59.5 t -104.19 131.23 53.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 107.911 -1.144 . . . . 72.32 107.911 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -74.34 117.78 16.55 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.824 0.821 . . . . 73.03 110.285 179.376 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -141.82 -62.84 0.45 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.487 -1.233 . . . . 73.14 109.356 -179.222 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 95.22 160.72 33.72 Favored Glycine 0 N--CA 1.407 -3.279 0 N-CA-C 110.655 -0.978 . . . . 62.02 110.655 -178.537 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.6 -33.04 61.97 Favored Glycine 0 C--N 1.292 -1.864 0 CA-C-N 115.031 -0.584 . . . . 43.51 113.735 -178.629 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 35.3 t -70.25 -29.19 65.93 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 109.647 -0.501 . . . . 52.41 109.647 -178.076 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -95.69 -2.28 48.31 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.493 -0.322 . . . . 73.52 110.991 -178.599 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 73.24 116.45 0.05 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.966 1.307 . . . . 75.14 111.268 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -78.4 61.69 2.87 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.736 0.779 . . . . 70.42 110.781 -179.025 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -87.07 160.09 18.7 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.712 -0.676 . . . . 75.02 109.402 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.484 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 99.5 t -63.6 130.23 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 106.904 -1.517 . . . . 64.35 106.904 170.677 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.7 t -96.31 -47.45 12.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.384 0.611 . . . . 63.21 109.504 -175.173 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -150.58 144.43 25.27 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 106.925 -1.509 . . . . 73.04 106.925 -178.283 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -128.64 143.99 51.06 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.325 -0.991 . . . . 65.42 108.325 178.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.47 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 3.3 t-20 -60.18 -54.62 53.43 Favored Pre-proline 0 CA--C 1.553 1.067 0 N-CA-C 112.504 0.557 . . . . 74.25 112.504 -179.412 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 9.3 Cg_endo -94.24 123.44 0.41 Allowed 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 121.929 1.753 . . . . 72.35 111.954 178.899 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -67.67 153.46 76.01 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 122.168 1.912 . . . . 62.03 110.747 175.05 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.4 139.46 58.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.744 0.307 . . . . 60.12 110.275 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.14 -11.69 62.03 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 120.317 -0.944 . . . . 52.14 111.993 -178.368 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 90.6 m -76.58 146.34 38.38 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.763 -0.829 . . . . 62.02 108.763 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -73.81 122.69 7.75 Favored Glycine 0 N--CA 1.42 -2.415 0 C-N-CA 119.654 -1.26 . . . . 71.2 110.531 175.899 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.7 m -114.08 141.57 29.79 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 108.676 -0.861 . . . . 54.4 108.676 176.407 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.426 ' N ' ' HG2' ' A' ' 560' ' ' GLN . 33.4 p-10 -52.0 168.42 0.09 Allowed 'General case' 0 C--O 1.209 -1.072 0 C-N-CA 124.457 1.103 . . . . 72.31 112.696 -176.423 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -58.15 -24.77 60.1 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.819 0.674 . . . . 72.12 112.819 -176.486 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -88.56 -8.55 54.56 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 109.402 -0.592 . . . . 61.5 109.402 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.12 16.08 63.92 Favored Glycine 0 CA--C 1.502 -0.757 0 CA-C-N 116.016 -0.538 . . . . 64.23 113.95 171.211 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.17 119.31 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 122.208 1.004 . . . . 73.5 110.927 -167.165 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.425 ' O ' HD12 ' A' ' 620' ' ' ILE . 2.8 pp -129.0 134.05 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 114.477 -1.238 . . . . 73.31 110.673 -177.351 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 11.9 t -110.03 133.02 53.64 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.7 -0.852 . . . . 75.45 108.7 179.294 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 3.2 pp -138.78 168.75 19.12 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.69 -0.686 . . . . 75.22 110.788 -175.384 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -126.92 135.82 51.44 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.343 -0.984 . . . . 63.33 108.343 174.253 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.484 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 2.1 p90 -142.41 168.23 20.23 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.083 -0.508 . . . . 74.51 109.805 -172.941 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -56.25 109.52 1.56 Allowed Glycine 0 CA--C 1.529 0.926 0 O-C-N 123.954 0.784 . . . . 63.44 111.855 175.768 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 . . . . . 0 C--O 1.263 1.783 0 C-N-CA 125.734 1.614 . . . . 74.35 112.745 -179.392 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.345 0 N-CA-C 110.979 -0.848 . . . . 53.44 110.979 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.21 146.37 95.96 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.009 2.473 . . . . 72.23 112.343 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -92.36 -11.78 34.07 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 122.016 0.912 . . . . 64.23 110.708 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 9.2 p -143.09 145.59 33.01 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 114.743 -1.117 . . . . 72.02 108.13 -178.606 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -140.54 140.81 35.28 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.265 -0.643 . . . . 44.52 109.265 -179.57 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.578 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.1 p-10 -78.83 140.48 38.17 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.395 0.617 . . . . 72.41 110.656 178.289 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 39.0 pt -96.36 137.07 21.62 Favored Pre-proline 0 C--N 1.294 -1.812 0 CA-C-N 114.91 -1.041 . . . . 75.23 109.776 179.185 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.22 176.89 9.24 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.979 1.786 . . . . 54.45 111.924 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.57 110.27 19.69 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.856 -1.165 . . . . 64.12 107.856 177.785 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 29.3 m -117.84 12.3 7.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-O 120.982 0.42 . . . . 73.42 111.812 -178.847 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -84.72 102.25 12.85 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.486 -0.485 . . . . 61.34 109.954 -178.24 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 156.38 -26.07 0.54 Allowed Glycine 0 C--N 1.301 -1.385 0 C-N-CA 120.653 -0.784 . . . . 42.35 112.136 179.826 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.47 ' O ' HG12 ' A' ' 534' ' ' VAL . 11.4 pm0 -102.44 -173.86 2.43 Favored 'General case' 0 N--CA 1.427 -1.605 0 O-C-N 122.527 -0.396 . . . . 63.53 110.276 177.49 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.1 m -69.84 155.46 40.52 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.474 -0.935 . . . . 62.32 108.474 -179.236 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.507 HG21 HG22 ' A' ' 555' ' ' VAL . 7.3 p -61.64 -42.68 95.13 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 O-C-N 123.018 0.199 . . . . 64.45 111.428 -178.276 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.71 -39.82 94.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.286 0.565 . . . . 71.35 110.21 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 66.9 t -70.36 -39.69 76.85 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.452 0 CA-C-N 115.431 -0.804 . . . . 71.32 109.8 178.759 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.22 -44.28 92.38 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 122.276 0.23 . . . . 62.11 110.996 177.783 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 97.3 mt-30 -63.1 -41.6 99.41 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.896 -0.409 . . . . 74.41 109.896 178.035 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 514' ' ' VAL . 72.3 mmtt -66.31 -38.79 88.54 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.939 -0.573 . . . . 74.21 111.897 175.772 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.14 -48.45 80.04 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 122.026 0.917 . . . . 74.45 108.8 176.91 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.426 HD11 HD12 ' A' ' 551' ' ' ILE . 2.2 tm? -59.55 -42.3 92.06 Favored 'General case' 0 C--O 1.21 -1.011 0 CA-C-N 113.909 -1.496 . . . . 72.21 109.623 -179.255 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -60.47 -35.21 75.35 Favored 'General case' 0 N--CA 1.427 -1.608 0 C-N-CA 124.169 0.988 . . . . 65.23 111.16 -179.732 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 510' ' ' LYS . 98.1 t -64.34 -35.85 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.444 0.64 . . . . 71.32 110.832 178.342 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -101.46 5.0 41.79 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.184 -0.462 . . . . 52.42 109.931 -177.079 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -132.94 -58.29 0.08 OUTLIER Glycine 0 N--CA 1.426 -2.033 0 C-N-CA 119.89 -1.148 . . . . 63.31 114.232 -171.863 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 59.66 29.56 19.13 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 122.465 1.126 . . . . 73.12 108.97 -172.631 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.1 p -96.87 -165.39 1.26 Allowed 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 114.061 -1.427 . . . . 65.32 110.559 -177.754 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -107.83 138.6 43.79 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.827 -1.175 . . . . 73.22 107.827 178.489 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -128.93 148.5 50.93 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.297 0.57 . . . . 72.32 111.192 -179.243 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.5 m -140.25 152.41 45.91 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.016 -1.105 . . . . 75.43 108.016 176.366 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -120.38 142.13 49.45 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.02 0.438 . . . . 62.02 111.041 -176.227 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -131.94 135.94 46.98 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.465 -1.68 . . . . 54.13 106.465 176.462 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 75.0 p -104.83 139.45 39.57 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.259 1.028 . . . . 74.15 113.234 -173.815 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.5 p -123.95 152.99 29.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 105.858 -1.904 . . . . 53.32 105.858 176.388 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.585 ' HA ' ' HG3' ' A' ' 557' ' ' LYS . 1.1 p-10 -84.74 136.94 33.5 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.407 -0.96 . . . . 65.21 108.407 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 23.3 m -149.45 169.87 8.53 Favored Pre-proline 0 C--N 1.285 -2.203 0 N-CA-C 107.586 -1.264 . . . . 43.22 107.586 -175.507 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -69.93 -16.3 36.8 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 121.992 1.795 . . . . 34.3 112.385 176.804 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.412 ' N ' ' HD2' ' A' ' 529' ' ' ARG . 3.2 mpt_? -81.57 135.0 50.05 Favored Pre-proline 0 CA--C 1.512 -0.492 0 CA-C-N 116.499 -0.319 . . . . 74.31 110.432 179.757 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.66 156.98 20.55 Favored 'Trans proline' 0 C--O 1.257 1.446 0 C-N-CA 123.141 2.561 . . . . 72.52 112.557 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.24 104.6 0.33 Allowed 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.348 -0.842 . . . . 71.33 111.251 -176.872 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 151.93 -26.33 0.92 Allowed Glycine 0 N--CA 1.419 -2.494 0 C-N-CA 120.142 -1.028 . . . . 74.1 112.707 179.711 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -82.67 144.49 30.23 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 119.378 -0.929 . . . . 75.41 109.33 -179.595 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 503' ' ' GLN . 7.4 p -92.34 117.63 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 CA-C-O 121.822 0.82 . . . . 72.43 108.845 177.568 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.99 -30.74 70.93 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.444 -1.253 . . . . 74.35 109.932 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 156.02 -167.62 33.32 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 111.085 -0.806 . . . . 43.11 111.085 178.61 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 537' ' ' THR . . . . . 0.462 HG22 HD13 ' A' ' 553' ' ' LEU . 11.4 p -116.59 147.55 41.76 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.694 -0.854 . . . . 72.23 108.694 178.846 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -57.94 -50.32 88.75 Favored Pre-proline 0 N--CA 1.476 0.839 0 O-C-N 123.577 0.548 . . . . 74.14 111.458 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -76.29 131.0 12.43 Favored 'Trans proline' 0 N--CA 1.438 -1.76 0 N-CA-C 107.978 -1.585 . . . . 75.13 107.978 168.747 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -56.55 140.94 90.76 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 122.492 2.128 . . . . 71.12 111.736 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.01 137.83 58.0 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 120.702 0.287 . . . . 43.42 110.635 -178.746 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.69 -12.66 58.0 Favored Glycine 0 C--N 1.309 -0.949 0 N-CA-C 111.782 -0.527 . . . . 61.41 111.782 -176.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 26.4 m -84.35 137.31 33.49 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 122.85 -0.206 . . . . 62.32 110.567 -178.772 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 9.7 t -82.33 127.69 33.48 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.592 -0.892 . . . . 74.22 108.592 175.198 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.8 m -123.07 156.75 62.32 Favored Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 107.75 -1.204 . . . . 63.34 107.75 -179.053 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -65.44 137.66 51.8 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 120.834 1.023 . . . . 74.0 111.39 -179.205 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.8 p -64.98 -19.64 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.481 -0.781 . . . . 71.52 110.599 179.902 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -89.33 -12.32 40.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.183 0.516 . . . . 63.1 111.456 -179.041 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 50.4 m -87.21 163.78 16.71 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.617 0.722 . . . . 74.52 111.14 178.901 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.3 p -98.02 137.66 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.849 0 CA-C-N 115.122 -0.945 . . . . 55.14 109.462 178.139 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 551' ' ' ILE . . . . . 0.426 HD12 HD11 ' A' ' 512' ' ' LEU . 78.4 mt -94.41 135.56 28.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.985 -0.552 . . . . 62.52 110.306 -178.571 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -103.3 119.99 39.92 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-N 115.852 -0.613 . . . . 65.52 110.817 -173.914 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.462 HD13 HG22 ' A' ' 537' ' ' THR . 3.5 mm? -102.66 122.96 45.48 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 124.06 0.944 . . . . 75.01 109.235 177.978 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -85.13 122.28 29.11 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.895 -0.78 . . . . 71.34 108.895 174.163 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.507 HG22 HG21 ' A' ' 505' ' ' VAL . 26.5 t -98.69 134.18 38.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 108.573 -0.899 . . . . 43.0 108.573 179.482 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.638 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 23.6 m -85.06 117.77 24.23 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.92 -0.77 . . . . 54.14 108.92 176.492 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.585 ' HG3' ' HA ' ' A' ' 526' ' ' ASP . 2.6 ptpp? -96.66 133.33 41.32 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 106.612 -1.625 . . . . 72.32 106.612 166.956 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -60.13 -23.98 60.31 Favored Glycine 0 CA--C 1.492 -1.397 0 O-C-N 124.344 1.028 . . . . 72.01 113.167 -175.481 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 559' ' ' ASN . . . . . 0.497 ' OD1' ' HG3' ' A' ' 616' ' ' ARG . 45.1 t-20 79.77 -15.71 0.73 Allowed 'General case' 0 C--O 1.211 -0.951 0 C-N-CA 125.231 1.412 . . . . 75.5 108.587 179.403 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 86.3 mt-30 -112.52 141.72 45.93 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 115.563 -0.744 . . . . 71.11 112.233 -173.411 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -123.8 158.24 32.23 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.104 -1.407 . . . . 74.12 107.936 177.827 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.1 p -64.42 125.36 21.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.228 0.537 . . . . 72.54 110.078 177.895 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.529 ' SD ' HG21 ' A' ' 620' ' ' ILE . 52.1 ttp -83.88 133.52 45.91 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 109.874 -0.417 . . . . 72.45 109.874 -178.502 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.11 169.62 14.75 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.634 2.223 . . . . 63.3 110.768 174.732 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -82.48 134.11 35.21 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.276 0.56 . . . . 74.32 111.022 -178.74 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.5 pp -137.66 14.19 2.94 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.77 -1.105 . . . . 71.12 110.234 178.197 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 22.9 t -81.01 152.76 27.78 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.691 -1.14 . . . . 52.4 110.213 -178.826 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 64.21 26.14 70.24 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 114.942 0.737 . . . . 70.03 114.942 174.349 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 569' ' ' MET . . . . . 0.452 ' SD ' ' HG3' ' A' ' 577' ' ' ARG . 20.4 ptp -127.08 171.99 10.9 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 122.305 -0.527 . . . . 71.31 109.945 179.41 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -95.98 165.44 12.26 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.054 -1.461 . . . . 64.04 107.054 -177.07 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -61.76 -30.04 70.53 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.373 -0.603 . . . . 63.43 109.373 178.924 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.82 -15.91 18.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.971 -0.559 . . . . 73.22 111.671 -178.447 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.431 ' C ' ' HD2' ' A' ' 576' ' ' PRO . 38.3 t70 -101.62 -28.5 12.47 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 122.245 1.022 . . . . 74.03 108.247 176.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 574' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 577' ' ' ARG . . . -67.91 -37.46 81.73 Favored 'General case' 0 C--O 1.212 -0.908 0 CA-C-N 114.565 -1.198 . . . . 73.2 111.275 177.307 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.526 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 23.5 tt0 -56.18 -51.13 83.2 Favored Pre-proline 0 CA--C 1.568 1.658 0 CA-C-O 119.373 -0.346 . . . . 75.33 110.973 178.269 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 85.1 Cg_exo -53.36 -37.36 81.34 Favored 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 122.095 1.863 . . . . 75.32 112.203 171.698 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.541 ' O ' ' HB3' ' A' ' 581' ' ' LEU . 1.5 mmp_? -58.62 -42.6 88.62 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.742 -0.208 . . . . 74.24 110.494 176.701 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.538 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 10.8 mp -63.47 -49.27 74.29 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 120.727 0.299 . . . . 71.42 110.993 -178.226 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -67.21 -39.69 86.32 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 113.303 0.853 . . . . 62.41 113.303 -179.229 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.06 -36.47 75.0 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.113 0.482 . . . . 33.4 111.453 -178.83 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.541 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 2.0 tp -81.47 -10.17 59.55 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.108 -0.496 . . . . 74.43 110.109 -179.59 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 61.88 40.25 98.59 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.728 -0.949 . . . . 52.12 110.728 -178.045 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.538 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 10.7 t90 -71.81 127.43 32.54 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 121.578 0.704 . . . . 75.43 109.675 -178.259 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 9.9 p -79.05 -50.05 11.68 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 114.534 -1.212 . . . . 71.42 111.807 -177.094 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -71.48 -169.47 10.43 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 116.004 1.162 . . . . 65.44 116.004 -176.091 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 61.7 mtm -113.76 155.94 24.73 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.105 -1.048 . . . . 72.31 108.501 -179.404 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 6.3 tt -85.14 119.82 25.96 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.039 -1.097 . . . . 70.34 108.039 179.255 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.647 ' O ' ' HA ' ' A' ' 621' ' ' THR . 23.4 t70 -95.75 104.87 16.82 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.66 0.743 . . . . 63.13 109.818 -179.666 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.505 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.1 OUTLIER -90.03 129.12 36.39 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.988 -0.745 . . . . 70.42 108.988 178.155 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -83.4 -48.95 5.13 Favored Glycine 0 C--N 1.28 -2.565 0 N-CA-C 109.936 -1.265 . . . . 53.24 109.936 -178.17 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.15 142.41 38.01 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 109.114 -0.699 . . . . 60.53 109.114 179.782 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -115.57 125.19 52.66 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.024 -1.472 . . . . 71.13 107.024 175.444 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.89 131.47 55.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 108.816 -0.809 . . . . 74.42 108.816 -176.77 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.96 108.09 5.68 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.164 -1.05 . . . . 64.33 108.164 178.687 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -115.23 -55.81 2.43 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 116.088 -0.506 . . . . 71.02 110.688 -174.577 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 89.4 148.12 17.81 Favored Glycine 0 N--CA 1.422 -2.278 0 C-N-CA 120.31 -0.947 . . . . 73.43 111.358 -175.098 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.25 -32.44 60.28 Favored Glycine 0 C--N 1.304 -1.216 0 C-N-CA 123.483 0.563 . . . . 65.03 113.487 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 14.4 m -66.19 -24.44 66.63 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 124.076 0.951 . . . . 72.22 110.545 -176.869 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -104.29 -0.73 27.93 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.106 -0.952 . . . . 53.33 109.533 -176.634 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 60.8 m80 69.04 93.69 0.08 Allowed 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 122.135 0.969 . . . . 74.24 110.692 -174.457 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -82.2 73.28 9.24 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.553 -1.203 . . . . 75.23 110.339 -179.099 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -106.33 162.74 13.41 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.701 -1.136 . . . . 71.1 110.659 -176.428 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 78.8 t -67.25 130.09 32.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 N-CA-C 106.295 -1.743 . . . . 73.34 106.295 169.759 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.91 -34.12 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 113.091 0.775 . . . . 73.51 113.091 -174.28 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 605' ' ' TYR . . . . . 0.496 ' HB3' ' CG ' ' A' ' 623' ' ' ARG . 46.8 t80 -141.77 135.85 30.12 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.752 -0.833 . . . . 73.54 108.752 -177.301 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -133.31 144.52 49.72 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.288 -1.375 . . . . 73.33 107.288 178.738 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.565 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 46.3 t30 -58.91 -54.72 53.66 Favored Pre-proline 0 CA--C 1.553 1.077 0 O-C-N 123.466 0.479 . . . . 73.11 111.899 -179.235 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 94.9 Cg_endo -105.31 117.16 0.04 OUTLIER 'Trans proline' 0 CA--C 1.571 2.349 0 C-N-CA 121.502 1.468 . . . . 73.31 111.508 173.649 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.0 160.57 40.85 Favored 'Trans proline' 0 N--CA 1.482 0.821 0 C-N-CA 122.92 2.413 . . . . 74.23 112.66 -178.489 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -53.0 132.51 37.79 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.8 0.44 . . . . 72.24 110.928 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.07 -6.03 42.75 Favored Glycine 0 C--O 1.24 0.503 0 C-N-CA 120.695 -0.764 . . . . 50.33 111.201 -176.597 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 612' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 608' ' ' PRO . 12.6 t -72.55 166.33 22.89 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 123.619 0.767 . . . . 74.41 109.69 178.832 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -104.09 118.38 5.96 Favored Glycine 0 N--CA 1.427 -1.937 0 N-CA-C 109.247 -1.541 . . . . 73.11 109.247 175.322 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 35.9 m -116.33 142.08 31.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.992 -0.373 . . . . 72.33 109.992 -179.643 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -57.53 169.81 0.62 Allowed 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 124.238 1.015 . . . . 65.42 112.805 -177.775 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 616' ' ' ARG . . . . . 0.497 ' HG3' ' OD1' ' A' ' 559' ' ' ASN 0.331 0.0 OUTLIER -59.29 -23.75 62.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 114.638 1.347 . . . . 75.1 114.638 178.832 . . . . . . . . 4 4 . 1 . 026 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -84.98 -8.55 58.69 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.015 -0.735 . . . . 74.43 109.015 175.867 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.24 12.55 58.38 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 123.682 0.658 . . . . 73.52 114.451 170.184 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.37 119.41 16.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 122.002 0.906 . . . . 71.14 112.076 -165.751 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.529 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.8 pp -126.82 134.84 65.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-N 114.507 -1.224 . . . . 54.35 112.592 -178.469 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.647 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 87.7 m -98.88 122.92 42.75 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.849 -0.614 . . . . 70.11 109.473 178.384 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 3.3 pp -139.1 167.01 23.02 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.092 0.404 . . . . 61.41 112.092 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 623' ' ' ARG . . . . . 0.496 ' CG ' ' HB3' ' A' ' 605' ' ' TYR . 18.4 ptp180 -127.79 137.8 52.52 Favored 'General case' 0 C--O 1.257 1.49 0 N-CA-C 107.69 -1.226 . . . . 75.13 107.69 175.453 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -141.07 165.37 27.74 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.389 -0.524 . . . . 62.14 111.77 -172.393 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -82.62 131.17 10.18 Favored Glycine 0 N--CA 1.417 -2.629 0 CA-C-N 114.97 -1.014 . . . . 74.21 110.907 175.772 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 . . . . . 0 C--N 1.276 -2.614 0 C-N-CA 125.35 1.46 . . . . 74.32 109.097 -179.734 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.499 0 N-CA-C 110.526 -1.03 . . . . 43.05 110.526 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.23 142.23 37.3 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.25 1.966 . . . . 73.51 109.652 178.775 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -90.73 -5.47 55.68 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.34 0.59 . . . . 73.04 111.807 -176.461 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.458 ' HB ' HG22 ' A' ' 544' ' ' THR . 20.3 p -139.72 141.63 36.9 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.838 -0.619 . . . . 73.33 110.165 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 495' ' ' LYS . . . . . 0.61 ' HG2' ' O ' ' A' ' 515' ' ' TYR . 0.6 OUTLIER -138.11 139.64 39.56 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 122.572 0.349 . . . . 74.21 110.659 177.543 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.645 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.4 p-10 -85.98 140.68 30.1 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.943 -0.572 . . . . 61.45 109.795 173.283 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.5 pt -98.06 136.88 20.87 Favored Pre-proline 0 C--N 1.294 -1.829 0 CA-C-N 115.347 -0.842 . . . . 64.5 111.354 -178.205 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -81.94 -178.49 4.16 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.924 1.749 . . . . 73.32 110.756 175.197 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -83.48 118.62 23.88 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.737 -0.838 . . . . 73.34 108.737 177.246 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.475 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 27.1 m -110.47 12.23 8.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 122.101 0.953 . . . . 72.32 110.145 -178.817 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -80.63 100.67 8.77 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.545 -1.207 . . . . 21.21 109.998 178.347 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 149.88 -30.27 1.12 Allowed Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.892 -0.671 . . . . 53.21 111.906 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -91.65 177.47 6.2 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-O 121.232 0.539 . . . . 72.33 110.211 179.192 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 27.9 m -74.22 156.18 37.53 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.454 -1.314 . . . . 70.42 107.454 177.13 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.453 ' HA ' HG23 ' A' ' 534' ' ' VAL . 11.4 p -56.43 -45.19 81.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 112.87 0.693 . . . . 64.2 112.87 -179.523 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -62.18 -39.69 93.52 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 120.535 -0.466 . . . . 72.03 110.171 177.902 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 78.6 t -68.87 -44.39 81.78 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.866 0 CA-C-N 115.437 -0.801 . . . . 70.54 110.04 -178.577 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.475 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -63.58 -45.3 91.03 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 123.216 0.607 . . . . 55.31 110.522 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 97.4 mt-30 -65.06 -45.64 84.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 123.31 0.382 . . . . 72.24 110.841 -179.226 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.469 ' O ' HG23 ' A' ' 514' ' ' VAL . 20.9 ptmt -67.12 -38.48 85.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.043 0.449 . . . . 63.45 110.363 179.022 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -60.86 -49.59 76.85 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 124.169 0.988 . . . . 75.45 110.081 -178.531 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -69.17 -35.4 76.26 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 115.704 -0.68 . . . . 72.44 110.524 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.44 ' N ' HD12 ' A' ' 512' ' ' LEU . 45.3 t30 -59.89 -39.49 85.49 Favored 'General case' 0 C--O 1.204 -1.33 0 C-N-CA 123.982 0.913 . . . . 64.43 110.587 -178.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 510' ' ' LYS . 82.0 t -57.56 -32.43 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-O 121.326 0.584 . . . . 74.12 111.793 179.272 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 515' ' ' TYR . . . . . 0.61 ' O ' ' HG2' ' A' ' 495' ' ' LYS . 60.6 m-85 -98.24 -26.26 14.59 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.439 0.638 . . . . 74.3 110.293 179.314 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -101.36 -58.09 0.82 Allowed Glycine 0 CA--C 1.478 -2.23 0 CA-C-N 115.464 -0.789 . . . . 74.22 113.554 -167.663 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 64.86 29.59 12.46 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.135 0.969 . . . . 64.44 109.898 -174.917 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.7 p -88.96 -166.52 1.62 Allowed 'General case' 0 N--CA 1.422 -1.849 0 C-N-CA 125.702 1.601 . . . . 52.31 111.026 -179.516 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 13.6 mptt -107.56 143.55 35.82 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.199 -1.408 . . . . 73.44 107.199 176.187 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -131.87 151.77 51.47 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 120.904 0.383 . . . . 71.22 111.986 -179.046 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 36.7 m -132.91 156.59 46.97 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.887 -1.524 . . . . 70.32 106.887 177.369 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -129.41 144.85 51.41 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 110.03 -0.359 . . . . 62.41 110.03 177.844 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -137.75 127.24 24.95 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.955 -1.128 . . . . 71.55 107.955 176.973 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 15.0 m -99.3 125.27 44.91 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.053 0.454 . . . . 64.14 111.942 -175.771 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 41.9 t -121.73 151.37 25.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 106.868 -1.53 . . . . 63.43 106.868 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.34 135.62 50.62 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 121.407 0.622 . . . . 73.1 111.507 -178.571 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 527' ' ' SER . . . . . 0.614 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 49.3 m -155.38 170.42 8.73 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 108.451 -0.944 . . . . 61.32 108.451 -178.916 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.87 -16.86 25.91 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 122.14 1.893 . . . . 74.43 114.031 -179.696 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.23 149.47 38.59 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 119.509 -0.877 . . . . 74.41 111.843 -176.521 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.95 147.65 72.77 Favored 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 123.27 2.647 . . . . 72.25 112.882 -176.078 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.715 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.65 103.86 0.37 Allowed 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 114.858 -1.065 . . . . 50.35 113.119 -174.115 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 147.04 -17.03 1.55 Allowed Glycine 0 N--CA 1.422 -2.242 0 CA-C-N 115.043 -0.981 . . . . 62.44 111.643 -178.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -82.22 141.76 32.71 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.628 -0.508 . . . . 63.24 109.628 177.843 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.453 HG23 ' HA ' ' A' ' 505' ' ' VAL . 41.4 t -93.32 115.84 33.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.039 -0.726 . . . . 73.34 109.039 176.438 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 535' ' ' THR . . . . . 0.581 HG23 ' HB2' ' A' ' 556' ' ' SER . 2.3 p -83.87 -17.81 39.6 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.241 -0.891 . . . . 73.23 112.357 178.965 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 165.88 174.86 35.79 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.185 -1.007 . . . . 73.03 112.404 178.246 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 5.7 p -117.38 152.89 34.03 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.222 -1.029 . . . . 73.24 108.222 177.359 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -67.22 -50.64 38.98 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 118.333 -1.347 . . . . 75.32 111.151 176.447 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -67.87 127.75 16.67 Favored 'Trans proline' 0 C--N 1.377 2.057 0 N-CA-C 108.043 -1.56 . . . . 61.34 108.043 170.074 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -68.92 157.39 62.04 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 122.236 1.957 . . . . 75.03 113.879 -175.909 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.17 136.12 56.94 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.622 -0.717 . . . . 73.3 110.444 179.646 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.51 -11.25 59.65 Favored Glycine 0 C--N 1.305 -1.155 0 N-CA-C 111.637 -0.585 . . . . 21.11 111.637 -178.491 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 28.4 m -77.87 127.98 33.24 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 122.568 -0.372 . . . . 52.02 110.945 -178.426 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.645 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 24.8 m -87.73 123.65 32.76 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 108.0 -1.111 . . . . 72.41 108.0 175.858 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.75 157.57 62.42 Favored Pre-proline 0 C--N 1.301 -1.503 0 N-CA-C 108.763 -0.828 . . . . 71.15 108.763 -178.826 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -63.87 140.65 74.4 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.615 1.543 . . . . 73.14 110.763 177.371 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 14.6 p -56.85 -25.62 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-O 121.455 0.645 . . . . 64.53 110.855 178.158 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.05 -15.08 52.44 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.738 -0.664 . . . . 62.32 112.008 -178.706 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 97.0 p -82.94 178.08 8.33 Favored 'General case' 0 C--O 1.254 1.32 0 N-CA-C 113.388 0.885 . . . . 63.44 113.388 -174.633 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 15.0 p -117.03 138.04 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.518 -0.765 . . . . 70.01 110.933 -176.488 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 54.9 mt -108.59 134.35 50.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.687 -0.857 . . . . 52.52 108.687 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -104.27 122.95 46.47 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.43 0.633 . . . . 73.03 112.563 179.529 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.23 119.37 34.6 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 125.487 1.515 . . . . 72.44 109.685 -179.525 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -88.82 113.81 24.76 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.656 0.741 . . . . 75.04 109.485 175.317 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 524' ' ' SER . 42.8 t -94.97 131.21 42.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 114.456 -1.247 . . . . 75.14 109.521 -175.754 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.715 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 39.1 t -77.47 117.63 19.12 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 108.261 -1.014 . . . . 62.33 108.261 176.693 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.15 134.07 43.61 Favored 'General case' 0 N--CA 1.417 -2.118 0 N-CA-C 105.444 -2.058 . . . . 74.14 105.444 168.725 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' A' ' 560' ' ' GLN . . . -64.01 -24.44 68.58 Favored Glycine 0 CA--C 1.499 -0.94 0 N-CA-C 110.484 -1.046 . . . . 75.02 110.484 179.253 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 559' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 63.5 t30 63.83 24.67 13.83 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.962 1.305 . . . . 65.54 108.438 -179.192 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 558' ' ' GLY . 97.7 mt-30 -127.52 155.57 43.56 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 114.48 -1.236 . . . . 74.5 111.234 -173.429 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -131.22 151.12 51.79 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.893 -1.049 . . . . 73.43 108.264 176.277 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.19 123.07 16.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-O 121.439 0.638 . . . . 62.53 110.317 178.777 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.536 ' SD ' HG13 ' A' ' 620' ' ' ILE . 42.9 ttp -86.45 125.63 66.96 Favored Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 115.495 -0.775 . . . . 62.45 111.014 -178.458 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 564' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 24.1 Cg_exo -65.43 170.41 10.98 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.687 2.925 . . . . 55.3 112.402 176.591 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.94 115.51 15.71 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.46 -0.336 . . . . 71.05 110.492 -179.681 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -91.59 -16.66 26.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.87 0.843 . . . . 70.24 109.047 175.601 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 15.3 m -73.91 140.1 45.41 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.156 -0.929 . . . . 42.23 110.008 -179.331 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 94.17 11.42 57.47 Favored Glycine 0 C--O 1.217 -0.921 0 C-N-CA 120.713 -0.756 . . . . 62.03 114.395 177.065 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 569' ' ' MET . . . . . 0.443 ' HB2' ' HB2' ' A' ' 573' ' ' ASP . 23.9 ptp -131.83 167.6 19.27 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.329 -0.989 . . . . 70.02 108.329 176.759 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -88.9 170.34 10.79 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.049 -1.093 . . . . 62.33 108.049 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -65.95 -28.31 68.82 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.416 -0.957 . . . . 74.54 108.416 176.331 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.7 p -75.53 -11.85 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-N 115.297 -0.865 . . . . 73.3 110.564 -179.283 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 56.5 m-20 -98.72 -40.56 8.1 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 107.441 -1.318 . . . . 74.4 107.441 174.161 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 574' ' ' ALA . . . . . 0.73 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -55.83 -54.3 46.16 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-N 114.566 -1.197 . . . . 74.31 112.87 -176.636 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 40.4 mt-10 -57.77 -48.57 96.95 Favored Pre-proline 0 N--CA 1.473 0.686 0 N-CA-C 113.7 1.0 . . . . 64.4 113.7 -178.787 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -52.96 -38.2 79.27 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.168 1.912 . . . . 75.12 112.761 171.575 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 3.6 mmp_? -68.71 -38.89 80.6 Favored 'General case' 0 C--O 1.199 -1.554 0 N-CA-C 109.929 -0.397 . . . . 71.31 109.929 176.537 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.73 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 65.3 mt -65.26 -47.11 77.88 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 122.66 0.384 . . . . 74.2 110.634 -175.401 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 35.7 ptt85 -66.0 -35.16 79.82 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 116.29 -0.414 . . . . 74.32 111.659 176.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.44 -30.79 67.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.481 0.658 . . . . 71.34 110.619 177.503 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 14.1 tp -80.85 -9.05 59.86 Favored 'General case' 0 N--CA 1.425 -1.707 0 C-N-CA 124.14 0.976 . . . . 70.53 110.175 179.595 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 67.44 46.5 69.56 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.346 -0.454 . . . . 41.55 112.002 178.84 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.422 ' CE3' HD22 ' A' ' 578' ' ' LEU . 12.5 t90 -83.5 131.13 35.03 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.924 -0.399 . . . . 65.54 109.924 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 12.8 p -100.12 -26.77 13.84 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.29 1.036 . . . . 71.14 112.748 -178.193 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -82.16 -175.19 50.4 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 116.283 -0.417 . . . . 74.45 113.644 -177.069 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 70.5 mtm -107.19 149.56 27.58 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.968 -0.382 . . . . 73.22 109.968 -178.514 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.9 tt -91.83 130.18 37.65 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.074 -1.084 . . . . 75.13 108.074 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 621' ' ' THR . 14.0 t70 -112.19 123.42 50.22 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.266 -1.013 . . . . 64.44 108.266 176.62 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.531 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -104.07 133.91 48.22 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.285 0.564 . . . . 75.31 109.563 -178.595 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -74.93 -53.86 6.08 Favored Glycine 0 C--N 1.281 -2.504 0 N-CA-C 110.603 -0.999 . . . . 75.31 110.603 -179.303 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.29 141.8 35.75 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.083 -0.558 . . . . 54.4 110.485 -179.58 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -117.21 124.53 49.32 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 104.311 -2.477 . . . . 72.11 104.311 168.136 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.17 117.06 51.02 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 109.156 -0.683 . . . . 54.21 109.156 -175.695 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 594' ' ' ASP . . . . . 0.43 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 4.8 p-10 -73.34 123.21 23.34 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.612 0.72 . . . . 70.55 109.118 179.707 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -132.23 -5.31 3.42 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 114.985 -1.007 . . . . 52.35 110.433 179.942 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 93.71 137.01 8.26 Favored Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 120.164 -1.017 . . . . 43.32 111.907 -178.369 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.71 -32.9 62.16 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 122.956 0.312 . . . . 52.25 113.542 -179.282 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 47.9 t -63.62 -23.93 67.59 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.054 0.93 . . . . 71.54 110.644 -175.686 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -89.46 -1.08 57.92 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.195 -0.911 . . . . 64.44 111.879 -174.723 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 60.5 m170 60.35 86.65 0.1 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.789 0.804 . . . . 60.52 111.652 -179.225 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -88.45 85.88 6.94 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.509 1.147 . . . . 63.13 112.241 -176.59 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 602' ' ' ARG . . . . . 0.41 ' HG2' ' H ' ' A' ' 602' ' ' ARG . 5.5 ptp180 -92.41 169.57 10.46 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 113.164 -1.835 . . . . 61.15 110.258 -179.799 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 96.7 t -73.07 130.28 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 105.357 -2.09 . . . . 74.52 105.357 173.42 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.6 m -105.26 -28.97 2.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 120.2 -0.6 . . . . 51.25 112.371 -173.359 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -156.1 142.43 18.4 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 109.545 -0.539 . . . . 75.25 109.545 -176.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -121.42 138.63 54.19 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.13 -1.063 . . . . 73.34 108.13 175.421 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.523 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 56.6 t30 -60.26 -51.91 76.93 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 123.303 0.377 . . . . 55.44 111.023 -175.591 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.5 Cg_endo -88.84 118.74 0.97 Allowed 'Trans proline' 0 N--CA 1.437 -1.829 0 N-CA-C 107.934 -1.602 . . . . 62.04 107.934 169.138 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 609' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 28.1 Cg_exo -63.54 159.68 39.47 Favored 'Trans proline' 0 C--O 1.249 1.042 0 C-N-CA 122.206 1.938 . . . . 74.12 112.681 -176.208 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -62.35 139.04 58.54 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.987 -0.551 . . . . 74.13 109.872 179.269 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.66 -8.74 60.12 Favored Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 120.189 -1.005 . . . . 65.23 111.668 -177.619 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 79.5 m -80.07 138.78 37.04 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.554 -0.906 . . . . 72.33 108.554 178.744 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -77.19 122.85 6.29 Favored Glycine 0 N--CA 1.419 -2.499 0 N-CA-C 110.379 -1.089 . . . . 53.25 110.379 177.847 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 28.4 m -112.49 141.84 26.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 108.697 -0.853 . . . . 51.01 108.697 177.071 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 559' ' ' ASN . 34.3 p-10 -54.89 173.37 0.09 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.536 0.734 . . . . 73.41 112.654 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -57.09 -24.92 57.44 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.524 0.935 . . . . 64.34 113.524 179.568 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -84.02 -9.67 58.47 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.557 -0.857 . . . . 52.43 110.077 178.679 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 65.33 19.03 66.02 Favored Glycine 0 C--O 1.22 -0.778 0 N-CA-C 114.576 0.59 . . . . 52.02 114.576 165.817 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.2 118.5 13.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-O 122.396 1.093 . . . . 63.1 112.135 -166.624 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.536 HG13 ' SD ' ' A' ' 563' ' ' MET . 0.0 OUTLIER -130.06 133.53 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 114.183 -1.371 . . . . 75.45 111.295 -176.473 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 42.0 m -105.06 126.74 52.4 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.614 -0.884 . . . . 72.24 108.614 178.843 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.3 pp -138.13 166.76 23.32 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.164 0.431 . . . . 70.22 112.164 -176.742 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -128.43 136.99 51.63 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.074 -0.713 . . . . 72.24 109.074 175.249 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -142.0 168.08 20.59 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.612 -1.255 . . . . 74.03 107.612 -174.363 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -70.52 -124.7 0.05 OUTLIER Glycine 0 CA--C 1.538 1.494 0 C-N-CA 119.177 -1.487 . . . . 64.31 110.765 172.572 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 48.2 tt0 . . . . . 0 C--N 1.27 -2.875 0 N-CA-C 108.729 -0.841 . . . . 74.55 108.729 175.761 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.693 0 N-CA-C 110.104 -1.198 . . . . 73.12 110.104 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -76.18 142.02 23.96 Favored 'Trans proline' 0 C--O 1.247 0.973 0 CA-C-N 119.631 1.715 . . . . 71.15 109.533 174.65 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 60.1 10.83 2.42 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.699 1.2 . . . . 34.32 113.084 179.302 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 7.1 p -147.19 139.55 24.65 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 122.565 0.346 . . . . 74.31 110.29 -177.595 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -139.42 132.95 30.33 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.584 -0.895 . . . . 62.43 108.584 179.297 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.3 p-10 -95.1 135.26 36.86 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.43 0.633 . . . . 72.3 110.847 -177.937 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.4 pt -81.91 127.88 70.54 Favored Pre-proline 0 C--N 1.303 -1.449 0 CA-C-N 114.667 -1.151 . . . . 75.53 111.797 -175.588 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -82.3 178.48 6.24 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.319 2.013 . . . . 73.14 111.967 178.088 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -97.47 107.82 20.41 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 122.289 1.042 . . . . 64.22 110.075 178.448 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.441 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 25.7 m -111.39 18.75 7.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 114.4 -1.273 . . . . 74.21 109.566 179.389 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -74.16 100.6 3.71 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.734 -1.121 . . . . 50.42 110.342 -178.546 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 155.7 -41.53 0.58 Allowed Glycine 0 N--CA 1.426 -2.023 0 C-N-CA 120.953 -0.641 . . . . 53.15 111.641 177.576 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.483 ' O ' HG12 ' A' ' 534' ' ' VAL . 19.3 mp0 -77.13 -177.46 4.53 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.45 0.643 . . . . 70.22 110.381 -179.219 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 11.4 m -75.23 155.62 36.6 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 106.428 -1.693 . . . . 75.53 106.428 174.599 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.43 HG21 HG22 ' A' ' 555' ' ' VAL . 7.4 p -62.01 -42.13 93.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 118.166 0.439 . . . . 72.34 111.66 -178.285 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.91 -42.88 98.94 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 122.854 0.462 . . . . 65.14 110.609 178.678 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 82.3 t -67.6 -49.03 74.29 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.906 0 N-CA-C 109.139 -0.689 . . . . 64.22 109.139 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.461 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -59.28 -43.49 92.54 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 122.717 0.407 . . . . 75.23 111.897 -177.699 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.9 mt-30 -63.32 -44.34 95.21 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 120.757 0.313 . . . . 73.53 110.287 179.688 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.48 ' HA ' ' HE2' ' A' ' 510' ' ' LYS . 11.2 mmpt? -67.23 -40.22 86.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.406 -0.361 . . . . 64.2 110.155 178.51 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 511' ' ' ASN . . . . . 0.613 ' O ' HG12 ' A' ' 514' ' ' VAL . 9.2 m-20 -62.47 -45.66 92.04 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.316 -0.857 . . . . 73.04 111.688 -178.122 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 512' ' ' LEU . . . . . 0.458 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -69.05 -37.53 78.61 Favored 'General case' 0 C--O 1.211 -0.949 0 C-N-CA 119.683 -0.807 . . . . 55.41 110.722 -179.577 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.458 ' N ' HD12 ' A' ' 512' ' ' LEU . 49.1 t30 -64.36 -35.66 81.61 Favored 'General case' 0 N--CA 1.421 -1.915 0 C-N-CA 124.645 1.178 . . . . 70.04 111.108 -178.455 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 511' ' ' ASN . 5.0 p -67.26 -31.27 52.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.944 0.402 . . . . 72.41 110.764 -178.523 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -104.51 6.22 34.6 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.625 -0.509 . . . . 75.53 109.625 -179.58 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -131.1 -53.4 0.09 OUTLIER Glycine 0 CA--C 1.477 -2.31 0 C-N-CA 119.7 -1.238 . . . . 72.42 114.399 -168.902 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 65.16 77.32 0.31 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 106.939 -1.504 . . . . 71.35 106.939 -173.58 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.3 p -140.29 177.1 8.23 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 115.061 -0.972 . . . . 72.33 111.539 -170.279 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.97 132.76 53.78 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.119 -1.438 . . . . 71.11 107.119 179.185 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -130.55 154.48 47.78 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.154 0.502 . . . . 73.22 112.095 -176.704 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 69.6 m -140.4 160.56 39.71 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 105.969 -1.863 . . . . 72.23 105.969 174.159 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 522' ' ' GLN . . . . . 0.416 ' HB2' ' CG2' ' A' ' 555' ' ' VAL . 3.8 pt20 -131.11 135.98 47.98 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.695 -0.802 . . . . 75.53 111.035 -178.895 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.72 129.22 56.39 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.601 -1.259 . . . . 70.45 107.601 178.343 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.8 m -100.59 124.74 46.57 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.244 0.545 . . . . 64.32 111.842 -177.668 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.54 150.82 24.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.444 -1.317 . . . . 72.31 107.444 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -91.35 135.3 33.91 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.445 -0.576 . . . . 54.34 109.445 179.484 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 52.3 m -160.53 162.86 22.63 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 107.549 -1.278 . . . . 74.21 107.549 -175.932 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -64.15 -8.54 16.66 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.699 2.266 . . . . 75.25 113.564 178.587 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -74.07 134.49 77.58 Favored Pre-proline 0 N--CA 1.432 -1.333 0 N-CA-C 107.437 -1.32 . . . . 70.12 107.437 175.878 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.53 149.82 89.69 Favored 'Trans proline' 0 C--O 1.249 1.063 0 C-N-CA 122.303 2.002 . . . . 72.14 112.495 -175.789 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.26 120.09 7.53 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.357 -0.838 . . . . 62.41 111.979 -176.72 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.53 -20.77 10.12 Favored Glycine 0 N--CA 1.428 -1.872 0 CA-C-N 114.98 -1.009 . . . . 61.23 111.414 177.645 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -78.67 137.15 37.67 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.345 -0.613 . . . . 72.31 109.345 179.046 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.499 HG22 ' H ' ' A' ' 536' ' ' GLY . 11.5 p -99.47 120.49 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.091 0 N-CA-C 108.566 -0.901 . . . . 75.43 108.566 -179.217 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.21 -1.43 44.72 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.097 -0.956 . . . . 70.12 112.072 178.948 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.499 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 132.67 -141.57 12.95 Favored Glycine 0 N--CA 1.419 -2.447 0 N-CA-C 111.226 -0.75 . . . . 32.2 111.226 175.265 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 2.2 p -116.61 157.14 25.83 Favored 'General case' 0 C--N 1.262 -3.217 0 N-CA-C 108.547 -0.908 . . . . 74.3 108.547 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.515 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 55.1 t30 -64.92 -53.51 41.92 Favored Pre-proline 0 C--N 1.324 -0.51 0 C-N-CA 120.087 -0.645 . . . . 72.11 109.923 175.953 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 15.8 Cg_exo -71.66 137.63 30.48 Favored 'Trans proline' 0 C--N 1.372 1.782 0 N-CA-C 107.002 -1.961 . . . . 64.03 107.002 168.488 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -55.78 139.91 84.22 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.209 1.939 . . . . 75.21 113.384 -175.66 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.84 132.38 51.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.39 -0.823 . . . . 74.32 110.775 -178.356 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.75 -10.17 37.96 Favored Glycine 0 C--N 1.303 -1.253 0 N-CA-C 111.668 -0.573 . . . . 55.11 111.668 -175.747 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 86.8 m -77.46 129.02 35.19 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 122.817 -0.225 . . . . 72.01 110.517 179.563 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 11.3 t -82.14 125.55 31.02 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.095 -1.076 . . . . 61.54 108.095 174.926 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.73 160.0 53.23 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 109.189 -0.671 . . . . 54.05 109.189 -177.707 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -65.89 143.13 71.97 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.697 1.598 . . . . 72.51 110.14 177.054 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.44 -19.72 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 CA-C-O 121.591 0.71 . . . . 74.41 110.555 178.513 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.25 -12.76 59.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.884 -0.598 . . . . 75.3 111.848 176.18 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 10.2 t -93.06 148.19 22.21 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.92 -0.77 . . . . 75.02 108.92 -179.813 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 9.9 p -91.79 138.71 19.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 115.836 -0.62 . . . . 61.4 111.508 -177.062 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 60.0 mt -80.72 124.28 38.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.417 -0.957 . . . . 73.11 108.417 177.336 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -103.65 117.9 35.48 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.305 -0.998 . . . . 71.43 108.305 -178.227 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.5 128.54 41.15 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.253 0.621 . . . . 55.44 111.485 -178.561 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -83.0 102.76 11.96 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 123.204 0.602 . . . . 64.35 110.061 177.363 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.43 HG22 HG21 ' A' ' 505' ' ' VAL . 25.9 t -95.94 123.58 48.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.407 -0.961 . . . . 73.44 108.407 -179.654 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 51.1 m -95.07 127.99 41.55 Favored 'General case' 0 N--CA 1.409 -2.481 0 CA-C-O 121.457 0.646 . . . . 73.13 111.413 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -100.12 135.23 41.87 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 106.453 -1.684 . . . . 72.33 106.453 170.472 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -55.03 -22.88 29.86 Favored Glycine 0 CA--C 1.503 -0.676 0 O-C-N 124.698 1.249 . . . . 43.54 115.077 -172.748 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 81.73 -24.4 0.19 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.449 1.499 . . . . 71.21 109.755 -178.437 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.5 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 91.6 mt-30 -113.25 158.02 21.02 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.391 -0.822 . . . . 71.05 110.913 -176.852 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -127.02 150.21 49.54 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.217 -1.031 . . . . 74.45 108.217 175.359 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 31.0 t -71.28 118.14 15.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.588 -0.523 . . . . 62.13 109.588 -178.784 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.6 ' SD ' HG21 ' A' ' 620' ' ' ILE . 49.4 ttp -87.13 129.13 52.99 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-N 116.119 -0.491 . . . . 65.41 111.147 -176.314 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.49 169.55 22.28 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.529 2.153 . . . . 73.44 111.114 174.027 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -74.63 142.12 44.59 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.986 0.422 . . . . 73.1 110.375 179.168 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -135.05 15.46 3.53 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.936 0.874 . . . . 74.03 109.179 177.777 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 31.6 t -79.22 139.38 37.95 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.118 -0.947 . . . . 74.34 108.867 178.71 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 97.03 26.0 10.74 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.462 -0.875 . . . . 71.01 114.022 176.926 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.9 -175.55 3.71 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.964 -0.754 . . . . 74.53 108.964 177.928 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -117.06 159.07 23.11 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.65 -1.241 . . . . 75.22 107.65 -175.309 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 571' ' ' TRP . . . . . 0.415 ' CH2' ' HB3' ' A' ' 589' ' ' LYS . 27.2 t-105 -63.48 -24.81 67.98 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.324 0.583 . . . . 74.45 110.21 -176.398 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.0 m -66.97 -18.94 24.99 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 CA-C-N 115.025 -0.989 . . . . 62.33 110.735 179.247 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.547 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 22.9 t70 -101.69 -28.56 12.41 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.078 -0.712 . . . . 71.42 109.078 177.759 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -56.47 -47.52 79.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.962 0.905 . . . . 75.52 112.676 -178.727 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -64.25 -47.98 77.36 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 119.633 -0.827 . . . . 74.22 112.769 178.568 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -52.66 -37.2 74.65 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 121.999 1.8 . . . . 74.41 112.796 171.057 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 6.4 mmp_? -59.35 -44.27 92.7 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 109.347 -0.612 . . . . 70.52 109.347 176.446 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 583' ' ' TRP . 1.7 tp -59.85 -49.57 77.19 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-N 115.271 -0.877 . . . . 65.12 111.44 -176.149 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -66.73 -40.93 88.55 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.712 0.634 . . . . 73.13 112.712 176.682 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.62 -37.68 73.84 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.908 0.707 . . . . 75.33 112.908 -177.257 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.414 HD11 ' HB2' ' A' ' 583' ' ' TRP . 0.7 OUTLIER -82.89 -8.93 59.53 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 122.14 -0.35 . . . . 72.52 110.962 -174.918 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.26 47.03 18.7 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.145 -0.782 . . . . 43.22 111.145 -179.68 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 583' ' ' TRP . . . . . 0.528 ' HB3' HD12 ' A' ' 578' ' ' LEU . 12.4 t90 -87.18 127.86 35.14 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 121.636 0.731 . . . . 72.13 110.134 -178.689 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 27.0 m -89.1 -17.45 29.24 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 124.367 1.067 . . . . 71.34 112.947 -174.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -96.79 -171.04 34.2 Favored Glycine 0 CA--C 1.497 -1.038 0 C-N-CA 121.372 -0.442 . . . . 64.13 113.223 -176.142 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 81.4 mtp -117.73 155.85 29.27 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 120.908 0.385 . . . . 72.44 110.878 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 587' ' ' LEU . . . . . 0.523 ' HG ' ' CH2' ' A' ' 583' ' ' TRP . 5.0 mt -80.31 125.56 30.05 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 115.076 -0.965 . . . . 75.42 112.245 -178.48 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 621' ' ' THR . 2.4 m-20 -110.93 118.11 35.21 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.269 -1.332 . . . . 74.41 110.122 176.313 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.415 ' HB3' ' CH2' ' A' ' 571' ' ' TRP . 0.0 OUTLIER -107.33 133.83 51.29 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 120.176 -0.61 . . . . 75.43 109.39 -178.961 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -78.59 -69.85 1.36 Allowed Glycine 0 C--N 1.284 -2.322 0 CA-C-N 115.354 -0.839 . . . . 64.2 111.176 -179.686 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.09 149.24 42.84 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.706 0.288 . . . . 61.13 111.508 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -96.61 124.09 40.49 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 105.925 -1.88 . . . . 74.24 105.925 170.898 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 40.2 t -105.76 119.99 55.9 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.5 0 CA-C-N 115.683 -0.69 . . . . 75.35 109.832 -175.601 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -73.54 107.06 5.6 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.37 -0.974 . . . . 54.1 108.37 176.506 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -107.84 -39.75 5.47 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.432 0.634 . . . . 63.33 110.014 -179.338 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 114.34 152.06 10.49 Favored Glycine 0 N--CA 1.412 -2.9 0 N-CA-C 110.674 -0.971 . . . . 43.01 110.674 -177.225 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.98 -32.66 62.74 Favored Glycine 0 C--N 1.305 -1.174 0 C-N-CA 123.287 0.47 . . . . 35.25 113.1 -179.592 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 4.3 p -69.59 -24.92 63.74 Favored 'General case' 0 N--CA 1.422 -1.859 0 C-N-CA 124.283 1.033 . . . . 41.13 111.608 -176.466 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -93.95 -14.18 26.25 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.602 -0.726 . . . . 73.25 109.971 -177.006 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 65.1 m80 56.69 108.73 0.01 OUTLIER 'General case' 0 C--O 1.238 0.47 0 O-C-N 124.345 1.028 . . . . 63.32 111.684 -173.691 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 601' ' ' ASN . . . . . 0.401 ' HB3' ' HA3' ' A' ' 625' ' ' GLY . 48.1 m-80 -73.53 75.52 1.46 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.943 -1.026 . . . . 75.52 113.404 -172.177 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -86.5 171.24 11.24 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 124.702 1.201 . . . . 74.33 109.001 177.674 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.93 129.75 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.666 -1.976 . . . . 61.42 105.666 169.728 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 14.5 p -96.64 -32.32 4.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 120.13 -0.628 . . . . 64.34 110.424 -174.311 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -151.3 134.94 16.32 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 116.182 -0.463 . . . . 70.35 110.62 -179.449 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -106.54 130.16 54.36 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.321 -1.362 . . . . 71.12 107.321 172.935 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.432 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 24.2 t-20 -55.33 -55.52 38.85 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 113.654 0.983 . . . . 74.3 113.654 -176.695 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.3 Cg_endo -87.71 131.73 2.86 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.14 1.227 . . . . 53.41 110.433 175.589 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 609' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 38.5 Cg_exo -64.88 160.32 41.64 Favored 'Trans proline' 0 C--O 1.253 1.234 0 C-N-CA 122.642 2.228 . . . . 75.4 112.383 177.964 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -64.8 138.5 58.42 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.15 -0.685 . . . . 61.25 109.15 177.519 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 91.84 0.4 71.96 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 119.8 -1.19 . . . . 75.35 111.912 -179.178 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 24.0 m -90.35 146.31 24.28 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.881 -0.785 . . . . 52.1 108.881 178.575 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -83.56 123.2 6.06 Favored Glycine 0 N--CA 1.419 -2.45 0 N-CA-C 110.962 -0.855 . . . . 74.34 110.962 177.623 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.9 m -111.44 142.55 23.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 107.901 -1.148 . . . . 62.32 107.901 176.787 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.5 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 37.8 p30 -46.1 163.09 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 113.769 1.026 . . . . 72.44 113.769 179.077 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -57.15 -25.31 58.71 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.331 -0.85 . . . . 73.2 112.219 177.617 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.35 -10.96 59.75 Favored 'General case' 0 C--O 1.214 -0.802 0 C-N-CA 119.372 -0.931 . . . . 74.22 109.254 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.85 11.42 57.87 Favored Glycine 0 CA--C 1.494 -1.264 0 C-N-CA 123.455 0.55 . . . . 71.12 112.885 167.344 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.96 118.77 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.114 0 CA-C-O 122.44 1.114 . . . . 74.21 110.985 -169.638 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.6 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.7 pp -124.95 133.92 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 CA-C-N 113.74 -1.573 . . . . 62.45 111.813 -177.943 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 28.3 m -99.0 130.52 45.34 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.669 -1.234 . . . . 72.43 107.669 177.369 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.404 HD23 ' H ' ' A' ' 622' ' ' LEU . 2.0 pt? -138.65 162.78 33.77 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 110.145 -0.316 . . . . 62.11 110.145 -178.157 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -128.1 136.98 51.92 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.221 -1.4 . . . . 75.11 107.221 178.202 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -141.92 167.53 21.92 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.997 -0.547 . . . . 72.31 110.127 -168.432 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 625' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 601' ' ' ASN . . . -64.55 -170.43 2.21 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-O 121.944 0.747 . . . . 64.3 113.633 176.555 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 . . . . . 0 C--N 1.28 -2.418 0 C-N-CA 124.066 0.946 . . . . 74.11 111.0 -175.91 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.652 0 N-CA-C 110.319 -1.112 . . . . 65.24 110.319 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.84 145.33 90.41 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.743 2.295 . . . . 71.1 111.844 179.118 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -84.45 -10.6 57.36 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.42 0.629 . . . . 74.2 111.476 -176.307 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 33.2 p -136.87 148.56 47.15 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 115.5 -0.773 . . . . 74.23 110.251 -178.622 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -140.66 153.54 46.04 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.026 -0.731 . . . . 74.33 109.026 176.213 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -90.2 140.77 29.35 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.215 0.531 . . . . 71.31 110.148 -178.85 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 22.8 pt -101.98 112.71 65.66 Favored Pre-proline 0 C--N 1.301 -1.515 0 CA-C-N 115.592 -0.731 . . . . 74.55 110.57 177.705 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -69.65 167.68 23.6 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.439 2.092 . . . . 74.24 112.264 177.46 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -75.2 96.11 3.25 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.477 0.656 . . . . 74.24 110.207 179.183 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 31.5 m -94.81 9.33 5.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 115.259 -0.882 . . . . 63.32 110.055 177.323 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.71 101.04 1.99 Allowed 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 114.638 -1.165 . . . . 61.12 110.222 -179.146 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 147.41 -23.18 1.53 Allowed Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 115.455 -0.793 . . . . 71.22 111.846 178.918 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.432 ' O ' HG12 ' A' ' 534' ' ' VAL . 1.9 mp0 -94.06 178.47 5.64 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 108.62 -0.881 . . . . 72.44 108.62 179.518 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 24.8 m -72.05 155.33 40.43 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.487 -1.301 . . . . 74.13 107.487 176.71 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.454 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.7 p -61.94 -43.21 97.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 111.42 0.156 . . . . 72.02 111.42 -178.73 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.16 -39.2 93.97 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 110.088 -0.338 . . . . 74.31 110.088 -179.314 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 99.7 t -69.06 -46.93 77.71 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 CA-C-N 115.142 -0.936 . . . . 63.02 109.748 -179.72 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.59 -44.38 96.29 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 122.99 0.181 . . . . 73.21 111.251 178.924 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 509' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 98.5 mt-30 -64.14 -46.55 83.62 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 120.699 0.285 . . . . 74.43 111.233 -178.912 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.451 ' O ' HG23 ' A' ' 514' ' ' VAL . 21.2 ptmt -67.1 -38.63 85.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.028 -0.533 . . . . 64.43 110.199 -178.099 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -67.13 -43.98 81.04 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.681 -0.69 . . . . 72.42 110.648 -179.788 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.07 -41.33 98.06 Favored 'General case' 0 C--O 1.207 -1.16 0 N-CA-C 108.317 -0.994 . . . . 74.14 108.317 -179.408 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -59.64 -34.89 73.38 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 124.12 0.968 . . . . 74.33 111.054 -179.688 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 510' ' ' LYS . 97.7 t -57.66 -38.2 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-O 121.168 0.508 . . . . 70.33 111.118 178.997 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.43 19.81 13.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 122.123 0.963 . . . . 64.42 111.159 -178.814 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -128.81 -59.43 0.11 Allowed Glycine 0 N--CA 1.416 -2.665 0 CA-C-N 114.68 -1.146 . . . . 63.03 111.595 -177.246 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 63.95 24.56 13.67 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 122.058 0.932 . . . . 75.42 110.016 -174.708 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 6.4 p -84.18 -179.66 7.27 Favored 'General case' 0 N--CA 1.404 -2.746 0 CA-C-N 113.984 -1.462 . . . . 63.01 110.277 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 519' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 56.7 mtpt -108.43 134.23 51.52 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.448 -1.686 . . . . 61.42 106.448 179.486 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -132.89 154.28 50.54 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 112.871 0.693 . . . . 72.45 112.871 -175.411 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 34.2 p -140.03 156.34 46.66 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.789 -1.189 . . . . 64.31 107.789 176.3 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -124.84 145.21 49.9 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.979 -0.288 . . . . 74.45 111.186 -178.939 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -132.59 117.53 18.06 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.388 -0.597 . . . . 42.24 109.388 177.526 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 524' ' ' SER . . . . . 0.455 ' HA ' ' HB ' ' A' ' 555' ' ' VAL . 49.1 m -84.53 116.76 23.3 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.535 0.683 . . . . 74.31 110.157 178.58 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 44.9 t -120.96 149.81 23.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 106.435 -1.691 . . . . 72.53 106.435 -176.519 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -68.29 134.52 50.48 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 120.717 0.294 . . . . 54.53 110.588 -176.833 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 49.3 m -163.08 160.51 18.72 Favored Pre-proline 0 C--O 1.208 -1.116 0 N-CA-C 108.397 -0.964 . . . . 71.41 108.397 -179.726 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -73.48 3.35 4.84 Favored 'Trans proline' 0 CA--C 1.556 1.623 0 C-N-CA 122.624 2.216 . . . . 72.32 113.651 178.875 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 529' ' ' ARG . . . . . 0.477 ' N ' ' HD2' ' A' ' 529' ' ' ARG . 2.7 mpt_? -92.39 140.02 24.1 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 107.992 -1.114 . . . . 71.25 107.992 177.114 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -62.19 150.75 85.65 Favored 'Trans proline' 0 C--O 1.254 1.324 0 C-N-CA 122.847 2.365 . . . . 63.35 113.052 -176.438 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.625 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.47 110.11 1.18 Allowed 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.196 -0.911 . . . . 62.12 112.253 -174.752 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 136.86 -26.92 2.97 Favored Glycine 0 N--CA 1.433 -1.5 0 C-N-CA 120.621 -0.799 . . . . 73.05 112.394 177.838 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -82.03 140.57 33.84 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.044 0.45 . . . . 74.33 110.558 -178.281 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 503' ' ' GLN . 7.9 p -96.96 118.24 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 CA-C-O 121.687 0.756 . . . . 75.02 109.162 -179.509 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -25.77 54.46 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 114.853 -1.067 . . . . 60.3 110.999 179.275 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 162.44 -164.69 35.76 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 120.547 -0.835 . . . . 63.41 111.776 179.172 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 1.7 p -116.87 157.9 24.87 Favored 'General case' 0 C--N 1.282 -2.336 0 C-N-CA 123.184 0.594 . . . . 61.01 109.639 -178.793 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.432 ' HB2' HE22 ' A' ' 554' ' ' GLN . 25.0 t-20 -58.33 -54.46 55.68 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 120.712 -0.395 . . . . 72.52 110.657 175.533 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -73.2 135.99 23.68 Favored 'Trans proline' 0 C--N 1.359 1.102 0 N-CA-C 108.337 -1.447 . . . . 70.44 108.337 168.734 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.16 140.93 94.78 Favored 'Trans proline' 0 C--O 1.245 0.852 0 C-N-CA 122.406 2.071 . . . . 64.35 112.445 -178.069 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.46 140.48 58.03 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.955 -0.566 . . . . 71.13 110.004 -179.507 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.78 -15.09 55.94 Favored Glycine 0 C--N 1.3 -1.454 0 N-CA-C 110.775 -0.93 . . . . 74.21 110.775 -175.806 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.7 m -85.16 138.22 32.52 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 122.802 0.441 . . . . 63.24 109.955 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 8.0 t -76.29 128.06 34.14 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 108.645 -0.872 . . . . 71.52 108.645 173.057 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 32.1 m -123.78 154.79 67.23 Favored Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 108.691 -0.855 . . . . 64.3 108.691 -179.078 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -64.88 134.84 41.84 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 120.693 0.929 . . . . 74.11 111.703 178.958 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 8.6 p -67.38 -27.46 38.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.902 -1.044 . . . . 72.35 112.907 -176.206 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -90.19 -7.04 54.57 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.534 0.683 . . . . 63.33 110.908 -175.433 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.1 t -89.79 179.14 6.06 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.131 0.491 . . . . 63.11 109.684 -178.355 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 12.2 p -107.6 128.7 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.261 0 CA-C-N 115.511 -0.768 . . . . 73.05 109.82 -177.605 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 60.2 mt -93.22 135.95 26.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 108.4 -0.963 . . . . 75.25 108.4 -179.691 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -103.33 117.86 35.45 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.652 -0.499 . . . . 72.54 109.652 -176.687 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.426 HD12 HG21 ' A' ' 534' ' ' VAL . 3.6 mm? -95.46 120.83 36.38 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 123.748 0.819 . . . . 75.54 109.464 179.187 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 554' ' ' GLN . . . . . 0.432 HE22 ' HB2' ' A' ' 538' ' ' ASN . 2.8 mp0 -88.13 110.55 20.75 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.293 0.568 . . . . 75.34 109.964 178.61 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 555' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 524' ' ' SER . 15.7 t -96.47 135.86 29.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 107.796 -1.187 . . . . 65.33 107.796 -178.201 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.625 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 68.7 m -89.19 124.65 34.56 Favored 'General case' 0 N--CA 1.4 -2.959 0 C-N-CA 120.375 -0.53 . . . . 51.43 110.304 176.709 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -97.79 131.21 44.5 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 104.384 -2.451 . . . . 61.25 104.384 166.87 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -56.14 -26.37 49.45 Favored Glycine 0 CA--C 1.491 -1.448 0 O-C-N 124.258 0.974 . . . . 51.33 112.303 -175.173 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 57.2 t30 68.38 21.64 8.23 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 123.035 1.398 . . . . 75.2 108.716 174.159 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.5 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 63.4 mt-30 -126.94 145.27 50.75 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 113.176 -1.829 . . . . 73.44 107.183 177.993 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -122.8 149.5 44.07 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 120.605 -0.438 . . . . 62.2 110.174 -177.134 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.74 115.51 7.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 O-C-N 123.83 0.706 . . . . 71.03 109.111 -178.711 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.516 ' SD ' HG21 ' A' ' 620' ' ' ILE . 35.7 ttp -79.85 123.24 83.87 Favored Pre-proline 0 C--N 1.306 -1.285 0 CA-C-N 115.575 -0.739 . . . . 73.41 111.747 -175.657 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 564' ' ' PRO . . . . . 0.456 ' HG2' ' HB2' ' A' ' 581' ' ' LEU . 20.8 Cg_exo -68.76 156.73 64.49 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.945 2.43 . . . . 73.21 110.773 174.4 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.97 123.48 28.36 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.761 0.791 . . . . 64.41 110.702 179.009 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 566' ' ' LEU . . . . . 0.466 ' H ' HD13 ' A' ' 566' ' ' LEU . 0.0 OUTLIER -119.81 14.07 12.45 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.903 -1.517 . . . . 75.42 106.903 173.411 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 3.0 m -69.13 140.46 54.73 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 112.967 -1.924 . . . . 73.24 110.18 -177.541 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 73.72 70.53 1.22 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 116.276 -0.42 . . . . 55.4 113.46 177.937 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 22.1 ptp -174.07 172.21 3.41 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.742 -0.836 . . . . 65.01 108.742 179.28 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 570' ' ' PHE . . . . . 0.452 ' HB2' HG12 ' A' ' 572' ' ' VAL . 95.7 m-85 -100.36 178.66 4.69 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.478 -0.934 . . . . 74.35 108.478 178.275 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 571' ' ' TRP . . . . . 0.413 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 11.7 t-105 -64.76 -28.71 69.77 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.806 0.336 . . . . 72.3 110.259 -177.449 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 572' ' ' VAL . . . . . 0.452 HG12 ' HB2' ' A' ' 570' ' ' PHE . 12.7 p -58.02 -30.05 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 123.339 0.656 . . . . 62.11 111.789 179.598 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 573' ' ' ASP . . . . . 0.503 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 29.5 m-20 -100.81 -38.65 8.17 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 120.982 -0.287 . . . . 75.4 110.313 175.762 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 574' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -58.73 -43.11 90.1 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.357 0.873 . . . . 73.44 113.357 -176.658 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 575' ' ' GLU . . . . . 0.664 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 31.4 tt0 -65.3 -50.71 57.77 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 120.42 -0.512 . . . . 64.41 111.06 -179.193 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 576' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 71.2 Cg_exo -56.19 -35.74 95.73 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 121.314 1.342 . . . . 70.3 111.911 172.903 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 577' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 14.5 mmt180 -64.76 -38.49 91.16 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 111.711 0.263 . . . . 72.55 111.711 178.44 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.1 pp -65.93 -46.36 78.48 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.126 -0.63 . . . . 64.22 110.561 -176.762 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 579' ' ' ARG . . . . . 0.475 ' N ' HD12 ' A' ' 578' ' ' LEU . 11.9 ptm180 -66.35 -39.54 89.23 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.027 -0.533 . . . . 71.13 112.058 176.045 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.56 -27.31 64.04 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 112.567 0.58 . . . . 55.44 112.567 -177.537 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 581' ' ' LEU . . . . . 0.456 ' HB2' ' HG2' ' A' ' 564' ' ' PRO . 2.3 pp -92.28 -8.46 45.17 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 119.867 -0.733 . . . . 74.23 110.426 -179.677 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 77.27 48.69 8.0 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 120.633 -0.794 . . . . 75.33 111.323 -178.148 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -84.49 127.45 34.04 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.095 -1.076 . . . . 71.34 108.095 177.54 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 3.4 p -90.35 -5.52 56.11 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 124.71 1.204 . . . . 62.11 113.114 -175.948 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -114.09 -168.57 16.4 Favored Glycine 0 C--N 1.302 -1.346 0 N-CA-C 111.66 -0.576 . . . . 70.5 111.66 -179.516 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 26.4 mmt -121.15 153.86 36.96 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 110.087 -0.338 . . . . 71.31 110.087 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 6.3 tt -83.26 127.32 33.54 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.608 -0.886 . . . . 73.04 108.608 -178.159 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -125.08 116.48 22.15 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.165 -0.679 . . . . 74.23 109.165 178.434 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.63 133.56 36.84 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 118.756 -1.177 . . . . 74.31 110.636 177.821 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -78.97 -41.58 14.05 Favored Glycine 0 C--N 1.285 -2.298 0 CA-C-N 114.603 -1.181 . . . . 72.24 112.956 -172.908 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -138.29 142.04 39.82 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.77 -0.455 . . . . 71.32 109.77 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -111.78 125.13 53.66 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.907 -1.516 . . . . 72.44 106.907 175.452 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.68 116.79 48.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 N-CA-C 107.902 -1.147 . . . . 72.21 107.902 179.17 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 594' ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 5.3 p-10 -73.96 107.12 5.98 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.022 0.915 . . . . 61.13 112.483 -176.777 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -146.68 -61.34 0.3 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.184 -1.413 . . . . 70.21 107.184 175.377 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 132.31 147.56 5.89 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 120.132 -1.033 . . . . 53.12 112.283 177.365 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.66 -33.36 62.7 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 122.745 0.212 . . . . 53.03 113.508 -178.695 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 3.3 m -62.96 -23.52 67.45 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.534 1.134 . . . . 73.23 111.092 -177.936 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -87.44 0.55 55.34 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 124.801 1.24 . . . . 70.54 111.111 -175.082 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 66.3 m80 71.78 32.71 1.88 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.783 1.278 . . . . 75.24 109.098 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 601' ' ' ASN . . . . . 0.441 ' CG ' ' HA3' ' A' ' 625' ' ' GLY . 2.2 t-20 -82.31 41.82 0.71 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 112.815 -1.993 . . . . 55.53 109.84 -175.839 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -74.22 174.45 8.74 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 126.282 1.833 . . . . 73.23 110.303 178.686 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.6 129.86 17.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.242 -1.022 . . . . 73.03 108.242 -178.925 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 24.7 m -106.3 -28.27 2.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.606 -0.725 . . . . 54.03 111.271 -176.67 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -156.74 141.64 17.06 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.144 -0.48 . . . . 74.15 111.081 -178.268 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -122.64 142.05 51.07 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.138 -1.43 . . . . 75.43 107.138 172.471 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -58.05 -50.09 90.02 Favored Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 113.312 0.856 . . . . 51.34 113.312 -175.077 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -89.86 128.2 1.62 Allowed 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 121.068 1.179 . . . . 63.11 110.823 174.316 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.3 151.01 65.75 Favored 'Trans proline' 0 C--O 1.247 0.936 0 C-N-CA 122.446 2.098 . . . . 71.12 112.37 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.69 135.68 57.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.332 -0.394 . . . . 61.22 110.438 178.821 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.09 -11.88 48.66 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.386 -0.911 . . . . 65.02 112.38 -179.714 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 4.7 t -90.09 167.91 12.39 Favored 'General case' 0 C--O 1.255 1.373 0 C-N-CA 119.682 -0.807 . . . . 75.13 109.197 -179.361 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -90.83 117.5 5.14 Favored Glycine 0 N--CA 1.427 -1.929 0 N-CA-C 111.432 -0.667 . . . . 75.03 111.432 -178.826 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.03 142.58 16.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 109.686 -0.487 . . . . 75.53 109.686 178.06 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.5 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 28.9 p-10 -51.07 165.16 0.13 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.26 1.024 . . . . 63.22 112.187 -179.213 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -58.8 -25.12 62.84 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.554 0.576 . . . . 75.22 112.554 -178.148 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -80.81 -9.23 59.83 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.66 -0.496 . . . . 71.04 109.66 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.4 -0.89 5.87 Favored Glycine 0 C--O 1.211 -1.291 0 C-N-CA 124.756 1.169 . . . . 72.31 114.247 171.84 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.45 119.43 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 CA-C-O 122.266 1.032 . . . . 54.43 112.051 -164.008 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.516 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.5 pp -125.68 133.98 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 CA-C-N 114.288 -1.324 . . . . 70.32 109.313 -178.529 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 11.5 t -101.52 139.23 37.45 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 108.31 -0.996 . . . . 65.45 108.31 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.6 pp -138.64 168.73 19.15 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.738 -0.665 . . . . 44.21 111.215 -174.839 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -123.95 137.06 54.68 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.1 -1.445 . . . . 73.44 107.1 -178.967 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . 0.279 0.2 OUTLIER -135.85 166.17 23.93 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.207 -1.361 . . . . 63.44 108.164 -161.952 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 625' ' ' GLY . . . . . 0.441 ' HA3' ' CG ' ' A' ' 601' ' ' ASN . . . -84.57 -140.72 4.91 Favored Glycine 0 N--CA 1.407 -3.274 0 C-N-CA 119.286 -1.435 . . . . 62.4 110.31 166.762 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.471 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 53.8 tp60 . . . . . 0 C--N 1.283 -2.301 0 CA-C-O 118.275 -0.869 . . . . 73.14 108.924 -179.139 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.94 0 N-CA-C 110.558 -1.017 . . . . 43.05 110.558 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.64 156.48 65.87 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 122.396 2.064 . . . . 74.24 112.681 -177.653 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 493' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . 71.84 2.23 4.21 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 125.346 1.459 . . . . 71.12 112.935 177.296 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 13.8 p -145.79 140.31 27.04 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 122.283 -0.26 . . . . 74.11 111.172 -177.053 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -141.85 154.44 45.16 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.623 -0.51 . . . . 71.23 109.623 178.068 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 496' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.4 p-10 -89.5 144.23 26.2 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.167 0.508 . . . . 74.32 111.365 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.5 pt -99.85 137.71 20.22 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 115.506 -0.77 . . . . 52.31 110.954 -179.517 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -82.21 163.67 17.42 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.111 1.874 . . . . 63.04 111.197 176.812 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.16 103.93 8.41 Favored 'General case' 0 CA--C 1.491 -1.312 0 CA-C-O 122.647 1.213 . . . . 74.24 109.454 176.079 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.486 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 15.0 m -106.99 63.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.437 0 CA-C-O 123.219 1.485 . . . . 73.34 110.394 -177.514 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 501' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -118.54 110.84 17.86 Favored 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 112.357 -2.201 . . . . 63.2 108.683 172.306 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 145.3 -37.4 1.31 Allowed Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 119.768 -1.206 . . . . 51.21 112.715 177.621 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 503' ' ' GLN . . . . . 0.492 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.5 OUTLIER -95.79 -175.16 3.34 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.494 -0.558 . . . . 71.14 109.494 -178.614 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 24.4 m -72.02 155.38 40.38 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.34 -0.985 . . . . 63.42 108.34 176.587 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.501 ' HA ' ' HB ' ' A' ' 534' ' ' VAL . 7.1 p -61.25 -41.75 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 116.41 -0.359 . . . . 64.24 111.846 -179.398 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 506' ' ' ASP . . . . . 0.551 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 35.5 t70 -65.26 -39.98 93.35 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 110.02 -0.363 . . . . 72.2 110.02 179.166 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.58 -42.61 93.34 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 N-CA-C 109.434 -0.58 . . . . 72.52 109.434 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 508' ' ' ALA . . . . . 0.486 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -62.26 -44.43 96.57 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 123.456 0.473 . . . . 61.31 111.275 175.895 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -63.01 -45.42 92.43 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 120.505 0.193 . . . . 73.34 111.284 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 32.2 mmmt -65.0 -39.49 93.53 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.514 -0.55 . . . . 74.32 109.514 178.814 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -61.27 -49.81 75.55 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.678 -1.146 . . . . 74.31 110.247 -177.702 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.95 -34.71 75.78 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.496 -0.774 . . . . 75.05 110.894 -177.991 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -61.6 -38.01 86.02 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.79 -0.641 . . . . 65.25 110.272 179.717 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 510' ' ' LYS . 69.3 t -59.51 -33.84 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.035 0.445 . . . . 75.32 111.268 178.309 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -111.89 15.9 20.59 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.372 0.606 . . . . 74.12 109.806 -177.253 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -141.17 -60.6 0.03 OUTLIER Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 119.969 -1.11 . . . . 72.03 113.919 -172.834 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 63.54 41.48 7.31 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 122.667 1.222 . . . . 62.11 109.281 -173.642 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 518' ' ' THR . . . . . 0.558 HG22 ' HA ' ' A' ' 547' ' ' VAL . 14.8 p -95.27 -171.68 2.47 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 113.58 -1.646 . . . . 70.21 110.48 -178.847 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -107.91 137.49 45.82 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.346 -1.724 . . . . 72.0 106.346 174.719 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -132.92 151.87 51.98 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 112.233 0.457 . . . . 72.14 112.233 -178.866 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 52.8 p -139.6 159.42 42.21 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.168 -1.049 . . . . 61.32 108.168 176.571 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -117.5 134.23 55.09 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.638 -0.425 . . . . 71.51 110.708 177.671 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -112.28 126.74 55.57 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.573 -0.899 . . . . 73.32 108.573 177.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 6.5 p -96.03 130.55 43.01 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.192 0.52 . . . . 51.42 111.601 -178.032 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 11.4 p -139.86 156.28 25.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 106.654 -1.61 . . . . 75.35 106.654 177.194 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 526' ' ' ASP . . . . . 0.492 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 4.1 p30 -96.24 136.44 36.72 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 120.168 -0.613 . . . . 61.44 111.921 -179.707 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.4 m -161.84 161.04 22.29 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 107.061 -1.459 . . . . 60.3 107.061 179.352 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -66.57 8.61 0.31 Allowed 'Trans proline' 0 CA--C 1.557 1.653 0 C-N-CA 122.799 2.333 . . . . 72.41 114.559 -178.957 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.74 132.11 47.39 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 107.0 -1.481 . . . . 73.53 107.0 174.782 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -59.85 142.49 98.7 Favored 'Trans proline' 0 C--O 1.253 1.271 0 C-N-CA 122.261 1.974 . . . . 71.11 112.486 -177.733 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.39 107.43 0.49 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.04 -0.982 . . . . 63.51 111.219 -177.59 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 140.1 -28.85 2.46 Favored Glycine 0 N--CA 1.429 -1.794 0 CA-C-N 115.267 -0.879 . . . . 71.12 111.009 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -76.83 125.67 29.67 Favored 'General case' 0 C--O 1.251 1.144 0 CA-C-O 121.672 0.748 . . . . 65.11 110.292 -179.79 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 534' ' ' VAL . . . . . 0.501 ' HB ' ' HA ' ' A' ' 505' ' ' VAL . 7.1 p -82.15 121.99 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.927 0 N-CA-C 107.611 -1.255 . . . . 72.21 107.611 177.429 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.74 16.85 11.39 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 113.638 -1.619 . . . . 53.03 110.361 -173.247 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.449 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 115.58 -161.68 12.77 Favored Glycine 0 N--CA 1.424 -2.124 0 N-CA-C 111.405 -0.678 . . . . 70.24 111.405 177.765 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 537' ' ' THR . . . . . 0.403 HG22 HD13 ' A' ' 553' ' ' LEU . 9.6 p -117.16 154.76 30.52 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 109.274 -0.639 . . . . 72.24 109.274 -179.184 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 538' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 552' ' ' GLU . 20.9 t-20 -63.95 -53.02 52.38 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 119.735 -0.786 . . . . 64.13 110.932 173.31 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 539' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 26.0 Cg_exo -67.11 145.99 75.09 Favored 'Trans proline' 0 C--N 1.378 2.125 0 N-CA-C 108.773 -1.279 . . . . 64.44 108.773 171.931 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.84 140.7 94.64 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 122.281 1.987 . . . . 63.24 112.493 -178.827 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.83 137.95 55.74 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.981 -0.554 . . . . 71.51 109.534 178.72 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 96.52 -14.66 63.96 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 121.001 -0.619 . . . . 72.13 111.894 -178.506 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 43.4 m -79.72 137.42 37.03 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-O 121.027 0.441 . . . . 60.23 110.919 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 544' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.3 t -80.78 124.45 29.07 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 121.503 0.668 . . . . 74.43 109.571 177.551 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.43 159.15 56.33 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.996 -1.113 . . . . 72.02 107.996 -178.086 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 546' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 20.7 Cg_exo -63.5 137.76 61.55 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.137 1.225 . . . . 73.23 111.323 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 547' ' ' VAL . . . . . 0.558 ' HA ' HG22 ' A' ' 518' ' ' THR . 12.1 p -66.21 -19.64 25.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 122.272 1.034 . . . . 63.41 109.629 179.182 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -88.42 -13.24 40.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.201 -1.363 . . . . 73.24 111.143 -177.78 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 92.8 p -84.25 170.43 13.72 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-O 121.17 0.51 . . . . 55.31 110.697 -177.864 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.6 p -104.38 124.42 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.338 0 CA-C-N 115.271 -0.877 . . . . 74.33 109.036 177.878 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.32 135.4 26.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.402 -0.962 . . . . 63.14 108.402 -178.206 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 552' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 538' ' ' ASN . 5.6 tp10 -102.55 117.57 34.98 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.795 -0.817 . . . . 63.25 108.795 -177.643 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.403 HD13 HG22 ' A' ' 537' ' ' THR . 3.7 mm? -93.78 127.69 39.64 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.419 -0.956 . . . . 75.32 108.419 178.135 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -90.09 117.83 29.17 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.701 -0.481 . . . . 60.24 109.701 -177.529 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.51 122.18 64.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 109.095 -0.705 . . . . 45.5 109.095 -178.585 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 71.4 m -90.71 127.98 36.5 Favored 'General case' 0 N--CA 1.412 -2.33 0 C-N-CA 120.058 -0.657 . . . . 75.03 110.251 176.595 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -89.22 137.79 32.01 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 103.971 -2.603 . . . . 60.02 103.971 168.571 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -60.82 -24.25 62.24 Favored Glycine 0 C--N 1.314 -0.686 0 O-C-N 123.938 0.774 . . . . 62.24 113.553 -174.105 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 559' ' ' ASN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 23.6 t-20 76.94 -23.96 0.23 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.83 1.652 . . . . 71.2 109.951 -179.454 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.589 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 86.8 mt-30 -112.4 143.58 43.29 Favored 'General case' 0 N--CA 1.399 -2.989 0 CA-C-N 114.596 -1.184 . . . . 72.01 110.144 -174.298 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -122.99 158.57 30.2 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 114.884 -1.053 . . . . 74.45 108.686 -179.49 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 53.3 t -63.47 117.11 3.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 O-C-N 123.65 0.594 . . . . 71.14 109.658 -179.567 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 563' ' ' MET . . . . . 0.615 ' HE3' HG13 ' A' ' 620' ' ' ILE . 22.2 ttt -70.4 127.1 92.4 Favored Pre-proline 0 C--N 1.297 -1.696 0 C-N-CA 124.408 1.083 . . . . 74.23 112.706 -177.795 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.91 169.66 22.11 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.148 2.565 . . . . 64.32 111.032 172.894 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -90.87 126.95 36.19 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 110.089 -0.337 . . . . 70.01 110.089 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 566' ' ' LEU . . . . . 0.467 ' O ' ' HG2' ' A' ' 569' ' ' MET . 1.7 tm? -104.84 -16.38 14.91 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.836 0.827 . . . . 74.45 109.031 -175.59 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 24.0 m -72.41 143.26 48.58 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.939 -0.573 . . . . 72.32 110.596 -178.19 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 101.18 4.76 53.53 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.628 -0.796 . . . . 62.52 113.912 178.199 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 569' ' ' MET . . . . . 0.532 ' SD ' ' HA ' ' A' ' 574' ' ' ALA . 23.5 ptp -123.0 166.88 14.36 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 117.526 0.663 . . . . 74.04 109.947 179.101 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -101.54 166.32 10.78 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.692 -1.595 . . . . 63.1 106.692 -178.591 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 13.7 t-105 -62.58 -30.13 71.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 118.572 0.624 . . . . 52.51 109.679 179.737 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.2 m -71.5 -21.95 21.79 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 CA-C-N 115.923 -0.58 . . . . 74.42 111.632 -179.253 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -101.31 -27.39 13.2 Favored 'General case' 0 C--O 1.256 1.405 0 N-CA-C 109.04 -0.726 . . . . 74.33 109.04 -178.594 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 574' ' ' ALA . . . . . 0.64 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -63.52 -54.23 39.47 Favored 'General case' 0 C--O 1.207 -1.132 0 CA-C-N 114.419 -1.264 . . . . 34.11 112.284 -178.38 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -53.02 -52.19 67.73 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 114.181 1.178 . . . . 74.53 114.181 -176.442 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -54.73 -39.7 88.1 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 121.454 1.436 . . . . 61.41 112.218 174.234 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -69.12 -34.55 75.23 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.63 0.604 . . . . 74.32 112.63 176.577 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 47.8 mt -65.88 -48.37 71.74 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.596 0.712 . . . . 74.13 109.21 -177.74 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -34.62 78.29 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.197 -0.911 . . . . 63.11 111.64 178.277 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.39 -32.12 69.64 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.373 -0.376 . . . . 71.44 111.287 -177.987 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.4 pp -85.71 -8.74 57.99 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.499 0.666 . . . . 75.21 109.622 179.242 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 77.13 44.79 12.75 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.126 -0.943 . . . . 53.4 112.5 178.367 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -74.03 127.64 33.45 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.378 0.609 . . . . 71.54 109.688 179.218 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 2.8 p -85.06 -40.12 17.2 Favored 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 124.859 1.264 . . . . 63.21 112.928 -177.26 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -80.47 -161.05 24.09 Favored Glycine 0 C--O 1.242 0.656 0 N-CA-C 115.571 0.988 . . . . 72.24 115.571 -174.368 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 54.5 mtt -119.86 154.01 34.96 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 123.624 0.769 . . . . 74.13 109.28 -176.386 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 6.8 tt -83.48 123.44 29.71 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.339 0.59 . . . . 74.05 109.689 -178.453 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 588' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 621' ' ' THR . 36.6 t70 -113.7 114.29 26.17 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.898 -1.046 . . . . 74.31 108.568 -179.801 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 589' ' ' LYS . . . . . 0.475 ' HD2' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -99.8 133.56 43.97 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.381 -0.927 . . . . 73.22 109.851 -179.059 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -86.81 -46.05 5.25 Favored Glycine 0 C--N 1.285 -2.302 0 CA-C-N 115.616 -0.72 . . . . 35.21 111.543 -177.461 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.67 135.01 32.78 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 110.119 -0.326 . . . . 71.43 110.119 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -116.73 127.45 54.4 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.242 -1.022 . . . . 74.33 108.242 174.246 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 99.4 t -111.28 116.83 53.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 116.452 -0.34 . . . . 73.33 110.262 -177.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 594' ' ' ASP . . . . . 0.593 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 27.6 t70 -73.77 116.77 14.76 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-O 120.82 0.343 . . . . 54.42 111.268 -177.338 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -139.77 -42.63 0.44 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.819 -0.628 . . . . 72.23 109.727 178.065 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 123.16 140.1 5.6 Favored Glycine 0 N--CA 1.426 -1.992 0 C-N-CA 120.731 -0.747 . . . . 43.14 111.842 178.827 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.75 -32.18 61.56 Favored Glycine 0 C--N 1.315 -0.636 0 CA-C-O 121.09 0.272 . . . . 72.43 112.552 179.593 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 4.7 p -64.02 -23.23 67.25 Favored 'General case' 0 N--CA 1.432 -1.349 0 C-N-CA 125.218 1.407 . . . . 64.44 111.563 -178.866 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -87.22 -0.53 56.85 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.199 -0.909 . . . . 71.31 109.9 -176.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 13.9 m170 65.26 65.39 0.58 Allowed 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 122.573 1.178 . . . . 72.13 110.954 -178.737 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -81.38 92.52 6.43 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 114.137 -1.392 . . . . 72.44 111.729 -179.057 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 41.3 mtm-85 -91.39 171.71 9.02 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 113.674 -1.603 . . . . 53.41 107.678 176.772 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 603' ' ' VAL . . . . . 0.48 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 86.9 t -67.67 130.26 32.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 105.497 -2.038 . . . . 75.12 105.497 169.263 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 59.4 t -101.15 -52.59 8.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 C-N-CA 120.501 -0.48 . . . . 44.44 110.813 -172.194 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -133.1 136.28 45.76 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.901 -0.59 . . . . 72.24 109.831 -177.88 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 606' ' ' GLN . . . . . 0.466 ' HB2' HD11 ' A' ' 620' ' ' ILE . 13.3 pt20 -112.29 140.13 47.26 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.441 -1.689 . . . . 71.02 106.441 175.429 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 607' ' ' ASN . . . . . 0.423 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 11.6 t30 -56.74 -53.7 61.93 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 113.418 0.895 . . . . 74.31 113.418 -175.74 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 608' ' ' PRO . . . . . 0.446 ' O ' ' HG3' ' A' ' 606' ' ' GLN . 7.2 Cg_endo -91.43 134.01 1.56 Allowed 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.434 1.422 . . . . 75.21 110.459 173.526 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.07 157.69 58.98 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 121.447 1.432 . . . . 44.22 111.306 178.188 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.88 138.52 58.36 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 108.892 -0.781 . . . . 42.02 108.892 177.811 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.6 -8.76 43.99 Favored Glycine 0 C--N 1.302 -1.339 0 C-N-CA 120.679 -0.772 . . . . 73.44 111.928 -176.155 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 54.3 m -77.04 146.83 37.11 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.892 -0.781 . . . . 73.21 108.892 176.629 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -81.1 114.63 3.86 Favored Glycine 0 N--CA 1.432 -1.632 0 N-CA-C 109.818 -1.313 . . . . 52.34 109.818 174.07 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 614' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 22.0 m -108.26 141.26 23.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 116.908 0.354 . . . . 63.34 110.592 178.945 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 615' ' ' ASN . . . . . 0.589 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 41.3 p30 -51.57 173.15 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.219 1.562 . . . . 72.53 115.219 -177.758 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -60.91 -25.21 66.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.059 -1.428 . . . . 70.01 112.289 178.161 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -85.63 -11.1 54.72 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.2 -1.037 . . . . 75.12 108.2 -178.036 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.46 15.12 63.31 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 115.44 -0.8 . . . . 63.43 112.639 168.178 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.72 125.55 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 122.056 0.932 . . . . 74.43 111.365 -167.885 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 620' ' ' ILE . . . . . 0.615 HG13 ' HE3' ' A' ' 563' ' ' MET . 0.0 OUTLIER -129.67 132.1 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.261 0 CA-C-N 114.193 -1.367 . . . . 72.42 109.466 -179.055 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 74.7 m -104.33 122.45 45.47 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.935 -1.135 . . . . 65.31 107.935 178.364 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 622' ' ' LEU . . . . . 0.423 HD13 ' H ' ' A' ' 622' ' ' LEU . 0.0 OUTLIER -132.99 166.93 21.25 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.25 -0.432 . . . . 73.05 111.714 -176.177 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -127.11 136.43 52.12 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.921 -1.14 . . . . 70.31 107.921 175.616 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.48 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 3.3 p90 -142.35 165.44 27.41 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.788 -0.642 . . . . 52.23 110.969 -173.672 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -80.66 150.54 31.34 Favored Glycine 0 N--CA 1.421 -2.35 0 N-CA-C 109.748 -1.341 . . . . 53.03 109.748 175.449 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 626' ' ' GLN . . . . . 0.593 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 42.0 tt0 . . . . . 0 C--N 1.275 -2.657 0 CA-C-O 117.949 -1.024 . . . . 54.53 108.582 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.9 0 CA-C-O 120.854 0.359 . . . . 75.340000000000003 111.382 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 21.8 p -134.84 147.96 50.04 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.231 -0.655 . . . . 73.230000000000004 109.231 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -148.26 143.94 27.31 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.844 -1.539 . . . . 73.329999999999998 106.844 -177.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.2 p-10 -88.93 137.88 31.92 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.028 -0.669 . . . . 70.140000000000001 109.414 178.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 498' ' ' PRO . 40.9 pt -89.63 134.39 32.49 Favored Pre-proline 0 C--N 1.297 -1.691 0 CA-C-N 116.147 -0.479 . . . . 62.32 111.94 -177.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 3.9 Cg_exo -84.71 156.45 11.94 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.543 2.162 . . . . 74.219999999999999 110.051 171.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -88.54 121.22 30.68 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-O 122.401 1.096 . . . . 70.120000000000005 109.055 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.403 ' CG2' ' HB1' ' A' ' 508' ' ' ALA . 5.6 m -109.62 61.11 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.655 0 CA-C-N 113.999 -1.455 . . . . 65.120000000000005 109.378 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -105.73 109.95 22.08 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 112.462 -2.154 . . . . 75.530000000000001 109.426 174.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 152.57 -29.44 0.85 Allowed Glycine 0 C--N 1.305 -1.193 0 C-N-CA 119.561 -1.304 . . . . 61.409999999999997 113.124 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.428 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.3 OUTLIER -107.81 -169.73 1.57 Allowed 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.856 -0.424 . . . . 70.120000000000005 109.856 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.413 ' HB ' HG23 ' A' ' 507' ' ' VAL . 9.7 m -70.57 155.46 40.7 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.409 -0.96 . . . . 72.120000000000005 108.409 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.443 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.1 p -60.95 -41.43 88.99 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.792 0 O-C-N 123.135 0.272 . . . . 63.210000000000001 110.915 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -59.85 -44.28 94.19 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 120.767 0.317 . . . . 73.219999999999999 110.534 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.413 HG23 ' HB ' ' A' ' 504' ' ' THR . 46.3 t -69.18 -38.63 78.21 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.137 0 CA-C-N 115.529 -0.76 . . . . 63.43 109.548 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.452 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -63.68 -45.6 89.35 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.252 -0.431 . . . . 60.219999999999999 110.957 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.7 mt-30 -64.93 -41.34 95.61 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.935 -0.575 . . . . 73.019999999999996 110.552 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.504 ' O ' HG23 ' A' ' 514' ' ' VAL . 47.8 mmtm -66.11 -42.28 89.45 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 116.097 -0.501 . . . . 73.239999999999995 110.459 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -62.51 -44.89 95.25 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 116.289 -0.414 . . . . 75.540000000000006 111.493 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 513' ' ' ASN . 3.9 pp -68.14 -35.24 77.77 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-O 121.132 0.492 . . . . 74.019999999999996 110.829 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.46 ' N ' HD12 ' A' ' 512' ' ' LEU . 2.4 t-20 -59.8 -35.7 75.22 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 123.894 0.878 . . . . 72.519999999999996 109.938 176.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 510' ' ' LYS . 89.5 t -64.63 -33.65 64.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-O 121.251 0.548 . . . . 74.510000000000005 110.929 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -97.71 -0.78 44.85 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.463 -0.335 . . . . 70.140000000000001 110.451 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -134.96 -57.09 0.06 OUTLIER Glycine 0 CA--C 1.484 -1.868 0 C-N-CA 119.619 -1.277 . . . . 64.010000000000005 114.841 -169.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 69.24 20.56 7.45 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 122.143 0.973 . . . . 74.530000000000001 109.3 -171.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.5 p -79.37 -172.02 3.01 Favored 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 125.973 1.709 . . . . 52.100000000000001 110.65 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.0 142.09 38.66 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.758 -1.201 . . . . 75.25 107.758 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -133.14 147.9 52.1 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.142 0.496 . . . . 72.209999999999994 111.846 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 55.6 m -140.91 151.78 44.52 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.193 -1.04 . . . . 54.130000000000003 108.193 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -121.1 145.34 47.9 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 120.96 0.41 . . . . 74.430000000000007 111.683 -174.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -138.6 132.82 31.63 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.687 -0.857 . . . . 41.020000000000003 108.687 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.525 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 11.1 p -96.32 126.74 41.74 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 113.421 0.897 . . . . 74.140000000000001 113.421 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.1 p -121.18 150.85 24.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.076 -1.083 . . . . 64.140000000000001 108.076 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.98 136.14 45.09 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.493 -0.558 . . . . 75.310000000000002 109.493 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.544 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 39.4 m -159.51 168.14 12.8 Favored Pre-proline 0 C--N 1.301 -1.505 0 N-CA-C 108.117 -1.068 . . . . 64.319999999999993 108.117 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -71.75 -14.27 29.9 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.019 1.813 . . . . 64.140000000000001 111.853 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.12 140.81 95.96 Favored Pre-proline 0 C--O 1.219 -0.549 0 N-CA-C 109.297 -0.631 . . . . 73.219999999999999 109.297 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.41 146.86 86.49 Favored 'Trans proline' 0 C--O 1.252 1.213 0 C-N-CA 121.935 1.756 . . . . 44.229999999999997 111.236 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.16 113.57 1.78 Allowed 'General case' 0 C--O 1.242 0.678 0 CA-C-N 116.002 -0.544 . . . . 53.240000000000002 111.644 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 132.37 -22.9 4.12 Favored Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 115.4 -0.818 . . . . 53.240000000000002 111.551 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.01 139.49 33.25 Favored 'General case' 0 CA--C 1.493 -1.222 0 CA-C-O 121.018 0.437 . . . . 74.349999999999994 110.04 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.505 HG22 ' H ' ' A' ' 536' ' ' GLY . 7.4 p -102.96 124.86 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.817 0 CA-C-O 121.884 0.849 . . . . 73.209999999999994 109.667 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.63 -4.93 59.24 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.697 -1.138 . . . . 65.439999999999998 112.635 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.505 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 141.53 -162.68 26.93 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 119.772 -1.204 . . . . 62.140000000000001 113.488 173.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 13.2 p -116.45 159.19 22.39 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 107.651 -1.24 . . . . 70.239999999999995 107.651 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -60.02 -53.59 63.69 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 119.103 -1.039 . . . . 71.049999999999997 112.36 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -82.21 140.73 11.19 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 121.266 1.311 . . . . 43.0 110.521 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.6 162.95 40.59 Favored 'Trans proline' 0 C--O 1.251 1.137 0 C-N-CA 122.999 2.466 . . . . 62.350000000000001 113.613 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.71 129.7 43.18 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.639 -0.71 . . . . 52.340000000000003 110.461 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.83 -5.44 34.66 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.778 -0.646 . . . . 74.420000000000002 111.536 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 99.7 m -77.1 121.02 22.99 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 122.64 -0.33 . . . . 73.140000000000001 110.238 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 4.0 t -80.3 124.1 28.55 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.887 -0.783 . . . . 74.109999999999999 108.887 176.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 32.6 m -126.45 160.07 59.91 Favored Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 107.658 -1.238 . . . . 64.310000000000002 107.658 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -63.97 138.62 63.56 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 120.942 1.095 . . . . 73.109999999999999 109.512 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.1 p -60.7 -19.86 20.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.518 0.675 . . . . 75.340000000000003 111.475 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -100.02 3.41 44.18 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.148 0.499 . . . . 62.149999999999999 110.694 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 97.4 p -83.88 171.78 12.74 Favored 'General case' 0 C--O 1.251 1.133 0 O-C-N 121.404 -0.81 . . . . 45.009999999999998 111.525 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.2 p -103.83 134.43 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 CA-C-N 115.268 -0.878 . . . . 64.219999999999999 110.394 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 55.8 mt -103.37 136.26 36.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.106 -1.072 . . . . 72.439999999999998 108.106 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.52 118.58 37.06 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.985 0.898 . . . . 63.130000000000003 111.52 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.6 118.89 32.41 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.839 -1.528 . . . . 43.020000000000003 109.786 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -86.28 102.54 14.06 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.813 0.816 . . . . 54.149999999999999 110.383 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 524' ' ' SER . 23.3 t -85.63 128.17 39.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 114.304 -1.316 . . . . 60.229999999999997 107.523 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' ' 527' ' ' SER . 62.7 m -88.63 125.65 34.92 Favored 'General case' 0 N--CA 1.394 -3.25 0 CA-C-O 121.173 0.511 . . . . 60.450000000000003 110.823 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -101.64 134.21 45.13 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 107.275 -1.38 . . . . 61.450000000000003 107.275 173.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -63.29 -22.3 65.2 Favored Glycine 0 CA--C 1.493 -1.312 0 O-C-N 124.049 0.843 . . . . 75.430000000000007 112.365 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 79.55 2.88 2.21 Favored 'General case' 0 C--O 1.215 -0.725 0 C-N-CA 125.022 1.329 . . . . 73.409999999999997 108.674 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.403 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 90.6 mt-30 -113.09 150.23 32.37 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 114.998 -1.001 . . . . 73.340000000000003 112.363 -171.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -128.0 155.91 43.55 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.81 -1.181 . . . . 71.340000000000003 107.81 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 6.4 p -71.22 118.51 16.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 109.512 -0.551 . . . . 72.510000000000005 109.512 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 52.5 ttp -76.1 129.87 79.47 Favored Pre-proline 0 C--N 1.306 -1.322 0 C-N-CA 119.925 -0.71 . . . . 54.539999999999999 110.459 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.98 166.38 23.03 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.659 2.24 . . . . 51.100000000000001 111.27 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . 0.419 ' HA ' ' CB ' ' A' ' 610' ' ' ALA . 2.2 p-10 -81.03 131.85 35.33 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-O 121.368 0.604 . . . . 72.140000000000001 111.102 -175.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.2 pp -159.82 20.3 0.17 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.58 -1.191 . . . . 65.140000000000001 110.196 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 8.3 t -79.88 147.51 31.68 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 109.11 -0.7 . . . . 74.5 109.11 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 74.84 69.16 1.43 Allowed Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 120.922 -0.656 . . . . 75.209999999999994 112.068 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -147.97 174.05 12.27 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.143 -1.058 . . . . 73.099999999999994 108.143 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -98.77 169.42 9.48 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.786 -1.561 . . . . 61.329999999999998 106.786 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -67.88 -31.67 71.63 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.94 -0.763 . . . . 73.25 108.94 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 30.3 m -78.16 -13.9 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-N 115.907 -0.588 . . . . 65.230000000000004 110.929 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 37.2 t70 -95.29 -34.19 12.27 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.402 -1.333 . . . . 71.319999999999993 107.402 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . 0.725 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -57.76 -53.55 56.91 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.529 -1.214 . . . . 72.299999999999997 111.856 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 38.0 mt-10 -51.23 -54.56 36.97 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 113.871 1.063 . . . . 72.0 113.871 -175.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -57.53 -38.3 94.36 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 121.515 1.477 . . . . 64.5 112.225 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 24.2 mmm-85 -65.08 -38.66 91.49 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.342 0.115 . . . . 65.239999999999995 110.967 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 25.7 mt -66.69 -47.93 70.86 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.947 -0.39 . . . . 44.100000000000001 109.947 -176.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 2.3 ptp180 -66.56 -34.93 78.99 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 112.558 0.577 . . . . 74.319999999999993 112.558 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.82 -34.27 77.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.249 0.547 . . . . 63.43 110.272 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 12.5 tp -82.05 -9.76 59.44 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.635 -0.711 . . . . 73.150000000000006 110.339 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 64.11 41.02 98.61 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.892 -0.594 . . . . 62.409999999999997 112.382 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.469 ' CE3' HD22 ' A' ' 578' ' ' LEU . 18.2 t90 -78.55 127.24 31.87 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.919 0.39 . . . . 75.439999999999998 110.686 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 35.9 p -96.19 -22.2 17.42 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 112.988 0.736 . . . . 73.299999999999997 112.988 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -77.85 -173.09 40.16 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.353 -0.451 . . . . 55.149999999999999 113.995 -176.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 22.5 ttt -104.69 141.59 36.19 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 122.771 0.428 . . . . 42.299999999999997 110.871 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 33.9 tp -86.86 110.13 19.76 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.619 -0.882 . . . . 62.43 108.619 176.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.543 ' O ' ' HA ' ' A' ' 621' ' ' THR . 22.4 t70 -95.86 104.62 16.56 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.967 0.889 . . . . 62.109999999999999 110.26 -175.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -87.66 123.35 32.41 Favored 'General case' 0 N--CA 1.396 -3.171 0 CA-C-N 114.645 -1.161 . . . . 72.200000000000003 109.462 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -84.88 -100.04 0.66 Allowed Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.757 -0.937 . . . . 64.120000000000005 110.757 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -107.78 154.94 20.8 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 109.851 -0.426 . . . . 45.240000000000002 109.851 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . 0.422 ' OD1' ' HB3' ' A' ' 626' ' ' GLN . 3.0 p30 -106.53 145.69 31.55 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.469 -0.937 . . . . 61.210000000000001 108.469 174.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 57.4 t -104.5 138.71 28.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.033 -0.729 . . . . 70.420000000000002 109.033 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . 0.448 ' HA ' ' CD ' ' A' ' 626' ' ' GLN . 3.8 p30 -73.06 124.72 26.07 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 121.388 0.613 . . . . 55.350000000000001 110.045 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -159.64 -62.07 0.07 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.724 -1.125 . . . . 34.130000000000003 108.493 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 105.77 153.24 20.92 Favored Glycine 0 N--CA 1.422 -2.264 0 C-N-CA 119.659 -1.258 . . . . 65.510000000000005 111.787 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.34 -32.2 60.36 Favored Glycine 0 C--N 1.311 -0.851 0 C-N-CA 123.511 0.577 . . . . 52.420000000000002 113.643 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 4.9 p -72.67 -25.04 61.12 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-O 121.965 0.888 . . . . 62.130000000000003 110.383 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -95.09 -0.91 53.07 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.937 -1.029 . . . . 65.400000000000006 109.495 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 39.8 m80 74.06 99.51 0.07 Allowed 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 125.051 1.34 . . . . 72.140000000000001 112.148 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -80.3 83.32 6.17 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.382 -0.827 . . . . 71.209999999999994 110.99 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -108.17 160.31 15.92 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.282 -0.872 . . . . 73.239999999999995 109.728 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 71.2 t -64.83 130.2 29.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.084 -1.45 . . . . 52.210000000000001 107.084 171.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 43.5 t -108.61 -40.33 4.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 121.524 0.678 . . . . 70.299999999999997 110.108 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -142.9 142.07 31.65 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.793 -0.817 . . . . 73.239999999999995 108.793 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -137.56 143.56 41.63 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.906 -1.516 . . . . 72.040000000000006 106.906 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.431 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 24.6 t-20 -65.84 -53.11 37.33 Favored Pre-proline 0 C--N 1.308 -1.218 0 C-N-CA 119.235 -0.986 . . . . 61.229999999999997 112.132 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.8 Cg_endo -90.64 107.93 0.33 Allowed 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.09 1.86 . . . . 73.129999999999995 110.351 173.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -71.13 160.37 49.34 Favored 'Trans proline' 0 C--O 1.246 0.896 0 C-N-CA 123.258 2.638 . . . . 72.099999999999994 113.411 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . 0.419 ' CB ' ' HA ' ' A' ' 565' ' ' ASP . . . -67.85 138.54 56.17 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.351 -0.981 . . . . 64.129999999999995 108.351 175.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 96.69 -8.95 66.27 Favored Glycine 0 C--N 1.297 -1.6 0 C-N-CA 120.27 -0.967 . . . . 72.5 110.904 -175.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 24.2 m -101.88 153.17 20.09 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 108.06 -1.089 . . . . 65.340000000000003 108.06 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -74.77 127.16 9.38 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 121.242 -0.504 . . . . 71.510000000000005 112.151 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 30.9 m -119.98 142.6 34.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.898 -1.149 . . . . 74.209999999999994 107.898 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.403 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 33.9 p-10 -51.7 169.14 0.07 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.708 0.803 . . . . 75.209999999999994 112.736 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -60.29 -26.17 66.3 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 120.859 0.361 . . . . 64.329999999999998 111.699 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.433 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 5.4 m-20 -83.31 -7.82 59.53 Favored 'General case' 0 C--O 1.204 -1.324 0 CA-C-N 116.069 -0.514 . . . . 70.310000000000002 110.398 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.18 19.34 68.1 Favored Glycine 0 C--O 1.22 -0.776 0 O-C-N 123.285 0.366 . . . . 71.010000000000005 112.996 171.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.79 119.4 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-O 121.913 0.863 . . . . 54.039999999999999 111.217 -167.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 48.3 pt -126.21 133.92 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 115.096 -0.957 . . . . 71.219999999999999 110.522 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 14.9 t -105.8 128.73 53.91 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.924 -1.139 . . . . 41.0 107.924 177.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.5 pp -139.24 166.69 23.87 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 114.16 1.17 . . . . 72.510000000000005 114.16 -173.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -127.68 137.04 52.37 Favored 'General case' 0 C--O 1.256 1.411 0 N-CA-C 108.173 -1.047 . . . . 75.329999999999998 108.173 175.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -142.3 166.89 23.45 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.859 -0.61 . . . . 72.430000000000007 109.617 -174.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -60.94 145.79 47.96 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 121.102 -0.571 . . . . 75.239999999999995 112.296 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.448 ' CD ' ' HA ' ' A' ' 594' ' ' ASP . 3.3 pt20 . . . . . 0 C--O 1.251 1.179 0 N-CA-C 113.885 1.068 . . . . 72.150000000000006 113.885 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.874 0 CA-C-O 121.813 0.816 . . . . 51.219999999999999 110.838 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 15.0 p -136.55 155.06 50.47 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 114.981 -1.008 . . . . 62.32 110.317 -176.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.57 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 4.6 tmtt? -150.49 139.66 21.18 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.884 -0.784 . . . . 74.329999999999998 108.884 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.57 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 8.3 p-10 -78.18 129.75 35.51 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 123.633 0.773 . . . . 64.430000000000007 109.58 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.5 pt -99.03 131.65 25.0 Favored Pre-proline 0 C--N 1.304 -1.374 0 C-N-CA 120.45 -0.5 . . . . 71.329999999999998 111.689 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.08 158.54 34.0 Favored 'Trans proline' 0 C--O 1.243 0.742 0 C-N-CA 122.78 2.32 . . . . 53.329999999999998 112.167 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . 0.53 ' HA ' ' HB1' ' A' ' 541' ' ' ALA . 5.1 p-10 -82.23 112.7 19.48 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.95 0.881 . . . . 72.120000000000005 108.979 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 31.7 m -117.41 0.95 8.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 112.973 0.731 . . . . 65.420000000000002 112.973 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -69.63 100.98 1.55 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.298 0.57 . . . . 63.399999999999999 109.917 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 138.8 -13.5 3.39 Favored Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 110.717 -0.953 . . . . 61.219999999999999 110.717 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 508' ' ' ALA . 31.7 mm-40 -82.2 -178.25 6.95 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 108.692 -0.855 . . . . 71.349999999999994 108.692 175.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.7 m -78.6 156.15 29.27 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 104.293 -2.484 . . . . 62.25 104.293 169.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.473 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 8.4 p -60.13 -42.4 89.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 119.557 1.071 . . . . 75.540000000000006 112.224 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . 0.418 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 17.3 t70 -64.68 -43.43 93.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.945 0.402 . . . . 63.409999999999997 110.455 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 62.9 t -67.82 -39.11 81.31 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.252 0 CA-C-N 115.628 -0.714 . . . . 71.239999999999995 109.803 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 503' ' ' GLN . . . -62.4 -45.14 94.5 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.951 -0.389 . . . . 74.549999999999997 109.951 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.8 mt-30 -62.05 -46.68 88.06 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.759 -0.655 . . . . 71.239999999999995 111.353 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.567 ' O ' HG23 ' A' ' 514' ' ' VAL 0.359 0.0 OUTLIER -67.37 -38.15 84.32 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 112.48 0.548 . . . . 62.100000000000001 112.48 177.333 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -60.71 -50.04 75.07 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 110.602 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 513' ' ' ASN . 3.8 pp -68.49 -36.06 78.4 Favored 'General case' 0 C--O 1.208 -1.098 0 C-N-CA 120.156 -0.618 . . . . 72.430000000000007 111.598 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.487 ' N ' HD12 ' A' ' 512' ' ' LEU . 3.4 t-20 -69.79 -35.19 74.66 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 112.558 0.577 . . . . 73.430000000000007 112.558 -175.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 510' ' ' LYS . 72.2 t -57.33 -31.1 37.24 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 CA-C-O 121.438 0.637 . . . . 71.120000000000005 110.121 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -120.22 29.17 7.63 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.771 -0.649 . . . . 74.200000000000003 109.591 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -145.84 -56.79 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.423 0 C-N-CA 120.058 -1.068 . . . . 53.109999999999999 112.181 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 62.89 33.78 14.79 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.521 1.153 . . . . 73.340000000000003 111.151 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 547' ' ' VAL . 3.1 p -88.52 -171.43 3.33 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-N 113.83 -1.532 . . . . 53.530000000000001 109.047 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -111.77 142.49 44.06 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.891 -1.522 . . . . 74.109999999999999 106.891 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -132.47 148.81 52.4 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 113.201 0.815 . . . . 75.340000000000003 113.201 -174.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 51.0 m -133.06 157.66 44.7 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 106.713 -1.588 . . . . 61.219999999999999 106.713 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -125.97 126.89 45.07 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 109.693 -0.484 . . . . 63.409999999999997 109.693 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -124.16 143.27 50.59 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.45 -1.315 . . . . 64.540000000000006 107.45 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 65.8 p -102.8 139.94 37.72 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.094 -1.043 . . . . 72.430000000000007 112.426 -175.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 12.1 p -131.15 151.52 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 N-CA-C 107.768 -1.197 . . . . 75.329999999999998 107.768 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -87.34 137.2 32.55 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 121.3 0.571 . . . . 72.340000000000003 110.94 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.4 m -160.08 157.51 25.25 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 106.802 -1.555 . . . . 63.530000000000001 106.802 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -64.56 2.07 1.42 Allowed 'Trans proline' 0 CA--C 1.555 1.549 0 C-N-CA 122.653 2.235 . . . . 71.299999999999997 114.076 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -96.1 144.17 27.37 Favored Pre-proline 0 N--CA 1.433 -1.319 0 N-CA-C 109.523 -0.547 . . . . 60.229999999999997 109.523 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.03 146.59 97.53 Favored 'Trans proline' 0 C--O 1.249 1.07 0 C-N-CA 123.418 2.745 . . . . 74.340000000000003 114.618 -173.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.66 113.64 2.12 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.663 -1.153 . . . . 74.25 111.064 178.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 139.91 -23.53 2.76 Favored Glycine 0 C--N 1.301 -1.368 0 N-CA-C 111.083 -0.807 . . . . 62.109999999999999 111.083 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -79.33 144.91 33.79 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.81 -0.811 . . . . 73.420000000000002 108.81 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.449 HG11 ' HB2' ' A' ' 508' ' ' ALA . 7.7 p -94.35 114.99 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 N-CA-C 108.288 -1.004 . . . . 71.349999999999994 108.288 173.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.2 -31.3 72.44 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.18 -1.373 . . . . 63.240000000000002 109.433 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 152.78 -168.34 31.71 Favored Glycine 0 N--CA 1.407 -3.244 0 N-CA-C 109.728 -1.349 . . . . 74.230000000000004 109.728 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . 0.511 HG22 ' HG ' ' A' ' 553' ' ' LEU . 3.6 p -116.62 153.53 32.11 Favored 'General case' 0 C--N 1.268 -2.943 0 N-CA-C 107.807 -1.183 . . . . 52.439999999999998 107.807 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.455 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 54.0 t30 -67.41 -48.0 46.74 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 118.382 -1.327 . . . . 64.239999999999995 110.706 176.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.495 ' HD3' ' OE1' ' A' ' 552' ' ' GLU . 20.7 Cg_exo -71.9 129.66 15.67 Favored 'Trans proline' 0 C--N 1.374 1.882 0 N-CA-C 108.398 -1.424 . . . . 73.239999999999995 108.398 168.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.73 139.99 93.1 Favored 'Trans proline' 0 C--O 1.245 0.87 0 C-N-CA 122.955 2.437 . . . . 74.0 115.335 -174.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . 0.53 ' HB1' ' HA ' ' A' ' 499' ' ' ASP . . . -68.27 135.85 52.58 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.297 -1.32 . . . . 74.430000000000007 110.236 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 93.54 -16.58 60.38 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 111.455 -0.658 . . . . 54.520000000000003 111.455 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 63.1 m -88.67 139.16 30.75 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 124.151 0.98 . . . . 52.009999999999998 110.821 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.1 t -73.88 128.09 34.58 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 121.529 0.68 . . . . 75.439999999999998 109.21 175.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.72 164.98 27.65 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 107.13 -1.433 . . . . 64.420000000000002 107.13 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -67.25 136.07 39.11 Favored 'Trans proline' 0 N--CA 1.442 -1.543 0 CA-C-N 120.564 1.237 . . . . 73.200000000000003 110.437 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.444 ' HA ' HG22 ' A' ' 518' ' ' THR . 9.2 p -67.49 -22.11 28.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 122.037 0.923 . . . . 45.210000000000001 109.639 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -84.26 -12.68 54.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.141 -1.391 . . . . 61.439999999999998 110.992 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 11.4 t -93.14 153.12 18.84 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-O 121.555 0.693 . . . . 70.420000000000002 110.246 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 13.2 p -94.89 134.78 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.07 0 CA-C-N 114.865 -1.061 . . . . 72.219999999999999 108.583 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 62.1 mt -102.63 135.73 38.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.553 -0.748 . . . . 71.230000000000004 109.12 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . 0.495 ' OE1' ' HD3' ' A' ' 539' ' ' PRO . 2.1 pm0 -102.93 121.61 42.87 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-O 121.764 0.793 . . . . 64.439999999999998 110.551 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.511 ' HG ' HG22 ' A' ' 537' ' ' THR . 7.0 mp -98.66 122.19 41.56 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.208 -1.36 . . . . 74.439999999999998 108.369 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.549 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 2.7 mp0 -88.09 127.09 35.41 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.844 -0.616 . . . . 75.400000000000006 110.971 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 25.2 t -95.21 125.94 47.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.057 -0.974 . . . . 73.349999999999994 108.437 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.716 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 5.5 m -77.63 119.38 21.09 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.106 -1.072 . . . . 62.310000000000002 108.106 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -108.72 134.73 51.04 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 107.468 -1.308 . . . . 74.450000000000003 107.468 169.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -59.18 -23.49 57.54 Favored Glycine 0 CA--C 1.509 -0.297 0 O-C-N 124.035 0.834 . . . . 25.329999999999998 112.181 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 76.52 7.88 3.29 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.977 1.711 . . . . 74.439999999999998 108.181 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 89.0 mt-30 -126.77 146.16 50.34 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 114.889 -1.051 . . . . 72.040000000000006 110.649 -176.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . 0.447 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 53.8 p90 -124.01 152.83 42.14 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.332 -0.988 . . . . 74.430000000000007 108.332 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.47 124.4 13.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.401 0.62 . . . . 73.109999999999999 111.981 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 47.9 ttp -92.89 134.83 26.85 Favored Pre-proline 0 C--O 1.256 1.41 0 CA-C-N 115.697 -0.683 . . . . 74.129999999999995 110.057 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.73 169.07 16.82 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.884 2.389 . . . . 62.32 111.075 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.79 115.03 26.04 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.42 -0.955 . . . . 72.340000000000003 108.42 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . 0.419 ' O ' ' HG2' ' A' ' 569' ' ' MET . 91.5 mt -107.0 -0.21 23.21 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.722 0.772 . . . . 72.540000000000006 110.384 -176.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 20.6 t -79.52 153.47 29.53 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.502 -0.772 . . . . 75.329999999999998 109.317 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' A' ' 602' ' ' ARG . . . 82.62 25.26 51.03 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 120.22 -0.99 . . . . 71.140000000000001 114.031 177.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 23.2 ptp -140.69 176.77 8.52 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.305 -0.998 . . . . 72.019999999999996 108.305 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -98.34 169.12 9.79 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.656 -0.868 . . . . 50.450000000000003 108.656 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -64.18 -27.62 69.19 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.579 0.704 . . . . 71.319999999999993 109.355 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.5 p -72.95 -17.32 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 CA-C-N 115.46 -0.791 . . . . 72.150000000000006 110.74 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.489 ' O ' ' HD2' ' A' ' 576' ' ' PRO . 16.5 m-20 -91.17 -38.92 12.42 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 107.97 -1.122 . . . . 74.549999999999997 107.97 175.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . 0.678 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -56.79 -52.97 62.97 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.229 -1.351 . . . . 75.439999999999998 112.068 -178.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.493 ' HB2' ' HD3' ' A' ' 576' ' ' PRO . 47.2 mt-10 -51.08 -54.02 42.26 Favored Pre-proline 0 CA--C 1.559 1.304 0 N-CA-C 113.782 1.031 . . . . 72.030000000000001 113.782 -176.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.493 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 35.9 Cg_exo -61.15 -36.32 81.58 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 121.557 1.505 . . . . 74.239999999999995 112.137 177.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.457 ' HA ' ' NE ' ' A' ' 577' ' ' ARG . 3.3 mmp_? -62.84 -40.17 96.63 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.743 0.275 . . . . 71.239999999999995 111.743 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 25.0 mt -65.4 -48.92 71.2 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.333 0.587 . . . . 73.120000000000005 110.327 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -66.7 -36.84 83.45 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.704 -0.68 . . . . 62.539999999999999 112.455 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.12 -34.26 72.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.78 0.324 . . . . 43.219999999999999 111.258 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' A' ' 583' ' ' TRP . 1.5 pp -81.51 -6.22 58.75 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.396 0.617 . . . . 72.510000000000005 109.916 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.54 44.14 27.75 Favored Glycine 0 CA--C 1.498 -0.978 0 CA-C-N 115.585 -0.734 . . . . 74.430000000000007 111.988 177.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.464 ' CE3' HD22 ' A' ' 578' ' ' LEU . 15.3 t90 -87.35 127.04 35.2 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 109.32 -0.622 . . . . 71.450000000000003 109.32 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 17.2 p -101.27 -21.13 14.97 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.167 -0.469 . . . . 71.450000000000003 111.94 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -73.98 -175.12 31.74 Favored Glycine 0 C--O 1.242 0.628 0 CA-C-N 116.535 -0.302 . . . . 75.230000000000004 113.459 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 53.1 mtt -106.03 144.15 33.16 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.835 -0.182 . . . . 73.439999999999998 111.016 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 37.5 tp -89.64 108.02 19.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.473 0.654 . . . . 75.319999999999993 109.413 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' A' ' 621' ' ' THR . 28.4 t70 -97.73 117.1 31.28 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.139 -0.937 . . . . 75.439999999999998 110.351 -176.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.98 133.55 44.2 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 119.042 -1.063 . . . . 75.439999999999998 108.987 174.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -80.42 -54.39 3.77 Favored Glycine 0 C--N 1.299 -1.527 0 N-CA-C 111.267 -0.733 . . . . 50.210000000000001 111.267 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.04 146.9 39.6 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.644 -0.502 . . . . 60.32 109.644 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -113.31 131.83 55.8 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.694 -1.595 . . . . 61.509999999999998 106.694 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 46.2 t -105.0 115.59 47.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 C-N-CA 119.891 -0.724 . . . . 73.200000000000003 109.107 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . 0.494 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 24.3 t70 -78.0 126.63 31.11 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 112.756 0.65 . . . . 72.109999999999999 112.756 -175.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . 0.445 ' HB3' ' ND2' ' A' ' 601' ' ' ASN . . . -158.2 -30.62 0.08 Allowed 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.811 0.694 . . . . 53.409999999999997 111.153 174.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 108.66 144.08 10.72 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 119.45 -1.357 . . . . 24.199999999999999 112.959 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -60.67 -32.79 79.85 Favored Glycine 0 C--N 1.317 -0.506 0 C-N-CA 123.014 0.34 . . . . 52.329999999999998 113.267 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 31.3 t -62.18 -23.93 66.89 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.862 0.839 . . . . 71.219999999999999 110.326 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -86.78 -0.62 56.71 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.675 -1.148 . . . . 71.430000000000007 110.773 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 52.0 m80 66.19 38.7 4.52 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 122.137 0.97 . . . . 74.310000000000002 109.473 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . 0.445 ' ND2' ' HB3' ' A' ' 595' ' ' ALA . 15.4 t30 -74.72 89.63 2.28 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.701 -1.59 . . . . 60.420000000000002 108.629 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.407 ' HD3' ' HA2' ' A' ' 568' ' ' GLY . 16.6 ptp180 -97.52 171.65 8.23 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.763 -1.562 . . . . 74.450000000000003 110.896 -175.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 569' ' ' MET . 83.7 t -58.52 130.73 22.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.244 -1.021 . . . . 70.329999999999998 108.244 174.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 27.7 m -106.26 -30.44 2.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 120.535 -0.466 . . . . 73.420000000000002 111.901 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -149.43 135.98 19.33 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 120.258 -0.577 . . . . 74.430000000000007 110.717 -176.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -120.88 143.12 49.09 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.491 -1.67 . . . . 70.340000000000003 106.491 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.493 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 19.9 t-20 -52.61 -58.17 12.94 Favored Pre-proline 0 N--CA 1.487 1.387 0 N-CA-C 113.95 1.093 . . . . 70.430000000000007 113.95 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.1 Cg_endo -91.04 135.25 1.84 Allowed 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 121.476 1.451 . . . . 65.349999999999994 110.739 177.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -67.08 160.04 49.25 Favored 'Trans proline' 0 C--O 1.249 1.057 0 C-N-CA 121.518 1.479 . . . . 63.039999999999999 110.856 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.17 127.17 30.22 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 110.257 -0.275 . . . . 74.040000000000006 110.257 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 104.71 -5.21 43.28 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.317 -0.944 . . . . 73.310000000000002 112.251 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 73.9 m -90.63 147.35 23.36 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.861 -0.792 . . . . 61.450000000000003 108.861 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -78.72 137.89 20.12 Favored Glycine 0 N--CA 1.425 -2.043 0 C-N-CA 121.529 -0.367 . . . . 43.340000000000003 113.234 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.3 m -117.99 142.76 30.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.744 -0.836 . . . . 53.109999999999999 108.744 175.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -49.85 170.8 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.433 1.093 . . . . 51.030000000000001 113.608 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -58.9 -26.99 64.81 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.999 -0.546 . . . . 65.340000000000003 111.946 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -84.75 -7.28 59.27 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 121.22 0.533 . . . . 75.340000000000003 110.264 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.6 18.93 68.56 Favored Glycine 0 C--O 1.219 -0.838 0 CA-C-N 115.928 -0.578 . . . . 61.329999999999998 113.967 172.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.49 119.93 17.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 122.555 1.169 . . . . 71.329999999999998 112.121 -167.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.11 130.78 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 114.212 -1.358 . . . . 60.140000000000001 109.46 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.605 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 13.0 t -104.66 137.06 43.05 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.031 -1.1 . . . . 73.430000000000007 108.031 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -138.63 167.51 21.81 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.354 0.597 . . . . 73.519999999999996 112.338 -173.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -127.03 134.63 50.27 Favored 'General case' 0 C--O 1.251 1.138 0 N-CA-C 104.806 -2.294 . . . . 74.129999999999995 104.806 174.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.407 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 29.3 p90 -142.94 165.33 27.65 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.627 -0.829 . . . . 75.400000000000006 112.221 -174.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -79.74 126.64 7.55 Favored Glycine 1 N--CA 1.388 -4.552 0 C-N-CA 120.65 -0.786 . . . . 21.41 111.609 173.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.494 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 9.3 tt0 . . . . . 0 C--O 1.271 2.204 0 C-N-CA 124.75 1.22 . . . . 72.430000000000007 107.812 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.625 0 CA-C-O 121.852 0.834 . . . . 62.229999999999997 110.288 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 40.9 p -138.23 149.89 46.19 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.42 -1.326 . . . . 74.420000000000002 107.42 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -141.64 145.03 34.49 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.728 -1.212 . . . . 73.120000000000005 107.728 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 17.2 m-20 -88.93 141.94 28.06 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.34 -0.615 . . . . 74.439999999999998 109.34 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.7 pt -101.76 123.83 42.64 Favored Pre-proline 0 C--N 1.3 -1.564 0 C-N-CA 120.609 -0.436 . . . . 73.319999999999993 110.288 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -84.58 172.39 9.18 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.383 2.055 . . . . 75.430000000000007 112.018 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -85.97 100.66 12.28 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 122.399 1.095 . . . . 73.340000000000003 109.998 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 31.4 m -89.38 1.73 7.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 114.401 -1.272 . . . . 74.340000000000003 111.261 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -64.52 100.74 0.39 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.564 -0.744 . . . . 61.229999999999997 110.079 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 158.2 -32.06 0.5 Allowed Glycine 0 C--N 1.302 -1.356 0 C-N-CA 120.797 -0.716 . . . . 61.409999999999997 111.583 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.461 ' O ' HG12 ' A' ' 534' ' ' VAL . 10.1 pm0 -102.62 -179.69 4.04 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 109.816 -0.438 . . . . 71.230000000000004 109.816 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 17.5 m -70.31 155.76 40.21 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.579 -1.267 . . . . 74.329999999999998 107.579 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.494 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 14.2 p -64.71 -40.38 88.86 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 N-CA-C 109.657 -0.497 . . . . 73.530000000000001 109.657 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 11.8 t70 -58.79 -39.86 82.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.422 -0.808 . . . . 70.310000000000002 109.842 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 86.0 t -74.93 -43.55 45.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.099 -0.955 . . . . 74.25 110.61 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -58.82 -43.29 90.57 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.472 0.177 . . . . 72.129999999999995 110.739 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.2 mt-30 -64.66 -46.44 82.48 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.043 -0.526 . . . . 73.439999999999998 110.915 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.594 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 2.7 ptpp? -67.36 -38.4 84.74 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 112.802 0.667 . . . . 75.430000000000007 112.802 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 56.1 m-20 -61.98 -48.07 81.97 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.238 0.542 . . . . 74.209999999999994 110.353 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.44 -36.92 84.0 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.203 -0.908 . . . . 64.310000000000002 108.849 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 2.2 t-20 -59.4 -35.39 73.87 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 124.046 0.938 . . . . 74.329999999999998 110.534 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 510' ' ' LYS . 86.0 t -61.99 -33.14 56.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-O 121.286 0.565 . . . . 72.150000000000006 110.789 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -105.08 4.07 31.08 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.588 -0.523 . . . . 72.340000000000003 109.588 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -133.32 -60.96 0.08 OUTLIER Glycine 0 N--CA 1.426 -1.994 0 C-N-CA 119.987 -1.102 . . . . 72.200000000000003 114.425 -171.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 62.84 29.02 16.63 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.158 0.98 . . . . 71.230000000000004 109.102 -172.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 547' ' ' VAL . 17.2 p -85.62 -166.21 1.45 Allowed 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 126.019 1.728 . . . . 73.510000000000005 109.851 -177.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -108.55 137.68 46.11 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.312 -0.625 . . . . 65.400000000000006 109.312 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -132.2 147.37 52.41 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 116.017 -0.538 . . . . 64.040000000000006 110.203 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.1 m -140.26 145.91 37.92 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.342 -0.984 . . . . 73.120000000000005 108.342 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -117.97 135.22 54.28 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 121.371 0.605 . . . . 73.140000000000001 111.065 -175.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -123.02 126.81 47.83 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.235 -1.024 . . . . 52.43 108.235 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 22.2 m -88.14 125.87 34.83 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.297 0.57 . . . . 73.150000000000006 111.404 -176.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 10.5 p -120.31 150.67 23.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 106.611 -1.625 . . . . 62.020000000000003 106.611 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.416 ' OD1' ' HE2' ' A' ' 557' ' ' LYS . 21.1 m-20 -75.29 135.63 40.92 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 120.311 -0.556 . . . . 74.140000000000001 109.71 -174.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 73.9 m -153.11 169.57 9.52 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 108.343 -0.984 . . . . 72.219999999999999 108.343 -175.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -82.35 -17.53 7.63 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.597 1.531 . . . . 64.109999999999999 111.182 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.605 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 53.1 mtt-85 -75.51 143.68 76.26 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 116.089 -0.505 . . . . 73.420000000000002 110.273 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.97 143.18 96.59 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 123.164 2.576 . . . . 63.219999999999999 112.521 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -56.51 108.97 0.54 Allowed 'General case' 0 C--O 1.242 0.7 0 O-C-N 124.092 0.87 . . . . 64.340000000000003 112.321 -177.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 140.38 -20.0 2.8 Favored Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 115.381 -0.827 . . . . 31.309999999999999 112.494 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . 0.605 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 31.1 tt0 -82.86 144.83 29.82 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.602 -0.518 . . . . 74.140000000000001 109.602 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 503' ' ' GLN . 8.0 p -91.5 115.8 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 CA-C-O 122.094 0.949 . . . . 74.299999999999997 110.455 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.8 -30.86 69.52 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 113.671 -1.604 . . . . 61.439999999999998 110.253 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 154.82 -164.87 31.91 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 110.587 -1.005 . . . . 64.420000000000002 110.587 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 6.4 p -117.29 154.88 30.47 Favored 'General case' 0 C--N 1.288 -2.109 0 N-CA-C 109.542 -0.54 . . . . 62.130000000000003 109.542 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.452 ' HB2' HE22 ' A' ' 554' ' ' GLN . 9.7 t30 -63.79 -51.57 64.01 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 120.149 -0.621 . . . . 70.310000000000002 110.84 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -74.23 134.3 19.01 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 N-CA-C 108.644 -1.329 . . . . 63.119999999999997 108.644 170.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.45 154.4 71.85 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 122.753 2.302 . . . . 73.010000000000005 113.381 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.02 139.89 58.39 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.588 -0.733 . . . . 55.509999999999998 110.284 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 96.86 -8.8 65.76 Favored Glycine 0 C--N 1.302 -1.339 0 C-N-CA 120.595 -0.812 . . . . 65.129999999999995 111.695 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 25.2 m -82.5 133.97 35.2 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.646 -0.872 . . . . 60.329999999999998 108.646 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.1 t -94.64 132.79 38.98 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 108.301 -1.0 . . . . 71.140000000000001 108.301 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.17 155.2 64.96 Favored Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 107.839 -1.171 . . . . 72.319999999999993 107.839 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.525 ' HG2' ' OG ' ' A' ' 549' ' ' SER . 7.6 Cg_endo -60.32 136.52 68.72 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 N-CA-C 109.421 -1.03 . . . . 73.439999999999998 109.421 176.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.572 ' O ' HG22 ' A' ' 518' ' ' THR . 9.7 p -66.56 -21.38 28.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.34 -0.845 . . . . 62.119999999999997 112.941 -172.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -93.35 3.69 55.2 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.766 0.793 . . . . 54.310000000000002 111.043 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . 0.525 ' OG ' ' HG2' ' A' ' 546' ' ' PRO . 68.3 m -87.56 -174.7 4.91 Favored 'General case' 0 C--O 1.251 1.171 0 O-C-N 121.544 -0.723 . . . . 54.299999999999997 112.389 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 13.3 p -113.48 138.25 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 115.221 -0.9 . . . . 75.340000000000003 109.741 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.7 mt -102.92 137.4 31.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.76 -0.83 . . . . 73.340000000000003 108.76 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -102.43 117.49 34.83 Favored 'General case' 0 C--O 1.251 1.132 0 N-CA-C 107.999 -1.111 . . . . 74.010000000000005 107.999 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.44 129.93 55.25 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 123.343 0.402 . . . . 64.439999999999998 110.505 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.452 HE22 ' HB2' ' A' ' 538' ' ' ASN . 2.9 mp0 -90.66 119.38 30.86 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.003 -0.544 . . . . 74.340000000000003 110.785 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 40.2 t -92.99 129.57 43.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.316 -0.994 . . . . 54.229999999999997 108.316 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.658 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 16.1 m -75.71 117.72 17.77 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 108.081 -1.081 . . . . 74.200000000000003 108.081 176.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.416 ' HE2' ' OD1' ' A' ' 526' ' ' ASP . 26.5 pttm -109.05 118.49 36.91 Favored 'General case' 0 N--CA 1.411 -2.399 0 N-CA-C 107.576 -1.268 . . . . 72.150000000000006 107.576 171.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -56.79 -23.86 46.5 Favored Glycine 0 CA--C 1.497 -1.09 0 O-C-N 124.319 1.012 . . . . 32.409999999999997 113.175 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 77.85 -3.84 2.32 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 125.331 1.452 . . . . 75.230000000000004 109.24 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.549 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 63.2 mt-30 -112.58 150.21 31.67 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 115.592 -0.731 . . . . 61.450000000000003 112.831 -173.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -133.13 156.5 47.32 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.646 -1.613 . . . . 74.120000000000005 106.646 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 47.5 t -73.41 122.87 27.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.595 -0.891 . . . . 63.399999999999999 108.595 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.421 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 57.0 ttp -73.97 127.37 88.28 Favored Pre-proline 0 C--O 1.25 1.082 0 O-C-N 123.22 0.325 . . . . 62.100000000000001 111.428 -175.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 51.9 Cg_exo -61.71 169.64 6.79 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.598 2.865 . . . . 70.049999999999997 112.59 175.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -65.92 129.47 39.9 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.373 0.669 . . . . 63.049999999999997 112.766 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.7 pp -152.45 14.32 0.58 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.182 0.992 . . . . 74.109999999999999 109.075 172.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 4.2 m -79.95 140.89 36.46 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.414 -1.267 . . . . 70.299999999999997 111.995 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 53.18 43.1 63.37 Favored Glycine 0 C--O 1.223 -0.544 0 N-CA-C 115.112 0.805 . . . . 52.43 115.112 172.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 18.1 ptp -127.15 -179.65 4.97 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.874 -1.158 . . . . 75.099999999999994 107.874 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . 0.426 ' HB2' HG12 ' A' ' 572' ' ' VAL . 21.7 m-85 -96.24 168.96 10.27 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.665 -0.865 . . . . 74.310000000000002 108.665 -175.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 37.8 t-105 -63.39 -28.08 69.74 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.445 -0.576 . . . . 73.030000000000001 109.445 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . 0.426 HG12 ' HB2' ' A' ' 570' ' ' PHE . 8.9 p -75.11 -9.58 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 CA-C-N 115.695 -0.684 . . . . 74.040000000000006 110.484 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.587 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 42.6 m-20 -101.1 -42.0 6.54 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 107.858 -1.164 . . . . 52.240000000000002 107.858 173.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . 0.55 ' O ' HD12 ' A' ' 578' ' ' LEU . . . -55.54 -45.92 77.15 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.782 -1.099 . . . . 62.43 112.044 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.563 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 3.0 tm-20 -53.98 -58.46 13.33 Favored Pre-proline 0 CA--C 1.567 1.616 0 CA-C-O 118.949 -0.548 . . . . 72.25 110.533 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 57.9 Cg_exo -53.17 -32.25 58.94 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 121.978 1.785 . . . . 72.540000000000006 112.808 173.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 26.2 mmm180 -61.93 -36.25 80.81 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-O 118.659 -0.686 . . . . 75.099999999999994 112.42 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.632 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 5.4 mp -62.66 -48.54 78.88 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.708 -1.197 . . . . 73.230000000000004 110.115 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 576' ' ' PRO . 0.7 OUTLIER -66.1 -41.23 90.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.824 -0.625 . . . . 71.329999999999998 112.322 178.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.28 -39.54 74.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.746 0.647 . . . . 62.100000000000001 112.746 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.01 -9.02 58.46 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.926 0.394 . . . . 64.219999999999999 110.433 -175.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 72.47 48.36 24.12 Favored Glycine 0 CA--C 1.505 -0.556 0 N-CA-C 111.316 -0.713 . . . . 63.039999999999999 111.316 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.632 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 8.6 t90 -85.99 133.4 33.92 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.0 0.429 . . . . 72.450000000000003 110.011 -176.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 1.3 p -86.82 -39.36 15.95 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.583 1.553 . . . . 64.310000000000002 112.826 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -79.7 -162.16 24.28 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-O 121.797 0.665 . . . . 64.5 114.279 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 61.5 mtm -122.79 152.87 40.24 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.974 -0.75 . . . . 75.530000000000001 108.974 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 4.4 tt -81.92 111.67 18.32 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.648 -1.241 . . . . 71.019999999999996 107.648 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 621' ' ' THR . 33.0 t70 -95.34 107.97 20.12 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.658 0.742 . . . . 71.049999999999997 110.049 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.504 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.3 OUTLIER -97.1 133.66 41.46 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.677 -0.861 . . . . 65.25 108.677 178.451 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.25 -69.29 1.4 Allowed Glycine 0 C--N 1.28 -2.532 0 N-CA-C 110.57 -1.012 . . . . 71.450000000000003 110.57 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -137.22 149.34 47.13 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 110.065 -0.346 . . . . 73.400000000000006 110.065 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -115.77 124.7 51.42 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.645 0.736 . . . . 75.209999999999994 109.072 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 44.2 t -106.74 153.52 7.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.758 -1.201 . . . . 73.420000000000002 107.758 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.42 126.2 29.26 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.934 0.873 . . . . 71.319999999999993 110.752 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -133.54 -48.34 0.83 Allowed 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 114.386 -1.279 . . . . 62.310000000000002 108.747 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 102.51 123.14 5.2 Favored Glycine 0 N--CA 1.422 -2.254 0 N-CA-C 111.254 -0.738 . . . . 64.450000000000003 111.254 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -60.58 -33.83 83.5 Favored Glycine 0 C--N 1.317 -0.514 0 N-CA-C 111.704 -0.559 . . . . 14.31 111.704 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.2 m -70.27 -23.88 62.96 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-O 121.819 0.819 . . . . 62.210000000000001 110.135 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -92.06 -1.58 57.13 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.195 -0.911 . . . . 74.129999999999995 110.085 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 69.82 81.73 0.17 Allowed 'General case' 0 C--O 1.244 0.772 0 CA-C-O 123.229 1.49 . . . . 72.209999999999994 111.283 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 625' ' ' GLY . 15.8 p-10 -79.77 89.31 5.21 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 113.32 -1.764 . . . . 72.25 113.056 -174.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -81.9 170.93 15.06 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.146 -0.934 . . . . 61.409999999999997 111.722 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 75.0 t -70.29 131.83 33.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 114.55 -1.205 . . . . 64.420000000000002 108.529 171.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 86.5 t -91.07 -43.92 14.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.499 0.666 . . . . 72.430000000000007 110.568 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -153.14 140.05 19.14 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.783 -0.644 . . . . 64.340000000000003 109.693 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -127.51 139.49 52.75 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.663 -1.236 . . . . 74.219999999999999 107.663 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.59 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 23.8 t-20 -58.99 -62.48 5.73 Favored Pre-proline 0 CA--C 1.555 1.153 0 CA-C-O 118.922 -0.561 . . . . 73.450000000000003 111.929 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.625 ' HD2' HG12 ' A' ' 620' ' ' ILE . 7.4 Cg_endo -95.74 120.44 0.24 Allowed 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 122.003 1.802 . . . . 75.239999999999995 110.027 171.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 19.0 Cg_exo -70.34 156.82 60.99 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.437 2.091 . . . . 74.450000000000003 112.276 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.38 138.61 56.85 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.466 -0.938 . . . . 53.340000000000003 108.466 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 97.77 -2.13 60.14 Favored Glycine 0 C--N 1.301 -1.398 0 N-CA-C 110.637 -0.985 . . . . 30.41 110.637 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 26.9 m -109.54 155.52 21.28 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.281 -1.377 . . . . 63.039999999999999 107.281 175.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -78.43 138.46 21.12 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.972 -0.632 . . . . 75.439999999999998 113.393 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.89 143.05 42.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 124.068 0.947 . . . . 72.040000000000006 109.11 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.549 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.2 p-10 -48.38 168.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.852 0.861 . . . . 70.450000000000003 113.023 175.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -57.14 -25.54 59.04 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.531 0.732 . . . . 71.120000000000005 112.806 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.95 -8.53 58.71 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 120.037 -0.665 . . . . 71.129999999999995 109.37 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.16 15.77 63.56 Favored Glycine 0 C--O 1.216 -1.024 0 CA-C-N 116.127 -0.488 . . . . 64.329999999999998 113.141 172.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.4 119.38 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-O 122.623 1.202 . . . . 70.299999999999997 112.409 -166.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.625 HG12 ' HD2' ' A' ' 608' ' ' PRO . 0.0 OUTLIER -125.62 128.25 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 CA-C-N 113.694 -1.594 . . . . 74.310000000000002 110.2 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 21.2 m -100.51 129.59 46.47 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.673 -1.149 . . . . 74.409999999999997 108.896 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.8 pp -138.92 166.24 24.99 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.742 0.645 . . . . 74.409999999999997 112.742 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -127.57 137.46 52.6 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.519 -2.03 . . . . 72.329999999999998 105.519 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -140.8 165.67 26.87 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 120.199 -0.6 . . . . 74.219999999999999 111.113 -172.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 601' ' ' ASN . . . -81.2 142.64 23.29 Favored Glycine 0 N--CA 1.412 -2.913 0 CA-C-N 115.405 -0.816 . . . . 43.149999999999999 111.125 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.406 HE21 ' HB3' ' A' ' 626' ' ' GLN . 0.8 OUTLIER . . . . . 0 N--CA 1.402 -2.865 0 C-N-CA 124.336 1.054 . . . . 72.010000000000005 108.472 178.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.669 0 CA-C-O 122.44 1.114 . . . . 74.510000000000005 109.82 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 3.5 p -137.64 147.47 44.97 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 113.998 -1.455 . . . . 52.009999999999998 108.907 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -130.86 149.7 52.37 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.965 -0.754 . . . . 73.319999999999993 108.965 177.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.7 p-10 -87.71 135.55 33.32 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 122.986 0.514 . . . . 71.329999999999998 109.744 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 29.6 pt -88.43 130.39 45.79 Favored Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 116.586 -0.279 . . . . 75.510000000000005 110.957 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -88.44 172.75 4.81 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.629 2.219 . . . . 71.549999999999997 112.807 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -92.31 111.94 23.7 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.369 -0.832 . . . . 73.439999999999998 108.85 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 24.1 m -106.41 16.44 6.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.408 -0.815 . . . . 72.099999999999994 111.212 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -67.06 98.12 0.55 Allowed 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.822 -0.627 . . . . 73.519999999999996 111.399 -176.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 146.34 -26.03 1.7 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 115.667 -0.697 . . . . 31.0 111.637 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.447 ' O ' HG12 ' A' ' 534' ' ' VAL . 31.8 mt-30 -82.65 171.08 14.42 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.82 -0.807 . . . . 64.219999999999999 108.82 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 4.8 m -74.25 155.94 37.74 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 105.129 -2.174 . . . . 63.100000000000001 105.129 172.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.433 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.2 p -61.93 -41.94 92.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 118.648 0.658 . . . . 73.530000000000001 111.442 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 17.1 t70 -62.4 -41.66 98.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.546 -0.297 . . . . 65.540000000000006 110.357 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 87.4 t -67.1 -44.15 88.26 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.247 0 CA-C-N 116.036 -0.529 . . . . 72.349999999999994 109.843 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.477 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -60.84 -39.79 90.4 Favored 'General case' 0 C--O 1.214 -0.809 0 O-C-N 123.18 0.3 . . . . 72.040000000000006 111.159 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.1 mt-30 -65.06 -43.94 90.62 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.473 -0.195 . . . . 74.439999999999998 110.473 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 75.7 mmtt -63.95 -45.21 90.16 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.049 -0.723 . . . . 73.310000000000002 109.049 177.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -61.22 -43.06 99.49 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.279 -1.328 . . . . 75.129999999999995 110.077 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 66.3 tp -67.23 -45.81 75.66 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.14 -1.391 . . . . 74.430000000000007 109.219 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -64.88 -34.98 79.68 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 123.942 0.897 . . . . 63.299999999999997 113.155 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 510' ' ' LYS . 85.8 t -57.18 -33.06 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 120.928 0.394 . . . . 63.43 111.278 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -118.5 8.57 12.09 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.924 0.869 . . . . 71.329999999999998 110.267 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -114.42 -59.08 0.37 Allowed Glycine 0 N--CA 1.416 -2.688 0 CA-C-N 114.936 -1.029 . . . . 70.019999999999996 111.707 -174.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 65.53 18.72 11.36 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 122.479 1.133 . . . . 75.409999999999997 109.53 -176.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.2 p -92.54 -175.86 4.11 Favored 'General case' 0 N--CA 1.403 -2.795 0 CA-C-N 114.04 -1.436 . . . . 55.530000000000001 110.416 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -107.82 142.21 38.21 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.531 -0.914 . . . . 75.25 108.531 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -129.03 153.3 47.73 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.458 0.647 . . . . 72.400000000000006 111.427 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 71.0 m -140.12 155.71 46.87 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 107.095 -1.446 . . . . 72.099999999999994 107.095 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -124.14 123.23 39.84 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.313 0.578 . . . . 72.120000000000005 111.274 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -105.56 119.31 38.79 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.429 -0.952 . . . . 71.129999999999995 108.429 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 20.2 m -100.72 137.19 39.45 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.877 -0.329 . . . . 75.120000000000005 110.905 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.1 p -144.21 153.91 15.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.754 -1.202 . . . . 54.420000000000002 107.754 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.435 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 3.3 p30 -84.08 136.22 34.1 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.304 0.573 . . . . 63.030000000000001 110.927 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.441 ' HB3' ' HD2' ' A' ' 528' ' ' PRO . 50.6 m -159.04 171.38 7.49 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 106.394 -1.706 . . . . 63.119999999999997 106.394 -177.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 527' ' ' SER . 37.3 Cg_endo -68.99 -10.11 28.26 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 121.4 1.4 . . . . 62.210000000000001 112.597 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.414 ' HB2' ' CB ' ' A' ' 556' ' ' SER . 23.5 mmm180 -72.59 140.14 81.46 Favored Pre-proline 0 N--CA 1.435 -1.189 0 N-CA-C 109.573 -0.529 . . . . 72.439999999999998 109.573 177.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.36 151.34 83.48 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.608 2.206 . . . . 72.400000000000006 113.344 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -64.96 121.55 14.91 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.187 -0.915 . . . . 74.120000000000005 111.542 -177.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 114.58 -18.91 17.02 Favored Glycine 0 C--O 1.249 1.044 0 C-N-CA 120.838 -0.696 . . . . 73.310000000000002 111.373 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -78.2 129.18 34.81 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 109.025 -0.732 . . . . 64.329999999999998 109.025 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 10.1 p -90.81 117.42 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.844 0 N-CA-C 106.78 -1.563 . . . . 42.109999999999999 106.78 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.4 m -92.94 9.74 34.25 Favored 'General case' 0 C--N 1.27 -2.886 0 CA-C-N 114.341 -1.3 . . . . 51.140000000000001 110.567 -173.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.411 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 132.7 -154.79 21.27 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 111.338 -0.705 . . . . 34.32 111.338 176.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.8 p -116.96 157.95 24.89 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.804 -0.813 . . . . 52.030000000000001 108.804 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.403 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 11.9 t-20 -60.53 -55.76 41.91 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 119.004 -0.522 . . . . 54.439999999999998 111.448 176.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 16.3 Cg_exo -70.53 144.78 50.9 Favored 'Trans proline' 0 C--N 1.367 1.533 0 N-CA-C 108.658 -1.324 . . . . 72.510000000000005 108.658 171.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -58.15 147.52 83.09 Favored 'Trans proline' 0 C--O 1.24 0.577 0 C-N-CA 122.79 2.327 . . . . 70.310000000000002 113.047 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.05 137.89 57.76 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-N 116.27 -0.423 . . . . 63.020000000000003 110.432 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.62 -19.98 48.17 Favored Glycine 0 C--N 1.31 -0.896 0 C-N-CA 120.926 -0.654 . . . . 42.32 111.948 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 35.4 m -67.46 136.79 55.19 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.705 -0.48 . . . . 74.329999999999998 109.705 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 14.8 t -96.34 133.23 40.98 Favored 'General case' 0 N--CA 1.406 -2.67 0 N-CA-C 108.984 -0.747 . . . . 74.420000000000002 108.984 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.7 m -123.39 155.88 64.67 Favored Pre-proline 0 C--N 1.296 -1.753 0 N-CA-C 108.042 -1.096 . . . . 71.430000000000007 108.042 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -63.9 138.28 62.19 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 121.385 1.39 . . . . 65.430000000000007 110.486 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 13.2 p -62.2 -19.99 23.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.611 -0.722 . . . . 75.209999999999994 111.426 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -90.18 -15.89 30.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.172 0.51 . . . . 43.549999999999997 111.507 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 60.0 m -80.39 -175.69 5.27 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 121.109 0.481 . . . . 73.439999999999998 111.723 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 12.4 p -113.19 137.61 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 115.931 -0.577 . . . . 73.340000000000003 110.168 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 70.2 mt -97.33 129.89 46.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 109.371 -0.603 . . . . 73.120000000000005 109.371 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -102.56 117.59 35.01 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.135 -0.691 . . . . 74.409999999999997 109.135 -177.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.3 mp -98.59 134.84 40.97 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.813 -0.631 . . . . 74.25 110.006 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -91.82 113.63 25.95 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 116.292 -0.413 . . . . 71.409999999999997 110.365 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 524' ' ' SER . 20.1 t -106.65 126.93 62.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.421 -0.955 . . . . 65.0 108.421 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.556 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 50.5 m -95.55 143.34 26.94 Favored 'General case' 0 C--N 1.277 -2.58 0 C-N-CA 119.661 -0.816 . . . . 73.099999999999994 110.824 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 0.6 OUTLIER -105.79 144.38 32.61 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 106.163 -1.792 . . . . 74.439999999999998 106.163 168.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -55.02 -23.35 31.34 Favored Glycine 0 CA--C 1.492 -1.36 0 O-C-N 124.903 1.377 . . . . 64.120000000000005 114.624 -171.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 22.4 t-20 77.09 -27.29 0.18 Allowed 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 124.604 1.162 . . . . 74.120000000000005 110.92 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' A' ' 558' ' ' GLY . 72.1 mt-30 -114.1 162.18 16.81 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 114.517 -1.22 . . . . 74.420000000000002 109.665 -175.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -127.19 155.9 42.68 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 107.805 -1.183 . . . . 74.420000000000002 107.805 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 6.2 p -77.78 121.05 29.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.554 -0.536 . . . . 63.310000000000002 109.554 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.497 ' SD ' HG21 ' A' ' 620' ' ' ILE . 47.6 ttp -74.11 125.23 90.27 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 116.403 -0.362 . . . . 74.540000000000006 111.43 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -72.45 170.61 18.89 Favored 'Trans proline' 0 C--O 1.242 0.721 0 C-N-CA 123.491 2.794 . . . . 72.519999999999996 111.891 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.06 114.47 5.86 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.914 0.864 . . . . 74.420000000000002 112.703 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.5 pp -125.12 7.15 7.89 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.105 -1.407 . . . . 72.530000000000001 107.476 171.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 16.7 m -79.81 144.04 33.87 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 113.497 -1.683 . . . . 74.540000000000006 110.564 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 68.03 43.13 83.02 Favored Glycine 0 CA--C 1.521 0.413 0 O-C-N 123.686 0.616 . . . . 74.019999999999996 114.007 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 22.2 ptp -146.91 174.79 11.18 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.288 -0.634 . . . . 64.5 109.288 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -98.05 172.87 7.34 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.547 -1.279 . . . . 64.549999999999997 107.547 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -62.97 -35.63 80.79 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.708 -0.849 . . . . 75.140000000000001 108.708 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.8 -22.36 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 115.636 -0.711 . . . . 61.43 111.506 -175.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.403 ' C ' ' HD2' ' A' ' 576' ' ' PRO . 28.4 t70 -102.18 -31.35 10.62 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-O 121.479 0.657 . . . . 71.299999999999997 110.667 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -71.41 -32.39 68.34 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.506 -0.77 . . . . 63.210000000000001 111.484 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.615 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 34.3 tt0 -64.56 -48.95 73.2 Favored Pre-proline 0 CA--C 1.56 1.336 0 CA-C-N 116.47 -0.332 . . . . 52.210000000000001 111.196 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 88.5 Cg_exo -54.69 -38.01 91.38 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 121.471 1.447 . . . . 33.310000000000002 111.76 170.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.439 ' HA ' ' NE ' ' A' ' 577' ' ' ARG . 1.4 mmp_? -58.94 -43.18 91.14 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 121.359 -0.136 . . . . 50.130000000000003 111.325 176.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.5 pp -67.05 -45.66 76.71 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.542 0.571 . . . . 73.299999999999997 112.542 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.47 ' N ' HD12 ' A' ' 578' ' ' LEU . 5.9 ptp85 -66.71 -35.04 79.18 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.478 0.547 . . . . 72.439999999999998 112.478 176.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.97 -36.56 83.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.181 0.515 . . . . 64.530000000000001 110.03 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 12.1 tp -81.26 -9.85 59.7 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.651 -0.704 . . . . 63.329999999999998 110.694 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 67.79 42.82 85.97 Favored Glycine 0 C--O 1.243 0.671 0 N-CA-C 111.883 -0.487 . . . . 73.409999999999997 111.883 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.406 ' HE3' ' CB ' ' A' ' 578' ' ' LEU . 13.7 t90 -75.19 126.49 31.13 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 120.977 0.418 . . . . 61.049999999999997 109.879 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 18.1 p -103.52 -15.44 15.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.822 -0.626 . . . . 73.25 112.084 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -83.79 -176.71 51.37 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 121.161 -0.542 . . . . 65.129999999999995 112.953 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 51.5 ttp -100.86 141.37 33.84 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 122.344 0.258 . . . . 74.430000000000007 111.286 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 8.0 tt -80.96 107.5 13.83 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.075 -1.083 . . . . 74.230000000000004 108.075 174.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.545 ' O ' ' HA ' ' A' ' 621' ' ' THR . 24.5 t70 -98.39 116.2 30.12 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.486 -0.779 . . . . 72.0 109.578 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -106.46 134.38 49.68 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.534 -0.757 . . . . 54.200000000000003 109.192 178.61 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -70.84 -75.24 0.63 Allowed Glycine 0 C--N 1.293 -1.846 0 N-CA-C 111.116 -0.793 . . . . 72.150000000000006 111.116 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.09 121.32 15.87 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.284 -0.635 . . . . 72.439999999999998 109.284 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -84.57 137.01 33.54 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.992 -1.114 . . . . 53.340000000000003 107.992 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 47.0 t -105.76 126.75 61.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 116.223 -0.444 . . . . 72.409999999999997 110.049 -174.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . 0.507 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 9.7 p-10 -72.12 111.55 7.44 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 122.403 1.097 . . . . 63.310000000000002 111.489 -176.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -133.98 -45.68 0.79 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.356 -1.293 . . . . 42.219999999999999 109.133 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 103.44 149.36 20.79 Favored Glycine 0 N--CA 1.422 -2.261 0 C-N-CA 120.837 -0.697 . . . . 62.329999999999998 112.356 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.494 ' HA2' ' OD1' ' A' ' 601' ' ' ASN . . . -61.51 -32.58 81.74 Favored Glycine 0 C--N 1.302 -1.339 0 CA-C-N 114.981 -0.61 . . . . 62.5 112.71 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 10.6 t -71.03 -23.56 62.19 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 122.253 1.025 . . . . 75.030000000000001 109.449 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -88.58 -1.13 57.9 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.681 -1.145 . . . . 74.25 110.672 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 48.4 m80 70.29 80.7 0.17 Allowed 'General case' 0 C--O 1.244 0.792 0 CA-C-O 122.755 1.264 . . . . 72.219999999999999 110.567 -178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . 0.494 ' OD1' ' HA2' ' A' ' 597' ' ' GLY . 30.0 p-10 -87.58 78.53 8.53 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 113.812 -1.54 . . . . 74.109999999999999 111.452 -175.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -94.07 171.61 8.74 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.601 -1.181 . . . . 73.25 109.232 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 96.4 t -64.93 130.75 30.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 106.829 -1.545 . . . . 54.549999999999997 106.829 170.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.8 t -96.51 -52.72 8.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 121.169 0.509 . . . . 70.530000000000001 110.535 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -147.91 150.55 34.3 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.161 -0.681 . . . . 73.209999999999994 109.161 -175.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -139.4 144.34 38.09 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.871 -1.159 . . . . 63.149999999999999 107.871 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.403 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 9.6 t30 -63.52 -51.48 66.66 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 120.444 -0.502 . . . . 72.340000000000003 111.98 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 57.6 Cg_endo -93.13 116.67 0.32 Allowed 'Trans proline' 0 N--CA 1.442 -1.532 0 C-N-CA 121.212 1.275 . . . . 75.120000000000005 110.328 171.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.88 160.96 34.8 Favored 'Trans proline' 0 C--O 1.248 0.989 0 C-N-CA 122.857 2.371 . . . . 75.510000000000005 112.215 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.61 133.67 56.32 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.085 -0.709 . . . . 73.109999999999999 109.085 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 100.65 -0.56 55.44 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.636 -0.792 . . . . 63.109999999999999 112.265 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 35.3 m -90.18 145.76 24.78 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.555 -0.535 . . . . 72.150000000000006 109.555 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -77.28 124.21 6.82 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 110.733 -0.947 . . . . 41.43 110.733 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.9 m -125.78 143.2 40.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 108.374 -0.972 . . . . 63.420000000000002 108.374 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.431 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.4 p-10 -48.23 163.03 0.07 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.92 0.888 . . . . 74.409999999999997 111.965 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . 0.331 0.0 OUTLIER -56.04 -24.5 39.98 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.971 1.471 . . . . 64.219999999999999 114.971 -178.387 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -83.65 -6.26 59.4 Favored 'General case' 0 C--O 1.199 -1.589 0 C-N-CA 119.256 -0.977 . . . . 75.219999999999999 112.497 175.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.83 19.52 69.61 Favored Glycine 0 CA--C 1.491 -1.441 0 CA-C-O 119.464 -0.631 . . . . 64.099999999999994 114.561 166.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.83 118.63 14.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-O 122.12 0.962 . . . . 72.310000000000002 110.419 -168.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.497 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.7 pp -129.36 133.86 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 114.708 -1.133 . . . . 41.409999999999997 111.866 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 15.4 t -102.21 122.92 45.12 Favored 'General case' 0 C--O 1.26 1.633 0 CA-C-O 121.802 0.81 . . . . 73.310000000000002 109.553 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 1.8 pt? -139.36 167.27 22.47 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.334 -0.848 . . . . 74.409999999999997 111.742 -173.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -128.22 137.08 51.86 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.262 -1.014 . . . . 71.219999999999999 108.262 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.463 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 35.0 p90 -141.28 166.63 24.24 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.788 -0.187 . . . . 64.019999999999996 111.126 -174.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -75.57 135.2 17.8 Favored Glycine 0 N--CA 1.435 -1.4 0 CA-C-O 121.69 0.605 . . . . 71.420000000000002 113.954 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.507 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 4.2 tt0 . . . . . 0 C--N 1.296 -1.755 0 N-CA-C 107.1 -1.445 . . . . 74.230000000000004 107.1 175.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.193 0 CA-C-O 121.357 0.598 . . . . 61.43 111.594 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 16.1 p -139.18 141.1 37.99 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.823 -0.806 . . . . 61.240000000000002 108.823 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -143.02 148.42 36.74 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.818 0.342 . . . . 43.520000000000003 111.32 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.9 p-10 -79.1 139.08 38.17 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 115.407 -0.815 . . . . 72.349999999999994 110.209 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.4 pt -96.17 137.35 21.69 Favored Pre-proline 0 C--N 1.296 -1.722 0 CA-C-N 115.628 -0.715 . . . . 72.209999999999994 111.116 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -89.86 -177.22 1.34 Allowed 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.487 2.124 . . . . 72.420000000000002 109.829 170.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -99.9 137.28 38.57 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.919 -1.141 . . . . 73.450000000000003 107.919 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.502 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 16.7 m -110.81 17.31 7.65 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 CA-C-N 115.543 -0.753 . . . . 51.130000000000003 110.178 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -72.93 100.83 3.03 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.456 -0.793 . . . . 72.439999999999998 110.206 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 169.12 -46.43 0.22 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-N 115.379 -0.828 . . . . 63.32 111.864 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.431 ' O ' HG12 ' A' ' 534' ' ' VAL . 18.2 pm0 -98.07 -171.06 2.08 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 122.344 -0.504 . . . . 75.040000000000006 110.505 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 15.1 m -70.92 155.12 41.2 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.452 -0.944 . . . . 71.329999999999998 108.452 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 9.7 p -65.5 -41.73 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 O-C-N 123.06 0.225 . . . . 63.049999999999997 110.88 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -61.82 -37.98 86.44 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.913 -0.773 . . . . 65.120000000000005 108.913 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 95.1 t -71.02 -48.77 53.74 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.624 0 CA-C-N 115.525 -0.761 . . . . 53.350000000000001 109.684 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.502 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -60.58 -36.73 79.25 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 122.769 0.428 . . . . 72.510000000000005 111.767 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.422 ' O ' ' HB2' ' A' ' 513' ' ' ASN . 23.8 mt-30 -65.23 -45.2 85.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.56 0.219 . . . . 53.219999999999999 110.47 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.524 ' O ' HG23 ' A' ' 514' ' ' VAL . 75.1 mmtt -66.6 -39.53 88.43 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 109.137 -0.69 . . . . 74.140000000000001 109.137 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' A' ' 508' ' ' ALA . 20.3 t-20 -60.18 -47.02 87.68 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 125.771 1.628 . . . . 71.109999999999999 110.091 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -69.48 -42.06 75.32 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.761 -1.109 . . . . 71.129999999999995 108.592 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 1.0 OUTLIER -63.7 -35.59 81.07 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.421 -0.809 . . . . 75.120000000000005 111.392 -174.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 510' ' ' LYS . 71.4 t -57.78 -32.46 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.068 0.461 . . . . 63.450000000000003 111.737 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -115.36 4.76 14.45 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.559 0.695 . . . . 74.420000000000002 110.108 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -120.21 -57.59 0.24 Allowed Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 115.817 -0.629 . . . . 53.030000000000001 113.094 -174.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 64.76 28.96 12.9 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.89 0.876 . . . . 73.109999999999999 111.411 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 16.7 p -89.09 -166.92 1.72 Allowed 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.665 -1.152 . . . . 72.200000000000003 109.208 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -107.74 143.98 35.51 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 106.754 -1.572 . . . . 73.349999999999994 106.754 173.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -126.84 144.8 50.86 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.387 0.613 . . . . 62.299999999999997 112.327 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 73.5 m -132.81 149.92 52.22 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.651 -0.87 . . . . 72.25 108.651 176.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.405 ' HB2' ' CG2' ' A' ' 555' ' ' VAL . 3.7 pt20 -123.18 131.78 53.81 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.025 0.44 . . . . 74.129999999999995 110.536 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -120.45 118.88 31.43 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.576 -0.898 . . . . 73.200000000000003 108.576 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 78.4 p -94.78 139.3 31.45 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.451 0.643 . . . . 73.310000000000002 112.203 -176.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.8 p -133.6 150.17 31.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.097 -1.075 . . . . 75.209999999999994 108.097 178.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.11 136.03 44.83 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.348 0.594 . . . . 72.319999999999993 111.281 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 74.3 m -156.01 163.2 25.59 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 106.803 -1.554 . . . . 74.030000000000001 106.803 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.52 -10.83 27.45 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.387 1.392 . . . . 65.120000000000005 112.709 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.455 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 10.2 mtm180 -84.48 152.51 60.77 Favored Pre-proline 0 N--CA 1.429 -1.483 0 N-CA-C 108.891 -0.781 . . . . 74.329999999999998 108.891 -176.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.17 149.35 70.57 Favored 'Trans proline' 0 C--O 1.246 0.893 0 C-N-CA 122.239 1.959 . . . . 73.530000000000001 114.41 -170.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -63.94 124.45 21.58 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.399 -1.273 . . . . 71.010000000000005 110.689 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 125.71 -21.65 6.26 Favored Glycine 0 C--N 1.291 -1.927 0 N-CA-C 111.049 -0.82 . . . . 50.219999999999999 111.049 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -75.0 137.59 41.64 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.584 -0.524 . . . . 44.5 109.584 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 503' ' ' GLN . 4.3 p -90.87 113.22 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.95 0 CA-C-O 122.084 0.945 . . . . 72.230000000000004 108.825 174.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -24.72 64.33 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.21 -1.359 . . . . 74.420000000000002 111.087 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 152.24 -157.42 27.25 Favored Glycine 0 N--CA 1.432 -1.617 0 N-CA-C 110.013 -1.235 . . . . 43.450000000000003 110.013 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.2 p -117.37 155.01 30.32 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 117.356 0.578 . . . . 60.340000000000003 109.903 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.495 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 25.7 t-20 -53.39 -51.7 73.27 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 119.252 -0.404 . . . . 74.219999999999999 111.902 174.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.9 Cg_endo -87.02 153.29 8.37 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 121.773 1.649 . . . . 75.420000000000002 110.453 174.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.32 160.68 48.86 Favored 'Trans proline' 0 C--O 1.26 1.58 0 C-N-CA 122.413 2.075 . . . . 72.319999999999993 112.545 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.6 131.83 46.86 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.84 -0.618 . . . . 53.310000000000002 109.712 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.74 -6.63 38.12 Favored Glycine 0 C--N 1.303 -1.256 0 C-N-CA 120.831 -0.7 . . . . 73.329999999999998 111.848 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 25.7 m -78.78 126.45 30.74 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.452 -0.574 . . . . 74.439999999999998 109.452 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 9.4 t -87.05 126.33 34.68 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.431 0.634 . . . . 64.099999999999994 109.319 176.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.67 159.49 55.38 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 107.782 -1.192 . . . . 74.25 107.782 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -66.38 137.56 47.52 Favored 'Trans proline' 0 N--CA 1.437 -1.808 0 C-N-CA 120.874 1.049 . . . . 75.239999999999995 110.354 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.41 -19.06 23.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.323 -0.853 . . . . 54.340000000000003 111.408 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -96.39 -9.8 29.11 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 112.211 0.448 . . . . 55.549999999999997 112.211 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 60.3 m -89.6 -175.99 4.86 Favored 'General case' 0 C--O 1.255 1.345 0 N-CA-C 112.871 0.693 . . . . 53.32 112.871 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.9 p -104.03 138.07 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 115.508 -0.769 . . . . 72.219999999999999 111.024 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 61.0 mt -107.55 138.34 34.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.88 -1.155 . . . . 74.209999999999994 107.88 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . 0.417 ' HG2' ' NE2' ' A' ' 554' ' ' GLN . 25.1 tt0 -102.84 126.89 50.15 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.145 0.498 . . . . 72.409999999999997 111.083 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.2 mp -108.04 134.72 50.53 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.108 -0.951 . . . . 70.510000000000005 109.281 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.417 ' NE2' ' HG2' ' A' ' 552' ' ' GLU . 25.0 mm-40 -89.41 134.04 34.26 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.921 -1.14 . . . . 75.409999999999997 107.921 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 524' ' ' SER . 38.3 t -116.08 131.2 69.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 110.21 -0.293 . . . . 72.340000000000003 110.21 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.655 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 2.3 m -83.79 122.03 28.11 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 107.839 -1.171 . . . . 73.329999999999998 107.839 177.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.73 140.18 30.91 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 106.725 -1.583 . . . . 63.039999999999999 106.725 171.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -57.91 -23.44 51.23 Favored Glycine 0 CA--C 1.489 -1.592 0 O-C-N 124.894 1.371 . . . . 73.409999999999997 114.282 -171.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 77.98 -19.52 0.43 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.759 1.224 . . . . 75.109999999999999 110.851 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.487 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 75.8 mt-30 -112.41 155.29 24.45 Favored 'General case' 0 N--CA 1.428 -1.549 0 O-C-N 121.502 -0.749 . . . . 72.430000000000007 112.042 -174.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -135.36 150.6 49.97 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.377 -1.342 . . . . 75.230000000000004 107.377 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 6.2 p -66.95 125.35 24.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 121.202 0.525 . . . . 73.400000000000006 111.661 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.504 ' SD ' HG21 ' A' ' 620' ' ' ILE . 51.3 ttp -88.34 131.02 43.66 Favored Pre-proline 0 C--N 1.309 -1.189 0 CA-C-N 116.095 -0.502 . . . . 55.399999999999999 109.731 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.18 169.21 17.21 Favored 'Trans proline' 0 C--O 1.244 0.803 0 C-N-CA 122.51 2.14 . . . . 63.049999999999997 110.88 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . 0.469 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 0.9 OUTLIER -79.22 127.83 32.54 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.286 1.041 . . . . 72.439999999999998 111.916 -177.225 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.3 pp -135.51 19.64 3.35 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 113.62 -1.627 . . . . 75.099999999999994 108.534 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 13.2 m -79.14 143.08 35.81 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 114.376 -1.284 . . . . 60.329999999999998 109.417 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 74.54 46.0 21.03 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 121.046 -0.597 . . . . 53.0 112.256 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -129.05 174.35 9.62 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 109.076 -0.712 . . . . 52.420000000000002 109.076 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -111.37 165.65 11.78 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.018 -1.845 . . . . 63.219999999999999 106.018 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 18.6 t-105 -61.75 -31.49 71.67 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.134 0.492 . . . . 74.230000000000004 110.139 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.5 p -65.37 -25.62 37.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 115.694 -0.684 . . . . 73.030000000000001 111.08 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.633 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 37.1 t70 -93.8 -26.2 17.06 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.578 -0.527 . . . . 74.400000000000006 109.578 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.19 -45.48 93.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.128 -0.942 . . . . 71.340000000000003 111.877 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.542 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 40.7 mt-10 -57.15 -52.95 70.31 Favored Pre-proline 0 CA--C 1.56 1.329 0 N-CA-C 112.547 0.573 . . . . 75.530000000000001 112.547 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 31.5 Cg_exo -61.28 -35.22 85.67 Favored 'Trans proline' 0 C--N 1.365 1.439 0 CA-C-N 120.491 1.211 . . . . 74.230000000000004 112.414 173.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 5.7 mmp_? -60.4 -44.74 95.39 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 120.934 -0.306 . . . . 73.310000000000002 110.651 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.6 pp -65.88 -47.09 76.02 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.023 -0.535 . . . . 71.329999999999998 112.203 -174.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.5 ' N ' HD12 ' A' ' 578' ' ' LEU . 16.8 ptm180 -66.64 -37.63 85.22 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.261 -0.427 . . . . 75.329999999999998 111.707 177.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.47 -35.61 73.39 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 111.822 0.305 . . . . 73.420000000000002 111.822 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.0 pp -83.97 -9.15 58.89 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 119.654 -0.818 . . . . 63.43 110.532 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 78.96 41.99 13.32 Favored Glycine 0 C--O 1.243 0.718 0 C-N-CA 121.197 -0.525 . . . . 73.140000000000001 112.211 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -78.21 128.78 34.26 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.565 -0.531 . . . . 73.519999999999996 109.565 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 5.2 p -82.18 -47.98 11.84 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 123.732 0.813 . . . . 64.540000000000006 112.092 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -68.42 -166.4 3.94 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 115.698 1.039 . . . . 43.450000000000003 115.698 -176.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 17.5 tpt -118.46 149.15 41.75 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 123.452 0.701 . . . . 53.329999999999998 109.538 -175.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 28.5 tp -80.46 117.61 21.34 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 121.252 0.548 . . . . 65.25 109.82 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 621' ' ' THR . 25.5 t70 -100.49 120.58 40.21 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 115.237 -0.892 . . . . 74.549999999999997 109.5 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.493 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.3 OUTLIER -108.18 134.29 51.24 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.217 0.532 . . . . 64.099999999999994 109.784 178.046 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -86.47 -70.28 1.32 Allowed Glycine 0 C--N 1.288 -2.098 0 CA-C-N 115.396 -0.82 . . . . 73.120000000000005 112.651 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.42 154.13 47.73 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.656 0.265 . . . . 63.450000000000003 111.433 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -93.07 124.76 37.27 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.177 -0.92 . . . . 71.340000000000003 108.813 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 52.3 t -104.96 147.81 10.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 107.589 -1.263 . . . . 72.420000000000002 107.589 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . 0.495 ' HA ' ' HG2' ' A' ' 626' ' ' GLN . 10.7 p-10 -78.38 120.76 23.58 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.58 -0.896 . . . . 72.230000000000004 108.58 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -124.22 -52.39 1.74 Allowed 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.231 -0.588 . . . . 65.439999999999998 110.611 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 96.04 143.48 14.79 Favored Glycine 0 N--CA 1.427 -1.915 0 C-N-CA 119.935 -1.126 . . . . 64.230000000000004 111.697 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -60.5 -33.31 81.0 Favored Glycine 0 C--N 1.309 -0.956 0 N-CA-C 115.096 0.798 . . . . 72.530000000000001 115.096 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 33.4 t -77.14 -27.77 54.01 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 118.104 0.952 . . . . 72.120000000000005 109.528 -175.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -90.28 -3.42 57.8 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.102 -0.954 . . . . 70.129999999999995 109.947 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 34.0 m80 69.07 111.25 0.05 OUTLIER 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 114.491 -1.231 . . . . 72.219999999999999 112.486 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 625' ' ' GLY . 21.5 p-10 -79.4 65.01 4.44 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 123.306 1.527 . . . . 73.319999999999993 110.83 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -91.53 171.23 9.33 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 113.055 -1.884 . . . . 51.009999999999998 110.07 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 94.8 t -65.65 130.11 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 106.645 -1.613 . . . . 73.299999999999997 106.645 170.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 29.9 m -101.29 -36.32 4.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.152 0.501 . . . . 63.229999999999997 111.206 -176.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -144.27 135.98 25.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 116.167 -0.469 . . . . 62.420000000000002 109.965 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -126.62 137.79 53.35 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.161 -1.422 . . . . 41.399999999999999 107.161 174.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.523 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 45.0 t-20 -62.63 -59.11 13.62 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-O 118.99 -0.529 . . . . 72.430000000000007 112.162 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.0 Cg_exo -82.84 120.67 3.1 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.553 1.502 . . . . 75.230000000000004 110.065 175.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 14.6 Cg_exo -69.8 148.31 64.55 Favored 'Trans proline' 0 C--O 1.243 0.758 0 C-N-CA 122.341 2.027 . . . . 65.329999999999998 112.29 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -68.07 129.46 39.98 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.761 -0.654 . . . . 74.109999999999999 109.403 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.04 -10.4 47.82 Favored Glycine 0 C--N 1.302 -1.333 0 N-CA-C 110.219 -1.152 . . . . 60.25 110.219 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 37.1 m -101.68 161.92 13.29 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.801 -1.185 . . . . 70.010000000000005 107.801 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -82.82 135.22 13.72 Favored Glycine 0 N--CA 1.418 -2.528 0 C-N-CA 121.271 -0.49 . . . . 52.329999999999998 112.537 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.1 m -114.08 142.98 24.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 107.434 -1.321 . . . . 60.399999999999999 107.434 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.487 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 33.1 p-10 -56.37 170.86 0.32 Allowed 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 112.683 0.623 . . . . 75.540000000000006 112.683 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -56.98 -25.19 57.79 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.181 0.808 . . . . 73.420000000000002 113.181 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -87.57 -9.05 55.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.497 0.665 . . . . 73.150000000000006 109.5 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.54 14.92 63.18 Favored Glycine 0 C--O 1.217 -0.917 0 CA-C-N 115.628 -0.714 . . . . 70.319999999999993 113.406 172.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.57 119.74 17.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 122.416 1.103 . . . . 61.130000000000003 112.458 -167.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.504 HG21 ' SD ' ' A' ' 563' ' ' MET . 36.0 pt -122.42 133.32 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.975 0 CA-C-N 114.337 -1.301 . . . . 44.009999999999998 109.02 178.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 9.9 t -109.49 131.37 55.12 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.189 -1.041 . . . . 73.319999999999993 108.189 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.7 pp -138.73 165.91 25.76 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 112.873 0.694 . . . . 73.129999999999995 112.873 -175.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -128.45 137.83 52.02 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.51 -1.293 . . . . 72.109999999999999 107.51 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -133.44 163.13 30.04 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 120.161 -0.616 . . . . 73.540000000000006 111.387 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 601' ' ' ASN . . . -84.41 153.16 28.63 Favored Glycine 0 N--CA 1.42 -2.388 0 CA-C-N 115.446 -0.797 . . . . 64.150000000000006 112.507 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.495 ' HG2' ' HA ' ' A' ' 594' ' ' ASP . 1.0 OUTLIER . . . . . 0 C--O 1.271 2.202 0 N-CA-C 107.577 -1.268 . . . . 51.350000000000001 107.577 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 120.989 0.423 . . . . 63.350000000000001 112.035 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.44 ' HB ' HG22 ' A' ' 544' ' ' THR . 40.3 p -138.96 139.87 38.09 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.035 -0.728 . . . . 52.350000000000001 109.035 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.612 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 6.1 tmtt? -134.8 143.0 46.82 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.699 -0.852 . . . . 64.109999999999999 108.699 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.612 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 9.3 p-10 -77.41 128.9 35.04 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.879 0.872 . . . . 42.549999999999997 110.712 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.7 pt -84.15 138.01 39.75 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.352 -0.84 . . . . 75.030000000000001 111.007 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.08 176.56 8.95 Favored 'Trans proline' 0 C--O 1.238 0.511 0 C-N-CA 122.666 2.244 . . . . 75.209999999999994 112.516 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -81.45 127.85 33.24 Favored 'General case' 0 C--O 1.253 1.263 0 N-CA-C 108.177 -1.046 . . . . 64.400000000000006 108.177 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.585 ' HA ' ' NE2' ' A' ' 503' ' ' GLN . 34.8 m -123.28 -16.92 4.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 113.465 0.913 . . . . 73.040000000000006 113.465 -175.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -71.11 94.84 1.16 Allowed 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 120.721 0.296 . . . . 54.210000000000001 110.897 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 153.01 -39.23 0.73 Allowed Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 120.224 -0.989 . . . . 65.239999999999995 112.224 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.585 ' NE2' ' HA ' ' A' ' 500' ' ' VAL . 15.2 pm0 -88.2 -176.91 5.56 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 119.98 -0.688 . . . . 61.200000000000003 109.685 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 14.7 m -70.84 155.3 40.97 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.435 -1.32 . . . . 74.150000000000006 107.435 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.484 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.5 p -64.39 -41.48 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 121.031 -0.267 . . . . 74.5 110.713 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 14.3 t70 -61.75 -40.88 96.68 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.596 -0.52 . . . . 73.239999999999995 109.596 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.37 -43.35 84.31 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.803 0 CA-C-N 115.576 -0.738 . . . . 55.329999999999998 109.794 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.519 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -58.37 -45.04 89.0 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 123.15 0.281 . . . . 73.219999999999999 110.6 176.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.2 mt-30 -63.52 -45.29 91.3 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.754 -0.657 . . . . 63.140000000000001 110.369 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.533 ' O ' HG23 ' A' ' 514' ' ' VAL . 47.0 mmtm -62.99 -43.91 97.47 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.142 -0.481 . . . . 54.32 110.535 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -64.58 -43.74 92.9 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.656 -0.702 . . . . 74.310000000000002 111.85 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.2 pp -69.22 -36.43 77.22 Favored 'General case' 0 C--O 1.207 -1.181 0 C-N-CA 120.308 -0.557 . . . . 73.310000000000002 110.63 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.429 ' N ' HD12 ' A' ' 512' ' ' LEU . 2.0 t-20 -63.13 -35.79 81.45 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 123.155 0.582 . . . . 75.340000000000003 110.45 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 510' ' ' LYS . 89.1 t -60.84 -36.34 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.05 0.452 . . . . 75.319999999999993 110.83 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . 0.461 ' O ' ' HE3' ' A' ' 495' ' ' LYS . 84.2 m-85 -112.71 22.64 14.32 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.15 0.5 . . . . 75.25 110.024 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -144.3 -58.83 0.02 OUTLIER Glycine 0 CA--C 1.48 -2.11 0 C-N-CA 119.849 -1.167 . . . . 64.140000000000001 112.797 -176.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 66.06 23.66 11.06 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 122.93 1.347 . . . . 72.099999999999994 109.656 -173.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.496 ' C ' ' HD2' ' A' ' 519' ' ' LYS . 5.8 p -83.08 174.7 10.61 Favored 'General case' 0 N--CA 1.394 -3.233 0 CA-C-N 112.646 -2.07 . . . . 71.200000000000003 108.373 176.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.496 ' HD2' ' C ' ' A' ' 518' ' ' THR . 11.8 mptt -107.94 140.28 41.3 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 108.848 -0.797 . . . . 75.430000000000007 108.848 -177.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -125.41 154.03 42.55 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 121.16 0.505 . . . . 71.140000000000001 111.81 -172.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 32.9 p -135.59 147.17 48.6 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 107.724 -1.213 . . . . 74.340000000000003 107.724 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -119.74 119.83 34.81 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.245 0.545 . . . . 72.450000000000003 110.687 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -110.77 116.66 31.67 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.053 -1.092 . . . . 75.129999999999995 108.053 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.6 m -96.39 126.91 41.92 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.587 -0.445 . . . . 72.030000000000001 110.199 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.35 149.09 24.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 106.819 -1.549 . . . . 74.420000000000002 106.819 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.501 ' HB2' HD22 ' A' ' 559' ' ' ASN . 6.1 p-10 -80.18 135.85 36.37 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-O 121.186 0.517 . . . . 73.219999999999999 110.565 -176.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 43.7 m -153.0 168.91 10.55 Favored Pre-proline 0 C--N 1.293 -1.869 0 N-CA-C 106.152 -1.796 . . . . 71.25 106.152 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -75.78 -10.63 20.02 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 121.255 1.303 . . . . 73.329999999999998 111.503 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.48 ' HA ' ' HD3' ' A' ' 530' ' ' PRO . 17.9 mtp180 -81.01 137.2 49.91 Favored Pre-proline 0 N--CA 1.413 -2.289 0 N-CA-C 108.252 -1.018 . . . . 72.340000000000003 108.252 -178.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 529' ' ' ARG . 15.9 Cg_exo -65.3 142.39 72.73 Favored 'Trans proline' 0 C--O 1.255 1.325 0 C-N-CA 123.351 2.701 . . . . 53.310000000000002 115.304 -170.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.729 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -59.58 118.2 5.8 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 114.613 -1.176 . . . . 62.530000000000001 111.739 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 136.0 -27.04 3.07 Favored Glycine 0 C--N 1.296 -1.69 0 N-CA-C 109.846 -1.302 . . . . 63.520000000000003 109.846 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -74.46 136.04 42.28 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.943 -0.629 . . . . 63.539999999999999 110.273 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 5.7 p -100.95 113.9 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.315 0 N-CA-C 108.201 -1.037 . . . . 63.140000000000001 108.201 172.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.95 -8.1 58.6 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.024 -0.534 . . . . 52.420000000000002 112.11 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 147.06 -171.86 27.66 Favored Glycine 0 N--CA 1.42 -2.408 0 C-N-CA 120.271 -0.966 . . . . 73.239999999999995 112.178 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 4.5 p -116.9 159.0 23.09 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 107.485 -1.302 . . . . 64.519999999999996 107.485 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -64.77 -47.17 75.71 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 118.33 -1.348 . . . . 74.549999999999997 112.084 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -73.58 137.07 24.6 Favored 'Trans proline' 0 C--N 1.366 1.465 0 N-CA-C 108.384 -1.429 . . . . 65.129999999999995 108.384 169.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . 0.434 ' HG2' ' OG1' ' A' ' 543' ' ' THR . 15.7 Cg_endo -59.97 140.62 93.68 Favored 'Trans proline' 0 C--O 1.246 0.89 0 C-N-CA 122.299 1.999 . . . . 62.140000000000001 112.589 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.6 132.69 54.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.758 -0.655 . . . . 63.140000000000001 109.59 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.44 -21.01 36.01 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.207 -0.757 . . . . 71.340000000000003 111.207 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.434 ' OG1' ' HG2' ' A' ' 540' ' ' PRO . 70.5 m -77.08 137.93 39.24 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.21 0.529 . . . . 43.409999999999997 110.873 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 7.1 m -84.39 123.2 29.96 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 108.628 -0.878 . . . . 62.009999999999998 108.628 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.98 157.39 63.71 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 108.424 -0.954 . . . . 63.420000000000002 108.424 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -59.99 136.26 68.27 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 121.355 1.37 . . . . 75.349999999999994 112.866 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.93 -20.54 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.671 -1.15 . . . . 73.430000000000007 111.105 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -84.13 -17.93 38.47 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.434 -1.257 . . . . 72.200000000000003 111.535 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 50.0 m -97.28 163.29 12.96 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 114.107 1.151 . . . . 61.520000000000003 114.107 -171.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.8 p -89.81 129.72 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 114.568 -1.196 . . . . 61.039999999999999 110.522 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 56.4 mt -92.74 132.13 37.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 107.697 -1.223 . . . . 73.329999999999998 107.697 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.43 117.75 35.17 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 121.509 0.671 . . . . 72.519999999999996 110.293 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.0 mp -103.96 124.51 49.13 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.884 -1.053 . . . . 74.219999999999999 108.948 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -92.46 118.79 31.32 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.412 0.625 . . . . 72.140000000000001 110.252 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.69 133.82 41.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.002 -0.999 . . . . 72.310000000000002 109.24 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.729 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 3.1 m -83.13 119.75 24.92 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.312 -1.366 . . . . 74.549999999999997 107.312 176.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.456 ' HG3' ' HA ' ' A' ' 526' ' ' ASP . 8.6 ptpp? -96.07 142.95 27.66 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.922 -1.51 . . . . 72.530000000000001 106.922 172.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -56.04 -23.47 39.37 Favored Glycine 0 C--O 1.244 0.773 0 O-C-N 124.641 1.213 . . . . 60.310000000000002 114.773 -171.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . 0.501 HD22 ' HB2' ' A' ' 526' ' ' ASP . 24.0 t-20 78.55 -9.26 1.53 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 124.082 0.953 . . . . 72.319999999999993 110.364 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -112.6 156.88 21.93 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 113.387 0.884 . . . . 73.420000000000002 113.387 -170.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -130.67 157.04 43.86 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.479 -1.237 . . . . 71.409999999999997 107.915 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 97.0 t -74.72 121.49 26.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 O-C-N 123.212 0.32 . . . . 64.420000000000002 110.838 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 564' ' ' PRO . 42.8 ttm -64.84 125.81 89.74 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 123.461 0.705 . . . . 64.129999999999995 111.836 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . 0.464 ' O ' ' HG2' ' A' ' 563' ' ' MET . 16.2 Cg_exo -74.07 169.35 22.64 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.825 2.35 . . . . 74.299999999999997 110.504 172.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.87 138.42 46.27 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.41 0.624 . . . . 75.439999999999998 112.263 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -152.79 24.62 0.58 Allowed 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.786 -1.191 . . . . 71.420000000000002 107.786 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 6.2 m -78.07 141.53 38.76 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.434 -1.257 . . . . 72.430000000000007 111.371 -173.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 70.42 27.6 72.44 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 116.065 -0.516 . . . . 73.230000000000004 113.51 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . 0.523 ' O ' ' HA ' ' A' ' 602' ' ' ARG . 27.0 ptt? -99.51 160.02 14.59 Favored 'General case' 0 CA--C 1.476 -1.884 0 C-N-CA 120.233 -0.587 . . . . 62.530000000000001 109.936 -176.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . 0.587 ' HA ' ' O ' ' A' ' 601' ' ' ASN . 6.5 m-85 -103.38 175.05 5.61 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.638 -1.986 . . . . 74.409999999999997 105.638 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -70.1 -28.49 65.44 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 118.507 -1.277 . . . . 71.530000000000001 109.579 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.9 m -73.37 -13.38 16.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.557 -0.747 . . . . 71.230000000000004 110.548 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.597 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 24.0 t70 -101.46 -28.63 12.46 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.899 -0.778 . . . . 74.219999999999999 108.899 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -59.11 -53.05 62.77 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.046 -0.979 . . . . 75.329999999999998 111.803 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -54.8 -50.5 85.59 Favored Pre-proline 0 CA--C 1.558 1.287 0 N-CA-C 113.365 0.876 . . . . 74.420000000000002 113.365 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -57.67 -28.96 83.79 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 121.336 1.357 . . . . 62.240000000000002 112.766 172.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.597 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 23.0 mmm180 -68.76 -38.9 80.41 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 121.802 -0.561 . . . . 72.040000000000006 110.805 176.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.541 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 11.0 mp -59.75 -48.05 83.22 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 120.707 0.289 . . . . 74.439999999999998 110.453 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -66.37 -38.44 87.58 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.838 -0.619 . . . . 72.219999999999999 112.411 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.03 -39.06 76.0 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.545 0.688 . . . . 61.25 111.018 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.457 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 8.5 tp -83.28 -9.5 59.07 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 115.24 -0.891 . . . . 73.299999999999997 110.522 -178.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 60.87 42.35 99.57 Favored Glycine 0 CA--C 1.507 -0.466 0 N-CA-C 111.028 -0.829 . . . . 34.450000000000003 111.028 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.541 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 14.6 t90 -85.21 126.74 33.9 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.469 -0.567 . . . . 71.319999999999993 109.469 -175.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 12.7 t -99.14 -16.24 18.67 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 116.127 -0.488 . . . . 52.100000000000001 110.956 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -77.15 -177.49 45.88 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 121.509 -0.377 . . . . 74.219999999999999 112.691 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 48.4 tpp -112.8 147.16 37.5 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.192 -0.67 . . . . 72.140000000000001 109.192 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.4 tt -86.91 127.87 35.06 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.42 -1.326 . . . . 64.140000000000001 107.42 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 621' ' ' THR . 31.3 t70 -100.07 119.11 37.8 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.547 -0.538 . . . . 74.049999999999997 109.547 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.49 133.79 46.87 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.461 -0.896 . . . . 60.299999999999997 109.91 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.36 -79.05 0.95 Allowed Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.456 -0.793 . . . . 45.240000000000002 112.091 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -137.72 145.77 42.93 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 110.047 -0.353 . . . . 74.150000000000006 110.047 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -88.15 124.63 34.0 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.729 -1.582 . . . . 74.239999999999995 106.729 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 39.1 t -104.43 126.18 59.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.531 -0.914 . . . . 62.340000000000003 108.531 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . 0.525 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 32.2 t70 -73.58 106.39 5.33 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.379 -0.528 . . . . 75.439999999999998 111.114 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -113.54 -12.33 12.92 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.142 -0.936 . . . . 75.109999999999999 109.536 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 114.49 137.6 6.52 Favored Glycine 0 N--CA 1.428 -1.855 0 N-CA-C 111.084 -0.807 . . . . 42.420000000000002 111.084 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -63.23 -38.49 96.56 Favored Glycine 0 C--N 1.318 -0.464 0 C-N-CA 121.725 -0.274 . . . . 75.299999999999997 112.887 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 33.6 t -72.79 -22.82 60.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.869 0.842 . . . . 61.140000000000001 109.414 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -86.92 -3.43 59.08 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.006 -0.997 . . . . 65.030000000000001 110.546 -175.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 70.5 m80 67.67 158.11 0.14 Allowed 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.798 1.239 . . . . 75.219999999999999 113.199 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 570' ' ' PHE . 21.1 p30 -93.77 68.16 3.9 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.592 0.71 . . . . 64.519999999999996 112.905 -179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.523 ' HA ' ' O ' ' A' ' 569' ' ' MET . 2.7 ptp180 -85.47 146.72 26.81 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 119.365 -0.934 . . . . 72.530000000000001 112.171 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 74.2 t -57.95 130.11 20.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 114.053 -1.431 . . . . 72.340000000000003 109.516 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.17 -23.02 4.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.025 0.441 . . . . 73.400000000000006 111.086 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -155.97 135.9 12.76 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.548 -0.751 . . . . 75.400000000000006 109.726 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -124.5 137.64 54.4 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.698 -1.964 . . . . 74.120000000000005 105.698 173.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.41 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 28.6 t-20 -65.71 -53.52 35.68 Favored Pre-proline 0 C--N 1.317 -0.832 0 C-N-CA 119.066 -1.053 . . . . 70.420000000000002 112.86 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 5.3 Cg_endo -91.94 113.76 0.34 Allowed 'Trans proline' 0 N--CA 1.438 -1.789 0 C-N-CA 121.217 1.278 . . . . 64.329999999999998 109.344 171.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -70.14 160.11 50.75 Favored 'Trans proline' 0 C--O 1.247 0.947 0 C-N-CA 122.332 2.021 . . . . 64.129999999999995 111.539 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -62.18 138.89 58.48 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 109.844 -0.428 . . . . 73.200000000000003 109.844 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 102.1 -14.74 57.01 Favored Glycine 0 C--N 1.306 -1.113 0 N-CA-C 111.579 -0.608 . . . . 62.530000000000001 111.579 -175.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 6.0 m -92.05 155.03 18.37 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.881 -0.785 . . . . 71.310000000000002 108.881 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -80.01 134.22 13.31 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 121.033 -0.603 . . . . 71.140000000000001 112.496 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 13.6 m -127.06 143.13 41.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 124.226 1.01 . . . . 61.310000000000002 109.879 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.413 HD21 HG22 ' A' ' 619' ' ' ILE . 29.2 p-10 -49.58 162.87 0.14 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.322 1.049 . . . . 72.409999999999997 112.971 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -59.45 -24.83 63.87 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 114.056 1.132 . . . . 75.310000000000002 114.056 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.403 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 28.9 t70 -82.71 -8.82 59.57 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 119.598 -0.841 . . . . 73.030000000000001 109.523 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.2 14.68 64.31 Favored Glycine 0 C--O 1.221 -0.68 0 C-N-CA 123.519 0.581 . . . . 72.109999999999999 113.678 173.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . 0.413 HG22 HD21 ' A' ' 615' ' ' ASN . 0.1 OUTLIER -70.29 119.9 17.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 122.099 0.952 . . . . 63.32 110.556 -168.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.423 ' O ' HD12 ' A' ' 620' ' ' ILE . 2.7 pp -128.64 134.62 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-N 115.087 -0.961 . . . . 75.400000000000006 112.768 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 10.2 t -105.11 124.69 49.97 Favored 'General case' 0 C--O 1.258 1.551 0 CA-C-N 115.355 -0.839 . . . . 45.530000000000001 109.641 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.1 pp -140.12 167.35 22.33 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.514 -0.767 . . . . 62.039999999999999 112.411 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -127.3 140.25 52.33 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.788 -0.819 . . . . 75.0 108.788 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -139.97 167.37 22.28 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.628 -0.715 . . . . 55.439999999999998 110.039 -170.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -60.1 177.15 3.33 Favored Glycine 0 CA--C 1.538 1.472 0 O-C-N 124.008 0.818 . . . . 71.349999999999994 113.847 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.525 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 5.6 tp-100 . . . . . 0 C--N 1.292 -1.921 0 C-N-CA 123.712 0.805 . . . . 73.230000000000004 108.971 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.231 0 CA-C-O 121.895 0.855 . . . . 72.200000000000003 110.882 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 7.9 p -135.27 144.82 47.02 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.807 -1.183 . . . . 72.409999999999997 107.807 176.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -141.34 143.79 34.21 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 109.533 -0.543 . . . . 75.120000000000005 109.533 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.5 m-20 -83.02 124.73 30.7 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.036 -0.529 . . . . 72.400000000000006 110.46 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.4 pt -88.83 137.35 30.0 Favored Pre-proline 0 C--N 1.305 -1.327 0 CA-C-N 115.81 -0.632 . . . . 74.420000000000002 110.434 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.89 -177.34 3.76 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.311 2.007 . . . . 73.239999999999995 111.776 177.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -93.61 127.44 39.29 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.317 -0.994 . . . . 44.109999999999999 108.317 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.555 ' O ' ' HG2' ' A' ' 503' ' ' GLN . 28.2 m -122.06 -3.98 8.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 112.717 0.636 . . . . 73.439999999999998 112.717 -176.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -66.3 102.3 0.84 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.018 0.437 . . . . 75.420000000000002 110.423 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 141.94 -22.28 2.47 Favored Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 120.808 -0.711 . . . . 63.340000000000003 112.742 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.555 ' HG2' ' O ' ' A' ' 500' ' ' VAL . 6.3 pt20 -100.46 -179.1 4.0 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 109.091 -0.707 . . . . 65.219999999999999 109.091 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 21.1 m -74.4 155.41 38.11 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 108.495 -0.928 . . . . 73.200000000000003 108.495 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.18 -41.57 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 C-N-CA 122.697 0.399 . . . . 62.229999999999997 110.883 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . 0.497 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 28.5 t70 -59.69 -43.7 93.93 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.056 0.455 . . . . 61.229999999999997 110.162 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 90.2 t -67.99 -46.61 81.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 114.491 -1.231 . . . . 72.430000000000007 110.052 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.423 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -59.6 -45.79 90.86 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 123.41 0.444 . . . . 70.400000000000006 111.258 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -65.23 -44.49 88.07 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.178 -0.464 . . . . 75.25 111.745 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.567 ' O ' HG23 ' A' ' 514' ' ' VAL . 3.4 ptpp? -67.45 -39.92 85.4 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 119.632 -0.827 . . . . 64.430000000000007 111.186 176.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -62.44 -44.27 96.81 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.524 0.678 . . . . 73.200000000000003 110.918 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.65 -47.14 86.8 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-N 114.395 -1.275 . . . . 74.299999999999997 108.951 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -65.98 -35.23 80.02 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 115.439 -0.8 . . . . 64.329999999999998 112.675 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 510' ' ' LYS . 72.5 t -58.45 -33.76 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.115 0.483 . . . . 71.239999999999995 110.552 176.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -114.2 11.34 17.47 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.056 0.455 . . . . 74.25 110.117 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -127.47 -59.82 0.13 Allowed Glycine 0 CA--C 1.475 -2.416 0 C-N-CA 120.437 -0.887 . . . . 60.5 113.242 -172.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 66.25 21.55 11.03 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 121.926 0.87 . . . . 73.150000000000006 109.134 -172.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.4 p -91.48 -173.57 3.62 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 114.16 -1.382 . . . . 62.420000000000002 110.148 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 52.5 mtmt -108.11 143.85 36.28 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.384 -0.969 . . . . 75.519999999999996 108.384 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -129.17 151.08 50.23 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 120.866 0.365 . . . . 73.409999999999997 111.357 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 67.7 m -140.25 151.5 45.18 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 107.419 -1.326 . . . . 74.340000000000003 107.419 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -121.66 124.47 44.38 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.704 0.764 . . . . 64.0 112.334 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -101.43 133.05 46.66 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.999 -1.482 . . . . 75.150000000000006 106.999 175.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 22.2 m -118.37 122.12 42.06 Favored 'General case' 0 C--N 1.29 -1.978 0 C-N-CA 120.114 -0.634 . . . . 71.129999999999995 111.519 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.9 p -122.41 149.56 25.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.691 -1.226 . . . . 75.329999999999998 107.691 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -85.79 136.72 33.21 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 119.808 -0.757 . . . . 64.450000000000003 111.636 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 53.1 m -157.47 162.22 27.75 Favored Pre-proline 0 C--N 1.302 -1.486 0 N-CA-C 106.346 -1.724 . . . . 72.329999999999998 106.346 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.13 10.26 0.42 Allowed 'Trans proline' 0 CA--C 1.556 1.578 0 C-N-CA 122.343 2.028 . . . . 74.019999999999996 114.44 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.552 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 0.6 OUTLIER -95.26 145.77 30.13 Favored Pre-proline 0 CA--C 1.506 -0.716 0 N-CA-C 107.453 -1.314 . . . . 63.329999999999998 107.453 175.724 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -64.81 148.38 89.99 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.45 2.1 . . . . 72.109999999999999 114.341 -172.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.458 ' HB2' ' H ' ' A' ' 558' ' ' GLY . . . -61.85 113.76 2.96 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-N 114.323 -1.308 . . . . 74.040000000000006 110.742 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 126.57 -16.95 6.54 Favored Glycine 0 N--CA 1.42 -2.396 0 C-N-CA 119.918 -1.134 . . . . 64.209999999999994 111.768 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -82.92 128.18 34.21 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.28 -0.637 . . . . 75.430000000000007 109.28 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 5.3 p -94.36 112.71 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 N-CA-C 107.207 -1.405 . . . . 73.109999999999999 107.207 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 29.7 p -102.86 12.81 35.68 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 115.253 -0.885 . . . . 73.120000000000005 112.523 -172.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 169.04 172.42 35.77 Favored Glycine 0 N--CA 1.432 -1.616 0 C-N-CA 120.007 -1.092 . . . . 64.430000000000007 111.693 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 4.0 p -131.21 146.82 52.48 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.864 -0.791 . . . . 72.329999999999998 108.864 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 552' ' ' GLU . 2.8 t-20 -64.44 -51.58 59.19 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 119.784 -0.767 . . . . 75.540000000000006 109.872 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 58.8 Cg_endo -75.62 139.75 23.08 Favored 'Trans proline' 0 C--N 1.366 1.457 0 C-N-CA 120.859 1.039 . . . . 65.140000000000001 109.975 171.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 25.2 Cg_exo -64.55 140.53 69.35 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 122.259 1.973 . . . . 54.340000000000003 112.834 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -68.15 132.54 47.38 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.452 -0.795 . . . . 72.310000000000002 109.752 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.68 -9.07 58.5 Favored Glycine 0 N--CA 1.436 -1.33 0 N-CA-C 111.187 -0.765 . . . . 51.020000000000003 111.187 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 91.3 m -86.2 136.83 33.04 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.187 0.518 . . . . 71.25 111.291 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 9.8 t -81.31 125.79 30.78 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.757 -0.831 . . . . 73.209999999999994 108.757 174.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.74 161.8 44.32 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 107.89 -1.152 . . . . 72.319999999999993 107.89 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -62.54 138.51 70.77 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 120.967 1.112 . . . . 41.420000000000002 110.768 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.87 -19.9 24.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 121.376 0.608 . . . . 75.209999999999994 111.343 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -96.17 -0.74 49.61 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 121.789 -0.569 . . . . 55.409999999999997 110.523 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 10.4 t -86.6 171.95 10.63 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.4 0.619 . . . . 51.140000000000001 109.501 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 7.6 p -115.68 137.86 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.296 0 CA-C-N 115.379 -0.828 . . . . 73.120000000000005 110.071 -177.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 3.1 mp -94.48 135.1 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 108.342 -0.985 . . . . 75.049999999999997 108.342 175.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 538' ' ' ASN . 6.3 tp10 -102.46 117.32 34.46 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.695 -1.224 . . . . 72.340000000000003 107.695 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -91.58 121.45 33.27 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.43 -0.952 . . . . 72.120000000000005 108.43 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -89.9 101.99 14.69 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.641 -1.244 . . . . 73.239999999999995 107.641 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 524' ' ' SER . 38.4 t -101.31 136.83 31.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-N 115.223 -0.899 . . . . 73.010000000000005 110.025 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 59.7 m -91.71 128.18 37.45 Favored 'General case' 0 N--CA 1.41 -2.469 0 CA-C-N 115.973 -0.558 . . . . 71.030000000000001 109.744 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -90.58 142.93 27.25 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 105.904 -1.887 . . . . 74.439999999999998 105.904 169.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -54.48 -24.07 29.74 Favored Glycine 0 CA--C 1.479 -2.182 0 O-C-N 125.145 1.528 . . . . 35.310000000000002 115.25 -168.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 74.43 -22.74 0.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.441 1.097 . . . . 73.329999999999998 110.794 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.583 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 44.3 mt-30 -113.37 148.31 36.03 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-O 121.488 0.661 . . . . 61.229999999999997 111.461 -172.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -125.53 158.02 35.58 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.886 -1.052 . . . . 63.520000000000003 108.835 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.88 125.12 22.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 121.315 0.578 . . . . 65.209999999999994 111.127 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 20.2 ttt -75.42 125.83 88.34 Favored Pre-proline 0 N--CA 1.427 -1.601 0 CA-C-N 115.356 -0.838 . . . . 73.430000000000007 110.988 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.06 169.74 20.68 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 123.039 2.493 . . . . 64.140000000000001 111.799 177.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -75.29 130.04 38.41 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.682 0.753 . . . . 61.049999999999997 112.036 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 569' ' ' MET . 2.6 pp -141.27 18.26 2.24 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 123.021 1.391 . . . . 74.310000000000002 107.823 174.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 7.3 m -79.14 132.2 36.48 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 113.283 -1.781 . . . . 60.409999999999997 111.174 -173.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . 0.408 ' H ' ' CG1' ' A' ' 603' ' ' VAL . . . 64.54 39.66 96.99 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.541 -0.754 . . . . 72.450000000000003 114.29 174.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 16.0 ptp -128.89 -177.34 4.17 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 117.312 0.556 . . . . 55.399999999999999 109.933 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . 0.554 ' HA ' ' O ' ' A' ' 601' ' ' ASN . 49.3 m-85 -93.53 163.44 13.57 Favored 'General case' 0 C--O 1.25 1.083 0 N-CA-C 108.202 -1.036 . . . . 75.239999999999995 108.202 -178.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . 0.474 ' CH2' HD13 ' A' ' 587' ' ' LEU . 16.3 t-105 -63.07 -32.16 73.47 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.166 -1.05 . . . . 64.140000000000001 108.166 174.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.75 -10.48 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.471 -0.786 . . . . 63.420000000000002 111.159 -176.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -101.36 -43.9 5.8 Favored 'General case' 0 C--O 1.256 1.401 0 N-CA-C 108.09 -1.078 . . . . 73.329999999999998 108.09 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . 0.517 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -62.82 -51.44 67.05 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.326 -1.306 . . . . 74.219999999999999 111.945 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.562 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 37.8 tt0 -51.75 -54.1 43.64 Favored Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 112.395 0.517 . . . . 75.200000000000003 112.395 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 52.9 Cg_exo -59.55 -38.29 83.47 Favored 'Trans proline' 0 C--N 1.38 2.237 0 C-N-CA 121.972 1.782 . . . . 73.430000000000007 112.721 177.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -66.76 -37.14 84.04 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 120.381 -0.528 . . . . 72.230000000000004 112.198 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.585 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 89.7 mt -66.75 -47.49 72.08 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.898 -0.592 . . . . 75.0 110.529 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -65.59 -34.52 78.43 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.635 -0.426 . . . . 71.150000000000006 111.048 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.24 -32.02 71.92 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.953 0.406 . . . . 74.310000000000002 110.943 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 578' ' ' LEU . 2.8 pp -80.89 -6.92 59.27 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.537 -0.465 . . . . 72.299999999999997 110.033 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 85.6 34.86 12.65 Favored Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 115.833 -0.621 . . . . 65.140000000000001 112.878 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.43 ' CZ3' HD13 ' A' ' 578' ' ' LEU . 21.3 t90 -67.19 130.6 43.64 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.544 0.172 . . . . 75.209999999999994 111.054 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 62.8 p -103.24 -23.14 13.63 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-O 120.987 0.422 . . . . 72.549999999999997 112.023 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -75.98 -175.92 39.82 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-O 121.72 0.622 . . . . 62.329999999999998 114.359 -174.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 54.3 ttp -115.05 141.35 48.12 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.951 -0.625 . . . . 74.430000000000007 109.753 -176.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . 0.474 HD13 ' CH2' ' A' ' 571' ' ' TRP . 5.5 tt -85.64 125.68 33.34 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.061 0.457 . . . . 64.099999999999994 110.074 -175.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -95.89 104.35 16.28 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.543 -0.753 . . . . 74.120000000000005 110.333 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.467 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -112.16 133.51 54.25 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.138 -1.43 . . . . 62.539999999999999 107.138 173.209 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -111.68 -42.33 1.04 Allowed Glycine 0 C--N 1.284 -2.318 0 C-N-CA 119.874 -1.155 . . . . 74.530000000000001 113.993 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.4 135.64 33.86 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 120.569 -0.453 . . . . 63.140000000000001 111.379 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -90.86 124.44 35.17 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 105.954 -1.869 . . . . 70.0 105.954 172.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . 0.491 ' O ' ' HG2' ' A' ' 626' ' ' GLN . 46.3 t -104.81 156.26 6.02 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 N-CA-C 109.049 -0.723 . . . . 74.310000000000002 109.049 -174.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . 0.448 ' HA ' ' HG2' ' A' ' 626' ' ' GLN . 1.6 p-10 -71.49 126.94 30.99 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.298 0.571 . . . . 73.099999999999994 109.894 -176.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -148.36 -57.09 0.22 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.953 -1.021 . . . . 74.420000000000002 109.318 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 116.34 124.57 3.66 Favored Glycine 0 N--CA 1.426 -2.005 0 C-N-CA 120.638 -0.791 . . . . 65.329999999999998 111.764 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -63.64 -35.96 92.72 Favored Glycine 0 C--N 1.316 -0.542 0 N-CA-C 112.113 -0.395 . . . . 75.200000000000003 112.113 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 6.5 m -76.04 -24.02 55.15 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-O 122.014 0.911 . . . . 64.109999999999999 108.99 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -87.96 -2.41 58.59 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.607 -1.179 . . . . 73.129999999999995 109.343 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . 0.539 ' HB3' ' CE2' ' A' ' 570' ' ' PHE . 30.6 m80 81.56 125.19 0.04 OUTLIER 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.41 1.884 . . . . 74.140000000000001 111.952 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 570' ' ' PHE . 8.5 p30 -73.57 96.23 2.41 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 122.597 1.189 . . . . 74.510000000000005 109.42 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 21.4 mmm-85 -100.17 151.49 21.36 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 107.351 -1.351 . . . . 74.530000000000001 107.351 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.408 ' CG1' ' H ' ' A' ' 568' ' ' GLY . 8.1 p -65.58 131.68 31.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 106.971 -1.492 . . . . 55.219999999999999 106.971 172.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.61 -26.21 3.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 120.112 -0.635 . . . . 71.5 111.895 -174.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -155.6 138.21 15.1 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.949 -0.76 . . . . 72.450000000000003 108.949 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -133.64 139.5 46.52 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.524 -1.288 . . . . 72.5 107.524 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.43 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 26.3 t-20 -71.99 -51.47 8.45 Favored Pre-proline 0 C--N 1.307 -1.246 0 C-N-CA 119.627 -0.829 . . . . 74.129999999999995 111.152 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 74.6 Cg_endo -92.3 122.19 0.58 Allowed 'Trans proline' 0 N--CA 1.442 -1.516 0 C-N-CA 121.111 1.207 . . . . 73.209999999999994 111.332 174.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -70.35 153.35 66.29 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 121.77 1.646 . . . . 75.310000000000002 110.11 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -65.36 133.08 50.6 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.266 -0.642 . . . . 60.329999999999998 109.266 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.15 -7.68 44.27 Favored Glycine 0 C--N 1.314 -0.656 0 C-N-CA 120.786 -0.721 . . . . 73.540000000000006 111.481 -176.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 19.5 m -88.16 155.59 19.69 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.532 -0.914 . . . . 71.019999999999996 108.532 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.54 126.53 7.51 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 111.116 -0.794 . . . . 74.239999999999995 111.116 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 18.5 m -113.84 141.97 28.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.609 -0.515 . . . . 63.149999999999999 109.609 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.583 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.3 p-10 -53.4 167.94 0.18 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.682 1.193 . . . . 72.340000000000003 113.16 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -57.68 -24.66 57.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.533 -0.758 . . . . 73.450000000000003 112.98 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.451 ' OD2' ' HB ' ' A' ' 619' ' ' ILE . 28.2 t70 -82.47 -9.49 59.41 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.493 -0.483 . . . . 72.510000000000005 109.703 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.63 18.3 67.89 Favored Glycine 0 CA--C 1.506 -0.525 0 CA-C-N 116.094 -0.503 . . . . 53.049999999999997 112.649 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . 0.451 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -69.86 119.5 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-O 122.269 1.033 . . . . 73.430000000000007 111.329 -167.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.447 ' O ' HD12 ' A' ' 620' ' ' ILE . 2.6 pp -116.98 131.3 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.067 0 CA-C-N 114.703 -1.135 . . . . 72.540000000000006 111.191 177.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 54.4 m -104.68 117.88 35.19 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.549 -0.908 . . . . 73.319999999999993 108.549 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.6 pp -139.72 165.82 26.25 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.602 -0.272 . . . . 72.349999999999994 111.16 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -139.47 140.9 37.39 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.647 -0.871 . . . . 74.349999999999994 108.647 174.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -128.0 166.44 18.38 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 116.216 -0.447 . . . . 74.430000000000007 111.192 -171.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -71.77 153.34 50.08 Favored Glycine 0 N--CA 1.428 -1.864 0 CA-C-N 115.524 -0.762 . . . . 65.040000000000006 113.529 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 593' ' ' VAL . 3.4 pt20 . . . . . 0 C--N 1.299 -1.593 0 C-N-CA 123.514 0.726 . . . . 51.100000000000001 110.171 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.595 0 CA-C-O 121.152 0.501 . . . . 63.109999999999999 109.916 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.9 p -135.55 149.41 49.43 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.65 -0.705 . . . . 74.109999999999999 110.711 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.452 ' HE2' ' H ' ' A' ' 496' ' ' ASP . 0.1 OUTLIER -150.6 132.61 15.21 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.259 -1.756 . . . . 65.519999999999996 106.259 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.3 p-10 -81.47 133.1 35.35 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.149 0.5 . . . . 74.349999999999994 110.349 175.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.1 pt -86.09 138.22 34.86 Favored Pre-proline 0 C--N 1.304 -1.383 0 CA-C-N 115.465 -0.789 . . . . 74.129999999999995 111.886 -177.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.64 178.41 7.61 Favored 'Trans proline' 0 C--O 1.245 0.832 0 C-N-CA 122.408 2.072 . . . . 74.430000000000007 112.009 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -80.07 96.99 6.65 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 122.627 1.203 . . . . 73.329999999999998 110.446 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.64 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 28.5 m -95.39 -1.07 10.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 CA-C-N 115.313 -0.858 . . . . 65.099999999999994 111.828 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -76.12 107.27 8.23 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 108.738 -0.838 . . . . 43.43 108.738 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 142.71 -30.17 2.08 Favored Glycine 0 C--N 1.299 -1.494 0 C-N-CA 120.746 -0.74 . . . . 62.420000000000002 112.791 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.442 ' NE2' ' HA ' ' A' ' 500' ' ' VAL . 7.8 pt20 -100.35 -177.88 3.64 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 120.109 -0.636 . . . . 70.420000000000002 110.501 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.407 ' HB ' HG23 ' A' ' 507' ' ' VAL . 2.8 m -70.34 155.61 40.43 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.565 -0.532 . . . . 65.439999999999998 109.565 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.432 ' HA ' ' CG2' ' A' ' 534' ' ' VAL . 5.9 p -55.04 -46.32 77.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 123.394 0.678 . . . . 71.439999999999998 112.1 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.69 -39.18 90.51 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.898 -0.592 . . . . 64.549999999999997 110.543 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.407 HG23 ' HB ' ' A' ' 504' ' ' THR . 59.9 t -73.07 -49.01 41.61 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.258 0 CA-C-N 115.337 -0.847 . . . . 74.209999999999994 109.888 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.64 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -58.73 -44.8 90.54 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 122.994 0.518 . . . . 62.340000000000003 110.972 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -64.99 -45.68 84.61 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.367 -0.378 . . . . 74.209999999999994 111.304 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.543 ' O ' HG23 ' A' ' 514' ' ' VAL . 17.8 ptpt -68.0 -37.86 81.97 Favored 'General case' 0 C--O 1.21 -1.0 0 C-N-CA 120.656 -0.418 . . . . 72.5 111.254 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -60.04 -48.4 81.86 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 123.4 0.437 . . . . 71.129999999999995 110.517 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -68.71 -36.21 78.14 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 120.259 -0.577 . . . . 74.129999999999995 110.886 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.444 ' N ' HD12 ' A' ' 512' ' ' LEU . 1.2 t-20 -66.14 -35.59 80.88 Favored 'General case' 0 C--O 1.203 -1.376 0 C-N-CA 123.783 0.833 . . . . 75.219999999999999 110.505 -178.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 510' ' ' LYS . 75.9 t -60.94 -33.41 55.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.95 0.405 . . . . 63.140000000000001 111.11 177.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -102.51 -4.67 24.99 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.145 -0.622 . . . . 71.0 111.014 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -122.85 -50.84 0.22 Allowed Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 120.427 -0.892 . . . . 64.049999999999997 113.544 -171.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 67.5 27.18 8.02 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 122.515 1.15 . . . . 74.010000000000005 109.337 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.7 p -80.29 -167.09 1.2 Allowed 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 113.027 -1.897 . . . . 63.119999999999997 110.981 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -119.2 142.79 47.69 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.595 -1.261 . . . . 71.310000000000002 107.595 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -132.65 153.41 51.12 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 112.545 0.572 . . . . 71.530000000000001 112.545 -175.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.7 m -132.65 151.51 51.94 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.057 -1.461 . . . . 71.340000000000003 107.057 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -124.27 133.36 53.51 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 109.179 -0.674 . . . . 64.140000000000001 109.179 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -125.41 116.1 21.33 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.221 -1.029 . . . . 62.439999999999998 108.221 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 23.9 m -98.46 124.97 43.48 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.13 0.491 . . . . 73.150000000000006 111.053 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 11.0 p -126.56 154.19 36.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.799 -1.185 . . . . 74.219999999999999 107.799 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.93 135.63 35.38 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.34 0.59 . . . . 71.200000000000003 110.183 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 50.3 m -167.65 139.13 2.47 Favored Pre-proline 0 C--O 1.197 -1.68 0 N-CA-C 105.097 -2.186 . . . . 43.539999999999999 105.097 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.43 9.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.566 2.124 0 C-N-CA 123.466 2.777 . . . . 72.150000000000006 116.997 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.23 147.07 63.93 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 106.338 -1.727 . . . . 74.230000000000004 106.338 172.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.72 141.56 95.62 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.194 1.93 . . . . 75.299999999999997 112.921 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 557' ' ' LYS . . . -61.69 116.12 4.53 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 114.811 -1.086 . . . . 65.129999999999995 112.128 -176.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 121.46 -16.24 9.12 Favored Glycine 0 N--CA 1.423 -2.226 0 CA-C-N 115.044 -0.98 . . . . 71.439999999999998 111.538 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -77.47 128.28 33.95 Favored 'General case' 0 C--O 1.248 1.012 0 N-CA-C 109.328 -0.619 . . . . 74.209999999999994 109.328 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.432 ' CG2' ' HA ' ' A' ' 505' ' ' VAL . 38.0 t -86.1 112.43 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.165 0 N-CA-C 106.952 -1.499 . . . . 53.450000000000003 106.952 173.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 17.4 p -84.33 -2.42 57.04 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.594 0.712 . . . . 64.019999999999996 111.209 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.66 179.43 27.33 Favored Glycine 0 N--CA 1.419 -2.491 0 C-N-CA 120.606 -0.806 . . . . 65.540000000000006 112.435 174.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 1.6 p -116.69 158.05 24.43 Favored 'General case' 0 C--N 1.271 -2.825 0 N-CA-C 106.694 -1.595 . . . . 54.130000000000003 106.694 177.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -60.43 -49.5 89.97 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 118.794 -1.162 . . . . 71.430000000000007 112.015 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 38.8 Cg_endo -73.61 128.8 12.97 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 N-CA-C 108.238 -1.485 . . . . 33.329999999999998 108.238 167.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 24.9 Cg_exo -63.72 155.93 60.53 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 122.501 2.134 . . . . 64.439999999999998 113.126 -177.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.05 129.63 43.08 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.245 0.618 . . . . 65.150000000000006 110.152 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.2 -15.22 54.8 Favored Glycine 0 N--CA 1.435 -1.422 0 N-CA-C 111.715 -0.554 . . . . 54.439999999999998 111.715 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 37.6 m -76.27 134.1 39.88 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.939 0.4 . . . . 70.109999999999999 111.407 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.0 t -76.53 124.06 27.02 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.45 -0.945 . . . . 64.310000000000002 108.45 173.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.04 160.72 50.77 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 108.14 -1.059 . . . . 54.340000000000003 108.14 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.48 136.84 26.89 Favored 'Trans proline' 0 N--CA 1.435 -1.952 0 CA-C-N 119.627 0.903 . . . . 72.010000000000005 110.218 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.17 -19.85 26.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.764 0.792 . . . . 74.239999999999995 110.943 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -89.64 -7.71 54.11 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.058 -0.974 . . . . 74.409999999999997 110.812 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.4 t -88.08 167.51 13.6 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.46 0.648 . . . . 70.150000000000006 109.887 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 9.8 p -108.73 121.25 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 CA-C-N 115.266 -0.879 . . . . 74.019999999999996 109.254 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 58.5 mt -87.24 133.14 30.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 115.298 -0.864 . . . . 74.409999999999997 110.045 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.15 117.6 34.91 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.763 0.792 . . . . 73.319999999999993 111.85 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.404 HD12 HG11 ' A' ' 534' ' ' VAL . 3.4 mm? -92.36 114.01 26.43 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 113.614 -1.63 . . . . 73.120000000000005 108.862 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -85.35 104.86 15.56 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.75 0.786 . . . . 61.549999999999997 109.766 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 524' ' ' SER . 23.7 t -92.96 132.8 36.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 114.667 -1.151 . . . . 71.150000000000006 108.171 -177.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 53.0 m -105.47 135.83 46.15 Favored 'General case' 0 N--CA 1.409 -2.516 0 CA-C-O 121.244 0.545 . . . . 42.340000000000003 111.093 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.0 ptpt -116.57 128.01 55.02 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 108.107 -1.071 . . . . 64.420000000000002 108.107 174.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -58.71 -24.81 57.8 Favored Glycine 0 CA--C 1.496 -1.125 0 O-C-N 123.877 0.735 . . . . 21.199999999999999 111.37 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . 0.425 ' ND2' ' HB3' ' A' ' 616' ' ' ARG . 65.0 t30 63.88 28.03 14.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 122.846 1.308 . . . . 64.140000000000001 109.063 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.517 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 82.7 mt-30 -112.5 151.03 30.43 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 113.725 -1.58 . . . . 74.329999999999998 108.333 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -130.42 147.42 52.12 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 109.254 -0.647 . . . . 74.450000000000003 109.254 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.93 120.07 13.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 O-C-N 123.896 0.748 . . . . 73.150000000000006 109.683 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.615 ' SD ' HG21 ' A' ' 620' ' ' ILE . 42.9 ttp -83.17 129.08 62.35 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 116.26 -0.427 . . . . 62.329999999999998 111.158 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . 0.426 ' O ' ' HG2' ' A' ' 563' ' ' MET . 57.9 Cg_endo -73.76 169.57 22.05 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.547 2.165 . . . . 71.319999999999993 110.317 174.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -76.93 135.31 38.76 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.383 0.611 . . . . 73.200000000000003 111.259 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . 0.415 ' O ' ' HG2' ' A' ' 569' ' ' MET . 0.9 OUTLIER -114.53 -14.98 12.08 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.326 -0.99 . . . . 62.140000000000001 108.326 -177.259 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . 0.404 ' HA ' ' HB ' ' A' ' 603' ' ' VAL . 33.2 t -77.47 147.39 35.92 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.585 -0.697 . . . . 70.129999999999995 110.91 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 96.26 11.01 55.37 Favored Glycine 0 CA--C 1.501 -0.798 0 CA-C-N 115.806 -0.634 . . . . 75.519999999999996 113.411 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 19.2 ptm -133.49 169.11 17.46 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.749 -0.463 . . . . 62.149999999999999 109.749 177.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 601' ' ' ASN . 10.9 m-85 -89.52 158.25 17.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.683 -0.858 . . . . 74.25 108.683 -176.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 29.0 t-105 -65.6 -25.05 67.23 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.189 -0.671 . . . . 74.340000000000003 109.189 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 23.0 m -69.22 -26.99 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 115.599 -0.728 . . . . 51.219999999999999 112.497 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 12.0 t70 -101.85 -23.45 14.17 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 108.538 -0.912 . . . . 74.230000000000004 108.538 175.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 577' ' ' ARG . . . -61.98 -46.73 87.96 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 115.531 -0.759 . . . . 54.5 112.341 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.476 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 0.9 OUTLIER -60.31 -49.19 91.65 Favored Pre-proline 0 CA--C 1.565 1.532 0 C-N-CA 120.279 -0.568 . . . . 62.299999999999997 110.199 179.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 62.5 Cg_exo -52.59 -29.78 42.36 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.328 2.019 . . . . 72.019999999999996 113.328 169.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 10.4 mmm180 -62.57 -39.53 93.97 Favored 'General case' 0 C--O 1.21 -1.007 0 O-C-N 121.791 -0.568 . . . . 41.32 110.47 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.788 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 9.6 mp -58.84 -49.65 76.94 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.155 0.503 . . . . 62.219999999999999 110.615 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' A' ' 576' ' ' PRO . 14.4 ptp180 -66.74 -38.37 86.52 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.388 -0.823 . . . . 64.230000000000004 112.389 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.29 -35.7 73.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.982 0.42 . . . . 42.310000000000002 111.583 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 6.0 tp -81.7 -9.67 59.58 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 123.892 0.877 . . . . 64.219999999999999 110.801 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 66.05 39.8 94.89 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.905 -0.878 . . . . 43.240000000000002 110.905 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.788 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 7.3 t90 -79.69 127.52 32.29 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 108.528 -0.916 . . . . 72.310000000000002 108.528 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' ' 617' ' ' ASP . 0.8 OUTLIER -78.62 -39.7 36.48 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 125.345 1.458 . . . . 75.319999999999993 112.78 -176.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -77.92 -162.01 17.92 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.929 -0.578 . . . . 71.030000000000001 111.759 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 65.8 mtt -133.82 160.76 36.64 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 122.426 -0.456 . . . . 72.140000000000001 109.867 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 22.7 tp -80.53 111.06 16.59 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.853 -1.166 . . . . 64.400000000000006 107.853 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 621' ' ' THR . 22.6 t70 -99.51 112.63 24.81 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.073 -0.512 . . . . 63.229999999999997 111.198 -172.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.88 133.61 34.23 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 118.848 -1.141 . . . . 45.32 109.975 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.71 -63.84 1.8 Allowed Glycine 0 C--N 1.296 -1.663 0 N-CA-C 110.998 -0.841 . . . . 60.149999999999999 110.998 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -137.04 145.12 43.64 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 121.012 0.434 . . . . 71.450000000000003 109.965 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -91.79 127.38 37.23 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.4 -1.704 . . . . 62.340000000000003 106.4 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 61.3 t -102.98 125.63 57.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 108.328 -0.99 . . . . 60.43 108.328 -175.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -72.31 107.99 5.21 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 121.491 0.662 . . . . 75.409999999999997 109.802 -173.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -123.56 -54.47 1.76 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.572 -0.74 . . . . 72.319999999999993 110.957 -175.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 104.18 147.55 17.45 Favored Glycine 0 N--CA 1.413 -2.879 0 N-CA-C 109.636 -1.386 . . . . 70.400000000000006 109.636 -173.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.74 -33.08 62.49 Favored Glycine 0 C--N 1.309 -0.921 0 N-CA-C 113.875 0.31 . . . . 52.130000000000003 113.875 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 11.8 m -68.33 -24.06 64.79 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 123.918 0.887 . . . . 73.099999999999994 110.879 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -88.6 -1.85 58.28 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.317 -0.856 . . . . 73.530000000000001 110.303 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 41.5 m80 74.5 121.23 0.04 OUTLIER 'General case' 0 C--O 1.242 0.689 0 C-N-CA 125.527 1.531 . . . . 64.519999999999996 111.952 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 570' ' ' PHE . 21.2 m120 -82.4 63.4 6.55 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 115.493 -0.776 . . . . 72.120000000000005 111.497 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -95.55 160.5 14.48 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.397 -0.82 . . . . 75.230000000000004 109.729 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.411 HG11 HD12 ' A' ' 622' ' ' LEU . 72.7 t -71.11 130.37 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.104 0 N-CA-C 105.144 -2.169 . . . . 70.109999999999999 105.144 169.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.7 m -102.69 -28.6 3.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 120.284 -0.567 . . . . 73.230000000000004 111.763 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -157.08 135.81 11.58 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 116.62 -0.264 . . . . 70.209999999999994 111.049 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -111.62 128.95 56.21 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.731 -1.211 . . . . 72.430000000000007 107.731 170.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.472 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 8.4 t30 -57.78 -52.37 74.9 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 112.206 0.447 . . . . 63.240000000000002 112.206 -176.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 5.2 Cg_exo -83.65 122.74 3.15 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 121.823 1.682 . . . . 72.400000000000006 109.318 171.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.02 155.8 61.13 Favored 'Trans proline' 0 C--O 1.258 1.484 0 C-N-CA 122.859 2.373 . . . . 74.450000000000003 113.848 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.53 138.72 58.3 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.436 -0.802 . . . . 51.25 109.599 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 103.53 -11.64 54.04 Favored Glycine 0 C--N 1.298 -1.531 0 C-N-CA 120.438 -0.887 . . . . 74.420000000000002 111.864 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 17.2 m -83.48 141.97 31.26 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.377 -0.601 . . . . 71.319999999999993 109.377 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.69 113.9 3.75 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.109 -1.196 . . . . 22.34 110.109 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.5 m -102.01 142.67 16.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 O-C-N 122.982 -0.128 . . . . 71.329999999999998 110.667 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.517 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 0.7 OUTLIER -50.33 164.78 0.11 Allowed 'General case' 0 C--O 1.21 -0.982 0 N-CA-C 113.465 0.913 . . . . 44.210000000000001 113.465 177.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . 0.425 ' HB3' ' ND2' ' A' ' 559' ' ' ASN . 14.9 ptm180 -48.74 -27.89 3.24 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.66 1.726 . . . . 75.25 115.66 -171.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.477 ' HA ' ' OG1' ' A' ' 584' ' ' THR . 20.0 p-10 -97.2 -7.06 33.27 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.545 -0.462 . . . . 72.310000000000002 111.287 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.0 17.14 65.14 Favored Glycine 0 C--O 1.215 -1.058 0 CA-C-O 119.657 -0.524 . . . . 62.43 114.311 167.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.49 119.09 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-O 121.716 0.77 . . . . 70.409999999999997 110.768 -168.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.615 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.6 pp -129.35 134.05 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-N 115.277 -0.874 . . . . 74.25 111.31 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 13.1 t -99.03 130.42 45.36 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.45 -0.795 . . . . 74.120000000000005 108.984 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.411 HD12 HG11 ' A' ' 603' ' ' VAL . 1.7 pt? -139.59 167.91 21.03 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.671 -0.695 . . . . 65.409999999999997 111.76 -174.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -127.07 140.74 52.06 Favored 'General case' 0 C--O 1.256 1.41 0 N-CA-C 109.045 -0.724 . . . . 72.140000000000001 109.045 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -139.26 165.75 26.36 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.465 -0.334 . . . . 63.509999999999998 110.354 -175.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -78.64 139.47 22.3 Favored Glycine 0 N--CA 1.434 -1.467 0 O-C-N 123.677 0.611 . . . . 32.439999999999998 113.328 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 C--N 1.288 -2.108 0 C-N-CA 125.525 1.53 . . . . 72.400000000000006 107.881 -179.301 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.744 0 CA-C-O 121.044 0.449 . . . . 64.329999999999998 110.589 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.437 HG22 ' HA ' ' A' ' 546' ' ' PRO . 25.9 p -140.12 145.36 37.49 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 110.043 -0.354 . . . . 74.129999999999995 110.043 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -139.64 155.51 47.37 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.428 -1.323 . . . . 73.239999999999995 107.428 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.596 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.4 p-10 -98.15 144.26 27.8 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.203 -0.599 . . . . 64.340000000000003 110.749 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.1 pt -87.09 137.42 33.05 Favored Pre-proline 0 C--N 1.295 -1.781 0 CA-C-N 115.073 -0.967 . . . . 75.150000000000006 111.592 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -85.03 -176.03 2.26 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.551 2.168 . . . . 74.120000000000005 111.053 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -86.22 114.94 23.45 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.18 0.514 . . . . 72.329999999999998 109.793 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.529 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 17.5 m -119.73 58.78 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-O 122.746 1.26 . . . . 61.340000000000003 110.422 175.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -118.73 107.47 13.7 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.181 -1.372 . . . . 53.420000000000002 108.677 174.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 142.42 -25.38 2.32 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 118.972 -1.585 . . . . 44.100000000000001 113.734 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -101.74 -174.68 2.65 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 117.782 0.791 . . . . 43.119999999999997 109.858 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.448 ' HB ' HG23 ' A' ' 507' ' ' VAL . 7.5 m -73.13 155.5 39.61 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.895 -1.15 . . . . 73.530000000000001 107.895 178.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.542 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.4 p -60.2 -44.72 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 111.715 0.265 . . . . 64.239999999999995 111.715 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.12 -36.11 82.96 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 120.543 -0.463 . . . . 54.130000000000003 110.084 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.448 HG23 ' HB ' ' A' ' 504' ' ' THR . 68.4 t -68.9 -45.38 80.66 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.445 0 CA-C-N 115.616 -0.72 . . . . 74.200000000000003 109.257 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.529 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -60.29 -42.95 96.56 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 123.228 0.33 . . . . 72.420000000000002 110.538 177.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.542 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.7 mt-30 -63.46 -43.22 97.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.011 -0.366 . . . . 74.150000000000006 110.011 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 514' ' ' VAL . 46.0 mmtm -64.48 -43.91 92.67 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.443 0.639 . . . . 70.310000000000002 109.792 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -61.95 -48.26 81.21 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.109 -1.405 . . . . 75.400000000000006 110.13 -175.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.2 pp -69.65 -35.78 75.49 Favored 'General case' 0 C--O 1.208 -1.082 0 CA-C-N 115.509 -0.769 . . . . 75.430000000000007 110.862 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 1.7 t-20 -61.44 -35.32 77.24 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 123.925 0.89 . . . . 74.120000000000005 110.105 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 510' ' ' LYS . 97.7 t -59.18 -38.0 71.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.872 0.368 . . . . 70.310000000000002 111.298 178.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -108.22 10.26 27.89 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.628 -0.508 . . . . 62.520000000000003 109.628 -176.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -132.66 -56.74 0.08 OUTLIER Glycine 0 N--CA 1.428 -1.835 0 C-N-CA 120.074 -1.06 . . . . 75.010000000000005 113.813 -172.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 63.41 23.21 13.62 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 122.055 0.931 . . . . 72.209999999999994 110.082 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.479 HG22 ' HA ' ' A' ' 547' ' ' VAL . 1.0 OUTLIER -83.72 -174.8 5.49 Favored 'General case' 0 N--CA 1.412 -2.327 0 C-N-CA 125.984 1.714 . . . . 63.229999999999997 110.669 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 0.4 OUTLIER -107.74 141.89 38.6 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.357 -1.349 . . . . 74.150000000000006 107.357 178.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -133.05 148.37 52.21 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.056 0.455 . . . . 70.150000000000006 112.192 -175.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 48.4 m -141.48 155.39 45.84 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.57 -0.9 . . . . 65.239999999999995 108.57 173.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -116.92 139.29 50.81 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.07 0.462 . . . . 75.140000000000001 111.493 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -122.37 118.71 29.07 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.333 -1.358 . . . . 70.230000000000004 107.333 176.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 11.6 m -103.93 127.32 51.46 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 120.689 -0.404 . . . . 61.039999999999999 111.493 -174.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 14.3 p -121.08 156.7 24.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.883 -1.155 . . . . 63.520000000000003 107.883 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -70.85 135.15 47.88 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-O 120.84 0.353 . . . . 75.150000000000006 110.647 -176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 65.9 m -165.04 158.07 14.05 Favored Pre-proline 0 C--N 1.31 -1.148 0 N-CA-C 107.667 -1.235 . . . . 74.140000000000001 107.667 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -66.25 -15.05 46.9 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.332 2.022 . . . . 65.209999999999994 113.257 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.66 140.22 81.32 Favored Pre-proline 0 CA--C 1.519 -0.225 0 N-CA-C 108.936 -0.765 . . . . 70.230000000000004 108.936 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.56 146.28 97.07 Favored 'Trans proline' 0 C--O 1.252 1.192 0 C-N-CA 122.764 2.31 . . . . 65.420000000000002 112.888 -175.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -59.82 110.95 1.28 Allowed 'General case' 0 C--O 1.244 0.813 0 CA-C-N 115.29 -0.868 . . . . 74.349999999999994 110.883 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 136.03 -20.86 3.56 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 120.569 -0.824 . . . . 62.329999999999998 112.129 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -82.79 132.91 35.15 Favored 'General case' 0 C--O 1.248 1.019 0 CA-C-O 121.15 0.5 . . . . 74.120000000000005 110.673 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.44 HG11 ' CB ' ' A' ' 508' ' ' ALA . 7.3 p -99.32 119.64 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.533 0 N-CA-C 107.902 -1.147 . . . . 75.340000000000003 107.902 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.5 p -98.77 12.92 34.12 Favored 'General case' 0 C--N 1.274 -2.694 0 CA-C-N 115.107 -0.951 . . . . 72.349999999999994 113.301 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 143.23 -176.93 22.43 Favored Glycine 0 CA--C 1.493 -1.296 0 C-N-CA 120.433 -0.889 . . . . 73.230000000000004 112.196 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 7.0 p -117.41 157.1 26.78 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.372 -0.973 . . . . 55.25 108.372 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.409 ' HB2' ' OE2' ' A' ' 552' ' ' GLU . 44.3 t-20 -56.5 -58.22 18.4 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 119.983 -0.687 . . . . 71.340000000000003 110.689 175.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.96 140.75 32.06 Favored 'Trans proline' 0 C--N 1.365 1.422 0 CA-C-N 120.63 1.261 . . . . 73.109999999999999 109.965 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.57 156.48 63.74 Favored 'Trans proline' 0 C--O 1.252 1.18 0 C-N-CA 122.466 2.111 . . . . 65.120000000000005 112.348 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.58 137.62 58.3 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.015 -0.539 . . . . 54.219999999999999 110.798 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.1 -16.13 50.32 Favored Glycine 0 CA--C 1.492 -1.347 0 N-CA-C 111.485 -0.646 . . . . 51.32 111.485 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 71.0 m -74.05 122.95 23.47 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 109.945 -0.391 . . . . 74.040000000000006 109.945 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.3 t -80.43 124.62 29.06 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 108.473 -0.936 . . . . 70.340000000000003 108.473 176.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.7 m -122.72 156.58 61.54 Favored Pre-proline 0 C--N 1.294 -1.835 0 N-CA-C 107.468 -1.308 . . . . 73.230000000000004 107.468 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.437 ' HA ' HG22 ' A' ' 494' ' ' THR . 5.2 Cg_exo -67.67 138.47 45.4 Favored 'Trans proline' 0 N--CA 1.436 -1.894 0 C-N-CA 121.68 1.587 . . . . 75.120000000000005 111.82 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.479 ' HA ' HG22 ' A' ' 518' ' ' THR . 7.5 p -63.79 -20.53 26.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 115.087 -0.961 . . . . 51.100000000000001 111.455 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -87.79 -17.46 31.53 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.882 0.372 . . . . 72.109999999999999 110.488 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 53.3 m -88.07 159.61 18.17 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-O 122.312 1.053 . . . . 53.229999999999997 113.304 -173.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 68.9 t -89.85 129.49 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 CA-C-N 113.204 -1.816 . . . . 64.219999999999999 110.267 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 56.0 mt -91.57 140.59 15.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.727 -1.212 . . . . 51.299999999999997 107.727 176.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . 0.409 ' OE2' ' HB2' ' A' ' 538' ' ' ASN . 21.9 tt0 -103.26 117.7 35.11 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 110.339 -0.245 . . . . 72.329999999999998 110.339 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.3 mp -99.76 123.22 43.8 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 123.851 0.72 . . . . 55.210000000000001 110.016 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -85.95 106.89 17.46 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 123.472 0.709 . . . . 65.209999999999994 109.193 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 524' ' ' SER . 42.8 t -105.63 144.96 14.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.479 -0.782 . . . . 74.129999999999995 109.492 -176.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.549 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 46.8 m -93.35 126.92 38.73 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 116.077 -0.511 . . . . 64.109999999999999 109.961 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -99.01 131.43 45.06 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 106.175 -1.787 . . . . 74.239999999999995 106.175 169.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -62.92 -24.25 66.56 Favored Glycine 0 CA--C 1.492 -1.394 0 O-C-N 124.673 1.233 . . . . 70.25 114.271 -170.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 75.15 -27.02 0.19 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.52 1.128 . . . . 70.209999999999994 111.199 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.516 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 59.9 mt-30 -111.92 163.53 14.12 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 115.713 -0.676 . . . . 73.219999999999999 110.646 -172.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -141.09 157.28 45.52 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.895 -1.048 . . . . 71.510000000000005 108.841 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.22 126.75 33.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.931 -0.396 . . . . 72.519999999999996 109.931 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.454 ' SD ' HG21 ' A' ' 620' ' ' ILE . 49.5 ttp -94.23 137.13 22.92 Favored Pre-proline 0 C--N 1.314 -0.958 0 N-CA-C 111.946 0.351 . . . . 73.140000000000001 111.946 -176.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.25 169.81 21.36 Favored 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 122.861 2.374 . . . . 73.549999999999997 111.261 173.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -84.79 140.65 31.06 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.796 -0.446 . . . . 65.420000000000002 109.796 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . 0.448 ' O ' ' HG2' ' A' ' 569' ' ' MET . 2.4 pp -138.73 16.62 2.69 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.622 0.725 . . . . 74.310000000000002 111.471 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 60.1 p -79.8 150.28 30.79 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.453 -0.573 . . . . 71.340000000000003 109.453 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . 0.408 ' O ' ' HD2' ' A' ' 602' ' ' ARG . . . 85.32 29.95 26.29 Favored Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 120.077 -1.059 . . . . 71.120000000000005 113.289 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 19.8 ptp -131.84 -176.1 3.94 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.796 -0.816 . . . . 75.400000000000006 108.796 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -109.53 165.43 11.67 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.149 -1.426 . . . . 54.109999999999999 107.149 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -64.78 -30.45 71.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.41 0.624 . . . . 74.120000000000005 109.348 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.6 p -72.37 -10.97 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.882 0.849 . . . . 74.299999999999997 109.955 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 45.8 t0 -101.7 -40.84 6.79 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.974 -1.121 . . . . 75.439999999999998 107.974 174.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.29 -42.53 95.66 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.067 -0.97 . . . . 71.129999999999995 112.817 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.691 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 32.8 tt0 -59.7 -53.24 67.57 Favored Pre-proline 0 CA--C 1.567 1.628 0 C-N-CA 120.236 -0.586 . . . . 64.319999999999993 110.977 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 80.2 Cg_exo -56.32 -32.32 87.86 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 121.812 1.675 . . . . 72.0 112.716 172.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 3.6 mmp_? -59.82 -42.47 93.57 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-O 119.39 -0.338 . . . . 73.219999999999999 111.034 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.7 pp -65.81 -47.08 76.26 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 120.71 -0.396 . . . . 75.430000000000007 111.846 -175.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.462 ' N ' HD12 ' A' ' 578' ' ' LEU . 4.5 ptp180 -65.72 -37.27 85.94 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 112.175 0.435 . . . . 72.040000000000006 112.175 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.99 -32.68 69.57 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.009 0.433 . . . . 70.219999999999999 112.038 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 14.3 tp -85.82 -9.1 57.58 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 121.424 0.631 . . . . 64.409999999999997 110.926 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 75.63 21.47 76.96 Favored Glycine 0 C--N 1.311 -0.806 0 C-N-CA 120.563 -0.827 . . . . 63.310000000000002 112.652 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 15.0 t90 -87.46 127.35 35.23 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.576 -1.268 . . . . 75.439999999999998 107.576 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 15.0 t -116.07 2.26 13.38 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 119.678 -0.809 . . . . 54.340000000000003 112.254 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -74.06 177.07 45.91 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 119.448 -1.358 . . . . 43.5 110.402 172.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 67.2 mtt -97.57 140.14 32.43 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.145 -0.622 . . . . 73.120000000000005 112.124 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 48.5 tp -88.43 116.72 26.86 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.878 -1.156 . . . . 63.299999999999997 107.878 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 621' ' ' THR . 30.6 t70 -106.66 117.49 34.18 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.066 0.46 . . . . 71.099999999999994 111.327 -176.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.496 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.2 OUTLIER -93.14 134.55 35.19 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.971 -0.559 . . . . 71.230000000000004 110.524 177.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -75.51 -84.34 0.38 Allowed Glycine 0 C--N 1.294 -1.793 0 CA-C-N 115.357 -0.838 . . . . 60.329999999999998 111.812 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.05 154.5 47.1 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.343 0.116 . . . . 61.32 110.777 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -101.63 127.84 48.19 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 124.795 1.238 . . . . 65.530000000000001 108.346 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . 0.542 ' O ' ' HB2' ' A' ' 626' ' ' GLN . 40.2 t -104.13 132.72 50.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 115.527 -0.761 . . . . 72.409999999999997 109.243 -175.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -72.4 126.82 30.78 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.202 0.525 . . . . 64.219999999999999 111.771 -175.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . 0.429 ' HB3' ' ND2' ' A' ' 601' ' ' ASN . . . -150.97 -57.9 0.16 Allowed 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.865 -1.061 . . . . 62.200000000000003 108.701 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 140.88 130.92 2.65 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 111.016 -0.834 . . . . 63.210000000000001 111.016 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.67 -31.95 61.07 Favored Glycine 0 C--O 1.22 -0.771 0 C-N-CA 122.856 0.265 . . . . 44.109999999999999 112.54 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 29.4 t -61.55 -23.61 66.08 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.033 0.933 . . . . 73.239999999999995 110.312 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -87.41 -12.2 46.91 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.503 -0.771 . . . . 74.120000000000005 110.343 -176.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 55.05 72.96 0.44 Allowed 'General case' 0 C--O 1.249 1.061 0 C-N-CA 123.956 0.902 . . . . 71.530000000000001 111.437 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . 0.449 ' HB3' ' HA3' ' A' ' 625' ' ' GLY . 45.3 m-80 -84.44 93.72 8.36 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.531 1.158 . . . . 71.450000000000003 111.213 -174.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.408 ' HD2' ' O ' ' A' ' 568' ' ' GLY . 18.6 mtm180 -74.46 171.49 13.68 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 113.027 -1.897 . . . . 51.020000000000003 110.282 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 90.0 t -58.7 129.33 20.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.185 -0.672 . . . . 73.109999999999999 109.185 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 24.2 m -110.19 -27.98 2.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-O 120.972 0.415 . . . . 73.219999999999999 111.358 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -139.49 135.51 33.59 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 116.025 -0.534 . . . . 65.099999999999994 110.439 -176.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -132.66 128.77 37.75 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 104.642 -2.355 . . . . 72.040000000000006 104.642 171.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 28.5 t-20 -59.36 -55.5 45.44 Favored Pre-proline 0 N--CA 1.471 0.608 0 N-CA-C 113.232 0.826 . . . . 73.109999999999999 113.232 -175.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.486 ' HG2' HG22 ' A' ' 620' ' ' ILE . 12.4 Cg_exo -79.17 116.39 3.65 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 121.056 1.171 . . . . 73.019999999999996 109.328 171.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.71 161.27 46.64 Favored 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 123.129 2.553 . . . . 73.439999999999998 112.85 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.08 139.0 57.75 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.937 -0.574 . . . . 61.130000000000003 109.707 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 90.56 -8.05 80.41 Favored Glycine 0 C--N 1.303 -1.262 0 C-N-CA 120.402 -0.904 . . . . 62.340000000000003 112.305 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 52.6 m -90.62 151.65 21.2 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.236 -0.653 . . . . 63.130000000000003 109.236 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -76.98 130.14 10.24 Favored Glycine 0 N--CA 1.433 -1.546 0 N-CA-C 111.416 -0.674 . . . . 63.310000000000002 111.416 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.49 142.79 33.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 109.898 -0.408 . . . . 75.329999999999998 109.898 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.516 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.0 p-10 -51.42 166.94 0.1 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.646 1.179 . . . . 64.340000000000003 112.749 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -58.64 -25.8 63.08 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 113.037 0.754 . . . . 75.140000000000001 113.037 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.536 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 68.0 m-20 -86.17 -7.13 58.78 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 119.855 -0.738 . . . . 45.039999999999999 111.007 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 65.59 18.55 65.97 Favored Glycine 0 C--O 1.215 -1.052 0 O-C-N 123.448 0.467 . . . . 52.310000000000002 112.865 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.89 119.62 17.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 122.349 1.071 . . . . 61.200000000000003 111.802 -166.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.486 HG22 ' HG2' ' A' ' 608' ' ' PRO . 40.1 pt -128.21 134.37 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 CA-C-N 114.544 -1.207 . . . . 62.130000000000003 110.753 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 8.9 t -104.9 130.06 53.14 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.611 -1.255 . . . . 74.030000000000001 107.611 174.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -138.79 165.65 26.45 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.221 -0.445 . . . . 63.210000000000001 110.435 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -137.8 147.32 44.51 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.253 0.549 . . . . 74.010000000000005 110.587 175.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -136.14 165.31 26.03 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.161 -1.052 . . . . 74.340000000000003 108.161 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . 0.449 ' HA3' ' HB3' ' A' ' 601' ' ' ASN . . . -86.17 -164.78 39.93 Favored Glycine 0 N--CA 1.422 -2.245 0 C-N-CA 119.77 -1.205 . . . . 72.030000000000001 112.058 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.542 ' HB2' ' O ' ' A' ' 593' ' ' VAL . 3.1 tp-100 . . . . . 0 C--N 1.281 -2.399 0 C-N-CA 123.52 0.728 . . . . 75.5 109.45 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.708 0 CA-C-O 121.518 0.675 . . . . 73.129999999999995 111.357 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 48.8 p -133.75 155.44 49.76 Favored 'General case' 0 C--O 1.25 1.125 0 N-CA-C 107.405 -1.332 . . . . 64.109999999999999 107.405 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.625 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 4.9 tmtt? -131.28 134.02 45.98 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.693 -0.854 . . . . 75.5 108.693 175.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.625 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 0.8 OUTLIER -78.05 124.05 27.57 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 124.679 1.192 . . . . 74.349999999999994 110.954 176.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.3 pt -86.77 131.52 45.04 Favored Pre-proline 0 C--N 1.295 -1.79 0 CA-C-N 115.703 -0.68 . . . . 75.430000000000007 110.846 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -93.48 176.92 1.34 Allowed 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 122.133 1.889 . . . . 41.43 111.571 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -90.22 103.36 16.04 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.273 1.035 . . . . 54.310000000000002 108.233 176.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 534' ' ' VAL . 17.9 m -92.45 23.99 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 114.595 -1.184 . . . . 70.030000000000001 111.77 -175.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -74.11 99.03 3.25 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.21 -0.45 . . . . 51.43 110.321 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 163.04 -44.0 0.34 Allowed Glycine 0 N--CA 1.428 -1.843 0 C-N-CA 119.541 -1.314 . . . . 74.329999999999998 113.004 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.418 ' O ' HG12 ' A' ' 534' ' ' VAL . 18.6 pm0 -92.75 -171.27 2.68 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 120.231 -0.588 . . . . 74.319999999999993 110.419 -177.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.449 ' HB ' HG23 ' A' ' 507' ' ' VAL . 6.8 m -77.77 155.22 31.3 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 108.167 -1.049 . . . . 74.129999999999995 108.167 177.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.463 ' HA ' ' HB ' ' A' ' 534' ' ' VAL . 7.9 p -63.4 -42.01 94.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 111.859 0.318 . . . . 54.140000000000001 111.859 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 27.4 t70 -62.8 -39.02 92.98 Favored 'General case' 0 C--O 1.199 -1.554 0 N-CA-C 109.442 -0.577 . . . . 71.010000000000005 109.442 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.449 HG23 ' HB ' ' A' ' 504' ' ' THR . 90.1 t -66.06 -44.82 91.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.74 -0.664 . . . . 73.540000000000006 109.567 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.484 ' HB2' HG11 ' A' ' 534' ' ' VAL . . . -60.78 -44.06 97.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 120.189 -0.604 . . . . 75.120000000000005 111.668 175.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.4 mt-30 -63.62 -43.38 97.01 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 122.515 0.326 . . . . 72.420000000000002 110.914 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.484 ' O ' HG23 ' A' ' 514' ' ' VAL . 32.0 mmtp -65.1 -39.82 93.69 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.997 -0.547 . . . . 73.140000000000001 110.067 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . 0.42 ' O ' ' HD1' ' A' ' 515' ' ' TYR . 5.8 m-80 -61.31 -45.97 92.22 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 116.105 -0.498 . . . . 52.539999999999999 110.633 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.26 -37.51 83.61 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.699 -0.682 . . . . 73.450000000000003 110.882 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -65.09 -37.63 88.12 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 116.555 -0.293 . . . . 72.25 110.542 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 510' ' ' LYS . 95.3 t -62.58 -32.53 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 121.154 0.502 . . . . 54.140000000000001 111.119 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . 0.42 ' HD1' ' O ' ' A' ' 511' ' ' ASN . 97.3 m-85 -108.78 14.9 24.01 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.986 -0.446 . . . . 73.150000000000006 110.267 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -146.99 -58.36 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 119.043 -1.551 . . . . 52.130000000000003 115.056 -172.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 67.93 31.97 5.38 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.451 1.119 . . . . 62.340000000000003 108.047 -169.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.509 HG22 ' HA ' ' A' ' 547' ' ' VAL . 12.9 p -79.91 179.04 7.79 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 113.238 -1.801 . . . . 72.319999999999993 110.479 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -108.67 138.83 44.36 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.129 -1.434 . . . . 54.229999999999997 107.129 176.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -132.73 145.54 51.11 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.162 0.506 . . . . 75.329999999999998 111.961 -176.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.1 m -141.59 150.28 41.84 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.751 -0.833 . . . . 63.030000000000001 108.751 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.42 ' HB2' ' CG2' ' A' ' 555' ' ' VAL . 3.0 pt20 -119.65 149.91 41.2 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-O 120.907 0.384 . . . . 71.439999999999998 111.25 -174.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -123.47 143.01 50.43 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.215 -1.772 . . . . 61.119999999999997 106.215 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 20.0 m -118.85 130.91 56.01 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.231 0.539 . . . . 53.32 112.254 -175.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.5 p -123.75 151.01 28.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.746 -0.661 . . . . 72.5 110.05 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.17 134.11 52.07 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.104 -1.073 . . . . 74.530000000000001 108.104 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 62.6 m -156.81 176.85 2.35 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-O 119.485 -0.293 . . . . 75.109999999999999 110.596 -176.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -79.45 -25.29 5.73 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 122.2 1.933 . . . . 71.409999999999997 112.777 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.87 146.74 34.45 Favored Pre-proline 0 CA--C 1.506 -0.713 0 C-N-CA 120.132 -0.627 . . . . 75.140000000000001 110.38 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.62 159.92 30.45 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 123.419 2.746 . . . . 64.420000000000002 113.947 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -63.64 99.19 0.21 Allowed 'General case' 0 C--O 1.245 0.825 0 CA-C-N 114.698 -1.137 . . . . 74.109999999999999 110.132 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 163.9 -29.94 0.24 Allowed Glycine 0 N--CA 1.414 -2.769 0 CA-C-N 114.862 -1.063 . . . . 63.310000000000002 111.127 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -71.12 130.38 41.35 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 120.36 -0.536 . . . . 75.420000000000002 110.194 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 7.2 p -96.6 119.5 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.675 0 N-CA-C 106.559 -1.645 . . . . 54.119999999999997 106.559 171.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.4 m -104.66 20.54 18.45 Favored 'General case' 0 C--N 1.261 -3.252 0 CA-C-N 114.328 -1.306 . . . . 74.209999999999994 110.715 -171.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 126.3 -168.05 18.55 Favored Glycine 0 N--CA 1.429 -1.823 0 C-N-CA 120.721 -0.752 . . . . 64.200000000000003 112.053 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 33.4 p -116.89 146.42 42.95 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.53 -1.285 . . . . 74.239999999999995 107.53 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -68.66 -46.74 34.65 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 119.102 -1.039 . . . . 61.240000000000002 111.18 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 27.3 Cg_exo -66.53 151.23 83.38 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 120.948 1.099 . . . . 62.329999999999998 109.966 171.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 46.1 Cg_exo -57.66 140.73 94.43 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.142 2.561 . . . . 74.219999999999999 113.722 -177.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -68.03 129.76 40.89 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.714 -0.847 . . . . 74.099999999999994 108.714 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.53 -14.37 46.67 Favored Glycine 0 C--N 1.294 -1.786 0 N-CA-C 110.851 -0.9 . . . . 23.309999999999999 110.851 -176.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 98.7 m -75.83 127.49 33.11 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 109.563 -0.532 . . . . 75.510000000000005 109.563 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.2 t -93.85 130.25 39.96 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 108.351 -0.981 . . . . 70.129999999999995 108.351 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.01 154.15 64.46 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 108.19 -1.041 . . . . 74.129999999999995 108.19 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.425 ' HG2' ' OG ' ' A' ' 549' ' ' SER . 3.2 Cg_endo -59.42 137.83 80.49 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 121.43 1.42 . . . . 62.229999999999997 111.837 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.509 ' HA ' HG22 ' A' ' 518' ' ' THR . 12.8 p -57.02 -29.5 31.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.662 -1.154 . . . . 74.140000000000001 113.08 -176.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -90.03 3.31 53.61 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 123.266 0.627 . . . . 72.400000000000006 110.582 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . 0.425 ' OG ' ' HG2' ' A' ' 546' ' ' PRO . 52.2 m -104.38 177.56 4.81 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 116.234 -0.439 . . . . 74.319999999999993 111.013 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 7.5 p -97.63 130.67 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 N-CA-C 113.084 0.772 . . . . 75.150000000000006 113.084 -172.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 66.1 mt -93.48 129.62 43.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 106.256 -1.757 . . . . 72.299999999999997 106.256 172.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -103.52 116.99 33.4 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.289 0.566 . . . . 70.230000000000004 110.923 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.53 133.06 50.9 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.809 -1.087 . . . . 74.420000000000002 111.346 -177.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -87.43 117.71 26.4 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.959 -0.564 . . . . 75.140000000000001 110.397 178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 524' ' ' SER . 43.3 t -108.64 126.64 65.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 109.079 -0.712 . . . . 71.129999999999995 109.079 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 74.9 m -89.24 132.07 35.06 Favored 'General case' 0 N--CA 1.408 -2.562 0 CA-C-N 115.84 -0.618 . . . . 71.540000000000006 109.43 176.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.5 ptpt -114.05 138.62 50.15 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.327 -1.36 . . . . 74.329999999999998 107.327 174.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.574 ' O ' ' HG3' ' A' ' 560' ' ' GLN . . . -67.41 -26.82 73.51 Favored Glycine 0 CA--C 1.493 -1.324 0 N-CA-C 109.92 -1.272 . . . . 72.010000000000005 109.92 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 60.6 t30 61.14 29.3 18.75 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-O 122.757 1.265 . . . . 52.549999999999997 108.247 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 558' ' ' GLY . 91.9 mt-30 -129.33 172.2 11.73 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 113.642 -1.617 . . . . 73.450000000000003 110.755 -174.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -143.81 152.51 41.29 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.506 -1.294 . . . . 75.239999999999995 107.506 174.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 68.0 t -78.1 116.54 21.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 108.684 -0.858 . . . . 63.5 108.684 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.517 ' SD ' HG21 ' A' ' 620' ' ' ILE . 45.1 ttp -73.6 128.53 86.91 Favored Pre-proline 0 C--N 1.315 -0.912 0 CA-C-N 116.314 -0.403 . . . . 73.400000000000006 112.016 -175.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.7 170.2 18.27 Favored 'Trans proline' 0 C--O 1.242 0.705 0 C-N-CA 123.189 2.592 . . . . 70.409999999999997 112.118 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . 0.418 ' HA ' ' HB2' ' A' ' 610' ' ' ALA . 14.8 t70 -60.8 128.62 37.44 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 113.054 0.761 . . . . 75.349999999999994 113.054 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . 0.406 ' O ' HD13 ' A' ' 566' ' ' LEU . 0.8 OUTLIER -132.07 -9.85 3.4 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 114.81 -1.086 . . . . 75.040000000000006 108.604 178.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 22.6 t -79.25 151.81 30.95 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.653 -0.654 . . . . 74.310000000000002 110.645 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 62.65 52.05 51.51 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 116.004 -0.544 . . . . 55.039999999999999 114.172 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 23.6 ptp -158.4 169.69 23.9 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 107.568 -1.271 . . . . 74.430000000000007 107.568 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -88.32 167.98 13.08 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.217 -0.66 . . . . 72.340000000000003 109.217 -174.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 26.3 t-105 -64.89 -27.61 68.97 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.51 -0.922 . . . . 72.450000000000003 108.51 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.3 m -73.59 -9.99 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 115.398 -0.819 . . . . 41.100000000000001 111.371 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 9.6 m-20 -96.39 -44.08 7.37 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.719 -1.215 . . . . 74.519999999999996 107.719 173.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -57.47 -44.74 85.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.764 -1.107 . . . . 70.349999999999994 112.585 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.633 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 1.6 tm-20 -57.25 -58.99 14.19 Favored Pre-proline 0 CA--C 1.571 1.777 0 C-N-CA 122.824 0.45 . . . . 74.109999999999999 111.288 -177.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -61.37 -31.89 88.92 Favored 'Trans proline' 0 C--N 1.372 1.81 0 CA-C-N 120.652 1.269 . . . . 65.439999999999998 112.323 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 26.3 mmt180 -68.99 -33.82 74.3 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.24 0.83 . . . . 71.420000000000002 113.24 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.6 pp -66.34 -47.15 74.41 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.238 0.542 . . . . 72.030000000000001 110.733 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.481 ' N ' HD12 ' A' ' 578' ' ' LEU . 15.1 ptm180 -65.86 -34.53 78.35 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.671 -0.695 . . . . 63.119999999999997 111.133 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.79 -38.39 88.88 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 123.375 0.67 . . . . 73.129999999999995 111.502 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.491 HD11 ' HB2' ' A' ' 583' ' ' TRP . 2.0 pp -85.98 -8.16 58.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.313 0.577 . . . . 71.019999999999996 110.751 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 82.5 39.3 11.02 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.737 -0.665 . . . . 35.119999999999997 111.706 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.491 ' HB2' HD11 ' A' ' 581' ' ' LEU . 12.6 t90 -87.04 126.29 34.66 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.548 -0.908 . . . . 72.450000000000003 108.548 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 1.9 p -108.24 2.96 23.1 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.967 0.729 . . . . 50.229999999999997 112.967 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -94.64 -173.38 38.15 Favored Glycine 0 N--CA 1.438 -1.186 0 N-CA-C 110.381 -1.088 . . . . 75.299999999999997 110.381 176.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 60.6 mtm -114.27 151.33 33.03 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.397 -0.594 . . . . 75.450000000000003 109.397 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.7 tt -83.07 125.18 31.19 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.962 -1.125 . . . . 62.310000000000002 107.962 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 621' ' ' THR . 30.8 t70 -104.05 123.55 47.43 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.081 0.467 . . . . 53.340000000000003 109.941 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.562 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -101.39 133.44 45.99 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 108.566 -0.902 . . . . 74.019999999999996 108.566 177.22 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -77.42 -68.7 1.48 Allowed Glycine 0 C--N 1.283 -2.387 0 N-CA-C 110.505 -1.038 . . . . 72.329999999999998 110.505 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.53 142.73 37.23 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.854 -0.795 . . . . 63.439999999999998 108.854 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -83.63 134.49 34.79 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.762 -1.199 . . . . 73.329999999999998 107.762 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 626' ' ' GLN . 42.8 t -104.13 141.62 19.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 107.893 -1.151 . . . . 73.209999999999994 107.893 -176.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . 0.405 ' HA ' ' HG2' ' A' ' 626' ' ' GLN . 16.5 t70 -72.46 118.2 15.06 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 109.484 -0.561 . . . . 65.450000000000003 109.484 -177.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -137.3 -59.76 0.68 Allowed 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 115.466 -0.788 . . . . 63.539999999999999 109.768 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 85.84 154.09 23.0 Favored Glycine 0 N--CA 1.412 -2.903 0 C-N-CA 119.07 -1.538 . . . . 44.43 109.818 -173.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.96 -33.82 75.78 Favored Glycine 0 C--N 1.284 -2.357 0 N-CA-C 114.934 0.733 . . . . 52.109999999999999 114.934 -177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 6.9 t -73.62 -24.74 60.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 117.68 0.74 . . . . 74.230000000000004 110.231 -174.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -87.92 -1.68 58.13 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.16 0.505 . . . . 75.400000000000006 109.827 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 57.0 m80 68.34 86.64 0.13 Allowed 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 124.993 1.317 . . . . 73.319999999999993 110.868 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -74.37 82.38 1.91 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 112.697 -2.047 . . . . 64.109999999999999 111.623 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -129.28 171.32 12.59 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.015 -1.448 . . . . 74.120000000000005 110.47 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.47 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 70.7 t -57.94 130.77 21.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 O-C-N 123.338 0.399 . . . . 54.310000000000002 110.075 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 27.0 m -106.53 -34.1 2.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 C-N-CA 120.579 -0.448 . . . . 64.310000000000002 110.922 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -152.92 135.92 15.54 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 116.352 -0.386 . . . . 64.219999999999999 110.5 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -118.79 128.59 54.62 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.593 -1.632 . . . . 75.010000000000005 106.593 171.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.436 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 4.4 t-20 -63.09 -47.94 84.95 Favored Pre-proline 0 N--CA 1.469 0.496 0 C-N-CA 119.717 -0.793 . . . . 73.310000000000002 110.954 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.9 Cg_exo -84.64 108.66 1.26 Allowed 'Trans proline' 0 C--N 1.361 1.187 0 N-CA-C 108.17 -1.512 . . . . 54.240000000000002 108.17 168.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.38 161.02 47.54 Favored 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 123.386 2.724 . . . . 75.530000000000001 113.13 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 565' ' ' ASP . . . -61.78 134.72 57.08 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.35 -0.611 . . . . 61.549999999999997 109.35 176.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 103.55 -5.03 47.56 Favored Glycine 0 C--N 1.304 -1.211 0 C-N-CA 120.554 -0.831 . . . . 71.150000000000006 111.508 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 59.1 m -86.36 141.36 29.25 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.725 -0.472 . . . . 74.450000000000003 109.725 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -78.33 117.36 4.63 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 110.072 -1.211 . . . . 74.120000000000005 110.072 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 28.6 m -115.48 142.2 29.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 110.167 -0.308 . . . . 74.230000000000004 110.167 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.428 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.6 p-10 -50.08 170.15 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.961 1.304 . . . . 73.409999999999997 113.041 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -60.98 -25.64 67.0 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.85 0.685 . . . . 71.099999999999994 112.85 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.465 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 17.8 m-20 -82.84 -8.83 59.55 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 119.185 -1.006 . . . . 55.130000000000003 110.832 177.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 64.85 15.48 60.17 Favored Glycine 0 C--O 1.219 -0.826 0 C-N-CA 123.599 0.618 . . . . 75.030000000000001 114.592 168.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.71 118.37 15.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 122.612 1.196 . . . . 72.329999999999998 112.515 -164.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.517 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.8 pp -128.46 134.34 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 114.012 -1.449 . . . . 71.430000000000007 111.266 -177.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 15.1 t -104.11 129.16 51.8 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.456 -0.572 . . . . 44.119999999999997 109.456 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.5 pp -139.43 167.2 22.62 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.355 0.502 . . . . 63.310000000000002 112.355 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 25.9 ptt85 -127.8 137.81 52.52 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.49 -0.559 . . . . 73.019999999999996 109.49 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.47 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 20.0 p90 -139.94 165.93 26.0 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.918 -0.583 . . . . 75.129999999999995 110.896 -173.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -76.15 134.64 16.16 Favored Glycine 0 N--CA 1.431 -1.647 0 CA-C-N 115.832 -0.622 . . . . 42.119999999999997 112.615 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 593' ' ' VAL . 2.7 pt20 . . . . . 0 C--N 1.305 -1.36 0 C-N-CA 123.768 0.827 . . . . 65.239999999999995 109.293 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.702 0 CA-C-O 121.517 0.675 . . . . 40.109999999999999 111.174 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 31.2 p -137.66 147.3 44.79 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 115.338 -0.847 . . . . 72.219999999999999 109.744 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -127.68 139.86 52.44 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.614 -0.884 . . . . 71.099999999999994 108.614 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.4 p-10 -96.02 130.25 43.07 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.485 0.659 . . . . 74.219999999999999 110.414 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 34.8 pt -91.12 127.06 52.94 Favored Pre-proline 0 C--N 1.304 -1.383 0 CA-C-N 114.717 -1.129 . . . . 75.430000000000007 111.198 -176.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -84.42 -179.42 3.85 Favored 'Trans proline' 0 N--CA 1.441 -1.585 0 C-N-CA 121.632 1.555 . . . . 64.329999999999998 110.696 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -82.3 103.37 11.83 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 122.253 1.025 . . . . 72.329999999999998 110.182 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.414 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 26.8 m -100.79 7.67 9.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 114.946 -1.025 . . . . 74.209999999999994 111.384 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.426 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -80.56 102.81 10.0 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 109.054 -0.721 . . . . 60.149999999999999 109.054 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 159.05 -36.14 0.49 Allowed Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.566 -0.826 . . . . 61.25 112.131 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 16.6 pm0 -94.45 -173.08 2.95 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 109.301 -0.629 . . . . 73.409999999999997 109.301 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 27.9 m -70.1 154.89 41.37 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.856 -1.164 . . . . 72.219999999999999 107.856 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.438 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.2 p -63.02 -41.89 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 C-N-CA 120.891 -0.324 . . . . 74.010000000000005 111.049 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . 0.539 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 18.7 t70 -62.18 -43.95 97.68 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 109.645 -0.502 . . . . 60.219999999999999 109.645 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 64.0 t -66.61 -41.85 88.93 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 CA-C-N 115.79 -0.641 . . . . 60.329999999999998 109.737 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.427 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -61.15 -44.57 97.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 120.442 0.163 . . . . 62.43 110.684 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 26.3 mt-30 -65.0 -43.82 91.28 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.266 -0.425 . . . . 65.430000000000007 111.086 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.566 ' O ' HG23 ' A' ' 514' ' ' VAL . 32.7 mmtp -62.92 -47.14 84.54 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.429 -0.582 . . . . 74.430000000000007 109.429 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -63.99 -37.95 89.3 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.515 -0.766 . . . . 74.099999999999994 111.345 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.64 -46.28 69.61 Favored 'General case' 0 C--O 1.203 -1.348 0 N-CA-C 108.151 -1.055 . . . . 64.25 108.151 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -59.99 -38.13 81.7 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 124.077 0.951 . . . . 73.200000000000003 111.188 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 510' ' ' LYS . 57.7 t -57.57 -37.56 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-O 120.845 0.355 . . . . 72.150000000000006 111.326 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -110.0 0.91 18.69 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.865 0.84 . . . . 74.439999999999998 111.098 -176.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -113.5 -60.4 0.41 Allowed Glycine 0 N--CA 1.416 -2.698 0 CA-C-N 115.18 -0.918 . . . . 70.109999999999999 111.331 -174.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 70.74 16.49 6.74 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.58 1.152 . . . . 74.400000000000006 110.415 -175.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 547' ' ' VAL . 4.4 p -83.05 -176.17 6.2 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-N 114.082 -1.417 . . . . 75.25 109.496 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 0.1 OUTLIER -108.69 143.14 38.18 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.29 -1.004 . . . . 61.0 108.29 177.018 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -123.1 148.61 45.46 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-O 121.428 0.633 . . . . 74.129999999999995 111.804 -175.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 16.9 p -135.31 140.26 44.97 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 107.369 -1.345 . . . . 71.310000000000002 107.369 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -117.45 127.27 53.85 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-O 121.246 0.546 . . . . 73.010000000000005 110.466 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -116.11 143.36 45.58 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.161 -1.422 . . . . 74.219999999999999 107.161 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.0 p -119.44 132.66 55.85 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 113.783 1.031 . . . . 72.109999999999999 113.783 -175.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.64 149.97 24.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 107.902 -1.147 . . . . 63.409999999999997 107.902 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -79.61 136.86 36.95 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.923 -0.311 . . . . 33.039999999999999 110.881 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.436 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 59.9 m -163.24 155.08 15.13 Favored Pre-proline 0 C--O 1.204 -1.335 0 N-CA-C 107.106 -1.442 . . . . 43.450000000000003 107.106 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.39 -14.66 36.01 Favored 'Trans proline' 0 CA--C 1.552 1.376 0 C-N-CA 122.439 2.093 . . . . 73.25 114.587 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -70.9 145.58 91.99 Favored Pre-proline 0 C--O 1.215 -0.711 0 N-CA-C 109.529 -0.545 . . . . 75.519999999999996 109.529 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.33 144.39 91.13 Favored 'Trans proline' 0 C--O 1.26 1.59 0 C-N-CA 122.317 2.012 . . . . 65.430000000000007 112.619 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.693 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -64.14 100.34 0.32 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.246 -0.888 . . . . 63.009999999999998 111.171 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 157.43 -23.41 0.43 Allowed Glycine 0 N--CA 1.427 -1.93 0 C-N-CA 120.559 -0.829 . . . . 74.349999999999994 111.979 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -80.65 138.92 36.43 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 119.904 -0.718 . . . . 75.099999999999994 109.842 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.427 HG11 ' CB ' ' A' ' 508' ' ' ALA . 5.4 p -93.85 113.93 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 N-CA-C 107.294 -1.373 . . . . 72.239999999999995 107.294 172.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.7 m -99.62 8.74 44.15 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 113.929 -1.487 . . . . 74.319999999999993 111.186 -172.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.426 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 157.31 172.89 25.05 Favored Glycine 0 N--CA 1.428 -1.883 0 C-N-CA 119.704 -1.236 . . . . 42.43 113.245 174.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.6 p -120.52 158.27 27.65 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 105.798 -1.927 . . . . 73.319999999999993 105.798 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 3.9 t-20 -67.05 -54.33 20.83 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 117.517 -1.673 . . . . 70.230000000000004 111.368 177.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 8.2 Cg_exo -74.33 143.21 31.2 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 121.282 1.321 . . . . 61.509999999999998 109.792 174.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.74 157.99 59.61 Favored 'Trans proline' 0 C--O 1.25 1.106 0 C-N-CA 122.635 2.224 . . . . 71.120000000000005 113.284 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.28 139.59 58.08 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.806 -0.633 . . . . 42.43 110.505 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.18 -14.36 59.79 Favored Glycine 0 C--N 1.3 -1.436 0 N-CA-C 111.706 -0.557 . . . . 71.439999999999998 111.706 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 20.4 m -75.32 135.23 40.89 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 109.771 -0.455 . . . . 54.439999999999998 109.771 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.8 t -96.58 125.47 41.07 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 107.916 -1.142 . . . . 75.030000000000001 107.916 177.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.26 154.55 65.44 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 108.622 -0.881 . . . . 64.519999999999996 108.622 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.64 137.48 77.56 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.784 1.656 . . . . 60.030000000000001 112.283 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.45 ' HA ' HG22 ' A' ' 518' ' ' THR . 13.5 p -65.33 -24.03 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-N 115.19 -0.913 . . . . 62.030000000000001 110.82 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -78.02 -10.02 59.4 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.559 -1.201 . . . . 73.25 111.632 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 22.9 t -94.01 -176.84 4.13 Favored 'General case' 0 C--O 1.26 1.637 0 CA-C-O 121.631 0.729 . . . . 61.350000000000001 112.176 -174.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 14.7 p -119.13 137.92 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 114.774 -1.103 . . . . 54.539999999999999 109.037 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.3 mt -108.71 138.33 36.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 109.149 -0.686 . . . . 73.439999999999998 109.149 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.53 122.06 44.17 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.689 0.757 . . . . 73.209999999999994 111.756 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.1 mp -108.08 122.23 46.45 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.212 -1.358 . . . . 63.109999999999999 108.776 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -90.63 116.23 28.35 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.916 0.865 . . . . 73.329999999999998 111.26 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 524' ' ' SER . 21.3 t -98.8 135.21 34.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 114.263 -1.335 . . . . 41.229999999999997 108.811 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.693 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 66.4 m -86.33 129.04 34.99 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.538 -0.541 . . . . 74.400000000000006 109.538 174.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -101.03 130.05 46.98 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 105.883 -1.895 . . . . 72.150000000000006 105.883 172.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -62.22 -24.93 65.92 Favored Glycine 0 CA--C 1.5 -0.898 0 O-C-N 124.006 0.816 . . . . 74.510000000000005 114.146 -173.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . 0.486 ' OD1' ' HG3' ' A' ' 616' ' ' ARG . 49.0 t-20 71.93 -14.62 0.51 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.841 1.256 . . . . 74.439999999999998 111.363 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -111.93 149.55 31.76 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.307 -0.87 . . . . 72.150000000000006 112.856 -170.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -131.0 158.4 40.39 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.248 -1.342 . . . . 71.129999999999995 107.449 177.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.61 125.33 32.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 120.991 0.424 . . . . 62.219999999999999 111.217 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 55.2 ttp -86.6 129.51 52.64 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 110.092 -0.336 . . . . 72.129999999999995 110.092 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.07 170.46 20.07 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.363 2.708 . . . . 72.420000000000002 112.337 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.02 126.65 28.7 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 112.784 0.661 . . . . 72.310000000000002 112.784 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . 0.464 ' O ' ' HG2' ' A' ' 569' ' ' MET . 0.0 OUTLIER -132.05 7.25 4.31 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.504 1.145 . . . . 55.439999999999998 109.06 171.382 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 3.1 m -79.19 138.19 37.75 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.559 -1.201 . . . . 75.120000000000005 108.926 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 84.15 18.62 62.46 Favored Glycine 0 C--N 1.315 -0.624 0 C-N-CA 120.533 -0.841 . . . . 74.310000000000002 113.876 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 20.2 ptp -124.0 175.12 7.16 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.291 -1.003 . . . . 75.109999999999999 108.291 176.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -94.8 164.98 12.71 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.595 -1.631 . . . . 63.119999999999997 106.595 -175.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . 0.504 ' O ' ' HG3' ' A' ' 575' ' ' GLU . 10.8 t-105 -63.49 -34.16 77.17 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.781 -0.822 . . . . 73.400000000000006 108.781 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.6 p -74.23 -14.78 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.648 -0.705 . . . . 73.310000000000002 110.669 -175.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -100.98 -28.6 12.65 Favored 'General case' 0 C--O 1.263 1.814 0 CA-C-O 122.025 0.917 . . . . 54.43 108.766 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . 0.643 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -64.12 -41.67 97.14 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.486 -1.234 . . . . 51.109999999999999 109.98 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 571' ' ' TRP . 46.0 mt-10 -51.21 -56.12 22.83 Favored Pre-proline 0 CA--C 1.567 1.615 0 N-CA-C 112.519 0.562 . . . . 74.319999999999993 112.519 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -58.4 -33.34 97.76 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 121.554 1.502 . . . . 71.420000000000002 112.71 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -68.64 -34.3 75.5 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 119.487 -0.885 . . . . 71.319999999999993 111.735 176.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 41.0 mt -63.06 -48.31 79.23 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.147 0.499 . . . . 63.219999999999999 110.383 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 6.9 ptp85 -66.19 -36.83 84.1 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.136 -0.484 . . . . 75.219999999999999 111.324 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.31 77.85 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.134 -0.484 . . . . 54.020000000000003 112.097 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' A' ' 583' ' ' TRP . 1.7 pp -81.93 -8.54 59.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.158 0.504 . . . . 73.340000000000003 109.868 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 80.3 42.45 10.52 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.528 -0.76 . . . . 71.319999999999993 112.311 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.457 ' CE3' HD22 ' A' ' 578' ' ' LEU . 18.1 t90 -87.31 126.59 34.94 Favored 'General case' 0 N--CA 1.427 -1.619 0 C-N-CA 120.147 -0.621 . . . . 73.519999999999996 109.888 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 26.9 p -100.95 -14.28 17.95 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.33 0.492 . . . . 74.409999999999997 112.33 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -82.96 -171.09 46.91 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 121.344 -0.455 . . . . 42.43 113.349 -177.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 92.3 mmm -117.57 147.47 42.79 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.907 -0.405 . . . . 62.509999999999998 109.907 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . 0.455 HD21 ' HG ' ' A' ' 622' ' ' LEU . 3.6 tt -93.02 129.56 38.9 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.88 0.372 . . . . 53.229999999999997 110.203 -175.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -113.96 124.85 53.16 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-N 115.911 -0.586 . . . . 72.140000000000001 109.719 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.485 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.3 OUTLIER -90.8 133.95 34.81 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.806 -0.442 . . . . 55.329999999999998 109.806 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -84.06 -106.8 0.57 Allowed Glycine 0 C--N 1.291 -1.937 0 CA-C-N 115.829 -0.623 . . . . 54.100000000000001 112.32 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . 0.605 ' O ' ' HB2' ' A' ' 623' ' ' ARG . . . -96.14 116.58 29.21 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.948 0.404 . . . . 74.319999999999993 110.343 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -87.24 140.08 29.9 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 123.499 0.719 . . . . 71.340000000000003 110.898 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 48.4 t -122.36 128.74 75.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.313 -0.995 . . . . 61.43 108.313 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.59 122.61 21.66 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.92 0.391 . . . . 65.049999999999997 110.397 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -134.45 -43.47 0.77 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.815 -0.63 . . . . 71.109999999999999 110.596 -177.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 106.86 128.92 6.1 Favored Glycine 0 N--CA 1.433 -1.524 0 N-CA-C 111.543 -0.623 . . . . 55.32 111.543 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.17 -32.95 84.33 Favored Glycine 0 N--CA 1.46 0.235 0 CA-C-O 121.067 0.26 . . . . 54.350000000000001 112.485 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 3.0 p -64.94 -23.94 67.37 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 124.938 1.295 . . . . 55.229999999999997 110.944 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 599' ' ' GLN . 4.8 mt-30 -92.23 -0.78 57.4 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.776 -0.647 . . . . 72.209999999999994 110.283 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 30.5 m170 75.01 97.23 0.07 Allowed 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 125.017 1.327 . . . . 71.239999999999995 112.29 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . 0.683 ' HB2' ' O ' ' A' ' 625' ' ' GLY . 19.2 p30 -83.2 88.85 6.91 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 114.016 -1.447 . . . . 60.219999999999999 112.748 -175.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 -91.85 155.68 18.03 Favored 'General case' 0 C--O 1.254 1.307 0 CA-C-N 114.504 -1.226 . . . . 75.319999999999993 110.818 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 88.0 t -62.86 131.89 28.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 114.955 -1.021 . . . . 70.439999999999998 108.3 172.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.74 -46.55 12.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 120.996 0.427 . . . . 63.43 110.666 -175.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -151.69 154.11 35.69 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.346 -0.983 . . . . 71.150000000000006 108.346 -176.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -142.55 149.31 38.92 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.309 -0.626 . . . . 74.150000000000006 109.309 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.524 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 50.8 t-20 -69.23 -56.45 8.59 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 120.611 -0.436 . . . . 64.439999999999998 111.265 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.8 Cg_exo -84.44 115.36 1.89 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 120.729 1.296 . . . . 42.25 108.888 173.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -70.2 157.91 58.04 Favored 'Trans proline' 0 C--O 1.248 1.017 0 C-N-CA 122.303 2.002 . . . . 70.150000000000006 112.458 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.31 137.81 56.34 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.721 -0.844 . . . . 63.409999999999997 108.721 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 96.94 -7.18 64.71 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.892 -0.671 . . . . 74.349999999999994 111.646 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 38.5 m -94.71 150.15 20.51 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.987 -0.375 . . . . 74.439999999999998 109.987 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -75.63 126.5 8.54 Favored Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 111.823 -0.511 . . . . 54.140000000000001 111.823 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.3 m -118.65 142.65 32.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 109.077 -0.712 . . . . 75.349999999999994 109.077 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -52.25 165.87 0.2 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.887 0.875 . . . . 72.099999999999994 112.035 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . 0.486 ' HG3' ' OD1' ' A' ' 559' ' ' ASN . 0.0 OUTLIER -57.82 -25.3 60.42 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.864 1.061 . . . . 75.25 113.864 -178.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.38 -10.31 59.75 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 119.95 -0.7 . . . . 72.310000000000002 109.48 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 65.34 16.1 62.19 Favored Glycine 0 CA--C 1.498 -1.019 0 CA-C-N 115.61 -0.723 . . . . 73.140000000000001 113.472 169.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.16 119.29 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 122.567 1.175 . . . . 73.219999999999999 111.067 -165.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.415 HG12 ' HD2' ' A' ' 608' ' ' PRO . 0.0 OUTLIER -129.2 132.48 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.176 0 CA-C-N 113.824 -1.535 . . . . 72.409999999999997 109.11 -176.071 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 8.9 t -114.96 133.53 55.94 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.399 -0.963 . . . . 65.200000000000003 108.399 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.455 ' HG ' HD21 ' A' ' 587' ' ' LEU . 3.1 pp -138.97 166.65 23.93 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.748 -0.66 . . . . 41.25 112.073 -174.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . 0.605 ' HB2' ' O ' ' A' ' 591' ' ' ALA . 7.4 ptm180 -126.93 137.42 53.13 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 106.915 -1.513 . . . . 74.239999999999995 106.915 175.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -139.49 165.93 25.92 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 115.808 -0.633 . . . . 74.299999999999997 109.324 -171.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . 0.683 ' O ' ' HB2' ' A' ' 601' ' ' ASN . . . -72.7 140.03 28.45 Favored Glycine 0 N--CA 1.418 -2.561 0 N-CA-C 108.493 -1.843 . . . . 63.219999999999999 108.493 174.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 . . . . . 0 C--N 1.265 -3.107 0 CA-C-O 118.11 -0.947 . . . . 72.450000000000003 108.643 -179.401 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.443 0 CA-C-O 121.133 0.492 . . . . 73.129999999999995 111.677 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 38.3 p -139.5 144.18 37.81 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.423 -0.584 . . . . 64.109999999999999 109.423 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.545 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 4.3 tmtt? -134.93 139.38 44.91 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.05 -1.093 . . . . 75.5 108.05 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.545 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 10.5 p-10 -78.77 132.97 37.12 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 124.097 0.959 . . . . 74.349999999999994 110.051 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 42.6 pt -98.58 128.45 32.81 Favored Pre-proline 0 C--N 1.306 -1.309 0 C-N-CA 120.386 -0.526 . . . . 75.430000000000007 110.584 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.92 -163.33 0.19 Allowed 'Trans proline' 0 C--O 1.251 1.139 0 C-N-CA 122.682 2.254 . . . . 41.43 111.018 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -86.18 127.3 34.7 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.609 0.719 . . . . 54.310000000000002 109.984 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.511 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 15.9 m -122.99 62.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-O 123.359 1.552 . . . . 70.030000000000001 108.425 171.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -120.43 108.58 14.29 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 112.825 -1.988 . . . . 51.43 109.191 176.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 138.39 -25.47 2.87 Favored Glycine 0 N--CA 1.431 -1.661 0 C-N-CA 119.613 -1.279 . . . . 74.329999999999998 113.42 175.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.453 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.4 OUTLIER -101.39 -177.0 3.31 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 117.835 0.817 . . . . 74.319999999999993 109.382 179.342 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.414 ' HB ' HG23 ' A' ' 507' ' ' VAL . 9.1 m -74.36 155.45 38.13 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.78 -1.193 . . . . 74.129999999999995 107.78 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 8.9 p -64.3 -41.32 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-O 119.471 -0.3 . . . . 54.140000000000001 111.715 -177.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 15.5 t70 -59.56 -42.6 92.77 Favored 'General case' 0 C--O 1.213 -0.844 0 N-CA-C 108.417 -0.957 . . . . 71.010000000000005 108.417 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.414 HG23 ' HB ' ' A' ' 504' ' ' THR . 76.9 t -65.34 -44.84 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 114.983 -1.008 . . . . 73.540000000000006 110.044 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.511 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -63.24 -44.98 93.68 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 111.725 0.269 . . . . 75.120000000000005 111.725 177.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.6 mt-30 -61.88 -45.26 94.55 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 122.804 0.441 . . . . 72.420000000000002 110.08 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 514' ' ' VAL . 31.5 mmtp -67.01 -39.28 87.05 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.631 -0.713 . . . . 73.140000000000001 110.579 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -61.49 -43.98 97.9 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 121.31 0.576 . . . . 52.539999999999999 110.492 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.57 -43.06 86.04 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.842 -1.17 . . . . 73.450000000000003 107.842 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -59.81 -36.5 76.88 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 124.035 0.934 . . . . 72.25 111.664 -177.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 510' ' ' LYS . 90.4 t -60.07 -40.48 83.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.732 0.301 . . . . 54.140000000000001 110.929 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -107.15 13.17 27.63 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.414 0.626 . . . . 73.150000000000006 110.281 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -134.65 -54.29 0.07 OUTLIER Glycine 0 N--CA 1.429 -1.801 0 C-N-CA 120.534 -0.841 . . . . 52.130000000000003 113.72 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 65.22 25.76 12.3 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.404 1.097 . . . . 62.340000000000003 109.088 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.485 HG22 ' HA ' ' A' ' 547' ' ' VAL . 6.2 p -80.77 -173.54 4.25 Favored 'General case' 0 N--CA 1.416 -2.143 0 C-N-CA 125.719 1.608 . . . . 72.319999999999993 111.602 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -108.76 138.41 45.14 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.451 -1.685 . . . . 54.229999999999997 106.451 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -132.43 149.01 52.42 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.065 0.459 . . . . 75.329999999999998 111.607 -178.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 71.3 m -141.22 150.9 43.26 Favored 'General case' 0 N--CA 1.418 -2.025 0 N-CA-C 108.515 -0.92 . . . . 63.030000000000001 108.515 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.46 ' HB2' ' CG2' ' A' ' 555' ' ' VAL . 3.6 pt20 -119.56 136.63 54.27 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.036 0.446 . . . . 71.439999999999998 110.294 -178.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -120.04 137.34 54.16 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.184 -1.413 . . . . 61.119999999999997 107.184 176.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 33.8 m -106.1 134.5 49.12 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 112.295 0.48 . . . . 53.32 112.295 -175.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.6 p -131.13 153.04 38.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.357 -0.838 . . . . 72.5 109.006 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -73.24 134.92 44.45 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.24 -1.022 . . . . 74.530000000000001 108.24 177.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.571 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 65.5 m -161.13 168.04 12.3 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.513 -0.551 . . . . 75.109999999999999 109.513 -177.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -71.96 -21.91 23.78 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.055 1.837 . . . . 71.409999999999997 112.077 176.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -69.73 144.22 93.39 Favored Pre-proline 0 C--O 1.221 -0.426 0 CA-C-N 116.2 -0.455 . . . . 75.140000000000001 111.311 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.47 152.42 81.67 Favored 'Trans proline' 0 C--O 1.248 0.996 0 C-N-CA 122.586 2.191 . . . . 64.420000000000002 111.72 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 557' ' ' LYS . . . -62.31 112.01 2.24 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 115.63 -0.714 . . . . 74.109999999999999 110.999 -177.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 131.53 -23.62 4.24 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 115.427 -0.806 . . . . 63.310000000000002 111.623 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -80.08 133.83 36.14 Favored 'General case' 0 C--O 1.246 0.912 0 CA-C-O 121.262 0.553 . . . . 75.420000000000002 109.768 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 503' ' ' GLN . 8.1 p -97.32 120.09 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.875 0 N-CA-C 108.094 -1.076 . . . . 54.119999999999997 108.094 -178.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 4.1 p -90.13 1.24 56.62 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.207 -0.906 . . . . 74.209999999999994 112.376 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.445 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 144.0 -161.7 27.83 Favored Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.314 -0.946 . . . . 64.200000000000003 112.321 175.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 3.8 p -116.97 155.14 29.65 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.807 -0.812 . . . . 74.239999999999995 108.807 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -65.31 -50.52 58.63 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.306 -0.627 . . . . 61.240000000000002 109.306 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.67 138.91 46.73 Favored 'Trans proline' 0 C--N 1.375 1.966 0 N-CA-C 108.97 -1.204 . . . . 62.329999999999998 108.97 170.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.01 143.64 91.34 Favored 'Trans proline' 0 C--O 1.243 0.725 0 C-N-CA 122.86 2.373 . . . . 74.219999999999999 113.659 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.01 131.53 47.88 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.63 -0.714 . . . . 74.099999999999994 109.745 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.22 -5.39 35.91 Favored Glycine 0 N--CA 1.434 -1.448 0 CA-C-N 115.708 -0.678 . . . . 23.309999999999999 111.465 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 5.9 t -84.97 138.16 32.65 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.233 0.54 . . . . 75.510000000000005 110.714 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 9.2 t -81.56 131.37 35.27 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.158 -1.053 . . . . 70.129999999999995 108.158 174.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.0 m -126.51 154.99 75.24 Favored Pre-proline 0 C--N 1.315 -0.935 0 N-CA-C 108.786 -0.82 . . . . 74.129999999999995 108.786 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -70.18 138.89 37.51 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.635 1.557 . . . . 62.229999999999997 111.29 176.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.485 ' HA ' HG22 ' A' ' 518' ' ' THR . 8.9 p -64.73 -19.08 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 CA-C-O 122.345 1.069 . . . . 74.140000000000001 110.608 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -86.38 -18.35 32.06 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.17 -0.923 . . . . 72.400000000000006 110.768 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 50.4 m -91.98 167.78 11.86 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.362 0.601 . . . . 74.319999999999993 111.968 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 10.7 p -97.22 138.15 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-N 115.096 -0.956 . . . . 75.150000000000006 111.051 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 56.7 mt -97.48 134.19 36.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 107.615 -1.254 . . . . 72.299999999999997 107.615 176.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -103.33 117.34 34.27 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.097 -0.705 . . . . 70.230000000000004 109.097 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.8 mp -104.42 133.13 49.82 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 120.916 0.388 . . . . 74.420000000000002 111.657 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -87.51 108.83 19.22 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 123.558 0.743 . . . . 75.140000000000001 110.853 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 522' ' ' GLN . 32.5 t -95.85 124.3 48.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.468 -0.938 . . . . 71.129999999999995 108.468 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.571 ' HB3' ' HB2' ' A' ' 527' ' ' SER . 58.0 m -88.05 133.24 34.02 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 115.972 -0.558 . . . . 71.540000000000006 110.733 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.1 ptpt -115.72 130.96 57.05 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 107.843 -1.169 . . . . 74.329999999999998 107.843 171.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 527' ' ' SER . . . -64.93 -23.75 69.6 Favored Glycine 0 CA--C 1.497 -1.061 0 N-CA-C 110.264 -1.134 . . . . 72.010000000000005 110.264 178.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 53.9 t30 70.22 -5.55 1.31 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.041 1.736 . . . . 52.549999999999997 111.051 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 77.9 mt-30 -113.54 142.72 45.62 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 115.796 -0.638 . . . . 73.450000000000003 110.572 -176.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -123.36 158.21 31.59 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.665 -0.865 . . . . 75.239999999999995 108.665 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.29 118.3 10.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 O-C-N 123.499 0.499 . . . . 63.5 109.78 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.556 ' SD ' HG21 ' A' ' 620' ' ' ILE . 35.9 ttp -79.32 136.93 56.26 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 116.219 -0.446 . . . . 73.400000000000006 111.402 -178.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.32 171.24 10.71 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.623 2.882 . . . . 70.409999999999997 111.742 172.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -82.53 129.39 34.91 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 116.529 -0.305 . . . . 75.349999999999994 111.314 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -123.05 16.5 9.99 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.258 1.028 . . . . 75.040000000000006 109.191 176.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 50.8 m -79.03 130.91 36.03 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 114.386 -1.279 . . . . 74.310000000000002 112.363 -175.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . 0.426 ' HA2' ' HD3' ' A' ' 602' ' ' ARG . . . 71.12 62.53 3.49 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.45 -0.796 . . . . 55.039999999999999 114.377 176.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 24.4 ptp -159.86 164.84 33.26 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 109.057 -0.719 . . . . 74.430000000000007 109.057 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -92.88 174.7 7.11 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.835 -0.431 . . . . 72.340000000000003 109.835 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 35.3 t-105 -64.48 -29.64 70.68 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.885 -0.783 . . . . 72.450000000000003 108.885 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 22.1 m -74.96 -6.4 8.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.469 -0.787 . . . . 41.100000000000001 111.214 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -102.21 -44.35 5.45 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.501 -0.925 . . . . 74.519999999999996 108.501 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -64.68 -40.09 94.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.94 -1.027 . . . . 70.349999999999994 113.122 -177.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.711 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 6.0 tm-20 -66.22 -50.81 48.12 Favored Pre-proline 0 CA--C 1.564 1.482 0 N-CA-C 109.943 -0.392 . . . . 74.109999999999999 109.943 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 61.7 Cg_exo -53.12 -34.32 67.99 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 121.584 1.523 . . . . 65.439999999999998 111.646 169.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -60.88 -39.63 89.94 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.433 0.531 . . . . 71.420000000000002 112.433 175.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.711 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 3.9 pp -65.98 -44.45 84.85 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 120.184 -0.606 . . . . 72.030000000000001 110.727 -178.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.461 ' N ' HD12 ' A' ' 578' ' ' LEU . 6.6 ptm180 -66.46 -34.58 78.26 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.833 0.349 . . . . 63.119999999999997 111.69 176.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.24 -36.53 74.55 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.161 0.505 . . . . 73.129999999999995 111.35 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.5 tp -87.9 -9.22 54.33 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 123.695 0.798 . . . . 71.019999999999996 110.622 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 66.04 37.51 93.2 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.114 -0.795 . . . . 35.119999999999997 111.114 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -80.73 126.43 31.29 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.409 0.623 . . . . 72.450000000000003 110.172 -176.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 17.0 p -96.67 -18.5 19.65 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 113.313 0.857 . . . . 50.229999999999997 113.313 -174.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -80.36 -156.57 13.23 Favored Glycine 0 C--O 1.24 0.471 0 C-N-CA 121.327 -0.463 . . . . 75.299999999999997 114.115 -176.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 67.2 mtm -128.68 155.32 45.22 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.561 -0.533 . . . . 75.450000000000003 109.561 -176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.5 tt -106.67 113.71 27.38 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.648 -1.241 . . . . 62.310000000000002 107.648 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 621' ' ' THR . 51.9 m-20 -98.65 110.1 22.75 Favored 'General case' 0 CA--C 1.478 -1.804 0 N-CA-C 109.305 -0.628 . . . . 53.340000000000003 109.305 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.0 OUTLIER -87.55 133.07 33.85 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 118.418 -1.313 . . . . 74.019999999999996 107.633 174.115 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -82.59 -55.67 2.96 Favored Glycine 0 C--N 1.29 -1.976 0 CA-C-N 115.605 -0.725 . . . . 72.329999999999998 112.04 -174.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.85 154.13 47.23 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.569 -0.53 . . . . 63.439999999999998 109.569 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . 0.554 ' HB3' ' HB2' ' A' ' 626' ' ' GLN . 10.5 m-20 -99.54 129.79 45.74 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 105.385 -2.08 . . . . 73.329999999999998 105.385 173.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 16.5 t -103.49 135.78 39.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 107.138 -1.43 . . . . 73.209999999999994 107.138 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.71 121.86 19.61 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 118.219 0.463 . . . . 65.450000000000003 111.083 -169.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -138.3 -56.99 0.65 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.547 -0.751 . . . . 63.539999999999999 110.489 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 100.06 142.31 12.96 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 109.573 -1.411 . . . . 44.43 109.573 -173.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.93 -35.4 83.02 Favored Glycine 0 C--N 1.314 -0.676 0 N-CA-C 113.914 0.326 . . . . 52.109999999999999 113.914 -176.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 9.3 t -71.85 -24.41 61.69 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.284 0.564 . . . . 74.230000000000004 110.329 -176.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -88.19 -0.55 57.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.33 -0.396 . . . . 75.400000000000006 110.734 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 50.8 m80 79.2 84.33 0.06 Allowed 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 125.426 1.49 . . . . 73.319999999999993 110.275 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -81.16 71.98 8.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 123.21 1.481 . . . . 64.109999999999999 111.182 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.426 ' HD3' ' HA2' ' A' ' 568' ' ' GLY . 4.6 ppt_? -115.21 172.32 7.14 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 113.233 -1.803 . . . . 74.120000000000005 110.653 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.448 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 63.2 t -56.54 130.79 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 109.588 -0.523 . . . . 54.310000000000002 109.588 -178.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 26.3 m -110.39 -30.04 2.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.277 -0.874 . . . . 64.310000000000002 111.488 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -156.75 135.71 11.83 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 109.68 -0.489 . . . . 64.219999999999999 109.68 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -116.17 136.24 53.19 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.601 -0.518 . . . . 75.010000000000005 109.601 173.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.447 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 9.5 t30 -56.99 -50.76 86.36 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 123.627 0.579 . . . . 73.310000000000002 111.594 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.496 ' O ' ' HE1' ' A' ' 563' ' ' MET . 57.8 Cg_endo -89.3 112.32 0.56 Allowed 'Trans proline' 0 N--CA 1.43 -2.216 0 N-CA-C 109.361 -1.053 . . . . 54.240000000000002 109.361 169.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.18 161.03 47.48 Favored 'Trans proline' 0 C--O 1.249 1.049 0 C-N-CA 122.709 2.272 . . . . 75.530000000000001 111.132 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -54.89 132.91 47.58 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 122.622 0.369 . . . . 61.549999999999997 110.316 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.64 -6.54 59.0 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.159 -1.019 . . . . 71.150000000000006 112.972 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 37.5 m -86.25 149.54 25.0 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.857 -0.423 . . . . 74.450000000000003 109.857 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.5 123.3 6.07 Favored Glycine 0 N--CA 1.433 -1.562 0 C-N-CA 121.211 -0.519 . . . . 74.120000000000005 112.478 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 35.5 m -116.28 142.31 30.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.716 -0.846 . . . . 74.230000000000004 108.716 176.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -55.74 175.31 0.09 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.922 0.889 . . . . 73.409999999999997 113.287 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -60.99 -27.0 67.98 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.5 -0.318 . . . . 71.099999999999994 111.639 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -82.34 -8.24 59.63 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.171 -0.612 . . . . 55.130000000000003 109.799 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.19 18.75 67.49 Favored Glycine 0 C--O 1.214 -1.131 0 O-C-N 123.302 0.376 . . . . 75.030000000000001 113.105 173.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.68 120.09 17.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 121.739 0.781 . . . . 72.329999999999998 111.396 -167.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.556 HG21 ' SD ' ' A' ' 563' ' ' MET . 50.7 pt -126.88 135.49 63.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 115.026 -0.988 . . . . 71.430000000000007 111.985 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 14.0 t -109.62 128.25 55.09 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.796 -0.816 . . . . 44.119999999999997 108.796 177.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 3.8 pp -139.78 168.08 20.65 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.297 -0.41 . . . . 63.310000000000002 111.631 -176.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -127.6 138.1 52.76 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.435 -0.58 . . . . 73.019999999999996 109.435 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.448 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 22.9 p90 -129.67 165.8 21.09 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 112.53 0.567 . . . . 75.129999999999995 112.53 -175.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -64.85 137.61 39.05 Favored Glycine 0 N--CA 1.423 -2.21 0 CA-C-N 114.886 -1.052 . . . . 42.119999999999997 112.488 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.554 ' HB2' ' HB3' ' A' ' 592' ' ' ASP . 10.3 tt0 . . . . . 0 C--N 1.277 -2.567 0 C-N-CA 125.431 1.492 . . . . 65.239999999999995 107.416 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 114.148 1.166 . . . . 74.230000000000004 114.148 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.8 p -147.94 147.29 29.53 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 122.169 -0.332 . . . . 74.439999999999998 111.465 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -143.83 143.69 31.44 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 123.689 0.795 . . . . 74.329999999999998 109.443 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.8 p-10 -91.13 139.48 30.72 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.825 -0.806 . . . . 74.549999999999997 108.825 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.5 pt -97.65 132.17 25.6 Favored Pre-proline 0 C--N 1.293 -1.861 0 CA-C-N 115.463 -0.79 . . . . 75.319999999999993 111.9 -176.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -83.96 175.85 7.29 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.22 1.947 . . . . 60.229999999999997 110.187 173.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -86.55 127.09 34.86 Favored 'General case' 0 CA--C 1.489 -1.376 0 CA-C-O 122.047 0.927 . . . . 70.209999999999994 109.909 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.437 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 16.2 m -113.85 59.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 CA-C-O 122.827 1.298 . . . . 64.530000000000001 109.481 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -112.57 105.77 14.05 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 113.61 -1.632 . . . . 72.319999999999993 109.648 174.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 141.97 -17.03 2.57 Favored Glycine 0 C--N 1.313 -0.705 0 C-N-CA 118.472 -1.823 . . . . 71.109999999999999 114.61 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.442 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.1 OUTLIER -112.72 -175.27 2.63 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.041 -0.726 . . . . 73.040000000000006 109.041 177.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.412 ' HB ' HG23 ' A' ' 507' ' ' VAL . 2.8 m -74.66 155.44 37.76 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 107.973 -1.121 . . . . 74.530000000000001 107.973 178.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.527 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 8.3 p -62.82 -42.13 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 121.123 -0.231 . . . . 52.450000000000003 111.48 -178.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.25 -34.41 78.28 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 110.06 -0.348 . . . . 71.430000000000007 110.06 -178.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.412 HG23 ' HB ' ' A' ' 504' ' ' THR . 59.0 t -71.9 -44.32 67.41 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.966 0 N-CA-C 109.351 -0.611 . . . . 74.439999999999998 109.351 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.443 ' HB2' HG11 ' A' ' 534' ' ' VAL . . . -58.58 -43.68 89.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.78 0.324 . . . . 72.349999999999994 110.83 177.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.3 mt-30 -62.75 -44.24 96.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.722 -0.672 . . . . 74.319999999999993 110.445 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 514' ' ' VAL . 71.8 mmtt -65.86 -42.61 90.18 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.924 -0.58 . . . . 64.120000000000005 111.129 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -62.86 -47.23 84.25 Favored 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 124.06 0.85 . . . . 72.209999999999994 111.237 -176.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -68.41 -35.31 77.46 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 115.689 -0.687 . . . . 75.030000000000001 110.6 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.45 ' N ' HD12 ' A' ' 512' ' ' LEU . 4.0 t-20 -63.87 -34.0 76.95 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 115.171 -0.922 . . . . 74.519999999999996 111.431 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 510' ' ' LYS . 84.0 t -57.22 -32.53 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 121.164 0.507 . . . . 75.099999999999994 110.731 177.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -107.85 4.77 25.81 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.489 -0.93 . . . . 70.549999999999997 108.489 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -126.96 -60.18 0.14 Allowed Glycine 0 N--CA 1.416 -2.666 0 C-N-CA 119.547 -1.311 . . . . 51.420000000000002 114.577 -169.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 64.8 25.12 12.89 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 122.561 1.172 . . . . 65.310000000000002 108.224 -171.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.6 p -82.87 -172.88 4.36 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 113.271 -1.786 . . . . 23.32 111.007 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 519' ' ' LYS . 0.1 OUTLIER -108.71 136.56 48.1 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.537 -1.282 . . . . 74.450000000000003 107.537 179.461 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -132.26 147.22 52.4 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.121 0.486 . . . . 74.329999999999998 111.699 -177.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 64.5 m -140.74 149.24 41.89 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.637 -0.875 . . . . 71.310000000000002 108.637 176.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -117.9 140.55 49.56 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 116.255 -0.429 . . . . 63.509999999999998 110.326 -176.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -132.23 130.51 41.06 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.421 -0.955 . . . . 43.210000000000001 108.421 176.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 27.0 m -88.61 126.78 35.45 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 120.933 0.397 . . . . 64.430000000000007 111.522 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.77 150.68 25.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.216 -1.031 . . . . 72.019999999999996 108.216 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -66.91 135.02 53.2 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.453 -0.573 . . . . 62.140000000000001 109.453 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 33.4 m -154.17 165.94 16.9 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 107.935 -1.135 . . . . 72.219999999999999 107.935 -177.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -83.42 -18.47 5.87 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 120.979 1.119 . . . . 73.310000000000002 111.394 172.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.444 HH21 ' CD ' ' A' ' 533' ' ' GLU . 25.1 mtp180 -79.17 145.72 65.52 Favored Pre-proline 0 N--CA 1.437 -1.086 0 C-N-CA 124.697 1.199 . . . . 72.219999999999999 109.668 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.5 146.3 97.15 Favored 'Trans proline' 0 C--O 1.25 1.087 0 C-N-CA 123.638 2.892 . . . . 73.519999999999996 115.056 -170.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.91 105.31 0.55 Allowed 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.859 -1.064 . . . . 75.230000000000004 112.012 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 142.51 -26.22 2.28 Favored Glycine 0 C--N 1.308 -1.011 0 N-CA-C 110.656 -0.977 . . . . 74.010000000000005 110.656 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . 0.444 ' CD ' HH21 ' A' ' 529' ' ' ARG . 43.9 tt0 -80.35 136.48 36.4 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 121.227 0.536 . . . . 74.340000000000003 110.182 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 536' ' ' GLY . 8.0 p -98.27 124.78 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.66 0 CA-C-N 115.491 -0.777 . . . . 63.0 109.104 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.43 8.95 40.28 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.827 -1.079 . . . . 63.020000000000003 113.465 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.498 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 127.82 -163.57 21.45 Favored Glycine 0 C--N 1.298 -1.57 0 C-N-CA 120.288 -0.958 . . . . 73.420000000000002 112.703 174.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 28.1 p -116.69 158.94 22.99 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.504 -0.925 . . . . 72.340000000000003 108.504 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -59.87 -57.08 29.46 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 120.134 -0.626 . . . . 60.5 110.352 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -68.81 144.68 60.09 Favored 'Trans proline' 0 C--N 1.376 1.984 0 CA-C-N 120.26 1.128 . . . . 75.5 110.72 173.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.7 157.64 60.87 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 123.063 2.508 . . . . 72.239999999999995 113.506 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.22 130.74 46.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.517 -0.765 . . . . 43.350000000000001 110.765 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.82 -12.79 41.89 Favored Glycine 0 C--N 1.303 -1.299 0 CA-C-N 116.025 -0.534 . . . . 72.340000000000003 112.236 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 45.8 m -73.83 125.72 28.79 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 110.174 -0.306 . . . . 74.519999999999996 110.174 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 11.7 t -81.39 124.36 29.34 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.38 -0.97 . . . . 65.25 108.38 176.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.2 m -123.95 159.26 57.18 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 107.903 -1.147 . . . . 75.239999999999995 107.903 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -66.69 137.66 46.59 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 120.723 0.948 . . . . 75.420000000000002 111.191 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.5 p -63.24 -23.61 33.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.233 -0.894 . . . . 71.450000000000003 112.104 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -101.7 3.17 39.42 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.744 -0.782 . . . . 72.510000000000005 110.194 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 9.9 t -95.86 -178.62 4.43 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 108.619 -0.882 . . . . 64.310000000000002 108.619 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.2 p -103.24 137.24 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 CA-C-O 121.635 0.731 . . . . 74.340000000000003 111.639 -174.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.37 128.24 50.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 106.647 -1.612 . . . . 74.439999999999998 106.647 175.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -103.4 117.5 34.62 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.613 0.72 . . . . 71.329999999999998 112.08 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.7 mp -102.04 130.65 48.66 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.368 -1.287 . . . . 73.310000000000002 110.17 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -93.58 115.85 28.35 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.752 0.787 . . . . 73.340000000000003 112.135 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 40.1 t -88.41 129.77 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 107.281 -1.378 . . . . 54.420000000000002 107.281 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.664 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 2.2 m -84.06 117.74 23.62 Favored 'General case' 0 C--N 1.271 -2.813 0 N-CA-C 108.498 -0.927 . . . . 73.319999999999993 108.498 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -94.32 125.75 39.16 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.77 -1.567 . . . . 72.329999999999998 106.77 171.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -61.85 -23.4 63.37 Favored Glycine 0 C--N 1.308 -1.011 0 N-CA-C 115.014 0.766 . . . . 73.400000000000006 115.014 -173.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 78.08 -20.3 0.39 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.87 1.268 . . . . 74.230000000000004 108.532 -175.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.472 ' H ' ' C ' ' A' ' 558' ' ' GLY . 78.3 mt-30 -112.78 148.17 35.36 Favored 'General case' 0 N--CA 1.403 -2.784 0 CA-C-N 115.376 -0.829 . . . . 75.129999999999995 111.012 -174.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -123.84 154.9 38.96 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 106.205 -1.776 . . . . 64.439999999999998 106.205 175.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 44.2 t -71.96 126.97 33.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 109.314 -0.624 . . . . 65.430000000000007 109.314 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.439 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 51.9 ttp -84.24 127.53 66.0 Favored Pre-proline 0 C--O 1.251 1.153 0 CA-C-N 116.28 -0.418 . . . . 72.030000000000001 110.19 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 11.9 Cg_exo -70.73 169.53 19.92 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.707 2.271 . . . . 65.239999999999995 111.101 175.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -72.53 142.13 48.49 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.381 0.61 . . . . 71.209999999999994 111.321 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.8 pp -154.87 25.9 0.44 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.599 -1.182 . . . . 64.400000000000006 109.624 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 21.7 m -79.58 146.81 32.38 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.101 -0.954 . . . . 53.140000000000001 110.372 -177.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 63.72 53.79 35.7 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.116 -0.564 . . . . 71.239999999999995 113.098 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -130.04 173.07 11.08 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.19 -1.041 . . . . 72.409999999999997 108.19 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -108.4 172.29 6.92 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.808 -1.182 . . . . 74.219999999999999 107.808 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . 0.521 ' CZ3' HD22 ' A' ' 587' ' ' LEU . 12.8 t-105 -65.93 -32.27 73.68 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.452 -0.944 . . . . 71.430000000000007 108.452 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.59 -15.1 18.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.537 -0.756 . . . . 73.530000000000001 111.238 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.557 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 25.9 t70 -101.07 -21.56 14.96 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.608 -0.886 . . . . 63.520000000000003 108.608 177.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -68.24 -39.18 82.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.189 -0.914 . . . . 61.530000000000001 111.92 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.644 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 2.7 tm-20 -58.77 -52.31 75.66 Favored Pre-proline 0 CA--C 1.57 1.742 0 N-CA-C 109.283 -0.636 . . . . 60.439999999999998 109.283 177.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 75.1 Cg_exo -55.23 -40.66 84.55 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 121.271 1.314 . . . . 72.349999999999994 112.486 171.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.557 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 16.7 mmt180 -61.62 -38.21 86.81 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 111.906 0.336 . . . . 62.020000000000003 111.906 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.1 pp -66.5 -47.13 73.99 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.969 -0.692 . . . . 40.350000000000001 110.964 -176.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.478 ' N ' HD12 ' A' ' 578' ' ' LEU . 14.7 ptm180 -66.12 -34.85 78.99 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.528 -0.305 . . . . 73.239999999999995 110.696 176.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.31 -39.52 92.59 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.823 -0.626 . . . . 45.409999999999997 111.284 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.423 HD11 ' HB2' ' A' ' 583' ' ' TRP . 1.1 pp -92.51 -8.73 43.67 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.01 -0.676 . . . . 71.340000000000003 110.963 -178.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 76.83 42.91 19.4 Favored Glycine 0 CA--C 1.517 0.165 0 N-CA-C 111.53 -0.628 . . . . 51.200000000000003 111.53 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.423 ' HB2' HD11 ' A' ' 581' ' ' LEU . 16.2 t90 -87.22 127.56 35.16 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 123.276 0.63 . . . . 75.400000000000006 110.145 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 5.8 m -103.99 -21.3 13.63 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.064 0.459 . . . . 73.040000000000006 111.557 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -72.56 177.97 39.7 Favored Glycine 0 C--O 1.241 0.567 0 CA-C-O 121.598 0.555 . . . . 73.109999999999999 114.472 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . 0.434 ' O ' HG12 ' A' ' 619' ' ' ILE . 55.7 ttp -95.54 145.6 25.09 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 123.597 0.759 . . . . 61.43 110.654 -177.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . 0.521 HD22 ' CZ3' ' A' ' 571' ' ' TRP . 5.4 tt -85.64 112.44 21.01 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.438 -0.949 . . . . 73.420000000000002 108.438 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 621' ' ' THR . 25.4 t70 -101.83 105.26 16.08 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.686 0.755 . . . . 75.150000000000006 110.324 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.482 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.1 OUTLIER -90.48 133.87 34.75 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 115.033 -0.985 . . . . 74.239999999999995 108.561 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -73.35 -63.35 2.8 Favored Glycine 0 C--N 1.288 -2.106 0 N-CA-C 110.792 -0.923 . . . . 72.430000000000007 110.792 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.16 151.3 45.15 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.462 -0.369 . . . . 45.420000000000002 111.032 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -115.6 123.49 48.57 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 104.41 -2.441 . . . . 71.040000000000006 104.41 168.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 50.7 t -112.64 120.69 63.37 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 CA-C-N 116.007 -0.542 . . . . 52.520000000000003 109.579 -174.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . 0.446 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 21.9 t70 -76.35 106.7 8.12 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 106.385 -1.709 . . . . 70.120000000000005 106.385 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -134.83 8.0 3.51 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.607 -0.437 . . . . 44.439999999999998 111.75 -175.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 117.28 95.68 1.84 Allowed Glycine 0 N--CA 1.422 -2.241 0 C-N-CA 120.194 -1.003 . . . . 50.149999999999999 111.7 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.25 -31.29 59.24 Favored Glycine 0 C--N 1.32 -0.348 0 N-CA-C 111.951 -0.46 . . . . 32.140000000000001 111.951 177.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 46.4 t -59.4 -24.6 63.6 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.185 0.994 . . . . 54.219999999999999 110.669 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -87.33 -4.22 59.05 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.568 -0.742 . . . . 71.230000000000004 111.169 -175.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 39.6 m80 63.7 94.06 0.05 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 122.102 0.953 . . . . 71.219999999999999 111.051 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . 0.494 ' N ' HD22 ' A' ' 601' ' ' ASN . 0.8 OUTLIER -85.28 87.86 7.43 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.967 0.889 . . . . 72.239999999999995 112.215 -173.249 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -90.82 169.93 10.52 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.045 -1.434 . . . . 55.329999999999998 108.996 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.412 HG11 HD12 ' A' ' 622' ' ' LEU . 85.1 t -60.45 129.83 23.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.007 -0.738 . . . . 71.310000000000002 109.007 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 11.7 p -112.79 -35.75 2.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 O-C-N 123.645 0.591 . . . . 51.439999999999998 111.041 -175.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -136.58 139.62 42.28 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.306 -0.406 . . . . 63.149999999999999 110.082 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -137.75 139.2 39.97 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.295 -1.372 . . . . 71.129999999999995 107.295 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -65.7 -52.81 40.54 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 113.125 0.787 . . . . 73.239999999999995 113.125 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 609' ' ' PRO . 34.0 Cg_endo -85.92 125.19 2.69 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 CA-C-N 120.424 1.187 . . . . 53.009999999999998 110.941 176.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 11.6 Cg_exo -70.88 158.99 53.98 Favored 'Trans proline' 0 C--O 1.244 0.823 0 C-N-CA 122.382 2.055 . . . . 72.040000000000006 112.81 178.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.58 130.79 44.14 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 108.488 -0.93 . . . . 70.310000000000002 108.488 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 98.18 0.01 58.6 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 120.222 -0.989 . . . . 65.409999999999997 112.084 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 35.6 m -102.17 154.52 18.94 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.421 -0.955 . . . . 75.5 108.421 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.45 133.2 12.15 Favored Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 120.914 -0.66 . . . . 54.039999999999999 111.792 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.5 m -117.38 142.36 31.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.922 -0.77 . . . . 71.409999999999997 108.922 176.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.455 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 34.2 p30 -47.55 166.35 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 114.112 1.153 . . . . 64.530000000000001 114.112 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -61.35 -26.03 67.55 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.303 -0.862 . . . . 74.519999999999996 112.626 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -83.46 -10.89 58.08 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 119.037 -1.065 . . . . 72.109999999999999 109.481 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.73 9.77 56.73 Favored Glycine 0 CA--C 1.499 -0.946 0 N-CA-C 111.293 -0.723 . . . . 22.34 111.293 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 586' ' ' MET . 0.0 OUTLIER -70.45 118.83 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.167 0 CA-C-O 122.212 1.006 . . . . 73.129999999999995 108.615 -171.041 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.44 ' O ' HD12 ' A' ' 620' ' ' ILE . 2.7 pp -121.11 132.6 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.872 0 CA-C-N 114.02 -1.445 . . . . 52.439999999999998 110.251 -177.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 15.3 t -104.93 119.35 38.79 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.57 -0.9 . . . . 61.450000000000003 108.57 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.442 HD21 HD21 ' A' ' 587' ' ' LEU . 1.3 pt? -139.49 165.88 26.05 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.4 -0.818 . . . . 61.229999999999997 110.813 -175.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -128.82 142.32 51.01 Favored 'General case' 0 C--O 1.257 1.469 0 CA-C-O 121.279 0.561 . . . . 74.129999999999995 110.458 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -142.0 166.75 23.87 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.186 -1.413 . . . . 53.310000000000002 107.186 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -79.31 -142.94 2.55 Favored Glycine 0 C--N 1.294 -1.785 0 C-N-CA 119.107 -1.52 . . . . 64.340000000000003 113.096 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.446 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 6.5 tp-100 . . . . . 0 C--N 1.279 -2.488 0 N-CA-C 109.294 -0.632 . . . . 60.0 109.294 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 112.661 0.615 . . . . 73.329999999999998 112.661 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.0 p -139.21 143.43 38.06 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.675 -0.491 . . . . 75.400000000000006 109.675 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -131.81 143.47 50.22 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 121.197 0.523 . . . . 73.219999999999999 110.546 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 2.3 m-20 -88.32 121.85 31.18 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.897 -1.047 . . . . 72.209999999999994 109.817 -177.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.0 pt -86.62 122.56 71.7 Favored Pre-proline 0 C--N 1.302 -1.465 0 CA-C-N 116.318 -0.401 . . . . 71.310000000000002 110.637 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -85.86 -169.57 0.6 Allowed 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.294 1.996 . . . . 73.420000000000002 110.593 177.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -89.5 129.81 35.93 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.569 -0.9 . . . . 75.0 108.569 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.504 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 27.8 m -121.77 7.84 5.85 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 CA-C-N 115.208 -0.905 . . . . 71.129999999999995 109.969 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.97 103.78 4.59 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.397 -0.82 . . . . 74.129999999999995 110.119 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 161.98 -41.39 0.38 Allowed Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 115.517 -0.765 . . . . 44.539999999999999 111.195 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 14.3 pm0 -93.94 -177.51 4.36 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 108.984 -0.747 . . . . 71.540000000000006 108.984 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 7.8 m -70.56 155.4 40.77 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 108.467 -0.938 . . . . 73.340000000000003 108.467 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.472 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 11.5 p -64.87 -42.05 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 O-C-N 123.122 0.264 . . . . 74.530000000000001 110.717 -177.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -62.2 -40.72 97.04 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 109.866 -0.42 . . . . 72.519999999999996 109.866 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 84.4 t -66.14 -47.28 85.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.894 0 CA-C-N 115.271 -0.877 . . . . 60.350000000000001 109.333 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.504 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -60.9 -45.15 95.76 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 111.828 0.307 . . . . 72.439999999999998 111.828 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.5 mt-30 -64.88 -46.76 80.42 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 116.038 -0.528 . . . . 75.420000000000002 111.232 -177.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.515 ' O ' HG23 ' A' ' 514' ' ' VAL . 21.5 ptmt -67.49 -38.84 84.95 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 116.208 -0.451 . . . . 73.530000000000001 110.645 -178.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -62.87 -42.32 99.72 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.186 0.517 . . . . 61.130000000000003 111.15 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -68.71 -41.97 78.34 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.337 -0.847 . . . . 64.25 108.74 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -59.38 -40.84 87.82 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.644 1.178 . . . . 73.209999999999994 111.734 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 510' ' ' LYS . 91.6 t -57.58 -33.18 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 121.173 0.511 . . . . 74.209999999999994 111.507 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -114.84 16.42 17.3 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.621 -0.511 . . . . 73.200000000000003 109.621 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -133.94 -58.46 0.07 OUTLIER Glycine 0 N--CA 1.428 -1.879 0 C-N-CA 119.64 -1.267 . . . . 32.119999999999997 113.618 -173.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 64.07 28.2 14.22 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 122.629 1.204 . . . . 72.319999999999993 111.013 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.2 p -79.61 171.99 14.4 Favored 'General case' 0 N--CA 1.396 -3.137 0 CA-C-N 113.643 -1.617 . . . . 74.409999999999997 108.17 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.535 ' HD2' ' N ' ' A' ' 519' ' ' LYS . 10.2 mptt -107.56 136.06 47.96 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 107.549 -1.278 . . . . 73.530000000000001 107.549 -176.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -133.51 149.24 51.71 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.026 0.441 . . . . 72.099999999999994 112.145 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.7 m -138.73 142.93 38.88 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.076 -1.453 . . . . 63.030000000000001 107.076 174.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -117.54 137.75 52.36 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.62 -0.432 . . . . 72.230000000000004 111.094 -176.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -122.62 119.73 31.64 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.63 -0.878 . . . . 64.219999999999999 108.63 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 12.8 m -96.36 120.34 36.48 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.097 0.475 . . . . 74.109999999999999 111.17 -176.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.7 p -123.82 155.31 30.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.448 -1.316 . . . . 74.430000000000007 107.448 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.443 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 4.3 p30 -75.78 136.42 40.27 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.496 0.665 . . . . 72.510000000000005 111.745 -178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 64.9 m -160.45 159.69 26.06 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 107.047 -1.464 . . . . 52.350000000000001 107.047 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -65.58 -9.77 23.82 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 C-N-CA 122.788 2.326 . . . . 74.219999999999999 113.561 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.449 ' HB2' ' CB ' ' A' ' 556' ' ' SER . 14.7 mmm180 -78.36 141.94 62.21 Favored Pre-proline 0 N--CA 1.436 -1.15 0 N-CA-C 107.27 -1.382 . . . . 72.549999999999997 107.27 176.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -64.43 152.2 82.5 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 122.862 2.374 . . . . 73.140000000000001 113.958 -173.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.649 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.91 111.15 1.19 Allowed 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.815 -0.629 . . . . 63.539999999999999 111.963 -178.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 123.85 -16.17 7.83 Favored Glycine 0 C--N 1.299 -1.491 0 CA-C-N 115.283 -0.871 . . . . 52.039999999999999 112.121 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.16 138.36 34.74 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.535 -0.542 . . . . 64.150000000000006 109.535 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 6.1 p -87.16 116.84 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 CA-C-O 122.136 0.969 . . . . 74.0 109.48 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.97 -27.31 60.93 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 113.976 -1.466 . . . . 74.219999999999999 109.884 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.51 -162.31 29.54 Favored Glycine 0 N--CA 1.416 -2.651 0 N-CA-C 110.583 -1.007 . . . . 64.400000000000006 110.583 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 5.3 p -117.03 157.7 25.39 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 109.481 -0.563 . . . . 63.420000000000002 109.481 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.484 ' HB2' HE22 ' A' ' 554' ' ' GLN . 7.7 t30 -63.94 -54.14 43.21 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 120.766 -0.374 . . . . 72.450000000000003 110.2 174.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -69.32 134.4 28.81 Favored 'Trans proline' 0 C--N 1.369 1.617 0 N-CA-C 108.679 -1.316 . . . . 72.120000000000005 108.679 170.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.57 155.96 50.12 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 122.437 2.091 . . . . 51.219999999999999 112.93 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.4 131.21 45.86 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.964 -0.562 . . . . 73.510000000000005 109.718 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.84 -7.44 38.52 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 111.459 -0.656 . . . . 73.140000000000001 111.459 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 30.1 m -80.9 137.25 36.15 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.842 -0.429 . . . . 70.030000000000001 109.842 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 5.6 t -92.04 128.32 37.84 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 107.819 -1.178 . . . . 73.040000000000006 107.819 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 29.5 m -123.95 154.85 67.83 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.74 -0.837 . . . . 62.109999999999999 108.74 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -65.56 137.94 52.46 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 121.054 1.169 . . . . 74.409999999999997 111.269 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.6 -19.76 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-O 122.219 1.009 . . . . 74.340000000000003 109.691 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -84.76 -16.05 42.91 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.148 -1.387 . . . . 71.219999999999999 110.747 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 22.8 t -94.45 -173.29 3.01 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-N 115.869 -0.605 . . . . 71.200000000000003 110.737 -175.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.2 p -118.95 138.15 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 C-N-CA 123.6 0.76 . . . . 75.129999999999995 111.207 -175.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 43.8 mt -95.0 143.9 10.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.509 -0.922 . . . . 42.219999999999999 108.509 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -103.8 117.06 33.46 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.43 -0.952 . . . . 73.450000000000003 108.43 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.95 120.6 41.86 Favored 'General case' 0 C--N 1.311 -1.071 0 O-C-N 123.735 0.647 . . . . 71.439999999999998 110.083 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.484 HE22 ' HB2' ' A' ' 538' ' ' ASN . 2.6 mp0 -90.74 120.96 32.22 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.215 0.531 . . . . 63.340000000000003 109.991 176.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.459 HG22 HG21 ' A' ' 505' ' ' VAL . 23.9 t -105.59 137.22 36.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.216 -1.031 . . . . 74.310000000000002 108.216 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.649 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 71.2 m -89.89 133.15 34.92 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-O 120.756 0.312 . . . . 74.299999999999997 110.362 176.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 18.8 ptpt -106.1 127.18 53.01 Favored 'General case' 0 N--CA 1.406 -2.638 0 N-CA-C 104.317 -2.475 . . . . 72.239999999999995 104.317 164.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -55.42 -23.66 35.39 Favored Glycine 0 CA--C 1.506 -0.511 0 O-C-N 124.062 0.851 . . . . 55.140000000000001 114.128 -173.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . 0.443 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 19.6 t-20 81.77 -19.13 0.44 Allowed 'General case' 0 CA--C 1.495 -1.161 0 C-N-CA 126.236 1.815 . . . . 44.25 108.903 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.483 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 85.2 mt-30 -111.83 144.91 40.36 Favored 'General case' 0 N--CA 1.407 -2.59 0 CA-C-N 115.259 -0.882 . . . . 73.209999999999994 110.528 -173.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -123.29 146.67 47.71 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 107.535 -1.284 . . . . 64.209999999999994 107.535 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 84.5 t -62.33 116.63 2.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 123.66 0.6 . . . . 71.400000000000006 109.825 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.415 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 56.3 ttp -77.59 126.63 84.24 Favored Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 116.387 -0.37 . . . . 50.530000000000001 110.686 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 16.1 Cg_exo -69.45 168.49 21.01 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.5 2.133 . . . . 61.0 110.95 175.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -77.66 132.13 38.07 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 113.122 0.786 . . . . 74.209999999999994 113.122 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.0 pp -140.49 16.21 2.37 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.384 -1.28 . . . . 74.439999999999998 110.07 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 71.3 p -73.89 148.3 42.41 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 116.151 -0.477 . . . . 73.040000000000006 112.227 -175.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 72.97 57.28 5.35 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 115.689 -0.687 . . . . 61.329999999999998 113.987 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -136.93 167.93 20.54 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.115 -0.698 . . . . 72.430000000000007 109.115 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -95.5 165.76 12.19 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.387 -1.338 . . . . 75.5 107.387 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -67.21 -29.04 68.6 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.356 -0.609 . . . . 64.340000000000003 109.356 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.2 p -71.78 -22.81 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.558 0.694 . . . . 71.109999999999999 109.982 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -95.97 -34.29 11.84 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.039 -0.982 . . . . 55.240000000000002 108.936 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -54.7 -53.11 59.24 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 114.973 -1.012 . . . . 73.109999999999999 112.635 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.426 ' HB2' ' HD3' ' A' ' 576' ' ' PRO . 38.2 mt-10 -53.82 -54.95 40.91 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 115.122 1.527 . . . . 71.439999999999998 115.122 -176.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 24.5 Cg_exo -61.83 -28.11 81.17 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.413 1.409 . . . . 53.409999999999997 111.446 175.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -67.98 -35.12 77.82 Favored 'General case' 0 C--O 1.198 -1.646 0 CA-C-O 118.999 -0.524 . . . . 70.420000000000002 111.847 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.592 HD22 ' CE3' ' A' ' 583' ' ' TRP . 16.6 mt -60.25 -48.95 79.55 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.406 -0.59 . . . . 71.319999999999993 109.406 -176.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -66.5 -40.82 89.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.764 -0.653 . . . . 62.420000000000002 111.492 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.76 65.43 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.132 0.492 . . . . 74.239999999999995 111.762 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.7 tp -91.87 -9.11 44.49 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 124.33 1.052 . . . . 65.420000000000002 110.022 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.65 22.35 77.31 Favored Glycine 0 C--N 1.315 -0.588 0 C-N-CA 121.112 -0.566 . . . . 53.229999999999997 112.55 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.592 ' CE3' HD22 ' A' ' 578' ' ' LEU . 16.7 t90 -87.48 127.31 35.23 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.053 -0.721 . . . . 74.120000000000005 109.053 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 14.8 p -100.11 -14.49 18.55 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 113.877 1.066 . . . . 75.540000000000006 113.877 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -80.11 -159.29 18.73 Favored Glycine 0 C--N 1.313 -0.711 0 N-CA-C 114.321 0.488 . . . . 73.319999999999993 114.321 -175.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 65.7 mtt -114.41 139.5 49.45 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.868 0.366 . . . . 71.340000000000003 111.383 -174.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 21.5 tp -80.71 101.88 9.56 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 106.709 -1.589 . . . . 51.200000000000003 106.709 177.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 621' ' ' THR . 31.0 t70 -98.99 117.45 33.54 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.872 -0.331 . . . . 75.219999999999999 111.036 -173.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.0 OUTLIER -91.19 133.44 35.37 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 119.587 -0.845 . . . . 70.409999999999997 110.503 -179.102 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -74.34 -72.99 0.96 Allowed Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 110.798 -0.921 . . . . 42.329999999999998 110.798 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.16 142.28 35.97 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.715 -0.846 . . . . 75.349999999999994 108.715 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -79.88 123.58 27.89 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 107.079 -1.452 . . . . 74.549999999999997 107.079 174.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 50.4 t -104.68 128.28 58.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.398 -1.334 . . . . 72.25 107.398 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -72.01 114.04 9.68 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.768 -0.827 . . . . 54.520000000000003 108.768 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -124.53 -44.29 1.99 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.918 -1.037 . . . . 51.130000000000003 111.0 -173.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 109.08 122.52 4.62 Favored Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.561 -0.828 . . . . 44.32 112.111 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -61.22 -33.63 85.04 Favored Glycine 0 C--N 1.316 -0.548 0 CA-C-N 116.001 -0.1 . . . . 72.310000000000002 113.057 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 22.8 t -70.59 -22.85 62.51 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.94 0.876 . . . . 53.299999999999997 110.377 -177.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -87.12 -1.3 57.79 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.304 -0.862 . . . . 70.540000000000006 108.935 -175.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 69.77 82.63 0.16 Allowed 'General case' 0 CA--C 1.492 -1.274 0 C-N-CA 124.59 1.156 . . . . 73.420000000000002 108.611 -173.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -79.43 79.63 5.87 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 114.16 -1.382 . . . . 75.230000000000004 111.549 -176.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -87.68 173.23 9.15 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.746 -1.57 . . . . 73.209999999999994 108.234 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.489 HG11 HD12 ' A' ' 622' ' ' LEU . 91.1 t -58.68 130.4 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.322 -1.733 . . . . 74.120000000000005 106.322 168.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.2 m -101.57 -29.92 3.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 120.703 -0.399 . . . . 64.510000000000005 111.687 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -155.78 144.55 20.42 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 109.824 -0.436 . . . . 64.329999999999998 109.824 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -135.04 140.73 45.82 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.977 -1.49 . . . . 73.129999999999995 106.977 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.43 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 27.4 t-20 -66.32 -54.82 22.78 Favored Pre-proline 0 C--N 1.312 -1.046 0 C-N-CA 119.647 -0.821 . . . . 75.439999999999998 112.314 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.3 Cg_exo -84.8 119.16 2.17 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 121.996 1.797 . . . . 35.200000000000003 111.388 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.14 160.77 48.1 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 123.048 2.498 . . . . 53.049999999999997 112.252 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.07 134.94 51.46 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.657 -0.868 . . . . 62.409999999999997 108.657 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.32 -15.09 47.11 Favored Glycine 0 C--N 1.293 -1.81 0 N-CA-C 110.948 -0.861 . . . . 62.340000000000003 110.948 -175.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 37.3 m -92.61 146.77 23.41 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.042 -1.096 . . . . 64.349999999999994 108.042 178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -78.2 130.92 10.47 Favored Glycine 0 N--CA 1.426 -1.995 0 C-N-CA 121.163 -0.541 . . . . 70.439999999999998 112.427 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 26.8 m -114.69 142.12 28.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.829 -1.174 . . . . 65.310000000000002 107.829 176.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.483 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.9 p-10 -50.92 172.85 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.149 0.98 . . . . 64.400000000000006 113.397 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -54.71 -27.14 38.46 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 113.811 1.041 . . . . 74.409999999999997 113.811 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.422 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 1.2 m-20 -94.77 -6.5 42.89 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.17 -0.612 . . . . 62.109999999999999 110.645 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.49 19.19 68.59 Favored Glycine 0 C--O 1.214 -1.118 0 CA-C-O 119.806 -0.441 . . . . 71.140000000000001 113.35 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.72 119.15 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 122.083 0.944 . . . . 64.219999999999999 110.835 -167.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.415 HG22 ' HG2' ' A' ' 608' ' ' PRO . 48.7 pt -125.54 134.98 65.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.89 -1.05 . . . . 43.229999999999997 110.909 -176.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 15.1 t -100.31 125.37 46.52 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 108.461 -0.94 . . . . 73.340000000000003 108.461 177.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 1.8 pt? -139.32 165.27 27.63 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.285 -0.87 . . . . 73.420000000000002 110.288 -175.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -128.81 140.06 51.88 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.64 -0.504 . . . . 71.430000000000007 109.64 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 603' ' ' VAL . 5.2 p90 -130.97 165.16 23.76 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.862 0.363 . . . . 71.519999999999996 111.452 -174.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -76.96 141.89 26.82 Favored Glycine 0 N--CA 1.415 -2.762 0 CA-C-N 114.955 -1.021 . . . . 64.109999999999999 113.604 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 . . . . . 0 C--N 1.272 -2.798 0 N-CA-C 106.98 -1.489 . . . . 72.310000000000002 106.98 178.66 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 112.449 0.537 . . . . 72.299999999999997 112.449 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 546' ' ' PRO . 29.5 p -139.84 145.46 38.14 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.572 -0.529 . . . . 54.420000000000002 109.572 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -128.51 137.04 51.57 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 123.396 0.435 . . . . 74.319999999999993 110.305 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.587 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.9 p-10 -84.87 124.79 32.02 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.474 0.654 . . . . 54.43 110.099 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 498' ' ' PRO . 37.3 pt -84.89 125.35 71.02 Favored Pre-proline 0 C--N 1.305 -1.357 0 CA-C-N 115.673 -0.694 . . . . 63.350000000000001 111.735 -176.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 8.2 Cg_exo -74.44 172.65 15.7 Favored 'Trans proline' 0 C--O 1.254 1.28 0 C-N-CA 122.449 2.099 . . . . 62.340000000000003 111.124 174.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -80.25 105.44 11.52 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.989 -0.55 . . . . 73.319999999999993 109.616 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.432 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 15.4 m -106.87 59.3 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-O 123.24 1.495 . . . . 75.329999999999998 110.308 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -118.0 111.49 19.01 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 112.658 -2.064 . . . . 61.439999999999998 108.127 173.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 136.22 -15.85 3.93 Favored Glycine 0 C--N 1.303 -1.289 0 C-N-CA 119.042 -1.551 . . . . 61.219999999999999 113.937 177.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.469 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.4 OUTLIER -111.39 -175.46 2.71 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 117.695 0.748 . . . . 73.109999999999999 109.231 176.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 10.6 m -71.67 155.0 40.99 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.542 -0.91 . . . . 72.519999999999996 108.542 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.435 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.7 p -61.64 -42.48 94.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 111.508 0.188 . . . . 73.200000000000003 111.508 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . 0.433 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 25.7 t70 -62.51 -41.63 98.96 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.965 -0.383 . . . . 73.239999999999995 109.965 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 68.0 t -67.46 -41.66 86.3 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.966 0 CA-C-N 115.64 -0.709 . . . . 71.319999999999993 109.476 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.514 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -61.97 -43.51 98.69 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 121.365 -0.134 . . . . 72.340000000000003 111.146 176.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 26.3 mt-30 -64.85 -43.13 94.0 Favored 'General case' 0 CA--C 1.511 -0.539 0 O-C-N 123.089 0.243 . . . . 71.420000000000002 110.811 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.556 ' O ' HG23 ' A' ' 514' ' ' VAL . 75.9 mmtt -63.77 -46.6 84.52 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.586 -0.524 . . . . 64.409999999999997 109.586 176.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -63.57 -38.63 91.84 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.733 -0.667 . . . . 73.349999999999994 111.715 -177.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.71 -45.29 83.31 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.552 -1.277 . . . . 62.240000000000002 107.552 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -59.77 -36.1 75.97 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 124.03 0.932 . . . . 75.030000000000001 110.947 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 510' ' ' LYS . 83.5 t -57.2 -39.5 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 122.875 0.47 . . . . 51.240000000000002 111.317 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -105.0 -8.32 18.63 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.584 0.707 . . . . 73.25 110.012 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -108.43 -59.6 0.54 Allowed Glycine 0 N--CA 1.414 -2.802 0 CA-C-N 115.574 -0.739 . . . . 52.140000000000001 112.836 -169.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 65.44 25.81 11.92 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 122.398 1.094 . . . . 75.219999999999999 109.434 -173.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 547' ' ' VAL . 1.9 p -90.61 -172.99 3.59 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 113.741 -1.572 . . . . 75.510000000000005 110.239 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -108.75 142.05 39.86 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.38 -1.341 . . . . 72.420000000000002 107.38 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -132.44 153.11 51.18 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.11 0.481 . . . . 73.239999999999995 112.278 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.7 m -141.4 152.73 44.56 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.169 -1.048 . . . . 74.040000000000006 108.169 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -117.46 126.43 52.61 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.396 0.617 . . . . 60.409999999999997 111.719 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.02 130.38 56.17 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.891 -1.151 . . . . 65.129999999999995 107.891 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 18.7 p -103.87 139.58 38.86 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.323 0.582 . . . . 63.039999999999999 112.435 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.0 p -136.64 149.58 26.87 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 107.276 -1.379 . . . . 71.530000000000001 107.276 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 1.6 p-10 -87.61 136.83 32.79 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.93 -0.708 . . . . 73.200000000000003 110.521 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 50.6 m -156.27 163.79 23.67 Favored Pre-proline 0 C--N 1.293 -1.879 0 N-CA-C 106.415 -1.698 . . . . 75.239999999999995 106.415 -178.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.4 10.69 0.7 Allowed 'Trans proline' 0 CA--C 1.558 1.676 0 C-N-CA 121.935 1.757 . . . . 73.430000000000007 114.355 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.459 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 0.0 OUTLIER -96.59 140.99 22.46 Favored Pre-proline 0 C--O 1.214 -0.788 0 N-CA-C 108.686 -0.857 . . . . 74.099999999999994 108.686 177.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.1 145.88 73.15 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 123.251 2.634 . . . . 62.530000000000001 113.643 -176.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -66.83 99.39 0.62 Allowed 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.972 -1.013 . . . . 71.439999999999998 112.781 -174.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 152.3 -26.64 0.88 Allowed Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 115.045 -0.98 . . . . 64.519999999999996 110.734 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -74.39 131.4 41.06 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.687 0.756 . . . . 70.329999999999998 110.831 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.514 HG11 ' CB ' ' A' ' 508' ' ' ALA . 12.4 p -97.97 125.65 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.063 0 N-CA-C 107.33 -1.359 . . . . 73.510000000000005 107.33 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 p -97.59 10.95 38.58 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 115.184 -0.916 . . . . 65.439999999999998 113.024 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.466 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 133.18 -165.77 23.93 Favored Glycine 0 N--CA 1.434 -1.491 0 C-N-CA 119.963 -1.113 . . . . 74.040000000000006 113.448 173.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 14.2 p -116.94 158.4 24.13 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 124.293 1.037 . . . . 53.409999999999997 108.736 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.442 ' HB2' HE22 ' A' ' 554' ' ' GLN . 9.4 t30 -62.14 -50.4 80.38 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 119.31 -0.956 . . . . 61.409999999999997 112.454 178.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -69.17 143.27 53.12 Favored 'Trans proline' 0 C--N 1.367 1.529 0 N-CA-C 108.929 -1.219 . . . . 55.030000000000001 108.929 170.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.94 144.93 89.34 Favored 'Trans proline' 0 C--O 1.253 1.229 0 C-N-CA 122.411 2.074 . . . . 55.43 112.634 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.27 137.51 58.27 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.458 -0.792 . . . . 73.329999999999998 109.629 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.52 -12.59 47.17 Favored Glycine 0 C--N 1.304 -1.242 0 N-CA-C 111.48 -0.648 . . . . 63.240000000000002 111.48 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.417 ' O ' HG12 ' A' ' 497' ' ' ILE . 31.9 m -81.03 136.81 36.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.518 0.199 . . . . 61.130000000000003 110.895 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.2 t -90.59 128.32 36.55 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 108.214 -1.032 . . . . 41.299999999999997 108.214 173.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.77 153.99 67.0 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 108.907 -0.775 . . . . 52.130000000000003 108.907 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.457 ' HA ' HG22 ' A' ' 494' ' ' THR . 14.9 Cg_endo -60.54 138.19 78.61 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.76 1.64 . . . . 74.420000000000002 111.702 178.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.545 ' HA ' HG22 ' A' ' 518' ' ' THR . 8.7 p -61.27 -19.03 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 CA-C-O 122.177 0.989 . . . . 33.200000000000003 110.552 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -81.12 -15.8 54.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.638 -1.165 . . . . 75.540000000000006 111.954 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 77.6 p -92.79 157.96 16.14 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 112.905 0.706 . . . . 64.420000000000002 112.905 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.9 p -98.56 128.15 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 115.261 -0.881 . . . . 75.400000000000006 110.119 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.6 mt -98.95 136.05 31.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.508 -0.769 . . . . 62.100000000000001 109.798 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.88 125.25 50.16 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.889 0.852 . . . . 73.0 111.754 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.63 120.92 39.89 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 113.884 -1.507 . . . . 74.329999999999998 109.128 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.442 HE22 ' HB2' ' A' ' 538' ' ' ASN . 2.6 mp0 -85.7 108.5 18.07 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.731 0.777 . . . . 63.43 112.057 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 16.2 t -90.6 129.84 40.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 114.962 -1.017 . . . . 63.439999999999998 108.307 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 67.7 m -94.69 117.99 31.01 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 109.83 -0.433 . . . . 44.130000000000003 109.83 177.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.401 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 18.2 ptpt -90.94 136.74 32.87 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.431 -1.692 . . . . 75.120000000000005 106.431 173.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -62.85 -24.39 66.55 Favored Glycine 0 CA--C 1.489 -1.561 0 O-C-N 124.233 0.958 . . . . 65.109999999999999 114.423 -171.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . 0.457 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 31.7 t-20 77.75 -24.99 0.2 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.571 1.148 . . . . 64.239999999999995 109.574 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.444 ' H ' ' C ' ' A' ' 558' ' ' GLY . 86.5 mt-30 -111.46 150.46 29.85 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 115.782 -0.645 . . . . 63.399999999999999 111.078 -174.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -132.35 149.86 52.27 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.347 -1.297 . . . . 75.420000000000002 107.622 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 63.2 t -68.25 125.72 26.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 109.833 -0.432 . . . . 71.140000000000001 109.833 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 48.1 ttp -92.18 125.63 55.88 Favored Pre-proline 0 C--N 1.308 -1.233 0 CA-C-N 116.072 -0.513 . . . . 60.210000000000001 111.184 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.81 155.01 71.57 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.957 2.438 . . . . 71.450000000000003 111.027 174.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . 0.524 ' HA ' ' CB ' ' A' ' 610' ' ' ALA . 29.4 t70 -67.03 139.42 57.63 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 114.851 1.426 . . . . 65.519999999999996 114.851 -174.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . 0.417 ' O ' ' HG2' ' A' ' 569' ' ' MET . 2.1 pt? -141.35 15.63 2.21 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.772 -1.103 . . . . 63.43 109.688 176.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 84.2 p -80.06 153.28 28.88 Favored 'General case' 0 C--O 1.251 1.161 0 C-N-CA 120.171 -0.611 . . . . 65.310000000000002 110.571 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 79.08 31.49 42.76 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.856 -0.688 . . . . 52.219999999999999 113.91 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . 0.487 ' SD ' ' HG3' ' A' ' 577' ' ' ARG . 21.5 ptp -134.01 -179.07 5.32 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.795 -0.817 . . . . 24.02 108.795 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -101.82 167.43 10.08 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.275 -1.38 . . . . 74.540000000000006 107.275 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 -67.24 -30.01 69.8 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.678 -0.86 . . . . 73.120000000000005 108.678 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 11.5 p -72.11 -16.83 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 115.395 -0.821 . . . . 74.209999999999994 110.34 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.613 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 18.6 t70 -101.35 -39.16 7.72 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.706 -0.85 . . . . 73.140000000000001 108.706 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.7 -42.46 97.23 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 115.034 -0.984 . . . . 55.439999999999998 112.019 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.539 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 39.2 tt0 -55.4 -53.18 64.96 Favored Pre-proline 0 CA--C 1.569 1.701 0 CA-C-O 119.142 -0.456 . . . . 72.010000000000005 111.776 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 71.6 Cg_exo -55.77 -30.33 75.72 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 122.124 1.883 . . . . 74.099999999999994 112.6 171.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 11.4 mmm180 -62.81 -38.29 90.14 Favored 'General case' 0 C--O 1.202 -1.421 0 C-N-CA 120.707 -0.397 . . . . 74.439999999999998 110.816 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.741 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 10.5 mp -58.01 -49.28 77.4 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 118.001 0.364 . . . . 72.409999999999997 110.807 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -66.17 -40.87 90.8 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.62 -0.718 . . . . 72.329999999999998 112.675 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.02 -27.78 64.96 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.898 0.38 . . . . 33.350000000000001 111.735 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 8.3 tp -89.73 -9.36 49.67 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 123.939 0.896 . . . . 55.039999999999999 110.545 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 68.73 32.11 73.9 Favored Glycine 0 C--O 1.243 0.672 0 C-N-CA 120.829 -0.701 . . . . 72.519999999999996 111.995 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.741 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 10.9 t90 -87.03 126.78 34.97 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 107.576 -1.268 . . . . 73.040000000000006 107.576 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 4.2 p -91.78 -27.95 17.68 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 113.031 0.752 . . . . 62.409999999999997 113.031 -174.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -71.7 179.36 34.23 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 116.122 -0.49 . . . . 75.150000000000006 112.878 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 62.6 mtm -107.28 148.8 28.52 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.073 0.463 . . . . 74.340000000000003 111.056 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 29.9 tp -80.63 111.47 17.09 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 107.182 -1.414 . . . . 75.409999999999997 107.182 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.58 ' O ' ' HA ' ' A' ' 621' ' ' THR . 15.3 t70 -97.94 114.92 27.15 Favored 'General case' 0 CA--C 1.485 -1.531 0 CA-C-N 116.086 -0.506 . . . . 74.109999999999999 110.237 -174.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.468 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.1 OUTLIER -91.6 133.45 35.54 Favored 'General case' 0 C--N 1.276 -2.6 0 C-N-CA 119.853 -0.739 . . . . 72.200000000000003 109.399 177.67 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -83.01 -61.77 1.89 Allowed Glycine 0 C--N 1.291 -1.952 0 N-CA-C 109.884 -1.286 . . . . 74.549999999999997 109.884 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.67 149.45 43.73 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 109.348 -0.612 . . . . 52.549999999999997 109.348 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -90.06 150.14 22.21 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.221 -1.029 . . . . 61.039999999999999 108.221 176.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 19.9 t -117.44 136.7 53.75 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 108.636 -0.876 . . . . 55.200000000000003 108.636 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.59 106.97 5.59 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.709 -1.219 . . . . 54.43 107.709 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -120.42 -61.5 1.57 Allowed 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.618 -0.719 . . . . 75.409999999999997 109.342 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 89.08 151.83 24.84 Favored Glycine 0 N--CA 1.419 -2.457 0 C-N-CA 119.575 -1.298 . . . . 70.319999999999993 111.238 -176.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.4 -33.69 62.34 Favored Glycine 0 C--N 1.3 -1.441 0 N-CA-C 114.649 0.62 . . . . 73.25 114.649 -177.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 32.2 t -73.1 -24.89 60.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.95 0.881 . . . . 75.310000000000002 109.794 -176.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -99.83 -3.38 32.72 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.044 -0.98 . . . . 65.120000000000005 109.645 -177.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 56.6 m80 74.37 126.98 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.201 1.4 . . . . 72.129999999999995 112.677 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -83.74 51.07 1.93 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.249 1.023 . . . . 72.219999999999999 108.987 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.402 ' HE ' ' HB3' ' A' ' 602' ' ' ARG . 37.4 mtp180 -83.91 158.17 21.69 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.729 -1.123 . . . . 52.310000000000002 113.299 -176.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.16 131.73 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 106.136 -1.801 . . . . 61.32 106.136 167.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 44.0 t -97.47 -44.07 12.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-O 121.594 0.712 . . . . 64.519999999999996 109.512 -177.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -154.24 145.38 22.81 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.431 -0.804 . . . . 74.349999999999994 110.167 -176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -126.41 133.58 51.24 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 105.833 -1.914 . . . . 72.519999999999996 105.833 174.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.408 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 65.7 t30 -63.52 -51.09 69.47 Favored Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 112.744 0.646 . . . . 41.100000000000001 112.744 -174.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.5 Cg_exo -87.65 111.15 0.76 Allowed 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 122.002 1.801 . . . . 64.430000000000007 109.815 172.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.92 143.49 45.38 Favored 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 122.588 2.192 . . . . 73.0 113.485 -177.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . 0.524 ' CB ' ' HA ' ' A' ' 565' ' ' ASP . . . -65.82 139.85 58.35 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.81 -0.632 . . . . 72.420000000000002 109.737 176.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.45 -9.16 44.96 Favored Glycine 0 C--N 1.301 -1.365 0 N-CA-C 109.578 -1.409 . . . . 43.32 109.578 -172.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 63.0 m -108.67 154.18 22.38 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.491 -0.929 . . . . 75.109999999999999 108.491 176.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -72.74 128.54 12.59 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 111.898 -0.481 . . . . 75.430000000000007 111.898 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 30.1 m -112.7 143.14 23.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 123.666 0.786 . . . . 70.310000000000002 109.464 178.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.437 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 9.4 p30 -43.56 167.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 125.492 1.517 . . . . 71.099999999999994 113.259 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -57.29 -25.35 59.13 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 113.907 1.077 . . . . 74.230000000000004 113.907 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -93.04 -7.57 45.33 Favored 'General case' 0 C--O 1.208 -1.103 0 C-N-CA 119.327 -0.949 . . . . 75.120000000000005 108.543 -178.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 68.09 11.7 61.62 Favored Glycine 0 CA--C 1.491 -1.444 0 CA-C-N 115.557 -0.747 . . . . 64.239999999999995 111.788 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.46 118.85 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-O 122.279 1.037 . . . . 51.439999999999998 111.627 -169.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 45.0 pt -121.18 134.33 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 113.8 -1.546 . . . . 51.310000000000002 110.265 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 14.1 t -98.66 131.31 44.94 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 108.035 -1.098 . . . . 73.340000000000003 108.035 177.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -139.36 167.57 21.79 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.863 -0.608 . . . . 71.219999999999999 111.733 -174.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -126.75 136.42 52.4 Favored 'General case' 0 C--O 1.255 1.392 0 N-CA-C 107.228 -1.397 . . . . 71.019999999999996 107.228 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -141.39 163.23 33.5 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.448 -0.342 . . . . 75.420000000000002 110.603 -172.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -76.27 129.43 10.06 Favored Glycine 0 N--CA 1.416 -2.643 0 O-C-N 123.827 0.705 . . . . 63.210000000000001 111.545 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 C--N 1.299 -1.6 0 C-N-CA 123.948 0.899 . . . . 63.240000000000002 109.678 -179.503 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.374 0 CA-C-O 120.861 0.362 . . . . 64.239999999999995 110.329 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 25.4 p -130.89 140.32 50.2 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.891 -0.411 . . . . 71.439999999999998 109.891 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.564 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 8.8 tmtm? -150.56 144.22 25.17 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.724 -1.213 . . . . 75.430000000000007 107.724 172.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.564 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 9.6 p-10 -78.58 130.13 35.59 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.48 0.657 . . . . 60.210000000000001 110.808 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 29.3 pt -87.24 133.69 38.17 Favored Pre-proline 0 C--N 1.288 -2.103 0 C-N-CA 120.212 -0.595 . . . . 73.409999999999997 110.331 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -69.52 170.87 15.29 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 121.864 1.709 . . . . 74.120000000000005 111.85 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -78.01 83.23 4.32 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 122.876 1.322 . . . . 73.109999999999999 110.626 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.434 ' HB ' ' CB ' ' A' ' 508' ' ' ALA . 26.9 m -86.73 -6.82 10.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 114.399 -1.273 . . . . 72.129999999999995 112.268 -177.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.67 101.85 3.76 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.817 -0.809 . . . . 61.299999999999997 108.817 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 157.18 -38.54 0.56 Allowed Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.799 -0.715 . . . . 50.450000000000003 111.89 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 17.4 pm0 -97.54 -168.02 1.62 Allowed 'General case' 0 C--O 1.243 0.738 0 C-N-CA 120.761 -0.376 . . . . 63.409999999999997 110.006 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.402 ' HB ' HG23 ' A' ' 507' ' ' VAL . 14.5 m -70.15 155.35 40.76 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.21 -0.663 . . . . 74.549999999999997 109.21 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.427 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.3 p -63.18 -41.45 92.86 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.547 0 O-C-N 123.302 0.376 . . . . 65.510000000000005 110.72 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 18.7 t70 -59.84 -42.91 94.64 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.891 0.377 . . . . 63.0 110.04 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.402 HG23 ' HB ' ' A' ' 504' ' ' THR . 61.6 t -68.32 -45.42 82.58 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.622 0 CA-C-N 115.352 -0.84 . . . . 62.409999999999997 109.226 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.434 ' CB ' ' HB ' ' A' ' 500' ' ' VAL . . . -58.83 -45.38 90.15 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 120.638 0.256 . . . . 75.510000000000005 111.006 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.0 mt-30 -64.12 -45.64 87.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.972 -0.558 . . . . 72.430000000000007 111.237 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.563 ' O ' HG23 ' A' ' 514' ' ' VAL 0.314 0.0 OUTLIER -67.32 -37.65 83.66 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 119.632 -0.827 . . . . 73.140000000000001 111.607 177.353 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . 0.456 ' N ' ' HD3' ' A' ' 510' ' ' LYS . 7.9 m-20 -60.45 -50.2 74.53 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 116.276 -0.42 . . . . 62.509999999999998 110.723 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.451 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -68.05 -36.25 79.56 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.937 -0.574 . . . . 71.019999999999996 111.239 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.451 ' N ' HD12 ' A' ' 512' ' ' LEU . 1.5 t-20 -65.9 -38.43 88.73 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 122.999 0.52 . . . . 41.340000000000003 110.528 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 510' ' ' LYS . 78.2 t -59.59 -32.98 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.093 0.473 . . . . 64.019999999999996 111.102 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -111.54 16.35 20.73 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.881 -0.328 . . . . 74.239999999999995 110.275 -177.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -143.01 -53.83 0.03 OUTLIER Glycine 0 CA--C 1.488 -1.62 0 C-N-CA 119.421 -1.371 . . . . 43.049999999999997 113.826 -173.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 61.46 39.37 15.09 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.652 1.215 . . . . 74.430000000000007 108.899 -174.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 547' ' ' VAL . 20.3 p -91.23 -172.24 3.23 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 112.814 -1.994 . . . . 65.450000000000003 109.3 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.5 142.38 39.0 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.393 -1.336 . . . . 71.230000000000004 107.393 176.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -131.53 152.05 51.07 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.401 0.619 . . . . 74.219999999999999 112.244 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 20.4 p -140.29 146.42 38.52 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 107.962 -1.125 . . . . 71.099999999999994 107.962 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -119.79 129.47 54.47 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.237 -0.585 . . . . 74.349999999999994 110.942 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -121.01 118.7 30.5 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.945 -0.761 . . . . 72.019999999999996 108.945 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.8 m -90.78 137.09 32.63 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.132 0.491 . . . . 53.420000000000002 111.895 -176.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 47.2 t -128.89 149.06 33.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 105.793 -1.929 . . . . 62.210000000000001 105.793 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.1 135.68 36.38 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 118.327 0.512 . . . . 63.539999999999999 110.941 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 42.9 m -159.46 169.75 9.92 Favored Pre-proline 0 C--N 1.31 -1.151 0 N-CA-C 107.623 -1.251 . . . . 52.240000000000002 107.623 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -73.12 -13.78 25.97 Favored 'Trans proline' 0 C--O 1.25 1.078 0 C-N-CA 122.004 1.803 . . . . 73.430000000000007 112.838 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.516 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 48.6 mtt180 -73.35 143.05 82.41 Favored Pre-proline 0 N--CA 1.442 -0.825 0 N-CA-C 108.988 -0.745 . . . . 74.129999999999995 108.988 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.71 144.6 97.36 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 122.5 2.133 . . . . 74.329999999999998 112.034 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.642 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.78 99.21 0.08 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.367 -0.833 . . . . 62.420000000000002 111.762 -178.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 153.56 -22.4 0.73 Allowed Glycine 0 N--CA 1.423 -2.185 0 C-N-CA 120.573 -0.823 . . . . 53.140000000000001 112.154 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . 0.516 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 32.6 tt0 -79.99 138.35 37.03 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 117.239 0.52 . . . . 74.040000000000006 109.97 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 5.1 p -91.97 113.2 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 N-CA-C 108.502 -0.925 . . . . 74.310000000000002 108.502 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.54 -33.25 73.78 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.199 -1.364 . . . . 72.420000000000002 110.189 -177.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 167.91 177.78 39.44 Favored Glycine 0 N--CA 1.42 -2.401 0 CA-C-N 115.089 -0.959 . . . . 63.329999999999998 110.959 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . 0.425 HG22 HD13 ' A' ' 553' ' ' LEU . 10.0 p -118.1 153.83 33.11 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 108.502 -0.925 . . . . 71.519999999999996 108.502 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -72.32 -48.01 10.08 Favored Pre-proline 0 C--N 1.318 -0.784 0 C-N-CA 118.235 -1.386 . . . . 75.340000000000003 110.246 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 32.3 Cg_exo -62.52 131.5 34.03 Favored 'Trans proline' 0 C--N 1.381 2.274 0 N-CA-C 108.529 -1.373 . . . . 61.299999999999997 108.529 169.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 8.3 Cg_exo -69.01 139.97 44.24 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 122.184 1.923 . . . . 75.319999999999993 114.732 -173.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -68.66 133.66 48.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.93 -1.032 . . . . 65.510000000000005 110.415 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 91.16 -19.29 47.45 Favored Glycine 0 C--N 1.306 -1.115 0 N-CA-C 110.839 -0.904 . . . . 53.420000000000002 110.839 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.2 m -87.82 139.46 30.5 Favored 'General case' 0 N--CA 1.413 -2.324 0 C-N-CA 123.623 0.769 . . . . 74.310000000000002 110.555 -175.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 3.4 t -72.45 124.6 25.51 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.662 -0.699 . . . . 64.239999999999995 109.323 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.72 163.82 36.68 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 107.236 -1.394 . . . . 73.340000000000003 107.236 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -76.46 135.3 16.32 Favored 'Trans proline' 0 N--CA 1.423 -2.642 0 CA-C-N 120.004 1.037 . . . . 72.099999999999994 111.715 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.711 ' HA ' HG22 ' A' ' 518' ' ' THR . 35.3 t -67.53 -24.91 31.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-N 114.122 -1.399 . . . . 61.43 110.46 176.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -78.19 -17.86 56.23 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.441 -1.254 . . . . 73.450000000000003 111.509 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 94.6 p -90.82 177.38 6.32 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.637 -0.425 . . . . 73.150000000000006 110.993 -177.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 12.9 p -109.07 126.31 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.831 0 CA-C-O 121.75 0.786 . . . . 72.209999999999994 109.908 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 63.1 mt -86.11 129.45 38.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 108.794 -0.817 . . . . 63.049999999999997 108.794 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -103.79 117.32 34.08 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.718 0.771 . . . . 75.140000000000001 110.664 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.425 HD13 HG22 ' A' ' 537' ' ' THR . 2.7 mm? -95.45 114.03 25.75 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.653 -1.612 . . . . 73.049999999999997 108.218 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -84.32 116.39 22.99 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.922 -0.77 . . . . 74.120000000000005 108.922 176.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 524' ' ' SER . 23.9 t -104.15 131.79 52.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 115.099 -0.955 . . . . 61.130000000000003 109.244 -175.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 74.1 m -84.76 122.22 28.8 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 109.621 -0.511 . . . . 43.130000000000003 109.621 175.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.0 ptpt -93.49 141.25 28.68 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 104.672 -2.344 . . . . 74.219999999999999 104.672 169.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.584 ' O ' ' HG3' ' A' ' 560' ' ' GLN . . . -66.46 -27.17 72.95 Favored Glycine 0 CA--C 1.488 -1.649 0 C-N-CA 120.138 -1.03 . . . . 44.340000000000003 110.652 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 64.4 t30 65.27 11.84 7.58 Favored 'General case' 0 C--O 1.216 -0.689 0 C-N-CA 124.697 1.199 . . . . 63.210000000000001 109.885 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.584 ' HG3' ' O ' ' A' ' 558' ' ' GLY . 40.9 mt-30 -124.68 142.85 51.09 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 115.478 -0.783 . . . . 51.439999999999998 109.21 -176.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . 0.407 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 53.6 p90 -123.34 148.24 46.21 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.389 -0.967 . . . . 71.120000000000005 108.389 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.1 122.14 14.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.144 0.497 . . . . 72.25 111.002 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.432 ' SD ' HD13 ' A' ' 620' ' ' ILE . 56.9 ttp -97.45 122.43 55.58 Favored Pre-proline 0 C--N 1.31 -1.133 0 CA-C-N 115.885 -0.598 . . . . 74.230000000000004 110.953 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -68.15 169.81 15.88 Favored 'Trans proline' 0 C--O 1.241 0.661 0 C-N-CA 123.065 2.51 . . . . 72.040000000000006 110.843 172.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . 0.443 ' HB3' ' HB2' ' A' ' 610' ' ' ALA . 5.8 p-10 -77.6 142.42 38.95 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.138 0.494 . . . . 75.120000000000005 110.569 -178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . 0.461 ' O ' ' HG2' ' A' ' 569' ' ' MET . 2.0 pt? -126.69 5.29 6.73 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 122.206 1.003 . . . . 73.209999999999994 108.91 174.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . 0.485 ' HA ' ' HB ' ' A' ' 603' ' ' VAL . 29.0 t -79.44 140.62 37.31 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 107.808 -1.182 . . . . 64.200000000000003 107.808 176.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 99.39 -2.46 57.6 Favored Glycine 0 C--N 1.302 -1.314 0 C-N-CA 120.018 -1.086 . . . . 74.109999999999999 112.878 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 24.0 ptp -120.06 169.35 10.29 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.561 -0.903 . . . . 73.340000000000003 108.561 177.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -92.59 171.59 8.92 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.004 -1.11 . . . . 70.420000000000002 108.004 -174.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -62.44 -32.87 73.79 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.69 -0.856 . . . . 74.129999999999995 108.69 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 30.7 m -68.9 -12.88 16.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 CA-C-N 116.076 -0.511 . . . . 43.140000000000001 112.107 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -102.27 -43.91 5.57 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 110.033 -0.358 . . . . 75.25 110.033 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -61.32 -39.5 90.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.799 -0.637 . . . . 74.109999999999999 112.235 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.658 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 44.0 tt0 -63.16 -53.36 54.87 Favored Pre-proline 0 CA--C 1.561 1.382 0 CA-C-N 116.622 -0.263 . . . . 74.120000000000005 111.494 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 92.7 Cg_exo -54.14 -40.43 81.87 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 121.547 1.498 . . . . 75.329999999999998 112.315 171.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.423 ' HA ' ' HE ' ' A' ' 577' ' ' ARG . 0.3 OUTLIER -59.24 -42.49 91.2 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.479 0.18 . . . . 64.319999999999993 110.634 178.428 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.5 pp -66.17 -46.85 75.94 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 120.359 -0.536 . . . . 62.229999999999997 111.716 -175.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.451 ' N ' HD12 ' A' ' 578' ' ' LEU . 1.7 ptm180 -66.24 -36.23 82.46 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.792 -0.64 . . . . 64.329999999999998 111.563 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -71.17 -37.99 72.18 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 112.367 0.506 . . . . 63.310000000000002 112.367 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.0 pp -80.65 -8.66 59.7 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.22 0.533 . . . . 72.430000000000007 110.496 -176.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 85.6 32.55 18.65 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 115.46 -0.791 . . . . 71.120000000000005 112.509 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -77.02 126.2 30.57 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 107.197 -1.408 . . . . 73.439999999999998 107.197 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 2.1 p -106.08 6.42 31.07 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 112.833 0.679 . . . . 54.109999999999999 112.833 -175.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -95.68 -152.96 29.68 Favored Glycine 0 N--CA 1.436 -1.338 0 N-CA-C 110.723 -0.951 . . . . 73.430000000000007 110.723 174.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 57.6 ttp -136.87 147.0 46.23 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.03 -1.1 . . . . 71.109999999999999 108.03 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . 0.448 HD21 HD11 ' A' ' 622' ' ' LEU . 6.0 tt -80.16 118.34 21.77 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.494 -0.928 . . . . 62.299999999999997 108.494 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 621' ' ' THR . 26.5 t70 -98.76 120.61 39.48 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.641 -0.708 . . . . 71.340000000000003 109.332 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.485 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.1 OUTLIER -98.5 133.21 43.18 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 119.194 -1.002 . . . . 73.310000000000002 108.724 176.447 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -85.2 -51.64 3.67 Favored Glycine 0 C--N 1.284 -2.35 0 N-CA-C 109.616 -1.394 . . . . 71.209999999999994 109.616 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -134.81 117.69 16.2 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 109.362 -0.607 . . . . 62.420000000000002 109.362 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -105.31 123.84 48.53 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.712 -1.218 . . . . 62.43 107.712 173.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 53.9 t -112.09 129.34 67.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 109.087 -0.708 . . . . 55.329999999999998 109.087 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . 0.42 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 23.3 t70 -72.67 114.47 10.84 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 108.798 -0.816 . . . . 61.310000000000002 108.798 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -124.27 -57.41 1.59 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.572 -0.74 . . . . 55.340000000000003 109.843 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 106.53 151.16 18.47 Favored Glycine 0 N--CA 1.423 -2.222 0 C-N-CA 120.062 -1.066 . . . . 60.310000000000002 110.863 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.498 ' HA2' ' OD1' ' A' ' 601' ' ' ASN . . . -58.77 -33.99 75.43 Favored Glycine 0 C--N 1.311 -0.811 0 N-CA-C 115.038 0.775 . . . . 43.32 115.038 -177.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 11.3 t -74.83 -23.91 58.53 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 122.125 0.964 . . . . 74.019999999999996 109.117 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -89.84 0.18 57.19 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.822 -1.081 . . . . 73.439999999999998 110.301 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 27.3 m170 78.41 85.67 0.07 Allowed 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 125.821 1.648 . . . . 60.310000000000002 109.789 -177.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . 0.498 ' OD1' ' HA2' ' A' ' 597' ' ' GLY . 26.0 p-10 -89.15 58.91 4.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 122.987 1.375 . . . . 75.239999999999995 110.428 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -97.16 163.59 12.86 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.893 -1.503 . . . . 74.310000000000002 108.431 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.485 ' HB ' ' HA ' ' A' ' 567' ' ' SER . 92.8 t -70.17 130.52 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 104.74 -2.318 . . . . 71.129999999999995 104.74 168.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 13.4 p -103.11 -35.52 3.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 121.289 0.566 . . . . 73.530000000000001 111.133 -173.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -146.1 134.62 22.05 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 109.147 -0.686 . . . . 74.150000000000006 109.147 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -115.78 131.93 56.79 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.402 -1.703 . . . . 74.150000000000006 106.402 174.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.453 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 20.8 t-20 -58.25 -51.7 79.87 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 112.376 0.51 . . . . 73.209999999999994 112.376 -175.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.1 Cg_endo -87.13 118.97 1.44 Allowed 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.234 1.289 . . . . 74.230000000000004 109.494 172.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -64.56 159.71 43.39 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 122.549 2.166 . . . . 64.299999999999997 111.906 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 565' ' ' ASP . . . -60.9 135.23 57.72 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.174 -0.466 . . . . 71.409999999999997 110.415 177.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.43 -11.94 47.3 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 111.35 -0.7 . . . . 73.129999999999995 111.35 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 34.2 m -82.1 136.75 35.14 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.592 -0.521 . . . . 75.530000000000001 109.592 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -77.33 123.13 6.36 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 110.271 -1.131 . . . . 63.020000000000003 110.271 175.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.6 m -113.62 142.38 26.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 109.643 -0.503 . . . . 64.120000000000005 109.643 178.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 559' ' ' ASN . 29.9 p30 -48.59 164.62 0.06 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.176 1.176 . . . . 74.040000000000006 114.176 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -57.74 -27.9 63.42 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.788 0.835 . . . . 72.329999999999998 112.629 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.444 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 4.4 p-10 -90.24 -9.37 48.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 119.486 -0.885 . . . . 72.430000000000007 110.459 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.11 14.86 62.1 Favored Glycine 0 CA--C 1.49 -1.503 0 C-N-CA 124.065 0.841 . . . . 61.340000000000003 114.685 163.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.05 117.66 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-O 122.566 1.174 . . . . 44.140000000000001 110.869 -167.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.432 HD13 ' SD ' ' A' ' 563' ' ' MET . 49.3 pt -129.81 135.28 61.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 113.755 -1.566 . . . . 71.239999999999995 110.37 -177.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 13.8 t -99.21 129.87 45.48 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 108.235 -1.024 . . . . 75.319999999999993 108.235 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.448 HD11 HD21 ' A' ' 587' ' ' LEU . 4.0 pp -138.76 167.13 22.65 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 116.136 -0.484 . . . . 75.340000000000003 111.462 -178.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -128.09 136.33 51.04 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.808 -0.812 . . . . 71.420000000000002 108.808 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.422 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 18.8 p90 -142.55 165.58 27.02 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 116.187 -0.46 . . . . 75.120000000000005 111.827 -172.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -86.73 132.47 11.17 Favored Glycine 0 N--CA 1.42 -2.407 0 N-CA-C 109.221 -1.552 . . . . 40.229999999999997 109.221 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.42 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 9.9 tt0 . . . . . 0 C--N 1.279 -2.463 0 C-N-CA 123.066 0.547 . . . . 38.009999999999998 109.593 -178.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.605 0 CA-C-O 121.599 0.714 . . . . 72.510000000000005 109.899 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 13.0 p -129.96 155.32 46.26 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 115.53 -0.759 . . . . 72.230000000000004 110.827 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -143.11 146.36 33.7 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.426 -0.806 . . . . 53.329999999999998 109.758 176.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.565 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.1 p-10 -91.56 140.03 30.12 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.094 -0.706 . . . . 73.019999999999996 109.094 177.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.4 pt -96.53 124.6 50.24 Favored Pre-proline 0 C--N 1.298 -1.664 0 CA-C-N 115.673 -0.694 . . . . 70.209999999999994 110.467 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -66.76 157.5 60.85 Favored 'Trans proline' 0 C--O 1.245 0.829 0 C-N-CA 122.475 2.117 . . . . 65.239999999999995 111.843 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . 0.429 ' HA ' ' HB1' ' A' ' 541' ' ' ALA . 27.1 t70 -77.65 99.98 6.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.587 0.708 . . . . 63.210000000000001 109.704 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 30.3 m -105.63 11.14 8.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 114.96 -1.018 . . . . 74.120000000000005 112.169 -175.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -80.01 96.96 6.59 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.036 0.445 . . . . 53.310000000000002 110.798 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 162.38 -40.93 0.37 Allowed Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.777 -0.725 . . . . 74.319999999999993 111.914 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 16.1 pm0 -90.77 -171.89 3.19 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 110.251 -0.277 . . . . 74.549999999999997 110.251 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 28.1 m -70.1 155.0 41.23 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.818 -0.808 . . . . 52.210000000000001 108.818 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.42 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.2 p -62.48 -41.63 92.62 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 O-C-N 123.075 0.235 . . . . 44.439999999999998 110.722 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -59.4 -40.83 87.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.385 0.612 . . . . 74.299999999999997 109.645 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.436 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 75.4 t -71.88 -45.95 62.61 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.608 0 CA-C-N 115.292 -0.867 . . . . 74.109999999999999 110.057 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.463 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -58.85 -44.34 90.99 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 111.917 0.34 . . . . 73.209999999999994 111.917 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.6 mt-30 -62.42 -45.79 91.53 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.295 -0.411 . . . . 43.32 110.957 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.568 ' O ' HG23 ' A' ' 514' ' ' VAL . 16.6 ptpt -67.97 -38.82 83.19 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 120.486 -0.485 . . . . 75.299999999999997 110.175 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -60.84 -47.36 86.7 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 116.056 -0.52 . . . . 74.340000000000003 110.86 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 513' ' ' ASN . 3.9 pp -68.48 -35.73 77.95 Favored 'General case' 0 C--O 1.211 -0.923 0 CA-C-N 115.863 -0.608 . . . . 64.200000000000003 111.154 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.48 ' N ' HD12 ' A' ' 512' ' ' LEU . 4.1 t-20 -66.02 -34.86 79.06 Favored 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 123.287 0.635 . . . . 74.219999999999999 111.99 -178.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 510' ' ' LYS . 89.1 t -57.0 -32.42 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 121.491 0.663 . . . . 65.409999999999997 110.354 177.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -114.45 17.26 17.5 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.757 -0.656 . . . . 70.140000000000001 109.666 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -138.09 -55.03 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 119.923 -1.132 . . . . 63.210000000000001 113.57 -174.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 66.87 17.85 10.58 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.277 1.037 . . . . 73.349999999999994 109.922 -176.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.7 p -78.13 -170.7 2.06 Favored 'General case' 0 N--CA 1.411 -2.401 0 C-N-CA 125.481 1.512 . . . . 65.319999999999993 111.492 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -108.24 143.12 37.5 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.013 -1.477 . . . . 74.230000000000004 107.013 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -132.7 150.43 52.16 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.242 -0.583 . . . . 74.450000000000003 111.938 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.2 m -140.83 146.29 37.37 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.98 -1.489 . . . . 71.409999999999997 106.98 175.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -118.08 136.01 53.83 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 120.13 -0.628 . . . . 74.010000000000005 110.104 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -130.29 131.95 45.67 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.624 -0.88 . . . . 55.100000000000001 108.624 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 73.1 m -100.18 131.36 46.17 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.542 0.687 . . . . 71.019999999999996 112.596 -178.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 556' ' ' SER . 7.4 p -121.78 149.27 25.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.373 -1.714 . . . . 72.519999999999996 106.373 176.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -76.83 135.63 38.9 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 121.49 0.662 . . . . 61.219999999999999 111.674 -176.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 50.3 m -162.79 156.09 17.0 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 106.338 -1.727 . . . . 61.32 106.338 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -63.93 -3.12 5.35 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 122.762 2.308 . . . . 74.239999999999995 114.288 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -80.12 136.58 53.62 Favored Pre-proline 0 CA--C 1.51 -0.587 0 N-CA-C 106.967 -1.494 . . . . 65.540000000000006 106.967 176.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -61.6 147.94 94.2 Favored 'Trans proline' 0 C--O 1.256 1.382 0 C-N-CA 122.343 2.028 . . . . 50.310000000000002 112.701 -175.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -56.61 115.89 2.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.292 -0.867 . . . . 61.509999999999998 110.88 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 134.21 -27.78 3.24 Favored Glycine 0 N--CA 1.434 -1.436 0 C-N-CA 120.825 -0.703 . . . . 45.329999999999998 111.643 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -80.85 135.68 35.97 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-O 121.254 0.549 . . . . 74.329999999999998 110.295 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.463 HG11 ' CB ' ' A' ' 508' ' ' ALA . 7.2 p -96.67 120.78 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.722 0 N-CA-C 107.702 -1.221 . . . . 73.129999999999995 107.702 178.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.2 p -97.74 -1.23 43.85 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.167 -0.924 . . . . 74.530000000000001 113.132 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 163.23 -166.56 37.13 Favored Glycine 0 N--CA 1.423 -2.219 0 C-N-CA 120.278 -0.963 . . . . 53.240000000000002 111.52 176.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 2.4 p -135.39 152.91 51.87 Favored 'General case' 0 C--N 1.273 -2.746 0 N-CA-C 107.866 -1.161 . . . . 65.439999999999998 107.866 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.48 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 62.0 t30 -58.29 -50.83 85.93 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 119.834 -0.747 . . . . 72.239999999999995 111.201 175.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 4.8 Cg_exo -81.36 128.47 6.27 Favored 'Trans proline' 0 C--N 1.37 1.676 0 N-CA-C 107.568 -1.743 . . . . 44.109999999999999 107.568 168.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.38 140.31 88.41 Favored 'Trans proline' 0 C--O 1.245 0.846 0 C-N-CA 122.42 2.08 . . . . 75.099999999999994 113.04 -176.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' A' ' 499' ' ' ASP . . . -64.82 138.65 58.51 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.91 -0.587 . . . . 71.549999999999997 110.122 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.72 -11.58 57.8 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 120.752 -0.737 . . . . 71.150000000000006 111.294 -176.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 18.4 m -88.32 137.49 32.28 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.167 -0.309 . . . . 75.530000000000001 110.167 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 13.3 t -81.16 129.79 34.73 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 109.233 -0.655 . . . . 51.100000000000001 109.233 173.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.5 m -123.83 164.13 30.95 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 107.315 -1.365 . . . . 73.519999999999996 107.315 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -68.23 139.38 45.88 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 120.936 1.09 . . . . 63.030000000000001 110.646 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.8 p -62.6 -20.3 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 CA-C-N 115.696 -0.684 . . . . 70.120000000000005 112.296 -175.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -93.31 -7.35 45.14 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.757 0.313 . . . . 54.399999999999999 110.916 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 69.9 m -82.06 165.69 20.4 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.697 0.761 . . . . 73.540000000000006 112.624 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.2 p -102.31 137.7 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.292 0 CA-C-N 114.697 -1.138 . . . . 54.140000000000001 109.554 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 60.2 mt -101.96 132.38 48.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.076 -1.083 . . . . 63.399999999999999 108.076 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -102.8 117.95 35.75 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.218 0.532 . . . . 61.409999999999997 110.541 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.421 HD12 HG21 ' A' ' 534' ' ' VAL . 3.6 mm? -88.31 114.47 24.97 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.394 -1.275 . . . . 72.310000000000002 108.522 178.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -83.27 101.7 11.45 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.226 -1.028 . . . . 74.409999999999997 108.226 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 524' ' ' SER . 17.2 t -96.06 144.18 10.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 107.541 -1.281 . . . . 73.310000000000002 107.541 -177.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 67.9 m -97.8 133.82 41.79 Favored 'General case' 0 N--CA 1.394 -3.245 0 C-N-CA 119.444 -0.902 . . . . 65.040000000000006 110.694 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -97.5 129.5 44.67 Favored 'General case' 0 N--CA 1.405 -2.706 0 N-CA-C 103.882 -2.636 . . . . 63.420000000000002 103.882 168.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -60.47 -23.92 61.02 Favored Glycine 0 CA--C 1.49 -1.507 0 O-C-N 123.923 0.764 . . . . 62.119999999999997 113.599 -173.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 79.95 -15.54 0.74 Allowed 'General case' 0 C--O 1.211 -0.967 0 C-N-CA 124.946 1.298 . . . . 71.430000000000007 107.87 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.469 ' H ' ' C ' ' A' ' 558' ' ' GLY . 92.7 mt-30 -112.62 145.04 41.09 Favored 'General case' 0 N--CA 1.402 -2.832 0 CA-C-N 114.71 -1.132 . . . . 73.200000000000003 110.496 -175.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . 0.43 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 48.5 p90 -123.84 154.53 39.49 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 107.193 -1.41 . . . . 71.010000000000005 107.193 177.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.25 121.89 16.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.018 0.437 . . . . 70.450000000000003 110.864 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.617 ' SD ' HG21 ' A' ' 620' ' ' ILE . 47.4 ttp -79.23 122.73 84.53 Favored Pre-proline 0 C--N 1.316 -0.86 0 N-CA-C 109.653 -0.499 . . . . 63.539999999999999 109.653 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.77 169.62 20.71 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.214 1.942 . . . . 72.310000000000002 111.006 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -72.01 118.18 14.55 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.536 0.684 . . . . 54.140000000000001 110.424 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.9 pp -136.11 11.55 3.32 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.206 -0.907 . . . . 75.120000000000005 110.477 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 2.2 t -80.24 144.15 33.14 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.318 -0.855 . . . . 65.340000000000003 109.985 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 80.82 70.01 1.36 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.643 -0.789 . . . . 42.140000000000001 113.58 175.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -163.91 179.85 6.76 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.345 -1.354 . . . . 72.349999999999994 107.345 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . 0.457 ' HB2' HG12 ' A' ' 572' ' ' VAL . 26.1 m-85 -95.14 176.4 6.24 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.567 -0.531 . . . . 71.5 109.567 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . 0.554 ' CZ3' HD22 ' A' ' 587' ' ' LEU . 11.6 t-105 -71.56 -28.1 63.62 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.989 -1.486 . . . . 74.409999999999997 106.989 175.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 570' ' ' PHE . 9.0 p -71.61 -6.72 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-N 115.429 -0.805 . . . . 72.310000000000002 110.264 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 6.7 m-20 -101.11 -45.06 5.5 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.341 -0.985 . . . . 65.120000000000005 108.341 171.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -63.21 -46.0 89.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.331 -0.849 . . . . 72.319999999999993 113.25 -176.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.501 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 31.4 tt0 -64.19 -49.94 70.69 Favored Pre-proline 0 CA--C 1.561 1.376 0 N-CA-C 111.838 0.31 . . . . 74.519999999999996 111.838 -177.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 51.5 Cg_exo -61.1 -34.42 89.7 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.675 1.583 . . . . 75.439999999999998 112.279 174.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 30.6 mmm180 -68.98 -33.97 74.55 Favored 'General case' 0 C--O 1.216 -0.663 0 C-N-CA 120.147 -0.621 . . . . 75.200000000000003 110.625 176.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.523 ' HG ' ' HB3' ' A' ' 583' ' ' TRP . 5.4 tt -60.41 -48.87 79.89 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.348 0.659 . . . . 74.510000000000005 109.363 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 576' ' ' PRO . 7.7 ptm180 -66.25 -41.09 90.44 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.914 0.339 . . . . 73.439999999999998 111.914 176.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.42 -37.01 82.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.152 -0.476 . . . . 72.329999999999998 112.168 -177.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.56 -9.28 54.86 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.154 0.502 . . . . 65.329999999999998 110.02 -177.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 70.52 46.66 46.63 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.768 -0.933 . . . . 71.129999999999995 110.768 -178.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.523 ' HB3' ' HG ' ' A' ' 578' ' ' LEU . 11.3 t90 -73.39 126.76 30.9 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 109.357 -0.608 . . . . 74.310000000000002 109.357 -177.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . 0.432 ' OG1' ' HA ' ' A' ' 617' ' ' ASP . 7.6 p -90.42 -24.38 20.77 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.409 -0.814 . . . . 53.240000000000002 112.101 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -85.19 -174.3 50.15 Favored Glycine 0 N--CA 1.432 -1.589 0 CA-C-N 116.076 -0.511 . . . . 61.140000000000001 113.075 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 27.4 ttt -117.33 149.04 41.14 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.967 -0.383 . . . . 60.439999999999998 109.967 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . 0.554 HD22 ' CZ3' ' A' ' 571' ' ' TRP . 6.1 tt -80.7 108.83 14.67 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.27 -1.382 . . . . 62.140000000000001 107.27 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.411 ' O ' ' HA ' ' A' ' 621' ' ' THR . 21.8 t70 -105.37 119.28 38.7 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.942 -0.572 . . . . 74.549999999999997 111.612 -177.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.1 OUTLIER -111.91 133.21 54.25 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.035 -1.098 . . . . 74.219999999999999 108.035 171.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -111.01 -5.13 27.26 Favored Glycine 0 C--N 1.297 -1.625 0 C-N-CA 120.096 -1.05 . . . . 65.109999999999999 112.83 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.35 130.57 26.7 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 121.137 -0.225 . . . . 73.109999999999999 110.743 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.35 124.2 31.02 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 123.907 0.755 . . . . 62.539999999999999 109.829 176.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . 0.508 ' O ' ' HA2' ' A' ' 625' ' ' GLY . 86.9 t -104.64 131.85 52.7 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 105.22 -2.141 . . . . 71.519999999999996 105.22 171.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -82.88 122.95 28.91 Favored 'General case' 0 C--N 1.281 -2.406 0 C-N-CA 118.681 -1.208 . . . . 72.329999999999998 110.93 -177.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -147.46 -68.86 0.24 Allowed 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.002 -1.453 . . . . 72.230000000000004 108.359 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 92.75 157.8 33.85 Favored Glycine 0 N--CA 1.417 -2.628 0 C-N-CA 119.827 -1.178 . . . . 54.210000000000001 110.985 -176.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -57.99 -37.63 86.06 Favored Glycine 0 C--N 1.291 -1.931 0 N-CA-C 115.441 0.936 . . . . 61.350000000000001 115.441 -176.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 36.4 m -76.11 -24.55 54.98 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-N 118.05 0.925 . . . . 74.450000000000003 110.628 -174.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -89.13 -0.04 57.12 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.601 -1.181 . . . . 72.329999999999998 111.458 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 40.1 m80 77.6 89.79 0.07 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.619 1.2 . . . . 74.25 109.833 -176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -81.62 85.99 6.46 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 113.93 -1.487 . . . . 74.010000000000005 109.964 -171.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -111.52 170.03 8.4 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.567 0.951 . . . . 70.109999999999999 113.567 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.419 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 99.3 t -77.72 133.27 30.88 Favored 'Isoleucine or valine' 0 C--O 1.248 0.995 0 CA-C-N 114.27 -1.332 . . . . 72.109999999999999 108.05 173.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.5 m -112.21 -42.42 4.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 120.285 -0.566 . . . . 71.530000000000001 112.36 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -144.69 151.04 38.32 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.969 -0.382 . . . . 72.209999999999994 109.969 -174.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 622' ' ' LEU . 16.4 pt20 -140.06 144.67 36.97 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 123.491 0.494 . . . . 50.240000000000002 110.355 177.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.43 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 58.4 t30 -64.77 -51.82 55.12 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-N 116.181 -0.463 . . . . 61.229999999999997 111.734 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.4 Cg_exo -85.21 115.74 1.69 Allowed 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 121.756 1.637 . . . . 73.310000000000002 110.134 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 11.5 Cg_exo -70.21 152.31 66.92 Favored 'Trans proline' 0 C--O 1.256 1.379 0 C-N-CA 122.401 2.067 . . . . 74.109999999999999 111.799 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -58.71 135.84 57.54 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.49 -0.559 . . . . 75.299999999999997 109.49 176.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 103.23 -7.36 51.61 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.571 -0.823 . . . . 60.039999999999999 111.908 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 28.0 m -93.78 144.46 25.39 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.237 -0.653 . . . . 63.409999999999997 109.237 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -70.34 131.22 22.08 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 111.952 -0.459 . . . . 73.239999999999995 111.952 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.7 m -124.56 141.64 44.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.917 -0.772 . . . . 74.420000000000002 108.917 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.414 ' N ' ' HG2' ' A' ' 560' ' ' GLN . 28.4 p-10 -51.52 171.72 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.204 1.402 . . . . 64.230000000000004 114.301 -176.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.68 -27.1 37.81 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.824 1.046 . . . . 52.219999999999999 113.824 -179.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.432 ' HA ' ' OG1' ' A' ' 584' ' ' THR . 11.0 m-20 -87.74 -8.18 56.36 Favored 'General case' 0 C--O 1.198 -1.632 0 C-N-CA 119.149 -1.02 . . . . 74.530000000000001 110.988 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.02 17.81 65.99 Favored Glycine 0 C--O 1.219 -0.784 0 C-N-CA 121.755 -0.259 . . . . 60.210000000000001 112.661 173.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.96 119.28 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 121.724 0.773 . . . . 72.209999999999994 110.726 -169.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.617 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.6 pp -123.76 133.29 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 115.29 -0.868 . . . . 64.109999999999999 112.546 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 14.2 t -102.86 122.48 44.63 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 122.118 0.961 . . . . 74.239999999999995 109.26 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -136.64 169.43 17.73 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.777 -1.101 . . . . 71.420000000000002 110.471 -173.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -125.95 135.84 52.33 Favored 'General case' 0 C--O 1.261 1.667 0 N-CA-C 107.866 -1.161 . . . . 75.109999999999999 107.866 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.419 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 3.7 p90 -142.98 169.05 18.29 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.783 -1.192 . . . . 74.310000000000002 107.783 -175.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 593' ' ' VAL . . . -49.47 109.5 0.62 Allowed Glycine 0 CA--C 1.544 1.896 0 O-C-N 124.193 0.933 . . . . 61.549999999999997 113.549 175.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 . . . . . 0 C--O 1.253 1.277 0 C-N-CA 125.816 1.646 . . . . 64.25 112.934 176.843 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.69 0 N-CA-C 112.976 0.732 . . . . 73.530000000000001 112.976 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 19.3 p -141.0 142.42 34.27 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.936 -0.478 . . . . 73.319999999999993 110.521 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -138.88 135.01 34.04 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.75 -0.833 . . . . 64.5 108.75 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.631 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.3 p-10 -83.66 144.99 29.03 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.186 0.517 . . . . 74.430000000000007 110.318 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.5 pt -90.38 116.92 67.5 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 115.13 -0.941 . . . . 62.420000000000002 111.086 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . 0.487 ' HD2' HD22 ' A' ' 512' ' ' LEU . 27.5 Cg_exo -66.2 160.57 44.3 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.484 2.122 . . . . 72.439999999999998 111.106 173.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -67.91 110.99 4.11 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.801 0.81 . . . . 74.450000000000003 110.423 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 14.2 m -130.27 65.17 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 122.757 1.265 . . . . 63.539999999999999 109.494 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -128.99 93.29 3.56 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 113.559 -1.655 . . . . 73.340000000000003 108.382 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 160.82 -38.73 0.43 Allowed Glycine 0 N--CA 1.428 -1.861 0 C-N-CA 119.905 -1.14 . . . . 54.539999999999999 112.787 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.555 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.3 OUTLIER -89.71 -170.27 2.76 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 110.231 -0.285 . . . . 74.340000000000003 110.231 -178.784 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.52 ' HB ' HG23 ' A' ' 507' ' ' VAL . 21.3 m -71.79 155.58 40.28 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.15 -0.685 . . . . 62.409999999999997 109.15 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.6 p -60.38 -41.77 88.48 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.587 0 O-C-N 123.243 0.34 . . . . 73.219999999999999 111.391 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.77 -40.7 97.34 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 109.684 -0.487 . . . . 74.450000000000003 109.684 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . 0.52 HG23 ' HB ' ' A' ' 504' ' ' THR . 47.8 t -67.03 -42.88 89.09 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.177 0 N-CA-C 109.073 -0.714 . . . . 64.019999999999996 109.073 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.609 ' HB2' HG11 ' A' ' 534' ' ' VAL . . . -59.34 -45.55 91.05 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.855 0.36 . . . . 75.340000000000003 110.959 177.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 26.0 mt-30 -65.32 -42.58 92.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.66 -0.7 . . . . 55.299999999999997 110.689 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.61 ' O ' HG23 ' A' ' 514' ' ' VAL . 45.0 mmtm -61.63 -45.69 92.97 Favored 'General case' 0 CA--C 1.495 -1.152 0 O-C-N 123.392 0.433 . . . . 65.129999999999995 110.122 177.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -61.88 -41.49 97.92 Favored 'General case' 0 N--CA 1.435 -1.221 0 O-C-N 123.821 0.701 . . . . 72.329999999999998 110.89 -176.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.487 HD22 ' HD2' ' A' ' 498' ' ' PRO . 0.2 OUTLIER -68.04 -46.62 70.63 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.859 -1.064 . . . . 63.119999999999997 108.208 -179.196 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -61.7 -35.87 79.28 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 124.001 0.92 . . . . 64.150000000000006 111.612 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 510' ' ' LYS . 89.6 t -57.62 -38.97 67.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 O-C-N 123.269 0.356 . . . . 74.340000000000003 111.525 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -105.21 -3.73 22.57 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.458 0.647 . . . . 74.040000000000006 109.523 -176.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -116.33 -58.64 0.32 Allowed Glycine 0 N--CA 1.42 -2.4 0 CA-C-N 115.473 -0.785 . . . . 71.129999999999995 113.828 -170.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 63.31 26.78 15.2 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 122.351 1.072 . . . . 75.319999999999993 110.212 -172.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.4 p -83.46 -177.14 6.62 Favored 'General case' 0 N--CA 1.403 -2.817 0 CA-C-N 113.872 -1.513 . . . . 71.109999999999999 109.447 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -107.99 139.69 42.24 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.371 -1.344 . . . . 64.129999999999995 107.371 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -129.2 149.07 51.16 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-O 121.117 0.485 . . . . 63.130000000000003 111.255 -176.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.3 m -139.97 152.44 46.32 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 106.688 -1.597 . . . . 71.030000000000001 106.688 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -122.84 142.07 51.16 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 112.51 0.559 . . . . 71.219999999999999 112.51 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -132.26 143.33 49.84 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.086 -1.45 . . . . 63.009999999999998 107.086 176.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 80.2 p -103.14 138.11 40.41 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.427 -0.909 . . . . 63.0 111.676 -175.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.9 p -121.43 149.64 24.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 106.547 -1.649 . . . . 71.140000000000001 106.547 177.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -72.32 136.93 46.34 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.521 -0.548 . . . . 74.230000000000004 109.521 -177.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.468 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 56.6 m -153.51 160.07 31.37 Favored Pre-proline 0 C--N 1.291 -1.971 0 N-CA-C 107.768 -1.197 . . . . 73.120000000000005 107.768 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.32 -2.75 12.96 Favored 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 121.865 1.71 . . . . 73.319999999999993 113.09 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.18 152.02 38.56 Favored Pre-proline 0 N--CA 1.451 -0.412 0 N-CA-C 109.624 -0.51 . . . . 71.340000000000003 109.624 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -57.34 146.61 81.85 Favored 'Trans proline' 0 C--O 1.25 1.087 0 C-N-CA 122.96 2.44 . . . . 72.430000000000007 113.458 -177.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.708 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.16 99.83 0.11 Allowed 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 114.943 -1.026 . . . . 73.319999999999993 111.651 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 157.82 -23.09 0.4 Allowed Glycine 0 C--N 1.3 -1.464 0 CA-C-N 115.758 -0.656 . . . . 74.439999999999998 111.874 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -74.38 144.74 44.25 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.349 -0.982 . . . . 74.230000000000004 108.349 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.609 HG11 ' HB2' ' A' ' 508' ' ' ALA . 11.0 p -91.38 118.6 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.413 0 CA-C-O 121.854 0.835 . . . . 64.430000000000007 108.779 176.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.83 -23.59 60.79 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.514 -1.221 . . . . 61.439999999999998 109.374 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 138.99 -152.8 22.41 Favored Glycine 0 N--CA 1.421 -2.305 0 N-CA-C 110.581 -1.007 . . . . 63.049999999999997 110.581 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.0 p -116.48 157.93 24.4 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 109.71 -0.478 . . . . 71.209999999999994 109.71 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.461 ' HB2' HE22 ' A' ' 554' ' ' GLN . 26.5 t-20 -66.45 -53.68 28.79 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 120.236 -0.586 . . . . 74.129999999999995 110.261 173.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 37.0 Cg_endo -67.71 149.82 79.03 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 121.319 1.346 . . . . 62.229999999999997 109.767 173.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 23.5 Cg_exo -64.04 139.36 66.85 Favored 'Trans proline' 0 C--O 1.246 0.923 0 C-N-CA 121.659 1.572 . . . . 70.120000000000005 113.02 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.97 137.43 55.13 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-N 115.204 -0.907 . . . . 61.399999999999999 110.178 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 93.81 -11.8 70.42 Favored Glycine 0 N--CA 1.442 -0.967 0 C-N-CA 121.092 -0.575 . . . . 61.140000000000001 111.668 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 51.8 m -88.52 137.83 31.97 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 122.745 0.418 . . . . 72.120000000000005 110.358 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.9 t -74.74 136.83 41.74 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.95 -0.568 . . . . 62.100000000000001 109.729 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.3 m -130.89 154.46 81.96 Favored Pre-proline 0 C--N 1.312 -1.064 0 N-CA-C 108.161 -1.051 . . . . 64.319999999999993 108.161 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -61.72 136.88 65.02 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.15 1.233 . . . . 54.399999999999999 111.202 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 13.3 p -65.99 -23.22 31.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.724 0.773 . . . . 64.140000000000001 111.872 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -78.06 -17.41 57.04 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.096 -0.502 . . . . 74.530000000000001 110.75 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 25.2 t -78.29 162.54 26.44 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.885 0.85 . . . . 74.239999999999995 111.499 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.8 p -98.64 137.74 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.388 0 CA-C-N 114.246 -1.343 . . . . 74.549999999999997 108.282 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 61.7 mt -100.88 137.53 28.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.168 -0.678 . . . . 74.409999999999997 109.168 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -103.24 117.78 35.29 Favored 'General case' 0 C--O 1.254 1.336 0 N-CA-C 108.816 -0.809 . . . . 73.519999999999996 108.816 -177.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -101.49 120.36 40.17 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 123.735 0.814 . . . . 71.319999999999993 109.624 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.461 HE22 ' HB2' ' A' ' 538' ' ' ASN . 2.8 mp0 -86.52 123.17 31.43 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 121.17 0.51 . . . . 73.430000000000007 110.795 178.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 39.6 t -96.01 132.19 40.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.781 -1.192 . . . . 61.149999999999999 107.781 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.708 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 13.0 m -79.7 117.35 20.53 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 107.033 -1.469 . . . . 52.140000000000001 107.033 176.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 21.3 pttm -107.52 128.78 54.82 Favored 'General case' 0 N--CA 1.422 -1.869 0 C-N-CA 119.566 -0.854 . . . . 72.319999999999993 108.838 173.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 527' ' ' SER . . . -58.61 -24.83 57.5 Favored Glycine 0 CA--C 1.501 -0.79 0 O-C-N 124.462 1.101 . . . . 74.340000000000003 113.993 -175.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 73.93 -0.16 3.44 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.995 1.318 . . . . 73.219999999999999 109.8 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.478 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 70.3 mt-30 -113.74 149.63 34.54 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 115.661 -0.699 . . . . 72.040000000000006 111.971 -174.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -124.12 158.79 31.47 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.454 -1.248 . . . . 64.299999999999997 108.351 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.15 126.94 37.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.336 0.589 . . . . 53.450000000000003 110.516 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 18.8 ttt -78.21 125.15 85.47 Favored Pre-proline 0 N--CA 1.432 -1.344 0 C-N-CA 124.542 1.137 . . . . 52.439999999999998 111.436 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.66 169.43 22.58 Favored 'Trans proline' 0 C--O 1.245 0.869 0 C-N-CA 122.805 2.336 . . . . 74.040000000000006 111.125 174.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.79 116.79 26.19 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.86 0.838 . . . . 75.510000000000005 111.36 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . 0.441 ' H ' HD23 ' A' ' 566' ' ' LEU . 2.1 pt? -117.64 9.11 13.01 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.204 -1.406 . . . . 70.219999999999999 107.204 170.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 22.0 t -80.65 147.22 30.77 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 114.211 -1.359 . . . . 62.409999999999997 107.953 176.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 66.75 56.74 11.68 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 121.357 -0.449 . . . . 55.140000000000001 112.897 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 22.9 ptp -168.49 179.76 4.23 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.165 -1.791 . . . . 75.099999999999994 106.165 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . 0.457 ' HB2' HG12 ' A' ' 572' ' ' VAL . 52.3 m-85 -100.1 170.45 8.47 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.06 -0.719 . . . . 73.239999999999995 109.06 -176.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . 0.427 ' CH2' HD22 ' A' ' 587' ' ' LEU . 12.1 t-105 -65.63 -27.53 68.45 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 108.569 -0.9 . . . . 52.43 108.569 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 570' ' ' PHE . 14.6 p -71.16 -13.2 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 115.735 -0.666 . . . . 73.230000000000004 110.479 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -99.41 -35.87 9.77 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 109.017 -0.735 . . . . 73.310000000000002 109.017 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . 0.64 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -62.64 -39.61 94.41 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 115.323 -0.853 . . . . 74.049999999999997 110.397 177.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.416 ' HB3' ' CD ' ' A' ' 576' ' ' PRO . 2.5 tm-20 -51.3 -59.13 8.42 Favored Pre-proline 0 CA--C 1.585 2.303 0 C-N-CA 124.138 0.975 . . . . 75.340000000000003 110.57 -178.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.416 ' CD ' ' HB3' ' A' ' 575' ' ' GLU . 19.8 Cg_endo -61.57 -32.49 87.78 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 121.891 1.727 . . . . 61.409999999999997 113.013 175.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 7.6 mmp_? -61.98 -41.25 97.82 Favored 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 120.593 -0.443 . . . . 74.409999999999997 110.726 177.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 16.8 mt -65.99 -46.39 78.19 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-O 120.782 0.325 . . . . 62.210000000000001 110.465 -175.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -65.76 -39.73 91.34 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 112.472 0.545 . . . . 73.049999999999997 112.472 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -69.17 -33.61 73.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.878 0.371 . . . . 62.399999999999999 111.247 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.3 tp -81.01 -10.16 59.74 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 121.471 0.653 . . . . 55.350000000000001 110.156 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 62.0 35.6 91.65 Favored Glycine 0 C--O 1.224 -0.496 0 CA-C-N 115.961 -0.563 . . . . 54.310000000000002 112.569 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.477 ' CE3' HD22 ' A' ' 578' ' ' LEU . 18.4 t90 -78.83 126.68 31.03 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.638 -0.504 . . . . 74.140000000000001 109.638 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 12.9 t -109.39 6.62 24.49 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 111.966 0.358 . . . . 63.219999999999999 111.966 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -89.11 -171.82 45.8 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 119.955 -1.117 . . . . 73.420000000000002 111.261 176.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 94.4 mmm -105.05 139.16 40.15 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 116.749 0.274 . . . . 61.32 110.375 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . 0.427 HD22 ' CH2' ' A' ' 571' ' ' TRP . 6.4 tt -80.64 110.01 15.72 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 107.354 -1.35 . . . . 74.120000000000005 107.354 176.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.509 ' O ' ' HA ' ' A' ' 621' ' ' THR . 30.6 t70 -95.65 114.23 25.95 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.909 -1.041 . . . . 72.209999999999994 109.679 -178.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.452 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -110.9 134.78 52.28 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 108.172 -1.047 . . . . 73.040000000000006 108.172 177.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -101.07 -89.69 2.07 Favored Glycine 0 C--N 1.268 -3.197 0 CA-C-N 115.306 -0.861 . . . . 43.43 112.646 -175.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -99.63 149.15 23.58 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.025 0.44 . . . . 73.219999999999999 111.665 -176.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -93.45 139.18 31.0 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.395 -0.965 . . . . 71.040000000000006 108.395 176.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 39.5 t -105.11 153.96 6.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 109.014 -0.735 . . . . 74.420000000000002 109.014 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -73.11 119.2 17.02 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 121.599 0.714 . . . . 75.430000000000007 109.728 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -143.46 -65.35 0.38 Allowed 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.154 -1.424 . . . . 73.299999999999997 107.154 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 100.05 158.8 28.34 Favored Glycine 0 N--CA 1.4 -3.753 0 C-N-CA 119.967 -1.111 . . . . 70.530000000000001 112.074 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.23 -32.38 60.19 Favored Glycine 0 C--N 1.302 -1.324 0 C-N-CA 123.689 0.662 . . . . 45.450000000000003 113.514 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 26.8 t -69.5 -23.91 63.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 122.057 0.932 . . . . 61.200000000000003 109.828 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 55.9 mm-40 -100.96 -12.09 19.2 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.553 -0.748 . . . . 73.120000000000005 109.712 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 43.7 m80 67.11 172.69 0.26 Allowed 'General case' 0 C--O 1.242 0.658 0 C-N-CA 124.603 1.161 . . . . 75.129999999999995 111.824 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -89.55 84.85 6.39 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 112.526 0.565 . . . . 72.209999999999994 112.526 -174.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 624' ' ' PHE . 48.0 mtp180 -91.08 145.96 24.24 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.09 -0.959 . . . . 73.540000000000006 110.542 176.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.403 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 59.5 t -74.43 130.51 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 105.904 -1.887 . . . . 53.409999999999997 105.904 173.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 73.8 t -102.96 -59.91 3.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-O 120.738 0.304 . . . . 65.409999999999997 111.206 -173.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -144.61 141.05 29.13 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.162 -0.472 . . . . 74.150000000000006 110.037 -172.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.56 160.89 22.29 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 107.251 -1.389 . . . . 71.340000000000003 107.251 176.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.526 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 3.2 t-20 -67.03 -52.61 30.16 Favored Pre-proline 0 C--N 1.312 -1.034 0 N-CA-C 109.689 -0.486 . . . . 75.040000000000006 109.689 171.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.2 Cg_exo -87.47 122.8 1.78 Allowed 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 121.589 1.526 . . . . 63.140000000000001 110.91 173.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -67.26 158.39 57.18 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.184 1.923 . . . . 31.399999999999999 110.874 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.5 127.63 33.44 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.79 -0.448 . . . . 73.430000000000007 109.79 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.31 -0.02 40.64 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.713 -0.756 . . . . 71.5 112.091 -177.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 10.2 m -92.32 166.34 12.63 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.81 -0.811 . . . . 54.329999999999998 108.81 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -90.73 130.69 10.39 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.91 -0.662 . . . . 74.400000000000006 112.082 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.4 m -125.05 141.93 43.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.783 -0.821 . . . . 75.340000000000003 108.783 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.478 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.9 p-10 -62.42 179.28 0.33 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.437 0.902 . . . . 60.109999999999999 113.437 -175.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -61.03 -25.78 67.15 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.375 -0.375 . . . . 70.129999999999995 112.0 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.497 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 34.5 t70 -83.18 -9.45 59.16 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.091 -0.707 . . . . 75.129999999999995 109.091 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . 0.418 ' HA3' ' CD1' ' A' ' 583' ' ' TRP . . . 64.9 15.9 60.89 Favored Glycine 0 CA--C 1.492 -1.355 0 CA-C-N 115.195 -0.911 . . . . 73.540000000000006 113.704 168.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.58 119.13 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 CA-C-O 122.974 1.368 . . . . 70.129999999999995 113.255 -164.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.448 HG22 ' HG2' ' A' ' 608' ' ' PRO . 48.1 pt -123.47 133.09 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 CA-C-N 113.42 -1.718 . . . . 61.039999999999999 108.581 177.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 12.1 t -109.86 124.93 52.19 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.419 -0.956 . . . . 63.399999999999999 108.419 177.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.38 167.17 21.53 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 113.229 0.826 . . . . 75.099999999999994 113.229 -176.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -127.21 137.52 52.92 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.501 -1.227 . . . . 74.019999999999996 107.86 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 602' ' ' ARG . 15.1 p90 -139.35 166.7 23.85 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.486 -0.325 . . . . 64.209999999999994 111.162 -175.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -57.93 145.61 40.18 Favored Glycine 0 N--CA 1.447 -0.621 0 O-C-N 123.978 0.799 . . . . 75.430000000000007 114.412 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 . . . . . 0 C--N 1.308 -1.232 0 C-N-CA 124.391 1.076 . . . . 73.109999999999999 109.924 177.654 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.479 0 CA-C-O 121.873 0.844 . . . . 70.239999999999995 110.996 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 5.9 p -140.59 144.59 35.9 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.787 -1.19 . . . . 61.340000000000003 107.787 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -139.03 135.51 34.31 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 108.806 -0.813 . . . . 74.510000000000005 108.806 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.563 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.4 p-10 -81.53 133.99 35.46 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.885 -0.598 . . . . 52.310000000000002 109.936 177.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.0 pt -89.63 131.23 40.52 Favored Pre-proline 0 C--N 1.291 -1.945 0 CA-C-N 115.061 -0.972 . . . . 71.230000000000004 110.993 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.49 -174.4 2.11 Favored 'Trans proline' 0 C--O 1.251 1.144 0 C-N-CA 121.966 1.777 . . . . 73.209999999999994 110.011 174.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -85.38 117.17 24.14 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.002 0.906 . . . . 65.040000000000006 110.773 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.466 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 16.6 m -117.58 66.29 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.38 0 CA-C-O 123.277 1.513 . . . . 72.25 108.487 172.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -129.75 109.55 11.05 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 112.018 -2.355 . . . . 72.099999999999994 107.369 174.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 138.44 -20.05 3.16 Favored Glycine 0 C--N 1.299 -1.477 0 C-N-CA 119.837 -1.173 . . . . 41.219999999999999 112.956 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.471 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.0 OUTLIER -107.44 -173.88 2.4 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 117.484 0.642 . . . . 72.140000000000001 110.087 178.416 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 10.0 m -75.99 155.99 34.48 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.229 -1.026 . . . . 63.009999999999998 108.229 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.444 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 6.0 p -57.5 -46.59 85.98 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 111.801 0.297 . . . . 74.319999999999993 111.801 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -64.33 -37.93 89.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.308 0.575 . . . . 65.219999999999999 110.559 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 97.7 t -68.04 -42.42 85.23 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.982 0 CA-C-N 115.231 -0.895 . . . . 73.329999999999998 109.554 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.519 ' HB2' HG11 ' A' ' 534' ' ' VAL . . . -62.34 -45.36 93.56 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 122.298 0.239 . . . . 71.430000000000007 110.87 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 22.9 mt-30 -64.89 -45.81 84.38 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.458 -0.337 . . . . 74.530000000000001 111.261 -178.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.473 ' O ' HG23 ' A' ' 514' ' ' VAL . 0.0 OUTLIER -67.27 -38.92 85.88 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 120.473 -0.491 . . . . 74.120000000000005 110.716 179.165 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -63.2 -45.61 90.88 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 121.152 0.501 . . . . 73.209999999999994 110.479 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -62.17 -42.19 99.03 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 108.172 -1.047 . . . . 65.140000000000001 108.172 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -59.7 -34.95 73.55 Favored 'General case' 0 N--CA 1.428 -1.561 0 C-N-CA 123.613 0.765 . . . . 70.230000000000004 112.54 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 510' ' ' LYS . 75.2 t -57.89 -34.44 48.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-O 121.682 0.753 . . . . 72.450000000000003 110.866 177.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -104.47 -6.49 20.61 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.49 0.662 . . . . 74.519999999999996 109.763 -177.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -114.8 -66.59 0.43 Allowed Glycine 0 N--CA 1.416 -2.686 0 CA-C-N 115.352 -0.84 . . . . 52.420000000000002 113.425 -171.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 64.31 30.01 13.51 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 122.8 1.285 . . . . 74.219999999999999 109.07 -168.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 10.7 p -88.99 -175.35 4.8 Favored 'General case' 0 N--CA 1.409 -2.516 0 CA-C-N 112.954 -1.93 . . . . 71.430000000000007 109.545 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 13.5 mptt -108.24 143.47 37.02 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.131 -1.063 . . . . 73.099999999999994 108.131 177.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -132.41 157.14 45.3 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.364 0.602 . . . . 72.219999999999999 112.493 -175.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 62.3 m -140.42 150.16 43.5 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.716 -1.216 . . . . 50.420000000000002 107.716 174.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -123.82 138.18 54.54 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 120.713 0.292 . . . . 64.349999999999994 110.493 -176.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -136.33 143.23 44.02 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.712 -0.848 . . . . 72.510000000000005 108.712 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 45.5 m -97.17 135.13 39.56 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.404 1.097 . . . . 63.450000000000003 111.906 -178.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.43 153.01 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.813 0 CA-C-N 113.028 -1.897 . . . . 53.32 107.023 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -90.58 133.92 34.75 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.774 -0.77 . . . . 70.150000000000006 109.704 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.572 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 69.0 m -162.26 162.8 19.38 Favored Pre-proline 0 C--O 1.202 -1.438 0 N-CA-C 107.926 -1.138 . . . . 73.439999999999998 107.926 177.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -68.27 -3.93 11.79 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 122.194 1.929 . . . . 74.040000000000006 113.157 177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.402 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 25.2 mmm180 -79.48 136.66 55.9 Favored Pre-proline 0 N--CA 1.425 -1.69 0 N-CA-C 107.948 -1.13 . . . . 73.239999999999995 107.948 178.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -59.34 147.98 88.6 Favored 'Trans proline' 0 C--O 1.247 0.927 0 C-N-CA 123.047 2.498 . . . . 72.310000000000002 113.391 -175.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.709 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.72 108.12 0.8 Allowed 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.391 -0.822 . . . . 52.109999999999999 111.232 -177.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 131.62 -21.05 4.54 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 115.387 -0.824 . . . . 45.32 111.203 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.65 137.21 36.32 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.638 -0.875 . . . . 64.0 108.638 178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.519 HG11 ' HB2' ' A' ' 508' ' ' ALA . 10.3 p -91.42 121.43 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.719 0 CA-C-O 121.939 0.875 . . . . 63.219999999999999 109.207 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.474 HG23 ' HB2' ' A' ' 556' ' ' SER . 2.5 p -79.47 -16.56 55.88 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.774 -1.103 . . . . 75.5 111.174 176.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.405 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 145.98 -162.7 28.35 Favored Glycine 0 N--CA 1.425 -2.082 0 C-N-CA 120.774 -0.727 . . . . 75.049999999999997 112.18 175.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.9 p -116.26 157.68 24.55 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.646 -1.242 . . . . 72.340000000000003 107.646 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.405 ' HB3' ' CD ' ' A' ' 552' ' ' GLU . 23.5 t-20 -63.38 -49.4 79.1 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 118.634 -1.226 . . . . 73.519999999999996 112.279 178.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -71.48 136.11 27.88 Favored 'Trans proline' 0 C--N 1.364 1.347 0 N-CA-C 108.705 -1.306 . . . . 70.019999999999996 108.705 170.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -66.12 159.34 50.0 Favored 'Trans proline' 0 C--O 1.248 0.984 0 C-N-CA 122.324 2.016 . . . . 74.430000000000007 113.199 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.96 139.19 58.74 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.756 -0.656 . . . . 71.310000000000002 109.86 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.81 -19.67 51.22 Favored Glycine 0 N--CA 1.432 -1.585 0 N-CA-C 111.781 -0.528 . . . . 71.219999999999999 111.781 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 17.5 m -74.13 129.06 37.1 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 110.354 -0.239 . . . . 64.230000000000004 110.354 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 14.6 t -82.7 126.76 32.73 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-O 121.578 0.704 . . . . 51.0 109.388 175.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.3 m -123.81 155.52 66.61 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 107.716 -1.216 . . . . 64.400000000000006 107.716 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -61.69 137.65 69.97 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 120.973 1.115 . . . . 75.030000000000001 111.531 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.26 -20.23 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.961 0.886 . . . . 61.340000000000003 110.655 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -87.72 -18.07 30.3 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.143 -0.935 . . . . 75.299999999999997 111.647 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 85.1 p -89.89 175.05 7.36 Favored 'General case' 0 C--O 1.252 1.235 0 N-CA-C 113.453 0.909 . . . . 73.129999999999995 113.453 -172.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 11.1 p -96.93 138.6 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 CA-C-N 114.281 -1.327 . . . . 73.540000000000006 111.175 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.4 mt -114.52 137.96 46.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.791 -1.189 . . . . 71.530000000000001 107.791 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . 0.405 ' CD ' ' HB3' ' A' ' 538' ' ' ASN . 1.7 pm0 -103.39 128.69 50.45 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.788 0.804 . . . . 72.450000000000003 112.188 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.86 122.03 42.74 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.678 -1.601 . . . . 72.400000000000006 108.876 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -88.23 113.2 23.61 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.53 0.681 . . . . 62.409999999999997 110.344 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 524' ' ' SER . 18.2 t -93.07 122.96 44.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 107.341 -1.355 . . . . 71.430000000000007 107.341 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.709 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 48.5 t -81.92 131.95 35.26 Favored 'General case' 0 N--CA 1.405 -2.681 0 N-CA-C 108.797 -0.816 . . . . 51.539999999999999 108.797 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -95.11 141.55 28.61 Favored 'General case' 0 N--CA 1.412 -2.363 0 N-CA-C 105.526 -2.028 . . . . 75.349999999999994 105.526 168.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -56.05 -23.94 41.15 Favored Glycine 0 CA--C 1.499 -0.952 0 O-C-N 124.48 1.112 . . . . 44.130000000000003 112.564 -177.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.2 t30 68.16 20.98 8.77 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-O 123.129 1.442 . . . . 74.310000000000002 109.026 174.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.589 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 66.7 mt-30 -141.79 164.54 29.93 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 113.094 -1.866 . . . . 75.120000000000005 107.117 178.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -143.23 151.65 40.84 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.785 -1.191 . . . . 65.010000000000005 107.785 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 13.6 p -70.45 132.23 33.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 121.01 0.433 . . . . 73.109999999999999 110.116 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.415 ' SD ' HG21 ' A' ' 620' ' ' ILE . 44.2 ttp -91.15 109.52 36.04 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 108.405 -0.961 . . . . 72.430000000000007 108.405 175.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.75 160.24 44.62 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.478 2.118 . . . . 73.450000000000003 110.897 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -73.8 115.06 12.79 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.971 0.891 . . . . 73.120000000000005 112.329 -178.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.7 pp -135.3 18.98 3.38 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.096 -1.411 . . . . 75.349999999999994 107.789 174.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 8.7 t -74.41 136.89 42.39 Favored 'General case' 0 N--CA 1.417 -2.08 0 CA-C-N 114.603 -1.18 . . . . 75.519999999999996 108.902 -175.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . 0.473 ' HA2' ' CZ ' ' A' ' 602' ' ' ARG . . . 113.96 50.28 0.51 Allowed Glycine 0 N--CA 1.42 -2.377 0 CA-C-N 115.546 -0.752 . . . . 73.430000000000007 111.914 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 19.8 ptp -142.17 173.36 11.59 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 120.099 -0.64 . . . . 64.340000000000003 110.246 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -98.61 175.63 5.93 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.987 -1.116 . . . . 73.0 107.987 -177.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 38.3 t-105 -68.82 -29.91 68.35 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.188 -0.671 . . . . 74.409999999999997 109.188 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.38 -15.64 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 115.579 -0.737 . . . . 55.420000000000002 110.299 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.595 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 9.0 m-20 -96.5 -44.69 7.06 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 108.44 -0.948 . . . . 64.239999999999995 108.44 176.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.98 -45.86 90.44 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.705 -1.134 . . . . 74.129999999999995 113.529 -174.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.514 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 35.4 tt0 -60.46 -50.46 85.54 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 120.664 -0.414 . . . . 61.340000000000003 111.828 -177.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 51.5 Cg_exo -58.88 -28.46 87.39 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 121.469 1.446 . . . . 74.5 111.576 173.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.672 ' O ' ' HB3' ' A' ' 581' ' ' LEU . 17.0 mmt180 -62.88 -38.45 90.92 Favored 'General case' 0 C--O 1.204 -1.324 0 CA-C-O 118.306 -0.854 . . . . 74.200000000000003 112.688 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.793 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 6.5 mp -59.38 -49.51 77.52 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.652 -1.219 . . . . 71.030000000000001 109.547 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -67.33 -42.07 84.2 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.518 -1.219 . . . . 74.019999999999996 113.515 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -71.15 -39.64 71.83 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.839 0.681 . . . . 62.310000000000002 112.839 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.672 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 1.7 tp -82.97 -9.43 59.29 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.38 0.672 . . . . 63.25 111.053 -176.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 69.48 40.81 78.63 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 110.616 -0.993 . . . . 63.039999999999999 110.616 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.793 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 11.3 t90 -87.46 126.45 34.9 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.217 -1.401 . . . . 74.019999999999996 107.217 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 17.4 p -86.81 -28.79 22.73 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 123.08 0.552 . . . . 53.439999999999998 112.389 -174.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -74.71 -175.5 34.99 Favored Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 115.588 -0.733 . . . . 75.219999999999999 111.636 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 23.9 mmt -123.3 155.21 37.69 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.681 -0.489 . . . . 74.040000000000006 109.681 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 47.4 tp -94.12 118.51 31.64 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 123.613 0.571 . . . . 74.340000000000003 109.578 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -118.14 122.12 42.27 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.127 -1.064 . . . . 74.530000000000001 108.127 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.3 OUTLIER -87.34 130.02 34.79 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 106.928 -1.508 . . . . 62.439999999999998 106.928 172.14 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.75 -35.12 23.06 Favored Glycine 0 C--N 1.285 -2.253 0 CA-C-N 115.585 -0.734 . . . . 51.439999999999998 111.688 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.61 147.72 39.81 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 120.828 0.347 . . . . 72.239999999999995 110.8 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -100.18 123.66 44.68 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 102.814 -3.032 . . . . 75.129999999999995 102.814 170.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.89 137.41 32.7 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.611 0 N-CA-C 106.531 -1.655 . . . . 73.540000000000006 106.531 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -75.53 106.88 7.32 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 118.418 -1.313 . . . . 65.510000000000005 111.122 -178.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . 0.447 ' HB3' ' HA3' ' A' ' 625' ' ' GLY . . . -129.61 -64.34 0.89 Allowed 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.023 -1.473 . . . . 74.140000000000001 107.023 172.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 111.8 150.15 11.41 Favored Glycine 0 N--CA 1.42 -2.367 0 C-N-CA 120.394 -0.908 . . . . 73.409999999999997 111.111 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.95 -32.76 62.77 Favored Glycine 0 C--N 1.307 -1.083 0 C-N-CA 123.356 0.503 . . . . 72.0 113.685 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 20.3 t -72.37 -24.18 61.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.952 0.882 . . . . 74.230000000000004 109.968 -175.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -90.3 -0.98 57.87 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.301 -0.863 . . . . 75.049999999999997 109.82 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 37.1 m80 75.99 99.61 0.07 Allowed 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 124.975 1.31 . . . . 71.010000000000005 109.906 -173.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -82.75 72.28 9.83 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.615 1.197 . . . . 62.520000000000003 112.076 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.473 ' CZ ' ' HA2' ' A' ' 568' ' ' GLY . 9.9 ptm180 -100.14 166.48 10.99 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.362 -1.29 . . . . 73.219999999999999 109.594 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.41 ' CG1' ' H ' ' A' ' 568' ' ' GLY . 10.4 p -62.86 131.64 28.37 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 CA-C-N 115.995 -0.548 . . . . 73.420000000000002 109.931 177.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 12.9 p -109.99 -26.68 3.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 121.724 0.773 . . . . 71.129999999999995 110.276 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -154.01 135.53 14.28 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.52 -0.764 . . . . 74.340000000000003 110.188 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -127.09 136.1 51.68 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.035 -1.468 . . . . 74.209999999999994 107.035 171.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.405 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 28.5 t-20 -65.68 -51.62 48.42 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 112.816 0.673 . . . . 65.400000000000006 112.816 -175.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 8.1 Cg_exo -79.11 114.01 3.3 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.576 1.517 . . . . 75.120000000000005 108.934 172.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.06 145.19 54.66 Favored 'Trans proline' 0 C--O 1.25 1.121 0 C-N-CA 122.359 2.039 . . . . 72.530000000000001 113.046 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -63.42 132.46 51.49 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.603 -0.726 . . . . 73.040000000000006 109.227 176.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 102.65 0.03 49.34 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 110.971 -0.852 . . . . 72.25 110.971 -175.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 32.3 m -105.51 150.43 25.34 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 109.559 -0.534 . . . . 71.129999999999995 109.559 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -73.38 127.19 10.56 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 111.172 -0.771 . . . . 71.230000000000004 111.172 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.6 m -117.09 142.76 29.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 108.22 -1.03 . . . . 74.239999999999995 108.22 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.589 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 29.3 p30 -44.1 167.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.073 1.509 . . . . 40.420000000000002 115.073 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -55.08 -25.53 31.72 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.483 1.113 . . . . 55.219999999999999 113.739 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -96.27 -8.93 31.5 Favored 'General case' 0 C--O 1.207 -1.163 0 C-N-CA 120.05 -0.66 . . . . 64.200000000000003 110.105 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.64 18.96 70.66 Favored Glycine 0 C--O 1.217 -0.923 0 CA-C-O 120.044 -0.309 . . . . 74.430000000000007 113.765 167.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.93 119.74 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-O 121.82 0.819 . . . . 73.030000000000001 110.711 -171.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.415 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.7 pp -127.36 133.97 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 115.132 -0.94 . . . . 52.43 110.767 -177.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.2 t -103.24 135.93 43.96 Favored 'General case' 0 C--O 1.259 1.597 0 N-CA-C 108.748 -0.834 . . . . 74.299999999999997 108.748 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 2.7 pp -139.2 165.99 25.7 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.815 -0.629 . . . . 62.539999999999999 111.608 -178.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -131.4 137.93 48.89 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.944 -0.761 . . . . 72.420000000000002 108.944 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -136.65 166.48 23.45 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.038 -0.528 . . . . 71.439999999999998 110.319 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . 0.447 ' HA3' ' HB3' ' A' ' 595' ' ' ALA . . . -71.58 67.84 0.99 Allowed Glycine 0 CA--C 1.527 0.803 0 O-C-N 124.069 0.855 . . . . 75.400000000000006 114.925 -175.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 . . . . . 0 C--O 1.262 1.715 0 C-N-CA 126.628 1.971 . . . . 75.530000000000001 112.064 -175.371 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.508 0 CA-C-O 122.26 1.029 . . . . 73.019999999999996 109.341 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.404 ' HB ' HG22 ' A' ' 544' ' ' THR . 27.8 p -140.03 153.97 46.97 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.69 -1.141 . . . . 73.129999999999995 109.003 -176.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.479 ' NZ ' ' HB2' ' A' ' 495' ' ' LYS . 0.0 OUTLIER -137.97 145.09 41.53 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.893 -0.41 . . . . 75.519999999999996 109.893 173.371 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 19.9 m-20 -77.89 141.89 38.8 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.849 -0.797 . . . . 63.25 108.849 173.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.6 pt -108.71 130.12 23.12 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 115.728 -0.669 . . . . 65.519999999999996 110.336 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -80.7 -177.49 3.79 Favored 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.705 2.27 . . . . 63.450000000000003 112.333 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -87.78 89.83 8.14 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 122.459 1.123 . . . . 64.319999999999993 110.521 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.0 m -80.59 -0.31 4.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-N 114.936 -1.029 . . . . 61.109999999999999 111.96 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -69.53 100.84 1.48 Allowed 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.734 -0.666 . . . . 71.140000000000001 110.494 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 156.86 -38.11 0.57 Allowed Glycine 0 C--N 1.304 -1.224 0 C-N-CA 120.808 -0.71 . . . . 64.430000000000007 111.979 178.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -92.62 -175.66 4.03 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 109.543 -0.54 . . . . 74.310000000000002 109.543 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 13.2 m -70.18 154.86 41.42 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.35 -0.981 . . . . 63.140000000000001 108.35 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.475 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.4 p -64.14 -41.33 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 C-N-CA 120.737 -0.385 . . . . 73.540000000000006 110.797 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . 0.589 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 28.1 t70 -59.69 -43.24 94.11 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 109.815 -0.439 . . . . 54.240000000000002 109.815 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 46.3 t -69.29 -41.54 81.08 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 CA-C-N 115.868 -0.606 . . . . 61.140000000000001 110.085 -178.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -58.24 -44.02 88.09 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.753 0.311 . . . . 35.310000000000002 110.671 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.0 mt-30 -64.8 -44.88 88.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.027 -0.533 . . . . 74.510000000000005 110.617 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 33.4 mmtp -64.76 -40.17 94.84 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 116.19 -0.459 . . . . 72.439999999999998 110.129 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . 0.481 ' O ' HG12 ' A' ' 514' ' ' VAL . 85.9 m-20 -66.72 -40.49 88.44 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.856 -0.611 . . . . 71.230000000000004 111.585 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.4 pp -69.9 -41.37 74.78 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.42 -0.912 . . . . 41.310000000000002 110.776 177.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.482 ' N ' HD12 ' A' ' 512' ' ' LEU . 2.4 t-20 -64.38 -38.91 92.69 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 124.136 0.974 . . . . 74.319999999999993 111.259 -177.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 511' ' ' ASN . 9.0 p -64.06 -31.62 54.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.196 0.522 . . . . 74.319999999999993 110.876 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -112.62 23.24 13.73 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.409 -0.589 . . . . 74.25 109.409 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -146.07 -56.13 0.02 OUTLIER Glycine 0 CA--C 1.484 -1.866 0 C-N-CA 119.653 -1.26 . . . . 51.350000000000001 113.963 -174.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 65.76 26.28 11.32 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.211 1.005 . . . . 74.519999999999996 109.618 -175.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 14.7 p -82.95 -175.71 5.97 Favored 'General case' 0 N--CA 1.409 -2.489 0 CA-C-N 113.755 -1.566 . . . . 74.519999999999996 108.905 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.51 142.92 38.2 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.042 -1.095 . . . . 75.200000000000003 108.042 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -130.33 148.78 52.2 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.078 0.466 . . . . 61.409999999999997 111.332 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 32.2 m -138.32 139.99 39.33 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.058 -0.719 . . . . 53.299999999999997 109.058 176.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -118.09 138.67 52.09 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.85 0.357 . . . . 73.120000000000005 110.795 -176.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -135.02 130.42 35.65 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.268 -0.424 . . . . 52.549999999999997 109.862 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 73.9 m -88.96 129.15 35.68 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.695 0.76 . . . . 71.409999999999997 112.175 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.83 149.68 25.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.109 -1.811 . . . . 54.530000000000001 106.109 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -81.48 136.44 35.64 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.908 -0.717 . . . . 73.510000000000005 109.772 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 67.2 m -158.56 164.85 19.91 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 107.982 -1.118 . . . . 53.43 107.982 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -65.35 -14.78 46.77 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.251 1.968 . . . . 63.009999999999998 113.534 178.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.435 HH21 HG23 ' A' ' 535' ' ' THR . 0.4 OUTLIER -87.36 146.85 40.74 Favored Pre-proline 0 C--N 1.326 -0.413 0 C-N-CA 120.945 -0.302 . . . . 65.349999999999994 110.993 -179.149 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.77 155.47 37.56 Favored 'Trans proline' 0 C--O 1.263 1.758 0 C-N-CA 123.633 2.889 . . . . 72.329999999999998 115.378 -175.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.681 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -68.71 110.4 4.28 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 113.617 -1.629 . . . . 70.239999999999995 110.602 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 137.39 -21.63 3.26 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.574 -0.822 . . . . 75.329999999999998 111.546 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -82.88 138.18 33.99 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.99 -0.745 . . . . 71.219999999999999 108.99 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 6.6 p -86.16 114.74 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.193 0 CA-C-O 122.12 0.962 . . . . 75.140000000000001 108.907 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.435 HG23 HH21 ' A' ' 529' ' ' ARG . 0.5 OUTLIER -65.06 -32.57 74.34 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 113.575 -1.648 . . . . 70.340000000000003 109.681 -179.007 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 153.26 -166.69 31.68 Favored Glycine 0 N--CA 1.418 -2.546 0 N-CA-C 110.102 -1.199 . . . . 65.439999999999998 110.102 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 6.6 p -116.96 157.44 25.75 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 109.448 -0.575 . . . . 54.420000000000002 109.448 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -63.45 -55.17 37.55 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 119.17 -0.443 . . . . 75.329999999999998 110.495 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -69.02 126.5 13.88 Favored 'Trans proline' 0 C--N 1.365 1.442 0 N-CA-C 108.346 -1.444 . . . . 54.420000000000002 108.346 170.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.59 155.22 67.89 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.497 2.131 . . . . 53.240000000000002 113.293 -176.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.98 130.81 47.32 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.925 -0.58 . . . . 55.32 110.294 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.85 -4.82 42.44 Favored Glycine 0 C--N 1.303 -1.258 0 C-N-CA 120.205 -0.998 . . . . 74.230000000000004 111.725 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 25.3 m -88.16 133.28 34.05 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.467 -0.568 . . . . 74.549999999999997 109.467 178.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 0.2 OUTLIER -86.71 123.9 32.39 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 106.84 -1.541 . . . . 75.030000000000001 106.84 174.74 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.67 155.06 63.53 Favored Pre-proline 0 C--N 1.295 -1.798 0 N-CA-C 108.454 -0.943 . . . . 63.140000000000001 108.454 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -64.34 138.3 59.94 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 121.552 1.501 . . . . 74.430000000000007 111.636 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.31 -19.96 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 CA-C-O 122.168 0.985 . . . . 71.099999999999994 109.858 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -91.12 -8.38 48.94 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.785 -1.098 . . . . 73.439999999999998 111.687 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 15.1 t -89.79 -175.64 4.7 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-O 121.282 0.563 . . . . 53.530000000000001 110.416 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.1 p -118.89 137.65 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-N 115.869 -0.605 . . . . 72.409999999999997 109.511 -177.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 59.8 mt -97.55 132.56 41.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.883 -0.784 . . . . 63.32 108.883 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -103.12 116.1 31.84 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.416 -1.327 . . . . 72.219999999999999 107.416 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.84 125.8 52.36 Favored 'General case' 0 C--N 1.312 -1.035 0 O-C-N 123.625 0.578 . . . . 55.219999999999999 111.0 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -93.09 121.66 34.66 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.699 -0.682 . . . . 71.129999999999995 109.293 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.446 HG22 HG21 ' A' ' 505' ' ' VAL . 15.1 t -104.37 137.4 33.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 107.447 -1.316 . . . . 64.510000000000005 107.447 -178.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.681 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 24.5 p -88.08 139.53 30.42 Favored 'General case' 0 N--CA 1.413 -2.315 0 C-N-CA 119.92 -0.712 . . . . 74.239999999999995 109.839 178.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -108.41 145.03 35.2 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 105.299 -2.112 . . . . 73.219999999999999 105.299 167.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 559' ' ' ASN . . . -54.68 -22.58 25.98 Favored Glycine 0 CA--C 1.506 -0.516 0 O-C-N 124.72 1.262 . . . . 62.340000000000003 114.743 -174.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . 0.428 ' HB3' ' O ' ' A' ' 558' ' ' GLY . 18.9 t-20 82.79 -16.4 0.59 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.816 1.246 . . . . 62.030000000000001 109.678 -178.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.518 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 86.9 mt-30 -113.48 157.33 22.12 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.283 -0.871 . . . . 71.099999999999994 111.383 -176.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -136.8 157.85 45.81 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.278 -1.379 . . . . 74.239999999999995 107.278 176.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.97 119.3 23.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.434 -0.58 . . . . 74.420000000000002 109.434 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 54.8 ttp -79.98 133.46 58.02 Favored Pre-proline 0 C--N 1.311 -1.077 0 C-N-CA 120.817 -0.353 . . . . 75.409999999999997 110.088 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.95 169.67 17.33 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.71 2.273 . . . . 74.540000000000006 111.525 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . 0.445 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 24.6 t70 -89.62 119.87 30.42 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 113.219 0.822 . . . . 75.310000000000002 113.219 -178.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.36 12.73 3.02 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.504 -1.225 . . . . 51.340000000000003 109.272 173.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 84.5 p -69.03 153.41 43.83 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 115.69 -0.686 . . . . 73.019999999999996 112.824 -173.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . 0.444 ' H ' ' CG1' ' A' ' 603' ' ' VAL . . . 86.13 56.66 2.26 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.793 -0.923 . . . . 44.329999999999998 110.793 -178.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 602' ' ' ARG . 14.4 ptm -142.49 177.04 8.55 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.01 -0.367 . . . . 73.439999999999998 110.01 -175.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -95.5 160.63 14.42 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 106.69 -1.596 . . . . 75.310000000000002 106.69 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . 0.46 ' CZ3' ' HB3' ' A' ' 589' ' ' LYS . 19.3 t-105 -66.49 -32.32 73.61 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.482 -0.932 . . . . 75.209999999999994 108.482 176.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.1 m -76.2 -13.53 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.284 -0.871 . . . . 62.32 111.159 -174.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -96.96 -27.23 14.73 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.779 -1.193 . . . . 62.310000000000002 107.779 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -68.82 -40.33 79.57 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.25 -0.886 . . . . 70.310000000000002 111.773 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.639 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 44.9 mt-10 -55.36 -55.6 38.07 Favored Pre-proline 0 CA--C 1.567 1.606 0 N-CA-C 112.725 0.639 . . . . 71.129999999999995 112.725 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.5 -30.38 79.75 Favored 'Trans proline' 0 C--N 1.364 1.391 0 CA-C-N 120.707 1.288 . . . . 63.109999999999999 112.606 172.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -68.73 -36.36 78.31 Favored 'General case' 0 N--CA 1.435 -1.197 0 O-C-N 122.091 -0.38 . . . . 61.229999999999997 111.009 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.3 pp -64.51 -45.97 84.96 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 120.728 0.299 . . . . 73.540000000000006 110.655 -178.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.529 ' N ' HD12 ' A' ' 578' ' ' LEU . 8.5 ptm180 -65.93 -34.84 79.04 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.358 -0.383 . . . . 73.219999999999999 111.242 175.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.24 -39.31 82.32 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 116.41 -0.359 . . . . 63.240000000000002 111.548 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' A' ' 583' ' ' TRP . 1.5 pp -91.93 -9.66 42.32 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.555 -0.458 . . . . 75.209999999999994 111.399 -177.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 79.43 42.37 11.85 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.071 -0.585 . . . . 72.349999999999994 112.339 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.473 ' CH2' ' HG ' ' A' ' 587' ' ' LEU . 10.0 t90 -81.46 127.26 32.62 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.799 -0.815 . . . . 74.450000000000003 108.799 178.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 22.5 m -83.19 -29.63 28.42 Favored 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 113.083 0.771 . . . . 55.109999999999999 113.083 -176.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -90.72 -175.62 44.3 Favored Glycine 0 C--N 1.315 -0.611 0 CA-C-N 116.555 -0.293 . . . . 72.329999999999998 112.905 -177.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 70.1 mtm -117.73 163.33 16.65 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.368 -0.604 . . . . 63.229999999999997 109.368 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . 0.473 ' HG ' ' CH2' ' A' ' 583' ' ' TRP . 5.1 mp -84.26 131.14 34.76 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 109.703 -0.48 . . . . 71.439999999999998 109.703 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 621' ' ' THR . 32.8 t70 -101.86 116.07 31.9 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 108.831 -0.803 . . . . 73.329999999999998 108.831 177.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.46 ' HB3' ' CZ3' ' A' ' 571' ' ' TRP . 0.0 OUTLIER -95.08 134.23 38.02 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.659 0.742 . . . . 63.109999999999999 112.204 -175.077 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -95.58 -145.0 18.03 Favored Glycine 0 C--N 1.29 -1.982 0 N-CA-C 109.264 -1.534 . . . . 63.219999999999999 109.264 174.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -74.49 126.16 30.16 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 117.309 0.554 . . . . 73.120000000000005 110.547 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -69.75 144.21 52.8 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 123.913 0.758 . . . . 72.010000000000005 109.703 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 58.6 t -106.68 143.44 17.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-N 115.272 -0.877 . . . . 71.310000000000002 109.638 -174.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -74.94 107.0 6.73 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.968 -0.753 . . . . 63.009999999999998 108.968 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -126.98 -53.88 1.4 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 116.057 -0.52 . . . . 65.299999999999997 110.125 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 101.81 129.44 6.68 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.963 -0.855 . . . . 72.310000000000002 110.963 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.68 -43.11 91.55 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 116.539 0.169 . . . . 72.439999999999998 113.224 -177.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 35.3 t -68.7 -24.68 64.52 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.323 0.583 . . . . 62.200000000000003 110.65 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -93.53 -1.75 55.16 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 116.088 -0.505 . . . . 75.510000000000005 110.593 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 42.2 m170 80.55 98.33 0.06 Allowed 'General case' 0 C--O 1.246 0.892 0 C-N-CA 125.437 1.495 . . . . 71.319999999999993 113.216 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -73.08 90.39 1.53 Allowed 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 114.091 -1.413 . . . . 73.409999999999997 109.952 177.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 569' ' ' MET . 19.6 mtm180 -107.94 171.14 7.57 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.865 -0.607 . . . . 73.120000000000005 110.003 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.444 ' CG1' ' H ' ' A' ' 568' ' ' GLY . 14.7 p -73.4 137.97 22.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.751 -0.833 . . . . 72.219999999999999 108.751 175.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 33.5 m -107.26 -29.19 2.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 119.752 -0.779 . . . . 73.519999999999996 110.865 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -156.55 139.17 15.03 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.65 -0.705 . . . . 74.310000000000002 109.464 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -133.02 141.96 48.55 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.057 -1.831 . . . . 70.150000000000006 106.057 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.536 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 23.7 t-20 -62.14 -60.36 10.37 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-O 118.923 -0.561 . . . . 74.200000000000003 112.483 -177.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.536 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 6.3 Cg_exo -87.98 109.26 0.62 Allowed 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 121.752 1.635 . . . . 54.43 109.844 173.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 7.1 Cg_exo -71.11 160.63 48.58 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 123.225 2.616 . . . . 62.119999999999997 113.112 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . 0.445 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -68.02 132.67 47.7 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.821 -0.807 . . . . 65.420000000000002 108.821 175.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 103.18 -11.88 55.32 Favored Glycine 0 C--N 1.302 -1.336 0 N-CA-C 110.852 -0.899 . . . . 44.539999999999999 110.852 -175.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 44.8 m -100.27 159.5 15.07 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.787 -0.82 . . . . 72.540000000000006 108.787 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -76.86 120.61 5.72 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 112.036 -0.426 . . . . 71.129999999999995 112.036 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.7 m -112.42 143.32 22.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 107.793 -1.188 . . . . 53.409999999999997 107.793 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.518 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.2 p-10 -52.99 168.8 0.11 Allowed 'General case' 0 C--O 1.216 -0.704 0 C-N-CA 123.534 0.734 . . . . 74.120000000000005 112.184 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . 0.267 0.0 OUTLIER -60.91 -24.95 66.4 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 113.642 0.978 . . . . 73.040000000000006 113.642 -176.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -80.97 -9.2 59.87 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 119.686 -0.806 . . . . 55.439999999999998 109.522 176.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.18 18.9 67.66 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 112.008 -0.437 . . . . 75.239999999999995 112.008 175.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.49 119.34 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-O 122.379 1.085 . . . . 62.310000000000002 111.694 -166.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.469 ' O ' HD12 ' A' ' 620' ' ' ILE . 2.8 pp -118.17 132.19 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 CA-C-N 114.77 -1.105 . . . . 72.329999999999998 110.352 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 12.9 t -99.19 128.76 45.37 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.007 -1.479 . . . . 65.420000000000002 107.007 174.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.1 166.64 23.97 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 112.599 0.592 . . . . 74.230000000000004 112.599 -172.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -126.21 134.88 51.11 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 105.231 -2.137 . . . . 53.340000000000003 105.231 173.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -142.29 166.05 25.74 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.912 -0.585 . . . . 71.209999999999994 110.571 -169.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -63.45 130.49 40.72 Favored Glycine 0 N--CA 1.433 -1.546 0 O-C-N 124.203 0.939 . . . . 42.32 111.956 175.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 . . . . . 0 C--N 1.301 -1.501 0 C-N-CA 126.162 1.785 . . . . 64.340000000000003 114.446 -178.878 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.985 0 CA-C-O 120.96 0.409 . . . . 43.509999999999998 110.816 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.449 ' HB ' ' OG1' ' A' ' 544' ' ' THR . 33.9 p -137.49 144.87 42.43 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.389 -0.596 . . . . 75.5 109.389 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -141.93 148.9 39.42 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 123.493 0.717 . . . . 70.310000000000002 109.343 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 14.3 m-20 -89.58 131.17 35.72 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 120.942 0.401 . . . . 73.030000000000001 110.759 -175.07 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.0 pt -90.77 128.05 49.81 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 116.048 -0.524 . . . . 74.109999999999999 110.579 178.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.27 -177.57 2.17 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.706 2.271 . . . . 43.530000000000001 112.463 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -81.26 99.84 8.84 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.789 -0.641 . . . . 71.310000000000002 109.556 177.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.49 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 27.1 m -102.13 -3.31 9.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.301 -0.863 . . . . 34.109999999999999 111.442 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -64.87 103.65 0.74 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.836 -0.62 . . . . 51.240000000000002 110.219 -178.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 145.87 -24.08 1.79 Allowed Glycine 0 C--N 1.295 -1.707 0 CA-C-N 115.476 -0.784 . . . . 74.219999999999999 111.984 178.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.456 ' O ' HG12 ' A' ' 534' ' ' VAL . 2.2 mp0 -92.04 -179.24 5.22 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.124 -1.065 . . . . 70.310000000000002 108.124 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 31.5 m -75.85 155.17 35.57 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.457 -1.683 . . . . 61.399999999999999 106.457 175.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.551 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.2 p -61.29 -43.19 96.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 118.103 0.41 . . . . 73.329999999999998 111.438 -177.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . 0.546 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 25.6 t70 -63.17 -41.29 99.21 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.415 -0.357 . . . . 73.230000000000004 110.176 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 94.5 t -68.04 -42.99 85.69 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.984 0 CA-C-N 115.386 -0.825 . . . . 44.210000000000001 110.33 -178.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.49 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -62.5 -44.38 96.53 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 121.12 -0.232 . . . . 73.439999999999998 110.532 178.582 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.551 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 21.5 mt-30 -64.54 -46.5 82.56 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 116.437 -0.347 . . . . 74.150000000000006 110.676 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 506' ' ' ASP 0.359 0.0 OUTLIER -65.68 -37.0 85.27 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 112.386 0.513 . . . . 72.400000000000006 112.386 179.468 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -60.55 -47.4 86.36 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.445 -0.576 . . . . 75.450000000000003 109.445 178.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.54 -37.66 80.16 Favored 'General case' 0 C--O 1.205 -1.275 0 CA-C-N 115.457 -0.792 . . . . 70.25 109.743 177.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -59.74 -34.44 72.95 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 123.884 0.874 . . . . 73.239999999999995 111.745 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.6 t -56.57 -31.33 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 O-C-N 123.645 0.591 . . . . 42.520000000000003 110.524 176.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -114.08 5.92 16.2 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.095 -0.706 . . . . 70.239999999999995 109.095 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -124.42 -62.09 0.18 Allowed Glycine 0 CA--C 1.481 -2.06 0 C-N-CA 120.342 -0.932 . . . . 64.010000000000005 113.988 -169.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 61.07 32.66 19.74 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 122.144 0.973 . . . . 75.420000000000002 109.071 -172.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 547' ' ' VAL . 4.9 p -87.02 -178.43 6.27 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.377 -1.283 . . . . 75.239999999999995 111.331 -177.265 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -108.22 143.11 37.49 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.98 -1.119 . . . . 64.540000000000006 107.98 178.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -125.3 146.14 49.69 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.745 0.307 . . . . 74.430000000000007 110.71 -174.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 56.3 p -126.92 141.07 51.9 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 106.18 -1.785 . . . . 72.0 106.18 171.043 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -129.72 122.57 29.15 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.299 0.571 . . . . 71.439999999999998 110.996 -174.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -118.09 125.31 50.04 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.632 -0.713 . . . . 42.5 109.493 -179.041 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 40.3 m -85.78 130.44 34.55 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-O 121.558 0.694 . . . . 55.030000000000001 111.287 -179.188 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.4 p -121.05 149.14 24.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 107.146 -1.427 . . . . 75.140000000000001 107.146 178.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -80.63 135.44 36.05 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.164 -0.615 . . . . 75.420000000000002 109.762 -177.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.8 m -159.75 165.27 18.3 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 108.1 -1.074 . . . . 74.099999999999994 108.1 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -71.5 -8.08 22.55 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.103 1.869 . . . . 72.510000000000005 112.549 177.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.471 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 16.0 mtm180 -81.57 141.71 48.96 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 123.48 0.712 . . . . 71.409999999999997 109.866 178.106 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.61 153.67 59.89 Favored 'Trans proline' 0 C--O 1.249 1.056 0 C-N-CA 123.431 2.754 . . . . 75.200000000000003 113.596 -174.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.687 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -68.37 105.98 2.35 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.192 -0.913 . . . . 64.019999999999996 110.576 -177.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 139.44 -17.13 3.11 Favored Glycine 0 N--CA 1.434 -1.5 0 CA-C-N 115.293 -0.867 . . . . 72.230000000000004 112.162 -179.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -81.33 130.05 34.87 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 109.594 -0.521 . . . . 75.200000000000003 109.594 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.496 ' HB ' ' HA ' ' A' ' 505' ' ' VAL . 7.8 p -81.36 118.01 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.252 0 CA-C-O 122.612 1.196 . . . . 74.329999999999998 108.871 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 m -80.07 -17.73 51.91 Favored 'General case' 0 C--N 1.269 -2.905 0 CA-C-N 112.938 -1.937 . . . . 61.219999999999999 110.177 -175.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 139.93 -163.12 26.3 Favored Glycine 0 N--CA 1.41 -3.034 0 C-N-CA 120.544 -0.836 . . . . 44.039999999999999 111.234 176.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . 0.415 HG22 HD13 ' A' ' 553' ' ' LEU . 11.6 p -117.37 157.92 25.32 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 109.194 -0.669 . . . . 72.040000000000006 109.194 -179.502 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.433 ' HB2' HE22 ' A' ' 554' ' ' GLN . 3.8 t-20 -66.61 -54.52 22.71 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 120.364 -0.535 . . . . 62.350000000000001 110.002 175.438 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.422 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 23.1 Cg_endo -67.93 138.85 45.52 Favored 'Trans proline' 0 C--N 1.373 1.844 0 N-CA-C 109.395 -1.04 . . . . 61.450000000000003 109.395 170.47 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 38.0 Cg_exo -62.9 155.39 60.49 Favored 'Trans proline' 0 C--O 1.244 0.801 0 C-N-CA 122.763 2.309 . . . . 71.230000000000004 113.106 -177.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.89 134.61 53.38 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.264 -0.426 . . . . 64.25 109.904 179.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.31 -5.53 57.45 Favored Glycine 0 C--N 1.303 -1.283 0 N-CA-C 111.344 -0.702 . . . . 34.049999999999997 111.344 -177.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 20.6 m -88.72 135.25 33.61 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.516 -0.55 . . . . 72.430000000000007 109.516 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 14.5 t -82.44 132.98 35.2 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.503 -0.925 . . . . 52.329999999999998 108.503 175.062 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.1 m -123.6 156.4 64.59 Favored Pre-proline 0 C--N 1.294 -1.834 0 N-CA-C 107.269 -1.382 . . . . 71.030000000000001 107.269 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.3 135.37 26.71 Favored 'Trans proline' 0 N--CA 1.433 -2.064 0 CA-C-N 119.833 0.976 . . . . 51.25 111.219 -178.061 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.416 ' HA ' HG22 ' A' ' 518' ' ' THR . 8.3 p -67.68 -22.24 28.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 122.496 1.141 . . . . 62.130000000000003 108.838 177.304 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -79.9 -18.12 51.39 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 113.113 -1.858 . . . . 71.209999999999994 110.188 -175.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 18.7 t -102.07 -166.6 1.31 Allowed 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.612 -0.722 . . . . 52.119999999999997 109.512 -176.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 8.7 p -117.09 137.67 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.398 0 CA-C-N 115.162 -0.926 . . . . 73.5 109.196 -177.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.0 mt -91.68 141.37 14.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.324 -0.991 . . . . 74.400000000000006 108.324 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -102.29 116.93 33.68 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 108.506 -0.924 . . . . 73.430000000000007 108.506 -177.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.415 HD13 HG22 ' A' ' 537' ' ' THR . 3.2 mm? -106.78 121.11 43.74 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.785 0.834 . . . . 70.340000000000003 109.921 -179.316 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.433 HE22 ' HB2' ' A' ' 538' ' ' ASN . 2.9 mp0 -88.35 122.76 32.22 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.922 -0.769 . . . . 62.340000000000003 108.922 174.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 524' ' ' SER . 25.4 t -110.2 134.66 51.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 108.763 -0.828 . . . . 72.239999999999995 108.763 -178.269 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.687 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 75.5 m -81.57 131.1 35.26 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 120.093 -0.643 . . . . 74.150000000000006 109.885 176.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -99.69 131.78 45.46 Favored 'General case' 0 N--CA 1.411 -2.407 0 N-CA-C 104.28 -2.489 . . . . 64.329999999999998 104.28 166.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -60.17 -26.01 63.09 Favored Glycine 0 CA--C 1.49 -1.517 0 O-C-N 124.13 0.893 . . . . 65.439999999999998 112.924 -173.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 71.77 -15.44 0.45 Allowed 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 125.191 1.396 . . . . 74.310000000000002 110.721 178.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.466 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 89.9 mt-30 -113.18 144.34 42.84 Favored 'General case' 0 N--CA 1.416 -2.167 0 C-N-CA 123.37 0.668 . . . . 61.009999999999998 111.754 -174.371 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -123.31 146.69 47.7 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.678 -1.23 . . . . 73.209999999999994 107.678 177.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.81 117.97 12.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.417 0.627 . . . . 74.120000000000005 110.504 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 51.9 ttp -81.11 120.51 78.82 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 115.626 -0.715 . . . . 63.409999999999997 110.246 -177.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.76 169.78 12.49 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 123.156 2.571 . . . . 61.539999999999999 111.917 176.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -65.53 115.49 5.81 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 122.195 0.998 . . . . 72.310000000000002 112.634 -178.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.2 pp -131.37 6.19 4.46 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 113.81 -1.541 . . . . 74.140000000000001 107.784 170.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 14.5 m -80.08 142.09 35.2 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 113.627 -1.624 . . . . 72.519999999999996 109.499 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . 0.549 ' H ' ' CG1' ' A' ' 603' ' ' VAL . . . 80.64 48.17 6.38 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 121.353 -0.451 . . . . 73.319999999999993 112.839 178.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 21.6 ptp -152.31 -174.71 4.98 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 109.331 -0.618 . . . . 71.310000000000002 109.331 178.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -95.08 166.65 11.82 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.637 -0.875 . . . . 71.400000000000006 108.637 -173.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 -66.58 -29.06 69.03 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.998 -0.742 . . . . 53.219999999999999 108.998 178.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.9 p -73.89 -12.36 15.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 CA-C-O 121.968 0.89 . . . . 63.020000000000003 109.948 -178.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -101.49 -29.48 11.96 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 115.725 -0.671 . . . . 64.430000000000007 111.146 173.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.46 -47.77 82.55 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.75 0.657 . . . . 71.140000000000001 111.166 179.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.492 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 43.1 mt-10 -55.5 -51.81 77.0 Favored Pre-proline 0 CA--C 1.56 1.348 0 N-CA-C 113.463 0.912 . . . . 72.430000000000007 113.463 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 31.9 Cg_exo -61.86 -40.24 45.93 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.613 1.542 . . . . 73.409999999999997 113.128 174.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.425 ' HA ' ' NE ' ' A' ' 577' ' ' ARG . 3.3 mmp_? -60.76 -40.58 93.04 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 111.4 0.148 . . . . 63.450000000000003 111.4 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 579' ' ' ARG . 4.3 pp -65.97 -46.58 77.54 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.543 -0.463 . . . . 72.239999999999995 112.029 -176.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.551 ' N ' HD12 ' A' ' 578' ' ' LEU . 15.1 ptp180 -66.82 -36.1 81.6 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.503 -0.317 . . . . 74.219999999999999 111.611 178.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.1 -30.67 67.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.255 0.55 . . . . 50.119999999999997 110.53 178.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 11.4 tp -81.43 -9.73 59.66 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.294 0.569 . . . . 62.299999999999997 110.452 177.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 76.5 26.71 62.73 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.445 -0.884 . . . . 75.030000000000001 112.062 179.44 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.414 ' CD1' ' HA3' ' A' ' 618' ' ' GLY . 16.0 t90 -87.33 126.49 34.88 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 107.705 -1.22 . . . . 71.340000000000003 107.705 176.192 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 41.7 p -115.24 0.49 13.54 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 112.918 0.711 . . . . 72.239999999999995 112.918 -175.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -81.5 -173.88 48.58 Favored Glycine 0 C--O 1.248 0.996 0 C-N-CA 120.499 -0.857 . . . . 54.420000000000002 112.011 178.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 65.8 mtt -100.27 147.91 25.24 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 120.853 0.359 . . . . 74.010000000000005 110.729 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.1 tt -91.56 122.49 34.18 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.346 -1.353 . . . . 74.340000000000003 107.346 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.561 ' O ' ' HA ' ' A' ' 621' ' ' THR . 32.3 t70 -98.65 119.87 38.11 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.231 -0.655 . . . . 64.340000000000003 109.231 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.49 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -111.88 135.05 53.02 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 116.181 -0.463 . . . . 64.120000000000005 110.035 179.953 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -73.01 -88.4 0.17 Allowed Glycine 0 C--N 1.297 -1.609 0 N-CA-C 110.727 -0.949 . . . . 64.010000000000005 110.727 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.7 154.12 47.4 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.778 -0.452 . . . . 73.340000000000003 109.778 177.192 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . 0.524 ' HA ' ' O ' ' A' ' 624' ' ' PHE . 3.3 p30 -100.49 132.54 45.82 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.62 -0.881 . . . . 75.439999999999998 108.62 174.254 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 46.3 t -105.08 139.09 27.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 108.651 -0.87 . . . . 75.299999999999997 108.651 -176.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . 0.605 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 7.3 p-10 -71.53 110.9 6.41 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 122.185 0.993 . . . . 73.219999999999999 111.884 -173.316 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -113.24 -55.78 2.48 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.008 -0.996 . . . . 64.120000000000005 108.469 179.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 139.18 141.7 4.14 Favored Glycine 0 N--CA 1.416 -2.64 0 CA-C-N 115.613 -0.721 . . . . 71.209999999999994 111.465 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -59.77 -36.05 88.52 Favored Glycine 0 N--CA 1.446 -0.686 0 O-C-N 123.844 0.379 . . . . 73.299999999999997 112.744 -178.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 15.1 m -67.07 -24.7 66.0 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 123.053 0.541 . . . . 62.329999999999998 111.269 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -92.81 -12.75 30.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.867 0.365 . . . . 75.120000000000005 110.759 -178.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 23.2 m170 67.71 145.83 0.04 OUTLIER 'General case' 0 C--O 1.246 0.889 0 N-CA-C 114.914 1.45 . . . . 75.450000000000003 114.914 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -77.68 89.15 3.96 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 114.11 -1.405 . . . . 74.140000000000001 111.027 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -101.13 154.34 18.82 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.651 -1.24 . . . . 73.340000000000003 107.651 176.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.549 ' CG1' ' H ' ' A' ' 568' ' ' GLY . 8.8 p -67.87 141.96 17.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.402 -0.962 . . . . 72.239999999999995 108.402 176.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.51 -53.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.726 -0.842 . . . . 73.200000000000003 108.726 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -149.0 145.65 27.42 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.779 -0.823 . . . . 75.420000000000002 108.779 -178.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -129.19 136.26 49.91 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.543 -1.28 . . . . 74.109999999999999 107.543 173.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.494 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 48.7 t30 -55.4 -54.1 54.81 Favored Pre-proline 0 C--N 1.314 -0.959 0 N-CA-C 112.697 0.629 . . . . 71.129999999999995 112.697 -178.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.8 Cg_endo -87.72 107.2 0.6 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 121.579 1.519 . . . . 75.230000000000004 109.47 173.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.29 160.8 47.76 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 123.308 2.672 . . . . 71.420000000000002 113.362 -177.407 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.64 130.07 44.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.149 -0.478 . . . . 65.120000000000005 109.772 177.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.3 -3.08 40.18 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.707 -0.758 . . . . 63.130000000000003 112.833 -178.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 2.1 t -101.88 162.99 12.49 Favored 'General case' 0 C--O 1.25 1.104 0 N-CA-C 108.329 -0.989 . . . . 75.120000000000005 108.329 178.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -85.13 127.81 8.39 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 120.657 -0.782 . . . . 72.129999999999995 111.726 179.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 32.7 m -112.04 141.65 26.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.801 -0.814 . . . . 53.0 108.801 177.243 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.466 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 33.7 p-10 -56.47 176.27 0.09 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.631 1.173 . . . . 60.210000000000001 114.025 -175.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -56.93 -27.98 61.56 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.881 0.872 . . . . 72.430000000000007 112.504 -177.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.448 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 6.5 m-20 -94.25 -6.11 45.31 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 120.629 -0.428 . . . . 75.120000000000005 110.592 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . 0.414 ' HA3' ' CD1' ' A' ' 583' ' ' TRP . . . 66.19 17.93 66.51 Favored Glycine 0 CA--C 1.497 -1.053 0 C-N-CA 124.088 0.851 . . . . 31.199999999999999 113.993 170.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.21 119.24 15.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 122.312 1.053 . . . . 71.409999999999997 111.767 -165.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 45.0 pt -122.18 134.56 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 114.679 -1.146 . . . . 71.319999999999993 110.141 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 9.7 t -105.8 129.85 53.9 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.447 -0.945 . . . . 62.229999999999997 108.447 177.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.5 pp -138.86 166.03 25.49 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 113.037 0.754 . . . . 60.350000000000001 113.037 -176.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -128.11 137.33 52.08 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.085 -1.45 . . . . 73.230000000000004 107.085 176.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 592' ' ' ASP . 3.0 p90 -140.09 166.1 25.57 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.316 -0.554 . . . . 74.099999999999994 111.909 -172.321 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -76.27 169.39 54.87 Favored Glycine 0 N--CA 1.429 -1.817 0 CA-C-N 115.621 -0.718 . . . . 52.420000000000002 113.136 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.605 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 27.0 tt0 . . . . . 0 C--N 1.274 -2.717 0 N-CA-C 106.919 -1.511 . . . . 75.319999999999993 106.919 178.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 113.687 0.995 . . . . 64.129999999999995 113.687 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 14.1 p -138.01 139.57 39.7 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 109.079 -0.712 . . . . 73.239999999999995 109.079 179.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.444 ' HE3' ' O ' ' A' ' 516' ' ' GLY . 74.7 mmtt -123.27 134.01 54.13 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-O 121.007 0.432 . . . . 71.140000000000001 110.311 -175.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.4 p-10 -95.78 127.77 42.09 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.091 -0.959 . . . . 74.209999999999994 109.135 178.441 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 27.0 pt -106.2 122.87 40.8 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 115.976 -0.556 . . . . 64.409999999999997 111.217 -178.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.41 -175.45 1.79 Allowed 'Trans proline' 0 C--O 1.248 0.992 0 C-N-CA 122.165 1.91 . . . . 73.329999999999998 110.477 175.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . 0.404 ' HA ' ' HB1' ' A' ' 541' ' ' ALA . 9.1 p-10 -79.71 89.98 5.19 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.617 1.199 . . . . 51.140000000000001 110.565 178.41 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.29 -11.01 12.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.001 -1.454 . . . . 52.32 110.178 177.212 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.413 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -67.38 103.15 1.22 Allowed 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 114.53 -1.214 . . . . 72.519999999999996 109.12 178.388 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 148.86 -30.92 1.22 Allowed Glycine 0 C--N 1.293 -1.816 0 C-N-CA 120.493 -0.86 . . . . 54.520000000000003 112.095 178.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.42 ' O ' HG12 ' A' ' 534' ' ' VAL . 10.0 pt20 -94.76 -169.83 2.1 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 120.009 -0.677 . . . . 74.239999999999995 110.14 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 2.9 m -74.16 156.08 37.71 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.785 -0.82 . . . . 73.430000000000007 108.785 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.532 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.7 p -57.91 -47.76 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 O-C-N 123.464 0.477 . . . . 72.129999999999995 112.152 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -65.24 -36.69 84.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 120.565 -0.454 . . . . 32.229999999999997 110.012 -178.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.79 -41.92 85.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.831 0 CA-C-N 115.907 -0.588 . . . . 74.340000000000003 109.523 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -65.39 -45.24 84.76 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.749 -0.205 . . . . 70.209999999999994 110.912 177.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.5 mt-30 -63.97 -45.75 87.69 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 123.395 0.435 . . . . 65.439999999999998 110.759 -178.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.532 ' O ' HG23 ' A' ' 514' ' ' VAL . 0.1 OUTLIER -67.34 -39.35 85.78 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 116.154 -0.476 . . . . 62.420000000000002 110.007 -178.229 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -62.62 -46.89 86.16 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 123.39 0.431 . . . . 63.420000000000002 111.013 -179.332 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.3 pp -68.5 -35.81 78.03 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 115.83 -0.623 . . . . 62.450000000000003 110.995 -178.328 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.402 ' N ' HD12 ' A' ' 512' ' ' LEU . 1.9 t-20 -63.3 -35.98 82.17 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 123.512 0.725 . . . . 72.439999999999998 110.315 179.016 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 510' ' ' LYS . 85.0 t -63.47 -32.47 56.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.884 0 CA-C-O 121.127 0.489 . . . . 75.209999999999994 110.838 177.107 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . 0.435 ' O ' ' HD2' ' A' ' 495' ' ' LYS . 11.1 m-85 -103.32 3.65 35.57 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.928 -0.397 . . . . 64.239999999999995 109.928 -178.052 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . 0.444 ' O ' ' HE3' ' A' ' 495' ' ' LYS . . . -134.88 -54.99 0.07 OUTLIER Glycine 0 N--CA 1.416 -2.634 0 C-N-CA 118.803 -1.665 . . . . 74.439999999999998 115.019 -169.094 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 66.1 20.82 11.21 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.94 0.876 . . . . 74.329999999999998 109.032 -172.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.8 p -81.6 -174.87 5.23 Favored 'General case' 0 N--CA 1.407 -2.59 0 CA-C-N 114.155 -1.384 . . . . 63.43 110.462 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.69 138.99 42.92 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.951 -1.129 . . . . 72.299999999999997 107.951 -178.204 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 18.9 p90 -130.02 152.56 49.35 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 123.303 0.377 . . . . 72.219999999999999 110.588 -178.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 11.1 p -140.83 144.69 35.5 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 107.888 -1.153 . . . . 73.319999999999993 107.888 177.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -117.71 136.68 53.19 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.112 -0.635 . . . . 71.409999999999997 111.084 -178.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -132.29 129.85 40.1 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.013 -1.106 . . . . 72.439999999999998 108.013 177.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 32.6 t -99.73 135.03 41.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.443 0.64 . . . . 73.340000000000003 110.716 -177.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 556' ' ' SER . 8.7 p -135.21 150.99 29.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 107.747 -1.205 . . . . 75.019999999999996 107.747 178.092 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -82.79 135.67 34.9 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.398 0.618 . . . . 74.209999999999994 111.308 -178.012 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 72.4 m -164.23 160.2 16.36 Favored Pre-proline 0 C--N 1.308 -1.217 0 N-CA-C 106.32 -1.733 . . . . 75.540000000000006 106.32 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -64.29 -4.6 8.19 Favored 'Trans proline' 0 CA--C 1.553 1.471 0 C-N-CA 122.576 2.184 . . . . 62.450000000000003 114.084 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -70.69 130.08 89.18 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 107.755 -1.202 . . . . 73.129999999999995 107.755 173.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.8 148.13 76.83 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 122.417 2.078 . . . . 73.109999999999999 112.283 -176.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.25 111.52 1.1 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.303 -0.862 . . . . 75.400000000000006 111.614 -176.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 123.88 -16.76 7.75 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 115.397 -0.82 . . . . 71.030000000000001 112.143 178.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.69 129.42 34.96 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.216 -0.661 . . . . 71.430000000000007 109.216 179.505 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 503' ' ' GLN . 6.5 p -87.38 115.35 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 CA-C-O 121.459 0.647 . . . . 72.420000000000002 109.345 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -31.74 72.71 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.109 -0.951 . . . . 74.239999999999995 110.04 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 164.15 -174.61 40.27 Favored Glycine 0 N--CA 1.416 -2.656 0 CA-C-N 115.243 -0.89 . . . . 63.439999999999998 111.309 179.079 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . 0.449 HG22 ' HG ' ' A' ' 553' ' ' LEU . 5.8 p -116.36 153.21 32.42 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 108.215 -1.032 . . . . 63.219999999999999 108.215 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -61.9 -47.57 91.08 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 119.47 -0.892 . . . . 72.420000000000002 111.431 179.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -67.82 120.32 7.32 Favored 'Trans proline' 0 C--N 1.367 1.551 0 N-CA-C 107.216 -1.878 . . . . 74.0 107.216 165.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.21 142.57 97.35 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.887 2.391 . . . . 75.420000000000002 113.687 -174.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . 0.404 ' HB1' ' HA ' ' A' ' 499' ' ' ASP . . . -61.57 129.89 43.31 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.855 -0.612 . . . . 71.420000000000002 110.253 178.072 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.69 -7.05 49.34 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 111.386 -0.686 . . . . 54.030000000000001 111.386 -178.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 24.0 m -89.33 137.11 32.61 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 122.729 -0.277 . . . . 70.310000000000002 110.507 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.8 t -88.7 125.35 34.81 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 107.028 -1.471 . . . . 64.25 107.028 171.627 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 36.0 m -122.87 159.77 52.15 Favored Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 109.416 -0.587 . . . . 73.140000000000001 109.416 -175.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -66.92 139.91 53.22 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.92 1.746 . . . . 72.109999999999999 111.031 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.5 p -61.2 -20.85 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 CA-C-O 121.591 0.71 . . . . 73.019999999999996 110.378 178.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -77.87 -19.04 55.51 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.222 -0.899 . . . . 71.120000000000005 112.105 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 78.5 p -83.21 174.0 11.15 Favored 'General case' 0 C--O 1.247 0.958 0 N-CA-C 112.635 0.605 . . . . 64.120000000000005 112.635 -176.223 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.6 p -113.52 137.92 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 109.133 -0.691 . . . . 72.120000000000005 109.133 -178.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 59.8 mt -103.95 115.39 45.8 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 N-CA-C 107.706 -1.22 . . . . 72.230000000000004 107.706 178.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -103.73 129.18 51.06 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.399 -0.92 . . . . 72.5 110.556 178.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.449 ' HG ' HG22 ' A' ' 537' ' ' THR . 7.4 mp -97.78 126.91 43.37 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 114.314 -1.312 . . . . 72.209999999999994 110.259 -177.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -88.15 111.94 22.16 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 107.058 -1.46 . . . . 61.409999999999997 107.058 173.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 524' ' ' SER . 22.2 t -97.52 132.68 41.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 107.207 -1.405 . . . . 65.420000000000002 107.207 -178.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 72.3 m -94.7 134.03 37.73 Favored 'General case' 0 N--CA 1.404 -2.772 0 C-N-CA 119.36 -0.936 . . . . 74.150000000000006 111.684 177.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.0 133.88 41.86 Favored 'General case' 0 N--CA 1.402 -2.859 0 N-CA-C 104.637 -2.357 . . . . 72.420000000000002 104.637 168.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -54.32 -23.27 25.63 Favored Glycine 0 N--CA 1.468 0.822 0 O-C-N 124.493 1.12 . . . . 73.340000000000003 114.842 -171.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 81.06 -23.85 0.21 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.988 1.715 . . . . 72.040000000000006 109.253 -177.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.463 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 77.6 mt-30 -110.75 161.44 15.77 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 115.208 -0.905 . . . . 75.299999999999997 109.922 -172.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . 0.422 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 47.5 p90 -137.56 155.44 49.22 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 107.793 -1.188 . . . . 71.409999999999997 107.793 177.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.14 118.65 14.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 O-C-N 123.751 0.657 . . . . 74.120000000000005 110.188 179.177 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 40.2 ttp -85.86 128.48 58.22 Favored Pre-proline 0 C--N 1.298 -1.633 0 CA-C-N 116.026 -0.533 . . . . 70.430000000000007 110.495 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.54 169.96 14.69 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.183 2.589 . . . . 71.450000000000003 111.514 175.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . 0.42 ' HA ' ' HB2' ' A' ' 610' ' ' ALA . 5.8 p-10 -66.09 124.11 21.71 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.742 0.782 . . . . 72.530000000000001 112.355 -179.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 8.9 tt -115.76 3.91 13.91 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.746 -1.576 . . . . 65.310000000000002 106.746 174.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 14.3 m -76.39 131.42 39.12 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.055 -1.429 . . . . 74.109999999999999 109.123 179.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 74.22 61.06 3.33 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.989 -0.624 . . . . 71.310000000000002 113.44 176.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . 0.529 ' HB2' ' HB2' ' A' ' 573' ' ' ASP . 20.1 ptp -162.66 173.12 14.31 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.696 -0.853 . . . . 73.140000000000001 108.696 177.528 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -101.15 175.73 5.49 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.864 -0.791 . . . . 75.439999999999998 108.864 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -61.64 -34.89 76.48 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.169 -1.049 . . . . 74.409999999999997 108.169 177.34 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 31.6 m -69.29 -10.25 13.22 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 115.386 -0.825 . . . . 63.229999999999997 112.084 -179.171 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 569' ' ' MET . 16.0 m-20 -101.87 -44.22 5.58 Favored 'General case' 0 C--O 1.248 1.02 0 N-CA-C 108.946 -0.761 . . . . 62.039999999999999 108.946 174.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . 0.444 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -62.0 -53.22 58.64 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 114.173 -1.376 . . . . 62.130000000000003 112.107 -175.741 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.45 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 33.8 tt0 -56.93 -47.83 98.42 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 123.396 0.435 . . . . 73.129999999999995 111.993 -176.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.465 ' HA ' ' HG2' ' A' ' 579' ' ' ARG . 73.8 Cg_exo -52.72 -44.74 45.51 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.242 1.961 . . . . 73.329999999999998 113.411 172.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -64.64 -37.92 89.21 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.705 -0.479 . . . . 74.239999999999995 109.705 178.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.599 HD13 ' CZ3' ' A' ' 583' ' ' TRP . 78.5 mt -67.38 -48.29 67.83 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.564 -0.744 . . . . 65.140000000000001 111.679 -178.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.465 ' HG2' ' HA ' ' A' ' 576' ' ' PRO . 16.9 ptp180 -65.85 -34.18 77.56 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 120.953 0.406 . . . . 73.209999999999994 111.086 177.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -69.95 -30.81 68.28 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.208 -0.451 . . . . 73.129999999999995 110.409 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 578' ' ' LEU . 3.1 pp -81.34 -8.54 59.76 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 119.751 -0.779 . . . . 64.040000000000006 111.244 177.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 80.08 54.43 3.85 Favored Glycine 0 CA--C 1.504 -0.648 0 N-CA-C 110.824 -0.911 . . . . 65.439999999999998 110.824 -178.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.599 ' CZ3' HD13 ' A' ' 578' ' ' LEU . 14.0 t90 -80.45 127.89 32.94 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.758 0.313 . . . . 72.310000000000002 111.361 -178.651 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 32.0 p -106.59 -12.95 15.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.508 -0.314 . . . . 55.130000000000003 111.727 179.296 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -85.95 -175.18 49.95 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 121.055 -0.593 . . . . 51.229999999999997 112.809 -175.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 64.1 mtt -118.91 149.28 41.84 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.674 0.273 . . . . 73.510000000000005 110.27 -178.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 7.7 tt -87.91 130.17 35.0 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-O 121.212 0.53 . . . . 54.329999999999998 111.08 -175.494 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.558 ' O ' ' HA ' ' A' ' 621' ' ' THR . 18.9 t70 -117.59 121.76 41.8 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.041 -0.981 . . . . 72.439999999999998 109.172 175.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.3 OUTLIER -104.4 133.48 49.22 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.743 -1.206 . . . . 75.329999999999998 107.743 174.351 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -85.75 -26.39 35.26 Favored Glycine 0 C--N 1.294 -1.804 0 C-N-CA 120.784 -0.722 . . . . 65.239999999999995 112.548 -176.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.42 139.76 37.18 Favored 'General case' 0 N--CA 1.42 -1.973 0 C-N-CA 120.847 -0.341 . . . . 70.420000000000002 110.905 -178.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -116.11 124.45 50.4 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 105.046 -2.205 . . . . 61.310000000000002 105.046 171.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . 0.416 ' HB ' ' HA2' ' A' ' 625' ' ' GLY . 58.6 t -115.29 117.44 55.62 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 N-CA-C 108.659 -0.867 . . . . 70.319999999999993 108.659 -177.05 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -73.69 106.65 5.53 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.617 0.722 . . . . 71.140000000000001 109.838 -179.1 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -123.51 -58.37 1.61 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.976 -1.011 . . . . 75.349999999999994 108.899 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 131.8 148.23 6.1 Favored Glycine 0 N--CA 1.431 -1.648 0 N-CA-C 110.717 -0.953 . . . . 72.540000000000006 110.717 178.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.99 -33.95 88.62 Favored Glycine 0 C--N 1.314 -0.676 0 N-CA-C 112.468 -0.253 . . . . 73.310000000000002 112.468 -178.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 23.4 t -75.14 -23.51 57.85 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.199 1.0 . . . . 72.109999999999999 108.661 -179.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -87.81 -3.02 58.97 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.713 -1.13 . . . . 61.439999999999998 110.236 -178.178 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 47.4 m80 69.73 95.44 0.07 Allowed 'General case' 0 C--O 1.247 0.925 0 C-N-CA 124.987 1.315 . . . . 71.340000000000003 112.977 175.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -83.93 80.22 9.23 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 109.044 -0.724 . . . . 45.020000000000003 109.044 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -98.48 159.8 14.71 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.535 -0.757 . . . . 62.520000000000003 109.964 -179.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 59.6 t -70.84 130.2 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 107.331 -1.359 . . . . 74.420000000000002 107.331 176.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 31.5 m -108.84 -29.8 2.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 123.574 0.546 . . . . 64.049999999999997 111.516 -176.207 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -155.91 139.27 15.75 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 120.74 0.305 . . . . 74.030000000000001 110.252 -179.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -121.19 128.38 52.4 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.516 -0.766 . . . . 61.399999999999999 109.19 173.609 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -56.6 -51.1 83.81 Favored Pre-proline 0 N--CA 1.475 0.816 0 O-C-N 123.846 0.716 . . . . 71.140000000000001 110.799 178.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -77.07 111.81 3.29 Favored 'Trans proline' 0 C--N 1.371 1.756 0 N-CA-C 108.495 -1.387 . . . . 52.340000000000003 108.495 168.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.93 155.19 62.51 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.78 2.32 . . . . 44.520000000000003 113.491 -177.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . 0.42 ' HB2' ' HA ' ' A' ' 565' ' ' ASP . . . -67.58 130.76 44.02 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.378 -0.828 . . . . 61.549999999999997 109.876 177.335 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.18 -5.88 59.42 Favored Glycine 0 C--N 1.305 -1.159 0 N-CA-C 111.245 -0.742 . . . . 44.329999999999998 111.245 -177.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 28.8 m -101.66 156.11 17.69 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.889 -0.782 . . . . 54.32 108.889 -179.591 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -80.28 135.07 14.28 Favored Glycine 0 N--CA 1.422 -2.274 0 CA-C-N 116.363 -0.381 . . . . 63.399999999999999 112.431 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.3 m -120.74 142.98 34.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 107.777 -1.194 . . . . 75.349999999999994 107.777 175.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.463 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 29.4 p-10 -48.97 163.47 0.08 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.766 0.826 . . . . 71.519999999999996 112.144 -179.098 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -58.67 -27.7 65.03 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.43 0.53 . . . . 71.420000000000002 112.43 -175.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -81.15 -7.18 59.51 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 119.931 -0.708 . . . . 73.150000000000006 111.138 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.35 19.66 68.76 Favored Glycine 0 CA--C 1.492 -1.374 0 CA-C-O 119.831 -0.427 . . . . 62.229999999999997 113.445 169.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.88 119.27 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-O 121.834 0.826 . . . . 74.430000000000007 109.69 -168.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 39.4 pt -118.84 133.84 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 CA-C-N 114.857 -1.065 . . . . 74.340000000000003 112.258 -176.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 8.8 t -110.84 118.24 35.58 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 107.327 -1.36 . . . . 64.200000000000003 107.327 174.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -138.54 168.95 18.68 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.578 -0.737 . . . . 64.239999999999995 111.476 -173.938 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -125.95 135.76 52.23 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-O 122.53 1.157 . . . . 53.539999999999999 110.026 175.482 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -142.9 169.63 17.2 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 105.114 -2.18 . . . . 74.140000000000001 105.114 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . 0.416 ' HA2' ' HB ' ' A' ' 593' ' ' VAL . . . -52.33 -128.08 0.0 OUTLIER Glycine 0 CA--C 1.559 2.802 0 N-CA-C 115.878 1.111 . . . . 31.41 115.878 178.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 . . . . . 0 C--N 1.277 -2.554 0 O-C-N 120.805 -1.409 . . . . 52.420000000000002 110.561 -176.292 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.607 0 CA-C-O 121.461 0.648 . . . . 65.109999999999999 111.114 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 44.9 p -136.02 147.01 47.76 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.244 -0.889 . . . . 64.209999999999994 108.987 178.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -135.77 145.84 46.98 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.151 0.5 . . . . 75.439999999999998 110.272 176.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.0 m-20 -79.87 126.83 31.5 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.077 -0.965 . . . . 74.450000000000003 108.992 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.5 pt -91.93 131.12 36.17 Favored Pre-proline 0 C--N 1.306 -1.313 0 C-N-CA 120.455 -0.498 . . . . 72.030000000000001 110.746 178.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -83.39 177.06 6.72 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.371 2.047 . . . . 61.32 111.626 177.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -88.44 122.71 32.23 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.289 0.566 . . . . 74.439999999999998 109.942 178.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.458 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 27.8 m -120.27 8.28 6.36 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-N 115.234 -0.893 . . . . 74.319999999999993 110.803 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -78.13 99.86 6.35 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 116.024 -0.535 . . . . 74.299999999999997 110.953 -177.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 157.55 -37.67 0.55 Allowed Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.667 -0.778 . . . . 61.030000000000001 111.945 178.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -89.46 -172.04 3.45 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 122.534 -0.392 . . . . 74.430000000000007 109.983 -178.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 3.6 m -71.2 155.53 40.63 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.618 -0.882 . . . . 71.019999999999996 108.618 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.49 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.7 p -62.65 -43.56 98.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 O-C-N 123.109 0.256 . . . . 62.140000000000001 111.584 -178.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.17 -37.89 88.78 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.061 -0.256 . . . . 74.430000000000007 110.526 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 66.0 t -67.59 -45.92 84.06 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.375 0 N-CA-C 109.272 -0.64 . . . . 75.129999999999995 109.272 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.458 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -59.17 -44.88 92.16 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.553 0.216 . . . . 74.319999999999993 111.43 179.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.2 mt-30 -63.84 -45.88 87.53 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.098 -0.501 . . . . 74.109999999999999 111.028 -178.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.549 ' O ' HG23 ' A' ' 514' ' ' VAL . 13.7 ptmm? -67.54 -37.97 83.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.335 -0.393 . . . . 73.239999999999995 111.086 179.325 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -61.18 -48.86 79.61 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 116.059 -0.519 . . . . 73.340000000000003 110.631 -179.566 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.4 pp -68.17 -35.47 78.09 Favored 'General case' 0 C--O 1.209 -1.046 0 CA-C-N 115.945 -0.57 . . . . 73.099999999999994 110.619 -178.633 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -59.95 -35.73 75.57 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 123.951 0.9 . . . . 62.200000000000003 110.751 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 510' ' ' LYS . 98.8 t -58.28 -35.03 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 122.763 0.425 . . . . 64.340000000000003 111.862 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -112.28 -1.38 15.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.567 0.699 . . . . 63.109999999999999 109.959 -177.612 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -113.37 -60.2 0.41 Allowed Glycine 0 N--CA 1.421 -2.35 0 CA-C-N 115.321 -0.854 . . . . 71.140000000000001 113.033 -171.105 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 63.0 27.09 15.79 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.519 1.152 . . . . 75.239999999999995 109.293 -174.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.3 p -85.43 -170.03 2.93 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 113.914 -1.494 . . . . 53.43 109.722 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -107.95 139.41 42.61 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.466 -1.309 . . . . 73.409999999999997 107.466 174.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -130.7 149.49 52.32 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.149 0.5 . . . . 72.040000000000006 111.224 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.7 p -140.8 157.67 45.07 Favored 'General case' 0 N--CA 1.405 -2.693 0 N-CA-C 107.142 -1.429 . . . . 71.430000000000007 107.142 178.366 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -125.57 141.17 52.17 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 120.711 -0.396 . . . . 71.430000000000007 110.094 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -131.63 143.16 50.11 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.249 -1.389 . . . . 51.409999999999997 107.249 178.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.9 m -105.47 139.64 39.79 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.071 -0.651 . . . . 54.229999999999997 111.839 -175.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.47 149.54 33.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 109.218 -0.66 . . . . 71.219999999999999 109.218 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.28 134.79 50.92 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.445 -0.576 . . . . 71.549999999999997 109.445 177.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 556' ' ' SER . 74.1 m -160.22 166.59 15.47 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 109.885 -0.413 . . . . 54.329999999999998 109.885 179.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -78.1 -6.91 16.08 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.976 1.784 . . . . 45.350000000000001 113.03 175.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.449 ' HG2' ' OE2' ' A' ' 533' ' ' GLU . 3.3 mpt_? -88.52 149.32 44.09 Favored Pre-proline 0 CA--C 1.516 -0.352 0 N-CA-C 109.769 -0.456 . . . . 72.200000000000003 109.769 -179.351 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.47 147.01 86.55 Favored 'Trans proline' 0 C--O 1.258 1.488 0 C-N-CA 122.668 2.245 . . . . 73.310000000000002 112.792 -178.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.91 106.9 0.63 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.054 -0.975 . . . . 74.209999999999994 110.759 -179.282 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 152.1 -31.58 0.88 Allowed Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 110.193 -1.163 . . . . 72.239999999999995 110.193 -178.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . 0.449 ' OE2' ' HG2' ' A' ' 529' ' ' ARG . 34.1 tt0 -76.98 139.1 40.0 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.154 0.502 . . . . 72.540000000000006 109.977 178.148 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.25 118.44 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.462 0 N-CA-C 108.132 -1.062 . . . . 70.209999999999994 108.132 174.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.4 p -79.51 -11.33 59.9 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.43 -0.804 . . . . 73.430000000000007 112.56 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.87 -168.17 29.36 Favored Glycine 0 CA--C 1.481 -2.087 0 C-N-CA 120.119 -1.039 . . . . 61.520000000000003 112.404 175.154 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . 0.489 HG22 ' HG ' ' A' ' 553' ' ' LEU . 12.6 p -116.68 158.18 24.21 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 107.469 -1.308 . . . . 53.539999999999999 107.469 179.188 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -63.21 -49.44 80.07 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 118.505 -1.278 . . . . 72.239999999999995 111.995 176.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 18.9 Cg_exo -70.24 149.25 63.57 Favored 'Trans proline' 0 C--N 1.369 1.647 0 CA-C-N 120.486 1.209 . . . . 62.530000000000001 110.447 173.103 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 13.8 Cg_exo -70.5 144.85 51.24 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.706 2.271 . . . . 74.340000000000003 113.167 -178.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -68.41 129.73 40.79 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.428 -0.582 . . . . 73.409999999999997 109.428 176.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.35 -10.82 50.8 Favored Glycine 0 C--N 1.309 -0.938 0 N-CA-C 110.94 -0.864 . . . . 52.240000000000002 110.94 -176.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 92.3 m -88.09 137.11 32.62 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 109.985 -0.376 . . . . 54.420000000000002 109.985 178.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.1 t -86.36 132.28 34.0 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.688 -0.856 . . . . 71.219999999999999 108.688 175.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.89 155.98 74.7 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 108.289 -1.004 . . . . 74.109999999999999 108.289 -179.594 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.407 ' HG2' ' HB3' ' A' ' 549' ' ' SER . 10.1 Cg_endo -58.48 137.11 78.57 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.551 1.501 . . . . 60.140000000000001 111.289 178.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.63 -23.85 34.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 123.701 0.801 . . . . 73.209999999999994 113.016 -174.088 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -97.38 -0.11 46.91 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 120.317 -0.553 . . . . 74.420000000000002 111.857 -177.2 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . 0.407 ' HB3' ' HG2' ' A' ' 546' ' ' PRO . 89.4 p -78.08 170.94 15.77 Favored 'General case' 0 C--O 1.256 1.429 0 C-N-CA 119.63 -0.828 . . . . 72.140000000000001 110.96 -178.614 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.8 p -110.24 115.75 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-O 121.934 0.874 . . . . 43.030000000000001 109.839 -178.256 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 52.1 mt -85.55 130.82 35.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 114.94 -1.027 . . . . 61.409999999999997 108.579 -177.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . 0.413 ' OE1' ' HD3' ' A' ' 539' ' ' PRO . 0.4 OUTLIER -103.55 120.73 41.44 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.727 0.775 . . . . 63.100000000000001 111.182 178.873 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.489 ' HG ' HG22 ' A' ' 537' ' ' THR . 7.1 mp -99.2 124.09 43.99 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 113.983 -1.462 . . . . 73.209999999999994 109.338 178.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 2.9 mp0 -88.28 117.73 27.39 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.436 -0.802 . . . . 62.350000000000001 111.04 -179.087 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 32.0 t -93.23 126.41 45.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.004 -0.998 . . . . 60.030000000000001 108.35 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 527' ' ' SER . 17.0 p -82.04 117.87 22.57 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 109.489 -0.56 . . . . 30.239999999999998 109.489 178.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -97.68 137.46 36.54 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 108.432 -0.951 . . . . 72.230000000000004 108.432 174.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -63.02 -22.3 64.64 Favored Glycine 0 CA--C 1.5 -0.894 0 O-C-N 124.174 0.921 . . . . 35.340000000000003 111.846 177.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 81.01 -5.92 1.65 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.684 1.593 . . . . 75.439999999999998 109.282 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 42.5 mt-30 -111.93 144.3 41.5 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 115.655 -0.702 . . . . 65.230000000000004 111.517 -172.117 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . 0.468 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 55.1 p90 -123.69 154.59 39.19 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.68 -1.146 . . . . 74.299999999999997 108.052 178.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.32 117.82 5.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.031 0.443 . . . . 75.040000000000006 110.492 177.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.446 ' HB2' HG22 ' A' ' 614' ' ' VAL . 50.8 ttp -81.56 130.91 59.75 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.953 -0.567 . . . . 50.219999999999999 111.889 -176.077 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -65.58 169.46 12.76 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.988 2.458 . . . . 75.129999999999995 111.068 172.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -87.14 143.13 27.44 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.215 0.531 . . . . 64.150000000000006 111.582 -177.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . 0.414 ' H ' HD23 ' A' ' 566' ' ' LEU . 2.1 pt? -133.03 25.21 4.26 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.155 -1.794 . . . . 73.310000000000002 106.155 176.131 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 4.4 m -75.61 148.69 38.59 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 113.13 -1.85 . . . . 71.530000000000001 111.909 -174.242 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 70.09 59.04 5.69 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.254 -0.885 . . . . 64.540000000000006 114.066 173.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . 0.464 ' HB2' ' HB2' ' A' ' 573' ' ' ASP . 23.0 ptp -159.55 175.07 13.69 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-N 117.335 0.568 . . . . 74.230000000000004 111.079 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -97.79 176.13 5.92 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.102 -1.073 . . . . 75.129999999999995 108.102 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . 0.493 ' CZ3' HD22 ' A' ' 587' ' ' LEU . 23.1 t-105 -64.19 -33.91 76.87 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.723 -0.843 . . . . 74.439999999999998 108.723 173.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.72 -14.65 18.57 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 CA-C-N 115.762 -0.653 . . . . 74.129999999999995 111.765 -178.498 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 569' ' ' MET . 14.5 m-20 -93.66 -41.14 9.87 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.172 -1.047 . . . . 62.039999999999999 108.172 174.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -52.67 -47.63 67.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.961 -1.018 . . . . 53.509999999999998 113.067 -177.312 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.502 ' O ' ' HG ' ' A' ' 578' ' ' LEU 0.255 32.0 mt-10 -60.18 -56.16 38.22 Favored Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 114.059 1.133 . . . . 72.319999999999993 114.059 179.416 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -58.72 -31.1 94.25 Favored 'Trans proline' 0 C--N 1.365 1.4 0 C-N-CA 121.392 1.395 . . . . 70.140000000000001 112.874 174.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.453 ' HG3' ' SD ' ' A' ' 569' ' ' MET . 2.8 mmp_? -66.2 -45.37 81.01 Favored 'General case' 0 C--O 1.209 -1.07 0 C-N-CA 121.314 -0.154 . . . . 71.340000000000003 110.626 176.116 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.3 pp -66.12 -39.75 90.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.263 0.468 . . . . 73.010000000000005 112.263 -174.192 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.414 ' N ' HD12 ' A' ' 578' ' ' LEU . 15.2 ptm180 -66.33 -39.6 89.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.388 -0.369 . . . . 71.329999999999998 111.072 176.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.24 -34.56 73.0 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 121.055 0.455 . . . . 71.409999999999997 110.876 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 28.6 tp -81.22 -9.15 59.83 Favored 'General case' 0 N--CA 1.42 -1.929 0 C-N-CA 123.939 0.895 . . . . 71.230000000000004 110.808 -179.261 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 65.62 36.53 92.54 Favored Glycine 0 C--N 1.315 -0.601 0 CA-C-N 116.199 -0.455 . . . . 75.349999999999994 112.079 178.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -78.38 127.13 31.76 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 107.825 -1.176 . . . . 72.109999999999999 107.825 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 10.2 m -94.37 -20.03 20.11 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.979 0.418 . . . . 70.530000000000001 111.671 -176.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -83.4 175.59 52.51 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 121.094 -0.574 . . . . 71.530000000000001 113.397 -178.029 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 10.4 mmt -101.31 155.27 18.14 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.396 -0.594 . . . . 72.230000000000004 109.396 -179.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . 0.493 HD22 ' CZ3' ' A' ' 571' ' ' TRP . 6.1 tt -89.88 118.2 29.27 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.904 -0.589 . . . . 71.430000000000007 109.761 -176.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 621' ' ' THR . 26.4 t70 -95.91 117.47 30.67 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 109.017 -0.735 . . . . 73.400000000000006 109.017 178.043 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.416 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -112.31 135.47 52.95 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.693 -0.685 . . . . 71.230000000000004 110.572 -178.716 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -70.21 -87.65 0.11 Allowed Glycine 0 C--N 1.296 -1.67 0 CA-C-N 115.313 -0.858 . . . . 74.299999999999997 111.076 -179.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.29 154.16 47.88 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 122.728 -0.278 . . . . 73.5 110.371 177.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.9 128.24 35.97 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 107.76 -1.2 . . . . 72.319999999999993 107.76 176.146 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 81.7 t -104.01 135.91 39.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 109.688 -0.486 . . . . 72.150000000000006 109.688 -179.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.95 107.32 11.62 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 122.062 0.934 . . . . 60.049999999999997 111.327 -177.507 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -119.35 -44.97 2.55 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.757 -1.111 . . . . 72.340000000000003 109.317 177.299 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 103.84 143.35 12.51 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.076 -1.059 . . . . 73.239999999999995 111.718 179.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.37 -37.4 87.54 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 114.228 0.451 . . . . 51.25 114.228 -177.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 23.0 t -77.35 -23.62 50.84 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.43 0.633 . . . . 71.400000000000006 109.573 -176.264 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -91.08 -5.01 55.8 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.412 -0.813 . . . . 72.019999999999996 109.84 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 32.9 m170 66.31 97.13 0.05 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.406 1.082 . . . . 74.319999999999993 112.474 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . 0.57 ' HB3' ' C ' ' A' ' 625' ' ' GLY . 62.2 m-80 -70.93 85.3 0.69 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.902 -1.045 . . . . 72.340000000000003 111.973 -177.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -110.33 172.52 6.82 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.9 -0.591 . . . . 72.420000000000002 111.253 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 13.0 p -57.53 134.98 21.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 CA-C-N 116.064 -0.516 . . . . 73.310000000000002 110.37 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 29.6 m -108.6 -34.72 2.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 116.235 -0.439 . . . . 55.509999999999998 111.137 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -156.22 142.11 18.01 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.449 -0.341 . . . . 75.319999999999993 110.203 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . 0.409 ' HB2' HD11 ' A' ' 620' ' ' ILE . 20.4 pt20 -129.03 134.67 48.22 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.162 -1.792 . . . . 54.109999999999999 106.162 173.708 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 609' ' ' PRO . 4.4 t-20 -67.21 -49.48 44.36 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 119.623 -0.831 . . . . 53.229999999999997 111.786 -176.202 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.7 Cg_endo -90.62 105.05 0.3 Allowed 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 121.567 1.511 . . . . 72.109999999999999 109.522 170.331 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 607' ' ' ASN . 19.0 Cg_exo -68.67 160.75 48.19 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 122.682 2.255 . . . . 73.340000000000003 111.448 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -57.67 130.03 44.57 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.257 -0.429 . . . . 75.109999999999999 110.35 178.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.3 -9.83 46.19 Favored Glycine 0 C--N 1.31 -0.869 0 C-N-CA 120.542 -0.837 . . . . 65.540000000000006 111.882 -176.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 34.4 m -87.3 151.28 23.26 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.824 -0.806 . . . . 73.439999999999998 108.824 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -75.96 131.9 12.35 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 120.702 -0.761 . . . . 73.219999999999999 111.855 177.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 563' ' ' MET . 29.4 m -125.63 143.4 39.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.134 -1.061 . . . . 61.109999999999999 108.134 176.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -54.25 176.29 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.729 0.812 . . . . 35.549999999999997 113.152 -177.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -55.58 -27.61 50.28 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.883 0.873 . . . . 72.099999999999994 112.761 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.459 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 1.0 OUTLIER -85.79 -6.55 59.09 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 120.897 -0.321 . . . . 72.219999999999999 111.083 178.119 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.77 20.52 72.36 Favored Glycine 0 CA--C 1.496 -1.116 0 C-N-CA 121.511 -0.376 . . . . 73.140000000000001 112.507 173.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.52 119.75 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 CA-C-O 122.595 1.188 . . . . 74.219999999999999 111.194 -168.685 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' A' ' 606' ' ' GLN . 0.0 OUTLIER -126.64 132.38 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 CA-C-N 113.926 -1.488 . . . . 72.439999999999998 108.651 -177.801 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 10.1 t -106.37 124.25 49.3 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-N 115.48 -0.782 . . . . 64.010000000000005 109.551 -178.347 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.404 HD21 HD21 ' A' ' 587' ' ' LEU . 2.1 pt? -138.69 166.25 24.86 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.754 -0.657 . . . . 73.209999999999994 111.501 -176.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -128.89 137.52 51.49 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.127 -1.064 . . . . 73.329999999999998 108.127 175.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -139.74 165.44 27.27 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 116.367 -0.379 . . . . 74.25 111.032 -171.115 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . 0.57 ' C ' ' HB3' ' A' ' 601' ' ' ASN . . . -66.52 139.54 37.47 Favored Glycine 0 N--CA 1.427 -1.937 0 O-C-N 124.088 0.867 . . . . 53.130000000000003 111.524 175.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 . . . . . 0 C--N 1.306 -1.32 0 C-N-CA 126.306 1.843 . . . . 74.420000000000002 114.676 -177.138 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.547 0 CA-C-O 121.897 0.856 . . . . 55.240000000000002 109.852 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 25.4 p -129.71 158.41 39.45 Favored 'General case' 0 N--CA 1.409 -2.525 0 N-CA-C 107.257 -1.386 . . . . 75.140000000000001 107.257 -179.345 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -149.03 142.47 25.27 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 108.211 -1.033 . . . . 73.040000000000006 108.211 179.368 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.04 134.65 35.37 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.278 0.561 . . . . 70.140000000000001 110.638 179.195 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 39.5 pt -85.03 137.96 37.29 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 114.972 -1.013 . . . . 70.120000000000005 111.953 -177.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.99 166.14 29.84 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.741 2.294 . . . . 61.140000000000001 113.776 178.426 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -88.21 44.76 1.22 Allowed 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 125.158 1.383 . . . . 44.039999999999999 111.223 -177.427 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 17.2 m -72.05 14.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 114.516 1.302 . . . . 55.240000000000002 114.516 -175.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.419 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -79.66 101.63 8.48 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.351 -0.611 . . . . 52.439999999999998 109.351 178.2 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 150.79 -31.09 1.01 Allowed Glycine 0 C--N 1.297 -1.602 0 N-CA-C 110.951 -0.86 . . . . 32.210000000000001 110.951 -179.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.424 ' O ' HG12 ' A' ' 534' ' ' VAL . 18.1 mp0 -81.61 -177.26 6.46 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 109.103 -0.703 . . . . 74.299999999999997 109.103 177.537 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 2.4 m -71.5 155.94 40.01 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 107.451 -1.314 . . . . 70.140000000000001 107.451 176.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.424 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.5 p -63.27 -42.0 94.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 117.737 0.244 . . . . 71.239999999999995 110.999 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 23.4 t70 -59.77 -43.77 94.19 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.258 0.551 . . . . 74.340000000000003 110.045 178.482 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 95.8 t -67.74 -44.81 85.52 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.126 0 CA-C-N 114.868 -1.06 . . . . 65.200000000000003 109.871 -178.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.35 -45.19 94.33 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 123.104 0.253 . . . . 54.130000000000003 111.458 179.092 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 27.2 mt-30 -62.27 -46.79 87.22 Favored 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 123.404 0.44 . . . . 62.219999999999999 110.996 -179.25 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.502 ' O ' HG23 ' A' ' 514' ' ' VAL 0.321 20.4 pttp -68.79 -37.55 79.35 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 112.375 0.509 . . . . 62.140000000000001 112.375 178.359 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -61.03 -49.5 77.17 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 120.771 0.319 . . . . 71.109999999999999 110.501 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.416 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.2 pp -65.85 -35.75 81.55 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-N 116.071 -0.513 . . . . 74.040000000000006 110.962 -178.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.416 ' N ' HD12 ' A' ' 512' ' ' LEU . 1.7 t-20 -62.9 -36.17 82.49 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 123.085 0.554 . . . . 71.439999999999998 110.669 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 510' ' ' LYS . 93.9 t -63.08 -34.27 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 121.261 0.553 . . . . 63.25 110.829 177.516 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -106.58 12.2 29.7 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.221 0.534 . . . . 70.319999999999993 110.371 -176.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -141.45 -54.05 0.04 OUTLIER Glycine 0 CA--C 1.488 -1.596 0 C-N-CA 119.935 -1.126 . . . . 22.109999999999999 114.023 -172.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 66.66 20.49 10.73 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.811 0.815 . . . . 74.510000000000005 110.032 -173.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.2 p -76.12 -178.48 4.47 Favored 'General case' 0 N--CA 1.415 -2.219 0 C-N-CA 125.449 1.499 . . . . 75.430000000000007 109.371 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 34.5 mtmm -107.62 142.98 36.71 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 108.168 -1.049 . . . . 73.329999999999998 108.168 175.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -126.54 147.46 49.86 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.301 0.572 . . . . 71.319999999999993 111.977 -176.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 13.6 p -133.75 146.65 50.95 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 114.537 -1.211 . . . . 74.319999999999993 107.763 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -121.67 136.5 54.94 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 120.96 0.409 . . . . 74.439999999999998 111.245 -177.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -122.54 122.09 38.06 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.838 -0.801 . . . . 73.349999999999994 108.838 178.018 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.1 m -87.48 134.79 33.55 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.834 0.35 . . . . 71.0 110.891 -177.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 556' ' ' SER . 47.6 t -136.55 150.14 27.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 106.086 -1.82 . . . . 72.150000000000006 106.086 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -99.21 135.82 40.06 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.655 -0.869 . . . . 71.099999999999994 108.655 175.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 66.7 m -162.58 171.4 6.52 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 107.289 -1.374 . . . . 52.25 107.289 -176.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.92 -15.05 44.98 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 121.935 1.757 . . . . 74.239999999999995 113.104 177.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.43 135.65 94.79 Favored Pre-proline 0 C--O 1.224 -0.268 0 N-CA-C 108.472 -0.936 . . . . 75.530000000000001 108.472 176.207 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.8 149.84 86.44 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.575 2.183 . . . . 74.239999999999995 113.392 -175.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 557' ' ' LYS . . . -59.77 106.89 0.53 Allowed 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 115.146 -0.934 . . . . 44.200000000000003 111.679 -178.657 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 124.09 -14.4 7.9 Favored Glycine 0 N--CA 1.424 -2.161 0 CA-C-N 115.129 -0.941 . . . . 63.140000000000001 111.578 179.151 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -82.45 130.75 35.17 Favored 'General case' 0 C--O 1.258 1.541 0 N-CA-C 108.873 -0.788 . . . . 53.32 108.873 179.485 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 503' ' ' GLN . 7.0 p -81.67 117.87 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.833 0 N-CA-C 107.509 -1.293 . . . . 65.340000000000003 107.509 176.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.3 m -72.79 -27.13 61.81 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 113.533 -1.667 . . . . 74.239999999999995 109.311 -175.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 153.15 -166.46 31.56 Favored Glycine 0 N--CA 1.412 -2.929 0 N-CA-C 110.086 -1.206 . . . . 42.119999999999997 110.086 177.097 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.0 p -116.2 157.85 24.22 Favored 'General case' 0 C--N 1.267 -3.002 0 N-CA-C 106.88 -1.526 . . . . 75.329999999999998 106.88 178.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -62.68 -51.11 74.58 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 118.469 -1.292 . . . . 73.319999999999993 111.439 177.229 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -73.07 147.13 42.47 Favored 'Trans proline' 0 C--N 1.369 1.606 0 CA-C-N 120.191 1.104 . . . . 73.040000000000006 110.173 173.332 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.55 145.1 75.36 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.497 2.131 . . . . 72.450000000000003 111.679 -179.207 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.11 142.0 57.83 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 110.128 -0.323 . . . . 73.430000000000007 110.128 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.19 -21.86 43.83 Favored Glycine 0 C--N 1.313 -0.701 0 N-CA-C 111.635 -0.586 . . . . 51.43 111.635 -177.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 47.1 m -71.53 137.3 47.99 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 122.872 0.469 . . . . 74.299999999999997 111.354 -177.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 12.4 t -84.44 126.29 33.12 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 109.254 -0.647 . . . . 73.150000000000006 109.254 176.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.63 157.96 73.51 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 106.973 -1.491 . . . . 73.319999999999993 106.973 177.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 10.0 Cg_endo -59.43 135.31 64.15 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 CA-C-N 120.639 1.264 . . . . 72.319999999999993 111.81 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.84 -19.89 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-N 114.95 -1.023 . . . . 74.340000000000003 112.835 -174.561 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -92.4 -17.55 24.46 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.796 -0.638 . . . . 74.310000000000002 112.038 -178.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 99.0 p -78.4 179.41 7.01 Favored 'General case' 0 C--O 1.253 1.288 0 N-CA-C 112.506 0.558 . . . . 70.230000000000004 112.506 -174.067 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 14.3 p -109.85 128.42 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.809 0 CA-C-O 121.513 0.673 . . . . 75.340000000000003 110.41 -178.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 47.8 mt -98.0 138.86 21.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.286 -1.005 . . . . 71.319999999999993 108.286 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.6 120.29 40.6 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.717 0.77 . . . . 63.310000000000002 112.224 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.7 mp -102.18 122.13 43.57 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 113.853 -1.521 . . . . 71.409999999999997 108.644 178.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -85.87 122.68 30.27 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 115.433 -0.803 . . . . 65.25 108.996 179.14 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.13 125.33 68.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.514 -0.921 . . . . 62.109999999999999 108.514 -176.203 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 525' ' ' VAL . 67.9 m -97.29 147.63 23.95 Favored 'General case' 0 C--N 1.285 -2.237 0 C-N-CA 119.515 -0.874 . . . . 54.539999999999999 111.973 179.026 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.4 ptpt -111.57 141.39 45.21 Favored 'General case' 0 N--CA 1.404 -2.74 0 N-CA-C 105.323 -2.103 . . . . 74.420000000000002 105.323 169.243 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -54.71 -22.09 24.45 Favored Glycine 0 C--O 1.242 0.633 0 O-C-N 124.441 1.088 . . . . 62.049999999999997 114.52 -174.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 88.14 -22.35 0.14 Allowed 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 126.576 1.95 . . . . 43.329999999999998 107.594 -176.72 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.56 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 77.6 mt-30 -112.99 146.92 38.21 Favored 'General case' 0 N--CA 1.405 -2.676 0 CA-C-N 114.468 -1.242 . . . . 72.010000000000005 111.298 -175.677 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -124.65 153.32 42.45 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 107.282 -1.377 . . . . 75.540000000000006 107.282 176.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.99 121.61 22.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 109.556 -0.535 . . . . 75.120000000000005 109.556 -179.78 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 54.3 ttp -79.53 130.1 69.33 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 116.292 -0.413 . . . . 73.400000000000006 110.318 -177.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.69 168.97 9.23 Favored 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.782 2.321 . . . . 73.420000000000002 110.881 174.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.2 129.9 34.79 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.739 0.78 . . . . 71.420000000000002 110.42 -179.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . 0.495 ' O ' ' HG2' ' A' ' 569' ' ' MET . 3.1 pp -126.74 10.33 7.12 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.148 -1.387 . . . . 72.519999999999996 108.677 176.086 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . 0.438 ' HB3' ' OE1' ' A' ' 606' ' ' GLN . 1.6 p -79.06 131.71 36.36 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 114.548 -1.206 . . . . 65.019999999999996 110.959 -179.332 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . 0.468 ' H ' HG12 ' A' ' 603' ' ' VAL . . . 87.85 37.03 8.1 Favored Glycine 0 N--CA 1.428 -1.888 0 C-N-CA 120.809 -0.71 . . . . 74.540000000000006 113.178 179.431 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . 0.495 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 22.4 ptp -142.73 174.72 10.39 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 117.654 0.727 . . . . 72.010000000000005 109.422 177.424 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -99.45 177.8 5.07 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.037 -0.727 . . . . 73.430000000000007 109.037 -177.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -72.59 -26.01 61.54 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.671 -0.863 . . . . 75.530000000000001 108.671 -178.72 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.2 p -71.57 -14.84 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-N 115.3 -0.863 . . . . 72.040000000000006 109.75 178.151 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 10.9 m-20 -94.33 -39.14 10.64 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.103 -0.703 . . . . 30.140000000000001 109.103 175.547 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -55.83 -46.48 78.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.653 -0.703 . . . . 61.539999999999999 112.429 -178.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.538 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 11.9 mm-40 -54.0 -58.08 15.06 Favored Pre-proline 0 CA--C 1.573 1.864 0 N-CA-C 112.757 0.651 . . . . 63.409999999999997 112.757 -179.552 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -61.54 -36.0 78.87 Favored 'Trans proline' 0 C--N 1.369 1.648 0 CA-C-N 120.727 1.295 . . . . 75.219999999999999 113.066 175.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.524 ' HA ' ' NE ' ' A' ' 577' ' ' ARG . 9.0 mmp_? -63.4 -39.63 95.03 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.762 -0.375 . . . . 73.129999999999995 111.058 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.3 pp -65.92 -47.31 75.16 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 112.664 0.616 . . . . 74.349999999999994 112.664 -176.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.514 ' N ' HD12 ' A' ' 578' ' ' LEU . 5.8 ptp180 -66.44 -35.14 79.54 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 111.711 0.263 . . . . 75.439999999999998 111.711 177.636 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -71.12 -38.92 72.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.313 0.486 . . . . 71.0 112.313 -178.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 583' ' ' TRP . 1.3 pp -82.38 -8.98 59.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.463 0.649 . . . . 53.509999999999998 110.219 -178.124 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 82.91 35.96 17.07 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.607 -0.724 . . . . 32.130000000000003 112.261 177.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.454 ' HB2' HD11 ' A' ' 581' ' ' LEU . 18.9 t90 -87.35 127.49 35.2 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 108.506 -0.924 . . . . 72.540000000000006 108.506 177.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 24.4 p -106.1 -10.33 16.56 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.39 0.885 . . . . 73.239999999999995 113.39 -176.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -84.36 -170.37 46.75 Favored Glycine 0 C--N 1.323 -0.182 0 C-N-CA 120.754 -0.736 . . . . 60.439999999999998 113.909 -177.34 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 69.6 mtm -102.8 145.42 29.79 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 123.003 0.521 . . . . 70.140000000000001 111.679 -175.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 28.2 tp -94.76 125.67 39.57 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.555 -0.906 . . . . 75.409999999999997 108.555 177.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 621' ' ' THR . 23.5 t70 -113.63 121.18 43.39 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.85 -0.613 . . . . 74.129999999999995 109.804 -177.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.78 133.82 45.92 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.86 -1.136 . . . . 62.409999999999997 110.134 175.655 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -79.25 -65.59 1.78 Allowed Glycine 0 N--CA 1.428 -1.883 0 C-N-CA 120.65 -0.786 . . . . 64.540000000000006 111.68 179.33 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.24 140.99 35.91 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 120.762 0.315 . . . . 70.420000000000002 110.742 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 624' ' ' PHE . 9.5 p-10 -110.49 124.76 52.4 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 105.339 -2.097 . . . . 54.100000000000001 105.339 170.201 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 73.8 t -104.59 137.6 32.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 120.909 -0.316 . . . . 63.140000000000001 110.75 -173.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.73 108.04 4.85 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 109.153 -0.684 . . . . 65.25 109.153 -174.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -127.07 -36.13 2.19 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 120.791 0.329 . . . . 45.130000000000003 110.895 -179.642 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 104.83 146.75 15.46 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 119.823 -1.179 . . . . 64.140000000000001 112.324 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.34 -32.2 60.33 Favored Glycine 0 C--N 1.314 -0.659 0 C-N-CA 123.909 0.766 . . . . 71.549999999999997 114.147 -178.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.3 t -59.46 -23.27 62.58 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.276 1.43 . . . . 74.239999999999995 110.99 -176.212 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -86.42 -9.63 55.91 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.472 -0.785 . . . . 74.120000000000005 111.713 -173.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 55.14 70.87 0.58 Allowed 'General case' 0 C--O 1.245 0.839 0 CA-C-O 122.371 1.081 . . . . 73.349999999999994 109.104 -174.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -77.97 89.83 4.15 Favored 'General case' 0 CA--C 1.481 -1.687 0 CA-C-N 113.699 -1.591 . . . . 75.540000000000006 113.675 -171.159 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -84.86 172.1 11.68 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 113.844 -1.526 . . . . 70.450000000000003 107.413 176.634 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.468 HG12 ' H ' ' A' ' 568' ' ' GLY . 7.1 p -61.09 131.66 26.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 107.436 -1.32 . . . . 74.200000000000003 107.436 171.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 30.4 m -107.76 -27.12 3.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 112.53 0.566 . . . . 75.450000000000003 112.53 -174.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -147.48 141.37 25.83 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 109.194 -0.669 . . . . 72.129999999999995 109.194 -178.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . 0.438 ' OE1' ' HB3' ' A' ' 567' ' ' SER . 18.0 pt20 -140.42 146.19 38.0 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.547 -0.908 . . . . 65.430000000000007 108.547 177.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.563 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 22.0 t-20 -61.38 -61.52 7.73 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 112.648 0.61 . . . . 75.329999999999998 112.648 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.4 Cg_endo -91.87 120.55 0.56 Allowed 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 122.027 1.818 . . . . 64.310000000000002 109.458 175.189 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.33 160.6 46.92 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 122.348 2.032 . . . . 71.400000000000006 112.278 178.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -59.99 127.38 31.6 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.03 -0.532 . . . . 74.25 109.87 178.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 101.05 -1.34 54.93 Favored Glycine 0 C--N 1.309 -0.93 0 C-N-CA 120.039 -1.076 . . . . 55.439999999999998 112.084 -178.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 54.6 m -95.39 146.76 24.15 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.903 -0.406 . . . . 72.420000000000002 109.903 178.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -74.47 123.8 7.85 Favored Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 115.912 -0.586 . . . . 63.030000000000001 112.175 177.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 19.1 m -107.08 142.53 19.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.949 -0.76 . . . . 71.310000000000002 108.949 176.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.56 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.7 p-10 -51.85 174.82 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.756 1.222 . . . . 62.210000000000001 113.353 -177.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -54.04 -32.25 53.92 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.7 0.63 . . . . 73.299999999999997 112.7 -179.238 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.459 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 37.4 t70 -85.75 -7.52 58.72 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 120.991 0.424 . . . . 64.239999999999995 109.994 -177.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.12 19.73 70.37 Favored Glycine 0 CA--C 1.499 -0.965 0 CA-C-N 116.077 -0.51 . . . . 72.530000000000001 112.558 174.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.05 120.94 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-O 122.68 1.229 . . . . 71.25 111.511 -166.26 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.527 HG12 ' HD2' ' A' ' 608' ' ' PRO . 0.0 OUTLIER -128.83 132.17 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 0 CA-C-N 113.605 -1.634 . . . . 63.340000000000003 108.725 -179.015 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 6.6 t -113.03 137.42 51.45 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.334 -0.987 . . . . 50.049999999999997 108.334 178.493 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.4 pp -138.6 165.72 26.19 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 113.66 0.985 . . . . 74.140000000000001 113.66 -173.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -128.9 137.41 51.41 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.555 -1.276 . . . . 74.530000000000001 107.555 176.534 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 592' ' ' ASP . 50.2 p90 -141.3 165.64 26.95 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 120.797 0.332 . . . . 73.439999999999998 110.812 -175.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -88.05 146.78 19.93 Favored Glycine 0 N--CA 1.423 -2.215 0 C-N-CA 120.329 -0.939 . . . . 65.349999999999994 111.363 177.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 C--N 1.281 -2.373 0 N-CA-C 107.214 -1.402 . . . . 74.099999999999994 107.214 177.976 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 122.125 0.964 . . . . 55.210000000000001 108.854 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 546' ' ' PRO . 13.8 p -135.74 140.53 44.44 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-N 114.556 -1.202 . . . . 72.099999999999994 107.825 179.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -130.12 142.49 50.59 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 120.946 0.403 . . . . 74.230000000000004 111.331 -179.395 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.5 p-10 -78.96 124.2 28.02 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.949 -1.023 . . . . 71.109999999999999 109.184 176.229 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.7 pt -77.97 133.38 65.55 Favored Pre-proline 0 C--N 1.302 -1.49 0 CA-C-N 115.78 -0.645 . . . . 54.539999999999999 111.532 -177.062 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.89 -174.85 2.4 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.349 2.033 . . . . 53.210000000000001 111.26 174.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -98.67 122.96 42.56 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.098 0.475 . . . . 73.200000000000003 110.034 179.137 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.633 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 17.0 m -124.86 49.73 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-O 122.245 1.022 . . . . 71.439999999999998 110.206 178.041 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -107.31 108.54 19.98 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.076 -0.965 . . . . 24.140000000000001 109.368 176.076 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 136.69 -17.13 3.72 Favored Glycine 0 C--N 1.304 -1.218 0 C-N-CA 120.323 -0.942 . . . . 63.140000000000001 111.971 177.27 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -91.79 179.12 5.71 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.412 -0.959 . . . . 52.130000000000003 108.412 178.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 21.1 m -75.05 155.55 37.11 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 105.455 -2.054 . . . . 71.239999999999995 105.455 171.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.499 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 9.2 p -62.23 -43.79 98.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 118.794 0.725 . . . . 63.32 111.642 -176.624 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 20.5 t70 -63.56 -40.3 96.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.74 0.305 . . . . 54.340000000000003 110.477 179.565 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 58.5 t -70.23 -39.81 77.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.33 0 CA-C-N 116.146 -0.479 . . . . 65.019999999999996 109.991 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.633 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -60.9 -44.76 96.68 Favored 'General case' 0 C--O 1.209 -1.069 0 N-CA-C 109.671 -0.492 . . . . 41.329999999999998 109.671 176.569 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 22.8 mt-30 -64.81 -42.69 94.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.157 -0.474 . . . . 61.219999999999999 110.715 -179.216 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.522 ' O ' HG23 ' A' ' 514' ' ' VAL . 75.3 mmtt -66.46 -42.67 87.2 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.252 -0.431 . . . . 75.140000000000001 110.49 177.792 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -67.62 -38.05 83.36 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.621 0.724 . . . . 70.450000000000003 111.08 -177.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.43 -46.49 86.09 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.565 -1.198 . . . . 72.319999999999993 108.343 177.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -61.09 -33.83 73.97 Favored 'General case' 0 N--CA 1.423 -1.823 0 C-N-CA 124.088 0.955 . . . . 61.020000000000003 112.937 -178.129 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 510' ' ' LYS . 65.9 t -56.58 -34.26 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.199 0.523 . . . . 73.109999999999999 110.54 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -110.96 -2.21 16.08 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.584 0.707 . . . . 72.400000000000006 110.147 -178.359 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -110.33 -63.54 0.52 Allowed Glycine 0 N--CA 1.414 -2.802 0 CA-C-N 115.439 -0.8 . . . . 74.0 112.366 -173.354 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 64.82 21.95 12.44 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 122.426 1.108 . . . . 74.25 109.503 -172.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.3 p -89.19 -169.89 2.68 Favored 'General case' 0 N--CA 1.408 -2.54 0 CA-C-N 113.367 -1.742 . . . . 73.040000000000006 110.417 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -111.79 141.13 45.8 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 109.173 -0.677 . . . . 70.519999999999996 109.173 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -132.48 151.11 52.02 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.657 0.741 . . . . 73.019999999999996 112.25 -175.121 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 55.1 p -138.82 157.18 46.54 Favored 'General case' 0 N--CA 1.403 -2.803 0 N-CA-C 106.62 -1.622 . . . . 44.210000000000001 106.62 178.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -131.44 147.11 52.52 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 109.524 -0.547 . . . . 73.450000000000003 109.524 -178.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -142.45 143.29 32.53 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.27 -1.381 . . . . 62.039999999999999 107.27 175.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 18.3 m -103.15 136.1 43.58 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-O 121.442 0.639 . . . . 70.019999999999996 112.07 -174.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 10.8 p -124.11 154.02 30.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 106.285 -1.746 . . . . 73.310000000000002 106.285 175.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.522 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 6.0 p-10 -91.52 135.88 33.53 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 120.078 -0.649 . . . . 51.049999999999997 111.146 -178.228 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.537 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 57.4 m -163.64 165.13 14.35 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 107.163 -1.421 . . . . 42.520000000000003 107.163 -178.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -66.72 -7.95 19.78 Favored 'Trans proline' 0 CA--C 1.549 1.24 0 C-N-CA 122.177 1.918 . . . . 73.040000000000006 113.962 179.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.442 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 0.0 OUTLIER -74.12 127.51 87.85 Favored Pre-proline 0 C--O 1.238 0.482 0 N-CA-C 107.898 -1.149 . . . . 72.120000000000005 107.898 176.555 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.9 145.66 83.39 Favored 'Trans proline' 0 C--O 1.25 1.12 0 C-N-CA 122.888 2.392 . . . . 74.239999999999995 112.911 -177.18 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -54.56 117.96 3.78 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.739 -1.119 . . . . 64.510000000000005 111.806 -177.186 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 127.62 -24.74 5.17 Favored Glycine 0 N--CA 1.428 -1.839 0 CA-C-N 115.227 -0.897 . . . . 73.239999999999995 111.458 178.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -83.11 138.5 33.65 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.91 -0.404 . . . . 71.219999999999999 109.91 178.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.452 HG11 ' CB ' ' A' ' 508' ' ' ALA . 4.3 p -101.25 116.78 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 CA-C-O 121.902 0.858 . . . . 62.340000000000003 109.361 -177.403 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.1 p -81.04 -8.68 59.82 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.575 -1.193 . . . . 65.230000000000004 112.809 -178.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.65 -164.96 29.14 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.471 -0.871 . . . . 61.009999999999998 112.487 175.398 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 21.8 p -116.77 158.5 23.79 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.423 -1.325 . . . . 65.450000000000003 107.423 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -63.54 -56.82 23.16 Favored Pre-proline 0 C--O 1.241 0.626 0 C-N-CA 118.184 -1.406 . . . . 72.299999999999997 112.172 176.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.14 137.34 40.36 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 120.822 1.014 . . . . 65.329999999999998 109.628 173.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.38 148.03 93.05 Favored 'Trans proline' 0 C--O 1.25 1.106 0 C-N-CA 122.464 2.109 . . . . 62.539999999999999 112.422 -178.415 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.35 143.07 50.61 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.009 -0.541 . . . . 63.229999999999997 110.31 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.66 -18.73 54.65 Favored Glycine 0 C--N 1.303 -1.283 0 N-CA-C 111.549 -0.62 . . . . 40.109999999999999 111.549 -177.348 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 53.3 m -73.26 136.85 44.64 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.533 0.206 . . . . 70.510000000000005 110.772 -179.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 13.5 t -88.59 134.53 33.85 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.502 -0.555 . . . . 62.100000000000001 109.502 177.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.49 155.92 80.69 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 107.847 -1.168 . . . . 75.540000000000006 107.847 177.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.456 ' HA ' HG22 ' A' ' 494' ' ' THR . 23.1 Cg_exo -59.09 141.68 98.45 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.598 1.532 . . . . 51.450000000000003 111.17 177.12 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 8.3 p -60.16 -19.79 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 CA-C-N 115.627 -0.715 . . . . 72.25 111.619 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -98.92 -5.15 31.27 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 121.539 0.685 . . . . 75.439999999999998 111.107 178.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 34.2 t -72.82 151.61 41.94 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 121.185 0.516 . . . . 73.129999999999995 110.273 -178.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.9 p -98.24 121.2 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.983 0 CA-C-N 115.358 -0.837 . . . . 73.120000000000005 109.015 179.273 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 54.9 mt -92.79 139.51 17.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.76 -0.83 . . . . 71.420000000000002 108.76 -177.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -103.71 123.42 46.99 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.756 0.789 . . . . 62.130000000000003 111.82 178.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.3 mp -103.57 126.95 51.03 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.409 -1.268 . . . . 71.349999999999994 108.832 177.159 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -90.13 116.01 27.81 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.566 0.698 . . . . 72.0 110.804 -178.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 524' ' ' SER . 25.6 t -90.72 129.21 41.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 107.704 -1.221 . . . . 73.019999999999996 107.704 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 43.4 t -87.48 125.09 34.1 Favored 'General case' 0 N--CA 1.403 -2.798 0 N-CA-C 108.6 -0.889 . . . . 65.420000000000002 108.6 177.114 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 3.2 ptpp? -105.46 139.31 40.28 Favored 'General case' 0 N--CA 1.406 -2.667 0 N-CA-C 106.706 -1.59 . . . . 63.030000000000001 106.706 169.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -58.18 -21.9 48.21 Favored Glycine 0 C--N 1.312 -0.769 0 O-C-N 124.295 0.997 . . . . 71.450000000000003 112.126 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 24.5 t-20 90.43 -2.74 0.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 126.771 2.028 . . . . 71.310000000000002 107.796 -179.468 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.426 ' HG2' ' N ' ' A' ' 615' ' ' ASN . 98.0 mt-30 -112.82 147.73 36.32 Favored 'General case' 0 N--CA 1.405 -2.724 0 CA-C-N 114.135 -1.393 . . . . 72.310000000000002 112.64 -169.33 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -123.31 158.34 31.21 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 114.19 -1.368 . . . . 73.25 107.496 177.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.84 120.31 13.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 121.114 0.483 . . . . 52.229999999999997 111.368 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 22.2 ttt -70.52 123.62 89.38 Favored Pre-proline 0 N--CA 1.434 -1.243 0 C-N-CA 123.86 0.864 . . . . 72.430000000000007 111.335 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -67.25 169.32 15.57 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.316 2.677 . . . . 53.340000000000003 112.16 176.248 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -87.43 124.31 33.29 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.088 0.471 . . . . 64.310000000000002 111.753 -177.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . 0.534 HD23 ' O ' ' A' ' 566' ' ' LEU . 9.5 tt -133.66 18.93 3.89 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 122.533 1.158 . . . . 72.349999999999994 108.35 -177.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 77.2 p -77.46 143.76 38.29 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 121.496 -0.752 . . . . 54.329999999999998 112.36 -174.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 65.24 42.76 96.12 Favored Glycine 0 N--CA 1.453 -0.182 0 CA-C-N 115.693 -0.685 . . . . 72.319999999999993 114.642 174.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 22.7 ptp -137.57 177.5 7.82 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.042 -0.725 . . . . 44.100000000000001 109.042 177.193 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -94.42 178.24 5.68 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.616 -0.513 . . . . 70.319999999999993 109.616 -178.044 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . 0.438 ' CZ3' HD22 ' A' ' 587' ' ' LEU . 18.9 t-105 -68.97 -30.22 68.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.786 -1.191 . . . . 74.219999999999999 107.786 175.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.0 p -74.94 -9.21 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-N 115.203 -0.908 . . . . 35.439999999999998 110.388 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.635 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 15.3 m-20 -99.25 -37.49 9.25 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 108.519 -0.919 . . . . 72.299999999999997 108.519 173.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -59.46 -43.95 93.08 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.108 -0.951 . . . . 54.140000000000001 111.926 179.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.616 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 33.3 mt-10 -57.66 -52.43 74.38 Favored Pre-proline 0 CA--C 1.556 1.187 0 N-CA-C 113.941 1.089 . . . . 74.239999999999995 113.941 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.3 -33.76 98.0 Favored 'Trans proline' 0 C--N 1.364 1.349 0 CA-C-N 120.438 1.192 . . . . 61.32 112.993 173.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.635 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 9.3 mmp_? -64.29 -45.55 87.48 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 109.57 -0.53 . . . . 71.409999999999997 109.57 178.101 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.3 pp -66.11 -44.04 85.45 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.833 -0.621 . . . . 60.240000000000002 112.162 -172.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -66.67 -37.83 85.56 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.161 -0.472 . . . . 64.120000000000005 110.928 178.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -71.28 -37.12 71.9 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 112.008 0.373 . . . . 73.439999999999998 112.008 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.0 pp -83.76 -9.35 58.88 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 120.532 -0.467 . . . . 73.439999999999998 110.794 -179.022 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 75.95 44.96 17.62 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 121.232 -0.509 . . . . 72.430000000000007 112.467 179.033 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -75.96 127.46 33.03 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.968 -0.753 . . . . 63.539999999999999 108.968 178.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 1.3 p -86.72 -32.68 20.32 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 124.303 1.041 . . . . 75.129999999999995 113.006 -178.068 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -82.91 -169.35 44.37 Favored Glycine 0 C--N 1.311 -0.836 0 N-CA-C 113.951 0.341 . . . . 73.420000000000002 113.951 -178.075 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 85.3 mtp -115.55 150.38 36.68 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 110.216 -0.29 . . . . 61.340000000000003 110.216 -178.408 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . 0.438 HD22 ' CZ3' ' A' ' 571' ' ' TRP . 2.3 tt -80.43 130.23 35.03 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.228 -1.027 . . . . 72.400000000000006 108.228 -179.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 621' ' ' THR . 21.3 t70 -126.77 122.63 35.34 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.611 -0.722 . . . . 72.349999999999994 110.933 -178.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.0 OUTLIER -101.94 128.48 48.33 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 118.302 -1.359 . . . . 70.109999999999999 109.109 173.311 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -76.96 -38.3 30.94 Favored Glycine 0 N--CA 1.428 -1.885 0 C-N-CA 120.763 -0.732 . . . . 70.420000000000002 112.444 -176.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -136.74 147.66 46.83 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 121.012 0.434 . . . . 72.409999999999997 110.714 -177.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -99.18 125.79 44.83 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.002 -1.481 . . . . 70.299999999999997 107.002 176.04 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 59.5 t -104.19 131.23 53.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 107.911 -1.144 . . . . 72.319999999999993 107.911 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . 0.439 ' HA ' ' NE2' ' A' ' 626' ' ' GLN . 6.8 p-10 -74.34 117.78 16.55 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.824 0.821 . . . . 73.030000000000001 110.285 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -141.82 -62.84 0.45 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.487 -1.233 . . . . 73.140000000000001 109.356 -179.222 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 95.22 160.72 33.72 Favored Glycine 0 N--CA 1.407 -3.279 0 N-CA-C 110.655 -0.978 . . . . 62.020000000000003 110.655 -178.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.6 -33.04 61.97 Favored Glycine 0 C--N 1.292 -1.864 0 CA-C-N 115.031 -0.584 . . . . 43.509999999999998 113.735 -178.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 35.3 t -70.25 -29.19 65.93 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 109.647 -0.501 . . . . 52.409999999999997 109.647 -178.076 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -95.69 -2.28 48.31 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.493 -0.322 . . . . 73.519999999999996 110.991 -178.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 73.24 116.45 0.05 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.966 1.307 . . . . 75.140000000000001 111.268 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -78.4 61.69 2.87 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.736 0.779 . . . . 70.420000000000002 110.781 -179.025 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -87.07 160.09 18.7 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.712 -0.676 . . . . 75.019999999999996 109.402 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.484 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 99.5 t -63.6 130.23 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 106.904 -1.517 . . . . 64.349999999999994 106.904 170.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.7 t -96.31 -47.45 12.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.384 0.611 . . . . 63.210000000000001 109.504 -175.173 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -150.58 144.43 25.27 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 106.925 -1.509 . . . . 73.040000000000006 106.925 -178.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -128.64 143.99 51.06 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.325 -0.991 . . . . 65.420000000000002 108.325 178.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.47 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 3.3 t-20 -60.18 -54.62 53.43 Favored Pre-proline 0 CA--C 1.553 1.067 0 N-CA-C 112.504 0.557 . . . . 74.25 112.504 -179.412 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 9.3 Cg_endo -94.24 123.44 0.41 Allowed 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 121.929 1.753 . . . . 72.349999999999994 111.954 178.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -67.67 153.46 76.01 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 122.168 1.912 . . . . 62.030000000000001 110.747 175.05 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.4 139.46 58.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.744 0.307 . . . . 60.119999999999997 110.275 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.14 -11.69 62.03 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 120.317 -0.944 . . . . 52.140000000000001 111.993 -178.368 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 90.6 m -76.58 146.34 38.38 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.763 -0.829 . . . . 62.020000000000003 108.763 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -73.81 122.69 7.75 Favored Glycine 0 N--CA 1.42 -2.415 0 C-N-CA 119.654 -1.26 . . . . 71.200000000000003 110.531 175.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.7 m -114.08 141.57 29.79 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 108.676 -0.861 . . . . 54.399999999999999 108.676 176.407 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.426 ' N ' ' HG2' ' A' ' 560' ' ' GLN . 33.4 p-10 -52.0 168.42 0.09 Allowed 'General case' 0 C--O 1.209 -1.072 0 C-N-CA 124.457 1.103 . . . . 72.310000000000002 112.696 -176.423 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -58.15 -24.77 60.1 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.819 0.674 . . . . 72.120000000000005 112.819 -176.486 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -88.56 -8.55 54.56 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 109.402 -0.592 . . . . 61.5 109.402 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.12 16.08 63.92 Favored Glycine 0 CA--C 1.502 -0.757 0 CA-C-N 116.016 -0.538 . . . . 64.230000000000004 113.95 171.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.17 119.31 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 122.208 1.004 . . . . 73.5 110.927 -167.165 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.425 ' O ' HD12 ' A' ' 620' ' ' ILE . 2.8 pp -129.0 134.05 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 114.477 -1.238 . . . . 73.310000000000002 110.673 -177.351 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 11.9 t -110.03 133.02 53.64 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.7 -0.852 . . . . 75.450000000000003 108.7 179.294 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 3.2 pp -138.78 168.75 19.12 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.69 -0.686 . . . . 75.219999999999999 110.788 -175.384 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -126.92 135.82 51.44 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.343 -0.984 . . . . 63.329999999999998 108.343 174.253 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.484 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 2.1 p90 -142.41 168.23 20.23 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.083 -0.508 . . . . 74.510000000000005 109.805 -172.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -56.25 109.52 1.56 Allowed Glycine 0 CA--C 1.529 0.926 0 O-C-N 123.954 0.784 . . . . 63.439999999999998 111.855 175.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.439 ' NE2' ' HA ' ' A' ' 594' ' ' ASP . 27.7 mm-40 . . . . . 0 C--O 1.263 1.783 0 C-N-CA 125.734 1.614 . . . . 74.349999999999994 112.745 -179.392 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.585 0 CA-C-O 122.016 0.912 . . . . 64.230000000000004 110.708 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 9.2 p -143.09 145.59 33.01 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 114.743 -1.117 . . . . 72.019999999999996 108.13 -178.606 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -140.54 140.81 35.28 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.265 -0.643 . . . . 44.520000000000003 109.265 -179.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.578 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.1 p-10 -78.83 140.48 38.17 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.395 0.617 . . . . 72.409999999999997 110.656 178.289 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 39.0 pt -96.36 137.07 21.62 Favored Pre-proline 0 C--N 1.294 -1.812 0 CA-C-N 114.91 -1.041 . . . . 75.230000000000004 109.776 179.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.22 176.89 9.24 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.979 1.786 . . . . 54.450000000000003 111.924 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.57 110.27 19.69 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.856 -1.165 . . . . 64.120000000000005 107.856 177.785 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 29.3 m -117.84 12.3 7.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-O 120.982 0.42 . . . . 73.420000000000002 111.812 -178.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -84.72 102.25 12.85 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.486 -0.485 . . . . 61.340000000000003 109.954 -178.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 156.38 -26.07 0.54 Allowed Glycine 0 C--N 1.301 -1.385 0 C-N-CA 120.653 -0.784 . . . . 42.350000000000001 112.136 179.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.47 ' O ' HG12 ' A' ' 534' ' ' VAL . 11.4 pm0 -102.44 -173.86 2.43 Favored 'General case' 0 N--CA 1.427 -1.605 0 O-C-N 122.527 -0.396 . . . . 63.530000000000001 110.276 177.49 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.1 m -69.84 155.46 40.52 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.474 -0.935 . . . . 62.32 108.474 -179.236 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.507 HG21 HG22 ' A' ' 555' ' ' VAL . 7.3 p -61.64 -42.68 95.13 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 O-C-N 123.018 0.199 . . . . 64.450000000000003 111.428 -178.276 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.71 -39.82 94.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.286 0.565 . . . . 71.349999999999994 110.21 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 66.9 t -70.36 -39.69 76.85 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.452 0 CA-C-N 115.431 -0.804 . . . . 71.319999999999993 109.8 178.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.22 -44.28 92.38 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 122.276 0.23 . . . . 62.109999999999999 110.996 177.783 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 23.0 mt-30 -63.1 -41.6 99.41 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.896 -0.409 . . . . 74.409999999999997 109.896 178.035 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 514' ' ' VAL . 72.3 mmtt -66.31 -38.79 88.54 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.939 -0.573 . . . . 74.209999999999994 111.897 175.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.14 -48.45 80.04 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 122.026 0.917 . . . . 74.450000000000003 108.8 176.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.426 HD11 HD12 ' A' ' 551' ' ' ILE . 2.2 tm? -59.55 -42.3 92.06 Favored 'General case' 0 C--O 1.21 -1.011 0 CA-C-N 113.909 -1.496 . . . . 72.209999999999994 109.623 -179.255 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 513' ' ' ASN . 2.2 t-20 -60.47 -35.21 75.35 Favored 'General case' 0 N--CA 1.427 -1.608 0 C-N-CA 124.169 0.988 . . . . 65.230000000000004 111.16 -179.732 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 510' ' ' LYS . 98.1 t -64.34 -35.85 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.444 0.64 . . . . 71.319999999999993 110.832 178.342 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -101.46 5.0 41.79 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.184 -0.462 . . . . 52.420000000000002 109.931 -177.079 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -132.94 -58.29 0.08 OUTLIER Glycine 0 N--CA 1.426 -2.033 0 C-N-CA 119.89 -1.148 . . . . 63.310000000000002 114.232 -171.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 59.66 29.56 19.13 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 122.465 1.126 . . . . 73.120000000000005 108.97 -172.631 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.1 p -96.87 -165.39 1.26 Allowed 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 114.061 -1.427 . . . . 65.319999999999993 110.559 -177.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -107.83 138.6 43.79 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.827 -1.175 . . . . 73.219999999999999 107.827 178.489 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -128.93 148.5 50.93 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.297 0.57 . . . . 72.319999999999993 111.192 -179.243 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.5 m -140.25 152.41 45.91 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.016 -1.105 . . . . 75.430000000000007 108.016 176.366 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -120.38 142.13 49.45 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.02 0.438 . . . . 62.020000000000003 111.041 -176.227 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -131.94 135.94 46.98 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.465 -1.68 . . . . 54.130000000000003 106.465 176.462 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 75.0 p -104.83 139.45 39.57 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.259 1.028 . . . . 74.150000000000006 113.234 -173.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.5 p -123.95 152.99 29.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 105.858 -1.904 . . . . 53.32 105.858 176.388 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.585 ' HA ' ' HG3' ' A' ' 557' ' ' LYS . 1.1 p-10 -84.74 136.94 33.5 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.407 -0.96 . . . . 65.209999999999994 108.407 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 23.3 m -149.45 169.87 8.53 Favored Pre-proline 0 C--N 1.285 -2.203 0 N-CA-C 107.586 -1.264 . . . . 43.219999999999999 107.586 -175.507 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -69.93 -16.3 36.8 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 121.992 1.795 . . . . 34.299999999999997 112.385 176.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.412 ' HD2' ' N ' ' A' ' 529' ' ' ARG . 3.2 mpt_? -81.57 135.0 50.05 Favored Pre-proline 0 CA--C 1.512 -0.492 0 CA-C-N 116.499 -0.319 . . . . 74.310000000000002 110.432 179.757 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.66 156.98 20.55 Favored 'Trans proline' 0 C--O 1.257 1.446 0 C-N-CA 123.141 2.561 . . . . 72.519999999999996 112.557 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.24 104.6 0.33 Allowed 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.348 -0.842 . . . . 71.329999999999998 111.251 -176.872 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 151.93 -26.33 0.92 Allowed Glycine 0 N--CA 1.419 -2.494 0 C-N-CA 120.142 -1.028 . . . . 74.099999999999994 112.707 179.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -82.67 144.49 30.23 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 119.378 -0.929 . . . . 75.409999999999997 109.33 -179.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 503' ' ' GLN . 7.4 p -92.34 117.63 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 CA-C-O 121.822 0.82 . . . . 72.430000000000007 108.845 177.568 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.99 -30.74 70.93 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.444 -1.253 . . . . 74.349999999999994 109.932 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 156.02 -167.62 33.32 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 111.085 -0.806 . . . . 43.109999999999999 111.085 178.61 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . 0.462 HG22 HD13 ' A' ' 553' ' ' LEU . 11.4 p -116.59 147.55 41.76 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.694 -0.854 . . . . 72.230000000000004 108.694 178.846 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -57.94 -50.32 88.75 Favored Pre-proline 0 N--CA 1.476 0.839 0 O-C-N 123.577 0.548 . . . . 74.140000000000001 111.458 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -76.29 131.0 12.43 Favored 'Trans proline' 0 N--CA 1.438 -1.76 0 N-CA-C 107.978 -1.585 . . . . 75.129999999999995 107.978 168.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -56.55 140.94 90.76 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 122.492 2.128 . . . . 71.120000000000005 111.736 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.01 137.83 58.0 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 120.702 0.287 . . . . 43.420000000000002 110.635 -178.746 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.69 -12.66 58.0 Favored Glycine 0 C--N 1.309 -0.949 0 N-CA-C 111.782 -0.527 . . . . 61.409999999999997 111.782 -176.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 26.4 m -84.35 137.31 33.49 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 122.85 -0.206 . . . . 62.32 110.567 -178.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 9.7 t -82.33 127.69 33.48 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.592 -0.892 . . . . 74.219999999999999 108.592 175.198 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.8 m -123.07 156.75 62.32 Favored Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 107.75 -1.204 . . . . 63.340000000000003 107.75 -179.053 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -65.44 137.66 51.8 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 120.834 1.023 . . . . 74.0 111.39 -179.205 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.8 p -64.98 -19.64 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.481 -0.781 . . . . 71.519999999999996 110.599 179.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -89.33 -12.32 40.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.183 0.516 . . . . 63.100000000000001 111.456 -179.041 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 50.4 m -87.21 163.78 16.71 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.617 0.722 . . . . 74.519999999999996 111.14 178.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.3 p -98.02 137.66 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.849 0 CA-C-N 115.122 -0.945 . . . . 55.140000000000001 109.462 178.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . 0.426 HD12 HD11 ' A' ' 512' ' ' LEU . 78.4 mt -94.41 135.56 28.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.985 -0.552 . . . . 62.520000000000003 110.306 -178.571 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -103.3 119.99 39.92 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-N 115.852 -0.613 . . . . 65.519999999999996 110.817 -173.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.462 HD13 HG22 ' A' ' 537' ' ' THR . 3.5 mm? -102.66 122.96 45.48 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 124.06 0.944 . . . . 75.010000000000005 109.235 177.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -85.13 122.28 29.11 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.895 -0.78 . . . . 71.340000000000003 108.895 174.163 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.507 HG22 HG21 ' A' ' 505' ' ' VAL . 26.5 t -98.69 134.18 38.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 108.573 -0.899 . . . . 43.0 108.573 179.482 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.638 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 23.6 m -85.06 117.77 24.23 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.92 -0.77 . . . . 54.140000000000001 108.92 176.492 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.585 ' HG3' ' HA ' ' A' ' 526' ' ' ASP . 2.6 ptpp? -96.66 133.33 41.32 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 106.612 -1.625 . . . . 72.319999999999993 106.612 166.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -60.13 -23.98 60.31 Favored Glycine 0 CA--C 1.492 -1.397 0 O-C-N 124.344 1.028 . . . . 72.010000000000005 113.167 -175.481 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . 0.497 ' OD1' ' HG3' ' A' ' 616' ' ' ARG . 45.1 t-20 79.77 -15.71 0.73 Allowed 'General case' 0 C--O 1.211 -0.951 0 C-N-CA 125.231 1.412 . . . . 75.5 108.587 179.403 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 86.3 mt-30 -112.52 141.72 45.93 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 115.563 -0.744 . . . . 71.109999999999999 112.233 -173.411 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -123.8 158.24 32.23 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.104 -1.407 . . . . 74.120000000000005 107.936 177.827 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.1 p -64.42 125.36 21.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.228 0.537 . . . . 72.540000000000006 110.078 177.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.529 ' SD ' HG21 ' A' ' 620' ' ' ILE . 52.1 ttp -83.88 133.52 45.91 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 109.874 -0.417 . . . . 72.450000000000003 109.874 -178.502 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.11 169.62 14.75 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.634 2.223 . . . . 63.299999999999997 110.768 174.732 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -82.48 134.11 35.21 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.276 0.56 . . . . 74.319999999999993 111.022 -178.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.5 pp -137.66 14.19 2.94 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.77 -1.105 . . . . 71.120000000000005 110.234 178.197 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 22.9 t -81.01 152.76 27.78 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.691 -1.14 . . . . 52.399999999999999 110.213 -178.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 64.21 26.14 70.24 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 114.942 0.737 . . . . 70.030000000000001 114.942 174.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . 0.452 ' SD ' ' HG3' ' A' ' 577' ' ' ARG . 20.4 ptp -127.08 171.99 10.9 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 122.305 -0.527 . . . . 71.310000000000002 109.945 179.41 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -95.98 165.44 12.26 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.054 -1.461 . . . . 64.040000000000006 107.054 -177.07 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -61.76 -30.04 70.53 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.373 -0.603 . . . . 63.43 109.373 178.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.82 -15.91 18.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.971 -0.559 . . . . 73.219999999999999 111.671 -178.447 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.431 ' C ' ' HD2' ' A' ' 576' ' ' PRO . 38.3 t70 -101.62 -28.5 12.47 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 122.245 1.022 . . . . 74.030000000000001 108.247 176.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 577' ' ' ARG . . . -67.91 -37.46 81.73 Favored 'General case' 0 C--O 1.212 -0.908 0 CA-C-N 114.565 -1.198 . . . . 73.200000000000003 111.275 177.307 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.526 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 23.5 tt0 -56.18 -51.13 83.2 Favored Pre-proline 0 CA--C 1.568 1.658 0 CA-C-O 119.373 -0.346 . . . . 75.329999999999998 110.973 178.269 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 85.1 Cg_exo -53.36 -37.36 81.34 Favored 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 122.095 1.863 . . . . 75.319999999999993 112.203 171.698 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.541 ' O ' ' HB3' ' A' ' 581' ' ' LEU . 1.5 mmp_? -58.62 -42.6 88.62 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.742 -0.208 . . . . 74.239999999999995 110.494 176.701 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.538 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 10.8 mp -63.47 -49.27 74.29 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 120.727 0.299 . . . . 71.420000000000002 110.993 -178.226 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -67.21 -39.69 86.32 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 113.303 0.853 . . . . 62.409999999999997 113.303 -179.229 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.06 -36.47 75.0 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.113 0.482 . . . . 33.399999999999999 111.453 -178.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.541 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 2.0 tp -81.47 -10.17 59.55 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.108 -0.496 . . . . 74.430000000000007 110.109 -179.59 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 61.88 40.25 98.59 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.728 -0.949 . . . . 52.119999999999997 110.728 -178.045 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.538 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 10.7 t90 -71.81 127.43 32.54 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 121.578 0.704 . . . . 75.430000000000007 109.675 -178.259 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 9.9 p -79.05 -50.05 11.68 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 114.534 -1.212 . . . . 71.420000000000002 111.807 -177.094 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -71.48 -169.47 10.43 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 116.004 1.162 . . . . 65.439999999999998 116.004 -176.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 61.7 mtm -113.76 155.94 24.73 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.105 -1.048 . . . . 72.310000000000002 108.501 -179.404 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 6.3 tt -85.14 119.82 25.96 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.039 -1.097 . . . . 70.340000000000003 108.039 179.255 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.647 ' O ' ' HA ' ' A' ' 621' ' ' THR . 23.4 t70 -95.75 104.87 16.82 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.66 0.743 . . . . 63.130000000000003 109.818 -179.666 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.505 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.1 OUTLIER -90.03 129.12 36.39 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.988 -0.745 . . . . 70.420000000000002 108.988 178.155 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -83.4 -48.95 5.13 Favored Glycine 0 C--N 1.28 -2.565 0 N-CA-C 109.936 -1.265 . . . . 53.240000000000002 109.936 -178.17 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.15 142.41 38.01 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 109.114 -0.699 . . . . 60.530000000000001 109.114 179.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -115.57 125.19 52.66 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.024 -1.472 . . . . 71.129999999999995 107.024 175.444 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.89 131.47 55.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 108.816 -0.809 . . . . 74.420000000000002 108.816 -176.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.96 108.09 5.68 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.164 -1.05 . . . . 64.329999999999998 108.164 178.687 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -115.23 -55.81 2.43 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 116.088 -0.506 . . . . 71.019999999999996 110.688 -174.577 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 89.4 148.12 17.81 Favored Glycine 0 N--CA 1.422 -2.278 0 C-N-CA 120.31 -0.947 . . . . 73.430000000000007 111.358 -175.098 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.25 -32.44 60.28 Favored Glycine 0 C--N 1.304 -1.216 0 C-N-CA 123.483 0.563 . . . . 65.030000000000001 113.487 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 14.4 m -66.19 -24.44 66.63 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 124.076 0.951 . . . . 72.219999999999999 110.545 -176.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -104.29 -0.73 27.93 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.106 -0.952 . . . . 53.329999999999998 109.533 -176.634 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 60.8 m80 69.04 93.69 0.08 Allowed 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 122.135 0.969 . . . . 74.239999999999995 110.692 -174.457 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -82.2 73.28 9.24 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.553 -1.203 . . . . 75.230000000000004 110.339 -179.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -106.33 162.74 13.41 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.701 -1.136 . . . . 71.099999999999994 110.659 -176.428 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 78.8 t -67.25 130.09 32.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 N-CA-C 106.295 -1.743 . . . . 73.340000000000003 106.295 169.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.91 -34.12 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 113.091 0.775 . . . . 73.510000000000005 113.091 -174.28 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . 0.496 ' HB3' ' CG ' ' A' ' 623' ' ' ARG . 46.8 t80 -141.77 135.85 30.12 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.752 -0.833 . . . . 73.540000000000006 108.752 -177.301 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -133.31 144.52 49.72 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.288 -1.375 . . . . 73.329999999999998 107.288 178.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.565 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 46.3 t30 -58.91 -54.72 53.66 Favored Pre-proline 0 CA--C 1.553 1.077 0 O-C-N 123.466 0.479 . . . . 73.109999999999999 111.899 -179.235 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 94.9 Cg_endo -105.31 117.16 0.04 OUTLIER 'Trans proline' 0 CA--C 1.571 2.349 0 C-N-CA 121.502 1.468 . . . . 73.310000000000002 111.508 173.649 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.0 160.57 40.85 Favored 'Trans proline' 0 N--CA 1.482 0.821 0 C-N-CA 122.92 2.413 . . . . 74.230000000000004 112.66 -178.489 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -53.0 132.51 37.79 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.8 0.44 . . . . 72.239999999999995 110.928 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.07 -6.03 42.75 Favored Glycine 0 C--O 1.24 0.503 0 C-N-CA 120.695 -0.764 . . . . 50.329999999999998 111.201 -176.597 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 608' ' ' PRO . 12.6 t -72.55 166.33 22.89 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 123.619 0.767 . . . . 74.409999999999997 109.69 178.832 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -104.09 118.38 5.96 Favored Glycine 0 N--CA 1.427 -1.937 0 N-CA-C 109.247 -1.541 . . . . 73.109999999999999 109.247 175.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 35.9 m -116.33 142.08 31.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.992 -0.373 . . . . 72.329999999999998 109.992 -179.643 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -57.53 169.81 0.62 Allowed 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 124.238 1.015 . . . . 65.420000000000002 112.805 -177.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . 0.497 ' HG3' ' OD1' ' A' ' 559' ' ' ASN 0.331 0.0 OUTLIER -59.29 -23.75 62.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 114.638 1.347 . . . . 75.099999999999994 114.638 178.832 . . . . . . . . 4 4 . 1 . 026 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -84.98 -8.55 58.69 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.015 -0.735 . . . . 74.430000000000007 109.015 175.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.24 12.55 58.38 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 123.682 0.658 . . . . 73.519999999999996 114.451 170.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.37 119.41 16.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 122.002 0.906 . . . . 71.140000000000001 112.076 -165.751 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.529 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.8 pp -126.82 134.84 65.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-N 114.507 -1.224 . . . . 54.350000000000001 112.592 -178.469 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.647 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 87.7 m -98.88 122.92 42.75 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.849 -0.614 . . . . 70.109999999999999 109.473 178.384 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 3.3 pp -139.1 167.01 23.02 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.092 0.404 . . . . 61.409999999999997 112.092 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . 0.496 ' CG ' ' HB3' ' A' ' 605' ' ' TYR . 18.4 ptp180 -127.79 137.8 52.52 Favored 'General case' 0 C--O 1.257 1.49 0 N-CA-C 107.69 -1.226 . . . . 75.129999999999995 107.69 175.453 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -141.07 165.37 27.74 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.389 -0.524 . . . . 62.140000000000001 111.77 -172.393 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -82.62 131.17 10.18 Favored Glycine 0 N--CA 1.417 -2.629 0 CA-C-N 114.97 -1.014 . . . . 74.209999999999994 110.907 175.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--N 1.276 -2.614 0 C-N-CA 125.35 1.46 . . . . 74.319999999999993 109.097 -179.734 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.719 0 CA-C-O 121.34 0.59 . . . . 73.040000000000006 111.807 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.458 ' HB ' HG22 ' A' ' 544' ' ' THR . 20.3 p -139.72 141.63 36.9 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.838 -0.619 . . . . 73.329999999999998 110.165 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . 0.61 ' HG2' ' O ' ' A' ' 515' ' ' TYR . 0.6 OUTLIER -138.11 139.64 39.56 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 122.572 0.349 . . . . 74.209999999999994 110.659 177.543 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.645 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.4 p-10 -85.98 140.68 30.1 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.943 -0.572 . . . . 61.450000000000003 109.795 173.283 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.5 pt -98.06 136.88 20.87 Favored Pre-proline 0 C--N 1.294 -1.829 0 CA-C-N 115.347 -0.842 . . . . 64.5 111.354 -178.205 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -81.94 -178.49 4.16 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.924 1.749 . . . . 73.319999999999993 110.756 175.197 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -83.48 118.62 23.88 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.737 -0.838 . . . . 73.340000000000003 108.737 177.246 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.475 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 27.1 m -110.47 12.23 8.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 122.101 0.953 . . . . 72.319999999999993 110.145 -178.817 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -80.63 100.67 8.77 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.545 -1.207 . . . . 21.210000000000001 109.998 178.347 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 149.88 -30.27 1.12 Allowed Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.892 -0.671 . . . . 53.210000000000001 111.906 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -91.65 177.47 6.2 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-O 121.232 0.539 . . . . 72.329999999999998 110.211 179.192 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 27.9 m -74.22 156.18 37.53 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.454 -1.314 . . . . 70.420000000000002 107.454 177.13 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.453 ' HA ' HG23 ' A' ' 534' ' ' VAL . 11.4 p -56.43 -45.19 81.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 112.87 0.693 . . . . 64.200000000000003 112.87 -179.523 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -62.18 -39.69 93.52 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 120.535 -0.466 . . . . 72.030000000000001 110.171 177.902 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 78.6 t -68.87 -44.39 81.78 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.866 0 CA-C-N 115.437 -0.801 . . . . 70.540000000000006 110.04 -178.577 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.475 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -63.58 -45.3 91.03 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 123.216 0.607 . . . . 55.310000000000002 110.522 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.8 mt-30 -65.06 -45.64 84.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 123.31 0.382 . . . . 72.239999999999995 110.841 -179.226 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.469 ' O ' HG23 ' A' ' 514' ' ' VAL . 20.9 ptmt -67.12 -38.48 85.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.043 0.449 . . . . 63.450000000000003 110.363 179.022 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -60.86 -49.59 76.85 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 124.169 0.988 . . . . 75.450000000000003 110.081 -178.531 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -69.17 -35.4 76.26 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 115.704 -0.68 . . . . 72.439999999999998 110.524 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.44 ' N ' HD12 ' A' ' 512' ' ' LEU . 2.3 t-20 -59.89 -39.49 85.49 Favored 'General case' 0 C--O 1.204 -1.33 0 C-N-CA 123.982 0.913 . . . . 64.430000000000007 110.587 -178.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 510' ' ' LYS . 82.0 t -57.56 -32.43 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-O 121.326 0.584 . . . . 74.120000000000005 111.793 179.272 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . 0.61 ' O ' ' HG2' ' A' ' 495' ' ' LYS . 60.6 m-85 -98.24 -26.26 14.59 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.439 0.638 . . . . 74.299999999999997 110.293 179.314 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -101.36 -58.09 0.82 Allowed Glycine 0 CA--C 1.478 -2.23 0 CA-C-N 115.464 -0.789 . . . . 74.219999999999999 113.554 -167.663 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 64.86 29.59 12.46 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.135 0.969 . . . . 64.439999999999998 109.898 -174.917 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.7 p -88.96 -166.52 1.62 Allowed 'General case' 0 N--CA 1.422 -1.849 0 C-N-CA 125.702 1.601 . . . . 52.310000000000002 111.026 -179.516 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 13.6 mptt -107.56 143.55 35.82 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.199 -1.408 . . . . 73.439999999999998 107.199 176.187 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -131.87 151.77 51.47 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 120.904 0.383 . . . . 71.219999999999999 111.986 -179.046 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 36.7 m -132.91 156.59 46.97 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.887 -1.524 . . . . 70.319999999999993 106.887 177.369 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -129.41 144.85 51.41 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 110.03 -0.359 . . . . 62.409999999999997 110.03 177.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -137.75 127.24 24.95 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.955 -1.128 . . . . 71.549999999999997 107.955 176.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 15.0 m -99.3 125.27 44.91 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.053 0.454 . . . . 64.140000000000001 111.942 -175.771 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 41.9 t -121.73 151.37 25.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 106.868 -1.53 . . . . 63.43 106.868 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.34 135.62 50.62 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 121.407 0.622 . . . . 73.099999999999994 111.507 -178.571 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . 0.614 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 49.3 m -155.38 170.42 8.73 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 108.451 -0.944 . . . . 61.32 108.451 -178.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.87 -16.86 25.91 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 122.14 1.893 . . . . 74.430000000000007 114.031 -179.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.23 149.47 38.59 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 119.509 -0.877 . . . . 74.409999999999997 111.843 -176.521 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.95 147.65 72.77 Favored 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 123.27 2.647 . . . . 72.25 112.882 -176.078 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.715 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.65 103.86 0.37 Allowed 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 114.858 -1.065 . . . . 50.350000000000001 113.119 -174.115 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 147.04 -17.03 1.55 Allowed Glycine 0 N--CA 1.422 -2.242 0 CA-C-N 115.043 -0.981 . . . . 62.439999999999998 111.643 -178.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -82.22 141.76 32.71 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.628 -0.508 . . . . 63.240000000000002 109.628 177.843 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.453 HG23 ' HA ' ' A' ' 505' ' ' VAL . 41.4 t -93.32 115.84 33.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.039 -0.726 . . . . 73.340000000000003 109.039 176.438 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . 0.581 HG23 ' HB2' ' A' ' 556' ' ' SER . 2.3 p -83.87 -17.81 39.6 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.241 -0.891 . . . . 73.230000000000004 112.357 178.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 165.88 174.86 35.79 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.185 -1.007 . . . . 73.030000000000001 112.404 178.246 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 5.7 p -117.38 152.89 34.03 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.222 -1.029 . . . . 73.239999999999995 108.222 177.359 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -67.22 -50.64 38.98 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 118.333 -1.347 . . . . 75.319999999999993 111.151 176.447 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -67.87 127.75 16.67 Favored 'Trans proline' 0 C--N 1.377 2.057 0 N-CA-C 108.043 -1.56 . . . . 61.340000000000003 108.043 170.074 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -68.92 157.39 62.04 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 122.236 1.957 . . . . 75.030000000000001 113.879 -175.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.17 136.12 56.94 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.622 -0.717 . . . . 73.299999999999997 110.444 179.646 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.51 -11.25 59.65 Favored Glycine 0 C--N 1.305 -1.155 0 N-CA-C 111.637 -0.585 . . . . 21.109999999999999 111.637 -178.491 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 28.4 m -77.87 127.98 33.24 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 122.568 -0.372 . . . . 52.020000000000003 110.945 -178.426 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.645 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 24.8 m -87.73 123.65 32.76 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 108.0 -1.111 . . . . 72.409999999999997 108.0 175.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.75 157.57 62.42 Favored Pre-proline 0 C--N 1.301 -1.503 0 N-CA-C 108.763 -0.828 . . . . 71.150000000000006 108.763 -178.826 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -63.87 140.65 74.4 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.615 1.543 . . . . 73.140000000000001 110.763 177.371 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 14.6 p -56.85 -25.62 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-O 121.455 0.645 . . . . 64.530000000000001 110.855 178.158 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.05 -15.08 52.44 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.738 -0.664 . . . . 62.32 112.008 -178.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 97.0 p -82.94 178.08 8.33 Favored 'General case' 0 C--O 1.254 1.32 0 N-CA-C 113.388 0.885 . . . . 63.439999999999998 113.388 -174.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 15.0 p -117.03 138.04 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.518 -0.765 . . . . 70.010000000000005 110.933 -176.488 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 54.9 mt -108.59 134.35 50.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.687 -0.857 . . . . 52.520000000000003 108.687 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -104.27 122.95 46.47 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.43 0.633 . . . . 73.030000000000001 112.563 179.529 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.23 119.37 34.6 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 125.487 1.515 . . . . 72.439999999999998 109.685 -179.525 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -88.82 113.81 24.76 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.656 0.741 . . . . 75.040000000000006 109.485 175.317 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 524' ' ' SER . 42.8 t -94.97 131.21 42.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 114.456 -1.247 . . . . 75.140000000000001 109.521 -175.754 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.715 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 39.1 t -77.47 117.63 19.12 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 108.261 -1.014 . . . . 62.329999999999998 108.261 176.693 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.15 134.07 43.61 Favored 'General case' 0 N--CA 1.417 -2.118 0 N-CA-C 105.444 -2.058 . . . . 74.140000000000001 105.444 168.725 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' A' ' 560' ' ' GLN . . . -64.01 -24.44 68.58 Favored Glycine 0 CA--C 1.499 -0.94 0 N-CA-C 110.484 -1.046 . . . . 75.019999999999996 110.484 179.253 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 63.5 t30 63.83 24.67 13.83 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.962 1.305 . . . . 65.540000000000006 108.438 -179.192 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 558' ' ' GLY . 97.7 mt-30 -127.52 155.57 43.56 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 114.48 -1.236 . . . . 74.5 111.234 -173.429 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -131.22 151.12 51.79 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.893 -1.049 . . . . 73.430000000000007 108.264 176.277 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.19 123.07 16.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-O 121.439 0.638 . . . . 62.530000000000001 110.317 178.777 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.536 ' SD ' HG13 ' A' ' 620' ' ' ILE . 42.9 ttp -86.45 125.63 66.96 Favored Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 115.495 -0.775 . . . . 62.450000000000003 111.014 -178.458 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 24.1 Cg_exo -65.43 170.41 10.98 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.687 2.925 . . . . 55.299999999999997 112.402 176.591 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.94 115.51 15.71 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.46 -0.336 . . . . 71.049999999999997 110.492 -179.681 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -91.59 -16.66 26.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.87 0.843 . . . . 70.239999999999995 109.047 175.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 15.3 m -73.91 140.1 45.41 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.156 -0.929 . . . . 42.229999999999997 110.008 -179.331 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 94.17 11.42 57.47 Favored Glycine 0 C--O 1.217 -0.921 0 C-N-CA 120.713 -0.756 . . . . 62.030000000000001 114.395 177.065 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . 0.443 ' HB2' ' HB2' ' A' ' 573' ' ' ASP . 23.9 ptp -131.83 167.6 19.27 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.329 -0.989 . . . . 70.019999999999996 108.329 176.759 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -88.9 170.34 10.79 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.049 -1.093 . . . . 62.329999999999998 108.049 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -65.95 -28.31 68.82 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.416 -0.957 . . . . 74.540000000000006 108.416 176.331 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.7 p -75.53 -11.85 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-N 115.297 -0.865 . . . . 73.299999999999997 110.564 -179.283 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 56.5 m-20 -98.72 -40.56 8.1 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 107.441 -1.318 . . . . 74.400000000000006 107.441 174.161 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . 0.73 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -55.83 -54.3 46.16 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-N 114.566 -1.197 . . . . 74.310000000000002 112.87 -176.636 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 40.4 mt-10 -57.77 -48.57 96.95 Favored Pre-proline 0 N--CA 1.473 0.686 0 N-CA-C 113.7 1.0 . . . . 64.400000000000006 113.7 -178.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -52.96 -38.2 79.27 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.168 1.912 . . . . 75.120000000000005 112.761 171.575 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 3.6 mmp_? -68.71 -38.89 80.6 Favored 'General case' 0 C--O 1.199 -1.554 0 N-CA-C 109.929 -0.397 . . . . 71.310000000000002 109.929 176.537 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.73 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 65.3 mt -65.26 -47.11 77.88 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 122.66 0.384 . . . . 74.200000000000003 110.634 -175.401 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 35.7 ptt85 -66.0 -35.16 79.82 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 116.29 -0.414 . . . . 74.319999999999993 111.659 176.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.44 -30.79 67.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.481 0.658 . . . . 71.340000000000003 110.619 177.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 14.1 tp -80.85 -9.05 59.86 Favored 'General case' 0 N--CA 1.425 -1.707 0 C-N-CA 124.14 0.976 . . . . 70.530000000000001 110.175 179.595 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 67.44 46.5 69.56 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.346 -0.454 . . . . 41.549999999999997 112.002 178.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.422 ' CE3' HD22 ' A' ' 578' ' ' LEU . 12.5 t90 -83.5 131.13 35.03 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.924 -0.399 . . . . 65.540000000000006 109.924 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 12.8 p -100.12 -26.77 13.84 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.29 1.036 . . . . 71.140000000000001 112.748 -178.193 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -82.16 -175.19 50.4 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 116.283 -0.417 . . . . 74.450000000000003 113.644 -177.069 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 70.5 mtm -107.19 149.56 27.58 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.968 -0.382 . . . . 73.219999999999999 109.968 -178.514 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.9 tt -91.83 130.18 37.65 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.074 -1.084 . . . . 75.129999999999995 108.074 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 621' ' ' THR . 14.0 t70 -112.19 123.42 50.22 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.266 -1.013 . . . . 64.439999999999998 108.266 176.62 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.531 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -104.07 133.91 48.22 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.285 0.564 . . . . 75.310000000000002 109.563 -178.595 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -74.93 -53.86 6.08 Favored Glycine 0 C--N 1.281 -2.504 0 N-CA-C 110.603 -0.999 . . . . 75.310000000000002 110.603 -179.303 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.29 141.8 35.75 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.083 -0.558 . . . . 54.399999999999999 110.485 -179.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -117.21 124.53 49.32 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 104.311 -2.477 . . . . 72.109999999999999 104.311 168.136 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.17 117.06 51.02 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 109.156 -0.683 . . . . 54.210000000000001 109.156 -175.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . 0.43 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 4.8 p-10 -73.34 123.21 23.34 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.612 0.72 . . . . 70.549999999999997 109.118 179.707 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -132.23 -5.31 3.42 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 114.985 -1.007 . . . . 52.350000000000001 110.433 179.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 93.71 137.01 8.26 Favored Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 120.164 -1.017 . . . . 43.32 111.907 -178.369 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.71 -32.9 62.16 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 122.956 0.312 . . . . 52.25 113.542 -179.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 47.9 t -63.62 -23.93 67.59 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.054 0.93 . . . . 71.540000000000006 110.644 -175.686 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -89.46 -1.08 57.92 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.195 -0.911 . . . . 64.439999999999998 111.879 -174.723 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 60.5 m170 60.35 86.65 0.1 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.789 0.804 . . . . 60.520000000000003 111.652 -179.225 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -88.45 85.88 6.94 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.509 1.147 . . . . 63.130000000000003 112.241 -176.59 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . 0.41 ' HG2' ' H ' ' A' ' 602' ' ' ARG . 5.5 ptp180 -92.41 169.57 10.46 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 113.164 -1.835 . . . . 61.149999999999999 110.258 -179.799 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 96.7 t -73.07 130.28 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 105.357 -2.09 . . . . 74.519999999999996 105.357 173.42 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.6 m -105.26 -28.97 2.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 120.2 -0.6 . . . . 51.25 112.371 -173.359 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -156.1 142.43 18.4 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 109.545 -0.539 . . . . 75.25 109.545 -176.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -121.42 138.63 54.19 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.13 -1.063 . . . . 73.340000000000003 108.13 175.421 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.523 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 3.0 t-20 -60.26 -51.91 76.93 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 123.303 0.377 . . . . 55.439999999999998 111.023 -175.591 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.5 Cg_endo -88.84 118.74 0.97 Allowed 'Trans proline' 0 N--CA 1.437 -1.829 0 N-CA-C 107.934 -1.602 . . . . 62.039999999999999 107.934 169.138 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 28.1 Cg_exo -63.54 159.68 39.47 Favored 'Trans proline' 0 C--O 1.249 1.042 0 C-N-CA 122.206 1.938 . . . . 74.120000000000005 112.681 -176.208 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -62.35 139.04 58.54 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.987 -0.551 . . . . 74.129999999999995 109.872 179.269 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.66 -8.74 60.12 Favored Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 120.189 -1.005 . . . . 65.230000000000004 111.668 -177.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 79.5 m -80.07 138.78 37.04 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.554 -0.906 . . . . 72.329999999999998 108.554 178.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -77.19 122.85 6.29 Favored Glycine 0 N--CA 1.419 -2.499 0 N-CA-C 110.379 -1.089 . . . . 53.25 110.379 177.847 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 28.4 m -112.49 141.84 26.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 108.697 -0.853 . . . . 51.009999999999998 108.697 177.071 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 559' ' ' ASN . 34.3 p-10 -54.89 173.37 0.09 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.536 0.734 . . . . 73.409999999999997 112.654 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -57.09 -24.92 57.44 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.524 0.935 . . . . 64.340000000000003 113.524 179.568 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -84.02 -9.67 58.47 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.557 -0.857 . . . . 52.43 110.077 178.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 65.33 19.03 66.02 Favored Glycine 0 C--O 1.22 -0.778 0 N-CA-C 114.576 0.59 . . . . 52.020000000000003 114.576 165.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.2 118.5 13.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-O 122.396 1.093 . . . . 63.100000000000001 112.135 -166.624 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.536 HG13 ' SD ' ' A' ' 563' ' ' MET . 0.0 OUTLIER -130.06 133.53 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 114.183 -1.371 . . . . 75.450000000000003 111.295 -176.473 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 42.0 m -105.06 126.74 52.4 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.614 -0.884 . . . . 72.239999999999995 108.614 178.843 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.3 pp -138.13 166.76 23.32 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.164 0.431 . . . . 70.219999999999999 112.164 -176.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -128.43 136.99 51.63 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.074 -0.713 . . . . 72.239999999999995 109.074 175.249 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -142.0 168.08 20.59 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.612 -1.255 . . . . 74.030000000000001 107.612 -174.363 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -70.52 -124.7 0.05 OUTLIER Glycine 0 CA--C 1.538 1.494 0 C-N-CA 119.177 -1.487 . . . . 64.310000000000002 110.765 172.572 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 7.9 tt0 . . . . . 0 C--N 1.27 -2.875 0 N-CA-C 108.729 -0.841 . . . . 74.549999999999997 108.729 175.761 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 113.084 0.772 . . . . 34.32 113.084 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 7.1 p -147.19 139.55 24.65 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 122.565 0.346 . . . . 74.310000000000002 110.29 -177.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -139.42 132.95 30.33 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.584 -0.895 . . . . 62.43 108.584 179.297 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.3 p-10 -95.1 135.26 36.86 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.43 0.633 . . . . 72.299999999999997 110.847 -177.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.4 pt -81.91 127.88 70.54 Favored Pre-proline 0 C--N 1.303 -1.449 0 CA-C-N 114.667 -1.151 . . . . 75.530000000000001 111.797 -175.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -82.3 178.48 6.24 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.319 2.013 . . . . 73.140000000000001 111.967 178.088 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -97.47 107.82 20.41 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 122.289 1.042 . . . . 64.219999999999999 110.075 178.448 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.441 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 25.7 m -111.39 18.75 7.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 114.4 -1.273 . . . . 74.209999999999994 109.566 179.389 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -74.16 100.6 3.71 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.734 -1.121 . . . . 50.420000000000002 110.342 -178.546 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 155.7 -41.53 0.58 Allowed Glycine 0 N--CA 1.426 -2.023 0 C-N-CA 120.953 -0.641 . . . . 53.149999999999999 111.641 177.576 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.483 ' O ' HG12 ' A' ' 534' ' ' VAL . 19.3 mp0 -77.13 -177.46 4.53 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.45 0.643 . . . . 70.219999999999999 110.381 -179.219 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 11.4 m -75.23 155.62 36.6 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 106.428 -1.693 . . . . 75.530000000000001 106.428 174.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.43 HG21 HG22 ' A' ' 555' ' ' VAL . 7.4 p -62.01 -42.13 93.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 118.166 0.439 . . . . 72.340000000000003 111.66 -178.285 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.91 -42.88 98.94 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 122.854 0.462 . . . . 65.140000000000001 110.609 178.678 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 82.3 t -67.6 -49.03 74.29 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.906 0 N-CA-C 109.139 -0.689 . . . . 64.219999999999999 109.139 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.461 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -59.28 -43.49 92.54 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 122.717 0.407 . . . . 75.230000000000004 111.897 -177.699 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.9 mt-30 -63.32 -44.34 95.21 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 120.757 0.313 . . . . 73.530000000000001 110.287 179.688 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.48 ' HA ' ' HE2' ' A' ' 510' ' ' LYS . 11.2 mmpt? -67.23 -40.22 86.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.406 -0.361 . . . . 64.200000000000003 110.155 178.51 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . 0.613 ' O ' HG12 ' A' ' 514' ' ' VAL . 9.2 m-20 -62.47 -45.66 92.04 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.316 -0.857 . . . . 73.040000000000006 111.688 -178.122 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . 0.458 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -69.05 -37.53 78.61 Favored 'General case' 0 C--O 1.211 -0.949 0 C-N-CA 119.683 -0.807 . . . . 55.409999999999997 110.722 -179.577 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.632 ' ND2' ' H ' ' A' ' 518' ' ' THR . 2.7 t-20 -64.36 -35.66 81.61 Favored 'General case' 0 N--CA 1.421 -1.915 0 C-N-CA 124.645 1.178 . . . . 70.040000000000006 111.108 -178.455 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 511' ' ' ASN . 5.0 p -67.26 -31.27 52.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.944 0.402 . . . . 72.409999999999997 110.764 -178.523 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -104.51 6.22 34.6 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.625 -0.509 . . . . 75.530000000000001 109.625 -179.58 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -131.1 -53.4 0.09 OUTLIER Glycine 0 CA--C 1.477 -2.31 0 C-N-CA 119.7 -1.238 . . . . 72.420000000000002 114.399 -168.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 65.16 77.32 0.31 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 106.939 -1.504 . . . . 71.349999999999994 106.939 -173.58 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.632 ' H ' ' ND2' ' A' ' 513' ' ' ASN . 3.3 p -140.29 177.1 8.23 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 115.061 -0.972 . . . . 72.329999999999998 111.539 -170.279 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.97 132.76 53.78 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.119 -1.438 . . . . 71.109999999999999 107.119 179.185 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -130.55 154.48 47.78 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.154 0.502 . . . . 73.219999999999999 112.095 -176.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 69.6 m -140.4 160.56 39.71 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 105.969 -1.863 . . . . 72.230000000000004 105.969 174.159 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.416 ' HB2' ' CG2' ' A' ' 555' ' ' VAL . 3.8 pt20 -131.11 135.98 47.98 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.695 -0.802 . . . . 75.530000000000001 111.035 -178.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.72 129.22 56.39 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.601 -1.259 . . . . 70.450000000000003 107.601 178.343 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.8 m -100.59 124.74 46.57 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.244 0.545 . . . . 64.319999999999993 111.842 -177.668 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.54 150.82 24.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.444 -1.317 . . . . 72.310000000000002 107.444 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -91.35 135.3 33.91 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.445 -0.576 . . . . 54.340000000000003 109.445 179.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 52.3 m -160.53 162.86 22.63 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 107.549 -1.278 . . . . 74.209999999999994 107.549 -175.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -64.15 -8.54 16.66 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.699 2.266 . . . . 75.25 113.564 178.587 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -74.07 134.49 77.58 Favored Pre-proline 0 N--CA 1.432 -1.333 0 N-CA-C 107.437 -1.32 . . . . 70.120000000000005 107.437 175.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.53 149.82 89.69 Favored 'Trans proline' 0 C--O 1.249 1.063 0 C-N-CA 122.303 2.002 . . . . 72.140000000000001 112.495 -175.789 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.26 120.09 7.53 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.357 -0.838 . . . . 62.409999999999997 111.979 -176.72 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.53 -20.77 10.12 Favored Glycine 0 N--CA 1.428 -1.872 0 CA-C-N 114.98 -1.009 . . . . 61.229999999999997 111.414 177.645 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -78.67 137.15 37.67 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.345 -0.613 . . . . 72.310000000000002 109.345 179.046 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.499 HG22 ' H ' ' A' ' 536' ' ' GLY . 11.5 p -99.47 120.49 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.091 0 N-CA-C 108.566 -0.901 . . . . 75.430000000000007 108.566 -179.217 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.21 -1.43 44.72 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.097 -0.956 . . . . 70.120000000000005 112.072 178.948 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.499 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 132.67 -141.57 12.95 Favored Glycine 0 N--CA 1.419 -2.447 0 N-CA-C 111.226 -0.75 . . . . 32.200000000000003 111.226 175.265 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 2.2 p -116.61 157.14 25.83 Favored 'General case' 0 C--N 1.262 -3.217 0 N-CA-C 108.547 -0.908 . . . . 74.299999999999997 108.547 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.515 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 55.1 t30 -64.92 -53.51 41.92 Favored Pre-proline 0 C--N 1.324 -0.51 0 C-N-CA 120.087 -0.645 . . . . 72.109999999999999 109.923 175.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 15.8 Cg_exo -71.66 137.63 30.48 Favored 'Trans proline' 0 C--N 1.372 1.782 0 N-CA-C 107.002 -1.961 . . . . 64.030000000000001 107.002 168.488 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -55.78 139.91 84.22 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.209 1.939 . . . . 75.209999999999994 113.384 -175.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.84 132.38 51.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.39 -0.823 . . . . 74.319999999999993 110.775 -178.356 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.75 -10.17 37.96 Favored Glycine 0 C--N 1.303 -1.253 0 N-CA-C 111.668 -0.573 . . . . 55.109999999999999 111.668 -175.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 86.8 m -77.46 129.02 35.19 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 122.817 -0.225 . . . . 72.010000000000005 110.517 179.563 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 11.3 t -82.14 125.55 31.02 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.095 -1.076 . . . . 61.539999999999999 108.095 174.926 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.73 160.0 53.23 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 109.189 -0.671 . . . . 54.049999999999997 109.189 -177.707 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -65.89 143.13 71.97 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.697 1.598 . . . . 72.510000000000005 110.14 177.054 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.44 -19.72 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 CA-C-O 121.591 0.71 . . . . 74.409999999999997 110.555 178.513 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.25 -12.76 59.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.884 -0.598 . . . . 75.299999999999997 111.848 176.18 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 10.2 t -93.06 148.19 22.21 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.92 -0.77 . . . . 75.019999999999996 108.92 -179.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 9.9 p -91.79 138.71 19.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 115.836 -0.62 . . . . 61.399999999999999 111.508 -177.062 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 60.0 mt -80.72 124.28 38.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.417 -0.957 . . . . 73.109999999999999 108.417 177.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -103.65 117.9 35.48 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.305 -0.998 . . . . 71.430000000000007 108.305 -178.227 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.5 128.54 41.15 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.253 0.621 . . . . 55.439999999999998 111.485 -178.561 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -83.0 102.76 11.96 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 123.204 0.602 . . . . 64.349999999999994 110.061 177.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.43 HG22 HG21 ' A' ' 505' ' ' VAL . 25.9 t -95.94 123.58 48.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.407 -0.961 . . . . 73.439999999999998 108.407 -179.654 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 51.1 m -95.07 127.99 41.55 Favored 'General case' 0 N--CA 1.409 -2.481 0 CA-C-O 121.457 0.646 . . . . 73.129999999999995 111.413 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -100.12 135.23 41.87 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 106.453 -1.684 . . . . 72.329999999999998 106.453 170.472 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -55.03 -22.88 29.86 Favored Glycine 0 CA--C 1.503 -0.676 0 O-C-N 124.698 1.249 . . . . 43.539999999999999 115.077 -172.748 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 81.73 -24.4 0.19 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.449 1.499 . . . . 71.209999999999994 109.755 -178.437 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.5 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 91.6 mt-30 -113.25 158.02 21.02 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.391 -0.822 . . . . 71.049999999999997 110.913 -176.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -127.02 150.21 49.54 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.217 -1.031 . . . . 74.450000000000003 108.217 175.359 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 31.0 t -71.28 118.14 15.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.588 -0.523 . . . . 62.130000000000003 109.588 -178.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.6 ' SD ' HG21 ' A' ' 620' ' ' ILE . 49.4 ttp -87.13 129.13 52.99 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-N 116.119 -0.491 . . . . 65.409999999999997 111.147 -176.314 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.49 169.55 22.28 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.529 2.153 . . . . 73.439999999999998 111.114 174.027 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -74.63 142.12 44.59 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.986 0.422 . . . . 73.099999999999994 110.375 179.168 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -135.05 15.46 3.53 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.936 0.874 . . . . 74.030000000000001 109.179 177.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 31.6 t -79.22 139.38 37.95 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.118 -0.947 . . . . 74.340000000000003 108.867 178.71 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 97.03 26.0 10.74 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.462 -0.875 . . . . 71.010000000000005 114.022 176.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.9 -175.55 3.71 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.964 -0.754 . . . . 74.530000000000001 108.964 177.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -117.06 159.07 23.11 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.65 -1.241 . . . . 75.219999999999999 107.65 -175.309 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . 0.415 ' CH2' ' HB3' ' A' ' 589' ' ' LYS . 27.2 t-105 -63.48 -24.81 67.98 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.324 0.583 . . . . 74.450000000000003 110.21 -176.398 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.0 m -66.97 -18.94 24.99 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 CA-C-N 115.025 -0.989 . . . . 62.329999999999998 110.735 179.247 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.547 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 22.9 t70 -101.69 -28.56 12.41 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.078 -0.712 . . . . 71.420000000000002 109.078 177.759 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -56.47 -47.52 79.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.962 0.905 . . . . 75.519999999999996 112.676 -178.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -64.25 -47.98 77.36 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 119.633 -0.827 . . . . 74.219999999999999 112.769 178.568 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -52.66 -37.2 74.65 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 121.999 1.8 . . . . 74.409999999999997 112.796 171.057 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 6.4 mmp_? -59.35 -44.27 92.7 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 109.347 -0.612 . . . . 70.519999999999996 109.347 176.446 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 583' ' ' TRP . 1.7 tp -59.85 -49.57 77.19 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-N 115.271 -0.877 . . . . 65.120000000000005 111.44 -176.149 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -66.73 -40.93 88.55 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.712 0.634 . . . . 73.129999999999995 112.712 176.682 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.62 -37.68 73.84 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.908 0.707 . . . . 75.329999999999998 112.908 -177.257 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.414 HD11 ' HB2' ' A' ' 583' ' ' TRP . 0.7 OUTLIER -82.89 -8.93 59.53 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 122.14 -0.35 . . . . 72.519999999999996 110.962 -174.918 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.26 47.03 18.7 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.145 -0.782 . . . . 43.219999999999999 111.145 -179.68 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . 0.528 ' HB3' HD12 ' A' ' 578' ' ' LEU . 12.4 t90 -87.18 127.86 35.14 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 121.636 0.731 . . . . 72.129999999999995 110.134 -178.689 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 27.0 m -89.1 -17.45 29.24 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 124.367 1.067 . . . . 71.340000000000003 112.947 -174.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -96.79 -171.04 34.2 Favored Glycine 0 CA--C 1.497 -1.038 0 C-N-CA 121.372 -0.442 . . . . 64.129999999999995 113.223 -176.142 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 81.4 mtp -117.73 155.85 29.27 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 120.908 0.385 . . . . 72.439999999999998 110.878 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . 0.523 ' HG ' ' CH2' ' A' ' 583' ' ' TRP . 5.0 mt -80.31 125.56 30.05 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 115.076 -0.965 . . . . 75.420000000000002 112.245 -178.48 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 621' ' ' THR . 2.4 m-20 -110.93 118.11 35.21 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.269 -1.332 . . . . 74.409999999999997 110.122 176.313 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.415 ' HB3' ' CH2' ' A' ' 571' ' ' TRP . 0.0 OUTLIER -107.33 133.83 51.29 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 120.176 -0.61 . . . . 75.430000000000007 109.39 -178.961 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -78.59 -69.85 1.36 Allowed Glycine 0 C--N 1.284 -2.322 0 CA-C-N 115.354 -0.839 . . . . 64.200000000000003 111.176 -179.686 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.09 149.24 42.84 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.706 0.288 . . . . 61.130000000000003 111.508 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -96.61 124.09 40.49 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 105.925 -1.88 . . . . 74.239999999999995 105.925 170.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 40.2 t -105.76 119.99 55.9 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.5 0 CA-C-N 115.683 -0.69 . . . . 75.349999999999994 109.832 -175.601 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -73.54 107.06 5.6 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.37 -0.974 . . . . 54.100000000000001 108.37 176.506 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -107.84 -39.75 5.47 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.432 0.634 . . . . 63.329999999999998 110.014 -179.338 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 114.34 152.06 10.49 Favored Glycine 0 N--CA 1.412 -2.9 0 N-CA-C 110.674 -0.971 . . . . 43.009999999999998 110.674 -177.225 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.98 -32.66 62.74 Favored Glycine 0 C--N 1.305 -1.174 0 C-N-CA 123.287 0.47 . . . . 35.25 113.1 -179.592 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 4.3 p -69.59 -24.92 63.74 Favored 'General case' 0 N--CA 1.422 -1.859 0 C-N-CA 124.283 1.033 . . . . 41.130000000000003 111.608 -176.466 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -93.95 -14.18 26.25 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.602 -0.726 . . . . 73.25 109.971 -177.006 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 65.1 m80 56.69 108.73 0.01 OUTLIER 'General case' 0 C--O 1.238 0.47 0 O-C-N 124.345 1.028 . . . . 63.32 111.684 -173.691 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . 0.401 ' HB3' ' HA3' ' A' ' 625' ' ' GLY . 48.1 m-80 -73.53 75.52 1.46 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.943 -1.026 . . . . 75.519999999999996 113.404 -172.177 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -86.5 171.24 11.24 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 124.702 1.201 . . . . 74.329999999999998 109.001 177.674 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.93 129.75 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.666 -1.976 . . . . 61.420000000000002 105.666 169.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 14.5 p -96.64 -32.32 4.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 120.13 -0.628 . . . . 64.340000000000003 110.424 -174.311 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -151.3 134.94 16.32 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 116.182 -0.463 . . . . 70.349999999999994 110.62 -179.449 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -106.54 130.16 54.36 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.321 -1.362 . . . . 71.120000000000005 107.321 172.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.432 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 24.2 t-20 -55.33 -55.52 38.85 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 113.654 0.983 . . . . 74.299999999999997 113.654 -176.695 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.3 Cg_endo -87.71 131.73 2.86 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.14 1.227 . . . . 53.409999999999997 110.433 175.589 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 38.5 Cg_exo -64.88 160.32 41.64 Favored 'Trans proline' 0 C--O 1.253 1.234 0 C-N-CA 122.642 2.228 . . . . 75.400000000000006 112.383 177.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -64.8 138.5 58.42 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.15 -0.685 . . . . 61.25 109.15 177.519 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 91.84 0.4 71.96 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 119.8 -1.19 . . . . 75.349999999999994 111.912 -179.178 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 24.0 m -90.35 146.31 24.28 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.881 -0.785 . . . . 52.100000000000001 108.881 178.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -83.56 123.2 6.06 Favored Glycine 0 N--CA 1.419 -2.45 0 N-CA-C 110.962 -0.855 . . . . 74.340000000000003 110.962 177.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.9 m -111.44 142.55 23.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 107.901 -1.148 . . . . 62.32 107.901 176.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.5 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 37.8 p30 -46.1 163.09 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 113.769 1.026 . . . . 72.439999999999998 113.769 179.077 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -57.15 -25.31 58.71 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.331 -0.85 . . . . 73.200000000000003 112.219 177.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.35 -10.96 59.75 Favored 'General case' 0 C--O 1.214 -0.802 0 C-N-CA 119.372 -0.931 . . . . 74.219999999999999 109.254 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.85 11.42 57.87 Favored Glycine 0 CA--C 1.494 -1.264 0 C-N-CA 123.455 0.55 . . . . 71.120000000000005 112.885 167.344 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.96 118.77 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.114 0 CA-C-O 122.44 1.114 . . . . 74.209999999999994 110.985 -169.638 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.6 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.7 pp -124.95 133.92 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 CA-C-N 113.74 -1.573 . . . . 62.450000000000003 111.813 -177.943 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 28.3 m -99.0 130.52 45.34 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.669 -1.234 . . . . 72.430000000000007 107.669 177.369 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.404 HD23 ' H ' ' A' ' 622' ' ' LEU . 2.0 pt? -138.65 162.78 33.77 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 110.145 -0.316 . . . . 62.109999999999999 110.145 -178.157 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -128.1 136.98 51.92 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.221 -1.4 . . . . 75.109999999999999 107.221 178.202 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -141.92 167.53 21.92 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.997 -0.547 . . . . 72.310000000000002 110.127 -168.432 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 601' ' ' ASN . . . -64.55 -170.43 2.21 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-O 121.944 0.747 . . . . 64.299999999999997 113.633 176.555 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 . . . . . 0 C--N 1.28 -2.418 0 C-N-CA 124.066 0.946 . . . . 74.109999999999999 111.0 -175.91 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.58 0 CA-C-O 121.42 0.629 . . . . 74.200000000000003 111.476 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 33.2 p -136.87 148.56 47.15 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 115.5 -0.773 . . . . 74.230000000000004 110.251 -178.622 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -140.66 153.54 46.04 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.026 -0.731 . . . . 74.329999999999998 109.026 176.213 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -90.2 140.77 29.35 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.215 0.531 . . . . 71.310000000000002 110.148 -178.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 22.8 pt -101.98 112.71 65.66 Favored Pre-proline 0 C--N 1.301 -1.515 0 CA-C-N 115.592 -0.731 . . . . 74.549999999999997 110.57 177.705 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -69.65 167.68 23.6 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.439 2.092 . . . . 74.239999999999995 112.264 177.46 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -75.2 96.11 3.25 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.477 0.656 . . . . 74.239999999999995 110.207 179.183 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 31.5 m -94.81 9.33 5.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 115.259 -0.882 . . . . 63.32 110.055 177.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.71 101.04 1.99 Allowed 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 114.638 -1.165 . . . . 61.119999999999997 110.222 -179.146 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 147.41 -23.18 1.53 Allowed Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 115.455 -0.793 . . . . 71.219999999999999 111.846 178.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.432 ' O ' HG12 ' A' ' 534' ' ' VAL . 1.9 mp0 -94.06 178.47 5.64 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 108.62 -0.881 . . . . 72.439999999999998 108.62 179.518 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 24.8 m -72.05 155.33 40.43 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.487 -1.301 . . . . 74.129999999999995 107.487 176.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.454 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.7 p -61.94 -43.21 97.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 111.42 0.156 . . . . 72.019999999999996 111.42 -178.73 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.16 -39.2 93.97 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 110.088 -0.338 . . . . 74.310000000000002 110.088 -179.314 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 99.7 t -69.06 -46.93 77.71 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 CA-C-N 115.142 -0.936 . . . . 63.020000000000003 109.748 -179.72 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.59 -44.38 96.29 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 122.99 0.181 . . . . 73.209999999999994 111.251 178.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.9 mt-30 -64.14 -46.55 83.62 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 120.699 0.285 . . . . 74.430000000000007 111.233 -178.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.451 ' O ' HG23 ' A' ' 514' ' ' VAL . 21.2 ptmt -67.1 -38.63 85.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.028 -0.533 . . . . 64.430000000000007 110.199 -178.099 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -67.13 -43.98 81.04 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.681 -0.69 . . . . 72.420000000000002 110.648 -179.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.07 -41.33 98.06 Favored 'General case' 0 C--O 1.207 -1.16 0 N-CA-C 108.317 -0.994 . . . . 74.140000000000001 108.317 -179.408 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -59.64 -34.89 73.38 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 124.12 0.968 . . . . 74.329999999999998 111.054 -179.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 510' ' ' LYS . 97.7 t -57.66 -38.2 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-O 121.168 0.508 . . . . 70.329999999999998 111.118 178.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.43 19.81 13.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 122.123 0.963 . . . . 64.420000000000002 111.159 -178.814 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -128.81 -59.43 0.11 Allowed Glycine 0 N--CA 1.416 -2.665 0 CA-C-N 114.68 -1.146 . . . . 63.030000000000001 111.595 -177.246 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 63.95 24.56 13.67 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 122.058 0.932 . . . . 75.420000000000002 110.016 -174.708 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 6.4 p -84.18 -179.66 7.27 Favored 'General case' 0 N--CA 1.404 -2.746 0 CA-C-N 113.984 -1.462 . . . . 63.009999999999998 110.277 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 56.7 mtpt -108.43 134.23 51.52 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.448 -1.686 . . . . 61.420000000000002 106.448 179.486 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -132.89 154.28 50.54 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 112.871 0.693 . . . . 72.450000000000003 112.871 -175.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 34.2 p -140.03 156.34 46.66 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.789 -1.189 . . . . 64.310000000000002 107.789 176.3 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -124.84 145.21 49.9 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.979 -0.288 . . . . 74.450000000000003 111.186 -178.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -132.59 117.53 18.06 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.388 -0.597 . . . . 42.240000000000002 109.388 177.526 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . 0.455 ' HA ' ' HB ' ' A' ' 555' ' ' VAL . 49.1 m -84.53 116.76 23.3 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.535 0.683 . . . . 74.310000000000002 110.157 178.58 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 44.9 t -120.96 149.81 23.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 106.435 -1.691 . . . . 72.530000000000001 106.435 -176.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -68.29 134.52 50.48 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 120.717 0.294 . . . . 54.530000000000001 110.588 -176.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 49.3 m -163.08 160.51 18.72 Favored Pre-proline 0 C--O 1.208 -1.116 0 N-CA-C 108.397 -0.964 . . . . 71.409999999999997 108.397 -179.726 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -73.48 3.35 4.84 Favored 'Trans proline' 0 CA--C 1.556 1.623 0 C-N-CA 122.624 2.216 . . . . 72.319999999999993 113.651 178.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . 0.477 ' HD2' ' N ' ' A' ' 529' ' ' ARG . 2.7 mpt_? -92.39 140.02 24.1 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 107.992 -1.114 . . . . 71.25 107.992 177.114 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -62.19 150.75 85.65 Favored 'Trans proline' 0 C--O 1.254 1.324 0 C-N-CA 122.847 2.365 . . . . 63.350000000000001 113.052 -176.438 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.625 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.47 110.11 1.18 Allowed 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.196 -0.911 . . . . 62.119999999999997 112.253 -174.752 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 136.86 -26.92 2.97 Favored Glycine 0 N--CA 1.433 -1.5 0 C-N-CA 120.621 -0.799 . . . . 73.049999999999997 112.394 177.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -82.03 140.57 33.84 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.044 0.45 . . . . 74.329999999999998 110.558 -178.281 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 503' ' ' GLN . 7.9 p -96.96 118.24 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 CA-C-O 121.687 0.756 . . . . 75.019999999999996 109.162 -179.509 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -25.77 54.46 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 114.853 -1.067 . . . . 60.299999999999997 110.999 179.275 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 162.44 -164.69 35.76 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 120.547 -0.835 . . . . 63.409999999999997 111.776 179.172 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 1.7 p -116.87 157.9 24.87 Favored 'General case' 0 C--N 1.282 -2.336 0 C-N-CA 123.184 0.594 . . . . 61.009999999999998 109.639 -178.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.432 ' HB2' HE22 ' A' ' 554' ' ' GLN . 25.0 t-20 -58.33 -54.46 55.68 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 120.712 -0.395 . . . . 72.519999999999996 110.657 175.533 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -73.2 135.99 23.68 Favored 'Trans proline' 0 C--N 1.359 1.102 0 N-CA-C 108.337 -1.447 . . . . 70.439999999999998 108.337 168.734 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.16 140.93 94.78 Favored 'Trans proline' 0 C--O 1.245 0.852 0 C-N-CA 122.406 2.071 . . . . 64.349999999999994 112.445 -178.069 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.46 140.48 58.03 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.955 -0.566 . . . . 71.129999999999995 110.004 -179.507 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.78 -15.09 55.94 Favored Glycine 0 C--N 1.3 -1.454 0 N-CA-C 110.775 -0.93 . . . . 74.209999999999994 110.775 -175.806 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.7 m -85.16 138.22 32.52 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 122.802 0.441 . . . . 63.240000000000002 109.955 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 8.0 t -76.29 128.06 34.14 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 108.645 -0.872 . . . . 71.519999999999996 108.645 173.057 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 32.1 m -123.78 154.79 67.23 Favored Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 108.691 -0.855 . . . . 64.299999999999997 108.691 -179.078 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -64.88 134.84 41.84 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 120.693 0.929 . . . . 74.109999999999999 111.703 178.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 8.6 p -67.38 -27.46 38.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.902 -1.044 . . . . 72.349999999999994 112.907 -176.206 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -90.19 -7.04 54.57 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.534 0.683 . . . . 63.329999999999998 110.908 -175.433 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.1 t -89.79 179.14 6.06 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.131 0.491 . . . . 63.109999999999999 109.684 -178.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 12.2 p -107.6 128.7 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.261 0 CA-C-N 115.511 -0.768 . . . . 73.049999999999997 109.82 -177.605 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 60.2 mt -93.22 135.95 26.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 108.4 -0.963 . . . . 75.25 108.4 -179.691 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -103.33 117.86 35.45 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.652 -0.499 . . . . 72.540000000000006 109.652 -176.687 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.426 HD12 HG21 ' A' ' 534' ' ' VAL . 3.6 mm? -95.46 120.83 36.38 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 123.748 0.819 . . . . 75.540000000000006 109.464 179.187 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . 0.432 HE22 ' HB2' ' A' ' 538' ' ' ASN . 2.8 mp0 -88.13 110.55 20.75 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.293 0.568 . . . . 75.340000000000003 109.964 178.61 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 524' ' ' SER . 15.7 t -96.47 135.86 29.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 107.796 -1.187 . . . . 65.329999999999998 107.796 -178.201 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.625 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 68.7 m -89.19 124.65 34.56 Favored 'General case' 0 N--CA 1.4 -2.959 0 C-N-CA 120.375 -0.53 . . . . 51.43 110.304 176.709 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -97.79 131.21 44.5 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 104.384 -2.451 . . . . 61.25 104.384 166.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -56.14 -26.37 49.45 Favored Glycine 0 CA--C 1.491 -1.448 0 O-C-N 124.258 0.974 . . . . 51.329999999999998 112.303 -175.173 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 57.2 t30 68.38 21.64 8.23 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 123.035 1.398 . . . . 75.200000000000003 108.716 174.159 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.5 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 63.4 mt-30 -126.94 145.27 50.75 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 113.176 -1.829 . . . . 73.439999999999998 107.183 177.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -122.8 149.5 44.07 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 120.605 -0.438 . . . . 62.200000000000003 110.174 -177.134 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.74 115.51 7.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 O-C-N 123.83 0.706 . . . . 71.030000000000001 109.111 -178.711 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.516 ' SD ' HG21 ' A' ' 620' ' ' ILE . 35.7 ttp -79.85 123.24 83.87 Favored Pre-proline 0 C--N 1.306 -1.285 0 CA-C-N 115.575 -0.739 . . . . 73.409999999999997 111.747 -175.657 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . 0.456 ' HG2' ' HB2' ' A' ' 581' ' ' LEU . 20.8 Cg_exo -68.76 156.73 64.49 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.945 2.43 . . . . 73.209999999999994 110.773 174.4 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.97 123.48 28.36 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.761 0.791 . . . . 64.409999999999997 110.702 179.009 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . 0.466 HD13 ' H ' ' A' ' 566' ' ' LEU . 0.0 OUTLIER -119.81 14.07 12.45 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.903 -1.517 . . . . 75.420000000000002 106.903 173.411 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 3.0 m -69.13 140.46 54.73 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 112.967 -1.924 . . . . 73.239999999999995 110.18 -177.541 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 73.72 70.53 1.22 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 116.276 -0.42 . . . . 55.399999999999999 113.46 177.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 22.1 ptp -174.07 172.21 3.41 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.742 -0.836 . . . . 65.010000000000005 108.742 179.28 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . 0.452 ' HB2' HG12 ' A' ' 572' ' ' VAL . 95.7 m-85 -100.36 178.66 4.69 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.478 -0.934 . . . . 74.349999999999994 108.478 178.275 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . 0.413 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 11.7 t-105 -64.76 -28.71 69.77 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.806 0.336 . . . . 72.299999999999997 110.259 -177.449 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . 0.452 HG12 ' HB2' ' A' ' 570' ' ' PHE . 12.7 p -58.02 -30.05 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 123.339 0.656 . . . . 62.109999999999999 111.789 179.598 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . 0.503 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 29.5 m-20 -100.81 -38.65 8.17 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 120.982 -0.287 . . . . 75.400000000000006 110.313 175.762 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -58.73 -43.11 90.1 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.357 0.873 . . . . 73.439999999999998 113.357 -176.658 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . 0.664 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 31.4 tt0 -65.3 -50.71 57.77 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 120.42 -0.512 . . . . 64.409999999999997 111.06 -179.193 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 71.2 Cg_exo -56.19 -35.74 95.73 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 121.314 1.342 . . . . 70.299999999999997 111.911 172.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 14.5 mmt180 -64.76 -38.49 91.16 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 111.711 0.263 . . . . 72.549999999999997 111.711 178.44 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.1 pp -65.93 -46.36 78.48 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.126 -0.63 . . . . 64.219999999999999 110.561 -176.762 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . 0.475 ' N ' HD12 ' A' ' 578' ' ' LEU . 11.9 ptm180 -66.35 -39.54 89.23 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.027 -0.533 . . . . 71.129999999999995 112.058 176.045 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.56 -27.31 64.04 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 112.567 0.58 . . . . 55.439999999999998 112.567 -177.537 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . 0.456 ' HB2' ' HG2' ' A' ' 564' ' ' PRO . 2.3 pp -92.28 -8.46 45.17 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 119.867 -0.733 . . . . 74.230000000000004 110.426 -179.677 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 77.27 48.69 8.0 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 120.633 -0.794 . . . . 75.329999999999998 111.323 -178.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -84.49 127.45 34.04 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.095 -1.076 . . . . 71.340000000000003 108.095 177.54 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 3.4 p -90.35 -5.52 56.11 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 124.71 1.204 . . . . 62.109999999999999 113.114 -175.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -114.09 -168.57 16.4 Favored Glycine 0 C--N 1.302 -1.346 0 N-CA-C 111.66 -0.576 . . . . 70.5 111.66 -179.516 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 26.4 mmt -121.15 153.86 36.96 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 110.087 -0.338 . . . . 71.310000000000002 110.087 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 6.3 tt -83.26 127.32 33.54 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.608 -0.886 . . . . 73.040000000000006 108.608 -178.159 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -125.08 116.48 22.15 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.165 -0.679 . . . . 74.230000000000004 109.165 178.434 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.63 133.56 36.84 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 118.756 -1.177 . . . . 74.310000000000002 110.636 177.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -78.97 -41.58 14.05 Favored Glycine 0 C--N 1.285 -2.298 0 CA-C-N 114.603 -1.181 . . . . 72.239999999999995 112.956 -172.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -138.29 142.04 39.82 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.77 -0.455 . . . . 71.319999999999993 109.77 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -111.78 125.13 53.66 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.907 -1.516 . . . . 72.439999999999998 106.907 175.452 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.68 116.79 48.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 N-CA-C 107.902 -1.147 . . . . 72.209999999999994 107.902 179.17 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 5.3 p-10 -73.96 107.12 5.98 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.022 0.915 . . . . 61.130000000000003 112.483 -176.777 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -146.68 -61.34 0.3 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.184 -1.413 . . . . 70.209999999999994 107.184 175.377 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 132.31 147.56 5.89 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 120.132 -1.033 . . . . 53.119999999999997 112.283 177.365 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.66 -33.36 62.7 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 122.745 0.212 . . . . 53.030000000000001 113.508 -178.695 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 3.3 m -62.96 -23.52 67.45 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.534 1.134 . . . . 73.230000000000004 111.092 -177.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -87.44 0.55 55.34 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 124.801 1.24 . . . . 70.540000000000006 111.111 -175.082 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 66.3 m80 71.78 32.71 1.88 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.783 1.278 . . . . 75.239999999999995 109.098 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . 0.441 ' CG ' ' HA3' ' A' ' 625' ' ' GLY . 2.2 t-20 -82.31 41.82 0.71 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 112.815 -1.993 . . . . 55.530000000000001 109.84 -175.839 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -74.22 174.45 8.74 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 126.282 1.833 . . . . 73.230000000000004 110.303 178.686 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.6 129.86 17.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.242 -1.022 . . . . 73.030000000000001 108.242 -178.925 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 24.7 m -106.3 -28.27 2.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.606 -0.725 . . . . 54.030000000000001 111.271 -176.67 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -156.74 141.64 17.06 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.144 -0.48 . . . . 74.150000000000006 111.081 -178.268 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -122.64 142.05 51.07 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.138 -1.43 . . . . 75.430000000000007 107.138 172.471 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -58.05 -50.09 90.02 Favored Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 113.312 0.856 . . . . 51.340000000000003 113.312 -175.077 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -89.86 128.2 1.62 Allowed 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 121.068 1.179 . . . . 63.109999999999999 110.823 174.316 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.3 151.01 65.75 Favored 'Trans proline' 0 C--O 1.247 0.936 0 C-N-CA 122.446 2.098 . . . . 71.120000000000005 112.37 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.69 135.68 57.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.332 -0.394 . . . . 61.219999999999999 110.438 178.821 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.09 -11.88 48.66 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.386 -0.911 . . . . 65.019999999999996 112.38 -179.714 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 4.7 t -90.09 167.91 12.39 Favored 'General case' 0 C--O 1.255 1.373 0 C-N-CA 119.682 -0.807 . . . . 75.129999999999995 109.197 -179.361 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -90.83 117.5 5.14 Favored Glycine 0 N--CA 1.427 -1.929 0 N-CA-C 111.432 -0.667 . . . . 75.030000000000001 111.432 -178.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.03 142.58 16.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 109.686 -0.487 . . . . 75.530000000000001 109.686 178.06 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.5 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 28.9 p-10 -51.07 165.16 0.13 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.26 1.024 . . . . 63.219999999999999 112.187 -179.213 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -58.8 -25.12 62.84 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.554 0.576 . . . . 75.219999999999999 112.554 -178.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -80.81 -9.23 59.83 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.66 -0.496 . . . . 71.040000000000006 109.66 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.4 -0.89 5.87 Favored Glycine 0 C--O 1.211 -1.291 0 C-N-CA 124.756 1.169 . . . . 72.310000000000002 114.247 171.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.45 119.43 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 CA-C-O 122.266 1.032 . . . . 54.43 112.051 -164.008 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.516 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.5 pp -125.68 133.98 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 CA-C-N 114.288 -1.324 . . . . 70.319999999999993 109.313 -178.529 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 11.5 t -101.52 139.23 37.45 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 108.31 -0.996 . . . . 65.450000000000003 108.31 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.6 pp -138.64 168.73 19.15 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.738 -0.665 . . . . 44.210000000000001 111.215 -174.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -123.95 137.06 54.68 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.1 -1.445 . . . . 73.439999999999998 107.1 -178.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . . . . . . . . 0.279 0.2 OUTLIER -135.85 166.17 23.93 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.207 -1.361 . . . . 63.439999999999998 108.164 -161.952 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . 0.441 ' HA3' ' CG ' ' A' ' 601' ' ' ASN . . . -84.57 -140.72 4.91 Favored Glycine 0 N--CA 1.407 -3.274 0 C-N-CA 119.286 -1.435 . . . . 62.399999999999999 110.31 166.762 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.471 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 8.3 tp-100 . . . . . 0 C--N 1.283 -2.301 0 CA-C-O 118.275 -0.869 . . . . 73.140000000000001 108.924 -179.139 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 493' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . . . . . . 0 N--CA 1.462 0.156 0 N-CA-C 112.935 0.717 . . . . 71.120000000000005 112.935 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 13.8 p -145.79 140.31 27.04 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 122.283 -0.26 . . . . 74.109999999999999 111.172 -177.053 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -141.85 154.44 45.16 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.623 -0.51 . . . . 71.230000000000004 109.623 178.068 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.4 p-10 -89.5 144.23 26.2 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.167 0.508 . . . . 74.319999999999993 111.365 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.5 pt -99.85 137.71 20.22 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 115.506 -0.77 . . . . 52.310000000000002 110.954 -179.517 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -82.21 163.67 17.42 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.111 1.874 . . . . 63.039999999999999 111.197 176.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.16 103.93 8.41 Favored 'General case' 0 CA--C 1.491 -1.312 0 CA-C-O 122.647 1.213 . . . . 74.239999999999995 109.454 176.079 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.486 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 15.0 m -106.99 63.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.437 0 CA-C-O 123.219 1.485 . . . . 73.340000000000003 110.394 -177.514 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 501' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -118.54 110.84 17.86 Favored 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 112.357 -2.201 . . . . 63.200000000000003 108.683 172.306 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 145.3 -37.4 1.31 Allowed Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 119.768 -1.206 . . . . 51.210000000000001 112.715 177.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 503' ' ' GLN . . . . . 0.492 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.5 OUTLIER -95.79 -175.16 3.34 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.494 -0.558 . . . . 71.140000000000001 109.494 -178.614 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 24.4 m -72.02 155.38 40.38 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.34 -0.985 . . . . 63.420000000000002 108.34 176.587 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.501 ' HA ' ' HB ' ' A' ' 534' ' ' VAL . 7.1 p -61.25 -41.75 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 116.41 -0.359 . . . . 64.239999999999995 111.846 -179.398 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 506' ' ' ASP . . . . . 0.551 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 35.5 t70 -65.26 -39.98 93.35 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 110.02 -0.363 . . . . 72.200000000000003 110.02 179.166 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.58 -42.61 93.34 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 N-CA-C 109.434 -0.58 . . . . 72.519999999999996 109.434 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 508' ' ' ALA . . . . . 0.486 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -62.26 -44.43 96.57 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 123.456 0.473 . . . . 61.310000000000002 111.275 175.895 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -63.01 -45.42 92.43 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 120.505 0.193 . . . . 73.340000000000003 111.284 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 32.2 mmmt -65.0 -39.49 93.53 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.514 -0.55 . . . . 74.319999999999993 109.514 178.814 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -61.27 -49.81 75.55 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.678 -1.146 . . . . 74.310000000000002 110.247 -177.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.95 -34.71 75.78 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.496 -0.774 . . . . 75.049999999999997 110.894 -177.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.402 HD22 ' HA ' ' A' ' 513' ' ' ASN . 1.7 t-20 -61.6 -38.01 86.02 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.79 -0.641 . . . . 65.25 110.272 179.717 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 510' ' ' LYS . 69.3 t -59.51 -33.84 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.035 0.445 . . . . 75.319999999999993 111.268 178.309 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -111.89 15.9 20.59 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.372 0.606 . . . . 74.120000000000005 109.806 -177.253 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -141.17 -60.6 0.03 OUTLIER Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 119.969 -1.11 . . . . 72.030000000000001 113.919 -172.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 63.54 41.48 7.31 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 122.667 1.222 . . . . 62.109999999999999 109.281 -173.642 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 518' ' ' THR . . . . . 0.558 HG22 ' HA ' ' A' ' 547' ' ' VAL . 14.8 p -95.27 -171.68 2.47 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 113.58 -1.646 . . . . 70.209999999999994 110.48 -178.847 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -107.91 137.49 45.82 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.346 -1.724 . . . . 72.0 106.346 174.719 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -132.92 151.87 51.98 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 112.233 0.457 . . . . 72.140000000000001 112.233 -178.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 52.8 p -139.6 159.42 42.21 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.168 -1.049 . . . . 61.32 108.168 176.571 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -117.5 134.23 55.09 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.638 -0.425 . . . . 71.510000000000005 110.708 177.671 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -112.28 126.74 55.57 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.573 -0.899 . . . . 73.319999999999993 108.573 177.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 6.5 p -96.03 130.55 43.01 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.192 0.52 . . . . 51.420000000000002 111.601 -178.032 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 11.4 p -139.86 156.28 25.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 106.654 -1.61 . . . . 75.349999999999994 106.654 177.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 526' ' ' ASP . . . . . 0.492 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 4.1 p30 -96.24 136.44 36.72 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 120.168 -0.613 . . . . 61.439999999999998 111.921 -179.707 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.4 m -161.84 161.04 22.29 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 107.061 -1.459 . . . . 60.299999999999997 107.061 179.352 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -66.57 8.61 0.31 Allowed 'Trans proline' 0 CA--C 1.557 1.653 0 C-N-CA 122.799 2.333 . . . . 72.409999999999997 114.559 -178.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.74 132.11 47.39 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 107.0 -1.481 . . . . 73.530000000000001 107.0 174.782 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -59.85 142.49 98.7 Favored 'Trans proline' 0 C--O 1.253 1.271 0 C-N-CA 122.261 1.974 . . . . 71.109999999999999 112.486 -177.733 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.39 107.43 0.49 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.04 -0.982 . . . . 63.509999999999998 111.219 -177.59 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 140.1 -28.85 2.46 Favored Glycine 0 N--CA 1.429 -1.794 0 CA-C-N 115.267 -0.879 . . . . 71.120000000000005 111.009 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -76.83 125.67 29.67 Favored 'General case' 0 C--O 1.251 1.144 0 CA-C-O 121.672 0.748 . . . . 65.109999999999999 110.292 -179.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 534' ' ' VAL . . . . . 0.501 ' HB ' ' HA ' ' A' ' 505' ' ' VAL . 7.1 p -82.15 121.99 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.927 0 N-CA-C 107.611 -1.255 . . . . 72.209999999999994 107.611 177.429 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.74 16.85 11.39 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 113.638 -1.619 . . . . 53.030000000000001 110.361 -173.247 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.449 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 115.58 -161.68 12.77 Favored Glycine 0 N--CA 1.424 -2.124 0 N-CA-C 111.405 -0.678 . . . . 70.239999999999995 111.405 177.765 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 537' ' ' THR . . . . . 0.403 HG22 HD13 ' A' ' 553' ' ' LEU . 9.6 p -117.16 154.76 30.52 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 109.274 -0.639 . . . . 72.239999999999995 109.274 -179.184 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 538' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 552' ' ' GLU . 20.9 t-20 -63.95 -53.02 52.38 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 119.735 -0.786 . . . . 64.129999999999995 110.932 173.31 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 539' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 26.0 Cg_exo -67.11 145.99 75.09 Favored 'Trans proline' 0 C--N 1.378 2.125 0 N-CA-C 108.773 -1.279 . . . . 64.439999999999998 108.773 171.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.84 140.7 94.64 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 122.281 1.987 . . . . 63.240000000000002 112.493 -178.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.83 137.95 55.74 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.981 -0.554 . . . . 71.510000000000005 109.534 178.72 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 96.52 -14.66 63.96 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 121.001 -0.619 . . . . 72.129999999999995 111.894 -178.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 43.4 m -79.72 137.42 37.03 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-O 121.027 0.441 . . . . 60.229999999999997 110.919 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 544' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.3 t -80.78 124.45 29.07 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 121.503 0.668 . . . . 74.430000000000007 109.571 177.551 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.43 159.15 56.33 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.996 -1.113 . . . . 72.019999999999996 107.996 -178.086 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 546' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 20.7 Cg_exo -63.5 137.76 61.55 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.137 1.225 . . . . 73.230000000000004 111.323 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . 0.558 ' HA ' HG22 ' A' ' 518' ' ' THR . 12.1 p -66.21 -19.64 25.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 122.272 1.034 . . . . 63.409999999999997 109.629 179.182 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -88.42 -13.24 40.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.201 -1.363 . . . . 73.239999999999995 111.143 -177.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 92.8 p -84.25 170.43 13.72 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-O 121.17 0.51 . . . . 55.310000000000002 110.697 -177.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.6 p -104.38 124.42 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.338 0 CA-C-N 115.271 -0.877 . . . . 74.329999999999998 109.036 177.878 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.32 135.4 26.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.402 -0.962 . . . . 63.140000000000001 108.402 -178.206 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 552' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 538' ' ' ASN . 5.6 tp10 -102.55 117.57 34.98 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.795 -0.817 . . . . 63.25 108.795 -177.643 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.403 HD13 HG22 ' A' ' 537' ' ' THR . 3.7 mm? -93.78 127.69 39.64 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.419 -0.956 . . . . 75.319999999999993 108.419 178.135 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -90.09 117.83 29.17 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.701 -0.481 . . . . 60.240000000000002 109.701 -177.529 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.51 122.18 64.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 109.095 -0.705 . . . . 45.5 109.095 -178.585 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 71.4 m -90.71 127.98 36.5 Favored 'General case' 0 N--CA 1.412 -2.33 0 C-N-CA 120.058 -0.657 . . . . 75.030000000000001 110.251 176.595 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -89.22 137.79 32.01 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 103.971 -2.603 . . . . 60.020000000000003 103.971 168.571 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -60.82 -24.25 62.24 Favored Glycine 0 C--N 1.314 -0.686 0 O-C-N 123.938 0.774 . . . . 62.240000000000002 113.553 -174.105 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 559' ' ' ASN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 23.6 t-20 76.94 -23.96 0.23 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.83 1.652 . . . . 71.200000000000003 109.951 -179.454 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 560' ' ' GLN . . . . . 0.589 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 86.8 mt-30 -112.4 143.58 43.29 Favored 'General case' 0 N--CA 1.399 -2.989 0 CA-C-N 114.596 -1.184 . . . . 72.010000000000005 110.144 -174.298 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -122.99 158.57 30.2 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 114.884 -1.053 . . . . 74.450000000000003 108.686 -179.49 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 53.3 t -63.47 117.11 3.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 O-C-N 123.65 0.594 . . . . 71.140000000000001 109.658 -179.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 563' ' ' MET . . . . . 0.615 ' HE3' HG13 ' A' ' 620' ' ' ILE . 22.2 ttt -70.4 127.1 92.4 Favored Pre-proline 0 C--N 1.297 -1.696 0 C-N-CA 124.408 1.083 . . . . 74.230000000000004 112.706 -177.795 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.91 169.66 22.11 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.148 2.565 . . . . 64.319999999999993 111.032 172.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -90.87 126.95 36.19 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 110.089 -0.337 . . . . 70.010000000000005 110.089 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 566' ' ' LEU . . . . . 0.467 ' O ' ' HG2' ' A' ' 569' ' ' MET . 1.7 tm? -104.84 -16.38 14.91 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.836 0.827 . . . . 74.450000000000003 109.031 -175.59 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 24.0 m -72.41 143.26 48.58 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.939 -0.573 . . . . 72.319999999999993 110.596 -178.19 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 101.18 4.76 53.53 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.628 -0.796 . . . . 62.520000000000003 113.912 178.199 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 569' ' ' MET . . . . . 0.532 ' SD ' ' HA ' ' A' ' 574' ' ' ALA . 23.5 ptp -123.0 166.88 14.36 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 117.526 0.663 . . . . 74.040000000000006 109.947 179.101 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -101.54 166.32 10.78 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.692 -1.595 . . . . 63.100000000000001 106.692 -178.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 13.7 t-105 -62.58 -30.13 71.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 118.572 0.624 . . . . 52.509999999999998 109.679 179.737 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.2 m -71.5 -21.95 21.79 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 CA-C-N 115.923 -0.58 . . . . 74.420000000000002 111.632 -179.253 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -101.31 -27.39 13.2 Favored 'General case' 0 C--O 1.256 1.405 0 N-CA-C 109.04 -0.726 . . . . 74.329999999999998 109.04 -178.594 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 574' ' ' ALA . . . . . 0.64 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -63.52 -54.23 39.47 Favored 'General case' 0 C--O 1.207 -1.132 0 CA-C-N 114.419 -1.264 . . . . 34.109999999999999 112.284 -178.38 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -53.02 -52.19 67.73 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 114.181 1.178 . . . . 74.530000000000001 114.181 -176.442 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -54.73 -39.7 88.1 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 121.454 1.436 . . . . 61.409999999999997 112.218 174.234 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -69.12 -34.55 75.23 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.63 0.604 . . . . 74.319999999999993 112.63 176.577 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 47.8 mt -65.88 -48.37 71.74 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.596 0.712 . . . . 74.129999999999995 109.21 -177.74 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -34.62 78.29 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.197 -0.911 . . . . 63.109999999999999 111.64 178.277 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.39 -32.12 69.64 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.373 -0.376 . . . . 71.439999999999998 111.287 -177.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.4 pp -85.71 -8.74 57.99 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.499 0.666 . . . . 75.209999999999994 109.622 179.242 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 77.13 44.79 12.75 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.126 -0.943 . . . . 53.399999999999999 112.5 178.367 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -74.03 127.64 33.45 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.378 0.609 . . . . 71.540000000000006 109.688 179.218 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 2.8 p -85.06 -40.12 17.2 Favored 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 124.859 1.264 . . . . 63.210000000000001 112.928 -177.26 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -80.47 -161.05 24.09 Favored Glycine 0 C--O 1.242 0.656 0 N-CA-C 115.571 0.988 . . . . 72.239999999999995 115.571 -174.368 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 54.5 mtt -119.86 154.01 34.96 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 123.624 0.769 . . . . 74.129999999999995 109.28 -176.386 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 6.8 tt -83.48 123.44 29.71 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.339 0.59 . . . . 74.049999999999997 109.689 -178.453 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 588' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 621' ' ' THR . 36.6 t70 -113.7 114.29 26.17 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.898 -1.046 . . . . 74.310000000000002 108.568 -179.801 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 589' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -99.8 133.56 43.97 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.381 -0.927 . . . . 73.219999999999999 109.851 -179.059 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -86.81 -46.05 5.25 Favored Glycine 0 C--N 1.285 -2.302 0 CA-C-N 115.616 -0.72 . . . . 35.210000000000001 111.543 -177.461 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.67 135.01 32.78 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 110.119 -0.326 . . . . 71.430000000000007 110.119 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -116.73 127.45 54.4 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.242 -1.022 . . . . 74.329999999999998 108.242 174.246 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 99.4 t -111.28 116.83 53.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 116.452 -0.34 . . . . 73.329999999999998 110.262 -177.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 594' ' ' ASP . . . . . 0.593 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 27.6 t70 -73.77 116.77 14.76 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-O 120.82 0.343 . . . . 54.420000000000002 111.268 -177.338 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -139.77 -42.63 0.44 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.819 -0.628 . . . . 72.230000000000004 109.727 178.065 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 123.16 140.1 5.6 Favored Glycine 0 N--CA 1.426 -1.992 0 C-N-CA 120.731 -0.747 . . . . 43.140000000000001 111.842 178.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.75 -32.18 61.56 Favored Glycine 0 C--N 1.315 -0.636 0 CA-C-O 121.09 0.272 . . . . 72.430000000000007 112.552 179.593 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 4.7 p -64.02 -23.23 67.25 Favored 'General case' 0 N--CA 1.432 -1.349 0 C-N-CA 125.218 1.407 . . . . 64.439999999999998 111.563 -178.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -87.22 -0.53 56.85 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.199 -0.909 . . . . 71.310000000000002 109.9 -176.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 13.9 m170 65.26 65.39 0.58 Allowed 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 122.573 1.178 . . . . 72.129999999999995 110.954 -178.737 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -81.38 92.52 6.43 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 114.137 -1.392 . . . . 72.439999999999998 111.729 -179.057 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 41.3 mtm-85 -91.39 171.71 9.02 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 113.674 -1.603 . . . . 53.409999999999997 107.678 176.772 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . 0.48 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 86.9 t -67.67 130.26 32.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 105.497 -2.038 . . . . 75.120000000000005 105.497 169.263 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 59.4 t -101.15 -52.59 8.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 C-N-CA 120.501 -0.48 . . . . 44.439999999999998 110.813 -172.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -133.1 136.28 45.76 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.901 -0.59 . . . . 72.239999999999995 109.831 -177.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 606' ' ' GLN . . . . . 0.466 ' HB2' HD11 ' A' ' 620' ' ' ILE . 13.3 pt20 -112.29 140.13 47.26 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.441 -1.689 . . . . 71.019999999999996 106.441 175.429 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 607' ' ' ASN . . . . . 0.423 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 11.6 t30 -56.74 -53.7 61.93 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 113.418 0.895 . . . . 74.310000000000002 113.418 -175.74 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 608' ' ' PRO . . . . . 0.446 ' O ' ' HG3' ' A' ' 606' ' ' GLN . 7.2 Cg_endo -91.43 134.01 1.56 Allowed 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.434 1.422 . . . . 75.209999999999994 110.459 173.526 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.07 157.69 58.98 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 121.447 1.432 . . . . 44.219999999999999 111.306 178.188 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.88 138.52 58.36 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 108.892 -0.781 . . . . 42.020000000000003 108.892 177.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.6 -8.76 43.99 Favored Glycine 0 C--N 1.302 -1.339 0 C-N-CA 120.679 -0.772 . . . . 73.439999999999998 111.928 -176.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 54.3 m -77.04 146.83 37.11 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.892 -0.781 . . . . 73.209999999999994 108.892 176.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -81.1 114.63 3.86 Favored Glycine 0 N--CA 1.432 -1.632 0 N-CA-C 109.818 -1.313 . . . . 52.340000000000003 109.818 174.07 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 614' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 22.0 m -108.26 141.26 23.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 116.908 0.354 . . . . 63.340000000000003 110.592 178.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 615' ' ' ASN . . . . . 0.589 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 41.3 p30 -51.57 173.15 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.219 1.562 . . . . 72.530000000000001 115.219 -177.758 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -60.91 -25.21 66.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.059 -1.428 . . . . 70.010000000000005 112.289 178.161 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -85.63 -11.1 54.72 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.2 -1.037 . . . . 75.120000000000005 108.2 -178.036 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.46 15.12 63.31 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 115.44 -0.8 . . . . 63.43 112.639 168.178 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.72 125.55 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 122.056 0.932 . . . . 74.430000000000007 111.365 -167.885 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 620' ' ' ILE . . . . . 0.615 HG13 ' HE3' ' A' ' 563' ' ' MET . 0.0 OUTLIER -129.67 132.1 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.261 0 CA-C-N 114.193 -1.367 . . . . 72.420000000000002 109.466 -179.055 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 74.7 m -104.33 122.45 45.47 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.935 -1.135 . . . . 65.310000000000002 107.935 178.364 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 622' ' ' LEU . . . . . 0.423 HD13 ' H ' ' A' ' 622' ' ' LEU . 0.0 OUTLIER -132.99 166.93 21.25 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.25 -0.432 . . . . 73.049999999999997 111.714 -176.177 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -127.11 136.43 52.12 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.921 -1.14 . . . . 70.310000000000002 107.921 175.616 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.48 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 3.3 p90 -142.35 165.44 27.41 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.788 -0.642 . . . . 52.229999999999997 110.969 -173.672 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -80.66 150.54 31.34 Favored Glycine 0 N--CA 1.421 -2.35 0 N-CA-C 109.748 -1.341 . . . . 53.030000000000001 109.748 175.449 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 626' ' ' GLN . . . . . 0.593 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 7.3 tt0 . . . . . 0 C--N 1.275 -2.657 0 CA-C-O 117.949 -1.024 . . . . 54.530000000000001 108.582 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.813 0 N-CA-C 109.386 -1.486 . . . . 43.049999999999997 109.386 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.28 141.73 43.87 Favored 'Trans proline' 0 C--O 1.247 0.953 0 CA-C-N 119.421 1.61 . . . . 73.150000000000006 110.128 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -105.7 6.33 31.82 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.352 -0.386 . . . . 75.340000000000003 111.382 -177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 21.8 p -134.84 147.96 50.04 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.231 -0.655 . . . . 73.230000000000004 109.231 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -148.26 143.94 27.31 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.844 -1.539 . . . . 73.329999999999998 106.844 -177.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.2 p-10 -88.93 137.88 31.92 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.028 -0.669 . . . . 70.140000000000001 109.414 178.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 498' ' ' PRO . 40.9 pt -89.63 134.39 32.49 Favored Pre-proline 0 C--N 1.297 -1.691 0 CA-C-N 116.147 -0.479 . . . . 62.32 111.94 -177.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 3.9 Cg_exo -84.71 156.45 11.94 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.543 2.162 . . . . 74.219999999999999 110.051 171.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -88.54 121.22 30.68 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-O 122.401 1.096 . . . . 70.120000000000005 109.055 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.403 ' CG2' ' HB1' ' A' ' 508' ' ' ALA . 5.6 m -109.62 61.11 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.655 0 CA-C-N 113.999 -1.455 . . . . 65.120000000000005 109.378 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -105.73 109.95 22.08 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 112.462 -2.154 . . . . 75.530000000000001 109.426 174.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 152.57 -29.44 0.85 Allowed Glycine 0 C--N 1.305 -1.193 0 C-N-CA 119.561 -1.304 . . . . 61.409999999999997 113.124 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.428 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.3 OUTLIER -107.81 -169.73 1.57 Allowed 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.856 -0.424 . . . . 70.120000000000005 109.856 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.413 ' HB ' HG23 ' A' ' 507' ' ' VAL . 9.7 m -70.57 155.46 40.7 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.409 -0.96 . . . . 72.120000000000005 108.409 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.443 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.1 p -60.95 -41.43 88.99 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.792 0 O-C-N 123.135 0.272 . . . . 63.210000000000001 110.915 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -59.85 -44.28 94.19 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 120.767 0.317 . . . . 73.219999999999999 110.534 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.413 HG23 ' HB ' ' A' ' 504' ' ' THR . 46.3 t -69.18 -38.63 78.21 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.137 0 CA-C-N 115.529 -0.76 . . . . 63.43 109.548 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.452 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -63.68 -45.6 89.35 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.252 -0.431 . . . . 60.219999999999999 110.957 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.7 mt-30 -64.93 -41.34 95.61 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.935 -0.575 . . . . 73.019999999999996 110.552 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.504 ' O ' HG23 ' A' ' 514' ' ' VAL . 47.8 mmtm -66.11 -42.28 89.45 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 116.097 -0.501 . . . . 73.239999999999995 110.459 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -62.51 -44.89 95.25 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 116.289 -0.414 . . . . 75.540000000000006 111.493 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 513' ' ' ASN . 3.9 pp -68.14 -35.24 77.77 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-O 121.132 0.492 . . . . 74.019999999999996 110.829 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.46 ' N ' HD12 ' A' ' 512' ' ' LEU . 2.4 t-20 -59.8 -35.7 75.22 Favored 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 123.894 0.878 . . . . 72.519999999999996 109.938 176.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 510' ' ' LYS . 89.5 t -64.63 -33.65 64.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-O 121.251 0.548 . . . . 74.510000000000005 110.929 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -97.71 -0.78 44.85 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.463 -0.335 . . . . 70.140000000000001 110.451 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -134.96 -57.09 0.06 OUTLIER Glycine 0 CA--C 1.484 -1.868 0 C-N-CA 119.619 -1.277 . . . . 64.010000000000005 114.841 -169.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 69.24 20.56 7.45 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 122.143 0.973 . . . . 74.530000000000001 109.3 -171.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.5 p -79.37 -172.02 3.01 Favored 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 125.973 1.709 . . . . 52.100000000000001 110.65 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -108.0 142.09 38.66 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.758 -1.201 . . . . 75.25 107.758 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -133.14 147.9 52.1 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.142 0.496 . . . . 72.209999999999994 111.846 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 55.6 m -140.91 151.78 44.52 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.193 -1.04 . . . . 54.130000000000003 108.193 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -121.1 145.34 47.9 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 120.96 0.41 . . . . 74.430000000000007 111.683 -174.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -138.6 132.82 31.63 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.687 -0.857 . . . . 41.020000000000003 108.687 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.525 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 11.1 p -96.32 126.74 41.74 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 113.421 0.897 . . . . 74.140000000000001 113.421 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.1 p -121.18 150.85 24.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.076 -1.083 . . . . 64.140000000000001 108.076 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.98 136.14 45.09 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.493 -0.558 . . . . 75.310000000000002 109.493 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.544 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 39.4 m -159.51 168.14 12.8 Favored Pre-proline 0 C--N 1.301 -1.505 0 N-CA-C 108.117 -1.068 . . . . 64.319999999999993 108.117 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -71.75 -14.27 29.9 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.019 1.813 . . . . 64.140000000000001 111.853 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.12 140.81 95.96 Favored Pre-proline 0 C--O 1.219 -0.549 0 N-CA-C 109.297 -0.631 . . . . 73.219999999999999 109.297 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.41 146.86 86.49 Favored 'Trans proline' 0 C--O 1.252 1.213 0 C-N-CA 121.935 1.756 . . . . 44.229999999999997 111.236 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.16 113.57 1.78 Allowed 'General case' 0 C--O 1.242 0.678 0 CA-C-N 116.002 -0.544 . . . . 53.240000000000002 111.644 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 132.37 -22.9 4.12 Favored Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 115.4 -0.818 . . . . 53.240000000000002 111.551 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.01 139.49 33.25 Favored 'General case' 0 CA--C 1.493 -1.222 0 CA-C-O 121.018 0.437 . . . . 74.349999999999994 110.04 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.505 HG22 ' H ' ' A' ' 536' ' ' GLY . 7.4 p -102.96 124.86 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.817 0 CA-C-O 121.884 0.849 . . . . 73.209999999999994 109.667 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.63 -4.93 59.24 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.697 -1.138 . . . . 65.439999999999998 112.635 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.505 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 141.53 -162.68 26.93 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 119.772 -1.204 . . . . 62.140000000000001 113.488 173.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 13.2 p -116.45 159.19 22.39 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 107.651 -1.24 . . . . 70.239999999999995 107.651 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -60.02 -53.59 63.69 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 119.103 -1.039 . . . . 71.049999999999997 112.36 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -82.21 140.73 11.19 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 121.266 1.311 . . . . 43.0 110.521 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.6 162.95 40.59 Favored 'Trans proline' 0 C--O 1.251 1.137 0 C-N-CA 122.999 2.466 . . . . 62.350000000000001 113.613 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.71 129.7 43.18 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.639 -0.71 . . . . 52.340000000000003 110.461 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.83 -5.44 34.66 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 115.778 -0.646 . . . . 74.420000000000002 111.536 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 99.7 m -77.1 121.02 22.99 Favored 'General case' 0 N--CA 1.436 -1.162 0 O-C-N 122.64 -0.33 . . . . 73.140000000000001 110.238 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 4.0 t -80.3 124.1 28.55 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 108.887 -0.783 . . . . 74.109999999999999 108.887 176.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 32.6 m -126.45 160.07 59.91 Favored Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 107.658 -1.238 . . . . 64.310000000000002 107.658 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -63.97 138.62 63.56 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 120.942 1.095 . . . . 73.109999999999999 109.512 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.1 p -60.7 -19.86 20.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.518 0.675 . . . . 75.340000000000003 111.475 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -100.02 3.41 44.18 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.148 0.499 . . . . 62.149999999999999 110.694 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 97.4 p -83.88 171.78 12.74 Favored 'General case' 0 C--O 1.251 1.133 0 O-C-N 121.404 -0.81 . . . . 45.009999999999998 111.525 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.2 p -103.83 134.43 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 CA-C-N 115.268 -0.878 . . . . 64.219999999999999 110.394 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 55.8 mt -103.37 136.26 36.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.106 -1.072 . . . . 72.439999999999998 108.106 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.52 118.58 37.06 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.985 0.898 . . . . 63.130000000000003 111.52 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.6 118.89 32.41 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.839 -1.528 . . . . 43.020000000000003 109.786 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -86.28 102.54 14.06 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.813 0.816 . . . . 54.149999999999999 110.383 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 524' ' ' SER . 23.3 t -85.63 128.17 39.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 114.304 -1.316 . . . . 60.229999999999997 107.523 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' ' 527' ' ' SER . 62.7 m -88.63 125.65 34.92 Favored 'General case' 0 N--CA 1.394 -3.25 0 CA-C-O 121.173 0.511 . . . . 60.450000000000003 110.823 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -101.64 134.21 45.13 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 107.275 -1.38 . . . . 61.450000000000003 107.275 173.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -63.29 -22.3 65.2 Favored Glycine 0 CA--C 1.493 -1.312 0 O-C-N 124.049 0.843 . . . . 75.430000000000007 112.365 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 79.55 2.88 2.21 Favored 'General case' 0 C--O 1.215 -0.725 0 C-N-CA 125.022 1.329 . . . . 73.409999999999997 108.674 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.403 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 90.6 mt-30 -113.09 150.23 32.37 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 114.998 -1.001 . . . . 73.340000000000003 112.363 -171.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -128.0 155.91 43.55 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.81 -1.181 . . . . 71.340000000000003 107.81 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 6.4 p -71.22 118.51 16.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 109.512 -0.551 . . . . 72.510000000000005 109.512 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 52.5 ttp -76.1 129.87 79.47 Favored Pre-proline 0 C--N 1.306 -1.322 0 C-N-CA 119.925 -0.71 . . . . 54.539999999999999 110.459 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.98 166.38 23.03 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.659 2.24 . . . . 51.100000000000001 111.27 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . 0.419 ' HA ' ' CB ' ' A' ' 610' ' ' ALA . 2.2 p-10 -81.03 131.85 35.33 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-O 121.368 0.604 . . . . 72.140000000000001 111.102 -175.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.2 pp -159.82 20.3 0.17 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.58 -1.191 . . . . 65.140000000000001 110.196 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 8.3 t -79.88 147.51 31.68 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 109.11 -0.7 . . . . 74.5 109.11 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 74.84 69.16 1.43 Allowed Glycine 0 N--CA 1.436 -1.33 0 C-N-CA 120.922 -0.656 . . . . 75.209999999999994 112.068 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -147.97 174.05 12.27 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.143 -1.058 . . . . 73.099999999999994 108.143 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -98.77 169.42 9.48 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.786 -1.561 . . . . 61.329999999999998 106.786 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -67.88 -31.67 71.63 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.94 -0.763 . . . . 73.25 108.94 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 30.3 m -78.16 -13.9 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-N 115.907 -0.588 . . . . 65.230000000000004 110.929 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 37.2 t70 -95.29 -34.19 12.27 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.402 -1.333 . . . . 71.319999999999993 107.402 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . 0.725 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -57.76 -53.55 56.91 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.529 -1.214 . . . . 72.299999999999997 111.856 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 38.0 mt-10 -51.23 -54.56 36.97 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 113.871 1.063 . . . . 72.0 113.871 -175.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -57.53 -38.3 94.36 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 121.515 1.477 . . . . 64.5 112.225 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 24.2 mmm-85 -65.08 -38.66 91.49 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.342 0.115 . . . . 65.239999999999995 110.967 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 25.7 mt -66.69 -47.93 70.86 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.947 -0.39 . . . . 44.100000000000001 109.947 -176.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 2.3 ptp180 -66.56 -34.93 78.99 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 112.558 0.577 . . . . 74.319999999999993 112.558 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -66.82 -34.27 77.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.249 0.547 . . . . 63.43 110.272 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 12.5 tp -82.05 -9.76 59.44 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.635 -0.711 . . . . 73.150000000000006 110.339 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 64.11 41.02 98.61 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.892 -0.594 . . . . 62.409999999999997 112.382 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.469 ' CE3' HD22 ' A' ' 578' ' ' LEU . 18.2 t90 -78.55 127.24 31.87 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.919 0.39 . . . . 75.439999999999998 110.686 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 35.9 p -96.19 -22.2 17.42 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 112.988 0.736 . . . . 73.299999999999997 112.988 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -77.85 -173.09 40.16 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.353 -0.451 . . . . 55.149999999999999 113.995 -176.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 22.5 ttt -104.69 141.59 36.19 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 122.771 0.428 . . . . 42.299999999999997 110.871 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 33.9 tp -86.86 110.13 19.76 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.619 -0.882 . . . . 62.43 108.619 176.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.543 ' O ' ' HA ' ' A' ' 621' ' ' THR . 22.4 t70 -95.86 104.62 16.56 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.967 0.889 . . . . 62.109999999999999 110.26 -175.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -87.66 123.35 32.41 Favored 'General case' 0 N--CA 1.396 -3.171 0 CA-C-N 114.645 -1.161 . . . . 72.200000000000003 109.462 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -84.88 -100.04 0.66 Allowed Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.757 -0.937 . . . . 64.120000000000005 110.757 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -107.78 154.94 20.8 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 109.851 -0.426 . . . . 45.240000000000002 109.851 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . 0.422 ' OD1' ' HB3' ' A' ' 626' ' ' GLN . 3.0 p30 -106.53 145.69 31.55 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.469 -0.937 . . . . 61.210000000000001 108.469 174.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 57.4 t -104.5 138.71 28.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.033 -0.729 . . . . 70.420000000000002 109.033 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . 0.448 ' HA ' ' CD ' ' A' ' 626' ' ' GLN . 3.8 p30 -73.06 124.72 26.07 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 121.388 0.613 . . . . 55.350000000000001 110.045 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -159.64 -62.07 0.07 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.724 -1.125 . . . . 34.130000000000003 108.493 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 105.77 153.24 20.92 Favored Glycine 0 N--CA 1.422 -2.264 0 C-N-CA 119.659 -1.258 . . . . 65.510000000000005 111.787 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.34 -32.2 60.36 Favored Glycine 0 C--N 1.311 -0.851 0 C-N-CA 123.511 0.577 . . . . 52.420000000000002 113.643 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 4.9 p -72.67 -25.04 61.12 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-O 121.965 0.888 . . . . 62.130000000000003 110.383 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -95.09 -0.91 53.07 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.937 -1.029 . . . . 65.400000000000006 109.495 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 39.8 m80 74.06 99.51 0.07 Allowed 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 125.051 1.34 . . . . 72.140000000000001 112.148 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -80.3 83.32 6.17 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.382 -0.827 . . . . 71.209999999999994 110.99 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -108.17 160.31 15.92 Favored 'General case' 0 C--N 1.281 -2.372 0 CA-C-N 115.282 -0.872 . . . . 73.239999999999995 109.728 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 71.2 t -64.83 130.2 29.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.084 -1.45 . . . . 52.210000000000001 107.084 171.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 43.5 t -108.61 -40.33 4.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 121.524 0.678 . . . . 70.299999999999997 110.108 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -142.9 142.07 31.65 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.793 -0.817 . . . . 73.239999999999995 108.793 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -137.56 143.56 41.63 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.906 -1.516 . . . . 72.040000000000006 106.906 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.431 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 24.6 t-20 -65.84 -53.11 37.33 Favored Pre-proline 0 C--N 1.308 -1.218 0 C-N-CA 119.235 -0.986 . . . . 61.229999999999997 112.132 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.8 Cg_endo -90.64 107.93 0.33 Allowed 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.09 1.86 . . . . 73.129999999999995 110.351 173.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -71.13 160.37 49.34 Favored 'Trans proline' 0 C--O 1.246 0.896 0 C-N-CA 123.258 2.638 . . . . 72.099999999999994 113.411 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . 0.419 ' CB ' ' HA ' ' A' ' 565' ' ' ASP . . . -67.85 138.54 56.17 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.351 -0.981 . . . . 64.129999999999995 108.351 175.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 96.69 -8.95 66.27 Favored Glycine 0 C--N 1.297 -1.6 0 C-N-CA 120.27 -0.967 . . . . 72.5 110.904 -175.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 24.2 m -101.88 153.17 20.09 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 108.06 -1.089 . . . . 65.340000000000003 108.06 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -74.77 127.16 9.38 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 121.242 -0.504 . . . . 71.510000000000005 112.151 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 30.9 m -119.98 142.6 34.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.898 -1.149 . . . . 74.209999999999994 107.898 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.403 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 33.9 p-10 -51.7 169.14 0.07 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.708 0.803 . . . . 75.209999999999994 112.736 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -60.29 -26.17 66.3 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 120.859 0.361 . . . . 64.329999999999998 111.699 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.433 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 5.4 m-20 -83.31 -7.82 59.53 Favored 'General case' 0 C--O 1.204 -1.324 0 CA-C-N 116.069 -0.514 . . . . 70.310000000000002 110.398 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.18 19.34 68.1 Favored Glycine 0 C--O 1.22 -0.776 0 O-C-N 123.285 0.366 . . . . 71.010000000000005 112.996 171.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.79 119.4 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-O 121.913 0.863 . . . . 54.039999999999999 111.217 -167.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 48.3 pt -126.21 133.92 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 115.096 -0.957 . . . . 71.219999999999999 110.522 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 14.9 t -105.8 128.73 53.91 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.924 -1.139 . . . . 41.0 107.924 177.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.5 pp -139.24 166.69 23.87 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 114.16 1.17 . . . . 72.510000000000005 114.16 -173.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -127.68 137.04 52.37 Favored 'General case' 0 C--O 1.256 1.411 0 N-CA-C 108.173 -1.047 . . . . 75.329999999999998 108.173 175.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -142.3 166.89 23.45 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.859 -0.61 . . . . 72.430000000000007 109.617 -174.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -60.94 145.79 47.96 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 121.102 -0.571 . . . . 75.239999999999995 112.296 175.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.448 ' CD ' ' HA ' ' A' ' 594' ' ' ASP . 3.3 pt20 . . . . . 0 C--O 1.251 1.179 0 N-CA-C 113.885 1.068 . . . . 72.150000000000006 113.885 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.527 0 N-CA-C 110.395 -1.082 . . . . 43.049999999999997 110.395 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.65 154.47 71.36 Favored 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 122.53 2.153 . . . . 63.210000000000001 111.48 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -105.35 -25.55 12.35 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.813 0.816 . . . . 51.219999999999999 110.838 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 15.0 p -136.55 155.06 50.47 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 114.981 -1.008 . . . . 62.32 110.317 -176.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.57 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 4.6 tmtt? -150.49 139.66 21.18 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.884 -0.784 . . . . 74.329999999999998 108.884 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.57 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 8.3 p-10 -78.18 129.75 35.51 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 123.633 0.773 . . . . 64.430000000000007 109.58 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.5 pt -99.03 131.65 25.0 Favored Pre-proline 0 C--N 1.304 -1.374 0 C-N-CA 120.45 -0.5 . . . . 71.329999999999998 111.689 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.08 158.54 34.0 Favored 'Trans proline' 0 C--O 1.243 0.742 0 C-N-CA 122.78 2.32 . . . . 53.329999999999998 112.167 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.53 ' HA ' ' HB1' ' A' ' 541' ' ' ALA . 5.1 p-10 -82.23 112.7 19.48 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.95 0.881 . . . . 72.120000000000005 108.979 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 31.7 m -117.41 0.95 8.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 112.973 0.731 . . . . 65.420000000000002 112.973 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -69.63 100.98 1.55 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.298 0.57 . . . . 63.399999999999999 109.917 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 138.8 -13.5 3.39 Favored Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 110.717 -0.953 . . . . 61.219999999999999 110.717 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 508' ' ' ALA . 31.7 mm-40 -82.2 -178.25 6.95 Favored 'General case' 0 C--O 1.248 1.013 0 N-CA-C 108.692 -0.855 . . . . 71.349999999999994 108.692 175.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 5.7 m -78.6 156.15 29.27 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 104.293 -2.484 . . . . 62.25 104.293 169.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.473 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 8.4 p -60.13 -42.4 89.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 119.557 1.071 . . . . 75.540000000000006 112.224 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . 0.418 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 17.3 t70 -64.68 -43.43 93.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.945 0.402 . . . . 63.409999999999997 110.455 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 62.9 t -67.82 -39.11 81.31 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.252 0 CA-C-N 115.628 -0.714 . . . . 71.239999999999995 109.803 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.465 ' HB2' ' HB2' ' A' ' 503' ' ' GLN . . . -62.4 -45.14 94.5 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.951 -0.389 . . . . 74.549999999999997 109.951 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.8 mt-30 -62.05 -46.68 88.06 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.759 -0.655 . . . . 71.239999999999995 111.353 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.567 ' O ' HG23 ' A' ' 514' ' ' VAL 0.359 0.0 OUTLIER -67.37 -38.15 84.32 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 112.48 0.548 . . . . 62.100000000000001 112.48 177.333 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -60.71 -50.04 75.07 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 110.602 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 513' ' ' ASN . 3.8 pp -68.49 -36.06 78.4 Favored 'General case' 0 C--O 1.208 -1.098 0 C-N-CA 120.156 -0.618 . . . . 72.430000000000007 111.598 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.487 ' N ' HD12 ' A' ' 512' ' ' LEU . 3.4 t-20 -69.79 -35.19 74.66 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 112.558 0.577 . . . . 73.430000000000007 112.558 -175.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 510' ' ' LYS . 72.2 t -57.33 -31.1 37.24 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 CA-C-O 121.438 0.637 . . . . 71.120000000000005 110.121 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -120.22 29.17 7.63 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.771 -0.649 . . . . 74.200000000000003 109.591 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -145.84 -56.79 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.423 0 C-N-CA 120.058 -1.068 . . . . 53.109999999999999 112.181 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 62.89 33.78 14.79 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.521 1.153 . . . . 73.340000000000003 111.151 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 547' ' ' VAL . 3.1 p -88.52 -171.43 3.33 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-N 113.83 -1.532 . . . . 53.530000000000001 109.047 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -111.77 142.49 44.06 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.891 -1.522 . . . . 74.109999999999999 106.891 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -132.47 148.81 52.4 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 113.201 0.815 . . . . 75.340000000000003 113.201 -174.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 51.0 m -133.06 157.66 44.7 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 106.713 -1.588 . . . . 61.219999999999999 106.713 177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -125.97 126.89 45.07 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 109.693 -0.484 . . . . 63.409999999999997 109.693 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -124.16 143.27 50.59 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.45 -1.315 . . . . 64.540000000000006 107.45 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 65.8 p -102.8 139.94 37.72 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.094 -1.043 . . . . 72.430000000000007 112.426 -175.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 12.1 p -131.15 151.52 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 N-CA-C 107.768 -1.197 . . . . 75.329999999999998 107.768 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -87.34 137.2 32.55 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 121.3 0.571 . . . . 72.340000000000003 110.94 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.4 m -160.08 157.51 25.25 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 106.802 -1.555 . . . . 63.530000000000001 106.802 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -64.56 2.07 1.42 Allowed 'Trans proline' 0 CA--C 1.555 1.549 0 C-N-CA 122.653 2.235 . . . . 71.299999999999997 114.076 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -96.1 144.17 27.37 Favored Pre-proline 0 N--CA 1.433 -1.319 0 N-CA-C 109.523 -0.547 . . . . 60.229999999999997 109.523 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.03 146.59 97.53 Favored 'Trans proline' 0 C--O 1.249 1.07 0 C-N-CA 123.418 2.745 . . . . 74.340000000000003 114.618 -173.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.66 113.64 2.12 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.663 -1.153 . . . . 74.25 111.064 178.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 139.91 -23.53 2.76 Favored Glycine 0 C--N 1.301 -1.368 0 N-CA-C 111.083 -0.807 . . . . 62.109999999999999 111.083 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -79.33 144.91 33.79 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 108.81 -0.811 . . . . 73.420000000000002 108.81 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.449 HG11 ' HB2' ' A' ' 508' ' ' ALA . 7.7 p -94.35 114.99 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 N-CA-C 108.288 -1.004 . . . . 71.349999999999994 108.288 173.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.2 -31.3 72.44 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.18 -1.373 . . . . 63.240000000000002 109.433 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 152.78 -168.34 31.71 Favored Glycine 0 N--CA 1.407 -3.244 0 N-CA-C 109.728 -1.349 . . . . 74.230000000000004 109.728 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . 0.511 HG22 ' HG ' ' A' ' 553' ' ' LEU . 3.6 p -116.62 153.53 32.11 Favored 'General case' 0 C--N 1.268 -2.943 0 N-CA-C 107.807 -1.183 . . . . 52.439999999999998 107.807 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.455 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 54.0 t30 -67.41 -48.0 46.74 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 118.382 -1.327 . . . . 64.239999999999995 110.706 176.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.495 ' HD3' ' OE1' ' A' ' 552' ' ' GLU . 20.7 Cg_exo -71.9 129.66 15.67 Favored 'Trans proline' 0 C--N 1.374 1.882 0 N-CA-C 108.398 -1.424 . . . . 73.239999999999995 108.398 168.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.73 139.99 93.1 Favored 'Trans proline' 0 C--O 1.245 0.87 0 C-N-CA 122.955 2.437 . . . . 74.0 115.335 -174.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . 0.53 ' HB1' ' HA ' ' A' ' 499' ' ' ASP . . . -68.27 135.85 52.58 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.297 -1.32 . . . . 74.430000000000007 110.236 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 93.54 -16.58 60.38 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 111.455 -0.658 . . . . 54.520000000000003 111.455 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 63.1 m -88.67 139.16 30.75 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 124.151 0.98 . . . . 52.009999999999998 110.821 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.1 t -73.88 128.09 34.58 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 121.529 0.68 . . . . 75.439999999999998 109.21 175.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.72 164.98 27.65 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 107.13 -1.433 . . . . 64.420000000000002 107.13 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -67.25 136.07 39.11 Favored 'Trans proline' 0 N--CA 1.442 -1.543 0 CA-C-N 120.564 1.237 . . . . 73.200000000000003 110.437 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.444 ' HA ' HG22 ' A' ' 518' ' ' THR . 9.2 p -67.49 -22.11 28.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 122.037 0.923 . . . . 45.210000000000001 109.639 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -84.26 -12.68 54.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.141 -1.391 . . . . 61.439999999999998 110.992 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 11.4 t -93.14 153.12 18.84 Favored 'General case' 0 N--CA 1.421 -1.925 0 CA-C-O 121.555 0.693 . . . . 70.420000000000002 110.246 -176.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 13.2 p -94.89 134.78 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.07 0 CA-C-N 114.865 -1.061 . . . . 72.219999999999999 108.583 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 62.1 mt -102.63 135.73 38.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.553 -0.748 . . . . 71.230000000000004 109.12 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . 0.495 ' OE1' ' HD3' ' A' ' 539' ' ' PRO . 2.1 pm0 -102.93 121.61 42.87 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-O 121.764 0.793 . . . . 64.439999999999998 110.551 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.511 ' HG ' HG22 ' A' ' 537' ' ' THR . 7.0 mp -98.66 122.19 41.56 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.208 -1.36 . . . . 74.439999999999998 108.369 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.549 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 2.7 mp0 -88.09 127.09 35.41 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.844 -0.616 . . . . 75.400000000000006 110.971 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 25.2 t -95.21 125.94 47.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.057 -0.974 . . . . 73.349999999999994 108.437 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.716 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 5.5 m -77.63 119.38 21.09 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.106 -1.072 . . . . 62.310000000000002 108.106 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -108.72 134.73 51.04 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 107.468 -1.308 . . . . 74.450000000000003 107.468 169.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -59.18 -23.49 57.54 Favored Glycine 0 CA--C 1.509 -0.297 0 O-C-N 124.035 0.834 . . . . 25.329999999999998 112.181 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 76.52 7.88 3.29 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.977 1.711 . . . . 74.439999999999998 108.181 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 89.0 mt-30 -126.77 146.16 50.34 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 114.889 -1.051 . . . . 72.040000000000006 110.649 -176.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . 0.447 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 53.8 p90 -124.01 152.83 42.14 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.332 -0.988 . . . . 74.430000000000007 108.332 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.47 124.4 13.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.401 0.62 . . . . 73.109999999999999 111.981 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 47.9 ttp -92.89 134.83 26.85 Favored Pre-proline 0 C--O 1.256 1.41 0 CA-C-N 115.697 -0.683 . . . . 74.129999999999995 110.057 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.73 169.07 16.82 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.884 2.389 . . . . 62.32 111.075 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.79 115.03 26.04 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.42 -0.955 . . . . 72.340000000000003 108.42 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . 0.419 ' O ' ' HG2' ' A' ' 569' ' ' MET . 91.5 mt -107.0 -0.21 23.21 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.722 0.772 . . . . 72.540000000000006 110.384 -176.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 20.6 t -79.52 153.47 29.53 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.502 -0.772 . . . . 75.329999999999998 109.317 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' A' ' 602' ' ' ARG . . . 82.62 25.26 51.03 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 120.22 -0.99 . . . . 71.140000000000001 114.031 177.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 23.2 ptp -140.69 176.77 8.52 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.305 -0.998 . . . . 72.019999999999996 108.305 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -98.34 169.12 9.79 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.656 -0.868 . . . . 50.450000000000003 108.656 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 27.7 t-105 -64.18 -27.62 69.19 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.579 0.704 . . . . 71.319999999999993 109.355 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.5 p -72.95 -17.32 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 CA-C-N 115.46 -0.791 . . . . 72.150000000000006 110.74 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.489 ' O ' ' HD2' ' A' ' 576' ' ' PRO . 16.5 m-20 -91.17 -38.92 12.42 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 107.97 -1.122 . . . . 74.549999999999997 107.97 175.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . 0.678 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -56.79 -52.97 62.97 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.229 -1.351 . . . . 75.439999999999998 112.068 -178.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.493 ' HB2' ' HD3' ' A' ' 576' ' ' PRO . 47.2 mt-10 -51.08 -54.02 42.26 Favored Pre-proline 0 CA--C 1.559 1.304 0 N-CA-C 113.782 1.031 . . . . 72.030000000000001 113.782 -176.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.493 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 35.9 Cg_exo -61.15 -36.32 81.58 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 121.557 1.505 . . . . 74.239999999999995 112.137 177.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.457 ' HA ' ' NE ' ' A' ' 577' ' ' ARG . 3.3 mmp_? -62.84 -40.17 96.63 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.743 0.275 . . . . 71.239999999999995 111.743 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 25.0 mt -65.4 -48.92 71.2 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.333 0.587 . . . . 73.120000000000005 110.327 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -66.7 -36.84 83.45 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.704 -0.68 . . . . 62.539999999999999 112.455 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.12 -34.26 72.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.78 0.324 . . . . 43.219999999999999 111.258 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' A' ' 583' ' ' TRP . 1.5 pp -81.51 -6.22 58.75 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.396 0.617 . . . . 72.510000000000005 109.916 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.54 44.14 27.75 Favored Glycine 0 CA--C 1.498 -0.978 0 CA-C-N 115.585 -0.734 . . . . 74.430000000000007 111.988 177.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.464 ' CE3' HD22 ' A' ' 578' ' ' LEU . 15.3 t90 -87.35 127.04 35.2 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 109.32 -0.622 . . . . 71.450000000000003 109.32 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 17.2 p -101.27 -21.13 14.97 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.167 -0.469 . . . . 71.450000000000003 111.94 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -73.98 -175.12 31.74 Favored Glycine 0 C--O 1.242 0.628 0 CA-C-N 116.535 -0.302 . . . . 75.230000000000004 113.459 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 53.1 mtt -106.03 144.15 33.16 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.835 -0.182 . . . . 73.439999999999998 111.016 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 37.5 tp -89.64 108.02 19.43 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.473 0.654 . . . . 75.319999999999993 109.413 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' A' ' 621' ' ' THR . 28.4 t70 -97.73 117.1 31.28 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.139 -0.937 . . . . 75.439999999999998 110.351 -176.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.98 133.55 44.2 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 119.042 -1.063 . . . . 75.439999999999998 108.987 174.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -80.42 -54.39 3.77 Favored Glycine 0 C--N 1.299 -1.527 0 N-CA-C 111.267 -0.733 . . . . 50.210000000000001 111.267 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.04 146.9 39.6 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.644 -0.502 . . . . 60.32 109.644 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -113.31 131.83 55.8 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.694 -1.595 . . . . 61.509999999999998 106.694 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 46.2 t -105.0 115.59 47.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 C-N-CA 119.891 -0.724 . . . . 73.200000000000003 109.107 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . 0.494 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 24.3 t70 -78.0 126.63 31.11 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 112.756 0.65 . . . . 72.109999999999999 112.756 -175.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . 0.445 ' HB3' ' ND2' ' A' ' 601' ' ' ASN . . . -158.2 -30.62 0.08 Allowed 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.811 0.694 . . . . 53.409999999999997 111.153 174.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 108.66 144.08 10.72 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 119.45 -1.357 . . . . 24.199999999999999 112.959 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -60.67 -32.79 79.85 Favored Glycine 0 C--N 1.317 -0.506 0 C-N-CA 123.014 0.34 . . . . 52.329999999999998 113.267 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 31.3 t -62.18 -23.93 66.89 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.862 0.839 . . . . 71.219999999999999 110.326 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -86.78 -0.62 56.71 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.675 -1.148 . . . . 71.430000000000007 110.773 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 52.0 m80 66.19 38.7 4.52 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 122.137 0.97 . . . . 74.310000000000002 109.473 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . 0.445 ' ND2' ' HB3' ' A' ' 595' ' ' ALA . 15.4 t30 -74.72 89.63 2.28 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.701 -1.59 . . . . 60.420000000000002 108.629 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.407 ' HD3' ' HA2' ' A' ' 568' ' ' GLY . 16.6 ptp180 -97.52 171.65 8.23 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.763 -1.562 . . . . 74.450000000000003 110.896 -175.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 569' ' ' MET . 83.7 t -58.52 130.73 22.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.244 -1.021 . . . . 70.329999999999998 108.244 174.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 27.7 m -106.26 -30.44 2.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 C-N-CA 120.535 -0.466 . . . . 73.420000000000002 111.901 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -149.43 135.98 19.33 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 120.258 -0.577 . . . . 74.430000000000007 110.717 -176.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -120.88 143.12 49.09 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.491 -1.67 . . . . 70.340000000000003 106.491 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.493 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 19.9 t-20 -52.61 -58.17 12.94 Favored Pre-proline 0 N--CA 1.487 1.387 0 N-CA-C 113.95 1.093 . . . . 70.430000000000007 113.95 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.1 Cg_endo -91.04 135.25 1.84 Allowed 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 121.476 1.451 . . . . 65.349999999999994 110.739 177.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -67.08 160.04 49.25 Favored 'Trans proline' 0 C--O 1.249 1.057 0 C-N-CA 121.518 1.479 . . . . 63.039999999999999 110.856 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.17 127.17 30.22 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 110.257 -0.275 . . . . 74.040000000000006 110.257 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 104.71 -5.21 43.28 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.317 -0.944 . . . . 73.310000000000002 112.251 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 73.9 m -90.63 147.35 23.36 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.861 -0.792 . . . . 61.450000000000003 108.861 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -78.72 137.89 20.12 Favored Glycine 0 N--CA 1.425 -2.043 0 C-N-CA 121.529 -0.367 . . . . 43.340000000000003 113.234 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.3 m -117.99 142.76 30.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.744 -0.836 . . . . 53.109999999999999 108.744 175.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -49.85 170.8 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.433 1.093 . . . . 51.030000000000001 113.608 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -58.9 -26.99 64.81 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.999 -0.546 . . . . 65.340000000000003 111.946 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -84.75 -7.28 59.27 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 121.22 0.533 . . . . 75.340000000000003 110.264 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.6 18.93 68.56 Favored Glycine 0 C--O 1.219 -0.838 0 CA-C-N 115.928 -0.578 . . . . 61.329999999999998 113.967 172.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.49 119.93 17.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 122.555 1.169 . . . . 71.329999999999998 112.121 -167.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.11 130.78 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 114.212 -1.358 . . . . 60.140000000000001 109.46 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.605 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 13.0 t -104.66 137.06 43.05 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.031 -1.1 . . . . 73.430000000000007 108.031 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -138.63 167.51 21.81 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.354 0.597 . . . . 73.519999999999996 112.338 -173.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -127.03 134.63 50.27 Favored 'General case' 0 C--O 1.251 1.138 0 N-CA-C 104.806 -2.294 . . . . 74.129999999999995 104.806 174.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.407 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 29.3 p90 -142.94 165.33 27.65 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.627 -0.829 . . . . 75.400000000000006 112.221 -174.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -79.74 126.64 7.55 Favored Glycine 1 N--CA 1.388 -4.552 0 C-N-CA 120.65 -0.786 . . . . 21.41 111.609 173.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.494 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 9.3 tt0 . . . . . 0 C--O 1.271 2.204 0 C-N-CA 124.75 1.22 . . . . 72.430000000000007 107.812 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.022 0 N-CA-C 110.405 -1.078 . . . . 43.049999999999997 110.405 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.87 144.97 79.02 Favored 'Trans proline' 0 CA--C 1.513 -0.558 0 C-N-CA 122.181 1.921 . . . . 72.439999999999998 111.583 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -104.9 -7.1 19.58 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.852 0.834 . . . . 62.229999999999997 110.288 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 40.9 p -138.23 149.89 46.19 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.42 -1.326 . . . . 74.420000000000002 107.42 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -141.64 145.03 34.49 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.728 -1.212 . . . . 73.120000000000005 107.728 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 17.2 m-20 -88.93 141.94 28.06 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.34 -0.615 . . . . 74.439999999999998 109.34 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.7 pt -101.76 123.83 42.64 Favored Pre-proline 0 C--N 1.3 -1.564 0 C-N-CA 120.609 -0.436 . . . . 73.319999999999993 110.288 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -84.58 172.39 9.18 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.383 2.055 . . . . 75.430000000000007 112.018 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -85.97 100.66 12.28 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 122.399 1.095 . . . . 73.340000000000003 109.998 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 31.4 m -89.38 1.73 7.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 114.401 -1.272 . . . . 74.340000000000003 111.261 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -64.52 100.74 0.39 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.564 -0.744 . . . . 61.229999999999997 110.079 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 158.2 -32.06 0.5 Allowed Glycine 0 C--N 1.302 -1.356 0 C-N-CA 120.797 -0.716 . . . . 61.409999999999997 111.583 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.461 ' O ' HG12 ' A' ' 534' ' ' VAL . 10.1 pm0 -102.62 -179.69 4.04 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 109.816 -0.438 . . . . 71.230000000000004 109.816 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 17.5 m -70.31 155.76 40.21 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.579 -1.267 . . . . 74.329999999999998 107.579 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.494 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 14.2 p -64.71 -40.38 88.86 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 N-CA-C 109.657 -0.497 . . . . 73.530000000000001 109.657 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 11.8 t70 -58.79 -39.86 82.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.422 -0.808 . . . . 70.310000000000002 109.842 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 86.0 t -74.93 -43.55 45.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.099 -0.955 . . . . 74.25 110.61 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -58.82 -43.29 90.57 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.472 0.177 . . . . 72.129999999999995 110.739 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.2 mt-30 -64.66 -46.44 82.48 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.043 -0.526 . . . . 73.439999999999998 110.915 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.594 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 2.7 ptpp? -67.36 -38.4 84.74 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 112.802 0.667 . . . . 75.430000000000007 112.802 178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 56.1 m-20 -61.98 -48.07 81.97 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.238 0.542 . . . . 74.209999999999994 110.353 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.44 -36.92 84.0 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.203 -0.908 . . . . 64.310000000000002 108.849 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 2.2 t-20 -59.4 -35.39 73.87 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 124.046 0.938 . . . . 74.329999999999998 110.534 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 510' ' ' LYS . 86.0 t -61.99 -33.14 56.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-O 121.286 0.565 . . . . 72.150000000000006 110.789 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -105.08 4.07 31.08 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.588 -0.523 . . . . 72.340000000000003 109.588 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -133.32 -60.96 0.08 OUTLIER Glycine 0 N--CA 1.426 -1.994 0 C-N-CA 119.987 -1.102 . . . . 72.200000000000003 114.425 -171.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 62.84 29.02 16.63 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.158 0.98 . . . . 71.230000000000004 109.102 -172.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 547' ' ' VAL . 17.2 p -85.62 -166.21 1.45 Allowed 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 126.019 1.728 . . . . 73.510000000000005 109.851 -177.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -108.55 137.68 46.11 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.312 -0.625 . . . . 65.400000000000006 109.312 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -132.2 147.37 52.41 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 116.017 -0.538 . . . . 64.040000000000006 110.203 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.1 m -140.26 145.91 37.92 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.342 -0.984 . . . . 73.120000000000005 108.342 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -117.97 135.22 54.28 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 121.371 0.605 . . . . 73.140000000000001 111.065 -175.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -123.02 126.81 47.83 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.235 -1.024 . . . . 52.43 108.235 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 22.2 m -88.14 125.87 34.83 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.297 0.57 . . . . 73.150000000000006 111.404 -176.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 10.5 p -120.31 150.67 23.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 106.611 -1.625 . . . . 62.020000000000003 106.611 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.416 ' OD1' ' HE2' ' A' ' 557' ' ' LYS . 21.1 m-20 -75.29 135.63 40.92 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 120.311 -0.556 . . . . 74.140000000000001 109.71 -174.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 73.9 m -153.11 169.57 9.52 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 108.343 -0.984 . . . . 72.219999999999999 108.343 -175.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -82.35 -17.53 7.63 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.597 1.531 . . . . 64.109999999999999 111.182 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.605 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 53.1 mtt-85 -75.51 143.68 76.26 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 116.089 -0.505 . . . . 73.420000000000002 110.273 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.97 143.18 96.59 Favored 'Trans proline' 0 C--O 1.247 0.967 0 C-N-CA 123.164 2.576 . . . . 63.219999999999999 112.521 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -56.51 108.97 0.54 Allowed 'General case' 0 C--O 1.242 0.7 0 O-C-N 124.092 0.87 . . . . 64.340000000000003 112.321 -177.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 140.38 -20.0 2.8 Favored Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 115.381 -0.827 . . . . 31.309999999999999 112.494 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . 0.605 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 31.1 tt0 -82.86 144.83 29.82 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.602 -0.518 . . . . 74.140000000000001 109.602 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 503' ' ' GLN . 8.0 p -91.5 115.8 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 CA-C-O 122.094 0.949 . . . . 74.299999999999997 110.455 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.8 -30.86 69.52 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 113.671 -1.604 . . . . 61.439999999999998 110.253 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 154.82 -164.87 31.91 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 110.587 -1.005 . . . . 64.420000000000002 110.587 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 6.4 p -117.29 154.88 30.47 Favored 'General case' 0 C--N 1.288 -2.109 0 N-CA-C 109.542 -0.54 . . . . 62.130000000000003 109.542 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.452 ' HB2' HE22 ' A' ' 554' ' ' GLN . 9.7 t30 -63.79 -51.57 64.01 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 120.149 -0.621 . . . . 70.310000000000002 110.84 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -74.23 134.3 19.01 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 N-CA-C 108.644 -1.329 . . . . 63.119999999999997 108.644 170.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.45 154.4 71.85 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 122.753 2.302 . . . . 73.010000000000005 113.381 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.02 139.89 58.39 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.588 -0.733 . . . . 55.509999999999998 110.284 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 96.86 -8.8 65.76 Favored Glycine 0 C--N 1.302 -1.339 0 C-N-CA 120.595 -0.812 . . . . 65.129999999999995 111.695 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 25.2 m -82.5 133.97 35.2 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.646 -0.872 . . . . 60.329999999999998 108.646 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.1 t -94.64 132.79 38.98 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 108.301 -1.0 . . . . 71.140000000000001 108.301 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.17 155.2 64.96 Favored Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 107.839 -1.171 . . . . 72.319999999999993 107.839 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.525 ' HG2' ' OG ' ' A' ' 549' ' ' SER . 7.6 Cg_endo -60.32 136.52 68.72 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 N-CA-C 109.421 -1.03 . . . . 73.439999999999998 109.421 176.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.572 ' O ' HG22 ' A' ' 518' ' ' THR . 9.7 p -66.56 -21.38 28.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.34 -0.845 . . . . 62.119999999999997 112.941 -172.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -93.35 3.69 55.2 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.766 0.793 . . . . 54.310000000000002 111.043 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . 0.525 ' OG ' ' HG2' ' A' ' 546' ' ' PRO . 68.3 m -87.56 -174.7 4.91 Favored 'General case' 0 C--O 1.251 1.171 0 O-C-N 121.544 -0.723 . . . . 54.299999999999997 112.389 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 13.3 p -113.48 138.25 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 115.221 -0.9 . . . . 75.340000000000003 109.741 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.7 mt -102.92 137.4 31.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.76 -0.83 . . . . 73.340000000000003 108.76 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -102.43 117.49 34.83 Favored 'General case' 0 C--O 1.251 1.132 0 N-CA-C 107.999 -1.111 . . . . 74.010000000000005 107.999 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.44 129.93 55.25 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 123.343 0.402 . . . . 64.439999999999998 110.505 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.452 HE22 ' HB2' ' A' ' 538' ' ' ASN . 2.9 mp0 -90.66 119.38 30.86 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.003 -0.544 . . . . 74.340000000000003 110.785 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 40.2 t -92.99 129.57 43.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.316 -0.994 . . . . 54.229999999999997 108.316 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.658 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 16.1 m -75.71 117.72 17.77 Favored 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 108.081 -1.081 . . . . 74.200000000000003 108.081 176.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.416 ' HE2' ' OD1' ' A' ' 526' ' ' ASP . 26.5 pttm -109.05 118.49 36.91 Favored 'General case' 0 N--CA 1.411 -2.399 0 N-CA-C 107.576 -1.268 . . . . 72.150000000000006 107.576 171.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -56.79 -23.86 46.5 Favored Glycine 0 CA--C 1.497 -1.09 0 O-C-N 124.319 1.012 . . . . 32.409999999999997 113.175 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 77.85 -3.84 2.32 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 125.331 1.452 . . . . 75.230000000000004 109.24 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.549 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 63.2 mt-30 -112.58 150.21 31.67 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 115.592 -0.731 . . . . 61.450000000000003 112.831 -173.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -133.13 156.5 47.32 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.646 -1.613 . . . . 74.120000000000005 106.646 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 47.5 t -73.41 122.87 27.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.595 -0.891 . . . . 63.399999999999999 108.595 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.421 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 57.0 ttp -73.97 127.37 88.28 Favored Pre-proline 0 C--O 1.25 1.082 0 O-C-N 123.22 0.325 . . . . 62.100000000000001 111.428 -175.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 51.9 Cg_exo -61.71 169.64 6.79 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.598 2.865 . . . . 70.049999999999997 112.59 175.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -65.92 129.47 39.9 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.373 0.669 . . . . 63.049999999999997 112.766 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.7 pp -152.45 14.32 0.58 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.182 0.992 . . . . 74.109999999999999 109.075 172.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 4.2 m -79.95 140.89 36.46 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.414 -1.267 . . . . 70.299999999999997 111.995 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 53.18 43.1 63.37 Favored Glycine 0 C--O 1.223 -0.544 0 N-CA-C 115.112 0.805 . . . . 52.43 115.112 172.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 18.1 ptp -127.15 -179.65 4.97 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.874 -1.158 . . . . 75.099999999999994 107.874 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . 0.426 ' HB2' HG12 ' A' ' 572' ' ' VAL . 21.7 m-85 -96.24 168.96 10.27 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.665 -0.865 . . . . 74.310000000000002 108.665 -175.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 37.8 t-105 -63.39 -28.08 69.74 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.445 -0.576 . . . . 73.030000000000001 109.445 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . 0.426 HG12 ' HB2' ' A' ' 570' ' ' PHE . 8.9 p -75.11 -9.58 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 CA-C-N 115.695 -0.684 . . . . 74.040000000000006 110.484 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.587 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 42.6 m-20 -101.1 -42.0 6.54 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 107.858 -1.164 . . . . 52.240000000000002 107.858 173.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . 0.55 ' O ' HD12 ' A' ' 578' ' ' LEU . . . -55.54 -45.92 77.15 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.782 -1.099 . . . . 62.43 112.044 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.563 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 3.0 tm-20 -53.98 -58.46 13.33 Favored Pre-proline 0 CA--C 1.567 1.616 0 CA-C-O 118.949 -0.548 . . . . 72.25 110.533 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 57.9 Cg_exo -53.17 -32.25 58.94 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 121.978 1.785 . . . . 72.540000000000006 112.808 173.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 26.2 mmm180 -61.93 -36.25 80.81 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-O 118.659 -0.686 . . . . 75.099999999999994 112.42 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.632 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 5.4 mp -62.66 -48.54 78.88 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.708 -1.197 . . . . 73.230000000000004 110.115 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 576' ' ' PRO . 0.7 OUTLIER -66.1 -41.23 90.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.824 -0.625 . . . . 71.329999999999998 112.322 178.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.28 -39.54 74.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.746 0.647 . . . . 62.100000000000001 112.746 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.01 -9.02 58.46 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.926 0.394 . . . . 64.219999999999999 110.433 -175.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 72.47 48.36 24.12 Favored Glycine 0 CA--C 1.505 -0.556 0 N-CA-C 111.316 -0.713 . . . . 63.039999999999999 111.316 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.632 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 8.6 t90 -85.99 133.4 33.92 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.0 0.429 . . . . 72.450000000000003 110.011 -176.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 1.3 p -86.82 -39.36 15.95 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.583 1.553 . . . . 64.310000000000002 112.826 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -79.7 -162.16 24.28 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-O 121.797 0.665 . . . . 64.5 114.279 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 61.5 mtm -122.79 152.87 40.24 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.974 -0.75 . . . . 75.530000000000001 108.974 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 4.4 tt -81.92 111.67 18.32 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.648 -1.241 . . . . 71.019999999999996 107.648 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 621' ' ' THR . 33.0 t70 -95.34 107.97 20.12 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.658 0.742 . . . . 71.049999999999997 110.049 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.504 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.3 OUTLIER -97.1 133.66 41.46 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.677 -0.861 . . . . 65.25 108.677 178.451 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.25 -69.29 1.4 Allowed Glycine 0 C--N 1.28 -2.532 0 N-CA-C 110.57 -1.012 . . . . 71.450000000000003 110.57 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -137.22 149.34 47.13 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 110.065 -0.346 . . . . 73.400000000000006 110.065 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -115.77 124.7 51.42 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.645 0.736 . . . . 75.209999999999994 109.072 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 44.2 t -106.74 153.52 7.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.758 -1.201 . . . . 73.420000000000002 107.758 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.42 126.2 29.26 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.934 0.873 . . . . 71.319999999999993 110.752 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -133.54 -48.34 0.83 Allowed 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 114.386 -1.279 . . . . 62.310000000000002 108.747 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 102.51 123.14 5.2 Favored Glycine 0 N--CA 1.422 -2.254 0 N-CA-C 111.254 -0.738 . . . . 64.450000000000003 111.254 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -60.58 -33.83 83.5 Favored Glycine 0 C--N 1.317 -0.514 0 N-CA-C 111.704 -0.559 . . . . 14.31 111.704 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.2 m -70.27 -23.88 62.96 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-O 121.819 0.819 . . . . 62.210000000000001 110.135 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -92.06 -1.58 57.13 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.195 -0.911 . . . . 74.129999999999995 110.085 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 69.82 81.73 0.17 Allowed 'General case' 0 C--O 1.244 0.772 0 CA-C-O 123.229 1.49 . . . . 72.209999999999994 111.283 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 625' ' ' GLY . 15.8 p-10 -79.77 89.31 5.21 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 113.32 -1.764 . . . . 72.25 113.056 -174.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -81.9 170.93 15.06 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.146 -0.934 . . . . 61.409999999999997 111.722 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 75.0 t -70.29 131.83 33.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 114.55 -1.205 . . . . 64.420000000000002 108.529 171.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 86.5 t -91.07 -43.92 14.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.499 0.666 . . . . 72.430000000000007 110.568 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -153.14 140.05 19.14 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.783 -0.644 . . . . 64.340000000000003 109.693 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -127.51 139.49 52.75 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.663 -1.236 . . . . 74.219999999999999 107.663 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.59 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 23.8 t-20 -58.99 -62.48 5.73 Favored Pre-proline 0 CA--C 1.555 1.153 0 CA-C-O 118.922 -0.561 . . . . 73.450000000000003 111.929 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.625 ' HD2' HG12 ' A' ' 620' ' ' ILE . 7.4 Cg_endo -95.74 120.44 0.24 Allowed 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 122.003 1.802 . . . . 75.239999999999995 110.027 171.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 19.0 Cg_exo -70.34 156.82 60.99 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.437 2.091 . . . . 74.450000000000003 112.276 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.38 138.61 56.85 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.466 -0.938 . . . . 53.340000000000003 108.466 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 97.77 -2.13 60.14 Favored Glycine 0 C--N 1.301 -1.398 0 N-CA-C 110.637 -0.985 . . . . 30.41 110.637 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 26.9 m -109.54 155.52 21.28 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.281 -1.377 . . . . 63.039999999999999 107.281 175.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -78.43 138.46 21.12 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.972 -0.632 . . . . 75.439999999999998 113.393 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.89 143.05 42.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 124.068 0.947 . . . . 72.040000000000006 109.11 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.549 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.2 p-10 -48.38 168.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.852 0.861 . . . . 70.450000000000003 113.023 175.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -57.14 -25.54 59.04 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.531 0.732 . . . . 71.120000000000005 112.806 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.95 -8.53 58.71 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 120.037 -0.665 . . . . 71.129999999999995 109.37 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.16 15.77 63.56 Favored Glycine 0 C--O 1.216 -1.024 0 CA-C-N 116.127 -0.488 . . . . 64.329999999999998 113.141 172.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.4 119.38 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-O 122.623 1.202 . . . . 70.299999999999997 112.409 -166.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.625 HG12 ' HD2' ' A' ' 608' ' ' PRO . 0.0 OUTLIER -125.62 128.25 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 0 CA-C-N 113.694 -1.594 . . . . 74.310000000000002 110.2 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 21.2 m -100.51 129.59 46.47 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.673 -1.149 . . . . 74.409999999999997 108.896 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.8 pp -138.92 166.24 24.99 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.742 0.645 . . . . 74.409999999999997 112.742 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -127.57 137.46 52.6 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.519 -2.03 . . . . 72.329999999999998 105.519 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -140.8 165.67 26.87 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 120.199 -0.6 . . . . 74.219999999999999 111.113 -172.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 601' ' ' ASN . . . -81.2 142.64 23.29 Favored Glycine 0 N--CA 1.412 -2.913 0 CA-C-N 115.405 -0.816 . . . . 43.149999999999999 111.125 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.406 HE21 ' HB3' ' A' ' 626' ' ' GLN . 0.8 OUTLIER . . . . . 0 N--CA 1.402 -2.865 0 C-N-CA 124.336 1.054 . . . . 72.010000000000005 108.472 178.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.788 0 N-CA-C 110.098 -1.201 . . . . 43.049999999999997 110.098 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.13 142.35 24.48 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 121.949 1.766 . . . . 73.230000000000004 110.916 177.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -92.44 -10.54 37.61 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 122.44 1.114 . . . . 74.510000000000005 109.82 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 3.5 p -137.64 147.47 44.97 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 113.998 -1.455 . . . . 52.009999999999998 108.907 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -130.86 149.7 52.37 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.965 -0.754 . . . . 73.319999999999993 108.965 177.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.7 p-10 -87.71 135.55 33.32 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 122.986 0.514 . . . . 71.329999999999998 109.744 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 29.6 pt -88.43 130.39 45.79 Favored Pre-proline 0 C--N 1.307 -1.28 0 CA-C-N 116.586 -0.279 . . . . 75.510000000000005 110.957 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -88.44 172.75 4.81 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.629 2.219 . . . . 71.549999999999997 112.807 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -92.31 111.94 23.7 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.369 -0.832 . . . . 73.439999999999998 108.85 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 24.1 m -106.41 16.44 6.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.408 -0.815 . . . . 72.099999999999994 111.212 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -67.06 98.12 0.55 Allowed 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.822 -0.627 . . . . 73.519999999999996 111.399 -176.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 146.34 -26.03 1.7 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-N 115.667 -0.697 . . . . 31.0 111.637 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.447 ' O ' HG12 ' A' ' 534' ' ' VAL . 31.8 mt-30 -82.65 171.08 14.42 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.82 -0.807 . . . . 64.219999999999999 108.82 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 4.8 m -74.25 155.94 37.74 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 105.129 -2.174 . . . . 63.100000000000001 105.129 172.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.433 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.2 p -61.93 -41.94 92.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 118.648 0.658 . . . . 73.530000000000001 111.442 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 17.1 t70 -62.4 -41.66 98.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.546 -0.297 . . . . 65.540000000000006 110.357 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 87.4 t -67.1 -44.15 88.26 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.247 0 CA-C-N 116.036 -0.529 . . . . 72.349999999999994 109.843 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.477 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -60.84 -39.79 90.4 Favored 'General case' 0 C--O 1.214 -0.809 0 O-C-N 123.18 0.3 . . . . 72.040000000000006 111.159 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.1 mt-30 -65.06 -43.94 90.62 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.473 -0.195 . . . . 74.439999999999998 110.473 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 75.7 mmtt -63.95 -45.21 90.16 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.049 -0.723 . . . . 73.310000000000002 109.049 177.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -61.22 -43.06 99.49 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.279 -1.328 . . . . 75.129999999999995 110.077 -175.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 66.3 tp -67.23 -45.81 75.66 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.14 -1.391 . . . . 74.430000000000007 109.219 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -64.88 -34.98 79.68 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 123.942 0.897 . . . . 63.299999999999997 113.155 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 510' ' ' LYS . 85.8 t -57.18 -33.06 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 120.928 0.394 . . . . 63.43 111.278 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -118.5 8.57 12.09 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.924 0.869 . . . . 71.329999999999998 110.267 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -114.42 -59.08 0.37 Allowed Glycine 0 N--CA 1.416 -2.688 0 CA-C-N 114.936 -1.029 . . . . 70.019999999999996 111.707 -174.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 65.53 18.72 11.36 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 122.479 1.133 . . . . 75.409999999999997 109.53 -176.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 3.2 p -92.54 -175.86 4.11 Favored 'General case' 0 N--CA 1.403 -2.795 0 CA-C-N 114.04 -1.436 . . . . 55.530000000000001 110.416 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -107.82 142.21 38.21 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.531 -0.914 . . . . 75.25 108.531 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -129.03 153.3 47.73 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.458 0.647 . . . . 72.400000000000006 111.427 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 71.0 m -140.12 155.71 46.87 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 107.095 -1.446 . . . . 72.099999999999994 107.095 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -124.14 123.23 39.84 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.313 0.578 . . . . 72.120000000000005 111.274 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -105.56 119.31 38.79 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.429 -0.952 . . . . 71.129999999999995 108.429 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 20.2 m -100.72 137.19 39.45 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.877 -0.329 . . . . 75.120000000000005 110.905 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.1 p -144.21 153.91 15.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.754 -1.202 . . . . 54.420000000000002 107.754 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.435 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 3.3 p30 -84.08 136.22 34.1 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.304 0.573 . . . . 63.030000000000001 110.927 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.441 ' HB3' ' HD2' ' A' ' 528' ' ' PRO . 50.6 m -159.04 171.38 7.49 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 106.394 -1.706 . . . . 63.119999999999997 106.394 -177.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 527' ' ' SER . 37.3 Cg_endo -68.99 -10.11 28.26 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 121.4 1.4 . . . . 62.210000000000001 112.597 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.414 ' HB2' ' CB ' ' A' ' 556' ' ' SER . 23.5 mmm180 -72.59 140.14 81.46 Favored Pre-proline 0 N--CA 1.435 -1.189 0 N-CA-C 109.573 -0.529 . . . . 72.439999999999998 109.573 177.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.36 151.34 83.48 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.608 2.206 . . . . 72.400000000000006 113.344 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -64.96 121.55 14.91 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.187 -0.915 . . . . 74.120000000000005 111.542 -177.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 114.58 -18.91 17.02 Favored Glycine 0 C--O 1.249 1.044 0 C-N-CA 120.838 -0.696 . . . . 73.310000000000002 111.373 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -78.2 129.18 34.81 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 109.025 -0.732 . . . . 64.329999999999998 109.025 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 10.1 p -90.81 117.42 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.844 0 N-CA-C 106.78 -1.563 . . . . 42.109999999999999 106.78 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.4 m -92.94 9.74 34.25 Favored 'General case' 0 C--N 1.27 -2.886 0 CA-C-N 114.341 -1.3 . . . . 51.140000000000001 110.567 -173.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.411 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 132.7 -154.79 21.27 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 111.338 -0.705 . . . . 34.32 111.338 176.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.8 p -116.96 157.95 24.89 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.804 -0.813 . . . . 52.030000000000001 108.804 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.403 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 11.9 t-20 -60.53 -55.76 41.91 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 119.004 -0.522 . . . . 54.439999999999998 111.448 176.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 16.3 Cg_exo -70.53 144.78 50.9 Favored 'Trans proline' 0 C--N 1.367 1.533 0 N-CA-C 108.658 -1.324 . . . . 72.510000000000005 108.658 171.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -58.15 147.52 83.09 Favored 'Trans proline' 0 C--O 1.24 0.577 0 C-N-CA 122.79 2.327 . . . . 70.310000000000002 113.047 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.05 137.89 57.76 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-N 116.27 -0.423 . . . . 63.020000000000003 110.432 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.62 -19.98 48.17 Favored Glycine 0 C--N 1.31 -0.896 0 C-N-CA 120.926 -0.654 . . . . 42.32 111.948 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 35.4 m -67.46 136.79 55.19 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.705 -0.48 . . . . 74.329999999999998 109.705 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 14.8 t -96.34 133.23 40.98 Favored 'General case' 0 N--CA 1.406 -2.67 0 N-CA-C 108.984 -0.747 . . . . 74.420000000000002 108.984 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.7 m -123.39 155.88 64.67 Favored Pre-proline 0 C--N 1.296 -1.753 0 N-CA-C 108.042 -1.096 . . . . 71.430000000000007 108.042 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -63.9 138.28 62.19 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 121.385 1.39 . . . . 65.430000000000007 110.486 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 13.2 p -62.2 -19.99 23.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.611 -0.722 . . . . 75.209999999999994 111.426 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -90.18 -15.89 30.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.172 0.51 . . . . 43.549999999999997 111.507 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 60.0 m -80.39 -175.69 5.27 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 121.109 0.481 . . . . 73.439999999999998 111.723 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 12.4 p -113.19 137.61 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 115.931 -0.577 . . . . 73.340000000000003 110.168 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 70.2 mt -97.33 129.89 46.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 109.371 -0.603 . . . . 73.120000000000005 109.371 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -102.56 117.59 35.01 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.135 -0.691 . . . . 74.409999999999997 109.135 -177.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.3 mp -98.59 134.84 40.97 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.813 -0.631 . . . . 74.25 110.006 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -91.82 113.63 25.95 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 116.292 -0.413 . . . . 71.409999999999997 110.365 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 524' ' ' SER . 20.1 t -106.65 126.93 62.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.421 -0.955 . . . . 65.0 108.421 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.556 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 50.5 m -95.55 143.34 26.94 Favored 'General case' 0 C--N 1.277 -2.58 0 C-N-CA 119.661 -0.816 . . . . 73.099999999999994 110.824 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 0.6 OUTLIER -105.79 144.38 32.61 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 106.163 -1.792 . . . . 74.439999999999998 106.163 168.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -55.02 -23.35 31.34 Favored Glycine 0 CA--C 1.492 -1.36 0 O-C-N 124.903 1.377 . . . . 64.120000000000005 114.624 -171.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 22.4 t-20 77.09 -27.29 0.18 Allowed 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 124.604 1.162 . . . . 74.120000000000005 110.92 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' A' ' 558' ' ' GLY . 72.1 mt-30 -114.1 162.18 16.81 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 114.517 -1.22 . . . . 74.420000000000002 109.665 -175.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -127.19 155.9 42.68 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 107.805 -1.183 . . . . 74.420000000000002 107.805 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 6.2 p -77.78 121.05 29.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.554 -0.536 . . . . 63.310000000000002 109.554 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.497 ' SD ' HG21 ' A' ' 620' ' ' ILE . 47.6 ttp -74.11 125.23 90.27 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 116.403 -0.362 . . . . 74.540000000000006 111.43 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -72.45 170.61 18.89 Favored 'Trans proline' 0 C--O 1.242 0.721 0 C-N-CA 123.491 2.794 . . . . 72.519999999999996 111.891 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.06 114.47 5.86 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.914 0.864 . . . . 74.420000000000002 112.703 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.5 pp -125.12 7.15 7.89 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.105 -1.407 . . . . 72.530000000000001 107.476 171.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 16.7 m -79.81 144.04 33.87 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 113.497 -1.683 . . . . 74.540000000000006 110.564 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 68.03 43.13 83.02 Favored Glycine 0 CA--C 1.521 0.413 0 O-C-N 123.686 0.616 . . . . 74.019999999999996 114.007 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 22.2 ptp -146.91 174.79 11.18 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.288 -0.634 . . . . 64.5 109.288 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -98.05 172.87 7.34 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.547 -1.279 . . . . 64.549999999999997 107.547 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -62.97 -35.63 80.79 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.708 -0.849 . . . . 75.140000000000001 108.708 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.8 -22.36 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 115.636 -0.711 . . . . 61.43 111.506 -175.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.403 ' C ' ' HD2' ' A' ' 576' ' ' PRO . 28.4 t70 -102.18 -31.35 10.62 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-O 121.479 0.657 . . . . 71.299999999999997 110.667 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -71.41 -32.39 68.34 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.506 -0.77 . . . . 63.210000000000001 111.484 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.615 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 34.3 tt0 -64.56 -48.95 73.2 Favored Pre-proline 0 CA--C 1.56 1.336 0 CA-C-N 116.47 -0.332 . . . . 52.210000000000001 111.196 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 88.5 Cg_exo -54.69 -38.01 91.38 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 121.471 1.447 . . . . 33.310000000000002 111.76 170.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.439 ' HA ' ' NE ' ' A' ' 577' ' ' ARG . 1.4 mmp_? -58.94 -43.18 91.14 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 121.359 -0.136 . . . . 50.130000000000003 111.325 176.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.5 pp -67.05 -45.66 76.71 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.542 0.571 . . . . 73.299999999999997 112.542 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.47 ' N ' HD12 ' A' ' 578' ' ' LEU . 5.9 ptp85 -66.71 -35.04 79.18 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.478 0.547 . . . . 72.439999999999998 112.478 176.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.97 -36.56 83.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.181 0.515 . . . . 64.530000000000001 110.03 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 12.1 tp -81.26 -9.85 59.7 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.651 -0.704 . . . . 63.329999999999998 110.694 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 67.79 42.82 85.97 Favored Glycine 0 C--O 1.243 0.671 0 N-CA-C 111.883 -0.487 . . . . 73.409999999999997 111.883 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.406 ' HE3' ' CB ' ' A' ' 578' ' ' LEU . 13.7 t90 -75.19 126.49 31.13 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 120.977 0.418 . . . . 61.049999999999997 109.879 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 18.1 p -103.52 -15.44 15.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.822 -0.626 . . . . 73.25 112.084 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -83.79 -176.71 51.37 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 121.161 -0.542 . . . . 65.129999999999995 112.953 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 51.5 ttp -100.86 141.37 33.84 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 122.344 0.258 . . . . 74.430000000000007 111.286 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 8.0 tt -80.96 107.5 13.83 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.075 -1.083 . . . . 74.230000000000004 108.075 174.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.545 ' O ' ' HA ' ' A' ' 621' ' ' THR . 24.5 t70 -98.39 116.2 30.12 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 115.486 -0.779 . . . . 72.0 109.578 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -106.46 134.38 49.68 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.534 -0.757 . . . . 54.200000000000003 109.192 178.61 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -70.84 -75.24 0.63 Allowed Glycine 0 C--N 1.293 -1.846 0 N-CA-C 111.116 -0.793 . . . . 72.150000000000006 111.116 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.09 121.32 15.87 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.284 -0.635 . . . . 72.439999999999998 109.284 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -84.57 137.01 33.54 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.992 -1.114 . . . . 53.340000000000003 107.992 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 47.0 t -105.76 126.75 61.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 116.223 -0.444 . . . . 72.409999999999997 110.049 -174.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . 0.507 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 9.7 p-10 -72.12 111.55 7.44 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 122.403 1.097 . . . . 63.310000000000002 111.489 -176.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -133.98 -45.68 0.79 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.356 -1.293 . . . . 42.219999999999999 109.133 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 103.44 149.36 20.79 Favored Glycine 0 N--CA 1.422 -2.261 0 C-N-CA 120.837 -0.697 . . . . 62.329999999999998 112.356 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.494 ' HA2' ' OD1' ' A' ' 601' ' ' ASN . . . -61.51 -32.58 81.74 Favored Glycine 0 C--N 1.302 -1.339 0 CA-C-N 114.981 -0.61 . . . . 62.5 112.71 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 10.6 t -71.03 -23.56 62.19 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 122.253 1.025 . . . . 75.030000000000001 109.449 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -88.58 -1.13 57.9 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.681 -1.145 . . . . 74.25 110.672 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 48.4 m80 70.29 80.7 0.17 Allowed 'General case' 0 C--O 1.244 0.792 0 CA-C-O 122.755 1.264 . . . . 72.219999999999999 110.567 -178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . 0.494 ' OD1' ' HA2' ' A' ' 597' ' ' GLY . 30.0 p-10 -87.58 78.53 8.53 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 113.812 -1.54 . . . . 74.109999999999999 111.452 -175.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -94.07 171.61 8.74 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.601 -1.181 . . . . 73.25 109.232 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 96.4 t -64.93 130.75 30.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 106.829 -1.545 . . . . 54.549999999999997 106.829 170.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.8 t -96.51 -52.72 8.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 121.169 0.509 . . . . 70.530000000000001 110.535 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -147.91 150.55 34.3 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.161 -0.681 . . . . 73.209999999999994 109.161 -175.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -139.4 144.34 38.09 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.871 -1.159 . . . . 63.149999999999999 107.871 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.403 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 9.6 t30 -63.52 -51.48 66.66 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 120.444 -0.502 . . . . 72.340000000000003 111.98 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 57.6 Cg_endo -93.13 116.67 0.32 Allowed 'Trans proline' 0 N--CA 1.442 -1.532 0 C-N-CA 121.212 1.275 . . . . 75.120000000000005 110.328 171.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.88 160.96 34.8 Favored 'Trans proline' 0 C--O 1.248 0.989 0 C-N-CA 122.857 2.371 . . . . 75.510000000000005 112.215 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.61 133.67 56.32 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.085 -0.709 . . . . 73.109999999999999 109.085 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 100.65 -0.56 55.44 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.636 -0.792 . . . . 63.109999999999999 112.265 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 35.3 m -90.18 145.76 24.78 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.555 -0.535 . . . . 72.150000000000006 109.555 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -77.28 124.21 6.82 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 110.733 -0.947 . . . . 41.43 110.733 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.9 m -125.78 143.2 40.11 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 108.374 -0.972 . . . . 63.420000000000002 108.374 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.431 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.4 p-10 -48.23 163.03 0.07 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.92 0.888 . . . . 74.409999999999997 111.965 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . 0.331 0.0 OUTLIER -56.04 -24.5 39.98 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.971 1.471 . . . . 64.219999999999999 114.971 -178.387 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -83.65 -6.26 59.4 Favored 'General case' 0 C--O 1.199 -1.589 0 C-N-CA 119.256 -0.977 . . . . 75.219999999999999 112.497 175.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.83 19.52 69.61 Favored Glycine 0 CA--C 1.491 -1.441 0 CA-C-O 119.464 -0.631 . . . . 64.099999999999994 114.561 166.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.83 118.63 14.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-O 122.12 0.962 . . . . 72.310000000000002 110.419 -168.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.497 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.7 pp -129.36 133.86 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 114.708 -1.133 . . . . 41.409999999999997 111.866 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 15.4 t -102.21 122.92 45.12 Favored 'General case' 0 C--O 1.26 1.633 0 CA-C-O 121.802 0.81 . . . . 73.310000000000002 109.553 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 1.8 pt? -139.36 167.27 22.47 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.334 -0.848 . . . . 74.409999999999997 111.742 -173.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -128.22 137.08 51.86 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.262 -1.014 . . . . 71.219999999999999 108.262 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.463 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 35.0 p90 -141.28 166.63 24.24 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.788 -0.187 . . . . 64.019999999999996 111.126 -174.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -75.57 135.2 17.8 Favored Glycine 0 N--CA 1.435 -1.4 0 CA-C-O 121.69 0.605 . . . . 71.420000000000002 113.954 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.507 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 4.2 tt0 . . . . . 0 C--N 1.296 -1.755 0 N-CA-C 107.1 -1.445 . . . . 74.230000000000004 107.1 175.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.114 0 N-CA-C 110.167 -1.173 . . . . 43.049999999999997 110.167 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.13 161.46 43.16 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 122.41 2.073 . . . . 73.430000000000007 111.793 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -87.0 5.22 38.49 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.357 0.598 . . . . 61.43 111.594 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 16.1 p -139.18 141.1 37.99 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.823 -0.806 . . . . 61.240000000000002 108.823 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -143.02 148.42 36.74 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.818 0.342 . . . . 43.520000000000003 111.32 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.9 p-10 -79.1 139.08 38.17 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 115.407 -0.815 . . . . 72.349999999999994 110.209 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.4 pt -96.17 137.35 21.69 Favored Pre-proline 0 C--N 1.296 -1.722 0 CA-C-N 115.628 -0.715 . . . . 72.209999999999994 111.116 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -89.86 -177.22 1.34 Allowed 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.487 2.124 . . . . 72.420000000000002 109.829 170.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -99.9 137.28 38.57 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.919 -1.141 . . . . 73.450000000000003 107.919 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.502 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 16.7 m -110.81 17.31 7.65 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 CA-C-N 115.543 -0.753 . . . . 51.130000000000003 110.178 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -72.93 100.83 3.03 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.456 -0.793 . . . . 72.439999999999998 110.206 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 169.12 -46.43 0.22 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-N 115.379 -0.828 . . . . 63.32 111.864 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.431 ' O ' HG12 ' A' ' 534' ' ' VAL . 18.2 pm0 -98.07 -171.06 2.08 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 122.344 -0.504 . . . . 75.040000000000006 110.505 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 15.1 m -70.92 155.12 41.2 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.452 -0.944 . . . . 71.329999999999998 108.452 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 9.7 p -65.5 -41.73 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 O-C-N 123.06 0.225 . . . . 63.049999999999997 110.88 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -61.82 -37.98 86.44 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.913 -0.773 . . . . 65.120000000000005 108.913 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 95.1 t -71.02 -48.77 53.74 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.624 0 CA-C-N 115.525 -0.761 . . . . 53.350000000000001 109.684 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.502 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -60.58 -36.73 79.25 Favored 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 122.769 0.428 . . . . 72.510000000000005 111.767 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.422 ' O ' ' HB2' ' A' ' 513' ' ' ASN . 23.8 mt-30 -65.23 -45.2 85.62 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.56 0.219 . . . . 53.219999999999999 110.47 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.524 ' O ' HG23 ' A' ' 514' ' ' VAL . 75.1 mmtt -66.6 -39.53 88.43 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 109.137 -0.69 . . . . 74.140000000000001 109.137 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' A' ' 508' ' ' ALA . 20.3 t-20 -60.18 -47.02 87.68 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 125.771 1.628 . . . . 71.109999999999999 110.091 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -69.48 -42.06 75.32 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.761 -1.109 . . . . 71.129999999999995 108.592 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 1.0 OUTLIER -63.7 -35.59 81.07 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.421 -0.809 . . . . 75.120000000000005 111.392 -174.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 510' ' ' LYS . 71.4 t -57.78 -32.46 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.068 0.461 . . . . 63.450000000000003 111.737 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -115.36 4.76 14.45 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.559 0.695 . . . . 74.420000000000002 110.108 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -120.21 -57.59 0.24 Allowed Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 115.817 -0.629 . . . . 53.030000000000001 113.094 -174.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 64.76 28.96 12.9 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.89 0.876 . . . . 73.109999999999999 111.411 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 16.7 p -89.09 -166.92 1.72 Allowed 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.665 -1.152 . . . . 72.200000000000003 109.208 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -107.74 143.98 35.51 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 106.754 -1.572 . . . . 73.349999999999994 106.754 173.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -126.84 144.8 50.86 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.387 0.613 . . . . 62.299999999999997 112.327 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 73.5 m -132.81 149.92 52.22 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 108.651 -0.87 . . . . 72.25 108.651 176.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.405 ' HB2' ' CG2' ' A' ' 555' ' ' VAL . 3.7 pt20 -123.18 131.78 53.81 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.025 0.44 . . . . 74.129999999999995 110.536 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -120.45 118.88 31.43 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.576 -0.898 . . . . 73.200000000000003 108.576 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 78.4 p -94.78 139.3 31.45 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.451 0.643 . . . . 73.310000000000002 112.203 -176.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.8 p -133.6 150.17 31.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.097 -1.075 . . . . 75.209999999999994 108.097 178.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -73.11 136.03 44.83 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.348 0.594 . . . . 72.319999999999993 111.281 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 74.3 m -156.01 163.2 25.59 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 106.803 -1.554 . . . . 74.030000000000001 106.803 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.52 -10.83 27.45 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.387 1.392 . . . . 65.120000000000005 112.709 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.455 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 10.2 mtm180 -84.48 152.51 60.77 Favored Pre-proline 0 N--CA 1.429 -1.483 0 N-CA-C 108.891 -0.781 . . . . 74.329999999999998 108.891 -176.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.17 149.35 70.57 Favored 'Trans proline' 0 C--O 1.246 0.893 0 C-N-CA 122.239 1.959 . . . . 73.530000000000001 114.41 -170.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -63.94 124.45 21.58 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.399 -1.273 . . . . 71.010000000000005 110.689 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 125.71 -21.65 6.26 Favored Glycine 0 C--N 1.291 -1.927 0 N-CA-C 111.049 -0.82 . . . . 50.219999999999999 111.049 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -75.0 137.59 41.64 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 109.584 -0.524 . . . . 44.5 109.584 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 503' ' ' GLN . 4.3 p -90.87 113.22 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.95 0 CA-C-O 122.084 0.945 . . . . 72.230000000000004 108.825 174.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -24.72 64.33 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.21 -1.359 . . . . 74.420000000000002 111.087 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 152.24 -157.42 27.25 Favored Glycine 0 N--CA 1.432 -1.617 0 N-CA-C 110.013 -1.235 . . . . 43.450000000000003 110.013 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.2 p -117.37 155.01 30.32 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 117.356 0.578 . . . . 60.340000000000003 109.903 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.495 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 25.7 t-20 -53.39 -51.7 73.27 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 119.252 -0.404 . . . . 74.219999999999999 111.902 174.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 2.9 Cg_endo -87.02 153.29 8.37 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 121.773 1.649 . . . . 75.420000000000002 110.453 174.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.32 160.68 48.86 Favored 'Trans proline' 0 C--O 1.26 1.58 0 C-N-CA 122.413 2.075 . . . . 72.319999999999993 112.545 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.6 131.83 46.86 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.84 -0.618 . . . . 53.310000000000002 109.712 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.74 -6.63 38.12 Favored Glycine 0 C--N 1.303 -1.256 0 C-N-CA 120.831 -0.7 . . . . 73.329999999999998 111.848 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 25.7 m -78.78 126.45 30.74 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.452 -0.574 . . . . 74.439999999999998 109.452 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 9.4 t -87.05 126.33 34.68 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.431 0.634 . . . . 64.099999999999994 109.319 176.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.67 159.49 55.38 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 107.782 -1.192 . . . . 74.25 107.782 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -66.38 137.56 47.52 Favored 'Trans proline' 0 N--CA 1.437 -1.808 0 C-N-CA 120.874 1.049 . . . . 75.239999999999995 110.354 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.41 -19.06 23.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.323 -0.853 . . . . 54.340000000000003 111.408 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -96.39 -9.8 29.11 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 112.211 0.448 . . . . 55.549999999999997 112.211 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 60.3 m -89.6 -175.99 4.86 Favored 'General case' 0 C--O 1.255 1.345 0 N-CA-C 112.871 0.693 . . . . 53.32 112.871 -177.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.9 p -104.03 138.07 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 115.508 -0.769 . . . . 72.219999999999999 111.024 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 61.0 mt -107.55 138.34 34.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.88 -1.155 . . . . 74.209999999999994 107.88 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . 0.417 ' HG2' ' NE2' ' A' ' 554' ' ' GLN . 25.1 tt0 -102.84 126.89 50.15 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.145 0.498 . . . . 72.409999999999997 111.083 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.2 mp -108.04 134.72 50.53 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.108 -0.951 . . . . 70.510000000000005 109.281 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.417 ' NE2' ' HG2' ' A' ' 552' ' ' GLU . 25.0 mm-40 -89.41 134.04 34.26 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.921 -1.14 . . . . 75.409999999999997 107.921 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 524' ' ' SER . 38.3 t -116.08 131.2 69.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 110.21 -0.293 . . . . 72.340000000000003 110.21 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.655 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 2.3 m -83.79 122.03 28.11 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 107.839 -1.171 . . . . 73.329999999999998 107.839 177.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.73 140.18 30.91 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 106.725 -1.583 . . . . 63.039999999999999 106.725 171.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -57.91 -23.44 51.23 Favored Glycine 0 CA--C 1.489 -1.592 0 O-C-N 124.894 1.371 . . . . 73.409999999999997 114.282 -171.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 77.98 -19.52 0.43 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.759 1.224 . . . . 75.109999999999999 110.851 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.487 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 75.8 mt-30 -112.41 155.29 24.45 Favored 'General case' 0 N--CA 1.428 -1.549 0 O-C-N 121.502 -0.749 . . . . 72.430000000000007 112.042 -174.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -135.36 150.6 49.97 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.377 -1.342 . . . . 75.230000000000004 107.377 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 6.2 p -66.95 125.35 24.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 121.202 0.525 . . . . 73.400000000000006 111.661 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.504 ' SD ' HG21 ' A' ' 620' ' ' ILE . 51.3 ttp -88.34 131.02 43.66 Favored Pre-proline 0 C--N 1.309 -1.189 0 CA-C-N 116.095 -0.502 . . . . 55.399999999999999 109.731 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.18 169.21 17.21 Favored 'Trans proline' 0 C--O 1.244 0.803 0 C-N-CA 122.51 2.14 . . . . 63.049999999999997 110.88 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . 0.469 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 0.9 OUTLIER -79.22 127.83 32.54 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 122.286 1.041 . . . . 72.439999999999998 111.916 -177.225 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.3 pp -135.51 19.64 3.35 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 113.62 -1.627 . . . . 75.099999999999994 108.534 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 13.2 m -79.14 143.08 35.81 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 114.376 -1.284 . . . . 60.329999999999998 109.417 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 74.54 46.0 21.03 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 121.046 -0.597 . . . . 53.0 112.256 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -129.05 174.35 9.62 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 109.076 -0.712 . . . . 52.420000000000002 109.076 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -111.37 165.65 11.78 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.018 -1.845 . . . . 63.219999999999999 106.018 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 18.6 t-105 -61.75 -31.49 71.67 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.134 0.492 . . . . 74.230000000000004 110.139 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.5 p -65.37 -25.62 37.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 115.694 -0.684 . . . . 73.030000000000001 111.08 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.633 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 37.1 t70 -93.8 -26.2 17.06 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.578 -0.527 . . . . 74.400000000000006 109.578 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.19 -45.48 93.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.128 -0.942 . . . . 71.340000000000003 111.877 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.542 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 40.7 mt-10 -57.15 -52.95 70.31 Favored Pre-proline 0 CA--C 1.56 1.329 0 N-CA-C 112.547 0.573 . . . . 75.530000000000001 112.547 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 31.5 Cg_exo -61.28 -35.22 85.67 Favored 'Trans proline' 0 C--N 1.365 1.439 0 CA-C-N 120.491 1.211 . . . . 74.230000000000004 112.414 173.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 5.7 mmp_? -60.4 -44.74 95.39 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 120.934 -0.306 . . . . 73.310000000000002 110.651 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.6 pp -65.88 -47.09 76.02 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.023 -0.535 . . . . 71.329999999999998 112.203 -174.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.5 ' N ' HD12 ' A' ' 578' ' ' LEU . 16.8 ptm180 -66.64 -37.63 85.22 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.261 -0.427 . . . . 75.329999999999998 111.707 177.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.47 -35.61 73.39 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 111.822 0.305 . . . . 73.420000000000002 111.822 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.0 pp -83.97 -9.15 58.89 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 119.654 -0.818 . . . . 63.43 110.532 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 78.96 41.99 13.32 Favored Glycine 0 C--O 1.243 0.718 0 C-N-CA 121.197 -0.525 . . . . 73.140000000000001 112.211 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -78.21 128.78 34.26 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.565 -0.531 . . . . 73.519999999999996 109.565 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 5.2 p -82.18 -47.98 11.84 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 123.732 0.813 . . . . 64.540000000000006 112.092 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -68.42 -166.4 3.94 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 115.698 1.039 . . . . 43.450000000000003 115.698 -176.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 17.5 tpt -118.46 149.15 41.75 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 123.452 0.701 . . . . 53.329999999999998 109.538 -175.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 28.5 tp -80.46 117.61 21.34 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 121.252 0.548 . . . . 65.25 109.82 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 621' ' ' THR . 25.5 t70 -100.49 120.58 40.21 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 115.237 -0.892 . . . . 74.549999999999997 109.5 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.493 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.3 OUTLIER -108.18 134.29 51.24 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.217 0.532 . . . . 64.099999999999994 109.784 178.046 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -86.47 -70.28 1.32 Allowed Glycine 0 C--N 1.288 -2.098 0 CA-C-N 115.396 -0.82 . . . . 73.120000000000005 112.651 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.42 154.13 47.73 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.656 0.265 . . . . 63.450000000000003 111.433 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -93.07 124.76 37.27 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.177 -0.92 . . . . 71.340000000000003 108.813 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 52.3 t -104.96 147.81 10.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 107.589 -1.263 . . . . 72.420000000000002 107.589 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . 0.495 ' HA ' ' HG2' ' A' ' 626' ' ' GLN . 10.7 p-10 -78.38 120.76 23.58 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.58 -0.896 . . . . 72.230000000000004 108.58 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -124.22 -52.39 1.74 Allowed 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.231 -0.588 . . . . 65.439999999999998 110.611 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 96.04 143.48 14.79 Favored Glycine 0 N--CA 1.427 -1.915 0 C-N-CA 119.935 -1.126 . . . . 64.230000000000004 111.697 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -60.5 -33.31 81.0 Favored Glycine 0 C--N 1.309 -0.956 0 N-CA-C 115.096 0.798 . . . . 72.530000000000001 115.096 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 33.4 t -77.14 -27.77 54.01 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 118.104 0.952 . . . . 72.120000000000005 109.528 -175.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -90.28 -3.42 57.8 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.102 -0.954 . . . . 70.129999999999995 109.947 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 34.0 m80 69.07 111.25 0.05 OUTLIER 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 114.491 -1.231 . . . . 72.219999999999999 112.486 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 625' ' ' GLY . 21.5 p-10 -79.4 65.01 4.44 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 123.306 1.527 . . . . 73.319999999999993 110.83 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -91.53 171.23 9.33 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 113.055 -1.884 . . . . 51.009999999999998 110.07 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 94.8 t -65.65 130.11 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 106.645 -1.613 . . . . 73.299999999999997 106.645 170.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 29.9 m -101.29 -36.32 4.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.152 0.501 . . . . 63.229999999999997 111.206 -176.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -144.27 135.98 25.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 116.167 -0.469 . . . . 62.420000000000002 109.965 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -126.62 137.79 53.35 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.161 -1.422 . . . . 41.399999999999999 107.161 174.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.523 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 45.0 t-20 -62.63 -59.11 13.62 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-O 118.99 -0.529 . . . . 72.430000000000007 112.162 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.0 Cg_exo -82.84 120.67 3.1 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.553 1.502 . . . . 75.230000000000004 110.065 175.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 14.6 Cg_exo -69.8 148.31 64.55 Favored 'Trans proline' 0 C--O 1.243 0.758 0 C-N-CA 122.341 2.027 . . . . 65.329999999999998 112.29 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -68.07 129.46 39.98 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.761 -0.654 . . . . 74.109999999999999 109.403 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.04 -10.4 47.82 Favored Glycine 0 C--N 1.302 -1.333 0 N-CA-C 110.219 -1.152 . . . . 60.25 110.219 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 37.1 m -101.68 161.92 13.29 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.801 -1.185 . . . . 70.010000000000005 107.801 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -82.82 135.22 13.72 Favored Glycine 0 N--CA 1.418 -2.528 0 C-N-CA 121.271 -0.49 . . . . 52.329999999999998 112.537 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.1 m -114.08 142.98 24.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 107.434 -1.321 . . . . 60.399999999999999 107.434 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.487 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 33.1 p-10 -56.37 170.86 0.32 Allowed 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 112.683 0.623 . . . . 75.540000000000006 112.683 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -56.98 -25.19 57.79 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.181 0.808 . . . . 73.420000000000002 113.181 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -87.57 -9.05 55.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.497 0.665 . . . . 73.150000000000006 109.5 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.54 14.92 63.18 Favored Glycine 0 C--O 1.217 -0.917 0 CA-C-N 115.628 -0.714 . . . . 70.319999999999993 113.406 172.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.57 119.74 17.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 122.416 1.103 . . . . 61.130000000000003 112.458 -167.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.504 HG21 ' SD ' ' A' ' 563' ' ' MET . 36.0 pt -122.42 133.32 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.975 0 CA-C-N 114.337 -1.301 . . . . 44.009999999999998 109.02 178.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 9.9 t -109.49 131.37 55.12 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.189 -1.041 . . . . 73.319999999999993 108.189 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.7 pp -138.73 165.91 25.76 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 112.873 0.694 . . . . 73.129999999999995 112.873 -175.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -128.45 137.83 52.02 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.51 -1.293 . . . . 72.109999999999999 107.51 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -133.44 163.13 30.04 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 120.161 -0.616 . . . . 73.540000000000006 111.387 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 601' ' ' ASN . . . -84.41 153.16 28.63 Favored Glycine 0 N--CA 1.42 -2.388 0 CA-C-N 115.446 -0.797 . . . . 64.150000000000006 112.507 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.495 ' HG2' ' HA ' ' A' ' 594' ' ' ASP . 1.0 OUTLIER . . . . . 0 C--O 1.271 2.202 0 N-CA-C 107.577 -1.268 . . . . 51.350000000000001 107.577 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . 0.418 ' HA3' ' HD3' ' A' ' 492' ' ' PRO . . . . . . . . 0 N--CA 1.469 0.892 0 N-CA-C 110.901 -0.879 . . . . 43.049999999999997 110.901 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.418 ' HD3' ' HA3' ' A' ' 491' ' ' GLY . 12.6 Cg_exo -73.21 145.01 38.23 Favored 'Trans proline' 0 C--O 1.241 0.674 0 C-N-CA 122.611 2.207 . . . . 74.319999999999993 111.699 177.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 66.3 24.65 10.58 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.317 1.047 . . . . 63.350000000000001 112.035 178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.44 ' HB ' HG22 ' A' ' 544' ' ' THR . 40.3 p -138.96 139.87 38.09 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.035 -0.728 . . . . 52.350000000000001 109.035 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.612 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 6.1 tmtt? -134.8 143.0 46.82 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.699 -0.852 . . . . 64.109999999999999 108.699 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.612 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 9.3 p-10 -77.41 128.9 35.04 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.879 0.872 . . . . 42.549999999999997 110.712 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.7 pt -84.15 138.01 39.75 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.352 -0.84 . . . . 75.030000000000001 111.007 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.08 176.56 8.95 Favored 'Trans proline' 0 C--O 1.238 0.511 0 C-N-CA 122.666 2.244 . . . . 75.209999999999994 112.516 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -81.45 127.85 33.24 Favored 'General case' 0 C--O 1.253 1.263 0 N-CA-C 108.177 -1.046 . . . . 64.400000000000006 108.177 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.585 ' HA ' ' NE2' ' A' ' 503' ' ' GLN . 34.8 m -123.28 -16.92 4.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 113.465 0.913 . . . . 73.040000000000006 113.465 -175.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -71.11 94.84 1.16 Allowed 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 120.721 0.296 . . . . 54.210000000000001 110.897 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 153.01 -39.23 0.73 Allowed Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 120.224 -0.989 . . . . 65.239999999999995 112.224 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.585 ' NE2' ' HA ' ' A' ' 500' ' ' VAL . 15.2 pm0 -88.2 -176.91 5.56 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 119.98 -0.688 . . . . 61.200000000000003 109.685 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 14.7 m -70.84 155.3 40.97 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.435 -1.32 . . . . 74.150000000000006 107.435 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.484 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.5 p -64.39 -41.48 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 121.031 -0.267 . . . . 74.5 110.713 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 14.3 t70 -61.75 -40.88 96.68 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.596 -0.52 . . . . 73.239999999999995 109.596 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.37 -43.35 84.31 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.803 0 CA-C-N 115.576 -0.738 . . . . 55.329999999999998 109.794 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.519 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -58.37 -45.04 89.0 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 123.15 0.281 . . . . 73.219999999999999 110.6 176.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.2 mt-30 -63.52 -45.29 91.3 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.754 -0.657 . . . . 63.140000000000001 110.369 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.533 ' O ' HG23 ' A' ' 514' ' ' VAL . 47.0 mmtm -62.99 -43.91 97.47 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.142 -0.481 . . . . 54.32 110.535 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -64.58 -43.74 92.9 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.656 -0.702 . . . . 74.310000000000002 111.85 -176.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.2 pp -69.22 -36.43 77.22 Favored 'General case' 0 C--O 1.207 -1.181 0 C-N-CA 120.308 -0.557 . . . . 73.310000000000002 110.63 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.429 ' N ' HD12 ' A' ' 512' ' ' LEU . 2.0 t-20 -63.13 -35.79 81.45 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 123.155 0.582 . . . . 75.340000000000003 110.45 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 510' ' ' LYS . 89.1 t -60.84 -36.34 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.05 0.452 . . . . 75.319999999999993 110.83 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . 0.461 ' O ' ' HE3' ' A' ' 495' ' ' LYS . 84.2 m-85 -112.71 22.64 14.32 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.15 0.5 . . . . 75.25 110.024 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -144.3 -58.83 0.02 OUTLIER Glycine 0 CA--C 1.48 -2.11 0 C-N-CA 119.849 -1.167 . . . . 64.140000000000001 112.797 -176.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 66.06 23.66 11.06 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 122.93 1.347 . . . . 72.099999999999994 109.656 -173.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.496 ' C ' ' HD2' ' A' ' 519' ' ' LYS . 5.8 p -83.08 174.7 10.61 Favored 'General case' 0 N--CA 1.394 -3.233 0 CA-C-N 112.646 -2.07 . . . . 71.200000000000003 108.373 176.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.496 ' HD2' ' C ' ' A' ' 518' ' ' THR . 11.8 mptt -107.94 140.28 41.3 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 108.848 -0.797 . . . . 75.430000000000007 108.848 -177.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -125.41 154.03 42.55 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 121.16 0.505 . . . . 71.140000000000001 111.81 -172.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 32.9 p -135.59 147.17 48.6 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 107.724 -1.213 . . . . 74.340000000000003 107.724 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -119.74 119.83 34.81 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.245 0.545 . . . . 72.450000000000003 110.687 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -110.77 116.66 31.67 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.053 -1.092 . . . . 75.129999999999995 108.053 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.6 m -96.39 126.91 41.92 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.587 -0.445 . . . . 72.030000000000001 110.199 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.35 149.09 24.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 106.819 -1.549 . . . . 74.420000000000002 106.819 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.501 ' HB2' HD22 ' A' ' 559' ' ' ASN . 6.1 p-10 -80.18 135.85 36.37 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-O 121.186 0.517 . . . . 73.219999999999999 110.565 -176.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 43.7 m -153.0 168.91 10.55 Favored Pre-proline 0 C--N 1.293 -1.869 0 N-CA-C 106.152 -1.796 . . . . 71.25 106.152 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -75.78 -10.63 20.02 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 121.255 1.303 . . . . 73.329999999999998 111.503 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.48 ' HA ' ' HD3' ' A' ' 530' ' ' PRO . 17.9 mtp180 -81.01 137.2 49.91 Favored Pre-proline 0 N--CA 1.413 -2.289 0 N-CA-C 108.252 -1.018 . . . . 72.340000000000003 108.252 -178.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 529' ' ' ARG . 15.9 Cg_exo -65.3 142.39 72.73 Favored 'Trans proline' 0 C--O 1.255 1.325 0 C-N-CA 123.351 2.701 . . . . 53.310000000000002 115.304 -170.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.729 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -59.58 118.2 5.8 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 114.613 -1.176 . . . . 62.530000000000001 111.739 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 136.0 -27.04 3.07 Favored Glycine 0 C--N 1.296 -1.69 0 N-CA-C 109.846 -1.302 . . . . 63.520000000000003 109.846 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -74.46 136.04 42.28 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.943 -0.629 . . . . 63.539999999999999 110.273 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 5.7 p -100.95 113.9 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.315 0 N-CA-C 108.201 -1.037 . . . . 63.140000000000001 108.201 172.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.95 -8.1 58.6 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.024 -0.534 . . . . 52.420000000000002 112.11 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 147.06 -171.86 27.66 Favored Glycine 0 N--CA 1.42 -2.408 0 C-N-CA 120.271 -0.966 . . . . 73.239999999999995 112.178 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 4.5 p -116.9 159.0 23.09 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 107.485 -1.302 . . . . 64.519999999999996 107.485 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -64.77 -47.17 75.71 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 118.33 -1.348 . . . . 74.549999999999997 112.084 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -73.58 137.07 24.6 Favored 'Trans proline' 0 C--N 1.366 1.465 0 N-CA-C 108.384 -1.429 . . . . 65.129999999999995 108.384 169.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . 0.434 ' HG2' ' OG1' ' A' ' 543' ' ' THR . 15.7 Cg_endo -59.97 140.62 93.68 Favored 'Trans proline' 0 C--O 1.246 0.89 0 C-N-CA 122.299 1.999 . . . . 62.140000000000001 112.589 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.6 132.69 54.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.758 -0.655 . . . . 63.140000000000001 109.59 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.44 -21.01 36.01 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.207 -0.757 . . . . 71.340000000000003 111.207 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.434 ' OG1' ' HG2' ' A' ' 540' ' ' PRO . 70.5 m -77.08 137.93 39.24 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.21 0.529 . . . . 43.409999999999997 110.873 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 7.1 m -84.39 123.2 29.96 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 108.628 -0.878 . . . . 62.009999999999998 108.628 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.98 157.39 63.71 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 108.424 -0.954 . . . . 63.420000000000002 108.424 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -59.99 136.26 68.27 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 121.355 1.37 . . . . 75.349999999999994 112.866 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.93 -20.54 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.671 -1.15 . . . . 73.430000000000007 111.105 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -84.13 -17.93 38.47 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.434 -1.257 . . . . 72.200000000000003 111.535 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 50.0 m -97.28 163.29 12.96 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 114.107 1.151 . . . . 61.520000000000003 114.107 -171.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.8 p -89.81 129.72 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 114.568 -1.196 . . . . 61.039999999999999 110.522 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 56.4 mt -92.74 132.13 37.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 107.697 -1.223 . . . . 73.329999999999998 107.697 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.43 117.75 35.17 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 121.509 0.671 . . . . 72.519999999999996 110.293 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.0 mp -103.96 124.51 49.13 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.884 -1.053 . . . . 74.219999999999999 108.948 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -92.46 118.79 31.32 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.412 0.625 . . . . 72.140000000000001 110.252 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.69 133.82 41.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.002 -0.999 . . . . 72.310000000000002 109.24 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.729 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 3.1 m -83.13 119.75 24.92 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.312 -1.366 . . . . 74.549999999999997 107.312 176.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.456 ' HG3' ' HA ' ' A' ' 526' ' ' ASP . 8.6 ptpp? -96.07 142.95 27.66 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.922 -1.51 . . . . 72.530000000000001 106.922 172.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -56.04 -23.47 39.37 Favored Glycine 0 C--O 1.244 0.773 0 O-C-N 124.641 1.213 . . . . 60.310000000000002 114.773 -171.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . 0.501 HD22 ' HB2' ' A' ' 526' ' ' ASP . 24.0 t-20 78.55 -9.26 1.53 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 124.082 0.953 . . . . 72.319999999999993 110.364 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -112.6 156.88 21.93 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 113.387 0.884 . . . . 73.420000000000002 113.387 -170.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -130.67 157.04 43.86 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.479 -1.237 . . . . 71.409999999999997 107.915 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 97.0 t -74.72 121.49 26.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 O-C-N 123.212 0.32 . . . . 64.420000000000002 110.838 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 564' ' ' PRO . 42.8 ttm -64.84 125.81 89.74 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 123.461 0.705 . . . . 64.129999999999995 111.836 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . 0.464 ' O ' ' HG2' ' A' ' 563' ' ' MET . 16.2 Cg_exo -74.07 169.35 22.64 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.825 2.35 . . . . 74.299999999999997 110.504 172.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.87 138.42 46.27 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-O 121.41 0.624 . . . . 75.439999999999998 112.263 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -152.79 24.62 0.58 Allowed 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.786 -1.191 . . . . 71.420000000000002 107.786 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 6.2 m -78.07 141.53 38.76 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.434 -1.257 . . . . 72.430000000000007 111.371 -173.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 70.42 27.6 72.44 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 116.065 -0.516 . . . . 73.230000000000004 113.51 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . 0.523 ' O ' ' HA ' ' A' ' 602' ' ' ARG . 27.0 ptt? -99.51 160.02 14.59 Favored 'General case' 0 CA--C 1.476 -1.884 0 C-N-CA 120.233 -0.587 . . . . 62.530000000000001 109.936 -176.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . 0.587 ' HA ' ' O ' ' A' ' 601' ' ' ASN . 6.5 m-85 -103.38 175.05 5.61 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 105.638 -1.986 . . . . 74.409999999999997 105.638 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -70.1 -28.49 65.44 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 118.507 -1.277 . . . . 71.530000000000001 109.579 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.9 m -73.37 -13.38 16.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.557 -0.747 . . . . 71.230000000000004 110.548 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.597 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 24.0 t70 -101.46 -28.63 12.46 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.899 -0.778 . . . . 74.219999999999999 108.899 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -59.11 -53.05 62.77 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.046 -0.979 . . . . 75.329999999999998 111.803 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -54.8 -50.5 85.59 Favored Pre-proline 0 CA--C 1.558 1.287 0 N-CA-C 113.365 0.876 . . . . 74.420000000000002 113.365 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -57.67 -28.96 83.79 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 121.336 1.357 . . . . 62.240000000000002 112.766 172.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.597 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 23.0 mmm180 -68.76 -38.9 80.41 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 121.802 -0.561 . . . . 72.040000000000006 110.805 176.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.541 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 11.0 mp -59.75 -48.05 83.22 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 120.707 0.289 . . . . 74.439999999999998 110.453 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -66.37 -38.44 87.58 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.838 -0.619 . . . . 72.219999999999999 112.411 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.03 -39.06 76.0 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.545 0.688 . . . . 61.25 111.018 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.457 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 8.5 tp -83.28 -9.5 59.07 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 115.24 -0.891 . . . . 73.299999999999997 110.522 -178.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 60.87 42.35 99.57 Favored Glycine 0 CA--C 1.507 -0.466 0 N-CA-C 111.028 -0.829 . . . . 34.450000000000003 111.028 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.541 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 14.6 t90 -85.21 126.74 33.9 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.469 -0.567 . . . . 71.319999999999993 109.469 -175.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 12.7 t -99.14 -16.24 18.67 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 116.127 -0.488 . . . . 52.100000000000001 110.956 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -77.15 -177.49 45.88 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 121.509 -0.377 . . . . 74.219999999999999 112.691 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 48.4 tpp -112.8 147.16 37.5 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.192 -0.67 . . . . 72.140000000000001 109.192 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.4 tt -86.91 127.87 35.06 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.42 -1.326 . . . . 64.140000000000001 107.42 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 621' ' ' THR . 31.3 t70 -100.07 119.11 37.8 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.547 -0.538 . . . . 74.049999999999997 109.547 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.49 133.79 46.87 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.461 -0.896 . . . . 60.299999999999997 109.91 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.36 -79.05 0.95 Allowed Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.456 -0.793 . . . . 45.240000000000002 112.091 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -137.72 145.77 42.93 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 110.047 -0.353 . . . . 74.150000000000006 110.047 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -88.15 124.63 34.0 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.729 -1.582 . . . . 74.239999999999995 106.729 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 39.1 t -104.43 126.18 59.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.531 -0.914 . . . . 62.340000000000003 108.531 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . 0.525 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 32.2 t70 -73.58 106.39 5.33 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.379 -0.528 . . . . 75.439999999999998 111.114 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -113.54 -12.33 12.92 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.142 -0.936 . . . . 75.109999999999999 109.536 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 114.49 137.6 6.52 Favored Glycine 0 N--CA 1.428 -1.855 0 N-CA-C 111.084 -0.807 . . . . 42.420000000000002 111.084 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -63.23 -38.49 96.56 Favored Glycine 0 C--N 1.318 -0.464 0 C-N-CA 121.725 -0.274 . . . . 75.299999999999997 112.887 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 33.6 t -72.79 -22.82 60.77 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.869 0.842 . . . . 61.140000000000001 109.414 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -86.92 -3.43 59.08 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.006 -0.997 . . . . 65.030000000000001 110.546 -175.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 70.5 m80 67.67 158.11 0.14 Allowed 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.798 1.239 . . . . 75.219999999999999 113.199 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 570' ' ' PHE . 21.1 p30 -93.77 68.16 3.9 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.592 0.71 . . . . 64.519999999999996 112.905 -179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.523 ' HA ' ' O ' ' A' ' 569' ' ' MET . 2.7 ptp180 -85.47 146.72 26.81 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 119.365 -0.934 . . . . 72.530000000000001 112.171 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 74.2 t -57.95 130.11 20.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 114.053 -1.431 . . . . 72.340000000000003 109.516 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.17 -23.02 4.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.025 0.441 . . . . 73.400000000000006 111.086 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -155.97 135.9 12.76 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.548 -0.751 . . . . 75.400000000000006 109.726 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -124.5 137.64 54.4 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.698 -1.964 . . . . 74.120000000000005 105.698 173.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.41 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 28.6 t-20 -65.71 -53.52 35.68 Favored Pre-proline 0 C--N 1.317 -0.832 0 C-N-CA 119.066 -1.053 . . . . 70.420000000000002 112.86 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 5.3 Cg_endo -91.94 113.76 0.34 Allowed 'Trans proline' 0 N--CA 1.438 -1.789 0 C-N-CA 121.217 1.278 . . . . 64.329999999999998 109.344 171.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -70.14 160.11 50.75 Favored 'Trans proline' 0 C--O 1.247 0.947 0 C-N-CA 122.332 2.021 . . . . 64.129999999999995 111.539 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -62.18 138.89 58.48 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 109.844 -0.428 . . . . 73.200000000000003 109.844 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 102.1 -14.74 57.01 Favored Glycine 0 C--N 1.306 -1.113 0 N-CA-C 111.579 -0.608 . . . . 62.530000000000001 111.579 -175.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 6.0 m -92.05 155.03 18.37 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.881 -0.785 . . . . 71.310000000000002 108.881 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -80.01 134.22 13.31 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 121.033 -0.603 . . . . 71.140000000000001 112.496 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 13.6 m -127.06 143.13 41.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 124.226 1.01 . . . . 61.310000000000002 109.879 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.413 HD21 HG22 ' A' ' 619' ' ' ILE . 29.2 p-10 -49.58 162.87 0.14 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.322 1.049 . . . . 72.409999999999997 112.971 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -59.45 -24.83 63.87 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 114.056 1.132 . . . . 75.310000000000002 114.056 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.403 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 28.9 t70 -82.71 -8.82 59.57 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 119.598 -0.841 . . . . 73.030000000000001 109.523 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.2 14.68 64.31 Favored Glycine 0 C--O 1.221 -0.68 0 C-N-CA 123.519 0.581 . . . . 72.109999999999999 113.678 173.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . 0.413 HG22 HD21 ' A' ' 615' ' ' ASN . 0.1 OUTLIER -70.29 119.9 17.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 122.099 0.952 . . . . 63.32 110.556 -168.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.423 ' O ' HD12 ' A' ' 620' ' ' ILE . 2.7 pp -128.64 134.62 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-N 115.087 -0.961 . . . . 75.400000000000006 112.768 -175.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 10.2 t -105.11 124.69 49.97 Favored 'General case' 0 C--O 1.258 1.551 0 CA-C-N 115.355 -0.839 . . . . 45.530000000000001 109.641 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.1 pp -140.12 167.35 22.33 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.514 -0.767 . . . . 62.039999999999999 112.411 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -127.3 140.25 52.33 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.788 -0.819 . . . . 75.0 108.788 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -139.97 167.37 22.28 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.628 -0.715 . . . . 55.439999999999998 110.039 -170.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -60.1 177.15 3.33 Favored Glycine 0 CA--C 1.538 1.472 0 O-C-N 124.008 0.818 . . . . 71.349999999999994 113.847 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.525 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 5.6 tp-100 . . . . . 0 C--N 1.292 -1.921 0 C-N-CA 123.712 0.805 . . . . 73.230000000000004 108.971 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . 0.411 ' HA2' ' HD3' ' A' ' 492' ' ' PRO . . . . . . . . 0 CA--C 1.496 -1.129 0 N-CA-C 110.937 -0.865 . . . . 62.229999999999997 110.937 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . 0.411 ' HD3' ' HA2' ' A' ' 491' ' ' GLY . 24.5 Cg_exo -63.63 158.72 44.55 Favored 'Trans proline' 0 C--O 1.246 0.875 0 C-N-CA 122.349 2.032 . . . . 74.219999999999999 111.16 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -87.86 -5.15 58.74 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.895 0.855 . . . . 72.200000000000003 110.882 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 7.9 p -135.27 144.82 47.02 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.807 -1.183 . . . . 72.409999999999997 107.807 176.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -141.34 143.79 34.21 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 109.533 -0.543 . . . . 75.120000000000005 109.533 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.5 m-20 -83.02 124.73 30.7 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.036 -0.529 . . . . 72.400000000000006 110.46 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.4 pt -88.83 137.35 30.0 Favored Pre-proline 0 C--N 1.305 -1.327 0 CA-C-N 115.81 -0.632 . . . . 74.420000000000002 110.434 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.89 -177.34 3.76 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.311 2.007 . . . . 73.239999999999995 111.776 177.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -93.61 127.44 39.29 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.317 -0.994 . . . . 44.109999999999999 108.317 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.555 ' O ' ' HG2' ' A' ' 503' ' ' GLN . 28.2 m -122.06 -3.98 8.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 112.717 0.636 . . . . 73.439999999999998 112.717 -176.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -66.3 102.3 0.84 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.018 0.437 . . . . 75.420000000000002 110.423 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 141.94 -22.28 2.47 Favored Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 120.808 -0.711 . . . . 63.340000000000003 112.742 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.555 ' HG2' ' O ' ' A' ' 500' ' ' VAL . 6.3 pt20 -100.46 -179.1 4.0 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 109.091 -0.707 . . . . 65.219999999999999 109.091 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 21.1 m -74.4 155.41 38.11 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 108.495 -0.928 . . . . 73.200000000000003 108.495 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.18 -41.57 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 C-N-CA 122.697 0.399 . . . . 62.229999999999997 110.883 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . 0.497 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 28.5 t70 -59.69 -43.7 93.93 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.056 0.455 . . . . 61.229999999999997 110.162 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 90.2 t -67.99 -46.61 81.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 114.491 -1.231 . . . . 72.430000000000007 110.052 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.423 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -59.6 -45.79 90.86 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 123.41 0.444 . . . . 70.400000000000006 111.258 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -65.23 -44.49 88.07 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.178 -0.464 . . . . 75.25 111.745 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.567 ' O ' HG23 ' A' ' 514' ' ' VAL . 3.4 ptpp? -67.45 -39.92 85.4 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 119.632 -0.827 . . . . 64.430000000000007 111.186 176.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -62.44 -44.27 96.81 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.524 0.678 . . . . 73.200000000000003 110.918 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.65 -47.14 86.8 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-N 114.395 -1.275 . . . . 74.299999999999997 108.951 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -65.98 -35.23 80.02 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 115.439 -0.8 . . . . 64.329999999999998 112.675 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 510' ' ' LYS . 72.5 t -58.45 -33.76 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.115 0.483 . . . . 71.239999999999995 110.552 176.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -114.2 11.34 17.47 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.056 0.455 . . . . 74.25 110.117 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -127.47 -59.82 0.13 Allowed Glycine 0 CA--C 1.475 -2.416 0 C-N-CA 120.437 -0.887 . . . . 60.5 113.242 -172.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 66.25 21.55 11.03 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 121.926 0.87 . . . . 73.150000000000006 109.134 -172.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.4 p -91.48 -173.57 3.62 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 114.16 -1.382 . . . . 62.420000000000002 110.148 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 52.5 mtmt -108.11 143.85 36.28 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.384 -0.969 . . . . 75.519999999999996 108.384 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -129.17 151.08 50.23 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 120.866 0.365 . . . . 73.409999999999997 111.357 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 67.7 m -140.25 151.5 45.18 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 107.419 -1.326 . . . . 74.340000000000003 107.419 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -121.66 124.47 44.38 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.704 0.764 . . . . 64.0 112.334 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -101.43 133.05 46.66 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.999 -1.482 . . . . 75.150000000000006 106.999 175.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 22.2 m -118.37 122.12 42.06 Favored 'General case' 0 C--N 1.29 -1.978 0 C-N-CA 120.114 -0.634 . . . . 71.129999999999995 111.519 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.9 p -122.41 149.56 25.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.691 -1.226 . . . . 75.329999999999998 107.691 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -85.79 136.72 33.21 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 119.808 -0.757 . . . . 64.450000000000003 111.636 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 53.1 m -157.47 162.22 27.75 Favored Pre-proline 0 C--N 1.302 -1.486 0 N-CA-C 106.346 -1.724 . . . . 72.329999999999998 106.346 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.13 10.26 0.42 Allowed 'Trans proline' 0 CA--C 1.556 1.578 0 C-N-CA 122.343 2.028 . . . . 74.019999999999996 114.44 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.552 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 0.6 OUTLIER -95.26 145.77 30.13 Favored Pre-proline 0 CA--C 1.506 -0.716 0 N-CA-C 107.453 -1.314 . . . . 63.329999999999998 107.453 175.724 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -64.81 148.38 89.99 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.45 2.1 . . . . 72.109999999999999 114.341 -172.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.458 ' HB2' ' H ' ' A' ' 558' ' ' GLY . . . -61.85 113.76 2.96 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-N 114.323 -1.308 . . . . 74.040000000000006 110.742 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 126.57 -16.95 6.54 Favored Glycine 0 N--CA 1.42 -2.396 0 C-N-CA 119.918 -1.134 . . . . 64.209999999999994 111.768 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -82.92 128.18 34.21 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.28 -0.637 . . . . 75.430000000000007 109.28 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 5.3 p -94.36 112.71 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 N-CA-C 107.207 -1.405 . . . . 73.109999999999999 107.207 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 29.7 p -102.86 12.81 35.68 Favored 'General case' 0 C--N 1.28 -2.445 0 CA-C-N 115.253 -0.885 . . . . 73.120000000000005 112.523 -172.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 169.04 172.42 35.77 Favored Glycine 0 N--CA 1.432 -1.616 0 C-N-CA 120.007 -1.092 . . . . 64.430000000000007 111.693 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 4.0 p -131.21 146.82 52.48 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.864 -0.791 . . . . 72.329999999999998 108.864 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 552' ' ' GLU . 2.8 t-20 -64.44 -51.58 59.19 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 119.784 -0.767 . . . . 75.540000000000006 109.872 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 58.8 Cg_endo -75.62 139.75 23.08 Favored 'Trans proline' 0 C--N 1.366 1.457 0 C-N-CA 120.859 1.039 . . . . 65.140000000000001 109.975 171.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 25.2 Cg_exo -64.55 140.53 69.35 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 122.259 1.973 . . . . 54.340000000000003 112.834 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -68.15 132.54 47.38 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.452 -0.795 . . . . 72.310000000000002 109.752 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.68 -9.07 58.5 Favored Glycine 0 N--CA 1.436 -1.33 0 N-CA-C 111.187 -0.765 . . . . 51.020000000000003 111.187 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 91.3 m -86.2 136.83 33.04 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.187 0.518 . . . . 71.25 111.291 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 9.8 t -81.31 125.79 30.78 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.757 -0.831 . . . . 73.209999999999994 108.757 174.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.74 161.8 44.32 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 107.89 -1.152 . . . . 72.319999999999993 107.89 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -62.54 138.51 70.77 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 120.967 1.112 . . . . 41.420000000000002 110.768 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.87 -19.9 24.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 121.376 0.608 . . . . 75.209999999999994 111.343 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -96.17 -0.74 49.61 Favored 'General case' 0 N--CA 1.435 -1.219 0 O-C-N 121.789 -0.569 . . . . 55.409999999999997 110.523 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 10.4 t -86.6 171.95 10.63 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.4 0.619 . . . . 51.140000000000001 109.501 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 7.6 p -115.68 137.86 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.296 0 CA-C-N 115.379 -0.828 . . . . 73.120000000000005 110.071 -177.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 3.1 mp -94.48 135.1 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 108.342 -0.985 . . . . 75.049999999999997 108.342 175.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 538' ' ' ASN . 6.3 tp10 -102.46 117.32 34.46 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.695 -1.224 . . . . 72.340000000000003 107.695 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -91.58 121.45 33.27 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.43 -0.952 . . . . 72.120000000000005 108.43 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -89.9 101.99 14.69 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.641 -1.244 . . . . 73.239999999999995 107.641 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 524' ' ' SER . 38.4 t -101.31 136.83 31.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-N 115.223 -0.899 . . . . 73.010000000000005 110.025 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 59.7 m -91.71 128.18 37.45 Favored 'General case' 0 N--CA 1.41 -2.469 0 CA-C-N 115.973 -0.558 . . . . 71.030000000000001 109.744 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -90.58 142.93 27.25 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 105.904 -1.887 . . . . 74.439999999999998 105.904 169.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -54.48 -24.07 29.74 Favored Glycine 0 CA--C 1.479 -2.182 0 O-C-N 125.145 1.528 . . . . 35.310000000000002 115.25 -168.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 74.43 -22.74 0.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.441 1.097 . . . . 73.329999999999998 110.794 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.583 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 44.3 mt-30 -113.37 148.31 36.03 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-O 121.488 0.661 . . . . 61.229999999999997 111.461 -172.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -125.53 158.02 35.58 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.886 -1.052 . . . . 63.520000000000003 108.835 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.88 125.12 22.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 121.315 0.578 . . . . 65.209999999999994 111.127 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 20.2 ttt -75.42 125.83 88.34 Favored Pre-proline 0 N--CA 1.427 -1.601 0 CA-C-N 115.356 -0.838 . . . . 73.430000000000007 110.988 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.06 169.74 20.68 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 123.039 2.493 . . . . 64.140000000000001 111.799 177.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -75.29 130.04 38.41 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.682 0.753 . . . . 61.049999999999997 112.036 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 569' ' ' MET . 2.6 pp -141.27 18.26 2.24 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 123.021 1.391 . . . . 74.310000000000002 107.823 174.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 7.3 m -79.14 132.2 36.48 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 113.283 -1.781 . . . . 60.409999999999997 111.174 -173.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . 0.408 ' H ' ' CG1' ' A' ' 603' ' ' VAL . . . 64.54 39.66 96.99 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.541 -0.754 . . . . 72.450000000000003 114.29 174.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 16.0 ptp -128.89 -177.34 4.17 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 117.312 0.556 . . . . 55.399999999999999 109.933 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . 0.554 ' HA ' ' O ' ' A' ' 601' ' ' ASN . 49.3 m-85 -93.53 163.44 13.57 Favored 'General case' 0 C--O 1.25 1.083 0 N-CA-C 108.202 -1.036 . . . . 75.239999999999995 108.202 -178.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . 0.474 ' CH2' HD13 ' A' ' 587' ' ' LEU . 16.3 t-105 -63.07 -32.16 73.47 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.166 -1.05 . . . . 64.140000000000001 108.166 174.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.75 -10.48 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.471 -0.786 . . . . 63.420000000000002 111.159 -176.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -101.36 -43.9 5.8 Favored 'General case' 0 C--O 1.256 1.401 0 N-CA-C 108.09 -1.078 . . . . 73.329999999999998 108.09 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . 0.517 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -62.82 -51.44 67.05 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.326 -1.306 . . . . 74.219999999999999 111.945 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.562 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 37.8 tt0 -51.75 -54.1 43.64 Favored Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 112.395 0.517 . . . . 75.200000000000003 112.395 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 52.9 Cg_exo -59.55 -38.29 83.47 Favored 'Trans proline' 0 C--N 1.38 2.237 0 C-N-CA 121.972 1.782 . . . . 73.430000000000007 112.721 177.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -66.76 -37.14 84.04 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 120.381 -0.528 . . . . 72.230000000000004 112.198 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.585 ' O ' ' HG ' ' A' ' 581' ' ' LEU . 89.7 mt -66.75 -47.49 72.08 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.898 -0.592 . . . . 75.0 110.529 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -65.59 -34.52 78.43 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.635 -0.426 . . . . 71.150000000000006 111.048 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.24 -32.02 71.92 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.953 0.406 . . . . 74.310000000000002 110.943 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 578' ' ' LEU . 2.8 pp -80.89 -6.92 59.27 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.537 -0.465 . . . . 72.299999999999997 110.033 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 85.6 34.86 12.65 Favored Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 115.833 -0.621 . . . . 65.140000000000001 112.878 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.43 ' CZ3' HD13 ' A' ' 578' ' ' LEU . 21.3 t90 -67.19 130.6 43.64 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.544 0.172 . . . . 75.209999999999994 111.054 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 62.8 p -103.24 -23.14 13.63 Favored 'General case' 0 C--O 1.247 0.962 0 CA-C-O 120.987 0.422 . . . . 72.549999999999997 112.023 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -75.98 -175.92 39.82 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-O 121.72 0.622 . . . . 62.329999999999998 114.359 -174.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 54.3 ttp -115.05 141.35 48.12 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.951 -0.625 . . . . 74.430000000000007 109.753 -176.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . 0.474 HD13 ' CH2' ' A' ' 571' ' ' TRP . 5.5 tt -85.64 125.68 33.34 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.061 0.457 . . . . 64.099999999999994 110.074 -175.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -95.89 104.35 16.28 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.543 -0.753 . . . . 74.120000000000005 110.333 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.467 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -112.16 133.51 54.25 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.138 -1.43 . . . . 62.539999999999999 107.138 173.209 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -111.68 -42.33 1.04 Allowed Glycine 0 C--N 1.284 -2.318 0 C-N-CA 119.874 -1.155 . . . . 74.530000000000001 113.993 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.4 135.64 33.86 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 120.569 -0.453 . . . . 63.140000000000001 111.379 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -90.86 124.44 35.17 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 105.954 -1.869 . . . . 70.0 105.954 172.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . 0.491 ' O ' ' HG2' ' A' ' 626' ' ' GLN . 46.3 t -104.81 156.26 6.02 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 N-CA-C 109.049 -0.723 . . . . 74.310000000000002 109.049 -174.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . 0.448 ' HA ' ' HG2' ' A' ' 626' ' ' GLN . 1.6 p-10 -71.49 126.94 30.99 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-O 121.298 0.571 . . . . 73.099999999999994 109.894 -176.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -148.36 -57.09 0.22 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.953 -1.021 . . . . 74.420000000000002 109.318 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 116.34 124.57 3.66 Favored Glycine 0 N--CA 1.426 -2.005 0 C-N-CA 120.638 -0.791 . . . . 65.329999999999998 111.764 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -63.64 -35.96 92.72 Favored Glycine 0 C--N 1.316 -0.542 0 N-CA-C 112.113 -0.395 . . . . 75.200000000000003 112.113 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 6.5 m -76.04 -24.02 55.15 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-O 122.014 0.911 . . . . 64.109999999999999 108.99 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -87.96 -2.41 58.59 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.607 -1.179 . . . . 73.129999999999995 109.343 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . 0.539 ' HB3' ' CE2' ' A' ' 570' ' ' PHE . 30.6 m80 81.56 125.19 0.04 OUTLIER 'General case' 0 C--O 1.235 0.309 0 C-N-CA 126.41 1.884 . . . . 74.140000000000001 111.952 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 570' ' ' PHE . 8.5 p30 -73.57 96.23 2.41 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 122.597 1.189 . . . . 74.510000000000005 109.42 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 21.4 mmm-85 -100.17 151.49 21.36 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 107.351 -1.351 . . . . 74.530000000000001 107.351 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.408 ' CG1' ' H ' ' A' ' 568' ' ' GLY . 8.1 p -65.58 131.68 31.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 106.971 -1.492 . . . . 55.219999999999999 106.971 172.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.61 -26.21 3.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 120.112 -0.635 . . . . 71.5 111.895 -174.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -155.6 138.21 15.1 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.949 -0.76 . . . . 72.450000000000003 108.949 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -133.64 139.5 46.52 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.524 -1.288 . . . . 72.5 107.524 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.43 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 26.3 t-20 -71.99 -51.47 8.45 Favored Pre-proline 0 C--N 1.307 -1.246 0 C-N-CA 119.627 -0.829 . . . . 74.129999999999995 111.152 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 74.6 Cg_endo -92.3 122.19 0.58 Allowed 'Trans proline' 0 N--CA 1.442 -1.516 0 C-N-CA 121.111 1.207 . . . . 73.209999999999994 111.332 174.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -70.35 153.35 66.29 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 121.77 1.646 . . . . 75.310000000000002 110.11 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -65.36 133.08 50.6 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.266 -0.642 . . . . 60.329999999999998 109.266 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.15 -7.68 44.27 Favored Glycine 0 C--N 1.314 -0.656 0 C-N-CA 120.786 -0.721 . . . . 73.540000000000006 111.481 -176.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 19.5 m -88.16 155.59 19.69 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.532 -0.914 . . . . 71.019999999999996 108.532 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.54 126.53 7.51 Favored Glycine 0 N--CA 1.426 -1.993 0 N-CA-C 111.116 -0.794 . . . . 74.239999999999995 111.116 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 18.5 m -113.84 141.97 28.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.609 -0.515 . . . . 63.149999999999999 109.609 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.583 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.3 p-10 -53.4 167.94 0.18 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.682 1.193 . . . . 72.340000000000003 113.16 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -57.68 -24.66 57.9 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.533 -0.758 . . . . 73.450000000000003 112.98 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.451 ' OD2' ' HB ' ' A' ' 619' ' ' ILE . 28.2 t70 -82.47 -9.49 59.41 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.493 -0.483 . . . . 72.510000000000005 109.703 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.63 18.3 67.89 Favored Glycine 0 CA--C 1.506 -0.525 0 CA-C-N 116.094 -0.503 . . . . 53.049999999999997 112.649 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . 0.451 ' HB ' ' OD2' ' A' ' 617' ' ' ASP . 0.0 OUTLIER -69.86 119.5 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-O 122.269 1.033 . . . . 73.430000000000007 111.329 -167.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.447 ' O ' HD12 ' A' ' 620' ' ' ILE . 2.6 pp -116.98 131.3 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.067 0 CA-C-N 114.703 -1.135 . . . . 72.540000000000006 111.191 177.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 54.4 m -104.68 117.88 35.19 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.549 -0.908 . . . . 73.319999999999993 108.549 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.6 pp -139.72 165.82 26.25 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.602 -0.272 . . . . 72.349999999999994 111.16 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -139.47 140.9 37.39 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.647 -0.871 . . . . 74.349999999999994 108.647 174.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -128.0 166.44 18.38 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 116.216 -0.447 . . . . 74.430000000000007 111.192 -171.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -71.77 153.34 50.08 Favored Glycine 0 N--CA 1.428 -1.864 0 CA-C-N 115.524 -0.762 . . . . 65.040000000000006 113.529 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 593' ' ' VAL . 3.4 pt20 . . . . . 0 C--N 1.299 -1.593 0 C-N-CA 123.514 0.726 . . . . 51.100000000000001 110.171 177.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.953 0 N-CA-C 111.101 -0.799 . . . . 43.049999999999997 111.101 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.72 142.84 36.43 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.038 1.825 . . . . 62.329999999999998 110.799 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -90.04 7.28 38.46 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.152 0.501 . . . . 63.109999999999999 109.916 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.9 p -135.55 149.41 49.43 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.65 -0.705 . . . . 74.109999999999999 110.711 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.452 ' HE2' ' H ' ' A' ' 496' ' ' ASP . 0.1 OUTLIER -150.6 132.61 15.21 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.259 -1.756 . . . . 65.519999999999996 106.259 -179.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.3 p-10 -81.47 133.1 35.35 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.149 0.5 . . . . 74.349999999999994 110.349 175.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.1 pt -86.09 138.22 34.86 Favored Pre-proline 0 C--N 1.304 -1.383 0 CA-C-N 115.465 -0.789 . . . . 74.129999999999995 111.886 -177.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.64 178.41 7.61 Favored 'Trans proline' 0 C--O 1.245 0.832 0 C-N-CA 122.408 2.072 . . . . 74.430000000000007 112.009 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -80.07 96.99 6.65 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 122.627 1.203 . . . . 73.329999999999998 110.446 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.64 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 28.5 m -95.39 -1.07 10.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 CA-C-N 115.313 -0.858 . . . . 65.099999999999994 111.828 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -76.12 107.27 8.23 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 108.738 -0.838 . . . . 43.43 108.738 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 142.71 -30.17 2.08 Favored Glycine 0 C--N 1.299 -1.494 0 C-N-CA 120.746 -0.74 . . . . 62.420000000000002 112.791 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.442 ' NE2' ' HA ' ' A' ' 500' ' ' VAL . 7.8 pt20 -100.35 -177.88 3.64 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 120.109 -0.636 . . . . 70.420000000000002 110.501 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.407 ' HB ' HG23 ' A' ' 507' ' ' VAL . 2.8 m -70.34 155.61 40.43 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.565 -0.532 . . . . 65.439999999999998 109.565 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.432 ' HA ' ' CG2' ' A' ' 534' ' ' VAL . 5.9 p -55.04 -46.32 77.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 123.394 0.678 . . . . 71.439999999999998 112.1 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.69 -39.18 90.51 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.898 -0.592 . . . . 64.549999999999997 110.543 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.407 HG23 ' HB ' ' A' ' 504' ' ' THR . 59.9 t -73.07 -49.01 41.61 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.258 0 CA-C-N 115.337 -0.847 . . . . 74.209999999999994 109.888 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.64 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -58.73 -44.8 90.54 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 122.994 0.518 . . . . 62.340000000000003 110.972 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -64.99 -45.68 84.61 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.367 -0.378 . . . . 74.209999999999994 111.304 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.543 ' O ' HG23 ' A' ' 514' ' ' VAL . 17.8 ptpt -68.0 -37.86 81.97 Favored 'General case' 0 C--O 1.21 -1.0 0 C-N-CA 120.656 -0.418 . . . . 72.5 111.254 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -60.04 -48.4 81.86 Favored 'General case' 0 CA--C 1.498 -1.04 0 O-C-N 123.4 0.437 . . . . 71.129999999999995 110.517 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -68.71 -36.21 78.14 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 120.259 -0.577 . . . . 74.129999999999995 110.886 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.444 ' N ' HD12 ' A' ' 512' ' ' LEU . 1.2 t-20 -66.14 -35.59 80.88 Favored 'General case' 0 C--O 1.203 -1.376 0 C-N-CA 123.783 0.833 . . . . 75.219999999999999 110.505 -178.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 510' ' ' LYS . 75.9 t -60.94 -33.41 55.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.95 0.405 . . . . 63.140000000000001 111.11 177.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -102.51 -4.67 24.99 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.145 -0.622 . . . . 71.0 111.014 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -122.85 -50.84 0.22 Allowed Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 120.427 -0.892 . . . . 64.049999999999997 113.544 -171.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 67.5 27.18 8.02 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 122.515 1.15 . . . . 74.010000000000005 109.337 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.7 p -80.29 -167.09 1.2 Allowed 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 113.027 -1.897 . . . . 63.119999999999997 110.981 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -119.2 142.79 47.69 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.595 -1.261 . . . . 71.310000000000002 107.595 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -132.65 153.41 51.12 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 112.545 0.572 . . . . 71.530000000000001 112.545 -175.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.7 m -132.65 151.51 51.94 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.057 -1.461 . . . . 71.340000000000003 107.057 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -124.27 133.36 53.51 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 109.179 -0.674 . . . . 64.140000000000001 109.179 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -125.41 116.1 21.33 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.221 -1.029 . . . . 62.439999999999998 108.221 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 23.9 m -98.46 124.97 43.48 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.13 0.491 . . . . 73.150000000000006 111.053 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 11.0 p -126.56 154.19 36.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.799 -1.185 . . . . 74.219999999999999 107.799 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.93 135.63 35.38 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.34 0.59 . . . . 71.200000000000003 110.183 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 50.3 m -167.65 139.13 2.47 Favored Pre-proline 0 C--O 1.197 -1.68 0 N-CA-C 105.097 -2.186 . . . . 43.539999999999999 105.097 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.43 9.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.566 2.124 0 C-N-CA 123.466 2.777 . . . . 72.150000000000006 116.997 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.23 147.07 63.93 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 106.338 -1.727 . . . . 74.230000000000004 106.338 172.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.72 141.56 95.62 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 122.194 1.93 . . . . 75.299999999999997 112.921 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 557' ' ' LYS . . . -61.69 116.12 4.53 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 114.811 -1.086 . . . . 65.129999999999995 112.128 -176.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 121.46 -16.24 9.12 Favored Glycine 0 N--CA 1.423 -2.226 0 CA-C-N 115.044 -0.98 . . . . 71.439999999999998 111.538 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -77.47 128.28 33.95 Favored 'General case' 0 C--O 1.248 1.012 0 N-CA-C 109.328 -0.619 . . . . 74.209999999999994 109.328 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.432 ' CG2' ' HA ' ' A' ' 505' ' ' VAL . 38.0 t -86.1 112.43 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.165 0 N-CA-C 106.952 -1.499 . . . . 53.450000000000003 106.952 173.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 17.4 p -84.33 -2.42 57.04 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.594 0.712 . . . . 64.019999999999996 111.209 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.66 179.43 27.33 Favored Glycine 0 N--CA 1.419 -2.491 0 C-N-CA 120.606 -0.806 . . . . 65.540000000000006 112.435 174.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 1.6 p -116.69 158.05 24.43 Favored 'General case' 0 C--N 1.271 -2.825 0 N-CA-C 106.694 -1.595 . . . . 54.130000000000003 106.694 177.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -60.43 -49.5 89.97 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 118.794 -1.162 . . . . 71.430000000000007 112.015 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 38.8 Cg_endo -73.61 128.8 12.97 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 N-CA-C 108.238 -1.485 . . . . 33.329999999999998 108.238 167.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 24.9 Cg_exo -63.72 155.93 60.53 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 122.501 2.134 . . . . 64.439999999999998 113.126 -177.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.05 129.63 43.08 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.245 0.618 . . . . 65.150000000000006 110.152 177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.2 -15.22 54.8 Favored Glycine 0 N--CA 1.435 -1.422 0 N-CA-C 111.715 -0.554 . . . . 54.439999999999998 111.715 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 37.6 m -76.27 134.1 39.88 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.939 0.4 . . . . 70.109999999999999 111.407 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.0 t -76.53 124.06 27.02 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.45 -0.945 . . . . 64.310000000000002 108.45 173.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.04 160.72 50.77 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 108.14 -1.059 . . . . 54.340000000000003 108.14 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.48 136.84 26.89 Favored 'Trans proline' 0 N--CA 1.435 -1.952 0 CA-C-N 119.627 0.903 . . . . 72.010000000000005 110.218 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.17 -19.85 26.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.764 0.792 . . . . 74.239999999999995 110.943 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -89.64 -7.71 54.11 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.058 -0.974 . . . . 74.409999999999997 110.812 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 32.4 t -88.08 167.51 13.6 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.46 0.648 . . . . 70.150000000000006 109.887 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 9.8 p -108.73 121.25 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 CA-C-N 115.266 -0.879 . . . . 74.019999999999996 109.254 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 58.5 mt -87.24 133.14 30.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 115.298 -0.864 . . . . 74.409999999999997 110.045 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.15 117.6 34.91 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.763 0.792 . . . . 73.319999999999993 111.85 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.404 HD12 HG11 ' A' ' 534' ' ' VAL . 3.4 mm? -92.36 114.01 26.43 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 113.614 -1.63 . . . . 73.120000000000005 108.862 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -85.35 104.86 15.56 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.75 0.786 . . . . 61.549999999999997 109.766 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 524' ' ' SER . 23.7 t -92.96 132.8 36.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 114.667 -1.151 . . . . 71.150000000000006 108.171 -177.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 53.0 m -105.47 135.83 46.15 Favored 'General case' 0 N--CA 1.409 -2.516 0 CA-C-O 121.244 0.545 . . . . 42.340000000000003 111.093 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.0 ptpt -116.57 128.01 55.02 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 108.107 -1.071 . . . . 64.420000000000002 108.107 174.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -58.71 -24.81 57.8 Favored Glycine 0 CA--C 1.496 -1.125 0 O-C-N 123.877 0.735 . . . . 21.199999999999999 111.37 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . 0.425 ' ND2' ' HB3' ' A' ' 616' ' ' ARG . 65.0 t30 63.88 28.03 14.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 122.846 1.308 . . . . 64.140000000000001 109.063 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.517 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 82.7 mt-30 -112.5 151.03 30.43 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 113.725 -1.58 . . . . 74.329999999999998 108.333 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -130.42 147.42 52.12 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 109.254 -0.647 . . . . 74.450000000000003 109.254 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.93 120.07 13.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 O-C-N 123.896 0.748 . . . . 73.150000000000006 109.683 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.615 ' SD ' HG21 ' A' ' 620' ' ' ILE . 42.9 ttp -83.17 129.08 62.35 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 116.26 -0.427 . . . . 62.329999999999998 111.158 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . 0.426 ' O ' ' HG2' ' A' ' 563' ' ' MET . 57.9 Cg_endo -73.76 169.57 22.05 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.547 2.165 . . . . 71.319999999999993 110.317 174.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -76.93 135.31 38.76 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.383 0.611 . . . . 73.200000000000003 111.259 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . 0.415 ' O ' ' HG2' ' A' ' 569' ' ' MET . 0.9 OUTLIER -114.53 -14.98 12.08 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.326 -0.99 . . . . 62.140000000000001 108.326 -177.259 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . 0.404 ' HA ' ' HB ' ' A' ' 603' ' ' VAL . 33.2 t -77.47 147.39 35.92 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.585 -0.697 . . . . 70.129999999999995 110.91 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 96.26 11.01 55.37 Favored Glycine 0 CA--C 1.501 -0.798 0 CA-C-N 115.806 -0.634 . . . . 75.519999999999996 113.411 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 19.2 ptm -133.49 169.11 17.46 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.749 -0.463 . . . . 62.149999999999999 109.749 177.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 601' ' ' ASN . 10.9 m-85 -89.52 158.25 17.75 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.683 -0.858 . . . . 74.25 108.683 -176.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 29.0 t-105 -65.6 -25.05 67.23 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.189 -0.671 . . . . 74.340000000000003 109.189 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 23.0 m -69.22 -26.99 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 115.599 -0.728 . . . . 51.219999999999999 112.497 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 12.0 t70 -101.85 -23.45 14.17 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 108.538 -0.912 . . . . 74.230000000000004 108.538 175.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 577' ' ' ARG . . . -61.98 -46.73 87.96 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 115.531 -0.759 . . . . 54.5 112.341 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.476 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 0.9 OUTLIER -60.31 -49.19 91.65 Favored Pre-proline 0 CA--C 1.565 1.532 0 C-N-CA 120.279 -0.568 . . . . 62.299999999999997 110.199 179.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 62.5 Cg_exo -52.59 -29.78 42.36 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.328 2.019 . . . . 72.019999999999996 113.328 169.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 10.4 mmm180 -62.57 -39.53 93.97 Favored 'General case' 0 C--O 1.21 -1.007 0 O-C-N 121.791 -0.568 . . . . 41.32 110.47 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.788 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 9.6 mp -58.84 -49.65 76.94 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.155 0.503 . . . . 62.219999999999999 110.615 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' A' ' 576' ' ' PRO . 14.4 ptp180 -66.74 -38.37 86.52 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.388 -0.823 . . . . 64.230000000000004 112.389 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.29 -35.7 73.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.982 0.42 . . . . 42.310000000000002 111.583 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 6.0 tp -81.7 -9.67 59.58 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 123.892 0.877 . . . . 64.219999999999999 110.801 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 66.05 39.8 94.89 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.905 -0.878 . . . . 43.240000000000002 110.905 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.788 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 7.3 t90 -79.69 127.52 32.29 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 108.528 -0.916 . . . . 72.310000000000002 108.528 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' ' 617' ' ' ASP . 0.8 OUTLIER -78.62 -39.7 36.48 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 125.345 1.458 . . . . 75.319999999999993 112.78 -176.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -77.92 -162.01 17.92 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.929 -0.578 . . . . 71.030000000000001 111.759 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 65.8 mtt -133.82 160.76 36.64 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 122.426 -0.456 . . . . 72.140000000000001 109.867 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 22.7 tp -80.53 111.06 16.59 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.853 -1.166 . . . . 64.400000000000006 107.853 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 621' ' ' THR . 22.6 t70 -99.51 112.63 24.81 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.073 -0.512 . . . . 63.229999999999997 111.198 -172.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.88 133.61 34.23 Favored 'General case' 0 C--N 1.295 -1.791 0 C-N-CA 118.848 -1.141 . . . . 45.32 109.975 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.71 -63.84 1.8 Allowed Glycine 0 C--N 1.296 -1.663 0 N-CA-C 110.998 -0.841 . . . . 60.149999999999999 110.998 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -137.04 145.12 43.64 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 121.012 0.434 . . . . 71.450000000000003 109.965 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -91.79 127.38 37.23 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.4 -1.704 . . . . 62.340000000000003 106.4 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 61.3 t -102.98 125.63 57.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 108.328 -0.99 . . . . 60.43 108.328 -175.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -72.31 107.99 5.21 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 121.491 0.662 . . . . 75.409999999999997 109.802 -173.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -123.56 -54.47 1.76 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.572 -0.74 . . . . 72.319999999999993 110.957 -175.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 104.18 147.55 17.45 Favored Glycine 0 N--CA 1.413 -2.879 0 N-CA-C 109.636 -1.386 . . . . 70.400000000000006 109.636 -173.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.74 -33.08 62.49 Favored Glycine 0 C--N 1.309 -0.921 0 N-CA-C 113.875 0.31 . . . . 52.130000000000003 113.875 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 11.8 m -68.33 -24.06 64.79 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 123.918 0.887 . . . . 73.099999999999994 110.879 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -88.6 -1.85 58.28 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.317 -0.856 . . . . 73.530000000000001 110.303 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 41.5 m80 74.5 121.23 0.04 OUTLIER 'General case' 0 C--O 1.242 0.689 0 C-N-CA 125.527 1.531 . . . . 64.519999999999996 111.952 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 570' ' ' PHE . 21.2 m120 -82.4 63.4 6.55 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 115.493 -0.776 . . . . 72.120000000000005 111.497 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -95.55 160.5 14.48 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.397 -0.82 . . . . 75.230000000000004 109.729 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.411 HG11 HD12 ' A' ' 622' ' ' LEU . 72.7 t -71.11 130.37 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.104 0 N-CA-C 105.144 -2.169 . . . . 70.109999999999999 105.144 169.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.7 m -102.69 -28.6 3.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 120.284 -0.567 . . . . 73.230000000000004 111.763 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -157.08 135.81 11.58 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 116.62 -0.264 . . . . 70.209999999999994 111.049 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -111.62 128.95 56.21 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.731 -1.211 . . . . 72.430000000000007 107.731 170.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.472 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 8.4 t30 -57.78 -52.37 74.9 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 112.206 0.447 . . . . 63.240000000000002 112.206 -176.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 5.2 Cg_exo -83.65 122.74 3.15 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 121.823 1.682 . . . . 72.400000000000006 109.318 171.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.02 155.8 61.13 Favored 'Trans proline' 0 C--O 1.258 1.484 0 C-N-CA 122.859 2.373 . . . . 74.450000000000003 113.848 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.53 138.72 58.3 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.436 -0.802 . . . . 51.25 109.599 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 103.53 -11.64 54.04 Favored Glycine 0 C--N 1.298 -1.531 0 C-N-CA 120.438 -0.887 . . . . 74.420000000000002 111.864 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 17.2 m -83.48 141.97 31.26 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.377 -0.601 . . . . 71.319999999999993 109.377 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.69 113.9 3.75 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.109 -1.196 . . . . 22.34 110.109 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.5 m -102.01 142.67 16.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 O-C-N 122.982 -0.128 . . . . 71.329999999999998 110.667 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.517 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 0.7 OUTLIER -50.33 164.78 0.11 Allowed 'General case' 0 C--O 1.21 -0.982 0 N-CA-C 113.465 0.913 . . . . 44.210000000000001 113.465 177.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . 0.425 ' HB3' ' ND2' ' A' ' 559' ' ' ASN . 14.9 ptm180 -48.74 -27.89 3.24 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.66 1.726 . . . . 75.25 115.66 -171.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.477 ' HA ' ' OG1' ' A' ' 584' ' ' THR . 20.0 p-10 -97.2 -7.06 33.27 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.545 -0.462 . . . . 72.310000000000002 111.287 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.0 17.14 65.14 Favored Glycine 0 C--O 1.215 -1.058 0 CA-C-O 119.657 -0.524 . . . . 62.43 114.311 167.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.49 119.09 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-O 121.716 0.77 . . . . 70.409999999999997 110.768 -168.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.615 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.6 pp -129.35 134.05 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-N 115.277 -0.874 . . . . 74.25 111.31 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 13.1 t -99.03 130.42 45.36 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.45 -0.795 . . . . 74.120000000000005 108.984 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.411 HD12 HG11 ' A' ' 603' ' ' VAL . 1.7 pt? -139.59 167.91 21.03 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.671 -0.695 . . . . 65.409999999999997 111.76 -174.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -127.07 140.74 52.06 Favored 'General case' 0 C--O 1.256 1.41 0 N-CA-C 109.045 -0.724 . . . . 72.140000000000001 109.045 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -139.26 165.75 26.36 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.465 -0.334 . . . . 63.509999999999998 110.354 -175.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -78.64 139.47 22.3 Favored Glycine 0 N--CA 1.434 -1.467 0 O-C-N 123.677 0.611 . . . . 32.439999999999998 113.328 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 C--N 1.288 -2.108 0 C-N-CA 125.525 1.53 . . . . 72.400000000000006 107.881 -179.301 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.005 0 N-CA-C 109.67 -1.372 . . . . 43.049999999999997 109.67 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -74.21 141.88 29.77 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.891 1.727 . . . . 74.340000000000003 109.567 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -126.4 11.94 7.5 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.512 -0.475 . . . . 64.329999999999998 110.589 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.437 HG22 ' HA ' ' A' ' 546' ' ' PRO . 25.9 p -140.12 145.36 37.49 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 110.043 -0.354 . . . . 74.129999999999995 110.043 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -139.64 155.51 47.37 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.428 -1.323 . . . . 73.239999999999995 107.428 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.596 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.4 p-10 -98.15 144.26 27.8 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.203 -0.599 . . . . 64.340000000000003 110.749 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 36.1 pt -87.09 137.42 33.05 Favored Pre-proline 0 C--N 1.295 -1.781 0 CA-C-N 115.073 -0.967 . . . . 75.150000000000006 111.592 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -85.03 -176.03 2.26 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.551 2.168 . . . . 74.120000000000005 111.053 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -86.22 114.94 23.45 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.18 0.514 . . . . 72.329999999999998 109.793 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.529 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 17.5 m -119.73 58.78 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-O 122.746 1.26 . . . . 61.340000000000003 110.422 175.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -118.73 107.47 13.7 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.181 -1.372 . . . . 53.420000000000002 108.677 174.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 142.42 -25.38 2.32 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 118.972 -1.585 . . . . 44.100000000000001 113.734 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -101.74 -174.68 2.65 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 117.782 0.791 . . . . 43.119999999999997 109.858 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.448 ' HB ' HG23 ' A' ' 507' ' ' VAL . 7.5 m -73.13 155.5 39.61 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.895 -1.15 . . . . 73.530000000000001 107.895 178.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.542 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.4 p -60.2 -44.72 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 111.715 0.265 . . . . 64.239999999999995 111.715 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.12 -36.11 82.96 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 120.543 -0.463 . . . . 54.130000000000003 110.084 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.448 HG23 ' HB ' ' A' ' 504' ' ' THR . 68.4 t -68.9 -45.38 80.66 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.445 0 CA-C-N 115.616 -0.72 . . . . 74.200000000000003 109.257 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.529 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -60.29 -42.95 96.56 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 123.228 0.33 . . . . 72.420000000000002 110.538 177.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.542 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.7 mt-30 -63.46 -43.22 97.99 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.011 -0.366 . . . . 74.150000000000006 110.011 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 514' ' ' VAL . 46.0 mmtm -64.48 -43.91 92.67 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.443 0.639 . . . . 70.310000000000002 109.792 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -61.95 -48.26 81.21 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.109 -1.405 . . . . 75.400000000000006 110.13 -175.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.2 pp -69.65 -35.78 75.49 Favored 'General case' 0 C--O 1.208 -1.082 0 CA-C-N 115.509 -0.769 . . . . 75.430000000000007 110.862 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 509' ' ' GLN . 1.7 t-20 -61.44 -35.32 77.24 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 123.925 0.89 . . . . 74.120000000000005 110.105 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 510' ' ' LYS . 97.7 t -59.18 -38.0 71.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.872 0.368 . . . . 70.310000000000002 111.298 178.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -108.22 10.26 27.89 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.628 -0.508 . . . . 62.520000000000003 109.628 -176.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -132.66 -56.74 0.08 OUTLIER Glycine 0 N--CA 1.428 -1.835 0 C-N-CA 120.074 -1.06 . . . . 75.010000000000005 113.813 -172.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 63.41 23.21 13.62 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 122.055 0.931 . . . . 72.209999999999994 110.082 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.479 HG22 ' HA ' ' A' ' 547' ' ' VAL . 1.0 OUTLIER -83.72 -174.8 5.49 Favored 'General case' 0 N--CA 1.412 -2.327 0 C-N-CA 125.984 1.714 . . . . 63.229999999999997 110.669 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 0.4 OUTLIER -107.74 141.89 38.6 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.357 -1.349 . . . . 74.150000000000006 107.357 178.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -133.05 148.37 52.21 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.056 0.455 . . . . 70.150000000000006 112.192 -175.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 48.4 m -141.48 155.39 45.84 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.57 -0.9 . . . . 65.239999999999995 108.57 173.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -116.92 139.29 50.81 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.07 0.462 . . . . 75.140000000000001 111.493 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -122.37 118.71 29.07 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.333 -1.358 . . . . 70.230000000000004 107.333 176.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 11.6 m -103.93 127.32 51.46 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 120.689 -0.404 . . . . 61.039999999999999 111.493 -174.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 14.3 p -121.08 156.7 24.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.883 -1.155 . . . . 63.520000000000003 107.883 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -70.85 135.15 47.88 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-O 120.84 0.353 . . . . 75.150000000000006 110.647 -176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 65.9 m -165.04 158.07 14.05 Favored Pre-proline 0 C--N 1.31 -1.148 0 N-CA-C 107.667 -1.235 . . . . 74.140000000000001 107.667 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -66.25 -15.05 46.9 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.332 2.022 . . . . 65.209999999999994 113.257 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.66 140.22 81.32 Favored Pre-proline 0 CA--C 1.519 -0.225 0 N-CA-C 108.936 -0.765 . . . . 70.230000000000004 108.936 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.56 146.28 97.07 Favored 'Trans proline' 0 C--O 1.252 1.192 0 C-N-CA 122.764 2.31 . . . . 65.420000000000002 112.888 -175.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -59.82 110.95 1.28 Allowed 'General case' 0 C--O 1.244 0.813 0 CA-C-N 115.29 -0.868 . . . . 74.349999999999994 110.883 -178.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 136.03 -20.86 3.56 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 120.569 -0.824 . . . . 62.329999999999998 112.129 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -82.79 132.91 35.15 Favored 'General case' 0 C--O 1.248 1.019 0 CA-C-O 121.15 0.5 . . . . 74.120000000000005 110.673 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.44 HG11 ' CB ' ' A' ' 508' ' ' ALA . 7.3 p -99.32 119.64 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.533 0 N-CA-C 107.902 -1.147 . . . . 75.340000000000003 107.902 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.5 p -98.77 12.92 34.12 Favored 'General case' 0 C--N 1.274 -2.694 0 CA-C-N 115.107 -0.951 . . . . 72.349999999999994 113.301 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 143.23 -176.93 22.43 Favored Glycine 0 CA--C 1.493 -1.296 0 C-N-CA 120.433 -0.889 . . . . 73.230000000000004 112.196 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 7.0 p -117.41 157.1 26.78 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.372 -0.973 . . . . 55.25 108.372 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.409 ' HB2' ' OE2' ' A' ' 552' ' ' GLU . 44.3 t-20 -56.5 -58.22 18.4 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 119.983 -0.687 . . . . 71.340000000000003 110.689 175.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.96 140.75 32.06 Favored 'Trans proline' 0 C--N 1.365 1.422 0 CA-C-N 120.63 1.261 . . . . 73.109999999999999 109.965 173.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.57 156.48 63.74 Favored 'Trans proline' 0 C--O 1.252 1.18 0 C-N-CA 122.466 2.111 . . . . 65.120000000000005 112.348 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.58 137.62 58.3 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.015 -0.539 . . . . 54.219999999999999 110.798 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.1 -16.13 50.32 Favored Glycine 0 CA--C 1.492 -1.347 0 N-CA-C 111.485 -0.646 . . . . 51.32 111.485 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 71.0 m -74.05 122.95 23.47 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 109.945 -0.391 . . . . 74.040000000000006 109.945 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.3 t -80.43 124.62 29.06 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 108.473 -0.936 . . . . 70.340000000000003 108.473 176.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.7 m -122.72 156.58 61.54 Favored Pre-proline 0 C--N 1.294 -1.835 0 N-CA-C 107.468 -1.308 . . . . 73.230000000000004 107.468 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.437 ' HA ' HG22 ' A' ' 494' ' ' THR . 5.2 Cg_exo -67.67 138.47 45.4 Favored 'Trans proline' 0 N--CA 1.436 -1.894 0 C-N-CA 121.68 1.587 . . . . 75.120000000000005 111.82 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.479 ' HA ' HG22 ' A' ' 518' ' ' THR . 7.5 p -63.79 -20.53 26.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 115.087 -0.961 . . . . 51.100000000000001 111.455 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -87.79 -17.46 31.53 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.882 0.372 . . . . 72.109999999999999 110.488 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 53.3 m -88.07 159.61 18.17 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-O 122.312 1.053 . . . . 53.229999999999997 113.304 -173.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 68.9 t -89.85 129.49 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 CA-C-N 113.204 -1.816 . . . . 64.219999999999999 110.267 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 56.0 mt -91.57 140.59 15.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.727 -1.212 . . . . 51.299999999999997 107.727 176.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . 0.409 ' OE2' ' HB2' ' A' ' 538' ' ' ASN . 21.9 tt0 -103.26 117.7 35.11 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 110.339 -0.245 . . . . 72.329999999999998 110.339 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.3 mp -99.76 123.22 43.8 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 123.851 0.72 . . . . 55.210000000000001 110.016 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -85.95 106.89 17.46 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 123.472 0.709 . . . . 65.209999999999994 109.193 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 524' ' ' SER . 42.8 t -105.63 144.96 14.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.479 -0.782 . . . . 74.129999999999995 109.492 -176.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.549 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 46.8 m -93.35 126.92 38.73 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-N 116.077 -0.511 . . . . 64.109999999999999 109.961 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -99.01 131.43 45.06 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 106.175 -1.787 . . . . 74.239999999999995 106.175 169.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -62.92 -24.25 66.56 Favored Glycine 0 CA--C 1.492 -1.394 0 O-C-N 124.673 1.233 . . . . 70.25 114.271 -170.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 75.15 -27.02 0.19 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.52 1.128 . . . . 70.209999999999994 111.199 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.516 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 59.9 mt-30 -111.92 163.53 14.12 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 115.713 -0.676 . . . . 73.219999999999999 110.646 -172.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -141.09 157.28 45.52 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.895 -1.048 . . . . 71.510000000000005 108.841 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.22 126.75 33.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.931 -0.396 . . . . 72.519999999999996 109.931 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.454 ' SD ' HG21 ' A' ' 620' ' ' ILE . 49.5 ttp -94.23 137.13 22.92 Favored Pre-proline 0 C--N 1.314 -0.958 0 N-CA-C 111.946 0.351 . . . . 73.140000000000001 111.946 -176.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.25 169.81 21.36 Favored 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 122.861 2.374 . . . . 73.549999999999997 111.261 173.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -84.79 140.65 31.06 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.796 -0.446 . . . . 65.420000000000002 109.796 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . 0.448 ' O ' ' HG2' ' A' ' 569' ' ' MET . 2.4 pp -138.73 16.62 2.69 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.622 0.725 . . . . 74.310000000000002 111.471 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 60.1 p -79.8 150.28 30.79 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.453 -0.573 . . . . 71.340000000000003 109.453 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . 0.408 ' O ' ' HD2' ' A' ' 602' ' ' ARG . . . 85.32 29.95 26.29 Favored Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 120.077 -1.059 . . . . 71.120000000000005 113.289 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 19.8 ptp -131.84 -176.1 3.94 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.796 -0.816 . . . . 75.400000000000006 108.796 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -109.53 165.43 11.67 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.149 -1.426 . . . . 54.109999999999999 107.149 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -64.78 -30.45 71.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.41 0.624 . . . . 74.120000000000005 109.348 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.6 p -72.37 -10.97 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.882 0.849 . . . . 74.299999999999997 109.955 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 45.8 t0 -101.7 -40.84 6.79 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.974 -1.121 . . . . 75.439999999999998 107.974 174.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.29 -42.53 95.66 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.067 -0.97 . . . . 71.129999999999995 112.817 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.691 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 32.8 tt0 -59.7 -53.24 67.57 Favored Pre-proline 0 CA--C 1.567 1.628 0 C-N-CA 120.236 -0.586 . . . . 64.319999999999993 110.977 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 80.2 Cg_exo -56.32 -32.32 87.86 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 121.812 1.675 . . . . 72.0 112.716 172.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 3.6 mmp_? -59.82 -42.47 93.57 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-O 119.39 -0.338 . . . . 73.219999999999999 111.034 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.7 pp -65.81 -47.08 76.26 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 120.71 -0.396 . . . . 75.430000000000007 111.846 -175.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.462 ' N ' HD12 ' A' ' 578' ' ' LEU . 4.5 ptp180 -65.72 -37.27 85.94 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 112.175 0.435 . . . . 72.040000000000006 112.175 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.99 -32.68 69.57 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.009 0.433 . . . . 70.219999999999999 112.038 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 14.3 tp -85.82 -9.1 57.58 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 121.424 0.631 . . . . 64.409999999999997 110.926 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 75.63 21.47 76.96 Favored Glycine 0 C--N 1.311 -0.806 0 C-N-CA 120.563 -0.827 . . . . 63.310000000000002 112.652 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 15.0 t90 -87.46 127.35 35.23 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.576 -1.268 . . . . 75.439999999999998 107.576 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 15.0 t -116.07 2.26 13.38 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 119.678 -0.809 . . . . 54.340000000000003 112.254 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -74.06 177.07 45.91 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 119.448 -1.358 . . . . 43.5 110.402 172.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 67.2 mtt -97.57 140.14 32.43 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.145 -0.622 . . . . 73.120000000000005 112.124 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 48.5 tp -88.43 116.72 26.86 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.878 -1.156 . . . . 63.299999999999997 107.878 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 621' ' ' THR . 30.6 t70 -106.66 117.49 34.18 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.066 0.46 . . . . 71.099999999999994 111.327 -176.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.496 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.2 OUTLIER -93.14 134.55 35.19 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.971 -0.559 . . . . 71.230000000000004 110.524 177.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -75.51 -84.34 0.38 Allowed Glycine 0 C--N 1.294 -1.793 0 CA-C-N 115.357 -0.838 . . . . 60.329999999999998 111.812 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.05 154.5 47.1 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.343 0.116 . . . . 61.32 110.777 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -101.63 127.84 48.19 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 124.795 1.238 . . . . 65.530000000000001 108.346 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . 0.542 ' O ' ' HB2' ' A' ' 626' ' ' GLN . 40.2 t -104.13 132.72 50.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-N 115.527 -0.761 . . . . 72.409999999999997 109.243 -175.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -72.4 126.82 30.78 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.202 0.525 . . . . 64.219999999999999 111.771 -175.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . 0.429 ' HB3' ' ND2' ' A' ' 601' ' ' ASN . . . -150.97 -57.9 0.16 Allowed 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.865 -1.061 . . . . 62.200000000000003 108.701 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 140.88 130.92 2.65 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 111.016 -0.834 . . . . 63.210000000000001 111.016 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.67 -31.95 61.07 Favored Glycine 0 C--O 1.22 -0.771 0 C-N-CA 122.856 0.265 . . . . 44.109999999999999 112.54 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 29.4 t -61.55 -23.61 66.08 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.033 0.933 . . . . 73.239999999999995 110.312 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -87.41 -12.2 46.91 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.503 -0.771 . . . . 74.120000000000005 110.343 -176.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 55.05 72.96 0.44 Allowed 'General case' 0 C--O 1.249 1.061 0 C-N-CA 123.956 0.902 . . . . 71.530000000000001 111.437 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . 0.449 ' HB3' ' HA3' ' A' ' 625' ' ' GLY . 45.3 m-80 -84.44 93.72 8.36 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.531 1.158 . . . . 71.450000000000003 111.213 -174.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.408 ' HD2' ' O ' ' A' ' 568' ' ' GLY . 18.6 mtm180 -74.46 171.49 13.68 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 113.027 -1.897 . . . . 51.020000000000003 110.282 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 90.0 t -58.7 129.33 20.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.185 -0.672 . . . . 73.109999999999999 109.185 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 24.2 m -110.19 -27.98 2.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-O 120.972 0.415 . . . . 73.219999999999999 111.358 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -139.49 135.51 33.59 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 116.025 -0.534 . . . . 65.099999999999994 110.439 -176.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -132.66 128.77 37.75 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 104.642 -2.355 . . . . 72.040000000000006 104.642 171.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 28.5 t-20 -59.36 -55.5 45.44 Favored Pre-proline 0 N--CA 1.471 0.608 0 N-CA-C 113.232 0.826 . . . . 73.109999999999999 113.232 -175.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.486 ' HG2' HG22 ' A' ' 620' ' ' ILE . 12.4 Cg_exo -79.17 116.39 3.65 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 121.056 1.171 . . . . 73.019999999999996 109.328 171.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.71 161.27 46.64 Favored 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 123.129 2.553 . . . . 73.439999999999998 112.85 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.08 139.0 57.75 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.937 -0.574 . . . . 61.130000000000003 109.707 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 90.56 -8.05 80.41 Favored Glycine 0 C--N 1.303 -1.262 0 C-N-CA 120.402 -0.904 . . . . 62.340000000000003 112.305 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 52.6 m -90.62 151.65 21.2 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.236 -0.653 . . . . 63.130000000000003 109.236 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -76.98 130.14 10.24 Favored Glycine 0 N--CA 1.433 -1.546 0 N-CA-C 111.416 -0.674 . . . . 63.310000000000002 111.416 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.49 142.79 33.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 109.898 -0.408 . . . . 75.329999999999998 109.898 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.516 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.0 p-10 -51.42 166.94 0.1 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.646 1.179 . . . . 64.340000000000003 112.749 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -58.64 -25.8 63.08 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 113.037 0.754 . . . . 75.140000000000001 113.037 -178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.536 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 68.0 m-20 -86.17 -7.13 58.78 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 119.855 -0.738 . . . . 45.039999999999999 111.007 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 65.59 18.55 65.97 Favored Glycine 0 C--O 1.215 -1.052 0 O-C-N 123.448 0.467 . . . . 52.310000000000002 112.865 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.89 119.62 17.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 122.349 1.071 . . . . 61.200000000000003 111.802 -166.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.486 HG22 ' HG2' ' A' ' 608' ' ' PRO . 40.1 pt -128.21 134.37 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 CA-C-N 114.544 -1.207 . . . . 62.130000000000003 110.753 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 8.9 t -104.9 130.06 53.14 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.611 -1.255 . . . . 74.030000000000001 107.611 174.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -138.79 165.65 26.45 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.221 -0.445 . . . . 63.210000000000001 110.435 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -137.8 147.32 44.51 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.253 0.549 . . . . 74.010000000000005 110.587 175.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -136.14 165.31 26.03 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.161 -1.052 . . . . 74.340000000000003 108.161 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . 0.449 ' HA3' ' HB3' ' A' ' 601' ' ' ASN . . . -86.17 -164.78 39.93 Favored Glycine 0 N--CA 1.422 -2.245 0 C-N-CA 119.77 -1.205 . . . . 72.030000000000001 112.058 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.542 ' HB2' ' O ' ' A' ' 593' ' ' VAL . 3.1 tp-100 . . . . . 0 C--N 1.281 -2.399 0 C-N-CA 123.52 0.728 . . . . 75.5 109.45 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.029 0 N-CA-C 111.106 -0.798 . . . . 73.200000000000003 111.106 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.82 157.07 61.52 Favored 'Trans proline' 0 C--O 1.249 1.049 0 C-N-CA 122.558 2.172 . . . . 73.0 111.154 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 62.43 35.5 14.79 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.662 0.785 . . . . 73.129999999999995 111.357 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 48.8 p -133.75 155.44 49.76 Favored 'General case' 0 C--O 1.25 1.125 0 N-CA-C 107.405 -1.332 . . . . 64.109999999999999 107.405 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.625 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 4.9 tmtt? -131.28 134.02 45.98 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.693 -0.854 . . . . 75.5 108.693 175.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.625 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 0.8 OUTLIER -78.05 124.05 27.57 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 124.679 1.192 . . . . 74.349999999999994 110.954 176.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.3 pt -86.77 131.52 45.04 Favored Pre-proline 0 C--N 1.295 -1.79 0 CA-C-N 115.703 -0.68 . . . . 75.430000000000007 110.846 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -93.48 176.92 1.34 Allowed 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 122.133 1.889 . . . . 41.43 111.571 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -90.22 103.36 16.04 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.273 1.035 . . . . 54.310000000000002 108.233 176.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 534' ' ' VAL . 17.9 m -92.45 23.99 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 114.595 -1.184 . . . . 70.030000000000001 111.77 -175.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -74.11 99.03 3.25 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.21 -0.45 . . . . 51.43 110.321 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 163.04 -44.0 0.34 Allowed Glycine 0 N--CA 1.428 -1.843 0 C-N-CA 119.541 -1.314 . . . . 74.329999999999998 113.004 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.418 ' O ' HG12 ' A' ' 534' ' ' VAL . 18.6 pm0 -92.75 -171.27 2.68 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 120.231 -0.588 . . . . 74.319999999999993 110.419 -177.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.449 ' HB ' HG23 ' A' ' 507' ' ' VAL . 6.8 m -77.77 155.22 31.3 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 108.167 -1.049 . . . . 74.129999999999995 108.167 177.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.463 ' HA ' ' HB ' ' A' ' 534' ' ' VAL . 7.9 p -63.4 -42.01 94.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 111.859 0.318 . . . . 54.140000000000001 111.859 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 27.4 t70 -62.8 -39.02 92.98 Favored 'General case' 0 C--O 1.199 -1.554 0 N-CA-C 109.442 -0.577 . . . . 71.010000000000005 109.442 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.449 HG23 ' HB ' ' A' ' 504' ' ' THR . 90.1 t -66.06 -44.82 91.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.74 -0.664 . . . . 73.540000000000006 109.567 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.484 ' HB2' HG11 ' A' ' 534' ' ' VAL . . . -60.78 -44.06 97.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 120.189 -0.604 . . . . 75.120000000000005 111.668 175.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.4 mt-30 -63.62 -43.38 97.01 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 122.515 0.326 . . . . 72.420000000000002 110.914 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.484 ' O ' HG23 ' A' ' 514' ' ' VAL . 32.0 mmtp -65.1 -39.82 93.69 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.997 -0.547 . . . . 73.140000000000001 110.067 177.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . 0.42 ' O ' ' HD1' ' A' ' 515' ' ' TYR . 5.8 m-80 -61.31 -45.97 92.22 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 116.105 -0.498 . . . . 52.539999999999999 110.633 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.26 -37.51 83.61 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.699 -0.682 . . . . 73.450000000000003 110.882 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -65.09 -37.63 88.12 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 116.555 -0.293 . . . . 72.25 110.542 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 510' ' ' LYS . 95.3 t -62.58 -32.53 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 121.154 0.502 . . . . 54.140000000000001 111.119 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . 0.42 ' HD1' ' O ' ' A' ' 511' ' ' ASN . 97.3 m-85 -108.78 14.9 24.01 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.986 -0.446 . . . . 73.150000000000006 110.267 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -146.99 -58.36 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 119.043 -1.551 . . . . 52.130000000000003 115.056 -172.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 67.93 31.97 5.38 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 122.451 1.119 . . . . 62.340000000000003 108.047 -169.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.509 HG22 ' HA ' ' A' ' 547' ' ' VAL . 12.9 p -79.91 179.04 7.79 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 113.238 -1.801 . . . . 72.319999999999993 110.479 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -108.67 138.83 44.36 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.129 -1.434 . . . . 54.229999999999997 107.129 176.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -132.73 145.54 51.11 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.162 0.506 . . . . 75.329999999999998 111.961 -176.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.1 m -141.59 150.28 41.84 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 108.751 -0.833 . . . . 63.030000000000001 108.751 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.42 ' HB2' ' CG2' ' A' ' 555' ' ' VAL . 3.0 pt20 -119.65 149.91 41.2 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-O 120.907 0.384 . . . . 71.439999999999998 111.25 -174.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -123.47 143.01 50.43 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.215 -1.772 . . . . 61.119999999999997 106.215 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 20.0 m -118.85 130.91 56.01 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.231 0.539 . . . . 53.32 112.254 -175.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.5 p -123.75 151.01 28.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.746 -0.661 . . . . 72.5 110.05 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -66.17 134.11 52.07 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.104 -1.073 . . . . 74.530000000000001 108.104 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 62.6 m -156.81 176.85 2.35 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-O 119.485 -0.293 . . . . 75.109999999999999 110.596 -176.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -79.45 -25.29 5.73 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 122.2 1.933 . . . . 71.409999999999997 112.777 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.87 146.74 34.45 Favored Pre-proline 0 CA--C 1.506 -0.713 0 C-N-CA 120.132 -0.627 . . . . 75.140000000000001 110.38 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.62 159.92 30.45 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 123.419 2.746 . . . . 64.420000000000002 113.947 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -63.64 99.19 0.21 Allowed 'General case' 0 C--O 1.245 0.825 0 CA-C-N 114.698 -1.137 . . . . 74.109999999999999 110.132 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 163.9 -29.94 0.24 Allowed Glycine 0 N--CA 1.414 -2.769 0 CA-C-N 114.862 -1.063 . . . . 63.310000000000002 111.127 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -71.12 130.38 41.35 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 120.36 -0.536 . . . . 75.420000000000002 110.194 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 501' ' ' ALA . 7.2 p -96.6 119.5 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.675 0 N-CA-C 106.559 -1.645 . . . . 54.119999999999997 106.559 171.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.4 m -104.66 20.54 18.45 Favored 'General case' 0 C--N 1.261 -3.252 0 CA-C-N 114.328 -1.306 . . . . 74.209999999999994 110.715 -171.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 126.3 -168.05 18.55 Favored Glycine 0 N--CA 1.429 -1.823 0 C-N-CA 120.721 -0.752 . . . . 64.200000000000003 112.053 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 33.4 p -116.89 146.42 42.95 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.53 -1.285 . . . . 74.239999999999995 107.53 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -68.66 -46.74 34.65 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 119.102 -1.039 . . . . 61.240000000000002 111.18 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 27.3 Cg_exo -66.53 151.23 83.38 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 120.948 1.099 . . . . 62.329999999999998 109.966 171.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 46.1 Cg_exo -57.66 140.73 94.43 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.142 2.561 . . . . 74.219999999999999 113.722 -177.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -68.03 129.76 40.89 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.714 -0.847 . . . . 74.099999999999994 108.714 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.53 -14.37 46.67 Favored Glycine 0 C--N 1.294 -1.786 0 N-CA-C 110.851 -0.9 . . . . 23.309999999999999 110.851 -176.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 98.7 m -75.83 127.49 33.11 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 109.563 -0.532 . . . . 75.510000000000005 109.563 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.2 t -93.85 130.25 39.96 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 108.351 -0.981 . . . . 70.129999999999995 108.351 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.01 154.15 64.46 Favored Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 108.19 -1.041 . . . . 74.129999999999995 108.19 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.425 ' HG2' ' OG ' ' A' ' 549' ' ' SER . 3.2 Cg_endo -59.42 137.83 80.49 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 121.43 1.42 . . . . 62.229999999999997 111.837 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.509 ' HA ' HG22 ' A' ' 518' ' ' THR . 12.8 p -57.02 -29.5 31.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.662 -1.154 . . . . 74.140000000000001 113.08 -176.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -90.03 3.31 53.61 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 123.266 0.627 . . . . 72.400000000000006 110.582 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . 0.425 ' OG ' ' HG2' ' A' ' 546' ' ' PRO . 52.2 m -104.38 177.56 4.81 Favored 'General case' 0 N--CA 1.423 -1.825 0 CA-C-N 116.234 -0.439 . . . . 74.319999999999993 111.013 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 7.5 p -97.63 130.67 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 N-CA-C 113.084 0.772 . . . . 75.150000000000006 113.084 -172.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 66.1 mt -93.48 129.62 43.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 106.256 -1.757 . . . . 72.299999999999997 106.256 172.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -103.52 116.99 33.4 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.289 0.566 . . . . 70.230000000000004 110.923 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.53 133.06 50.9 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.809 -1.087 . . . . 74.420000000000002 111.346 -177.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -87.43 117.71 26.4 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.959 -0.564 . . . . 75.140000000000001 110.397 178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 524' ' ' SER . 43.3 t -108.64 126.64 65.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 109.079 -0.712 . . . . 71.129999999999995 109.079 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 74.9 m -89.24 132.07 35.06 Favored 'General case' 0 N--CA 1.408 -2.562 0 CA-C-N 115.84 -0.618 . . . . 71.540000000000006 109.43 176.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.5 ptpt -114.05 138.62 50.15 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.327 -1.36 . . . . 74.329999999999998 107.327 174.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.574 ' O ' ' HG3' ' A' ' 560' ' ' GLN . . . -67.41 -26.82 73.51 Favored Glycine 0 CA--C 1.493 -1.324 0 N-CA-C 109.92 -1.272 . . . . 72.010000000000005 109.92 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 60.6 t30 61.14 29.3 18.75 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-O 122.757 1.265 . . . . 52.549999999999997 108.247 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 558' ' ' GLY . 91.9 mt-30 -129.33 172.2 11.73 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 113.642 -1.617 . . . . 73.450000000000003 110.755 -174.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -143.81 152.51 41.29 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.506 -1.294 . . . . 75.239999999999995 107.506 174.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 68.0 t -78.1 116.54 21.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 108.684 -0.858 . . . . 63.5 108.684 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.517 ' SD ' HG21 ' A' ' 620' ' ' ILE . 45.1 ttp -73.6 128.53 86.91 Favored Pre-proline 0 C--N 1.315 -0.912 0 CA-C-N 116.314 -0.403 . . . . 73.400000000000006 112.016 -175.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.7 170.2 18.27 Favored 'Trans proline' 0 C--O 1.242 0.705 0 C-N-CA 123.189 2.592 . . . . 70.409999999999997 112.118 175.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . 0.418 ' HA ' ' HB2' ' A' ' 610' ' ' ALA . 14.8 t70 -60.8 128.62 37.44 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 113.054 0.761 . . . . 75.349999999999994 113.054 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . 0.406 ' O ' HD13 ' A' ' 566' ' ' LEU . 0.8 OUTLIER -132.07 -9.85 3.4 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 114.81 -1.086 . . . . 75.040000000000006 108.604 178.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 22.6 t -79.25 151.81 30.95 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.653 -0.654 . . . . 74.310000000000002 110.645 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 62.65 52.05 51.51 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 116.004 -0.544 . . . . 55.039999999999999 114.172 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 23.6 ptp -158.4 169.69 23.9 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 107.568 -1.271 . . . . 74.430000000000007 107.568 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -88.32 167.98 13.08 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.217 -0.66 . . . . 72.340000000000003 109.217 -174.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 26.3 t-105 -64.89 -27.61 68.97 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.51 -0.922 . . . . 72.450000000000003 108.51 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.3 m -73.59 -9.99 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-N 115.398 -0.819 . . . . 41.100000000000001 111.371 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.404 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 9.6 m-20 -96.39 -44.08 7.37 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.719 -1.215 . . . . 74.519999999999996 107.719 173.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -57.47 -44.74 85.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.764 -1.107 . . . . 70.349999999999994 112.585 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.633 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 1.6 tm-20 -57.25 -58.99 14.19 Favored Pre-proline 0 CA--C 1.571 1.777 0 C-N-CA 122.824 0.45 . . . . 74.109999999999999 111.288 -177.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -61.37 -31.89 88.92 Favored 'Trans proline' 0 C--N 1.372 1.81 0 CA-C-N 120.652 1.269 . . . . 65.439999999999998 112.323 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 26.3 mmt180 -68.99 -33.82 74.3 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.24 0.83 . . . . 71.420000000000002 113.24 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.6 pp -66.34 -47.15 74.41 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.238 0.542 . . . . 72.030000000000001 110.733 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.481 ' N ' HD12 ' A' ' 578' ' ' LEU . 15.1 ptm180 -65.86 -34.53 78.35 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.671 -0.695 . . . . 63.119999999999997 111.133 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.79 -38.39 88.88 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 123.375 0.67 . . . . 73.129999999999995 111.502 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.491 HD11 ' HB2' ' A' ' 583' ' ' TRP . 2.0 pp -85.98 -8.16 58.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.313 0.577 . . . . 71.019999999999996 110.751 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 82.5 39.3 11.02 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.737 -0.665 . . . . 35.119999999999997 111.706 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.491 ' HB2' HD11 ' A' ' 581' ' ' LEU . 12.6 t90 -87.04 126.29 34.66 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.548 -0.908 . . . . 72.450000000000003 108.548 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 1.9 p -108.24 2.96 23.1 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.967 0.729 . . . . 50.229999999999997 112.967 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -94.64 -173.38 38.15 Favored Glycine 0 N--CA 1.438 -1.186 0 N-CA-C 110.381 -1.088 . . . . 75.299999999999997 110.381 176.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 60.6 mtm -114.27 151.33 33.03 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.397 -0.594 . . . . 75.450000000000003 109.397 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.7 tt -83.07 125.18 31.19 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.962 -1.125 . . . . 62.310000000000002 107.962 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 621' ' ' THR . 30.8 t70 -104.05 123.55 47.43 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.081 0.467 . . . . 53.340000000000003 109.941 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.562 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -101.39 133.44 45.99 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 108.566 -0.902 . . . . 74.019999999999996 108.566 177.22 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -77.42 -68.7 1.48 Allowed Glycine 0 C--N 1.283 -2.387 0 N-CA-C 110.505 -1.038 . . . . 72.329999999999998 110.505 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.53 142.73 37.23 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.854 -0.795 . . . . 63.439999999999998 108.854 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -83.63 134.49 34.79 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.762 -1.199 . . . . 73.329999999999998 107.762 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 626' ' ' GLN . 42.8 t -104.13 141.62 19.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 107.893 -1.151 . . . . 73.209999999999994 107.893 -176.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . 0.405 ' HA ' ' HG2' ' A' ' 626' ' ' GLN . 16.5 t70 -72.46 118.2 15.06 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 109.484 -0.561 . . . . 65.450000000000003 109.484 -177.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -137.3 -59.76 0.68 Allowed 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 115.466 -0.788 . . . . 63.539999999999999 109.768 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 85.84 154.09 23.0 Favored Glycine 0 N--CA 1.412 -2.903 0 C-N-CA 119.07 -1.538 . . . . 44.43 109.818 -173.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.96 -33.82 75.78 Favored Glycine 0 C--N 1.284 -2.357 0 N-CA-C 114.934 0.733 . . . . 52.109999999999999 114.934 -177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 6.9 t -73.62 -24.74 60.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 117.68 0.74 . . . . 74.230000000000004 110.231 -174.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -87.92 -1.68 58.13 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.16 0.505 . . . . 75.400000000000006 109.827 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 57.0 m80 68.34 86.64 0.13 Allowed 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 124.993 1.317 . . . . 73.319999999999993 110.868 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -74.37 82.38 1.91 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 112.697 -2.047 . . . . 64.109999999999999 111.623 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -129.28 171.32 12.59 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.015 -1.448 . . . . 74.120000000000005 110.47 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.47 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 70.7 t -57.94 130.77 21.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 O-C-N 123.338 0.399 . . . . 54.310000000000002 110.075 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 27.0 m -106.53 -34.1 2.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 C-N-CA 120.579 -0.448 . . . . 64.310000000000002 110.922 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -152.92 135.92 15.54 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 116.352 -0.386 . . . . 64.219999999999999 110.5 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -118.79 128.59 54.62 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.593 -1.632 . . . . 75.010000000000005 106.593 171.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.436 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 4.4 t-20 -63.09 -47.94 84.95 Favored Pre-proline 0 N--CA 1.469 0.496 0 C-N-CA 119.717 -0.793 . . . . 73.310000000000002 110.954 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.9 Cg_exo -84.64 108.66 1.26 Allowed 'Trans proline' 0 C--N 1.361 1.187 0 N-CA-C 108.17 -1.512 . . . . 54.240000000000002 108.17 168.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.38 161.02 47.54 Favored 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 123.386 2.724 . . . . 75.530000000000001 113.13 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 565' ' ' ASP . . . -61.78 134.72 57.08 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.35 -0.611 . . . . 61.549999999999997 109.35 176.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 103.55 -5.03 47.56 Favored Glycine 0 C--N 1.304 -1.211 0 C-N-CA 120.554 -0.831 . . . . 71.150000000000006 111.508 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 59.1 m -86.36 141.36 29.25 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.725 -0.472 . . . . 74.450000000000003 109.725 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -78.33 117.36 4.63 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 110.072 -1.211 . . . . 74.120000000000005 110.072 176.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 28.6 m -115.48 142.2 29.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 110.167 -0.308 . . . . 74.230000000000004 110.167 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.428 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.6 p-10 -50.08 170.15 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.961 1.304 . . . . 73.409999999999997 113.041 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -60.98 -25.64 67.0 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.85 0.685 . . . . 71.099999999999994 112.85 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.465 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 17.8 m-20 -82.84 -8.83 59.55 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 119.185 -1.006 . . . . 55.130000000000003 110.832 177.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 64.85 15.48 60.17 Favored Glycine 0 C--O 1.219 -0.826 0 C-N-CA 123.599 0.618 . . . . 75.030000000000001 114.592 168.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.71 118.37 15.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 122.612 1.196 . . . . 72.329999999999998 112.515 -164.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.517 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.8 pp -128.46 134.34 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 114.012 -1.449 . . . . 71.430000000000007 111.266 -177.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 15.1 t -104.11 129.16 51.8 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.456 -0.572 . . . . 44.119999999999997 109.456 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.5 pp -139.43 167.2 22.62 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 112.355 0.502 . . . . 63.310000000000002 112.355 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 25.9 ptt85 -127.8 137.81 52.52 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.49 -0.559 . . . . 73.019999999999996 109.49 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.47 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 20.0 p90 -139.94 165.93 26.0 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.918 -0.583 . . . . 75.129999999999995 110.896 -173.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -76.15 134.64 16.16 Favored Glycine 0 N--CA 1.431 -1.647 0 CA-C-N 115.832 -0.622 . . . . 42.119999999999997 112.615 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 593' ' ' VAL . 2.7 pt20 . . . . . 0 C--N 1.305 -1.36 0 C-N-CA 123.768 0.827 . . . . 65.239999999999995 109.293 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.909 0 N-CA-C 110.476 -1.05 . . . . 43.049999999999997 110.476 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -67.61 142.33 58.32 Favored 'Trans proline' 0 C--O 1.241 0.63 0 C-N-CA 122.442 2.095 . . . . 64.040000000000006 110.748 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -96.54 -8.2 32.57 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.517 0.675 . . . . 40.109999999999999 111.174 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 31.2 p -137.66 147.3 44.79 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 115.338 -0.847 . . . . 72.219999999999999 109.744 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -127.68 139.86 52.44 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.614 -0.884 . . . . 71.099999999999994 108.614 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.4 p-10 -96.02 130.25 43.07 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.485 0.659 . . . . 74.219999999999999 110.414 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 34.8 pt -91.12 127.06 52.94 Favored Pre-proline 0 C--N 1.304 -1.383 0 CA-C-N 114.717 -1.129 . . . . 75.430000000000007 111.198 -176.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -84.42 -179.42 3.85 Favored 'Trans proline' 0 N--CA 1.441 -1.585 0 C-N-CA 121.632 1.555 . . . . 64.329999999999998 110.696 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -82.3 103.37 11.83 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 122.253 1.025 . . . . 72.329999999999998 110.182 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.414 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 26.8 m -100.79 7.67 9.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 114.946 -1.025 . . . . 74.209999999999994 111.384 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.426 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -80.56 102.81 10.0 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 109.054 -0.721 . . . . 60.149999999999999 109.054 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 159.05 -36.14 0.49 Allowed Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.566 -0.826 . . . . 61.25 112.131 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 16.6 pm0 -94.45 -173.08 2.95 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 109.301 -0.629 . . . . 73.409999999999997 109.301 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 27.9 m -70.1 154.89 41.37 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.856 -1.164 . . . . 72.219999999999999 107.856 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.438 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.2 p -63.02 -41.89 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 C-N-CA 120.891 -0.324 . . . . 74.010000000000005 111.049 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . 0.539 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 18.7 t70 -62.18 -43.95 97.68 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 109.645 -0.502 . . . . 60.219999999999999 109.645 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 64.0 t -66.61 -41.85 88.93 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 CA-C-N 115.79 -0.641 . . . . 60.329999999999998 109.737 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.427 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -61.15 -44.57 97.11 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 120.442 0.163 . . . . 62.43 110.684 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 26.3 mt-30 -65.0 -43.82 91.28 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.266 -0.425 . . . . 65.430000000000007 111.086 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.566 ' O ' HG23 ' A' ' 514' ' ' VAL . 32.7 mmtp -62.92 -47.14 84.54 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.429 -0.582 . . . . 74.430000000000007 109.429 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -63.99 -37.95 89.3 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.515 -0.766 . . . . 74.099999999999994 111.345 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.64 -46.28 69.61 Favored 'General case' 0 C--O 1.203 -1.348 0 N-CA-C 108.151 -1.055 . . . . 64.25 108.151 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -59.99 -38.13 81.7 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 124.077 0.951 . . . . 73.200000000000003 111.188 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 510' ' ' LYS . 57.7 t -57.57 -37.56 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-O 120.845 0.355 . . . . 72.150000000000006 111.326 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -110.0 0.91 18.69 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.865 0.84 . . . . 74.439999999999998 111.098 -176.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -113.5 -60.4 0.41 Allowed Glycine 0 N--CA 1.416 -2.698 0 CA-C-N 115.18 -0.918 . . . . 70.109999999999999 111.331 -174.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 70.74 16.49 6.74 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.58 1.152 . . . . 74.400000000000006 110.415 -175.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 547' ' ' VAL . 4.4 p -83.05 -176.17 6.2 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-N 114.082 -1.417 . . . . 75.25 109.496 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 0.1 OUTLIER -108.69 143.14 38.18 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.29 -1.004 . . . . 61.0 108.29 177.018 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -123.1 148.61 45.46 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-O 121.428 0.633 . . . . 74.129999999999995 111.804 -175.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 16.9 p -135.31 140.26 44.97 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 107.369 -1.345 . . . . 71.310000000000002 107.369 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -117.45 127.27 53.85 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-O 121.246 0.546 . . . . 73.010000000000005 110.466 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -116.11 143.36 45.58 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.161 -1.422 . . . . 74.219999999999999 107.161 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.0 p -119.44 132.66 55.85 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 113.783 1.031 . . . . 72.109999999999999 113.783 -175.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.64 149.97 24.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 107.902 -1.147 . . . . 63.409999999999997 107.902 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -79.61 136.86 36.95 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.923 -0.311 . . . . 33.039999999999999 110.881 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.436 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 59.9 m -163.24 155.08 15.13 Favored Pre-proline 0 C--O 1.204 -1.335 0 N-CA-C 107.106 -1.442 . . . . 43.450000000000003 107.106 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.39 -14.66 36.01 Favored 'Trans proline' 0 CA--C 1.552 1.376 0 C-N-CA 122.439 2.093 . . . . 73.25 114.587 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -70.9 145.58 91.99 Favored Pre-proline 0 C--O 1.215 -0.711 0 N-CA-C 109.529 -0.545 . . . . 75.519999999999996 109.529 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.33 144.39 91.13 Favored 'Trans proline' 0 C--O 1.26 1.59 0 C-N-CA 122.317 2.012 . . . . 65.430000000000007 112.619 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.693 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -64.14 100.34 0.32 Allowed 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.246 -0.888 . . . . 63.009999999999998 111.171 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 157.43 -23.41 0.43 Allowed Glycine 0 N--CA 1.427 -1.93 0 C-N-CA 120.559 -0.829 . . . . 74.349999999999994 111.979 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -80.65 138.92 36.43 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 119.904 -0.718 . . . . 75.099999999999994 109.842 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.427 HG11 ' CB ' ' A' ' 508' ' ' ALA . 5.4 p -93.85 113.93 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.888 0 N-CA-C 107.294 -1.373 . . . . 72.239999999999995 107.294 172.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.7 m -99.62 8.74 44.15 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 113.929 -1.487 . . . . 74.319999999999993 111.186 -172.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.426 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 157.31 172.89 25.05 Favored Glycine 0 N--CA 1.428 -1.883 0 C-N-CA 119.704 -1.236 . . . . 42.43 113.245 174.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 18.6 p -120.52 158.27 27.65 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 105.798 -1.927 . . . . 73.319999999999993 105.798 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.452 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 3.9 t-20 -67.05 -54.33 20.83 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 117.517 -1.673 . . . . 70.230000000000004 111.368 177.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 8.2 Cg_exo -74.33 143.21 31.2 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 121.282 1.321 . . . . 61.509999999999998 109.792 174.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.74 157.99 59.61 Favored 'Trans proline' 0 C--O 1.25 1.106 0 C-N-CA 122.635 2.224 . . . . 71.120000000000005 113.284 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.28 139.59 58.08 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.806 -0.633 . . . . 42.43 110.505 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.18 -14.36 59.79 Favored Glycine 0 C--N 1.3 -1.436 0 N-CA-C 111.706 -0.557 . . . . 71.439999999999998 111.706 -178.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 20.4 m -75.32 135.23 40.89 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 109.771 -0.455 . . . . 54.439999999999998 109.771 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.8 t -96.58 125.47 41.07 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 107.916 -1.142 . . . . 75.030000000000001 107.916 177.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.26 154.55 65.44 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 108.622 -0.881 . . . . 64.519999999999996 108.622 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.64 137.48 77.56 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.784 1.656 . . . . 60.030000000000001 112.283 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.45 ' HA ' HG22 ' A' ' 518' ' ' THR . 13.5 p -65.33 -24.03 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-N 115.19 -0.913 . . . . 62.030000000000001 110.82 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -78.02 -10.02 59.4 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.559 -1.201 . . . . 73.25 111.632 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 22.9 t -94.01 -176.84 4.13 Favored 'General case' 0 C--O 1.26 1.637 0 CA-C-O 121.631 0.729 . . . . 61.350000000000001 112.176 -174.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 14.7 p -119.13 137.92 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 114.774 -1.103 . . . . 54.539999999999999 109.037 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.3 mt -108.71 138.33 36.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 109.149 -0.686 . . . . 73.439999999999998 109.149 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.53 122.06 44.17 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.689 0.757 . . . . 73.209999999999994 111.756 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.1 mp -108.08 122.23 46.45 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.212 -1.358 . . . . 63.109999999999999 108.776 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -90.63 116.23 28.35 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.916 0.865 . . . . 73.329999999999998 111.26 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 524' ' ' SER . 21.3 t -98.8 135.21 34.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 114.263 -1.335 . . . . 41.229999999999997 108.811 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.693 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 66.4 m -86.33 129.04 34.99 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.538 -0.541 . . . . 74.400000000000006 109.538 174.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -101.03 130.05 46.98 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 105.883 -1.895 . . . . 72.150000000000006 105.883 172.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -62.22 -24.93 65.92 Favored Glycine 0 CA--C 1.5 -0.898 0 O-C-N 124.006 0.816 . . . . 74.510000000000005 114.146 -173.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . 0.486 ' OD1' ' HG3' ' A' ' 616' ' ' ARG . 49.0 t-20 71.93 -14.62 0.51 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.841 1.256 . . . . 74.439999999999998 111.363 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -111.93 149.55 31.76 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.307 -0.87 . . . . 72.150000000000006 112.856 -170.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -131.0 158.4 40.39 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.248 -1.342 . . . . 71.129999999999995 107.449 177.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.61 125.33 32.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 120.991 0.424 . . . . 62.219999999999999 111.217 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 55.2 ttp -86.6 129.51 52.64 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 110.092 -0.336 . . . . 72.129999999999995 110.092 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.07 170.46 20.07 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.363 2.708 . . . . 72.420000000000002 112.337 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.02 126.65 28.7 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 112.784 0.661 . . . . 72.310000000000002 112.784 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . 0.464 ' O ' ' HG2' ' A' ' 569' ' ' MET . 0.0 OUTLIER -132.05 7.25 4.31 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.504 1.145 . . . . 55.439999999999998 109.06 171.382 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 3.1 m -79.19 138.19 37.75 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.559 -1.201 . . . . 75.120000000000005 108.926 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 84.15 18.62 62.46 Favored Glycine 0 C--N 1.315 -0.624 0 C-N-CA 120.533 -0.841 . . . . 74.310000000000002 113.876 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 20.2 ptp -124.0 175.12 7.16 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.291 -1.003 . . . . 75.109999999999999 108.291 176.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -94.8 164.98 12.71 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.595 -1.631 . . . . 63.119999999999997 106.595 -175.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . 0.504 ' O ' ' HG3' ' A' ' 575' ' ' GLU . 10.8 t-105 -63.49 -34.16 77.17 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.781 -0.822 . . . . 73.400000000000006 108.781 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.6 p -74.23 -14.78 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.648 -0.705 . . . . 73.310000000000002 110.669 -175.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -100.98 -28.6 12.65 Favored 'General case' 0 C--O 1.263 1.814 0 CA-C-O 122.025 0.917 . . . . 54.43 108.766 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . 0.643 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -64.12 -41.67 97.14 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.486 -1.234 . . . . 51.109999999999999 109.98 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 571' ' ' TRP . 46.0 mt-10 -51.21 -56.12 22.83 Favored Pre-proline 0 CA--C 1.567 1.615 0 N-CA-C 112.519 0.562 . . . . 74.319999999999993 112.519 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -58.4 -33.34 97.76 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 121.554 1.502 . . . . 71.420000000000002 112.71 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -68.64 -34.3 75.5 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 119.487 -0.885 . . . . 71.319999999999993 111.735 176.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 41.0 mt -63.06 -48.31 79.23 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.147 0.499 . . . . 63.219999999999999 110.383 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 6.9 ptp85 -66.19 -36.83 84.1 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.136 -0.484 . . . . 75.219999999999999 111.324 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.31 77.85 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.134 -0.484 . . . . 54.020000000000003 112.097 -177.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' A' ' 583' ' ' TRP . 1.7 pp -81.93 -8.54 59.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.158 0.504 . . . . 73.340000000000003 109.868 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 80.3 42.45 10.52 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.528 -0.76 . . . . 71.319999999999993 112.311 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.457 ' CE3' HD22 ' A' ' 578' ' ' LEU . 18.1 t90 -87.31 126.59 34.94 Favored 'General case' 0 N--CA 1.427 -1.619 0 C-N-CA 120.147 -0.621 . . . . 73.519999999999996 109.888 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 26.9 p -100.95 -14.28 17.95 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.33 0.492 . . . . 74.409999999999997 112.33 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -82.96 -171.09 46.91 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 121.344 -0.455 . . . . 42.43 113.349 -177.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 92.3 mmm -117.57 147.47 42.79 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.907 -0.405 . . . . 62.509999999999998 109.907 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . 0.455 HD21 ' HG ' ' A' ' 622' ' ' LEU . 3.6 tt -93.02 129.56 38.9 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.88 0.372 . . . . 53.229999999999997 110.203 -175.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -113.96 124.85 53.16 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-N 115.911 -0.586 . . . . 72.140000000000001 109.719 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.485 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.3 OUTLIER -90.8 133.95 34.81 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.806 -0.442 . . . . 55.329999999999998 109.806 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -84.06 -106.8 0.57 Allowed Glycine 0 C--N 1.291 -1.937 0 CA-C-N 115.829 -0.623 . . . . 54.100000000000001 112.32 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . 0.605 ' O ' ' HB2' ' A' ' 623' ' ' ARG . . . -96.14 116.58 29.21 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.948 0.404 . . . . 74.319999999999993 110.343 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -87.24 140.08 29.9 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 123.499 0.719 . . . . 71.340000000000003 110.898 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 48.4 t -122.36 128.74 75.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.313 -0.995 . . . . 61.43 108.313 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.59 122.61 21.66 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.92 0.391 . . . . 65.049999999999997 110.397 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -134.45 -43.47 0.77 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.815 -0.63 . . . . 71.109999999999999 110.596 -177.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 106.86 128.92 6.1 Favored Glycine 0 N--CA 1.433 -1.524 0 N-CA-C 111.543 -0.623 . . . . 55.32 111.543 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.17 -32.95 84.33 Favored Glycine 0 N--CA 1.46 0.235 0 CA-C-O 121.067 0.26 . . . . 54.350000000000001 112.485 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 3.0 p -64.94 -23.94 67.37 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 124.938 1.295 . . . . 55.229999999999997 110.944 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 599' ' ' GLN . 4.8 mt-30 -92.23 -0.78 57.4 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.776 -0.647 . . . . 72.209999999999994 110.283 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 30.5 m170 75.01 97.23 0.07 Allowed 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 125.017 1.327 . . . . 71.239999999999995 112.29 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . 0.683 ' HB2' ' O ' ' A' ' 625' ' ' GLY . 19.2 p30 -83.2 88.85 6.91 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 114.016 -1.447 . . . . 60.219999999999999 112.748 -175.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 -91.85 155.68 18.03 Favored 'General case' 0 C--O 1.254 1.307 0 CA-C-N 114.504 -1.226 . . . . 75.319999999999993 110.818 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 88.0 t -62.86 131.89 28.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 114.955 -1.021 . . . . 70.439999999999998 108.3 172.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.74 -46.55 12.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 120.996 0.427 . . . . 63.43 110.666 -175.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -151.69 154.11 35.69 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.346 -0.983 . . . . 71.150000000000006 108.346 -176.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -142.55 149.31 38.92 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.309 -0.626 . . . . 74.150000000000006 109.309 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.524 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 50.8 t-20 -69.23 -56.45 8.59 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 120.611 -0.436 . . . . 64.439999999999998 111.265 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.8 Cg_exo -84.44 115.36 1.89 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 120.729 1.296 . . . . 42.25 108.888 173.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -70.2 157.91 58.04 Favored 'Trans proline' 0 C--O 1.248 1.017 0 C-N-CA 122.303 2.002 . . . . 70.150000000000006 112.458 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.31 137.81 56.34 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.721 -0.844 . . . . 63.409999999999997 108.721 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 96.94 -7.18 64.71 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.892 -0.671 . . . . 74.349999999999994 111.646 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 38.5 m -94.71 150.15 20.51 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.987 -0.375 . . . . 74.439999999999998 109.987 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -75.63 126.5 8.54 Favored Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 111.823 -0.511 . . . . 54.140000000000001 111.823 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.3 m -118.65 142.65 32.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 109.077 -0.712 . . . . 75.349999999999994 109.077 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -52.25 165.87 0.2 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.887 0.875 . . . . 72.099999999999994 112.035 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . 0.486 ' HG3' ' OD1' ' A' ' 559' ' ' ASN . 0.0 OUTLIER -57.82 -25.3 60.42 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.864 1.061 . . . . 75.25 113.864 -178.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.38 -10.31 59.75 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 119.95 -0.7 . . . . 72.310000000000002 109.48 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 65.34 16.1 62.19 Favored Glycine 0 CA--C 1.498 -1.019 0 CA-C-N 115.61 -0.723 . . . . 73.140000000000001 113.472 169.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.16 119.29 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 122.567 1.175 . . . . 73.219999999999999 111.067 -165.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.415 HG12 ' HD2' ' A' ' 608' ' ' PRO . 0.0 OUTLIER -129.2 132.48 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.176 0 CA-C-N 113.824 -1.535 . . . . 72.409999999999997 109.11 -176.071 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 8.9 t -114.96 133.53 55.94 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.399 -0.963 . . . . 65.200000000000003 108.399 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.455 ' HG ' HD21 ' A' ' 587' ' ' LEU . 3.1 pp -138.97 166.65 23.93 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.748 -0.66 . . . . 41.25 112.073 -174.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . 0.605 ' HB2' ' O ' ' A' ' 591' ' ' ALA . 7.4 ptm180 -126.93 137.42 53.13 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 106.915 -1.513 . . . . 74.239999999999995 106.915 175.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -139.49 165.93 25.92 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 115.808 -0.633 . . . . 74.299999999999997 109.324 -171.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . 0.683 ' O ' ' HB2' ' A' ' 601' ' ' ASN . . . -72.7 140.03 28.45 Favored Glycine 0 N--CA 1.418 -2.561 0 N-CA-C 108.493 -1.843 . . . . 63.219999999999999 108.493 174.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 . . . . . 0 C--N 1.265 -3.107 0 CA-C-O 118.11 -0.947 . . . . 72.450000000000003 108.643 -179.401 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.636 0 N-CA-C 110.569 -1.012 . . . . 73.200000000000003 110.569 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -76.45 142.71 23.88 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 122.503 2.135 . . . . 73.0 110.758 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 61.57 31.22 18.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.865 0.866 . . . . 73.129999999999995 111.677 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 38.3 p -139.5 144.18 37.81 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.423 -0.584 . . . . 64.109999999999999 109.423 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.545 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 4.3 tmtt? -134.93 139.38 44.91 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.05 -1.093 . . . . 75.5 108.05 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.545 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 10.5 p-10 -78.77 132.97 37.12 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 124.097 0.959 . . . . 74.349999999999994 110.051 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 42.6 pt -98.58 128.45 32.81 Favored Pre-proline 0 C--N 1.306 -1.309 0 C-N-CA 120.386 -0.526 . . . . 75.430000000000007 110.584 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.92 -163.33 0.19 Allowed 'Trans proline' 0 C--O 1.251 1.139 0 C-N-CA 122.682 2.254 . . . . 41.43 111.018 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -86.18 127.3 34.7 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.609 0.719 . . . . 54.310000000000002 109.984 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.511 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 15.9 m -122.99 62.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-O 123.359 1.552 . . . . 70.030000000000001 108.425 171.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -120.43 108.58 14.29 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 112.825 -1.988 . . . . 51.43 109.191 176.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 138.39 -25.47 2.87 Favored Glycine 0 N--CA 1.431 -1.661 0 C-N-CA 119.613 -1.279 . . . . 74.329999999999998 113.42 175.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.453 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.4 OUTLIER -101.39 -177.0 3.31 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 117.835 0.817 . . . . 74.319999999999993 109.382 179.342 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.414 ' HB ' HG23 ' A' ' 507' ' ' VAL . 9.1 m -74.36 155.45 38.13 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.78 -1.193 . . . . 74.129999999999995 107.78 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 8.9 p -64.3 -41.32 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-O 119.471 -0.3 . . . . 54.140000000000001 111.715 -177.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 15.5 t70 -59.56 -42.6 92.77 Favored 'General case' 0 C--O 1.213 -0.844 0 N-CA-C 108.417 -0.957 . . . . 71.010000000000005 108.417 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.414 HG23 ' HB ' ' A' ' 504' ' ' THR . 76.9 t -65.34 -44.84 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 114.983 -1.008 . . . . 73.540000000000006 110.044 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.511 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -63.24 -44.98 93.68 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 111.725 0.269 . . . . 75.120000000000005 111.725 177.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.6 mt-30 -61.88 -45.26 94.55 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 122.804 0.441 . . . . 72.420000000000002 110.08 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 514' ' ' VAL . 31.5 mmtp -67.01 -39.28 87.05 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.631 -0.713 . . . . 73.140000000000001 110.579 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -61.49 -43.98 97.9 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 121.31 0.576 . . . . 52.539999999999999 110.492 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.57 -43.06 86.04 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.842 -1.17 . . . . 73.450000000000003 107.842 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -59.81 -36.5 76.88 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 124.035 0.934 . . . . 72.25 111.664 -177.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 510' ' ' LYS . 90.4 t -60.07 -40.48 83.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.732 0.301 . . . . 54.140000000000001 110.929 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -107.15 13.17 27.63 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.414 0.626 . . . . 73.150000000000006 110.281 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -134.65 -54.29 0.07 OUTLIER Glycine 0 N--CA 1.429 -1.801 0 C-N-CA 120.534 -0.841 . . . . 52.130000000000003 113.72 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 65.22 25.76 12.3 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.404 1.097 . . . . 62.340000000000003 109.088 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.485 HG22 ' HA ' ' A' ' 547' ' ' VAL . 6.2 p -80.77 -173.54 4.25 Favored 'General case' 0 N--CA 1.416 -2.143 0 C-N-CA 125.719 1.608 . . . . 72.319999999999993 111.602 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -108.76 138.41 45.14 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.451 -1.685 . . . . 54.229999999999997 106.451 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -132.43 149.01 52.42 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.065 0.459 . . . . 75.329999999999998 111.607 -178.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 71.3 m -141.22 150.9 43.26 Favored 'General case' 0 N--CA 1.418 -2.025 0 N-CA-C 108.515 -0.92 . . . . 63.030000000000001 108.515 174.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.46 ' HB2' ' CG2' ' A' ' 555' ' ' VAL . 3.6 pt20 -119.56 136.63 54.27 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.036 0.446 . . . . 71.439999999999998 110.294 -178.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -120.04 137.34 54.16 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.184 -1.413 . . . . 61.119999999999997 107.184 176.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 33.8 m -106.1 134.5 49.12 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 112.295 0.48 . . . . 53.32 112.295 -175.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.6 p -131.13 153.04 38.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.357 -0.838 . . . . 72.5 109.006 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -73.24 134.92 44.45 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.24 -1.022 . . . . 74.530000000000001 108.24 177.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.571 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 65.5 m -161.13 168.04 12.3 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.513 -0.551 . . . . 75.109999999999999 109.513 -177.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -71.96 -21.91 23.78 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.055 1.837 . . . . 71.409999999999997 112.077 176.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -69.73 144.22 93.39 Favored Pre-proline 0 C--O 1.221 -0.426 0 CA-C-N 116.2 -0.455 . . . . 75.140000000000001 111.311 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.47 152.42 81.67 Favored 'Trans proline' 0 C--O 1.248 0.996 0 C-N-CA 122.586 2.191 . . . . 64.420000000000002 111.72 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 557' ' ' LYS . . . -62.31 112.01 2.24 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 115.63 -0.714 . . . . 74.109999999999999 110.999 -177.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 131.53 -23.62 4.24 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 115.427 -0.806 . . . . 63.310000000000002 111.623 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -80.08 133.83 36.14 Favored 'General case' 0 C--O 1.246 0.912 0 CA-C-O 121.262 0.553 . . . . 75.420000000000002 109.768 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 503' ' ' GLN . 8.1 p -97.32 120.09 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.875 0 N-CA-C 108.094 -1.076 . . . . 54.119999999999997 108.094 -178.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 4.1 p -90.13 1.24 56.62 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.207 -0.906 . . . . 74.209999999999994 112.376 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.445 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 144.0 -161.7 27.83 Favored Glycine 0 N--CA 1.424 -2.144 0 C-N-CA 120.314 -0.946 . . . . 64.200000000000003 112.321 175.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 3.8 p -116.97 155.14 29.65 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.807 -0.812 . . . . 74.239999999999995 108.807 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -65.31 -50.52 58.63 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.306 -0.627 . . . . 61.240000000000002 109.306 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.67 138.91 46.73 Favored 'Trans proline' 0 C--N 1.375 1.966 0 N-CA-C 108.97 -1.204 . . . . 62.329999999999998 108.97 170.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.01 143.64 91.34 Favored 'Trans proline' 0 C--O 1.243 0.725 0 C-N-CA 122.86 2.373 . . . . 74.219999999999999 113.659 -175.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.01 131.53 47.88 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.63 -0.714 . . . . 74.099999999999994 109.745 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.22 -5.39 35.91 Favored Glycine 0 N--CA 1.434 -1.448 0 CA-C-N 115.708 -0.678 . . . . 23.309999999999999 111.465 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 5.9 t -84.97 138.16 32.65 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.233 0.54 . . . . 75.510000000000005 110.714 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 9.2 t -81.56 131.37 35.27 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.158 -1.053 . . . . 70.129999999999995 108.158 174.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.0 m -126.51 154.99 75.24 Favored Pre-proline 0 C--N 1.315 -0.935 0 N-CA-C 108.786 -0.82 . . . . 74.129999999999995 108.786 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -70.18 138.89 37.51 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.635 1.557 . . . . 62.229999999999997 111.29 176.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.485 ' HA ' HG22 ' A' ' 518' ' ' THR . 8.9 p -64.73 -19.08 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 CA-C-O 122.345 1.069 . . . . 74.140000000000001 110.608 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -86.38 -18.35 32.06 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.17 -0.923 . . . . 72.400000000000006 110.768 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 50.4 m -91.98 167.78 11.86 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.362 0.601 . . . . 74.319999999999993 111.968 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 10.7 p -97.22 138.15 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-N 115.096 -0.956 . . . . 75.150000000000006 111.051 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 56.7 mt -97.48 134.19 36.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 107.615 -1.254 . . . . 72.299999999999997 107.615 176.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -103.33 117.34 34.27 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.097 -0.705 . . . . 70.230000000000004 109.097 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.8 mp -104.42 133.13 49.82 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 120.916 0.388 . . . . 74.420000000000002 111.657 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -87.51 108.83 19.22 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 123.558 0.743 . . . . 75.140000000000001 110.853 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 522' ' ' GLN . 32.5 t -95.85 124.3 48.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.468 -0.938 . . . . 71.129999999999995 108.468 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.571 ' HB3' ' HB2' ' A' ' 527' ' ' SER . 58.0 m -88.05 133.24 34.02 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 115.972 -0.558 . . . . 71.540000000000006 110.733 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.1 ptpt -115.72 130.96 57.05 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 107.843 -1.169 . . . . 74.329999999999998 107.843 171.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 527' ' ' SER . . . -64.93 -23.75 69.6 Favored Glycine 0 CA--C 1.497 -1.061 0 N-CA-C 110.264 -1.134 . . . . 72.010000000000005 110.264 178.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 53.9 t30 70.22 -5.55 1.31 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.041 1.736 . . . . 52.549999999999997 111.051 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 77.9 mt-30 -113.54 142.72 45.62 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 115.796 -0.638 . . . . 73.450000000000003 110.572 -176.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -123.36 158.21 31.59 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.665 -0.865 . . . . 75.239999999999995 108.665 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.29 118.3 10.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 O-C-N 123.499 0.499 . . . . 63.5 109.78 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.556 ' SD ' HG21 ' A' ' 620' ' ' ILE . 35.9 ttp -79.32 136.93 56.26 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 116.219 -0.446 . . . . 73.400000000000006 111.402 -178.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.32 171.24 10.71 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.623 2.882 . . . . 70.409999999999997 111.742 172.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -82.53 129.39 34.91 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 116.529 -0.305 . . . . 75.349999999999994 111.314 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -123.05 16.5 9.99 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.258 1.028 . . . . 75.040000000000006 109.191 176.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 50.8 m -79.03 130.91 36.03 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 114.386 -1.279 . . . . 74.310000000000002 112.363 -175.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . 0.426 ' HA2' ' HD3' ' A' ' 602' ' ' ARG . . . 71.12 62.53 3.49 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.45 -0.796 . . . . 55.039999999999999 114.377 176.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 24.4 ptp -159.86 164.84 33.26 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 109.057 -0.719 . . . . 74.430000000000007 109.057 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -92.88 174.7 7.11 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.835 -0.431 . . . . 72.340000000000003 109.835 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 35.3 t-105 -64.48 -29.64 70.68 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.885 -0.783 . . . . 72.450000000000003 108.885 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 22.1 m -74.96 -6.4 8.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.469 -0.787 . . . . 41.100000000000001 111.214 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -102.21 -44.35 5.45 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.501 -0.925 . . . . 74.519999999999996 108.501 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -64.68 -40.09 94.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.94 -1.027 . . . . 70.349999999999994 113.122 -177.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.711 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 6.0 tm-20 -66.22 -50.81 48.12 Favored Pre-proline 0 CA--C 1.564 1.482 0 N-CA-C 109.943 -0.392 . . . . 74.109999999999999 109.943 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 61.7 Cg_exo -53.12 -34.32 67.99 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 121.584 1.523 . . . . 65.439999999999998 111.646 169.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -60.88 -39.63 89.94 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.433 0.531 . . . . 71.420000000000002 112.433 175.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.711 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 3.9 pp -65.98 -44.45 84.85 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 120.184 -0.606 . . . . 72.030000000000001 110.727 -178.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.461 ' N ' HD12 ' A' ' 578' ' ' LEU . 6.6 ptm180 -66.46 -34.58 78.26 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.833 0.349 . . . . 63.119999999999997 111.69 176.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.24 -36.53 74.55 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.161 0.505 . . . . 73.129999999999995 111.35 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.5 tp -87.9 -9.22 54.33 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 123.695 0.798 . . . . 71.019999999999996 110.622 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 66.04 37.51 93.2 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.114 -0.795 . . . . 35.119999999999997 111.114 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -80.73 126.43 31.29 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.409 0.623 . . . . 72.450000000000003 110.172 -176.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 17.0 p -96.67 -18.5 19.65 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 113.313 0.857 . . . . 50.229999999999997 113.313 -174.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -80.36 -156.57 13.23 Favored Glycine 0 C--O 1.24 0.471 0 C-N-CA 121.327 -0.463 . . . . 75.299999999999997 114.115 -176.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 67.2 mtm -128.68 155.32 45.22 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.561 -0.533 . . . . 75.450000000000003 109.561 -176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.5 tt -106.67 113.71 27.38 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.648 -1.241 . . . . 62.310000000000002 107.648 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 621' ' ' THR . 51.9 m-20 -98.65 110.1 22.75 Favored 'General case' 0 CA--C 1.478 -1.804 0 N-CA-C 109.305 -0.628 . . . . 53.340000000000003 109.305 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.0 OUTLIER -87.55 133.07 33.85 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 118.418 -1.313 . . . . 74.019999999999996 107.633 174.115 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -82.59 -55.67 2.96 Favored Glycine 0 C--N 1.29 -1.976 0 CA-C-N 115.605 -0.725 . . . . 72.329999999999998 112.04 -174.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.85 154.13 47.23 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.569 -0.53 . . . . 63.439999999999998 109.569 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . 0.554 ' HB3' ' HB2' ' A' ' 626' ' ' GLN . 10.5 m-20 -99.54 129.79 45.74 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 105.385 -2.08 . . . . 73.329999999999998 105.385 173.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 16.5 t -103.49 135.78 39.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 107.138 -1.43 . . . . 73.209999999999994 107.138 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.71 121.86 19.61 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 118.219 0.463 . . . . 65.450000000000003 111.083 -169.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -138.3 -56.99 0.65 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.547 -0.751 . . . . 63.539999999999999 110.489 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 100.06 142.31 12.96 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 109.573 -1.411 . . . . 44.43 109.573 -173.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.93 -35.4 83.02 Favored Glycine 0 C--N 1.314 -0.676 0 N-CA-C 113.914 0.326 . . . . 52.109999999999999 113.914 -176.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 9.3 t -71.85 -24.41 61.69 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.284 0.564 . . . . 74.230000000000004 110.329 -176.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -88.19 -0.55 57.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.33 -0.396 . . . . 75.400000000000006 110.734 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 50.8 m80 79.2 84.33 0.06 Allowed 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 125.426 1.49 . . . . 73.319999999999993 110.275 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -81.16 71.98 8.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 123.21 1.481 . . . . 64.109999999999999 111.182 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.426 ' HD3' ' HA2' ' A' ' 568' ' ' GLY . 4.6 ppt_? -115.21 172.32 7.14 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 113.233 -1.803 . . . . 74.120000000000005 110.653 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.448 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 63.2 t -56.54 130.79 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 109.588 -0.523 . . . . 54.310000000000002 109.588 -178.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 26.3 m -110.39 -30.04 2.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.277 -0.874 . . . . 64.310000000000002 111.488 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -156.75 135.71 11.83 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 109.68 -0.489 . . . . 64.219999999999999 109.68 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -116.17 136.24 53.19 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.601 -0.518 . . . . 75.010000000000005 109.601 173.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.447 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 9.5 t30 -56.99 -50.76 86.36 Favored Pre-proline 0 CA--C 1.534 0.348 0 O-C-N 123.627 0.579 . . . . 73.310000000000002 111.594 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.496 ' O ' ' HE1' ' A' ' 563' ' ' MET . 57.8 Cg_endo -89.3 112.32 0.56 Allowed 'Trans proline' 0 N--CA 1.43 -2.216 0 N-CA-C 109.361 -1.053 . . . . 54.240000000000002 109.361 169.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.18 161.03 47.48 Favored 'Trans proline' 0 C--O 1.249 1.049 0 C-N-CA 122.709 2.272 . . . . 75.530000000000001 111.132 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -54.89 132.91 47.58 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 122.622 0.369 . . . . 61.549999999999997 110.316 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.64 -6.54 59.0 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.159 -1.019 . . . . 71.150000000000006 112.972 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 37.5 m -86.25 149.54 25.0 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.857 -0.423 . . . . 74.450000000000003 109.857 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.5 123.3 6.07 Favored Glycine 0 N--CA 1.433 -1.562 0 C-N-CA 121.211 -0.519 . . . . 74.120000000000005 112.478 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 35.5 m -116.28 142.31 30.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.716 -0.846 . . . . 74.230000000000004 108.716 176.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -55.74 175.31 0.09 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.922 0.889 . . . . 73.409999999999997 113.287 -177.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -60.99 -27.0 67.98 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.5 -0.318 . . . . 71.099999999999994 111.639 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -82.34 -8.24 59.63 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.171 -0.612 . . . . 55.130000000000003 109.799 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.19 18.75 67.49 Favored Glycine 0 C--O 1.214 -1.131 0 O-C-N 123.302 0.376 . . . . 75.030000000000001 113.105 173.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.68 120.09 17.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 121.739 0.781 . . . . 72.329999999999998 111.396 -167.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.556 HG21 ' SD ' ' A' ' 563' ' ' MET . 50.7 pt -126.88 135.49 63.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 115.026 -0.988 . . . . 71.430000000000007 111.985 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 14.0 t -109.62 128.25 55.09 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.796 -0.816 . . . . 44.119999999999997 108.796 177.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 3.8 pp -139.78 168.08 20.65 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.297 -0.41 . . . . 63.310000000000002 111.631 -176.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -127.6 138.1 52.76 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.435 -0.58 . . . . 73.019999999999996 109.435 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.448 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 22.9 p90 -129.67 165.8 21.09 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 112.53 0.567 . . . . 75.129999999999995 112.53 -175.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -64.85 137.61 39.05 Favored Glycine 0 N--CA 1.423 -2.21 0 CA-C-N 114.886 -1.052 . . . . 42.119999999999997 112.488 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.554 ' HB2' ' HB3' ' A' ' 592' ' ' ASP . 10.3 tt0 . . . . . 0 C--N 1.277 -2.567 0 C-N-CA 125.431 1.492 . . . . 65.239999999999995 107.416 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.805 0 CA-C-O 119.28 -0.733 . . . . 43.049999999999997 111.274 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -76.75 141.66 22.0 Favored 'Trans proline' 0 C--O 1.25 1.082 0 C-N-CA 122.305 2.003 . . . . 74.349999999999994 112.566 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 62.11 7.25 2.08 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.903 1.681 . . . . 74.230000000000004 114.148 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.8 p -147.94 147.29 29.53 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 122.169 -0.332 . . . . 74.439999999999998 111.465 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -143.83 143.69 31.44 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 123.689 0.795 . . . . 74.329999999999998 109.443 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.8 p-10 -91.13 139.48 30.72 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.825 -0.806 . . . . 74.549999999999997 108.825 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 32.5 pt -97.65 132.17 25.6 Favored Pre-proline 0 C--N 1.293 -1.861 0 CA-C-N 115.463 -0.79 . . . . 75.319999999999993 111.9 -176.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -83.96 175.85 7.29 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.22 1.947 . . . . 60.229999999999997 110.187 173.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -86.55 127.09 34.86 Favored 'General case' 0 CA--C 1.489 -1.376 0 CA-C-O 122.047 0.927 . . . . 70.209999999999994 109.909 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.437 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 16.2 m -113.85 59.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 CA-C-O 122.827 1.298 . . . . 64.530000000000001 109.481 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -112.57 105.77 14.05 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 113.61 -1.632 . . . . 72.319999999999993 109.648 174.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 141.97 -17.03 2.57 Favored Glycine 0 C--N 1.313 -0.705 0 C-N-CA 118.472 -1.823 . . . . 71.109999999999999 114.61 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.442 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.1 OUTLIER -112.72 -175.27 2.63 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.041 -0.726 . . . . 73.040000000000006 109.041 177.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.412 ' HB ' HG23 ' A' ' 507' ' ' VAL . 2.8 m -74.66 155.44 37.76 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 107.973 -1.121 . . . . 74.530000000000001 107.973 178.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.527 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 8.3 p -62.82 -42.13 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 121.123 -0.231 . . . . 52.450000000000003 111.48 -178.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.25 -34.41 78.28 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 110.06 -0.348 . . . . 71.430000000000007 110.06 -178.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.412 HG23 ' HB ' ' A' ' 504' ' ' THR . 59.0 t -71.9 -44.32 67.41 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.966 0 N-CA-C 109.351 -0.611 . . . . 74.439999999999998 109.351 178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.443 ' HB2' HG11 ' A' ' 534' ' ' VAL . . . -58.58 -43.68 89.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.78 0.324 . . . . 72.349999999999994 110.83 177.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.3 mt-30 -62.75 -44.24 96.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.722 -0.672 . . . . 74.319999999999993 110.445 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 514' ' ' VAL . 71.8 mmtt -65.86 -42.61 90.18 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.924 -0.58 . . . . 64.120000000000005 111.129 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -62.86 -47.23 84.25 Favored 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 124.06 0.85 . . . . 72.209999999999994 111.237 -176.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -68.41 -35.31 77.46 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 115.689 -0.687 . . . . 75.030000000000001 110.6 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.45 ' N ' HD12 ' A' ' 512' ' ' LEU . 4.0 t-20 -63.87 -34.0 76.95 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 115.171 -0.922 . . . . 74.519999999999996 111.431 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 510' ' ' LYS . 84.0 t -57.22 -32.53 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 121.164 0.507 . . . . 75.099999999999994 110.731 177.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -107.85 4.77 25.81 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.489 -0.93 . . . . 70.549999999999997 108.489 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -126.96 -60.18 0.14 Allowed Glycine 0 N--CA 1.416 -2.666 0 C-N-CA 119.547 -1.311 . . . . 51.420000000000002 114.577 -169.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 64.8 25.12 12.89 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 122.561 1.172 . . . . 65.310000000000002 108.224 -171.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.6 p -82.87 -172.88 4.36 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 113.271 -1.786 . . . . 23.32 111.007 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 519' ' ' LYS . 0.1 OUTLIER -108.71 136.56 48.1 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.537 -1.282 . . . . 74.450000000000003 107.537 179.461 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -132.26 147.22 52.4 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.121 0.486 . . . . 74.329999999999998 111.699 -177.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 64.5 m -140.74 149.24 41.89 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.637 -0.875 . . . . 71.310000000000002 108.637 176.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -117.9 140.55 49.56 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 116.255 -0.429 . . . . 63.509999999999998 110.326 -176.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -132.23 130.51 41.06 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.421 -0.955 . . . . 43.210000000000001 108.421 176.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 27.0 m -88.61 126.78 35.45 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 120.933 0.397 . . . . 64.430000000000007 111.522 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.77 150.68 25.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.216 -1.031 . . . . 72.019999999999996 108.216 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -66.91 135.02 53.2 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.453 -0.573 . . . . 62.140000000000001 109.453 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 33.4 m -154.17 165.94 16.9 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 107.935 -1.135 . . . . 72.219999999999999 107.935 -177.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -83.42 -18.47 5.87 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 120.979 1.119 . . . . 73.310000000000002 111.394 172.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.444 HH21 ' CD ' ' A' ' 533' ' ' GLU . 25.1 mtp180 -79.17 145.72 65.52 Favored Pre-proline 0 N--CA 1.437 -1.086 0 C-N-CA 124.697 1.199 . . . . 72.219999999999999 109.668 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.5 146.3 97.15 Favored 'Trans proline' 0 C--O 1.25 1.087 0 C-N-CA 123.638 2.892 . . . . 73.519999999999996 115.056 -170.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.91 105.31 0.55 Allowed 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.859 -1.064 . . . . 75.230000000000004 112.012 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 142.51 -26.22 2.28 Favored Glycine 0 C--N 1.308 -1.011 0 N-CA-C 110.656 -0.977 . . . . 74.010000000000005 110.656 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . 0.444 ' CD ' HH21 ' A' ' 529' ' ' ARG . 43.9 tt0 -80.35 136.48 36.4 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 121.227 0.536 . . . . 74.340000000000003 110.182 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 536' ' ' GLY . 8.0 p -98.27 124.78 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.66 0 CA-C-N 115.491 -0.777 . . . . 63.0 109.104 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.43 8.95 40.28 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.827 -1.079 . . . . 63.020000000000003 113.465 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.498 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 127.82 -163.57 21.45 Favored Glycine 0 C--N 1.298 -1.57 0 C-N-CA 120.288 -0.958 . . . . 73.420000000000002 112.703 174.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 28.1 p -116.69 158.94 22.99 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.504 -0.925 . . . . 72.340000000000003 108.504 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -59.87 -57.08 29.46 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 120.134 -0.626 . . . . 60.5 110.352 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -68.81 144.68 60.09 Favored 'Trans proline' 0 C--N 1.376 1.984 0 CA-C-N 120.26 1.128 . . . . 75.5 110.72 173.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.7 157.64 60.87 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 123.063 2.508 . . . . 72.239999999999995 113.506 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.22 130.74 46.79 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.517 -0.765 . . . . 43.350000000000001 110.765 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.82 -12.79 41.89 Favored Glycine 0 C--N 1.303 -1.299 0 CA-C-N 116.025 -0.534 . . . . 72.340000000000003 112.236 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 45.8 m -73.83 125.72 28.79 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 110.174 -0.306 . . . . 74.519999999999996 110.174 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 11.7 t -81.39 124.36 29.34 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.38 -0.97 . . . . 65.25 108.38 176.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.2 m -123.95 159.26 57.18 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 107.903 -1.147 . . . . 75.239999999999995 107.903 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -66.69 137.66 46.59 Favored 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 120.723 0.948 . . . . 75.420000000000002 111.191 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.5 p -63.24 -23.61 33.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.233 -0.894 . . . . 71.450000000000003 112.104 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -101.7 3.17 39.42 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.744 -0.782 . . . . 72.510000000000005 110.194 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 9.9 t -95.86 -178.62 4.43 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 108.619 -0.882 . . . . 64.310000000000002 108.619 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.2 p -103.24 137.24 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 CA-C-O 121.635 0.731 . . . . 74.340000000000003 111.639 -174.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 59.9 mt -98.37 128.24 50.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 106.647 -1.612 . . . . 74.439999999999998 106.647 175.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -103.4 117.5 34.62 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.613 0.72 . . . . 71.329999999999998 112.08 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.7 mp -102.04 130.65 48.66 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.368 -1.287 . . . . 73.310000000000002 110.17 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -93.58 115.85 28.35 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.752 0.787 . . . . 73.340000000000003 112.135 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 40.1 t -88.41 129.77 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 107.281 -1.378 . . . . 54.420000000000002 107.281 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.664 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 2.2 m -84.06 117.74 23.62 Favored 'General case' 0 C--N 1.271 -2.813 0 N-CA-C 108.498 -0.927 . . . . 73.319999999999993 108.498 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -94.32 125.75 39.16 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.77 -1.567 . . . . 72.329999999999998 106.77 171.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -61.85 -23.4 63.37 Favored Glycine 0 C--N 1.308 -1.011 0 N-CA-C 115.014 0.766 . . . . 73.400000000000006 115.014 -173.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 78.08 -20.3 0.39 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.87 1.268 . . . . 74.230000000000004 108.532 -175.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.472 ' H ' ' C ' ' A' ' 558' ' ' GLY . 78.3 mt-30 -112.78 148.17 35.36 Favored 'General case' 0 N--CA 1.403 -2.784 0 CA-C-N 115.376 -0.829 . . . . 75.129999999999995 111.012 -174.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -123.84 154.9 38.96 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 106.205 -1.776 . . . . 64.439999999999998 106.205 175.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 44.2 t -71.96 126.97 33.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 109.314 -0.624 . . . . 65.430000000000007 109.314 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.439 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 51.9 ttp -84.24 127.53 66.0 Favored Pre-proline 0 C--O 1.251 1.153 0 CA-C-N 116.28 -0.418 . . . . 72.030000000000001 110.19 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 11.9 Cg_exo -70.73 169.53 19.92 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.707 2.271 . . . . 65.239999999999995 111.101 175.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -72.53 142.13 48.49 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.381 0.61 . . . . 71.209999999999994 111.321 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.8 pp -154.87 25.9 0.44 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.599 -1.182 . . . . 64.400000000000006 109.624 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 21.7 m -79.58 146.81 32.38 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 115.101 -0.954 . . . . 53.140000000000001 110.372 -177.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 63.72 53.79 35.7 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.116 -0.564 . . . . 71.239999999999995 113.098 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -130.04 173.07 11.08 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.19 -1.041 . . . . 72.409999999999997 108.19 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -108.4 172.29 6.92 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.808 -1.182 . . . . 74.219999999999999 107.808 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . 0.521 ' CZ3' HD22 ' A' ' 587' ' ' LEU . 12.8 t-105 -65.93 -32.27 73.68 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.452 -0.944 . . . . 71.430000000000007 108.452 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.59 -15.1 18.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.537 -0.756 . . . . 73.530000000000001 111.238 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.557 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 25.9 t70 -101.07 -21.56 14.96 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.608 -0.886 . . . . 63.520000000000003 108.608 177.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -68.24 -39.18 82.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.189 -0.914 . . . . 61.530000000000001 111.92 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.644 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 2.7 tm-20 -58.77 -52.31 75.66 Favored Pre-proline 0 CA--C 1.57 1.742 0 N-CA-C 109.283 -0.636 . . . . 60.439999999999998 109.283 177.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 75.1 Cg_exo -55.23 -40.66 84.55 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 121.271 1.314 . . . . 72.349999999999994 112.486 171.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.557 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 16.7 mmt180 -61.62 -38.21 86.81 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 111.906 0.336 . . . . 62.020000000000003 111.906 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.1 pp -66.5 -47.13 73.99 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.969 -0.692 . . . . 40.350000000000001 110.964 -176.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.478 ' N ' HD12 ' A' ' 578' ' ' LEU . 14.7 ptm180 -66.12 -34.85 78.99 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.528 -0.305 . . . . 73.239999999999995 110.696 176.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -65.31 -39.52 92.59 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.823 -0.626 . . . . 45.409999999999997 111.284 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.423 HD11 ' HB2' ' A' ' 583' ' ' TRP . 1.1 pp -92.51 -8.73 43.67 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.01 -0.676 . . . . 71.340000000000003 110.963 -178.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 76.83 42.91 19.4 Favored Glycine 0 CA--C 1.517 0.165 0 N-CA-C 111.53 -0.628 . . . . 51.200000000000003 111.53 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.423 ' HB2' HD11 ' A' ' 581' ' ' LEU . 16.2 t90 -87.22 127.56 35.16 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 123.276 0.63 . . . . 75.400000000000006 110.145 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 5.8 m -103.99 -21.3 13.63 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.064 0.459 . . . . 73.040000000000006 111.557 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -72.56 177.97 39.7 Favored Glycine 0 C--O 1.241 0.567 0 CA-C-O 121.598 0.555 . . . . 73.109999999999999 114.472 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . 0.434 ' O ' HG12 ' A' ' 619' ' ' ILE . 55.7 ttp -95.54 145.6 25.09 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 123.597 0.759 . . . . 61.43 110.654 -177.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . 0.521 HD22 ' CZ3' ' A' ' 571' ' ' TRP . 5.4 tt -85.64 112.44 21.01 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.438 -0.949 . . . . 73.420000000000002 108.438 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 621' ' ' THR . 25.4 t70 -101.83 105.26 16.08 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.686 0.755 . . . . 75.150000000000006 110.324 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.482 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.1 OUTLIER -90.48 133.87 34.75 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 115.033 -0.985 . . . . 74.239999999999995 108.561 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -73.35 -63.35 2.8 Favored Glycine 0 C--N 1.288 -2.106 0 N-CA-C 110.792 -0.923 . . . . 72.430000000000007 110.792 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.16 151.3 45.15 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.462 -0.369 . . . . 45.420000000000002 111.032 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -115.6 123.49 48.57 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 104.41 -2.441 . . . . 71.040000000000006 104.41 168.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 50.7 t -112.64 120.69 63.37 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 CA-C-N 116.007 -0.542 . . . . 52.520000000000003 109.579 -174.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . 0.446 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 21.9 t70 -76.35 106.7 8.12 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 106.385 -1.709 . . . . 70.120000000000005 106.385 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -134.83 8.0 3.51 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.607 -0.437 . . . . 44.439999999999998 111.75 -175.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 117.28 95.68 1.84 Allowed Glycine 0 N--CA 1.422 -2.241 0 C-N-CA 120.194 -1.003 . . . . 50.149999999999999 111.7 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.25 -31.29 59.24 Favored Glycine 0 C--N 1.32 -0.348 0 N-CA-C 111.951 -0.46 . . . . 32.140000000000001 111.951 177.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 46.4 t -59.4 -24.6 63.6 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.185 0.994 . . . . 54.219999999999999 110.669 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -87.33 -4.22 59.05 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.568 -0.742 . . . . 71.230000000000004 111.169 -175.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 39.6 m80 63.7 94.06 0.05 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 122.102 0.953 . . . . 71.219999999999999 111.051 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . 0.494 ' N ' HD22 ' A' ' 601' ' ' ASN . 0.8 OUTLIER -85.28 87.86 7.43 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.967 0.889 . . . . 72.239999999999995 112.215 -173.249 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -90.82 169.93 10.52 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.045 -1.434 . . . . 55.329999999999998 108.996 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.412 HG11 HD12 ' A' ' 622' ' ' LEU . 85.1 t -60.45 129.83 23.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.007 -0.738 . . . . 71.310000000000002 109.007 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 11.7 p -112.79 -35.75 2.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 O-C-N 123.645 0.591 . . . . 51.439999999999998 111.041 -175.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -136.58 139.62 42.28 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.306 -0.406 . . . . 63.149999999999999 110.082 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -137.75 139.2 39.97 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.295 -1.372 . . . . 71.129999999999995 107.295 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -65.7 -52.81 40.54 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 113.125 0.787 . . . . 73.239999999999995 113.125 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 609' ' ' PRO . 34.0 Cg_endo -85.92 125.19 2.69 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 CA-C-N 120.424 1.187 . . . . 53.009999999999998 110.941 176.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 11.6 Cg_exo -70.88 158.99 53.98 Favored 'Trans proline' 0 C--O 1.244 0.823 0 C-N-CA 122.382 2.055 . . . . 72.040000000000006 112.81 178.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.58 130.79 44.14 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 108.488 -0.93 . . . . 70.310000000000002 108.488 175.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 98.18 0.01 58.6 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 120.222 -0.989 . . . . 65.409999999999997 112.084 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 35.6 m -102.17 154.52 18.94 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.421 -0.955 . . . . 75.5 108.421 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -79.45 133.2 12.15 Favored Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 120.914 -0.66 . . . . 54.039999999999999 111.792 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.5 m -117.38 142.36 31.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.922 -0.77 . . . . 71.409999999999997 108.922 176.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.455 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 34.2 p30 -47.55 166.35 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 114.112 1.153 . . . . 64.530000000000001 114.112 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -61.35 -26.03 67.55 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.303 -0.862 . . . . 74.519999999999996 112.626 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -83.46 -10.89 58.08 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 119.037 -1.065 . . . . 72.109999999999999 109.481 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.73 9.77 56.73 Favored Glycine 0 CA--C 1.499 -0.946 0 N-CA-C 111.293 -0.723 . . . . 22.34 111.293 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 586' ' ' MET . 0.0 OUTLIER -70.45 118.83 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.167 0 CA-C-O 122.212 1.006 . . . . 73.129999999999995 108.615 -171.041 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.44 ' O ' HD12 ' A' ' 620' ' ' ILE . 2.7 pp -121.11 132.6 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.872 0 CA-C-N 114.02 -1.445 . . . . 52.439999999999998 110.251 -177.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 15.3 t -104.93 119.35 38.79 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.57 -0.9 . . . . 61.450000000000003 108.57 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.442 HD21 HD21 ' A' ' 587' ' ' LEU . 1.3 pt? -139.49 165.88 26.05 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.4 -0.818 . . . . 61.229999999999997 110.813 -175.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -128.82 142.32 51.01 Favored 'General case' 0 C--O 1.257 1.469 0 CA-C-O 121.279 0.561 . . . . 74.129999999999995 110.458 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -142.0 166.75 23.87 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.186 -1.413 . . . . 53.310000000000002 107.186 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -79.31 -142.94 2.55 Favored Glycine 0 C--N 1.294 -1.785 0 C-N-CA 119.107 -1.52 . . . . 64.340000000000003 113.096 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.446 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 6.5 tp-100 . . . . . 0 C--N 1.279 -2.488 0 N-CA-C 109.294 -0.632 . . . . 60.0 109.294 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.591 0 N-CA-C 110.965 -0.854 . . . . 43.049999999999997 110.965 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -76.75 161.09 33.95 Favored 'Trans proline' 0 C--O 1.245 0.863 0 C-N-CA 122.661 2.24 . . . . 70.540000000000006 110.269 174.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 59.75 21.78 10.59 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.015 0.926 . . . . 73.329999999999998 112.661 176.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 2.0 p -139.21 143.43 38.06 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.675 -0.491 . . . . 75.400000000000006 109.675 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -131.81 143.47 50.22 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 121.197 0.523 . . . . 73.219999999999999 110.546 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 2.3 m-20 -88.32 121.85 31.18 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.897 -1.047 . . . . 72.209999999999994 109.817 -177.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 40.0 pt -86.62 122.56 71.7 Favored Pre-proline 0 C--N 1.302 -1.465 0 CA-C-N 116.318 -0.401 . . . . 71.310000000000002 110.637 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -85.86 -169.57 0.6 Allowed 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.294 1.996 . . . . 73.420000000000002 110.593 177.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -89.5 129.81 35.93 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.569 -0.9 . . . . 75.0 108.569 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.504 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 27.8 m -121.77 7.84 5.85 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 CA-C-N 115.208 -0.905 . . . . 71.129999999999995 109.969 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.97 103.78 4.59 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.397 -0.82 . . . . 74.129999999999995 110.119 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 161.98 -41.39 0.38 Allowed Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 115.517 -0.765 . . . . 44.539999999999999 111.195 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 14.3 pm0 -93.94 -177.51 4.36 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 108.984 -0.747 . . . . 71.540000000000006 108.984 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 7.8 m -70.56 155.4 40.77 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 108.467 -0.938 . . . . 73.340000000000003 108.467 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.472 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 11.5 p -64.87 -42.05 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 O-C-N 123.122 0.264 . . . . 74.530000000000001 110.717 -177.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -62.2 -40.72 97.04 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 109.866 -0.42 . . . . 72.519999999999996 109.866 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 84.4 t -66.14 -47.28 85.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.894 0 CA-C-N 115.271 -0.877 . . . . 60.350000000000001 109.333 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.504 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -60.9 -45.15 95.76 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 111.828 0.307 . . . . 72.439999999999998 111.828 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.5 mt-30 -64.88 -46.76 80.42 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 116.038 -0.528 . . . . 75.420000000000002 111.232 -177.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.515 ' O ' HG23 ' A' ' 514' ' ' VAL . 21.5 ptmt -67.49 -38.84 84.95 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 116.208 -0.451 . . . . 73.530000000000001 110.645 -178.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -62.87 -42.32 99.72 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.186 0.517 . . . . 61.130000000000003 111.15 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -68.71 -41.97 78.34 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.337 -0.847 . . . . 64.25 108.74 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -59.38 -40.84 87.82 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.644 1.178 . . . . 73.209999999999994 111.734 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 510' ' ' LYS . 91.6 t -57.58 -33.18 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 121.173 0.511 . . . . 74.209999999999994 111.507 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -114.84 16.42 17.3 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.621 -0.511 . . . . 73.200000000000003 109.621 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -133.94 -58.46 0.07 OUTLIER Glycine 0 N--CA 1.428 -1.879 0 C-N-CA 119.64 -1.267 . . . . 32.119999999999997 113.618 -173.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 64.07 28.2 14.22 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 122.629 1.204 . . . . 72.319999999999993 111.013 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.2 p -79.61 171.99 14.4 Favored 'General case' 0 N--CA 1.396 -3.137 0 CA-C-N 113.643 -1.617 . . . . 74.409999999999997 108.17 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.535 ' HD2' ' N ' ' A' ' 519' ' ' LYS . 10.2 mptt -107.56 136.06 47.96 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 107.549 -1.278 . . . . 73.530000000000001 107.549 -176.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -133.51 149.24 51.71 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.026 0.441 . . . . 72.099999999999994 112.145 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.7 m -138.73 142.93 38.88 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.076 -1.453 . . . . 63.030000000000001 107.076 174.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -117.54 137.75 52.36 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.62 -0.432 . . . . 72.230000000000004 111.094 -176.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -122.62 119.73 31.64 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.63 -0.878 . . . . 64.219999999999999 108.63 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 12.8 m -96.36 120.34 36.48 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.097 0.475 . . . . 74.109999999999999 111.17 -176.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.7 p -123.82 155.31 30.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.448 -1.316 . . . . 74.430000000000007 107.448 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.443 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 4.3 p30 -75.78 136.42 40.27 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.496 0.665 . . . . 72.510000000000005 111.745 -178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 64.9 m -160.45 159.69 26.06 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 107.047 -1.464 . . . . 52.350000000000001 107.047 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -65.58 -9.77 23.82 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 C-N-CA 122.788 2.326 . . . . 74.219999999999999 113.561 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.449 ' HB2' ' CB ' ' A' ' 556' ' ' SER . 14.7 mmm180 -78.36 141.94 62.21 Favored Pre-proline 0 N--CA 1.436 -1.15 0 N-CA-C 107.27 -1.382 . . . . 72.549999999999997 107.27 176.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -64.43 152.2 82.5 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 C-N-CA 122.862 2.374 . . . . 73.140000000000001 113.958 -173.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.649 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.91 111.15 1.19 Allowed 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.815 -0.629 . . . . 63.539999999999999 111.963 -178.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 123.85 -16.17 7.83 Favored Glycine 0 C--N 1.299 -1.491 0 CA-C-N 115.283 -0.871 . . . . 52.039999999999999 112.121 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.16 138.36 34.74 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.535 -0.542 . . . . 64.150000000000006 109.535 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 6.1 p -87.16 116.84 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 CA-C-O 122.136 0.969 . . . . 74.0 109.48 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.97 -27.31 60.93 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 113.976 -1.466 . . . . 74.219999999999999 109.884 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.51 -162.31 29.54 Favored Glycine 0 N--CA 1.416 -2.651 0 N-CA-C 110.583 -1.007 . . . . 64.400000000000006 110.583 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 5.3 p -117.03 157.7 25.39 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 109.481 -0.563 . . . . 63.420000000000002 109.481 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.484 ' HB2' HE22 ' A' ' 554' ' ' GLN . 7.7 t30 -63.94 -54.14 43.21 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 120.766 -0.374 . . . . 72.450000000000003 110.2 174.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -69.32 134.4 28.81 Favored 'Trans proline' 0 C--N 1.369 1.617 0 N-CA-C 108.679 -1.316 . . . . 72.120000000000005 108.679 170.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.57 155.96 50.12 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 122.437 2.091 . . . . 51.219999999999999 112.93 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.4 131.21 45.86 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.964 -0.562 . . . . 73.510000000000005 109.718 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 106.84 -7.44 38.52 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 111.459 -0.656 . . . . 73.140000000000001 111.459 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 30.1 m -80.9 137.25 36.15 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.842 -0.429 . . . . 70.030000000000001 109.842 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 5.6 t -92.04 128.32 37.84 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 107.819 -1.178 . . . . 73.040000000000006 107.819 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 29.5 m -123.95 154.85 67.83 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 108.74 -0.837 . . . . 62.109999999999999 108.74 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -65.56 137.94 52.46 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 121.054 1.169 . . . . 74.409999999999997 111.269 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.6 -19.76 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-O 122.219 1.009 . . . . 74.340000000000003 109.691 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -84.76 -16.05 42.91 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.148 -1.387 . . . . 71.219999999999999 110.747 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 22.8 t -94.45 -173.29 3.01 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-N 115.869 -0.605 . . . . 71.200000000000003 110.737 -175.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.2 p -118.95 138.15 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 C-N-CA 123.6 0.76 . . . . 75.129999999999995 111.207 -175.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 43.8 mt -95.0 143.9 10.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.509 -0.922 . . . . 42.219999999999999 108.509 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -103.8 117.06 33.46 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.43 -0.952 . . . . 73.450000000000003 108.43 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.95 120.6 41.86 Favored 'General case' 0 C--N 1.311 -1.071 0 O-C-N 123.735 0.647 . . . . 71.439999999999998 110.083 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.484 HE22 ' HB2' ' A' ' 538' ' ' ASN . 2.6 mp0 -90.74 120.96 32.22 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.215 0.531 . . . . 63.340000000000003 109.991 176.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.459 HG22 HG21 ' A' ' 505' ' ' VAL . 23.9 t -105.59 137.22 36.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 108.216 -1.031 . . . . 74.310000000000002 108.216 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.649 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 71.2 m -89.89 133.15 34.92 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-O 120.756 0.312 . . . . 74.299999999999997 110.362 176.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 18.8 ptpt -106.1 127.18 53.01 Favored 'General case' 0 N--CA 1.406 -2.638 0 N-CA-C 104.317 -2.475 . . . . 72.239999999999995 104.317 164.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -55.42 -23.66 35.39 Favored Glycine 0 CA--C 1.506 -0.511 0 O-C-N 124.062 0.851 . . . . 55.140000000000001 114.128 -173.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . 0.443 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 19.6 t-20 81.77 -19.13 0.44 Allowed 'General case' 0 CA--C 1.495 -1.161 0 C-N-CA 126.236 1.815 . . . . 44.25 108.903 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.483 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 85.2 mt-30 -111.83 144.91 40.36 Favored 'General case' 0 N--CA 1.407 -2.59 0 CA-C-N 115.259 -0.882 . . . . 73.209999999999994 110.528 -173.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -123.29 146.67 47.71 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 107.535 -1.284 . . . . 64.209999999999994 107.535 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 84.5 t -62.33 116.63 2.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 123.66 0.6 . . . . 71.400000000000006 109.825 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.415 ' HA ' ' HD3' ' A' ' 564' ' ' PRO . 56.3 ttp -77.59 126.63 84.24 Favored Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 116.387 -0.37 . . . . 50.530000000000001 110.686 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 16.1 Cg_exo -69.45 168.49 21.01 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.5 2.133 . . . . 61.0 110.95 175.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -77.66 132.13 38.07 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 113.122 0.786 . . . . 74.209999999999994 113.122 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.0 pp -140.49 16.21 2.37 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.384 -1.28 . . . . 74.439999999999998 110.07 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 71.3 p -73.89 148.3 42.41 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 116.151 -0.477 . . . . 73.040000000000006 112.227 -175.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 72.97 57.28 5.35 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 115.689 -0.687 . . . . 61.329999999999998 113.987 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -136.93 167.93 20.54 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.115 -0.698 . . . . 72.430000000000007 109.115 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -95.5 165.76 12.19 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.387 -1.338 . . . . 75.5 107.387 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -67.21 -29.04 68.6 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.356 -0.609 . . . . 64.340000000000003 109.356 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.2 p -71.78 -22.81 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.558 0.694 . . . . 71.109999999999999 109.982 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -95.97 -34.29 11.84 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.039 -0.982 . . . . 55.240000000000002 108.936 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -54.7 -53.11 59.24 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 114.973 -1.012 . . . . 73.109999999999999 112.635 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.426 ' HB2' ' HD3' ' A' ' 576' ' ' PRO . 38.2 mt-10 -53.82 -54.95 40.91 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 115.122 1.527 . . . . 71.439999999999998 115.122 -176.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 24.5 Cg_exo -61.83 -28.11 81.17 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.413 1.409 . . . . 53.409999999999997 111.446 175.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -67.98 -35.12 77.82 Favored 'General case' 0 C--O 1.198 -1.646 0 CA-C-O 118.999 -0.524 . . . . 70.420000000000002 111.847 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.592 HD22 ' CE3' ' A' ' 583' ' ' TRP . 16.6 mt -60.25 -48.95 79.55 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.406 -0.59 . . . . 71.319999999999993 109.406 -176.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -66.5 -40.82 89.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.764 -0.653 . . . . 62.420000000000002 111.492 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.76 65.43 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.132 0.492 . . . . 74.239999999999995 111.762 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.7 tp -91.87 -9.11 44.49 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 124.33 1.052 . . . . 65.420000000000002 110.022 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.65 22.35 77.31 Favored Glycine 0 C--N 1.315 -0.588 0 C-N-CA 121.112 -0.566 . . . . 53.229999999999997 112.55 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.592 ' CE3' HD22 ' A' ' 578' ' ' LEU . 16.7 t90 -87.48 127.31 35.23 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.053 -0.721 . . . . 74.120000000000005 109.053 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 14.8 p -100.11 -14.49 18.55 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 113.877 1.066 . . . . 75.540000000000006 113.877 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -80.11 -159.29 18.73 Favored Glycine 0 C--N 1.313 -0.711 0 N-CA-C 114.321 0.488 . . . . 73.319999999999993 114.321 -175.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 65.7 mtt -114.41 139.5 49.45 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.868 0.366 . . . . 71.340000000000003 111.383 -174.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 21.5 tp -80.71 101.88 9.56 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 106.709 -1.589 . . . . 51.200000000000003 106.709 177.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 621' ' ' THR . 31.0 t70 -98.99 117.45 33.54 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.872 -0.331 . . . . 75.219999999999999 111.036 -173.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.0 OUTLIER -91.19 133.44 35.37 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 119.587 -0.845 . . . . 70.409999999999997 110.503 -179.102 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -74.34 -72.99 0.96 Allowed Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 110.798 -0.921 . . . . 42.329999999999998 110.798 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.16 142.28 35.97 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.715 -0.846 . . . . 75.349999999999994 108.715 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -79.88 123.58 27.89 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 107.079 -1.452 . . . . 74.549999999999997 107.079 174.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 50.4 t -104.68 128.28 58.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.398 -1.334 . . . . 72.25 107.398 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -72.01 114.04 9.68 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.768 -0.827 . . . . 54.520000000000003 108.768 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -124.53 -44.29 1.99 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.918 -1.037 . . . . 51.130000000000003 111.0 -173.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 109.08 122.52 4.62 Favored Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.561 -0.828 . . . . 44.32 112.111 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -61.22 -33.63 85.04 Favored Glycine 0 C--N 1.316 -0.548 0 CA-C-N 116.001 -0.1 . . . . 72.310000000000002 113.057 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 22.8 t -70.59 -22.85 62.51 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.94 0.876 . . . . 53.299999999999997 110.377 -177.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -87.12 -1.3 57.79 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.304 -0.862 . . . . 70.540000000000006 108.935 -175.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 69.77 82.63 0.16 Allowed 'General case' 0 CA--C 1.492 -1.274 0 C-N-CA 124.59 1.156 . . . . 73.420000000000002 108.611 -173.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -79.43 79.63 5.87 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 114.16 -1.382 . . . . 75.230000000000004 111.549 -176.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -87.68 173.23 9.15 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.746 -1.57 . . . . 73.209999999999994 108.234 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.489 HG11 HD12 ' A' ' 622' ' ' LEU . 91.1 t -58.68 130.4 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.322 -1.733 . . . . 74.120000000000005 106.322 168.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.2 m -101.57 -29.92 3.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 120.703 -0.399 . . . . 64.510000000000005 111.687 -173.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -155.78 144.55 20.42 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 109.824 -0.436 . . . . 64.329999999999998 109.824 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -135.04 140.73 45.82 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.977 -1.49 . . . . 73.129999999999995 106.977 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.43 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 27.4 t-20 -66.32 -54.82 22.78 Favored Pre-proline 0 C--N 1.312 -1.046 0 C-N-CA 119.647 -0.821 . . . . 75.439999999999998 112.314 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.3 Cg_exo -84.8 119.16 2.17 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 121.996 1.797 . . . . 35.200000000000003 111.388 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.14 160.77 48.1 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 123.048 2.498 . . . . 53.049999999999997 112.252 176.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -68.07 134.94 51.46 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.657 -0.868 . . . . 62.409999999999997 108.657 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.32 -15.09 47.11 Favored Glycine 0 C--N 1.293 -1.81 0 N-CA-C 110.948 -0.861 . . . . 62.340000000000003 110.948 -175.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 37.3 m -92.61 146.77 23.41 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.042 -1.096 . . . . 64.349999999999994 108.042 178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -78.2 130.92 10.47 Favored Glycine 0 N--CA 1.426 -1.995 0 C-N-CA 121.163 -0.541 . . . . 70.439999999999998 112.427 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 26.8 m -114.69 142.12 28.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.829 -1.174 . . . . 65.310000000000002 107.829 176.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.483 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.9 p-10 -50.92 172.85 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.149 0.98 . . . . 64.400000000000006 113.397 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -54.71 -27.14 38.46 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 113.811 1.041 . . . . 74.409999999999997 113.811 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.422 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 1.2 m-20 -94.77 -6.5 42.89 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.17 -0.612 . . . . 62.109999999999999 110.645 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.49 19.19 68.59 Favored Glycine 0 C--O 1.214 -1.118 0 CA-C-O 119.806 -0.441 . . . . 71.140000000000001 113.35 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.72 119.15 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 122.083 0.944 . . . . 64.219999999999999 110.835 -167.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.415 HG22 ' HG2' ' A' ' 608' ' ' PRO . 48.7 pt -125.54 134.98 65.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.89 -1.05 . . . . 43.229999999999997 110.909 -176.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 15.1 t -100.31 125.37 46.52 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 108.461 -0.94 . . . . 73.340000000000003 108.461 177.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 1.8 pt? -139.32 165.27 27.63 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.285 -0.87 . . . . 73.420000000000002 110.288 -175.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -128.81 140.06 51.88 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.64 -0.504 . . . . 71.430000000000007 109.64 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 603' ' ' VAL . 5.2 p90 -130.97 165.16 23.76 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.862 0.363 . . . . 71.519999999999996 111.452 -174.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -76.96 141.89 26.82 Favored Glycine 0 N--CA 1.415 -2.762 0 CA-C-N 114.955 -1.021 . . . . 64.109999999999999 113.604 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 . . . . . 0 C--N 1.272 -2.798 0 N-CA-C 106.98 -1.489 . . . . 72.310000000000002 106.98 178.66 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.431 0 N-CA-C 109.973 -1.251 . . . . 72.420000000000002 109.973 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -68.2 142.09 54.43 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 122.164 1.909 . . . . 62.210000000000001 110.719 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 61.24 21.68 12.12 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.039 0.936 . . . . 72.299999999999997 112.449 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 546' ' ' PRO . 29.5 p -139.84 145.46 38.14 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.572 -0.529 . . . . 54.420000000000002 109.572 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -128.51 137.04 51.57 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 123.396 0.435 . . . . 74.319999999999993 110.305 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.587 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 7.9 p-10 -84.87 124.79 32.02 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.474 0.654 . . . . 54.43 110.099 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 498' ' ' PRO . 37.3 pt -84.89 125.35 71.02 Favored Pre-proline 0 C--N 1.305 -1.357 0 CA-C-N 115.673 -0.694 . . . . 63.350000000000001 111.735 -176.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 497' ' ' ILE . 8.2 Cg_exo -74.44 172.65 15.7 Favored 'Trans proline' 0 C--O 1.254 1.28 0 C-N-CA 122.449 2.099 . . . . 62.340000000000003 111.124 174.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -80.25 105.44 11.52 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.989 -0.55 . . . . 73.319999999999993 109.616 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.432 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 15.4 m -106.87 59.3 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-O 123.24 1.495 . . . . 75.329999999999998 110.308 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -118.0 111.49 19.01 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 112.658 -2.064 . . . . 61.439999999999998 108.127 173.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 136.22 -15.85 3.93 Favored Glycine 0 C--N 1.303 -1.289 0 C-N-CA 119.042 -1.551 . . . . 61.219999999999999 113.937 177.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.469 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.4 OUTLIER -111.39 -175.46 2.71 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 117.695 0.748 . . . . 73.109999999999999 109.231 176.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 10.6 m -71.67 155.0 40.99 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.542 -0.91 . . . . 72.519999999999996 108.542 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.435 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.7 p -61.64 -42.48 94.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 N-CA-C 111.508 0.188 . . . . 73.200000000000003 111.508 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . 0.433 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 25.7 t70 -62.51 -41.63 98.96 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.965 -0.383 . . . . 73.239999999999995 109.965 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 68.0 t -67.46 -41.66 86.3 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.966 0 CA-C-N 115.64 -0.709 . . . . 71.319999999999993 109.476 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.514 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -61.97 -43.51 98.69 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 121.365 -0.134 . . . . 72.340000000000003 111.146 176.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 26.3 mt-30 -64.85 -43.13 94.0 Favored 'General case' 0 CA--C 1.511 -0.539 0 O-C-N 123.089 0.243 . . . . 71.420000000000002 110.811 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.556 ' O ' HG23 ' A' ' 514' ' ' VAL . 75.9 mmtt -63.77 -46.6 84.52 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.586 -0.524 . . . . 64.409999999999997 109.586 176.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -63.57 -38.63 91.84 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.733 -0.667 . . . . 73.349999999999994 111.715 -177.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.71 -45.29 83.31 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.552 -1.277 . . . . 62.240000000000002 107.552 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -59.77 -36.1 75.97 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 124.03 0.932 . . . . 75.030000000000001 110.947 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 510' ' ' LYS . 83.5 t -57.2 -39.5 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 122.875 0.47 . . . . 51.240000000000002 111.317 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -105.0 -8.32 18.63 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.584 0.707 . . . . 73.25 110.012 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -108.43 -59.6 0.54 Allowed Glycine 0 N--CA 1.414 -2.802 0 CA-C-N 115.574 -0.739 . . . . 52.140000000000001 112.836 -169.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 65.44 25.81 11.92 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 122.398 1.094 . . . . 75.219999999999999 109.434 -173.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 547' ' ' VAL . 1.9 p -90.61 -172.99 3.59 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 113.741 -1.572 . . . . 75.510000000000005 110.239 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -108.75 142.05 39.86 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.38 -1.341 . . . . 72.420000000000002 107.38 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -132.44 153.11 51.18 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.11 0.481 . . . . 73.239999999999995 112.278 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 66.7 m -141.4 152.73 44.56 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.169 -1.048 . . . . 74.040000000000006 108.169 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -117.46 126.43 52.61 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.396 0.617 . . . . 60.409999999999997 111.719 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -113.02 130.38 56.17 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.891 -1.151 . . . . 65.129999999999995 107.891 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 18.7 p -103.87 139.58 38.86 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.323 0.582 . . . . 63.039999999999999 112.435 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.0 p -136.64 149.58 26.87 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 107.276 -1.379 . . . . 71.530000000000001 107.276 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 1.6 p-10 -87.61 136.83 32.79 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.93 -0.708 . . . . 73.200000000000003 110.521 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 50.6 m -156.27 163.79 23.67 Favored Pre-proline 0 C--N 1.293 -1.879 0 N-CA-C 106.415 -1.698 . . . . 75.239999999999995 106.415 -178.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.4 10.69 0.7 Allowed 'Trans proline' 0 CA--C 1.558 1.676 0 C-N-CA 121.935 1.757 . . . . 73.430000000000007 114.355 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.459 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 0.0 OUTLIER -96.59 140.99 22.46 Favored Pre-proline 0 C--O 1.214 -0.788 0 N-CA-C 108.686 -0.857 . . . . 74.099999999999994 108.686 177.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.1 145.88 73.15 Favored 'Trans proline' 0 C--O 1.246 0.884 0 C-N-CA 123.251 2.634 . . . . 62.530000000000001 113.643 -176.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -66.83 99.39 0.62 Allowed 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.972 -1.013 . . . . 71.439999999999998 112.781 -174.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 152.3 -26.64 0.88 Allowed Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 115.045 -0.98 . . . . 64.519999999999996 110.734 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -74.39 131.4 41.06 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.687 0.756 . . . . 70.329999999999998 110.831 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.514 HG11 ' CB ' ' A' ' 508' ' ' ALA . 12.4 p -97.97 125.65 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.063 0 N-CA-C 107.33 -1.359 . . . . 73.510000000000005 107.33 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 p -97.59 10.95 38.58 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 115.184 -0.916 . . . . 65.439999999999998 113.024 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.466 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 133.18 -165.77 23.93 Favored Glycine 0 N--CA 1.434 -1.491 0 C-N-CA 119.963 -1.113 . . . . 74.040000000000006 113.448 173.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 14.2 p -116.94 158.4 24.13 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 124.293 1.037 . . . . 53.409999999999997 108.736 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.442 ' HB2' HE22 ' A' ' 554' ' ' GLN . 9.4 t30 -62.14 -50.4 80.38 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 119.31 -0.956 . . . . 61.409999999999997 112.454 178.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -69.17 143.27 53.12 Favored 'Trans proline' 0 C--N 1.367 1.529 0 N-CA-C 108.929 -1.219 . . . . 55.030000000000001 108.929 170.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.94 144.93 89.34 Favored 'Trans proline' 0 C--O 1.253 1.229 0 C-N-CA 122.411 2.074 . . . . 55.43 112.634 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.27 137.51 58.27 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.458 -0.792 . . . . 73.329999999999998 109.629 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 105.52 -12.59 47.17 Favored Glycine 0 C--N 1.304 -1.242 0 N-CA-C 111.48 -0.648 . . . . 63.240000000000002 111.48 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.417 ' O ' HG12 ' A' ' 497' ' ' ILE . 31.9 m -81.03 136.81 36.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.518 0.199 . . . . 61.130000000000003 110.895 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 15.2 t -90.59 128.32 36.55 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 108.214 -1.032 . . . . 41.299999999999997 108.214 173.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.77 153.99 67.0 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 108.907 -0.775 . . . . 52.130000000000003 108.907 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.457 ' HA ' HG22 ' A' ' 494' ' ' THR . 14.9 Cg_endo -60.54 138.19 78.61 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.76 1.64 . . . . 74.420000000000002 111.702 178.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.545 ' HA ' HG22 ' A' ' 518' ' ' THR . 8.7 p -61.27 -19.03 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 CA-C-O 122.177 0.989 . . . . 33.200000000000003 110.552 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -81.12 -15.8 54.87 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.638 -1.165 . . . . 75.540000000000006 111.954 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 77.6 p -92.79 157.96 16.14 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 112.905 0.706 . . . . 64.420000000000002 112.905 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.9 p -98.56 128.15 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 115.261 -0.881 . . . . 75.400000000000006 110.119 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.6 mt -98.95 136.05 31.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.508 -0.769 . . . . 62.100000000000001 109.798 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.88 125.25 50.16 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.889 0.852 . . . . 73.0 111.754 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.63 120.92 39.89 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 113.884 -1.507 . . . . 74.329999999999998 109.128 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.442 HE22 ' HB2' ' A' ' 538' ' ' ASN . 2.6 mp0 -85.7 108.5 18.07 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.731 0.777 . . . . 63.43 112.057 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 16.2 t -90.6 129.84 40.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 114.962 -1.017 . . . . 63.439999999999998 108.307 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 67.7 m -94.69 117.99 31.01 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 109.83 -0.433 . . . . 44.130000000000003 109.83 177.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.401 ' HG2' ' HA ' ' A' ' 526' ' ' ASP . 18.2 ptpt -90.94 136.74 32.87 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.431 -1.692 . . . . 75.120000000000005 106.431 173.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -62.85 -24.39 66.55 Favored Glycine 0 CA--C 1.489 -1.561 0 O-C-N 124.233 0.958 . . . . 65.109999999999999 114.423 -171.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . 0.457 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 31.7 t-20 77.75 -24.99 0.2 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.571 1.148 . . . . 64.239999999999995 109.574 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.444 ' H ' ' C ' ' A' ' 558' ' ' GLY . 86.5 mt-30 -111.46 150.46 29.85 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-N 115.782 -0.645 . . . . 63.399999999999999 111.078 -174.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -132.35 149.86 52.27 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.347 -1.297 . . . . 75.420000000000002 107.622 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 63.2 t -68.25 125.72 26.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 109.833 -0.432 . . . . 71.140000000000001 109.833 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 48.1 ttp -92.18 125.63 55.88 Favored Pre-proline 0 C--N 1.308 -1.233 0 CA-C-N 116.072 -0.513 . . . . 60.210000000000001 111.184 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.81 155.01 71.57 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.957 2.438 . . . . 71.450000000000003 111.027 174.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . 0.524 ' HA ' ' CB ' ' A' ' 610' ' ' ALA . 29.4 t70 -67.03 139.42 57.63 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 114.851 1.426 . . . . 65.519999999999996 114.851 -174.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . 0.417 ' O ' ' HG2' ' A' ' 569' ' ' MET . 2.1 pt? -141.35 15.63 2.21 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.772 -1.103 . . . . 63.43 109.688 176.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 84.2 p -80.06 153.28 28.88 Favored 'General case' 0 C--O 1.251 1.161 0 C-N-CA 120.171 -0.611 . . . . 65.310000000000002 110.571 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 79.08 31.49 42.76 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.856 -0.688 . . . . 52.219999999999999 113.91 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . 0.487 ' SD ' ' HG3' ' A' ' 577' ' ' ARG . 21.5 ptp -134.01 -179.07 5.32 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.795 -0.817 . . . . 24.02 108.795 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -101.82 167.43 10.08 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.275 -1.38 . . . . 74.540000000000006 107.275 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 -67.24 -30.01 69.8 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.678 -0.86 . . . . 73.120000000000005 108.678 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 11.5 p -72.11 -16.83 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 115.395 -0.821 . . . . 74.209999999999994 110.34 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.613 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 18.6 t70 -101.35 -39.16 7.72 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.706 -0.85 . . . . 73.140000000000001 108.706 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -60.7 -42.46 97.23 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 115.034 -0.984 . . . . 55.439999999999998 112.019 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.539 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 39.2 tt0 -55.4 -53.18 64.96 Favored Pre-proline 0 CA--C 1.569 1.701 0 CA-C-O 119.142 -0.456 . . . . 72.010000000000005 111.776 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 71.6 Cg_exo -55.77 -30.33 75.72 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 122.124 1.883 . . . . 74.099999999999994 112.6 171.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 11.4 mmm180 -62.81 -38.29 90.14 Favored 'General case' 0 C--O 1.202 -1.421 0 C-N-CA 120.707 -0.397 . . . . 74.439999999999998 110.816 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.741 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 10.5 mp -58.01 -49.28 77.4 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 118.001 0.364 . . . . 72.409999999999997 110.807 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -66.17 -40.87 90.8 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.62 -0.718 . . . . 72.329999999999998 112.675 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.02 -27.78 64.96 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.898 0.38 . . . . 33.350000000000001 111.735 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 8.3 tp -89.73 -9.36 49.67 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 123.939 0.896 . . . . 55.039999999999999 110.545 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 68.73 32.11 73.9 Favored Glycine 0 C--O 1.243 0.672 0 C-N-CA 120.829 -0.701 . . . . 72.519999999999996 111.995 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.741 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 10.9 t90 -87.03 126.78 34.97 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 107.576 -1.268 . . . . 73.040000000000006 107.576 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 4.2 p -91.78 -27.95 17.68 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 113.031 0.752 . . . . 62.409999999999997 113.031 -174.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -71.7 179.36 34.23 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 116.122 -0.49 . . . . 75.150000000000006 112.878 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 62.6 mtm -107.28 148.8 28.52 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.073 0.463 . . . . 74.340000000000003 111.056 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 29.9 tp -80.63 111.47 17.09 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 107.182 -1.414 . . . . 75.409999999999997 107.182 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.58 ' O ' ' HA ' ' A' ' 621' ' ' THR . 15.3 t70 -97.94 114.92 27.15 Favored 'General case' 0 CA--C 1.485 -1.531 0 CA-C-N 116.086 -0.506 . . . . 74.109999999999999 110.237 -174.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.468 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.1 OUTLIER -91.6 133.45 35.54 Favored 'General case' 0 C--N 1.276 -2.6 0 C-N-CA 119.853 -0.739 . . . . 72.200000000000003 109.399 177.67 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -83.01 -61.77 1.89 Allowed Glycine 0 C--N 1.291 -1.952 0 N-CA-C 109.884 -1.286 . . . . 74.549999999999997 109.884 178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.67 149.45 43.73 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 109.348 -0.612 . . . . 52.549999999999997 109.348 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -90.06 150.14 22.21 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.221 -1.029 . . . . 61.039999999999999 108.221 176.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 19.9 t -117.44 136.7 53.75 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 108.636 -0.876 . . . . 55.200000000000003 108.636 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.59 106.97 5.59 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.709 -1.219 . . . . 54.43 107.709 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -120.42 -61.5 1.57 Allowed 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.618 -0.719 . . . . 75.409999999999997 109.342 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 89.08 151.83 24.84 Favored Glycine 0 N--CA 1.419 -2.457 0 C-N-CA 119.575 -1.298 . . . . 70.319999999999993 111.238 -176.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.4 -33.69 62.34 Favored Glycine 0 C--N 1.3 -1.441 0 N-CA-C 114.649 0.62 . . . . 73.25 114.649 -177.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 32.2 t -73.1 -24.89 60.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.95 0.881 . . . . 75.310000000000002 109.794 -176.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -99.83 -3.38 32.72 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.044 -0.98 . . . . 65.120000000000005 109.645 -177.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 56.6 m80 74.37 126.98 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.201 1.4 . . . . 72.129999999999995 112.677 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -83.74 51.07 1.93 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.249 1.023 . . . . 72.219999999999999 108.987 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.402 ' HE ' ' HB3' ' A' ' 602' ' ' ARG . 37.4 mtp180 -83.91 158.17 21.69 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.729 -1.123 . . . . 52.310000000000002 113.299 -176.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.16 131.73 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 106.136 -1.801 . . . . 61.32 106.136 167.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 44.0 t -97.47 -44.07 12.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-O 121.594 0.712 . . . . 64.519999999999996 109.512 -177.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -154.24 145.38 22.81 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.431 -0.804 . . . . 74.349999999999994 110.167 -176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -126.41 133.58 51.24 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 105.833 -1.914 . . . . 72.519999999999996 105.833 174.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.408 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 65.7 t30 -63.52 -51.09 69.47 Favored Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 112.744 0.646 . . . . 41.100000000000001 112.744 -174.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.5 Cg_exo -87.65 111.15 0.76 Allowed 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 122.002 1.801 . . . . 64.430000000000007 109.815 172.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.92 143.49 45.38 Favored 'Trans proline' 0 C--O 1.247 0.954 0 C-N-CA 122.588 2.192 . . . . 73.0 113.485 -177.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . 0.524 ' CB ' ' HA ' ' A' ' 565' ' ' ASP . . . -65.82 139.85 58.35 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.81 -0.632 . . . . 72.420000000000002 109.737 176.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.45 -9.16 44.96 Favored Glycine 0 C--N 1.301 -1.365 0 N-CA-C 109.578 -1.409 . . . . 43.32 109.578 -172.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 63.0 m -108.67 154.18 22.38 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 108.491 -0.929 . . . . 75.109999999999999 108.491 176.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -72.74 128.54 12.59 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 111.898 -0.481 . . . . 75.430000000000007 111.898 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 30.1 m -112.7 143.14 23.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 123.666 0.786 . . . . 70.310000000000002 109.464 178.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.437 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 9.4 p30 -43.56 167.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 125.492 1.517 . . . . 71.099999999999994 113.259 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -57.29 -25.35 59.13 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 113.907 1.077 . . . . 74.230000000000004 113.907 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -93.04 -7.57 45.33 Favored 'General case' 0 C--O 1.208 -1.103 0 C-N-CA 119.327 -0.949 . . . . 75.120000000000005 108.543 -178.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 68.09 11.7 61.62 Favored Glycine 0 CA--C 1.491 -1.444 0 CA-C-N 115.557 -0.747 . . . . 64.239999999999995 111.788 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.46 118.85 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-O 122.279 1.037 . . . . 51.439999999999998 111.627 -169.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 45.0 pt -121.18 134.33 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 113.8 -1.546 . . . . 51.310000000000002 110.265 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 14.1 t -98.66 131.31 44.94 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 108.035 -1.098 . . . . 73.340000000000003 108.035 177.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -139.36 167.57 21.79 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.863 -0.608 . . . . 71.219999999999999 111.733 -174.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -126.75 136.42 52.4 Favored 'General case' 0 C--O 1.255 1.392 0 N-CA-C 107.228 -1.397 . . . . 71.019999999999996 107.228 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -141.39 163.23 33.5 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.448 -0.342 . . . . 75.420000000000002 110.603 -172.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -76.27 129.43 10.06 Favored Glycine 0 N--CA 1.416 -2.643 0 O-C-N 123.827 0.705 . . . . 63.210000000000001 111.545 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 C--N 1.299 -1.6 0 C-N-CA 123.948 0.899 . . . . 63.240000000000002 109.678 -179.503 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.076 0 N-CA-C 110.087 -1.205 . . . . 43.049999999999997 110.087 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.36 142.56 96.18 Favored 'Trans proline' 0 C--O 1.251 1.125 0 C-N-CA 122.456 2.104 . . . . 42.310000000000002 111.309 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -123.42 46.42 2.21 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.973 -0.558 . . . . 64.239999999999995 110.329 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 25.4 p -130.89 140.32 50.2 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.891 -0.411 . . . . 71.439999999999998 109.891 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.564 ' HD3' ' N ' ' A' ' 496' ' ' ASP . 8.8 tmtm? -150.56 144.22 25.17 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.724 -1.213 . . . . 75.430000000000007 107.724 172.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.564 ' N ' ' HD3' ' A' ' 495' ' ' LYS . 9.6 p-10 -78.58 130.13 35.59 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.48 0.657 . . . . 60.210000000000001 110.808 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 29.3 pt -87.24 133.69 38.17 Favored Pre-proline 0 C--N 1.288 -2.103 0 C-N-CA 120.212 -0.595 . . . . 73.409999999999997 110.331 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -69.52 170.87 15.29 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 121.864 1.709 . . . . 74.120000000000005 111.85 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -78.01 83.23 4.32 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 122.876 1.322 . . . . 73.109999999999999 110.626 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.434 ' HB ' ' CB ' ' A' ' 508' ' ' ALA . 26.9 m -86.73 -6.82 10.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 114.399 -1.273 . . . . 72.129999999999995 112.268 -177.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -73.67 101.85 3.76 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.817 -0.809 . . . . 61.299999999999997 108.817 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 157.18 -38.54 0.56 Allowed Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.799 -0.715 . . . . 50.450000000000003 111.89 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 17.4 pm0 -97.54 -168.02 1.62 Allowed 'General case' 0 C--O 1.243 0.738 0 C-N-CA 120.761 -0.376 . . . . 63.409999999999997 110.006 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.402 ' HB ' HG23 ' A' ' 507' ' ' VAL . 14.5 m -70.15 155.35 40.76 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.21 -0.663 . . . . 74.549999999999997 109.21 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.427 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.3 p -63.18 -41.45 92.86 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.547 0 O-C-N 123.302 0.376 . . . . 65.510000000000005 110.72 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 18.7 t70 -59.84 -42.91 94.64 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 120.891 0.377 . . . . 63.0 110.04 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.402 HG23 ' HB ' ' A' ' 504' ' ' THR . 61.6 t -68.32 -45.42 82.58 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.622 0 CA-C-N 115.352 -0.84 . . . . 62.409999999999997 109.226 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.434 ' CB ' ' HB ' ' A' ' 500' ' ' VAL . . . -58.83 -45.38 90.15 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 120.638 0.256 . . . . 75.510000000000005 111.006 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.0 mt-30 -64.12 -45.64 87.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.972 -0.558 . . . . 72.430000000000007 111.237 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.563 ' O ' HG23 ' A' ' 514' ' ' VAL 0.314 0.0 OUTLIER -67.32 -37.65 83.66 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 119.632 -0.827 . . . . 73.140000000000001 111.607 177.353 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . 0.456 ' N ' ' HD3' ' A' ' 510' ' ' LYS . 7.9 m-20 -60.45 -50.2 74.53 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-N 116.276 -0.42 . . . . 62.509999999999998 110.723 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.451 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -68.05 -36.25 79.56 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.937 -0.574 . . . . 71.019999999999996 111.239 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.451 ' N ' HD12 ' A' ' 512' ' ' LEU . 1.5 t-20 -65.9 -38.43 88.73 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 122.999 0.52 . . . . 41.340000000000003 110.528 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 510' ' ' LYS . 78.2 t -59.59 -32.98 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.093 0.473 . . . . 64.019999999999996 111.102 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -111.54 16.35 20.73 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.881 -0.328 . . . . 74.239999999999995 110.275 -177.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -143.01 -53.83 0.03 OUTLIER Glycine 0 CA--C 1.488 -1.62 0 C-N-CA 119.421 -1.371 . . . . 43.049999999999997 113.826 -173.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 61.46 39.37 15.09 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 122.652 1.215 . . . . 74.430000000000007 108.899 -174.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.711 HG22 ' HA ' ' A' ' 547' ' ' VAL . 20.3 p -91.23 -172.24 3.23 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 112.814 -1.994 . . . . 65.450000000000003 109.3 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.5 142.38 39.0 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.393 -1.336 . . . . 71.230000000000004 107.393 176.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -131.53 152.05 51.07 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.401 0.619 . . . . 74.219999999999999 112.244 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 20.4 p -140.29 146.42 38.52 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 107.962 -1.125 . . . . 71.099999999999994 107.962 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -119.79 129.47 54.47 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.237 -0.585 . . . . 74.349999999999994 110.942 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -121.01 118.7 30.5 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.945 -0.761 . . . . 72.019999999999996 108.945 -178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 19.8 m -90.78 137.09 32.63 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.132 0.491 . . . . 53.420000000000002 111.895 -176.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 47.2 t -128.89 149.06 33.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 105.793 -1.929 . . . . 62.210000000000001 105.793 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.1 135.68 36.38 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 118.327 0.512 . . . . 63.539999999999999 110.941 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 42.9 m -159.46 169.75 9.92 Favored Pre-proline 0 C--N 1.31 -1.151 0 N-CA-C 107.623 -1.251 . . . . 52.240000000000002 107.623 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -73.12 -13.78 25.97 Favored 'Trans proline' 0 C--O 1.25 1.078 0 C-N-CA 122.004 1.803 . . . . 73.430000000000007 112.838 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.516 ' HD3' ' OE2' ' A' ' 533' ' ' GLU . 48.6 mtt180 -73.35 143.05 82.41 Favored Pre-proline 0 N--CA 1.442 -0.825 0 N-CA-C 108.988 -0.745 . . . . 74.129999999999995 108.988 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.71 144.6 97.36 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 122.5 2.133 . . . . 74.329999999999998 112.034 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.642 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.78 99.21 0.08 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.367 -0.833 . . . . 62.420000000000002 111.762 -178.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 153.56 -22.4 0.73 Allowed Glycine 0 N--CA 1.423 -2.185 0 C-N-CA 120.573 -0.823 . . . . 53.140000000000001 112.154 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . 0.516 ' OE2' ' HD3' ' A' ' 529' ' ' ARG . 32.6 tt0 -79.99 138.35 37.03 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 117.239 0.52 . . . . 74.040000000000006 109.97 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 5.1 p -91.97 113.2 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 N-CA-C 108.502 -0.925 . . . . 74.310000000000002 108.502 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.54 -33.25 73.78 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 114.199 -1.364 . . . . 72.420000000000002 110.189 -177.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 167.91 177.78 39.44 Favored Glycine 0 N--CA 1.42 -2.401 0 CA-C-N 115.089 -0.959 . . . . 63.329999999999998 110.959 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . 0.425 HG22 HD13 ' A' ' 553' ' ' LEU . 10.0 p -118.1 153.83 33.11 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 108.502 -0.925 . . . . 71.519999999999996 108.502 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -72.32 -48.01 10.08 Favored Pre-proline 0 C--N 1.318 -0.784 0 C-N-CA 118.235 -1.386 . . . . 75.340000000000003 110.246 173.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 32.3 Cg_exo -62.52 131.5 34.03 Favored 'Trans proline' 0 C--N 1.381 2.274 0 N-CA-C 108.529 -1.373 . . . . 61.299999999999997 108.529 169.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 8.3 Cg_exo -69.01 139.97 44.24 Favored 'Trans proline' 0 C--O 1.242 0.716 0 C-N-CA 122.184 1.923 . . . . 75.319999999999993 114.732 -173.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -68.66 133.66 48.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.93 -1.032 . . . . 65.510000000000005 110.415 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 91.16 -19.29 47.45 Favored Glycine 0 C--N 1.306 -1.115 0 N-CA-C 110.839 -0.904 . . . . 53.420000000000002 110.839 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 27.2 m -87.82 139.46 30.5 Favored 'General case' 0 N--CA 1.413 -2.324 0 C-N-CA 123.623 0.769 . . . . 74.310000000000002 110.555 -175.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 3.4 t -72.45 124.6 25.51 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.662 -0.699 . . . . 64.239999999999995 109.323 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.72 163.82 36.68 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 107.236 -1.394 . . . . 73.340000000000003 107.236 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -76.46 135.3 16.32 Favored 'Trans proline' 0 N--CA 1.423 -2.642 0 CA-C-N 120.004 1.037 . . . . 72.099999999999994 111.715 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.711 ' HA ' HG22 ' A' ' 518' ' ' THR . 35.3 t -67.53 -24.91 31.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 CA-C-N 114.122 -1.399 . . . . 61.43 110.46 176.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -78.19 -17.86 56.23 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.441 -1.254 . . . . 73.450000000000003 111.509 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 94.6 p -90.82 177.38 6.32 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.637 -0.425 . . . . 73.150000000000006 110.993 -177.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 12.9 p -109.07 126.31 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.831 0 CA-C-O 121.75 0.786 . . . . 72.209999999999994 109.908 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 63.1 mt -86.11 129.45 38.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 108.794 -0.817 . . . . 63.049999999999997 108.794 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -103.79 117.32 34.08 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.718 0.771 . . . . 75.140000000000001 110.664 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.425 HD13 HG22 ' A' ' 537' ' ' THR . 2.7 mm? -95.45 114.03 25.75 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 113.653 -1.612 . . . . 73.049999999999997 108.218 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -84.32 116.39 22.99 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.922 -0.77 . . . . 74.120000000000005 108.922 176.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 524' ' ' SER . 23.9 t -104.15 131.79 52.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 CA-C-N 115.099 -0.955 . . . . 61.130000000000003 109.244 -175.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 74.1 m -84.76 122.22 28.8 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 109.621 -0.511 . . . . 43.130000000000003 109.621 175.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.0 ptpt -93.49 141.25 28.68 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 104.672 -2.344 . . . . 74.219999999999999 104.672 169.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.584 ' O ' ' HG3' ' A' ' 560' ' ' GLN . . . -66.46 -27.17 72.95 Favored Glycine 0 CA--C 1.488 -1.649 0 C-N-CA 120.138 -1.03 . . . . 44.340000000000003 110.652 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 64.4 t30 65.27 11.84 7.58 Favored 'General case' 0 C--O 1.216 -0.689 0 C-N-CA 124.697 1.199 . . . . 63.210000000000001 109.885 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.584 ' HG3' ' O ' ' A' ' 558' ' ' GLY . 40.9 mt-30 -124.68 142.85 51.09 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 115.478 -0.783 . . . . 51.439999999999998 109.21 -176.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . 0.407 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 53.6 p90 -123.34 148.24 46.21 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.389 -0.967 . . . . 71.120000000000005 108.389 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.1 122.14 14.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.144 0.497 . . . . 72.25 111.002 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.432 ' SD ' HD13 ' A' ' 620' ' ' ILE . 56.9 ttp -97.45 122.43 55.58 Favored Pre-proline 0 C--N 1.31 -1.133 0 CA-C-N 115.885 -0.598 . . . . 74.230000000000004 110.953 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -68.15 169.81 15.88 Favored 'Trans proline' 0 C--O 1.241 0.661 0 C-N-CA 123.065 2.51 . . . . 72.040000000000006 110.843 172.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . 0.443 ' HB3' ' HB2' ' A' ' 610' ' ' ALA . 5.8 p-10 -77.6 142.42 38.95 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.138 0.494 . . . . 75.120000000000005 110.569 -178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . 0.461 ' O ' ' HG2' ' A' ' 569' ' ' MET . 2.0 pt? -126.69 5.29 6.73 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 122.206 1.003 . . . . 73.209999999999994 108.91 174.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . 0.485 ' HA ' ' HB ' ' A' ' 603' ' ' VAL . 29.0 t -79.44 140.62 37.31 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 107.808 -1.182 . . . . 64.200000000000003 107.808 176.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 99.39 -2.46 57.6 Favored Glycine 0 C--N 1.302 -1.314 0 C-N-CA 120.018 -1.086 . . . . 74.109999999999999 112.878 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 24.0 ptp -120.06 169.35 10.29 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.561 -0.903 . . . . 73.340000000000003 108.561 177.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -92.59 171.59 8.92 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.004 -1.11 . . . . 70.420000000000002 108.004 -174.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -62.44 -32.87 73.79 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.69 -0.856 . . . . 74.129999999999995 108.69 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 30.7 m -68.9 -12.88 16.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 CA-C-N 116.076 -0.511 . . . . 43.140000000000001 112.107 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -102.27 -43.91 5.57 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 110.033 -0.358 . . . . 75.25 110.033 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -61.32 -39.5 90.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.799 -0.637 . . . . 74.109999999999999 112.235 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.658 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 44.0 tt0 -63.16 -53.36 54.87 Favored Pre-proline 0 CA--C 1.561 1.382 0 CA-C-N 116.622 -0.263 . . . . 74.120000000000005 111.494 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 92.7 Cg_exo -54.14 -40.43 81.87 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 121.547 1.498 . . . . 75.329999999999998 112.315 171.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.423 ' HA ' ' HE ' ' A' ' 577' ' ' ARG . 0.3 OUTLIER -59.24 -42.49 91.2 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.479 0.18 . . . . 64.319999999999993 110.634 178.428 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.5 pp -66.17 -46.85 75.94 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 120.359 -0.536 . . . . 62.229999999999997 111.716 -175.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.451 ' N ' HD12 ' A' ' 578' ' ' LEU . 1.7 ptm180 -66.24 -36.23 82.46 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.792 -0.64 . . . . 64.329999999999998 111.563 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -71.17 -37.99 72.18 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 112.367 0.506 . . . . 63.310000000000002 112.367 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.0 pp -80.65 -8.66 59.7 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.22 0.533 . . . . 72.430000000000007 110.496 -176.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 85.6 32.55 18.65 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 115.46 -0.791 . . . . 71.120000000000005 112.509 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -77.02 126.2 30.57 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 107.197 -1.408 . . . . 73.439999999999998 107.197 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 2.1 p -106.08 6.42 31.07 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 112.833 0.679 . . . . 54.109999999999999 112.833 -175.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -95.68 -152.96 29.68 Favored Glycine 0 N--CA 1.436 -1.338 0 N-CA-C 110.723 -0.951 . . . . 73.430000000000007 110.723 174.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 57.6 ttp -136.87 147.0 46.23 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.03 -1.1 . . . . 71.109999999999999 108.03 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . 0.448 HD21 HD11 ' A' ' 622' ' ' LEU . 6.0 tt -80.16 118.34 21.77 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.494 -0.928 . . . . 62.299999999999997 108.494 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 621' ' ' THR . 26.5 t70 -98.76 120.61 39.48 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.641 -0.708 . . . . 71.340000000000003 109.332 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.485 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.1 OUTLIER -98.5 133.21 43.18 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 119.194 -1.002 . . . . 73.310000000000002 108.724 176.447 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -85.2 -51.64 3.67 Favored Glycine 0 C--N 1.284 -2.35 0 N-CA-C 109.616 -1.394 . . . . 71.209999999999994 109.616 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -134.81 117.69 16.2 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 109.362 -0.607 . . . . 62.420000000000002 109.362 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -105.31 123.84 48.53 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.712 -1.218 . . . . 62.43 107.712 173.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 53.9 t -112.09 129.34 67.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 109.087 -0.708 . . . . 55.329999999999998 109.087 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . 0.42 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 23.3 t70 -72.67 114.47 10.84 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 108.798 -0.816 . . . . 61.310000000000002 108.798 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -124.27 -57.41 1.59 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.572 -0.74 . . . . 55.340000000000003 109.843 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 106.53 151.16 18.47 Favored Glycine 0 N--CA 1.423 -2.222 0 C-N-CA 120.062 -1.066 . . . . 60.310000000000002 110.863 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.498 ' HA2' ' OD1' ' A' ' 601' ' ' ASN . . . -58.77 -33.99 75.43 Favored Glycine 0 C--N 1.311 -0.811 0 N-CA-C 115.038 0.775 . . . . 43.32 115.038 -177.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 11.3 t -74.83 -23.91 58.53 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 122.125 0.964 . . . . 74.019999999999996 109.117 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -89.84 0.18 57.19 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.822 -1.081 . . . . 73.439999999999998 110.301 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 27.3 m170 78.41 85.67 0.07 Allowed 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 125.821 1.648 . . . . 60.310000000000002 109.789 -177.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . 0.498 ' OD1' ' HA2' ' A' ' 597' ' ' GLY . 26.0 p-10 -89.15 58.91 4.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 122.987 1.375 . . . . 75.239999999999995 110.428 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -97.16 163.59 12.86 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.893 -1.503 . . . . 74.310000000000002 108.431 -178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.485 ' HB ' ' HA ' ' A' ' 567' ' ' SER . 92.8 t -70.17 130.52 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 104.74 -2.318 . . . . 71.129999999999995 104.74 168.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 13.4 p -103.11 -35.52 3.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 121.289 0.566 . . . . 73.530000000000001 111.133 -173.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -146.1 134.62 22.05 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 109.147 -0.686 . . . . 74.150000000000006 109.147 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -115.78 131.93 56.79 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.402 -1.703 . . . . 74.150000000000006 106.402 174.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.453 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 20.8 t-20 -58.25 -51.7 79.87 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 112.376 0.51 . . . . 73.209999999999994 112.376 -175.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.1 Cg_endo -87.13 118.97 1.44 Allowed 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.234 1.289 . . . . 74.230000000000004 109.494 172.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -64.56 159.71 43.39 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 122.549 2.166 . . . . 64.299999999999997 111.906 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 565' ' ' ASP . . . -60.9 135.23 57.72 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.174 -0.466 . . . . 71.409999999999997 110.415 177.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.43 -11.94 47.3 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 111.35 -0.7 . . . . 73.129999999999995 111.35 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 34.2 m -82.1 136.75 35.14 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.592 -0.521 . . . . 75.530000000000001 109.592 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -77.33 123.13 6.36 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 110.271 -1.131 . . . . 63.020000000000003 110.271 175.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.6 m -113.62 142.38 26.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 109.643 -0.503 . . . . 64.120000000000005 109.643 178.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 559' ' ' ASN . 29.9 p30 -48.59 164.62 0.06 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.176 1.176 . . . . 74.040000000000006 114.176 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -57.74 -27.9 63.42 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.788 0.835 . . . . 72.329999999999998 112.629 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.444 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 4.4 p-10 -90.24 -9.37 48.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 119.486 -0.885 . . . . 72.430000000000007 110.459 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.11 14.86 62.1 Favored Glycine 0 CA--C 1.49 -1.503 0 C-N-CA 124.065 0.841 . . . . 61.340000000000003 114.685 163.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.05 117.66 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 CA-C-O 122.566 1.174 . . . . 44.140000000000001 110.869 -167.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.432 HD13 ' SD ' ' A' ' 563' ' ' MET . 49.3 pt -129.81 135.28 61.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 113.755 -1.566 . . . . 71.239999999999995 110.37 -177.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 13.8 t -99.21 129.87 45.48 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 108.235 -1.024 . . . . 75.319999999999993 108.235 177.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.448 HD11 HD21 ' A' ' 587' ' ' LEU . 4.0 pp -138.76 167.13 22.65 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 116.136 -0.484 . . . . 75.340000000000003 111.462 -178.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -128.09 136.33 51.04 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.808 -0.812 . . . . 71.420000000000002 108.808 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.422 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 18.8 p90 -142.55 165.58 27.02 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 116.187 -0.46 . . . . 75.120000000000005 111.827 -172.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -86.73 132.47 11.17 Favored Glycine 0 N--CA 1.42 -2.407 0 N-CA-C 109.221 -1.552 . . . . 40.229999999999997 109.221 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.42 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 9.9 tt0 . . . . . 0 C--N 1.279 -2.463 0 C-N-CA 123.066 0.547 . . . . 38.009999999999998 109.593 -178.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.487 0 N-CA-C 109.709 -1.356 . . . . 51.030000000000001 109.709 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -67.63 142.63 59.28 Favored 'Trans proline' 0 C--O 1.239 0.571 0 C-N-CA 122.226 1.951 . . . . 64.129999999999995 110.894 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -115.88 11.11 15.44 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.599 0.714 . . . . 72.510000000000005 109.899 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 13.0 p -129.96 155.32 46.26 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 115.53 -0.759 . . . . 72.230000000000004 110.827 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -143.11 146.36 33.7 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.426 -0.806 . . . . 53.329999999999998 109.758 176.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.565 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.1 p-10 -91.56 140.03 30.12 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.094 -0.706 . . . . 73.019999999999996 109.094 177.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.4 pt -96.53 124.6 50.24 Favored Pre-proline 0 C--N 1.298 -1.664 0 CA-C-N 115.673 -0.694 . . . . 70.209999999999994 110.467 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -66.76 157.5 60.85 Favored 'Trans proline' 0 C--O 1.245 0.829 0 C-N-CA 122.475 2.117 . . . . 65.239999999999995 111.843 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.429 ' HA ' ' HB1' ' A' ' 541' ' ' ALA . 27.1 t70 -77.65 99.98 6.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.587 0.708 . . . . 63.210000000000001 109.704 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 30.3 m -105.63 11.14 8.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 114.96 -1.018 . . . . 74.120000000000005 112.169 -175.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -80.01 96.96 6.59 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.036 0.445 . . . . 53.310000000000002 110.798 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 162.38 -40.93 0.37 Allowed Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.777 -0.725 . . . . 74.319999999999993 111.914 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 16.1 pm0 -90.77 -171.89 3.19 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 110.251 -0.277 . . . . 74.549999999999997 110.251 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 28.1 m -70.1 155.0 41.23 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.818 -0.808 . . . . 52.210000000000001 108.818 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.42 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.2 p -62.48 -41.63 92.62 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 O-C-N 123.075 0.235 . . . . 44.439999999999998 110.722 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -59.4 -40.83 87.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.385 0.612 . . . . 74.299999999999997 109.645 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.436 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 75.4 t -71.88 -45.95 62.61 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.608 0 CA-C-N 115.292 -0.867 . . . . 74.109999999999999 110.057 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.463 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -58.85 -44.34 90.99 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 111.917 0.34 . . . . 73.209999999999994 111.917 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.6 mt-30 -62.42 -45.79 91.53 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.295 -0.411 . . . . 43.32 110.957 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.568 ' O ' HG23 ' A' ' 514' ' ' VAL . 16.6 ptpt -67.97 -38.82 83.19 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 120.486 -0.485 . . . . 75.299999999999997 110.175 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -60.84 -47.36 86.7 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 116.056 -0.52 . . . . 74.340000000000003 110.86 -177.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 513' ' ' ASN . 3.9 pp -68.48 -35.73 77.95 Favored 'General case' 0 C--O 1.211 -0.923 0 CA-C-N 115.863 -0.608 . . . . 64.200000000000003 111.154 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.48 ' N ' HD12 ' A' ' 512' ' ' LEU . 4.1 t-20 -66.02 -34.86 79.06 Favored 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 123.287 0.635 . . . . 74.219999999999999 111.99 -178.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 510' ' ' LYS . 89.1 t -57.0 -32.42 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 121.491 0.663 . . . . 65.409999999999997 110.354 177.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -114.45 17.26 17.5 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.757 -0.656 . . . . 70.140000000000001 109.666 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -138.09 -55.03 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 119.923 -1.132 . . . . 63.210000000000001 113.57 -174.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 66.87 17.85 10.58 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.277 1.037 . . . . 73.349999999999994 109.922 -176.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 1.7 p -78.13 -170.7 2.06 Favored 'General case' 0 N--CA 1.411 -2.401 0 C-N-CA 125.481 1.512 . . . . 65.319999999999993 111.492 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -108.24 143.12 37.5 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.013 -1.477 . . . . 74.230000000000004 107.013 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -132.7 150.43 52.16 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.242 -0.583 . . . . 74.450000000000003 111.938 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 50.2 m -140.83 146.29 37.37 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.98 -1.489 . . . . 71.409999999999997 106.98 175.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -118.08 136.01 53.83 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 120.13 -0.628 . . . . 74.010000000000005 110.104 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -130.29 131.95 45.67 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.624 -0.88 . . . . 55.100000000000001 108.624 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 73.1 m -100.18 131.36 46.17 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.542 0.687 . . . . 71.019999999999996 112.596 -178.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 556' ' ' SER . 7.4 p -121.78 149.27 25.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.373 -1.714 . . . . 72.519999999999996 106.373 176.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -76.83 135.63 38.9 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 121.49 0.662 . . . . 61.219999999999999 111.674 -176.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 50.3 m -162.79 156.09 17.0 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 106.338 -1.727 . . . . 61.32 106.338 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -63.93 -3.12 5.35 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 122.762 2.308 . . . . 74.239999999999995 114.288 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -80.12 136.58 53.62 Favored Pre-proline 0 CA--C 1.51 -0.587 0 N-CA-C 106.967 -1.494 . . . . 65.540000000000006 106.967 176.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -61.6 147.94 94.2 Favored 'Trans proline' 0 C--O 1.256 1.382 0 C-N-CA 122.343 2.028 . . . . 50.310000000000002 112.701 -175.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -56.61 115.89 2.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.292 -0.867 . . . . 61.509999999999998 110.88 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 134.21 -27.78 3.24 Favored Glycine 0 N--CA 1.434 -1.436 0 C-N-CA 120.825 -0.703 . . . . 45.329999999999998 111.643 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -80.85 135.68 35.97 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-O 121.254 0.549 . . . . 74.329999999999998 110.295 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.463 HG11 ' CB ' ' A' ' 508' ' ' ALA . 7.2 p -96.67 120.78 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.722 0 N-CA-C 107.702 -1.221 . . . . 73.129999999999995 107.702 178.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 6.2 p -97.74 -1.23 43.85 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.167 -0.924 . . . . 74.530000000000001 113.132 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 163.23 -166.56 37.13 Favored Glycine 0 N--CA 1.423 -2.219 0 C-N-CA 120.278 -0.963 . . . . 53.240000000000002 111.52 176.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 2.4 p -135.39 152.91 51.87 Favored 'General case' 0 C--N 1.273 -2.746 0 N-CA-C 107.866 -1.161 . . . . 65.439999999999998 107.866 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.48 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 62.0 t30 -58.29 -50.83 85.93 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 119.834 -0.747 . . . . 72.239999999999995 111.201 175.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 4.8 Cg_exo -81.36 128.47 6.27 Favored 'Trans proline' 0 C--N 1.37 1.676 0 N-CA-C 107.568 -1.743 . . . . 44.109999999999999 107.568 168.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.38 140.31 88.41 Favored 'Trans proline' 0 C--O 1.245 0.846 0 C-N-CA 122.42 2.08 . . . . 75.099999999999994 113.04 -176.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' A' ' 499' ' ' ASP . . . -64.82 138.65 58.51 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.91 -0.587 . . . . 71.549999999999997 110.122 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.72 -11.58 57.8 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 120.752 -0.737 . . . . 71.150000000000006 111.294 -176.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 18.4 m -88.32 137.49 32.28 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.167 -0.309 . . . . 75.530000000000001 110.167 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 13.3 t -81.16 129.79 34.73 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 109.233 -0.655 . . . . 51.100000000000001 109.233 173.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.5 m -123.83 164.13 30.95 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 107.315 -1.365 . . . . 73.519999999999996 107.315 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -68.23 139.38 45.88 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 120.936 1.09 . . . . 63.030000000000001 110.646 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.8 p -62.6 -20.3 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 CA-C-N 115.696 -0.684 . . . . 70.120000000000005 112.296 -175.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -93.31 -7.35 45.14 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.757 0.313 . . . . 54.399999999999999 110.916 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 69.9 m -82.06 165.69 20.4 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.697 0.761 . . . . 73.540000000000006 112.624 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.2 p -102.31 137.7 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.292 0 CA-C-N 114.697 -1.138 . . . . 54.140000000000001 109.554 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 60.2 mt -101.96 132.38 48.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 108.076 -1.083 . . . . 63.399999999999999 108.076 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -102.8 117.95 35.75 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.218 0.532 . . . . 61.409999999999997 110.541 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.421 HD12 HG21 ' A' ' 534' ' ' VAL . 3.6 mm? -88.31 114.47 24.97 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.394 -1.275 . . . . 72.310000000000002 108.522 178.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -83.27 101.7 11.45 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.226 -1.028 . . . . 74.409999999999997 108.226 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 524' ' ' SER . 17.2 t -96.06 144.18 10.72 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 107.541 -1.281 . . . . 73.310000000000002 107.541 -177.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 67.9 m -97.8 133.82 41.79 Favored 'General case' 0 N--CA 1.394 -3.245 0 C-N-CA 119.444 -0.902 . . . . 65.040000000000006 110.694 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -97.5 129.5 44.67 Favored 'General case' 0 N--CA 1.405 -2.706 0 N-CA-C 103.882 -2.636 . . . . 63.420000000000002 103.882 168.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -60.47 -23.92 61.02 Favored Glycine 0 CA--C 1.49 -1.507 0 O-C-N 123.923 0.764 . . . . 62.119999999999997 113.599 -173.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 79.95 -15.54 0.74 Allowed 'General case' 0 C--O 1.211 -0.967 0 C-N-CA 124.946 1.298 . . . . 71.430000000000007 107.87 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.469 ' H ' ' C ' ' A' ' 558' ' ' GLY . 92.7 mt-30 -112.62 145.04 41.09 Favored 'General case' 0 N--CA 1.402 -2.832 0 CA-C-N 114.71 -1.132 . . . . 73.200000000000003 110.496 -175.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . 0.43 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 48.5 p90 -123.84 154.53 39.49 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 107.193 -1.41 . . . . 71.010000000000005 107.193 177.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.25 121.89 16.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.018 0.437 . . . . 70.450000000000003 110.864 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.617 ' SD ' HG21 ' A' ' 620' ' ' ILE . 47.4 ttp -79.23 122.73 84.53 Favored Pre-proline 0 C--N 1.316 -0.86 0 N-CA-C 109.653 -0.499 . . . . 63.539999999999999 109.653 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.77 169.62 20.71 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.214 1.942 . . . . 72.310000000000002 111.006 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -72.01 118.18 14.55 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.536 0.684 . . . . 54.140000000000001 110.424 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.9 pp -136.11 11.55 3.32 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.206 -0.907 . . . . 75.120000000000005 110.477 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 2.2 t -80.24 144.15 33.14 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.318 -0.855 . . . . 65.340000000000003 109.985 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 80.82 70.01 1.36 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.643 -0.789 . . . . 42.140000000000001 113.58 175.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -163.91 179.85 6.76 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.345 -1.354 . . . . 72.349999999999994 107.345 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . 0.457 ' HB2' HG12 ' A' ' 572' ' ' VAL . 26.1 m-85 -95.14 176.4 6.24 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.567 -0.531 . . . . 71.5 109.567 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . 0.554 ' CZ3' HD22 ' A' ' 587' ' ' LEU . 11.6 t-105 -71.56 -28.1 63.62 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.989 -1.486 . . . . 74.409999999999997 106.989 175.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 570' ' ' PHE . 9.0 p -71.61 -6.72 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-N 115.429 -0.805 . . . . 72.310000000000002 110.264 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 6.7 m-20 -101.11 -45.06 5.5 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.341 -0.985 . . . . 65.120000000000005 108.341 171.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -63.21 -46.0 89.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.331 -0.849 . . . . 72.319999999999993 113.25 -176.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.501 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 31.4 tt0 -64.19 -49.94 70.69 Favored Pre-proline 0 CA--C 1.561 1.376 0 N-CA-C 111.838 0.31 . . . . 74.519999999999996 111.838 -177.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 51.5 Cg_exo -61.1 -34.42 89.7 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.675 1.583 . . . . 75.439999999999998 112.279 174.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 30.6 mmm180 -68.98 -33.97 74.55 Favored 'General case' 0 C--O 1.216 -0.663 0 C-N-CA 120.147 -0.621 . . . . 75.200000000000003 110.625 176.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.523 ' HG ' ' HB3' ' A' ' 583' ' ' TRP . 5.4 tt -60.41 -48.87 79.89 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.348 0.659 . . . . 74.510000000000005 109.363 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 576' ' ' PRO . 7.7 ptm180 -66.25 -41.09 90.44 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.914 0.339 . . . . 73.439999999999998 111.914 176.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -67.42 -37.01 82.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.152 -0.476 . . . . 72.329999999999998 112.168 -177.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.56 -9.28 54.86 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.154 0.502 . . . . 65.329999999999998 110.02 -177.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 70.52 46.66 46.63 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.768 -0.933 . . . . 71.129999999999995 110.768 -178.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.523 ' HB3' ' HG ' ' A' ' 578' ' ' LEU . 11.3 t90 -73.39 126.76 30.9 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 109.357 -0.608 . . . . 74.310000000000002 109.357 -177.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . 0.432 ' OG1' ' HA ' ' A' ' 617' ' ' ASP . 7.6 p -90.42 -24.38 20.77 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.409 -0.814 . . . . 53.240000000000002 112.101 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -85.19 -174.3 50.15 Favored Glycine 0 N--CA 1.432 -1.589 0 CA-C-N 116.076 -0.511 . . . . 61.140000000000001 113.075 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 27.4 ttt -117.33 149.04 41.14 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.967 -0.383 . . . . 60.439999999999998 109.967 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . 0.554 HD22 ' CZ3' ' A' ' 571' ' ' TRP . 6.1 tt -80.7 108.83 14.67 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.27 -1.382 . . . . 62.140000000000001 107.27 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.411 ' O ' ' HA ' ' A' ' 621' ' ' THR . 21.8 t70 -105.37 119.28 38.7 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.942 -0.572 . . . . 74.549999999999997 111.612 -177.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.1 OUTLIER -111.91 133.21 54.25 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.035 -1.098 . . . . 74.219999999999999 108.035 171.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -111.01 -5.13 27.26 Favored Glycine 0 C--N 1.297 -1.625 0 C-N-CA 120.096 -1.05 . . . . 65.109999999999999 112.83 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.35 130.57 26.7 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 121.137 -0.225 . . . . 73.109999999999999 110.743 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.35 124.2 31.02 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 123.907 0.755 . . . . 62.539999999999999 109.829 176.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . 0.508 ' O ' ' HA2' ' A' ' 625' ' ' GLY . 86.9 t -104.64 131.85 52.7 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 105.22 -2.141 . . . . 71.519999999999996 105.22 171.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -82.88 122.95 28.91 Favored 'General case' 0 C--N 1.281 -2.406 0 C-N-CA 118.681 -1.208 . . . . 72.329999999999998 110.93 -177.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -147.46 -68.86 0.24 Allowed 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.002 -1.453 . . . . 72.230000000000004 108.359 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 92.75 157.8 33.85 Favored Glycine 0 N--CA 1.417 -2.628 0 C-N-CA 119.827 -1.178 . . . . 54.210000000000001 110.985 -176.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -57.99 -37.63 86.06 Favored Glycine 0 C--N 1.291 -1.931 0 N-CA-C 115.441 0.936 . . . . 61.350000000000001 115.441 -176.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 36.4 m -76.11 -24.55 54.98 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-N 118.05 0.925 . . . . 74.450000000000003 110.628 -174.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -89.13 -0.04 57.12 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.601 -1.181 . . . . 72.329999999999998 111.458 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 40.1 m80 77.6 89.79 0.07 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.619 1.2 . . . . 74.25 109.833 -176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -81.62 85.99 6.46 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 113.93 -1.487 . . . . 74.010000000000005 109.964 -171.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -111.52 170.03 8.4 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.567 0.951 . . . . 70.109999999999999 113.567 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.419 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 99.3 t -77.72 133.27 30.88 Favored 'Isoleucine or valine' 0 C--O 1.248 0.995 0 CA-C-N 114.27 -1.332 . . . . 72.109999999999999 108.05 173.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.5 m -112.21 -42.42 4.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 120.285 -0.566 . . . . 71.530000000000001 112.36 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -144.69 151.04 38.32 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.969 -0.382 . . . . 72.209999999999994 109.969 -174.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 622' ' ' LEU . 16.4 pt20 -140.06 144.67 36.97 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 123.491 0.494 . . . . 50.240000000000002 110.355 177.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.43 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 58.4 t30 -64.77 -51.82 55.12 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-N 116.181 -0.463 . . . . 61.229999999999997 111.734 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.4 Cg_exo -85.21 115.74 1.69 Allowed 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 121.756 1.637 . . . . 73.310000000000002 110.134 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 11.5 Cg_exo -70.21 152.31 66.92 Favored 'Trans proline' 0 C--O 1.256 1.379 0 C-N-CA 122.401 2.067 . . . . 74.109999999999999 111.799 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -58.71 135.84 57.54 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.49 -0.559 . . . . 75.299999999999997 109.49 176.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 103.23 -7.36 51.61 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.571 -0.823 . . . . 60.039999999999999 111.908 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 28.0 m -93.78 144.46 25.39 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.237 -0.653 . . . . 63.409999999999997 109.237 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -70.34 131.22 22.08 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 111.952 -0.459 . . . . 73.239999999999995 111.952 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.7 m -124.56 141.64 44.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.917 -0.772 . . . . 74.420000000000002 108.917 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.414 ' N ' ' HG2' ' A' ' 560' ' ' GLN . 28.4 p-10 -51.52 171.72 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.204 1.402 . . . . 64.230000000000004 114.301 -176.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.68 -27.1 37.81 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.824 1.046 . . . . 52.219999999999999 113.824 -179.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.432 ' HA ' ' OG1' ' A' ' 584' ' ' THR . 11.0 m-20 -87.74 -8.18 56.36 Favored 'General case' 0 C--O 1.198 -1.632 0 C-N-CA 119.149 -1.02 . . . . 74.530000000000001 110.988 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.02 17.81 65.99 Favored Glycine 0 C--O 1.219 -0.784 0 C-N-CA 121.755 -0.259 . . . . 60.210000000000001 112.661 173.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.96 119.28 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 121.724 0.773 . . . . 72.209999999999994 110.726 -169.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.617 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.6 pp -123.76 133.29 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 115.29 -0.868 . . . . 64.109999999999999 112.546 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 14.2 t -102.86 122.48 44.63 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-O 122.118 0.961 . . . . 74.239999999999995 109.26 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -136.64 169.43 17.73 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.777 -1.101 . . . . 71.420000000000002 110.471 -173.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -125.95 135.84 52.33 Favored 'General case' 0 C--O 1.261 1.667 0 N-CA-C 107.866 -1.161 . . . . 75.109999999999999 107.866 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.419 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 3.7 p90 -142.98 169.05 18.29 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.783 -1.192 . . . . 74.310000000000002 107.783 -175.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 593' ' ' VAL . . . -49.47 109.5 0.62 Allowed Glycine 0 CA--C 1.544 1.896 0 O-C-N 124.193 0.933 . . . . 61.549999999999997 113.549 175.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 . . . . . 0 C--O 1.253 1.277 0 C-N-CA 125.816 1.646 . . . . 64.25 112.934 176.843 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . 0.563 ' N ' ' HG1' ' A' ' 494' ' ' THR . . . . . . . . 0 CA--C 1.49 -1.492 0 N-CA-C 109.078 -1.609 . . . . 54.130000000000003 109.078 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -74.3 141.51 28.98 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.668 1.579 . . . . 61.439999999999998 109.906 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 59.31 15.65 4.47 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.279 1.032 . . . . 73.530000000000001 112.976 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.563 ' HG1' ' N ' ' A' ' 491' ' ' GLY . 19.3 p -141.0 142.42 34.27 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.936 -0.478 . . . . 73.319999999999993 110.521 -177.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -138.88 135.01 34.04 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.75 -0.833 . . . . 64.5 108.75 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.631 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 6.3 p-10 -83.66 144.99 29.03 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.186 0.517 . . . . 74.430000000000007 110.318 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.5 pt -90.38 116.92 67.5 Favored Pre-proline 0 C--N 1.295 -1.77 0 CA-C-N 115.13 -0.941 . . . . 62.420000000000002 111.086 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . 0.487 ' HD2' HD22 ' A' ' 512' ' ' LEU . 27.5 Cg_exo -66.2 160.57 44.3 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.484 2.122 . . . . 72.439999999999998 111.106 173.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -67.91 110.99 4.11 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.801 0.81 . . . . 74.450000000000003 110.423 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 14.2 m -130.27 65.17 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 122.757 1.265 . . . . 63.539999999999999 109.494 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -128.99 93.29 3.56 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 113.559 -1.655 . . . . 73.340000000000003 108.382 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 160.82 -38.73 0.43 Allowed Glycine 0 N--CA 1.428 -1.861 0 C-N-CA 119.905 -1.14 . . . . 54.539999999999999 112.787 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.555 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.3 OUTLIER -89.71 -170.27 2.76 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 110.231 -0.285 . . . . 74.340000000000003 110.231 -178.784 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.52 ' HB ' HG23 ' A' ' 507' ' ' VAL . 21.3 m -71.79 155.58 40.28 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.15 -0.685 . . . . 62.409999999999997 109.15 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.6 p -60.38 -41.77 88.48 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.587 0 O-C-N 123.243 0.34 . . . . 73.219999999999999 111.391 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.77 -40.7 97.34 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 109.684 -0.487 . . . . 74.450000000000003 109.684 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . 0.52 HG23 ' HB ' ' A' ' 504' ' ' THR . 47.8 t -67.03 -42.88 89.09 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.177 0 N-CA-C 109.073 -0.714 . . . . 64.019999999999996 109.073 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.609 ' HB2' HG11 ' A' ' 534' ' ' VAL . . . -59.34 -45.55 91.05 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.855 0.36 . . . . 75.340000000000003 110.959 177.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 26.0 mt-30 -65.32 -42.58 92.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.66 -0.7 . . . . 55.299999999999997 110.689 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.61 ' O ' HG23 ' A' ' 514' ' ' VAL . 45.0 mmtm -61.63 -45.69 92.97 Favored 'General case' 0 CA--C 1.495 -1.152 0 O-C-N 123.392 0.433 . . . . 65.129999999999995 110.122 177.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -61.88 -41.49 97.92 Favored 'General case' 0 N--CA 1.435 -1.221 0 O-C-N 123.821 0.701 . . . . 72.329999999999998 110.89 -176.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.487 HD22 ' HD2' ' A' ' 498' ' ' PRO . 0.2 OUTLIER -68.04 -46.62 70.63 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.859 -1.064 . . . . 63.119999999999997 108.208 -179.196 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -61.7 -35.87 79.28 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 124.001 0.92 . . . . 64.150000000000006 111.612 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 510' ' ' LYS . 89.6 t -57.62 -38.97 67.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 O-C-N 123.269 0.356 . . . . 74.340000000000003 111.525 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -105.21 -3.73 22.57 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.458 0.647 . . . . 74.040000000000006 109.523 -176.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -116.33 -58.64 0.32 Allowed Glycine 0 N--CA 1.42 -2.4 0 CA-C-N 115.473 -0.785 . . . . 71.129999999999995 113.828 -170.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 63.31 26.78 15.2 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 122.351 1.072 . . . . 75.319999999999993 110.212 -172.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.4 p -83.46 -177.14 6.62 Favored 'General case' 0 N--CA 1.403 -2.817 0 CA-C-N 113.872 -1.513 . . . . 71.109999999999999 109.447 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -107.99 139.69 42.24 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.371 -1.344 . . . . 64.129999999999995 107.371 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -129.2 149.07 51.16 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-O 121.117 0.485 . . . . 63.130000000000003 111.255 -176.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 49.3 m -139.97 152.44 46.32 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 106.688 -1.597 . . . . 71.030000000000001 106.688 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -122.84 142.07 51.16 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 112.51 0.559 . . . . 71.219999999999999 112.51 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -132.26 143.33 49.84 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.086 -1.45 . . . . 63.009999999999998 107.086 176.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 80.2 p -103.14 138.11 40.41 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.427 -0.909 . . . . 63.0 111.676 -175.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.9 p -121.43 149.64 24.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 106.547 -1.649 . . . . 71.140000000000001 106.547 177.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -72.32 136.93 46.34 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.521 -0.548 . . . . 74.230000000000004 109.521 -177.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.468 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 56.6 m -153.51 160.07 31.37 Favored Pre-proline 0 C--N 1.291 -1.971 0 N-CA-C 107.768 -1.197 . . . . 73.120000000000005 107.768 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.32 -2.75 12.96 Favored 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 121.865 1.71 . . . . 73.319999999999993 113.09 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.18 152.02 38.56 Favored Pre-proline 0 N--CA 1.451 -0.412 0 N-CA-C 109.624 -0.51 . . . . 71.340000000000003 109.624 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -57.34 146.61 81.85 Favored 'Trans proline' 0 C--O 1.25 1.087 0 C-N-CA 122.96 2.44 . . . . 72.430000000000007 113.458 -177.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.708 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.16 99.83 0.11 Allowed 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 114.943 -1.026 . . . . 73.319999999999993 111.651 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 157.82 -23.09 0.4 Allowed Glycine 0 C--N 1.3 -1.464 0 CA-C-N 115.758 -0.656 . . . . 74.439999999999998 111.874 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -74.38 144.74 44.25 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.349 -0.982 . . . . 74.230000000000004 108.349 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.609 HG11 ' HB2' ' A' ' 508' ' ' ALA . 11.0 p -91.38 118.6 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.413 0 CA-C-O 121.854 0.835 . . . . 64.430000000000007 108.779 176.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.83 -23.59 60.79 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.514 -1.221 . . . . 61.439999999999998 109.374 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 138.99 -152.8 22.41 Favored Glycine 0 N--CA 1.421 -2.305 0 N-CA-C 110.581 -1.007 . . . . 63.049999999999997 110.581 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.0 p -116.48 157.93 24.4 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 109.71 -0.478 . . . . 71.209999999999994 109.71 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.461 ' HB2' HE22 ' A' ' 554' ' ' GLN . 26.5 t-20 -66.45 -53.68 28.79 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 120.236 -0.586 . . . . 74.129999999999995 110.261 173.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 37.0 Cg_endo -67.71 149.82 79.03 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 121.319 1.346 . . . . 62.229999999999997 109.767 173.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 23.5 Cg_exo -64.04 139.36 66.85 Favored 'Trans proline' 0 C--O 1.246 0.923 0 C-N-CA 121.659 1.572 . . . . 70.120000000000005 113.02 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.97 137.43 55.13 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-N 115.204 -0.907 . . . . 61.399999999999999 110.178 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 93.81 -11.8 70.42 Favored Glycine 0 N--CA 1.442 -0.967 0 C-N-CA 121.092 -0.575 . . . . 61.140000000000001 111.668 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 51.8 m -88.52 137.83 31.97 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 122.745 0.418 . . . . 72.120000000000005 110.358 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 12.9 t -74.74 136.83 41.74 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.95 -0.568 . . . . 62.100000000000001 109.729 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 30.3 m -130.89 154.46 81.96 Favored Pre-proline 0 C--N 1.312 -1.064 0 N-CA-C 108.161 -1.051 . . . . 64.319999999999993 108.161 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -61.72 136.88 65.02 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.15 1.233 . . . . 54.399999999999999 111.202 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 13.3 p -65.99 -23.22 31.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.724 0.773 . . . . 64.140000000000001 111.872 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -78.06 -17.41 57.04 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.096 -0.502 . . . . 74.530000000000001 110.75 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 25.2 t -78.29 162.54 26.44 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.885 0.85 . . . . 74.239999999999995 111.499 -175.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.8 p -98.64 137.74 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.388 0 CA-C-N 114.246 -1.343 . . . . 74.549999999999997 108.282 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 61.7 mt -100.88 137.53 28.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.168 -0.678 . . . . 74.409999999999997 109.168 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -103.24 117.78 35.29 Favored 'General case' 0 C--O 1.254 1.336 0 N-CA-C 108.816 -0.809 . . . . 73.519999999999996 108.816 -177.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -101.49 120.36 40.17 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 123.735 0.814 . . . . 71.319999999999993 109.624 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.461 HE22 ' HB2' ' A' ' 538' ' ' ASN . 2.8 mp0 -86.52 123.17 31.43 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 121.17 0.51 . . . . 73.430000000000007 110.795 178.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 39.6 t -96.01 132.19 40.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.781 -1.192 . . . . 61.149999999999999 107.781 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.708 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 13.0 m -79.7 117.35 20.53 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 107.033 -1.469 . . . . 52.140000000000001 107.033 176.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 21.3 pttm -107.52 128.78 54.82 Favored 'General case' 0 N--CA 1.422 -1.869 0 C-N-CA 119.566 -0.854 . . . . 72.319999999999993 108.838 173.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 527' ' ' SER . . . -58.61 -24.83 57.5 Favored Glycine 0 CA--C 1.501 -0.79 0 O-C-N 124.462 1.101 . . . . 74.340000000000003 113.993 -175.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 73.93 -0.16 3.44 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.995 1.318 . . . . 73.219999999999999 109.8 178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.478 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 70.3 mt-30 -113.74 149.63 34.54 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 115.661 -0.699 . . . . 72.040000000000006 111.971 -174.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -124.12 158.79 31.47 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.454 -1.248 . . . . 64.299999999999997 108.351 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.15 126.94 37.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.336 0.589 . . . . 53.450000000000003 110.516 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 18.8 ttt -78.21 125.15 85.47 Favored Pre-proline 0 N--CA 1.432 -1.344 0 C-N-CA 124.542 1.137 . . . . 52.439999999999998 111.436 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.66 169.43 22.58 Favored 'Trans proline' 0 C--O 1.245 0.869 0 C-N-CA 122.805 2.336 . . . . 74.040000000000006 111.125 174.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.79 116.79 26.19 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.86 0.838 . . . . 75.510000000000005 111.36 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . 0.441 ' H ' HD23 ' A' ' 566' ' ' LEU . 2.1 pt? -117.64 9.11 13.01 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.204 -1.406 . . . . 70.219999999999999 107.204 170.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 22.0 t -80.65 147.22 30.77 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 114.211 -1.359 . . . . 62.409999999999997 107.953 176.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 66.75 56.74 11.68 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 121.357 -0.449 . . . . 55.140000000000001 112.897 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 22.9 ptp -168.49 179.76 4.23 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.165 -1.791 . . . . 75.099999999999994 106.165 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . 0.457 ' HB2' HG12 ' A' ' 572' ' ' VAL . 52.3 m-85 -100.1 170.45 8.47 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.06 -0.719 . . . . 73.239999999999995 109.06 -176.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . 0.427 ' CH2' HD22 ' A' ' 587' ' ' LEU . 12.1 t-105 -65.63 -27.53 68.45 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 108.569 -0.9 . . . . 52.43 108.569 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 570' ' ' PHE . 14.6 p -71.16 -13.2 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 115.735 -0.666 . . . . 73.230000000000004 110.479 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -99.41 -35.87 9.77 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 109.017 -0.735 . . . . 73.310000000000002 109.017 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . 0.64 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -62.64 -39.61 94.41 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 115.323 -0.853 . . . . 74.049999999999997 110.397 177.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.416 ' HB3' ' CD ' ' A' ' 576' ' ' PRO . 2.5 tm-20 -51.3 -59.13 8.42 Favored Pre-proline 0 CA--C 1.585 2.303 0 C-N-CA 124.138 0.975 . . . . 75.340000000000003 110.57 -178.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.416 ' CD ' ' HB3' ' A' ' 575' ' ' GLU . 19.8 Cg_endo -61.57 -32.49 87.78 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 121.891 1.727 . . . . 61.409999999999997 113.013 175.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 7.6 mmp_? -61.98 -41.25 97.82 Favored 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 120.593 -0.443 . . . . 74.409999999999997 110.726 177.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 16.8 mt -65.99 -46.39 78.19 Favored 'General case' 0 C--O 1.247 0.956 0 CA-C-O 120.782 0.325 . . . . 62.210000000000001 110.465 -175.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -65.76 -39.73 91.34 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 112.472 0.545 . . . . 73.049999999999997 112.472 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -69.17 -33.61 73.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.878 0.371 . . . . 62.399999999999999 111.247 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 10.3 tp -81.01 -10.16 59.74 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 121.471 0.653 . . . . 55.350000000000001 110.156 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 62.0 35.6 91.65 Favored Glycine 0 C--O 1.224 -0.496 0 CA-C-N 115.961 -0.563 . . . . 54.310000000000002 112.569 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.477 ' CE3' HD22 ' A' ' 578' ' ' LEU . 18.4 t90 -78.83 126.68 31.03 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.638 -0.504 . . . . 74.140000000000001 109.638 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 12.9 t -109.39 6.62 24.49 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 111.966 0.358 . . . . 63.219999999999999 111.966 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -89.11 -171.82 45.8 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 119.955 -1.117 . . . . 73.420000000000002 111.261 176.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 94.4 mmm -105.05 139.16 40.15 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 116.749 0.274 . . . . 61.32 110.375 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . 0.427 HD22 ' CH2' ' A' ' 571' ' ' TRP . 6.4 tt -80.64 110.01 15.72 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 107.354 -1.35 . . . . 74.120000000000005 107.354 176.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.509 ' O ' ' HA ' ' A' ' 621' ' ' THR . 30.6 t70 -95.65 114.23 25.95 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.909 -1.041 . . . . 72.209999999999994 109.679 -178.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.452 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -110.9 134.78 52.28 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 108.172 -1.047 . . . . 73.040000000000006 108.172 177.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -101.07 -89.69 2.07 Favored Glycine 0 C--N 1.268 -3.197 0 CA-C-N 115.306 -0.861 . . . . 43.43 112.646 -175.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -99.63 149.15 23.58 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.025 0.44 . . . . 73.219999999999999 111.665 -176.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -93.45 139.18 31.0 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.395 -0.965 . . . . 71.040000000000006 108.395 176.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 39.5 t -105.11 153.96 6.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 109.014 -0.735 . . . . 74.420000000000002 109.014 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -73.11 119.2 17.02 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 121.599 0.714 . . . . 75.430000000000007 109.728 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -143.46 -65.35 0.38 Allowed 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.154 -1.424 . . . . 73.299999999999997 107.154 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 100.05 158.8 28.34 Favored Glycine 0 N--CA 1.4 -3.753 0 C-N-CA 119.967 -1.111 . . . . 70.530000000000001 112.074 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.23 -32.38 60.19 Favored Glycine 0 C--N 1.302 -1.324 0 C-N-CA 123.689 0.662 . . . . 45.450000000000003 113.514 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 26.8 t -69.5 -23.91 63.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 122.057 0.932 . . . . 61.200000000000003 109.828 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 55.9 mm-40 -100.96 -12.09 19.2 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.553 -0.748 . . . . 73.120000000000005 109.712 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 43.7 m80 67.11 172.69 0.26 Allowed 'General case' 0 C--O 1.242 0.658 0 C-N-CA 124.603 1.161 . . . . 75.129999999999995 111.824 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -89.55 84.85 6.39 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 112.526 0.565 . . . . 72.209999999999994 112.526 -174.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 624' ' ' PHE . 48.0 mtp180 -91.08 145.96 24.24 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.09 -0.959 . . . . 73.540000000000006 110.542 176.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.403 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 59.5 t -74.43 130.51 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 105.904 -1.887 . . . . 53.409999999999997 105.904 173.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 73.8 t -102.96 -59.91 3.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-O 120.738 0.304 . . . . 65.409999999999997 111.206 -173.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 93.6 t80 -144.61 141.05 29.13 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.162 -0.472 . . . . 74.150000000000006 110.037 -172.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.56 160.89 22.29 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 107.251 -1.389 . . . . 71.340000000000003 107.251 176.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.526 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 3.2 t-20 -67.03 -52.61 30.16 Favored Pre-proline 0 C--N 1.312 -1.034 0 N-CA-C 109.689 -0.486 . . . . 75.040000000000006 109.689 171.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.2 Cg_exo -87.47 122.8 1.78 Allowed 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 121.589 1.526 . . . . 63.140000000000001 110.91 173.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -67.26 158.39 57.18 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 122.184 1.923 . . . . 31.399999999999999 110.874 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -67.5 127.63 33.44 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.79 -0.448 . . . . 73.430000000000007 109.79 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.31 -0.02 40.64 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.713 -0.756 . . . . 71.5 112.091 -177.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 10.2 m -92.32 166.34 12.63 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.81 -0.811 . . . . 54.329999999999998 108.81 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -90.73 130.69 10.39 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.91 -0.662 . . . . 74.400000000000006 112.082 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.4 m -125.05 141.93 43.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.783 -0.821 . . . . 75.340000000000003 108.783 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.478 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.9 p-10 -62.42 179.28 0.33 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.437 0.902 . . . . 60.109999999999999 113.437 -175.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -61.03 -25.78 67.15 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.375 -0.375 . . . . 70.129999999999995 112.0 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.497 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 34.5 t70 -83.18 -9.45 59.16 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.091 -0.707 . . . . 75.129999999999995 109.091 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . 0.418 ' HA3' ' CD1' ' A' ' 583' ' ' TRP . . . 64.9 15.9 60.89 Favored Glycine 0 CA--C 1.492 -1.355 0 CA-C-N 115.195 -0.911 . . . . 73.540000000000006 113.704 168.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.58 119.13 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.648 0 CA-C-O 122.974 1.368 . . . . 70.129999999999995 113.255 -164.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.448 HG22 ' HG2' ' A' ' 608' ' ' PRO . 48.1 pt -123.47 133.09 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 CA-C-N 113.42 -1.718 . . . . 61.039999999999999 108.581 177.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 12.1 t -109.86 124.93 52.19 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.419 -0.956 . . . . 63.399999999999999 108.419 177.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.38 167.17 21.53 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 113.229 0.826 . . . . 75.099999999999994 113.229 -176.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -127.21 137.52 52.92 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.501 -1.227 . . . . 74.019999999999996 107.86 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 602' ' ' ARG . 15.1 p90 -139.35 166.7 23.85 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.486 -0.325 . . . . 64.209999999999994 111.162 -175.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -57.93 145.61 40.18 Favored Glycine 0 N--CA 1.447 -0.621 0 O-C-N 123.978 0.799 . . . . 75.430000000000007 114.412 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 . . . . . 0 C--N 1.308 -1.232 0 C-N-CA 124.391 1.076 . . . . 73.109999999999999 109.924 177.654 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.666 0 N-CA-C 110.544 -1.022 . . . . 43.229999999999997 110.544 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.03 142.23 67.37 Favored 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 122.39 2.06 . . . . 75.430000000000007 111.269 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -87.81 -4.22 58.89 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.873 0.844 . . . . 70.239999999999995 110.996 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 5.9 p -140.59 144.59 35.9 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.787 -1.19 . . . . 61.340000000000003 107.787 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -139.03 135.51 34.31 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 108.806 -0.813 . . . . 74.510000000000005 108.806 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.563 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.4 p-10 -81.53 133.99 35.46 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.885 -0.598 . . . . 52.310000000000002 109.936 177.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 33.0 pt -89.63 131.23 40.52 Favored Pre-proline 0 C--N 1.291 -1.945 0 CA-C-N 115.061 -0.972 . . . . 71.230000000000004 110.993 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.49 -174.4 2.11 Favored 'Trans proline' 0 C--O 1.251 1.144 0 C-N-CA 121.966 1.777 . . . . 73.209999999999994 110.011 174.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -85.38 117.17 24.14 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.002 0.906 . . . . 65.040000000000006 110.773 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.466 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 16.6 m -117.58 66.29 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.38 0 CA-C-O 123.277 1.513 . . . . 72.25 108.487 172.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -129.75 109.55 11.05 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 112.018 -2.355 . . . . 72.099999999999994 107.369 174.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 138.44 -20.05 3.16 Favored Glycine 0 C--N 1.299 -1.477 0 C-N-CA 119.837 -1.173 . . . . 41.219999999999999 112.956 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.471 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.0 OUTLIER -107.44 -173.88 2.4 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 117.484 0.642 . . . . 72.140000000000001 110.087 178.416 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 10.0 m -75.99 155.99 34.48 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.229 -1.026 . . . . 63.009999999999998 108.229 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.444 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 6.0 p -57.5 -46.59 85.98 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 111.801 0.297 . . . . 74.319999999999993 111.801 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -64.33 -37.93 89.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.308 0.575 . . . . 65.219999999999999 110.559 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 97.7 t -68.04 -42.42 85.23 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.982 0 CA-C-N 115.231 -0.895 . . . . 73.329999999999998 109.554 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.519 ' HB2' HG11 ' A' ' 534' ' ' VAL . . . -62.34 -45.36 93.56 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 122.298 0.239 . . . . 71.430000000000007 110.87 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 22.9 mt-30 -64.89 -45.81 84.38 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.458 -0.337 . . . . 74.530000000000001 111.261 -178.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.473 ' O ' HG23 ' A' ' 514' ' ' VAL . 0.0 OUTLIER -67.27 -38.92 85.88 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 120.473 -0.491 . . . . 74.120000000000005 110.716 179.165 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -63.2 -45.61 90.88 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 121.152 0.501 . . . . 73.209999999999994 110.479 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -62.17 -42.19 99.03 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 108.172 -1.047 . . . . 65.140000000000001 108.172 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -59.7 -34.95 73.55 Favored 'General case' 0 N--CA 1.428 -1.561 0 C-N-CA 123.613 0.765 . . . . 70.230000000000004 112.54 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 510' ' ' LYS . 75.2 t -57.89 -34.44 48.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-O 121.682 0.753 . . . . 72.450000000000003 110.866 177.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -104.47 -6.49 20.61 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.49 0.662 . . . . 74.519999999999996 109.763 -177.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -114.8 -66.59 0.43 Allowed Glycine 0 N--CA 1.416 -2.686 0 CA-C-N 115.352 -0.84 . . . . 52.420000000000002 113.425 -171.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 64.31 30.01 13.51 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 122.8 1.285 . . . . 74.219999999999999 109.07 -168.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 10.7 p -88.99 -175.35 4.8 Favored 'General case' 0 N--CA 1.409 -2.516 0 CA-C-N 112.954 -1.93 . . . . 71.430000000000007 109.545 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 13.5 mptt -108.24 143.47 37.02 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.131 -1.063 . . . . 73.099999999999994 108.131 177.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -132.41 157.14 45.3 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.364 0.602 . . . . 72.219999999999999 112.493 -175.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 62.3 m -140.42 150.16 43.5 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.716 -1.216 . . . . 50.420000000000002 107.716 174.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -123.82 138.18 54.54 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 120.713 0.292 . . . . 64.349999999999994 110.493 -176.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -136.33 143.23 44.02 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.712 -0.848 . . . . 72.510000000000005 108.712 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 45.5 m -97.17 135.13 39.56 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.404 1.097 . . . . 63.450000000000003 111.906 -178.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.43 153.01 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.813 0 CA-C-N 113.028 -1.897 . . . . 53.32 107.023 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -90.58 133.92 34.75 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.774 -0.77 . . . . 70.150000000000006 109.704 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.572 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 69.0 m -162.26 162.8 19.38 Favored Pre-proline 0 C--O 1.202 -1.438 0 N-CA-C 107.926 -1.138 . . . . 73.439999999999998 107.926 177.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -68.27 -3.93 11.79 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 122.194 1.929 . . . . 74.040000000000006 113.157 177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.402 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 25.2 mmm180 -79.48 136.66 55.9 Favored Pre-proline 0 N--CA 1.425 -1.69 0 N-CA-C 107.948 -1.13 . . . . 73.239999999999995 107.948 178.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -59.34 147.98 88.6 Favored 'Trans proline' 0 C--O 1.247 0.927 0 C-N-CA 123.047 2.498 . . . . 72.310000000000002 113.391 -175.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.709 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.72 108.12 0.8 Allowed 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.391 -0.822 . . . . 52.109999999999999 111.232 -177.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 131.62 -21.05 4.54 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 115.387 -0.824 . . . . 45.32 111.203 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.65 137.21 36.32 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.638 -0.875 . . . . 64.0 108.638 178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.519 HG11 ' HB2' ' A' ' 508' ' ' ALA . 10.3 p -91.42 121.43 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.719 0 CA-C-O 121.939 0.875 . . . . 63.219999999999999 109.207 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.474 HG23 ' HB2' ' A' ' 556' ' ' SER . 2.5 p -79.47 -16.56 55.88 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.774 -1.103 . . . . 75.5 111.174 176.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.405 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 145.98 -162.7 28.35 Favored Glycine 0 N--CA 1.425 -2.082 0 C-N-CA 120.774 -0.727 . . . . 75.049999999999997 112.18 175.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 11.9 p -116.26 157.68 24.55 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.646 -1.242 . . . . 72.340000000000003 107.646 178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.405 ' HB3' ' CD ' ' A' ' 552' ' ' GLU . 23.5 t-20 -63.38 -49.4 79.1 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 118.634 -1.226 . . . . 73.519999999999996 112.279 178.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -71.48 136.11 27.88 Favored 'Trans proline' 0 C--N 1.364 1.347 0 N-CA-C 108.705 -1.306 . . . . 70.019999999999996 108.705 170.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -66.12 159.34 50.0 Favored 'Trans proline' 0 C--O 1.248 0.984 0 C-N-CA 122.324 2.016 . . . . 74.430000000000007 113.199 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -63.96 139.19 58.74 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.756 -0.656 . . . . 71.310000000000002 109.86 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.81 -19.67 51.22 Favored Glycine 0 N--CA 1.432 -1.585 0 N-CA-C 111.781 -0.528 . . . . 71.219999999999999 111.781 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 17.5 m -74.13 129.06 37.1 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 110.354 -0.239 . . . . 64.230000000000004 110.354 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 14.6 t -82.7 126.76 32.73 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-O 121.578 0.704 . . . . 51.0 109.388 175.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 28.3 m -123.81 155.52 66.61 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 107.716 -1.216 . . . . 64.400000000000006 107.716 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -61.69 137.65 69.97 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 120.973 1.115 . . . . 75.030000000000001 111.531 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.26 -20.23 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.961 0.886 . . . . 61.340000000000003 110.655 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -87.72 -18.07 30.3 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.143 -0.935 . . . . 75.299999999999997 111.647 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 85.1 p -89.89 175.05 7.36 Favored 'General case' 0 C--O 1.252 1.235 0 N-CA-C 113.453 0.909 . . . . 73.129999999999995 113.453 -172.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 11.1 p -96.93 138.6 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 CA-C-N 114.281 -1.327 . . . . 73.540000000000006 111.175 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.4 mt -114.52 137.96 46.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.791 -1.189 . . . . 71.530000000000001 107.791 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . 0.405 ' CD ' ' HB3' ' A' ' 538' ' ' ASN . 1.7 pm0 -103.39 128.69 50.45 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.788 0.804 . . . . 72.450000000000003 112.188 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.86 122.03 42.74 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.678 -1.601 . . . . 72.400000000000006 108.876 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -88.23 113.2 23.61 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.53 0.681 . . . . 62.409999999999997 110.344 177.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 524' ' ' SER . 18.2 t -93.07 122.96 44.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 107.341 -1.355 . . . . 71.430000000000007 107.341 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.709 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 48.5 t -81.92 131.95 35.26 Favored 'General case' 0 N--CA 1.405 -2.681 0 N-CA-C 108.797 -0.816 . . . . 51.539999999999999 108.797 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -95.11 141.55 28.61 Favored 'General case' 0 N--CA 1.412 -2.363 0 N-CA-C 105.526 -2.028 . . . . 75.349999999999994 105.526 168.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -56.05 -23.94 41.15 Favored Glycine 0 CA--C 1.499 -0.952 0 O-C-N 124.48 1.112 . . . . 44.130000000000003 112.564 -177.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 64.2 t30 68.16 20.98 8.77 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-O 123.129 1.442 . . . . 74.310000000000002 109.026 174.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.589 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 66.7 mt-30 -141.79 164.54 29.93 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 113.094 -1.866 . . . . 75.120000000000005 107.117 178.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -143.23 151.65 40.84 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 107.785 -1.191 . . . . 65.010000000000005 107.785 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 13.6 p -70.45 132.23 33.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 121.01 0.433 . . . . 73.109999999999999 110.116 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.415 ' SD ' HG21 ' A' ' 620' ' ' ILE . 44.2 ttp -91.15 109.52 36.04 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 108.405 -0.961 . . . . 72.430000000000007 108.405 175.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.75 160.24 44.62 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.478 2.118 . . . . 73.450000000000003 110.897 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -73.8 115.06 12.79 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.971 0.891 . . . . 73.120000000000005 112.329 -178.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.7 pp -135.3 18.98 3.38 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.096 -1.411 . . . . 75.349999999999994 107.789 174.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 8.7 t -74.41 136.89 42.39 Favored 'General case' 0 N--CA 1.417 -2.08 0 CA-C-N 114.603 -1.18 . . . . 75.519999999999996 108.902 -175.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . 0.473 ' HA2' ' CZ ' ' A' ' 602' ' ' ARG . . . 113.96 50.28 0.51 Allowed Glycine 0 N--CA 1.42 -2.377 0 CA-C-N 115.546 -0.752 . . . . 73.430000000000007 111.914 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 19.8 ptp -142.17 173.36 11.59 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 120.099 -0.64 . . . . 64.340000000000003 110.246 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -98.61 175.63 5.93 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.987 -1.116 . . . . 73.0 107.987 -177.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 38.3 t-105 -68.82 -29.91 68.35 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.188 -0.671 . . . . 74.409999999999997 109.188 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.38 -15.64 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 115.579 -0.737 . . . . 55.420000000000002 110.299 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.595 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 9.0 m-20 -96.5 -44.69 7.06 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 108.44 -0.948 . . . . 64.239999999999995 108.44 176.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.98 -45.86 90.44 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.705 -1.134 . . . . 74.129999999999995 113.529 -174.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.514 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 35.4 tt0 -60.46 -50.46 85.54 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 120.664 -0.414 . . . . 61.340000000000003 111.828 -177.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 51.5 Cg_exo -58.88 -28.46 87.39 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 121.469 1.446 . . . . 74.5 111.576 173.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.672 ' O ' ' HB3' ' A' ' 581' ' ' LEU . 17.0 mmt180 -62.88 -38.45 90.92 Favored 'General case' 0 C--O 1.204 -1.324 0 CA-C-O 118.306 -0.854 . . . . 74.200000000000003 112.688 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.793 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 6.5 mp -59.38 -49.51 77.52 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.652 -1.219 . . . . 71.030000000000001 109.547 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -67.33 -42.07 84.2 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.518 -1.219 . . . . 74.019999999999996 113.515 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -71.15 -39.64 71.83 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.839 0.681 . . . . 62.310000000000002 112.839 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.672 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 1.7 tp -82.97 -9.43 59.29 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.38 0.672 . . . . 63.25 111.053 -176.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 69.48 40.81 78.63 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 110.616 -0.993 . . . . 63.039999999999999 110.616 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.793 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 11.3 t90 -87.46 126.45 34.9 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.217 -1.401 . . . . 74.019999999999996 107.217 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 17.4 p -86.81 -28.79 22.73 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 123.08 0.552 . . . . 53.439999999999998 112.389 -174.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -74.71 -175.5 34.99 Favored Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 115.588 -0.733 . . . . 75.219999999999999 111.636 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 23.9 mmt -123.3 155.21 37.69 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.681 -0.489 . . . . 74.040000000000006 109.681 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 47.4 tp -94.12 118.51 31.64 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 123.613 0.571 . . . . 74.340000000000003 109.578 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -118.14 122.12 42.27 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.127 -1.064 . . . . 74.530000000000001 108.127 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.3 OUTLIER -87.34 130.02 34.79 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 106.928 -1.508 . . . . 62.439999999999998 106.928 172.14 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -81.75 -35.12 23.06 Favored Glycine 0 C--N 1.285 -2.253 0 CA-C-N 115.585 -0.734 . . . . 51.439999999999998 111.688 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.61 147.72 39.81 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 120.828 0.347 . . . . 72.239999999999995 110.8 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -100.18 123.66 44.68 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 102.814 -3.032 . . . . 75.129999999999995 102.814 170.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.89 137.41 32.7 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.611 0 N-CA-C 106.531 -1.655 . . . . 73.540000000000006 106.531 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -75.53 106.88 7.32 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 118.418 -1.313 . . . . 65.510000000000005 111.122 -178.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . 0.447 ' HB3' ' HA3' ' A' ' 625' ' ' GLY . . . -129.61 -64.34 0.89 Allowed 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.023 -1.473 . . . . 74.140000000000001 107.023 172.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 111.8 150.15 11.41 Favored Glycine 0 N--CA 1.42 -2.367 0 C-N-CA 120.394 -0.908 . . . . 73.409999999999997 111.111 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.95 -32.76 62.77 Favored Glycine 0 C--N 1.307 -1.083 0 C-N-CA 123.356 0.503 . . . . 72.0 113.685 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 20.3 t -72.37 -24.18 61.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.952 0.882 . . . . 74.230000000000004 109.968 -175.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -90.3 -0.98 57.87 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.301 -0.863 . . . . 75.049999999999997 109.82 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 37.1 m80 75.99 99.61 0.07 Allowed 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 124.975 1.31 . . . . 71.010000000000005 109.906 -173.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -82.75 72.28 9.83 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.615 1.197 . . . . 62.520000000000003 112.076 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.473 ' CZ ' ' HA2' ' A' ' 568' ' ' GLY . 9.9 ptm180 -100.14 166.48 10.99 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.362 -1.29 . . . . 73.219999999999999 109.594 177.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.41 ' CG1' ' H ' ' A' ' 568' ' ' GLY . 10.4 p -62.86 131.64 28.37 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 CA-C-N 115.995 -0.548 . . . . 73.420000000000002 109.931 177.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 12.9 p -109.99 -26.68 3.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 121.724 0.773 . . . . 71.129999999999995 110.276 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -154.01 135.53 14.28 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.52 -0.764 . . . . 74.340000000000003 110.188 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -127.09 136.1 51.68 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.035 -1.468 . . . . 74.209999999999994 107.035 171.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.405 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 28.5 t-20 -65.68 -51.62 48.42 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 112.816 0.673 . . . . 65.400000000000006 112.816 -175.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 8.1 Cg_exo -79.11 114.01 3.3 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.576 1.517 . . . . 75.120000000000005 108.934 172.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.06 145.19 54.66 Favored 'Trans proline' 0 C--O 1.25 1.121 0 C-N-CA 122.359 2.039 . . . . 72.530000000000001 113.046 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -63.42 132.46 51.49 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.603 -0.726 . . . . 73.040000000000006 109.227 176.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 102.65 0.03 49.34 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 110.971 -0.852 . . . . 72.25 110.971 -175.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 32.3 m -105.51 150.43 25.34 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 109.559 -0.534 . . . . 71.129999999999995 109.559 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -73.38 127.19 10.56 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 111.172 -0.771 . . . . 71.230000000000004 111.172 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 27.6 m -117.09 142.76 29.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 108.22 -1.03 . . . . 74.239999999999995 108.22 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.589 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 29.3 p30 -44.1 167.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.073 1.509 . . . . 40.420000000000002 115.073 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -55.08 -25.53 31.72 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.483 1.113 . . . . 55.219999999999999 113.739 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -96.27 -8.93 31.5 Favored 'General case' 0 C--O 1.207 -1.163 0 C-N-CA 120.05 -0.66 . . . . 64.200000000000003 110.105 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.64 18.96 70.66 Favored Glycine 0 C--O 1.217 -0.923 0 CA-C-O 120.044 -0.309 . . . . 74.430000000000007 113.765 167.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.93 119.74 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-O 121.82 0.819 . . . . 73.030000000000001 110.711 -171.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.415 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.7 pp -127.36 133.97 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 115.132 -0.94 . . . . 52.43 110.767 -177.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.2 t -103.24 135.93 43.96 Favored 'General case' 0 C--O 1.259 1.597 0 N-CA-C 108.748 -0.834 . . . . 74.299999999999997 108.748 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 2.7 pp -139.2 165.99 25.7 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.815 -0.629 . . . . 62.539999999999999 111.608 -178.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -131.4 137.93 48.89 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.944 -0.761 . . . . 72.420000000000002 108.944 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -136.65 166.48 23.45 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.038 -0.528 . . . . 71.439999999999998 110.319 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . 0.447 ' HA3' ' HB3' ' A' ' 595' ' ' ALA . . . -71.58 67.84 0.99 Allowed Glycine 0 CA--C 1.527 0.803 0 O-C-N 124.069 0.855 . . . . 75.400000000000006 114.925 -175.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 . . . . . 0 C--O 1.262 1.715 0 C-N-CA 126.628 1.971 . . . . 75.530000000000001 112.064 -175.371 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.724 0 N-CA-C 110.007 -1.237 . . . . 45.409999999999997 110.007 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.15 154.02 36.85 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.099 1.866 . . . . 74.140000000000001 111.92 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -102.0 -0.16 34.16 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.26 1.029 . . . . 73.019999999999996 109.341 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.404 ' HB ' HG22 ' A' ' 544' ' ' THR . 27.8 p -140.03 153.97 46.97 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.69 -1.141 . . . . 73.129999999999995 109.003 -176.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.479 ' NZ ' ' HB2' ' A' ' 495' ' ' LYS . 0.0 OUTLIER -137.97 145.09 41.53 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.893 -0.41 . . . . 75.519999999999996 109.893 173.371 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 19.9 m-20 -77.89 141.89 38.8 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.849 -0.797 . . . . 63.25 108.849 173.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.6 pt -108.71 130.12 23.12 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 115.728 -0.669 . . . . 65.519999999999996 110.336 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -80.7 -177.49 3.79 Favored 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.705 2.27 . . . . 63.450000000000003 112.333 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -87.78 89.83 8.14 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 122.459 1.123 . . . . 64.319999999999993 110.521 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 27.0 m -80.59 -0.31 4.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-N 114.936 -1.029 . . . . 61.109999999999999 111.96 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -69.53 100.84 1.48 Allowed 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.734 -0.666 . . . . 71.140000000000001 110.494 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 156.86 -38.11 0.57 Allowed Glycine 0 C--N 1.304 -1.224 0 C-N-CA 120.808 -0.71 . . . . 64.430000000000007 111.979 178.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -92.62 -175.66 4.03 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 109.543 -0.54 . . . . 74.310000000000002 109.543 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 13.2 m -70.18 154.86 41.42 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.35 -0.981 . . . . 63.140000000000001 108.35 -178.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.475 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.4 p -64.14 -41.33 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 C-N-CA 120.737 -0.385 . . . . 73.540000000000006 110.797 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . 0.589 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 28.1 t70 -59.69 -43.24 94.11 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 109.815 -0.439 . . . . 54.240000000000002 109.815 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 46.3 t -69.29 -41.54 81.08 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 CA-C-N 115.868 -0.606 . . . . 61.140000000000001 110.085 -178.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -58.24 -44.02 88.09 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.753 0.311 . . . . 35.310000000000002 110.671 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.0 mt-30 -64.8 -44.88 88.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.027 -0.533 . . . . 74.510000000000005 110.617 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 33.4 mmtp -64.76 -40.17 94.84 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 116.19 -0.459 . . . . 72.439999999999998 110.129 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . 0.481 ' O ' HG12 ' A' ' 514' ' ' VAL . 85.9 m-20 -66.72 -40.49 88.44 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 115.856 -0.611 . . . . 71.230000000000004 111.585 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.4 pp -69.9 -41.37 74.78 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.42 -0.912 . . . . 41.310000000000002 110.776 177.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.482 ' N ' HD12 ' A' ' 512' ' ' LEU . 2.4 t-20 -64.38 -38.91 92.69 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 124.136 0.974 . . . . 74.319999999999993 111.259 -177.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 511' ' ' ASN . 9.0 p -64.06 -31.62 54.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.196 0.522 . . . . 74.319999999999993 110.876 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -112.62 23.24 13.73 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.409 -0.589 . . . . 74.25 109.409 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -146.07 -56.13 0.02 OUTLIER Glycine 0 CA--C 1.484 -1.866 0 C-N-CA 119.653 -1.26 . . . . 51.350000000000001 113.963 -174.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 65.76 26.28 11.32 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.211 1.005 . . . . 74.519999999999996 109.618 -175.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 14.7 p -82.95 -175.71 5.97 Favored 'General case' 0 N--CA 1.409 -2.489 0 CA-C-N 113.755 -1.566 . . . . 74.519999999999996 108.905 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.51 142.92 38.2 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.042 -1.095 . . . . 75.200000000000003 108.042 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -130.33 148.78 52.2 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.078 0.466 . . . . 61.409999999999997 111.332 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 32.2 m -138.32 139.99 39.33 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.058 -0.719 . . . . 53.299999999999997 109.058 176.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -118.09 138.67 52.09 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.85 0.357 . . . . 73.120000000000005 110.795 -176.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -135.02 130.42 35.65 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.268 -0.424 . . . . 52.549999999999997 109.862 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 73.9 m -88.96 129.15 35.68 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.695 0.76 . . . . 71.409999999999997 112.175 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.83 149.68 25.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.109 -1.811 . . . . 54.530000000000001 106.109 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -81.48 136.44 35.64 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.908 -0.717 . . . . 73.510000000000005 109.772 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 67.2 m -158.56 164.85 19.91 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 107.982 -1.118 . . . . 53.43 107.982 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -65.35 -14.78 46.77 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.251 1.968 . . . . 63.009999999999998 113.534 178.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.435 HH21 HG23 ' A' ' 535' ' ' THR . 0.4 OUTLIER -87.36 146.85 40.74 Favored Pre-proline 0 C--N 1.326 -0.413 0 C-N-CA 120.945 -0.302 . . . . 65.349999999999994 110.993 -179.149 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.77 155.47 37.56 Favored 'Trans proline' 0 C--O 1.263 1.758 0 C-N-CA 123.633 2.889 . . . . 72.329999999999998 115.378 -175.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.681 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -68.71 110.4 4.28 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 113.617 -1.629 . . . . 70.239999999999995 110.602 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 137.39 -21.63 3.26 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.574 -0.822 . . . . 75.329999999999998 111.546 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -82.88 138.18 33.99 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.99 -0.745 . . . . 71.219999999999999 108.99 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 6.6 p -86.16 114.74 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.193 0 CA-C-O 122.12 0.962 . . . . 75.140000000000001 108.907 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.435 HG23 HH21 ' A' ' 529' ' ' ARG . 0.5 OUTLIER -65.06 -32.57 74.34 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 113.575 -1.648 . . . . 70.340000000000003 109.681 -179.007 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 153.26 -166.69 31.68 Favored Glycine 0 N--CA 1.418 -2.546 0 N-CA-C 110.102 -1.199 . . . . 65.439999999999998 110.102 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 6.6 p -116.96 157.44 25.75 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 109.448 -0.575 . . . . 54.420000000000002 109.448 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -63.45 -55.17 37.55 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 119.17 -0.443 . . . . 75.329999999999998 110.495 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -69.02 126.5 13.88 Favored 'Trans proline' 0 C--N 1.365 1.442 0 N-CA-C 108.346 -1.444 . . . . 54.420000000000002 108.346 170.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.59 155.22 67.89 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.497 2.131 . . . . 53.240000000000002 113.293 -176.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -61.98 130.81 47.32 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.925 -0.58 . . . . 55.32 110.294 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.85 -4.82 42.44 Favored Glycine 0 C--N 1.303 -1.258 0 C-N-CA 120.205 -0.998 . . . . 74.230000000000004 111.725 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 25.3 m -88.16 133.28 34.05 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.467 -0.568 . . . . 74.549999999999997 109.467 178.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 0.2 OUTLIER -86.71 123.9 32.39 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 106.84 -1.541 . . . . 75.030000000000001 106.84 174.74 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.67 155.06 63.53 Favored Pre-proline 0 C--N 1.295 -1.798 0 N-CA-C 108.454 -0.943 . . . . 63.140000000000001 108.454 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -64.34 138.3 59.94 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 121.552 1.501 . . . . 74.430000000000007 111.636 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.31 -19.96 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 CA-C-O 122.168 0.985 . . . . 71.099999999999994 109.858 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -91.12 -8.38 48.94 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.785 -1.098 . . . . 73.439999999999998 111.687 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 15.1 t -89.79 -175.64 4.7 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-O 121.282 0.563 . . . . 53.530000000000001 110.416 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.1 p -118.89 137.65 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-N 115.869 -0.605 . . . . 72.409999999999997 109.511 -177.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 59.8 mt -97.55 132.56 41.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.883 -0.784 . . . . 63.32 108.883 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -103.12 116.1 31.84 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.416 -1.327 . . . . 72.219999999999999 107.416 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.84 125.8 52.36 Favored 'General case' 0 C--N 1.312 -1.035 0 O-C-N 123.625 0.578 . . . . 55.219999999999999 111.0 -178.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -93.09 121.66 34.66 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.699 -0.682 . . . . 71.129999999999995 109.293 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.446 HG22 HG21 ' A' ' 505' ' ' VAL . 15.1 t -104.37 137.4 33.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 107.447 -1.316 . . . . 64.510000000000005 107.447 -178.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.681 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 24.5 p -88.08 139.53 30.42 Favored 'General case' 0 N--CA 1.413 -2.315 0 C-N-CA 119.92 -0.712 . . . . 74.239999999999995 109.839 178.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -108.41 145.03 35.2 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 105.299 -2.112 . . . . 73.219999999999999 105.299 167.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 559' ' ' ASN . . . -54.68 -22.58 25.98 Favored Glycine 0 CA--C 1.506 -0.516 0 O-C-N 124.72 1.262 . . . . 62.340000000000003 114.743 -174.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . 0.428 ' HB3' ' O ' ' A' ' 558' ' ' GLY . 18.9 t-20 82.79 -16.4 0.59 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.816 1.246 . . . . 62.030000000000001 109.678 -178.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.518 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 86.9 mt-30 -113.48 157.33 22.12 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.283 -0.871 . . . . 71.099999999999994 111.383 -176.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -136.8 157.85 45.81 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.278 -1.379 . . . . 74.239999999999995 107.278 176.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.97 119.3 23.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.434 -0.58 . . . . 74.420000000000002 109.434 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 54.8 ttp -79.98 133.46 58.02 Favored Pre-proline 0 C--N 1.311 -1.077 0 C-N-CA 120.817 -0.353 . . . . 75.409999999999997 110.088 -178.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.95 169.67 17.33 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.71 2.273 . . . . 74.540000000000006 111.525 176.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . 0.445 ' HA ' ' HB1' ' A' ' 610' ' ' ALA . 24.6 t70 -89.62 119.87 30.42 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 113.219 0.822 . . . . 75.310000000000002 113.219 -178.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.36 12.73 3.02 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.504 -1.225 . . . . 51.340000000000003 109.272 173.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 84.5 p -69.03 153.41 43.83 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 115.69 -0.686 . . . . 73.019999999999996 112.824 -173.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . 0.444 ' H ' ' CG1' ' A' ' 603' ' ' VAL . . . 86.13 56.66 2.26 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.793 -0.923 . . . . 44.329999999999998 110.793 -178.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 602' ' ' ARG . 14.4 ptm -142.49 177.04 8.55 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.01 -0.367 . . . . 73.439999999999998 110.01 -175.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -95.5 160.63 14.42 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 106.69 -1.596 . . . . 75.310000000000002 106.69 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . 0.46 ' CZ3' ' HB3' ' A' ' 589' ' ' LYS . 19.3 t-105 -66.49 -32.32 73.61 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.482 -0.932 . . . . 75.209999999999994 108.482 176.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.1 m -76.2 -13.53 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.284 -0.871 . . . . 62.32 111.159 -174.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -96.96 -27.23 14.73 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.779 -1.193 . . . . 62.310000000000002 107.779 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -68.82 -40.33 79.57 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.25 -0.886 . . . . 70.310000000000002 111.773 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.639 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 44.9 mt-10 -55.36 -55.6 38.07 Favored Pre-proline 0 CA--C 1.567 1.606 0 N-CA-C 112.725 0.639 . . . . 71.129999999999995 112.725 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.5 -30.38 79.75 Favored 'Trans proline' 0 C--N 1.364 1.391 0 CA-C-N 120.707 1.288 . . . . 63.109999999999999 112.606 172.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -68.73 -36.36 78.31 Favored 'General case' 0 N--CA 1.435 -1.197 0 O-C-N 122.091 -0.38 . . . . 61.229999999999997 111.009 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.3 pp -64.51 -45.97 84.96 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 120.728 0.299 . . . . 73.540000000000006 110.655 -178.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.529 ' N ' HD12 ' A' ' 578' ' ' LEU . 8.5 ptm180 -65.93 -34.84 79.04 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.358 -0.383 . . . . 73.219999999999999 111.242 175.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -68.24 -39.31 82.32 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 116.41 -0.359 . . . . 63.240000000000002 111.548 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' A' ' 583' ' ' TRP . 1.5 pp -91.93 -9.66 42.32 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.555 -0.458 . . . . 75.209999999999994 111.399 -177.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 79.43 42.37 11.85 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.071 -0.585 . . . . 72.349999999999994 112.339 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.473 ' CH2' ' HG ' ' A' ' 587' ' ' LEU . 10.0 t90 -81.46 127.26 32.62 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.799 -0.815 . . . . 74.450000000000003 108.799 178.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 22.5 m -83.19 -29.63 28.42 Favored 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 113.083 0.771 . . . . 55.109999999999999 113.083 -176.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -90.72 -175.62 44.3 Favored Glycine 0 C--N 1.315 -0.611 0 CA-C-N 116.555 -0.293 . . . . 72.329999999999998 112.905 -177.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 70.1 mtm -117.73 163.33 16.65 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.368 -0.604 . . . . 63.229999999999997 109.368 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . 0.473 ' HG ' ' CH2' ' A' ' 583' ' ' TRP . 5.1 mp -84.26 131.14 34.76 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 109.703 -0.48 . . . . 71.439999999999998 109.703 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 621' ' ' THR . 32.8 t70 -101.86 116.07 31.9 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 108.831 -0.803 . . . . 73.329999999999998 108.831 177.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.46 ' HB3' ' CZ3' ' A' ' 571' ' ' TRP . 0.0 OUTLIER -95.08 134.23 38.02 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.659 0.742 . . . . 63.109999999999999 112.204 -175.077 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -95.58 -145.0 18.03 Favored Glycine 0 C--N 1.29 -1.982 0 N-CA-C 109.264 -1.534 . . . . 63.219999999999999 109.264 174.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -74.49 126.16 30.16 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 117.309 0.554 . . . . 73.120000000000005 110.547 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -69.75 144.21 52.8 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 123.913 0.758 . . . . 72.010000000000005 109.703 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 58.6 t -106.68 143.44 17.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-N 115.272 -0.877 . . . . 71.310000000000002 109.638 -174.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -74.94 107.0 6.73 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 108.968 -0.753 . . . . 63.009999999999998 108.968 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -126.98 -53.88 1.4 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 116.057 -0.52 . . . . 65.299999999999997 110.125 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 101.81 129.44 6.68 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.963 -0.855 . . . . 72.310000000000002 110.963 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.68 -43.11 91.55 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 116.539 0.169 . . . . 72.439999999999998 113.224 -177.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 35.3 t -68.7 -24.68 64.52 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.323 0.583 . . . . 62.200000000000003 110.65 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -93.53 -1.75 55.16 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 116.088 -0.505 . . . . 75.510000000000005 110.593 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 42.2 m170 80.55 98.33 0.06 Allowed 'General case' 0 C--O 1.246 0.892 0 C-N-CA 125.437 1.495 . . . . 71.319999999999993 113.216 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -73.08 90.39 1.53 Allowed 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 114.091 -1.413 . . . . 73.409999999999997 109.952 177.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 569' ' ' MET . 19.6 mtm180 -107.94 171.14 7.57 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.865 -0.607 . . . . 73.120000000000005 110.003 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.444 ' CG1' ' H ' ' A' ' 568' ' ' GLY . 14.7 p -73.4 137.97 22.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.751 -0.833 . . . . 72.219999999999999 108.751 175.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 33.5 m -107.26 -29.19 2.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 119.752 -0.779 . . . . 73.519999999999996 110.865 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -156.55 139.17 15.03 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.65 -0.705 . . . . 74.310000000000002 109.464 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -133.02 141.96 48.55 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.057 -1.831 . . . . 70.150000000000006 106.057 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.536 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 23.7 t-20 -62.14 -60.36 10.37 Favored Pre-proline 0 C--N 1.315 -0.918 0 CA-C-O 118.923 -0.561 . . . . 74.200000000000003 112.483 -177.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.536 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 6.3 Cg_exo -87.98 109.26 0.62 Allowed 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 121.752 1.635 . . . . 54.43 109.844 173.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 7.1 Cg_exo -71.11 160.63 48.58 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 123.225 2.616 . . . . 62.119999999999997 113.112 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . 0.445 ' HB1' ' HA ' ' A' ' 565' ' ' ASP . . . -68.02 132.67 47.7 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.821 -0.807 . . . . 65.420000000000002 108.821 175.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 103.18 -11.88 55.32 Favored Glycine 0 C--N 1.302 -1.336 0 N-CA-C 110.852 -0.899 . . . . 44.539999999999999 110.852 -175.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 44.8 m -100.27 159.5 15.07 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.787 -0.82 . . . . 72.540000000000006 108.787 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -76.86 120.61 5.72 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 112.036 -0.426 . . . . 71.129999999999995 112.036 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 34.7 m -112.42 143.32 22.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 107.793 -1.188 . . . . 53.409999999999997 107.793 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.518 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 31.2 p-10 -52.99 168.8 0.11 Allowed 'General case' 0 C--O 1.216 -0.704 0 C-N-CA 123.534 0.734 . . . . 74.120000000000005 112.184 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . 0.267 0.0 OUTLIER -60.91 -24.95 66.4 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 113.642 0.978 . . . . 73.040000000000006 113.642 -176.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -80.97 -9.2 59.87 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 119.686 -0.806 . . . . 55.439999999999998 109.522 176.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.18 18.9 67.66 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 112.008 -0.437 . . . . 75.239999999999995 112.008 175.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.49 119.34 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-O 122.379 1.085 . . . . 62.310000000000002 111.694 -166.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.469 ' O ' HD12 ' A' ' 620' ' ' ILE . 2.8 pp -118.17 132.19 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 CA-C-N 114.77 -1.105 . . . . 72.329999999999998 110.352 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 12.9 t -99.19 128.76 45.37 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.007 -1.479 . . . . 65.420000000000002 107.007 174.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.1 166.64 23.97 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 112.599 0.592 . . . . 74.230000000000004 112.599 -172.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -126.21 134.88 51.11 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 105.231 -2.137 . . . . 53.340000000000003 105.231 173.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -142.29 166.05 25.74 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.912 -0.585 . . . . 71.209999999999994 110.571 -169.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -63.45 130.49 40.72 Favored Glycine 0 N--CA 1.433 -1.546 0 O-C-N 124.203 0.939 . . . . 42.32 111.956 175.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 . . . . . 0 C--N 1.301 -1.501 0 C-N-CA 126.162 1.785 . . . . 64.340000000000003 114.446 -178.878 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.685 0 N-CA-C 110.382 -1.087 . . . . 61.549999999999997 110.382 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -68.58 142.92 55.06 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.134 1.89 . . . . 71.439999999999998 111.475 178.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -117.61 9.59 13.17 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.995 -0.548 . . . . 43.509999999999998 110.816 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.449 ' HB ' ' OG1' ' A' ' 544' ' ' THR . 33.9 p -137.49 144.87 42.43 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.389 -0.596 . . . . 75.5 109.389 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -141.93 148.9 39.42 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 123.493 0.717 . . . . 70.310000000000002 109.343 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 14.3 m-20 -89.58 131.17 35.72 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 120.942 0.401 . . . . 73.030000000000001 110.759 -175.07 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.0 pt -90.77 128.05 49.81 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 116.048 -0.524 . . . . 74.109999999999999 110.579 178.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.27 -177.57 2.17 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 122.706 2.271 . . . . 43.530000000000001 112.463 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -81.26 99.84 8.84 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.789 -0.641 . . . . 71.310000000000002 109.556 177.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.49 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 27.1 m -102.13 -3.31 9.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.301 -0.863 . . . . 34.109999999999999 111.442 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -64.87 103.65 0.74 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.836 -0.62 . . . . 51.240000000000002 110.219 -178.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 145.87 -24.08 1.79 Allowed Glycine 0 C--N 1.295 -1.707 0 CA-C-N 115.476 -0.784 . . . . 74.219999999999999 111.984 178.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.456 ' O ' HG12 ' A' ' 534' ' ' VAL . 2.2 mp0 -92.04 -179.24 5.22 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.124 -1.065 . . . . 70.310000000000002 108.124 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 31.5 m -75.85 155.17 35.57 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.457 -1.683 . . . . 61.399999999999999 106.457 175.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.551 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.2 p -61.29 -43.19 96.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 118.103 0.41 . . . . 73.329999999999998 111.438 -177.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . 0.546 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 25.6 t70 -63.17 -41.29 99.21 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.415 -0.357 . . . . 73.230000000000004 110.176 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 94.5 t -68.04 -42.99 85.69 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.984 0 CA-C-N 115.386 -0.825 . . . . 44.210000000000001 110.33 -178.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.49 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -62.5 -44.38 96.53 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 121.12 -0.232 . . . . 73.439999999999998 110.532 178.582 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.551 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 21.5 mt-30 -64.54 -46.5 82.56 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 116.437 -0.347 . . . . 74.150000000000006 110.676 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 506' ' ' ASP 0.359 0.0 OUTLIER -65.68 -37.0 85.27 Favored 'General case' 0 C--O 1.215 -0.739 0 N-CA-C 112.386 0.513 . . . . 72.400000000000006 112.386 179.468 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -60.55 -47.4 86.36 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.445 -0.576 . . . . 75.450000000000003 109.445 178.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.54 -37.66 80.16 Favored 'General case' 0 C--O 1.205 -1.275 0 CA-C-N 115.457 -0.792 . . . . 70.25 109.743 177.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -59.74 -34.44 72.95 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 123.884 0.874 . . . . 73.239999999999995 111.745 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 510' ' ' LYS . 73.6 t -56.57 -31.33 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 O-C-N 123.645 0.591 . . . . 42.520000000000003 110.524 176.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -114.08 5.92 16.2 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.095 -0.706 . . . . 70.239999999999995 109.095 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -124.42 -62.09 0.18 Allowed Glycine 0 CA--C 1.481 -2.06 0 C-N-CA 120.342 -0.932 . . . . 64.010000000000005 113.988 -169.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 61.07 32.66 19.74 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 122.144 0.973 . . . . 75.420000000000002 109.071 -172.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 547' ' ' VAL . 4.9 p -87.02 -178.43 6.27 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.377 -1.283 . . . . 75.239999999999995 111.331 -177.265 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -108.22 143.11 37.49 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.98 -1.119 . . . . 64.540000000000006 107.98 178.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -125.3 146.14 49.69 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.745 0.307 . . . . 74.430000000000007 110.71 -174.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 56.3 p -126.92 141.07 51.9 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 106.18 -1.785 . . . . 72.0 106.18 171.043 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -129.72 122.57 29.15 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.299 0.571 . . . . 71.439999999999998 110.996 -174.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -118.09 125.31 50.04 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.632 -0.713 . . . . 42.5 109.493 -179.041 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 40.3 m -85.78 130.44 34.55 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-O 121.558 0.694 . . . . 55.030000000000001 111.287 -179.188 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.4 p -121.05 149.14 24.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 107.146 -1.427 . . . . 75.140000000000001 107.146 178.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -80.63 135.44 36.05 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.164 -0.615 . . . . 75.420000000000002 109.762 -177.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.8 m -159.75 165.27 18.3 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 108.1 -1.074 . . . . 74.099999999999994 108.1 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -71.5 -8.08 22.55 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.103 1.869 . . . . 72.510000000000005 112.549 177.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.471 ' O ' ' HA2' ' A' ' 558' ' ' GLY . 16.0 mtm180 -81.57 141.71 48.96 Favored Pre-proline 0 N--CA 1.44 -0.968 0 C-N-CA 123.48 0.712 . . . . 71.409999999999997 109.866 178.106 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.61 153.67 59.89 Favored 'Trans proline' 0 C--O 1.249 1.056 0 C-N-CA 123.431 2.754 . . . . 75.200000000000003 113.596 -174.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.687 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -68.37 105.98 2.35 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.192 -0.913 . . . . 64.019999999999996 110.576 -177.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 139.44 -17.13 3.11 Favored Glycine 0 N--CA 1.434 -1.5 0 CA-C-N 115.293 -0.867 . . . . 72.230000000000004 112.162 -179.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -81.33 130.05 34.87 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 109.594 -0.521 . . . . 75.200000000000003 109.594 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.496 ' HB ' ' HA ' ' A' ' 505' ' ' VAL . 7.8 p -81.36 118.01 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.252 0 CA-C-O 122.612 1.196 . . . . 74.329999999999998 108.871 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.5 m -80.07 -17.73 51.91 Favored 'General case' 0 C--N 1.269 -2.905 0 CA-C-N 112.938 -1.937 . . . . 61.219999999999999 110.177 -175.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 139.93 -163.12 26.3 Favored Glycine 0 N--CA 1.41 -3.034 0 C-N-CA 120.544 -0.836 . . . . 44.039999999999999 111.234 176.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . 0.415 HG22 HD13 ' A' ' 553' ' ' LEU . 11.6 p -117.37 157.92 25.32 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 109.194 -0.669 . . . . 72.040000000000006 109.194 -179.502 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.433 ' HB2' HE22 ' A' ' 554' ' ' GLN . 3.8 t-20 -66.61 -54.52 22.71 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 120.364 -0.535 . . . . 62.350000000000001 110.002 175.438 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.422 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 23.1 Cg_endo -67.93 138.85 45.52 Favored 'Trans proline' 0 C--N 1.373 1.844 0 N-CA-C 109.395 -1.04 . . . . 61.450000000000003 109.395 170.47 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 38.0 Cg_exo -62.9 155.39 60.49 Favored 'Trans proline' 0 C--O 1.244 0.801 0 C-N-CA 122.763 2.309 . . . . 71.230000000000004 113.106 -177.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -65.89 134.61 53.38 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.264 -0.426 . . . . 64.25 109.904 179.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.31 -5.53 57.45 Favored Glycine 0 C--N 1.303 -1.283 0 N-CA-C 111.344 -0.702 . . . . 34.049999999999997 111.344 -177.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 20.6 m -88.72 135.25 33.61 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.516 -0.55 . . . . 72.430000000000007 109.516 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 14.5 t -82.44 132.98 35.2 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.503 -0.925 . . . . 52.329999999999998 108.503 175.062 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.1 m -123.6 156.4 64.59 Favored Pre-proline 0 C--N 1.294 -1.834 0 N-CA-C 107.269 -1.382 . . . . 71.030000000000001 107.269 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.3 135.37 26.71 Favored 'Trans proline' 0 N--CA 1.433 -2.064 0 CA-C-N 119.833 0.976 . . . . 51.25 111.219 -178.061 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.416 ' HA ' HG22 ' A' ' 518' ' ' THR . 8.3 p -67.68 -22.24 28.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 122.496 1.141 . . . . 62.130000000000003 108.838 177.304 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -79.9 -18.12 51.39 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 113.113 -1.858 . . . . 71.209999999999994 110.188 -175.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 18.7 t -102.07 -166.6 1.31 Allowed 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 115.612 -0.722 . . . . 52.119999999999997 109.512 -176.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 8.7 p -117.09 137.67 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.398 0 CA-C-N 115.162 -0.926 . . . . 73.5 109.196 -177.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.0 mt -91.68 141.37 14.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.324 -0.991 . . . . 74.400000000000006 108.324 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -102.29 116.93 33.68 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 108.506 -0.924 . . . . 73.430000000000007 108.506 -177.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.415 HD13 HG22 ' A' ' 537' ' ' THR . 3.2 mm? -106.78 121.11 43.74 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.785 0.834 . . . . 70.340000000000003 109.921 -179.316 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.433 HE22 ' HB2' ' A' ' 538' ' ' ASN . 2.9 mp0 -88.35 122.76 32.22 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.922 -0.769 . . . . 62.340000000000003 108.922 174.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 524' ' ' SER . 25.4 t -110.2 134.66 51.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 108.763 -0.828 . . . . 72.239999999999995 108.763 -178.269 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.687 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 75.5 m -81.57 131.1 35.26 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 120.093 -0.643 . . . . 74.150000000000006 109.885 176.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -99.69 131.78 45.46 Favored 'General case' 0 N--CA 1.411 -2.407 0 N-CA-C 104.28 -2.489 . . . . 64.329999999999998 104.28 166.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 529' ' ' ARG . . . -60.17 -26.01 63.09 Favored Glycine 0 CA--C 1.49 -1.517 0 O-C-N 124.13 0.893 . . . . 65.439999999999998 112.924 -173.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 71.77 -15.44 0.45 Allowed 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 125.191 1.396 . . . . 74.310000000000002 110.721 178.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.466 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 89.9 mt-30 -113.18 144.34 42.84 Favored 'General case' 0 N--CA 1.416 -2.167 0 C-N-CA 123.37 0.668 . . . . 61.009999999999998 111.754 -174.371 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -123.31 146.69 47.7 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.678 -1.23 . . . . 73.209999999999994 107.678 177.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.81 117.97 12.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.417 0.627 . . . . 74.120000000000005 110.504 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 51.9 ttp -81.11 120.51 78.82 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 115.626 -0.715 . . . . 63.409999999999997 110.246 -177.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.76 169.78 12.49 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 123.156 2.571 . . . . 61.539999999999999 111.917 176.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -65.53 115.49 5.81 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 122.195 0.998 . . . . 72.310000000000002 112.634 -178.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 2.2 pp -131.37 6.19 4.46 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 113.81 -1.541 . . . . 74.140000000000001 107.784 170.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 14.5 m -80.08 142.09 35.2 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 113.627 -1.624 . . . . 72.519999999999996 109.499 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . 0.549 ' H ' ' CG1' ' A' ' 603' ' ' VAL . . . 80.64 48.17 6.38 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 121.353 -0.451 . . . . 73.319999999999993 112.839 178.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 21.6 ptp -152.31 -174.71 4.98 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 109.331 -0.618 . . . . 71.310000000000002 109.331 178.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -95.08 166.65 11.82 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.637 -0.875 . . . . 71.400000000000006 108.637 -173.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 22.3 t-105 -66.58 -29.06 69.03 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.998 -0.742 . . . . 53.219999999999999 108.998 178.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.9 p -73.89 -12.36 15.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 CA-C-O 121.968 0.89 . . . . 63.020000000000003 109.948 -178.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -101.49 -29.48 11.96 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 115.725 -0.671 . . . . 64.430000000000007 111.146 173.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -62.46 -47.77 82.55 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.75 0.657 . . . . 71.140000000000001 111.166 179.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.492 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 43.1 mt-10 -55.5 -51.81 77.0 Favored Pre-proline 0 CA--C 1.56 1.348 0 N-CA-C 113.463 0.912 . . . . 72.430000000000007 113.463 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 575' ' ' GLU . 31.9 Cg_exo -61.86 -40.24 45.93 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.613 1.542 . . . . 73.409999999999997 113.128 174.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.425 ' HA ' ' NE ' ' A' ' 577' ' ' ARG . 3.3 mmp_? -60.76 -40.58 93.04 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 111.4 0.148 . . . . 63.450000000000003 111.4 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 579' ' ' ARG . 4.3 pp -65.97 -46.58 77.54 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.543 -0.463 . . . . 72.239999999999995 112.029 -176.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.551 ' N ' HD12 ' A' ' 578' ' ' LEU . 15.1 ptp180 -66.82 -36.1 81.6 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.503 -0.317 . . . . 74.219999999999999 111.611 178.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.1 -30.67 67.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.255 0.55 . . . . 50.119999999999997 110.53 178.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 11.4 tp -81.43 -9.73 59.66 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.294 0.569 . . . . 62.299999999999997 110.452 177.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 76.5 26.71 62.73 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.445 -0.884 . . . . 75.030000000000001 112.062 179.44 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.414 ' CD1' ' HA3' ' A' ' 618' ' ' GLY . 16.0 t90 -87.33 126.49 34.88 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 107.705 -1.22 . . . . 71.340000000000003 107.705 176.192 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 41.7 p -115.24 0.49 13.54 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 112.918 0.711 . . . . 72.239999999999995 112.918 -175.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -81.5 -173.88 48.58 Favored Glycine 0 C--O 1.248 0.996 0 C-N-CA 120.499 -0.857 . . . . 54.420000000000002 112.011 178.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 65.8 mtt -100.27 147.91 25.24 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 120.853 0.359 . . . . 74.010000000000005 110.729 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.1 tt -91.56 122.49 34.18 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.346 -1.353 . . . . 74.340000000000003 107.346 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.561 ' O ' ' HA ' ' A' ' 621' ' ' THR . 32.3 t70 -98.65 119.87 38.11 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.231 -0.655 . . . . 64.340000000000003 109.231 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.49 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -111.88 135.05 53.02 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 116.181 -0.463 . . . . 64.120000000000005 110.035 179.953 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -73.01 -88.4 0.17 Allowed Glycine 0 C--N 1.297 -1.609 0 N-CA-C 110.727 -0.949 . . . . 64.010000000000005 110.727 179.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.7 154.12 47.4 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.778 -0.452 . . . . 73.340000000000003 109.778 177.192 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . 0.524 ' HA ' ' O ' ' A' ' 624' ' ' PHE . 3.3 p30 -100.49 132.54 45.82 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.62 -0.881 . . . . 75.439999999999998 108.62 174.254 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 46.3 t -105.08 139.09 27.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 108.651 -0.87 . . . . 75.299999999999997 108.651 -176.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . 0.605 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 7.3 p-10 -71.53 110.9 6.41 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 122.185 0.993 . . . . 73.219999999999999 111.884 -173.316 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -113.24 -55.78 2.48 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.008 -0.996 . . . . 64.120000000000005 108.469 179.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 139.18 141.7 4.14 Favored Glycine 0 N--CA 1.416 -2.64 0 CA-C-N 115.613 -0.721 . . . . 71.209999999999994 111.465 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -59.77 -36.05 88.52 Favored Glycine 0 N--CA 1.446 -0.686 0 O-C-N 123.844 0.379 . . . . 73.299999999999997 112.744 -178.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 15.1 m -67.07 -24.7 66.0 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 123.053 0.541 . . . . 62.329999999999998 111.269 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -92.81 -12.75 30.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.867 0.365 . . . . 75.120000000000005 110.759 -178.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 23.2 m170 67.71 145.83 0.04 OUTLIER 'General case' 0 C--O 1.246 0.889 0 N-CA-C 114.914 1.45 . . . . 75.450000000000003 114.914 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -77.68 89.15 3.96 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 114.11 -1.405 . . . . 74.140000000000001 111.027 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -101.13 154.34 18.82 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.651 -1.24 . . . . 73.340000000000003 107.651 176.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.549 ' CG1' ' H ' ' A' ' 568' ' ' GLY . 8.8 p -67.87 141.96 17.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.402 -0.962 . . . . 72.239999999999995 108.402 176.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.51 -53.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.726 -0.842 . . . . 73.200000000000003 108.726 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -149.0 145.65 27.42 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.779 -0.823 . . . . 75.420000000000002 108.779 -178.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -129.19 136.26 49.91 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.543 -1.28 . . . . 74.109999999999999 107.543 173.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.494 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 48.7 t30 -55.4 -54.1 54.81 Favored Pre-proline 0 C--N 1.314 -0.959 0 N-CA-C 112.697 0.629 . . . . 71.129999999999995 112.697 -178.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.8 Cg_endo -87.72 107.2 0.6 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 121.579 1.519 . . . . 75.230000000000004 109.47 173.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.29 160.8 47.76 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 123.308 2.672 . . . . 71.420000000000002 113.362 -177.407 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.64 130.07 44.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.149 -0.478 . . . . 65.120000000000005 109.772 177.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.3 -3.08 40.18 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.707 -0.758 . . . . 63.130000000000003 112.833 -178.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 2.1 t -101.88 162.99 12.49 Favored 'General case' 0 C--O 1.25 1.104 0 N-CA-C 108.329 -0.989 . . . . 75.120000000000005 108.329 178.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -85.13 127.81 8.39 Favored Glycine 0 N--CA 1.434 -1.472 0 C-N-CA 120.657 -0.782 . . . . 72.129999999999995 111.726 179.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 32.7 m -112.04 141.65 26.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.801 -0.814 . . . . 53.0 108.801 177.243 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.466 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 33.7 p-10 -56.47 176.27 0.09 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.631 1.173 . . . . 60.210000000000001 114.025 -175.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -56.93 -27.98 61.56 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.881 0.872 . . . . 72.430000000000007 112.504 -177.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.448 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 6.5 m-20 -94.25 -6.11 45.31 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 120.629 -0.428 . . . . 75.120000000000005 110.592 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . 0.414 ' HA3' ' CD1' ' A' ' 583' ' ' TRP . . . 66.19 17.93 66.51 Favored Glycine 0 CA--C 1.497 -1.053 0 C-N-CA 124.088 0.851 . . . . 31.199999999999999 113.993 170.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.21 119.24 15.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 122.312 1.053 . . . . 71.409999999999997 111.767 -165.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 45.0 pt -122.18 134.56 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 114.679 -1.146 . . . . 71.319999999999993 110.141 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 9.7 t -105.8 129.85 53.9 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.447 -0.945 . . . . 62.229999999999997 108.447 177.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.5 pp -138.86 166.03 25.49 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 113.037 0.754 . . . . 60.350000000000001 113.037 -176.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -128.11 137.33 52.08 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.085 -1.45 . . . . 73.230000000000004 107.085 176.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 592' ' ' ASP . 3.0 p90 -140.09 166.1 25.57 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.316 -0.554 . . . . 74.099999999999994 111.909 -172.321 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -76.27 169.39 54.87 Favored Glycine 0 N--CA 1.429 -1.817 0 CA-C-N 115.621 -0.718 . . . . 52.420000000000002 113.136 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.605 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 27.0 tt0 . . . . . 0 C--N 1.274 -2.717 0 N-CA-C 106.919 -1.511 . . . . 75.319999999999993 106.919 178.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.222 0 N-CA-C 110.194 -1.162 . . . . 63.409999999999997 110.194 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -72.24 149.55 51.63 Favored 'Trans proline' 0 C--O 1.243 0.759 0 C-N-CA 121.934 1.756 . . . . 74.230000000000004 111.463 178.586 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 61.76 6.02 1.49 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.302 1.441 . . . . 64.129999999999995 113.687 177.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 14.1 p -138.01 139.57 39.7 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 109.079 -0.712 . . . . 73.239999999999995 109.079 179.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.444 ' HE3' ' O ' ' A' ' 516' ' ' GLY . 74.7 mmtt -123.27 134.01 54.13 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-O 121.007 0.432 . . . . 71.140000000000001 110.311 -175.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.4 p-10 -95.78 127.77 42.09 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.091 -0.959 . . . . 74.209999999999994 109.135 178.441 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 27.0 pt -106.2 122.87 40.8 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 115.976 -0.556 . . . . 64.409999999999997 111.217 -178.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.41 -175.45 1.79 Allowed 'Trans proline' 0 C--O 1.248 0.992 0 C-N-CA 122.165 1.91 . . . . 73.329999999999998 110.477 175.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.404 ' HA ' ' HB1' ' A' ' 541' ' ' ALA . 9.1 p-10 -79.71 89.98 5.19 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.617 1.199 . . . . 51.140000000000001 110.565 178.41 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.29 -11.01 12.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.001 -1.454 . . . . 52.32 110.178 177.212 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.413 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -67.38 103.15 1.22 Allowed 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 114.53 -1.214 . . . . 72.519999999999996 109.12 178.388 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 148.86 -30.92 1.22 Allowed Glycine 0 C--N 1.293 -1.816 0 C-N-CA 120.493 -0.86 . . . . 54.520000000000003 112.095 178.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.42 ' O ' HG12 ' A' ' 534' ' ' VAL . 10.0 pt20 -94.76 -169.83 2.1 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 120.009 -0.677 . . . . 74.239999999999995 110.14 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 2.9 m -74.16 156.08 37.71 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.785 -0.82 . . . . 73.430000000000007 108.785 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.532 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.7 p -57.91 -47.76 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 O-C-N 123.464 0.477 . . . . 72.129999999999995 112.152 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -65.24 -36.69 84.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 120.565 -0.454 . . . . 32.229999999999997 110.012 -178.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.79 -41.92 85.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.831 0 CA-C-N 115.907 -0.588 . . . . 74.340000000000003 109.523 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -65.39 -45.24 84.76 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.749 -0.205 . . . . 70.209999999999994 110.912 177.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.5 mt-30 -63.97 -45.75 87.69 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 123.395 0.435 . . . . 65.439999999999998 110.759 -178.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.532 ' O ' HG23 ' A' ' 514' ' ' VAL . 0.1 OUTLIER -67.34 -39.35 85.78 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 116.154 -0.476 . . . . 62.420000000000002 110.007 -178.229 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -62.62 -46.89 86.16 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 123.39 0.431 . . . . 63.420000000000002 111.013 -179.332 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.3 pp -68.5 -35.81 78.03 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 115.83 -0.623 . . . . 62.450000000000003 110.995 -178.328 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.402 ' N ' HD12 ' A' ' 512' ' ' LEU . 1.9 t-20 -63.3 -35.98 82.17 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 123.512 0.725 . . . . 72.439999999999998 110.315 179.016 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 510' ' ' LYS . 85.0 t -63.47 -32.47 56.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.884 0 CA-C-O 121.127 0.489 . . . . 75.209999999999994 110.838 177.107 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . 0.435 ' O ' ' HD2' ' A' ' 495' ' ' LYS . 11.1 m-85 -103.32 3.65 35.57 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.928 -0.397 . . . . 64.239999999999995 109.928 -178.052 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . 0.444 ' O ' ' HE3' ' A' ' 495' ' ' LYS . . . -134.88 -54.99 0.07 OUTLIER Glycine 0 N--CA 1.416 -2.634 0 C-N-CA 118.803 -1.665 . . . . 74.439999999999998 115.019 -169.094 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 66.1 20.82 11.21 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.94 0.876 . . . . 74.329999999999998 109.032 -172.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 2.8 p -81.6 -174.87 5.23 Favored 'General case' 0 N--CA 1.407 -2.59 0 CA-C-N 114.155 -1.384 . . . . 63.43 110.462 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.69 138.99 42.92 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.951 -1.129 . . . . 72.299999999999997 107.951 -178.204 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 551' ' ' ILE . 18.9 p90 -130.02 152.56 49.35 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 123.303 0.377 . . . . 72.219999999999999 110.588 -178.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 11.1 p -140.83 144.69 35.5 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 107.888 -1.153 . . . . 73.319999999999993 107.888 177.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -117.71 136.68 53.19 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.112 -0.635 . . . . 71.409999999999997 111.084 -178.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -132.29 129.85 40.1 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.013 -1.106 . . . . 72.439999999999998 108.013 177.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 32.6 t -99.73 135.03 41.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.443 0.64 . . . . 73.340000000000003 110.716 -177.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 556' ' ' SER . 8.7 p -135.21 150.99 29.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 107.747 -1.205 . . . . 75.019999999999996 107.747 178.092 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -82.79 135.67 34.9 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.398 0.618 . . . . 74.209999999999994 111.308 -178.012 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 72.4 m -164.23 160.2 16.36 Favored Pre-proline 0 C--N 1.308 -1.217 0 N-CA-C 106.32 -1.733 . . . . 75.540000000000006 106.32 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -64.29 -4.6 8.19 Favored 'Trans proline' 0 CA--C 1.553 1.471 0 C-N-CA 122.576 2.184 . . . . 62.450000000000003 114.084 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -70.69 130.08 89.18 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 107.755 -1.202 . . . . 73.129999999999995 107.755 173.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.8 148.13 76.83 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 122.417 2.078 . . . . 73.109999999999999 112.283 -176.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.25 111.52 1.1 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.303 -0.862 . . . . 75.400000000000006 111.614 -176.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 123.88 -16.76 7.75 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 115.397 -0.82 . . . . 71.030000000000001 112.143 178.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.69 129.42 34.96 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.216 -0.661 . . . . 71.430000000000007 109.216 179.505 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 503' ' ' GLN . 6.5 p -87.38 115.35 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 CA-C-O 121.459 0.647 . . . . 72.420000000000002 109.345 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -31.74 72.71 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.109 -0.951 . . . . 74.239999999999995 110.04 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 164.15 -174.61 40.27 Favored Glycine 0 N--CA 1.416 -2.656 0 CA-C-N 115.243 -0.89 . . . . 63.439999999999998 111.309 179.079 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . 0.449 HG22 ' HG ' ' A' ' 553' ' ' LEU . 5.8 p -116.36 153.21 32.42 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 108.215 -1.032 . . . . 63.219999999999999 108.215 179.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -61.9 -47.57 91.08 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 119.47 -0.892 . . . . 72.420000000000002 111.431 179.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -67.82 120.32 7.32 Favored 'Trans proline' 0 C--N 1.367 1.551 0 N-CA-C 107.216 -1.878 . . . . 74.0 107.216 165.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.21 142.57 97.35 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.887 2.391 . . . . 75.420000000000002 113.687 -174.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . 0.404 ' HB1' ' HA ' ' A' ' 499' ' ' ASP . . . -61.57 129.89 43.31 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.855 -0.612 . . . . 71.420000000000002 110.253 178.072 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 103.69 -7.05 49.34 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 111.386 -0.686 . . . . 54.030000000000001 111.386 -178.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 24.0 m -89.33 137.11 32.61 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 122.729 -0.277 . . . . 70.310000000000002 110.507 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 8.8 t -88.7 125.35 34.81 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 107.028 -1.471 . . . . 64.25 107.028 171.627 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 36.0 m -122.87 159.77 52.15 Favored Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 109.416 -0.587 . . . . 73.140000000000001 109.416 -175.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -66.92 139.91 53.22 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.92 1.746 . . . . 72.109999999999999 111.031 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.5 p -61.2 -20.85 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 CA-C-O 121.591 0.71 . . . . 73.019999999999996 110.378 178.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -77.87 -19.04 55.51 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.222 -0.899 . . . . 71.120000000000005 112.105 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 78.5 p -83.21 174.0 11.15 Favored 'General case' 0 C--O 1.247 0.958 0 N-CA-C 112.635 0.605 . . . . 64.120000000000005 112.635 -176.223 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.6 p -113.52 137.92 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 109.133 -0.691 . . . . 72.120000000000005 109.133 -178.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 520' ' ' PHE . 59.8 mt -103.95 115.39 45.8 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 N-CA-C 107.706 -1.22 . . . . 72.230000000000004 107.706 178.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -103.73 129.18 51.06 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.399 -0.92 . . . . 72.5 110.556 178.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.449 ' HG ' HG22 ' A' ' 537' ' ' THR . 7.4 mp -97.78 126.91 43.37 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 114.314 -1.312 . . . . 72.209999999999994 110.259 -177.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -88.15 111.94 22.16 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 107.058 -1.46 . . . . 61.409999999999997 107.058 173.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 524' ' ' SER . 22.2 t -97.52 132.68 41.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 N-CA-C 107.207 -1.405 . . . . 65.420000000000002 107.207 -178.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 72.3 m -94.7 134.03 37.73 Favored 'General case' 0 N--CA 1.404 -2.772 0 C-N-CA 119.36 -0.936 . . . . 74.150000000000006 111.684 177.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.0 133.88 41.86 Favored 'General case' 0 N--CA 1.402 -2.859 0 N-CA-C 104.637 -2.357 . . . . 72.420000000000002 104.637 168.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -54.32 -23.27 25.63 Favored Glycine 0 N--CA 1.468 0.822 0 O-C-N 124.493 1.12 . . . . 73.340000000000003 114.842 -171.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 81.06 -23.85 0.21 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.988 1.715 . . . . 72.040000000000006 109.253 -177.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.463 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 77.6 mt-30 -110.75 161.44 15.77 Favored 'General case' 0 N--CA 1.41 -2.456 0 CA-C-N 115.208 -0.905 . . . . 75.299999999999997 109.922 -172.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . 0.422 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 47.5 p90 -137.56 155.44 49.22 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 107.793 -1.188 . . . . 71.409999999999997 107.793 177.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.14 118.65 14.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 O-C-N 123.751 0.657 . . . . 74.120000000000005 110.188 179.177 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 40.2 ttp -85.86 128.48 58.22 Favored Pre-proline 0 C--N 1.298 -1.633 0 CA-C-N 116.026 -0.533 . . . . 70.430000000000007 110.495 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.54 169.96 14.69 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.183 2.589 . . . . 71.450000000000003 111.514 175.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . 0.42 ' HA ' ' HB2' ' A' ' 610' ' ' ALA . 5.8 p-10 -66.09 124.11 21.71 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.742 0.782 . . . . 72.530000000000001 112.355 -179.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 8.9 tt -115.76 3.91 13.91 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.746 -1.576 . . . . 65.310000000000002 106.746 174.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 14.3 m -76.39 131.42 39.12 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.055 -1.429 . . . . 74.109999999999999 109.123 179.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 74.22 61.06 3.33 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.989 -0.624 . . . . 71.310000000000002 113.44 176.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . 0.529 ' HB2' ' HB2' ' A' ' 573' ' ' ASP . 20.1 ptp -162.66 173.12 14.31 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.696 -0.853 . . . . 73.140000000000001 108.696 177.528 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -101.15 175.73 5.49 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.864 -0.791 . . . . 75.439999999999998 108.864 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -61.64 -34.89 76.48 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.169 -1.049 . . . . 74.409999999999997 108.169 177.34 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 31.6 m -69.29 -10.25 13.22 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 CA-C-N 115.386 -0.825 . . . . 63.229999999999997 112.084 -179.171 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 569' ' ' MET . 16.0 m-20 -101.87 -44.22 5.58 Favored 'General case' 0 C--O 1.248 1.02 0 N-CA-C 108.946 -0.761 . . . . 62.039999999999999 108.946 174.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . 0.444 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -62.0 -53.22 58.64 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 114.173 -1.376 . . . . 62.130000000000003 112.107 -175.741 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.45 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 33.8 tt0 -56.93 -47.83 98.42 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 123.396 0.435 . . . . 73.129999999999995 111.993 -176.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.465 ' HA ' ' HG2' ' A' ' 579' ' ' ARG . 73.8 Cg_exo -52.72 -44.74 45.51 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.242 1.961 . . . . 73.329999999999998 113.411 172.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -64.64 -37.92 89.21 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.705 -0.479 . . . . 74.239999999999995 109.705 178.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.599 HD13 ' CZ3' ' A' ' 583' ' ' TRP . 78.5 mt -67.38 -48.29 67.83 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.564 -0.744 . . . . 65.140000000000001 111.679 -178.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.465 ' HG2' ' HA ' ' A' ' 576' ' ' PRO . 16.9 ptp180 -65.85 -34.18 77.56 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 120.953 0.406 . . . . 73.209999999999994 111.086 177.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -69.95 -30.81 68.28 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.208 -0.451 . . . . 73.129999999999995 110.409 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 578' ' ' LEU . 3.1 pp -81.34 -8.54 59.76 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 119.751 -0.779 . . . . 64.040000000000006 111.244 177.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 80.08 54.43 3.85 Favored Glycine 0 CA--C 1.504 -0.648 0 N-CA-C 110.824 -0.911 . . . . 65.439999999999998 110.824 -178.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.599 ' CZ3' HD13 ' A' ' 578' ' ' LEU . 14.0 t90 -80.45 127.89 32.94 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.758 0.313 . . . . 72.310000000000002 111.361 -178.651 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 32.0 p -106.59 -12.95 15.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.508 -0.314 . . . . 55.130000000000003 111.727 179.296 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -85.95 -175.18 49.95 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 121.055 -0.593 . . . . 51.229999999999997 112.809 -175.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 64.1 mtt -118.91 149.28 41.84 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.674 0.273 . . . . 73.510000000000005 110.27 -178.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 7.7 tt -87.91 130.17 35.0 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-O 121.212 0.53 . . . . 54.329999999999998 111.08 -175.494 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.558 ' O ' ' HA ' ' A' ' 621' ' ' THR . 18.9 t70 -117.59 121.76 41.8 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.041 -0.981 . . . . 72.439999999999998 109.172 175.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.3 OUTLIER -104.4 133.48 49.22 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.743 -1.206 . . . . 75.329999999999998 107.743 174.351 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -85.75 -26.39 35.26 Favored Glycine 0 C--N 1.294 -1.804 0 C-N-CA 120.784 -0.722 . . . . 65.239999999999995 112.548 -176.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.42 139.76 37.18 Favored 'General case' 0 N--CA 1.42 -1.973 0 C-N-CA 120.847 -0.341 . . . . 70.420000000000002 110.905 -178.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -116.11 124.45 50.4 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 105.046 -2.205 . . . . 61.310000000000002 105.046 171.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . 0.416 ' HB ' ' HA2' ' A' ' 625' ' ' GLY . 58.6 t -115.29 117.44 55.62 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 N-CA-C 108.659 -0.867 . . . . 70.319999999999993 108.659 -177.05 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -73.69 106.65 5.53 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.617 0.722 . . . . 71.140000000000001 109.838 -179.1 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -123.51 -58.37 1.61 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.976 -1.011 . . . . 75.349999999999994 108.899 179.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 131.8 148.23 6.1 Favored Glycine 0 N--CA 1.431 -1.648 0 N-CA-C 110.717 -0.953 . . . . 72.540000000000006 110.717 178.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -62.99 -33.95 88.62 Favored Glycine 0 C--N 1.314 -0.676 0 N-CA-C 112.468 -0.253 . . . . 73.310000000000002 112.468 -178.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 23.4 t -75.14 -23.51 57.85 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.199 1.0 . . . . 72.109999999999999 108.661 -179.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -87.81 -3.02 58.97 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.713 -1.13 . . . . 61.439999999999998 110.236 -178.178 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 47.4 m80 69.73 95.44 0.07 Allowed 'General case' 0 C--O 1.247 0.925 0 C-N-CA 124.987 1.315 . . . . 71.340000000000003 112.977 175.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -83.93 80.22 9.23 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 109.044 -0.724 . . . . 45.020000000000003 109.044 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -98.48 159.8 14.71 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.535 -0.757 . . . . 62.520000000000003 109.964 -179.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 59.6 t -70.84 130.2 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 107.331 -1.359 . . . . 74.420000000000002 107.331 176.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 31.5 m -108.84 -29.8 2.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 123.574 0.546 . . . . 64.049999999999997 111.516 -176.207 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -155.91 139.27 15.75 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 120.74 0.305 . . . . 74.030000000000001 110.252 -179.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -121.19 128.38 52.4 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 115.516 -0.766 . . . . 61.399999999999999 109.19 173.609 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -56.6 -51.1 83.81 Favored Pre-proline 0 N--CA 1.475 0.816 0 O-C-N 123.846 0.716 . . . . 71.140000000000001 110.799 178.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -77.07 111.81 3.29 Favored 'Trans proline' 0 C--N 1.371 1.756 0 N-CA-C 108.495 -1.387 . . . . 52.340000000000003 108.495 168.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.93 155.19 62.51 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.78 2.32 . . . . 44.520000000000003 113.491 -177.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . 0.42 ' HB2' ' HA ' ' A' ' 565' ' ' ASP . . . -67.58 130.76 44.02 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.378 -0.828 . . . . 61.549999999999997 109.876 177.335 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.18 -5.88 59.42 Favored Glycine 0 C--N 1.305 -1.159 0 N-CA-C 111.245 -0.742 . . . . 44.329999999999998 111.245 -177.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 28.8 m -101.66 156.11 17.69 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.889 -0.782 . . . . 54.32 108.889 -179.591 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -80.28 135.07 14.28 Favored Glycine 0 N--CA 1.422 -2.274 0 CA-C-N 116.363 -0.381 . . . . 63.399999999999999 112.431 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 29.3 m -120.74 142.98 34.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 N-CA-C 107.777 -1.194 . . . . 75.349999999999994 107.777 175.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.463 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 29.4 p-10 -48.97 163.47 0.08 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.766 0.826 . . . . 71.519999999999996 112.144 -179.098 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -58.67 -27.7 65.03 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.43 0.53 . . . . 71.420000000000002 112.43 -175.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -81.15 -7.18 59.51 Favored 'General case' 0 C--O 1.2 -1.51 0 C-N-CA 119.931 -0.708 . . . . 73.150000000000006 111.138 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.35 19.66 68.76 Favored Glycine 0 CA--C 1.492 -1.374 0 CA-C-O 119.831 -0.427 . . . . 62.229999999999997 113.445 169.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.88 119.27 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-O 121.834 0.826 . . . . 74.430000000000007 109.69 -168.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . . . . . . . . . 39.4 pt -118.84 133.84 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.807 0 CA-C-N 114.857 -1.065 . . . . 74.340000000000003 112.258 -176.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 8.8 t -110.84 118.24 35.58 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 107.327 -1.36 . . . . 64.200000000000003 107.327 174.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -138.54 168.95 18.68 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.578 -0.737 . . . . 64.239999999999995 111.476 -173.938 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -125.95 135.76 52.23 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-O 122.53 1.157 . . . . 53.539999999999999 110.026 175.482 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -142.9 169.63 17.2 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 105.114 -2.18 . . . . 74.140000000000001 105.114 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . 0.416 ' HA2' ' HB ' ' A' ' 593' ' ' VAL . . . -52.33 -128.08 0.0 OUTLIER Glycine 0 CA--C 1.559 2.802 0 N-CA-C 115.878 1.111 . . . . 31.41 115.878 178.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 . . . . . 0 C--N 1.277 -2.554 0 O-C-N 120.805 -1.409 . . . . 52.420000000000002 110.561 -176.292 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.845 0 N-CA-C 110.248 -1.141 . . . . 44.240000000000002 110.248 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.41 143.07 51.31 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.062 1.841 . . . . 74.519999999999996 111.511 178.438 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -91.41 -5.76 53.9 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.461 0.648 . . . . 65.109999999999999 111.114 -178.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 44.9 p -136.02 147.01 47.76 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.244 -0.889 . . . . 64.209999999999994 108.987 178.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -135.77 145.84 46.98 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.151 0.5 . . . . 75.439999999999998 110.272 176.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.0 m-20 -79.87 126.83 31.5 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.077 -0.965 . . . . 74.450000000000003 108.992 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.5 pt -91.93 131.12 36.17 Favored Pre-proline 0 C--N 1.306 -1.313 0 C-N-CA 120.455 -0.498 . . . . 72.030000000000001 110.746 178.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -83.39 177.06 6.72 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.371 2.047 . . . . 61.32 111.626 177.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -88.44 122.71 32.23 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.289 0.566 . . . . 74.439999999999998 109.942 178.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.458 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 27.8 m -120.27 8.28 6.36 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-N 115.234 -0.893 . . . . 74.319999999999993 110.803 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -78.13 99.86 6.35 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 116.024 -0.535 . . . . 74.299999999999997 110.953 -177.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 157.55 -37.67 0.55 Allowed Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.667 -0.778 . . . . 61.030000000000001 111.945 178.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -89.46 -172.04 3.45 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 122.534 -0.392 . . . . 74.430000000000007 109.983 -178.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 3.6 m -71.2 155.53 40.63 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 108.618 -0.882 . . . . 71.019999999999996 108.618 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.49 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.7 p -62.65 -43.56 98.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 O-C-N 123.109 0.256 . . . . 62.140000000000001 111.584 -178.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.17 -37.89 88.78 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.061 -0.256 . . . . 74.430000000000007 110.526 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 66.0 t -67.59 -45.92 84.06 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.375 0 N-CA-C 109.272 -0.64 . . . . 75.129999999999995 109.272 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.458 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -59.17 -44.88 92.16 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.553 0.216 . . . . 74.319999999999993 111.43 179.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.2 mt-30 -63.84 -45.88 87.53 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.098 -0.501 . . . . 74.109999999999999 111.028 -178.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.549 ' O ' HG23 ' A' ' 514' ' ' VAL . 13.7 ptmm? -67.54 -37.97 83.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.335 -0.393 . . . . 73.239999999999995 111.086 179.325 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -61.18 -48.86 79.61 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 116.059 -0.519 . . . . 73.340000000000003 110.631 -179.566 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.4 pp -68.17 -35.47 78.09 Favored 'General case' 0 C--O 1.209 -1.046 0 CA-C-N 115.945 -0.57 . . . . 73.099999999999994 110.619 -178.633 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -59.95 -35.73 75.57 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 123.951 0.9 . . . . 62.200000000000003 110.751 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 510' ' ' LYS . 98.8 t -58.28 -35.03 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 122.763 0.425 . . . . 64.340000000000003 111.862 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -112.28 -1.38 15.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.567 0.699 . . . . 63.109999999999999 109.959 -177.612 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -113.37 -60.2 0.41 Allowed Glycine 0 N--CA 1.421 -2.35 0 CA-C-N 115.321 -0.854 . . . . 71.140000000000001 113.033 -171.105 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 63.0 27.09 15.79 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.519 1.152 . . . . 75.239999999999995 109.293 -174.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.3 p -85.43 -170.03 2.93 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 113.914 -1.494 . . . . 53.43 109.722 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -107.95 139.41 42.61 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.466 -1.309 . . . . 73.409999999999997 107.466 174.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -130.7 149.49 52.32 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.149 0.5 . . . . 72.040000000000006 111.224 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 19.7 p -140.8 157.67 45.07 Favored 'General case' 0 N--CA 1.405 -2.693 0 N-CA-C 107.142 -1.429 . . . . 71.430000000000007 107.142 178.366 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -125.57 141.17 52.17 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 120.711 -0.396 . . . . 71.430000000000007 110.094 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 554' ' ' GLN . . . -131.63 143.16 50.11 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.249 -1.389 . . . . 51.409999999999997 107.249 178.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 14.9 m -105.47 139.64 39.79 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.071 -0.651 . . . . 54.229999999999997 111.839 -175.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.47 149.54 33.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 109.218 -0.66 . . . . 71.219999999999999 109.218 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.28 134.79 50.92 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.445 -0.576 . . . . 71.549999999999997 109.445 177.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 556' ' ' SER . 74.1 m -160.22 166.59 15.47 Favored Pre-proline 0 C--N 1.316 -0.886 0 N-CA-C 109.885 -0.413 . . . . 54.329999999999998 109.885 179.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -78.1 -6.91 16.08 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.976 1.784 . . . . 45.350000000000001 113.03 175.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.449 ' HG2' ' OE2' ' A' ' 533' ' ' GLU . 3.3 mpt_? -88.52 149.32 44.09 Favored Pre-proline 0 CA--C 1.516 -0.352 0 N-CA-C 109.769 -0.456 . . . . 72.200000000000003 109.769 -179.351 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.47 147.01 86.55 Favored 'Trans proline' 0 C--O 1.258 1.488 0 C-N-CA 122.668 2.245 . . . . 73.310000000000002 112.792 -178.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.91 106.9 0.63 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.054 -0.975 . . . . 74.209999999999994 110.759 -179.282 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 152.1 -31.58 0.88 Allowed Glycine 0 N--CA 1.433 -1.552 0 N-CA-C 110.193 -1.163 . . . . 72.239999999999995 110.193 -178.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . 0.449 ' OE2' ' HG2' ' A' ' 529' ' ' ARG . 34.1 tt0 -76.98 139.1 40.0 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.154 0.502 . . . . 72.540000000000006 109.977 178.148 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.25 118.44 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.462 0 N-CA-C 108.132 -1.062 . . . . 70.209999999999994 108.132 174.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.4 p -79.51 -11.33 59.9 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.43 -0.804 . . . . 73.430000000000007 112.56 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.87 -168.17 29.36 Favored Glycine 0 CA--C 1.481 -2.087 0 C-N-CA 120.119 -1.039 . . . . 61.520000000000003 112.404 175.154 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . 0.489 HG22 ' HG ' ' A' ' 553' ' ' LEU . 12.6 p -116.68 158.18 24.21 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 107.469 -1.308 . . . . 53.539999999999999 107.469 179.188 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -63.21 -49.44 80.07 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 118.505 -1.278 . . . . 72.239999999999995 111.995 176.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 540' ' ' PRO . 18.9 Cg_exo -70.24 149.25 63.57 Favored 'Trans proline' 0 C--N 1.369 1.647 0 CA-C-N 120.486 1.209 . . . . 62.530000000000001 110.447 173.103 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 539' ' ' PRO . 13.8 Cg_exo -70.5 144.85 51.24 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.706 2.271 . . . . 74.340000000000003 113.167 -178.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -68.41 129.73 40.79 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.428 -0.582 . . . . 73.409999999999997 109.428 176.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 104.35 -10.82 50.8 Favored Glycine 0 C--N 1.309 -0.938 0 N-CA-C 110.94 -0.864 . . . . 52.240000000000002 110.94 -176.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 92.3 m -88.09 137.11 32.62 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 109.985 -0.376 . . . . 54.420000000000002 109.985 178.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.1 t -86.36 132.28 34.0 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.688 -0.856 . . . . 71.219999999999999 108.688 175.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.89 155.98 74.7 Favored Pre-proline 0 C--N 1.305 -1.345 0 N-CA-C 108.289 -1.004 . . . . 74.109999999999999 108.289 -179.594 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.407 ' HG2' ' HB3' ' A' ' 549' ' ' SER . 10.1 Cg_endo -58.48 137.11 78.57 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.551 1.501 . . . . 60.140000000000001 111.289 178.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.63 -23.85 34.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 123.701 0.801 . . . . 73.209999999999994 113.016 -174.088 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -97.38 -0.11 46.91 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 120.317 -0.553 . . . . 74.420000000000002 111.857 -177.2 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . 0.407 ' HB3' ' HG2' ' A' ' 546' ' ' PRO . 89.4 p -78.08 170.94 15.77 Favored 'General case' 0 C--O 1.256 1.429 0 C-N-CA 119.63 -0.828 . . . . 72.140000000000001 110.96 -178.614 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.8 p -110.24 115.75 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-O 121.934 0.874 . . . . 43.030000000000001 109.839 -178.256 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 52.1 mt -85.55 130.82 35.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 114.94 -1.027 . . . . 61.409999999999997 108.579 -177.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . 0.413 ' OE1' ' HD3' ' A' ' 539' ' ' PRO . 0.4 OUTLIER -103.55 120.73 41.44 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.727 0.775 . . . . 63.100000000000001 111.182 178.873 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.489 ' HG ' HG22 ' A' ' 537' ' ' THR . 7.1 mp -99.2 124.09 43.99 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 113.983 -1.462 . . . . 73.209999999999994 109.338 178.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 523' ' ' ALA . 2.9 mp0 -88.28 117.73 27.39 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.436 -0.802 . . . . 62.350000000000001 111.04 -179.087 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 32.0 t -93.23 126.41 45.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.004 -0.998 . . . . 60.030000000000001 108.35 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 527' ' ' SER . 17.0 p -82.04 117.87 22.57 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 109.489 -0.56 . . . . 30.239999999999998 109.489 178.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -97.68 137.46 36.54 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 108.432 -0.951 . . . . 72.230000000000004 108.432 174.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -63.02 -22.3 64.64 Favored Glycine 0 CA--C 1.5 -0.894 0 O-C-N 124.174 0.921 . . . . 35.340000000000003 111.846 177.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 81.01 -5.92 1.65 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.684 1.593 . . . . 75.439999999999998 109.282 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 42.5 mt-30 -111.93 144.3 41.5 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 115.655 -0.702 . . . . 65.230000000000004 111.517 -172.117 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . 0.468 ' O ' ' HA2' ' A' ' 613' ' ' GLY . 55.1 p90 -123.69 154.59 39.19 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.68 -1.146 . . . . 74.299999999999997 108.052 178.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 5.8 p -64.32 117.82 5.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.031 0.443 . . . . 75.040000000000006 110.492 177.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.446 ' HB2' HG22 ' A' ' 614' ' ' VAL . 50.8 ttp -81.56 130.91 59.75 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.953 -0.567 . . . . 50.219999999999999 111.889 -176.077 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -65.58 169.46 12.76 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.988 2.458 . . . . 75.129999999999995 111.068 172.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -87.14 143.13 27.44 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.215 0.531 . . . . 64.150000000000006 111.582 -177.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . 0.414 ' H ' HD23 ' A' ' 566' ' ' LEU . 2.1 pt? -133.03 25.21 4.26 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.155 -1.794 . . . . 73.310000000000002 106.155 176.131 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 4.4 m -75.61 148.69 38.59 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 113.13 -1.85 . . . . 71.530000000000001 111.909 -174.242 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 70.09 59.04 5.69 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.254 -0.885 . . . . 64.540000000000006 114.066 173.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . 0.464 ' HB2' ' HB2' ' A' ' 573' ' ' ASP . 23.0 ptp -159.55 175.07 13.69 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-N 117.335 0.568 . . . . 74.230000000000004 111.079 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -97.79 176.13 5.92 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.102 -1.073 . . . . 75.129999999999995 108.102 179.018 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . 0.493 ' CZ3' HD22 ' A' ' 587' ' ' LEU . 23.1 t-105 -64.19 -33.91 76.87 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.723 -0.843 . . . . 74.439999999999998 108.723 173.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.72 -14.65 18.57 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 CA-C-N 115.762 -0.653 . . . . 74.129999999999995 111.765 -178.498 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 569' ' ' MET . 14.5 m-20 -93.66 -41.14 9.87 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.172 -1.047 . . . . 62.039999999999999 108.172 174.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -52.67 -47.63 67.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.961 -1.018 . . . . 53.509999999999998 113.067 -177.312 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.502 ' O ' ' HG ' ' A' ' 578' ' ' LEU 0.255 32.0 mt-10 -60.18 -56.16 38.22 Favored Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 114.059 1.133 . . . . 72.319999999999993 114.059 179.416 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -58.72 -31.1 94.25 Favored 'Trans proline' 0 C--N 1.365 1.4 0 C-N-CA 121.392 1.395 . . . . 70.140000000000001 112.874 174.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.453 ' HG3' ' SD ' ' A' ' 569' ' ' MET . 2.8 mmp_? -66.2 -45.37 81.01 Favored 'General case' 0 C--O 1.209 -1.07 0 C-N-CA 121.314 -0.154 . . . . 71.340000000000003 110.626 176.116 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.3 pp -66.12 -39.75 90.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.263 0.468 . . . . 73.010000000000005 112.263 -174.192 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.414 ' N ' HD12 ' A' ' 578' ' ' LEU . 15.2 ptm180 -66.33 -39.6 89.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.388 -0.369 . . . . 71.329999999999998 111.072 176.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.24 -34.56 73.0 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 121.055 0.455 . . . . 71.409999999999997 110.876 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 28.6 tp -81.22 -9.15 59.83 Favored 'General case' 0 N--CA 1.42 -1.929 0 C-N-CA 123.939 0.895 . . . . 71.230000000000004 110.808 -179.261 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 65.62 36.53 92.54 Favored Glycine 0 C--N 1.315 -0.601 0 CA-C-N 116.199 -0.455 . . . . 75.349999999999994 112.079 178.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 14.3 t90 -78.38 127.13 31.76 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 107.825 -1.176 . . . . 72.109999999999999 107.825 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 10.2 m -94.37 -20.03 20.11 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 120.979 0.418 . . . . 70.530000000000001 111.671 -176.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -83.4 175.59 52.51 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 121.094 -0.574 . . . . 71.530000000000001 113.397 -178.029 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 10.4 mmt -101.31 155.27 18.14 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.396 -0.594 . . . . 72.230000000000004 109.396 -179.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . 0.493 HD22 ' CZ3' ' A' ' 571' ' ' TRP . 6.1 tt -89.88 118.2 29.27 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.904 -0.589 . . . . 71.430000000000007 109.761 -176.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 621' ' ' THR . 26.4 t70 -95.91 117.47 30.67 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 109.017 -0.735 . . . . 73.400000000000006 109.017 178.043 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.416 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -112.31 135.47 52.95 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.693 -0.685 . . . . 71.230000000000004 110.572 -178.716 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -70.21 -87.65 0.11 Allowed Glycine 0 C--N 1.296 -1.67 0 CA-C-N 115.313 -0.858 . . . . 74.299999999999997 111.076 -179.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.29 154.16 47.88 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 122.728 -0.278 . . . . 73.5 110.371 177.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.9 128.24 35.97 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 107.76 -1.2 . . . . 72.319999999999993 107.76 176.146 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 81.7 t -104.01 135.91 39.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 109.688 -0.486 . . . . 72.150000000000006 109.688 -179.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.95 107.32 11.62 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 122.062 0.934 . . . . 60.049999999999997 111.327 -177.507 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -119.35 -44.97 2.55 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.757 -1.111 . . . . 72.340000000000003 109.317 177.299 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 103.84 143.35 12.51 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.076 -1.059 . . . . 73.239999999999995 111.718 179.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -58.37 -37.4 87.54 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 114.228 0.451 . . . . 51.25 114.228 -177.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 23.0 t -77.35 -23.62 50.84 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.43 0.633 . . . . 71.400000000000006 109.573 -176.264 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -91.08 -5.01 55.8 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.412 -0.813 . . . . 72.019999999999996 109.84 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 32.9 m170 66.31 97.13 0.05 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.406 1.082 . . . . 74.319999999999993 112.474 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . 0.57 ' HB3' ' C ' ' A' ' 625' ' ' GLY . 62.2 m-80 -70.93 85.3 0.69 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.902 -1.045 . . . . 72.340000000000003 111.973 -177.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -110.33 172.52 6.82 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.9 -0.591 . . . . 72.420000000000002 111.253 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 13.0 p -57.53 134.98 21.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 CA-C-N 116.064 -0.516 . . . . 73.310000000000002 110.37 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 29.6 m -108.6 -34.72 2.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 116.235 -0.439 . . . . 55.509999999999998 111.137 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -156.22 142.11 18.01 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.449 -0.341 . . . . 75.319999999999993 110.203 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . 0.409 ' HB2' HD11 ' A' ' 620' ' ' ILE . 20.4 pt20 -129.03 134.67 48.22 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.162 -1.792 . . . . 54.109999999999999 106.162 173.708 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 609' ' ' PRO . 4.4 t-20 -67.21 -49.48 44.36 Favored Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 119.623 -0.831 . . . . 53.229999999999997 111.786 -176.202 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 1.7 Cg_endo -90.62 105.05 0.3 Allowed 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 121.567 1.511 . . . . 72.109999999999999 109.522 170.331 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 607' ' ' ASN . 19.0 Cg_exo -68.67 160.75 48.19 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 122.682 2.255 . . . . 73.340000000000003 111.448 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -57.67 130.03 44.57 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.257 -0.429 . . . . 75.109999999999999 110.35 178.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.3 -9.83 46.19 Favored Glycine 0 C--N 1.31 -0.869 0 C-N-CA 120.542 -0.837 . . . . 65.540000000000006 111.882 -176.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 34.4 m -87.3 151.28 23.26 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.824 -0.806 . . . . 73.439999999999998 108.824 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 561' ' ' PHE . . . -75.96 131.9 12.35 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 120.702 -0.761 . . . . 73.219999999999999 111.855 177.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 563' ' ' MET . 29.4 m -125.63 143.4 39.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.134 -1.061 . . . . 61.109999999999999 108.134 176.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -54.25 176.29 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.729 0.812 . . . . 35.549999999999997 113.152 -177.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -55.58 -27.61 50.28 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.883 0.873 . . . . 72.099999999999994 112.761 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.459 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 1.0 OUTLIER -85.79 -6.55 59.09 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 120.897 -0.321 . . . . 72.219999999999999 111.083 178.119 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.77 20.52 72.36 Favored Glycine 0 CA--C 1.496 -1.116 0 C-N-CA 121.511 -0.376 . . . . 73.140000000000001 112.507 173.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.52 119.75 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 CA-C-O 122.595 1.188 . . . . 74.219999999999999 111.194 -168.685 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' A' ' 606' ' ' GLN . 0.0 OUTLIER -126.64 132.38 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 CA-C-N 113.926 -1.488 . . . . 72.439999999999998 108.651 -177.801 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 10.1 t -106.37 124.25 49.3 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-N 115.48 -0.782 . . . . 64.010000000000005 109.551 -178.347 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.404 HD21 HD21 ' A' ' 587' ' ' LEU . 2.1 pt? -138.69 166.25 24.86 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.754 -0.657 . . . . 73.209999999999994 111.501 -176.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -128.89 137.52 51.49 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.127 -1.064 . . . . 73.329999999999998 108.127 175.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -139.74 165.44 27.27 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 116.367 -0.379 . . . . 74.25 111.032 -171.115 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . 0.57 ' C ' ' HB3' ' A' ' 601' ' ' ASN . . . -66.52 139.54 37.47 Favored Glycine 0 N--CA 1.427 -1.937 0 O-C-N 124.088 0.867 . . . . 53.130000000000003 111.524 175.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 . . . . . 0 C--N 1.306 -1.32 0 C-N-CA 126.306 1.843 . . . . 74.420000000000002 114.676 -177.138 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.398 0 N-CA-C 110.235 -1.146 . . . . 43.049999999999997 110.235 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -75.93 142.78 25.51 Favored 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 121.644 1.563 . . . . 62.039999999999999 111.746 178.658 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -95.49 20.2 9.86 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.897 0.856 . . . . 55.240000000000002 109.852 -179.271 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 546' ' ' PRO . 25.4 p -129.71 158.41 39.45 Favored 'General case' 0 N--CA 1.409 -2.525 0 N-CA-C 107.257 -1.386 . . . . 75.140000000000001 107.257 -179.345 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -149.03 142.47 25.27 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 108.211 -1.033 . . . . 73.040000000000006 108.211 179.368 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.04 134.65 35.37 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.278 0.561 . . . . 70.140000000000001 110.638 179.195 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 39.5 pt -85.03 137.96 37.29 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 114.972 -1.013 . . . . 70.120000000000005 111.953 -177.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.99 166.14 29.84 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.741 2.294 . . . . 61.140000000000001 113.776 178.426 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -88.21 44.76 1.22 Allowed 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 125.158 1.383 . . . . 44.039999999999999 111.223 -177.427 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 17.2 m -72.05 14.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 114.516 1.302 . . . . 55.240000000000002 114.516 -175.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.419 ' HB2' ' HA2' ' A' ' 536' ' ' GLY . . . -79.66 101.63 8.48 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.351 -0.611 . . . . 52.439999999999998 109.351 178.2 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 150.79 -31.09 1.01 Allowed Glycine 0 C--N 1.297 -1.602 0 N-CA-C 110.951 -0.86 . . . . 32.210000000000001 110.951 -179.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.424 ' O ' HG12 ' A' ' 534' ' ' VAL . 18.1 mp0 -81.61 -177.26 6.46 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 109.103 -0.703 . . . . 74.299999999999997 109.103 177.537 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 2.4 m -71.5 155.94 40.01 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 107.451 -1.314 . . . . 70.140000000000001 107.451 176.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.424 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.5 p -63.27 -42.0 94.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 117.737 0.244 . . . . 71.239999999999995 110.999 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 23.4 t70 -59.77 -43.77 94.19 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.258 0.551 . . . . 74.340000000000003 110.045 178.482 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 95.8 t -67.74 -44.81 85.52 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.126 0 CA-C-N 114.868 -1.06 . . . . 65.200000000000003 109.871 -178.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -62.35 -45.19 94.33 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 123.104 0.253 . . . . 54.130000000000003 111.458 179.092 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 27.2 mt-30 -62.27 -46.79 87.22 Favored 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 123.404 0.44 . . . . 62.219999999999999 110.996 -179.25 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.502 ' O ' HG23 ' A' ' 514' ' ' VAL 0.321 20.4 pttp -68.79 -37.55 79.35 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 112.375 0.509 . . . . 62.140000000000001 112.375 178.359 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -61.03 -49.5 77.17 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 120.771 0.319 . . . . 71.109999999999999 110.501 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.416 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.2 pp -65.85 -35.75 81.55 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-N 116.071 -0.513 . . . . 74.040000000000006 110.962 -178.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.416 ' N ' HD12 ' A' ' 512' ' ' LEU . 1.7 t-20 -62.9 -36.17 82.49 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 123.085 0.554 . . . . 71.439999999999998 110.669 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 510' ' ' LYS . 93.9 t -63.08 -34.27 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 121.261 0.553 . . . . 63.25 110.829 177.516 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -106.58 12.2 29.7 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.221 0.534 . . . . 70.319999999999993 110.371 -176.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -141.45 -54.05 0.04 OUTLIER Glycine 0 CA--C 1.488 -1.596 0 C-N-CA 119.935 -1.126 . . . . 22.109999999999999 114.023 -172.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 66.66 20.49 10.73 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.811 0.815 . . . . 74.510000000000005 110.032 -173.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.2 p -76.12 -178.48 4.47 Favored 'General case' 0 N--CA 1.415 -2.219 0 C-N-CA 125.449 1.499 . . . . 75.430000000000007 109.371 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 34.5 mtmm -107.62 142.98 36.71 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 108.168 -1.049 . . . . 73.329999999999998 108.168 175.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -126.54 147.46 49.86 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.301 0.572 . . . . 71.319999999999993 111.977 -176.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 13.6 p -133.75 146.65 50.95 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 114.537 -1.211 . . . . 74.319999999999993 107.763 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -121.67 136.5 54.94 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 120.96 0.409 . . . . 74.439999999999998 111.245 -177.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -122.54 122.09 38.06 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.838 -0.801 . . . . 73.349999999999994 108.838 178.018 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.1 m -87.48 134.79 33.55 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.834 0.35 . . . . 71.0 110.891 -177.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 556' ' ' SER . 47.6 t -136.55 150.14 27.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 106.086 -1.82 . . . . 72.150000000000006 106.086 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -99.21 135.82 40.06 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.655 -0.869 . . . . 71.099999999999994 108.655 175.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 66.7 m -162.58 171.4 6.52 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 107.289 -1.374 . . . . 52.25 107.289 -176.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.92 -15.05 44.98 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 121.935 1.757 . . . . 74.239999999999995 113.104 177.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.43 135.65 94.79 Favored Pre-proline 0 C--O 1.224 -0.268 0 N-CA-C 108.472 -0.936 . . . . 75.530000000000001 108.472 176.207 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.8 149.84 86.44 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.575 2.183 . . . . 74.239999999999995 113.392 -175.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 557' ' ' LYS . . . -59.77 106.89 0.53 Allowed 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 115.146 -0.934 . . . . 44.200000000000003 111.679 -178.657 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 124.09 -14.4 7.9 Favored Glycine 0 N--CA 1.424 -2.161 0 CA-C-N 115.129 -0.941 . . . . 63.140000000000001 111.578 179.151 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -82.45 130.75 35.17 Favored 'General case' 0 C--O 1.258 1.541 0 N-CA-C 108.873 -0.788 . . . . 53.32 108.873 179.485 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 503' ' ' GLN . 7.0 p -81.67 117.87 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.833 0 N-CA-C 107.509 -1.293 . . . . 65.340000000000003 107.509 176.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 1.3 m -72.79 -27.13 61.81 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 113.533 -1.667 . . . . 74.239999999999995 109.311 -175.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 501' ' ' ALA . . . 153.15 -166.46 31.56 Favored Glycine 0 N--CA 1.412 -2.929 0 N-CA-C 110.086 -1.206 . . . . 42.119999999999997 110.086 177.097 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 10.0 p -116.2 157.85 24.22 Favored 'General case' 0 C--N 1.267 -3.002 0 N-CA-C 106.88 -1.526 . . . . 75.329999999999998 106.88 178.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -62.68 -51.11 74.58 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 118.469 -1.292 . . . . 73.319999999999993 111.439 177.229 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -73.07 147.13 42.47 Favored 'Trans proline' 0 C--N 1.369 1.606 0 CA-C-N 120.191 1.104 . . . . 73.040000000000006 110.173 173.332 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.55 145.1 75.36 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.497 2.131 . . . . 72.450000000000003 111.679 -179.207 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.11 142.0 57.83 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 110.128 -0.323 . . . . 73.430000000000007 110.128 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 98.19 -21.86 43.83 Favored Glycine 0 C--N 1.313 -0.701 0 N-CA-C 111.635 -0.586 . . . . 51.43 111.635 -177.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 47.1 m -71.53 137.3 47.99 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 122.872 0.469 . . . . 74.299999999999997 111.354 -177.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 12.4 t -84.44 126.29 33.12 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 109.254 -0.647 . . . . 73.150000000000006 109.254 176.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.63 157.96 73.51 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 106.973 -1.491 . . . . 73.319999999999993 106.973 177.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 494' ' ' THR . 10.0 Cg_endo -59.43 135.31 64.15 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 CA-C-N 120.639 1.264 . . . . 72.319999999999993 111.81 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.84 -19.89 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-N 114.95 -1.023 . . . . 74.340000000000003 112.835 -174.561 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -92.4 -17.55 24.46 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.796 -0.638 . . . . 74.310000000000002 112.038 -178.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 99.0 p -78.4 179.41 7.01 Favored 'General case' 0 C--O 1.253 1.288 0 N-CA-C 112.506 0.558 . . . . 70.230000000000004 112.506 -174.067 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 14.3 p -109.85 128.42 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.809 0 CA-C-O 121.513 0.673 . . . . 75.340000000000003 110.41 -178.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 47.8 mt -98.0 138.86 21.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.286 -1.005 . . . . 71.319999999999993 108.286 -178.038 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.6 120.29 40.6 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.717 0.77 . . . . 63.310000000000002 112.224 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 6.7 mp -102.18 122.13 43.57 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 113.853 -1.521 . . . . 71.409999999999997 108.644 178.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -85.87 122.68 30.27 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 115.433 -0.803 . . . . 65.25 108.996 179.14 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.13 125.33 68.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.514 -0.921 . . . . 62.109999999999999 108.514 -176.203 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 525' ' ' VAL . 67.9 m -97.29 147.63 23.95 Favored 'General case' 0 C--N 1.285 -2.237 0 C-N-CA 119.515 -0.874 . . . . 54.539999999999999 111.973 179.026 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 19.4 ptpt -111.57 141.39 45.21 Favored 'General case' 0 N--CA 1.404 -2.74 0 N-CA-C 105.323 -2.103 . . . . 74.420000000000002 105.323 169.243 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -54.71 -22.09 24.45 Favored Glycine 0 C--O 1.242 0.633 0 O-C-N 124.441 1.088 . . . . 62.049999999999997 114.52 -174.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 88.14 -22.35 0.14 Allowed 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 126.576 1.95 . . . . 43.329999999999998 107.594 -176.72 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.56 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 77.6 mt-30 -112.99 146.92 38.21 Favored 'General case' 0 N--CA 1.405 -2.676 0 CA-C-N 114.468 -1.242 . . . . 72.010000000000005 111.298 -175.677 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -124.65 153.32 42.45 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 107.282 -1.377 . . . . 75.540000000000006 107.282 176.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.99 121.61 22.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 109.556 -0.535 . . . . 75.120000000000005 109.556 -179.78 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 54.3 ttp -79.53 130.1 69.33 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 116.292 -0.413 . . . . 73.400000000000006 110.318 -177.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.69 168.97 9.23 Favored 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.782 2.321 . . . . 73.420000000000002 110.881 174.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.2 129.9 34.79 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.739 0.78 . . . . 71.420000000000002 110.42 -179.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . 0.495 ' O ' ' HG2' ' A' ' 569' ' ' MET . 3.1 pp -126.74 10.33 7.12 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.148 -1.387 . . . . 72.519999999999996 108.677 176.086 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . 0.438 ' HB3' ' OE1' ' A' ' 606' ' ' GLN . 1.6 p -79.06 131.71 36.36 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 114.548 -1.206 . . . . 65.019999999999996 110.959 -179.332 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . 0.468 ' H ' HG12 ' A' ' 603' ' ' VAL . . . 87.85 37.03 8.1 Favored Glycine 0 N--CA 1.428 -1.888 0 C-N-CA 120.809 -0.71 . . . . 74.540000000000006 113.178 179.431 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . 0.495 ' HG2' ' O ' ' A' ' 566' ' ' LEU . 22.4 ptp -142.73 174.72 10.39 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 117.654 0.727 . . . . 72.010000000000005 109.422 177.424 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -99.45 177.8 5.07 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.037 -0.727 . . . . 73.430000000000007 109.037 -177.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 19.8 t-105 -72.59 -26.01 61.54 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.671 -0.863 . . . . 75.530000000000001 108.671 -178.72 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 14.2 p -71.57 -14.84 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-N 115.3 -0.863 . . . . 72.040000000000006 109.75 178.151 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 10.9 m-20 -94.33 -39.14 10.64 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.103 -0.703 . . . . 30.140000000000001 109.103 175.547 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -55.83 -46.48 78.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.653 -0.703 . . . . 61.539999999999999 112.429 -178.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.538 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 11.9 mm-40 -54.0 -58.08 15.06 Favored Pre-proline 0 CA--C 1.573 1.864 0 N-CA-C 112.757 0.651 . . . . 63.409999999999997 112.757 -179.552 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -61.54 -36.0 78.87 Favored 'Trans proline' 0 C--N 1.369 1.648 0 CA-C-N 120.727 1.295 . . . . 75.219999999999999 113.066 175.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.524 ' HA ' ' NE ' ' A' ' 577' ' ' ARG . 9.0 mmp_? -63.4 -39.63 95.03 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.762 -0.375 . . . . 73.129999999999995 111.058 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.3 pp -65.92 -47.31 75.16 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 112.664 0.616 . . . . 74.349999999999994 112.664 -176.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.514 ' N ' HD12 ' A' ' 578' ' ' LEU . 5.8 ptp180 -66.44 -35.14 79.54 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 111.711 0.263 . . . . 75.439999999999998 111.711 177.636 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -71.12 -38.92 72.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.313 0.486 . . . . 71.0 112.313 -178.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 583' ' ' TRP . 1.3 pp -82.38 -8.98 59.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.463 0.649 . . . . 53.509999999999998 110.219 -178.124 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 82.91 35.96 17.07 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.607 -0.724 . . . . 32.130000000000003 112.261 177.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.454 ' HB2' HD11 ' A' ' 581' ' ' LEU . 18.9 t90 -87.35 127.49 35.2 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 108.506 -0.924 . . . . 72.540000000000006 108.506 177.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 24.4 p -106.1 -10.33 16.56 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.39 0.885 . . . . 73.239999999999995 113.39 -176.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 617' ' ' ASP . . . -84.36 -170.37 46.75 Favored Glycine 0 C--N 1.323 -0.182 0 C-N-CA 120.754 -0.736 . . . . 60.439999999999998 113.909 -177.34 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 69.6 mtm -102.8 145.42 29.79 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 123.003 0.521 . . . . 70.140000000000001 111.679 -175.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 28.2 tp -94.76 125.67 39.57 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.555 -0.906 . . . . 75.409999999999997 108.555 177.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 621' ' ' THR . 23.5 t70 -113.63 121.18 43.39 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.85 -0.613 . . . . 74.129999999999995 109.804 -177.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.78 133.82 45.92 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.86 -1.136 . . . . 62.409999999999997 110.134 175.655 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -79.25 -65.59 1.78 Allowed Glycine 0 N--CA 1.428 -1.883 0 C-N-CA 120.65 -0.786 . . . . 64.540000000000006 111.68 179.33 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.24 140.99 35.91 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 120.762 0.315 . . . . 70.420000000000002 110.742 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 624' ' ' PHE . 9.5 p-10 -110.49 124.76 52.4 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 105.339 -2.097 . . . . 54.100000000000001 105.339 170.201 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 73.8 t -104.59 137.6 32.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 C-N-CA 120.909 -0.316 . . . . 63.140000000000001 110.75 -173.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.73 108.04 4.85 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 109.153 -0.684 . . . . 65.25 109.153 -174.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -127.07 -36.13 2.19 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 120.791 0.329 . . . . 45.130000000000003 110.895 -179.642 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 104.83 146.75 15.46 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 119.823 -1.179 . . . . 64.140000000000001 112.324 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.34 -32.2 60.33 Favored Glycine 0 C--N 1.314 -0.659 0 C-N-CA 123.909 0.766 . . . . 71.549999999999997 114.147 -178.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 19.3 t -59.46 -23.27 62.58 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.276 1.43 . . . . 74.239999999999995 110.99 -176.212 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -86.42 -9.63 55.91 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.472 -0.785 . . . . 74.120000000000005 111.713 -173.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 55.14 70.87 0.58 Allowed 'General case' 0 C--O 1.245 0.839 0 CA-C-O 122.371 1.081 . . . . 73.349999999999994 109.104 -174.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -77.97 89.83 4.15 Favored 'General case' 0 CA--C 1.481 -1.687 0 CA-C-N 113.699 -1.591 . . . . 75.540000000000006 113.675 -171.159 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -84.86 172.1 11.68 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 113.844 -1.526 . . . . 70.450000000000003 107.413 176.634 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.468 HG12 ' H ' ' A' ' 568' ' ' GLY . 7.1 p -61.09 131.66 26.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 107.436 -1.32 . . . . 74.200000000000003 107.436 171.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 30.4 m -107.76 -27.12 3.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 112.53 0.566 . . . . 75.450000000000003 112.53 -174.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -147.48 141.37 25.83 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 109.194 -0.669 . . . . 72.129999999999995 109.194 -178.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . 0.438 ' OE1' ' HB3' ' A' ' 567' ' ' SER . 18.0 pt20 -140.42 146.19 38.0 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.547 -0.908 . . . . 65.430000000000007 108.547 177.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.563 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 22.0 t-20 -61.38 -61.52 7.73 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 112.648 0.61 . . . . 75.329999999999998 112.648 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 4.4 Cg_endo -91.87 120.55 0.56 Allowed 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 122.027 1.818 . . . . 64.310000000000002 109.458 175.189 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.33 160.6 46.92 Favored 'Trans proline' 0 C--O 1.246 0.886 0 C-N-CA 122.348 2.032 . . . . 71.400000000000006 112.278 178.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -59.99 127.38 31.6 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.03 -0.532 . . . . 74.25 109.87 178.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 101.05 -1.34 54.93 Favored Glycine 0 C--N 1.309 -0.93 0 C-N-CA 120.039 -1.076 . . . . 55.439999999999998 112.084 -178.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 54.6 m -95.39 146.76 24.15 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.903 -0.406 . . . . 72.420000000000002 109.903 178.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -74.47 123.8 7.85 Favored Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 115.912 -0.586 . . . . 63.030000000000001 112.175 177.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 19.1 m -107.08 142.53 19.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.949 -0.76 . . . . 71.310000000000002 108.949 176.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.56 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 30.7 p-10 -51.85 174.82 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.756 1.222 . . . . 62.210000000000001 113.353 -177.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -54.04 -32.25 53.92 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.7 0.63 . . . . 73.299999999999997 112.7 -179.238 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.459 ' O ' ' HA3' ' A' ' 585' ' ' GLY . 37.4 t70 -85.75 -7.52 58.72 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 120.991 0.424 . . . . 64.239999999999995 109.994 -177.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 67.12 19.73 70.37 Favored Glycine 0 CA--C 1.499 -0.965 0 CA-C-N 116.077 -0.51 . . . . 72.530000000000001 112.558 174.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.05 120.94 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-O 122.68 1.229 . . . . 71.25 111.511 -166.26 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.527 HG12 ' HD2' ' A' ' 608' ' ' PRO . 0.0 OUTLIER -128.83 132.17 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 0 CA-C-N 113.605 -1.634 . . . . 63.340000000000003 108.725 -179.015 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 6.6 t -113.03 137.42 51.45 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.334 -0.987 . . . . 50.049999999999997 108.334 178.493 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 2.4 pp -138.6 165.72 26.19 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 113.66 0.985 . . . . 74.140000000000001 113.66 -173.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -128.9 137.41 51.41 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.555 -1.276 . . . . 74.530000000000001 107.555 176.534 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 592' ' ' ASP . 50.2 p90 -141.3 165.64 26.95 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 120.797 0.332 . . . . 73.439999999999998 110.812 -175.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -88.05 146.78 19.93 Favored Glycine 0 N--CA 1.423 -2.215 0 C-N-CA 120.329 -0.939 . . . . 65.349999999999994 111.363 177.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 C--N 1.281 -2.373 0 N-CA-C 107.214 -1.402 . . . . 74.099999999999994 107.214 177.976 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.027 0 N-CA-C 110.475 -1.05 . . . . 72.049999999999997 110.475 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.31 147.58 29.39 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.902 1.735 . . . . 51.009999999999998 112.187 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -98.17 22.11 9.95 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.125 0.964 . . . . 55.210000000000001 108.854 178.499 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 546' ' ' PRO . 13.8 p -135.74 140.53 44.44 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-N 114.556 -1.202 . . . . 72.099999999999994 107.825 179.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -130.12 142.49 50.59 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 120.946 0.403 . . . . 74.230000000000004 111.331 -179.395 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 9.5 p-10 -78.96 124.2 28.02 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.949 -1.023 . . . . 71.109999999999999 109.184 176.229 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 38.7 pt -77.97 133.38 65.55 Favored Pre-proline 0 C--N 1.302 -1.49 0 CA-C-N 115.78 -0.645 . . . . 54.539999999999999 111.532 -177.062 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.89 -174.85 2.4 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.349 2.033 . . . . 53.210000000000001 111.26 174.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -98.67 122.96 42.56 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.098 0.475 . . . . 73.200000000000003 110.034 179.137 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.633 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 17.0 m -124.86 49.73 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-O 122.245 1.022 . . . . 71.439999999999998 110.206 178.041 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -107.31 108.54 19.98 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.076 -0.965 . . . . 24.140000000000001 109.368 176.076 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 136.69 -17.13 3.72 Favored Glycine 0 C--N 1.304 -1.218 0 C-N-CA 120.323 -0.942 . . . . 63.140000000000001 111.971 177.27 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -91.79 179.12 5.71 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.412 -0.959 . . . . 52.130000000000003 108.412 178.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 21.1 m -75.05 155.55 37.11 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 105.455 -2.054 . . . . 71.239999999999995 105.455 171.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.499 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 9.2 p -62.23 -43.79 98.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 118.794 0.725 . . . . 63.32 111.642 -176.624 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . 0.41 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 20.5 t70 -63.56 -40.3 96.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.74 0.305 . . . . 54.340000000000003 110.477 179.565 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 58.5 t -70.23 -39.81 77.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.33 0 CA-C-N 116.146 -0.479 . . . . 65.019999999999996 109.991 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.633 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -60.9 -44.76 96.68 Favored 'General case' 0 C--O 1.209 -1.069 0 N-CA-C 109.671 -0.492 . . . . 41.329999999999998 109.671 176.569 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 22.8 mt-30 -64.81 -42.69 94.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.157 -0.474 . . . . 61.219999999999999 110.715 -179.216 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.522 ' O ' HG23 ' A' ' 514' ' ' VAL . 75.3 mmtt -66.46 -42.67 87.2 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.252 -0.431 . . . . 75.140000000000001 110.49 177.792 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -67.62 -38.05 83.36 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.621 0.724 . . . . 70.450000000000003 111.08 -177.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.43 -46.49 86.09 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.565 -1.198 . . . . 72.319999999999993 108.343 177.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -61.09 -33.83 73.97 Favored 'General case' 0 N--CA 1.423 -1.823 0 C-N-CA 124.088 0.955 . . . . 61.020000000000003 112.937 -178.129 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 510' ' ' LYS . 65.9 t -56.58 -34.26 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.199 0.523 . . . . 73.109999999999999 110.54 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -110.96 -2.21 16.08 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.584 0.707 . . . . 72.400000000000006 110.147 -178.359 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -110.33 -63.54 0.52 Allowed Glycine 0 N--CA 1.414 -2.802 0 CA-C-N 115.439 -0.8 . . . . 74.0 112.366 -173.354 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 64.82 21.95 12.44 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 122.426 1.108 . . . . 74.25 109.503 -172.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 5.3 p -89.19 -169.89 2.68 Favored 'General case' 0 N--CA 1.408 -2.54 0 CA-C-N 113.367 -1.742 . . . . 73.040000000000006 110.417 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -111.79 141.13 45.8 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 109.173 -0.677 . . . . 70.519999999999996 109.173 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -132.48 151.11 52.02 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.657 0.741 . . . . 73.019999999999996 112.25 -175.121 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 55.1 p -138.82 157.18 46.54 Favored 'General case' 0 N--CA 1.403 -2.803 0 N-CA-C 106.62 -1.622 . . . . 44.210000000000001 106.62 178.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -131.44 147.11 52.52 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 109.524 -0.547 . . . . 73.450000000000003 109.524 -178.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -142.45 143.29 32.53 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.27 -1.381 . . . . 62.039999999999999 107.27 175.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 18.3 m -103.15 136.1 43.58 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-O 121.442 0.639 . . . . 70.019999999999996 112.07 -174.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 10.8 p -124.11 154.02 30.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 106.285 -1.746 . . . . 73.310000000000002 106.285 175.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.522 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 6.0 p-10 -91.52 135.88 33.53 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 120.078 -0.649 . . . . 51.049999999999997 111.146 -178.228 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.537 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 57.4 m -163.64 165.13 14.35 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 107.163 -1.421 . . . . 42.520000000000003 107.163 -178.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -66.72 -7.95 19.78 Favored 'Trans proline' 0 CA--C 1.549 1.24 0 C-N-CA 122.177 1.918 . . . . 73.040000000000006 113.962 179.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.442 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 0.0 OUTLIER -74.12 127.51 87.85 Favored Pre-proline 0 C--O 1.238 0.482 0 N-CA-C 107.898 -1.149 . . . . 72.120000000000005 107.898 176.555 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.9 145.66 83.39 Favored 'Trans proline' 0 C--O 1.25 1.12 0 C-N-CA 122.888 2.392 . . . . 74.239999999999995 112.911 -177.18 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -54.56 117.96 3.78 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.739 -1.119 . . . . 64.510000000000005 111.806 -177.186 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 127.62 -24.74 5.17 Favored Glycine 0 N--CA 1.428 -1.839 0 CA-C-N 115.227 -0.897 . . . . 73.239999999999995 111.458 178.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -83.11 138.5 33.65 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.91 -0.404 . . . . 71.219999999999999 109.91 178.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.452 HG11 ' CB ' ' A' ' 508' ' ' ALA . 4.3 p -101.25 116.78 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 CA-C-O 121.902 0.858 . . . . 62.340000000000003 109.361 -177.403 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 2.1 p -81.04 -8.68 59.82 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.575 -1.193 . . . . 65.230000000000004 112.809 -178.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.65 -164.96 29.14 Favored Glycine 0 N--CA 1.436 -1.308 0 C-N-CA 120.471 -0.871 . . . . 61.009999999999998 112.487 175.398 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 21.8 p -116.77 158.5 23.79 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.423 -1.325 . . . . 65.450000000000003 107.423 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -63.54 -56.82 23.16 Favored Pre-proline 0 C--O 1.241 0.626 0 C-N-CA 118.184 -1.406 . . . . 72.299999999999997 112.172 176.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.14 137.34 40.36 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 120.822 1.014 . . . . 65.329999999999998 109.628 173.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.38 148.03 93.05 Favored 'Trans proline' 0 C--O 1.25 1.106 0 C-N-CA 122.464 2.109 . . . . 62.539999999999999 112.422 -178.415 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -59.35 143.07 50.61 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.009 -0.541 . . . . 63.229999999999997 110.31 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.66 -18.73 54.65 Favored Glycine 0 C--N 1.303 -1.283 0 N-CA-C 111.549 -0.62 . . . . 40.109999999999999 111.549 -177.348 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 53.3 m -73.26 136.85 44.64 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.533 0.206 . . . . 70.510000000000005 110.772 -179.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 13.5 t -88.59 134.53 33.85 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.502 -0.555 . . . . 62.100000000000001 109.502 177.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.49 155.92 80.69 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 107.847 -1.168 . . . . 75.540000000000006 107.847 177.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.456 ' HA ' HG22 ' A' ' 494' ' ' THR . 23.1 Cg_exo -59.09 141.68 98.45 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.598 1.532 . . . . 51.450000000000003 111.17 177.12 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 8.3 p -60.16 -19.79 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.572 0 CA-C-N 115.627 -0.715 . . . . 72.25 111.619 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -98.92 -5.15 31.27 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 121.539 0.685 . . . . 75.439999999999998 111.107 178.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 34.2 t -72.82 151.61 41.94 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-O 121.185 0.516 . . . . 73.129999999999995 110.273 -178.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.9 p -98.24 121.2 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.983 0 CA-C-N 115.358 -0.837 . . . . 73.120000000000005 109.015 179.273 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 54.9 mt -92.79 139.51 17.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.76 -0.83 . . . . 71.420000000000002 108.76 -177.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -103.71 123.42 46.99 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.756 0.789 . . . . 62.130000000000003 111.82 178.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 7.3 mp -103.57 126.95 51.03 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.409 -1.268 . . . . 71.349999999999994 108.832 177.159 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -90.13 116.01 27.81 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.566 0.698 . . . . 72.0 110.804 -178.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 524' ' ' SER . 25.6 t -90.72 129.21 41.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 107.704 -1.221 . . . . 73.019999999999996 107.704 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 43.4 t -87.48 125.09 34.1 Favored 'General case' 0 N--CA 1.403 -2.798 0 N-CA-C 108.6 -0.889 . . . . 65.420000000000002 108.6 177.114 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 531' ' ' ALA . 3.2 ptpp? -105.46 139.31 40.28 Favored 'General case' 0 N--CA 1.406 -2.667 0 N-CA-C 106.706 -1.59 . . . . 63.030000000000001 106.706 169.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -58.18 -21.9 48.21 Favored Glycine 0 C--N 1.312 -0.769 0 O-C-N 124.295 0.997 . . . . 71.450000000000003 112.126 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 24.5 t-20 90.43 -2.74 0.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 126.771 2.028 . . . . 71.310000000000002 107.796 -179.468 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.426 ' HG2' ' N ' ' A' ' 615' ' ' ASN . 98.0 mt-30 -112.82 147.73 36.32 Favored 'General case' 0 N--CA 1.405 -2.724 0 CA-C-N 114.135 -1.393 . . . . 72.310000000000002 112.64 -169.33 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -123.31 158.34 31.21 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 114.19 -1.368 . . . . 73.25 107.496 177.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.84 120.31 13.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 121.114 0.483 . . . . 52.229999999999997 111.368 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . . . . . . . . . 22.2 ttt -70.52 123.62 89.38 Favored Pre-proline 0 N--CA 1.434 -1.243 0 C-N-CA 123.86 0.864 . . . . 72.430000000000007 111.335 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -67.25 169.32 15.57 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.316 2.677 . . . . 53.340000000000003 112.16 176.248 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -87.43 124.31 33.29 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.088 0.471 . . . . 64.310000000000002 111.753 -177.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . 0.534 HD23 ' O ' ' A' ' 566' ' ' LEU . 9.5 tt -133.66 18.93 3.89 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 122.533 1.158 . . . . 72.349999999999994 108.35 -177.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 77.2 p -77.46 143.76 38.29 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 121.496 -0.752 . . . . 54.329999999999998 112.36 -174.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 65.24 42.76 96.12 Favored Glycine 0 N--CA 1.453 -0.182 0 CA-C-N 115.693 -0.685 . . . . 72.319999999999993 114.642 174.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 22.7 ptp -137.57 177.5 7.82 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.042 -0.725 . . . . 44.100000000000001 109.042 177.193 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -94.42 178.24 5.68 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.616 -0.513 . . . . 70.319999999999993 109.616 -178.044 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . 0.438 ' CZ3' HD22 ' A' ' 587' ' ' LEU . 18.9 t-105 -68.97 -30.22 68.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.786 -1.191 . . . . 74.219999999999999 107.786 175.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 12.0 p -74.94 -9.21 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-N 115.203 -0.908 . . . . 35.439999999999998 110.388 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.635 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 15.3 m-20 -99.25 -37.49 9.25 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 108.519 -0.919 . . . . 72.299999999999997 108.519 173.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -59.46 -43.95 93.08 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.108 -0.951 . . . . 54.140000000000001 111.926 179.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.616 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 33.3 mt-10 -57.66 -52.43 74.38 Favored Pre-proline 0 CA--C 1.556 1.187 0 N-CA-C 113.941 1.089 . . . . 74.239999999999995 113.941 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.3 -33.76 98.0 Favored 'Trans proline' 0 C--N 1.364 1.349 0 CA-C-N 120.438 1.192 . . . . 61.32 112.993 173.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.635 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 9.3 mmp_? -64.29 -45.55 87.48 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 109.57 -0.53 . . . . 71.409999999999997 109.57 178.101 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.3 pp -66.11 -44.04 85.45 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.833 -0.621 . . . . 60.240000000000002 112.162 -172.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -66.67 -37.83 85.56 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.161 -0.472 . . . . 64.120000000000005 110.928 178.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -71.28 -37.12 71.9 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 112.008 0.373 . . . . 73.439999999999998 112.008 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.0 pp -83.76 -9.35 58.88 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 120.532 -0.467 . . . . 73.439999999999998 110.794 -179.022 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 75.95 44.96 17.62 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 121.232 -0.509 . . . . 72.430000000000007 112.467 179.033 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -75.96 127.46 33.03 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.968 -0.753 . . . . 63.539999999999999 108.968 178.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 1.3 p -86.72 -32.68 20.32 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 124.303 1.041 . . . . 75.129999999999995 113.006 -178.068 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -82.91 -169.35 44.37 Favored Glycine 0 C--N 1.311 -0.836 0 N-CA-C 113.951 0.341 . . . . 73.420000000000002 113.951 -178.075 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 85.3 mtp -115.55 150.38 36.68 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 110.216 -0.29 . . . . 61.340000000000003 110.216 -178.408 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . 0.438 HD22 ' CZ3' ' A' ' 571' ' ' TRP . 2.3 tt -80.43 130.23 35.03 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.228 -1.027 . . . . 72.400000000000006 108.228 -179.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 621' ' ' THR . 21.3 t70 -126.77 122.63 35.34 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.611 -0.722 . . . . 72.349999999999994 110.933 -178.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 622' ' ' LEU . 0.0 OUTLIER -101.94 128.48 48.33 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 118.302 -1.359 . . . . 70.109999999999999 109.109 173.311 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -76.96 -38.3 30.94 Favored Glycine 0 N--CA 1.428 -1.885 0 C-N-CA 120.763 -0.732 . . . . 70.420000000000002 112.444 -176.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -136.74 147.66 46.83 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 121.012 0.434 . . . . 72.409999999999997 110.714 -177.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -99.18 125.79 44.83 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.002 -1.481 . . . . 70.299999999999997 107.002 176.04 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 59.5 t -104.19 131.23 53.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 107.911 -1.144 . . . . 72.319999999999993 107.911 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . 0.439 ' HA ' ' NE2' ' A' ' 626' ' ' GLN . 6.8 p-10 -74.34 117.78 16.55 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.824 0.821 . . . . 73.030000000000001 110.285 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -141.82 -62.84 0.45 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.487 -1.233 . . . . 73.140000000000001 109.356 -179.222 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 95.22 160.72 33.72 Favored Glycine 0 N--CA 1.407 -3.279 0 N-CA-C 110.655 -0.978 . . . . 62.020000000000003 110.655 -178.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.6 -33.04 61.97 Favored Glycine 0 C--N 1.292 -1.864 0 CA-C-N 115.031 -0.584 . . . . 43.509999999999998 113.735 -178.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 35.3 t -70.25 -29.19 65.93 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 109.647 -0.501 . . . . 52.409999999999997 109.647 -178.076 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -95.69 -2.28 48.31 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.493 -0.322 . . . . 73.519999999999996 110.991 -178.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 73.24 116.45 0.05 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.966 1.307 . . . . 75.140000000000001 111.268 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -78.4 61.69 2.87 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.736 0.779 . . . . 70.420000000000002 110.781 -179.025 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -87.07 160.09 18.7 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.712 -0.676 . . . . 75.019999999999996 109.402 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.484 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 99.5 t -63.6 130.23 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 106.904 -1.517 . . . . 64.349999999999994 106.904 170.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 58.7 t -96.31 -47.45 12.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-O 121.384 0.611 . . . . 63.210000000000001 109.504 -175.173 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -150.58 144.43 25.27 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 106.925 -1.509 . . . . 73.040000000000006 106.925 -178.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -128.64 143.99 51.06 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.325 -0.991 . . . . 65.420000000000002 108.325 178.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.47 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 3.3 t-20 -60.18 -54.62 53.43 Favored Pre-proline 0 CA--C 1.553 1.067 0 N-CA-C 112.504 0.557 . . . . 74.25 112.504 -179.412 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 9.3 Cg_endo -94.24 123.44 0.41 Allowed 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 121.929 1.753 . . . . 72.349999999999994 111.954 178.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -67.67 153.46 76.01 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 122.168 1.912 . . . . 62.030000000000001 110.747 175.05 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.4 139.46 58.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.744 0.307 . . . . 60.119999999999997 110.275 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.14 -11.69 62.03 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 120.317 -0.944 . . . . 52.140000000000001 111.993 -178.368 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 90.6 m -76.58 146.34 38.38 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.763 -0.829 . . . . 62.020000000000003 108.763 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -73.81 122.69 7.75 Favored Glycine 0 N--CA 1.42 -2.415 0 C-N-CA 119.654 -1.26 . . . . 71.200000000000003 110.531 175.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 27.7 m -114.08 141.57 29.79 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 108.676 -0.861 . . . . 54.399999999999999 108.676 176.407 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.426 ' N ' ' HG2' ' A' ' 560' ' ' GLN . 33.4 p-10 -52.0 168.42 0.09 Allowed 'General case' 0 C--O 1.209 -1.072 0 C-N-CA 124.457 1.103 . . . . 72.310000000000002 112.696 -176.423 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -58.15 -24.77 60.1 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.819 0.674 . . . . 72.120000000000005 112.819 -176.486 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -88.56 -8.55 54.56 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 109.402 -0.592 . . . . 61.5 109.402 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.12 16.08 63.92 Favored Glycine 0 CA--C 1.502 -0.757 0 CA-C-N 116.016 -0.538 . . . . 64.230000000000004 113.95 171.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.17 119.31 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 122.208 1.004 . . . . 73.5 110.927 -167.165 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.425 ' O ' HD12 ' A' ' 620' ' ' ILE . 2.8 pp -129.0 134.05 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 114.477 -1.238 . . . . 73.310000000000002 110.673 -177.351 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 11.9 t -110.03 133.02 53.64 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.7 -0.852 . . . . 75.450000000000003 108.7 179.294 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 3.2 pp -138.78 168.75 19.12 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.69 -0.686 . . . . 75.219999999999999 110.788 -175.384 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -126.92 135.82 51.44 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.343 -0.984 . . . . 63.329999999999998 108.343 174.253 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.484 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 2.1 p90 -142.41 168.23 20.23 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.083 -0.508 . . . . 74.510000000000005 109.805 -172.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -56.25 109.52 1.56 Allowed Glycine 0 CA--C 1.529 0.926 0 O-C-N 123.954 0.784 . . . . 63.439999999999998 111.855 175.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.439 ' NE2' ' HA ' ' A' ' 594' ' ' ASP . 27.7 mm-40 . . . . . 0 C--O 1.263 1.783 0 C-N-CA 125.734 1.614 . . . . 74.349999999999994 112.745 -179.392 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.345 0 N-CA-C 110.979 -0.848 . . . . 53.439999999999998 110.979 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.21 146.37 95.96 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.009 2.473 . . . . 72.230000000000004 112.343 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -92.36 -11.78 34.07 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 122.016 0.912 . . . . 64.230000000000004 110.708 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 9.2 p -143.09 145.59 33.01 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 114.743 -1.117 . . . . 72.019999999999996 108.13 -178.606 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -140.54 140.81 35.28 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.265 -0.643 . . . . 44.520000000000003 109.265 -179.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.578 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 5.1 p-10 -78.83 140.48 38.17 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.395 0.617 . . . . 72.409999999999997 110.656 178.289 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 39.0 pt -96.36 137.07 21.62 Favored Pre-proline 0 C--N 1.294 -1.812 0 CA-C-N 114.91 -1.041 . . . . 75.230000000000004 109.776 179.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.22 176.89 9.24 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.979 1.786 . . . . 54.450000000000003 111.924 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.57 110.27 19.69 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.856 -1.165 . . . . 64.120000000000005 107.856 177.785 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 29.3 m -117.84 12.3 7.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-O 120.982 0.42 . . . . 73.420000000000002 111.812 -178.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -84.72 102.25 12.85 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.486 -0.485 . . . . 61.340000000000003 109.954 -178.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 156.38 -26.07 0.54 Allowed Glycine 0 C--N 1.301 -1.385 0 C-N-CA 120.653 -0.784 . . . . 42.350000000000001 112.136 179.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.47 ' O ' HG12 ' A' ' 534' ' ' VAL . 11.4 pm0 -102.44 -173.86 2.43 Favored 'General case' 0 N--CA 1.427 -1.605 0 O-C-N 122.527 -0.396 . . . . 63.530000000000001 110.276 177.49 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 20.1 m -69.84 155.46 40.52 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.474 -0.935 . . . . 62.32 108.474 -179.236 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.507 HG21 HG22 ' A' ' 555' ' ' VAL . 7.3 p -61.64 -42.68 95.13 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 O-C-N 123.018 0.199 . . . . 64.450000000000003 111.428 -178.276 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.71 -39.82 94.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.286 0.565 . . . . 71.349999999999994 110.21 -179.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 66.9 t -70.36 -39.69 76.85 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.452 0 CA-C-N 115.431 -0.804 . . . . 71.319999999999993 109.8 178.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -64.22 -44.28 92.38 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 122.276 0.23 . . . . 62.109999999999999 110.996 177.783 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 23.0 mt-30 -63.1 -41.6 99.41 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.896 -0.409 . . . . 74.409999999999997 109.896 178.035 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 514' ' ' VAL . 72.3 mmtt -66.31 -38.79 88.54 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.939 -0.573 . . . . 74.209999999999994 111.897 175.772 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.14 -48.45 80.04 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 122.026 0.917 . . . . 74.450000000000003 108.8 176.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.426 HD11 HD12 ' A' ' 551' ' ' ILE . 2.2 tm? -59.55 -42.3 92.06 Favored 'General case' 0 C--O 1.21 -1.011 0 CA-C-N 113.909 -1.496 . . . . 72.209999999999994 109.623 -179.255 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 513' ' ' ASN . 2.2 t-20 -60.47 -35.21 75.35 Favored 'General case' 0 N--CA 1.427 -1.608 0 C-N-CA 124.169 0.988 . . . . 65.230000000000004 111.16 -179.732 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 510' ' ' LYS . 98.1 t -64.34 -35.85 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.444 0.64 . . . . 71.319999999999993 110.832 178.342 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -101.46 5.0 41.79 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.184 -0.462 . . . . 52.420000000000002 109.931 -177.079 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -132.94 -58.29 0.08 OUTLIER Glycine 0 N--CA 1.426 -2.033 0 C-N-CA 119.89 -1.148 . . . . 63.310000000000002 114.232 -171.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 59.66 29.56 19.13 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 122.465 1.126 . . . . 73.120000000000005 108.97 -172.631 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 7.1 p -96.87 -165.39 1.26 Allowed 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 114.061 -1.427 . . . . 65.319999999999993 110.559 -177.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -107.83 138.6 43.79 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.827 -1.175 . . . . 73.219999999999999 107.827 178.489 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -128.93 148.5 50.93 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.297 0.57 . . . . 72.319999999999993 111.192 -179.243 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.5 m -140.25 152.41 45.91 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.016 -1.105 . . . . 75.430000000000007 108.016 176.366 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -120.38 142.13 49.45 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.02 0.438 . . . . 62.020000000000003 111.041 -176.227 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -131.94 135.94 46.98 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.465 -1.68 . . . . 54.130000000000003 106.465 176.462 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 75.0 p -104.83 139.45 39.57 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.259 1.028 . . . . 74.150000000000006 113.234 -173.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.5 p -123.95 152.99 29.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 105.858 -1.904 . . . . 53.32 105.858 176.388 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.585 ' HA ' ' HG3' ' A' ' 557' ' ' LYS . 1.1 p-10 -84.74 136.94 33.5 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.407 -0.96 . . . . 65.209999999999994 108.407 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 556' ' ' SER . 23.3 m -149.45 169.87 8.53 Favored Pre-proline 0 C--N 1.285 -2.203 0 N-CA-C 107.586 -1.264 . . . . 43.219999999999999 107.586 -175.507 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -69.93 -16.3 36.8 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 121.992 1.795 . . . . 34.299999999999997 112.385 176.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.412 ' HD2' ' N ' ' A' ' 529' ' ' ARG . 3.2 mpt_? -81.57 135.0 50.05 Favored Pre-proline 0 CA--C 1.512 -0.492 0 CA-C-N 116.499 -0.319 . . . . 74.310000000000002 110.432 179.757 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.66 156.98 20.55 Favored 'Trans proline' 0 C--O 1.257 1.446 0 C-N-CA 123.141 2.561 . . . . 72.519999999999996 112.557 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.24 104.6 0.33 Allowed 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.348 -0.842 . . . . 71.329999999999998 111.251 -176.872 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 151.93 -26.33 0.92 Allowed Glycine 0 N--CA 1.419 -2.494 0 C-N-CA 120.142 -1.028 . . . . 74.099999999999994 112.707 179.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -82.67 144.49 30.23 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 119.378 -0.929 . . . . 75.409999999999997 109.33 -179.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 503' ' ' GLN . 7.4 p -92.34 117.63 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 CA-C-O 121.822 0.82 . . . . 72.430000000000007 108.845 177.568 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.99 -30.74 70.93 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.444 -1.253 . . . . 74.349999999999994 109.932 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 156.02 -167.62 33.32 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 111.085 -0.806 . . . . 43.109999999999999 111.085 178.61 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . 0.462 HG22 HD13 ' A' ' 553' ' ' LEU . 11.4 p -116.59 147.55 41.76 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.694 -0.854 . . . . 72.230000000000004 108.694 178.846 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -57.94 -50.32 88.75 Favored Pre-proline 0 N--CA 1.476 0.839 0 O-C-N 123.577 0.548 . . . . 74.140000000000001 111.458 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -76.29 131.0 12.43 Favored 'Trans proline' 0 N--CA 1.438 -1.76 0 N-CA-C 107.978 -1.585 . . . . 75.129999999999995 107.978 168.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -56.55 140.94 90.76 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 122.492 2.128 . . . . 71.120000000000005 111.736 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -60.01 137.83 58.0 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 120.702 0.287 . . . . 43.420000000000002 110.635 -178.746 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 101.69 -12.66 58.0 Favored Glycine 0 C--N 1.309 -0.949 0 N-CA-C 111.782 -0.527 . . . . 61.409999999999997 111.782 -176.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 26.4 m -84.35 137.31 33.49 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 122.85 -0.206 . . . . 62.32 110.567 -178.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 9.7 t -82.33 127.69 33.48 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.592 -0.892 . . . . 74.219999999999999 108.592 175.198 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 35.8 m -123.07 156.75 62.32 Favored Pre-proline 0 C--N 1.299 -1.587 0 N-CA-C 107.75 -1.204 . . . . 63.340000000000003 107.75 -179.053 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -65.44 137.66 51.8 Favored 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 120.834 1.023 . . . . 74.0 111.39 -179.205 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 10.8 p -64.98 -19.64 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 115.481 -0.781 . . . . 71.519999999999996 110.599 179.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -89.33 -12.32 40.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.183 0.516 . . . . 63.100000000000001 111.456 -179.041 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 50.4 m -87.21 163.78 16.71 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.617 0.722 . . . . 74.519999999999996 111.14 178.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 14.3 p -98.02 137.66 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.849 0 CA-C-N 115.122 -0.945 . . . . 55.140000000000001 109.462 178.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . 0.426 HD12 HD11 ' A' ' 512' ' ' LEU . 78.4 mt -94.41 135.56 28.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.985 -0.552 . . . . 62.520000000000003 110.306 -178.571 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -103.3 119.99 39.92 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-N 115.852 -0.613 . . . . 65.519999999999996 110.817 -173.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.462 HD13 HG22 ' A' ' 537' ' ' THR . 3.5 mm? -102.66 122.96 45.48 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 124.06 0.944 . . . . 75.010000000000005 109.235 177.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -85.13 122.28 29.11 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.895 -0.78 . . . . 71.340000000000003 108.895 174.163 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.507 HG22 HG21 ' A' ' 505' ' ' VAL . 26.5 t -98.69 134.18 38.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 108.573 -0.899 . . . . 43.0 108.573 179.482 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.638 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 23.6 m -85.06 117.77 24.23 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 108.92 -0.77 . . . . 54.140000000000001 108.92 176.492 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.585 ' HG3' ' HA ' ' A' ' 526' ' ' ASP . 2.6 ptpp? -96.66 133.33 41.32 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 106.612 -1.625 . . . . 72.319999999999993 106.612 166.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -60.13 -23.98 60.31 Favored Glycine 0 CA--C 1.492 -1.397 0 O-C-N 124.344 1.028 . . . . 72.010000000000005 113.167 -175.481 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . 0.497 ' OD1' ' HG3' ' A' ' 616' ' ' ARG . 45.1 t-20 79.77 -15.71 0.73 Allowed 'General case' 0 C--O 1.211 -0.951 0 C-N-CA 125.231 1.412 . . . . 75.5 108.587 179.403 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 614' ' ' VAL . 86.3 mt-30 -112.52 141.72 45.93 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 115.563 -0.744 . . . . 71.109999999999999 112.233 -173.411 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -123.8 158.24 32.23 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.104 -1.407 . . . . 74.120000000000005 107.936 177.827 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 8.1 p -64.42 125.36 21.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.228 0.537 . . . . 72.540000000000006 110.078 177.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.529 ' SD ' HG21 ' A' ' 620' ' ' ILE . 52.1 ttp -83.88 133.52 45.91 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 109.874 -0.417 . . . . 72.450000000000003 109.874 -178.502 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.11 169.62 14.75 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.634 2.223 . . . . 63.299999999999997 110.768 174.732 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -82.48 134.11 35.21 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.276 0.56 . . . . 74.319999999999993 111.022 -178.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.5 pp -137.66 14.19 2.94 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.77 -1.105 . . . . 71.120000000000005 110.234 178.197 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 22.9 t -81.01 152.76 27.78 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.691 -1.14 . . . . 52.399999999999999 110.213 -178.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 64.21 26.14 70.24 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 114.942 0.737 . . . . 70.030000000000001 114.942 174.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . 0.452 ' SD ' ' HG3' ' A' ' 577' ' ' ARG . 20.4 ptp -127.08 171.99 10.9 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 122.305 -0.527 . . . . 71.310000000000002 109.945 179.41 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -95.98 165.44 12.26 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.054 -1.461 . . . . 64.040000000000006 107.054 -177.07 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -61.76 -30.04 70.53 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.373 -0.603 . . . . 63.43 109.373 178.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.82 -15.91 18.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.971 -0.559 . . . . 73.219999999999999 111.671 -178.447 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.431 ' C ' ' HD2' ' A' ' 576' ' ' PRO . 38.3 t70 -101.62 -28.5 12.47 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 122.245 1.022 . . . . 74.030000000000001 108.247 176.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 577' ' ' ARG . . . -67.91 -37.46 81.73 Favored 'General case' 0 C--O 1.212 -0.908 0 CA-C-N 114.565 -1.198 . . . . 73.200000000000003 111.275 177.307 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.526 ' HB3' ' HD3' ' A' ' 576' ' ' PRO . 23.5 tt0 -56.18 -51.13 83.2 Favored Pre-proline 0 CA--C 1.568 1.658 0 CA-C-O 119.373 -0.346 . . . . 75.329999999999998 110.973 178.269 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 85.1 Cg_exo -53.36 -37.36 81.34 Favored 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 122.095 1.863 . . . . 75.319999999999993 112.203 171.698 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.541 ' O ' ' HB3' ' A' ' 581' ' ' LEU . 1.5 mmp_? -58.62 -42.6 88.62 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.742 -0.208 . . . . 74.239999999999995 110.494 176.701 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.538 ' HG ' ' CE3' ' A' ' 583' ' ' TRP . 10.8 mp -63.47 -49.27 74.29 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 120.727 0.299 . . . . 71.420000000000002 110.993 -178.226 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -67.21 -39.69 86.32 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 113.303 0.853 . . . . 62.409999999999997 113.303 -179.229 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.06 -36.47 75.0 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.113 0.482 . . . . 33.399999999999999 111.453 -178.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.541 ' HB3' ' O ' ' A' ' 577' ' ' ARG . 2.0 tp -81.47 -10.17 59.55 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.108 -0.496 . . . . 74.430000000000007 110.109 -179.59 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 61.88 40.25 98.59 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.728 -0.949 . . . . 52.119999999999997 110.728 -178.045 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.538 ' CE3' ' HG ' ' A' ' 578' ' ' LEU . 10.7 t90 -71.81 127.43 32.54 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 121.578 0.704 . . . . 75.430000000000007 109.675 -178.259 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 9.9 p -79.05 -50.05 11.68 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 114.534 -1.212 . . . . 71.420000000000002 111.807 -177.094 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -71.48 -169.47 10.43 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 116.004 1.162 . . . . 65.439999999999998 116.004 -176.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 61.7 mtm -113.76 155.94 24.73 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.105 -1.048 . . . . 72.310000000000002 108.501 -179.404 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 6.3 tt -85.14 119.82 25.96 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.039 -1.097 . . . . 70.340000000000003 108.039 179.255 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.647 ' O ' ' HA ' ' A' ' 621' ' ' THR . 23.4 t70 -95.75 104.87 16.82 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.66 0.743 . . . . 63.130000000000003 109.818 -179.666 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.505 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.1 OUTLIER -90.03 129.12 36.39 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.988 -0.745 . . . . 70.420000000000002 108.988 178.155 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -83.4 -48.95 5.13 Favored Glycine 0 C--N 1.28 -2.565 0 N-CA-C 109.936 -1.265 . . . . 53.240000000000002 109.936 -178.17 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.15 142.41 38.01 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 109.114 -0.699 . . . . 60.530000000000001 109.114 179.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -115.57 125.19 52.66 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.024 -1.472 . . . . 71.129999999999995 107.024 175.444 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.89 131.47 55.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 108.816 -0.809 . . . . 74.420000000000002 108.816 -176.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.96 108.09 5.68 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.164 -1.05 . . . . 64.329999999999998 108.164 178.687 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -115.23 -55.81 2.43 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 116.088 -0.506 . . . . 71.019999999999996 110.688 -174.577 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 89.4 148.12 17.81 Favored Glycine 0 N--CA 1.422 -2.278 0 C-N-CA 120.31 -0.947 . . . . 73.430000000000007 111.358 -175.098 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.25 -32.44 60.28 Favored Glycine 0 C--N 1.304 -1.216 0 C-N-CA 123.483 0.563 . . . . 65.030000000000001 113.487 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 14.4 m -66.19 -24.44 66.63 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 124.076 0.951 . . . . 72.219999999999999 110.545 -176.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -104.29 -0.73 27.93 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.106 -0.952 . . . . 53.329999999999998 109.533 -176.634 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 60.8 m80 69.04 93.69 0.08 Allowed 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 122.135 0.969 . . . . 74.239999999999995 110.692 -174.457 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -82.2 73.28 9.24 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.553 -1.203 . . . . 75.230000000000004 110.339 -179.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -106.33 162.74 13.41 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.701 -1.136 . . . . 71.099999999999994 110.659 -176.428 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 78.8 t -67.25 130.09 32.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 N-CA-C 106.295 -1.743 . . . . 73.340000000000003 106.295 169.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.91 -34.12 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 113.091 0.775 . . . . 73.510000000000005 113.091 -174.28 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . 0.496 ' HB3' ' CG ' ' A' ' 623' ' ' ARG . 46.8 t80 -141.77 135.85 30.12 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.752 -0.833 . . . . 73.540000000000006 108.752 -177.301 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -133.31 144.52 49.72 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.288 -1.375 . . . . 73.329999999999998 107.288 178.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.565 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 46.3 t30 -58.91 -54.72 53.66 Favored Pre-proline 0 CA--C 1.553 1.077 0 O-C-N 123.466 0.479 . . . . 73.109999999999999 111.899 -179.235 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 94.9 Cg_endo -105.31 117.16 0.04 OUTLIER 'Trans proline' 0 CA--C 1.571 2.349 0 C-N-CA 121.502 1.468 . . . . 73.310000000000002 111.508 173.649 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.0 160.57 40.85 Favored 'Trans proline' 0 N--CA 1.482 0.821 0 C-N-CA 122.92 2.413 . . . . 74.230000000000004 112.66 -178.489 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -53.0 132.51 37.79 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.8 0.44 . . . . 72.239999999999995 110.928 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.07 -6.03 42.75 Favored Glycine 0 C--O 1.24 0.503 0 C-N-CA 120.695 -0.764 . . . . 50.329999999999998 111.201 -176.597 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 608' ' ' PRO . 12.6 t -72.55 166.33 22.89 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 123.619 0.767 . . . . 74.409999999999997 109.69 178.832 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -104.09 118.38 5.96 Favored Glycine 0 N--CA 1.427 -1.937 0 N-CA-C 109.247 -1.541 . . . . 73.109999999999999 109.247 175.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 35.9 m -116.33 142.08 31.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.992 -0.373 . . . . 72.329999999999998 109.992 -179.643 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -57.53 169.81 0.62 Allowed 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 124.238 1.015 . . . . 65.420000000000002 112.805 -177.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . 0.497 ' HG3' ' OD1' ' A' ' 559' ' ' ASN 0.331 0.0 OUTLIER -59.29 -23.75 62.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 114.638 1.347 . . . . 75.099999999999994 114.638 178.832 . . . . . . . . 4 4 . 1 . 026 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -84.98 -8.55 58.69 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.015 -0.735 . . . . 74.430000000000007 109.015 175.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.24 12.55 58.38 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 123.682 0.658 . . . . 73.519999999999996 114.451 170.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.37 119.41 16.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 122.002 0.906 . . . . 71.140000000000001 112.076 -165.751 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.529 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.8 pp -126.82 134.84 65.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 CA-C-N 114.507 -1.224 . . . . 54.350000000000001 112.592 -178.469 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.647 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 87.7 m -98.88 122.92 42.75 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.849 -0.614 . . . . 70.109999999999999 109.473 178.384 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 589' ' ' LYS . 3.3 pp -139.1 167.01 23.02 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.092 0.404 . . . . 61.409999999999997 112.092 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . 0.496 ' CG ' ' HB3' ' A' ' 605' ' ' TYR . 18.4 ptp180 -127.79 137.8 52.52 Favored 'General case' 0 C--O 1.257 1.49 0 N-CA-C 107.69 -1.226 . . . . 75.129999999999995 107.69 175.453 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -141.07 165.37 27.74 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.389 -0.524 . . . . 62.140000000000001 111.77 -172.393 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -82.62 131.17 10.18 Favored Glycine 0 N--CA 1.417 -2.629 0 CA-C-N 114.97 -1.014 . . . . 74.209999999999994 110.907 175.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--N 1.276 -2.614 0 C-N-CA 125.35 1.46 . . . . 74.319999999999993 109.097 -179.734 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.499 0 N-CA-C 110.526 -1.03 . . . . 43.049999999999997 110.526 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.23 142.23 37.3 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.25 1.966 . . . . 73.510000000000005 109.652 178.775 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -90.73 -5.47 55.68 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.34 0.59 . . . . 73.040000000000006 111.807 -176.461 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.458 ' HB ' HG22 ' A' ' 544' ' ' THR . 20.3 p -139.72 141.63 36.9 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.838 -0.619 . . . . 73.329999999999998 110.165 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . 0.61 ' HG2' ' O ' ' A' ' 515' ' ' TYR . 0.6 OUTLIER -138.11 139.64 39.56 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 122.572 0.349 . . . . 74.209999999999994 110.659 177.543 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.645 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 8.4 p-10 -85.98 140.68 30.1 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.943 -0.572 . . . . 61.450000000000003 109.795 173.283 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 37.5 pt -98.06 136.88 20.87 Favored Pre-proline 0 C--N 1.294 -1.829 0 CA-C-N 115.347 -0.842 . . . . 64.5 111.354 -178.205 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -81.94 -178.49 4.16 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.924 1.749 . . . . 73.319999999999993 110.756 175.197 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -83.48 118.62 23.88 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.737 -0.838 . . . . 73.340000000000003 108.737 177.246 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.475 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 27.1 m -110.47 12.23 8.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-O 122.101 0.953 . . . . 72.319999999999993 110.145 -178.817 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -80.63 100.67 8.77 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.545 -1.207 . . . . 21.210000000000001 109.998 178.347 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 149.88 -30.27 1.12 Allowed Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.892 -0.671 . . . . 53.210000000000001 111.906 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -91.65 177.47 6.2 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-O 121.232 0.539 . . . . 72.329999999999998 110.211 179.192 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 27.9 m -74.22 156.18 37.53 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.454 -1.314 . . . . 70.420000000000002 107.454 177.13 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.453 ' HA ' HG23 ' A' ' 534' ' ' VAL . 11.4 p -56.43 -45.19 81.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 112.87 0.693 . . . . 64.200000000000003 112.87 -179.523 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -62.18 -39.69 93.52 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 120.535 -0.466 . . . . 72.030000000000001 110.171 177.902 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 78.6 t -68.87 -44.39 81.78 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.866 0 CA-C-N 115.437 -0.801 . . . . 70.540000000000006 110.04 -178.577 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.475 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -63.58 -45.3 91.03 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 123.216 0.607 . . . . 55.310000000000002 110.522 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.8 mt-30 -65.06 -45.64 84.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 123.31 0.382 . . . . 72.239999999999995 110.841 -179.226 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.469 ' O ' HG23 ' A' ' 514' ' ' VAL . 20.9 ptmt -67.12 -38.48 85.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.043 0.449 . . . . 63.450000000000003 110.363 179.022 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -60.86 -49.59 76.85 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 124.169 0.988 . . . . 75.450000000000003 110.081 -178.531 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -69.17 -35.4 76.26 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 115.704 -0.68 . . . . 72.439999999999998 110.524 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.44 ' N ' HD12 ' A' ' 512' ' ' LEU . 2.3 t-20 -59.89 -39.49 85.49 Favored 'General case' 0 C--O 1.204 -1.33 0 C-N-CA 123.982 0.913 . . . . 64.430000000000007 110.587 -178.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 510' ' ' LYS . 82.0 t -57.56 -32.43 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-O 121.326 0.584 . . . . 74.120000000000005 111.793 179.272 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . 0.61 ' O ' ' HG2' ' A' ' 495' ' ' LYS . 60.6 m-85 -98.24 -26.26 14.59 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.439 0.638 . . . . 74.299999999999997 110.293 179.314 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -101.36 -58.09 0.82 Allowed Glycine 0 CA--C 1.478 -2.23 0 CA-C-N 115.464 -0.789 . . . . 74.219999999999999 113.554 -167.663 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 64.86 29.59 12.46 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.135 0.969 . . . . 64.439999999999998 109.898 -174.917 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 4.7 p -88.96 -166.52 1.62 Allowed 'General case' 0 N--CA 1.422 -1.849 0 C-N-CA 125.702 1.601 . . . . 52.310000000000002 111.026 -179.516 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 13.6 mptt -107.56 143.55 35.82 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.199 -1.408 . . . . 73.439999999999998 107.199 176.187 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -131.87 151.77 51.47 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 120.904 0.383 . . . . 71.219999999999999 111.986 -179.046 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 36.7 m -132.91 156.59 46.97 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.887 -1.524 . . . . 70.319999999999993 106.887 177.369 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -129.41 144.85 51.41 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 110.03 -0.359 . . . . 62.409999999999997 110.03 177.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -137.75 127.24 24.95 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.955 -1.128 . . . . 71.549999999999997 107.955 176.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 555' ' ' VAL . 15.0 m -99.3 125.27 44.91 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.053 0.454 . . . . 64.140000000000001 111.942 -175.771 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 41.9 t -121.73 151.37 25.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 106.868 -1.53 . . . . 63.43 106.868 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.34 135.62 50.62 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 121.407 0.622 . . . . 73.099999999999994 111.507 -178.571 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . 0.614 ' HB2' ' OG ' ' A' ' 556' ' ' SER . 49.3 m -155.38 170.42 8.73 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 108.451 -0.944 . . . . 61.32 108.451 -178.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -72.87 -16.86 25.91 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 122.14 1.893 . . . . 74.430000000000007 114.031 -179.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.23 149.47 38.59 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 119.509 -0.877 . . . . 74.409999999999997 111.843 -176.521 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.95 147.65 72.77 Favored 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 123.27 2.647 . . . . 72.25 112.882 -176.078 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.715 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -61.65 103.86 0.37 Allowed 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 114.858 -1.065 . . . . 50.350000000000001 113.119 -174.115 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 147.04 -17.03 1.55 Allowed Glycine 0 N--CA 1.422 -2.242 0 CA-C-N 115.043 -0.981 . . . . 62.439999999999998 111.643 -178.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -82.22 141.76 32.71 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.628 -0.508 . . . . 63.240000000000002 109.628 177.843 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.453 HG23 ' HA ' ' A' ' 505' ' ' VAL . 41.4 t -93.32 115.84 33.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.039 -0.726 . . . . 73.340000000000003 109.039 176.438 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . 0.581 HG23 ' HB2' ' A' ' 556' ' ' SER . 2.3 p -83.87 -17.81 39.6 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.241 -0.891 . . . . 73.230000000000004 112.357 178.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 165.88 174.86 35.79 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 120.185 -1.007 . . . . 73.030000000000001 112.404 178.246 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 5.7 p -117.38 152.89 34.03 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.222 -1.029 . . . . 73.239999999999995 108.222 177.359 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -67.22 -50.64 38.98 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 118.333 -1.347 . . . . 75.319999999999993 111.151 176.447 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -67.87 127.75 16.67 Favored 'Trans proline' 0 C--N 1.377 2.057 0 N-CA-C 108.043 -1.56 . . . . 61.340000000000003 108.043 170.074 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -68.92 157.39 62.04 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 122.236 1.957 . . . . 75.030000000000001 113.879 -175.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -64.17 136.12 56.94 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.622 -0.717 . . . . 73.299999999999997 110.444 179.646 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 100.51 -11.25 59.65 Favored Glycine 0 C--N 1.305 -1.155 0 N-CA-C 111.637 -0.585 . . . . 21.109999999999999 111.637 -178.491 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 496' ' ' ASP . 28.4 m -77.87 127.98 33.24 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 122.568 -0.372 . . . . 52.020000000000003 110.945 -178.426 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.645 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 24.8 m -87.73 123.65 32.76 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 108.0 -1.111 . . . . 72.409999999999997 108.0 175.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.75 157.57 62.42 Favored Pre-proline 0 C--N 1.301 -1.503 0 N-CA-C 108.763 -0.828 . . . . 71.150000000000006 108.763 -178.826 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -63.87 140.65 74.4 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.615 1.543 . . . . 73.140000000000001 110.763 177.371 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 14.6 p -56.85 -25.62 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-O 121.455 0.645 . . . . 64.530000000000001 110.855 178.158 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.05 -15.08 52.44 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.738 -0.664 . . . . 62.32 112.008 -178.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 97.0 p -82.94 178.08 8.33 Favored 'General case' 0 C--O 1.254 1.32 0 N-CA-C 113.388 0.885 . . . . 63.439999999999998 113.388 -174.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 15.0 p -117.03 138.04 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.518 -0.765 . . . . 70.010000000000005 110.933 -176.488 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 54.9 mt -108.59 134.35 50.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.687 -0.857 . . . . 52.520000000000003 108.687 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -104.27 122.95 46.47 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.43 0.633 . . . . 73.030000000000001 112.563 179.529 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.23 119.37 34.6 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 125.487 1.515 . . . . 72.439999999999998 109.685 -179.525 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -88.82 113.81 24.76 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.656 0.741 . . . . 75.040000000000006 109.485 175.317 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 524' ' ' SER . 42.8 t -94.97 131.21 42.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 114.456 -1.247 . . . . 75.140000000000001 109.521 -175.754 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.715 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 39.1 t -77.47 117.63 19.12 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 108.261 -1.014 . . . . 62.329999999999998 108.261 176.693 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.15 134.07 43.61 Favored 'General case' 0 N--CA 1.417 -2.118 0 N-CA-C 105.444 -2.058 . . . . 74.140000000000001 105.444 168.725 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' A' ' 560' ' ' GLN . . . -64.01 -24.44 68.58 Favored Glycine 0 CA--C 1.499 -0.94 0 N-CA-C 110.484 -1.046 . . . . 75.019999999999996 110.484 179.253 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 615' ' ' ASN . 63.5 t30 63.83 24.67 13.83 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.962 1.305 . . . . 65.540000000000006 108.438 -179.192 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 558' ' ' GLY . 97.7 mt-30 -127.52 155.57 43.56 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 114.48 -1.236 . . . . 74.5 111.234 -173.429 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -131.22 151.12 51.79 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.893 -1.049 . . . . 73.430000000000007 108.264 176.277 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.19 123.07 16.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-O 121.439 0.638 . . . . 62.530000000000001 110.317 178.777 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.536 ' SD ' HG13 ' A' ' 620' ' ' ILE . 42.9 ttp -86.45 125.63 66.96 Favored Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 115.495 -0.775 . . . . 62.450000000000003 111.014 -178.458 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 563' ' ' MET . 24.1 Cg_exo -65.43 170.41 10.98 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.687 2.925 . . . . 55.299999999999997 112.402 176.591 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.94 115.51 15.71 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.46 -0.336 . . . . 71.049999999999997 110.492 -179.681 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -91.59 -16.66 26.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.87 0.843 . . . . 70.239999999999995 109.047 175.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 15.3 m -73.91 140.1 45.41 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.156 -0.929 . . . . 42.229999999999997 110.008 -179.331 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 94.17 11.42 57.47 Favored Glycine 0 C--O 1.217 -0.921 0 C-N-CA 120.713 -0.756 . . . . 62.030000000000001 114.395 177.065 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . 0.443 ' HB2' ' HB2' ' A' ' 573' ' ' ASP . 23.9 ptp -131.83 167.6 19.27 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.329 -0.989 . . . . 70.019999999999996 108.329 176.759 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -88.9 170.34 10.79 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.049 -1.093 . . . . 62.329999999999998 108.049 -179.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -65.95 -28.31 68.82 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.416 -0.957 . . . . 74.540000000000006 108.416 176.331 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 10.7 p -75.53 -11.85 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-N 115.297 -0.865 . . . . 73.299999999999997 110.564 -179.283 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 56.5 m-20 -98.72 -40.56 8.1 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 107.441 -1.318 . . . . 74.400000000000006 107.441 174.161 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . 0.73 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -55.83 -54.3 46.16 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-N 114.566 -1.197 . . . . 74.310000000000002 112.87 -176.636 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 579' ' ' ARG . 40.4 mt-10 -57.77 -48.57 96.95 Favored Pre-proline 0 N--CA 1.473 0.686 0 N-CA-C 113.7 1.0 . . . . 64.400000000000006 113.7 -178.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -52.96 -38.2 79.27 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.168 1.912 . . . . 75.120000000000005 112.761 171.575 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 3.6 mmp_? -68.71 -38.89 80.6 Favored 'General case' 0 C--O 1.199 -1.554 0 N-CA-C 109.929 -0.397 . . . . 71.310000000000002 109.929 176.537 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.73 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 65.3 mt -65.26 -47.11 77.88 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 122.66 0.384 . . . . 74.200000000000003 110.634 -175.401 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 575' ' ' GLU . 35.7 ptt85 -66.0 -35.16 79.82 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 116.29 -0.414 . . . . 74.319999999999993 111.659 176.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.44 -30.79 67.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.481 0.658 . . . . 71.340000000000003 110.619 177.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 14.1 tp -80.85 -9.05 59.86 Favored 'General case' 0 N--CA 1.425 -1.707 0 C-N-CA 124.14 0.976 . . . . 70.530000000000001 110.175 179.595 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 67.44 46.5 69.56 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.346 -0.454 . . . . 41.549999999999997 112.002 178.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.422 ' CE3' HD22 ' A' ' 578' ' ' LEU . 12.5 t90 -83.5 131.13 35.03 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.924 -0.399 . . . . 65.540000000000006 109.924 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 12.8 p -100.12 -26.77 13.84 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.29 1.036 . . . . 71.140000000000001 112.748 -178.193 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -82.16 -175.19 50.4 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 116.283 -0.417 . . . . 74.450000000000003 113.644 -177.069 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 70.5 mtm -107.19 149.56 27.58 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.968 -0.382 . . . . 73.219999999999999 109.968 -178.514 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 5.9 tt -91.83 130.18 37.65 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.074 -1.084 . . . . 75.129999999999995 108.074 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 621' ' ' THR . 14.0 t70 -112.19 123.42 50.22 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.266 -1.013 . . . . 64.439999999999998 108.266 176.62 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.531 ' HD3' ' H ' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -104.07 133.91 48.22 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-O 121.285 0.564 . . . . 75.310000000000002 109.563 -178.595 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -74.93 -53.86 6.08 Favored Glycine 0 C--N 1.281 -2.504 0 N-CA-C 110.603 -0.999 . . . . 75.310000000000002 110.603 -179.303 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.29 141.8 35.75 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.083 -0.558 . . . . 54.399999999999999 110.485 -179.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -117.21 124.53 49.32 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 104.311 -2.477 . . . . 72.109999999999999 104.311 168.136 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.17 117.06 51.02 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 109.156 -0.683 . . . . 54.210000000000001 109.156 -175.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . 0.43 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 4.8 p-10 -73.34 123.21 23.34 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.612 0.72 . . . . 70.549999999999997 109.118 179.707 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -132.23 -5.31 3.42 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 114.985 -1.007 . . . . 52.350000000000001 110.433 179.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 93.71 137.01 8.26 Favored Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 120.164 -1.017 . . . . 43.32 111.907 -178.369 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.71 -32.9 62.16 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 122.956 0.312 . . . . 52.25 113.542 -179.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 47.9 t -63.62 -23.93 67.59 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.054 0.93 . . . . 71.540000000000006 110.644 -175.686 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -89.46 -1.08 57.92 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.195 -0.911 . . . . 64.439999999999998 111.879 -174.723 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 60.5 m170 60.35 86.65 0.1 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.789 0.804 . . . . 60.520000000000003 111.652 -179.225 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -88.45 85.88 6.94 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.509 1.147 . . . . 63.130000000000003 112.241 -176.59 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . 0.41 ' HG2' ' H ' ' A' ' 602' ' ' ARG . 5.5 ptp180 -92.41 169.57 10.46 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 113.164 -1.835 . . . . 61.149999999999999 110.258 -179.799 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 96.7 t -73.07 130.28 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 105.357 -2.09 . . . . 74.519999999999996 105.357 173.42 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 28.6 m -105.26 -28.97 2.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 120.2 -0.6 . . . . 51.25 112.371 -173.359 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -156.1 142.43 18.4 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 109.545 -0.539 . . . . 75.25 109.545 -176.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -121.42 138.63 54.19 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.13 -1.063 . . . . 73.340000000000003 108.13 175.421 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.523 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 3.0 t-20 -60.26 -51.91 76.93 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 123.303 0.377 . . . . 55.439999999999998 111.023 -175.591 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 2.5 Cg_endo -88.84 118.74 0.97 Allowed 'Trans proline' 0 N--CA 1.437 -1.829 0 N-CA-C 107.934 -1.602 . . . . 62.039999999999999 107.934 169.138 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 28.1 Cg_exo -63.54 159.68 39.47 Favored 'Trans proline' 0 C--O 1.249 1.042 0 C-N-CA 122.206 1.938 . . . . 74.120000000000005 112.681 -176.208 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -62.35 139.04 58.54 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.987 -0.551 . . . . 74.129999999999995 109.872 179.269 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 99.66 -8.74 60.12 Favored Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 120.189 -1.005 . . . . 65.230000000000004 111.668 -177.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 79.5 m -80.07 138.78 37.04 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.554 -0.906 . . . . 72.329999999999998 108.554 178.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -77.19 122.85 6.29 Favored Glycine 0 N--CA 1.419 -2.499 0 N-CA-C 110.379 -1.089 . . . . 53.25 110.379 177.847 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 28.4 m -112.49 141.84 26.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 108.697 -0.853 . . . . 51.009999999999998 108.697 177.071 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 559' ' ' ASN . 34.3 p-10 -54.89 173.37 0.09 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.536 0.734 . . . . 73.409999999999997 112.654 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -57.09 -24.92 57.44 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.524 0.935 . . . . 64.340000000000003 113.524 179.568 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -84.02 -9.67 58.47 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.557 -0.857 . . . . 52.43 110.077 178.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 65.33 19.03 66.02 Favored Glycine 0 C--O 1.22 -0.778 0 N-CA-C 114.576 0.59 . . . . 52.020000000000003 114.576 165.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.2 118.5 13.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-O 122.396 1.093 . . . . 63.100000000000001 112.135 -166.624 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.536 HG13 ' SD ' ' A' ' 563' ' ' MET . 0.0 OUTLIER -130.06 133.53 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 CA-C-N 114.183 -1.371 . . . . 75.450000000000003 111.295 -176.473 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 42.0 m -105.06 126.74 52.4 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.614 -0.884 . . . . 72.239999999999995 108.614 178.843 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.3 pp -138.13 166.76 23.32 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.164 0.431 . . . . 70.219999999999999 112.164 -176.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -128.43 136.99 51.63 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.074 -0.713 . . . . 72.239999999999995 109.074 175.249 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -142.0 168.08 20.59 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.612 -1.255 . . . . 74.030000000000001 107.612 -174.363 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -70.52 -124.7 0.05 OUTLIER Glycine 0 CA--C 1.538 1.494 0 C-N-CA 119.177 -1.487 . . . . 64.310000000000002 110.765 172.572 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 7.9 tt0 . . . . . 0 C--N 1.27 -2.875 0 N-CA-C 108.729 -0.841 . . . . 74.549999999999997 108.729 175.761 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.693 0 N-CA-C 110.104 -1.198 . . . . 73.120000000000005 110.104 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -76.18 142.02 23.96 Favored 'Trans proline' 0 C--O 1.247 0.973 0 CA-C-N 119.631 1.715 . . . . 71.150000000000006 109.533 174.65 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . 60.1 10.83 2.42 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.699 1.2 . . . . 34.32 113.084 179.302 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 7.1 p -147.19 139.55 24.65 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 122.565 0.346 . . . . 74.310000000000002 110.29 -177.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -139.42 132.95 30.33 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.584 -0.895 . . . . 62.43 108.584 179.297 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 10.3 p-10 -95.1 135.26 36.86 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.43 0.633 . . . . 72.299999999999997 110.847 -177.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 28.4 pt -81.91 127.88 70.54 Favored Pre-proline 0 C--N 1.303 -1.449 0 CA-C-N 114.667 -1.151 . . . . 75.530000000000001 111.797 -175.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -82.3 178.48 6.24 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.319 2.013 . . . . 73.140000000000001 111.967 178.088 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -97.47 107.82 20.41 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 122.289 1.042 . . . . 64.219999999999999 110.075 178.448 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.441 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 25.7 m -111.39 18.75 7.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 114.4 -1.273 . . . . 74.209999999999994 109.566 179.389 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -74.16 100.6 3.71 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.734 -1.121 . . . . 50.420000000000002 110.342 -178.546 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 155.7 -41.53 0.58 Allowed Glycine 0 N--CA 1.426 -2.023 0 C-N-CA 120.953 -0.641 . . . . 53.149999999999999 111.641 177.576 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.483 ' O ' HG12 ' A' ' 534' ' ' VAL . 19.3 mp0 -77.13 -177.46 4.53 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.45 0.643 . . . . 70.219999999999999 110.381 -179.219 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 11.4 m -75.23 155.62 36.6 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 106.428 -1.693 . . . . 75.530000000000001 106.428 174.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.43 HG21 HG22 ' A' ' 555' ' ' VAL . 7.4 p -62.01 -42.13 93.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 118.166 0.439 . . . . 72.340000000000003 111.66 -178.285 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.91 -42.88 98.94 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 122.854 0.462 . . . . 65.140000000000001 110.609 178.678 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 82.3 t -67.6 -49.03 74.29 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.906 0 N-CA-C 109.139 -0.689 . . . . 64.219999999999999 109.139 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.461 ' CB ' HG11 ' A' ' 534' ' ' VAL . . . -59.28 -43.49 92.54 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 122.717 0.407 . . . . 75.230000000000004 111.897 -177.699 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 24.9 mt-30 -63.32 -44.34 95.21 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 120.757 0.313 . . . . 73.530000000000001 110.287 179.688 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.48 ' HA ' ' HE2' ' A' ' 510' ' ' LYS . 11.2 mmpt? -67.23 -40.22 86.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.406 -0.361 . . . . 64.200000000000003 110.155 178.51 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . 0.613 ' O ' HG12 ' A' ' 514' ' ' VAL . 9.2 m-20 -62.47 -45.66 92.04 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.316 -0.857 . . . . 73.040000000000006 111.688 -178.122 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . 0.458 HD12 ' N ' ' A' ' 513' ' ' ASN . 4.1 pp -69.05 -37.53 78.61 Favored 'General case' 0 C--O 1.211 -0.949 0 C-N-CA 119.683 -0.807 . . . . 55.409999999999997 110.722 -179.577 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.632 ' ND2' ' H ' ' A' ' 518' ' ' THR . 2.7 t-20 -64.36 -35.66 81.61 Favored 'General case' 0 N--CA 1.421 -1.915 0 C-N-CA 124.645 1.178 . . . . 70.040000000000006 111.108 -178.455 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 511' ' ' ASN . 5.0 p -67.26 -31.27 52.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.944 0.402 . . . . 72.409999999999997 110.764 -178.523 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -104.51 6.22 34.6 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.625 -0.509 . . . . 75.530000000000001 109.625 -179.58 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -131.1 -53.4 0.09 OUTLIER Glycine 0 CA--C 1.477 -2.31 0 C-N-CA 119.7 -1.238 . . . . 72.420000000000002 114.399 -168.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 65.16 77.32 0.31 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 106.939 -1.504 . . . . 71.349999999999994 106.939 -173.58 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.632 ' H ' ' ND2' ' A' ' 513' ' ' ASN . 3.3 p -140.29 177.1 8.23 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 115.061 -0.972 . . . . 72.329999999999998 111.539 -170.279 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.97 132.76 53.78 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.119 -1.438 . . . . 71.109999999999999 107.119 179.185 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -130.55 154.48 47.78 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.154 0.502 . . . . 73.219999999999999 112.095 -176.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 69.6 m -140.4 160.56 39.71 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 105.969 -1.863 . . . . 72.230000000000004 105.969 174.159 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.416 ' HB2' ' CG2' ' A' ' 555' ' ' VAL . 3.8 pt20 -131.11 135.98 47.98 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.695 -0.802 . . . . 75.530000000000001 111.035 -178.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -115.72 129.22 56.39 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.601 -1.259 . . . . 70.450000000000003 107.601 178.343 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.8 m -100.59 124.74 46.57 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.244 0.545 . . . . 64.319999999999993 111.842 -177.668 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.54 150.82 24.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.444 -1.317 . . . . 72.310000000000002 107.444 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -91.35 135.3 33.91 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.445 -0.576 . . . . 54.340000000000003 109.445 179.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 52.3 m -160.53 162.86 22.63 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 107.549 -1.278 . . . . 74.209999999999994 107.549 -175.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -64.15 -8.54 16.66 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.699 2.266 . . . . 75.25 113.564 178.587 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -74.07 134.49 77.58 Favored Pre-proline 0 N--CA 1.432 -1.333 0 N-CA-C 107.437 -1.32 . . . . 70.120000000000005 107.437 175.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.53 149.82 89.69 Favored 'Trans proline' 0 C--O 1.249 1.063 0 C-N-CA 122.303 2.002 . . . . 72.140000000000001 112.495 -175.789 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -57.26 120.09 7.53 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.357 -0.838 . . . . 62.409999999999997 111.979 -176.72 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 118.53 -20.77 10.12 Favored Glycine 0 N--CA 1.428 -1.872 0 CA-C-N 114.98 -1.009 . . . . 61.229999999999997 111.414 177.645 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -78.67 137.15 37.67 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.345 -0.613 . . . . 72.310000000000002 109.345 179.046 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.499 HG22 ' H ' ' A' ' 536' ' ' GLY . 11.5 p -99.47 120.49 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.091 0 N-CA-C 108.566 -0.901 . . . . 75.430000000000007 108.566 -179.217 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.21 -1.43 44.72 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.097 -0.956 . . . . 70.120000000000005 112.072 178.948 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.499 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 132.67 -141.57 12.95 Favored Glycine 0 N--CA 1.419 -2.447 0 N-CA-C 111.226 -0.75 . . . . 32.200000000000003 111.226 175.265 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 2.2 p -116.61 157.14 25.83 Favored 'General case' 0 C--N 1.262 -3.217 0 N-CA-C 108.547 -0.908 . . . . 74.299999999999997 108.547 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.515 ' HB3' ' HD3' ' A' ' 539' ' ' PRO . 55.1 t30 -64.92 -53.51 41.92 Favored Pre-proline 0 C--N 1.324 -0.51 0 C-N-CA 120.087 -0.645 . . . . 72.109999999999999 109.923 175.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 15.8 Cg_exo -71.66 137.63 30.48 Favored 'Trans proline' 0 C--N 1.372 1.782 0 N-CA-C 107.002 -1.961 . . . . 64.030000000000001 107.002 168.488 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -55.78 139.91 84.22 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.209 1.939 . . . . 75.209999999999994 113.384 -175.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -62.84 132.38 51.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.39 -0.823 . . . . 74.319999999999993 110.775 -178.356 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 107.75 -10.17 37.96 Favored Glycine 0 C--N 1.303 -1.253 0 N-CA-C 111.668 -0.573 . . . . 55.109999999999999 111.668 -175.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 86.8 m -77.46 129.02 35.19 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 122.817 -0.225 . . . . 72.010000000000005 110.517 179.563 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 11.3 t -82.14 125.55 31.02 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 108.095 -1.076 . . . . 61.539999999999999 108.095 174.926 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.73 160.0 53.23 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 109.189 -0.671 . . . . 54.049999999999997 109.189 -177.707 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -65.89 143.13 71.97 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.697 1.598 . . . . 72.510000000000005 110.14 177.054 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.44 -19.72 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 CA-C-O 121.591 0.71 . . . . 74.409999999999997 110.555 178.513 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.25 -12.76 59.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.884 -0.598 . . . . 75.299999999999997 111.848 176.18 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 10.2 t -93.06 148.19 22.21 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.92 -0.77 . . . . 75.019999999999996 108.92 -179.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 9.9 p -91.79 138.71 19.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 115.836 -0.62 . . . . 61.399999999999999 111.508 -177.062 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 60.0 mt -80.72 124.28 38.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.417 -0.957 . . . . 73.109999999999999 108.417 177.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -103.65 117.9 35.48 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.305 -0.998 . . . . 71.430000000000007 108.305 -178.227 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.5 128.54 41.15 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.253 0.621 . . . . 55.439999999999998 111.485 -178.561 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -83.0 102.76 11.96 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 123.204 0.602 . . . . 64.349999999999994 110.061 177.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.43 HG22 HG21 ' A' ' 505' ' ' VAL . 25.9 t -95.94 123.58 48.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.407 -0.961 . . . . 73.439999999999998 108.407 -179.654 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 51.1 m -95.07 127.99 41.55 Favored 'General case' 0 N--CA 1.409 -2.481 0 CA-C-O 121.457 0.646 . . . . 73.129999999999995 111.413 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -100.12 135.23 41.87 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 106.453 -1.684 . . . . 72.329999999999998 106.453 170.472 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -55.03 -22.88 29.86 Favored Glycine 0 CA--C 1.503 -0.676 0 O-C-N 124.698 1.249 . . . . 43.539999999999999 115.077 -172.748 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 81.73 -24.4 0.19 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.449 1.499 . . . . 71.209999999999994 109.755 -178.437 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.5 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 91.6 mt-30 -113.25 158.02 21.02 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.391 -0.822 . . . . 71.049999999999997 110.913 -176.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -127.02 150.21 49.54 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.217 -1.031 . . . . 74.450000000000003 108.217 175.359 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 31.0 t -71.28 118.14 15.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.588 -0.523 . . . . 62.130000000000003 109.588 -178.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.6 ' SD ' HG21 ' A' ' 620' ' ' ILE . 49.4 ttp -87.13 129.13 52.99 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-N 116.119 -0.491 . . . . 65.409999999999997 111.147 -176.314 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.49 169.55 22.28 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.529 2.153 . . . . 73.439999999999998 111.114 174.027 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -74.63 142.12 44.59 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.986 0.422 . . . . 73.099999999999994 110.375 179.168 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -135.05 15.46 3.53 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.936 0.874 . . . . 74.030000000000001 109.179 177.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 31.6 t -79.22 139.38 37.95 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.118 -0.947 . . . . 74.340000000000003 108.867 178.71 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 97.03 26.0 10.74 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.462 -0.875 . . . . 71.010000000000005 114.022 176.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.9 -175.55 3.71 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.964 -0.754 . . . . 74.530000000000001 108.964 177.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -117.06 159.07 23.11 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.65 -1.241 . . . . 75.219999999999999 107.65 -175.309 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . 0.415 ' CH2' ' HB3' ' A' ' 589' ' ' LYS . 27.2 t-105 -63.48 -24.81 67.98 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.324 0.583 . . . . 74.450000000000003 110.21 -176.398 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 33.0 m -66.97 -18.94 24.99 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 CA-C-N 115.025 -0.989 . . . . 62.329999999999998 110.735 179.247 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.547 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 22.9 t70 -101.69 -28.56 12.41 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.078 -0.712 . . . . 71.420000000000002 109.078 177.759 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . . . . . . . . . . . -56.47 -47.52 79.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.962 0.905 . . . . 75.519999999999996 112.676 -178.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -64.25 -47.98 77.36 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 119.633 -0.827 . . . . 74.219999999999999 112.769 178.568 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -52.66 -37.2 74.65 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 121.999 1.8 . . . . 74.409999999999997 112.796 171.057 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 6.4 mmp_? -59.35 -44.27 92.7 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 109.347 -0.612 . . . . 70.519999999999996 109.347 176.446 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 583' ' ' TRP . 1.7 tp -59.85 -49.57 77.19 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-N 115.271 -0.877 . . . . 65.120000000000005 111.44 -176.149 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -66.73 -40.93 88.55 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.712 0.634 . . . . 73.129999999999995 112.712 176.682 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.62 -37.68 73.84 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.908 0.707 . . . . 75.329999999999998 112.908 -177.257 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.414 HD11 ' HB2' ' A' ' 583' ' ' TRP . 0.7 OUTLIER -82.89 -8.93 59.53 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 122.14 -0.35 . . . . 72.519999999999996 110.962 -174.918 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 74.26 47.03 18.7 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.145 -0.782 . . . . 43.219999999999999 111.145 -179.68 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . 0.528 ' HB3' HD12 ' A' ' 578' ' ' LEU . 12.4 t90 -87.18 127.86 35.14 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 121.636 0.731 . . . . 72.129999999999995 110.134 -178.689 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 27.0 m -89.1 -17.45 29.24 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 124.367 1.067 . . . . 71.340000000000003 112.947 -174.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -96.79 -171.04 34.2 Favored Glycine 0 CA--C 1.497 -1.038 0 C-N-CA 121.372 -0.442 . . . . 64.129999999999995 113.223 -176.142 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 81.4 mtp -117.73 155.85 29.27 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 120.908 0.385 . . . . 72.439999999999998 110.878 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . 0.523 ' HG ' ' CH2' ' A' ' 583' ' ' TRP . 5.0 mt -80.31 125.56 30.05 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 115.076 -0.965 . . . . 75.420000000000002 112.245 -178.48 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 621' ' ' THR . 2.4 m-20 -110.93 118.11 35.21 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.269 -1.332 . . . . 74.409999999999997 110.122 176.313 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.415 ' HB3' ' CH2' ' A' ' 571' ' ' TRP . 0.0 OUTLIER -107.33 133.83 51.29 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 120.176 -0.61 . . . . 75.430000000000007 109.39 -178.961 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -78.59 -69.85 1.36 Allowed Glycine 0 C--N 1.284 -2.322 0 CA-C-N 115.354 -0.839 . . . . 64.200000000000003 111.176 -179.686 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -140.09 149.24 42.84 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.706 0.288 . . . . 61.130000000000003 111.508 -179.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -96.61 124.09 40.49 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 105.925 -1.88 . . . . 74.239999999999995 105.925 170.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 40.2 t -105.76 119.99 55.9 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.5 0 CA-C-N 115.683 -0.69 . . . . 75.349999999999994 109.832 -175.601 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -73.54 107.06 5.6 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.37 -0.974 . . . . 54.100000000000001 108.37 176.506 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -107.84 -39.75 5.47 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.432 0.634 . . . . 63.329999999999998 110.014 -179.338 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 114.34 152.06 10.49 Favored Glycine 0 N--CA 1.412 -2.9 0 N-CA-C 110.674 -0.971 . . . . 43.009999999999998 110.674 -177.225 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.98 -32.66 62.74 Favored Glycine 0 C--N 1.305 -1.174 0 C-N-CA 123.287 0.47 . . . . 35.25 113.1 -179.592 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 4.3 p -69.59 -24.92 63.74 Favored 'General case' 0 N--CA 1.422 -1.859 0 C-N-CA 124.283 1.033 . . . . 41.130000000000003 111.608 -176.466 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -93.95 -14.18 26.25 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.602 -0.726 . . . . 73.25 109.971 -177.006 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 65.1 m80 56.69 108.73 0.01 OUTLIER 'General case' 0 C--O 1.238 0.47 0 O-C-N 124.345 1.028 . . . . 63.32 111.684 -173.691 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . 0.401 ' HB3' ' HA3' ' A' ' 625' ' ' GLY . 48.1 m-80 -73.53 75.52 1.46 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.943 -1.026 . . . . 75.519999999999996 113.404 -172.177 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -86.5 171.24 11.24 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 124.702 1.201 . . . . 74.329999999999998 109.001 177.674 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.93 129.75 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.666 -1.976 . . . . 61.420000000000002 105.666 169.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 14.5 p -96.64 -32.32 4.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 120.13 -0.628 . . . . 64.340000000000003 110.424 -174.311 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -151.3 134.94 16.32 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 116.182 -0.463 . . . . 70.349999999999994 110.62 -179.449 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -106.54 130.16 54.36 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.321 -1.362 . . . . 71.120000000000005 107.321 172.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.432 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 24.2 t-20 -55.33 -55.52 38.85 Favored Pre-proline 0 N--CA 1.477 0.876 0 N-CA-C 113.654 0.983 . . . . 74.299999999999997 113.654 -176.695 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 607' ' ' ASN . 3.3 Cg_endo -87.71 131.73 2.86 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.14 1.227 . . . . 53.409999999999997 110.433 175.589 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 608' ' ' PRO . 38.5 Cg_exo -64.88 160.32 41.64 Favored 'Trans proline' 0 C--O 1.253 1.234 0 C-N-CA 122.642 2.228 . . . . 75.400000000000006 112.383 177.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -64.8 138.5 58.42 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.15 -0.685 . . . . 61.25 109.15 177.519 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 91.84 0.4 71.96 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 119.8 -1.19 . . . . 75.349999999999994 111.912 -179.178 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 24.0 m -90.35 146.31 24.28 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.881 -0.785 . . . . 52.100000000000001 108.881 178.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -83.56 123.2 6.06 Favored Glycine 0 N--CA 1.419 -2.45 0 N-CA-C 110.962 -0.855 . . . . 74.340000000000003 110.962 177.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.9 m -111.44 142.55 23.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 107.901 -1.148 . . . . 62.32 107.901 176.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.5 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 37.8 p30 -46.1 163.09 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 113.769 1.026 . . . . 72.439999999999998 113.769 179.077 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -57.15 -25.31 58.71 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.331 -0.85 . . . . 73.200000000000003 112.219 177.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -80.35 -10.96 59.75 Favored 'General case' 0 C--O 1.214 -0.802 0 C-N-CA 119.372 -0.931 . . . . 74.219999999999999 109.254 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.85 11.42 57.87 Favored Glycine 0 CA--C 1.494 -1.264 0 C-N-CA 123.455 0.55 . . . . 71.120000000000005 112.885 167.344 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.96 118.77 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.114 0 CA-C-O 122.44 1.114 . . . . 74.209999999999994 110.985 -169.638 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.6 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.7 pp -124.95 133.92 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.222 0 CA-C-N 113.74 -1.573 . . . . 62.450000000000003 111.813 -177.943 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 28.3 m -99.0 130.52 45.34 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.669 -1.234 . . . . 72.430000000000007 107.669 177.369 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.404 HD23 ' H ' ' A' ' 622' ' ' LEU . 2.0 pt? -138.65 162.78 33.77 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 110.145 -0.316 . . . . 62.109999999999999 110.145 -178.157 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -128.1 136.98 51.92 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.221 -1.4 . . . . 75.109999999999999 107.221 178.202 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -141.92 167.53 21.92 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.997 -0.547 . . . . 72.310000000000002 110.127 -168.432 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 601' ' ' ASN . . . -64.55 -170.43 2.21 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-O 121.944 0.747 . . . . 64.299999999999997 113.633 176.555 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 . . . . . 0 C--N 1.28 -2.418 0 C-N-CA 124.066 0.946 . . . . 74.109999999999999 111.0 -175.91 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.652 0 N-CA-C 110.319 -1.112 . . . . 65.239999999999995 110.319 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.84 145.33 90.41 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.743 2.295 . . . . 71.099999999999994 111.844 179.118 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . . . . . . . . . . . -84.45 -10.6 57.36 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.42 0.629 . . . . 74.200000000000003 111.476 -176.307 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 33.2 p -136.87 148.56 47.15 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 115.5 -0.773 . . . . 74.230000000000004 110.251 -178.622 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -140.66 153.54 46.04 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.026 -0.731 . . . . 74.329999999999998 109.026 176.213 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -90.2 140.77 29.35 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.215 0.531 . . . . 71.310000000000002 110.148 -178.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 22.8 pt -101.98 112.71 65.66 Favored Pre-proline 0 C--N 1.301 -1.515 0 CA-C-N 115.592 -0.731 . . . . 74.549999999999997 110.57 177.705 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -69.65 167.68 23.6 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.439 2.092 . . . . 74.239999999999995 112.264 177.46 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -75.2 96.11 3.25 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.477 0.656 . . . . 74.239999999999995 110.207 179.183 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . . . . . . . . . 31.5 m -94.81 9.33 5.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 115.259 -0.882 . . . . 63.32 110.055 177.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . . . . . . . . . . . -70.71 101.04 1.99 Allowed 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 114.638 -1.165 . . . . 61.119999999999997 110.222 -179.146 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 147.41 -23.18 1.53 Allowed Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 115.455 -0.793 . . . . 71.219999999999999 111.846 178.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.432 ' O ' HG12 ' A' ' 534' ' ' VAL . 1.9 mp0 -94.06 178.47 5.64 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 108.62 -0.881 . . . . 72.439999999999998 108.62 179.518 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 24.8 m -72.05 155.33 40.43 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.487 -1.301 . . . . 74.129999999999995 107.487 176.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.454 ' O ' ' HG3' ' A' ' 509' ' ' GLN . 7.7 p -61.94 -43.21 97.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 111.42 0.156 . . . . 72.019999999999996 111.42 -178.73 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.16 -39.2 93.97 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 110.088 -0.338 . . . . 74.310000000000002 110.088 -179.314 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 99.7 t -69.06 -46.93 77.71 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 CA-C-N 115.142 -0.936 . . . . 63.020000000000003 109.748 -179.72 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . . . . . . . . . . . -60.59 -44.38 96.29 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 122.99 0.181 . . . . 73.209999999999994 111.251 178.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 505' ' ' VAL . 25.9 mt-30 -64.14 -46.55 83.62 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 120.699 0.285 . . . . 74.430000000000007 111.233 -178.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.451 ' O ' HG23 ' A' ' 514' ' ' VAL . 21.2 ptmt -67.1 -38.63 85.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.028 -0.533 . . . . 64.430000000000007 110.199 -178.099 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -67.13 -43.98 81.04 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.681 -0.69 . . . . 72.420000000000002 110.648 -179.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.07 -41.33 98.06 Favored 'General case' 0 C--O 1.207 -1.16 0 N-CA-C 108.317 -0.994 . . . . 74.140000000000001 108.317 -179.408 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -59.64 -34.89 73.38 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 124.12 0.968 . . . . 74.329999999999998 111.054 -179.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 510' ' ' LYS . 97.7 t -57.66 -38.2 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-O 121.168 0.508 . . . . 70.329999999999998 111.118 178.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.43 19.81 13.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 122.123 0.963 . . . . 64.420000000000002 111.159 -178.814 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -128.81 -59.43 0.11 Allowed Glycine 0 N--CA 1.416 -2.665 0 CA-C-N 114.68 -1.146 . . . . 63.030000000000001 111.595 -177.246 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 63.95 24.56 13.67 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 122.058 0.932 . . . . 75.420000000000002 110.016 -174.708 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . . . . . . . . . 6.4 p -84.18 -179.66 7.27 Favored 'General case' 0 N--CA 1.404 -2.746 0 CA-C-N 113.984 -1.462 . . . . 63.009999999999998 110.277 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 550' ' ' VAL . 56.7 mtpt -108.43 134.23 51.52 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.448 -1.686 . . . . 61.420000000000002 106.448 179.486 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -132.89 154.28 50.54 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 112.871 0.693 . . . . 72.450000000000003 112.871 -175.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 34.2 p -140.03 156.34 46.66 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.789 -1.189 . . . . 64.310000000000002 107.789 176.3 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -124.84 145.21 49.9 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.979 -0.288 . . . . 74.450000000000003 111.186 -178.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -132.59 117.53 18.06 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.388 -0.597 . . . . 42.240000000000002 109.388 177.526 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . 0.455 ' HA ' ' HB ' ' A' ' 555' ' ' VAL . 49.1 m -84.53 116.76 23.3 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.535 0.683 . . . . 74.310000000000002 110.157 178.58 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 44.9 t -120.96 149.81 23.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 106.435 -1.691 . . . . 72.530000000000001 106.435 -176.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -68.29 134.52 50.48 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 120.717 0.294 . . . . 54.530000000000001 110.588 -176.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 49.3 m -163.08 160.51 18.72 Favored Pre-proline 0 C--O 1.208 -1.116 0 N-CA-C 108.397 -0.964 . . . . 71.409999999999997 108.397 -179.726 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -73.48 3.35 4.84 Favored 'Trans proline' 0 CA--C 1.556 1.623 0 C-N-CA 122.624 2.216 . . . . 72.319999999999993 113.651 178.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . 0.477 ' HD2' ' N ' ' A' ' 529' ' ' ARG . 2.7 mpt_? -92.39 140.02 24.1 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 107.992 -1.114 . . . . 71.25 107.992 177.114 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -62.19 150.75 85.65 Favored 'Trans proline' 0 C--O 1.254 1.324 0 C-N-CA 122.847 2.365 . . . . 63.350000000000001 113.052 -176.438 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.625 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -60.47 110.11 1.18 Allowed 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.196 -0.911 . . . . 62.119999999999997 112.253 -174.752 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 136.86 -26.92 2.97 Favored Glycine 0 N--CA 1.433 -1.5 0 C-N-CA 120.621 -0.799 . . . . 73.049999999999997 112.394 177.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -82.03 140.57 33.84 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.044 0.45 . . . . 74.329999999999998 110.558 -178.281 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 503' ' ' GLN . 7.9 p -96.96 118.24 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 CA-C-O 121.687 0.756 . . . . 75.019999999999996 109.162 -179.509 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -25.77 54.46 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 114.853 -1.067 . . . . 60.299999999999997 110.999 179.275 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 162.44 -164.69 35.76 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 120.547 -0.835 . . . . 63.409999999999997 111.776 179.172 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . . . . . . . . . 1.7 p -116.87 157.9 24.87 Favored 'General case' 0 C--N 1.282 -2.336 0 C-N-CA 123.184 0.594 . . . . 61.009999999999998 109.639 -178.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.432 ' HB2' HE22 ' A' ' 554' ' ' GLN . 25.0 t-20 -58.33 -54.46 55.68 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 120.712 -0.395 . . . . 72.519999999999996 110.657 175.533 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -73.2 135.99 23.68 Favored 'Trans proline' 0 C--N 1.359 1.102 0 N-CA-C 108.337 -1.447 . . . . 70.439999999999998 108.337 168.734 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.16 140.93 94.78 Favored 'Trans proline' 0 C--O 1.245 0.852 0 C-N-CA 122.406 2.071 . . . . 64.349999999999994 112.445 -178.069 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -66.46 140.48 58.03 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.955 -0.566 . . . . 71.129999999999995 110.004 -179.507 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 102.78 -15.09 55.94 Favored Glycine 0 C--N 1.3 -1.454 0 N-CA-C 110.775 -0.93 . . . . 74.209999999999994 110.775 -175.806 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 23.7 m -85.16 138.22 32.52 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 122.802 0.441 . . . . 63.240000000000002 109.955 -179.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . . . . . . . . . 8.0 t -76.29 128.06 34.14 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 108.645 -0.872 . . . . 71.519999999999996 108.645 173.057 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 32.1 m -123.78 154.79 67.23 Favored Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 108.691 -0.855 . . . . 64.299999999999997 108.691 -179.078 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -64.88 134.84 41.84 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 120.693 0.929 . . . . 74.109999999999999 111.703 178.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 8.6 p -67.38 -27.46 38.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.902 -1.044 . . . . 72.349999999999994 112.907 -176.206 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -90.19 -7.04 54.57 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.534 0.683 . . . . 63.329999999999998 110.908 -175.433 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 23.1 t -89.79 179.14 6.06 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.131 0.491 . . . . 63.109999999999999 109.684 -178.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 519' ' ' LYS . 12.2 p -107.6 128.7 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.261 0 CA-C-N 115.511 -0.768 . . . . 73.049999999999997 109.82 -177.605 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 60.2 mt -93.22 135.95 26.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 108.4 -0.963 . . . . 75.25 108.4 -179.691 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -103.33 117.86 35.45 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.652 -0.499 . . . . 72.540000000000006 109.652 -176.687 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.426 HD12 HG21 ' A' ' 534' ' ' VAL . 3.6 mm? -95.46 120.83 36.38 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 123.748 0.819 . . . . 75.540000000000006 109.464 179.187 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . 0.432 HE22 ' HB2' ' A' ' 538' ' ' ASN . 2.8 mp0 -88.13 110.55 20.75 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.293 0.568 . . . . 75.340000000000003 109.964 178.61 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 524' ' ' SER . 15.7 t -96.47 135.86 29.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 107.796 -1.187 . . . . 65.329999999999998 107.796 -178.201 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.625 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 68.7 m -89.19 124.65 34.56 Favored 'General case' 0 N--CA 1.4 -2.959 0 C-N-CA 120.375 -0.53 . . . . 51.43 110.304 176.709 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -97.79 131.21 44.5 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 104.384 -2.451 . . . . 61.25 104.384 166.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -56.14 -26.37 49.45 Favored Glycine 0 CA--C 1.491 -1.448 0 O-C-N 124.258 0.974 . . . . 51.329999999999998 112.303 -175.173 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . . . . . . . . . 57.2 t30 68.38 21.64 8.23 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 123.035 1.398 . . . . 75.200000000000003 108.716 174.159 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.5 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 63.4 mt-30 -126.94 145.27 50.75 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 113.176 -1.829 . . . . 73.439999999999998 107.183 177.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -122.8 149.5 44.07 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 120.605 -0.438 . . . . 62.200000000000003 110.174 -177.134 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.74 115.51 7.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 O-C-N 123.83 0.706 . . . . 71.030000000000001 109.111 -178.711 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.516 ' SD ' HG21 ' A' ' 620' ' ' ILE . 35.7 ttp -79.85 123.24 83.87 Favored Pre-proline 0 C--N 1.306 -1.285 0 CA-C-N 115.575 -0.739 . . . . 73.409999999999997 111.747 -175.657 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . 0.456 ' HG2' ' HB2' ' A' ' 581' ' ' LEU . 20.8 Cg_exo -68.76 156.73 64.49 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.945 2.43 . . . . 73.209999999999994 110.773 174.4 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.97 123.48 28.36 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.761 0.791 . . . . 64.409999999999997 110.702 179.009 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . 0.466 HD13 ' H ' ' A' ' 566' ' ' LEU . 0.0 OUTLIER -119.81 14.07 12.45 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.903 -1.517 . . . . 75.420000000000002 106.903 173.411 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 3.0 m -69.13 140.46 54.73 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 112.967 -1.924 . . . . 73.239999999999995 110.18 -177.541 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 73.72 70.53 1.22 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 116.276 -0.42 . . . . 55.399999999999999 113.46 177.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . . . . . . . . . 22.1 ptp -174.07 172.21 3.41 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.742 -0.836 . . . . 65.010000000000005 108.742 179.28 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . 0.452 ' HB2' HG12 ' A' ' 572' ' ' VAL . 95.7 m-85 -100.36 178.66 4.69 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.478 -0.934 . . . . 74.349999999999994 108.478 178.275 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . 0.413 ' HA ' ' HB3' ' A' ' 574' ' ' ALA . 11.7 t-105 -64.76 -28.71 69.77 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.806 0.336 . . . . 72.299999999999997 110.259 -177.449 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . 0.452 HG12 ' HB2' ' A' ' 570' ' ' PHE . 12.7 p -58.02 -30.05 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 123.339 0.656 . . . . 62.109999999999999 111.789 179.598 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . 0.503 ' O ' ' HG2' ' A' ' 577' ' ' ARG . 29.5 m-20 -100.81 -38.65 8.17 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 120.982 -0.287 . . . . 75.400000000000006 110.313 175.762 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' A' ' 571' ' ' TRP . . . -58.73 -43.11 90.1 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.357 0.873 . . . . 73.439999999999998 113.357 -176.658 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . 0.664 ' O ' ' HG ' ' A' ' 578' ' ' LEU . 31.4 tt0 -65.3 -50.71 57.77 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 120.42 -0.512 . . . . 64.409999999999997 111.06 -179.193 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 575' ' ' GLU . 71.2 Cg_exo -56.19 -35.74 95.73 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 121.314 1.342 . . . . 70.299999999999997 111.911 172.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 573' ' ' ASP . 14.5 mmt180 -64.76 -38.49 91.16 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 111.711 0.263 . . . . 72.549999999999997 111.711 178.44 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 575' ' ' GLU . 4.1 pp -65.93 -46.36 78.48 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 120.126 -0.63 . . . . 64.219999999999999 110.561 -176.762 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . 0.475 ' N ' HD12 ' A' ' 578' ' ' LEU . 11.9 ptm180 -66.35 -39.54 89.23 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.027 -0.533 . . . . 71.129999999999995 112.058 176.045 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.56 -27.31 64.04 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 112.567 0.58 . . . . 55.439999999999998 112.567 -177.537 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . 0.456 ' HB2' ' HG2' ' A' ' 564' ' ' PRO . 2.3 pp -92.28 -8.46 45.17 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 119.867 -0.733 . . . . 74.230000000000004 110.426 -179.677 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 77.27 48.69 8.0 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 120.633 -0.794 . . . . 75.329999999999998 111.323 -178.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -84.49 127.45 34.04 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.095 -1.076 . . . . 71.340000000000003 108.095 177.54 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 3.4 p -90.35 -5.52 56.11 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 124.71 1.204 . . . . 62.109999999999999 113.114 -175.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -114.09 -168.57 16.4 Favored Glycine 0 C--N 1.302 -1.346 0 N-CA-C 111.66 -0.576 . . . . 70.5 111.66 -179.516 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 26.4 mmt -121.15 153.86 36.96 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 110.087 -0.338 . . . . 71.310000000000002 110.087 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 6.3 tt -83.26 127.32 33.54 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.608 -0.886 . . . . 73.040000000000006 108.608 -178.159 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -125.08 116.48 22.15 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.165 -0.679 . . . . 74.230000000000004 109.165 178.434 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.63 133.56 36.84 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 118.756 -1.177 . . . . 74.310000000000002 110.636 177.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -78.97 -41.58 14.05 Favored Glycine 0 C--N 1.285 -2.298 0 CA-C-N 114.603 -1.181 . . . . 72.239999999999995 112.956 -172.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -138.29 142.04 39.82 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.77 -0.455 . . . . 71.319999999999993 109.77 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -111.78 125.13 53.66 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.907 -1.516 . . . . 72.439999999999998 106.907 175.452 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.68 116.79 48.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 N-CA-C 107.902 -1.147 . . . . 72.209999999999994 107.902 179.17 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 626' ' ' GLN . 5.3 p-10 -73.96 107.12 5.98 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 122.022 0.915 . . . . 61.130000000000003 112.483 -176.777 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -146.68 -61.34 0.3 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.184 -1.413 . . . . 70.209999999999994 107.184 175.377 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 132.31 147.56 5.89 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 120.132 -1.033 . . . . 53.119999999999997 112.283 177.365 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.66 -33.36 62.7 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 122.745 0.212 . . . . 53.030000000000001 113.508 -178.695 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 3.3 m -62.96 -23.52 67.45 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.534 1.134 . . . . 73.230000000000004 111.092 -177.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -87.44 0.55 55.34 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 124.801 1.24 . . . . 70.540000000000006 111.111 -175.082 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 66.3 m80 71.78 32.71 1.88 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 122.783 1.278 . . . . 75.239999999999995 109.098 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . 0.441 ' CG ' ' HA3' ' A' ' 625' ' ' GLY . 2.2 t-20 -82.31 41.82 0.71 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 112.815 -1.993 . . . . 55.530000000000001 109.84 -175.839 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -74.22 174.45 8.74 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 126.282 1.833 . . . . 73.230000000000004 110.303 178.686 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.6 129.86 17.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.242 -1.022 . . . . 73.030000000000001 108.242 -178.925 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 24.7 m -106.3 -28.27 2.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.606 -0.725 . . . . 54.030000000000001 111.271 -176.67 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -156.74 141.64 17.06 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.144 -0.48 . . . . 74.150000000000006 111.081 -178.268 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -122.64 142.05 51.07 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.138 -1.43 . . . . 75.430000000000007 107.138 172.471 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -58.05 -50.09 90.02 Favored Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 113.312 0.856 . . . . 51.340000000000003 113.312 -175.077 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -89.86 128.2 1.62 Allowed 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 121.068 1.179 . . . . 63.109999999999999 110.823 174.316 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.3 151.01 65.75 Favored 'Trans proline' 0 C--O 1.247 0.936 0 C-N-CA 122.446 2.098 . . . . 71.120000000000005 112.37 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -60.69 135.68 57.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.332 -0.394 . . . . 61.219999999999999 110.438 178.821 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.09 -11.88 48.66 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.386 -0.911 . . . . 65.019999999999996 112.38 -179.714 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 4.7 t -90.09 167.91 12.39 Favored 'General case' 0 C--O 1.255 1.373 0 C-N-CA 119.682 -0.807 . . . . 75.129999999999995 109.197 -179.361 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -90.83 117.5 5.14 Favored Glycine 0 N--CA 1.427 -1.929 0 N-CA-C 111.432 -0.667 . . . . 75.030000000000001 111.432 -178.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.03 142.58 16.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 109.686 -0.487 . . . . 75.530000000000001 109.686 178.06 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.5 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 28.9 p-10 -51.07 165.16 0.13 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.26 1.024 . . . . 63.219999999999999 112.187 -179.213 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -58.8 -25.12 62.84 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.554 0.576 . . . . 75.219999999999999 112.554 -178.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -80.81 -9.23 59.83 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.66 -0.496 . . . . 71.040000000000006 109.66 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.4 -0.89 5.87 Favored Glycine 0 C--O 1.211 -1.291 0 C-N-CA 124.756 1.169 . . . . 72.310000000000002 114.247 171.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.45 119.43 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 CA-C-O 122.266 1.032 . . . . 54.43 112.051 -164.008 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.516 HG21 ' SD ' ' A' ' 563' ' ' MET . 2.5 pp -125.68 133.98 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 CA-C-N 114.288 -1.324 . . . . 70.319999999999993 109.313 -178.529 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 11.5 t -101.52 139.23 37.45 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 108.31 -0.996 . . . . 65.450000000000003 108.31 -179.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . . . . . . . . . 3.6 pp -138.64 168.73 19.15 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.738 -0.665 . . . . 44.210000000000001 111.215 -174.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -123.95 137.06 54.68 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.1 -1.445 . . . . 73.439999999999998 107.1 -178.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . . . . . . . . 0.279 0.2 OUTLIER -135.85 166.17 23.93 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.207 -1.361 . . . . 63.439999999999998 108.164 -161.952 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . 0.441 ' HA3' ' CG ' ' A' ' 601' ' ' ASN . . . -84.57 -140.72 4.91 Favored Glycine 0 N--CA 1.407 -3.274 0 C-N-CA 119.286 -1.435 . . . . 62.399999999999999 110.31 166.762 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.471 ' HB2' ' HA ' ' A' ' 594' ' ' ASP . 8.3 tp-100 . . . . . 0 C--N 1.283 -2.301 0 CA-C-O 118.275 -0.869 . . . . 73.140000000000001 108.924 -179.139 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.94 0 N-CA-C 110.558 -1.017 . . . . 43.049999999999997 110.558 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 492' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.64 156.48 65.87 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 122.396 2.064 . . . . 74.239999999999995 112.681 -177.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 493' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 546' ' ' PRO . . . 71.84 2.23 4.21 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 125.346 1.459 . . . . 71.120000000000005 112.935 177.296 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 13.8 p -145.79 140.31 27.04 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 122.283 -0.26 . . . . 74.109999999999999 111.172 -177.053 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 495' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -141.85 154.44 45.16 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.623 -0.51 . . . . 71.230000000000004 109.623 178.068 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 544' ' ' THR . 4.4 p-10 -89.5 144.23 26.2 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.167 0.508 . . . . 74.319999999999993 111.365 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 497' ' ' ILE . . . . . . . . . . . . . 31.5 pt -99.85 137.71 20.22 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 115.506 -0.77 . . . . 52.310000000000002 110.954 -179.517 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 498' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -82.21 163.67 17.42 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.111 1.874 . . . . 63.039999999999999 111.197 176.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.16 103.93 8.41 Favored 'General case' 0 CA--C 1.491 -1.312 0 CA-C-O 122.647 1.213 . . . . 74.239999999999995 109.454 176.079 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.486 ' HB ' ' HB1' ' A' ' 508' ' ' ALA . 15.0 m -106.99 63.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.437 0 CA-C-O 123.219 1.485 . . . . 73.340000000000003 110.394 -177.514 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 501' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 534' ' ' VAL . . . -118.54 110.84 17.86 Favored 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 112.357 -2.201 . . . . 63.200000000000003 108.683 172.306 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 502' ' ' GLY . . . . . . . . . . . . . . . 145.3 -37.4 1.31 Allowed Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 119.768 -1.206 . . . . 51.210000000000001 112.715 177.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 503' ' ' GLN . . . . . 0.492 ' O ' HG12 ' A' ' 534' ' ' VAL . 0.5 OUTLIER -95.79 -175.16 3.34 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.494 -0.558 . . . . 71.140000000000001 109.494 -178.614 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 24.4 m -72.02 155.38 40.38 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.34 -0.985 . . . . 63.420000000000002 108.34 176.587 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.501 ' HA ' ' HB ' ' A' ' 534' ' ' VAL . 7.1 p -61.25 -41.75 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 116.41 -0.359 . . . . 64.239999999999995 111.846 -179.398 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 506' ' ' ASP . . . . . 0.551 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 35.5 t70 -65.26 -39.98 93.35 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 110.02 -0.363 . . . . 72.200000000000003 110.02 179.166 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 507' ' ' VAL . . . . . . . . . . . . . 84.6 t -65.58 -42.61 93.34 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 N-CA-C 109.434 -0.58 . . . . 72.519999999999996 109.434 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 508' ' ' ALA . . . . . 0.486 ' HB1' ' HB ' ' A' ' 500' ' ' VAL . . . -62.26 -44.43 96.57 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 123.456 0.473 . . . . 61.310000000000002 111.275 175.895 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 509' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -63.01 -45.42 92.43 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 120.505 0.193 . . . . 73.340000000000003 111.284 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 506' ' ' ASP . 32.2 mmmt -65.0 -39.49 93.53 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.514 -0.55 . . . . 74.319999999999993 109.514 178.814 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 511' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -61.27 -49.81 75.55 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.678 -1.146 . . . . 74.310000000000002 110.247 -177.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 512' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.95 -34.71 75.78 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.496 -0.774 . . . . 75.049999999999997 110.894 -177.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.402 HD22 ' HA ' ' A' ' 513' ' ' ASN . 1.7 t-20 -61.6 -38.01 86.02 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.79 -0.641 . . . . 65.25 110.272 179.717 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 510' ' ' LYS . 69.3 t -59.51 -33.84 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.035 0.445 . . . . 75.319999999999993 111.268 178.309 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 515' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -111.89 15.9 20.59 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.372 0.606 . . . . 74.120000000000005 109.806 -177.253 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . -141.17 -60.6 0.03 OUTLIER Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 119.969 -1.11 . . . . 72.030000000000001 113.919 -172.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 517' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 63.54 41.48 7.31 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 122.667 1.222 . . . . 62.109999999999999 109.281 -173.642 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 518' ' ' THR . . . . . 0.558 HG22 ' HA ' ' A' ' 547' ' ' VAL . 14.8 p -95.27 -171.68 2.47 Favored 'General case' 0 N--CA 1.419 -2.014 0 CA-C-N 113.58 -1.646 . . . . 70.209999999999994 110.48 -178.847 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 519' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -107.91 137.49 45.82 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.346 -1.724 . . . . 72.0 106.346 174.719 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 520' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -132.92 151.87 51.98 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 112.233 0.457 . . . . 72.140000000000001 112.233 -178.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 52.8 p -139.6 159.42 42.21 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.168 -1.049 . . . . 61.32 108.168 176.571 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -117.5 134.23 55.09 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 120.638 -0.425 . . . . 71.510000000000005 110.708 177.671 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 523' ' ' ALA . . . . . . . . . . . . . . . -112.28 126.74 55.57 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.573 -0.899 . . . . 73.319999999999993 108.573 177.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 6.5 p -96.03 130.55 43.01 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.192 0.52 . . . . 51.420000000000002 111.601 -178.032 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 11.4 p -139.86 156.28 25.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 106.654 -1.61 . . . . 75.349999999999994 106.654 177.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 526' ' ' ASP . . . . . 0.492 ' HB2' ' HB2' ' A' ' 559' ' ' ASN . 4.1 p30 -96.24 136.44 36.72 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 120.168 -0.613 . . . . 61.439999999999998 111.921 -179.707 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 70.4 m -161.84 161.04 22.29 Favored Pre-proline 0 C--N 1.309 -1.152 0 N-CA-C 107.061 -1.459 . . . . 60.299999999999997 107.061 179.352 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 528' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -66.57 8.61 0.31 Allowed 'Trans proline' 0 CA--C 1.557 1.653 0 C-N-CA 122.799 2.333 . . . . 72.409999999999997 114.559 -178.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 529' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.74 132.11 47.39 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 107.0 -1.481 . . . . 73.530000000000001 107.0 174.782 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 530' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -59.85 142.49 98.7 Favored 'Trans proline' 0 C--O 1.253 1.271 0 C-N-CA 122.261 1.974 . . . . 71.109999999999999 112.486 -177.733 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 556' ' ' SER . . . -58.39 107.43 0.49 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.04 -0.982 . . . . 63.509999999999998 111.219 -177.59 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 532' ' ' GLY . . . . . . . . . . . . . . . 140.1 -28.85 2.46 Favored Glycine 0 N--CA 1.429 -1.794 0 CA-C-N 115.267 -0.879 . . . . 71.120000000000005 111.009 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 533' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -76.83 125.67 29.67 Favored 'General case' 0 C--O 1.251 1.144 0 CA-C-O 121.672 0.748 . . . . 65.109999999999999 110.292 -179.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 534' ' ' VAL . . . . . 0.501 ' HB ' ' HA ' ' A' ' 505' ' ' VAL . 7.1 p -82.15 121.99 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.927 0 N-CA-C 107.611 -1.255 . . . . 72.209999999999994 107.611 177.429 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 535' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.74 16.85 11.39 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 113.638 -1.619 . . . . 53.030000000000001 110.361 -173.247 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.449 ' H ' HG22 ' A' ' 534' ' ' VAL . . . 115.58 -161.68 12.77 Favored Glycine 0 N--CA 1.424 -2.124 0 N-CA-C 111.405 -0.678 . . . . 70.239999999999995 111.405 177.765 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 537' ' ' THR . . . . . 0.403 HG22 HD13 ' A' ' 553' ' ' LEU . 9.6 p -117.16 154.76 30.52 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 109.274 -0.639 . . . . 72.239999999999995 109.274 -179.184 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 538' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 552' ' ' GLU . 20.9 t-20 -63.95 -53.02 52.38 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 119.735 -0.786 . . . . 64.129999999999995 110.932 173.31 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 539' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 538' ' ' ASN . 26.0 Cg_exo -67.11 145.99 75.09 Favored 'Trans proline' 0 C--N 1.378 2.125 0 N-CA-C 108.773 -1.279 . . . . 64.439999999999998 108.773 171.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 540' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.84 140.7 94.64 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 122.281 1.987 . . . . 63.240000000000002 112.493 -178.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -67.83 137.95 55.74 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.981 -0.554 . . . . 71.510000000000005 109.534 178.72 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 96.52 -14.66 63.96 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 121.001 -0.619 . . . . 72.129999999999995 111.894 -178.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 43.4 m -79.72 137.42 37.03 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-O 121.027 0.441 . . . . 60.229999999999997 110.919 -179.687 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 544' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 496' ' ' ASP . 10.3 t -80.78 124.45 29.07 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 121.503 0.668 . . . . 74.430000000000007 109.571 177.551 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 545' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.43 159.15 56.33 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.996 -1.113 . . . . 72.019999999999996 107.996 -178.086 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 546' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 493' ' ' ALA . 20.7 Cg_exo -63.5 137.76 61.55 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 121.137 1.225 . . . . 73.230000000000004 111.323 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . 0.558 ' HA ' HG22 ' A' ' 518' ' ' THR . 12.1 p -66.21 -19.64 25.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 122.272 1.034 . . . . 63.409999999999997 109.629 179.182 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 548' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -88.42 -13.24 40.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.201 -1.363 . . . . 73.239999999999995 111.143 -177.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 549' ' ' SER . . . . . . . . . . . . . 92.8 p -84.25 170.43 13.72 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-O 121.17 0.51 . . . . 55.310000000000002 110.697 -177.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 11.6 p -104.38 124.42 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.338 0 CA-C-N 115.271 -0.877 . . . . 74.329999999999998 109.036 177.878 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 551' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.32 135.4 26.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.402 -0.962 . . . . 63.140000000000001 108.402 -178.206 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 552' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 538' ' ' ASN . 5.6 tp10 -102.55 117.57 34.98 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.795 -0.817 . . . . 63.25 108.795 -177.643 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.403 HD13 HG22 ' A' ' 537' ' ' THR . 3.7 mm? -93.78 127.69 39.64 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.419 -0.956 . . . . 75.319999999999993 108.419 178.135 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 554' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -90.09 117.83 29.17 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.701 -0.481 . . . . 60.240000000000002 109.701 -177.529 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 555' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.51 122.18 64.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 109.095 -0.705 . . . . 45.5 109.095 -178.585 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 531' ' ' ALA . 71.4 m -90.71 127.98 36.5 Favored 'General case' 0 N--CA 1.412 -2.33 0 C-N-CA 120.058 -0.657 . . . . 75.030000000000001 110.251 176.595 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -89.22 137.79 32.01 Favored 'General case' 0 N--CA 1.416 -2.129 0 N-CA-C 103.971 -2.603 . . . . 60.020000000000003 103.971 168.571 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 560' ' ' GLN . . . -60.82 -24.25 62.24 Favored Glycine 0 C--N 1.314 -0.686 0 O-C-N 123.938 0.774 . . . . 62.240000000000002 113.553 -174.105 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 559' ' ' ASN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 526' ' ' ASP . 23.6 t-20 76.94 -23.96 0.23 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.83 1.652 . . . . 71.200000000000003 109.951 -179.454 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.589 ' HG2' ' HA ' ' A' ' 615' ' ' ASN . 86.8 mt-30 -112.4 143.58 43.29 Favored 'General case' 0 N--CA 1.399 -2.989 0 CA-C-N 114.596 -1.184 . . . . 72.010000000000005 110.144 -174.298 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 561' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -122.99 158.57 30.2 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 114.884 -1.053 . . . . 74.450000000000003 108.686 -179.49 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 53.3 t -63.47 117.11 3.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 O-C-N 123.65 0.594 . . . . 71.140000000000001 109.658 -179.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 563' ' ' MET . . . . . 0.615 ' HE3' HG13 ' A' ' 620' ' ' ILE . 22.2 ttt -70.4 127.1 92.4 Favored Pre-proline 0 C--N 1.297 -1.696 0 C-N-CA 124.408 1.083 . . . . 74.230000000000004 112.706 -177.795 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 564' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.91 169.66 22.11 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.148 2.565 . . . . 64.319999999999993 111.032 172.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -90.87 126.95 36.19 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 110.089 -0.337 . . . . 70.010000000000005 110.089 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 566' ' ' LEU . . . . . 0.467 ' O ' ' HG2' ' A' ' 569' ' ' MET . 1.7 tm? -104.84 -16.38 14.91 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.836 0.827 . . . . 74.450000000000003 109.031 -175.59 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 567' ' ' SER . . . . . . . . . . . . . 24.0 m -72.41 143.26 48.58 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.939 -0.573 . . . . 72.319999999999993 110.596 -178.19 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 568' ' ' GLY . . . . . . . . . . . . . . . 101.18 4.76 53.53 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.628 -0.796 . . . . 62.520000000000003 113.912 178.199 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 569' ' ' MET . . . . . 0.532 ' SD ' ' HA ' ' A' ' 574' ' ' ALA . 23.5 ptp -123.0 166.88 14.36 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 117.526 0.663 . . . . 74.040000000000006 109.947 179.101 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 570' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -101.54 166.32 10.78 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.692 -1.595 . . . . 63.100000000000001 106.692 -178.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 571' ' ' TRP . . . . . . . . . . . . . 13.7 t-105 -62.58 -30.13 71.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 118.572 0.624 . . . . 52.509999999999998 109.679 179.737 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 572' ' ' VAL . . . . . . . . . . . . . 27.2 m -71.5 -21.95 21.79 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 CA-C-N 115.923 -0.58 . . . . 74.420000000000002 111.632 -179.253 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 573' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -101.31 -27.39 13.2 Favored 'General case' 0 C--O 1.256 1.405 0 N-CA-C 109.04 -0.726 . . . . 74.329999999999998 109.04 -178.594 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 574' ' ' ALA . . . . . 0.64 ' O ' ' HG ' ' A' ' 578' ' ' LEU . . . -63.52 -54.23 39.47 Favored 'General case' 0 C--O 1.207 -1.132 0 CA-C-N 114.419 -1.264 . . . . 34.109999999999999 112.284 -178.38 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 575' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -53.02 -52.19 67.73 Favored Pre-proline 0 N--CA 1.476 0.826 0 N-CA-C 114.181 1.178 . . . . 74.530000000000001 114.181 -176.442 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 576' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -54.73 -39.7 88.1 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 121.454 1.436 . . . . 61.409999999999997 112.218 174.234 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 577' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -69.12 -34.55 75.23 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.63 0.604 . . . . 74.319999999999993 112.63 176.577 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 574' ' ' ALA . 47.8 mt -65.88 -48.37 71.74 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.596 0.712 . . . . 74.129999999999995 109.21 -177.74 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -34.62 78.29 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.197 -0.911 . . . . 63.109999999999999 111.64 178.277 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 580' ' ' ALA . . . . . . . . . . . . . . . -70.39 -32.12 69.64 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.373 -0.376 . . . . 71.439999999999998 111.287 -177.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 581' ' ' LEU . . . . . . . . . . . . . 2.4 pp -85.71 -8.74 57.99 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.499 0.666 . . . . 75.209999999999994 109.622 179.242 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . 77.13 44.79 12.75 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.126 -0.943 . . . . 53.399999999999999 112.5 178.367 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 583' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -74.03 127.64 33.45 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.378 0.609 . . . . 71.540000000000006 109.688 179.218 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 2.8 p -85.06 -40.12 17.2 Favored 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 124.859 1.264 . . . . 63.210000000000001 112.928 -177.26 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -80.47 -161.05 24.09 Favored Glycine 0 C--O 1.242 0.656 0 N-CA-C 115.571 0.988 . . . . 72.239999999999995 115.571 -174.368 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 586' ' ' MET . . . . . . . . . . . . . 54.5 mtt -119.86 154.01 34.96 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 123.624 0.769 . . . . 74.129999999999995 109.28 -176.386 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 6.8 tt -83.48 123.44 29.71 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.339 0.59 . . . . 74.049999999999997 109.689 -178.453 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 588' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 621' ' ' THR . 36.6 t70 -113.7 114.29 26.17 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.898 -1.046 . . . . 74.310000000000002 108.568 -179.801 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 589' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' A' ' 589' ' ' LYS . 0.0 OUTLIER -99.8 133.56 43.97 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 119.381 -0.927 . . . . 73.219999999999999 109.851 -179.059 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 590' ' ' GLY . . . . . . . . . . . . . . . -86.81 -46.05 5.25 Favored Glycine 0 C--N 1.285 -2.302 0 CA-C-N 115.616 -0.72 . . . . 35.210000000000001 111.543 -177.461 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 591' ' ' ALA . . . . . . . . . . . . . . . -139.67 135.01 32.78 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 110.119 -0.326 . . . . 71.430000000000007 110.119 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -116.73 127.45 54.4 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.242 -1.022 . . . . 74.329999999999998 108.242 174.246 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 593' ' ' VAL . . . . . . . . . . . . . 99.4 t -111.28 116.83 53.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 116.452 -0.34 . . . . 73.329999999999998 110.262 -177.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 594' ' ' ASP . . . . . 0.593 ' HA ' ' HB3' ' A' ' 626' ' ' GLN . 27.6 t70 -73.77 116.77 14.76 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-O 120.82 0.343 . . . . 54.420000000000002 111.268 -177.338 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 595' ' ' ALA . . . . . . . . . . . . . . . -139.77 -42.63 0.44 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.819 -0.628 . . . . 72.230000000000004 109.727 178.065 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 596' ' ' GLY . . . . . . . . . . . . . . . 123.16 140.1 5.6 Favored Glycine 0 N--CA 1.426 -1.992 0 C-N-CA 120.731 -0.747 . . . . 43.140000000000001 111.842 178.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . -56.75 -32.18 61.56 Favored Glycine 0 C--N 1.315 -0.636 0 CA-C-O 121.09 0.272 . . . . 72.430000000000007 112.552 179.593 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 4.7 p -64.02 -23.23 67.25 Favored 'General case' 0 N--CA 1.432 -1.349 0 C-N-CA 125.218 1.407 . . . . 64.439999999999998 111.563 -178.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 599' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -87.22 -0.53 56.85 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.199 -0.909 . . . . 71.310000000000002 109.9 -176.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 600' ' ' HIS . . . . . . . . . . . . . 13.9 m170 65.26 65.39 0.58 Allowed 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 122.573 1.178 . . . . 72.129999999999995 110.954 -178.737 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 601' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -81.38 92.52 6.43 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 114.137 -1.392 . . . . 72.439999999999998 111.729 -179.057 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 602' ' ' ARG . . . . . . . . . . . . . 41.3 mtm-85 -91.39 171.71 9.02 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 113.674 -1.603 . . . . 53.409999999999997 107.678 176.772 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . 0.48 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 86.9 t -67.67 130.26 32.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 105.497 -2.038 . . . . 75.120000000000005 105.497 169.263 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 59.4 t -101.15 -52.59 8.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 C-N-CA 120.501 -0.48 . . . . 44.439999999999998 110.813 -172.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 605' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -133.1 136.28 45.76 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.901 -0.59 . . . . 72.239999999999995 109.831 -177.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 606' ' ' GLN . . . . . 0.466 ' HB2' HD11 ' A' ' 620' ' ' ILE . 13.3 pt20 -112.29 140.13 47.26 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.441 -1.689 . . . . 71.019999999999996 106.441 175.429 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 607' ' ' ASN . . . . . 0.423 ' HB3' ' HD3' ' A' ' 608' ' ' PRO . 11.6 t30 -56.74 -53.7 61.93 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 113.418 0.895 . . . . 74.310000000000002 113.418 -175.74 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 608' ' ' PRO . . . . . 0.446 ' O ' ' HG3' ' A' ' 606' ' ' GLN . 7.2 Cg_endo -91.43 134.01 1.56 Allowed 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.434 1.422 . . . . 75.209999999999994 110.459 173.526 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 609' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.07 157.69 58.98 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 121.447 1.432 . . . . 44.219999999999999 111.306 178.188 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 610' ' ' ALA . . . . . . . . . . . . . . . -61.88 138.52 58.36 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 108.892 -0.781 . . . . 42.020000000000003 108.892 177.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 105.6 -8.76 43.99 Favored Glycine 0 C--N 1.302 -1.339 0 C-N-CA 120.679 -0.772 . . . . 73.439999999999998 111.928 -176.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 54.3 m -77.04 146.83 37.11 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.892 -0.781 . . . . 73.209999999999994 108.892 176.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 613' ' ' GLY . . . . . . . . . . . . . . . -81.1 114.63 3.86 Favored Glycine 0 N--CA 1.432 -1.632 0 N-CA-C 109.818 -1.313 . . . . 52.340000000000003 109.818 174.07 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 614' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 560' ' ' GLN . 22.0 m -108.26 141.26 23.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 116.908 0.354 . . . . 63.340000000000003 110.592 178.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 615' ' ' ASN . . . . . 0.589 ' HA ' ' HG2' ' A' ' 560' ' ' GLN . 41.3 p30 -51.57 173.15 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.219 1.562 . . . . 72.530000000000001 115.219 -177.758 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 616' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -60.91 -25.21 66.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.059 -1.428 . . . . 70.010000000000005 112.289 178.161 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -85.63 -11.1 54.72 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.2 -1.037 . . . . 75.120000000000005 108.2 -178.036 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 618' ' ' GLY . . . . . . . . . . . . . . . 66.46 15.12 63.31 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 115.44 -0.8 . . . . 63.43 112.639 168.178 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 619' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.72 125.55 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 122.056 0.932 . . . . 74.430000000000007 111.365 -167.885 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 620' ' ' ILE . . . . . 0.615 HG13 ' HE3' ' A' ' 563' ' ' MET . 0.0 OUTLIER -129.67 132.1 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.261 0 CA-C-N 114.193 -1.367 . . . . 72.420000000000002 109.466 -179.055 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 588' ' ' ASP . 74.7 m -104.33 122.45 45.47 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.935 -1.135 . . . . 65.310000000000002 107.935 178.364 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 622' ' ' LEU . . . . . 0.423 HD13 ' H ' ' A' ' 622' ' ' LEU . 0.0 OUTLIER -132.99 166.93 21.25 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.25 -0.432 . . . . 73.049999999999997 111.714 -176.177 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 623' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -127.11 136.43 52.12 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.921 -1.14 . . . . 70.310000000000002 107.921 175.616 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.48 ' CB ' ' HA ' ' A' ' 603' ' ' VAL . 3.3 p90 -142.35 165.44 27.41 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.788 -0.642 . . . . 52.229999999999997 110.969 -173.672 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 625' ' ' GLY . . . . . . . . . . . . . . . -80.66 150.54 31.34 Favored Glycine 0 N--CA 1.421 -2.35 0 N-CA-C 109.748 -1.341 . . . . 53.030000000000001 109.748 175.449 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 626' ' ' GLN . . . . . 0.593 ' HB3' ' HA ' ' A' ' 594' ' ' ASP . 7.3 tt0 . . . . . 0 C--N 1.275 -2.657 0 CA-C-O 117.949 -1.024 . . . . 54.530000000000001 108.582 -177.013 . . . . . . . . 1 1 . 1 stop_ save_